[
  {
    "id": "dfb0e89e26a81319f14ead7a62611acb",
    "content": "Republic of Ghana\nMinistry of Health\nGhana National Drugs Programme (GNDP).",
    "title": "Introduction",
    "section": "Introduction",
    "chunk_id": "0",
    "type": "section",
    "keywords": [
      "drugs",
      "republic",
      "ministry",
      "ghana",
      "programme",
      "health",
      "gndp",
      "national"
    ]
  },
  {
    "id": "42ecd78ca34e16c7c7dc1e7b916697cf",
    "content": "© 2017 Ministry of Health (GNDP) Ghana\nAll rights reserved. No part of this publication may be reproduced, stored in any retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording and/or otherwise, without prior written permission of the Ministry of Health. Essential Drugs List & National Formulary with Therapeutic Guidelines, 1st Edition, 1988\nEssential Drugs List & National Formulary with Therapeutic Guidelines, 2nd Edition, 1993\nEssential Drugs List & National Formulary with Therapeutic Guidelines, 3rd Edition, 1996\nStandard Treatment Guidelines, 4th Edition, 2000 Standard Treatment Guidelines, 5th Edition, 2004 Standard Treatment Guidelines, 6th Edition, 2010 Standard Treatment Guidelines, 7th Edition, 2017\nISBN 978-9988-2-5787-3\nFor all enquiries write to the publishers:\nGhana National Drugs Programme (GNDP)\nMinistry of Health\nP.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1",
    "type": "section",
    "keywords": [
      "stored",
      "essential",
      "ministry",
      "rights",
      "formulary",
      "health",
      "programme",
      "form",
      "national",
      "publication",
      "edition",
      "part",
      "enquiries",
      "mechanical",
      "permission",
      "write",
      "retrieval",
      "written",
      "reserved",
      "prior"
    ]
  },
  {
    "id": "1ab0295c7c2b5b4bf6a930c75dab1d2e",
    "content": "O. Box MB-582, Accra, Ghana, West Africa Tel: +233 (0) 30 2661 670/1\nFax: +233 (0) 30 2664 309\nE-mail:  Website:\nLegal Disclaimer\nCare has been taken to confirm the accuracy of the information presented and to describe generally accepted practices. However, the authors, editors and publishers are not responsible for errors and omissions or any consequences from application of the information in this booklet and make no warranty, expressed or implied, with respect to the content of the publication.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2",
    "type": "section",
    "keywords": [
      "information",
      "legal",
      "application",
      "generally",
      "booklet",
      "describe",
      "responsible",
      "editors",
      "publication",
      "website",
      "errors",
      "content",
      "mail",
      "accepted",
      "expressed",
      "africa",
      "implied",
      "accuracy",
      "publishers",
      "accra"
    ]
  },
  {
    "id": "a87eb3f9382fd76155797ac54868173f",
    "content": "Printed by:\nYamens Press Limited, P. O. Box AF 274, Accra Tel: 0302-223 222\nE-mail:\nCover Design:\nQ-elements Limited, Accra\nTel: 0302-719432, 0268-080618\nE-mail:\nPreface\txii\nAcknowledgement\txiii\nintroduction\t1\nHow to use this book\t2\nPrescribing for NHIS reimbursement\t3\nNotes on cost-effectiveness\t3\nReferral\t4\nAbbreviations\t4\nPrescription writing\t5\nDosing and medication based on Age and body weight in children\t7\nPharmacovigilance and Adverse Drug Event Reporting\t7\nImportant contacts\t8.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "3",
    "type": "section",
    "keywords": [
      "based",
      "important",
      "weight",
      "limited",
      "writing",
      "effectiveness",
      "elements",
      "abbreviations",
      "reporting",
      "acknowledgement",
      "press",
      "printed",
      "book",
      "body",
      "cover",
      "drug",
      "dosing",
      "contacts",
      "design",
      "mail"
    ]
  },
  {
    "id": "843137f09cac1a47dd0f2dc72fbfe612",
    "content": "Pain Originating from the Oesophagus\t28\nHaemorrhoids\t29.",
    "title": "Gastro-oesophageal Reflux Disease\t25",
    "section": "Gastro-oesophageal Reflux Disease\t25",
    "chunk_id": "4",
    "type": "section",
    "keywords": [
      "oesophagus",
      "haemorrhoids",
      "pain",
      "originating"
    ]
  },
  {
    "id": "3e23f20d15a2b2c8574081fa5a15b1e2",
    "content": "Amoebic Liver Access\t33\nJaundice\t35\nAcute Hepatitis\t37\nChronic Hepatitis\t38\nHepatic Encephalopathy\t42\nAscites\t46\nVomiting\t48\nHepatocellular Carcinoma\t53\nDrugs and the Liver\t55.",
    "title": "Chapter 2. Disorders of the Liver\t33",
    "section": "Chapter 2. Disorders of the Liver\t33",
    "chunk_id": "5",
    "type": "section",
    "keywords": [
      "vomiting",
      "chronic",
      "acute",
      "hepatocellular",
      "drugs",
      "encephalopathy",
      "jaundice",
      "access",
      "carcinoma",
      "hepatitis",
      "liver",
      "ascites",
      "hepatic",
      "amoebic"
    ]
  },
  {
    "id": "92efc5177f8d5bf52451b3dc9f40763c",
    "content": "Plasma Cell Myeloma\t73\nLeukaemia\t75\nMalignant Lymphoma\t77.",
    "title": "Sickle Cell Disease\t69",
    "section": "Sickle Cell Disease\t69",
    "chunk_id": "6",
    "type": "section",
    "keywords": [
      "leukaemia",
      "lymphoma",
      "plasma",
      "malignant",
      "cell",
      "myeloma"
    ]
  },
  {
    "id": "963eb1d9c5274ab63af75875c4897f87",
    "content": "Immunisation\t80\nMeasles\t82\nPertussis\t84\nTetanus\t86\nPoliomyelitis\t89\nDiphtheria\t90\nYellow Fever\t92.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "7",
    "type": "section",
    "keywords": [
      "poliomyelitis",
      "yellow",
      "diphtheria",
      "tetanus",
      "fever",
      "immunisation",
      "measles",
      "pertussis"
    ]
  },
  {
    "id": "6607d1618777aa60d8728469fede292c",
    "content": "Sick newborn\t97\nNeonatal Hypoglycaemia\t100\nNeonatal Jaundice\t101\nBirth Injuries\t104\nNeonatal conjunctivitis\t106\nRetinoblastoma\t108\nWilms Tumour\t110.",
    "title": "Chapter 6.  Problems of the Newborn (Neonate)\t97",
    "section": "Chapter 6.  Problems of the Newborn (Neonate)\t97",
    "chunk_id": "8",
    "type": "section",
    "keywords": [
      "injuries",
      "neonatal",
      "conjunctivitis",
      "wilms",
      "sick",
      "jaundice",
      "newborn",
      "retinoblastoma",
      "birth",
      "tumour",
      "hypoglycaemia"
    ]
  },
  {
    "id": "e59f76e1cd840e18d8d6cc4f65f53010",
    "content": "Dyspnoea\t121\nDeep Vein Thrombosis (DVT)\t123\nPulmonary Embolism\t127\nStroke\t129\nHeart Failure\t134.",
    "title": "Ischaemic Heart Disease\t115",
    "section": "Ischaemic Heart Disease\t115",
    "chunk_id": "9",
    "type": "section",
    "keywords": [
      "dyspnoea",
      "deep",
      "stroke",
      "vein",
      "pulmonary",
      "thrombosis",
      "heart",
      "embolism",
      "failure"
    ]
  },
  {
    "id": "c0a7df495554c74423ca58ca6c1c9a8e",
    "content": "Hypercyanotic attack\t143\nPericarditis\t145\nHypertension\t146\nHypertension in children and adolescents\t151\nHypertension in Pregnancy\t154\nHypertensive Emergencies\t154\nArrhythmias\t156\nAcute Rheumatic Fever\t161\nDizziness and Blackouts\t164.",
    "title": "Congenital Heart Disease\t140",
    "section": "Congenital Heart Disease\t140",
    "chunk_id": "10",
    "type": "section",
    "keywords": [
      "hypertension",
      "adolescents",
      "attack",
      "blackouts",
      "fever",
      "dizziness",
      "emergencies",
      "arrhythmias",
      "pregnancy",
      "hypercyanotic",
      "children",
      "hypertensive",
      "acute",
      "rheumatic",
      "pericarditis"
    ]
  },
  {
    "id": "c5ed2eec9c12cd8346024608e0b0ec3a",
    "content": "Common Cold\t167\nPneumonia\t169\nBronchial Asthma\t175\nAcute Bronchitis\t180\nChronic Bronchitis\t183\nBronchiectasis\t187\nLung Abscess\t189.",
    "title": "Chapter 8. Disorders of the Respiratory System\t167",
    "section": "Chapter 8. Disorders of the Respiratory System\t167",
    "chunk_id": "11",
    "type": "section",
    "keywords": [
      "abscess",
      "chronic",
      "bronchial",
      "pneumonia",
      "common",
      "asthma",
      "bronchiectasis",
      "bronchitis",
      "acute",
      "lung",
      "cold"
    ]
  },
  {
    "id": "440d3072757147a3a11822a3150aa759",
    "content": "Headache\t193\nSeizures\t196\nEpilepsy\t200\nThe Unconscious Patient\t203.",
    "title": "Chapter 9. Disorders of the Central Nervous System\t193",
    "section": "Chapter 9. Disorders of the Central Nervous System\t193",
    "chunk_id": "12",
    "type": "section",
    "keywords": [
      "epilepsy",
      "headache",
      "seizures",
      "unconscious",
      "patient"
    ]
  },
  {
    "id": "29f46f6b05560725a66d7d1b305b7daa",
    "content": "Attention Deficit Hyperactivity Disorder (ADHD)\t207\nThe Acutely Disturbed Patient\t209\nPsychogenic Seizures\t213\nTable of Contents\nInsomnia\t214\nDepression\t216\nSchizophrenia\t220\nBipolar Disorder\t226\nAlcohol Withdrawal Syndromes\t229\nAlcoholic Delirium Tremens\t231.",
    "title": "Chapter 10. Psychiatric Disorders\t207",
    "section": "Chapter 10. Psychiatric Disorders\t207",
    "chunk_id": "13",
    "type": "section",
    "keywords": [
      "schizophrenia",
      "hyperactivity",
      "seizures",
      "bipolar",
      "table",
      "acutely",
      "patient",
      "psychogenic",
      "insomnia",
      "alcohol",
      "attention",
      "delirium",
      "alcoholic",
      "disturbed",
      "tremens",
      "disorder",
      "adhd",
      "deficit",
      "syndromes",
      "contents"
    ]
  },
  {
    "id": "753291b79acf9f323fbe2c2641028d1c",
    "content": "Bacterial Skin infections\t245\nBoils\t245\nImpetigo\t246\nCellulitis and Erysipelas\t249\nBuruli Ulcer\t249\nYaws\t250\nFungal Skin infections\t252\nSuperficial Fungal Skin Infections\t252\nPityriasis Versicolor\t255\nViral Skin infections\t257\nHerpes Simplex Infections\t257\nHerpes Zoster Infections\t259\nChicken pox\t261\nNon-Specific Skin infections\t265\nLarge Chronic Ulcers\t265\nPruritus\t267\nUrticaria\t272\nReactive Erythema and Bullous Reaction\t274\nAcne Vulgaris\t276\nEczema\t279\nIntertrigo\t283.",
    "title": "Chapter 11. Disorders of the Skin\t245",
    "section": "Chapter 11. Disorders of the Skin\t245",
    "chunk_id": "14",
    "type": "section",
    "keywords": [
      "infections",
      "urticaria",
      "chicken",
      "ulcer",
      "eczema",
      "superficial",
      "cellulitis",
      "versicolor",
      "erythema",
      "erysipelas",
      "fungal",
      "large",
      "specific",
      "reaction",
      "herpes",
      "zoster",
      "simplex",
      "vulgaris",
      "chronic",
      "reactive"
    ]
  },
  {
    "id": "6251cf6977c5c62d5a411d5f27939657",
    "content": "Diabetes Mellitus\t287\nDiabetic Ketoacidosis\t293\nDiabetes in Pregnancy\t297.",
    "title": "Chapter 12. Endocrine and Metabolic Disorders\t287",
    "section": "Chapter 12. Endocrine and Metabolic Disorders\t287",
    "chunk_id": "15",
    "type": "section",
    "keywords": [
      "diabetes",
      "mellitus",
      "pregnancy",
      "diabetic",
      "ketoacidosis"
    ]
  },
  {
    "id": "08f7bcccc4c67239a67e260b69a4739b",
    "content": "Dyslipidaemia\t300\nGoitre\t302\nHypothyroidism\t303\nHyperthyroidism\t305\nAdrenal Insufficiency\t307\nCushing’s Syndrome\t310\nOverweight and Obesity\t311.",
    "title": "Treatment-Induced Hypoglycaemia\t298",
    "section": "Treatment-Induced Hypoglycaemia\t298",
    "chunk_id": "16",
    "type": "section",
    "keywords": [
      "cushing",
      "overweight",
      "dyslipidaemia",
      "hypothyroidism",
      "goitre",
      "obesity",
      "adrenal",
      "syndrome",
      "insufficiency",
      "hyperthyroidism"
    ]
  },
  {
    "id": "4b68ccb5b5bbba3b75df44989f3fda45",
    "content": "Hyperemesis Gravidarum\t322\nHypertension in Pregnancy\t323\nPre-eclampsia\t325\nSevere Pre-Eclampsia and Imminent Eclampsia\t326\nEclampsia\t328\nMalaria in Pregnancy\t331\nAnaemia in Pregnancy\t331.",
    "title": "Antenatal Care\t314",
    "section": "Antenatal Care\t314",
    "chunk_id": "17",
    "type": "section",
    "keywords": [
      "gravidarum",
      "hypertension",
      "severe",
      "eclampsia",
      "anaemia",
      "hyperemesis",
      "pregnancy",
      "imminent",
      "malaria"
    ]
  },
  {
    "id": "83c4dd90675627c8b94667c353750b87",
    "content": "Jaundice in Pregnancy\t343\nPost-Partum Haemorrhage\t344\nPost-Partum Pyrexia\t349\nAnalgesia in Labour\t352\nPreterm Labour in Premature Delivery\t354\nPremature Rupture of the Membranes\t356.",
    "title": "Cardiac Disease in Pregnancy\t341",
    "section": "Cardiac Disease in Pregnancy\t341",
    "chunk_id": "18",
    "type": "section",
    "keywords": [
      "post",
      "preterm",
      "analgesia",
      "jaundice",
      "pyrexia",
      "premature",
      "labour",
      "rupture",
      "membranes",
      "pregnancy",
      "partum",
      "haemorrhage",
      "delivery"
    ]
  },
  {
    "id": "2e3671ca988efec2538f31712675fc41",
    "content": "Dysmenorrhoea\t358\nAbortion\t359\nAbnormal Vaginal Bleeding\t371\nAbnormal Vaginal Discharge\t373\nAcute Lower Abdominal Pain\t379\nFemale Infertility\t382\nMenopause\t384\nCarcinoma of the Cervix\t386.",
    "title": "Chapter 14. Gynaecological Disorders\t358",
    "section": "Chapter 14. Gynaecological Disorders\t358",
    "chunk_id": "19",
    "type": "section",
    "keywords": [
      "abdominal",
      "infertility",
      "pain",
      "dysmenorrhoea",
      "female",
      "bleeding",
      "menopause",
      "cervix",
      "abnormal",
      "lower",
      "discharge",
      "carcinoma",
      "acute",
      "vaginal",
      "abortion"
    ]
  },
  {
    "id": "14a19c3f19c1a98e254216788d8835b5",
    "content": "Acute Glomerulonephritis\t388\nNephrotic Syndrome\t390\nAcute Kidney Injury\t392.",
    "title": "Chapter 15. Disorders of the Kidney and Genitourinary System\t388",
    "section": "Chapter 15. Disorders of the Kidney and Genitourinary System\t388",
    "chunk_id": "20",
    "type": "section",
    "keywords": [
      "kidney",
      "injury",
      "nephrotic",
      "syndrome",
      "acute",
      "glomerulonephritis"
    ]
  },
  {
    "id": "7e3184f51f1591538d04938acf6d27df",
    "content": "Urinary Tract Infection\t401\nMedicines and the Kidney\t403\nAcute Cystitis\t406\nBenign Prostatic Hyperplasia\t408\nBacterial Prostatitis\t410\nScrotal Masses\t413\nThe Empty Scrotum\t414\nPriapism\t416\nPosterior Urethral Valves\t417\nUrinary Tract Calculi\t419\nUrethral Stricture\t421\nVasectomy (Male Sterilisation)\t422\nAcute Epididymo-orchitis\t423\nTesticular Torsion (Torsion of Spermatic Cord)\t425\nFournier’s Gangrene\t427\nBladder Cancer\t429\nCarcinoma of Prostate\t431\nErectile Dysfunction\t433\nMale Infertility\t435\nHaematuria\t437\nUrinary Schistosomiasis\t439\nPersistent or Recurrent Urethral Discharge\t440\nRetention of Urine\t440.",
    "title": "Anaemia in Chronic Kidney Disease\t399",
    "section": "Anaemia in Chronic Kidney Disease\t399",
    "chunk_id": "21",
    "type": "section",
    "keywords": [
      "urethral",
      "torsion",
      "recurrent",
      "empty",
      "valves",
      "fournier",
      "dysfunction",
      "prostatic",
      "spermatic",
      "urine",
      "scrotal",
      "acute",
      "masses",
      "prostate",
      "scrotum",
      "calculi",
      "gangrene",
      "carcinoma",
      "erectile",
      "prostatitis"
    ]
  },
  {
    "id": "9304724b6f4c8aca1e8bd40f59dc1eab",
    "content": "Sexually Transmitted Infections in Adults\t442\nSTI-related Urethral Discharge in Males\t443\nMycoplasma genitalum\t443\nSTI-related Persistent or Recurrent Urethral Discharge\t444\nSTI-related Vaginal Discharge\t445\nSTI-related Lower Abdominal Pain in Women\t447\nSTI-related Genital Ulcer\t448\nSTI-related Scrotal Swelling\t450\nTable of Contents\nSTI-related Inguinal Bubo. 451\nSTI-related Genital Warts\t452\nSTI-related Ano-rectal Related Syndromes\t453\nSexually Transmitted Infections in Children\t455\nSTI-related Neonatal Conjunctivitis (Opthalmia Neonatorum)\t455\nManagement of specific STi and STi syndromes in children\t456\nSTI-related Urethral Discharge Syndrome in Children\t456\nSTI-related Vaginal Discharge Syndromes in Children\t456.",
    "title": "Chapter 16. Sexually Transmitted infections\t442",
    "section": "Chapter 16. Sexually Transmitted infections\t442",
    "chunk_id": "22",
    "type": "section",
    "keywords": [
      "infections",
      "urethral",
      "inguinal",
      "recurrent",
      "management",
      "ulcer",
      "males",
      "swelling",
      "table",
      "scrotal",
      "vaginal",
      "abdominal",
      "rectal",
      "genitalum",
      "sexually",
      "specific",
      "neonatorum",
      "children",
      "genital",
      "warts"
    ]
  },
  {
    "id": "7f86a62e56549a98846016ecb9c6c05d",
    "content": "STI-related Genital Ulcer Syndrome in Children\t458\nSTI-related Ano-Rectal Related Syndromes in Children\t459\nHIV Infection and AIDS\t461.",
    "title": "STI-related Lower Abdominal Pain or Pelvic Inflammatory Disease Syndrome in Children\t457",
    "section": "STI-related Lower Abdominal Pain or Pelvic Inflammatory Disease Syndrome in Children\t457",
    "chunk_id": "23",
    "type": "section",
    "keywords": [
      "rectal",
      "syndromes",
      "infection",
      "ulcer",
      "aids",
      "syndrome",
      "children",
      "genital",
      "related"
    ]
  },
  {
    "id": "1f9dd8d48e280fb4dd38eaf2a0ec4bd6",
    "content": "Fever\t468\nTuberculosis\t471\nDrug resistant tuberculosis (DR-TB)\t476\nTyphoid Fever\t479\nMalaria\t482\nUncomplicated Malaria\t483\nSevere Malaria\t486\nMalaria in Pregnancy\t491\nSeasonal Malaria Chemoprevention (SMC)\t494\nMeningitis\t494\nWorm Infestation (Intestinal)\t498.",
    "title": "Chapter 18. infectious Diseases and infestations\t468",
    "section": "Chapter 18. infectious Diseases and infestations\t468",
    "chunk_id": "24",
    "type": "section",
    "keywords": [
      "severe",
      "typhoid",
      "chemoprevention",
      "meningitis",
      "infestation",
      "seasonal",
      "fever",
      "drug",
      "uncomplicated",
      "intestinal",
      "resistant",
      "worm",
      "tuberculosis",
      "pregnancy",
      "malaria"
    ]
  },
  {
    "id": "92897a5618934e9f8c20757dcaa40e2b",
    "content": "Neonatal Conjunctivitis\t503\nXerophthalmia\t503\nForeign body in the eye\t504\nRed Eye\t506\nGlaucoma\t508\nCataract\t510\nExposure Keratopathy\t511\nStrabismus\t512.",
    "title": "Chapter 19. Eye Disorders\t503",
    "section": "Chapter 19. Eye Disorders\t503",
    "chunk_id": "25",
    "type": "section",
    "keywords": [
      "glaucoma",
      "body",
      "xerophthalmia",
      "conjunctivitis",
      "neonatal",
      "cataract",
      "foreign",
      "strabismus",
      "exposure",
      "keratopathy"
    ]
  },
  {
    "id": "b1cc97747e812a5981eb516ca2f36bad",
    "content": "Stridor\t515\nAcute Epiglottitis\t519\nRetropharyngeal Abscess\t521\nPharyngitis and Tonsillitis\t523\nAcute Sinusitis\t526\nAcute Otitis Media\t529\nChronic Otitis Media\t531\nEpistaxis\t532.",
    "title": "Chapter 20. Ear, Nose and Throat Disorders\t515",
    "section": "Chapter 20. Ear, Nose and Throat Disorders\t515",
    "chunk_id": "26",
    "type": "section",
    "keywords": [
      "abscess",
      "chronic",
      "retropharyngeal",
      "stridor",
      "epiglottitis",
      "sinusitis",
      "epistaxis",
      "pharyngitis",
      "otitis",
      "tonsillitis",
      "media",
      "acute"
    ]
  },
  {
    "id": "58665b20bf21ae7192c95e887e2046da",
    "content": "Dental Caries\t534\nOral Candidiasis\t535\nAcute Necrotising Ulcerative Gingivitis\t536\nBacterial Endocarditis and Prophylaxis in Dentistry\t538.",
    "title": "Chapter 21. Oral and Dental Conditions\t534",
    "section": "Chapter 21. Oral and Dental Conditions\t534",
    "chunk_id": "27",
    "type": "section",
    "keywords": [
      "ulcerative",
      "candidiasis",
      "dentistry",
      "dental",
      "endocarditis",
      "bacterial",
      "caries",
      "prophylaxis",
      "oral",
      "necrotising",
      "acute",
      "gingivitis"
    ]
  },
  {
    "id": "a3fafb1b3de0c695a678f7ba109f2cdd",
    "content": "Acute Bacterial Sialoadenitis\t539\nLudwig’s Angina/Cervico-Facial Abscess\t540\nChronic Periodontal Infections\t543\nMouth Ulcers\t544\nOdontogenic Infections\t545\nOral Squamous Cell Carcinoma\t548\nTemporo-mandibular Joint dysfunction and masticatory muscle dysfunction\t549\nTrigerminal Neuralgia\t550.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "28",
    "type": "section",
    "keywords": [
      "infections",
      "dysfunction",
      "squamous",
      "acute",
      "abscess",
      "periodontal",
      "ludwig",
      "muscle",
      "angina",
      "joint",
      "neuralgia",
      "facial",
      "chronic",
      "mouth",
      "bacterial",
      "cervico",
      "sialoadenitis",
      "ulcers",
      "odontogenic",
      "mandibular"
    ]
  },
  {
    "id": "5b452d19f0b733155f9075f27c7b94cd",
    "content": "Osteoarthritis\t552\nRheumatoid arthritis\t554\nJuvenile Idiopathic Arthritis\t557\nBack pain\t560\nFibromyalgia\t563\nIdiopathic inflammatory myopathies\t568\nManagement of the Hot Swollen Joint\t570\nGout\t572\nPseudo-gout (chondrocalcinosis)\t575\nSystemic lupus erythematosus\t577.",
    "title": "Chapter 22. Disorders Of The Musculoskeletal System\t552",
    "section": "Chapter 22. Disorders Of The Musculoskeletal System\t552",
    "chunk_id": "29",
    "type": "section",
    "keywords": [
      "chondrocalcinosis",
      "rheumatoid",
      "idiopathic",
      "management",
      "pseudo",
      "systemic",
      "arthritis",
      "joint",
      "gout",
      "osteoarthritis",
      "back",
      "pain",
      "myopathies",
      "inflammatory",
      "lupus",
      "swollen",
      "fibromyalgia",
      "erythematosus",
      "juvenile"
    ]
  },
  {
    "id": "1821fb5c11efe3f13972c99fd95823b6",
    "content": "Head Injuries\t582\nAcute Abdomen\t585\nAbdominal Trauma\t588\nClosed Fractures\t590\nOpen Fractures\t592\nDislocations\t595\nAcute orthopaedic infections\t597\nChronic Osteomyelitis and Chronic Septic Arthritis\t601\nCellulitis\t604\nNecrotizing Fasciitis\t608\nHand Infections\t610\nTuberculosis in orthopaedics\t615\nRickets and Osteomalacia\t616\nScurvy\t618\nOsteoporosis\t619\nSickle-cell Vaso-occlusive Crisis\t620\nAvascular Necrosis\t621\nOsteogenesis Imperfecta\t623\nBurns\t624\nWounds\t630\nBites and Stings\t632\nShock\t641.",
    "title": "Chapter 23. Trauma And injuries\t582",
    "section": "Chapter 23. Trauma And injuries\t582",
    "chunk_id": "30",
    "type": "section",
    "keywords": [
      "infections",
      "injuries",
      "vaso",
      "stings",
      "necrotizing",
      "arthritis",
      "cellulitis",
      "acute",
      "occlusive",
      "open",
      "abdominal",
      "orthopaedics",
      "orthopaedic",
      "rickets",
      "osteogenesis",
      "burns",
      "crisis",
      "imperfecta",
      "hand",
      "chronic"
    ]
  },
  {
    "id": "6d02d73ed15746544970bffae2aa952f",
    "content": "Breast Cancer\t655\nGeneral Management of Poisoning\t657.",
    "title": "Chapter 27. Common Malignancies\t655",
    "section": "Chapter 27. Common Malignancies\t655",
    "chunk_id": "31",
    "type": "section",
    "keywords": [
      "breast",
      "cancer",
      "management",
      "poisoning",
      "general"
    ]
  },
  {
    "id": "a7808977694f6d147e06ad23aa17ccdb",
    "content": "Structured Approach to the Seriously Ill Child\t666\nForms\t671\nindex\t675.",
    "title": "Chapter 31. Structured Approach to the Seriously ill Child\t666",
    "section": "Chapter 31. Structured Approach to the Seriously ill Child\t666",
    "chunk_id": "32",
    "type": "section",
    "keywords": [
      "seriously",
      "approach",
      "structured",
      "forms",
      "child",
      "index"
    ]
  },
  {
    "id": "21ca02b4efbbfa2e4b72028cfb7443e4",
    "content": "list of Tables\nTable 0-1:\tTable of medical abbreviations for prescribing\t4\nTable 0-2:\tDosing and Medication based on body weight in children\t7\nTable 0-3:\tTable of important contacts and referral centres\t8\nTable 1-1:\tAssessment of degree of dehydration in children with diarrhoea\t12.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "33",
    "type": "section",
    "keywords": [
      "based",
      "important",
      "weight",
      "table",
      "abbreviations",
      "diarrhoea",
      "body",
      "dosing",
      "contacts",
      "children",
      "referral",
      "dehydration",
      "prescribing",
      "medication",
      "degree",
      "medical",
      "tables",
      "centres",
      "list",
      "assessment"
    ]
  },
  {
    "id": "33b18146e9be9c86f18c742c7b49a39a",
    "content": "Table 1-5:\tHelicobacter pylori Eradication Therapy\t24\nTable 2-1:\tPost-exposure management of healthcare workers after occupational exposure to Hepatitis B infection\t41\nTable 5-1:\tSchedule for routine Immunisation of children under 5 years\t80\nTable 6-1:\tMaintenance fluid requirement\t101\nTable 7-1:\tWell’s Score Interpretation for DVT\t124\nTable 7-2:\tWell’s Score Interpretation for PE\t127.",
    "title": "Table 1-4:\tTreatment by Fluid Therapy - Plan C\t18",
    "section": "Table 1-4:\tTreatment by Fluid Therapy - Plan C\t18",
    "chunk_id": "34",
    "type": "section",
    "keywords": [
      "years",
      "management",
      "table",
      "pylori",
      "eradication",
      "maintenance",
      "therapy",
      "under",
      "fluid",
      "schedule",
      "requirement",
      "occupational",
      "children",
      "workers",
      "routine",
      "post",
      "healthcare",
      "exposure",
      "immunisation",
      "hepatitis"
    ]
  },
  {
    "id": "5229666d3752126f89dc77136da8ab41",
    "content": "Table 7-4:\tNew York Heart Association (NYHA) Classification for Heart Failure. 134\nTable 10-1: Guide to pharmacological treatment of the unconscious patient. 204 Table 12-1: Regime for managing Diabetic Ketoacidosis in Adults\t295\nTable 12-2: Regime for managing Diabetic Ketoacidosis in Children\t296\nTable 13-1: Recommended schedule for Antenatal Visits for a Normal Healthy Woman\t315.",
    "title": "Table 7-3:\tTreatment flowchart for acute medical management of stroke\t132",
    "section": "Table 7-3:\tTreatment flowchart for acute medical management of stroke\t132",
    "chunk_id": "35",
    "type": "section",
    "keywords": [
      "york",
      "pharmacological",
      "guide",
      "managing",
      "unconscious",
      "table",
      "patient",
      "schedule",
      "association",
      "heart",
      "children",
      "diabetic",
      "treatment",
      "healthy",
      "regime",
      "classification",
      "adults",
      "visits",
      "nyha",
      "failure"
    ]
  },
  {
    "id": "4d13ecd84c6f95abe9cec7f8bcbf1848",
    "content": "Table 14-1: Dosage regimes for Mifepristone and Misoprostol for various gestational ages\t368\nTable 14-2: Misoprostol Uses and Dosage in Management of Pregnancy Complications\t369.",
    "title": "Table 13-2: Antenatal Care Protocol Chart\t320",
    "section": "Table 13-2: Antenatal Care Protocol Chart\t320",
    "chunk_id": "36",
    "type": "section",
    "keywords": [
      "ages",
      "various",
      "complications",
      "mifepristone",
      "management",
      "regimes",
      "dosage",
      "misoprostol",
      "uses",
      "table",
      "pregnancy",
      "gestational"
    ]
  },
  {
    "id": "34197d5f2332733b392d70dd45c0d803",
    "content": "Table 14-2: Summary of management of various stages of CKD\t399\nTable 14-3: Distinguishing between Torsion and Epididymo-orchitis\t426\nTable 14-4: Causes of Male Infertility\t435\nTable 17-1: Other baseline tests for HIV\t462.",
    "title": "Table 14-1: Stages of Chronic Kidney Disease\t396",
    "section": "Table 14-1: Stages of Chronic Kidney Disease\t396",
    "chunk_id": "37",
    "type": "section",
    "keywords": [
      "torsion",
      "various",
      "infertility",
      "summary",
      "management",
      "epididymo",
      "other",
      "male",
      "tests",
      "table",
      "between",
      "baseline",
      "stages",
      "orchitis",
      "causes",
      "distinguishing"
    ]
  },
  {
    "id": "5e8b09a7f2d67e350843a77546ac2e79",
    "content": "Table 17-5: Recommended Monitoring of Drug Toxicity & HIV Serology of Exposed Health Care Personnel\t467.",
    "title": "Table 17-4: Standard Treatment in special conditions for HIV-AIDS\t464",
    "section": "Table 17-4: Standard Treatment in special conditions for HIV-AIDS\t464",
    "chunk_id": "38",
    "type": "section",
    "keywords": [
      "monitoring",
      "recommended",
      "serology",
      "drug",
      "health",
      "table",
      "personnel",
      "exposed",
      "toxicity",
      "care"
    ]
  },
  {
    "id": "540afbea77270e8a56db3bb8ddd1c16e",
    "content": "Table 18-4: Dosing of Second-Line Medicines\t479\nTable 18-5: Artesunate + Amodiaquine co-blistered formulation (Regimen for ONCE DAILY DOSING)\t484\nTable 18-6: Artesunate + Amodiaquine co-blistered formulation (Regimen for TWICE DAILY DOSING)\t484\nTable 18-7: Artesunate and Amodiaquine Fixed Dose Combination (Standard Regimen, using the 3 available dosing strengths)\t484\nTable 18-8: Artemether and Lumefantrine (Dosing Regimen)\t485\nTable 18-9: Dihydroartemisinin and Piperaquine (Dosing Regimen)\t485\nTable 18-10: Dosing Regimen for Quinine IM Injection in young Children\t487.",
    "title": "Table 18-3: Treatment Protocol for Other Resistant Types\t478",
    "section": "Table 18-3: Treatment Protocol for Other Resistant Types\t478",
    "chunk_id": "39",
    "type": "section",
    "keywords": [
      "dihydroartemisinin",
      "table",
      "second",
      "twice",
      "formulation",
      "amodiaquine",
      "strengths",
      "dosing",
      "piperaquine",
      "combination",
      "injection",
      "children",
      "lumefantrine",
      "standard",
      "line",
      "artemether",
      "young",
      "medicines",
      "dose",
      "available"
    ]
  },
  {
    "id": "cfa4d9841eca4c1c3be8bb6314436e1a",
    "content": "Table 18-12: Approximate quantities for dilution\t490.",
    "title": "Table 18-11: Rectal Artesunate (Pre-Referral Treatment in Children)\t488",
    "section": "Table 18-11: Rectal Artesunate (Pre-Referral Treatment in Children)\t488",
    "chunk_id": "40",
    "type": "section",
    "keywords": [
      "dilution",
      "quantities",
      "table",
      "approximate"
    ]
  },
  {
    "id": "1ed8aae773f48f0f7ebdb0562e04bd6d",
    "content": "List of tables\nTable 19-1: Characterising Acute Red Eye with no history of injury\t506\nTable 19-2: Summary of the common types of Conjunctivitis and their management\t507\nTable 19-3: Characteristics of the various types of the common types of Glaucoma\t509\nTable 22-1: Recommendations for use of conventional immunosuppressive drugs\nin lupus\t580\nTable 23-1: Indication for use of Rabies Immunoglobulin and Rabies vaccine\t640\nTable 25-1: Choice of Antibiotics for prophylaxis\t648\nTable 28-1: Presentation of common Poisons and their Antidotes\t659\nList of Figures\nFig 7-1:  Flowchart: Angina Pectoris\t117\nFig 7-4:  Flowchart: Stroke\t132\nFig 7-5:  Flowchart: Heart Failure\t140\nFig 7-8:  Flowchart: Hypertension\t151\nFig 7-9:  Flowchart: Arrhythmias\t161\nFig 13-3: Flowchart: management of anaemia in pregnancy\t334\nFig 13-5: Flowchart: Post partum haemorrhage\t348\nFig 13-6: Flowchart: Postpartum pyrexia\t351\nFig 14-2: Flowchart: Abnormal Vaginal Discharge (Without Speculum)\t377\nFig 14-3: Flowchart: Vaginal Discharge with Speculum And Bimanual Examination. 378\nFig 14-5: Flowchart: Acute Lower Abdominal Pain\t381\nFig 22-2: Fibromyalgia tender points\t567.",
    "title": "Table 18-13: Summary of treatment options for Bacterial Meningitis\t498",
    "section": "Table 18-13: Summary of treatment options for Bacterial Meningitis\t498",
    "chunk_id": "41",
    "type": "section",
    "keywords": [
      "hypertension",
      "choice",
      "characterising",
      "types",
      "points",
      "antibiotics",
      "anaemia",
      "management",
      "characteristics",
      "conventional",
      "antidotes",
      "table",
      "pectoris",
      "acute",
      "bimanual",
      "vaginal",
      "abdominal",
      "speculum",
      "summary",
      "poisons"
    ]
  },
  {
    "id": "22ad78ee28d6ebde600221985db90d76",
    "content": "Preface\nStandard Treatment Guidelines (STGs) are systematically developed statements that assist healthcare providers in deciding on appropriate treatments for specific clinical problems. They usually reflect the consensus on the optimal treatment options within a health system and aim at beneficially influencing prescribing behaviour at all levels of care. Health systems, particularly in developing countries, are faced with growing health needs on one hand and limited resources on the other.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "42",
    "type": "section",
    "keywords": [
      "faced",
      "usually",
      "influencing",
      "providers",
      "limited",
      "optimal",
      "levels",
      "health",
      "within",
      "developing",
      "assist",
      "specific",
      "behaviour",
      "particularly",
      "reflect",
      "deciding",
      "treatment",
      "healthcare",
      "consensus",
      "growing"
    ]
  },
  {
    "id": "eb09871b867f5e260422e6e2a539b7ca",
    "content": "Policy makers at various levels are therefore engaged in designing cost- effective health interventions that ensure accessible and affordable quality care for all, in particular the poor and vulnerable groups. Inappropriate prescribing is one of the manifestations of irrational medication use behaviour. It occurs when medicines are not prescribed in accordance with guidelines that are based on scientific evidence to ensure safe, effective, and economic use.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "43",
    "type": "section",
    "keywords": [
      "safe",
      "ensure",
      "based",
      "makers",
      "irrational",
      "policy",
      "quality",
      "levels",
      "inappropriate",
      "health",
      "poor",
      "particular",
      "evidence",
      "therefore",
      "scientific",
      "interventions",
      "behaviour",
      "accordance",
      "affordable",
      "prescribing"
    ]
  },
  {
    "id": "561d709fb9941afc82c961322f90d651",
    "content": "STGs provide the tool for health care providers to give quality standardised care at affordable cost. For Ghana’s growing National Health Insurance Scheme, a standard treatment guideline is seen as a cost containment tool to ensure that inefficiencies, fraud and poly-pharmacy, often associated with Health Insurance Schemes, are minimised. Regular, objective and transparent reviews of STGs are very important because the development process is a continual effort and not limited to a one-time production.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "44",
    "type": "section",
    "keywords": [
      "fraud",
      "ensure",
      "providers",
      "important",
      "give",
      "often",
      "regular",
      "quality",
      "development",
      "limited",
      "seen",
      "health",
      "associated",
      "minimised",
      "national",
      "tool",
      "transparent",
      "process",
      "production",
      "containment"
    ]
  },
  {
    "id": "2a187277212a3bcb0306fd0a1c4d46b0",
    "content": "This process includes gaining acceptance of the concept and preparing the text for wide consultation and consensus building. This is to ensure that users identify with and collectively own the process of development. This document is the seventh edition of the Ministry of Health’s officially approved prescribers’ and dispensers’ guide for all levels of healthcare.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "45",
    "type": "section",
    "keywords": [
      "ensure",
      "guide",
      "development",
      "ministry",
      "levels",
      "health",
      "wide",
      "identify",
      "document",
      "consultation",
      "edition",
      "acceptance",
      "process",
      "prescribers",
      "seventh",
      "building",
      "officially",
      "concept",
      "consensus",
      "healthcare"
    ]
  },
  {
    "id": "2ea778d360bae4a114be21d5c281e98a",
    "content": "Great effort has been put into aligning the prevailing health insurance benefits package to this edition. The official release of this edition would be the e-copy, available at  edition is also available on compact disk. The Ministry of Health is particularly grateful to its development partners, experts, and other stakeholders for their continuous support to the health sector.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "46",
    "type": "section",
    "keywords": [
      "disk",
      "development",
      "ministry",
      "health",
      "release",
      "package",
      "into",
      "edition",
      "great",
      "support",
      "continuous",
      "sector",
      "particularly",
      "their",
      "effort",
      "prevailing",
      "experts",
      "benefits",
      "aligning",
      "also"
    ]
  },
  {
    "id": "8a5ed4dd07372ddc91765d9eb520de9e",
    "content": "I am confident that all users of this document would find this edition very useful. Hon. Kwaku Agyeman-Manu\nMinister for Health\nJune 2017\nAcknowledgement\nThe review of the Standard Treatment Guidelines and Essential Medicines List 2017 by the Ministry of Health with its agencies has been successfully completed as a result of the recommendations and contributions received from:\nMinistry of Health and its agencies.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "47",
    "type": "section",
    "keywords": [
      "completed",
      "find",
      "essential",
      "manu",
      "successfully",
      "confident",
      "ministry",
      "agencies",
      "june",
      "health",
      "acknowledgement",
      "document",
      "review",
      "edition",
      "result",
      "kwaku",
      "recommendations",
      "treatment",
      "agyeman",
      "standard"
    ]
  },
  {
    "id": "5fd8dd94609b7c5443ccfbd9db286ed1",
    "content": "Schools of Medicine and Pharmacy Executives\nGhana National Drugs Programme (GNDP)\nNational Medicines Selection Committee (NMSC).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "48",
    "type": "section",
    "keywords": [
      "medicine",
      "drugs",
      "executives",
      "pharmacy",
      "schools",
      "ghana",
      "medicines",
      "programme",
      "nmsc",
      "committee",
      "gndp",
      "selection",
      "national"
    ]
  },
  {
    "id": "fa95bc71f9b43195b523e0bb09ccc795",
    "content": "Co-opted experts\nNational Evidence Synthesis sub-group of NMSC\nEditorial Committee\nPublic Health Programmes\nContributors.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "49",
    "type": "section",
    "keywords": [
      "synthesis",
      "experts",
      "programmes",
      "contributors",
      "editorial",
      "nmsc",
      "public",
      "health",
      "committee",
      "opted",
      "group",
      "evidence",
      "national"
    ]
  },
  {
    "id": "538316be713fed4da1d56e6525c9b436",
    "content": "Supporting Development Partners\nThe Government of Ghana, through the National Medicine Policy, remains committed to ensuring the availability of and accessibility to, affordable and good quality medicines for all Ghanaians; and it is expected that these medicines would be used rationally. Achieving these objectives require a comprehensive strategy that not only includes supply and distribution, but also appropriate and thoughtful prescribing, dispensing and use of medicines. The Ministry of Health since 1983 has been publishing a list of Essential Drugs with Therapeutic Guidelines to aid the rational use of drugs.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "50",
    "type": "section",
    "keywords": [
      "medicine",
      "supply",
      "thoughtful",
      "essential",
      "development",
      "policy",
      "quality",
      "committed",
      "distribution",
      "dispensing",
      "ministry",
      "used",
      "objectives",
      "health",
      "ensuring",
      "accessibility",
      "national",
      "require",
      "publishing",
      "strategy"
    ]
  },
  {
    "id": "2e95bc49bafe61525836ebd97f98e353",
    "content": "This document has been reviewed in response to new knowledge on drugs and diseases and changes in the epidemiology of diseases in Ghana. The Ministry has also produced guidelines for specific disease control programmes, diseases and identifiable health providers. The Standard Treatment Guidelines have been prepared as a tool to assist and guide prescribers (including doctors, medical assistants, and midwives), pharmacists, dispensers, and other healthcare staff who prescribe at primary care facilities in providing quality care to patients.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "51",
    "type": "section",
    "keywords": [
      "programmes",
      "providers",
      "guide",
      "providing",
      "quality",
      "ministry",
      "health",
      "identifiable",
      "staff",
      "document",
      "primary",
      "diseases",
      "tool",
      "assist",
      "including",
      "prescribers",
      "facilities",
      "specific",
      "assistants",
      "patients"
    ]
  },
  {
    "id": "fb40871bc88904ea09965f7010adbcfb",
    "content": "The guidelines list the preferred treatments for common health problems experienced by people in the health system and were subjected to stakeholder discussions before being finalised to ensure that the opinion of the intended users were considered and incorporated. The guidelines are designed to be used as a guide to treatment choices and as a reference book to help in the overall management of patients, such as when to refer. The guidelines are meant for use at all levels within the health system, both public and private.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "52",
    "type": "section",
    "keywords": [
      "opinion",
      "ensure",
      "guide",
      "management",
      "both",
      "levels",
      "health",
      "help",
      "designed",
      "users",
      "book",
      "within",
      "private",
      "stakeholder",
      "public",
      "people",
      "being",
      "incorporated",
      "patients",
      "discussions"
    ]
  },
  {
    "id": "5d37377fda4e3a3d94e70a0a4b60a1bc",
    "content": "It is recognised that the treatment guidance detailed in this book may differ from current practice. It is emphasised that the choices described here have the weight of scientific evidence to support them, together with the collective opinion of a wide group of recognised national and international experts. The recommendations have been rated on the following basis:\nEvidence Rating A – requires at least one randomised control trial as part of a body of scientific literature of overall good quality and consistency addressing the specific recommendation.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "53",
    "type": "section",
    "keywords": [
      "opinion",
      "weight",
      "quality",
      "recognised",
      "wide",
      "addressing",
      "emphasised",
      "consistency",
      "evidence",
      "practice",
      "differ",
      "book",
      "together",
      "national",
      "scientific",
      "rated",
      "basis",
      "rating",
      "support",
      "following"
    ]
  },
  {
    "id": "7e4b5151efb3b8147a437339ca32a280",
    "content": "Evidence Rating B – requires the availability of well-conducted clinical studies but no randomised clinical trials on the topic of recommendation. Evidence Rating C – requires evidence obtained from expert committee reports or opinions and/or clinical experience of respected authorities. This indicates an absence of directly applicable clinical studies\nof good quality.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "54",
    "type": "section",
    "keywords": [
      "topic",
      "obtained",
      "trials",
      "quality",
      "respected",
      "conducted",
      "evidence",
      "indicates",
      "rating",
      "clinical",
      "applicable",
      "directly",
      "randomised",
      "availability",
      "authorities",
      "committee",
      "studies",
      "reports",
      "opinions",
      "requires"
    ]
  },
  {
    "id": "881c5186b2ffa2ed11d53ffb1198e19d",
    "content": "To use treatment other than those recommended here may have to be justified to colleagues, managers, or in law. The content of these treatment guidelines will undergo a process of continuous review. Comments or suggestions for improvement are welcome.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "55",
    "type": "section",
    "keywords": [
      "colleagues",
      "managers",
      "welcome",
      "review",
      "process",
      "continuous",
      "content",
      "treatment",
      "those",
      "justified",
      "guidelines",
      "undergo",
      "comments",
      "recommended",
      "suggestions",
      "other",
      "have",
      "these",
      "improvement"
    ]
  },
  {
    "id": "763f17be0904e4adc18a4daf3d969d19",
    "content": "Those comments or suggestions for addition of diseases should include evidence of prevalence as well as a draft treatment guideline using the format set out in this book. In the case of a request for a new drug or replacing a listed product with another product, the evidence base must be clearly defined and included with the request. These suggestions should be sent to: The Programme Manager\nGhana National Drugs Programme\nMinistry of Health\nPO Box MB 582\nAccra, Ghana West Africa\nWebsite:\nTo use these guidelines effectively, it is important that you become familiar with the contents.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "56",
    "type": "section",
    "keywords": [
      "sent",
      "replacing",
      "important",
      "ministry",
      "programme",
      "health",
      "request",
      "prevalence",
      "draft",
      "clearly",
      "evidence",
      "addition",
      "national",
      "book",
      "diseases",
      "website",
      "base",
      "drug",
      "guideline",
      "familiar"
    ]
  },
  {
    "id": "4fb8c431340bcf01e035cc1084eeb48b",
    "content": "Take time to read the book and understand the content and layout. The contents of this book have been arranged in approximately alphabetical order of ‘body systems’. Within each section, a number of disease states, which are significant in Ghana have been identified.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "57",
    "type": "section",
    "keywords": [
      "read",
      "which",
      "book",
      "body",
      "within",
      "section",
      "content",
      "identified",
      "alphabetical",
      "number",
      "disease",
      "each",
      "approximately",
      "layout",
      "arranged",
      "states",
      "order",
      "significant",
      "contents",
      "ghana"
    ]
  },
  {
    "id": "7e0e8e0f2feb362130108326dd67b5c9",
    "content": "For each of these disease states the structuring of the information and guidance has been standardised to include a brief description of the condition or disease and the more common signs and symptoms. In each case the objectives of treatment have been set out, followed by recommended non-pharmacological as well as the pharmacological treatment choices. The choice of treatment guidance used here is based on the principles of ‘evidence based medicine’.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "58",
    "type": "section",
    "keywords": [
      "choice",
      "pharmacological",
      "medicine",
      "based",
      "information",
      "used",
      "objectives",
      "evidence",
      "brief",
      "signs",
      "condition",
      "guidance",
      "choices",
      "treatment",
      "followed",
      "disease",
      "include",
      "principles",
      "description",
      "each"
    ]
  },
  {
    "id": "2607d17a0972c6d9010f429d1d59cc56",
    "content": "That is, it is based on the international medical and pharmaceutical literature, which clearly demonstrates the efficacy of the treatment choices. The treatment guidelines try to take the user through a sequence of diagnosis, treatment, treatment objectives, and choice of treatment\nintroduction\nand review of outcome. Prescribers are strongly recommended to adopt a similar approach to practice.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "59",
    "type": "section",
    "keywords": [
      "choice",
      "based",
      "efficacy",
      "outcome",
      "which",
      "objectives",
      "clearly",
      "review",
      "sequence",
      "prescribers",
      "pharmaceutical",
      "choices",
      "treatment",
      "literature",
      "diagnosis",
      "strongly",
      "similar",
      "international",
      "medical",
      "recommended"
    ]
  },
  {
    "id": "aeac09ce626b656596100ba03f63c11f",
    "content": "Care should be taken to avoid symptomatic management of uncertain diagnoses. When treating patients, the final responsibility for the well-being of the individual patient remains with the prescriber. Prescribers must take steps to ensure that they are competent to manage the most common conditions presenting at their practice and familiarise themselves particularly with those aspects of the treatment guidelines relating to those conditions.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "60",
    "type": "section",
    "keywords": [
      "avoid",
      "ensure",
      "aspects",
      "treating",
      "management",
      "familiarise",
      "presenting",
      "responsibility",
      "themselves",
      "patient",
      "prescriber",
      "individual",
      "prescribers",
      "patients",
      "being",
      "competent",
      "most",
      "their",
      "particularly",
      "relating"
    ]
  },
  {
    "id": "6e30a643c2df9b8eb72374d736e4fd58",
    "content": "It is important to remember that the guidance given in this book is based on the assumption that the prescriber is competent to handle patients at this level, including the availability of diagnostic tests and monitoring equipment. This edition uses the Recommended International Non-Proprietary Name (rINN) in line with WHO recommendations and practice. In most cases, the British Approved Name (BAN) and rINN are similar but in a few instances there are differences.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "61",
    "type": "section",
    "keywords": [
      "remember",
      "monitoring",
      "instances",
      "differences",
      "important",
      "based",
      "given",
      "diagnostic",
      "book",
      "prescriber",
      "british",
      "edition",
      "including",
      "rinn",
      "competent",
      "patients",
      "guidance",
      "most",
      "availability",
      "recommendations"
    ]
  },
  {
    "id": "74f6004af9726e09a7fdc5253759b3e3",
    "content": "Where these differences occur, the BAN has been put in parentheses to permit easy reference. The National Health Insurance Scheme (NHIS) operates with a defined benefits package and reimburses healthcare providers for services rendered to its members according to the treatment protocols outlined in the STG. It is important for prescribers to be adept with the benefit package and also with the operational manuals of the scheme to ensure members benefit appropriately and facilities receive full payment for services rendered.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "62",
    "type": "section",
    "keywords": [
      "differences",
      "important",
      "providers",
      "parentheses",
      "occur",
      "according",
      "ensure",
      "rendered",
      "protocols",
      "health",
      "full",
      "package",
      "national",
      "operational",
      "appropriately",
      "prescribers",
      "facilities",
      "where",
      "benefit",
      "easy"
    ]
  },
  {
    "id": "b8648650aa2998f20c6f5df296703f8f",
    "content": "The Tariff Operational Manual and the NHIS Medicines List (NHIS ML) are important reference documents for service providers. They indicate the individual conditions that are covered, the medicines available on the scheme’s formulary and the tariffs to be used for billing. Prescribers must note that for every condition that is covered, there are medicines listed in the NHIS ML in line with the STG recommendations.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "63",
    "type": "section",
    "keywords": [
      "important",
      "providers",
      "billing",
      "formulary",
      "documents",
      "covered",
      "individual",
      "service",
      "prescribers",
      "note",
      "condition",
      "recommendations",
      "manual",
      "nhis",
      "line",
      "medicines",
      "there",
      "available",
      "every",
      "scheme"
    ]
  },
  {
    "id": "89d3deb9abb1e32e8db9688fc5008ffd",
    "content": "In addition, the NHIS ML states the level of prescribing attached to each medicine as indicated in the Essential Medicines List of the MOH. Medicines should be prescribed by the generic names on the ML and prescribers must indicate the quantity of medicines to be supplied on the prescription. This is a normal requirement for prescribing and will be very helpful in claims processing for reimbursement.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "64",
    "type": "section",
    "keywords": [
      "medicine",
      "essential",
      "generic",
      "addition",
      "attached",
      "requirement",
      "helpful",
      "prescribers",
      "supplied",
      "names",
      "claims",
      "quantity",
      "prescribing",
      "level",
      "nhis",
      "each",
      "should",
      "reimbursement",
      "medicines",
      "states"
    ]
  },
  {
    "id": "822b0267f8301cf9941d94e1337ece20",
    "content": "These guidelines also make provision for referral of patients to other health facilities. Patients should be referred when the prescriber is not able to manage the patient either through lack of personal experience or the availability of appropriate facilities. Patients should be referred, in accordance with agreed arrangements, to facilities where the necessary competence, diagnosis and support facilities exist.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "65",
    "type": "section",
    "keywords": [
      "either",
      "competence",
      "arrangements",
      "health",
      "personal",
      "patient",
      "prescriber",
      "lack",
      "support",
      "facilities",
      "provision",
      "where",
      "patients",
      "accordance",
      "availability",
      "referral",
      "diagnosis",
      "manage",
      "should",
      "also"
    ]
  },
  {
    "id": "d50b695ef383d8ddfc26c6fa4bbcbe42",
    "content": "The patient should be given a letter or note indicating the problem and what has been done so far, including laboratory tests and treatment. When indicated, emergency treatment must be given before referring the patient. It may also be necessary for the patient to be accompanied by a member of health staff and it should be remembered that the act of referral does not remove from the prescriber the responsibility for the well-being of the patient.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "66",
    "type": "section",
    "keywords": [
      "remembered",
      "given",
      "health",
      "responsibility",
      "patient",
      "staff",
      "member",
      "prescriber",
      "emergency",
      "including",
      "indicating",
      "being",
      "note",
      "referring",
      "treatment",
      "referral",
      "before",
      "should",
      "done",
      "also"
    ]
  },
  {
    "id": "69a7a6c24c88c1b5c6b538db2a4cac87",
    "content": "The following are abbreviations commonly used in general prescribing of medicines. While several of them may be found in this treatment guideline, it has not been necessary to use all of them in the text of this book. introduction\n* medicines written as p.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "67",
    "type": "section",
    "keywords": [
      "book",
      "treatment",
      "text",
      "several",
      "following",
      "prescribing",
      "introduction",
      "necessary",
      "medicines",
      "found",
      "written",
      "guideline",
      "abbreviations",
      "used",
      "while",
      "general",
      "commonly"
    ]
  },
  {
    "id": "1039d05668147b33ff1b71b90e62a6e8",
    "content": "o. or oral could be tablets, capsules, caplets, suspensions or syrups. Medicines should be prescribed only when they are necessary in treatment following a clear diagnosis.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "68",
    "type": "section",
    "keywords": [
      "caplets",
      "treatment",
      "diagnosis",
      "following",
      "tablets",
      "should",
      "necessary",
      "oral",
      "suspensions",
      "syrups",
      "medicines",
      "only",
      "clear",
      "capsules",
      "prescribed",
      "could"
    ]
  },
  {
    "id": "7e4f27f829154ab688d2eaf5a21dae8a",
    "content": "Not all patients need a prescription for a medicine; non-pharmacological treatment may be suitable and this has been highlighted in these guidelines. In all cases the benefit of administering the medicine should be considered in relation to the risk involved. This is particularly important during pregnancy where the risk to both mother and foetus must be considered.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "69",
    "type": "section",
    "keywords": [
      "medicine",
      "pharmacological",
      "suitable",
      "important",
      "administering",
      "both",
      "during",
      "mother",
      "involved",
      "highlighted",
      "need",
      "benefit",
      "where",
      "patients",
      "pregnancy",
      "particularly",
      "treatment",
      "relation",
      "should",
      "foetus"
    ]
  },
  {
    "id": "3bffc341d8fd0422eeafa9370456418a",
    "content": "Prescriptions should\nbe written legibly in ink or otherwise so as to be indelible\nbe written by the prescriber and not left for another person to.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "70",
    "type": "section",
    "keywords": [
      "prescriber",
      "person",
      "prescriptions",
      "indelible",
      "should",
      "legibly",
      "left",
      "written",
      "otherwise",
      "another"
    ]
  },
  {
    "id": "09b5fcbd5be011efff4dbffbcf4bf41d",
    "content": "complete\nbe dated\nstate the full name and address of the patient\nspecify the age and weight of the patient (especially in the case of children)\nbe signed in ink by the prescriber\nbear the contact details of the prescriber (e. g. name and telephone number)\nWhen writing a prescription the following should be noted:\nName of medicines and preparations should be written in full.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "71",
    "type": "section",
    "keywords": [
      "bear",
      "weight",
      "especially",
      "full",
      "complete",
      "patient",
      "prescriber",
      "following",
      "telephone",
      "preparations",
      "written",
      "children",
      "specify",
      "number",
      "should",
      "address",
      "state",
      "medicines",
      "dated",
      "contact"
    ]
  },
  {
    "id": "1331b01d2f2afcae5db1b8cb5fbb528a",
    "content": "Unofficial abbreviations should not be used because there is a high risk of misinterpretation. Non-proprietary (generic) names are given in the book and they\nshould always be used in prescribing\nAvoid the unnecessary use of decimal points, e. g.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "72",
    "type": "section",
    "keywords": [
      "avoid",
      "points",
      "given",
      "generic",
      "abbreviations",
      "book",
      "always",
      "names",
      "misinterpretation",
      "proprietary",
      "because",
      "prescribing",
      "should",
      "unnecessary",
      "there",
      "decimal",
      "unofficial",
      "high",
      "risk",
      "used"
    ]
  },
  {
    "id": "137b49e5e53ecd7124e6ac4be9cdb1fa",
    "content": "3 mg, not 3. 0 mg. Quantities of 1 gram or more should be written 1 g.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "73",
    "type": "section",
    "keywords": [
      "should",
      "gram",
      "more",
      "quantities",
      "written"
    ]
  },
  {
    "id": "c710e464ce97ddd2884046a836432545",
    "content": "Quantities less than 1 gram should be written in milligrams, e. g. 500 mg, and not 0.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "74",
    "type": "section",
    "keywords": [
      "milligrams",
      "should",
      "gram",
      "less",
      "quantities",
      "written"
    ]
  },
  {
    "id": "54e9b6712387d4db5bb142664c1c6129",
    "content": "5 g. Quantities less than 1mg should be written in micrograms, e. g.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "75",
    "type": "section",
    "keywords": [
      "should",
      "micrograms",
      "less",
      "quantities",
      "written"
    ]
  },
  {
    "id": "ab769375f39aa8c5055e79320f209142",
    "content": "100\nmicrogram, not 0. 1 mg. Where decimals are unavoidable a zero should be written in front of the decimal point where there is no other figure, e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "76",
    "type": "section",
    "keywords": [
      "unavoidable",
      "front",
      "microgram",
      "should",
      "other",
      "where",
      "point",
      "there",
      "written",
      "zero",
      "decimals",
      "figure",
      "decimal"
    ]
  },
  {
    "id": "ca415b68517f556039b54b9102afa748",
    "content": "5ml. ‘Micrograms’ and ‘nanograms’ should NOT be abbreviated. Similarly, ‘units’ should NOT be abbreviated.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "77",
    "type": "section",
    "keywords": [
      "abbreviated",
      "units",
      "should",
      "similarly",
      "micrograms",
      "nanograms"
    ]
  },
  {
    "id": "948cf47a26a613ecc124caa3d0b08b18",
    "content": "Use the term ‘millilitre’ (ml or mL) NOT cubic centimetre (cc, or cm3). State dose and dose frequency. In the case of ‘as required’, a minimum dose interval should be specified, e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "78",
    "type": "section",
    "keywords": [
      "cubic",
      "term",
      "case",
      "interval",
      "should",
      "centimetre",
      "state",
      "minimum",
      "dose",
      "specified",
      "required",
      "millilitre",
      "frequency"
    ]
  },
  {
    "id": "544a3d398bebe25546dc7b419e2419ab",
    "content": "g. ‘every 4-6 hrs as required for pain’. State the quantity to be supplied or indicate the number of days of.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "79",
    "type": "section",
    "keywords": [
      "days",
      "pain",
      "number",
      "indicate",
      "supplied",
      "every",
      "state",
      "required",
      "quantity"
    ]
  },
  {
    "id": "386ed9ab104ca2b43d4fb56e57031aca",
    "content": "Write directions, preferably in English without abbreviation. It is recognised that some Latin abbreviations are used and these are detailed in the section on abbreviations. Do NOT use other abbreviations\nAvoid combination drugs, unless there is a significant therapeutic\nadvantage over single ingredient preparations (e.",
    "title": "treatment required.",
    "section": "treatment required.",
    "chunk_id": "80",
    "type": "section",
    "keywords": [
      "avoid",
      "abbreviation",
      "recognised",
      "used",
      "ingredient",
      "abbreviations",
      "english",
      "unless",
      "single",
      "section",
      "preparations",
      "write",
      "combination",
      "latin",
      "advantage",
      "preferably",
      "therapeutic",
      "there",
      "drugs",
      "detailed"
    ]
  },
  {
    "id": "8fa1fc1fbd315f72c8d8e4a2be6830d6",
    "content": "Avoid, where possible, the prescribing of placebos. Spend some time\neducating and reassuring the patient. Avoid multiple prescribing (polypharmacy), especially when the diagnosis is not clear.",
    "title": "Avoid the use of symptomatic treatments for minor self-limiting conditions.",
    "section": "Avoid the use of symptomatic treatments for minor self-limiting conditions.",
    "chunk_id": "81",
    "type": "section",
    "keywords": [
      "avoid",
      "multiple",
      "reassuring",
      "polypharmacy",
      "prescribing",
      "diagnosis",
      "placebos",
      "educating",
      "especially",
      "where",
      "possible",
      "clear",
      "spend",
      "patient"
    ]
  },
  {
    "id": "54c5ced24196d1b12e5b4522d571a52c",
    "content": "Avoid the use of the parenteral route of administration except where\nintroduction\nthere are clear, clinical indications for this route. Use the oral route whenever possible. * These figures relate to full term and not preterm infants.",
    "title": "Avoid the use of symptomatic treatments for minor self-limiting conditions.",
    "section": "Avoid the use of symptomatic treatments for minor self-limiting conditions.",
    "chunk_id": "82",
    "type": "section",
    "keywords": [
      "avoid",
      "parenteral",
      "full",
      "clear",
      "relate",
      "indications",
      "where",
      "except",
      "figures",
      "whenever",
      "infants",
      "there",
      "preterm",
      "term",
      "administration",
      "introduction",
      "oral",
      "possible",
      "route",
      "these"
    ]
  },
  {
    "id": "1e2e087211820699aca9deae9afd4b29",
    "content": "A reduced dosage may be required in preterm infants. The development of an undesirable medical condition such as a new symptom, sign, laboratory or other test alteration, deterioration of a pre-existing medical condition, disability or death during or following administration of a medicinal product (allopathic or herbal) or use of a medical device, or the lack of effect of the product, is considered an adverse event that needs to be reported, whether or not considered causally related to the product. Spontaneous, voluntary reporting of adverse events relating to the use of prescription only medicines and vaccines, over-the-counter medicines and medical devices is now generally considered a norm in many countries for healthcare professionals and consumers alike.",
    "title": "Avoid the use of symptomatic treatments for minor self-limiting conditions.",
    "section": "Avoid the use of symptomatic treatments for minor self-limiting conditions.",
    "chunk_id": "83",
    "type": "section",
    "keywords": [
      "alike",
      "vaccines",
      "test",
      "professionals",
      "development",
      "voluntary",
      "during",
      "generally",
      "undesirable",
      "alteration",
      "required",
      "reduced",
      "death",
      "medicinal",
      "herbal",
      "reporting",
      "effect",
      "devices",
      "following",
      "lack"
    ]
  },
  {
    "id": "e53851f0fcc48ed65734c3595c898c3f",
    "content": "For health professionals, the need to report adverse reactions to these products is also a moral and professional obligation. Although most medicines undergo rigorous safety monitoring during clinical trials before approval is given for their registration and use in any country, such trials have some limitations including the relatively small number of individuals involved. Post-marketing adverse drug event monitoring and reporting enables detection of less.",
    "title": "Avoid the use of symptomatic treatments for minor self-limiting conditions.",
    "section": "Avoid the use of symptomatic treatments for minor self-limiting conditions.",
    "chunk_id": "84",
    "type": "section",
    "keywords": [
      "monitoring",
      "professionals",
      "trials",
      "given",
      "during",
      "health",
      "registration",
      "report",
      "reporting",
      "marketing",
      "country",
      "limitations",
      "including",
      "involved",
      "drug",
      "need",
      "reactions",
      "safety",
      "most",
      "their"
    ]
  },
  {
    "id": "e1bd94e84646e4bda4ebf0f0f9a79eb0",
    "content": "commonly encountered, but potentially serious adverse events among a larger population. Older medicines and devices, with which healthcare practitioners may have experience with use, and newer ones with which they may not, can all give rise to adverse events in susceptible individuals. This edition of the Standard Treatment Guidelines, like the previous edition, includes copies of the Ghana Food and Drugs Authority (FDA) adverse reaction reporting form.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "85",
    "type": "section",
    "keywords": [
      "give",
      "which",
      "potentially",
      "form",
      "reporting",
      "serious",
      "devices",
      "encountered",
      "edition",
      "newer",
      "among",
      "population",
      "practitioners",
      "reaction",
      "previous",
      "ones",
      "treatment",
      "healthcare",
      "events",
      "standard"
    ]
  },
  {
    "id": "c397f8f275ea752f6633c97f9fa08fb7",
    "content": "Extra copies of the adverse reaction reporting form may be obtained from the FDA or through its Institutional Contact Persons at various health facilities throughout the country. Patients may also report directly through Patient Safety Centres in designated community pharmacies nationwide. Online submission of reports by both health professionals and patients can also be done through the SafetyWatch System at  or http:// fdaghana.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "86",
    "type": "section",
    "keywords": [
      "extra",
      "obtained",
      "institutional",
      "professionals",
      "designated",
      "both",
      "pharmacies",
      "health",
      "report",
      "form",
      "reporting",
      "patient",
      "country",
      "safetywatch",
      "facilities",
      "submission",
      "reaction",
      "directly",
      "patients",
      "safety"
    ]
  },
  {
    "id": "c863e622edeb4bf230f3578a9e0af857",
    "content": "gov. gh/adr/ or  An e-mail of a report may also be sent to the National Pharmacovigilance Centre at drug. safety@ fdaghana.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "87",
    "type": "section",
    "keywords": [
      "sent",
      "pharmacovigilance",
      "drug",
      "also",
      "centre",
      "safety",
      "mail",
      "fdaghana",
      "report",
      "national"
    ]
  },
  {
    "id": "398f3b96c0c7efa9e452fb35ab8afab2",
    "content": "gov. gh. A phone call to 0244 310 297 or to short code 4015\ncould be made for any assistance regarding drug safety issues.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "88",
    "type": "section",
    "keywords": [
      "issues",
      "call",
      "short",
      "made",
      "phone",
      "regarding",
      "drug",
      "assistance",
      "safety",
      "code",
      "could"
    ]
  },
  {
    "id": "e557b284a59e3a5a418e634a16530fa9",
    "content": "Assigning causality to each reported event is carried out by a committee of experts from several disciplines in medicine and pharmacy and others representing the pharmaceutical industry and consumer interests, selected by the FDA. The process is anonymous and handled with the strictest confidence and is linked to a World Health Organization pharmacovigilance system. The early identification of warning signals for a particular product from adverse event reporting and pharmacovigilance activities enables timely interventions to forestall any potential harm to the public.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "89",
    "type": "section",
    "keywords": [
      "interests",
      "medicine",
      "world",
      "handled",
      "industry",
      "confidence",
      "health",
      "potential",
      "particular",
      "reporting",
      "strictest",
      "disciplines",
      "others",
      "forestall",
      "process",
      "pharmaceutical",
      "public",
      "interventions",
      "anonymous",
      "assigning"
    ]
  },
  {
    "id": "2690bb8ede62806945b18d398aee8349",
    "content": "Ghana National Drugs Programme Comments and suggestions should be sent to: The Programme Manager\nGhana National Drugs Programme\nMinistry of Health\nP. O. Box MB-582, Accra, Ghana Telephone number: (0) 302-661 670/1\nFax number: (0) 302-664 309 E-mail:  Website:.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "90",
    "type": "section",
    "keywords": [
      "comments",
      "sent",
      "drugs",
      "website",
      "suggestions",
      "should",
      "ministry",
      "telephone",
      "ghana",
      "programme",
      "health",
      "manager",
      "mail",
      "accra",
      "number",
      "national"
    ]
  },
  {
    "id": "3e7c6979f6ead9238e601052f3934982",
    "content": "Diarrhoea is defined as the passage of frequent, loose, watery stools 3 or more times a day. Diarrhoea may be accompanied by vomiting. In children, the commonest cause is viral.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "91",
    "type": "section",
    "keywords": [
      "diarrhoea",
      "passage",
      "vomiting",
      "commonest",
      "loose",
      "stools",
      "accompanied",
      "watery",
      "cause",
      "times",
      "more",
      "children",
      "viral",
      "defined",
      "frequent"
    ]
  },
  {
    "id": "c83c5534985e91d165f82cb6e09d219e",
    "content": "There is therefore usually no need to prescribe antibiotics. Other diseases like malaria, pneumonia, ear infections and urinary tract infections, may be associated with diarrhoea. Fluid loss occurs quickly in this age group because of their size.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "92",
    "type": "section",
    "keywords": [
      "infections",
      "usually",
      "antibiotics",
      "associated",
      "fluid",
      "diarrhoea",
      "therefore",
      "diseases",
      "quickly",
      "need",
      "their",
      "malaria",
      "tract",
      "prescribe",
      "because",
      "pneumonia",
      "size",
      "there",
      "occurs",
      "other"
    ]
  },
  {
    "id": "cd3aded7c62cba10ab5990f3b3647d87",
    "content": "If not corrected, it may result in dehydration, which can be fatal. A complaint of diarrhoea should be taken seriously. Always ask about the frequency and the texture of the stools.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "93",
    "type": "section",
    "keywords": [
      "diarrhoea",
      "always",
      "about",
      "dehydration",
      "seriously",
      "taken",
      "result",
      "should",
      "stools",
      "fatal",
      "which",
      "texture",
      "corrected",
      "complaint",
      "frequency"
    ]
  },
  {
    "id": "58707226f1f173abd874db7a55a815a6",
    "content": "Giving antibiotics in all cases of diarrhoea may worsen or prolong the condition except in special circumstances (See section on ‘Causes’ below). Enemas and laxatives should not be given to patients with diarrhoea. Causes\nAcute diarrhoea (< 2 weeks)\nInfections\nViral: e.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "94",
    "type": "section",
    "keywords": [
      "infections",
      "giving",
      "antibiotics",
      "given",
      "special",
      "acute",
      "diarrhoea",
      "laxatives",
      "section",
      "except",
      "patients",
      "condition",
      "weeks",
      "causes",
      "should",
      "viral",
      "below",
      "prolong",
      "circumstances",
      "worsen"
    ]
  },
  {
    "id": "1e3a17ffacda6fd78d580bd642b06ec3",
    "content": "Salmonella spp. , Shigella, Campylobacter, E. coli, Vibrio cholerae\nProtozoal: e.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "95",
    "type": "section",
    "keywords": [
      "vibrio",
      "cholerae",
      "salmonella",
      "protozoal",
      "coli",
      "shigella",
      "campylobacter"
    ]
  },
  {
    "id": "26efa23019792a59a254412a9dc72c66",
    "content": "g. Entamoeba histolytica (amoebiasis)\nDrug-induced: e. g.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "96",
    "type": "section",
    "keywords": [
      "entamoeba",
      "amoebiasis",
      "drug",
      "histolytica",
      "induced"
    ]
  },
  {
    "id": "37687859283fe90fcce9055a45a3063b",
    "content": "penicillins\nChronic diarrhoea (> 2 weeks)\nChronic infections: e. g. amoebiasis, tuberculosis, opportunistic infections with HIV\nFunctional: e.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "97",
    "type": "section",
    "keywords": [
      "diarrhoea",
      "infections",
      "chronic",
      "functional",
      "amoebiasis",
      "penicillins",
      "tuberculosis",
      "opportunistic",
      "weeks"
    ]
  },
  {
    "id": "30d20752df13d9604b5cfc509d34b207",
    "content": "Malabsorption syndromes: e. g. chronic pancreatitis\nMalignancy: e.",
    "title": "Inflammatory: e.g. ulcerative colitis, Crohn’s disease",
    "section": "Inflammatory: e.g. ulcerative colitis, Crohn’s disease",
    "chunk_id": "98",
    "type": "section",
    "keywords": [
      "malignancy",
      "chronic",
      "pancreatitis",
      "malabsorption",
      "syndromes"
    ]
  },
  {
    "id": "7ab2faae26e146354b1830d91055effa",
    "content": "hyperthyroidism, diabetic autonomic neuropathy\nDrug-induced: e. g. laxatives, NSAIDs\nSymptoms\nFrequent watery stools\nBlood or mucus in the stool.",
    "title": "Inflammatory: e.g. ulcerative colitis, Crohn’s disease",
    "section": "Inflammatory: e.g. ulcerative colitis, Crohn’s disease",
    "chunk_id": "99",
    "type": "section",
    "keywords": [
      "laxatives",
      "blood",
      "nsaids",
      "mucus",
      "neuropathy",
      "symptoms",
      "drug",
      "stools",
      "watery",
      "induced",
      "stool",
      "diabetic",
      "autonomic",
      "hyperthyroidism",
      "frequent"
    ]
  },
  {
    "id": "67ff810dbb5e49c0d1101cf1921a50cd",
    "content": "Presence of fever\nReduced urine output\nAssociated vomiting\nSigns Adults\nAnaemia\nWeight loss\nAnorexia\nOral lesions e. g. oral ulcers, candidiasis\nSkin lesions e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "100",
    "type": "section",
    "keywords": [
      "vomiting",
      "anorexia",
      "candidiasis",
      "weight",
      "anaemia",
      "lesions",
      "output",
      "fever",
      "adults",
      "oral",
      "skin",
      "urine",
      "associated",
      "presence",
      "reduced",
      "signs",
      "loss",
      "ulcers"
    ]
  },
  {
    "id": "8249b0e468caabac3c215feb70f35c65",
    "content": "g. erythema nodosum\nSigns of dehydration (dry mucous membranes, reduction in skin turgor, capillary refill > 2 seconds, tachycardia, postural hypotension)\nEnlarged thyroid\nAbdominal masses\nRectal mass\nThe following table can be used to assess the degree of dehydration in children with diarrhoea:\nAssessment of degree of dehydration in children with diarrhoea.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "101",
    "type": "section",
    "keywords": [
      "turgor",
      "membranes",
      "assessment",
      "table",
      "postural",
      "tachycardia",
      "masses",
      "capillary",
      "diarrhoea",
      "erythema",
      "abdominal",
      "rectal",
      "following",
      "mucous",
      "assess",
      "signs",
      "children",
      "nodosum",
      "dehydration",
      "reduction"
    ]
  },
  {
    "id": "e6d80ad788ac77775edd014188c3bd3f",
    "content": "Assessment of degree of dehydration in children with diarrhoea\nAdapted from Integrated Management of Childhood Illnesses, WHO\ninvestigations\nFBC\nBlood film for malaria parasites\nStool routine examination\nStool for culture and sensitivity\nBlood urea and creatinine.",
    "title": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "section": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "chunk_id": "102",
    "type": "section",
    "keywords": [
      "urea",
      "management",
      "assessment",
      "sensitivity",
      "diarrhoea",
      "creatinine",
      "film",
      "childhood",
      "integrated",
      "culture",
      "children",
      "malaria",
      "blood",
      "routine",
      "dehydration",
      "investigations",
      "stool",
      "degree",
      "adapted",
      "illnesses"
    ]
  },
  {
    "id": "4d77fba559201f81e6f6a08310de9b91",
    "content": "To prevent dehydration\nTo replace lost fluid\nTo maintain nutrition by ensuring adequate dietary intake during\nillness\nTo maintain personal hygiene\nTo eliminate infecting organisms where appropriate.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "103",
    "type": "section",
    "keywords": [
      "during",
      "infecting",
      "personal",
      "ensuring",
      "fluid",
      "replace",
      "nutrition",
      "prevent",
      "dietary",
      "where",
      "eliminate",
      "intake",
      "dehydration",
      "organisms",
      "hygiene",
      "appropriate",
      "lost",
      "maintain",
      "illness",
      "adequate"
    ]
  },
  {
    "id": "cdf6bbabc8d2c986e3c9dfed8e16d2ac",
    "content": "Keep surroundings clean\nImprove personal hygiene e. g. hand washing after toilet\nAdequate fluid intake - oral and intravenous as necessary (See section on ‘Fluid management for children with diarrhoea’)\nMaintain adequate nutrition as can be tolerated.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "104",
    "type": "section",
    "keywords": [
      "improve",
      "intravenous",
      "management",
      "surroundings",
      "personal",
      "tolerated",
      "fluid",
      "diarrhoea",
      "nutrition",
      "toilet",
      "section",
      "intake",
      "children",
      "hand",
      "keep",
      "hygiene",
      "clean",
      "washing",
      "maintain",
      "necessary"
    ]
  },
  {
    "id": "7032e4c6b229f6a6f7f2a1201485b1c5",
    "content": "Bacterial gastroenteritis (fever, abdominal cramps, blood and\nmucus in stools).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "105",
    "type": "section",
    "keywords": [
      "abdominal",
      "mucus",
      "fever",
      "bacterial",
      "stools",
      "cramps",
      "gastroenteritis",
      "blood"
    ]
  },
  {
    "id": "917d04cc5e4689a9f2d169a1abcd5872",
    "content": "Ciprofloxacin, oral,\nAdults\n500 mg 12 hourly for 5 days Children (for all child age groups) 15 mg/kg 12 hourly for 5 days.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "106",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "adults",
      "oral",
      "child",
      "groups",
      "children",
      "ciprofloxacin"
    ]
  },
  {
    "id": "970c3db2856bf8d4010624e778f77f7a",
    "content": "Cefuroxime, IV,\nAdults\n750 mg 8 hourly\nChildren\n25 mg/kg body weight 12 hourly\nNeonates\n7 days;\t25 mg/kg body weight 8 hourly\n< 7 days;\t25 mg/kg body weight 12 hourly\nThen\nCefuroxime, oral,\nAdults\n250 mg 12 hourly for 5-7days\nChildren\n12-18 years;\t250 mg 12 hourly for 5-7 days\n2-12 years;\t15 mg/kg body weight for 5-7 days (max. 250 mg 12 hourly)\n3 months-2 years;\t10 mg/kg body weight for 5-7 days (max. 125 mg 12 hourly)\nAmoebic dysentery suspected (patient failing to respond to empirical treatment for bacterial gastroenteritis within 2 days or based on stool microscopy)\nEvidence Rating: [A]\nMetronidazole, oral,\nAdults\n800 mg 8 hourly for 5 days\nChildren.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "107",
    "type": "section",
    "keywords": [
      "metronidazole",
      "empirical",
      "years",
      "based",
      "neonates",
      "weight",
      "gastroenteritis",
      "patient",
      "evidence",
      "hourly",
      "body",
      "within",
      "microscopy",
      "rating",
      "failing",
      "respond",
      "children",
      "dysentery",
      "treatment",
      "days"
    ]
  },
  {
    "id": "c5e090a0614b4a7a0408077ed1ad7223",
    "content": "8-12 years;\t400 mg 8 hourly for 5 days\n4-7 years;\t200 mg 8 hourly for 5 days\n0-3 years;\t100 mg 8 hourly for 5 days\nCholera: profuse diarrhoea (rice water stool) + vomiting.",
    "title": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "section": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "chunk_id": "108",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "diarrhoea",
      "vomiting",
      "years",
      "rice",
      "cholera",
      "water",
      "profuse",
      "stool"
    ]
  },
  {
    "id": "00f9f752059e5354b17f06d29b362ade",
    "content": "Tetracycline, oral,\nAdults\n500 mg 6 hourly for 3 days\nChildren\nNot recommended\nOr\nDoxycycline, oral,\nAdults\n100 mg 12 hourly for 3 days\nChildren\nNot recommended\nOr\nErythromycin, oral,\nAdults\n500 mg 8 hourly for 5 days\nChildren\n13 years;\t500 mg 8 hourly for 5 days\n6-12 years;\t250-500 mg 8 hourly for 5 days\n2-6 years;\t250 mg 6 hourly for 5 days\n1 month-2 years;\t125 mg 6 hourly for 5 days\nNeonates;\t12. 5 mg/kg 6 hourly for 5 days\nZinc supplementation for diarrhoea\nEvidence Rating: [A]\nZinc supplement, oral,\nAdults\nNot required Children\n6 months;\t20 mg/day for 10-14 days\n< 6 months;\t10 mg/day for 10-14 days\nReferral Criteria\nRefer patients who fail to improve, or get worse, despite therapy for acute diarrhoea. Refer all patients with chronic diarrhoea to a specialist for further evaluation and management.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "109",
    "type": "section",
    "keywords": [
      "zinc",
      "years",
      "neonates",
      "improve",
      "management",
      "required",
      "therapy",
      "evidence",
      "acute",
      "supplement",
      "diarrhoea",
      "hourly",
      "rating",
      "worse",
      "specialist",
      "evaluation",
      "supplementation",
      "patients",
      "children",
      "criteria"
    ]
  },
  {
    "id": "2201f299687d315844b3f959e218ac41",
    "content": "Child can be treated safely at home\nInstruct mother to give home-based fluids like rice water, koko, soup,.",
    "title": "Treatment Plan A–Nodehydration",
    "section": "Treatment Plan A–Nodehydration",
    "chunk_id": "110",
    "type": "section",
    "keywords": [
      "based",
      "give",
      "treated",
      "rice",
      "soup",
      "safely",
      "child",
      "mother",
      "fluids",
      "water",
      "koko",
      "home",
      "instruct"
    ]
  },
  {
    "id": "cb9f7192bff8b30a65de13f9bbbca379",
    "content": "water, and Oral Rehydration Salt (ORS). Breastfed babies should be given breast milk and ORS\nGive as much as child wants of all the fluids\nChild should continue to feed\nAsk the mother to return to the health facility if the child gets worse, passes more watery stools, vomits repeatedly, becomes very thirsty, eats or drinks poorly or is not better in 2 days\nInstruct mother on how to prevent diarrhoea\nORS currently recommended for use in mild to moderate diarrhoea has a reduced sodium and glucose concentration (low osmolarity). How to prepare ORS\nORS: Dissolve the contents of one sachet of ORS in 600 ml or 1000 mls depending on type of ORS.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "111",
    "type": "section",
    "keywords": [
      "salt",
      "continue",
      "give",
      "given",
      "sachet",
      "rehydration",
      "breastfed",
      "repeatedly",
      "child",
      "mother",
      "health",
      "poorly",
      "glucose",
      "reduced",
      "worse",
      "babies",
      "breast",
      "diarrhoea",
      "moderate",
      "facility"
    ]
  },
  {
    "id": "b69297185d8e85a32ec8ef3eb72f0651",
    "content": "To get 600 ml, use 2 small (300 ml) soft drink bottles or 1 big beer\nbottle\nTo get 1000 ml, use 1L mineral water bottle\nThe child or adult should drink AS MUCH of it as he/she wants. If the child vomits, the mother should wait about 10 minutes and give it again.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "112",
    "type": "section",
    "keywords": [
      "drink",
      "bottles",
      "give",
      "child",
      "mother",
      "again",
      "minutes",
      "wait",
      "water",
      "bottle",
      "wants",
      "adult",
      "should",
      "mineral",
      "soft",
      "about",
      "small",
      "beer",
      "vomits"
    ]
  },
  {
    "id": "9a553a8bc1f45252c4d5fc67c68b845a",
    "content": "Child to be treated in the health facility\nGive ORS over the first 4 hours as shown in the Table for Plan B\nIf child vomits, wait 10 minutes and start again\nContinue with other fluids the child will accept\nInstruct mother to continue breast feeding if child is breastfeeding\nObserve stools passed and record quantity\nCheck for signs of worsening dehydration\nIf eyes become puffy, it means too much fluid has been given so stop ORS and re-evaluate\nReassess state of dehydration after 4 hours\nIf clinical state has improved with no dehydration - go to plan A\nIf there is still mild-moderate dehydration repeat plan B\nIf condition is worsening - go to plan C.",
    "title": "For thechild withmild-moderate dehydration, usetreatment PlanB",
    "section": "For thechild withmild-moderate dehydration, usetreatment PlanB",
    "chunk_id": "113",
    "type": "section",
    "keywords": [
      "continue",
      "give",
      "given",
      "evaluate",
      "accept",
      "check",
      "child",
      "mother",
      "health",
      "table",
      "feeding",
      "breastfeeding",
      "improved",
      "plan",
      "fluid",
      "breast",
      "again",
      "moderate",
      "facility",
      "start"
    ]
  },
  {
    "id": "6a6de1586ffa2014ed311b9633525047",
    "content": "*Use the child’s age only when you do not know the weight. The approximate amount of ORS required (in ml) can also be calculated by multiplying the child’s weight (in kg) by 75.",
    "title": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "section": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "chunk_id": "114",
    "type": "section",
    "keywords": [
      "approximate",
      "weight",
      "calculated",
      "amount",
      "also",
      "child",
      "only",
      "multiplying",
      "required"
    ]
  },
  {
    "id": "96e718b08db4622203f4b89e67df8744",
    "content": "If the child can drink, give ORS by mouth while the IV line is being\nset up\nStart IV fluids immediately. Give 100 ml/kg Ringer’s lactate solution or, if not available, normal saline or cholera replacement fluid (5:4:1), divided as shown in the Table for Plan C below:.",
    "title": "A child with severe dehydration requires urgent treatment with IV fluids in hospital",
    "section": "A child with severe dehydration requires urgent treatment with IV fluids in hospital",
    "chunk_id": "115",
    "type": "section",
    "keywords": [
      "drink",
      "give",
      "replacement",
      "child",
      "table",
      "while",
      "plan",
      "fluid",
      "start",
      "immediately",
      "saline",
      "fluids",
      "being",
      "ringer",
      "mouth",
      "line",
      "cholera",
      "available",
      "divided",
      "lactate"
    ]
  },
  {
    "id": "54d4936099455b04553e99d8822f5369",
    "content": "tube, refer to a health facility that can do so. Reassess the child every 1-2 hours. If hydration status is not improving, give the IV fluid more rapidly than as stated in the Table for Plan B\nAlso give ORS (about 5 ml/kg body weight/hour) as soon as the child\ncan drink: usually after 3-4 hours (infants) or 1–2 hours (children)\nReassess an infant after 6 hours and a child after 3 hours.",
    "title": "If you cannot give the above treatment and cannot pass a nasogastric",
    "section": "If you cannot give the above treatment and cannot pass a nasogastric",
    "chunk_id": "116",
    "type": "section",
    "keywords": [
      "usually",
      "hour",
      "drink",
      "weight",
      "give",
      "child",
      "health",
      "table",
      "plan",
      "fluid",
      "body",
      "facility",
      "stated",
      "children",
      "reassess",
      "status",
      "tube",
      "infants",
      "also",
      "every"
    ]
  },
  {
    "id": "d1998996ed3de463f05ac23549aed7a7",
    "content": "Classify dehydration. Then choose the appropriate plan (A, B, or C) to continue treatment\nAssess child hourly. If not improving or dehydration is worse, increase\ndrip rate\nDo not stop the IV fluids until the child has been observed to retain the ORS for at least 1 hour and there is improvement in the clinical condition.",
    "title": "If you cannot give the above treatment and cannot pass a nasogastric",
    "section": "If you cannot give the above treatment and cannot pass a nasogastric",
    "chunk_id": "117",
    "type": "section",
    "keywords": [
      "continue",
      "hour",
      "child",
      "drip",
      "retain",
      "increase",
      "plan",
      "worse",
      "hourly",
      "rate",
      "classify",
      "clinical",
      "assess",
      "fluids",
      "condition",
      "treatment",
      "observed",
      "dehydration",
      "choose",
      "stop"
    ]
  },
  {
    "id": "47f39bf7f0d1c4db67612255d877f10e",
    "content": "until child has no signs of dehydration, then move to Plan A\nSevere diarrhoea may be complicated by marked fluid loss accompanied by loss of potassium (hypokalaemia) or on the other hand, impaired renal function leading to acidosis and elevated blood potassium (hyperkalaemia)\nWhen the patient is passing adequate amounts of urine, probably\nindicating good renal function, start potassium containing foods such as coconut water and fresh fruits (e. g. banana)\nIf there is clinical and/or laboratory evidence of severe hypokalaemia,\npotassium should be given by the intravenous route using potassium chloride but only in a hospital.",
    "title": "Continue ORS on treatment plan B and continue to observe child",
    "section": "Continue ORS on treatment plan B and continue to observe child",
    "chunk_id": "118",
    "type": "section",
    "keywords": [
      "amounts",
      "move",
      "intravenous",
      "given",
      "coconut",
      "acidosis",
      "child",
      "urine",
      "potassium",
      "passing",
      "foods",
      "patient",
      "impaired",
      "evidence",
      "plan",
      "fluid",
      "diarrhoea",
      "start",
      "function",
      "banana"
    ]
  },
  {
    "id": "f50ce0d81b874e5711bbf50044c337f9",
    "content": "half strength Darrow’s solution or Ringer’s lactate may be added\nIf possible infants and children should continue to breastfeed or eat during the period of diarrhoea\n*Repeat once if radial pulse is still very weak or not detectable. Rotavirus is the most common cause of severe diarrhoea in young children. It accounts for more than a third of all hospitalizations of children less than 5 years.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "119",
    "type": "section",
    "keywords": [
      "continue",
      "years",
      "during",
      "hospitalizations",
      "detectable",
      "accounts",
      "diarrhoea",
      "added",
      "repeat",
      "rotavirus",
      "most",
      "children",
      "severe",
      "ringer",
      "weak",
      "breastfeed",
      "third",
      "should",
      "infants",
      "period"
    ]
  },
  {
    "id": "4ba4b26ce80a84ea762315784bb43976",
    "content": "It occurs year round with peaks between the dry months (December - March). Children are infected by age 2 to 3 years and re-infections are common. Causes\nRotavirus: 5 types of rotavirus are known to cause >90% of all cases worldwide\nSymptoms\nFever\nVomiting\nProfuse watery diarrhoea\nThirst\nSigns\nSunken eyes\nDiminished skin turgor\nAltered consciousness, depending on the degree of dehydration\ninvestigations\nDetection of rotavirus antigen in stool by an enzyme immunoassay (EIA).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "120",
    "type": "section",
    "keywords": [
      "infections",
      "types",
      "years",
      "turgor",
      "infected",
      "immunoassay",
      "diarrhoea",
      "known",
      "rotavirus",
      "december",
      "watery",
      "altered",
      "signs",
      "children",
      "causes",
      "dehydration",
      "worldwide",
      "enzyme",
      "investigations",
      "detection"
    ]
  },
  {
    "id": "a0fd83bb538b27243b917874f5fa4444",
    "content": "Replacement of on-going fluid losses\nAdequate nutrition to prevent malnutrition.",
    "title": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "section": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "chunk_id": "121",
    "type": "section",
    "keywords": [
      "going",
      "nutrition",
      "malnutrition",
      "losses",
      "prevent",
      "replacement",
      "adequate",
      "fluid"
    ]
  },
  {
    "id": "396b053ee91d1a5fa3d30815cca34669",
    "content": "Home-based fluids e. g. breast milk, porridges, coconut drink\nNutrition: feed as can be tolerated during the episode, give an extra meal per day for 2 weeks after the episode.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "122",
    "type": "section",
    "keywords": [
      "breast",
      "meal",
      "nutrition",
      "drink",
      "based",
      "extra",
      "give",
      "porridges",
      "weeks",
      "coconut",
      "feed",
      "during",
      "episode",
      "fluids",
      "after",
      "milk",
      "tolerated",
      "home"
    ]
  },
  {
    "id": "b71c5c7898c660a7ed0df499b591b359",
    "content": "A. ORS and Zinc supplementation\n(See section on ‘Diarrhoea’)\nReferral Criteria\nPoor response to rehydration process (passing more stools than drinking)\nPoor drinking\nBlood in stool\nPoor feeding\nAltered consciousness/convulsions\nDiarrhoea and vomiting continuing for > 3 days\nIn general, constipation refers to bowel movements that are infrequent or stools that are difficult to pass. There is great individual variation in normal bowel habits; therefore emphasis should be laid on changes in the bowel habit.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "123",
    "type": "section",
    "keywords": [
      "zinc",
      "rehydration",
      "feeding",
      "passing",
      "poor",
      "refers",
      "diarrhoea",
      "therefore",
      "individual",
      "movements",
      "process",
      "great",
      "bowel",
      "supplementation",
      "section",
      "stools",
      "altered",
      "convulsions",
      "constipation",
      "criteria"
    ]
  },
  {
    "id": "fb11387070be45a2d491afae451feed5",
    "content": "Diarrhoea alternating with constipation may indicate a large bowel cancer especially in those aged 40 years and above. In children and the elderly, this may indicate chronic constipation with spurious diarrhoea. The habitual use of laxatives is very common in the community.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "124",
    "type": "section",
    "keywords": [
      "years",
      "especially",
      "elderly",
      "spurious",
      "diarrhoea",
      "laxatives",
      "alternating",
      "bowel",
      "large",
      "children",
      "constipation",
      "above",
      "chronic",
      "habitual",
      "those",
      "cancer",
      "aged",
      "community",
      "indicate",
      "common"
    ]
  },
  {
    "id": "f3dc2f5ede10d617ecaa468cd2e16fe2",
    "content": "This practice must be discouraged to avoid hypokalaemia and its consequences. Causes\nMedical\nDiet deficient in roughage\nIgnoring the urge to defaecate e. g.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "125",
    "type": "section",
    "keywords": [
      "consequences",
      "diet",
      "avoid",
      "urge",
      "roughage",
      "deficient",
      "must",
      "hypokalaemia",
      "discouraged",
      "defaecate",
      "practice",
      "medical",
      "ignoring",
      "causes"
    ]
  },
  {
    "id": "5bf5218c8f4d6416b8e147dee623d0ad",
    "content": "due to immobility\nHypothyroidism\nIrritable bowel syndrome\nHypercalcaemia\nDrugs e. g. atropine, codeine, morphine, tricyclic antidepressants,.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "126",
    "type": "section",
    "keywords": [
      "tricyclic",
      "hypercalcaemia",
      "morphine",
      "drugs",
      "antidepressants",
      "codeine",
      "bowel",
      "hypothyroidism",
      "atropine",
      "immobility",
      "syndrome",
      "irritable"
    ]
  },
  {
    "id": "ddde535392841b2332e78fca6a26f5fd",
    "content": "disopyramide\nLazy bowel from chronic laxative use including ‘herbal’ preparations\nLack of exercise\nDehydration and starvation (particularly in children)\nSurgical\nGastrointestinal obstruction\nAnal fissure and other painful perianal lesions\nCarcinoma of the rectum and sigmoid colon\nForeign body in the gut\nPelvic mass e. g. fibroid, foetus\nAganglionic and acquired megacolon\nPseudo-bowel obstruction (Ogilvie syndrome) following immobility from any cause\nSymptoms\nInability to move bowels\nPassing hard stools\nInfrequent passing of stools\nStraining to pass stools\nFeeling of incomplete evacuation of bowel\nInability to pass flatus, colicky abdominal pain with or without vomiting\nSigns\nFrequent high pitched bowel sounds - suspect mechanical bowel obstruction\nAbsent bowel sounds - suspect paralytic ileus\nSigns of peritonitis (generalised tenderness, guarding and rebound tenderness, refer appropriate section) -`suspect gangrenous bowel\ninvestigations\nDigital rectal examination (must be carried out in all patients with suspected diagnosis of constipation)\nStool for occult blood\nPlain abdominal X-ray (erect and supine)\nProctoscopy/proctosigmoidoscopy/colonoscopy (must not be done if acute intestinal obstruction is suspected).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "127",
    "type": "section",
    "keywords": [
      "move",
      "peritonitis",
      "fibroid",
      "ogilvie",
      "exercise",
      "feeling",
      "abdominal",
      "proctosigmoidoscopy",
      "lack",
      "megacolon",
      "foreign",
      "pitched",
      "gangrenous",
      "signs",
      "constipation",
      "chronic",
      "foetus",
      "stool",
      "rectum",
      "colon"
    ]
  },
  {
    "id": "3cdf0f7c01789be395000e47ab4f6924",
    "content": "To identify possible cause of constipation\nTo relieve constipation.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "128",
    "type": "section",
    "keywords": [
      "cause",
      "relieve",
      "possible",
      "identify",
      "constipation"
    ]
  },
  {
    "id": "8067630b14b61f0e675220a0e59b58e0",
    "content": "Adherence to regular exercise\nHigh fibre diet\nAdequate fluid intake (minimum of 3. 2L of water per day if no contraindications exist).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "129",
    "type": "section",
    "keywords": [
      "diet",
      "regular",
      "fibre",
      "adherence",
      "exercise",
      "high",
      "minimum",
      "water",
      "contraindications",
      "intake",
      "exist",
      "adequate",
      "fluid"
    ]
  },
  {
    "id": "4ef8513f3340005926ccfa487d7b977c",
    "content": "Bisacodyl, oral, 10-20 mg at night\nOr\nSenna, oral, 15-30 mg at bedtime (maximum 70-100 mg daily). Doses above 70 mg should be divided 12 hourly\nOr\nLactulose, oral, 15-30 ml daily until response, then 10-20 ml daily.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "130",
    "type": "section",
    "keywords": [
      "hourly",
      "above",
      "bedtime",
      "should",
      "doses",
      "maximum",
      "response",
      "oral",
      "until",
      "bisacodyl",
      "senna",
      "then",
      "night",
      "lactulose",
      "daily",
      "divided"
    ]
  },
  {
    "id": "527e90463de7a9bfbd395bf16018743b",
    "content": "Bisacodyl, rectal, 10 mg in the morning\nOr\nGlycerol suppositories, rectal, 4 g at night\nOr\nLiquid paraffin, oral, 10-30 ml at night\nOr\nMilk of Magnesia, oral, 5-10 ml in a glass of water, 12-24 hourly\nManagement of Constipation in Children.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "131",
    "type": "section",
    "keywords": [
      "hourly",
      "rectal",
      "morning",
      "glycerol",
      "management",
      "glass",
      "liquid",
      "magnesia",
      "oral",
      "children",
      "suppositories",
      "water",
      "paraffin",
      "bisacodyl",
      "milk",
      "constipation",
      "night"
    ]
  },
  {
    "id": "b200c5d7ed5d74810886e1973aaef7ea",
    "content": "Lactulose, oral,\n10-18 years;\t15 ml 12 hourly\n5-10 years;\t10 ml 12 hourly\n1-5 years;\t5 ml 12 hourly\n< 1 year;\t2. 5 ml 12 hourly\nOr\nGlycerol suppositories, rectal,\nyears;\t2 g at night\n< 1 year;\t1 g at night\nOr\nBisacodyl, rectal,\n10 years;\t5 mg in the morning\n< 10 years;\ton medical advice only\nOr\nSenna, oral,\n6-12 years;\t5-40 ml at bedtime\nyears;\t2. 5-20 ml at bedtime.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "132",
    "type": "section",
    "keywords": [
      "hourly",
      "rectal",
      "advice",
      "years",
      "bedtime",
      "glycerol",
      "morning",
      "senna",
      "oral",
      "only",
      "suppositories",
      "bisacodyl",
      "medical",
      "night",
      "lactulose",
      "year"
    ]
  },
  {
    "id": "d29c5a9448bd2536731040b249622fac",
    "content": "Referral Criteria\nThe following categories of patients should be referred to a surgeon:\nPatients with absent bowel sounds, vomiting or not passing flatus.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "133",
    "type": "section",
    "keywords": [
      "categories",
      "referral",
      "vomiting",
      "following",
      "bowel",
      "flatus",
      "sounds",
      "should",
      "absent",
      "surgeon",
      "patients",
      "referred",
      "passing",
      "criteria"
    ]
  },
  {
    "id": "01ed9058bd56a5b7f59e8ab8fe918ccf",
    "content": "Any suspected surgical cause\nPeptic ulcer may be duodenal or gastric. Duodenal ulcers are more common and occur more often in younger adults. Gastric ulcers usually occur after middle age.",
    "title": "Cases resistant to medical treatment",
    "section": "Cases resistant to medical treatment",
    "chunk_id": "134",
    "type": "section",
    "keywords": [
      "usually",
      "younger",
      "surgical",
      "suspected",
      "occur",
      "often",
      "middle",
      "gastric",
      "ulcer",
      "common",
      "peptic",
      "cause",
      "adults",
      "more",
      "after",
      "duodenal",
      "ulcers"
    ]
  },
  {
    "id": "75f3d2198ccadfc8cf4ccefcf9186aef",
    "content": "Gastric ulcers should be taken seriously because they may be malignant. Peptic ulcers may lead to life threatening complications of bleeding, perforation and gastric outlet obstruction. Causes\nHelicobacter pylori (H.",
    "title": "Cases resistant to medical treatment",
    "section": "Cases resistant to medical treatment",
    "chunk_id": "135",
    "type": "section",
    "keywords": [
      "lead",
      "pylori",
      "malignant",
      "bleeding",
      "gastric",
      "obstruction",
      "causes",
      "because",
      "should",
      "peptic",
      "threatening",
      "ulcers",
      "perforation",
      "seriously",
      "complications",
      "outlet",
      "taken",
      "life",
      "helicobacter"
    ]
  },
  {
    "id": "0295faa53c31f8084721a46434a1cf47",
    "content": "pylori) infection\nExcessive secretion of gastric acid\nInadequate protection of the lining of the stomach and duodenum against digestion by acid and pepsin\nMedicines e. g. non-steroidal anti-inflammatory drugs (NSAIDs),\ncorticosteroids\nSymptoms\nEpisodic abdominal pain (often aggravated by dietary indiscretions and lifestyle)\nMay be a minor discomfort, gnawing, burning, dull ache or very\nsevere pain\nTypically pain is in the epigastrium or right hypochondrium\nOccasionally high up behind the sternum or low down around the umbilicus\nIn duodenal ulcer, pain typically comes on when the patient is\nhungry and may wake the patient up in the middle of the night.",
    "title": "Cases resistant to medical treatment",
    "section": "Cases resistant to medical treatment",
    "chunk_id": "136",
    "type": "section",
    "keywords": [
      "episodic",
      "hungry",
      "minor",
      "stomach",
      "aggravated",
      "often",
      "inadequate",
      "down",
      "ulcer",
      "discomfort",
      "typically",
      "umbilicus",
      "pylori",
      "duodenum",
      "lifestyle",
      "corticosteroids",
      "patient",
      "night",
      "abdominal",
      "epigastrium"
    ]
  },
  {
    "id": "5f9ef832f04bae7267a40f12cf7c75fe",
    "content": "In gastric ulcer, it is typically worsened by food, and may be re- lieved by vomiting\nIs relieved by alkalis and food in duodenal ulcer\nVomiting may occur in both duodenal and gastric ulcers. It is usually a complication in duodenal ulcer (gastric outlet obstruction) but may be self-induced in gastric ulcer to relieve pain\nIn children\nPain may be peri-umbilical\nSigns\nThere may be no abdominal signs\nWeight loss (sometimes in gastric ulcer)\nWeight gain (sometimes in duodenal ulcer)\nTenderness - epigastrium, right hypochondrium or umbilical region.",
    "title": "Cases resistant to medical treatment",
    "section": "Cases resistant to medical treatment",
    "chunk_id": "137",
    "type": "section",
    "keywords": [
      "usually",
      "occur",
      "self",
      "weight",
      "region",
      "both",
      "ulcer",
      "typically",
      "lieved",
      "alkalis",
      "induced",
      "sometimes",
      "worsened",
      "relieved",
      "abdominal",
      "epigastrium",
      "right",
      "complication",
      "gastric",
      "obstruction"
    ]
  },
  {
    "id": "e2893d20aa3fe87f53068aad4a7cd37b",
    "content": "investigations\nHaemoglobin\nH. pylori stool antigen\nOesophago-gastro-duodenoscopy (endoscopy)\nBarium meal (in the absence of endoscopy)\nStool examination (to exclude intestinal parasites).",
    "title": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "section": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "chunk_id": "138",
    "type": "section",
    "keywords": [
      "meal",
      "exclude",
      "investigations",
      "antigen",
      "oesophago",
      "duodenoscopy",
      "absence",
      "intestinal",
      "gastro",
      "parasites",
      "pylori",
      "stool",
      "barium",
      "endoscopy",
      "examination",
      "haemoglobin"
    ]
  },
  {
    "id": "9df98f842bec7f9b870d78e5eb5d7090",
    "content": "To relieve pain (dyspepsia) and reduce gastric acid secretion\nTo eradicate H. pylori if present\nTo promote healing of the ulcer\nTo prevent recurrence of the ulcer\nTo prevent and manage complications.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "139",
    "type": "section",
    "keywords": [
      "complications",
      "pain",
      "present",
      "healing",
      "recurrence",
      "acid",
      "prevent",
      "manage",
      "reduce",
      "gastric",
      "ulcer",
      "eradicate",
      "relieve",
      "pylori",
      "promote",
      "dyspepsia",
      "secretion"
    ]
  },
  {
    "id": "d94b706727e77ffaeba939e7e3448e6c",
    "content": "Avoid alcohol and tobacco intake\nAvoid foods that aggravate the pain\nAllay anxiety and stress\nSurgical treatment: for chronic cases with severe periodic attacks, failed medical treatment and complications e. g. perforation, gastric outlet obstruction and haemorrhage).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "140",
    "type": "section",
    "keywords": [
      "avoid",
      "haemorrhage",
      "foods",
      "anxiety",
      "periodic",
      "attacks",
      "stress",
      "alcohol",
      "gastric",
      "obstruction",
      "aggravate",
      "intake",
      "allay",
      "treatment",
      "severe",
      "chronic",
      "surgical",
      "failed",
      "medical",
      "perforation"
    ]
  },
  {
    "id": "fc7ccee93e3104a0d67c9c4e6838c78a",
    "content": "Magnesium trisilicate, oral, 15 ml 8 hourly (in-between meals and at\nbedtime to control dyspepsia)\nOr\nAluminium hydroxide, oral, 500 mg 6 hourly (in-between meals and at bedtime).",
    "title": "1st Line treatment Evidence Rating: [A]",
    "section": "1st Line treatment Evidence Rating: [A]",
    "chunk_id": "141",
    "type": "section",
    "keywords": [
      "hourly",
      "aluminium",
      "bedtime",
      "hydroxide",
      "trisilicate",
      "magnesium",
      "oral",
      "meals",
      "between",
      "dyspepsia",
      "control"
    ]
  },
  {
    "id": "330aed62ea816500ee58e95d2b7c7a2d",
    "content": "Omeprazole, oral,\nAdults\n20 mg daily for 4 weeks. Repeat course if ulcer is not fully healed. NSAiD-associated duodenal or gastric ulcer and gastro-duodenal\nerosions\nEvidence Rating: [A]\nEsomeprazole, oral,.",
    "title": "2nd Line treatment Evidence Rating: [A]",
    "section": "2nd Line treatment Evidence Rating: [A]",
    "chunk_id": "142",
    "type": "section",
    "keywords": [
      "ulcer",
      "associated",
      "evidence",
      "fully",
      "rating",
      "healed",
      "gastric",
      "repeat",
      "weeks",
      "daily",
      "erosions",
      "course",
      "adults",
      "duodenal",
      "omeprazole",
      "oral",
      "gastro",
      "nsaid",
      "esomeprazole"
    ]
  },
  {
    "id": "373cadc01b3b75aa8490c568b4166bba",
    "content": "Adults\n20 mg daily for 4 weeks. Repeat course if ulcer is not fully healed. Or\nOmeprazole, oral,\nAdults\n20 mg daily for 4 weeks.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "143",
    "type": "section",
    "keywords": [
      "course",
      "healed",
      "adults",
      "ulcer",
      "repeat",
      "oral",
      "omeprazole",
      "weeks",
      "fully",
      "daily"
    ]
  },
  {
    "id": "b3962ad8ba7e4231c9887bf6cff8c49c",
    "content": "Repeat course if ulcer is not fully healed. Or\nPantoprazole, oral,\nAdults\n20-40 mg daily for 4 weeks. Repeat course if ulcer is not fully healed.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "144",
    "type": "section",
    "keywords": [
      "pantoprazole",
      "course",
      "healed",
      "ulcer",
      "adults",
      "repeat",
      "oral",
      "weeks",
      "fully",
      "daily"
    ]
  },
  {
    "id": "32727469b85f1c9c295fd507df7862ab",
    "content": "Bleeding peptic ulcer (may be an indication for surgery)\nEvidence Rating: [A]\nEsomeprazole, IV,\nAdults\n40 mg daily\nOr\nOmeprazole, IV,\nAdults\n40 mg 12 hourly for up to 5 days\nHelicobacter pylori Eradication\nMajority of patients presenting with duodenal ulcer are infected with Helicobacter pylori. Eradication of H. pylori should therefore be done using a 10-14 day course of treatment consisting of a PPI plus a combination of two of the antibiotics indicated in the table below.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "145",
    "type": "section",
    "keywords": [
      "antibiotics",
      "ulcer",
      "presenting",
      "infected",
      "table",
      "eradication",
      "pylori",
      "evidence",
      "majority",
      "hourly",
      "rating",
      "therefore",
      "bleeding",
      "esomeprazole",
      "combination",
      "indication",
      "patients",
      "treatment",
      "days",
      "course"
    ]
  },
  {
    "id": "5b7e94ed0cc5d0af9481e5add8835136",
    "content": "or if surgery is indicated as stated above. Gastro-oesophageal Reflux Disease (GORD) is caused by backflow of gastric and/or duodenal contents past the lower oesophageal sphincter into the oesophagus without belching or vomiting. The disease is classified into two groups based on endoscopy findings as non-erosive gastro-oesophageal disease (non-erosive GORD) and erosive gastro-oesophageal disease (erosive GORD).",
    "title": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "section": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "chunk_id": "146",
    "type": "section",
    "keywords": [
      "based",
      "reflux",
      "erosive",
      "into",
      "sphincter",
      "gastric",
      "stated",
      "disease",
      "above",
      "caused",
      "findings",
      "belching",
      "oesophagus",
      "groups",
      "oesophageal",
      "duodenal",
      "backflow",
      "vomiting",
      "classified",
      "gord"
    ]
  },
  {
    "id": "84dcfc89804a327346196b34dadaad70",
    "content": "Failure to treat may result in oesophagitis, ulceration, strictures and rarely adenocarcinoma. Causes\nObesity\nHiatus hernia\nIncreased intra-abdominal pressure e. g.",
    "title": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "section": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "chunk_id": "147",
    "type": "section",
    "keywords": [
      "intra",
      "abdominal",
      "oesophagitis",
      "adenocarcinoma",
      "treat",
      "hiatus",
      "pressure",
      "result",
      "ulceration",
      "rarely",
      "hernia",
      "obesity",
      "failure",
      "increased",
      "causes",
      "strictures"
    ]
  },
  {
    "id": "52b80063730f0ec83e83d9a3d98365f9",
    "content": "in pregnancy\nLong term use of nasogastric tube\nAgents that decrease lower oesophageal sphincter pressure e. g. alcohol, cigarettes, anticholinergics (e.",
    "title": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "section": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "chunk_id": "148",
    "type": "section",
    "keywords": [
      "anticholinergics",
      "term",
      "agents",
      "decrease",
      "pressure",
      "sphincter",
      "tube",
      "alcohol",
      "cigarettes",
      "lower",
      "oesophageal",
      "pregnancy",
      "nasogastric"
    ]
  },
  {
    "id": "d3d779d072f51b81723b15432e9d0165",
    "content": "g. Hyoscine butylbromide, Propantheline bromide), other drugs – Morphine, Diazepam, Pethidine and Calcium channel blockers.",
    "title": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "section": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "chunk_id": "149",
    "type": "section",
    "keywords": [
      "bromide",
      "morphine",
      "diazepam",
      "drugs",
      "calcium",
      "propantheline",
      "other",
      "hyoscine",
      "pethidine",
      "blockers",
      "butylbromide",
      "channel"
    ]
  },
  {
    "id": "429fa5b04f211bd14bec7785f392d3f3",
    "content": "Symptoms\nHeartburn (worsens with vigorous exercise, bending forward, lying; relieved by antacids and sitting upright)\nDyspepsia\nEarly satiety\nRetrosternal and epigastric pain (mimics angina pectoris by radiating to neck, jaws and arms. The pain is worse on bending down e. g.",
    "title": "Children with chronic neurological disease (e.g. cerebral palsy)",
    "section": "Children with chronic neurological disease (e.g. cerebral palsy)",
    "chunk_id": "150",
    "type": "section",
    "keywords": [
      "retrosternal",
      "down",
      "exercise",
      "pectoris",
      "antacids",
      "relieved",
      "neck",
      "worse",
      "heartburn",
      "vigorous",
      "radiating",
      "angina",
      "dyspepsia",
      "jaws",
      "arms",
      "bending",
      "upright",
      "forward",
      "symptoms",
      "worsens"
    ]
  },
  {
    "id": "4b8cb5ebb7304dabee89366d76352c09",
    "content": "sweeping)\nPain on swallowing\nDifficulty swallowing\nNocturnal regurgitation (wakes patients up with coughing, choking and filling of the mouth with ‘saliva’)\nAsthma-like (may be worse at night)\nIn children\nFailure to thrive/refusing food\nVomiting\nCoughing\nForceful regurgitation which may lead to aspiration pneumonia\nIron deficiency anaemia\nWheezing\nSigns\nMay be none.",
    "title": "Children with chronic neurological disease (e.g. cerebral palsy)",
    "section": "Children with chronic neurological disease (e.g. cerebral palsy)",
    "chunk_id": "151",
    "type": "section",
    "keywords": [
      "choking",
      "regurgitation",
      "anaemia",
      "which",
      "nocturnal",
      "lead",
      "refusing",
      "thrive",
      "swallowing",
      "night",
      "worse",
      "aspiration",
      "saliva",
      "asthma",
      "wakes",
      "signs",
      "patients",
      "sweeping",
      "children",
      "deficiency"
    ]
  },
  {
    "id": "8474771ac2c43644426854659917628b",
    "content": "Epigastric tenderness occasionally\nChest signs (e. g. wheezing)\ninvestigations\nOesophago-gastro-duodenoscopy (OGD), i.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "152",
    "type": "section",
    "keywords": [
      "tenderness",
      "chest",
      "epigastric",
      "oesophago",
      "duodenoscopy",
      "signs",
      "gastro",
      "investigations",
      "occasionally",
      "wheezing"
    ]
  },
  {
    "id": "b8685db104a0e16a35cd61b7f810b650",
    "content": "e. upper gastro-intestinal\ntract endoscopy\nChest X-ray to exclude other causes.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "153",
    "type": "section",
    "keywords": [
      "tract",
      "chest",
      "exclude",
      "other",
      "intestinal",
      "gastro",
      "endoscopy",
      "upper",
      "causes"
    ]
  },
  {
    "id": "677851f55ca722395bfa973b2c7763b8",
    "content": "Barium swallow with fluoroscopy (especially useful in children)\nOesophageal pH monitoring (in cases that are difficult to diagnose)\nLower oesophageal sphincter manometry (in cases that are difficult to diagnose).",
    "title": "Abdominal ultrasound (to exclude other diseases)",
    "section": "Abdominal ultrasound (to exclude other diseases)",
    "chunk_id": "154",
    "type": "section",
    "keywords": [
      "monitoring",
      "sphincter",
      "swallow",
      "fluoroscopy",
      "especially",
      "manometry",
      "useful",
      "cases",
      "difficult",
      "oesophageal",
      "lower",
      "children",
      "barium",
      "diagnose"
    ]
  },
  {
    "id": "bb5adbd40e2565c76f643f12cc9c9409",
    "content": "Elevate head of bed by about 30 degrees or sleep on pillows\nAvoid sleeping within 3 hours after eating\nAvoid over-eating and heavy meals before bedtime\nAvoid foods that aggravate symptoms e. g. fatty and spicy food\nAvoid smoking and alcohol\nAvoid Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)\nEncourage moderate exercise\nWeight reduction in overweight and obese individuals\nAvoid corsets, instead wear loose clothing.",
    "title": "Non-pharmacological treatment Lifestyle changes:",
    "section": "Non-pharmacological treatment Lifestyle changes:",
    "chunk_id": "155",
    "type": "section",
    "keywords": [
      "obese",
      "avoid",
      "corsets",
      "overweight",
      "weight",
      "spicy",
      "pillows",
      "exercise",
      "instead",
      "foods",
      "within",
      "moderate",
      "loose",
      "wear",
      "alcohol",
      "encourage",
      "steroidal",
      "aggravate",
      "fatty",
      "eating"
    ]
  },
  {
    "id": "26d7499923762382677d81f402f8d9b4",
    "content": "Non-erosive GORD\nEvidence Rating: [B]\nMagnesium trisilicate, oral, 15 ml 8 hourly (in between meals and at bedtime to control dyspepsia)\nOr\nAntacids containing Aluminum hydroxide, Magnesium hydroxide, Simethicone, Calcium alginates\nOr\nOmeprazole, oral,\nAdults\n20 mg daily for 4-8 weeks\nChildren\n20 kg;\t20 mg daily for 4-8 weeks\n10-20 kg;\t10 mg daily for 4-8 weeks\n5-10 kg;\t5 mg daily for 4-8 weeks.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "156",
    "type": "section",
    "keywords": [
      "magnesium",
      "evidence",
      "erosive",
      "antacids",
      "hourly",
      "rating",
      "aluminum",
      "trisilicate",
      "dyspepsia",
      "weeks",
      "children",
      "calcium",
      "containing",
      "bedtime",
      "adults",
      "hydroxide",
      "between",
      "omeprazole",
      "simethicone",
      "alginates"
    ]
  },
  {
    "id": "4e1ac8f23bb77242364d6fdeebb983bb",
    "content": "Or\nEsomeprazole, oral,\nAdults\n40 mg daily for 4 to 8 weeks\nOr\nRabeprazole, oral,\nAdults\n20 mg daily for 4 to 8 weeks\nSevere or Erosive GORD\nOmeprazole, oral,\nAdults\n20 - 40 mg daily for 8 weeks\nChildren\n20 kg;\t20 mg daily for 4-8 weeks\n10-20 kg;\t10 mg daily for 4-8 weeks\n5-10 kg;\t5 mg daily for 4-8 weeks\nOr\nEsomeprazole, oral,\nAdults\n40 mg daily for 8 weeks\nOr\nRabeprazole, oral,\nAdults\n20-40 mg daily for 8 weeks\nSevere or Erosive GORD (with bloating)\nUse medications in Section B above for ‘Severe GORD’\nAnd\nMetoclopramide, oral,\nAdults\n10 - 20 mg 6-8 hourly\nOr\nDomperidone, oral,\nAdults\n10 mg 6-8 hourly\nReferral Criteria\nRefer cases not responding to the measures above to a physician or surgical specialist, as well as severe cases, treatment failures and individuals with complications. Oesophageal pain is usually burning in quality and tends to be localised behind the sternum. Oesophageal pain may be associated with difficulty in swallowing (dysphagia).",
    "title": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "section": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "chunk_id": "157",
    "type": "section",
    "keywords": [
      "usually",
      "quality",
      "associated",
      "localised",
      "swallowing",
      "failures",
      "erosive",
      "measures",
      "dysphagia",
      "hourly",
      "specialist",
      "metoclopramide",
      "section",
      "burning",
      "children",
      "weeks",
      "daily",
      "criteria",
      "domperidone",
      "treatment"
    ]
  },
  {
    "id": "fe62f1502945090faf7344503d8c1bba",
    "content": "while that to solids and not water suggests mechanical obstruction by tumour or stricture. It may sometimes be confused with other causes of chest pain (See section on ‘Chest Pain’). Causes\nIrritation of the oesophageal mucosa by reflux of the acidic contents of the stomach (Gastro-oesophageal Reflux Disease (GORD)\nOesophageal candidiasis\nHiatus hernia\nAchalasia\nSpasm of the oesophageal muscle in response to obstruction.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "158",
    "type": "section",
    "keywords": [
      "spasm",
      "acidic",
      "stomach",
      "reflux",
      "sometimes",
      "while",
      "candidiasis",
      "suggests",
      "chest",
      "mechanical",
      "section",
      "hernia",
      "muscle",
      "water",
      "obstruction",
      "solids",
      "tumour",
      "causes",
      "disease",
      "confused"
    ]
  },
  {
    "id": "0ce6e17b8bfe0701e9a20a49893e554a",
    "content": "Oesophageal tumours\nSymptoms\nRetrosternal chest pain worsened by swallowing (pain worse on lying flat may suggest GORD)\nRegurgitation of ingested material\nDifficulty in swallowing\nSigns\nUsually none\nPatient may be obese or severely underweight in the case of GORD\nSevere weight loss may suggest tumour or candidiasis from immune\nsuppression\nThere may be oral candidiasis in the case of oesophageal candidiasis\ninvestigations\nBarium swallow\nOesophago-gastroduodenoscopy (upper GI endoscopy)\nOesophageal manometry when achalasia is suspected.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "159",
    "type": "section",
    "keywords": [
      "severely",
      "usually",
      "obese",
      "weight",
      "tumours",
      "regurgitation",
      "retrosternal",
      "swallowing",
      "patient",
      "worsened",
      "worse",
      "candidiasis",
      "chest",
      "swallow",
      "oesophago",
      "signs",
      "underweight",
      "tumour",
      "suppression",
      "severe"
    ]
  },
  {
    "id": "8508eee52210efe4ce6fd38e96ae5ebe",
    "content": "Bland foods and milk (may sometimes relieve the pain).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "160",
    "type": "section",
    "keywords": [
      "pain",
      "milk",
      "relieve",
      "bland",
      "foods",
      "sometimes"
    ]
  },
  {
    "id": "40b1bef7b0031fd9f529907d4da6ec4f",
    "content": "Omeprazole, oral,\nAdults\n20 mg 12 hourly for 14 days\nOr\nEsomeprazole\nAdults.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "161",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "adults",
      "oral",
      "omeprazole",
      "esomeprazole"
    ]
  },
  {
    "id": "9b136bcf5c4e73288080ec788673d106",
    "content": "20-40 mg daily for 14 days\nFor patients not responding to monotherapy with PPi\nEvidence Rating: [B]\nOmeprazole, oral, 20 mg 12 hourly for 14 days\nOr\nEsomeprazole, oral, 20-40 mg daily for 14 days\nAnd\nMagnesium trisilicate, oral, 10 ml 8 hourly for 10 days\nFor oesophageal candidiasis\nEvidence Rating: [A]\nNystatin, oral, (swish in mouth for several minutes and then swallow)\nAdults\n400,000-600,000 units 6 hourly for 7 days\nOr\nFluconazole, oral,\nAdults\n200 mg stat. Then\n100 mg daily for 14 days\nReferral Criteria\nRefer to a specialist for confirmation of diagnosis and management. Haemorrhoids or “piles” are enlarged, displaced anal cushions derived from engorged veins, which primarily presents with anal bleeding.",
    "title": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "section": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "chunk_id": "162",
    "type": "section",
    "keywords": [
      "derived",
      "veins",
      "units",
      "engorged",
      "management",
      "confirmation",
      "which",
      "magnesium",
      "piles",
      "presents",
      "evidence",
      "monotherapy",
      "primarily",
      "hourly",
      "rating",
      "candidiasis",
      "swish",
      "specialist",
      "cushions",
      "swallow"
    ]
  },
  {
    "id": "ed7257799461184c8eda00731dc9bf4b",
    "content": "First-degree haemorrhoids remain in the anal canal. Second-degree haemorrhoids prolapse, but reduce spontaneously, whereas third degree haemorrhoids prolapse and have to be replaced manually or remain\nprolapsed permanently until surgically treated. The history is very important.",
    "title": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "section": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "chunk_id": "163",
    "type": "section",
    "keywords": [
      "important",
      "second",
      "treated",
      "prolapsed",
      "prolapse",
      "haemorrhoids",
      "permanently",
      "anal",
      "replaced",
      "first",
      "third",
      "canal",
      "degree",
      "remain",
      "spontaneously",
      "manually",
      "surgically",
      "reduce",
      "whereas",
      "history"
    ]
  },
  {
    "id": "bc343b034b0b660a192868f09d797906",
    "content": "The nature of the bleeding, associated pain and other symptoms help differentiate haemorrhoids from other more sinister conditions. Always do a digital rectal examination to exclude carcinoma and other conditions when a patient complains of pain or bleeding from the anus. Altered or dark blood, or blood mixed with stools, should raise suspicion of bleeding higher up in the rectum or colon.",
    "title": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "section": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "chunk_id": "164",
    "type": "section",
    "keywords": [
      "digital",
      "complains",
      "suspicion",
      "associated",
      "help",
      "nature",
      "patient",
      "anus",
      "always",
      "rectal",
      "bleeding",
      "stools",
      "altered",
      "haemorrhoids",
      "blood",
      "mixed",
      "should",
      "sinister",
      "differentiate",
      "symptoms"
    ]
  },
  {
    "id": "0506b87a238e56ad852d5947e92e76cc",
    "content": "Avoid the use of purgatives. Causes\nIncreased intra-abdominal pressure e. g.",
    "title": "No treatment is required for haemorrhoids that are asymptomatic.",
    "section": "No treatment is required for haemorrhoids that are asymptomatic.",
    "chunk_id": "165",
    "type": "section",
    "keywords": [
      "intra",
      "avoid",
      "abdominal",
      "pressure",
      "purgatives",
      "increased",
      "causes"
    ]
  },
  {
    "id": "d00a06d09458213c0eceacfa9b523001",
    "content": "chronic cough, pregnancy, intra-abdominal or pelvic tumours\nExcessive straining at stools from constipation or diarrhoea\nFamilial predisposition.",
    "title": "No treatment is required for haemorrhoids that are asymptomatic.",
    "section": "No treatment is required for haemorrhoids that are asymptomatic.",
    "chunk_id": "166",
    "type": "section",
    "keywords": [
      "diarrhoea",
      "intra",
      "abdominal",
      "chronic",
      "pelvic",
      "straining",
      "tumours",
      "cough",
      "stools",
      "familial",
      "pregnancy",
      "constipation",
      "predisposition",
      "excessive"
    ]
  },
  {
    "id": "6a039c192ec6d08b163260cd596bd2b8",
    "content": "Anorectal tumours\nSymptoms\nPassage of bright red blood at defaecation\nNot mixed with stools\nMay spray the toilet bowl or only found on the toilet paper after cleaning\nMucoid discharge\nSwelling at anus\nPerianal irritation or itch (pruritus ani)\nDiscomfort after opening bowels\nAnal pain (occurs during an acute attack of prolapse with thrombosis, congestion and oedema)\nSymptoms of anaemia\nSigns\nMay be none (inspection of the anus and digital rectal examination may be normal)\nRedundant folds of skin (skin tags) seen in the position of the\nhaemorrhoids. Straining may show the haemorrhoids\nSwelling at the anus (in third degree haemorrhoids)\nPalpable thrombosed internal haemorrhoids on rectal examination\nSigns of complications (profuse bleeding with anaemia or haemorrhagic shock, prolapse, strangulation, thrombosis, infection or ulceration)\nPallor\ninvestigations\nFBC\nProctoscopy (the gold standard for diagnosis)\nSigmoidoscopy (to exclude carcinoma of rectum).",
    "title": "Chronic liver disease with portal hypertension",
    "section": "Chronic liver disease with portal hypertension",
    "chunk_id": "167",
    "type": "section",
    "keywords": [
      "swelling",
      "seen",
      "position",
      "mucoid",
      "signs",
      "inspection",
      "prolapse",
      "haemorrhoids",
      "show",
      "thrombosis",
      "profuse",
      "itch",
      "rectum",
      "passage",
      "complications",
      "exclude",
      "pruritus",
      "none",
      "folds",
      "normal"
    ]
  },
  {
    "id": "5ab658a0355df9138c807bcf8aa73ea9",
    "content": "To correct anaemia, if present\nTo relieve symptoms\nTo prevent complications.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "168",
    "type": "section",
    "keywords": [
      "complications",
      "present",
      "correct",
      "anaemia",
      "prevent",
      "relieve",
      "symptoms"
    ]
  },
  {
    "id": "1c37369feb1521042645c3df7066bc48",
    "content": "Increase intake of fluid and roughage\nAvoid prolonged straining at defecation\nFor prolapsed haemorrhoids, lie patient down and elevate the foot end of the bed. Try gentle digital reduction after application of local anaesthetic cream. If this fails, apply cold compresses.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "169",
    "type": "section",
    "keywords": [
      "avoid",
      "prolonged",
      "compresses",
      "digital",
      "local",
      "down",
      "anaesthetic",
      "application",
      "patient",
      "increase",
      "fluid",
      "gentle",
      "defecation",
      "prolapsed",
      "cold",
      "intake",
      "haemorrhoids",
      "reduction",
      "straining",
      "elevate"
    ]
  },
  {
    "id": "e5679dd6649c7c4d965809b20eb45fd5",
    "content": "Sedation of the patient may be required\nFor infected haemorrhoids, warm sitz baths 2-3 times a day.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "170",
    "type": "section",
    "keywords": [
      "sitz",
      "infected",
      "warm",
      "sedation",
      "required",
      "times",
      "haemorrhoids",
      "patient",
      "baths"
    ]
  },
  {
    "id": "7a160963ffa58732e8638319c298393d",
    "content": "Rubber band ligation for second-degree haemorrhoids. Haemorrhoidectomy for third degree haemorrhoids. Haemorrhoids developing during pregnancy should be man- aged conservatively as most will resolve after delivery.",
    "title": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "section": "Chapter 1: Dısorders of the Gastroıntestınal Tract",
    "chunk_id": "171",
    "type": "section",
    "keywords": [
      "developing",
      "aged",
      "resolve",
      "third",
      "ligation",
      "should",
      "degree",
      "haemorrhoidectomy",
      "rubber",
      "during",
      "conservatively",
      "pregnancy",
      "most",
      "second",
      "after",
      "haemorrhoids",
      "band",
      "delivery"
    ]
  },
  {
    "id": "f27f699d28e4a2bee98b134197125490",
    "content": "When associated with constipation\nEvidence Rating: [C]\nLiquid paraffin, oral,\nAdults\n10-30 ml at night\nOr\nSenna granules, oral,\nAdults\n1 sachet with water after supper\nWhen associated with local itching or discomfort\nSoothing agent (with or without steroids), applied or inserted rec- tally,\nAdults\nOne suppository 12 hourly for 7-10 days.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "172",
    "type": "section",
    "keywords": [
      "local",
      "sachet",
      "agent",
      "granules",
      "discomfort",
      "associated",
      "paraffin",
      "senna",
      "night",
      "evidence",
      "hourly",
      "rating",
      "applied",
      "water",
      "tally",
      "constipation",
      "steroids",
      "days",
      "inserted",
      "liquid"
    ]
  },
  {
    "id": "6f8bc1fe5179f09dda47e884c3c70bb4",
    "content": "Gentamicin, IV,\nAdults\n40-80 mg 8 hourly for 5 to 7 days\nAnd\nMetronidazole, oral,\nAdults\n400 mg 8 hourly for 5 to 7 days.",
    "title": "For infected haemorrhoids 1st Line treatment Evidence Rating: [B]",
    "section": "For infected haemorrhoids 1st Line treatment Evidence Rating: [B]",
    "chunk_id": "173",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "gentamicin",
      "adults",
      "oral"
    ]
  },
  {
    "id": "95683bdf7263384cef448ee2468c4aec",
    "content": "Ciprofloxacin, oral,\nAdults\n500 mg 12 hourly\nAnd\nMetronidazole, oral,\nAdults\n400 mg 8 hourly for 5 - 7 days.",
    "title": "2nd Line treatment Evidence Rating: [B]",
    "section": "2nd Line treatment Evidence Rating: [B]",
    "chunk_id": "174",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "adults",
      "oral",
      "ciprofloxacin"
    ]
  },
  {
    "id": "659df255a63776104d9577df4bf1e1da",
    "content": "And\nMetronidazole, oral,\nAdults\n400 mg 8 hourly for 5 to 7 days\nWhen associated with anaemia\nIron preparation (ferrous sulphate/fumarate) (See section on ‘Anae- mia’)\nOr\nBlood transfusion as indicated\nReferral Criteria\nThe patient should be referred to a facility with resources for rubber band ligation or operative treatment if indicated.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "175",
    "type": "section",
    "keywords": [
      "metronidazole",
      "sulphate",
      "anaemia",
      "preparation",
      "associated",
      "patient",
      "hourly",
      "facility",
      "section",
      "ferrous",
      "criteria",
      "blood",
      "treatment",
      "days",
      "fumarate",
      "referral",
      "should",
      "adults",
      "resources",
      "rubber"
    ]
  },
  {
    "id": "786eaf57d1993a30a9b56297ba7548c3",
    "content": "Amoebic liver abscess is a collection of typically brownish coloured fluid in the liver, occurring often as a single mass in the right lobe and a complication of intestinal infection with Entamoeba histolytica. Lung, heart and brain infections are uncommon sequelae. Occasionally, pyogenic abscesses may have a similar clinical presentation.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "176",
    "type": "section",
    "keywords": [
      "infections",
      "often",
      "lobe",
      "typically",
      "fluid",
      "abscess",
      "entamoeba",
      "right",
      "complication",
      "single",
      "presentation",
      "intestinal",
      "histolytica",
      "heart",
      "coloured",
      "collection",
      "similar",
      "pyogenic",
      "occasionally",
      "amoebic"
    ]
  },
  {
    "id": "f4c609f5a3b19f103b331bd94fcf4197",
    "content": "Treatment of amoebic abscesses should be initiated with a tissue agent active against the trophozoite form followed by a luminal agent to eliminate intra-luminal cysts. Causes\nEntamoeba histolytica\nSymptoms\nRight upper abdominal pain referable to the epigastrium, right chest or right shoulder\nFever\nMalaise\nSweats\nCough\nHiccups\nAnorexia\nWeight loss\nJaundice (uncommon)\nConcurrent diarrhoea (less than one-third of patients)\nSigns\nLarge tender liver\nTenderness and/or bulging at right intercostal spaces\nJaundice\nDullness to percussion on the right lower chest zones with basal crepitations\nAmoebic empyema following extension into the chest cavity\nPeritonitis (uncommon).",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "177",
    "type": "section",
    "keywords": [
      "intra",
      "bulging",
      "peritonitis",
      "weight",
      "intercostal",
      "agent",
      "form",
      "spaces",
      "dullness",
      "into",
      "diarrhoea",
      "abdominal",
      "epigastrium",
      "upper",
      "entamoeba",
      "chest",
      "basal",
      "right",
      "following",
      "large"
    ]
  },
  {
    "id": "59975f899ee214c3cdb72891ad72f781",
    "content": "investigations\nAbdominal ultrasound\nChest X-ray\nFBC\nESR\nStool examination\nAbdominal CT scan\nSerology (amoebic antibodies).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "178",
    "type": "section",
    "keywords": [
      "ultrasound",
      "abdominal",
      "serology",
      "antibodies",
      "chest",
      "scan",
      "investigations",
      "stool",
      "examination",
      "amoebic"
    ]
  },
  {
    "id": "82d2d59aa5359d773ee88c065f4bbeea",
    "content": "To eradicate Entamoeba histolytica infection\nTo prevent further destruction of liver tissue\nTo prevent further complications (e. g. rupture of abscess into pleural, pericardial or peritoneal space).",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "179",
    "type": "section",
    "keywords": [
      "peritoneal",
      "abscess",
      "complications",
      "entamoeba",
      "pleural",
      "prevent",
      "infection",
      "pericardial",
      "space",
      "eradicate",
      "further",
      "rupture",
      "histolytica",
      "liver",
      "tissue",
      "into",
      "destruction"
    ]
  },
  {
    "id": "013b4df4877a91d5f9b2b222a36b24a8",
    "content": "Therapeutic aspiration may be required in patients with poor\nresponse to therapy.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "180",
    "type": "section",
    "keywords": [
      "aspiration",
      "therapeutic",
      "response",
      "poor",
      "patients",
      "required",
      "therapy"
    ]
  },
  {
    "id": "a5cd912024e33bcb2a88ad4ba3eb33b9",
    "content": "Metronidazole, oral,\nAdults\n800 mg 8 hourly for 10 days (tissue agent)\nChildren\n15 mg/kg 8 hourly for 10 days (tissue agent)\nThen\nDiloxanide furoate, oral,\nAdults\n500 mg 8 hourly for 10 days (luminal agent)\nChildren\nmg/kg 8 hourly for 10 days (luminal agent).",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "181",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "diloxanide",
      "furoate",
      "agent",
      "adults",
      "luminal",
      "oral",
      "children",
      "then",
      "tissue"
    ]
  },
  {
    "id": "1c4f6dabaf720be615138083be34e282",
    "content": "Tinidazole, oral,\nAdults\n2 g once daily for 5 days (tissue agent)\nChildren\n3 years; 50 mg/kg (max. 2 g) once daily for 5 days (tissue agent)\nThen\nParomomycin, oral,\nAdults\n8-10 mg/kg 8 hourly for 7 days (luminal agent)\nChildren\n8-10 mg/kg 8 hourly for 7 days (luminal agent).",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "182",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "tinidazole",
      "years",
      "agent",
      "adults",
      "luminal",
      "oral",
      "paromomycin",
      "children",
      "then",
      "tissue",
      "once",
      "daily"
    ]
  },
  {
    "id": "8b839f9438b30d887c540398462f0439",
    "content": "Referral Criteria\nPatients with abscesses that are large or not responding to treatment will need to be referred to a specialist. Jaundice refers to yellow pigmentation of skin, palms and the sclerae as a result of elevated levels of bilirubin in blood. It may be visible when serum levels exceed 35 micromol/L in adults and 100 micromol/L in children.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "183",
    "type": "section",
    "keywords": [
      "bilirubin",
      "levels",
      "refers",
      "specialist",
      "visible",
      "exceed",
      "large",
      "jaundice",
      "result",
      "need",
      "patients",
      "children",
      "criteria",
      "blood",
      "treatment",
      "palms",
      "yellow",
      "referral",
      "pigmentation",
      "adults"
    ]
  },
  {
    "id": "d68a0cde8c0d640d84e249713727c26f",
    "content": "The symptoms and signs that accompany jaundice often provide helpful clues to the underlying cause. In adults and children, hyperbilirubinaemia may result in hepatic encephalopathy (See sections on ‘Acute and Chronic Hepatitis’ and ‘Hepatic Encephalopathy’). Jaundice in neonates can result in kernicterus (bilirubin encephalopathy) because of the consequences of hyperbilirubinaemia on the brain of the newborn.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "184",
    "type": "section",
    "keywords": [
      "bilirubin",
      "neonates",
      "encephalopathy",
      "often",
      "hyperbilirubinaemia",
      "clues",
      "acute",
      "helpful",
      "jaundice",
      "result",
      "underlying",
      "signs",
      "children",
      "sections",
      "chronic",
      "kernicterus",
      "because",
      "adults",
      "cause",
      "accompany"
    ]
  },
  {
    "id": "be5b2c9e36eae17979db9f2c53904f29",
    "content": "(See section on ‘Neonatal Jaundice’)\nCauses Adults\nHepatitis - viral, alcoholic, drug-induced including allopathic and\nherbal preparations\nHaemolysis - various causes including malaria, Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency and sickle cell disease, allopathic drugs and herbal preparations.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "185",
    "type": "section",
    "keywords": [
      "phosphate",
      "herbal",
      "glucose",
      "induced",
      "including",
      "dehydrogenase",
      "jaundice",
      "section",
      "drug",
      "preparations",
      "malaria",
      "causes",
      "allopathic",
      "alcoholic",
      "deficiency",
      "disease",
      "neonatal",
      "haemolysis",
      "adults",
      "sickle"
    ]
  },
  {
    "id": "37e51d1569027587eae7206a412ba3a6",
    "content": "chronic hepatitis, hepatocellular carcinoma\nLiver malignancies - hepatocellular carcinoma, metastatic liver.",
    "title": "Chronic liver diseases - decompensated cirrhosis, biliary cirrhosis,",
    "section": "Chronic liver diseases - decompensated cirrhosis, biliary cirrhosis,",
    "chunk_id": "186",
    "type": "section",
    "keywords": [
      "chronic",
      "malignancies",
      "hepatocellular",
      "metastatic",
      "carcinoma",
      "hepatitis",
      "liver"
    ]
  },
  {
    "id": "1d55102470c8c0c7874500220349a481",
    "content": "Infections - malaria, hepatitis, urinary tract infections, typhoid fever and other septicaemic illnesses\nPregnancy\n(See section on ‘Jaundice in Pregnancy’)\nNeonates\n(See section on ‘Neonatal Jaundice’)\nSymptoms\nYellow or greenish discolouration of the eyes or skin\nDeep yellow discolouration of urine\nItching\nPale stools.",
    "title": "Haemolysis - sickle cell disease, G6PD deficiency, drugs",
    "section": "Haemolysis - sickle cell disease, G6PD deficiency, drugs",
    "chunk_id": "187",
    "type": "section",
    "keywords": [
      "infections",
      "pale",
      "neonates",
      "urine",
      "discolouration",
      "typhoid",
      "section",
      "jaundice",
      "stools",
      "pregnancy",
      "malaria",
      "yellow",
      "tract",
      "neonatal",
      "greenish",
      "deep",
      "fever",
      "skin",
      "hepatitis",
      "symptoms"
    ]
  },
  {
    "id": "3ef6e54ac033a7c828899beea0e01f85",
    "content": "Hepatomegaly (may be tender)\nSplenomegaly in portal hypertension\nPalpable gall bladder\nAscites\nBleeding\t(cephalhaematoma,\tsubgaleal\thaematoma,\tupper gastrointestinal bleeding)\nHepatic flap (indicative of liver failure)\ninvestigations Adults and children\nFBC\nINR\nSickling status\nG6PD status\nBlood film for red cell anomalies, malaria parasites\nLiver function tests\nUrea and electrolytes\nHepatitis screen (HBsAg, HCV Antibody, Hepatitis A IgM, Hepatitis E IgM)\nBlood culture\nUrinalysis\nAbdominal ultrasound\nAbdominal CT scan.",
    "title": "Stigmata of chronic liver disease (e.g. palmar erythema, clubbing, spider naevi)",
    "section": "Stigmata of chronic liver disease (e.g. palmar erythema, clubbing, spider naevi)",
    "chunk_id": "188",
    "type": "section",
    "keywords": [
      "hypertension",
      "ultrasound",
      "sickling",
      "hepatomegaly",
      "indicative",
      "parasites",
      "hbsag",
      "abdominal",
      "function",
      "bleeding",
      "film",
      "haematoma",
      "splenomegaly",
      "flap",
      "urinalysis",
      "culture",
      "palpable",
      "tender",
      "children",
      "ascites"
    ]
  },
  {
    "id": "9aa406f094e420065ae594d482329b0c",
    "content": "To identify and treat cause of jaundice\nTo relieve symptoms associated with jaundice\nTo prevent complications associated with elevated levels of bilirubin\nin the blood.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "189",
    "type": "section",
    "keywords": [
      "bilirubin",
      "complications",
      "treat",
      "blood",
      "prevent",
      "jaundice",
      "levels",
      "cause",
      "relieve",
      "elevated",
      "associated",
      "identify",
      "symptoms"
    ]
  },
  {
    "id": "8004951b0b5dd551f8287ef88fdf3d02",
    "content": "Adults and children\n(See section on ‘Hepatic encephalopathy’, Hepatitis’)\nAvoid alcohol and other hepatotoxic agents\nEnsure adequate hydration.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "190",
    "type": "section",
    "keywords": [
      "hydration",
      "avoid",
      "agents",
      "ensure",
      "adequate",
      "encephalopathy",
      "hepatotoxic",
      "alcohol",
      "section",
      "other",
      "adults",
      "children",
      "hepatitis",
      "hepatic"
    ]
  },
  {
    "id": "c94d2f7c47bb5d642faade1b2212739c",
    "content": "A. Cholestatic jaundice with severe pruritus while investigating for underlying aetiology.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "191",
    "type": "section",
    "keywords": [
      "severe",
      "pruritus",
      "investigating",
      "jaundice",
      "underlying",
      "aetiology",
      "while",
      "cholestatic"
    ]
  },
  {
    "id": "0194fcf48d36786875b9a651dc6f1e3d",
    "content": "Cholestyramine, oral,\nAdult\n4 g 12 hourly (titrate dose to response and tolerance: max. 16 g/day)\nChildren and Adolescents\ng 12 hourly (max. 8 g/day)\nReferral Criteria\nRefer patients with unexplained jaundice to a specialist for further evaluation and management.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "192",
    "type": "section",
    "keywords": [
      "adolescents",
      "management",
      "hourly",
      "specialist",
      "evaluation",
      "titrate",
      "jaundice",
      "patients",
      "children",
      "criteria",
      "referral",
      "cholestyramine",
      "adult",
      "response",
      "further",
      "dose",
      "tolerance",
      "refer",
      "unexplained",
      "oral"
    ]
  },
  {
    "id": "7ace8f2cc7c688c505b6dd1e76cffa51",
    "content": "Hepatitis is defined as inflammation of the liver and has multiple causes. It may present as an acute illness with jaundice and altered liver function tests. When symptoms, signs or laboratory abnormalities persist for more than 6 months it is considered chronic.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "193",
    "type": "section",
    "keywords": [
      "persist",
      "abnormalities",
      "acute",
      "multiple",
      "inflammation",
      "function",
      "jaundice",
      "altered",
      "signs",
      "causes",
      "chronic",
      "tests",
      "months",
      "hepatitis",
      "symptoms",
      "laboratory",
      "present",
      "considered",
      "illness",
      "more"
    ]
  },
  {
    "id": "df12da3b896066e5af8e305faff68d4e",
    "content": "Causes\nViruses (Hepatitis A, B, C, D and E, Yellow Fever etc. )\nDrugs (allopathic, alternative and herbal preparations)\nAlcohol\nAutoimmune\nSymptoms\nRight hypochondrial pain\nFever (occurring 1 to 4 weeks before the jaundice appears)\nMalaise\nAnorexia\nNausea\nVomiting\nYellow or dark coloured urine\nPale stools\nItching\nFatigue\nConfusion\nSigns\nJaundice\nRight hypochondrial tenderness\nHepatomegaly\nAsterixis\ninvestigations\nFBC\nLiver function tests\nHepatitis screen (HBsAg, HCV Antibody, Hepatitis A IgM, Hepatitis E IgM)\nAntinuclear Antibody, Anti-smooth muscle Antibody.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "194",
    "type": "section",
    "keywords": [
      "nausea",
      "pale",
      "hepatomegaly",
      "fatigue",
      "herbal",
      "urine",
      "appears",
      "hbsag",
      "antinuclear",
      "right",
      "alternative",
      "alcohol",
      "function",
      "jaundice",
      "preparations",
      "stools",
      "muscle",
      "signs",
      "weeks",
      "smooth"
    ]
  },
  {
    "id": "6def100843c16f769a02fc5e257164ac",
    "content": "To identify and eliminate the precipitating cause\nTo relieve symptoms.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "195",
    "type": "section",
    "keywords": [
      "precipitating",
      "cause",
      "relieve",
      "eliminate",
      "identify",
      "symptoms"
    ]
  },
  {
    "id": "e8dd7ac70bf25cb95c2c04abfcd9ec4e",
    "content": "Rest\nHigh calorie fluids (especially glucose drinks, fruit juice, light porridge, koko, rice-water, mashed kenkey)\nIntravenous fluids if volume deplete\nAny food that the patient can tolerate\nAvoid alcohol.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "196",
    "type": "section",
    "keywords": [
      "avoid",
      "intravenous",
      "deplete",
      "especially",
      "rice",
      "mashed",
      "glucose",
      "light",
      "patient",
      "fruit",
      "porridge",
      "juice",
      "drinks",
      "calorie",
      "alcohol",
      "water",
      "fluids",
      "tolerate",
      "volume",
      "rest"
    ]
  },
  {
    "id": "92580c99a98fd3579ea3422cc307ed22",
    "content": "Referral Criteria\nRefer patients with rapidly progressing symptoms and signs to a physician specialist. This refers to chronic inflammation of the liver of more than 6 months duration, with persistently elevated liver function tests. Chronic hepatitis can progress to liver cirrhosis, portal hypertension with upper gastrointestinal bleeding, hepatic encephalopathy and hepatocellular carcinoma.",
    "title": "Supportive care (analgesia, fluid replacement, etc. as required)",
    "section": "Supportive care (analgesia, fluid replacement, etc. as required)",
    "chunk_id": "197",
    "type": "section",
    "keywords": [
      "hypertension",
      "encephalopathy",
      "progressing",
      "refers",
      "specialist",
      "inflammation",
      "function",
      "bleeding",
      "persistently",
      "signs",
      "patients",
      "criteria",
      "gastrointestinal",
      "physician",
      "referral",
      "chronic",
      "hepatocellular",
      "duration",
      "progress",
      "elevated"
    ]
  },
  {
    "id": "47424931214d284dadca8e65b717898c",
    "content": "Immunisation against Hepatitis B is now available for children under the Expanded Programme on Immunisation (EPI). Adults in endemic areas including Ghana should be immunised against Hepatitis B infection after initial assessment of their immunological status regarding previous exposure to the virus. Long-term monitoring for disease activity and hepatocellular carcinoma screening with six-monthly Hepatitis B viral DNA quantification, LFTs, abdominal ultrasound and alpha fetoprotein is mandatory for patients with chronic hepatitis B.",
    "title": "Supportive care (analgesia, fluid replacement, etc. as required)",
    "section": "Supportive care (analgesia, fluid replacement, etc. as required)",
    "chunk_id": "198",
    "type": "section",
    "keywords": [
      "ultrasound",
      "initial",
      "monitoring",
      "activity",
      "virus",
      "mandatory",
      "programme",
      "monthly",
      "under",
      "abdominal",
      "quantification",
      "expanded",
      "including",
      "immunological",
      "regarding",
      "immunised",
      "screening",
      "patients",
      "children",
      "their"
    ]
  },
  {
    "id": "fca84cd0c63d27169738ea139e3a2e77",
    "content": "Causes\nHepatitis B virus (HBV)\nHepatitis C virus (HCV)\nHepatitis E virus (genotype 3).",
    "title": "Supportive care (analgesia, fluid replacement, etc. as required)",
    "section": "Supportive care (analgesia, fluid replacement, etc. as required)",
    "chunk_id": "199",
    "type": "section",
    "keywords": [
      "hepatitis",
      "genotype",
      "causes",
      "virus"
    ]
  },
  {
    "id": "e632fd6262dcef3abf1719380e2e3bff",
    "content": "Symptoms\nUsually asymptomatic\nMild non-specific symptoms\nRecurrent fever\nArthralgia\nMalaise\nJaundice\nLethargy\nSigns.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "200",
    "type": "section",
    "keywords": [
      "usually",
      "recurrent",
      "lethargy",
      "jaundice",
      "fever",
      "specific",
      "signs",
      "malaise",
      "arthralgia",
      "symptoms",
      "mild",
      "asymptomatic"
    ]
  },
  {
    "id": "a4aad04ac25bb260a74cccdf9e225cd4",
    "content": "Palmar erythema\nClubbing\nDupuytren’s contracture\nParotid enlargement\nGynaecomastia\nTesticular atrophy\nSpider naevi.",
    "title": "Stigmata of chronic liver disease",
    "section": "Stigmata of chronic liver disease",
    "chunk_id": "201",
    "type": "section",
    "keywords": [
      "gynaecomastia",
      "erythema",
      "spider",
      "testicular",
      "contracture",
      "parotid",
      "naevi",
      "enlargement",
      "palmar",
      "atrophy",
      "dupuytren",
      "clubbing"
    ]
  },
  {
    "id": "257077776f7ae3f8601754a79fefe183",
    "content": "Jaundice\nAscites\nEncephalopathy\nPeripheral oedema (hypoalbuminaemia)\nPurpura/skin bruising (coagulopathy)\ninvestigations\nFBC\nLFTs\nINR\nHIV\nBaseline Alpha-Feto-protein\nAbdominal ultrasound scan\nLiver biopsy\nChronic Hepatitis B\nHepatitis B surface Antigen (HBsAg)\nHBc IgG\nHepatitis-B-e-antigen (HBeAg) & Anti-HBe\nHepatitis B Viral Load\nChronic Hepatitis C\nHepatitis C Virus (HCV) antibody testing\nHCV RNA\nHCV genotyping.",
    "title": "Signs of decompensated liver disease",
    "section": "Signs of decompensated liver disease",
    "chunk_id": "202",
    "type": "section",
    "keywords": [
      "ultrasound",
      "oedema",
      "virus",
      "encephalopathy",
      "hbeag",
      "feto",
      "hbsag",
      "abdominal",
      "jaundice",
      "surface",
      "protein",
      "baseline",
      "ascites",
      "load",
      "chronic",
      "lfts",
      "genotyping",
      "alpha",
      "testing",
      "skin"
    ]
  },
  {
    "id": "9b5826ed3eebd02fa7d5f28e0bff19b9",
    "content": "To improve synthetic liver function through viral suppression\nTo prevent transmission.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "203",
    "type": "section",
    "keywords": [
      "synthetic",
      "improve",
      "function",
      "prevent",
      "transmission",
      "suppression",
      "through",
      "liver",
      "viral"
    ]
  },
  {
    "id": "95cd9c9bc53dec9e987e54d4d2868ee5",
    "content": "Prevention of transmission to partners (e. g. protected sex, not sharing of toothbrushes and sharps, blades, needles, body piercings, tattoos, cultural scarification practices, circumcisions etc.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "204",
    "type": "section",
    "keywords": [
      "body",
      "piercings",
      "prevention",
      "toothbrushes",
      "practices",
      "transmission",
      "sharps",
      "partners",
      "cultural",
      "scarification",
      "needles",
      "protected",
      "sharing",
      "tattoos",
      "blades",
      "circumcisions"
    ]
  },
  {
    "id": "1140a2e9827b811e89a84316d7e7caa1",
    "content": ")\nLifestyle/dietary advice\nSpouse/household screening.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "205",
    "type": "section",
    "keywords": [
      "advice",
      "household",
      "dietary",
      "screening",
      "lifestyle",
      "spouse"
    ]
  },
  {
    "id": "a789b811bcc33dc6a9bde60d6d49f4a9",
    "content": "Chronic Active Hepatitis B (HBeAg positive or HBeAg negative).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "206",
    "type": "section",
    "keywords": [
      "chronic",
      "hbeag",
      "active",
      "negative",
      "hepatitis",
      "positive"
    ]
  },
  {
    "id": "620564abb637e76b7714e79f7fc5dfa5",
    "content": "Pegylated Interferon alfa-2a, subcutaneous,\nOr\nTenofovir, oral,\nOr\nEntecavir, oral,.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "207",
    "type": "section",
    "keywords": [
      "subcutaneous",
      "tenofovir",
      "alfa",
      "interferon",
      "pegylated",
      "oral",
      "entecavir"
    ]
  },
  {
    "id": "abacc530e96ac0d9677aa286518e1962",
    "content": "Lamivudine, oral,\nDecompensated liver cirrhosis/ Fulminant Liver failure from.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "208",
    "type": "section",
    "keywords": [
      "cirrhosis",
      "lamivudine",
      "decompensated",
      "fulminant",
      "oral",
      "failure",
      "liver"
    ]
  },
  {
    "id": "625c3524218e88890714bbf225bf992a",
    "content": "Referral Criteria\nRefer all cases of chronic hepatitis B infection to a specialist, especially those who have failed first-line anti-viral therapy or had adverse reactions to anti-viral therapy or have liver-related complications (e. g. liver cirrhosis, liver failure, liver mass, signs of portal hypertension, ascites, peripheral oedema, hypoalbuminaemia).",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "209",
    "type": "section",
    "keywords": [
      "hypertension",
      "oedema",
      "especially",
      "therapy",
      "specialist",
      "signs",
      "reactions",
      "ascites",
      "criteria",
      "chronic",
      "referral",
      "first",
      "failed",
      "line",
      "anti",
      "those",
      "failure",
      "portal",
      "hepatitis",
      "related"
    ]
  },
  {
    "id": "93522e8f476064830223a9e17bef5189",
    "content": "Pregnant individuals and patients with hepatitis B co-infections (e. g. HIV/Hepatitis C) as well as those requiring chemotherapy or other immunosuppressive therapy should also be referred to a specialist.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "210",
    "type": "section",
    "keywords": [
      "infections",
      "specialist",
      "those",
      "other",
      "should",
      "also",
      "requiring",
      "individuals",
      "immunosuppressive",
      "patients",
      "pregnant",
      "hepatitis",
      "chemotherapy",
      "therapy",
      "referred"
    ]
  },
  {
    "id": "5aa6428e6060ec80a9f32e8e36bf44af",
    "content": "§HBIG: Hepatitis B Immunoglobulin as soon as possible when indicated (0. 06 ml/kg IM).",
    "title": "*HCW: Healthcare worker",
    "section": "*HCW: Healthcare worker",
    "chunk_id": "211",
    "type": "section",
    "keywords": [
      "immunoglobulin",
      "possible",
      "indicated",
      "hepatitis",
      "soon",
      "hbig"
    ]
  },
  {
    "id": "fd5d7e838ebf65591b8b1c126dc9dfb5",
    "content": "Pegylated Interferon alfa-2a, subcutaneous,\nOr\nPegylated Interferon alfa-2b, subcutaneous,\nAnd\nRibavirin, oral,\nChronic Hepatitis C (Genotype 1 & 4).",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "212",
    "type": "section",
    "keywords": [
      "subcutaneous",
      "chronic",
      "alfa",
      "interferon",
      "genotype",
      "ribavirin",
      "pegylated",
      "oral",
      "hepatitis"
    ]
  },
  {
    "id": "68b2c964f8a527c6c67f1bf1ccbfe43b",
    "content": "Pegylated Interferon alfa-2a, subcutaneous,\nOr\nPegylated Interferon alfa-2b, subcutaneous,\nAnd\nRibavirin, oral,\nReferral Criteria\nRefer all cases of chronic hepatitis C infection to a specialist, especially those who have failed first-line anti-viral therapy or had adverse reactions to anti-viral therapy or have liver-related complications (e. g. liver cirrhosis, liver failure, liver mass, signs of portal hypertension, ascites, peripheral oedema, hypoalbuminaemia).",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "213",
    "type": "section",
    "keywords": [
      "hypertension",
      "oedema",
      "alfa",
      "especially",
      "therapy",
      "specialist",
      "interferon",
      "signs",
      "reactions",
      "ascites",
      "criteria",
      "subcutaneous",
      "referral",
      "chronic",
      "first",
      "failed",
      "line",
      "pegylated",
      "anti",
      "those"
    ]
  },
  {
    "id": "7e13ef213f942bed7e749c51fd99c70b",
    "content": "Pregnant individuals and patients with hepatitis C co-infections (e. g. HIV/Hepatitis B) as well as those requiring chemotherapy or other immunosuppressive therapy should also be referred to a specialist.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "214",
    "type": "section",
    "keywords": [
      "infections",
      "specialist",
      "those",
      "other",
      "should",
      "also",
      "requiring",
      "individuals",
      "immunosuppressive",
      "patients",
      "pregnant",
      "hepatitis",
      "chemotherapy",
      "therapy",
      "referred"
    ]
  },
  {
    "id": "edccf7e44ea0b85ce4c342537d1da726",
    "content": "This condition is a complication of either acute or chronic liver disease. It presents with disordered central nervous system function, due to inability of the liver to detoxify ammonia and other chemicals. Causes\nViral hepatitis\nAlcoholic hepatitis.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "215",
    "type": "section",
    "keywords": [
      "either",
      "presents",
      "acute",
      "nervous",
      "detoxify",
      "complication",
      "function",
      "condition",
      "causes",
      "alcoholic",
      "disease",
      "chronic",
      "chemicals",
      "disordered",
      "inability",
      "hepatitis",
      "viral",
      "ammonia",
      "other",
      "central"
    ]
  },
  {
    "id": "1cbe29a854d78266d0d79eef89abf68e",
    "content": "Cirrhosis of the liver\nHepatocellular carcinoma\nDrugs\te. g. halothane, isoniazid, paracetamol overdose, herbal preparations\nFatty liver of pregnancy.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "216",
    "type": "section",
    "keywords": [
      "drugs",
      "overdose",
      "hepatocellular",
      "cirrhosis",
      "isoniazid",
      "halothane",
      "preparations",
      "paracetamol",
      "herbal",
      "fatty",
      "pregnancy",
      "carcinoma",
      "liver"
    ]
  },
  {
    "id": "d3de0cf7287a77a6dbd47a3ab362e0d5",
    "content": "Fever\nHypotension\nInfection\nFluid and electrolyte imbalance (excessive use of loop diuretics)\nSedatives\nIncreased gastrointestinal tract (GIT) protein load e. g. heavy GIT bleeding, alcoholic binge\nSymptoms\nJaundice\nConfusion\nDisturbed consciousness which progresses as follows: disorder of sleep, hypersomnia and inversion of sleep rhythm, apathy and eventually coma\nPersonality changes\nSigns\nCyanosis\nFetor hepaticus.",
    "title": "Precipitating factors in a patient with pre-existing liver disease:",
    "section": "Precipitating factors in a patient with pre-existing liver disease:",
    "chunk_id": "217",
    "type": "section",
    "keywords": [
      "hepaticus",
      "rhythm",
      "which",
      "cyanosis",
      "progresses",
      "fluid",
      "eventually",
      "imbalance",
      "inversion",
      "bleeding",
      "jaundice",
      "protein",
      "signs",
      "electrolyte",
      "heavy",
      "changes",
      "load",
      "gastrointestinal",
      "apathy",
      "alcoholic"
    ]
  },
  {
    "id": "4f4b210253ccaa196f7d8e42b40fc9eb",
    "content": "Neurological abnormalities:\nSpeech impairment\nAsterixis (a flapping tremor) indicates pre-coma and strongly supports the diagnosis of encephalopathy\nInability to draw or construct objects e. g. a 5-pointed star\nIncoordination\nLethargy\nEncephalopathy\nGrade 1: Mild confusion, irritable, tremor, restless\nGrade 2: Lethargic responses, decreased inhibitions, dis- orientation, agitation, asterixis\nGrade 3: Stuporous but arousable, aggressive bursts, inar-\nticulate speech and marked confusion\nGrade 4: Coma\ninvestigations\nFBC\nBlood glucose\nLiver function tests\nBlood urea and electrolytes\nHepatitis B-surface-Antigen\nHepatitis C screen.",
    "title": "Signs of chronic liver disease",
    "section": "Signs of chronic liver disease",
    "chunk_id": "218",
    "type": "section",
    "keywords": [
      "decreased",
      "encephalopathy",
      "abnormalities",
      "pointed",
      "incoordination",
      "responses",
      "inhibitions",
      "agitation",
      "glucose",
      "indicates",
      "lethargy",
      "construct",
      "speech",
      "neurological",
      "flapping",
      "function",
      "surface",
      "inar",
      "lethargic",
      "ticulate"
    ]
  },
  {
    "id": "d8cb3ccdcfbecf1129fa630ab23a0373",
    "content": "Prothrombin time, INR\nInfection screen (blood culture, urine RE, chest X-Ray, diagnostic ascitic tap).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "219",
    "type": "section",
    "keywords": [
      "ascitic",
      "chest",
      "infection",
      "urine",
      "prothrombin",
      "culture",
      "diagnostic",
      "screen",
      "blood"
    ]
  },
  {
    "id": "56bc950bafdb2b1d70dc9c81e0d8e372",
    "content": "To identify and correct precipitating factors promptly.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "220",
    "type": "section",
    "keywords": [
      "precipitating",
      "correct",
      "factors",
      "identify",
      "promptly"
    ]
  },
  {
    "id": "deb2666dc576d61db3edc7c65540774b",
    "content": "Place in the coma position if unconscious\nMaintain fluid and electrolyte balance (avoid dehydration and\nelectrolyte abnormalities such as hypokalaemia)\nMonitor temperature, pulse and respiratory rate, blood pressure, pupils, urine output and blood glucose regularly\nAvoid alcohol, paracetamol and other hepatotoxic agents\nAvoid sedatives such as benzodiazepines and drugs that impair the coagulation system\nPatients should NOT have their protein intake restricted\nMaintain an adequate protein intake of 1. 2-1. 5 g/kg per day\nEncourage intake of high carbohydrate diet by mouth or NG tube.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "221",
    "type": "section",
    "keywords": [
      "diet",
      "avoid",
      "agents",
      "benzodiazepines",
      "abnormalities",
      "unconscious",
      "urine",
      "glucose",
      "position",
      "fluid",
      "rate",
      "pressure",
      "restricted",
      "carbohydrate",
      "alcohol",
      "impair",
      "protein",
      "place",
      "patients",
      "regularly"
    ]
  },
  {
    "id": "6c1e5b9f87f04c2d39e97c5b447c3b96",
    "content": "Measures to correct hydration status and nutrition\nEvidence Rating: [A]\nAdults\nDextrose saline (5-10% dextrose in 0. 9% saline), IV, 500 ml 8 hourly (according to requirements)\nAnd\nHigh potency Vitamin B, IV, (formulated as two separate vials) One pair of vials daily (added to glucose IV solution)\nChildren\nDextrose saline (4. 3% in 0.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "222",
    "type": "section",
    "keywords": [
      "correct",
      "according",
      "dextrose",
      "solution",
      "glucose",
      "vitamin",
      "measures",
      "evidence",
      "hourly",
      "rating",
      "nutrition",
      "added",
      "saline",
      "children",
      "status",
      "adults",
      "requirements",
      "separate",
      "formulated",
      "vials"
    ]
  },
  {
    "id": "8ab07ad21abb435b2cff776ef9eab989",
    "content": "18% saline), IV,\nAnd\nHigh potency Vitamin B, IV, (formulated as two separate vials)\nMeasures to lower blood ammonia concentration.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "223",
    "type": "section",
    "keywords": [
      "formulated",
      "blood",
      "concentration",
      "vials",
      "ammonia",
      "saline",
      "high",
      "lower",
      "separate",
      "potency",
      "vitamin",
      "measures"
    ]
  },
  {
    "id": "b57e5c36b5500055f6cccb8c0f3bbd0b",
    "content": "Lactulose, oral,\nAdults\nStart with 30-45 ml (20-30 g), 6-12 hourly\n(Review dose to maintain 2-3 semi-solid stools per day)\nChildren and Adolescents\nStart with 5-20 ml 6-12 hourly\n(Review dose to maintain 2-3 semi-solid stools per day)\nNeonates.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "224",
    "type": "section",
    "keywords": [
      "hourly",
      "review",
      "adolescents",
      "start",
      "neonates",
      "maintain",
      "adults",
      "stools",
      "oral",
      "dose",
      "children",
      "solid",
      "lactulose",
      "semi"
    ]
  },
  {
    "id": "66c76a769cf967400a26ddbbcbdce8ef",
    "content": "Start with 0. 5-5 ml 6-12 hourly\n(Review dose to maintain 2-3 semi-solid stools per day)\nOr\nLactulose, rectal,\n300 ml diluted in 700 ml water (via rectal balloon catheter) 4-6 hour- ly, retain in the rectum for 30-60 minutes. (Review dose to maintain 2-3 semi-solid stools per day)\nAnd\nMetronidazole, oral,\nAdults\n400 mg 8 hourly\nChildren\n15 mg/kg 12 hourly\nNeonates\n2 kg;\t15 mg/kg 12 hourly\n1-2 kg;\t7.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "225",
    "type": "section",
    "keywords": [
      "metronidazole",
      "balloon",
      "hour",
      "neonates",
      "catheter",
      "retain",
      "lactulose",
      "hourly",
      "review",
      "rectal",
      "start",
      "minutes",
      "stools",
      "water",
      "children",
      "solid",
      "adults",
      "dose",
      "rectum",
      "semi"
    ]
  },
  {
    "id": "a827ebaafe8184e85fdbf821da78095b",
    "content": "Rifaximin, oral,\nAdults\n550 mg 12 hourly\nChildren\n12 years;\t200 mg 8 hourly\n< 12 years;\tnot recommended\nHepatic encephalopathy associated with active bleeding (iNR > 1. 5\nor platelet count < 50 x 109 /L)\nAdults and Children (liaise with Haematology)\nFresh frozen plasma, IV, (for INR >1. 5)\nOr\nPlatelet concentrate, IV, (platelet count < 50 x 109 /L)\nAntibiotic prophylaxis in Hepatic encephalopathy (associated with\ncirrhosis and upper gastro-intestinal haemorrhage) Patients in whom oral administration is not possible, Evidence Rating: [A]\nCiprofloxacin, IV,\nAdults\n400 mg 8-12 hourly (administered over 60 minutes)\nOr\nCeftriaxone, IV, 1 g daily for 7 days\nOr\nCiprofloxacin, oral, 500 mg 12 hourly\nOr\nNorfloxacin, oral, 400 mg 12 hourly for 7 days.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "226",
    "type": "section",
    "keywords": [
      "years",
      "encephalopathy",
      "plasma",
      "associated",
      "antibiotic",
      "evidence",
      "ciprofloxacin",
      "hourly",
      "liaise",
      "rating",
      "whom",
      "minutes",
      "count",
      "frozen",
      "bleeding",
      "fresh",
      "intestinal",
      "patients",
      "children",
      "daily"
    ]
  },
  {
    "id": "4a234a2989e91e28f39767470e5498db",
    "content": "Hepatic encephalopathy precipitated by bacterial infection.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "227",
    "type": "section",
    "keywords": [
      "encephalopathy",
      "infection",
      "bacterial",
      "precipitated",
      "hepatic"
    ]
  },
  {
    "id": "1363fecb50eba3b27674a7dbd22b2b2a",
    "content": "Ciprofloxacin, IV, 400 mg 8-12 hourly for 2 days (to be administered\nover 60 minutes)\nThen\nCiprofloxacin, oral, 500 mg 12 hourly for 5 days.",
    "title": "Evidence Rating: [A] 1st Line treatment",
    "section": "Evidence Rating: [A] 1st Line treatment",
    "chunk_id": "228",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "minutes",
      "oral",
      "administered",
      "then",
      "ciprofloxacin"
    ]
  },
  {
    "id": "68edf848e5cb741014545e329fcf263e",
    "content": "Cefotaxime, IV, 2 g 8 hourly for 7 days Or\nCeftriaxone, IV, 2 g daily for 7 days\nReferral Criteria\nRefer patients if the condition does not improve. All children with hepatic encephalopathy must be referred to a specialist. Ascites is the accumulation of excess fluid within the peritoneal cavity.",
    "title": "2nd Line treatment",
    "section": "2nd Line treatment",
    "chunk_id": "229",
    "type": "section",
    "keywords": [
      "encephalopathy",
      "improve",
      "fluid",
      "hourly",
      "within",
      "specialist",
      "patients",
      "condition",
      "children",
      "ascites",
      "criteria",
      "days",
      "referral",
      "excess",
      "does",
      "referred",
      "cefotaxime",
      "ceftriaxone",
      "must",
      "refer"
    ]
  },
  {
    "id": "2f18c73bed667f42c5b13921fc449aad",
    "content": "Causes\nPortal hypertension secondary to liver cirrhosis\nRenal failure\nNephrotic syndrome\nCardiac failure\nAbdominal tuberculosis\nIntra-abdominal or pelvic malignancies\nSymptoms\nAbdominal enlargement\nAbdominal discomfort or pain\nDifficulty breathing\nSigns\nDistended abdomen.",
    "title": "2nd Line treatment",
    "section": "2nd Line treatment",
    "chunk_id": "230",
    "type": "section",
    "keywords": [
      "hypertension",
      "intra",
      "discomfort",
      "breathing",
      "secondary",
      "distended",
      "abdominal",
      "nephrotic",
      "signs",
      "renal",
      "causes",
      "pelvic",
      "malignancies",
      "difficulty",
      "tuberculosis",
      "failure",
      "portal",
      "enlargement",
      "abdomen",
      "symptoms"
    ]
  },
  {
    "id": "195e45eef1e8e35c50196ce5a98f76cf",
    "content": "Shifting dullness\nFluid thrill\nAbdominal tenderness\nSigns relating to the underlying causes (See appropriate section)\ninvestigations\nFBC\nBUE & Creatinine\nLFTs\nINR\nUrinalysis\nAbdomino-pelvic ultrasound\nChest X-ray\nDiagnostic paracentesis\nAppearance and colour\nGram stain\nCell count and differential\nBiochemistry e. g. Albumin\nMicroscopy, culture (with bedside inoculation of aerobic & an- aerobic blood culture bottles)\nAcid fast bacilli\nCytology.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "231",
    "type": "section",
    "keywords": [
      "ultrasound",
      "appearance",
      "bottles",
      "inoculation",
      "shifting",
      "aerobic",
      "diagnostic",
      "albumin",
      "dullness",
      "fluid",
      "creatinine",
      "abdominal",
      "microscopy",
      "bedside",
      "chest",
      "count",
      "section",
      "underlying",
      "signs",
      "urinalysis"
    ]
  },
  {
    "id": "64ec1628b6dd4c0c788dd9d7c8120203",
    "content": "To relieve symptoms\nTo identify and manage underlying cause.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "232",
    "type": "section",
    "keywords": [
      "manage",
      "cause",
      "relieve",
      "underlying",
      "identify",
      "symptoms"
    ]
  },
  {
    "id": "05d0c6bec1114213f704e1c3e547d617",
    "content": "Bed rest\nSalt restriction <2 g/day\nFluid restriction to ≤1. 5 L/day\nAvoid NSAID-use\nAlcohol abstinence\nTherapeutic paracentesis (sterile abdominal tap) if ascites is tense\nand/or there is respiratory embarrassment.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "233",
    "type": "section",
    "keywords": [
      "avoid",
      "salt",
      "restriction",
      "abdominal",
      "alcohol",
      "therapeutic",
      "abstinence",
      "sterile",
      "respiratory",
      "there",
      "rest",
      "embarrassment",
      "ascites",
      "nsaid",
      "paracentesis",
      "tense",
      "fluid"
    ]
  },
  {
    "id": "f0d1c1bad0b7516384cad8893c1dbd0d",
    "content": "Children\n0. 3-3 mg/kg daily\nAnd\nFurosemide, oral,\nAdults\n20-80 mg daily\nChildren\n1-2 mg/kg daily\nMassive ascites in liver cirrhosis with respiratory embarrassment\nrequiring more than 5 litres of fluid drainage.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "234",
    "type": "section",
    "keywords": [
      "furosemide",
      "litres",
      "cirrhosis",
      "drainage",
      "adults",
      "massive",
      "oral",
      "respiratory",
      "requiring",
      "more",
      "children",
      "embarrassment",
      "ascites",
      "liver",
      "daily",
      "fluid"
    ]
  },
  {
    "id": "b79acad19b97513aeab3a58ebf366bca",
    "content": "Salt-poor human albumin solution, IV, 6-8 g per litre of ascitic fluid\ndrained\nReferral Criteria\nPatients with the following conditions must be referred to a specialist. Poor response to diuretic therapy or diuretic-refractory ascites, complicated cirrhotic ascites with suspected spontaneous bacterial peritonitis, hepato-renal syndrome, and hepatic encephalopathy. Also refer when an underlying cause cannot be identified.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "235",
    "type": "section",
    "keywords": [
      "salt",
      "peritonitis",
      "encephalopathy",
      "poor",
      "albumin",
      "therapy",
      "fluid",
      "ascitic",
      "specialist",
      "following",
      "identified",
      "litre",
      "underlying",
      "patients",
      "ascites",
      "criteria",
      "renal",
      "referral",
      "complicated",
      "cirrhotic"
    ]
  },
  {
    "id": "9be6792f2a5bd1c195e3a75e89d2cbed",
    "content": "Vomiting can be induced by a variety of disease processes including gastrointestinal, neurologic, renal, psychiatric, cardiovascular, endocrine, pain and the effects of drugs. The best course of action in identifying the underlying cause is to carry out a detailed clinical evaluation and management plan, looking out for the aetiology, consequences and potential complications of vomiting. Severe uncontrolled vomiting can result in significant dehydration and electrolyte imbalance accompanied by renal complications.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "236",
    "type": "section",
    "keywords": [
      "psychiatric",
      "management",
      "processes",
      "induced",
      "potential",
      "plan",
      "imbalance",
      "evaluation",
      "including",
      "result",
      "uncontrolled",
      "underlying",
      "aetiology",
      "identifying",
      "electrolyte",
      "renal",
      "gastrointestinal",
      "severe",
      "disease",
      "dehydration"
    ]
  },
  {
    "id": "6f620cbe16246685de6d19c6090d8b97",
    "content": "Anti-emetics should be prescribed only when the cause of vomiting is known as they may delay diagnosis. Causes\nDisorders of the gastro-intestinal tract (GIT) and liver: intestinal obstruction, peptic ulcer, pancreatitis, cholecystitis, gastroenteritis, hepatitis.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "237",
    "type": "section",
    "keywords": [
      "ulcer",
      "delay",
      "gastroenteritis",
      "pancreatitis",
      "known",
      "intestinal",
      "obstruction",
      "emetics",
      "causes",
      "tract",
      "diagnosis",
      "should",
      "cause",
      "peptic",
      "only",
      "anti",
      "disorders",
      "hepatitis",
      "vomiting",
      "cholecystitis"
    ]
  },
  {
    "id": "ecc0f756d4fc0f528e4353affc21d216",
    "content": "pressure (i. e. tumours, haemorrhage; meningitis); seizures, stroke\nEndocrine and metabolic: diabetic ketoacidosis, uraemia, hypercalcaemia, intestinal pseudo-obstruction\nPsychiatric: anxiety, depression, severe emotional upset, psychogenic\nvomiting\nDrugs:  cancer  chemotherapy,  aspirin,  allopurinol,  digoxin,.",
    "title": "Neurological disorders: severe pain, migraine, raised intracranial",
    "section": "Neurological disorders: severe pain, migraine, raised intracranial",
    "chunk_id": "238",
    "type": "section",
    "keywords": [
      "uraemia",
      "emotional",
      "haemorrhage",
      "psychiatric",
      "tumours",
      "pseudo",
      "seizures",
      "anxiety",
      "digoxin",
      "pressure",
      "psychogenic",
      "intestinal",
      "obstruction",
      "diabetic",
      "severe",
      "aspirin",
      "chemotherapy",
      "endocrine",
      "metabolic",
      "ketoacidosis"
    ]
  },
  {
    "id": "28ee5665bbe1bcc7a2911d47ccb03f7a",
    "content": "erythromycin, anticonvulsants, opioids\nInfections: malaria, urinary tract infections\nCardiovascular: acute myocardial infarction.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "239",
    "type": "section",
    "keywords": [
      "infections",
      "tract",
      "anticonvulsants",
      "erythromycin",
      "myocardial",
      "opioids",
      "malaria",
      "acute",
      "cardiovascular",
      "infarction",
      "urinary"
    ]
  },
  {
    "id": "de930473dadff79c2e05a9b8d7141108",
    "content": "Miscellaneous: pregnancy, cyclical vomiting syndrome, myocardial infarction, labyrinthitis, otitis media\nSymptoms\nVomiting may be associated with:\nAbdominal pain\nDiarrhoea: gastroenteritis\nAbdominal distension: suspected bowel obstruction.",
    "title": "Renal: uraemia from acute or chronic kidney disease",
    "section": "Renal: uraemia from acute or chronic kidney disease",
    "chunk_id": "240",
    "type": "section",
    "keywords": [
      "otitis",
      "associated",
      "gastroenteritis",
      "distension",
      "diarrhoea",
      "abdominal",
      "myocardial",
      "bowel",
      "obstruction",
      "pregnancy",
      "suspected",
      "symptoms",
      "infarction",
      "vomiting",
      "pain",
      "labyrinthitis",
      "miscellaneous",
      "cyclical",
      "syndrome",
      "media"
    ]
  },
  {
    "id": "6e48b094907e69007b3efc9550ad9d17",
    "content": "Vertigo and nystagmus: suspected vestibular neuronitis\nAnxiety\nDepression\nVomiting may have diagnostic clues e. g. :\nVomiting of food eaten several hours earlier: gastroparesis or gastric- outlet obstruction\nVomiting with blood: oesophageal, gastric or duodenal lesion\nEarly morning vomiting: pregnancy\nFaeculent vomiting: intestinal obstruction, gastro-colic fistula\nProjectile: if pyloric stenosis\nSigns\nAbdominal tenderness\nDehydration (reduced skin turgor, dry tongue, hypotension, tachycardia)\nAbdominal distension\nSuccussion splash\nJaundice\nSigns of peritonitis (rebound tenderness, rigidity, guarding)\nMiscellaneous: e.",
    "title": "Jaundice: hepato-biliary disease",
    "section": "Jaundice: hepato-biliary disease",
    "chunk_id": "241",
    "type": "section",
    "keywords": [
      "peritonitis",
      "pyloric",
      "morning",
      "earlier",
      "turgor",
      "rebound",
      "colic",
      "diagnostic",
      "reduced",
      "anxiety",
      "clues",
      "faeculent",
      "tachycardia",
      "distension",
      "lesion",
      "abdominal",
      "guarding",
      "jaundice",
      "gastric",
      "gastroparesis"
    ]
  },
  {
    "id": "a396f37824f4b08f26070c4cc21f9515",
    "content": "g. vertigo, nystagmus, focal neurological signs, Kussmaul breathing (uraemia, diabetic ketoacidosis)\ninvestigations\nFBC\nBUE and Creatinine\nLFT\nBlood glucose\nSerum amylase\nUrine RE\nUrine Pregnancy test\nECG (if myocardial infarction suspected)\nAbdominal X-ray: Intestinal obstruction.",
    "title": "Jaundice: hepato-biliary disease",
    "section": "Jaundice: hepato-biliary disease",
    "chunk_id": "242",
    "type": "section",
    "keywords": [
      "uraemia",
      "test",
      "breathing",
      "glucose",
      "urine",
      "creatinine",
      "focal",
      "abdominal",
      "neurological",
      "myocardial",
      "intestinal",
      "vertigo",
      "signs",
      "obstruction",
      "pregnancy",
      "diabetic",
      "blood",
      "suspected",
      "investigations",
      "infarction"
    ]
  },
  {
    "id": "54701b31c9ba917c95a5a0e20581c661",
    "content": "Erect Chest X-ray: bowel perforation with air under diaphragm\nPersistent Vomiting:\nUpper gastro-intestinal endoscopy\nSerum calcium level\nCT scan of brain.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "243",
    "type": "section",
    "keywords": [
      "perforation",
      "vomiting",
      "upper",
      "chest",
      "calcium",
      "bowel",
      "serum",
      "level",
      "scan",
      "erect",
      "intestinal",
      "brain",
      "gastro",
      "persistent",
      "endoscopy",
      "diaphragm",
      "under"
    ]
  },
  {
    "id": "80065f7917cf50909af5ec8bccb5d488",
    "content": "To identify and treat the underlying cause\nTo prevent dehydration and electrolyte imbalance\nTo maintain nutrition by ensuring adequate dietary intake during\nillness\nTo maintain personal hygiene\nTo eliminate infecting organisms where appropriate.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "244",
    "type": "section",
    "keywords": [
      "treat",
      "during",
      "infecting",
      "personal",
      "identify",
      "ensuring",
      "nutrition",
      "imbalance",
      "prevent",
      "dietary",
      "where",
      "underlying",
      "eliminate",
      "intake",
      "electrolyte",
      "dehydration",
      "cause",
      "organisms",
      "hygiene",
      "appropriate"
    ]
  },
  {
    "id": "b65e994186879d9b524652a024b0a37b",
    "content": "Maintain adequate oral fluid intake (if tolerated)\nMaintain adequate nutrition\nPlace naso-gastric tube when needed\nSurgical intervention in suspected intestinal obstruction, peritonitis.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "245",
    "type": "section",
    "keywords": [
      "nutrition",
      "peritonitis",
      "intervention",
      "surgical",
      "suspected",
      "tube",
      "tolerated",
      "maintain",
      "gastric",
      "needed",
      "oral",
      "intestinal",
      "obstruction",
      "place",
      "intake",
      "adequate",
      "naso",
      "fluid"
    ]
  },
  {
    "id": "7fced631fd58867cf50134e783213cb1",
    "content": "Suggested Anti-Emetics for use in Migraine\nEvidence Rating: [B]\nMetoclopramide, oral/IV/IM,\nAdults\n10 mg 8 hourly\nOr\nDomperidone, oral,\nAdults\n10 mg, 8 hourly\nChildren\n12 years (Body weight ≥ 35 kg); 10 mg 8-12 hourly (max. 30 mg per day)\n1 month-12 years (Body weight ≤ 35 kg); 250 micrograms/kg 8-12 hourly (max. 750 microgram/kg per day)\nOr\nOr\nPromethazine, IV/IM\nAdults\n12.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "246",
    "type": "section",
    "keywords": [
      "years",
      "migraine",
      "weight",
      "suggested",
      "evidence",
      "hourly",
      "rating",
      "body",
      "metoclopramide",
      "emetics",
      "promethazine",
      "children",
      "domperidone",
      "adults",
      "anti",
      "month",
      "microgram",
      "oral",
      "micrograms"
    ]
  },
  {
    "id": "b6174613346787f3c97b0b81d62c58fe",
    "content": "5-25 mg 6-8 hourly as needed (max. 100 mg in 24 hours)\nOr\nPromethazine, oral,\nChildren.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "247",
    "type": "section",
    "keywords": [
      "hourly",
      "needed",
      "oral",
      "children",
      "promethazine",
      "hours"
    ]
  },
  {
    "id": "9505b03d10625488325d93472d7f86cb",
    "content": "2-12 years;\t0. 25-1 mg 6-8 hourly as needed (max. 25 mg per dose)\n< 2 years;\tNot recommended\nSuggested Anti-Emetics for use in Vestibular Nausea and Vomiting\nPromethazine, oral,\nAdults\n20-25 mg 12 hourly\nChildren\n2-12 years;\t0.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "248",
    "type": "section",
    "keywords": [
      "hourly",
      "vomiting",
      "recommended",
      "years",
      "nausea",
      "needed",
      "adults",
      "oral",
      "children",
      "anti",
      "dose",
      "vestibular",
      "suggested",
      "emetics",
      "promethazine"
    ]
  },
  {
    "id": "1008e22976353281e99fc44de4b255d8",
    "content": "25-1 mg 6-8 hourly as needed (max. 25 mg per dose)\n< 2 years;\tNot recommended\nOr\nPromethazine, IV/IM\nAdults\n12. 5-25 mg 6-8 hourly as needed (max.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "249",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "needed",
      "adults",
      "dose",
      "promethazine"
    ]
  },
  {
    "id": "cab0369fa1ce2d587d2b657543467e51",
    "content": "100 mg in 24 hours)\nOr\nCyclizine, oral,\nAdults\n50 mg 8 hourly as needed\nChildren\n6-12 years; 25 mg 8 hourly as needed (max. 75 mg in 24 hours)\nOr\nCinnarizine, IV/IM,\nAdults and children > 12 years 30 mg 8 hourly as needed Children\n5-12 years;\t15 mg 8 hourly as needed\n< 5 years;\tnot recommended\nSuggested Anti-Emetics for use in Gastroenteritis\nMetoclopramide, oral/IV/IM,\nAdults\n10 mg 8 hourly\nOr\nDomperidone, oral,\nAdults\n10 mg, 8 hourly\nChildren\n12 years (Body weight ≥ 35 kg); 10 mg 8-12 hourly (max. 30 mg per day)\n1 month-12 years (Body weight ≤ 35 kg); 250 micrograms/kg 8-12 hourly (max.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "250",
    "type": "section",
    "keywords": [
      "years",
      "weight",
      "suggested",
      "gastroenteritis",
      "hourly",
      "body",
      "metoclopramide",
      "emetics",
      "children",
      "domperidone",
      "adults",
      "anti",
      "month",
      "cyclizine",
      "cinnarizine",
      "recommended",
      "needed",
      "oral",
      "micrograms",
      "hours"
    ]
  },
  {
    "id": "67ea8380b879106838a589baec75a9a9",
    "content": "750 microgram/kg per day)\nSuggested Anti-Emetics for use in Post-Operative Vomiting\nMetoclopramide, oral/IV/IM,\nAdults\n10 mg 8 hourly.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "251",
    "type": "section",
    "keywords": [
      "post",
      "hourly",
      "operative",
      "vomiting",
      "metoclopramide",
      "microgram",
      "adults",
      "oral",
      "anti",
      "suggested",
      "emetics"
    ]
  },
  {
    "id": "671eab8711b1877189d0206d21ca8e2a",
    "content": "Or\nCyclizine, oral/IV/IM,\nAdults\n50 mg 8 hourly as needed\nChildren\n6-12 years; 25 mg 8 hourly as needed (max. 75 mg in 24 hours)\nSuggested Anti-Emetics for use in Chemotherapy-induced Vomiting\nOndansetron, IV,\nAdults\n8 mg/ 0. 15 mg/kg (pre-chemotherapy) infused over 15 minutes\nChildren\n6 months;\t0.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "252",
    "type": "section",
    "keywords": [
      "hourly",
      "vomiting",
      "ondansetron",
      "years",
      "minutes",
      "needed",
      "adults",
      "months",
      "oral",
      "infused",
      "anti",
      "suggested",
      "emetics",
      "children",
      "induced",
      "hours",
      "chemotherapy",
      "cyclizine"
    ]
  },
  {
    "id": "f4360315d11b4370c33e3a27bfd255e6",
    "content": "15 mg/kg (pre-chemotherapy) infused over 15 minutes, then repeated 4 and 8 hours after first dose. (max is 16 mg/dose)\nOr\nOndansetron, oral,\nAdults\n8 mg 12 hourly\nChildren\n4-12 years;\t4 mg 30 minutes before chemotherapy, then 4 mg 8 hourly for 24-48 hours as needed\n< 4 years;\tnot recommended\nOr\nGranisetron, IV,\nAdults\n1mg/10 microgram/kg (30 minutes before Chemotherapy)\nChildren\n2-16 years;\tsame as adults\n<2 years;\tnot recommended\nOr\nGranisetron, oral,\nAdults\n1mg 1 hour before chemotherapy, then 1 mg 12 hours after 1st dose\nOr\n2 mg 1 hour before chemotherapy\nChildren\nNot recommended\nOr\nDexamethasone, oral/IV,\nAdults\n8-12 mg before chemotherapy, then 8 mg 24 hourly from days 2-4\nChildren\nNot recommended\nOr\nLorazepam, oral/IV,\nAdults.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "253",
    "type": "section",
    "keywords": [
      "hour",
      "years",
      "infused",
      "repeated",
      "hourly",
      "ondansetron",
      "minutes",
      "children",
      "dexamethasone",
      "days",
      "lorazepam",
      "first",
      "before",
      "adults",
      "dose",
      "same",
      "granisetron",
      "then",
      "chemotherapy",
      "recommended"
    ]
  },
  {
    "id": "3333303734f411681d793c758279291e",
    "content": "0. 5-2 mg 6 hourly as required\nChildren\nConsult a specialist\nSuggested Anti-Emetics for use in Pregnancy\nPromethazine teoclate, oral, 10-20 mg 8 hourly as needed Or\nPromethazine, IM,\n12. 5-25 mg 8 hourly as needed\nOr\nMetoclopramide, oral, 10 mg 8 hourly\nOr\nMetoclopramide, IV/IM, 10 mg 8 hourly as needed\nReferral Criteria\nRefer all patients in whom vomiting persists or who show signs of progression in disease, patients with unexplained or persistent vomiting, and patients with suspected surgical cause of vomiting for specialist or surgical assessment and management.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "254",
    "type": "section",
    "keywords": [
      "teoclate",
      "management",
      "required",
      "suggested",
      "hourly",
      "specialist",
      "metoclopramide",
      "whom",
      "signs",
      "patients",
      "emetics",
      "promethazine",
      "children",
      "pregnancy",
      "criteria",
      "persists",
      "disease",
      "referral",
      "show",
      "surgical"
    ]
  },
  {
    "id": "a3a8d93ecec7b00e7258a95518e0658d",
    "content": "Hepatocellular Carcinoma (HCC) is a primary malignancy of the liver cell and must be differentiated from malignancies elsewhere that metastasize to the liver. Hepatocellular carcinoma occurs more commonly in men than in women and is often diagnosed several years after establishment of the initial causative condition. The disease has a poor prognosis resulting from metastatic or locally advanced disease.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "255",
    "type": "section",
    "keywords": [
      "malignancy",
      "initial",
      "metastasize",
      "years",
      "locally",
      "often",
      "differentiated",
      "metastatic",
      "advanced",
      "causative",
      "poor",
      "primary",
      "condition",
      "disease",
      "malignancies",
      "hepatocellular",
      "women",
      "elsewhere",
      "occurs",
      "commonly"
    ]
  },
  {
    "id": "3b7dcc1a6ca9906916a95913534642e2",
    "content": "Complications include liver failure, variceal bleeding or tumour rupture with bleeding into the peritoneum. The tumour is often resistant to chemotherapy. Current strategies to prevent or treat hepatitis B and C infections and liver cirrhosis can potentially reduce the prevalence of HCC in the long term.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "256",
    "type": "section",
    "keywords": [
      "infections",
      "treat",
      "often",
      "strategies",
      "liver",
      "resistant",
      "potentially",
      "prevalence",
      "into",
      "prevent",
      "peritoneum",
      "variceal",
      "bleeding",
      "tumour",
      "include",
      "failure",
      "hepatitis",
      "chemotherapy",
      "term",
      "complications"
    ]
  },
  {
    "id": "5807f315da03f4a48598a774b733ea04",
    "content": "Chronic hepatitis B virus infection\nChronic hepatitis C virus infection\nChronic exposure to hepatic carcinogens e. g. aflatoxin\nSymptoms\nJaundice\nItching\nAnorexia.",
    "title": "Alcoholic liver disease",
    "section": "Alcoholic liver disease",
    "chunk_id": "257",
    "type": "section",
    "keywords": [
      "chronic",
      "anorexia",
      "virus",
      "infection",
      "jaundice",
      "aflatoxin",
      "itching",
      "exposure",
      "hepatitis",
      "symptoms",
      "hepatic",
      "carcinogens"
    ]
  },
  {
    "id": "9c4deb9f1bd7653b96bca01248658b60",
    "content": "Early satiety\nFeeling of a mass in the upper abdomen\nRight upper abdominal pain\nWeight loss\nHaematemesis\nAbdominal distension\nBone pain\nDyspnoea\nSigns\nJaundice\nCachexia\nHepatomegaly (irregular surface, multiple nodules, may be tender)\nAscites\nHepatic bruit\ninvestigations\nFBC\nLFTS\nINR\nSerum Alpha-Fetoprotein\nHepatitis B-Surface Antigen (HBsAg)\nHepatitis C Antibody (HCVab)\nChest X-Ray\nAbdominal ultrasound scan\nCT/MRI scan (if ultrasound inconclusive).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "258",
    "type": "section",
    "keywords": [
      "ultrasound",
      "hepatomegaly",
      "weight",
      "nodules",
      "bruit",
      "feeling",
      "distension",
      "hbsag",
      "abdominal",
      "dyspnoea",
      "multiple",
      "chest",
      "cachexia",
      "right",
      "inconclusive",
      "jaundice",
      "surface",
      "signs",
      "tender",
      "hcvab"
    ]
  },
  {
    "id": "29f472d6a57efc86dd08f5070151015b",
    "content": "To assess for potential resectability\nPalliative\nTo relieve pain\nTo relieve discomfort from gross ascites\nTo prevent or treat hepatic encephalopathy (See section on ‘Hepatic\nEncephalopathy’).",
    "title": "Treatment objectives Curative",
    "section": "Treatment objectives Curative",
    "chunk_id": "259",
    "type": "section",
    "keywords": [
      "pain",
      "treat",
      "encephalopathy",
      "prevent",
      "palliative",
      "section",
      "relieve",
      "discomfort",
      "assess",
      "potential",
      "ascites",
      "resectability",
      "hepatic",
      "gross"
    ]
  },
  {
    "id": "34c9e2e645fa94e02206d03a212293bc",
    "content": "Surgical resection of non-metastatic localised lesions\nParacentesis for tense ascites (See section on ‘Ascites’).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "260",
    "type": "section",
    "keywords": [
      "surgical",
      "lesions",
      "metastatic",
      "resection",
      "section",
      "localised",
      "ascites",
      "paracentesis",
      "tense"
    ]
  },
  {
    "id": "e52a29a65d41dd39679bc556a4893205",
    "content": "A. Pain control in patients with Hepatocellular Carcinoma.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "261",
    "type": "section",
    "keywords": [
      "pain",
      "hepatocellular",
      "patients",
      "control",
      "carcinoma"
    ]
  },
  {
    "id": "f598912150afaf4de264794baa1fb2b2",
    "content": "Tramadol, oral, 50 mg 12 hourly (titrate further as tolerated to de-\nsired effect: maximum 300 mg daily)\nOr.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "262",
    "type": "section",
    "keywords": [
      "hourly",
      "tramadol",
      "titrate",
      "daily",
      "further",
      "oral",
      "maximum",
      "tolerated",
      "sired",
      "effect"
    ]
  },
  {
    "id": "ccf99a408619d77006d7995f22057e88",
    "content": "Morphine sulphate, oral, 5-10 mg 8-12 hourly\nReferral Criteria\nRefer all patients with suspected HCC, especially those with small solitary lesion (< 5 cm) who may be considered for percutaneous alcohol injection or surgical resection, to a specialist. Drug-Induced Liver Injury (DILI) can occur following the use of a variety of either prescription or over-the-counter medications. A high index of suspicion is often necessary in establishing the diagnosis.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "263",
    "type": "section",
    "keywords": [
      "sulphate",
      "either",
      "occur",
      "often",
      "establishing",
      "especially",
      "solitary",
      "suspicion",
      "induced",
      "hourly",
      "lesion",
      "specialist",
      "following",
      "alcohol",
      "resection",
      "drug",
      "patients",
      "injection",
      "criteria",
      "injury"
    ]
  },
  {
    "id": "d98ca2e6f205824fb602c2a7c82e5167",
    "content": "Early recognition of drug toxicity is important to permit withdrawal of the offending drug, assessment of severity and monitoring for acute liver failure. Drug-induced liver injury can be dose-dependent or idiosyncratic.",
    "title": "Chapter 2: Dısorders of the Lıver",
    "section": "Chapter 2: Dısorders of the Lıver",
    "chunk_id": "264",
    "type": "section",
    "keywords": [
      "monitoring",
      "important",
      "idiosyncratic",
      "liver",
      "induced",
      "acute",
      "drug",
      "toxicity",
      "recognition",
      "permit",
      "dependent",
      "dose",
      "offending",
      "failure",
      "severity",
      "early",
      "assessment",
      "withdrawal",
      "injury"
    ]
  },
  {
    "id": "bbea64e985c8041df45e5b9dac4c9c33",
    "content": "Causes\nAllopathic drugs (prescription, over-the-counter, anaesthetic agents, e. g. paracetamol, statins, isoniazid, halothane, amiodarone, azathioprine, carbamazepine, phenytoin, nevirapine, ketoconazole, flucloxacillin etc.",
    "title": "The hallmark for the treatment of DILI is early withdrawal of the offending drug.",
    "section": "The hallmark for the treatment of DILI is early withdrawal of the offending drug.",
    "chunk_id": "265",
    "type": "section",
    "keywords": [
      "counter",
      "statins",
      "drugs",
      "agents",
      "amiodarone",
      "isoniazid",
      "prescription",
      "ketoconazole",
      "flucloxacillin",
      "halothane",
      "anaesthetic",
      "azathioprine",
      "nevirapine",
      "paracetamol",
      "phenytoin",
      "carbamazepine",
      "causes",
      "allopathic"
    ]
  },
  {
    "id": "4b7a7e1a3013b8304dae2614e7224ae8",
    "content": ")\nHerbal preparations\nDietary supplements\nSymptoms\nAsymptomatic\nRight upper quadrant pain\nNausea\nAnorexia\nMalaise\nLethargy\nPruritus\nSigns\nOccasionally none\nJaundice\nScratch marks\nBruising\nAsterixis\nAltered mental state.",
    "title": "The hallmark for the treatment of DILI is early withdrawal of the offending drug.",
    "section": "The hallmark for the treatment of DILI is early withdrawal of the offending drug.",
    "chunk_id": "266",
    "type": "section",
    "keywords": [
      "mental",
      "nausea",
      "supplements",
      "herbal",
      "lethargy",
      "asymptomatic",
      "right",
      "jaundice",
      "preparations",
      "dietary",
      "altered",
      "signs",
      "marks",
      "asterixis",
      "state",
      "occasionally",
      "symptoms",
      "anorexia",
      "pain",
      "bruising"
    ]
  },
  {
    "id": "c2aa460aefbd9b3da642de912387cb50",
    "content": "INR\nSerum glucose\nUrinalysis\nHepatitis screen (A, B, C, E) for exclusion\nAbdominal ultrasound scan.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "267",
    "type": "section",
    "keywords": [
      "ultrasound",
      "abdominal",
      "serum",
      "scan",
      "urinalysis",
      "glucose",
      "hepatitis",
      "screen",
      "exclusion"
    ]
  },
  {
    "id": "73aeb0943770fa9536f7591501bdc6f0",
    "content": "To identify and withdraw the offending agent\nTo report as adverse drug event to Food and Drugs Authority (FDA) promptly.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "268",
    "type": "section",
    "keywords": [
      "event",
      "drugs",
      "agent",
      "drug",
      "food",
      "withdraw",
      "offending",
      "identify",
      "authority",
      "adverse",
      "report",
      "promptly"
    ]
  },
  {
    "id": "b1383a8326a1ba2caa01a3e23148faca",
    "content": "To administer antidote where applicable or feasible.",
    "title": "To assess severity of liver disease",
    "section": "To assess severity of liver disease",
    "chunk_id": "269",
    "type": "section",
    "keywords": [
      "feasible",
      "applicable",
      "where",
      "antidote",
      "administer"
    ]
  },
  {
    "id": "c3f1f58908b3a242e914a2004c6bba28",
    "content": "A. Drug-induced liver injury following paracetamol toxicity.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "270",
    "type": "section",
    "keywords": [
      "following",
      "drug",
      "paracetamol",
      "liver",
      "induced",
      "toxicity",
      "injury"
    ]
  },
  {
    "id": "58ae6b6afadb1560774865c312e93559",
    "content": "N-Acetylcysteine\n(See section on ‘Management algorithm for Acute Paracetamol Poisioning’)\nReferral Criteria\nAll patients failing to improve or showing progression in liver injury despite withdrawal of offending drug should be referred to a specialist. Management algorithm for Acute Paracetamol Poisioning.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "271",
    "type": "section",
    "keywords": [
      "despite",
      "improve",
      "management",
      "acute",
      "specialist",
      "algorithm",
      "failing",
      "section",
      "drug",
      "acetylcysteine",
      "patients",
      "criteria",
      "injury",
      "referral",
      "should",
      "showing",
      "paracetamol",
      "poisioning",
      "offending",
      "referred"
    ]
  },
  {
    "id": "3b792160ca072210a6e50e0357c2939e",
    "content": "Malnutrition occurs when there is a deficiency in intake of essential nutrients (i. e. proteins, carbohydrates, fats, vitamins and minerals).",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "272",
    "type": "section",
    "keywords": [
      "vitamins",
      "minerals",
      "malnutrition",
      "essential",
      "occurs",
      "nutrients",
      "carbohydrates",
      "proteins",
      "there",
      "intake",
      "fats",
      "deficiency"
    ]
  },
  {
    "id": "c199beba32d8cfe9fbef6c70ec30dcf2",
    "content": "It is most commonly seen in children less than five years, particularly after weaning. Malnutrition reduces the individual’s ability to fight disease and infection thereby increasing the likelihood of the patient presenting with diarrhoea, vomiting, fever, worm infestation, pneumonia, tuberculosis, otitis media, urinary tract infection etc. In adults, malnutrition frequently occurs in association with chronic alcoholism.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "273",
    "type": "section",
    "keywords": [
      "years",
      "malnutrition",
      "alcoholism",
      "media",
      "seen",
      "presenting",
      "otitis",
      "frequently",
      "ability",
      "patient",
      "diarrhoea",
      "individual",
      "reduces",
      "likelihood",
      "thereby",
      "association",
      "infestation",
      "five",
      "most",
      "children"
    ]
  },
  {
    "id": "db2dba9f757fe0890e0f408bd2d90ef6",
    "content": "Protein energy malnutrition (PEM), when severe, presents in different forms such as marasmus, kwashiorkor or marasmic-kwashiokor. Birth-spacing, through family planning, as well as exclusive breast- feeding for up to 6 months, followed by Introduction of a weaning diet at 6 months and continuation with complimentary foods for up to 2 years, may be helpful measures in preventing malnutrition in young children. Encouraging a balanced diet for the family, including pregnant and lactating women, and nutrition education in schools and villages may help\nreduce the prevalence of malnutrition in the community.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "274",
    "type": "section",
    "keywords": [
      "diet",
      "years",
      "malnutrition",
      "villages",
      "continuation",
      "marasmic",
      "family",
      "feeding",
      "prevalence",
      "foods",
      "help",
      "presents",
      "complimentary",
      "measures",
      "breast",
      "nutrition",
      "helpful",
      "including",
      "planning",
      "protein"
    ]
  },
  {
    "id": "ed46127bb6996998176eb432bf168a76",
    "content": "Causes\nPoverty\nInadequate quality and/or quantity of food intake\nSocial neglect\nRepeated or chronic infections\nRepeated diarhoeal illness\nWorm infestations\nHIV, pulmonary tuberculosis, measles, pertussis\nChronic illness and cancers\nAlcoholism (adults)\nSymptoms\nPoor weight gain\nWeight loss (drop or flattening in weight on the child health record)\nBody swelling (kwashiorkor).",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "275",
    "type": "section",
    "keywords": [
      "infections",
      "flattening",
      "alcoholism",
      "weight",
      "inadequate",
      "quality",
      "diarhoeal",
      "cancers",
      "child",
      "swelling",
      "health",
      "poverty",
      "poor",
      "pertussis",
      "repeated",
      "neglect",
      "body",
      "infestations",
      "social",
      "intake"
    ]
  },
  {
    "id": "d3c39cad9dc017e2c79564403b7d9a20",
    "content": "Child plays less because of lack of energy\nDisinterest in food and surroundings\nSigns\nMarasmus\nThin (reduced muscle bulk)\nProminent bones\nHanging skin folds especially over the buttocks\nUnusually alert\nLooks like an old man\nKwashiorkor\nThin and wasted arms\nPuffy face and legs due to oedema\nBrownish or reddish hair\nFlaky skin rash especially on the legs\nSores on the oedematous parts of the body in severe cases\nMiserable and disinterested appearance\nDisinterest in food\nAnthropometric measurements\nModerate Acute Malnutrition\nMid Upper Arm Circumference: 11. 5 - < 12. 5 cm\nWeight for Age: < - 2 Z - Score but > - 3 Z Score\nWeight for Height: < - 2 Z - Score but > - 3 Z Score\nSevere Acute Malnutrition\nMid Upper Arm Circumference: < 11.",
    "title": "Chapter 3:  Nutrıtıonal Dısorders",
    "section": "Chapter 3:  Nutrıtıonal Dısorders",
    "chunk_id": "276",
    "type": "section",
    "keywords": [
      "oedema",
      "malnutrition",
      "appearance",
      "weight",
      "sores",
      "especially",
      "surroundings",
      "measurements",
      "face",
      "child",
      "wasted",
      "reduced",
      "anthropometric",
      "acute",
      "thin",
      "rash",
      "body",
      "moderate",
      "plays",
      "lack"
    ]
  },
  {
    "id": "ad56ed1243a450ee4c5e472b2946d243",
    "content": "5 cm (Age 6-59 months)\nWeight for Age: < - 3 Z - Score\nWeight for Height: < - 3 Z - Score\ninvestigations\nFBC\nUrea and electrolytes\nSerum albumin\nUrine culture and sensitivity\nBlood culture and sensitivity\nChest X-ray\nHIV testing\nGastric lavage for acid fast bacilli\nScreen for common infections such as tuberculosis, pneumonia, urinary tract infections, etc. (See relevant sections).",
    "title": "Chapter 3:  Nutrıtıonal Dısorders",
    "section": "Chapter 3:  Nutrıtıonal Dısorders",
    "chunk_id": "277",
    "type": "section",
    "keywords": [
      "infections",
      "weight",
      "urine",
      "sensitivity",
      "albumin",
      "chest",
      "gastric",
      "culture",
      "lavage",
      "screen",
      "blood",
      "sections",
      "tract",
      "electrolytes",
      "acid",
      "pneumonia",
      "testing",
      "relevant",
      "tuberculosis",
      "investigations"
    ]
  },
  {
    "id": "3731e2f2739ed10adc2a47bca2d205a7",
    "content": "To identify and treat associated infections and complications\nTo correct fluid and electrolyte imbalance and other complications\nTo correct the nutritional deficiency including Vitamin A.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "278",
    "type": "section",
    "keywords": [
      "infections",
      "complications",
      "imbalance",
      "treat",
      "correct",
      "including",
      "other",
      "nutritional",
      "associated",
      "identify",
      "electrolyte",
      "vitamin",
      "deficiency",
      "fluid"
    ]
  },
  {
    "id": "b9a51706d81b93a8fa5e6396177f8f5f",
    "content": "Malnourished children who have appetite, and do not have any overt medical condition, which requires admis- sion, should be managed as outpatients with Ready-to- Use Therapeutic Food (RUTF).",
    "title": "Out-patient Care",
    "section": "Out-patient Care",
    "chunk_id": "279",
    "type": "section",
    "keywords": [
      "overt",
      "outpatients",
      "medical",
      "requires",
      "should",
      "ready",
      "sion",
      "therapeutic",
      "which",
      "food",
      "admis",
      "rutf",
      "have",
      "condition",
      "children",
      "malnourished",
      "appetite",
      "managed"
    ]
  },
  {
    "id": "1b994e29092289f339b44a213a1ef8eb",
    "content": "Stabilisation Phase\nFrequent feeding with F75\nIntroduce Ready-To-Use Therapeutic Food - RUTF\nProgressively return to acceptable balanced family meals.",
    "title": "Admit all severely malnourished children who have medi- cal conditions requiring inpatient care",
    "section": "Admit all severely malnourished children who have medi- cal conditions requiring inpatient care",
    "chunk_id": "280",
    "type": "section",
    "keywords": [
      "stabilisation",
      "therapeutic",
      "acceptable",
      "ready",
      "food",
      "introduce",
      "progressively",
      "return",
      "feeding",
      "phase",
      "rutf",
      "family",
      "meals",
      "balanced",
      "frequent"
    ]
  },
  {
    "id": "b0b8b9229a6b7b652c38587fa2f22aa5",
    "content": "Vitamin A supplementation (children)\nEvidence Rating: [A]\nVitamin A, oral,\nChildren\n1 year;\t200,000 units daily for 2 days\n6-11 months;\t100,000 units daily for 2 days\n< 6 months;\t50,000 units daily for 2 days.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "281",
    "type": "section",
    "keywords": [
      "days",
      "rating",
      "units",
      "supplementation",
      "months",
      "oral",
      "children",
      "vitamin",
      "evidence",
      "daily",
      "year"
    ]
  },
  {
    "id": "fd1a2b6d44a86885c3d7b9381786629b",
    "content": "Inpatients\nEvidence Rating: [B]\nCefuroxime, IV, 20 mg/kg 8 hourly for 48-72 hours\nThen\nCefuroxime, oral,\n3 months-12 years;\t15 mg/kg 12 hourly for 5-7 days\nOutpatients Evidence Rating: [B]\nAmoxicillin, oral,\n5-18 years;\t500 mg 8 hourly for 10 days\n1-5 years;\t250 mg 8 hourly for 10 days\n1 month-1 year;\t125 mg 8 hourly for 10 days\nimmunisation (children)\n(See section on ‘Immunisation’ and National Expanded Programme.",
    "title": "Treatment of underlying infections (children)",
    "section": "Treatment of underlying infections (children)",
    "chunk_id": "282",
    "type": "section",
    "keywords": [
      "years",
      "programme",
      "inpatients",
      "evidence",
      "national",
      "hourly",
      "rating",
      "expanded",
      "section",
      "children",
      "days",
      "amoxicillin",
      "outpatients",
      "immunisation",
      "month",
      "months",
      "then",
      "year",
      "oral",
      "cefuroxime"
    ]
  },
  {
    "id": "542fcb59b592f782990f8ba77fa56975",
    "content": "(See section on ‘Worm Infestations’)\nReferral Criteria\nRefer to appropriate specialist for management of the underlying cause. Also refer to Reproductive and Child Health (RCH) unit for family planning services and Social welfare department within the health facility, district or region.",
    "title": "Treatment of worm infestations",
    "section": "Treatment of worm infestations",
    "chunk_id": "283",
    "type": "section",
    "keywords": [
      "region",
      "management",
      "department",
      "child",
      "health",
      "family",
      "within",
      "specialist",
      "facility",
      "district",
      "infestations",
      "section",
      "planning",
      "underlying",
      "social",
      "criteria",
      "services",
      "referral",
      "also",
      "cause"
    ]
  },
  {
    "id": "4c153b11605153e3d6d8091d343c665f",
    "content": "Anaemia is defined as decreased concentration of haemoglobin for the age and sex of the individual (i. e. below 13 g/dL in adult males, 12 g/dL in adult females, 11 g/dL in children, and below 13.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "284",
    "type": "section",
    "keywords": [
      "decreased",
      "individual",
      "below",
      "concentration",
      "anaemia",
      "adult",
      "males",
      "defined",
      "children",
      "females",
      "haemoglobin"
    ]
  },
  {
    "id": "8f4f5c1012aa7a4027b7ca88de6e3495",
    "content": "5 g/dL in the 1st week of life). Anaemia always has a cause, which must be identified and properly managed. The cause must be investigated before initiating treatment.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "285",
    "type": "section",
    "keywords": [
      "always",
      "before",
      "anaemia",
      "week",
      "must",
      "life",
      "identified",
      "cause",
      "which",
      "initiating",
      "properly",
      "investigated",
      "treatment",
      "managed"
    ]
  },
  {
    "id": "a58778dff4a3a22ef0ba4e86143dc976",
    "content": "In an emergency, blood samples must be taken for investigations before blood transfusion. Causes\nNutritional micronutrient and vitamin deficiency\nIron\nFolic acid\nVitamin B12\nBleeding\nHeavy menstruation\nHaemorrhoids (piles)\nPeptic ulcer\nInfestations e. g.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "286",
    "type": "section",
    "keywords": [
      "ulcer",
      "piles",
      "vitamin",
      "micronutrient",
      "emergency",
      "infestations",
      "bleeding",
      "heavy",
      "haemorrhoids",
      "blood",
      "causes",
      "deficiency",
      "before",
      "acid",
      "peptic",
      "menstruation",
      "investigations",
      "transfusion",
      "samples",
      "iron"
    ]
  },
  {
    "id": "c4d4fae122b036c6f9c1f16417c50ad5",
    "content": "hookworm, bilharzia\nSolid organ malignant tumours e. g. colonic cancer\nHaematological malignancies: e.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "287",
    "type": "section",
    "keywords": [
      "cancer",
      "malignancies",
      "colonic",
      "malignant",
      "organ",
      "tumours",
      "hookworm",
      "bilharzia",
      "solid",
      "haematological"
    ]
  },
  {
    "id": "845368e400a8913c9a7f7216ea6f67ef",
    "content": "G6PD deficiency\nHypersplenism\nAutoimmune\nDrugs\nBone Marrow Failure.",
    "title": "Sickle cell disease",
    "section": "Sickle cell disease",
    "chunk_id": "288",
    "type": "section",
    "keywords": [
      "drugs",
      "hypersplenism",
      "marrow",
      "failure",
      "autoimmune",
      "deficiency",
      "bone"
    ]
  },
  {
    "id": "e7da418cfd6e867e28746f27b82f5fdd",
    "content": "Aplasia – primary or secondary e. g. due to cytotoxics.",
    "title": "Disease infiltration e.g. leukaemia, lymphoma, tuberculosis",
    "section": "Disease infiltration e.g. leukaemia, lymphoma, tuberculosis",
    "chunk_id": "289",
    "type": "section",
    "keywords": [
      "aplasia",
      "secondary",
      "cytotoxics",
      "primary"
    ]
  },
  {
    "id": "5d4f4433afdbf9a634db4be3399d5b0a",
    "content": "SLE\nPernicious anaemia\nSymptoms\nEasy fatigability\nDizziness\nShortness of breath on exertion\nPalpitations\nFresh blood in stools\nBlack tarry stools (malaena)\nHaematuria\nCola-like urine\nSigns\nPale mucous membranes and palms\nAngular stomatitis\n“Spoon shaped” and ridged finger and toe nails\nSpleen, liver and lymph nodes may be palpable\nSigns of heart failure (in severe anaemia)\nJaundice (in haemolysis)\nPetechiae and purpura (bone marrow failure)\nHyperpigmentation of palms and soles of feet\ninvestigations\nFBC\nReticulocyte count and blood film comment\nSickling test and HB electrophoresis if indicated\nBlood film for malaria parasites\nKidney function tests\nSerum iron, Vitamin B12 and folate levels\nDirect Coomb’s test\nStool for hookworm ova\nStool for occult blood\nUrine for schistosoma ova\nSpecialized tests depending on the suspected cause e. g. bone marrow examination, antinuclear antibody (ANA) test, upper and lower GI endoscopy.",
    "title": "Autoimmune Disease",
    "section": "Autoimmune Disease",
    "chunk_id": "290",
    "type": "section",
    "keywords": [
      "fatigability",
      "soles",
      "malaena",
      "petechiae",
      "membranes",
      "count",
      "film",
      "mucous",
      "easy",
      "signs",
      "severe",
      "haematuria",
      "failure",
      "direct",
      "stool",
      "iron",
      "feet",
      "hyperpigmentation",
      "serum",
      "electrophoresis"
    ]
  },
  {
    "id": "4a328f702d5217afb6c179f37d605646",
    "content": "To treat underlying cause of anaemia\nTo restore haemoglobin levels to normal\nTo replenish iron stores after correction of anaemia in iron deficiency.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "291",
    "type": "section",
    "keywords": [
      "restore",
      "treat",
      "iron",
      "anaemia",
      "levels",
      "cause",
      "replenish",
      "underlying",
      "after",
      "normal",
      "correction",
      "stores",
      "haemoglobin",
      "deficiency"
    ]
  },
  {
    "id": "cbf090f02982c4642e9ea1b6ffee33e0",
    "content": "To correct anaemia in proven vitamin B12 and folate deficiency and.",
    "title": "To restore haemoglobin to steady state level in sickle cell disease patients",
    "section": "To restore haemoglobin to steady state level in sickle cell disease patients",
    "chunk_id": "292",
    "type": "section",
    "keywords": [
      "proven",
      "correct",
      "anaemia",
      "folate",
      "vitamin",
      "deficiency"
    ]
  },
  {
    "id": "96369808267429b96d6aa960ddc1be8c",
    "content": "Advise on a balanced diet. Regular intake of leafy foods as well as fresh fruits and vegetables, beans, liver, meat, eggs, fish\nHigh fibre diets to reduce bleeding from haemorrhoids.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "293",
    "type": "section",
    "keywords": [
      "diet",
      "regular",
      "foods",
      "eggs",
      "bleeding",
      "fibre",
      "fresh",
      "intake",
      "diets",
      "haemorrhoids",
      "advise",
      "fruits",
      "meat",
      "balanced",
      "beans",
      "fish",
      "vegetables",
      "reduce",
      "high",
      "leafy"
    ]
  },
  {
    "id": "d94ba93ceb4d87833a619f39204cde1f",
    "content": "Where applicable e. g. haemorrhoids, tumours, hypersplenism etc.",
    "title": "Surgical treatment",
    "section": "Surgical treatment",
    "chunk_id": "294",
    "type": "section",
    "keywords": [
      "hypersplenism",
      "tumours",
      "applicable",
      "where",
      "haemorrhoids"
    ]
  },
  {
    "id": "01c12d6c7dee4055bb6c48782d0010c8",
    "content": "Ferrous sulphate (dried or anhydrous), oral,\nAdults\n200 mg (65 mg elemental iron) 8 hourly for 3-6 months\nChildren\n10 years;\t200 mg 12 hourly for 3-6 months\n8-10 years;\t200 mg daily for 3-6 months\n5-7 years;\t80-120 mg 8-12 hourly for 3-6 months\nyears;\t45-90 mg 8-12 hourly for 3-6 months\n< 1 year;\t30-60 mg 8-12 hourly for 3-6 months\nOr\nFerrous fumarate, oral,\nAdults\n200 mg (65 mg elemental iron) 8 hourly\nChildren\n3-6 mg elemental iron/kg per day for 3-6 months.",
    "title": "iron Deficiency Anaemia 1st Line Treatment Evidence Rating: [B]",
    "section": "iron Deficiency Anaemia 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "295",
    "type": "section",
    "keywords": [
      "hourly",
      "sulphate",
      "fumarate",
      "years",
      "iron",
      "dried",
      "elemental",
      "anhydrous",
      "ferrous",
      "adults",
      "oral",
      "children",
      "months",
      "daily",
      "year"
    ]
  },
  {
    "id": "ac3f3ff1029350139557b4002fe92357",
    "content": "Or\nIron sucrose, IV, (as a slow bolus injection over 2-5 minutes)\nAdults\n200 mg every 3 days for 5 doses\nChildren\n0. 5 mg/kg every 4 weeks for 12 weeks (max. 100 mg per dose), cal- culated based on body weight and iron deficit and the target Hb\nOr\nIron dextran, IV, (as a slow bolus or IM by deep intramuscular) in- jection\nAdults\n25-100 mg daily as needed\nChildren.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "296",
    "type": "section",
    "keywords": [
      "based",
      "weight",
      "bolus",
      "body",
      "jection",
      "minutes",
      "doses",
      "injection",
      "children",
      "weeks",
      "dextran",
      "days",
      "deep",
      "target",
      "intramuscular",
      "adults",
      "slow",
      "sucrose",
      "dose",
      "every"
    ]
  },
  {
    "id": "285c5533dd95f1fe122c6da60ecbdb49",
    "content": "Not recommended\nVitamin B12 Deficiency\nEvidence Rating: [B]\nVitamin B (Hydroxocobalamin), IM,\nAdults\n1 mg every other day for 6 doses\nThen\n1 mg every 3 months for life\nChildren 1 mg stat. Then\n1 mg every 3 months for life\nFolate Deficiency\nFolic Acid, oral,\nAdults\n5 mg daily\nChildren\n2. 5-5 mg daily\nSevere Symptomatic Anaemia\nBlood transfusion with packed cells\nAnd\nTreat for cardiac failure if signs of cardiac failure.",
    "title": "Chapter 4: Haematologıcal Dısorders",
    "section": "Chapter 4: Haematologıcal Dısorders",
    "chunk_id": "297",
    "type": "section",
    "keywords": [
      "treat",
      "anaemia",
      "evidence",
      "vitamin",
      "rating",
      "doses",
      "signs",
      "children",
      "blood",
      "stat",
      "deficiency",
      "severe",
      "acid",
      "hydroxocobalamin",
      "cells",
      "adults",
      "packed",
      "symptomatic",
      "failure",
      "months"
    ]
  },
  {
    "id": "6da584ebb75cd2bdde89771cbf609eda",
    "content": "(See section on ‘Heart failure’)\nReferral Criteria\nRefer patients with haemoglobin levels that do not improve after two weeks on the above treatment or with severe anaemia from any cause, which recurs, to a specialist. Patients with suspected aplastic anaemia, anaemia due to uncontrolled bleeding, including heavy menstrual loss, would also require referral to a specialist. Bleeding disorders may present at birth or develop later in life.",
    "title": "Chapter 4: Haematologıcal Dısorders",
    "section": "Chapter 4: Haematologıcal Dısorders",
    "chunk_id": "298",
    "type": "section",
    "keywords": [
      "improve",
      "anaemia",
      "menstrual",
      "levels",
      "which",
      "specialist",
      "require",
      "aplastic",
      "including",
      "section",
      "bleeding",
      "uncontrolled",
      "heart",
      "patients",
      "weeks",
      "heavy",
      "criteria",
      "treatment",
      "severe",
      "referral"
    ]
  },
  {
    "id": "e59547876b6a75584a09647aa68f255e",
    "content": "The bleeding may be spontaneous or follow trauma or surgery and may be due to defective blood vessels, platelet disorders or clotting factor deficiency. Past episodes of excessive bleeding e. g.",
    "title": "Chapter 4: Haematologıcal Dısorders",
    "section": "Chapter 4: Haematologıcal Dısorders",
    "chunk_id": "299",
    "type": "section",
    "keywords": [
      "vessels",
      "episodes",
      "spontaneous",
      "blood",
      "follow",
      "defective",
      "bleeding",
      "factor",
      "clotting",
      "excessive",
      "disorders",
      "past",
      "surgery",
      "trauma",
      "platelet",
      "deficiency"
    ]
  },
  {
    "id": "4e1fb095cce7b77b3aa617bd1a01893a",
    "content": "following circumcision, a family history of bleeding and drug therapy may be important clues to the diagnosis. The pattern of bleeding is a helpful guide to its cause. In platelet and vessel wall defects, bleeding is usually into skin and mucosal surfaces like the gums, nose, gastrointestinal tract, whereas in coagulation factor deficiency (e.",
    "title": "Chapter 4: Haematologıcal Dısorders",
    "section": "Chapter 4: Haematologıcal Dısorders",
    "chunk_id": "300",
    "type": "section",
    "keywords": [
      "usually",
      "important",
      "guide",
      "mucosal",
      "family",
      "clues",
      "therapy",
      "vessel",
      "into",
      "helpful",
      "surfaces",
      "following",
      "bleeding",
      "factor",
      "drug",
      "gastrointestinal",
      "platelet",
      "deficiency",
      "tract",
      "diagnosis"
    ]
  },
  {
    "id": "d0a31f79e594036dee014830697985d8",
    "content": "g. haemophilia), bleeding is into deep tissues like the brain, joints and muscles.",
    "title": "Chapter 4: Haematologıcal Dısorders",
    "section": "Chapter 4: Haematologıcal Dısorders",
    "chunk_id": "301",
    "type": "section",
    "keywords": [
      "deep",
      "joints",
      "haemophilia",
      "bleeding",
      "muscles",
      "brain",
      "tissues",
      "into"
    ]
  },
  {
    "id": "6c9981e0c27ed8f709e2e70a1c9f1374",
    "content": "In newborns with vitamin K deficiency (which leads to multiple coagulation factor deficiency) spontaneous bleeding occurs from various sites such as the umbilical cord, gastrointestinal tract, scalp and brain. Causes\nHaemophilia.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "302",
    "type": "section",
    "keywords": [
      "which",
      "scalp",
      "vitamin",
      "multiple",
      "haemophilia",
      "bleeding",
      "factor",
      "sites",
      "causes",
      "gastrointestinal",
      "deficiency",
      "leads",
      "tract",
      "occurs",
      "umbilical",
      "spontaneous",
      "various",
      "cord",
      "coagulation",
      "brain"
    ]
  },
  {
    "id": "e88b05e03c6b7edf971b4c9a6112da30",
    "content": "Vitamin K deficiency especially in newborns\nBone marrow failure e. g. aplastic anaemia and leukaemia\nLow platelet count from any cause\nDisseminated Intravascular Coagulation (DIC) from any cause\nDrug induced - herbal preparations, aspirin, clopidogrel, warfarin, rivaroxaban, heparin\nSymptoms\nSpontaneous bleeding from mucous membranes or cuts\nEasy bruising, bleeding from orifices\nExcessive bleeding from cuts or incisions\nDeformed joints from recurrent joint bleeds\nSwelling at site of blood collection (pseudotumours)\nPain limiting movement\nSigns\nPallor\nExcessive bleeding\nLocalised swelling due to bleeding into body spaces e.",
    "title": "Liver disease",
    "section": "Liver disease",
    "chunk_id": "303",
    "type": "section",
    "keywords": [
      "recurrent",
      "intravascular",
      "anaemia",
      "orifices",
      "especially",
      "rivaroxaban",
      "swelling",
      "membranes",
      "herbal",
      "induced",
      "localised",
      "heparin",
      "clopidogrel",
      "vitamin",
      "into",
      "spaces",
      "body",
      "leukaemia",
      "aplastic",
      "incisions"
    ]
  },
  {
    "id": "b04f262ee934343dd292aca1b051a2ba",
    "content": "g. Joints\nTenderness\nLimitation of movement and joint deformities\nPurpura, petechiae, ecchymosis\ninvestigations\nFBC and blood film comment\nPlatelet count\nLiver function tests\nProthrombin time, INR, partial thromboplastin time\nBleeding time.",
    "title": "Liver disease",
    "section": "Liver disease",
    "chunk_id": "304",
    "type": "section",
    "keywords": [
      "thromboplastin",
      "comment",
      "petechiae",
      "deformities",
      "partial",
      "movement",
      "count",
      "function",
      "bleeding",
      "film",
      "joint",
      "prothrombin",
      "blood",
      "ecchymosis",
      "platelet",
      "tenderness",
      "joints",
      "tests",
      "investigations",
      "purpura"
    ]
  },
  {
    "id": "713fa7d26ba95be849ba98e7e6112fad",
    "content": "To prevent or arrest bleeding\nTo identify and correct underlying cause.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "305",
    "type": "section",
    "keywords": [
      "arrest",
      "correct",
      "prevent",
      "bleeding",
      "cause",
      "underlying",
      "identify"
    ]
  },
  {
    "id": "90cebe96d521986b95c8802f0b20c1ce",
    "content": "Apply regulated pressure dressing and/or ice packs to minimise bleeding where possible\nStop any event/drugs responsible for bleeding or which may\naggravate bleeding.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "306",
    "type": "section",
    "keywords": [
      "event",
      "pressure",
      "minimise",
      "drugs",
      "responsible",
      "bleeding",
      "packs",
      "stop",
      "which",
      "where",
      "possible",
      "aggravate",
      "dressing",
      "regulated",
      "apply"
    ]
  },
  {
    "id": "4efd7f8cfcbea0a58d565224265cac4d",
    "content": "minimise trauma-prone activities, and to inform doctors of their condition before any surgical procedure\nAvoid unnecessary injections and surgical procedures in all patients\n(especially, those with a family history of bleeding tendencies)\nPhysiotherapy on affected joints\nSurgery.",
    "title": "Chapter 4: Haematologıcal Dısorders",
    "section": "Chapter 4: Haematologıcal Dısorders",
    "chunk_id": "307",
    "type": "section",
    "keywords": [
      "procedures",
      "avoid",
      "inform",
      "affected",
      "especially",
      "family",
      "injections",
      "prone",
      "bleeding",
      "patients",
      "condition",
      "their",
      "joints",
      "before",
      "surgical",
      "procedure",
      "tendencies",
      "unnecessary",
      "those",
      "physiotherapy"
    ]
  },
  {
    "id": "07bf3bb6830acae73a28b79502da411b",
    "content": "General Measures: fluid replacement following acute severe blood\nloss\nSodium Chloride 0. 9%, IV,\nAdults\n(See Section on ‘Shock’) Children and Neonates 20 ml/kg bolus stat. Repeat if there is no clinical improvement\nAnd\nConcentrated red cell transfusion, IV,\nAdults, Children and Neonates\n3 ml/kg for each expected 1 g/dL haemoglobin rise.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "308",
    "type": "section",
    "keywords": [
      "neonates",
      "replacement",
      "acute",
      "bolus",
      "measures",
      "fluid",
      "following",
      "expected",
      "section",
      "sodium",
      "repeat",
      "children",
      "blood",
      "stat",
      "severe",
      "each",
      "adults",
      "shock",
      "there",
      "chloride"
    ]
  },
  {
    "id": "2c3ae95469d3c920c7b7f76799cad7bf",
    "content": "Vitamin K, IV,\nAdults\n5-10 mg stat. Children\n3-5 mg stat. Neonates (irrespective of history of vitamin K injection) Term;\t1 mg stat.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "309",
    "type": "section",
    "keywords": [
      "term",
      "neonates",
      "adults",
      "history",
      "irrespective",
      "injection",
      "children",
      "vitamin",
      "stat"
    ]
  },
  {
    "id": "8a00ed7408cde8b9e3cb17ae4000e177",
    "content": "Preterm;\t500 micrograms stat. And\nFresh Frozen Plasma, IV, Adults, Children, Neonates 15-20 ml/kg\nHaemophilia A\nRecombinant Factor VIII, intravenous,\n1 international unit raises % of Factor VIII on average by 2 per kg body weight\nRequired units = body weight (kg) x desired factor rise x 0. 5 (Repeated as needed)\nOr\nDesmopressin, Intranasal, 150 microgram spray into each nostril, 12 hourly.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "310",
    "type": "section",
    "keywords": [
      "recombinant",
      "desired",
      "units",
      "neonates",
      "weight",
      "plasma",
      "intravenous",
      "nostril",
      "required",
      "repeated",
      "spray",
      "into",
      "hourly",
      "body",
      "haemophilia",
      "frozen",
      "factor",
      "fresh",
      "children",
      "stat"
    ]
  },
  {
    "id": "f6e6c9530d228f0f8470de6f8eb94502",
    "content": "Haemophilia B\nRecombinant Factor IX\nAdministration of 1 unit/kg factor IX (recombinant) generally in- creases factor IX levels by approximately 0. 8% in adults and 0. 7% in children <15 years of age.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "311",
    "type": "section",
    "keywords": [
      "recombinant",
      "administration",
      "unit",
      "haemophilia",
      "years",
      "factor",
      "levels",
      "creases",
      "adults",
      "generally",
      "children",
      "approximately"
    ]
  },
  {
    "id": "46709c8e53c1d6ee454470864e267cc6",
    "content": "Desmopressin, Intranasal, 150 microgram spray into each nostril, 12 hourly. May be repeated for 3 days\nDIC\nTreat underlying cause. Fresh Frozen Plasma Adults, Children, Neonates 15-20 ml/kg\nOr\nCoagulation factor, red cell and platelet concentrates as needed\nThrombocytopaenia requiring platelet transfusion\nPlatelet Concentrate\nAdults, Children, Neonates\n10 ml/kg (raises platelet count by 5 x 109/L)\nPrevention of local fibrinolysis\nTranexamic Acid, oral and IV, 100 mg/kg\nThen\n10 mg/kg\nAdults\n1300 mg oral 8 hourly.",
    "title": "Von Willebrand Disease",
    "section": "Von Willebrand Disease",
    "chunk_id": "312",
    "type": "section",
    "keywords": [
      "treat",
      "neonates",
      "local",
      "plasma",
      "nostril",
      "repeated",
      "spray",
      "into",
      "hourly",
      "frozen",
      "count",
      "tranexamic",
      "factor",
      "fresh",
      "thrombocytopaenia",
      "underlying",
      "requiring",
      "children",
      "platelet",
      "days"
    ]
  },
  {
    "id": "f41f43a5361bbc25ce76f2bd820c1943",
    "content": "Haemophilia A\nPurified factor VIII\nCryoprecipitate, IV,\nAdults, Children, Neonates\n1. 5-2. 0 packs/10 kg\nHaemophilia B\nPurified factor IX\nFresh frozen plasma\nReferral Criteria\nRefer all haemophiliacs and all patients with unexplained recurring bleeding episodes and those requiring surgery to the physician specialist or haematologist for initial assessment, treatment plan and scheduled comprehensive review.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "313",
    "type": "section",
    "keywords": [
      "initial",
      "neonates",
      "plasma",
      "scheduled",
      "plan",
      "review",
      "specialist",
      "haemophilia",
      "frozen",
      "bleeding",
      "factor",
      "packs",
      "fresh",
      "requiring",
      "haematologist",
      "patients",
      "children",
      "purified",
      "criteria",
      "treatment"
    ]
  },
  {
    "id": "a6f5b61bc251b944a893c59131ddb37a",
    "content": "This is an inherited disease characterized by the possession of two abnormal haemoglobins, at least one of which is haemoglobin S. There are various types, including HBSS, HBSC and HBS βthalassaemia. The possession of one normal haemoglobin (haemoglobin A) together with one abnormal haemoglobin (e.",
    "title": "Chapter 4: Haematologıcal Dısorders",
    "section": "Chapter 4: Haematologıcal Dısorders",
    "chunk_id": "314",
    "type": "section",
    "keywords": [
      "disease",
      "together",
      "various",
      "types",
      "hbsc",
      "least",
      "possession",
      "including",
      "characterized",
      "inherited",
      "which",
      "abnormal",
      "there",
      "normal",
      "hbss",
      "haemoglobins",
      "haemoglobin"
    ]
  },
  {
    "id": "558fdd8ddea0df7b346e795ac1d484cd",
    "content": "g. AS or AC) constitute a haemoglobinopathy trait and not sickle cell disease. The use of the word ‹sickler› to describe patients with sickle cell disease must be avoided.",
    "title": "Chapter 4: Haematologıcal Dısorders",
    "section": "Chapter 4: Haematologıcal Dısorders",
    "chunk_id": "315",
    "type": "section",
    "keywords": [
      "disease",
      "haemoglobinopathy",
      "sickler",
      "constitute",
      "cell",
      "must",
      "sickle",
      "describe",
      "patients",
      "avoided",
      "word",
      "trait"
    ]
  },
  {
    "id": "4c64ed30afac5dce00f47c338bb8c3a2",
    "content": "Sickle cell disease patients may present either in the steady state, in crises or with complications. The crisis is commonly vaso-occlusive bone pain crisis. Other types of crises include acute chest syndrome, hyper-haemolytic crisis, aplastic crisis and sequestration crises.",
    "title": "Chapter 4: Haematologıcal Dısorders",
    "section": "Chapter 4: Haematologıcal Dısorders",
    "chunk_id": "316",
    "type": "section",
    "keywords": [
      "either",
      "types",
      "vaso",
      "hyper",
      "acute",
      "occlusive",
      "crises",
      "aplastic",
      "chest",
      "patients",
      "crisis",
      "disease",
      "include",
      "haemolytic",
      "sickle",
      "state",
      "steady",
      "bone",
      "commonly",
      "complications"
    ]
  },
  {
    "id": "3b2fa4f7f98b99dc6b4a20741d8e7650",
    "content": "In vaso-occlusive crises there is occlusion of small vessels by sickled cells causing infarction and pain; in Acute Chest Syndrome (ACS), the patient presents with sudden onset of cough, difficulty in breathing and fever; in aplastic crises, infection with parvovirus causes sudden severe anaemia with a low reticulocyte count; in sequestration crises the spleen and liver enlarge rapidly due to trapping of red blood cells. Patients with sickle cell disease should be encouraged to have periodic check-ups at a sickle cell clinic. Causes\nInheritance of two abnormal haemoglobin genes from both parents, at least one of which is an S.",
    "title": "Chapter 4: Haematologıcal Dısorders",
    "section": "Chapter 4: Haematologıcal Dısorders",
    "chunk_id": "317",
    "type": "section",
    "keywords": [
      "sudden",
      "trapping",
      "anaemia",
      "both",
      "vaso",
      "check",
      "which",
      "breathing",
      "spleen",
      "periodic",
      "acute",
      "presents",
      "patient",
      "occlusion",
      "occlusive",
      "vessels",
      "crises",
      "aplastic",
      "chest",
      "count"
    ]
  },
  {
    "id": "97ef4bf17fae3fa585bc1ccfa46d1422",
    "content": "Crises are typically precipitated by:\ncold weather\ndehydration\ninfection\nphysical exertion\nmental stress\nSymptoms\nJoint and bone pain, especially during cold wet seasons\nEasy fatiguability\nPallor\nJaundice\nDifficulty in breathing with or without chest pain\nChronic leg ulcer\nAbdominal pain, especially in the splenic area\nSpontaneous sustained erection without sexual arousal in male patients (See section on ‘Priapism’)\nSigns\nJaundice\nPallor\nHepatomegaly.",
    "title": "Chapter 4: Haematologıcal Dısorders",
    "section": "Chapter 4: Haematologıcal Dısorders",
    "chunk_id": "318",
    "type": "section",
    "keywords": [
      "mental",
      "hepatomegaly",
      "exertion",
      "especially",
      "ulcer",
      "during",
      "splenic",
      "breathing",
      "typically",
      "crises",
      "abdominal",
      "seasons",
      "sustained",
      "chest",
      "stress",
      "jaundice",
      "section",
      "male",
      "precipitated",
      "joint"
    ]
  },
  {
    "id": "4cd1b7ce02769b9fa88d53d275c71380",
    "content": "Splenomegaly (may be absent in older patients)\nOld or recent scarification marks by traditional healers, particularly over the abdominal wall and joints\nVenous ulcers\nBossing\nDactylitis (hand and foot syndrome)\nGnathopathy\nGrowth delay or tall, lanky stature (‘marfanoid’ habitus)\ninvestigations\nFBC\nBlood film comment\nReticulocyte count\nSickling test\nHaemoglobin electrophoresis\nUrine examination\nChest X-ray in case of ACS\nBlood and urine C/S when infection suspected\nG6PD assay.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "319",
    "type": "section",
    "keywords": [
      "recent",
      "sickling",
      "test",
      "venous",
      "comment",
      "absent",
      "tall",
      "urine",
      "healers",
      "delay",
      "stature",
      "marfanoid",
      "habitus",
      "abdominal",
      "chest",
      "count",
      "growth",
      "film",
      "splenomegaly",
      "bossing"
    ]
  },
  {
    "id": "6921bb8e929fa61bbfba6bf4a4cf9776",
    "content": "To prevent the development of sickle cell crises\nTo relieve pain\nTo identify and manage the precipitating cause of crises\nTo maintain a good steady state haemoglobin\nTo prevent long term complications and organ damage\nTo manage sickle cell crises and complications once developed.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "320",
    "type": "section",
    "keywords": [
      "organ",
      "development",
      "identify",
      "crises",
      "precipitating",
      "prevent",
      "manage",
      "sickle",
      "cause",
      "state",
      "damage",
      "steady",
      "once",
      "term",
      "complications",
      "pain",
      "cell",
      "maintain",
      "relieve",
      "developed"
    ]
  },
  {
    "id": "80d9c2b2aa4905811184f8177605eed2",
    "content": "Good hydration at all times by drinking adequate water/fluids\nAvoidance of common precipitating causes of crises such as malaria (bed nets etc. ), dehydration, stress, excessive exercise, and exposure to extremes of weather\nMaintenance of good nutrition\nClient education\nParental/guardian education\nGenetic counselling with voluntary family size restriction\nGeneral public knowledge.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "321",
    "type": "section",
    "keywords": [
      "avoidance",
      "voluntary",
      "exercise",
      "times",
      "family",
      "maintenance",
      "crises",
      "nutrition",
      "precipitating",
      "genetic",
      "restriction",
      "stress",
      "counselling",
      "client",
      "water",
      "fluids",
      "public",
      "malaria",
      "knowledge",
      "causes"
    ]
  },
  {
    "id": "3d27a6a3ee1f1aaccf3aacb61cdaf673",
    "content": "500 mg-1 g 6 - 8 hourly\nChildren\n6-12 years;\t250-500 mg 6-8 hourly\nyears;\t120-250 mg 6-8 hourly\n3 months-1 year;\t60-120 mg 6-8 hourly\nOr\nParacetamol, rectal, Adults and Children Doses as above\nOr\nIbuprofen, oral,\nAdults\n400 mg 6-8 hourly\nChildren\n6-12 years;\t200-400 mg 6-8 hourly\n1-5 years;\t100-200 mg 6-8 hourly 3 months-1 year;\tnot recommended\nOr\nDiclofenac, oral,\nAdults\n50 mg 8 hourly or 100 mg 12 hourly\nChildren\n12 years;\t50 mg 12 hourly\n< 12 years;\tnot recommended\nOr\nDiclofenac, rectal,\nAdults\n100 mg daily up to a maximum of 200 mg daily in divided doses\nChildren\n75-100 mg daily\nMorphine sulphate, oral/IV, consult specialist\nAnd\nDextrose in Sodium Chloride, IV Infusion,\nAdults\n5% Dextrose in 0. 9% Sodium Chloride 2-4 L daily\nChildren\n5% Dextrose in 0. 9% Sodium Chloride 150 ml/kg daily.",
    "title": "Chapter 4: Haematologıcal Dısorders",
    "section": "Chapter 4: Haematologıcal Dısorders",
    "chunk_id": "322",
    "type": "section",
    "keywords": [
      "sulphate",
      "years",
      "infusion",
      "dextrose",
      "ibuprofen",
      "hourly",
      "rectal",
      "specialist",
      "diclofenac",
      "doses",
      "sodium",
      "children",
      "above",
      "adults",
      "paracetamol",
      "chloride",
      "months",
      "divided",
      "consult",
      "year"
    ]
  },
  {
    "id": "d491ebd7baad60e4fd40ac8cf0928ddc",
    "content": "Or\nAdults\nNormal Saline alternating with 5% Dextrose 2-4L daily\nChildren\nNormal Saline alternating with 5% Dextrose 150 ml/kg daily\nSevere Pain.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "323",
    "type": "section",
    "keywords": [
      "severe",
      "alternating",
      "pain",
      "adults",
      "dextrose",
      "saline",
      "normal",
      "children",
      "daily"
    ]
  },
  {
    "id": "9a0b3e4593f0372848b73031ceb9ea17",
    "content": "Diclofenac sodium, IM,\nAdults\n75-150 mg daily in divided doses\nThen\nCodeine phosphate, oral,\nAdults and Children over 12 years 30-60 mg 4-6 hourly\nOr\nTramadol, oral, 50-100 mg 8 hourly\nAnd\nBlood transfusion (packed cells) when needed, but not routine. Transfusion will be necessary if haemoglobin level is < 5 g/dL\nSteady State\nFolic Acid, oral,\nAdults\n5 mg daily\nChildren\n1 year;\t5 mg daily\n< 1 year;\t2. 5 mg daily.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "324",
    "type": "section",
    "keywords": [
      "years",
      "phosphate",
      "haemoglobin",
      "hourly",
      "diclofenac",
      "doses",
      "sodium",
      "children",
      "blood",
      "routine",
      "acid",
      "level",
      "cells",
      "adults",
      "packed",
      "state",
      "then",
      "divided",
      "steady",
      "year"
    ]
  },
  {
    "id": "0e6dbfa3bceffe4ebcec1f4bf9937e06",
    "content": "Amoxicillin + Clavulanic Acid, IV, 1. 2 g and urgently transferred to a tertiary centre\nHydroxycarbamide, Aspirin, Opiates and /or Chronic transfusion.",
    "title": "Severe Disease",
    "section": "Severe Disease",
    "chunk_id": "325",
    "type": "section",
    "keywords": [
      "transfusion",
      "amoxicillin",
      "chronic",
      "urgently",
      "acid",
      "opiates",
      "centre",
      "clavulanic",
      "hydroxycarbamide",
      "aspirin",
      "transferred",
      "tertiary"
    ]
  },
  {
    "id": "df399310839252b87f8332d5228e146e",
    "content": "Prevention of pneumococcal infections\nPneumococcal conjugate vaccine 13 (PCV 13) vaccination in infancy, booster at 6 years\nReferral Criteria\nRefer all sickle cell patients with bleeding into the eye, priapism, haematuria or renal disease and stroke to a specialist. The presence of osteomyelitis, aseptic necrosis of the hip, acute chest syndrome and persistent jaundice after initial management as recommended above should also warrant a referral to a specialist centre. Patients with CNS events, unexplained high white cell and platelet counts (more than 15 and 500 x 109/L respectively), intractable morbid pain, repetitive crises or recurrent severe anaemia interfering with their lives should be referred to a specialist.",
    "title": "therapy may be used under specialist care",
    "section": "therapy may be used under specialist care",
    "chunk_id": "326",
    "type": "section",
    "keywords": [
      "infections",
      "initial",
      "infancy",
      "years",
      "recurrent",
      "anaemia",
      "white",
      "booster",
      "management",
      "morbid",
      "acute",
      "conjugate",
      "into",
      "aseptic",
      "specialist",
      "crises",
      "chest",
      "bleeding",
      "jaundice",
      "intractable"
    ]
  },
  {
    "id": "e5b05e830ee94118865fef6c6aab96aa",
    "content": "Plasma cell myeloma (previously referred to as multiple myeloma), is cancer affecting the plasma cells in the bone marrow. These abnormal plasma cells occur in increased numbers and produce abnormal non- functional immunoglobulins leading to impaired ability to fight infections in the patient affected, hyperviscosity and renal failure. In the bone marrow the increased plasma cells result in a reduction in normal blood cell production and erosion of bone with resultant peripheral blood cytopaenias, osteolytic lesions, pathological fractures and hypercalcaemia.",
    "title": "therapy may be used under specialist care",
    "section": "therapy may be used under specialist care",
    "chunk_id": "327",
    "type": "section",
    "keywords": [
      "infections",
      "erosion",
      "occur",
      "plasma",
      "lesions",
      "ability",
      "cytopaenias",
      "patient",
      "impaired",
      "previously",
      "multiple",
      "functional",
      "result",
      "production",
      "abnormal",
      "renal",
      "osteolytic",
      "blood",
      "leading",
      "reduction"
    ]
  },
  {
    "id": "8d33d9e34b1b51b263cd7fc62b25c8cb",
    "content": "The disease is commonest in the sixth decade and rare below the age of 40 years. Causes\nUnknown\nPotential precipitants:\nChemicals e. g.",
    "title": "therapy may be used under specialist care",
    "section": "therapy may be used under specialist care",
    "chunk_id": "328",
    "type": "section",
    "keywords": [
      "disease",
      "unknown",
      "rare",
      "below",
      "commonest",
      "years",
      "precipitants",
      "potential",
      "sixth",
      "chemicals",
      "decade",
      "causes"
    ]
  },
  {
    "id": "498e2f845267387264cd9ae873112f7b",
    "content": "dioxins, formaldehyde, and nitrobenzene found in solvents and cleaning agents\nIonizing radiation\nViruses e. g. Herpes Virus 8, Epstein-Barr, HIV, Hepatitis Virus.",
    "title": "therapy may be used under specialist care",
    "section": "therapy may be used under specialist care",
    "chunk_id": "329",
    "type": "section",
    "keywords": [
      "epstein",
      "dioxins",
      "ionizing",
      "agents",
      "cleaning",
      "viruses",
      "virus",
      "barr",
      "hepatitis",
      "formaldehyde",
      "nitrobenzene",
      "found",
      "radiation",
      "herpes",
      "solvents"
    ]
  },
  {
    "id": "f04ce333752cf1dcb3dc4837a0be2997",
    "content": "Symptoms\nBone pain\nEasy fatiguability\nExcessive weakness\nRecurrent infections\nBony swellings\nSigns\nPallor\nFever\nDehydration\nBony lumps\nParaplegia\nParesis\nRenal Impairment\nUnprovoked fractures\ninvestigations\nFBC and blood film comment\nESR\nBlood urea, electrolytes, creatinine\nPlasma calcium levels\nSerum uric acid\nBone marrow aspirate\nSkeletal survey including skull X-ray\nSerum protein levels\nSerum protein electrophoresis\nUrine Bence Jones protein.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "330",
    "type": "section",
    "keywords": [
      "infections",
      "recurrent",
      "plasma",
      "comment",
      "bony",
      "levels",
      "skeletal",
      "jones",
      "urine",
      "weakness",
      "skull",
      "creatinine",
      "including",
      "film",
      "protein",
      "easy",
      "signs",
      "paraplegia",
      "survey",
      "renal"
    ]
  },
  {
    "id": "4197672fe104717aed3a2b5340de9884",
    "content": "To reduce the number of abnormal plasma cells to normal and\nreduce their rate of increase\nTo treat anaemia\nTo reduce bone pain\nTo manage pathological fracture\nTo improve or maintain good bone mineral density\nTo treat infections\nTo prevent and treat renal complications.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "331",
    "type": "section",
    "keywords": [
      "infections",
      "treat",
      "plasma",
      "anaemia",
      "improve",
      "density",
      "increase",
      "rate",
      "prevent",
      "abnormal",
      "their",
      "renal",
      "number",
      "fracture",
      "manage",
      "cells",
      "mineral",
      "bone",
      "complications",
      "pain"
    ]
  },
  {
    "id": "c39ea51a1f4a45512f365b22fbab7d20",
    "content": "Patients should drink at least 3 litres of fluid each day throughout the.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "332",
    "type": "section",
    "keywords": [
      "litres",
      "drink",
      "least",
      "each",
      "throughout",
      "should",
      "patients",
      "fluid"
    ]
  },
  {
    "id": "11495981ff59de27ab5bffd1fa7a038b",
    "content": "To reduce number of plasma cells and rate of increase\nAvailable at specialized centres only\nTo reduce bone pain\nPain relief (avoid NSAIDS)\nTo treat anaemia\nPacked red cells transfusion and platelet transfusion when indicated\nTo prevent and treat renal complications\nIV and oral fluids\nTo mitigate tumour lysis\nAllopurinol to mitigate tumour lysis\nTo treat infections\n(See appropriate section)\nReferral Criteria\nAll patients suspected to have plasma cell myeloma should be referred to a haematologist at a specialised tertiary centre for further evaluation and definitive management. Subsequent follow-up can be done by a physician specialist with guidance from the haematologist. Leukaemia is cancer of the blood cells.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "333",
    "type": "section",
    "keywords": [
      "infections",
      "avoid",
      "treat",
      "plasma",
      "anaemia",
      "management",
      "relief",
      "lysis",
      "definitive",
      "mitigate",
      "increase",
      "rate",
      "specialist",
      "evaluation",
      "leukaemia",
      "follow",
      "prevent",
      "section",
      "fluids",
      "haematologist"
    ]
  },
  {
    "id": "4ba720290aaa0c917a833efd0ce6396d",
    "content": "There are two main types of leukaemia, which are lymphoid leukaemia and myeloid leukaemia. Each type of leukaemia can be classified as acute (where the patient falls suddenly ill) and chronic (where the patient may have been harbouring the disease for months without knowing). Thus in all, there are 4 main types of leukaemia: acute lymphoid leukaemia (ALL), chronic lymphoid leukaemia (CLL), acute myeloid leukaemia (AML) and chronic myeloid leukaemia (CML).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "334",
    "type": "section",
    "keywords": [
      "falls",
      "types",
      "which",
      "harbouring",
      "lymphoid",
      "acute",
      "patient",
      "leukaemia",
      "type",
      "thus",
      "where",
      "disease",
      "chronic",
      "knowing",
      "each",
      "there",
      "months",
      "main",
      "classified",
      "myeloid"
    ]
  },
  {
    "id": "ae3268e7243c63ec36c7c41252a091ab",
    "content": "ALL is commonest in children especially boys, CLL is commonest in the elderly, AML and CML cut across all age groups and sexes. The abnormal leukaemic cells especially in acute leukaemia, fill the marrow and prevent the marrow from producing the normal blood cells\ni. e.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "335",
    "type": "section",
    "keywords": [
      "especially",
      "elderly",
      "acute",
      "sexes",
      "leukaemia",
      "prevent",
      "producing",
      "abnormal",
      "children",
      "blood",
      "leukaemic",
      "cells",
      "marrow",
      "boys",
      "fill",
      "groups",
      "commonest",
      "across",
      "normal"
    ]
  },
  {
    "id": "a8d21bc0a01caf38e692f5d08a802050",
    "content": "red cells, white cells and platelets leading to anaemia, neutropaenia and thrombocytopaenia, respectively. Causes\nUsually unknown\nAssociated factors\nViruses e. g.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "336",
    "type": "section",
    "keywords": [
      "usually",
      "unknown",
      "leading",
      "viruses",
      "anaemia",
      "white",
      "cells",
      "platelets",
      "thrombocytopaenia",
      "factors",
      "associated",
      "respectively",
      "neutropaenia",
      "causes"
    ]
  },
  {
    "id": "086f51e732e17620c448c0c48359e98e",
    "content": "human T lymphotrophic virus type 1 (HTLV-1) and epstein barr virus (EBV)\nChemicals e. g. benzene, industrial solvents, pesticides (lin-.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "337",
    "type": "section",
    "keywords": [
      "epstein",
      "pesticides",
      "type",
      "human",
      "virus",
      "barr",
      "htlv",
      "solvents",
      "chemicals",
      "industrial",
      "benzene",
      "lymphotrophic"
    ]
  },
  {
    "id": "b1dc9b1635c5a7c3c5619d39535274f9",
    "content": "dane), dyes,\nDrugs e. g. alkylating agents such as melphalan\nIonizing radiation\nSymptoms\nAcute Leukaemia\nFever\nLymph node swelling\nEasy fatiguability\nBruising tendencies\nBone and joint pain (especially in children)\nChronic Leukaemia\nAsymptomatic\nDragging sensation (left side of abdomen)\nEasy satiety\nLymph node swelling\nWeight loss\nGeneralized itch\nExcessive sweating\nPriapism\nHearing loss\nSigns\nAcute Leukaemia\nPallor\nFever\nSkin and mucosal haemorrhages\nGum hypertrophy (AML subtype 5)\nFirm, rubbery, non-tender lymph nodes (lymphoid leukaemia)\nSplenomegaly\nChronic Leukaemia\nSplenomegaly\nWeight loss\nPallor\nGeneralized lymph node enlargement in CLL\ninvestigations\nFBC and blood film comment\nBone marrow aspirate\nUric acid levels\nLDH\nBUE and creatinine\nLiver function tests\nSeptic screen (especially in acute leukaemia)\nLP for CSF cytology (especially in acute lymphoid leukaemia).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "338",
    "type": "section",
    "keywords": [
      "agents",
      "weight",
      "firm",
      "dyes",
      "lymph",
      "especially",
      "comment",
      "levels",
      "swelling",
      "mucosal",
      "liver",
      "haemorrhages",
      "radiation",
      "dragging",
      "rubbery",
      "acute",
      "lymphoid",
      "asymptomatic",
      "creatinine",
      "leukaemia"
    ]
  },
  {
    "id": "021d38465f97875b9ce4787f4c52eee3",
    "content": "To aim for a cure in ALL in both children and adults\nTo achieve remission and prolong good quality life in AML\nTo aim for a complete haematological remission or cure in philadelphia positive CML\nTo control white cell counts, symptoms and prolong good quality of\nlife in philadelphia negative CML.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "339",
    "type": "section",
    "keywords": [
      "white",
      "quality",
      "both",
      "complete",
      "children",
      "haematological",
      "cure",
      "adults",
      "counts",
      "symptoms",
      "positive",
      "achieve",
      "prolong",
      "cell",
      "life",
      "remission",
      "philadelphia",
      "control",
      "negative"
    ]
  },
  {
    "id": "18a1f687acc16bd45d99ffc0c37e7b8a",
    "content": "Ensure good hydration\nEnsure good nutrition and food hygiene\nEnsure good oral and personal hygiene.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "340",
    "type": "section",
    "keywords": [
      "nutrition",
      "hygiene",
      "ensure",
      "food",
      "oral",
      "personal",
      "hydration"
    ]
  },
  {
    "id": "211e2f06a24cea46fd20dd1db35e01f2",
    "content": "Pain relief (avoid NSAIDS)\nPacked red cells transfusion and platelet transfusion when indicated\nIV and oral fluids\nAllopurinol to mitigate tumour lysis.",
    "title": "A.\tTreatment of the newly diagnosed patient Supportive treatment",
    "section": "A.\tTreatment of the newly diagnosed patient Supportive treatment",
    "chunk_id": "341",
    "type": "section",
    "keywords": [
      "transfusion",
      "avoid",
      "pain",
      "lysis",
      "cells",
      "packed",
      "relief",
      "oral",
      "fluids",
      "indicated",
      "allopurinol",
      "tumour",
      "mitigate",
      "nsaids",
      "platelet"
    ]
  },
  {
    "id": "a24005adf1e128f4e837593c15996041",
    "content": "Available at specialized tertiary centres only\nReferral Criteria\nRefer all patients to the haematologist at a specialized tertiary centre for confirmation of diagnosis and start of management. Follow-up can continue at a regional centre by a physician under the distant guidance of a haematologist. This refers to a group of disorders characterized by malignant proliferation of lymphoid tissue usually presenting as lymph node swellings.",
    "title": "Specific treatment",
    "section": "Specific treatment",
    "chunk_id": "342",
    "type": "section",
    "keywords": [
      "usually",
      "continue",
      "management",
      "lymph",
      "confirmation",
      "presenting",
      "lymphoid",
      "refers",
      "under",
      "start",
      "follow",
      "malignant",
      "haematologist",
      "patients",
      "guidance",
      "regional",
      "criteria",
      "tertiary",
      "proliferation",
      "physician"
    ]
  },
  {
    "id": "c6ced3dcf5b4016cd64d5d09f301437c",
    "content": "There are 2 major histological types distinguished by the presence or absence of the Reed Sternberg (RS) cell. The 2 main groups are Hodgkin’s lymphoma (RS cell present) and non-Hodgkin’s lymphoma (RS cell absent). No age is exempt although generally the incidence of non- Hodgkin’s lymphoma (NHL) increases with age and immunosuppression while Hodgkin’s lymphoma (HL) shows a bimodal peak, in that there is a high incidence in the third and seventh decades.",
    "title": "Specific treatment",
    "section": "Specific treatment",
    "chunk_id": "343",
    "type": "section",
    "keywords": [
      "types",
      "lymphoma",
      "increases",
      "decades",
      "absent",
      "hodgkin",
      "generally",
      "histological",
      "while",
      "bimodal",
      "sternberg",
      "presence",
      "seventh",
      "immunosuppression",
      "peak",
      "third",
      "incidence",
      "major",
      "there",
      "groups"
    ]
  },
  {
    "id": "ade6d5f1a52f24910d19058589720ad9",
    "content": "Burkitt’s lymphoma, a subtype of NHL, is one of the fastest growing.",
    "title": "Specific treatment",
    "section": "Specific treatment",
    "chunk_id": "344",
    "type": "section",
    "keywords": [
      "growing",
      "burkitt",
      "subtype",
      "lymphoma",
      "fastest"
    ]
  },
  {
    "id": "bb5d792e644cacf93b73540d997dc378",
    "content": "tumours known in man. There are three clinical variants - the endemic, sporadic and immunodeficiency associated forms. The endemic form is found in tropical and malaria endemic regions like Ghana and commonly presents as a jaw swelling with loosening of the associated teeth.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "345",
    "type": "section",
    "keywords": [
      "tumours",
      "immunodeficiency",
      "swelling",
      "associated",
      "form",
      "presents",
      "sporadic",
      "variants",
      "regions",
      "known",
      "malaria",
      "forms",
      "there",
      "three",
      "loosening",
      "teeth",
      "commonly",
      "endemic",
      "tropical",
      "ghana"
    ]
  },
  {
    "id": "a46b0d85290246c58d6a66e77a753ef2",
    "content": "In Ghana, it is the commonest childhood malignancy. It has a peak age incidence at 4-7 years with a male preponderance. Causes\nOften unknown\nAssociated aetiological agents\nChronic antigenic stimulation by Helicobacter pylori infection in gastric lymphoma\nViruses e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "346",
    "type": "section",
    "keywords": [
      "malignancy",
      "agents",
      "years",
      "lymphoma",
      "often",
      "associated",
      "preponderance",
      "pylori",
      "unknown",
      "stimulation",
      "aetiological",
      "gastric",
      "male",
      "childhood",
      "peak",
      "causes",
      "chronic",
      "antigenic",
      "incidence",
      "viruses"
    ]
  },
  {
    "id": "a825127106b556539285330d97f16b9d",
    "content": "g. herpes virus 8, epstein-barr virus, HTLV-1\nChemicals e. g.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "347",
    "type": "section",
    "keywords": [
      "epstein",
      "virus",
      "barr",
      "htlv",
      "chemicals",
      "herpes"
    ]
  },
  {
    "id": "f2f72ff6aa554c94d390c05a410fa77e",
    "content": "pesticides, herbicides\nWood dust\nSymptoms\nLymph node swelling which may wax and wane\nJaw swelling (in Burkitts)\nFever\nNight sweats\nWeight loss\nEasy fatiguability\nAbdominal distension, intestinal obstruction\t(in abdominal lymphomas)\nSigns\nFirm, rubbery, non-tender lymph nodes\nSplenomegaly\nSuperior vena cava syndrome (if bulky mediastinal masses are present)\nPallor (if marrow has been involved)\ninvestigations\nLymph node biopsy (of a significantly enlarged node)\nFine needle aspiration (in Burkitts)\nFBC and blood film comment\nChest X-ray, abdominal USG, CT scan when necessary\nBone marrow aspirate and trephine biopsy.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "348",
    "type": "section",
    "keywords": [
      "significantly",
      "dust",
      "weight",
      "firm",
      "lymph",
      "comment",
      "swelling",
      "which",
      "rubbery",
      "distension",
      "night",
      "masses",
      "trephine",
      "aspiration",
      "abdominal",
      "chest",
      "involved",
      "film",
      "intestinal",
      "obstruction"
    ]
  },
  {
    "id": "0f27951351b7ca3011cbb9fa7b3c626c",
    "content": "A. Hodgkin’s Lymphoma (HL) and Non-Hodgkin’s Lymphoma (NHL).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "349",
    "type": "section",
    "keywords": [
      "lymphoma",
      "hodgkin"
    ]
  },
  {
    "id": "211e2f06a24cea46fd20dd1db35e01f2",
    "content": "Pain relief (avoid NSAIDS)\nPacked red cells transfusion and platelet transfusion when indicated\nIV and oral fluids\nAllopurinol to mitigate tumour lysis.",
    "title": "Supportive treatment",
    "section": "Supportive treatment",
    "chunk_id": "350",
    "type": "section",
    "keywords": [
      "transfusion",
      "avoid",
      "pain",
      "lysis",
      "cells",
      "packed",
      "relief",
      "oral",
      "fluids",
      "indicated",
      "allopurinol",
      "tumour",
      "mitigate",
      "nsaids",
      "platelet"
    ]
  },
  {
    "id": "e0c9affadf690a9a4694668423e8f1a8",
    "content": "Available at specialized tertiary centres only\nReferral Criteria\nAll patients should be referred to a haematologist at a specialised tertiary centre.",
    "title": "Specific treatment",
    "section": "Specific treatment",
    "chunk_id": "351",
    "type": "section",
    "keywords": [
      "referral",
      "centres",
      "should",
      "centre",
      "criteria",
      "only",
      "haematologist",
      "specialised",
      "available",
      "specialized",
      "patients",
      "tertiary",
      "referred"
    ]
  },
  {
    "id": "ecaa62050775731f6fa2f057cb04c537",
    "content": "Immunisation against vaccine preventable diseases through the national Expanded Programme for Immunisation (EPI) is one of the most effective measures of reducing morbidity, disability and mortality in the population, especially, in children. Ghana currently has 12 (twelve) vaccines in the immunisation schedule, namely, BCG, oral poliomyelitis, diphtheria, pertussis, tetanus, hepatitis B, haemophilus influenzae type B, pneumococcus, rotavirus, measles, rubella and yellow fever. Newer vaccines may be introduced in the near future as they are discovered and found effective.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "352",
    "type": "section",
    "keywords": [
      "vaccines",
      "morbidity",
      "tetanus",
      "especially",
      "namely",
      "programme",
      "pertussis",
      "measures",
      "future",
      "national",
      "haemophilus",
      "diseases",
      "type",
      "schedule",
      "pneumococcus",
      "expanded",
      "newer",
      "population",
      "rotavirus",
      "most"
    ]
  },
  {
    "id": "d281c0ea06ec990b7e8600d313052b18",
    "content": "Immunisation is recommended for the following persons:.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "353",
    "type": "section",
    "keywords": [
      "recommended",
      "persons",
      "immunisation",
      "following"
    ]
  },
  {
    "id": "6a0bcf74d4b541017ba263639c66b8a3",
    "content": "Young children\nElderly\nThe malnourished\nThe current schedule for routine Immunisation for children under 5 years is as follows:\nEvidence Rating [A].",
    "title": "High risk groups (e.g. during a disease outbreak or by virtue of being exposed)",
    "section": "High risk groups (e.g. during a disease outbreak or by virtue of being exposed)",
    "chunk_id": "354",
    "type": "section",
    "keywords": [
      "rating",
      "schedule",
      "years",
      "young",
      "elderly",
      "immunisation",
      "follows",
      "children",
      "malnourished",
      "current",
      "evidence",
      "routine",
      "under"
    ]
  },
  {
    "id": "bcc7817d2c91a13b3807adaa2449f11c",
    "content": "*Five in One” Vaccine or Penta-Vaccine contains Diphtheria, Pertussis, Tetanus, Haemophilus\nInfluenzae B and Hepatitis B Antigens in one vaccine. Measles/Rubella is presented as a combined vaccine. Immunisation of preterm babies:\nConsider all premature babies for full immunisation course.",
    "title": "Chapter 5:  Immunısable Dıseases",
    "section": "Chapter 5:  Immunısable Dıseases",
    "chunk_id": "355",
    "type": "section",
    "keywords": [
      "tetanus",
      "contains",
      "full",
      "pertussis",
      "babies",
      "haemophilus",
      "penta",
      "consider",
      "five",
      "premature",
      "vaccine",
      "combined",
      "diphtheria",
      "course",
      "influenzae",
      "immunisation",
      "measles",
      "hepatitis",
      "rubella",
      "presented"
    ]
  },
  {
    "id": "41153e98a6b2a737716cfef5d953415b",
    "content": "Start immunisation in 2nd month after birth (after 4 weeks) irrespective of degree of prematurity. Give BCG on discharge. Delay OPV in neonatal unit since there is a small chance of transfer of\nOPV virus to other babies.",
    "title": "Chapter 5:  Immunısable Dıseases",
    "section": "Chapter 5:  Immunısable Dıseases",
    "chunk_id": "356",
    "type": "section",
    "keywords": [
      "virus",
      "give",
      "delay",
      "chance",
      "prematurity",
      "babies",
      "transfer",
      "start",
      "weeks",
      "neonatal",
      "immunisation",
      "birth",
      "there",
      "month",
      "degree",
      "since",
      "unit",
      "small",
      "other",
      "irrespective"
    ]
  },
  {
    "id": "b7d9a7769dac5ea714cf794aa40c05e1",
    "content": "Hence give OPV on discharge from nursery\n- not while still on admission. Contraindications to Immunisation:\nCurrent serious febrile illness: delay vaccine\nHistory of severe reaction after previous dose (e. g.",
    "title": "Chapter 5:  Immunısable Dıseases",
    "section": "Chapter 5:  Immunısable Dıseases",
    "chunk_id": "357",
    "type": "section",
    "keywords": [
      "give",
      "delay",
      "serious",
      "while",
      "reaction",
      "admission",
      "previous",
      "vaccine",
      "severe",
      "contraindications",
      "immunisation",
      "dose",
      "nursery",
      "febrile",
      "still",
      "hence",
      "history",
      "illness",
      "after",
      "discharge"
    ]
  },
  {
    "id": "2057c5657854113b0b621eb9acc4e0b2",
    "content": "whole cell pertussis vaccine\nNo DPT or DPT/HepB/Hib to child with convulsion/shock within 3 days of the most recent dose of DPT or DPT/HepB/Hib\nNo DPT or DPT/HepB/Hib to child with recurrent convulsions or.",
    "title": "Evolving neurological disease (e.g. uncontrolled epilepsy) - avoid",
    "section": "Evolving neurological disease (e.g. uncontrolled epilepsy) - avoid",
    "chunk_id": "358",
    "type": "section",
    "keywords": [
      "vaccine",
      "days",
      "within",
      "recent",
      "recurrent",
      "cell",
      "shock",
      "child",
      "convulsion",
      "dose",
      "pertussis",
      "convulsions",
      "most",
      "whole",
      "hepb"
    ]
  },
  {
    "id": "571f5e47a5a23c0e0a6dbfb91056cff3",
    "content": "Yellow fever vaccine should not be given if there is history of anaphylaxis with ingestion of egg\nIndividuals with symptomatic HIV infection should not receive BCG\nand yellow fever vaccines since these are live vaccines. BCG vaccine can be given at birth since the HIV infected newborn is asymptomatic\nLive vaccines should not be given to the following:\nPregnant women - for risk of teratogenic effect.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "359",
    "type": "section",
    "keywords": [
      "vaccines",
      "given",
      "infected",
      "live",
      "effect",
      "asymptomatic",
      "following",
      "vaccine",
      "yellow",
      "ingestion",
      "anaphylaxis",
      "women",
      "should",
      "fever",
      "receive",
      "there",
      "birth",
      "symptomatic",
      "since",
      "teratogenic"
    ]
  },
  {
    "id": "f24def48622f0feaf0081b5209a5172f",
    "content": "Patients with immune suppression, including Symptomatic HIV patients\nPatients on chemotherapy (defer for 6 months after stopping.",
    "title": "Malignant disease of the reticuloendothelial system,",
    "section": "Malignant disease of the reticuloendothelial system,",
    "chunk_id": "360",
    "type": "section",
    "keywords": [
      "including",
      "immune",
      "defer",
      "patients",
      "symptomatic",
      "after",
      "months",
      "stopping",
      "chemotherapy",
      "suppression"
    ]
  },
  {
    "id": "723ab825dc036faf831e444b29b02258",
    "content": "However:\nMeasles vaccine should be given to HIV positive patients even though it is a live vaccine because the benefit outweighs the risk\nReferral Criteria\nRefer all problems related to Immunisation to a paediatrician or EPI specialist. Measles is an acute infectious disease, which usually occurs in children between 6 months and 3 years who have not been immunised, or completed the full immunisation schedule. It is prevented by 2 doses of measles vaccination at 9 and 18 months.",
    "title": "chemotherapy treatment)",
    "section": "chemotherapy treatment)",
    "chunk_id": "361",
    "type": "section",
    "keywords": [
      "usually",
      "years",
      "completed",
      "given",
      "which",
      "live",
      "full",
      "acute",
      "paediatrician",
      "specialist",
      "schedule",
      "immunised",
      "doses",
      "even",
      "benefit",
      "patients",
      "children",
      "criteria",
      "vaccine",
      "disease"
    ]
  },
  {
    "id": "c4fe1dd75b357d5fa47da3cd0e734675",
    "content": "The condition is very infectious from up to 7 days before, to 5 days after, appearance of the rash. Complications include otitis media, with or without deafness, bronchopneumonia, croup, diarrhoea, vitamin A deficiency leading to xerophthalmia and blindness, malnutrition and activation of latent tuberculosis. Seriously ill measles patients requiring admission should be isolated.",
    "title": "chemotherapy treatment)",
    "section": "chemotherapy treatment)",
    "chunk_id": "362",
    "type": "section",
    "keywords": [
      "xerophthalmia",
      "malnutrition",
      "appearance",
      "otitis",
      "vitamin",
      "diarrhoea",
      "rash",
      "isolated",
      "bronchopneumonia",
      "blindness",
      "requiring",
      "patients",
      "condition",
      "admission",
      "deficiency",
      "days",
      "include",
      "deafness",
      "leading",
      "before"
    ]
  },
  {
    "id": "d3d31b21d750c1dbe2a8931e60cc2f80",
    "content": "There is no specific treatment for measles. Antibiotics are not required, except for some specific complications. Measles diagnosis is mainly clinical.",
    "title": "chemotherapy treatment)",
    "section": "chemotherapy treatment)",
    "chunk_id": "363",
    "type": "section",
    "keywords": [
      "complications",
      "diagnosis",
      "antibiotics",
      "specific",
      "there",
      "except",
      "measles",
      "required",
      "mainly",
      "treatment",
      "clinical"
    ]
  },
  {
    "id": "68b750eeed890268289123954096b5cb",
    "content": "The disease is now uncommon because of immunisation. However, high immunisation coverage needs to be maintained to keep the disease under control. Report all cases to the District Disease Control Officer for appropriate action.",
    "title": "chemotherapy treatment)",
    "section": "chemotherapy treatment)",
    "chunk_id": "364",
    "type": "section",
    "keywords": [
      "disease",
      "coverage",
      "uncommon",
      "because",
      "district",
      "appropriate",
      "action",
      "however",
      "keep",
      "high",
      "cases",
      "officer",
      "immunisation",
      "needs",
      "control",
      "report",
      "maintained",
      "under"
    ]
  },
  {
    "id": "f5a7915964ae085c76e4b28ec599c7a6",
    "content": "Cause\nMeasles virus\nSymptoms\nRunny nose\nCough\nRed eyes.",
    "title": "chemotherapy treatment)",
    "section": "chemotherapy treatment)",
    "chunk_id": "365",
    "type": "section",
    "keywords": [
      "virus",
      "runny",
      "cough",
      "cause",
      "measles",
      "nose",
      "symptoms",
      "eyes"
    ]
  },
  {
    "id": "391e1a0b4e99f11819fba7aa4e7f74ea",
    "content": "Sore mouth\nHigh fever, present before the rash appears\nRash - starts on face and neck\nDiarrhoea\nChild is generally miserable\nSigns\nFever\nConjunctivitis\nKoplik spots (white grain-like spots on the buccal mucosa 2 days before rash)\nRash - itchy, generalised maculo-papular\ninvestigations\nUsually none\nMeasles immunoglobulin M (IgM) antibody assay if required.",
    "title": "Chapter 5:  Immunısable Dıseases",
    "section": "Chapter 5:  Immunısable Dıseases",
    "chunk_id": "366",
    "type": "section",
    "keywords": [
      "usually",
      "grain",
      "white",
      "face",
      "child",
      "generally",
      "required",
      "neck",
      "diarrhoea",
      "rash",
      "appears",
      "signs",
      "generalised",
      "days",
      "conjunctivitis",
      "immunoglobulin",
      "before",
      "mouth",
      "miserable",
      "fever"
    ]
  },
  {
    "id": "b3fa22ce349eb1a9a2d26e4d3907c83b",
    "content": "To relieve symptoms\nTo maintain good nutrition\nTo prevent and treat complications.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "367",
    "type": "section",
    "keywords": [
      "nutrition",
      "complications",
      "treat",
      "prevent",
      "maintain",
      "relieve",
      "symptoms"
    ]
  },
  {
    "id": "a942f9cadef2840cca5673722598d5e0",
    "content": "Tepid sponging for fever\nEncourage oral hygiene with frequent saline mouth wash\nContinue feeding with soft high calorie foods\nWash eyes with clean water\nDiscourage use of harsh items on skin.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "368",
    "type": "section",
    "keywords": [
      "continue",
      "feeding",
      "foods",
      "items",
      "calorie",
      "saline",
      "discourage",
      "water",
      "wash",
      "tepid",
      "mouth",
      "fever",
      "skin",
      "soft",
      "eyes",
      "hygiene",
      "clean",
      "oral",
      "high",
      "harsh"
    ]
  },
  {
    "id": "0cbff554c2f60a5c723b8954a8fa85f7",
    "content": "For pain and fever\nEvidence Rating: [C]\nParacetamol, oral,\nAdults\n500 mg-1g 6-8 hourly\nChildren\n6-12 years;\t250-500 mg 6-8 hourly\n1-5 years;\t120-250 mg 6-8 hourly\n3 months-1 year;\t60-120 mg 6-8 hourly\nTo prevent eye complications due to Vitamin A deficiency\nEvidence Rating: [A]\nVitamin A, oral,\nChildren\n1 year;\t200,000 units daily for 2 days\n6-11 months;\t100,000 units daily for 2 days\n< 6 months;\t50,000 units daily for 2 days\nFor management of associated diarrhoea with dehydration\n(See section on ‘Diarrhoea’).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "369",
    "type": "section",
    "keywords": [
      "units",
      "years",
      "management",
      "associated",
      "vitamin",
      "evidence",
      "diarrhoea",
      "hourly",
      "rating",
      "prevent",
      "section",
      "children",
      "deficiency",
      "days",
      "dehydration",
      "fever",
      "adults",
      "paracetamol",
      "months",
      "year"
    ]
  },
  {
    "id": "4619bf0e62f140c0da3f49a65ebb3df4",
    "content": "For management of associated pneumonia and otitis media\n(See relevant sections)\nFor relief of skin irritation\nCalamine lotion (apply liberally to the whole skin)\nReferral Criteria\nRefer patients with complications such as a black (haemorrhagic) rash, stridor, pneumonia, coma, great difficulty in eating or drinking, dehydration or malnutrition to the hospital. This is a highly contagious bacterial respiratory tract infection common in children and adults. The incubation period is 7-21 days.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "370",
    "type": "section",
    "keywords": [
      "lotion",
      "malnutrition",
      "management",
      "relief",
      "otitis",
      "associated",
      "haemorrhagic",
      "contagious",
      "rash",
      "liberally",
      "stridor",
      "great",
      "calamine",
      "patients",
      "highly",
      "whole",
      "eating",
      "children",
      "criteria",
      "sections"
    ]
  },
  {
    "id": "9046e7a7396e971b9082fc18815affd8",
    "content": "Complications include subconjunctival haemorrhage, otitis media, apnoea, pneumonia, bronchiectasis, activation of latent tuberculosis, dehydration, fever, convulsions, rectal prolapse, and malnutrition. Admit to hospital when complications are present. Pertussis can be prevented by the “five-in-one” Immunisation recommended for all children (See section on ‘Immunisation’).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "371",
    "type": "section",
    "keywords": [
      "admit",
      "malnutrition",
      "subconjunctival",
      "bronchiectasis",
      "otitis",
      "pertussis",
      "rectal",
      "section",
      "five",
      "convulsions",
      "children",
      "prolapse",
      "include",
      "dehydration",
      "apnoea",
      "prevented",
      "pneumonia",
      "fever",
      "immunisation",
      "tuberculosis"
    ]
  },
  {
    "id": "5d3cd16243a2b6541e12047b23fe534a",
    "content": "In the event of a child developing pertussis before immunisation, the “five in one” vaccine should still be given to protect against the four other diseases. During epidemics, or when there is a clear history of contact in a child with catarrh, appropriate antibiotics may help reduce the period of infectivity and transmission. All cases should be reported to the District Disease Control Officer.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "372",
    "type": "section",
    "keywords": [
      "infectivity",
      "antibiotics",
      "given",
      "during",
      "officer",
      "child",
      "epidemics",
      "pertussis",
      "clear",
      "help",
      "four",
      "catarrh",
      "diseases",
      "district",
      "developing",
      "five",
      "vaccine",
      "against",
      "disease",
      "event"
    ]
  },
  {
    "id": "638eef8dc75e202bd89d98214fa26060",
    "content": "Cause\nBordetella pertussis\nSymptoms\nCatarrhal Phase: initial 1-2 weeks\nLow grade fever\nNasal discharge\nMild cough\nParoxysmal phase: within the following 6-10 weeks\nEpisodes of violent repetitive cough ending with inspiratory whoop or vomiting (whoop may be absent in babies and adults)\nRecovery (convalescent) phase: next 2-3 weeks\nGradual reduction in bouts of coughing\nSigns\nApnoea (long pause in breathing) common in babies\nCyanosis.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "373",
    "type": "section",
    "keywords": [
      "initial",
      "convalescent",
      "paroxysmal",
      "absent",
      "breathing",
      "pertussis",
      "cyanosis",
      "ending",
      "bordetella",
      "babies",
      "within",
      "whoop",
      "following",
      "catarrhal",
      "signs",
      "weeks",
      "grade",
      "episodes",
      "reduction",
      "coughing"
    ]
  },
  {
    "id": "8637f957a84f837503e389f520e09edf",
    "content": "investigations\nFBC - high total lymphocyte count\nChest X-ray (to exclude other causes of chronic cough).",
    "title": "Chapter 5:  Immunısable Dıseases",
    "section": "Chapter 5:  Immunısable Dıseases",
    "chunk_id": "374",
    "type": "section",
    "keywords": [
      "chronic",
      "chest",
      "exclude",
      "count",
      "cough",
      "other",
      "high",
      "investigations",
      "lymphocyte",
      "total",
      "causes"
    ]
  },
  {
    "id": "eb51be0658f08d4bf05bb56788926ee4",
    "content": "Feed frequently between coughing spasms\nEncourage adequate oral fluid intake.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "375",
    "type": "section",
    "keywords": [
      "coughing",
      "feed",
      "oral",
      "between",
      "frequently",
      "intake",
      "encourage",
      "adequate",
      "spasms",
      "fluid"
    ]
  },
  {
    "id": "c91f9d871055d34471b6eb72b404ae68",
    "content": "Patients and close contacts within 14 days of onset of symptoms.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "376",
    "type": "section",
    "keywords": [
      "days",
      "within",
      "contacts",
      "patients",
      "close",
      "symptoms",
      "onset"
    ]
  },
  {
    "id": "e095223612c5acd70732c77d7025d295",
    "content": "Erythromycin, oral,\nAdults\n500 mg 6 hourly for 7 days\nChildren\n8-12 years;\t250-500 mg 6 hourly for 7 days\n2-8 years;\t250 mg of suspension 6 hourly for 7 days\n6 months-2 years;\t125 mg of suspension 6 hourly for 7 days\n< 6 months;\tnot recommended (risk of pyloric stenosis). Consider Trimethoprim/Sulphamethoxazole instead. (See below).",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "377",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "trimethoprim",
      "erythromycin",
      "years",
      "recommended",
      "stenosis",
      "pyloric",
      "consider",
      "below",
      "suspension",
      "adults",
      "oral",
      "instead",
      "risk",
      "children",
      "months",
      "sulphamethoxazole"
    ]
  },
  {
    "id": "f0a7bc71c82ec0667ee6db19fa5ad8e6",
    "content": "Or\nEvidence Rating: [B]\nAzithromycin, oral,\nAdults\n500 mg daily for 3 days\nChildren\n10 mg/kg body weight daily for 3 days\n(not recommended for children less than 6 months because of a risk\nof pyloric stenosis). Consider Trimethoprim/Sulphamethoxazole instead. (See below).",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "378",
    "type": "section",
    "keywords": [
      "weight",
      "pyloric",
      "instead",
      "evidence",
      "trimethoprim",
      "rating",
      "body",
      "consider",
      "children",
      "sulphamethoxazole",
      "days",
      "because",
      "stenosis",
      "adults",
      "azithromycin",
      "months",
      "recommended",
      "below",
      "oral",
      "less"
    ]
  },
  {
    "id": "95c384ff85a0c68849f1bd69cdbdda3a",
    "content": "Or\nEvidence Rating: [C]\nClarithromycin, oral,\nAdults\n500 mg 12 hourly for 7 days\nChildren\n7. 5 mg/kg 12 hourly for 7 days.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "379",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "rating",
      "clarithromycin",
      "adults",
      "oral",
      "children",
      "evidence"
    ]
  },
  {
    "id": "6a2fccc1fb7f57317f89cf72f5cdd800",
    "content": "Adults\n160/800 mg 12 hourly for 7 days\nChildren\n4/20 mg/kg 12 hourly for 7 days\nOxygen therapy when oxygen saturation <92%\nOxygen, intranasal or face mask, (if the patient has difficulty in breathing or is cyanosed)\nReferral Criteria\nRefer infants who have an episode of apnoea or cyanosis after initial resuscitation to a specialist. Tetanus is a disease caused by a bacterium, which produces a neurotoxin responsible for the clinical features. These bacteria live predominantly in the soil, so it is easy to get this infection whenever a break in the skin is not cleaned properly.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "380",
    "type": "section",
    "keywords": [
      "initial",
      "produces",
      "bacteria",
      "tetanus",
      "cyanosed",
      "face",
      "which",
      "breathing",
      "features",
      "live",
      "properly",
      "cyanosis",
      "patient",
      "therapy",
      "responsible",
      "hourly",
      "specialist",
      "oxygen",
      "episode",
      "easy"
    ]
  },
  {
    "id": "1968464ce8f4e8bc76e5a2a9444c5668",
    "content": "Tetanus-prone wounds include burns, puncture injuries, or those contaminated by soil/manure, septic wounds, and those with much devitalised tissue and compound fractures. The use of non-sterilised instruments or dressings on the umbilical cord predisposes to neonatal tetanus. The incubation period is 3-21 days.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "381",
    "type": "section",
    "keywords": [
      "injuries",
      "compound",
      "tetanus",
      "instruments",
      "puncture",
      "prone",
      "burns",
      "days",
      "include",
      "neonatal",
      "fractures",
      "devitalised",
      "manure",
      "predisposes",
      "period",
      "septic",
      "those",
      "umbilical",
      "wounds",
      "sterilised"
    ]
  },
  {
    "id": "18381c900cb669479fc2278aba187043",
    "content": "Tetanus should be treated as a medical emergency. Tetanus immunisation is the key for prevention (See section on ‘Immunisation’). Cause\nClostridium tetani\nSymptoms\nDifficulty or inability to open mouth\nConstipation\nStiff body\nSpasms- these are painful and are triggered by noise, bright light or touch; spontaneous in severe cases.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "382",
    "type": "section",
    "keywords": [
      "triggered",
      "tetanus",
      "stiff",
      "light",
      "open",
      "body",
      "emergency",
      "treated",
      "section",
      "constipation",
      "bright",
      "severe",
      "prevention",
      "mouth",
      "touch",
      "should",
      "painful",
      "cause",
      "difficulty",
      "immunisation"
    ]
  },
  {
    "id": "6725f9ee1c2c3643ec70ca9fd05006bd",
    "content": "Signs\nUmbilicus may be infected\nPresence of wound (but may have healed)\nIrritability\nCyanosis during spasms\nSardonic (mocking) smile\nLock jaw (cannot open the mouth)\nOpisthotonus (stiff arched back)\nRigid abdomen and stiff neck and limbs\ninvestigations\nNo confirmatory test (diagnosis is clinical).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "383",
    "type": "section",
    "keywords": [
      "test",
      "lock",
      "rigid",
      "stiff",
      "during",
      "wound",
      "infected",
      "umbilicus",
      "cyanosis",
      "neck",
      "open",
      "healed",
      "sardonic",
      "signs",
      "limbs",
      "presence",
      "irritability",
      "diagnosis",
      "mouth",
      "cannot"
    ]
  },
  {
    "id": "df4de881d9ce469a2de220c7ef1e5b19",
    "content": "To prevent further spasms\nTo eliminate Clostridium tetani to stop further toxin production\nTo neutralise circulating toxin\nTo provide adequate hydration and nutrition.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "384",
    "type": "section",
    "keywords": [
      "hydration",
      "clostridium",
      "nutrition",
      "prevent",
      "circulating",
      "stop",
      "further",
      "provide",
      "production",
      "toxin",
      "neutralise",
      "eliminate",
      "adequate",
      "tetani",
      "spasms"
    ]
  },
  {
    "id": "f9f0cea180a0f73a155cf94a48fb9d2b",
    "content": "Always admit a suspected case of tetanus\nMaintain a clear airway\nAvoid noise, bright light and unnecessary physical examination of the patient\nClean the infected umbilicus or wound with soap and water or\nantiseptic solution (See section on ‘Wound management’)\nSurgical debridement of the wound when necessary.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "385",
    "type": "section",
    "keywords": [
      "avoid",
      "admit",
      "tetanus",
      "management",
      "wound",
      "infected",
      "umbilicus",
      "clear",
      "light",
      "patient",
      "always",
      "section",
      "water",
      "bright",
      "soap",
      "surgical",
      "suspected",
      "debridement",
      "unnecessary",
      "antiseptic"
    ]
  },
  {
    "id": "fb887d0d0c58006f4113847a370fb364",
    "content": "Eradication of bacteria in a patient diagnosed to have tetanus.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "386",
    "type": "section",
    "keywords": [
      "bacteria",
      "tetanus",
      "have",
      "eradication",
      "patient",
      "diagnosed"
    ]
  },
  {
    "id": "32c23414f1606c066d2c4a9c1f128daa",
    "content": "Metronidazole, IV,\nAdults\n500 mg 6 hourly for 7-10 days\nChildren\n1 month\t7. 5 mg/kg 8 hourly for 7-10 day\nNeonates\n7 days;\t7. 5 mg/kg 12 hourly\n< 7 days;\t7.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "387",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "neonates",
      "adults",
      "month",
      "children"
    ]
  },
  {
    "id": "7ae62ee178185d331694d43a9e8aed6f",
    "content": "Benzylpenicillin, IV,\nAdults\n50,000 units/kg stat, then 4 MU 6 hourly for 5 days\nChildren\n50,000 units/kg 6 hourly for 5 days\nNeonates\n250,000 units 6 hourly for 7 days\nAnd\nGentamicin, IV, (neonates only), 4 mg/kg 24 hourly\nTo neutralize free circulating toxin\nEvidence Rating: [B]\nHuman Tetanus Immunoglobulin, IM or IV,\nAdults and Children\n500 units stat. Neonates.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "388",
    "type": "section",
    "keywords": [
      "units",
      "neonates",
      "benzylpenicillin",
      "tetanus",
      "neutralize",
      "toxin",
      "evidence",
      "hourly",
      "rating",
      "children",
      "stat",
      "days",
      "immunoglobulin",
      "circulating",
      "adults",
      "only",
      "free",
      "then",
      "gentamicin",
      "human"
    ]
  },
  {
    "id": "481d294b404f07eff0aefa7a5f7fec7d",
    "content": "250 units stat. And\nTetanus Toxoid, IM, (inject at different site from Human Tetanus Im- munoglobulin)\nAdults and Children\n2 years;\t0. 5 ml stat.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "389",
    "type": "section",
    "keywords": [
      "human",
      "units",
      "years",
      "different",
      "tetanus",
      "adults",
      "site",
      "toxoid",
      "munoglobulin",
      "children",
      "inject",
      "stat"
    ]
  },
  {
    "id": "837de2e7818ab0c53c0ba1cae0267580",
    "content": "Repeat at 4-8 weeks (2nd dose) and at 6-12 months (3rd dose)\n< 2 years;\t3 doses of Pentavalent vaccine at intervals of four weeks\nTo control spasms Evidence Rating: [C] Adults\nChlorpromazine, IM, 50 mg 4-8 hourly\nAnd\nDiazepam, IV or IM, (by slow IV at a rate of not more than 5 mg/ minute), 5-10 mg 3-6 hourly when required\nOr\nPhenobarbitone, IM, 200 mg 8-12 hourly, gradually reduce sedation after about 2 weeks\nChildren\nChlorpromazine, IM or oral (via nasogastric tube), 12. 5-25 mg 8\nhourly\nAnd\nDiazepam, IV/IM/nasogastric tube/suppository, 0. 3 mg/kg 3-6 hourly when required (by slow IV at a rate of not more than 5 mg/minute) Or\nPhenobarbitone, IM or oral (via nasogastric Tube), 10 mg/kg stat.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "390",
    "type": "section",
    "keywords": [
      "years",
      "required",
      "evidence",
      "four",
      "diazepam",
      "hourly",
      "rating",
      "rate",
      "doses",
      "repeat",
      "weeks",
      "children",
      "nasogastric",
      "stat",
      "vaccine",
      "chlorpromazine",
      "tube",
      "pentavalent",
      "adults",
      "slow"
    ]
  },
  {
    "id": "6ffcd73ea7b85de0f8b841dea9c55118",
    "content": ",\nthen 2. 5 mg/kg 12 hourly\nNeonates\nChlorpromazine, IM or oral (via nasogastric tube), 7. 5 mg 8 hourly\nAnd\nPhenobarbital (Phenobarbitone), IM or oral (via nasogastric tube), 30 mg stat.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "391",
    "type": "section",
    "keywords": [
      "chlorpromazine",
      "hourly",
      "neonates",
      "nasogastric",
      "tube",
      "phenobarbitone",
      "oral",
      "phenobarbital",
      "then",
      "stat"
    ]
  },
  {
    "id": "67c589af0dff5868f137b620294d9b4a",
    "content": "Add\nDiazepam, rectal, 0. 5 mg/kg 3-6 hourly when required.",
    "title": "Neonates-if spasms are not controlled with the above treatment",
    "section": "Neonates-if spasms are not controlled with the above treatment",
    "chunk_id": "392",
    "type": "section",
    "keywords": [
      "diazepam",
      "hourly",
      "rectal",
      "required"
    ]
  },
  {
    "id": "c7a7f7bfbb1cbc3e1698fe262f487cb6",
    "content": "Referral Criteria\nRefer patients to a specialist if spasms cannot be controlled. Poliomyelitis is a viral disease, which is spread by faecal-oral or oral- to-oral transmission. Insanitary disposal of excreta and use of unsafe drinking water contribute to the spread.",
    "title": "Chapter 5:  Immunısable Dıseases",
    "section": "Chapter 5:  Immunısable Dıseases",
    "chunk_id": "393",
    "type": "section",
    "keywords": [
      "insanitary",
      "which",
      "specialist",
      "faecal",
      "unsafe",
      "water",
      "patients",
      "criteria",
      "poliomyelitis",
      "disease",
      "referral",
      "cannot",
      "viral",
      "spasms",
      "controlled",
      "transmission",
      "refer",
      "excreta",
      "drinking",
      "oral"
    ]
  },
  {
    "id": "7befbdd4eb0c53569052543c58424d18",
    "content": "The disease is characterised by varying degrees of acute flaccid paralysis, which commonly persists. Paralysis commonly affects one lower limb but any group of skeletal muscles, including the muscles of respiration and bulbar cells in the brain may be affected. Poliomyelitis is commonly acquired in childhood.",
    "title": "Chapter 5:  Immunısable Dıseases",
    "section": "Chapter 5:  Immunısable Dıseases",
    "chunk_id": "394",
    "type": "section",
    "keywords": [
      "skeletal",
      "muscles",
      "which",
      "characterised",
      "varying",
      "paralysis",
      "acute",
      "flaccid",
      "including",
      "childhood",
      "acquired",
      "persists",
      "disease",
      "poliomyelitis",
      "cells",
      "degrees",
      "commonly",
      "respiration",
      "limb",
      "bulbar"
    ]
  },
  {
    "id": "abd716827604671cf079a9285f64a86f",
    "content": "The infection is often sub-clinical and may only appear as a mild flu-like illness. Only few cases progress to develop paralysis. However, injections during periods of the febrile illness are associated with an increased incidence of paralytic poliomyelitis.",
    "title": "Chapter 5:  Immunısable Dıseases",
    "section": "Chapter 5:  Immunısable Dıseases",
    "chunk_id": "395",
    "type": "section",
    "keywords": [
      "often",
      "during",
      "associated",
      "paralytic",
      "paralysis",
      "injections",
      "poliomyelitis",
      "periods",
      "appear",
      "incidence",
      "progress",
      "only",
      "increased",
      "febrile",
      "mild",
      "develop",
      "infection",
      "however",
      "cases",
      "illness"
    ]
  },
  {
    "id": "c64c4ff4862d478de5a8e7b72bd65185",
    "content": "Poliomyelitis is preventable by Immunisation. Prevention is almost certain if 4 doses of oral polio vaccine are given as in the EPI schedule. Rarely Vaccine-Associated Paralytic Poliomyelitis (VAPP) may occur in recipients of oral polio vaccines and their unimmunised contacts.",
    "title": "Chapter 5:  Immunısable Dıseases",
    "section": "Chapter 5:  Immunısable Dıseases",
    "chunk_id": "396",
    "type": "section",
    "keywords": [
      "vaccines",
      "occur",
      "given",
      "associated",
      "paralytic",
      "certain",
      "recipients",
      "schedule",
      "unimmunised",
      "doses",
      "contacts",
      "almost",
      "their",
      "vaccine",
      "poliomyelitis",
      "prevention",
      "rarely",
      "immunisation",
      "preventable",
      "oral"
    ]
  },
  {
    "id": "e9d277d793c91dc47099bac0d4431dee",
    "content": "Causes\nPoliovirus serotypes 1, 2 or 3\nSymptoms\nFever\nHeadache\nSore throat\nMuscle pain\nFlaccid paralysis\nSigns\nAcute flaccid paralysis of affected muscles\nDiminished or absent muscle reflexes\ninvestigations\nTwo fresh stool samples taken 24-48 hours apart (to be sent on ice to the Regional Public Health Reference Laboratory for confirmation).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "397",
    "type": "section",
    "keywords": [
      "sent",
      "headache",
      "muscles",
      "absent",
      "confirmation",
      "health",
      "paralysis",
      "acute",
      "reference",
      "flaccid",
      "muscle",
      "fresh",
      "public",
      "signs",
      "regional",
      "causes",
      "poliovirus",
      "apart",
      "fever",
      "investigations"
    ]
  },
  {
    "id": "29c4f591ad269a9d8e427c1690d4ad7d",
    "content": "To avoid or limit the extent of paralysis\nTo provide rehabilitation in paralytic cases.",
    "title": "To provide supportive care till patient recovers from acute illness",
    "section": "To provide supportive care till patient recovers from acute illness",
    "chunk_id": "398",
    "type": "section",
    "keywords": [
      "avoid",
      "provide",
      "cases",
      "paralytic",
      "extent",
      "limit",
      "paralysis",
      "rehabilitation"
    ]
  },
  {
    "id": "30cfa6135465b015b24349ed8ee48974",
    "content": "Bed rest\nAvoid injections during febrile illness in children\nPhysiotherapy\nProvision of appropriate appliances to aid mobility.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "399",
    "type": "section",
    "keywords": [
      "avoid",
      "physiotherapy",
      "appropriate",
      "mobility",
      "during",
      "provision",
      "appliances",
      "rest",
      "illness",
      "children",
      "febrile",
      "injections"
    ]
  },
  {
    "id": "def123b68bf26a3d1fd9913ec212d0c5",
    "content": "Referral Criteria\nRefer all patients with difficulty in breathing and swallowing for hospital admission. The bacteria responsible for this disease produces a toxin that damages human body tissues and organs. It commonly affects the tonsils and sometimes the skin causing ulcers.",
    "title": "No specific antiviral treatment",
    "section": "No specific antiviral treatment",
    "chunk_id": "400",
    "type": "section",
    "keywords": [
      "produces",
      "bacteria",
      "breathing",
      "toxin",
      "swallowing",
      "sometimes",
      "responsible",
      "body",
      "tonsils",
      "patients",
      "admission",
      "criteria",
      "causing",
      "disease",
      "referral",
      "difficulty",
      "skin",
      "tissues",
      "ulcers",
      "commonly"
    ]
  },
  {
    "id": "f81bc31371e79f4cf5805aa7ee954a68",
    "content": "It is spread mainly by respiratory droplets from person to person, and less commonly through skin contact. Infected patients may recover after initial symptoms and signs or develop severe weakness and die within 6-10 days. Complications may develop in the early phase of the disease or weeks later such as abnormal heartbeat and heart failure, damage to valves of the heart, or respiratory\nobstruction leading to death.",
    "title": "No specific antiviral treatment",
    "section": "No specific antiviral treatment",
    "chunk_id": "401",
    "type": "section",
    "keywords": [
      "initial",
      "valves",
      "infected",
      "death",
      "weakness",
      "heartbeat",
      "within",
      "obstruction",
      "signs",
      "abnormal",
      "patients",
      "heart",
      "weeks",
      "severe",
      "days",
      "disease",
      "later",
      "leading",
      "recover",
      "respiratory"
    ]
  },
  {
    "id": "a9801f520997281c5faa8bcbc50585ae",
    "content": "The disease is now uncommon because of immunisation. However, high immunisation coverage needs to be maintained to keep the disease under control because it has a high mortality rate. Causes\nCorynebacterium diphtheriae\nSymptoms\nSore throat\nLoss of appetite\nSlight fever\nDysphagia\nDifficulty in breathing with or without stridor\nSigns\nGreyish white membrane or patch in the throat and on tonsils within 2-3 days of the onset of symptoms.",
    "title": "Chapter 5:  Immunısable Dıseases",
    "section": "Chapter 5:  Immunısable Dıseases",
    "chunk_id": "402",
    "type": "section",
    "keywords": [
      "coverage",
      "greyish",
      "white",
      "diphtheriae",
      "breathing",
      "under",
      "slight",
      "dysphagia",
      "within",
      "rate",
      "stridor",
      "patch",
      "tonsils",
      "signs",
      "causes",
      "maintained",
      "onset",
      "days",
      "disease",
      "because"
    ]
  },
  {
    "id": "32d26bd7f64f1f4abc6291faa399ff74",
    "content": "Membrane may bleed, become greyish green or black. investigations\nThroat/nasal swabs for culture for index case and close contacts.",
    "title": "Chapter 5:  Immunısable Dıseases",
    "section": "Chapter 5:  Immunısable Dıseases",
    "chunk_id": "403",
    "type": "section",
    "keywords": [
      "greyish",
      "black",
      "swabs",
      "case",
      "membrane",
      "investigations",
      "throat",
      "green",
      "bleed",
      "contacts",
      "index",
      "culture",
      "become",
      "close",
      "nasal"
    ]
  },
  {
    "id": "d930d1d6c69d22a2bb2fcfd6c77259e6",
    "content": "To neutralise the effect of circulating antitoxins before they become\nfixed to the tissues.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "404",
    "type": "section",
    "keywords": [
      "fixed",
      "before",
      "circulating",
      "become",
      "neutralise",
      "antitoxins",
      "tissues",
      "effect"
    ]
  },
  {
    "id": "c5f88cf2ea6e248d74dea5e2db720947",
    "content": "To eradicate the organism from the pharynx\nTo prevent spread.",
    "title": "To provide supportive care respiratory and feeding where indicated",
    "section": "To provide supportive care respiratory and feeding where indicated",
    "chunk_id": "405",
    "type": "section",
    "keywords": [
      "prevent",
      "eradicate",
      "organism",
      "pharynx",
      "spread"
    ]
  },
  {
    "id": "3e456ab57f9c77e34f8d5f8769996e97",
    "content": "Bed rest\nFeeding by nasogastric tube for patients who cannot swallow\nStrict isolation of suspected patients.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "406",
    "type": "section",
    "keywords": [
      "swallow",
      "tube",
      "suspected",
      "cannot",
      "feeding",
      "rest",
      "patients",
      "nasogastric",
      "strict",
      "isolation"
    ]
  },
  {
    "id": "c23f21d9062cd32a6024e7ed89f019e2",
    "content": "All patients clinically diagnosed with diphtheria\nEvidence Rating: [C]\nDiphtheria antitoxin, IV infusion, (following an intradermal test dose of 0. 1 ml of 1 in 10 dilution of antitoxin in Sodium Chloride 0. 9%) Adults\n10,000 to 20,000 units\nChildren\n10 years;\t10,000-20,000 units.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "407",
    "type": "section",
    "keywords": [
      "test",
      "units",
      "years",
      "antitoxin",
      "infusion",
      "evidence",
      "rating",
      "following",
      "sodium",
      "patients",
      "children",
      "diphtheria",
      "adults",
      "dose",
      "chloride",
      "intradermal",
      "dilution",
      "clinically",
      "diagnosed"
    ]
  },
  {
    "id": "e8ca14137ade6d7fcd9bcca2677b1085",
    "content": "< 10 years;\t5,000-10,000 units\nAnd\nBenzyl Penicillin, IV,\nAdults\n1. 2 g 6 hourly for 48 hours\nChildren and Neonates\n1 month-18 years;\t50 mg/kg 6 hourly for 48 hours\nThen\nAmoxicillin, oral,\nAdults\n1 g 12 hourly for 5 days\nChildren\n5-18 years;\t500 mg 12 hourly for 10 days\nyears;\t250 mg 12 hourly for 10 days\n1 month-1 year;\t125 mg 12 hourly for 10 days\nOr\nAzithromycin, oral,\nAdults\n500 mg daily for 5 days\nChildren\n10 mg/kg body weight daily for 5 days. Not recommended for children less than 6 months because of a risk\nof pyloric stenosis.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "408",
    "type": "section",
    "keywords": [
      "units",
      "years",
      "neonates",
      "weight",
      "penicillin",
      "pyloric",
      "hourly",
      "body",
      "children",
      "days",
      "amoxicillin",
      "because",
      "stenosis",
      "adults",
      "azithromycin",
      "month",
      "months",
      "then",
      "benzyl",
      "year"
    ]
  },
  {
    "id": "c9aa2db7f72489433191770c641b1125",
    "content": "All close contacts\nAmoxicillin, oral, for 14 days (refer dosing above)\nOr\nFor patients who may not tolerate penicillins:\nAzithromycin, oral, for 5 days (refer dosing above)\nReferral Criteria\nRefer patients with laryngeal obstruction or respiratory paralysis to an ENT specialist. Yellow fever is caused by a virus transmitted to man by a species of mosquitoes (Aedes aegypti) from infected monkeys. The disease is not spread from person to person.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "409",
    "type": "section",
    "keywords": [
      "virus",
      "penicillins",
      "infected",
      "paralysis",
      "close",
      "aegypti",
      "specialist",
      "species",
      "dosing",
      "laryngeal",
      "contacts",
      "obstruction",
      "patients",
      "tolerate",
      "criteria",
      "days",
      "disease",
      "amoxicillin",
      "above",
      "referral"
    ]
  },
  {
    "id": "8b9311d687f78943220cd0a47e9676b1",
    "content": "Classical yellow fever is usually fatal. After the onset of symptoms, there is a brief remission of 2-24 hours, following which the symptoms may recur with the development of epigastric pain, jaundice, renal insufficiency, cardiovascular instability and.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "410",
    "type": "section",
    "keywords": [
      "usually",
      "development",
      "which",
      "insufficiency",
      "brief",
      "following",
      "jaundice",
      "instability",
      "renal",
      "onset",
      "yellow",
      "fever",
      "fatal",
      "classical",
      "there",
      "symptoms",
      "recur",
      "cardiovascular",
      "pain",
      "epigastric"
    ]
  },
  {
    "id": "394dbffa36e93f597d3c2a0a216dbe4b",
    "content": "bleeding from various sites (e. g. gums and needle-puncture sites).",
    "title": "Chapter 5:  Immunısable Dıseases",
    "section": "Chapter 5:  Immunısable Dıseases",
    "chunk_id": "411",
    "type": "section",
    "keywords": [
      "various",
      "needle",
      "gums",
      "bleeding",
      "puncture",
      "sites"
    ]
  },
  {
    "id": "100a817fe969c81e6d9ffe32fc804cba",
    "content": "Yellow fever vaccination is protective against the disease and needs to be repeated every ten years. Yellow fever vaccination is a requirement for travel from Ghana to several countries. Causes\nYellow fever virus\nSymptoms\nFever\nMuscle pain, particularly backache\nHeadache\nShivering\nLoss of appetite\nNausea or vomiting\nDiarrhoea\nSigns\nCongestion of the conjunctivae\nJaundice\nBleeding from various sites (petechiae, ecchymosis, etc.",
    "title": "Chapter 5:  Immunısable Dıseases",
    "section": "Chapter 5:  Immunısable Dıseases",
    "chunk_id": "412",
    "type": "section",
    "keywords": [
      "shivering",
      "nausea",
      "years",
      "virus",
      "headache",
      "congestion",
      "backache",
      "petechiae",
      "travel",
      "repeated",
      "diarrhoea",
      "requirement",
      "jaundice",
      "bleeding",
      "muscle",
      "sites",
      "signs",
      "particularly",
      "causes",
      "ecchymosis"
    ]
  },
  {
    "id": "c5bc12c3d1a5278a3a3f94f0348014ea",
    "content": ")\nRight upper abdominal quadrant tenderness\nSigns of renal failure\ninvestigations\nUrinalysis - proteinuria and raised urobilinogen levels\nLiver function test\nBlood urea, electrolytes and creatinine\nBlood sample for yellow fever virus serology (at the Regional Public Health Reference Laboratory).",
    "title": "Chapter 5:  Immunısable Dıseases",
    "section": "Chapter 5:  Immunısable Dıseases",
    "chunk_id": "413",
    "type": "section",
    "keywords": [
      "test",
      "virus",
      "levels",
      "health",
      "creatinine",
      "abdominal",
      "right",
      "function",
      "sample",
      "urinalysis",
      "signs",
      "urobilinogen",
      "public",
      "renal",
      "regional",
      "blood",
      "yellow",
      "tenderness",
      "electrolytes",
      "fever"
    ]
  },
  {
    "id": "8fe9dcb2d5b2dcf0a54172b72c6b38b5",
    "content": "If yellow fever is suspected in a patient, admit immediately to an isolation ward.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "414",
    "type": "section",
    "keywords": [
      "yellow",
      "admit",
      "immediately",
      "suspected",
      "fever",
      "patient",
      "ward",
      "isolation"
    ]
  },
  {
    "id": "66e0e04dc6486a40cf3e03f321552f0c",
    "content": "For bleeding patients\nFresh frozen plasma\nReferral Criteria\nRefer to a hospital, preferably one with an isolation unit. The Haemophilus influenzae type b (Hib) bacterium is an important cause of infections such as acute bacterial meningitis, pneumonia, acute epiglottitis and otitis media in children less than 5 years old. Hib disease is not common beyond 5 years of age.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "415",
    "type": "section",
    "keywords": [
      "infections",
      "beyond",
      "years",
      "important",
      "plasma",
      "otitis",
      "acute",
      "isolation",
      "haemophilus",
      "type",
      "frozen",
      "bleeding",
      "fresh",
      "patients",
      "children",
      "criteria",
      "bacterium",
      "disease",
      "referral",
      "epiglottitis"
    ]
  },
  {
    "id": "6120a375508a508e04892ed317fcc63d",
    "content": "Hib infections are preventable by the five-in-one (penta-) vaccine (See EPI ‘Schedule for routine Immunisation of children under 5 years’). Causes\nHaemophilus influenzae type b (Hib)\nSymptoms\nFever\nOther symptoms associated with pneumonia, otitis media, meningitis, septicaemia\nSigns.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "416",
    "type": "section",
    "keywords": [
      "infections",
      "years",
      "septicaemia",
      "otitis",
      "associated",
      "under",
      "haemophilus",
      "type",
      "schedule",
      "penta",
      "five",
      "signs",
      "children",
      "causes",
      "routine",
      "vaccine",
      "pneumonia",
      "fever",
      "influenzae",
      "immunisation"
    ]
  },
  {
    "id": "6e54f23ce1a7c30c2265bf03e93b30ad",
    "content": "investigations\nCulture and sensitivity of appropriate body fluids (e. g. pus from the ear in suppurative otitis media, cerebrospinal fluid in meningitis, pleural aspirate in empyema, blood).",
    "title": "(See signs and symptoms of the specific diseases in other sections)",
    "section": "(See signs and symptoms of the specific diseases in other sections)",
    "chunk_id": "417",
    "type": "section",
    "keywords": [
      "body",
      "meningitis",
      "suppurative",
      "appropriate",
      "pleural",
      "aspirate",
      "cerebrospinal",
      "otitis",
      "fluids",
      "culture",
      "investigations",
      "sensitivity",
      "media",
      "blood",
      "empyema",
      "fluid"
    ]
  },
  {
    "id": "6cfadabea73d6e8224b228f8e1605df3",
    "content": "Refer to relevant sections on the presenting illness e. g. meningitis, pneumonia.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "418",
    "type": "section",
    "keywords": [
      "meningitis",
      "pneumonia",
      "refer",
      "relevant",
      "presenting",
      "illness",
      "sections"
    ]
  },
  {
    "id": "b1bd08d69f6f9a3ccf10052cf33c0dbc",
    "content": "Refer to relevant sections on the presenting illness e. g. meningitis, pneumonia\nReferral Criteria\nAll patients who fail to show remarkable signs of improvement in 3.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "419",
    "type": "section",
    "keywords": [
      "meningitis",
      "referral",
      "show",
      "pneumonia",
      "refer",
      "relevant",
      "presenting",
      "signs",
      "illness",
      "patients",
      "remarkable",
      "fail",
      "criteria",
      "sections",
      "improvement"
    ]
  },
  {
    "id": "15bc2d35252053f0921d6fa05d86865f",
    "content": "days following drug treatment, or present with complications should be referred for higher-level care. Pneumococcal disease presents more commonly as non-invasive disease in the form of non-bacteraemic pneumonia, middle-ear infections, sinusitis, or bronchitis. However, it may also manifest as Invasive Pneumococcal Diseases (IPD) in the form of pneumonia with empyema and/or bacteraemia or meningitis as a result of haematogenic spread.",
    "title": "Chapter 5:  Immunısable Dıseases",
    "section": "Chapter 5:  Immunısable Dıseases",
    "chunk_id": "420",
    "type": "section",
    "keywords": [
      "infections",
      "bacteraemia",
      "form",
      "presents",
      "bacteraemic",
      "diseases",
      "following",
      "manifest",
      "invasive",
      "result",
      "drug",
      "treatment",
      "days",
      "disease",
      "level",
      "pneumonia",
      "should",
      "also",
      "referred",
      "haematogenic"
    ]
  },
  {
    "id": "b48dc6697c8f923ae6e96510e51cddd0",
    "content": "In developing countries, non-bacteraemic pneumonia causes the majority of pneumococcal deaths. Ninety distinct serotypes have been identified. Pneumococcal disease is effectively prevented with Pneumococcal Conjugate Vaccine (PCV) at 6,10 and 14 weeks for infants.",
    "title": "Chapter 5:  Immunısable Dıseases",
    "section": "Chapter 5:  Immunısable Dıseases",
    "chunk_id": "421",
    "type": "section",
    "keywords": [
      "distinct",
      "majority",
      "bacteraemic",
      "conjugate",
      "ninety",
      "developing",
      "identified",
      "weeks",
      "causes",
      "vaccine",
      "disease",
      "prevented",
      "pneumonia",
      "infants",
      "countries",
      "serotypes",
      "deaths",
      "effectively",
      "pneumococcal",
      "have"
    ]
  },
  {
    "id": "3c436cf70706c9652aafcc42cb6c1aab",
    "content": "Pneumococcal Polysaccharide Vaccine (PPSV23) is recommended for persons older than 2 years with underlying medical conditions such as Sickle Cell Disease. Adults with immunocompromising conditions, functional or anatomic asplenia, cerebrospinal fluid leaks, or cochlear implants should receive PCV13 followed by PPSV23. Causes\nStreptococcus pneumoniae\nSymptoms\nFever\nOther symptoms associated with pneumonia, otitis media, meningitis, septicaemia\nSigns.",
    "title": "Chapter 5:  Immunısable Dıseases",
    "section": "Chapter 5:  Immunısable Dıseases",
    "chunk_id": "422",
    "type": "section",
    "keywords": [
      "leaks",
      "years",
      "streptococcus",
      "polysaccharide",
      "septicaemia",
      "otitis",
      "associated",
      "fluid",
      "immunocompromising",
      "functional",
      "asplenia",
      "anatomic",
      "cerebrospinal",
      "implants",
      "underlying",
      "signs",
      "pneumoniae",
      "causes",
      "vaccine",
      "disease"
    ]
  },
  {
    "id": "6e54f23ce1a7c30c2265bf03e93b30ad",
    "content": "investigations\nCulture and sensitivity of appropriate body fluids (e. g. pus from the ear in suppurative otitis media, cerebrospinal fluid in meningitis, pleural aspirate in empyema, blood).",
    "title": "Please refer to signs and symptoms of the specific diseases in other sections",
    "section": "Please refer to signs and symptoms of the specific diseases in other sections",
    "chunk_id": "423",
    "type": "section",
    "keywords": [
      "body",
      "meningitis",
      "suppurative",
      "appropriate",
      "pleural",
      "aspirate",
      "cerebrospinal",
      "otitis",
      "fluids",
      "culture",
      "investigations",
      "sensitivity",
      "media",
      "blood",
      "empyema",
      "fluid"
    ]
  },
  {
    "id": "856089a69891871dd1f291574f7e00cc",
    "content": "(See relevant sections on the presenting illness e. g. meningitis, pneumonia).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "424",
    "type": "section",
    "keywords": [
      "meningitis",
      "pneumonia",
      "relevant",
      "presenting",
      "illness",
      "sections"
    ]
  },
  {
    "id": "e82791b82b07db10d8b813237fb59a62",
    "content": "(See relevant sections on the presenting illness e. g. meningitis, pneumonia)\nReferral Criteria\nAll patients who fail to show remarkable signs of improvement in 3 days following drug treatment, or present with complications should be referred for higher-level care.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "425",
    "type": "section",
    "keywords": [
      "presenting",
      "following",
      "drug",
      "signs",
      "patients",
      "remarkable",
      "criteria",
      "sections",
      "treatment",
      "days",
      "referral",
      "show",
      "level",
      "pneumonia",
      "should",
      "relevant",
      "referred",
      "fail",
      "higher",
      "meningitis"
    ]
  },
  {
    "id": "0ba4dba473037f5dc4fabbc4ff09542e",
    "content": "The term newborn (neonate) refers to a baby in the first month of life. At birth all healthy newborns are active with a strong cry. Any baby born ill will show signs of poor activity or may be described as “being flat” or floppy in severe cases.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "426",
    "type": "section",
    "keywords": [
      "baby",
      "activity",
      "neonate",
      "poor",
      "refers",
      "born",
      "signs",
      "strong",
      "being",
      "severe",
      "first",
      "healthy",
      "show",
      "floppy",
      "active",
      "birth",
      "month",
      "flat",
      "term",
      "described"
    ]
  },
  {
    "id": "a5910c1663af0ef453d9a78dc39502c5",
    "content": "The newborn with one or more abnormal vital signs is unwell. These include colour, activity, temperature, respiration, heart rate, blood sugar, urine output, nature of bowel movements, signs of distress (pain). Causes\nBirth asphyxia\nPrematurity\nNeonatal infections\nCongenital malformations e.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "427",
    "type": "section",
    "keywords": [
      "infections",
      "activity",
      "urine",
      "vital",
      "nature",
      "prematurity",
      "rate",
      "movements",
      "bowel",
      "abnormal",
      "signs",
      "heart",
      "sugar",
      "blood",
      "causes",
      "unwell",
      "congenital",
      "include",
      "neonatal",
      "birth"
    ]
  },
  {
    "id": "e61d0a5785dadda1cce2e834a272670e",
    "content": "g. heart, central nervous system, bowel etc. Birth injury\nMaternal sedation or analgesia during labour\nMetabolic e.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "428",
    "type": "section",
    "keywords": [
      "maternal",
      "bowel",
      "analgesia",
      "central",
      "during",
      "labour",
      "heart",
      "birth",
      "system",
      "sedation",
      "injury",
      "nervous",
      "metabolic"
    ]
  },
  {
    "id": "82527327417fb0381a4b33f3d58b6f82",
    "content": "g. hypoglycaemia, hypocalcaemia\nSymptoms\nWeak cry or inability to cry\nDifficulty in breathing or recurrent cessation of breathing (apnoea)\nReduced spontaneous movements or being very floppy\nRefusal of feeds\nVomiting\nAbdominal distension\nConvulsions\nBlood in stools\nReduced urine output\nSigns\nRaised body temperature (> 37. 5 °C axillary )\nLow body temperature (< 36.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "429",
    "type": "section",
    "keywords": [
      "recurrent",
      "hypocalcaemia",
      "refusal",
      "breathing",
      "urine",
      "reduced",
      "distension",
      "abdominal",
      "movements",
      "body",
      "stools",
      "convulsions",
      "signs",
      "being",
      "blood",
      "apnoea",
      "floppy",
      "weak",
      "difficulty",
      "raised"
    ]
  },
  {
    "id": "c83d87ea11603ad4cf36f6eaf58b4fb3",
    "content": "Jaundice\nBradycardia (< 100 beats/minute)\nTachycardia (> 160 beats/minute)\nHeart murmurs\nRespiratory distress (> 60 breaths/minute, chest indrawing)\nRespiratory rate < 20 breaths/minute\nApnoea\nAbdominal distension\nDrowsiness or unconsciousness\nSeizures\nTenderness of any part of the body\ninvestigations\nFBC\nRandom blood glucose\nBlood urea and electrolytes\nBlood cultures\nUrine culture\nSwab of any lesions for culture and sensitivity\nChest X-ray\nPlain abdominal X-ray, erect and supine if indicated\nCerebrospinal fluid biochemistry and culture and sensitivity.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "430",
    "type": "section",
    "keywords": [
      "unconsciousness",
      "lesions",
      "seizures",
      "beats",
      "glucose",
      "urine",
      "sensitivity",
      "tachycardia",
      "distension",
      "fluid",
      "abdominal",
      "rate",
      "body",
      "indrawing",
      "chest",
      "swab",
      "part",
      "jaundice",
      "drowsiness",
      "cerebrospinal"
    ]
  },
  {
    "id": "bfa6b2866b579621b28d708c6dc4adf8",
    "content": "To diagnose and treat underlying cause appropriately\nTo identify and urgently correct hypoglycaemia\nTo prevent permanent organ damage.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "431",
    "type": "section",
    "keywords": [
      "treat",
      "correct",
      "urgently",
      "prevent",
      "organ",
      "appropriately",
      "permanent",
      "cause",
      "underlying",
      "damage",
      "identify",
      "hypoglycaemia",
      "diagnose"
    ]
  },
  {
    "id": "dfd648ab95948ba3b4997b4f4830a133",
    "content": "Establish airway, ensure breathing and adequate circulation (ABC)\nKeep baby warm either wrapped up in dry clothes or in an incubator.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "432",
    "type": "section",
    "keywords": [
      "circulation",
      "baby",
      "wrapped",
      "either",
      "ensure",
      "establish",
      "clothes",
      "keep",
      "incubator",
      "breathing",
      "warm",
      "airway",
      "adequate"
    ]
  },
  {
    "id": "898a90f48ca84061883c3d57c770b347",
    "content": "Evidence Rating: [A]\nOxygen Therapy\nOxygen by face mask or nasal prongs, 1-2 L/minute if available, (monitor and maintain oxygen saturation between 92-95%)\nMaintenance Fluid\nDextrose 10%, IV, on day of delivery, 2 drops/minute/kg (60 ml/kg/ day)\nNormal Saline 0. 18% with Dextrose 10% (60-150 ml/kg/day after day\n1)\nCorrection of Hypoglycemia\nIf hypoglycaemic, correct (See section on ‘Neonatal Hypoglycaemia’).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "433",
    "type": "section",
    "keywords": [
      "drops",
      "correct",
      "face",
      "dextrose",
      "maintenance",
      "therapy",
      "evidence",
      "delivery",
      "fluid",
      "rating",
      "oxygen",
      "section",
      "saline",
      "neonatal",
      "monitor",
      "hypoglycemia",
      "saturation",
      "between",
      "available",
      "correction"
    ]
  },
  {
    "id": "6876b992391e52f4f6d0e0430c92f390",
    "content": "For neonates having seizures (convulsions)\nPhenobarbitone, IV/IM, 10 mg/kg stat. then 5 mg/kg 12 hourly\nTo treat sepsis (other than cord sepsis)\nAmpicillin, IM/IV,\nNeonates\n7 days of age;\t50 mg/kg 8 hourly for 5-7 days\n< 7 days of age;\t50 mg/kg 12 hourly for 5-7 days\nAnd\nGentamicin, IM/IV, 4 mg/kg daily for 7 days (irrespective of age after birth)\nOr\nAmpicillin, IM/IV,\nNeonates\n7 days of age;\t50 mg/kg 8 hourly for 5-7 days\n< 7 days of age;\t50 mg/kg 12 hourly for 5-7 days\nAnd\nCefotaxime, IV, 25-50 mg/kg 8 hourly for 7 days (irrespective of age after birth)\nFor cord sepsis\nCloxacillin, IM/IV,\nNeonates\n7 days of age;\t25-50 mg/kg 8 hourly\n< 7 days of age;\t25-50 mg/kg 12 hourly\nAnd\nGentamicin, IM/IV, 4 mg/kg 24 hourly for 7 days (irrespective of age after birth)\nFor bowel related sepsis\nAmpicillin, IM/IV,\nNeonates\n7 days of age;\t50 mg/kg 8 hourly for 5-7 days\n< 7 days of age;\t50 mg/kg 12 hourly for 5-7 days\nAnd\nGentamicin, IM/IV, 4 mg/kg daily for 7 days (irrespective of age after birth)\nAnd\nMetronidazole, IV (over 20–30 minutes)\nNeonate\n34 weeks corrected gestational age; 15 mg/kg as a single loading dose followed after 8 hours by 7. 5 mg/kg every 8 hours\n26-34 weeks corrected gestational age; 15 mg/kg as a single loading dose followed after 12 hours by 7.",
    "title": "Chapter 6: Problems of the Newborn (Neonate)",
    "section": "Chapter 6: Problems of the Newborn (Neonate)",
    "chunk_id": "434",
    "type": "section",
    "keywords": [
      "metronidazole",
      "loading",
      "treat",
      "neonates",
      "having",
      "neonate",
      "seizures",
      "hourly",
      "ampicillin",
      "minutes",
      "bowel",
      "single",
      "convulsions",
      "corrected",
      "weeks",
      "stat",
      "days",
      "followed",
      "dose",
      "birth"
    ]
  },
  {
    "id": "45b36032547ee9ad13eb2e5dd6a4c32d",
    "content": "5 mg/kg every 12 hours\n< 26 weeks corrected gestational age; 15 mg/kg as a single loading.",
    "title": "Chapter 6: Problems of the Newborn (Neonate)",
    "section": "Chapter 6: Problems of the Newborn (Neonate)",
    "chunk_id": "435",
    "type": "section",
    "keywords": [
      "loading",
      "single",
      "corrected",
      "weeks",
      "hours",
      "gestational",
      "every"
    ]
  },
  {
    "id": "03e19947e316a09cb6a97f56d9c51c0c",
    "content": "dose followed after 24 hours by 7. 5 mg/kg daily\nReferral Criteria\nRefer the patient urgently to a specialist for further investigations and treatment if no improvement after 48 hours. Neonatal hypoglycaemia refers to a random blood glucose level below 2.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "436",
    "type": "section",
    "keywords": [
      "glucose",
      "refers",
      "patient",
      "specialist",
      "criteria",
      "blood",
      "treatment",
      "followed",
      "referral",
      "neonatal",
      "urgently",
      "level",
      "hours",
      "further",
      "dose",
      "investigations",
      "random",
      "below",
      "refer",
      "after"
    ]
  },
  {
    "id": "30fa5853bae7d712943de91446c90105",
    "content": "6 mmol/L in the newborn. As the clinical signs may be variable, or indeed absent, for small or sick babies or infants of diabetic mothers the random blood glucose level should be checked every three hours for the first 24 hours until it stays above 3. 5 mmol/L for a further 24 hours.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "437",
    "type": "section",
    "keywords": [
      "absent",
      "glucose",
      "mothers",
      "babies",
      "indeed",
      "signs",
      "diabetic",
      "blood",
      "mmol",
      "first",
      "above",
      "level",
      "should",
      "infants",
      "stays",
      "further",
      "variable",
      "three",
      "random",
      "every"
    ]
  },
  {
    "id": "73c2e6c4a194ed797dc52e6c9cfc5ae6",
    "content": "Neonatal hypoglycaemia may result in death if not promptly treated and should therefore be managed as soon as suspected. Successful treatment results in prompt response. To prevent hypoglycaemia, breastfeeding should be encouraged soon after birth.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "438",
    "type": "section",
    "keywords": [
      "breastfeeding",
      "results",
      "death",
      "therefore",
      "prevent",
      "treated",
      "result",
      "successful",
      "treatment",
      "neonatal",
      "prompt",
      "suspected",
      "should",
      "response",
      "encouraged",
      "birth",
      "managed",
      "promptly",
      "after",
      "hypoglycaemia"
    ]
  },
  {
    "id": "4a4cde4b3057647c2862c53cc9cc9caf",
    "content": "If the neonate is unable to suck, a nasogastric tube may be passed and expressed breast milk given. If enteral feeds are contraindicated, intravenous fluids should be started immediately. Causes\nPrematurity\nIntra uterine growth retardation\nBaby born to a diabetic mother\nInfection\nAsphyxia\nSymptoms\nIrritability and restlessness\nTremors\nSweating\nSeizures\nLethargy\nSigns\nSweating\nTremor\nTachycardia\nSeizures\nUnconsciousness\ninvestigations\nRandom blood glucose (RBS)\nUsing bed-side glucose meter\nCheck within 2 hours after birth and at regular 3 hourly intervals\nin infants at risk.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "439",
    "type": "section",
    "keywords": [
      "baby",
      "intra",
      "unconsciousness",
      "intravenous",
      "given",
      "regular",
      "neonate",
      "seizures",
      "check",
      "enteral",
      "mother",
      "glucose",
      "tachycardia",
      "lethargy",
      "breast",
      "prematurity",
      "within",
      "hourly",
      "born",
      "immediately"
    ]
  },
  {
    "id": "7374df3e6473f9adfbb2a9ae7ddbf088",
    "content": "Other investigations depend on the suspected underlying cause.",
    "title": "Chapter 6: Problems of the Newborn (Neonate)",
    "section": "Chapter 6: Problems of the Newborn (Neonate)",
    "chunk_id": "440",
    "type": "section",
    "keywords": [
      "depend",
      "suspected",
      "other",
      "cause",
      "underlying",
      "investigations"
    ]
  },
  {
    "id": "73b8e1f76e500b9d2a6430aaec0c2338",
    "content": "To maintain blood glucose levels within normal limits\nTo identify and treat underlying cause of hypoglycaemia\nTo prevent complications e. g. brain damage.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "441",
    "type": "section",
    "keywords": [
      "within",
      "complications",
      "treat",
      "limits",
      "prevent",
      "maintain",
      "levels",
      "cause",
      "underlying",
      "glucose",
      "brain",
      "identify",
      "normal",
      "damage",
      "hypoglycaemia",
      "blood"
    ]
  },
  {
    "id": "f84e6e88d7449c3a2f94074652e03534",
    "content": "Blood glucose monitoring ½ to 2 hourly in hypoglycaemic infants until normal levels attained.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "442",
    "type": "section",
    "keywords": [
      "hourly",
      "monitoring",
      "infants",
      "levels",
      "glucose",
      "normal",
      "attained",
      "hypoglycaemic",
      "blood",
      "until"
    ]
  },
  {
    "id": "db0618fabe45aa33a731e2f9f3cd4654",
    "content": "Evidence Rating: [A]\ninitial management\nDextrose 10%, IV, 4 ml/kg as a bolus.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "443",
    "type": "section",
    "keywords": [
      "rating",
      "initial",
      "management",
      "dextrose",
      "bolus",
      "evidence"
    ]
  },
  {
    "id": "4c012d851d486aeb7e689f0836454c3d",
    "content": "agement\nSaline 0. 18% in Dextrose 10%, 60-150 ml/kg/day depending on the age of the newborn (See table below). Additional management\nDepends on the underlying cause.",
    "title": "Maintenance treatment following immediately after initial man",
    "section": "Maintenance treatment following immediately after initial man",
    "chunk_id": "444",
    "type": "section",
    "keywords": [
      "depending",
      "below",
      "management",
      "newborn",
      "depends",
      "dextrose",
      "saline",
      "cause",
      "underlying",
      "table",
      "agement",
      "additional"
    ]
  },
  {
    "id": "9a92b4768a976d4283dca5da284bab9b",
    "content": "Jaundice in the neonate may be visible when the serum bilirubin level exceeds 100 micromol/L. Neonatal jaundice is important because of the consequences of hyperbilirubinaema on the brain of the newborn. This condition is called kernicterus (bilirubin encephalopathy) and may cause death.",
    "title": "Refer to a specialist if patient does not respond promptly in spite of adequate treatment.",
    "section": "Refer to a specialist if patient does not respond promptly in spite of adequate treatment.",
    "chunk_id": "445",
    "type": "section",
    "keywords": [
      "bilirubin",
      "important",
      "encephalopathy",
      "neonate",
      "death",
      "visible",
      "jaundice",
      "condition",
      "kernicterus",
      "neonatal",
      "because",
      "level",
      "hyperbilirubinaema",
      "cause",
      "consequences",
      "called",
      "serum",
      "newborn",
      "micromol",
      "brain"
    ]
  },
  {
    "id": "11c4dbd77db23ef330a0e53490931faf",
    "content": "Infants who survive may be handicapped with cerebral palsy, and associated deafness, mental retardation and motor incoordination.",
    "title": "Refer to a specialist if patient does not respond promptly in spite of adequate treatment.",
    "section": "Refer to a specialist if patient does not respond promptly in spite of adequate treatment.",
    "chunk_id": "446",
    "type": "section",
    "keywords": [
      "cerebral",
      "mental",
      "handicapped",
      "infants",
      "survive",
      "incoordination",
      "palsy",
      "associated",
      "motor",
      "retardation",
      "deafness"
    ]
  },
  {
    "id": "33185c2b2ebf39a8af8dacbd6be81333",
    "content": "Approximately 80% of newborns will be jaundiced in the first week of life and most of this is physiological. This occurs on day 3 and lasts up to 10 days. This jaundice is mild and the baby remains healthy.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "447",
    "type": "section",
    "keywords": [
      "physiological",
      "days",
      "baby",
      "first",
      "healthy",
      "week",
      "jaundice",
      "life",
      "approximately",
      "occurs",
      "lasts",
      "jaundiced",
      "remains",
      "most",
      "newborns",
      "mild"
    ]
  },
  {
    "id": "59d230f2fee9cfa95890d9814bae1f13",
    "content": "Jaundice in the neonate is likely to be pathological if it is present within the first day of life; or conjugated (direct) bilirubin is more than 40 micromol/L; or total bilirubin is more than 170 micromol/L in preterm and more than 260 micromol/L in the term infant; or the neonate is significantly jaundiced beyond 14 days or has jaundice with fever. Exchange transfusion is the definitive treatment for hyperbilirubinaemia that has reached the level where kernicterus may occur. Causes\nPhysiological\nHaemolysis - Rhesus, ABO incompatibility, G6PD deficiency\nBlood extravasation - cephalhaematoma, subgaleal haematoma\nSepsis\nCongenital infections.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "448",
    "type": "section",
    "keywords": [
      "infections",
      "bilirubin",
      "beyond",
      "significantly",
      "occur",
      "conjugated",
      "neonate",
      "hyperbilirubinaemia",
      "jaundiced",
      "likely",
      "definitive",
      "within",
      "jaundice",
      "haematoma",
      "where",
      "extravasation",
      "exchange",
      "total",
      "causes",
      "treatment"
    ]
  },
  {
    "id": "f7c579b4b7099268fc88cea8656a6a6e",
    "content": "Enhanced extra hepatic circulation - GIT obstruction, inadequate feeding\nCongenital defects of bilirubin metabolism\nBreast milk related jaundice\nSymptoms\nYellow eyes\nYellow skin, hands and feet\nPale stools (biliary atresia likely)\nSigns\nJaundice\nYellow pigment in skin\nYellow palms +/- yellow soles of feet\nPale stools (biliary atresia likely)\ninvestigations\nTotal and direct serum bilirubin concentration\nOther investigations as below, dependent on age at presentation and\nsuspected cause:\nEarly onset (within first 24 hours of birth)\nBlood group and rhesus (Rh) group of both infant and mother\nDirect Coombs test, Indirect Coombs test, FBC, G6PD\nBlood film for red cell anomalies, malaria parasites\nCultures of blood, urine, and spinal fluid may be indicated by the history, physical examination or initial laboratory findings\nProlonged jaundice (after 14 days)\nLiver Function tests.",
    "title": "Metabolic disorders - galactosemia, hypothyroidism",
    "section": "Metabolic disorders - galactosemia, hypothyroidism",
    "chunk_id": "449",
    "type": "section",
    "keywords": [
      "initial",
      "soles",
      "likely",
      "concentration",
      "film",
      "signs",
      "congenital",
      "first",
      "direct",
      "feet",
      "serum",
      "cell",
      "other",
      "early",
      "examination",
      "hepatic",
      "prolonged",
      "feeding",
      "jaundice",
      "stools"
    ]
  },
  {
    "id": "964ab6d122e0b75c1aa25485e3bc8401",
    "content": "Thyroid Function tests\nUrine for reducing substances\nUrine R/E and C/S\nTORCH (congenital infections) screen\nHep B\nAbdominal ultrasound scan (exclude biliary atresia).",
    "title": "Chapter 6: Problems of the Newborn (Neonate)",
    "section": "Chapter 6: Problems of the Newborn (Neonate)",
    "chunk_id": "450",
    "type": "section",
    "keywords": [
      "infections",
      "ultrasound",
      "reducing",
      "abdominal",
      "atresia",
      "exclude",
      "function",
      "scan",
      "biliary",
      "tests",
      "urine",
      "thyroid",
      "torch",
      "screen",
      "substances",
      "congenital"
    ]
  },
  {
    "id": "f69272fef3afa606b263b1626dc4f3ca",
    "content": "To prevent kernicterus (bilirubin encephalopathy)\nTo detect and treat underlying cause.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "451",
    "type": "section",
    "keywords": [
      "bilirubin",
      "kernicterus",
      "treat",
      "encephalopathy",
      "prevent",
      "cause",
      "detect",
      "underlying"
    ]
  },
  {
    "id": "4eb9991c165a0c268fc6d790e852d090",
    "content": "Phototherapy (See note below on ‘Phototherapy’)\nExchange blood transfusion (See note below on ‘Exchange transfusion’).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "452",
    "type": "section",
    "keywords": [
      "transfusion",
      "below",
      "note",
      "exchange",
      "blood",
      "phototherapy"
    ]
  },
  {
    "id": "f6b2d4f90c15fd102171ede585576ef6",
    "content": "(See section on ‘the Sick Newborn’)\nReferral Criteria\nRefer immediately, all babies who develop jaundice within 24 hours of life or who have prolonged jaundice to a paediatrician. Refer all patients requiring exchange transfusion to an appropriate facility. Birth injuries include extensive caput succedaneum, cephalhaematoma, subgaleal haemorrhage, nerve palsies and fractures.",
    "title": "A.\tTreatment of underlying sepsis",
    "section": "A.\tTreatment of underlying sepsis",
    "chunk_id": "453",
    "type": "section",
    "keywords": [
      "prolonged",
      "injuries",
      "succedaneum",
      "babies",
      "within",
      "paediatrician",
      "facility",
      "immediately",
      "section",
      "jaundice",
      "extensive",
      "requiring",
      "nerve",
      "patients",
      "exchange",
      "criteria",
      "cephalhaematoma",
      "include",
      "referral",
      "fractures"
    ]
  },
  {
    "id": "fa1643f036a113b863bb4c573eec3b94",
    "content": "The presentation varies depending on type and site of injury. Excessive traction may result in injury to the brachial plexus and may be associated with fracture or injury of the humerus or shoulder joint. Causes\nDifficult delivery (including instrumental delivery)\nSymptoms\nSwelling of head\nInability to move a limb properly\nPallor\nSigns\nExtensive Caput Succedaneum\nDiffuse swelling of the presenting part of the scalp that may extend\nbeyond cranial suture lines\nCephalhaematoma\nLarge swelling of the scalp that is restricted to one half and does not extend beyond the midline\nSubgaleal haemorrhage\nDiffuse swelling of the scalp which may result in a distorted shape of\nthe head and face\nSevere pallor.",
    "title": "A.\tTreatment of underlying sepsis",
    "section": "A.\tTreatment of underlying sepsis",
    "chunk_id": "454",
    "type": "section",
    "keywords": [
      "move",
      "beyond",
      "instrumental",
      "traction",
      "succedaneum",
      "cranial",
      "swelling",
      "presenting",
      "scalp",
      "associated",
      "varies",
      "which",
      "face",
      "properly",
      "extend",
      "delivery",
      "type",
      "part",
      "including",
      "restricted"
    ]
  },
  {
    "id": "c5cc161cdeb5628e3625d2a0d21acb10",
    "content": "Jaundice\nNerve injuries\nErbs Palsy - Whole upper limb does not move. There is movement only in the fingers\nKlumpke’s Palsy - Fingers of the affected hand do not move (claw\nhand) but there is active movement in the arm and forearm\nFractures\nReduced movement of affected limb\nSwelling of the affected limb\nAbnormal position of limb\nPain and tenderness on movement of limb\ninvestigations\nHaemoglobin level for subgaleal haemorrhage\nSerum bilirubin if jaundiced\nX-ray of relevant part if fracture is suspected.",
    "title": "Chapter 6: Problems of the Newborn (Neonate)",
    "section": "Chapter 6: Problems of the Newborn (Neonate)",
    "chunk_id": "455",
    "type": "section",
    "keywords": [
      "bilirubin",
      "move",
      "injuries",
      "haemorrhage",
      "swelling",
      "palsy",
      "jaundiced",
      "erbs",
      "reduced",
      "position",
      "movement",
      "part",
      "jaundice",
      "fingers",
      "claw",
      "nerve",
      "abnormal",
      "whole",
      "hand",
      "tenderness"
    ]
  },
  {
    "id": "35bf52db13f4c22449920006131984b3",
    "content": "To arrest further bleeding\nTo treat complications of anaemia and jaundice\nTo re-establish near normal movement in affected limb\nTo promote normal healing of fracture.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "456",
    "type": "section",
    "keywords": [
      "arrest",
      "limb",
      "complications",
      "fracture",
      "treat",
      "movement",
      "healing",
      "anaemia",
      "establish",
      "bleeding",
      "jaundice",
      "near",
      "further",
      "promote",
      "normal",
      "affected"
    ]
  },
  {
    "id": "ffe45ee9bedb7764e46a3092f47075c3",
    "content": "Extensive caput succedaneum\nReassure parents\nLeave swelling alone (spontaneous resolution over 3-4 days)\nCephalhaematoma\nReassure parents\nLeave swelling alone (spontaneous resolution with time)\nDo not perform incision and drainage\nPhototherapy if jaundiced\nSubgaleal Haemorrhage\nPhototherapy if jaundice levels require this (See section on ‘Neonatal Jaundice’)\nNerve injuries\nPhysiotherapy\nFractures\nMay require splinting.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "457",
    "type": "section",
    "keywords": [
      "resolution",
      "injuries",
      "levels",
      "succedaneum",
      "swelling",
      "jaundiced",
      "alone",
      "reassure",
      "phototherapy",
      "require",
      "jaundice",
      "extensive",
      "perform",
      "section",
      "incision",
      "nerve",
      "cephalhaematoma",
      "days",
      "neonatal",
      "fractures"
    ]
  },
  {
    "id": "fc7e891d0ce900fa1f52f387a8339e11",
    "content": "A. Cephalhaematoma and Subgaleal haematoma\nTo reduce bleeding Evidence Rating: [A].",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "458",
    "type": "section",
    "keywords": [
      "rating",
      "bleeding",
      "reduce",
      "haematoma",
      "evidence",
      "cephalhaematoma",
      "subgaleal"
    ]
  },
  {
    "id": "d47633f6da9196461a00d8eb9c7578cc",
    "content": "Phytomenadione (Vitamin K), IM, 1 mg stat. even if baby received a\ndose at birth\nTo correct Anaemia if Hb < 12 gm/dl\nBlood transfusion, 15-20 ml/kg\nReferral Criteria\nRefer severe cases to an appropriate specialist facility. Neonatal conjunctivitis or ophthalmia neonatorum is an acute purulent conjunctivitis during the first month of life.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "459",
    "type": "section",
    "keywords": [
      "baby",
      "correct",
      "anaemia",
      "during",
      "phytomenadione",
      "acute",
      "vitamin",
      "specialist",
      "facility",
      "ophthalmia",
      "even",
      "neonatorum",
      "criteria",
      "blood",
      "stat",
      "severe",
      "referral",
      "neonatal",
      "conjunctivitis",
      "first"
    ]
  },
  {
    "id": "6add644ba2a1f65ff487582329de9ada",
    "content": "It is usually contracted from infected genital secretions of the mother. Cleaning of the neonate’s eyes immediately after birth and the application of 1% tetracycline ointment into the eyes, is effective in preventing the condition. This must be implemented as a policy in all health facilities in which child deliveries are undertaken.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "460",
    "type": "section",
    "keywords": [
      "usually",
      "cleaning",
      "implemented",
      "policy",
      "neonate",
      "application",
      "which",
      "infected",
      "mother",
      "health",
      "child",
      "into",
      "immediately",
      "contracted",
      "facilities",
      "condition",
      "genital",
      "undertaken",
      "secretions",
      "birth"
    ]
  },
  {
    "id": "7b24b58fe39ac24f484d27fbba9f05b0",
    "content": "Causes\nNeisseria gonorrhoea\nChlamydia trachomatis\nStaphylococci\nStreptococci\nHerpes Simplex virus\nChemical e. g. silver nitrate\nSymptoms\nEye discharge\nSwelling of the eye lids\nSigns\nEye discharge, which may be purulent\nRedness and swelling of the conjunctivae\nOedema and redness of the eyelids\ninvestigations\nConjunctival swabs for Gram staining and culture.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "461",
    "type": "section",
    "keywords": [
      "conjunctival",
      "oedema",
      "virus",
      "swabs",
      "swelling",
      "which",
      "redness",
      "eyelids",
      "chemical",
      "signs",
      "culture",
      "gonorrhoea",
      "herpes",
      "staining",
      "causes",
      "simplex",
      "streptococci",
      "conjunctivae",
      "gram",
      "purulent"
    ]
  },
  {
    "id": "fd7a13ee61b287f8255a2066232e370f",
    "content": "Clean the eyelids frequently (every 2 hours) with cotton wool dipped in sterile saline solution. In the absence of sterile saline solution, use boiled water that has been left to cool.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "462",
    "type": "section",
    "keywords": [
      "cotton",
      "clean",
      "dipped",
      "boiled",
      "wool",
      "sterile",
      "saline",
      "solution",
      "absence",
      "water",
      "frequently",
      "left",
      "cool",
      "hours",
      "eyelids",
      "every"
    ]
  },
  {
    "id": "5bb6fc877f0b965574a66b58c7ad6382",
    "content": "Evidence Rating: [B]\nCeftriazone, IM or IV, 50 mg/kg stat. (max. 125 mg)\nOr\nCefotaxime, IM, 100 mg/kg stat.",
    "title": "Treatment of baby",
    "section": "Treatment of baby",
    "chunk_id": "463",
    "type": "section",
    "keywords": [
      "rating",
      "cefotaxime",
      "ceftriazone",
      "evidence",
      "stat"
    ]
  },
  {
    "id": "f95475bb426f957f9547bc55c0216113",
    "content": "And\nErythromycin, oral, 12. 5 mg/kg 6 hourly for 14 days\nAnd\nChloramphenicol eye drops, 0. 5% applied to each eye every 2 hours for 48 hours (after cleaning away discharge-saline irrigation)\nThen\nChloramphenicol eye drops, 0.",
    "title": "Treatment of baby",
    "section": "Treatment of baby",
    "chunk_id": "464",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "erythromycin",
      "applied",
      "drops",
      "cleaning",
      "irrigation",
      "then",
      "each",
      "away",
      "saline",
      "oral",
      "after",
      "discharge",
      "chloramphenicol",
      "hours",
      "every"
    ]
  },
  {
    "id": "4f59ea3f2bc0912f548f94f401a53123",
    "content": "5% applied to each eye 6 hourly\nAnd\nChloramphenicol eye ointment, 1% applied to each eye at night.",
    "title": "Treatment of baby",
    "section": "Treatment of baby",
    "chunk_id": "465",
    "type": "section",
    "keywords": [
      "hourly",
      "applied",
      "each",
      "ointment",
      "chloramphenicol",
      "night"
    ]
  },
  {
    "id": "767b56dfb52bf07179ac68bdba782cfb",
    "content": "Evidence Rating: [A]\nCeftriazone,IM, 250 mg stat. And\nErythromycin, oral, 500 mg 6 hourly for 7 days.",
    "title": "Treatment of mother",
    "section": "Treatment of mother",
    "chunk_id": "466",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "rating",
      "erythromycin",
      "ceftriazone",
      "oral",
      "evidence",
      "stat"
    ]
  },
  {
    "id": "bdf449e0cc4c01248b859155825165e4",
    "content": "Ceftriazone, IM, 250 mg stat. Or\nCefixime, oral, 400 mg stat. Or\nCiprofloxacin, oral, 500 mg stat.",
    "title": "Treatment of mother’s partner(s) for gonorrhoea and chlamydia",
    "section": "Treatment of mother’s partner(s) for gonorrhoea and chlamydia",
    "chunk_id": "467",
    "type": "section",
    "keywords": [
      "cefixime",
      "ceftriazone",
      "oral",
      "stat",
      "ciprofloxacin"
    ]
  },
  {
    "id": "6a3eaefa590fb9726ebeddbb8de91fa8",
    "content": "And\nDoxycycline, oral, 100 mg 12 hourly for 7 days\nOr\nTetracycline, oral, 500 mg 6 hourly for 7 days\nOr\nErythromycin, oral, 500 mg 6 hourly for 7 days\nOr\nAzithromycin, oral, 1 g stat. Referral Criteria\nRefer all neonates with corneal involvement and or severe neonatal conjuctivitis not responding to treatment to a paediatrician and or an ophthalmologist.",
    "title": "Treatment of mother’s partner(s) for gonorrhoea and chlamydia",
    "section": "Treatment of mother’s partner(s) for gonorrhoea and chlamydia",
    "chunk_id": "468",
    "type": "section",
    "keywords": [
      "neonates",
      "hourly",
      "paediatrician",
      "ophthalmologist",
      "involvement",
      "criteria",
      "treatment",
      "stat",
      "days",
      "severe",
      "referral",
      "erythromycin",
      "neonatal",
      "doxycycline",
      "azithromycin",
      "responding",
      "tetracycline",
      "corneal",
      "refer",
      "oral"
    ]
  },
  {
    "id": "be36d60870da500ab4e6c8f5a1014344",
    "content": "Retinoblastoma is a congenital malignant tumour originating from the retina of the eye. This tumour may be hereditary, particularly the bilateral form which forms about 30% of cases. Most tumours however are sporadic (spontaneous mutation).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "469",
    "type": "section",
    "keywords": [
      "hereditary",
      "tumours",
      "mutation",
      "which",
      "form",
      "sporadic",
      "malignant",
      "retinoblastoma",
      "most",
      "tumour",
      "particularly",
      "congenital",
      "forms",
      "about",
      "spontaneous",
      "originating",
      "retina",
      "however",
      "cases",
      "bilateral"
    ]
  },
  {
    "id": "f3c1242772a85696e58ad4efe3341a1e",
    "content": "This is the third commonest cancer seen amongst children in Ghana. Most children present before five years of age. It rarely occurs in older children.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "470",
    "type": "section",
    "keywords": [
      "amongst",
      "cancer",
      "years",
      "commonest",
      "present",
      "before",
      "third",
      "occurs",
      "five",
      "rarely",
      "seen",
      "ghana",
      "older",
      "most",
      "children"
    ]
  },
  {
    "id": "371fe8c9c4096059382249d9cee96cde",
    "content": "The prognosis with early presentation is excellent with a 95% chance of long term cure. There is a high rate of development of tumours of other organs later in life in the hereditary form. Causes\nGenetic (up to 40% of cases)\nSporadic (in about 60% of cases)\nSymptoms\nWhite, shiny spot (leukocoria) in the pupil, also known as the cat’s eye reflex is usually the first symptom in most patients\nSquint (strabismus)\nVisual loss\nProtruding eyeball\nRedness of the eye\nSigns\nAbsent red reflex\nTumour in the retina on fundoscopy\nVitreous haemorrhage and retinal detachment on fundoscopy\nIncreased intraocular pressure (glaucoma)\nOrbital cellulitis\ninvestigations\nUltrasound scan of orbit\nHead CT or MRI scan\nLumbar puncture for cerebrospinal fluid cytology\nBone marrow aspirate.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "471",
    "type": "section",
    "keywords": [
      "usually",
      "ultrasound",
      "hereditary",
      "shiny",
      "squint",
      "tumours",
      "white",
      "development",
      "haemorrhage",
      "absent",
      "fundoscopy",
      "puncture",
      "redness",
      "form",
      "chance",
      "cellulitis",
      "sporadic",
      "fluid",
      "intraocular",
      "genetic"
    ]
  },
  {
    "id": "8679875501c5e48761deb6bc7bbe4cc0",
    "content": "To arrest the progression of the tumour\nTo prevent distant spread of tumour\nTo achieve long term cure.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "472",
    "type": "section",
    "keywords": [
      "arrest",
      "achieve",
      "term",
      "progression",
      "prevent",
      "cure",
      "tumour",
      "distant",
      "spread"
    ]
  },
  {
    "id": "05ddcaab8f4be3204784b324a1faa7a8",
    "content": "Enucleation of the affected eye is curative in the early stages\nProsthetic eye insertion.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "473",
    "type": "section",
    "keywords": [
      "insertion",
      "early",
      "curative",
      "prosthetic",
      "stages",
      "enucleation",
      "affected"
    ]
  },
  {
    "id": "0abf4e2598820ba4923adb82044a021c",
    "content": "Laser therapy for focal control\nRadiotherapy for local spread of the tumour.",
    "title": "Chapter 6: Problems of the Newborn (Neonate)",
    "section": "Chapter 6: Problems of the Newborn (Neonate)",
    "chunk_id": "474",
    "type": "section",
    "keywords": [
      "focal",
      "tumour",
      "local",
      "radiotherapy",
      "control",
      "therapy",
      "laser",
      "spread"
    ]
  },
  {
    "id": "9787d78cccd9f57d7a962dc93ae8bd39",
    "content": "intraocular and extraocular retinoblastoma\nChemotherapy Evidence Rating: [A]\nVincristine, IV,\nEtoposide, IV,\nCarboplatin, IV,\nOr\nVincristine, IV,\nEtoposide, IV,\nCyclophosphamide, IV,.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "475",
    "type": "section",
    "keywords": [
      "intraocular",
      "rating",
      "vincristine",
      "etoposide",
      "extraocular",
      "carboplatin",
      "retinoblastoma",
      "cyclophosphamide",
      "chemotherapy",
      "evidence"
    ]
  },
  {
    "id": "70d50c292de08856b69f0896e847386c",
    "content": "Evidence Rating: [A]\nMetoclopramide, IV or oral, 100-400 microgram/kg 8 hourly\nOr\nGranisetron, IV, 40 microgram/kg (max. 3 mg) stat. May repeat 12 hourly if necessary\nOr\nGranisetron, oral,.",
    "title": "For treatment of vomiting",
    "section": "For treatment of vomiting",
    "chunk_id": "476",
    "type": "section",
    "keywords": [
      "hourly",
      "rating",
      "metoclopramide",
      "microgram",
      "repeat",
      "oral",
      "necessary",
      "granisetron",
      "evidence",
      "stat"
    ]
  },
  {
    "id": "4a948fb51508968ac9db631197aa478e",
    "content": "Then\n20 microgram/kg 12 hourly for up to 5 days\nOr\nOndansetron, IV,\nAdult\n5 mg/m2 stat. Repeat 8 hourly if necessary\nChildren\n12-18 years;  8 mg stat. (immediatley before chemotherapy)\nOr\nOndansetron, oral,\nAdult\n8 mg 8 hourly, administared 30 minutes before the start of chemo-\ntherapy Children\n12-18 years;\t8 mg 8-12 hourly up to 5 days\n1-12 years;\t4 mg 8-12 hourly up to 5 days.",
    "title": "20 microgram/kg (max. 1 mg) within 1 hour before start of treatment",
    "section": "20 microgram/kg (max. 1 mg) within 1 hour before start of treatment",
    "chunk_id": "477",
    "type": "section",
    "keywords": [
      "years",
      "therapy",
      "hourly",
      "ondansetron",
      "start",
      "administared",
      "minutes",
      "repeat",
      "chemo",
      "immediatley",
      "children",
      "stat",
      "days",
      "before",
      "adult",
      "then",
      "chemotherapy",
      "microgram",
      "necessary",
      "oral"
    ]
  },
  {
    "id": "90c26347bcab4091ae4a4561b4c711ac",
    "content": "Ceftriaxone, IV, 100 mg/kg daily\nAnd\nGentamicin, IV, 5 mg/kg daily\nAnd (if still febrile after 48 hours, add)\nCloxacillin, IV, 25-50 mg/kg 6 hourly\nAnd (if still febrile after 5 days, add)\nFluconazole, oral, 10 mg/kg daily.",
    "title": "For treatment of febrile neutropenia",
    "section": "For treatment of febrile neutropenia",
    "chunk_id": "478",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "gentamicin",
      "ceftriaxone",
      "fluconazole",
      "oral",
      "after",
      "cloxacillin",
      "hours",
      "febrile",
      "still",
      "daily"
    ]
  },
  {
    "id": "67710332efd221a470694db07cbcf1a3",
    "content": "Referral Criteria\nAll patients should be referred to a tertiary centre that can effectively treat retinoblastoma. Wilms tumour (nephroblastoma) is a malignant embryonal tumour of renal tissue. It is the fourth commonest cancer amongst children in Ghana.",
    "title": "Blood and blood product transfusions (See section on ‘Bleeding disorders’)",
    "section": "Blood and blood product transfusions (See section on ‘Bleeding disorders’)",
    "chunk_id": "479",
    "type": "section",
    "keywords": [
      "treat",
      "wilms",
      "malignant",
      "retinoblastoma",
      "patients",
      "fourth",
      "tumour",
      "renal",
      "tertiary",
      "criteria",
      "children",
      "referral",
      "nephroblastoma",
      "should",
      "referred",
      "effectively",
      "amongst",
      "cancer",
      "embryonal",
      "commonest"
    ]
  },
  {
    "id": "68e5b21c34691fcd2232de80390d8969",
    "content": "About 80% of children with Wilms tumour present before 5 years of age. It can present soon after delivery. It may be associated with congenital anomalies such as hemihypertrophy and the absence of the iris (aniridia).",
    "title": "Blood and blood product transfusions (See section on ‘Bleeding disorders’)",
    "section": "Blood and blood product transfusions (See section on ‘Bleeding disorders’)",
    "chunk_id": "480",
    "type": "section",
    "keywords": [
      "about",
      "aniridia",
      "years",
      "present",
      "tumour",
      "wilms",
      "before",
      "congenital",
      "anomalies",
      "absence",
      "hemihypertrophy",
      "associated",
      "after",
      "iris",
      "children",
      "soon",
      "delivery"
    ]
  },
  {
    "id": "72326bd15da64fcff1e8f7c9e89348e8",
    "content": "Wilms tumour has a very good prognosis with an over 80% chance of long-term cure. Causes\nSporadic gene mutation\nSymptoms\nVisible and or palpable abdominal mass\nFever\nBlood in urine\nSigns.",
    "title": "Blood and blood product transfusions (See section on ‘Bleeding disorders’)",
    "section": "Blood and blood product transfusions (See section on ‘Bleeding disorders’)",
    "chunk_id": "481",
    "type": "section",
    "keywords": [
      "mutation",
      "urine",
      "chance",
      "sporadic",
      "abdominal",
      "wilms",
      "visible",
      "signs",
      "palpable",
      "tumour",
      "blood",
      "causes",
      "cure",
      "fever",
      "gene",
      "symptoms",
      "prognosis",
      "term",
      "mass"
    ]
  },
  {
    "id": "4ef62628bfb84fbc5333cb52e29e6321",
    "content": "Haematuria (macroscopic or microscopic)\nHypertension\nAssociated congenital anomalies\ninvestigations\nAbdominal ultrasound scan\nAbdominal CT scan\nChest X-ray\nFull Blood Count\nBlood Urea, electrolytes and creatinine.",
    "title": "Abdominal mass (palpate with care to prevent rupture or dissemination)",
    "section": "Abdominal mass (palpate with care to prevent rupture or dissemination)",
    "chunk_id": "482",
    "type": "section",
    "keywords": [
      "microscopic",
      "hypertension",
      "haematuria",
      "abdominal",
      "ultrasound",
      "full",
      "chest",
      "creatinine",
      "electrolytes",
      "count",
      "scan",
      "anomalies",
      "associated",
      "macroscopic",
      "investigations",
      "urea",
      "blood",
      "congenital"
    ]
  },
  {
    "id": "28542ab98001f3075d2c6c9861fd9322",
    "content": "Nephrectomy\nRadiotherapy post-surgery for advanced cases.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "483",
    "type": "section",
    "keywords": [
      "post",
      "advanced",
      "nephrectomy",
      "cases",
      "radiotherapy",
      "surgery"
    ]
  },
  {
    "id": "76d7e8fd6cde436de8b24d477ba3dcb6",
    "content": "Vincristine, IV,\nAnd\nActinomycin D, IV,\nAnd\nDoxorubicin, IV, (if presence of metastases).",
    "title": "Pre-operative treatment 1st Line Treatment Evidence Rating: [A]",
    "section": "Pre-operative treatment 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "484",
    "type": "section",
    "keywords": [
      "doxorubicin",
      "vincristine",
      "metastases",
      "actinomycin",
      "presence"
    ]
  },
  {
    "id": "d33dfc02971227bf23fadacde44f52e8",
    "content": "Evidence Rating: [A]\nVincristine, IV,\nAnd\nActinomycin D, IV,\nAnd\nDoxorubicin, IV, (depending on stage and risk category)\nOr\nCarboplatin, IV,\nEtoposide, IV,\nDoxorubicin, IV, Cyclophosphamide IV in combination (For high risk tumours).",
    "title": "Post-operative treatment",
    "section": "Post-operative treatment",
    "chunk_id": "485",
    "type": "section",
    "keywords": [
      "doxorubicin",
      "depending",
      "rating",
      "vincristine",
      "actinomycin",
      "tumours",
      "etoposide",
      "category",
      "high",
      "carboplatin",
      "stage",
      "risk",
      "combination",
      "cyclophosphamide",
      "evidence"
    ]
  },
  {
    "id": "2de062ec3d22515b5850792d7c9fe623",
    "content": "Evidence Rating: [A]\nMetoclopramide, IV or oral, 100-400 microgram/kg 8 hourly Or\nGranisetron, IV, 40 microgram/kg (max. 3 mg) stat. May repeat 12 hourly if necessary Or\nGranisetron, oral, 20 microgram/kg (max.",
    "title": "For treatment of vomiting",
    "section": "For treatment of vomiting",
    "chunk_id": "486",
    "type": "section",
    "keywords": [
      "hourly",
      "rating",
      "metoclopramide",
      "microgram",
      "repeat",
      "oral",
      "necessary",
      "granisetron",
      "evidence",
      "stat"
    ]
  },
  {
    "id": "050370f6cb3a945f31b4a25fbd3519c9",
    "content": "Then\n20 microgram/kg 12 hourly for up to 5 days Or\nOndansetron, IV,\nAdults\n5 mg/m2 stat. Repeat 8 hourly if necessary.",
    "title": "start of treatment",
    "section": "start of treatment",
    "chunk_id": "487",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "ondansetron",
      "microgram",
      "adults",
      "repeat",
      "necessary",
      "then",
      "stat"
    ]
  },
  {
    "id": "cb21d056cb42c1a83761c7587f022419",
    "content": "Children\n12-18 years; 8 mg stat. (immediatley before chemotherapy)\nOr\nOndansetron, oral,\nAdults\n8 mg 8 hourly, administared 30 minutes before the start of chemo-\ntherapy Children\n12-18 years;\t8 mg 8-12 hourly up to 5 days\n1-12 years;\t4 mg 8-12 hourly up to 5 days.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "488",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "ondansetron",
      "years",
      "before",
      "administared",
      "minutes",
      "start",
      "adults",
      "oral",
      "immediatley",
      "chemo",
      "children",
      "chemotherapy",
      "therapy",
      "stat"
    ]
  },
  {
    "id": "90c26347bcab4091ae4a4561b4c711ac",
    "content": "Ceftriaxone, IV, 100 mg/kg daily\nAnd\nGentamicin, IV, 5 mg/kg daily\nAnd (if still febrile after 48 hours, add)\nCloxacillin, IV, 25-50 mg/kg 6 hourly\nAnd (if still febrile after 5 days, add)\nFluconazole, oral, 10 mg/kg daily.",
    "title": "For treatment of febrile neutropenia",
    "section": "For treatment of febrile neutropenia",
    "chunk_id": "489",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "gentamicin",
      "ceftriaxone",
      "fluconazole",
      "oral",
      "after",
      "cloxacillin",
      "hours",
      "febrile",
      "still",
      "daily"
    ]
  },
  {
    "id": "ab83ad4f63e0961f6099b6e0231b5594",
    "content": "Chest pain is a common patient complaint and must be treated as a medical emergency until proven otherwise as there are several life- threatening underlying causes. The top priority is to exclude or promptly treat serious cardiac and non-cardiac causes. A good history and examination is very helpful in this endeavour.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "490",
    "type": "section",
    "keywords": [
      "proven",
      "treat",
      "patient",
      "serious",
      "emergency",
      "helpful",
      "chest",
      "treated",
      "underlying",
      "causes",
      "endeavour",
      "there",
      "threatening",
      "medical",
      "complaint",
      "promptly",
      "cardiac",
      "pain",
      "exclude",
      "several"
    ]
  },
  {
    "id": "4c88c05c7d7a060de42289cd8ea71eab",
    "content": "Causes\nCommon Cardiac\nStable Angina\nAcute Coronary Syndrome\nPericarditis\nNon-cardiac.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "491",
    "type": "section",
    "keywords": [
      "stable",
      "pericarditis",
      "common",
      "angina",
      "syndrome",
      "coronary",
      "acute",
      "causes",
      "cardiac"
    ]
  },
  {
    "id": "1abdea69ff712aef5d2bea5fd49dc472",
    "content": "Pulmonary Embolus (PE)\nPneumonia\nPeptic Ulcer\nOesophageal spasm\nPleural effusion\nOthers to consider\nAortic dissection\nMitral valve prolapse (other valvular problem)\nCoronary vasospasm.",
    "title": "Gastro-oesophageal reflux disease",
    "section": "Gastro-oesophageal reflux disease",
    "chunk_id": "492",
    "type": "section",
    "keywords": [
      "spasm",
      "ulcer",
      "vasospasm",
      "valvular",
      "mitral",
      "aortic",
      "valve",
      "others",
      "consider",
      "prolapse",
      "pulmonary",
      "pneumonia",
      "dissection",
      "peptic",
      "problem",
      "oesophageal",
      "embolus",
      "coronary",
      "effusion",
      "pleural"
    ]
  },
  {
    "id": "c79ad547389f473566e5fd2d01fd5b15",
    "content": "Costochondritis\nNerve root compression\nCardiac neurosis/DaCosta’s syndrome\nHerpes Zoster.",
    "title": "Biliary tree disease",
    "section": "Biliary tree disease",
    "chunk_id": "493",
    "type": "section",
    "keywords": [
      "costochondritis",
      "neurosis",
      "nerve",
      "compression",
      "dacosta",
      "syndrome",
      "herpes",
      "zoster",
      "root",
      "cardiac"
    ]
  },
  {
    "id": "e2492517f78afabd0091eee30119cd12",
    "content": "Symptoms\nSigns\nShock, pallor, sweating - MI, Dissecting aneurysm, PE\nDyspnoea - MI with LVF, PE, Pneumonia\nBlood pressure\nNormal or high\nLow - suggests cardiogenic shock\nDifference > 30 mmHg between arms suggests aortic dissection\nPulse - rate high, low or normal; regular or irregular.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "494",
    "type": "section",
    "keywords": [
      "regular",
      "dissecting",
      "dyspnoea",
      "aortic",
      "aneurysm",
      "pressure",
      "suggests",
      "rate",
      "signs",
      "blood",
      "arms",
      "pallor",
      "dissection",
      "pneumonia",
      "shock",
      "sweating",
      "mmhg",
      "cardiogenic",
      "between",
      "symptoms"
    ]
  },
  {
    "id": "501ab8f3ea6a1ca3d9dbafb472261083",
    "content": "Pericardial rub - suggests pericarditis\nUnequal chest expansion - pneumonia and pneumothorax\nReduced/absent breath sounds - pneumothorax\nBronchial breathing - pneumonia\nPleural rub - consider pneumonia, PE.",
    "title": "Murmurs - consider valvular heart disease",
    "section": "Murmurs - consider valvular heart disease",
    "chunk_id": "495",
    "type": "section",
    "keywords": [
      "breath",
      "unequal",
      "suggests",
      "chest",
      "bronchial",
      "pleural",
      "consider",
      "pericardial",
      "pneumonia",
      "absent",
      "sounds",
      "pneumothorax",
      "breathing",
      "reduced",
      "expansion",
      "pericarditis"
    ]
  },
  {
    "id": "4890284e605dbd09c3aec3da70a33349",
    "content": "Guarding - perforated ulcer, peritonitis\nReduced bowel sounds - paralytic Ileus\nChest wall tenderness - musculo-skeletal cause\ninvestigations.",
    "title": "Abdominal (epigastric) tenderness - Peptic Ulcer Disease",
    "section": "Abdominal (epigastric) tenderness - Peptic Ulcer Disease",
    "chunk_id": "496",
    "type": "section",
    "keywords": [
      "musculo",
      "tenderness",
      "guarding",
      "peritonitis",
      "perforated",
      "chest",
      "bowel",
      "investigations",
      "sounds",
      "ileus",
      "ulcer",
      "skeletal",
      "cause",
      "reduced",
      "paralytic",
      "wall"
    ]
  },
  {
    "id": "35f2cb27e12c74f8d1a55ce6c43cf603",
    "content": "Symptomatic relief of chest pain\nReassurance to minimise anxiety.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "497",
    "type": "section",
    "keywords": [
      "pain",
      "minimise",
      "chest",
      "reassurance",
      "relief",
      "symptomatic",
      "anxiety"
    ]
  },
  {
    "id": "1294b2df7664743b3419e873b61e8b04",
    "content": "Referral Criteria\nPersistent unexplained chest pain. Ischaemic heart disease is a condition whereby there is reduced blood supply to the heart muscle. It comprises of stable angina pectoris and the acute coronary syndromes.",
    "title": "(See sections for specific disease conditions)",
    "section": "(See sections for specific disease conditions)",
    "chunk_id": "498",
    "type": "section",
    "keywords": [
      "whereby",
      "supply",
      "reduced",
      "pectoris",
      "acute",
      "stable",
      "chest",
      "muscle",
      "angina",
      "heart",
      "condition",
      "criteria",
      "blood",
      "disease",
      "referral",
      "comprises",
      "there",
      "persistent",
      "coronary",
      "pain"
    ]
  },
  {
    "id": "fe62cd4ee80f8a77c83ad756f9727514",
    "content": "STABLE ANGiNA PECTORiS\nStable angina pectoris is pain or discomfort that occurs in the front of the chest, and may radiate to the neck, shoulders, jaw or arms. The chest pain is typically induced by exertion or emotional stress and relieved by rest or glyceryl trinitrate. Individuals who experience stable angina pectoris are at a high risk of developing acute coronary syndromes or a heart attack.",
    "title": "(See sections for specific disease conditions)",
    "section": "(See sections for specific disease conditions)",
    "chunk_id": "499",
    "type": "section",
    "keywords": [
      "emotional",
      "radiate",
      "trinitrate",
      "exertion",
      "discomfort",
      "typically",
      "induced",
      "pectoris",
      "acute",
      "neck",
      "relieved",
      "stable",
      "front",
      "attack",
      "chest",
      "developing",
      "stress",
      "angina",
      "heart",
      "arms"
    ]
  },
  {
    "id": "00f77d34bddebb88cf77ac6b7100f2a3",
    "content": "Risk factors include diabetes mellitus, hypertension, cigarette smoking, plasma lipid abnormalities, obesity, family history of heart disease and persistently elevated markers of inflammation such as C-reactive protein. Risk factors for this condition include obesity, diabetes mellitus, hypertension, smoking, hyperlipidaemia. Causes\nAtherosclerosis with narrowing of the coronary blood vessels\nSpasms of the coronary arteries\nSymptoms\nCentral or precordial chest pain\nMay radiate into the left arm, neck or jaw\nRelieved by rest\nRelieved by glyceryl trinitrate\nSigns\nNo typical signs\ninvestigations\n12-lead ECG.",
    "title": "(See sections for specific disease conditions)",
    "section": "(See sections for specific disease conditions)",
    "chunk_id": "500",
    "type": "section",
    "keywords": [
      "hypertension",
      "radiate",
      "arteries",
      "trinitrate",
      "plasma",
      "abnormalities",
      "mellitus",
      "factors",
      "lead",
      "family",
      "narrowing",
      "precordial",
      "into",
      "neck",
      "vessels",
      "relieved",
      "chest",
      "inflammation",
      "hyperlipidaemia",
      "protein"
    ]
  },
  {
    "id": "3799cbf73fb56f39150266b00e4541ee",
    "content": "Cardiac enzymes: creatinine kinase-MB (CK-MB) and troponins\nBlood glucose\nBlood lipid profile\nFBC\nChest X-ray\nStress ECG\nEchocardiography\nCoronary angiography.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "501",
    "type": "section",
    "keywords": [
      "enzymes",
      "creatinine",
      "echocardiography",
      "chest",
      "stress",
      "kinase",
      "profile",
      "glucose",
      "angiography",
      "lipid",
      "coronary",
      "blood",
      "troponins",
      "cardiac"
    ]
  },
  {
    "id": "c914747a4aac07eb5d5f515b371b316b",
    "content": "To minimise symptoms\nTo prevent progression to acute coronary syndromes\nTo identify and manage modifiable risk factors\nTo improve quality of life.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "502",
    "type": "section",
    "keywords": [
      "minimise",
      "prevent",
      "progression",
      "syndromes",
      "manage",
      "improve",
      "quality",
      "life",
      "factors",
      "modifiable",
      "risk",
      "identify",
      "coronary",
      "acute",
      "symptoms"
    ]
  },
  {
    "id": "e0d5953e766e707206b941e55c7e7200",
    "content": "Educate and reassure patient\nHealthy lifestyle modifications\nDiet\nExercise\nWeight management\nReduction in alcohol consumption\nAvoid or quit smoking.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "503",
    "type": "section",
    "keywords": [
      "diet",
      "avoid",
      "reduction",
      "healthy",
      "smoking",
      "weight",
      "educate",
      "management",
      "alcohol",
      "exercise",
      "modifications",
      "lifestyle",
      "quit",
      "reassure",
      "patient",
      "consumption"
    ]
  },
  {
    "id": "30c8ccc8863951877fdbcf3e0ffff44b",
    "content": "Treating the acute chest pain\nEvidence Rating: [A]\nGlyceryl trinitrate, sublingual, 500 microgram stat. then as required\nAnd\nAspirin, oral, 300 mg stat. then 75 mg daily\nOr\nClopidogrel, oral, 300 mg stat.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "504",
    "type": "section",
    "keywords": [
      "rating",
      "pain",
      "chest",
      "microgram",
      "trinitrate",
      "treating",
      "clopidogrel",
      "oral",
      "sublingual",
      "required",
      "glyceryl",
      "aspirin",
      "then",
      "acute",
      "evidence",
      "stat",
      "daily"
    ]
  },
  {
    "id": "797d8c51a26335ae0c97172d165f19de",
    "content": "then 75 mg daily\nAnd\nAtenolol, oral, 50-100 mg daily\nOr\nBisoprolol, oral, 5-10 mg daily\nOr\nMetoprolol, oral, 50-100 mg 8-12 hourly\nOr\nVerapamil, oral, 80-120 mg 8 hourly.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "505",
    "type": "section",
    "keywords": [
      "hourly",
      "verapamil",
      "atenolol",
      "metoprolol",
      "bisoprolol",
      "oral",
      "then",
      "daily"
    ]
  },
  {
    "id": "fa861c096ba1e4ad77d30c07f6a89983",
    "content": "Use statins to treat abnormal blood lipids to target levels\nIf beta blockers or verapamil are contraindicated\nIsosorbide dinitrate, oral, 10 mg 8-12 hourly\nReferral Criteria\nRefer the following patients.",
    "title": "Optimise or initiate treatment for diabetes mellitus",
    "section": "Optimise or initiate treatment for diabetes mellitus",
    "chunk_id": "506",
    "type": "section",
    "keywords": [
      "statins",
      "treat",
      "levels",
      "dinitrate",
      "verapamil",
      "lipids",
      "isosorbide",
      "hourly",
      "following",
      "abnormal",
      "patients",
      "criteria",
      "blood",
      "referral",
      "target",
      "refer",
      "blockers",
      "oral",
      "beta",
      "contraindicated"
    ]
  },
  {
    "id": "d5237a2f72f88c5bab6aa01775ef5459",
    "content": "Those with worsening risk factors\nFlowchart\nACUTE CORONARY SYNDROME\nAcute Coronary Syndrome (ACS) is a term that describes symptoms resulting from severe acute myocardial ischaemia. The ischaemia may, or may not, lead to myocardial infarction (heart attack). ACS is classified.",
    "title": "Those with no significant improvement in symptoms after the initial treatment above",
    "section": "Those with no significant improvement in symptoms after the initial treatment above",
    "chunk_id": "507",
    "type": "section",
    "keywords": [
      "factors",
      "lead",
      "acute",
      "ischaemia",
      "describes",
      "attack",
      "myocardial",
      "heart",
      "severe",
      "worsening",
      "those",
      "coronary",
      "symptoms",
      "infarction",
      "term",
      "classified",
      "resulting",
      "risk",
      "syndrome",
      "flowchart"
    ]
  },
  {
    "id": "730517d391e990fb845e0b6cd07623ba",
    "content": "as ST segment elevation on an electrocardiogram (ST-segment elevation myocardial infarction - STEMI) or a non-ST-segment elevation myocardial infarction (NSTEMI) and unstable angina (an ACS without elevation of cardiac enzymes). The risk factors for ACS are identical to those for, and include previous episodes of, stable angina pectoris. Risk factors for this condition include obesity, diabetes mellitus, hypertension, smoking and hyperlipidaemia.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "508",
    "type": "section",
    "keywords": [
      "hypertension",
      "elevation",
      "electrocardiogram",
      "mellitus",
      "factors",
      "pectoris",
      "stable",
      "nstemi",
      "myocardial",
      "hyperlipidaemia",
      "angina",
      "condition",
      "previous",
      "enzymes",
      "include",
      "episodes",
      "segment",
      "those",
      "infarction",
      "cardiac"
    ]
  },
  {
    "id": "dbe8d5d82d0231b41a6881ea9ded98bb",
    "content": "Causes\nAtherosclerosis or obstruction of the coronary blood vessels leading to reduction in blood supply to the heart muscle\nSymptoms\nChest pain\nSudden onset\nVarying degree but often severe and described as tightness, heaviness or constrictive in nature. Persisting for more than 30 minutes\nNot relieved by rest or glyceryl trinitrate\nMay radiate to the left arm, the neck or jaw\nNausea\nVomiting\nShortness of breath or fatigue (this may be the only presentation in diabetics and the elderly)\nLoss of consciousness\nSigns\nRestlessness and apprehension\nExcessive sweating\nPeripheral or central cyanosis\nPulse may be thready, fast, irregular, slow or normal\nBlood pressure may be high, low or unrecordable (following extensive damage to heart muscle)\nBilateral crepitations in the chest (with left ventricular failure)\nPresence of a third or fourth heart sound (suggests heart failure)\nConfusion in the elderly\ninvestigations\nStandard 12 lead ECG\nCardiac enzymes: CK-MB, troponins T and I\nMyoglobin\nSerum lipid profile\nChest X-ray\nRandom blood glucose\nFBC, ESR\nSerum uric acid\nBlood urea, electrolytes and creatinine\nC-reactive protein.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "509",
    "type": "section",
    "keywords": [
      "sudden",
      "radiate",
      "nausea",
      "trinitrate",
      "profile",
      "lead",
      "protein",
      "signs",
      "causes",
      "severe",
      "restlessness",
      "leading",
      "acid",
      "reactive",
      "failure",
      "pulse",
      "serum",
      "normal",
      "diabetics",
      "elderly"
    ]
  },
  {
    "id": "f0cb3b26c819b41a2b7345d4630c51b9",
    "content": "To relieve distress and pain\nTo limit infarct size\nTo prevent and treat complications\nTo reverse cardiac remodelling\nTo prevent re-infarction\nTo identify and manage modifiable risk factors\nTo improve quality of life.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "510",
    "type": "section",
    "keywords": [
      "treat",
      "improve",
      "quality",
      "factors",
      "remodelling",
      "identify",
      "prevent",
      "infarct",
      "manage",
      "size",
      "reverse",
      "modifiable",
      "infarction",
      "cardiac",
      "complications",
      "pain",
      "life",
      "distress",
      "relieve",
      "risk"
    ]
  },
  {
    "id": "8c6408d848cfb3e1bde8558dcd8a53e5",
    "content": "Reassure patient and encourage bed rest in the first 48 hours\nEncourage cessation of smoking\nEnsure weight reduction (in overweight and obese individuals) in the long term.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "511",
    "type": "section",
    "keywords": [
      "cessation",
      "obese",
      "term",
      "first",
      "reduction",
      "ensure",
      "smoking",
      "weight",
      "overweight",
      "encourage",
      "individuals",
      "rest",
      "reassure",
      "hours",
      "patient"
    ]
  },
  {
    "id": "1bd5c641e11d88111e3f4d4c1bada3e3",
    "content": "Evidence Rating: [A]\nOxygen, intranasal, by face mask or nasal cannula\nAnd\nAspirin, oral (chewable), 300 mg stat. And\nClopidogrel, oral, 300 mg stat. And\nGlyceryl trinitrate, sublingual, 500 microgram stat.",
    "title": "initial treatment on admission",
    "section": "initial treatment on admission",
    "chunk_id": "512",
    "type": "section",
    "keywords": [
      "rating",
      "oxygen",
      "cannula",
      "microgram",
      "trinitrate",
      "face",
      "intranasal",
      "oral",
      "sublingual",
      "chewable",
      "aspirin",
      "mask",
      "glyceryl",
      "clopidogrel",
      "evidence",
      "stat",
      "nasal"
    ]
  },
  {
    "id": "dad4d8a69a1ccbe57ee2f6e2e08d9f8f",
    "content": "And\nMorphine, IV, 5-10 mg stat. And\nMetoclopramide, IV, 10 mg stat. (to prevent vomiting induced by\nmorphine).",
    "title": "initial treatment on admission",
    "section": "initial treatment on admission",
    "chunk_id": "513",
    "type": "section",
    "keywords": [
      "morphine",
      "vomiting",
      "metoclopramide",
      "prevent",
      "induced",
      "stat"
    ]
  },
  {
    "id": "03299eeb540874918ff0d325a58985ee",
    "content": "Aspirin, oral, 75-300 mg daily indefinitely\nAnd\nClopidogrel, oral, 75 mg daily (patients who receive revascularisation therapy will require treatment for up to 12 months)\nAnticoagulation\nEnoxaparin, SC, 1 mg/kg (100 units/kg) 12 hourly\nPrevention of cardiac arrhythmias and reduction of myocardial\nworkload\nAtenolol, oral, 25-100 mg daily (avoid only if beta-blockers are con-.",
    "title": "treatment",
    "section": "treatment",
    "chunk_id": "514",
    "type": "section",
    "keywords": [
      "avoid",
      "units",
      "atenolol",
      "enoxaparin",
      "revascularisation",
      "clopidogrel",
      "therapy",
      "workload",
      "hourly",
      "require",
      "anticoagulation",
      "myocardial",
      "patients",
      "treatment",
      "arrhythmias",
      "reduction",
      "prevention",
      "receive",
      "only",
      "indefinitely"
    ]
  },
  {
    "id": "63c69305ab3397966607aa3b0ebc7a9e",
    "content": "traindicated)\nOr\nBisoprolol, oral, 5-20 mg daily\nOr\nMetoprolol, oral, 50-100 mg 8-12 hourly\nAnd\nLisinopril, oral, 2. 5-20 mg daily\nOr\nLosartan, oral, 25-50 mg daily\nOr\nCandesartan, oral, 4-16 mg daily\nAnd\nIn patients with STEMI:\nFibrinolytic agents may be given as reperfusion therapy in patients presenting with STEMI under specialist care. Manage acute complications such as pulmonary oedema, cardiogenic\nshock and cardiac arrhythmias\nManage hyperglycaemia with insulin.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "515",
    "type": "section",
    "keywords": [
      "lisinopril",
      "agents",
      "oedema",
      "given",
      "metoprolol",
      "bisoprolol",
      "presenting",
      "traindicated",
      "therapy",
      "acute",
      "under",
      "hourly",
      "specialist",
      "candesartan",
      "patients",
      "arrhythmias",
      "manage",
      "reperfusion",
      "pulmonary",
      "shock"
    ]
  },
  {
    "id": "5d074ce7d776ffb86a7a8497113e692b",
    "content": "Change diabetic patients previously on oral hypoglycaemic agents to insulin.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "516",
    "type": "section",
    "keywords": [
      "agents",
      "previously",
      "insulin",
      "oral",
      "change",
      "patients",
      "diabetic",
      "hypoglycaemic"
    ]
  },
  {
    "id": "0342112fbc5204097310d630cededead",
    "content": "Aspirin, oral, 75-150 mg daily indefinitely\nAnd\nAtenolol, oral, 25-100 mg daily (avoid only if beta-blockers are con- traindicated)\nOr\nBisoprolol, oral, 5-20 mg daily\nOr\nMetoprolol, oral, 50-100 mg 8-12 hourly\nTo prevent cardiac remodelling and improve survival\nLisinopril, oral, 2. 5-20 mg daily\nOr\nLosartan, oral, 25-50 mg daily\nOr\nCandesartan, oral, 4-16 mg daily\nTo stabilise the clot and reduce blood cholesterol levels\nAtorvastatin, oral, 20-40 mg daily\nOr\nRosuvastatin, oral, 10-20 mg daily\nOr.",
    "title": "Long-term treatment (secondary prevention)",
    "section": "Long-term treatment (secondary prevention)",
    "chunk_id": "517",
    "type": "section",
    "keywords": [
      "avoid",
      "lisinopril",
      "atenolol",
      "improve",
      "levels",
      "bisoprolol",
      "remodelling",
      "traindicated",
      "hourly",
      "candesartan",
      "prevent",
      "stabilise",
      "cholesterol",
      "daily",
      "blood",
      "clot",
      "atorvastatin",
      "only",
      "indefinitely",
      "aspirin"
    ]
  },
  {
    "id": "43e642235ef4b4742b78384da0c82e38",
    "content": "Simvastatin, oral, 40-80 mg daily. Statins are indicated irrespective\nof lipid levels\nTo improve coronary dilatation and reduce myocardial workload\nIsosorbide dinitrate, oral, 10 mg 8-12 hourly\nControl of hypertension and hyperglycaemia, if present\n(See appropriate sections)\nReferral Criteria\nAll patients with suspected ACS require an urgent ECG. If ECG is not available or cannot be interpreted, refer immediately to a higher facility.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "518",
    "type": "section",
    "keywords": [
      "hypertension",
      "statins",
      "improve",
      "levels",
      "dinitrate",
      "workload",
      "isosorbide",
      "hourly",
      "require",
      "lipid",
      "facility",
      "immediately",
      "myocardial",
      "patients",
      "criteria",
      "sections",
      "referral",
      "suspected",
      "dilatation",
      "cannot"
    ]
  },
  {
    "id": "f42e2938b7e9cfcc1bbd19ff11a00fa1",
    "content": "Patients with confirmed STEMI in any facility should be referred urgently to a Physician Specialist or Cardiologist for reperfusion therapy (after an initial oral dose of 300 mg of aspirin). Other patients with N-STEMI and unstable angina should be referred to a physician specialist or cardiologist after the initial management above. Dyspnoea is an uncomfortable awareness of one’s own breathing.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "519",
    "type": "section",
    "keywords": [
      "initial",
      "management",
      "breathing",
      "therapy",
      "cardiologist",
      "dyspnoea",
      "specialist",
      "facility",
      "uncomfortable",
      "angina",
      "patients",
      "awareness",
      "physician",
      "above",
      "urgently",
      "reperfusion",
      "should",
      "dose",
      "referred",
      "aspirin"
    ]
  },
  {
    "id": "59882b0c5d45088966e47f08dafe9989",
    "content": "It is often the main symptom of cardiopulmonary disease although the differential diagnosis extends beyond these two systems. Dyspnoea of sudden onset should be treated as a medical emergency. Causes\nCardiac\nHeart Failure.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "520",
    "type": "section",
    "keywords": [
      "beyond",
      "sudden",
      "often",
      "cardiopulmonary",
      "dyspnoea",
      "emergency",
      "treated",
      "heart",
      "extends",
      "causes",
      "onset",
      "disease",
      "diagnosis",
      "should",
      "failure",
      "medical",
      "although",
      "main",
      "cardiac",
      "symptom"
    ]
  },
  {
    "id": "cc43ec53b40257ffdb3dfb4dcb83dc95",
    "content": "Cardiac Arrhythmias\nPericardial effusion\nRespiratory\nPneumonia\nPulmonary Embolus (PE).",
    "title": "Valvular Heart Disease - mitral stenosis, aortic stenosis",
    "section": "Valvular Heart Disease - mitral stenosis, aortic stenosis",
    "chunk_id": "521",
    "type": "section",
    "keywords": [
      "effusion",
      "cardiac",
      "pulmonary",
      "pericardial",
      "pneumonia",
      "respiratory",
      "embolus",
      "arrhythmias"
    ]
  },
  {
    "id": "c5c628b1d209d582f3272e0548af81a3",
    "content": "Pneumothorax\nPleural Effusion\nChest wall function limitation - myopathy, neuropathy, kypho-\nscoliosis\nOther\nAnaemia\nPsychogenic hyperventilation\nAcidosis - e. g. uraemia, Diabetic Ketoacidosis, drug overdose.",
    "title": "fibrolysing alveolitis and the occupational lung diseases",
    "section": "fibrolysing alveolitis and the occupational lung diseases",
    "chunk_id": "522",
    "type": "section",
    "keywords": [
      "uraemia",
      "myopathy",
      "anaemia",
      "acidosis",
      "pneumothorax",
      "hyperventilation",
      "kypho",
      "psychogenic",
      "chest",
      "function",
      "drug",
      "diabetic",
      "overdose",
      "scoliosis",
      "wall",
      "ketoacidosis",
      "effusion",
      "pleural",
      "neuropathy",
      "other"
    ]
  },
  {
    "id": "16ec34b070f4be4f55d47bb6142f577c",
    "content": "Foreign body aspiration\nMassive abdominal distension\nSymptoms\nBreathlessness\nQuality\ncontinuous or intermittent\nexertional - suggests cardiopulmonary cause\npositional - suggests paroxysmal nocturnal dyspnoea, or-\nthopnoea and a cardiac cause\nnocturnal - suggests cardiac or bronchial asthma\nTime since onset - recent (acute) or longstanding (chronic)\nDuration of episode(s)\nminutes to hours - suggests asthma, pneumothorax, pul- monary oedema, pneumonia, pulmonary oedema, ana- phylaxis\nweeks to months - suggests pleural effusion, pericardial\neffusion, pulmonary fibrosis, lung cancer, recurrent PE, cardiac failure, anaemia, neuromuscular disease, tuber- culosis\nyears - COPD, lung fibrosis\nAssociated features\ncough (suggests acute heart failure, pneumonia)\nsputum, haemoptysis\nwheeze (asthma, heart failure)\nankle oedema (heart, kidney, liver)\nSigns\nFever - pneumonia, less commonly PE\nPallor - severe anaemia acute heart failure, PE, myocardial infarction or cardiogenic shock\nSweating - acute heart failure, pneumonia, PE, myocardial infarction.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "523",
    "type": "section",
    "keywords": [
      "recurrent",
      "copd",
      "paroxysmal",
      "nocturnal",
      "distension",
      "abdominal",
      "dyspnoea",
      "foreign",
      "intermittent",
      "signs",
      "weeks",
      "severe",
      "disease",
      "chronic",
      "failure",
      "months",
      "since",
      "commonly",
      "breathlessness",
      "recent"
    ]
  },
  {
    "id": "61951f230a95f938a781c4f2b9613374",
    "content": "Cyanosis - hypoxia e. g. in COPD, heart failure, PE, pneumonia etc.",
    "title": "Clubbing - infections, cyanotic congenital heart disease, lung fibrosis",
    "section": "Clubbing - infections, cyanotic congenital heart disease, lung fibrosis",
    "chunk_id": "524",
    "type": "section",
    "keywords": [
      "copd",
      "pneumonia",
      "hypoxia",
      "heart",
      "failure",
      "cyanosis"
    ]
  },
  {
    "id": "727db93813f749d62902f82021d7dae1",
    "content": "Peripheral oedema - heart, liver or renal failure\nWheeze - heart failure or bronchial asthma\nBarrel shaped chest - COPD\nAscites - cardiac, renal, gastrointestinal, hepatic or intra-abdominal\nlesion\nPulse - fast (suggests tachyarrhythmia, PE) or slow (bradyarrhythmia)\nBlood pressure - may be high, normal or low.",
    "title": "Clubbing - infections, cyanotic congenital heart disease, lung fibrosis",
    "section": "Clubbing - infections, cyanotic congenital heart disease, lung fibrosis",
    "chunk_id": "525",
    "type": "section",
    "keywords": [
      "barrel",
      "intra",
      "oedema",
      "copd",
      "shaped",
      "abdominal",
      "lesion",
      "pressure",
      "wheeze",
      "chest",
      "suggests",
      "asthma",
      "heart",
      "bradyarrhythmia",
      "renal",
      "ascites",
      "blood",
      "gastrointestinal",
      "slow",
      "failure"
    ]
  },
  {
    "id": "f691029ff5a7f906d170010d603cfb08",
    "content": "Other signs - features of pneumonia, pneumothorax, pleural effusion\ninvestigations\nFull Blood Count\nUrea, Electrolytes, Creatinine\nChest X-ray.",
    "title": "Heart murmurs - valvular heart disease",
    "section": "Heart murmurs - valvular heart disease",
    "chunk_id": "526",
    "type": "section",
    "keywords": [
      "effusion",
      "creatinine",
      "full",
      "pleural",
      "chest",
      "electrolytes",
      "count",
      "pneumonia",
      "other",
      "pneumothorax",
      "features",
      "signs",
      "investigations",
      "urea",
      "blood"
    ]
  },
  {
    "id": "323d8e896c2fdef95c23c8a69cd97991",
    "content": "suspected\nEchocardiogram\nLung Function Tests (spirometry)\nCT pulmonary angiogram useful for confirming PE.",
    "title": "Cardiac enzymes, Troponin T, CK-MB if ischaemic heart disease is",
    "section": "Cardiac enzymes, Troponin T, CK-MB if ischaemic heart disease is",
    "chunk_id": "527",
    "type": "section",
    "keywords": [
      "angiogram",
      "confirming",
      "spirometry",
      "suspected",
      "function",
      "pulmonary",
      "useful",
      "tests",
      "echocardiogram",
      "lung"
    ]
  },
  {
    "id": "8f74ba068ebd467423042666f6caf5ca",
    "content": "Treat underlying cause - see relevant chapters\nMaintain oxygen saturation above 95% - caution if there is underlying COPD, as these patients are dependent on hypoxic drive.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "528",
    "type": "section",
    "keywords": [
      "above",
      "oxygen",
      "dependent",
      "treat",
      "copd",
      "maintain",
      "cause",
      "relevant",
      "chapters",
      "underlying",
      "saturation",
      "caution",
      "there",
      "patients",
      "hypoxic",
      "drive",
      "these"
    ]
  },
  {
    "id": "ee7810692423acb6daba6c7cf818331a",
    "content": "Based on underlying cause. (See relevant sections)\nReferral Criteria.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "529",
    "type": "section",
    "keywords": [
      "referral",
      "based",
      "cause",
      "relevant",
      "underlying",
      "criteria",
      "sections"
    ]
  },
  {
    "id": "a236d1180a8a9edfd355ca65df6e214a",
    "content": "Deep Vein Thrombosis (DVT) is a common disease although often asymptomatic. The deep veins of the lower limbs are affected most commonly, but thrombosis may affect other sites, including the upper limbs, intracranial and splanchnic veins. Complications include pulmonary thromboembolism, which can be life-threatening.",
    "title": "Refer to the next level of care if cause cannot be identified",
    "section": "Refer to the next level of care if cause cannot be identified",
    "chunk_id": "530",
    "type": "section",
    "keywords": [
      "veins",
      "intracranial",
      "often",
      "vein",
      "splanchnic",
      "which",
      "asymptomatic",
      "including",
      "sites",
      "limbs",
      "most",
      "thromboembolism",
      "disease",
      "affect",
      "deep",
      "include",
      "pulmonary",
      "thrombosis",
      "threatening",
      "although"
    ]
  },
  {
    "id": "8e33413a60eb947904f94d76dba6094b",
    "content": "It is therefore essential to have a reliable method for establishing the DVT risk of patients and to take active steps to provide prophylactic treatment as necessary. Common risk factors for DVT include obesity, smoking, prolonged immobility (e. g.",
    "title": "Refer to the next level of care if cause cannot be identified",
    "section": "Refer to the next level of care if cause cannot be identified",
    "chunk_id": "531",
    "type": "section",
    "keywords": [
      "prolonged",
      "essential",
      "establishing",
      "factors",
      "therefore",
      "patients",
      "treatment",
      "steps",
      "include",
      "active",
      "immobility",
      "reliable",
      "smoking",
      "common",
      "necessary",
      "provide",
      "obesity",
      "method",
      "have",
      "risk"
    ]
  },
  {
    "id": "0ffe59baca205636ae253d25d9f8b811",
    "content": "bed rest, long haul flights), major surgery e. g. orthopaedic, abdominal and pelvic surgery, pregnancy and the puerperium, after caesarean section, malignancies, inherited blood disorders, oestrogen therapy and medical conditions, e.",
    "title": "Refer to the next level of care if cause cannot be identified",
    "section": "Refer to the next level of care if cause cannot be identified",
    "chunk_id": "532",
    "type": "section",
    "keywords": [
      "oestrogen",
      "therapy",
      "abdominal",
      "orthopaedic",
      "section",
      "inherited",
      "pregnancy",
      "blood",
      "pelvic",
      "malignancies",
      "major",
      "disorders",
      "rest",
      "caesarean",
      "medical",
      "puerperium",
      "haul",
      "flights",
      "conditions",
      "after"
    ]
  },
  {
    "id": "2b53885847bb0ee27a35a4b6068cdc48",
    "content": "g. congestive cardiac failure, myocardial infarction, nephrotic syndrome, stroke, systemic lupus erythematosus. In cases of confirmed DVT, treatment with anticoagulants must not be delayed unnecessarily unless there are significant contraindications to their use such as recent intracerebral bleed, severe liver disease, active peptic ulcer, bleeding disorders, and severe hypertension.",
    "title": "Refer to the next level of care if cause cannot be identified",
    "section": "Refer to the next level of care if cause cannot be identified",
    "chunk_id": "533",
    "type": "section",
    "keywords": [
      "hypertension",
      "recent",
      "ulcer",
      "bleed",
      "systemic",
      "delayed",
      "anticoagulants",
      "myocardial",
      "unless",
      "bleeding",
      "nephrotic",
      "unnecessarily",
      "their",
      "treatment",
      "severe",
      "disease",
      "intracerebral",
      "active",
      "peptic",
      "disorders"
    ]
  },
  {
    "id": "68314bb33c9c7095ac32af7a8528839f",
    "content": "Causes\nStagnation of blood in the vein\nIncreased viscosity of blood\nInflammation of the blood vessel causing damage.",
    "title": "Refer to the next level of care if cause cannot be identified",
    "section": "Refer to the next level of care if cause cannot be identified",
    "chunk_id": "534",
    "type": "section",
    "keywords": [
      "stagnation",
      "blood",
      "vein",
      "inflammation",
      "viscosity",
      "damage",
      "increased",
      "causing",
      "causes",
      "vessel"
    ]
  },
  {
    "id": "87bb9bde38c4c1e8037a885729b60167",
    "content": "Symptoms\nSwelling or firmness of affected limb (usually unilateral)\nPain in the affected limb\nMild fever\nSigns\nSwelling of affected limb\nDifferential warmth\nTenderness\nRedness\nPitting oedema\nProminent superficial veins\nLow probability: D-Dimer test is recommended. Low pre-test probability combined with a neg- ative D-Dimer test essentially rules out a DVT. Moderate or High Probability: D-Dimer test with additional Doppler/compression ultra sound scan is recommended.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "535",
    "type": "section",
    "keywords": [
      "ative",
      "usually",
      "unilateral",
      "veins",
      "oedema",
      "test",
      "essentially",
      "sound",
      "affected",
      "swelling",
      "superficial",
      "redness",
      "rules",
      "moderate",
      "doppler",
      "probability",
      "signs",
      "tenderness",
      "firmness",
      "combined"
    ]
  },
  {
    "id": "97c5f86858c8c7419dde8cd452798e88",
    "content": "investigations\nD-Dimer test\nDoppler ultrasound\nThrombophilia screen e. g. protein C, protein S levels (in patients with recurrent DVT)\nFBC.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "536",
    "type": "section",
    "keywords": [
      "ultrasound",
      "test",
      "recurrent",
      "doppler",
      "levels",
      "protein",
      "dimer",
      "patients",
      "investigations",
      "screen",
      "thrombophilia"
    ]
  },
  {
    "id": "ac1953f72d7ddf49da37d1ca58216f4c",
    "content": "To prevent clot propagation and pulmonary embolism\nTo prevent recurrence.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "537",
    "type": "section",
    "keywords": [
      "clot",
      "recurrence",
      "prevent",
      "pulmonary",
      "propagation",
      "embolism"
    ]
  },
  {
    "id": "c5053f3c1fad3f3c5b722a881b0ef00b",
    "content": "Avoidance of prolonged recumbency and dehydration\nAvoidance of excess amounts of coffee, tea and alcohol, especially on long journeys\nIncrease water intake during long journeys or periods of immobility\nRegular exercise during long journeys e. g. stopping on road journeys to take a walk or moving about on a plane during long flights and leg flexing exercises while seated\nAvoid crossing legs for long periods on long journeys\nUse of elastic compression stockings.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "538",
    "type": "section",
    "keywords": [
      "amounts",
      "prolonged",
      "avoid",
      "avoidance",
      "regular",
      "especially",
      "during",
      "exercise",
      "while",
      "increase",
      "recumbency",
      "alcohol",
      "journeys",
      "water",
      "intake",
      "seated",
      "periods",
      "dehydration",
      "exercises",
      "excess"
    ]
  },
  {
    "id": "0d6caf915ce2fce09e6de10bcabd3e97",
    "content": "Heparin, SC,\nAdults\n5,000 units 8-12 hourly\nChildren\n1 month-18 years; 250 units/kg 12 hourly.",
    "title": "1st Line treatment Evidence Rating: [A]",
    "section": "1st Line treatment Evidence Rating: [A]",
    "chunk_id": "539",
    "type": "section",
    "keywords": [
      "hourly",
      "units",
      "years",
      "adults",
      "month",
      "children",
      "heparin"
    ]
  },
  {
    "id": "a84232efc562e5f4781d1fa69566b74c",
    "content": "Enoxaparin, SC,\nAdults\n40 mg daily\nChildren\n2 months-18 years;\t500 microgram /kg 12 hourly (max 40 mg)\n1-2 months;\t750 microgram /kg 12 hourly.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "540",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "microgram",
      "adults",
      "enoxaparin",
      "children",
      "months",
      "daily"
    ]
  },
  {
    "id": "da75a8d1f4b6d1efacbcdf3469a2d55b",
    "content": "Heparin, SC,\nChildren\n1 month-18 years; 250 units /kg 12 hourly\nOr\nHeparin, IV,\nAdults\n80 units/kg stat. continue with 18 units/kg / hour\nOr\n250 units/kg, SC, continue with 250 units /kg 12 hourly.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "541",
    "type": "section",
    "keywords": [
      "hourly",
      "continue",
      "hour",
      "units",
      "years",
      "adults",
      "month",
      "children",
      "heparin",
      "stat"
    ]
  },
  {
    "id": "b5b9a133f5d5637dd8d9e61853b5f71f",
    "content": "Children\n1-18 years; 75 units/kg stat. continue with 20 units/kg/hour\nmonth-1 year; 75 units/kg stat. continue with 25 units/kg/ hour Neonates (term baby); 75 units/kg stat.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "542",
    "type": "section",
    "keywords": [
      "baby",
      "continue",
      "hour",
      "units",
      "years",
      "term",
      "neonates",
      "month",
      "children",
      "stat",
      "year"
    ]
  },
  {
    "id": "28b43fc492cb3862a53575216bfd6e44",
    "content": "continue with 25 units/kg/ hour\nNeonates (< 35 weeks); 50 Units /kg stat. continue with 25 units/ kg/hour.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "543",
    "type": "section",
    "keywords": [
      "continue",
      "hour",
      "units",
      "neonates",
      "weeks",
      "stat"
    ]
  },
  {
    "id": "64a98ce037851dc534cd544ef8595946",
    "content": "Enoxaparin, SC,\nAdults\n1. 5 mg/kg (150 units/kg) daily\nChildren\nmonths-18 years;\t1 mg/kg 12 hourly\n1-2 months;\t1. 5 mg/kg 12 hourly\nNeonates;\t1.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "544",
    "type": "section",
    "keywords": [
      "hourly",
      "units",
      "years",
      "neonates",
      "adults",
      "enoxaparin",
      "children",
      "months",
      "daily"
    ]
  },
  {
    "id": "a55dec2cf167d1107d17397aea01bfad",
    "content": "5-2 mg/kg 12 hourly\nOr\nDalteparin, SC,\nAdults\n200 mg/kg (max. of 18,000 units) daily\nChildren\n12-18 years;\t200 units/kg once daily (max 18,000 units daily)\n1 month-12 years;\t100 units/kg 12 hourly\nNeonates;\t100 units/kg 12 hourly\nAnd\nWarfarin, oral, Adults Loading Dose.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "545",
    "type": "section",
    "keywords": [
      "once",
      "hourly",
      "units",
      "years",
      "loading",
      "neonates",
      "adults",
      "oral",
      "dose",
      "warfarin",
      "month",
      "children",
      "dalteparin",
      "daily"
    ]
  },
  {
    "id": "240dcb86cd85f7f2a3baea57baae87df",
    "content": "Referral Criteria\nRefer to physician specialist for management and monitoring. Pulmonary Embolism (PE) results from thrombi, often from the deep veins of the lower limbs or pelvis, which are transported via the right heart into the pulmonary vasculature. Large emboli may cause obstruction to blood flow and result in life-threatening hypoxia and high mortality.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "546",
    "type": "section",
    "keywords": [
      "veins",
      "monitoring",
      "often",
      "management",
      "which",
      "results",
      "into",
      "specialist",
      "emboli",
      "right",
      "transported",
      "large",
      "result",
      "thrombi",
      "pelvis",
      "obstruction",
      "limbs",
      "heart",
      "criteria",
      "blood"
    ]
  },
  {
    "id": "7651ed719069dc3be1376e186c4a64a3",
    "content": "PE should therefore be managed as a medical emergency. The risk factors and management for PE are similar to those for DVT. (See section on ‘DVT’).",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "547",
    "type": "section",
    "keywords": [
      "therefore",
      "emergency",
      "management",
      "section",
      "should",
      "similar",
      "factors",
      "risk",
      "those",
      "medical",
      "managed"
    ]
  },
  {
    "id": "bfc70a62adbeff9e3bc0b7c93266c0e1",
    "content": "Causes\n(See section on ‘DVT’)\nSymptoms\nDyspnoea\nPleuritic pain\nCough\nHaemoptysis (due to pulmonary infarction)\nPresyncope, syncope or collapse (massive PE)\nUnilateral swelling of a limb\nSigns\nTachypnoea\nTachycardia (may be regular or irregular)\nBlood pressure - low/unrecordable (suggests massive PE), normal or high\nPleural effusion\nLow oxygen saturation on pulse oximetry <90%\nPleural rub\nCyanosis\nUnilaterally swollen calf or thigh of DVT.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "548",
    "type": "section",
    "keywords": [
      "collapse",
      "unilateral",
      "unilaterally",
      "calf",
      "regular",
      "massive",
      "swelling",
      "syncope",
      "cyanosis",
      "tachycardia",
      "tachypnoea",
      "haemoptysis",
      "thigh",
      "pleuritic",
      "dyspnoea",
      "pressure",
      "oxygen",
      "suggests",
      "section",
      "signs"
    ]
  },
  {
    "id": "507a90586b3821c0df37dd155d260034",
    "content": "Low probability: D-Dimer test is recommended. Moderate or High Probability: D-Dimer test with additional CT Pulmonary angiogram is rec- ommended. investigations\nChest X-ray\nECG\nD-Dimer\nCT Pulmonary angiogram\nEchocardiography\nDoppler Ultrasound of the affected limb and pelvis\nFBC.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "549",
    "type": "section",
    "keywords": [
      "angiogram",
      "ultrasound",
      "moderate",
      "test",
      "recommended",
      "echocardiography",
      "chest",
      "limb",
      "affected",
      "doppler",
      "pulmonary",
      "pelvis",
      "ommended",
      "high",
      "probability",
      "dimer",
      "investigations",
      "additional"
    ]
  },
  {
    "id": "4a616e57943ddeb69244813b628543a1",
    "content": "To stabilise cardio-respiratory function\nTo prevent further clot formation and embolisation\nTo prevent recurrence and development of pulmonary hypertension.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "550",
    "type": "section",
    "keywords": [
      "hypertension",
      "clot",
      "recurrence",
      "cardio",
      "prevent",
      "function",
      "stabilise",
      "formation",
      "development",
      "pulmonary",
      "further",
      "respiratory",
      "embolisation"
    ]
  },
  {
    "id": "07bc4b4ea099d18b8e2b7d81249c25a6",
    "content": "Elevate affected leg on a pillow if DVT present\nApply compression stockings - after pain subsides if DVT present\nSurgical techniques e. g. embolectomy, inferior vena caval filters etc.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "551",
    "type": "section",
    "keywords": [
      "subsides",
      "vena",
      "techniques",
      "stockings",
      "pain",
      "present",
      "surgical",
      "pillow",
      "affected",
      "filters",
      "embolectomy",
      "compression",
      "after",
      "inferior",
      "apply",
      "elevate",
      "caval"
    ]
  },
  {
    "id": "6c98a86c011d536347a9db56ba98a71a",
    "content": "Oxygen, by face mask or nasal prongs or via non-rebreather mask\n(keep oxygen saturation > 95%)\nAnd\nMorphine, IV, 5-10 mg stat. And\nEnoxaparin, SC,\nAdults\n1. 5 mg/kg (150 units/kg) daily\nOr\nDalteparin, SC,\nAdult\n200 mg/kg (max.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "552",
    "type": "section",
    "keywords": [
      "morphine",
      "dalteparin",
      "oxygen",
      "units",
      "adult",
      "enoxaparin",
      "face",
      "keep",
      "saturation",
      "adults",
      "rebreather",
      "daily",
      "mask",
      "stat",
      "prongs",
      "nasal"
    ]
  },
  {
    "id": "3488904e4b18d47adcc01b8ba7d4c7c9",
    "content": "Warfarin, oral, simultaneously (NOT in pregnancy)\nAdults\nLoading Dose\nReferral Criteria\nRefer all patients with suspected pulmonary embolism, where facilities are unavailable for confirmation, to a physician specialist or cardiologist for expert management after stabilisation. A stroke can be defined as a sudden global or focal neurological deficit resulting from spontaneous haemorrhage or infarction of the central nervous system, with objective evidence of an infarction or haemorrhage, irrespective of the duration of clinical symptoms. A CT or MRI scan is required to make the diagnosis and exclude other intracranial lesions that could present similarly.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "553",
    "type": "section",
    "keywords": [
      "sudden",
      "loading",
      "haemorrhage",
      "intracranial",
      "lesions",
      "management",
      "confirmation",
      "required",
      "nervous",
      "evidence",
      "cardiologist",
      "focal",
      "specialist",
      "neurological",
      "facilities",
      "where",
      "warfarin",
      "patients",
      "pregnancy",
      "unavailable"
    ]
  },
  {
    "id": "93f9235593abd0575d9e90384c6cad8c",
    "content": "A Transient Ischaemic Attack (TIA), on the other hand, is a transient episode of neurologic dysfunction caused by focal brain, spinal cord, or retinal ischemia. There is no objective evidence of acute infarction in the affected region of brain or retina. In adults, hypertension, diabetes, dyslipidaemia, atrial fibrillation and smoking, increase the risk for strokes.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "554",
    "type": "section",
    "keywords": [
      "hypertension",
      "region",
      "dysfunction",
      "transient",
      "atrial",
      "spinal",
      "acute",
      "evidence",
      "increase",
      "focal",
      "attack",
      "dyslipidaemia",
      "retinal",
      "ischemia",
      "episode",
      "fibrillation",
      "hand",
      "objective",
      "caused",
      "strokes"
    ]
  },
  {
    "id": "6668c5fa33bcaf439c3beb014f5447b0",
    "content": "In children sickle cell disease and cyanotic heart disease are important risk factors for strokes.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "555",
    "type": "section",
    "keywords": [
      "disease",
      "important",
      "strokes",
      "cell",
      "sickle",
      "factors",
      "heart",
      "risk",
      "children",
      "cyanotic"
    ]
  },
  {
    "id": "397381b3d1e796db05bf284e555c609c",
    "content": "Causes\nCerebral infarction\nThrombosis of a cerebral vessel\nEmbolism from a distant site (e. g. atrial fibrillation)\nIntracerebral haemorrhage\nSubarachnoid haemorrhage.",
    "title": "Patients should ideally have multidisciplinary care.",
    "section": "Patients should ideally have multidisciplinary care.",
    "chunk_id": "556",
    "type": "section",
    "keywords": [
      "cerebral",
      "haemorrhage",
      "intracerebral",
      "thrombosis",
      "fibrillation",
      "site",
      "atrial",
      "embolism",
      "distant",
      "subarachnoid",
      "vessel",
      "infarction",
      "causes"
    ]
  },
  {
    "id": "8b2bfe4d9d779bbf0f1b8e5b17036b47",
    "content": "Symptoms\nWeakness of one side of the body including the face\nInability to rise up from a sitting or lying position\nSudden fall/collapse\nLoss of speech\nLoss of vision\nSevere headache and/or neck pain (subarachnoid haemorrhage)\nUnconsciousness in some patients\nSeizures\nSigns\nParalysis of a limb\nFacial paralysis (lower half)\nInitial flaccidity of limbs, but later spasticity and exaggerated reflexes\nHemianopia (loss of one-half of visual field)\nHemi-anaesthesia (loss of sensation of one-half of body)\nExtensor plantar response\nDysarthria/dysphasia (alteration of speech)\nNeck stiffness (in subarachnoid haemorrhage)\ninvestigations\nFBC, ESR\nBlood glucose\nSerum lipid profile\nBlood urea, electrolytes and creatinine\nUric acid\nECG\nCT scan/MRI of the head\nChest X-ray.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "557",
    "type": "section",
    "keywords": [
      "urea",
      "collapse",
      "initial",
      "sudden",
      "unconsciousness",
      "headache",
      "profile",
      "face",
      "seizures",
      "alteration",
      "glucose",
      "exaggerated",
      "position",
      "weakness",
      "paralysis",
      "neck",
      "speech",
      "creatinine",
      "body",
      "extensor"
    ]
  },
  {
    "id": "684754039e9b5452bf36dcf87327984a",
    "content": "To limit the area of brain damage\nTo protect patients from the dangers of unconsciousness and immobility\nTo prevent aspiration\nTo treat the underlying cause if possible\nTo identify and manage modifiable risk factors (hypertension, high cholesterol, diabetes mellitus etc. )\nTo institute measures to improve functional recovery\nTo support and rehabilitate patients who survive with residual\ndisability\nTo minimise adverse effects of drug therapy.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "558",
    "type": "section",
    "keywords": [
      "hypertension",
      "unconsciousness",
      "treat",
      "improve",
      "residual",
      "mellitus",
      "factors",
      "identify",
      "institute",
      "therapy",
      "measures",
      "aspiration",
      "support",
      "prevent",
      "functional",
      "drug",
      "dangers",
      "underlying",
      "cholesterol",
      "patients"
    ]
  },
  {
    "id": "c07cb892999cd7701df2ced3d7359b2e",
    "content": "Admit and monitor patient`s vital signs and neurological signs frequently (4 hourly).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "559",
    "type": "section",
    "keywords": [
      "hourly",
      "admit",
      "neurological",
      "monitor",
      "signs",
      "frequently",
      "vital",
      "patient"
    ]
  },
  {
    "id": "ea522067bf9ea7268453db6e01b05ace",
    "content": "Establish adequate airway in unconscious patients\nSwallowing test in an upright position (use 10-15ml of water)\nInsert nasogastric tube as early as possible for feeding and medications in unconscious patients or those with swallowing difficulties to prevent aspiration\nNurse in the lateral position with suctioning where necessary\nElevate head of bed to 30 degrees to reduce intracranial\npressure\nPrevent pressure sores by regular turning (every 2 hours) in bed\nMaintain adequate hydration\nKeep patient clean and dry by frequent use of bedpan/urine pot, diapers, condom catheter as required. Urethral catheter should be used only if absolutely necessary\nStart physiotherapy as soon as practicable.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "560",
    "type": "section",
    "keywords": [
      "urethral",
      "test",
      "practicable",
      "intracranial",
      "regular",
      "sores",
      "catheter",
      "unconscious",
      "feeding",
      "urine",
      "required",
      "position",
      "difficulties",
      "swallowing",
      "patient",
      "aspiration",
      "insert",
      "lateral",
      "condom",
      "pressure"
    ]
  },
  {
    "id": "4ea3c704115e22feda7ef6b215e8abba",
    "content": "Aspirin, oral,\nAdults\n300 mg stat. Then\n75 mg daily\nChildren\n16 years;\tsame as adult dose\n< 16 years;\tnot recommended\nAnd\nAtorvastatin, oral,\nAdults\n40-80 mg daily\nChildren\nNot recommended\nOr\nRosuvastatin, oral,\nAdults\n20-40 mg daily\nChildren\nNot recommended\nHaemorrhagic Stroke with evidence of cerebral oedema present.",
    "title": "infarctive Strokes and TiAs 1st Line Treatment Evidence Rating: [B]",
    "section": "infarctive Strokes and TiAs 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "561",
    "type": "section",
    "keywords": [
      "oedema",
      "years",
      "haemorrhagic",
      "evidence",
      "children",
      "stat",
      "atorvastatin",
      "adult",
      "adults",
      "same",
      "dose",
      "aspirin",
      "then",
      "stroke",
      "cerebral",
      "recommended",
      "present",
      "oral",
      "rosuvastatin",
      "daily"
    ]
  },
  {
    "id": "6eeb95e18af680524167671f2880387b",
    "content": "Mannitol, IV,\nAdults\n0. 5-1 g/kg 6 hourly (up to 2 g/kg per dose).",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "562",
    "type": "section",
    "keywords": [
      "hourly",
      "mannitol",
      "adults",
      "dose"
    ]
  },
  {
    "id": "c6c97a909267a815b0d4d9e39998007b",
    "content": "Control of co-morbidities (e. g. hypertension, diabetes etc.",
    "title": "(See treatment flowchart for acute medical management of stroke below)",
    "section": "(See treatment flowchart for acute medical management of stroke below)",
    "chunk_id": "563",
    "type": "section",
    "keywords": [
      "control",
      "diabetes",
      "hypertension",
      "morbidities"
    ]
  },
  {
    "id": "82cdde1a797c76d1b8ae52d70b252a91",
    "content": ")\n(See appropriate sections)\nReferral Criteria\nPatients with worsening symptoms and signs should be urgently referred for specialist evaluation and care. All stable patients with neurological deficits should be referred to a speech therapist, occupational therapist or physiotherapist as appropriate. Flowchart.",
    "title": "(See treatment flowchart for acute medical management of stroke below)",
    "section": "(See treatment flowchart for acute medical management of stroke below)",
    "chunk_id": "564",
    "type": "section",
    "keywords": [
      "physiotherapist",
      "deficits",
      "stable",
      "speech",
      "specialist",
      "evaluation",
      "neurological",
      "occupational",
      "signs",
      "patients",
      "criteria",
      "sections",
      "referral",
      "worsening",
      "urgently",
      "therapist",
      "should",
      "referred",
      "symptoms",
      "appropriate"
    ]
  },
  {
    "id": "ff73965122786f72d0cc73444b32ae33",
    "content": "This is a condition in which the heart is unable to produce adequate cardiac output, and in so doing, is unable to meet the body’s metabolic requirements. The cardiac dysfunction may predominantly involve the left or the right ventricle individually or both ventricles simultaneously. This later case is termed Biventricular Failure (BVF) or Congestive Cardiac Failure (CCF).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "565",
    "type": "section",
    "keywords": [
      "individually",
      "dysfunction",
      "both",
      "which",
      "ventricles",
      "body",
      "right",
      "doing",
      "heart",
      "condition",
      "termed",
      "biventricular",
      "unable",
      "later",
      "predominantly",
      "produce",
      "ventricle",
      "requirements",
      "meet",
      "failure"
    ]
  },
  {
    "id": "103aaaa59445b5e821e255ac6d8ee47d",
    "content": "The functional classification of heart failure using the New York Heart Association (NYHA) Classification is described in the table below. Causes\nSystemic arterial hypertension.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "566",
    "type": "section",
    "keywords": [
      "hypertension",
      "york",
      "using",
      "described",
      "below",
      "association",
      "functional",
      "classification",
      "arterial",
      "nyha",
      "systemic",
      "heart",
      "table",
      "failure",
      "causes"
    ]
  },
  {
    "id": "8f9a8d5a7bb7ab1cee85c5bcb27626bc",
    "content": "Pulmonary arterial hypertension\nCardiac arrhythmia\nSymptoms\nLeft Heart Failure\nBreathlessness\nOn exertion\nOn lying flat (orthopnoea)\nAt night (paroxysmal nocturnal dyspnoea)\nEasy fatiguability\nCough with frothy blood-stained sputum\nWheezing\nRight Heart Failure\nSwelling of the feet and lower extremities (may be absent in children below 6 months)\nAbdominal swelling.",
    "title": "Congenital heart disease",
    "section": "Congenital heart disease",
    "chunk_id": "567",
    "type": "section",
    "keywords": [
      "hypertension",
      "extremities",
      "paroxysmal",
      "exertion",
      "absent",
      "swelling",
      "nocturnal",
      "stained",
      "night",
      "sputum",
      "dyspnoea",
      "abdominal",
      "right",
      "heart",
      "easy",
      "children",
      "blood",
      "frothy",
      "pulmonary",
      "arterial"
    ]
  },
  {
    "id": "8ed802d20ff2a83bb9ab29b9823242cf",
    "content": "Right hypochondrial pain from an enlarging liver\nSigns\nLeft Heart Failure\nTachypnoea\nTachycardia\nBasal crepitations\nGallop rhythm\nDisplaced apex beat\nCardiac murmur\nRhonchi\nRight Heart Failure\nTachycardia\nPitting pedal oedema (may be absent in children below 6 months)\nAscites\nTender, smooth, soft hepatomegaly\nRaised jugular venous pressure\nGallop rhythm\nCardiac murmur\nIn children\nFailure to thrive\nDifficulty in feeding\ninvestigations\nFBC\nECG\nChest X-ray\nBlood urea, electrolytes and creatinine and eGFR (estimated glomerular filtration rate)\nLiver function test\nFasting blood sugar\nFasting lipids\nEchocardiography\nThyroid function tests\nCardiac enzymes, if myocardial infarction is suspected\nCoronary angiography.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "568",
    "type": "section",
    "keywords": [
      "test",
      "oedema",
      "rhythm",
      "hepatomegaly",
      "venous",
      "echocardiography",
      "estimated",
      "beat",
      "absent",
      "feeding",
      "angiography",
      "thrive",
      "tachycardia",
      "tachypnoea",
      "jugular",
      "lipids",
      "murmur",
      "creatinine",
      "rate",
      "pressure"
    ]
  },
  {
    "id": "ceccead0fb165aab3bd7c009c1289f6e",
    "content": "To relieve symptoms and improve quality of life\nTo treat the precipitating cause\nTo treat complications\nTo prevent recurrence of symptoms\nTo reduce need for hospital re-admissions\nTo reduce mortality.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "569",
    "type": "section",
    "keywords": [
      "complications",
      "precipitating",
      "hospital",
      "treat",
      "recurrence",
      "improve",
      "prevent",
      "quality",
      "reduce",
      "life",
      "cause",
      "relieve",
      "need",
      "admissions",
      "symptoms",
      "mortality"
    ]
  },
  {
    "id": "e90933f163cd90d1877ba5b6674de41c",
    "content": "Reduce weight in overweight and obese individuals\nAvoid alcohol\nAvoid or quit smoking\nEncourage moderate exercise\nBed rest (only in acute heart failure or exacerbations of chronic heart failure)\nProp up in bed.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "570",
    "type": "section",
    "keywords": [
      "obese",
      "avoid",
      "overweight",
      "weight",
      "exercise",
      "acute",
      "moderate",
      "exacerbations",
      "alcohol",
      "heart",
      "quit",
      "chronic",
      "only",
      "rest",
      "failure",
      "smoking",
      "reduce",
      "individuals",
      "encourage",
      "prop"
    ]
  },
  {
    "id": "555f2943b8f7ea8b9b281fb3944da7e8",
    "content": "Oxygen, by nasal cannula or face mask if there is hypoxaemia (SpO2\n< 90%)\nAnd\nFurosemide, IV,\nAdults\n40-80 mg, repeat after 30 minutes if necessary\nChildren\n12-18 years;\t20-40 mg repeated 8 hourly as necessary\n1 month-12 years;\t0. 5-1 mg/kg repeated 8 hourly (max 4 mg/ kg/dose).",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "571",
    "type": "section",
    "keywords": [
      "years",
      "face",
      "repeated",
      "hourly",
      "oxygen",
      "minutes",
      "repeat",
      "children",
      "hypoxaemia",
      "cannula",
      "adults",
      "there",
      "dose",
      "month",
      "nasal",
      "furosemide",
      "necessary",
      "after",
      "mask"
    ]
  },
  {
    "id": "2b05d6d175e577beef0dcceeb00b4796",
    "content": "Furosemide, IV,\nAdults\n40-80 mg 12 hourly\nChildren\n12-18 years;\t20-40 mg repeated 8 hourly as necessary\n1 month-12 years;\t0. 5-1 mg/kg repeated 8 hourly (max 4 mg/ kg/dose).",
    "title": "Acute heart failure - maintenance treatment after stabilisation",
    "section": "Acute heart failure - maintenance treatment after stabilisation",
    "chunk_id": "572",
    "type": "section",
    "keywords": [
      "furosemide",
      "hourly",
      "years",
      "adults",
      "necessary",
      "dose",
      "month",
      "children",
      "repeated"
    ]
  },
  {
    "id": "ef1769b794fb21ab2b4f37e7b1230e6b",
    "content": "Furosemide (Frusemide), IV,\nAdults\n40-80 mg 12 hourly\nChildren\n12-18 years;\t20-40 mg repeated 8 hourly as necessary\n1 month-12 years;\t0. 5-1 mg/kg repeated 8 hourly (max 4 mg/ kg/dose)\nAnd\nMorphine, IV,\nAdults\n5-10 mg slowly\nChildren\nNot recommended for this condition as safety is not well established\nAnd.",
    "title": "Acute heart failure - patient not improving after initial treatment",
    "section": "Acute heart failure - patient not improving after initial treatment",
    "chunk_id": "573",
    "type": "section",
    "keywords": [
      "furosemide",
      "hourly",
      "morphine",
      "recommended",
      "years",
      "adults",
      "necessary",
      "condition",
      "dose",
      "safety",
      "month",
      "children",
      "repeated",
      "established",
      "slowly",
      "frusemide"
    ]
  },
  {
    "id": "5840d4b8542f4389462c0bcd4b985aad",
    "content": "Metoclopramide, IV,\nAdults\n10 mg to prevent vomiting\nChildren\nNot required.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "574",
    "type": "section",
    "keywords": [
      "vomiting",
      "metoclopramide",
      "prevent",
      "adults",
      "required",
      "children"
    ]
  },
  {
    "id": "f06b10f48198c789769408613d488921",
    "content": "Furosemide, oral,\nAdults\n40-80 mg 12 hourly\nChildren\n0. 5-2 mg/kg 8-12 hourly\nAcute heart failure - patient with fast atrial fibrillation or in sinus\nrhythm with systolic dysfunction\nEvidence Rating: [C]\nDigoxin, oral,\nElderly\n125 micrograms 12 hourly for 24-48 hours\nAdults\n250 micrograms 12 hourly for 24-48 hours\nThen\n250 micrograms daily\nThen\n125 micrograms daily\nChildren > 10 years\n0. 5-1 mg in 3 divided doses over 24 hours\nThen\n62.",
    "title": "Acute heart failure - patient improving after initial treatment",
    "section": "Acute heart failure - patient improving after initial treatment",
    "chunk_id": "575",
    "type": "section",
    "keywords": [
      "rhythm",
      "years",
      "dysfunction",
      "atrial",
      "elderly",
      "acute",
      "evidence",
      "patient",
      "hourly",
      "rating",
      "digoxin",
      "systolic",
      "doses",
      "heart",
      "children",
      "sinus",
      "fibrillation",
      "adults",
      "failure",
      "then"
    ]
  },
  {
    "id": "8d0026a5fc65ee8a972fdfd507021fa4",
    "content": "5-250 microgram daily\nChildren 2-10 years\n20-30 microgram/kg in 3 divided doses over 24 hours\nThen\n8-10 microgram/kg daily\nChildren < 2 years\n30-40 microgram/kg in 3 divided doses over 24 hours\nThen\n10-12 microgram /kg daily\nNeonates (full term)\n20 microgram/kg in 3 divided doses in 24 hours\nThen\n8-10 microgram/kg daily\nNeonates ( < 1. 5 kg)\n25 microgram/kg in 3 divided doses in 24 hours Premature\n15 microgram/kg daily\nThen\n5 microgram/kg daily.",
    "title": "Acute heart failure - patient improving after initial treatment",
    "section": "Acute heart failure - patient improving after initial treatment",
    "chunk_id": "576",
    "type": "section",
    "keywords": [
      "term",
      "years",
      "then",
      "microgram",
      "neonates",
      "doses",
      "premature",
      "full",
      "children",
      "hours",
      "divided",
      "daily"
    ]
  },
  {
    "id": "606ac8619522666d527e52130cbdffa1",
    "content": "Acute heart failure - patients in cardiogenic shock (adult systolic blood pressure <85 mmHg) with hypotension and or hypoperfusion\nDobutamine, IV infusion,\nAdults\n2. 5-10 micrograms/kg per minute\nProphylactic anticoagulation against venous thrombosis\nEnoxaparin, SC,\nAdults\n1. 5 mg/kg (150 units/kg) daily\nChildren\n2 months-18 years;\t1 mg/kg 12 hourly\n1-2 months;\t1.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "577",
    "type": "section",
    "keywords": [
      "venous",
      "units",
      "years",
      "infusion",
      "enoxaparin",
      "dobutamine",
      "acute",
      "hourly",
      "pressure",
      "systolic",
      "anticoagulation",
      "hypoperfusion",
      "heart",
      "patients",
      "children",
      "daily",
      "blood",
      "against",
      "adult",
      "shock"
    ]
  },
  {
    "id": "affbbd1a3e84519a637cea9cd6aaccbe",
    "content": "5 mg/kg 12 hourly\nNeonates;\t1. 5-2 mg/kg 12 hourly\nIdentify and treat (if possible) precipitating causes such as hypertension, myocardial infarction, anaemia or thyrotoxicosis\nSymptomatic Heart Failure.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "578",
    "type": "section",
    "keywords": [
      "hypertension",
      "hourly",
      "thyrotoxicosis",
      "precipitating",
      "treat",
      "neonates",
      "myocardial",
      "anaemia",
      "possible",
      "heart",
      "identify",
      "symptomatic",
      "failure",
      "causes",
      "infarction"
    ]
  },
  {
    "id": "ac52b6f3e951e72c6a6b94e815da04ac",
    "content": "Furosemide, oral, Evidence Rating: [C] Adults\n40-80 mg daily\nChildren\n1-2 mg/kg daily\nAnd\nLisinopril, oral,\n(only when systolic blood pressure > 100 mmHg) Evidence Rating: [A]\nAdults\n2. 5-20 mg daily\nOr\nRamipril, oral,\n(only when systolic blood pressure > 100 mmHg ) Evidence Rating: [A]\nAdults\n2. 5-10 mg daily\nAnd\nCarvedilol, oral, Evidence Rating: [A] Adults\n3.",
    "title": "1st Line Treatment",
    "section": "1st Line Treatment",
    "chunk_id": "579",
    "type": "section",
    "keywords": [
      "furosemide",
      "rating",
      "lisinopril",
      "pressure",
      "blood",
      "systolic",
      "carvedilol",
      "adults",
      "ramipril",
      "oral",
      "only",
      "mmhg",
      "children",
      "evidence",
      "daily"
    ]
  },
  {
    "id": "bb01ee3eab729e08f9b2dbf3c7c1a464",
    "content": "Or\nBisoprolol, oral,\nEvidence Rating: [A]\nAdults\n1. 25-10 mg daily\nOr\nMetoprolol, oral, Evidence Rating: [A] Adults\n25-100 mg daily\ni. Patients not tolerating ACE inhibitors (replace Lisinopril or.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "580",
    "type": "section",
    "keywords": [
      "replace",
      "rating",
      "lisinopril",
      "tolerating",
      "metoprolol",
      "adults",
      "bisoprolol",
      "oral",
      "patients",
      "inhibitors",
      "evidence",
      "daily"
    ]
  },
  {
    "id": "ac317ba72ba1d82cb458b9f9d1e22de9",
    "content": "Losartan, oral, Evidence Rating: [A] Adults\n25-50 mg daily\nOr\nCandesartan, oral, Evidence Rating: [A] Adults\n4-16 mg daily\nPatients with fast atrial fibrillation or in sinus rhythm with systolic\ndysfunction;\nAdd\nDigoxin, oral,\nEvidence Rating: [B]\nElderly\n125 micrograms 12 hourly for 24-48 hours,\nThen\n125 micrograms 24 hourly\nAdults\n250 micrograms 12 hourly for 24-48 hours,\nThen\n250 micrograms once daily\nChildren\n5 micrograms/kg 12 hourly\nSymptomatic patients, inspite of the above medications And\nSpironolactone, oral,\nEvidence Rating: [A]\nAdults\n25-50 mg daily\nReferral\nAll patients must be referred to a specialist when clinically stable.",
    "title": "Ramipril with the following in the 1st line treatment above)",
    "section": "Ramipril with the following in the 1st line treatment above)",
    "chunk_id": "581",
    "type": "section",
    "keywords": [
      "rhythm",
      "inspite",
      "dysfunction",
      "atrial",
      "elderly",
      "evidence",
      "stable",
      "hourly",
      "rating",
      "digoxin",
      "specialist",
      "candesartan",
      "systolic",
      "spironolactone",
      "patients",
      "children",
      "sinus",
      "fibrillation",
      "above",
      "referral"
    ]
  },
  {
    "id": "fc48dba973020afce68e7d2d0b8c212e",
    "content": "for the identification and treatment of the underlying cause of the heart failure and for long-term maintenance therapy. Flowchart\nCongenital malformation of the heart, commonly referred to as “Hole-in-Heart”, is quite a common malformation with an incidence of 8 out of 1000 live births. There are two main groups of congenital heart disease namely, acyanotic and cyanotic.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "582",
    "type": "section",
    "keywords": [
      "namely",
      "live",
      "maintenance",
      "therapy",
      "malformation",
      "underlying",
      "heart",
      "cyanotic",
      "treatment",
      "congenital",
      "disease",
      "incidence",
      "cause",
      "there",
      "groups",
      "failure",
      "referred",
      "births",
      "commonly",
      "main"
    ]
  },
  {
    "id": "81497d1c5bca017e9e02ab45cec7dd1e",
    "content": "The acyanotic types include ventricular septal defect, atrial septal defect, patent ductus arteriosus as well as aortic stenosis, pulmonary stenosis and coarctation of the aorta. The cyanotic types are associated with a mixing of deoxygenated blood with oxygenated blood and include Tetralogy of Fallot (TOF) and Transposition of the Great Arteries (TGA). Early recognition of the specific type and appropriate medical or surgical intervention is important in improving the quality of life and reducing morbidity from complications.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "583",
    "type": "section",
    "keywords": [
      "types",
      "oxygenated",
      "arteries",
      "intervention",
      "important",
      "morbidity",
      "quality",
      "deoxygenated",
      "ventricular",
      "atrial",
      "associated",
      "aortic",
      "aorta",
      "type",
      "great",
      "arteriosus",
      "specific",
      "recognition",
      "coarctation",
      "patent"
    ]
  },
  {
    "id": "3f30f72027be1f4da4eca4f9822c88c6",
    "content": "Causes\nIdiopathic\nGenetic (higher risk with increasing maternal age).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "584",
    "type": "section",
    "keywords": [
      "higher",
      "genetic",
      "maternal",
      "idiopathic",
      "risk",
      "increasing",
      "causes"
    ]
  },
  {
    "id": "f01c9a6ae10351d0a4032b5cb10ed8ef",
    "content": "Maternal infections due to viruses in early pregnancy, notably rubella\nMaternal diabetes\nAlcohol, smoking, and use of drugs during early pregnancy\nExposure to X-rays and other radiation during early pregnancy\nPrematurity\nMultiple pregnancy\nSymptoms Acyanotic\nEasy fatiguability\nBreathlessness\nPoor feeding/Interruption of sucking in babies during feeding\nPoor growth\nCold sweat on forehead\nPuffy eyelids, swollen feet (however, these are uncommon in infants)\nDistended abdomen\nExertion may lead to chest pains, syncope or sudden death\nCyanotic.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "585",
    "type": "section",
    "keywords": [
      "infections",
      "notably",
      "sudden",
      "exertion",
      "during",
      "lead",
      "syncope",
      "feeding",
      "radiation",
      "poor",
      "death",
      "distended",
      "eyelids",
      "prematurity",
      "babies",
      "sweat",
      "multiple",
      "chest",
      "alcohol",
      "growth"
    ]
  },
  {
    "id": "ad5d4cbf2ea43437db15b593ff616c4a",
    "content": "Blue tongue and fingernails (cyanosis) at birth or becoming worse with exertion in older children\nSquatting several times during play in toddlers\nSigns\nAcyanotic\nSigns of heart failure for moderate to severe lesions:\nCold sweaty skin\nPuffy eyelids\nDistended neck veins and ankle oedema (in\nolder children)\nTachycardia\nTachypnoea\nWeak thready pulse\nCardiomegaly\nGallop rhythm\nCrepitations, rhonchi\nHepatomegaly\nHeart murmur (not always present)\nCyanotic\nSigns of heart failure as above, plus\nFinger clubbing\nCyanosis (low peripheral oxygen saturation measured by pulse oximetry)\nHeart murmur\nHypercyanotic attack i. e. respiratory distress with deepening cyanosis, loss of consciousness and convulsions.",
    "title": "All symptoms of acyanotic heart disease, plus the following:",
    "section": "All symptoms of acyanotic heart disease, plus the following:",
    "chunk_id": "586",
    "type": "section",
    "keywords": [
      "veins",
      "oedema",
      "rhythm",
      "hepatomegaly",
      "lesions",
      "exertion",
      "during",
      "becoming",
      "times",
      "cyanosis",
      "tachycardia",
      "distended",
      "tachypnoea",
      "eyelids",
      "neck",
      "worse",
      "murmur",
      "always",
      "moderate",
      "deepening"
    ]
  },
  {
    "id": "de776074f0626d6098828323bcc7846a",
    "content": "investigations\nFBC\nChest X-ray\nECG\nEchocardiography.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "587",
    "type": "section",
    "keywords": [
      "echocardiography",
      "chest",
      "investigations"
    ]
  },
  {
    "id": "200b6198a6eaab3d5d7dd1e651f98cf1",
    "content": "Early surgical correction if indicated\nPrevention of endocarditis.",
    "title": "Prompt treatment of heart failure",
    "section": "Prompt treatment of heart failure",
    "chunk_id": "588",
    "type": "section",
    "keywords": [
      "surgical",
      "prevention",
      "endocarditis",
      "early",
      "indicated",
      "correction"
    ]
  },
  {
    "id": "dc16a5f615f767ab8c2f92a5429e64c8",
    "content": "Ensure good nutrition, good oral and dental hygiene\nAvoid excessive physical exertion (notify parents and teachers).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "589",
    "type": "section",
    "keywords": [
      "avoid",
      "nutrition",
      "hygiene",
      "dental",
      "ensure",
      "notify",
      "physical",
      "exertion",
      "teachers",
      "oral",
      "parents",
      "excessive"
    ]
  },
  {
    "id": "5f1d15ab7d62b6113deac3db5f43b801",
    "content": "Evidence Rating: [C]\nOxygen, by face mask or nasal prongs, 2 L/minute if available, (monitor oxygen saturation).",
    "title": "Symptomatic congenital heart disease",
    "section": "Symptomatic congenital heart disease",
    "chunk_id": "590",
    "type": "section",
    "keywords": [
      "evidence",
      "rating",
      "oxygen",
      "minute",
      "monitor",
      "face",
      "saturation",
      "available",
      "mask",
      "prongs",
      "nasal"
    ]
  },
  {
    "id": "4354318ead2390e81ad7d5974d4efb2d",
    "content": "(See section on ‘Heart Failure’)\nTo improve blood flow into the lungs for patients with Tetralogy of\nFallot\nPropranolol, oral,\nChildren 1 month-12 years\n0. 25-1 mg/kg 6-8 hourly (max. 5 mg/kg daily)\nNeonates\n0.",
    "title": "Treatment of heart failure in symptomatic congenital heart disease",
    "section": "Treatment of heart failure in symptomatic congenital heart disease",
    "chunk_id": "591",
    "type": "section",
    "keywords": [
      "years",
      "neonates",
      "improve",
      "into",
      "hourly",
      "section",
      "heart",
      "patients",
      "children",
      "blood",
      "tetralogy",
      "month",
      "failure",
      "fallot",
      "flow",
      "propranolol",
      "oral",
      "lungs",
      "daily"
    ]
  },
  {
    "id": "a5441212692f4e4f6cca6c135a653b14",
    "content": "25-1 mg/kg 8-12hourly (max. 2mg/kg 8 hourly)\nPropranolol, slow IV with ECG monitoring,\nChildren 1 month - 12 years\n15-20 microgram/kg 6-8 hourly (max. 200 microgram/kg) repeated every 6-8 hours if necessary\nNeonates\n15-20 microgram/kg (max.",
    "title": "Treatment of heart failure in symptomatic congenital heart disease",
    "section": "Treatment of heart failure in symptomatic congenital heart disease",
    "chunk_id": "592",
    "type": "section",
    "keywords": [
      "hourly",
      "monitoring",
      "years",
      "microgram",
      "neonates",
      "propranolol",
      "necessary",
      "slow",
      "month",
      "children",
      "repeated",
      "hours",
      "every"
    ]
  },
  {
    "id": "d1cce27d918330c16bf6fab30e44ad55",
    "content": "100 microgram/kg) repeated every 12\nhours if necessary.",
    "title": "Treatment of heart failure in symptomatic congenital heart disease",
    "section": "Treatment of heart failure in symptomatic congenital heart disease",
    "chunk_id": "593",
    "type": "section",
    "keywords": [
      "microgram",
      "necessary",
      "repeated",
      "hours",
      "every"
    ]
  },
  {
    "id": "a9edd77f612bde8fcce56a1ae04d1c0c",
    "content": "Referral Criteria\nRefer all children with congenital heart disease to a paediatric cardiologist or paediatrician for further clinical assessment and management. This is a life threatening paediatric cardiac emergency. It usually occurs in infants with a peak incidence between 4 and 6 months.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "594",
    "type": "section",
    "keywords": [
      "usually",
      "management",
      "cardiologist",
      "paediatrician",
      "emergency",
      "heart",
      "children",
      "criteria",
      "peak",
      "congenital",
      "disease",
      "referral",
      "incidence",
      "infants",
      "further",
      "between",
      "occurs",
      "threatening",
      "months",
      "cardiac"
    ]
  },
  {
    "id": "2f7d0d2dfed2fa995fbe8e657a788d48",
    "content": "A severe episode may lead to limpness, seizures, cerebrovascular accident or even death. Spells may be brief (1-2 minutes) and self-correct or may progress to a severe, life-threatening episode. Prompt recognition by parents and medical staff is important.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "595",
    "type": "section",
    "keywords": [
      "important",
      "correct",
      "self",
      "seizures",
      "lead",
      "death",
      "staff",
      "cerebrovascular",
      "spells",
      "brief",
      "minutes",
      "limpness",
      "episode",
      "even",
      "recognition",
      "severe",
      "prompt",
      "progress",
      "threatening",
      "medical"
    ]
  },
  {
    "id": "3c14883a0d9808fc68ecc5a91cb523d2",
    "content": "The attack is often early in the morning with no apparent reason. It may be precipitated following a bath, by prolonged crying, defaecation, dehydration, febrile illness or induction of anaesthesia. Causes\nCongenital heart disease e.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "596",
    "type": "section",
    "keywords": [
      "prolonged",
      "often",
      "morning",
      "crying",
      "apparent",
      "attack",
      "following",
      "precipitated",
      "heart",
      "induction",
      "causes",
      "congenital",
      "disease",
      "dehydration",
      "febrile",
      "reason",
      "defaecation",
      "anaesthesia",
      "bath",
      "early"
    ]
  },
  {
    "id": "90d9f75e5e9285f59d2b8cf8f8209fd5",
    "content": "g. Tetralogy of Fallot, pulmonary stenosis, double outlet right ventricle, tricuspid atresia, Eisenmenger syndrome\nSymptoms\nIrritability and prolonged crying\nDeep rapid breathing\nIncreased severity of cyanosis\nSigns\nTachycardia\nSystolic murmur\nComa\nConvulsions\nHemiparesis\ninvestigations\nFBC\nChest X-ray\nECG\nEchocardiography.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "597",
    "type": "section",
    "keywords": [
      "atresia",
      "prolonged",
      "echocardiography",
      "hemiparesis",
      "breathing",
      "cyanosis",
      "tachycardia",
      "crying",
      "murmur",
      "eisenmenger",
      "chest",
      "systolic",
      "right",
      "tricuspid",
      "double",
      "convulsions",
      "signs",
      "irritability",
      "tetralogy",
      "deep"
    ]
  },
  {
    "id": "d62d168cf7dba23b980f05677dd32402",
    "content": "To recognise the problem early\nTo reverse obstruction\nTo correct metabolic derangement in severe hypoxia\nTo prevent complications and death from severe hypoxia.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "598",
    "type": "section",
    "keywords": [
      "severe",
      "complications",
      "correct",
      "prevent",
      "early",
      "hypoxia",
      "recognise",
      "derangement",
      "obstruction",
      "reverse",
      "problem",
      "death",
      "metabolic"
    ]
  },
  {
    "id": "f32655ba0f46a8ede8b63627a96b9f75",
    "content": "The above actions increase peripheral vascular resistance and help to reduce cyanosis.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "599",
    "type": "section",
    "keywords": [
      "actions",
      "above",
      "resistance",
      "vascular",
      "peripheral",
      "reduce",
      "help",
      "cyanosis",
      "increase"
    ]
  },
  {
    "id": "02a6ee43bc0dc3b39ce973e381fcaf86",
    "content": "All children with hypercyanotic attack\nEvidence Rating: [C]\nOxygen (100%), by face mask or nasal prongs,\n2 L/minute (monitoring oxygen saturation if possible)-to all patients to reduce hypoxia\nAnd\n0. 9% Normal Saline or Ringers’ Lactate, IV, 10 ml/kg, over 30 minutes\nthen assess response\nAnd\nMorphine sulphate, slow IV (preferred), or IM, if IV line not accessi- ble, 100-200 micrograms/kg stat. For patients with poor response to above measures, Add\nPropranolol, oral,\nChildren 1 month-12 years\n500 microgram/kg 8 hourly (max.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "600",
    "type": "section",
    "keywords": [
      "sulphate",
      "monitoring",
      "years",
      "face",
      "poor",
      "evidence",
      "measures",
      "accessi",
      "hourly",
      "rating",
      "oxygen",
      "attack",
      "minutes",
      "saline",
      "assess",
      "patients",
      "children",
      "stat",
      "above",
      "line"
    ]
  },
  {
    "id": "f79674e1472e0814897c3cad50d5809d",
    "content": "5 mg/kg daily)\nNeonates\n500 microgram/kg 8 hourly (max. 2 mg/kg 8 hourly)\nTo correct acidosis in cyanotic patients with no improvement after 10 minutes of above treatment, Add\nSodium Bicarbonate, IV,\nFor all age groups 1-2 mmol/kg.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "601",
    "type": "section",
    "keywords": [
      "hourly",
      "mmol",
      "above",
      "correct",
      "microgram",
      "neonates",
      "minutes",
      "acidosis",
      "sodium",
      "groups",
      "patients",
      "after",
      "bicarbonate",
      "cyanotic",
      "treatment",
      "daily",
      "improvement"
    ]
  },
  {
    "id": "eedfe82f3d497aed40f3978571d5af5a",
    "content": "surgery\nPropranolol, oral,\nChildren 1 month-12 years\n0. 25-1 mg/kg 6-8 hourly (max. 5 mg/kg daily)\nNeonates\n0.",
    "title": "Maintenance treatment to prevent recurrent attacks pending",
    "section": "Maintenance treatment to prevent recurrent attacks pending",
    "chunk_id": "602",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "neonates",
      "propranolol",
      "oral",
      "month",
      "children",
      "surgery",
      "daily"
    ]
  },
  {
    "id": "5f4e450940c176946f50f41097b4d8b5",
    "content": "25-1 mg/kg 8-12 hourly (max. 2 mg/kg 8 hourly)\nPropranolol, slow IV with ECG monitoring,\nChildren 1 month-12 years\n15-20 microgram/kg 6-8 hourly (max. 200 microgram/kg) repeated every 6-8 hours if necessary\nNeonates\n15-20 microgram/kg (max.",
    "title": "Maintenance treatment to prevent recurrent attacks pending",
    "section": "Maintenance treatment to prevent recurrent attacks pending",
    "chunk_id": "603",
    "type": "section",
    "keywords": [
      "hourly",
      "monitoring",
      "years",
      "microgram",
      "neonates",
      "propranolol",
      "necessary",
      "slow",
      "month",
      "children",
      "repeated",
      "hours",
      "every"
    ]
  },
  {
    "id": "d1cce27d918330c16bf6fab30e44ad55",
    "content": "100 microgram/kg) repeated every 12\nhours if necessary.",
    "title": "Maintenance treatment to prevent recurrent attacks pending",
    "section": "Maintenance treatment to prevent recurrent attacks pending",
    "chunk_id": "604",
    "type": "section",
    "keywords": [
      "microgram",
      "necessary",
      "repeated",
      "hours",
      "every"
    ]
  },
  {
    "id": "d5a1aa7d189cc42afd05bf7354a97300",
    "content": "Referral Criteria\nHypercyanotic attack is an indication for early surgery. Refer urgently to a paediatric specialist or cardiothoracic surgeon\nPericarditis is inflammation of the pericardium. It may be dry, fibrinous, effusive or constrictive.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "605",
    "type": "section",
    "keywords": [
      "constrictive",
      "pericardium",
      "specialist",
      "attack",
      "inflammation",
      "indication",
      "criteria",
      "fibrinous",
      "cardiothoracic",
      "referral",
      "urgently",
      "effusive",
      "hypercyanotic",
      "pericarditis",
      "paediatric",
      "early",
      "refer",
      "surgeon",
      "surgery"
    ]
  },
  {
    "id": "40cc0b23839d9ca05aaf9da51f06f29c",
    "content": "It may be acute or chronic (>3 months). Causes\nViral\nBacterial\nTuberculous\nFungal\nRheumatic fever\nPost-cardiotomy\nPostmyocardial infarction\nUraemia.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "606",
    "type": "section",
    "keywords": [
      "post",
      "uraemia",
      "chronic",
      "rheumatic",
      "postmyocardial",
      "fungal",
      "infarction",
      "cardiotomy",
      "bacterial",
      "fever",
      "tuberculous",
      "months",
      "acute",
      "causes",
      "viral"
    ]
  },
  {
    "id": "2333e213241c4ef46b784bf26215a177",
    "content": "Symptoms\nRetrosternal or left precordial chest pain (worsens with lying down and improves with sitting and leaning forward)\nPalpitation\nFatigue\nSigns\nFever\nMalaise\nMyalgia\nPericardial friction rub\nFast and regular heart rate\nDistant heart sounds (if there is a large effusion)\ninvestigations\nFBC and ESR\nASO titre\n12-lead ECG\nChest X-ray\nEchocardiogram\nChest CT scan.",
    "title": "Autoimmune diseases",
    "section": "Autoimmune diseases",
    "chunk_id": "607",
    "type": "section",
    "keywords": [
      "regular",
      "retrosternal",
      "down",
      "fatigue",
      "lead",
      "palpitation",
      "leaning",
      "precordial",
      "rate",
      "chest",
      "large",
      "pericardial",
      "signs",
      "heart",
      "myalgia",
      "titre",
      "fever",
      "there",
      "forward",
      "investigations"
    ]
  },
  {
    "id": "b1a61e78af14bbad9a6e78bc726c1aa0",
    "content": "To relieve pain\nTo treat underlying cause\nTo prevent cardiac tamponade.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "608",
    "type": "section",
    "keywords": [
      "pain",
      "treat",
      "prevent",
      "cause",
      "relieve",
      "underlying",
      "tamponade",
      "cardiac"
    ]
  },
  {
    "id": "798982db49f8fd138a421bf60da21d80",
    "content": "Bed rest\nPericardiocentesis (indicated when there is cardiac tamponade, large or symptomatic pericardial effusion). Evidence Rating: [B].",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "609",
    "type": "section",
    "keywords": [
      "effusion",
      "evidence",
      "rating",
      "large",
      "pericardial",
      "symptomatic",
      "there",
      "indicated",
      "rest",
      "tamponade",
      "pericardiocentesis",
      "cardiac"
    ]
  },
  {
    "id": "672ebcf535872ad7a490daab15a823cd",
    "content": "Ibuprofen, oral,\nAdults\n300-800 mg 6-8 hourly\nChildren\n7-18 years;\t200 mg 6-8 hourly\nyears;\t100 mg 6-8 hourly\n1-2 years;\t50 mg 6-8 hourly\n6-12 months;\t50 mg 8 hourly\nmonths;\t5 mg/kg 6-8 hourly\nAnd\nColchicine, oral,\nAdults\n0. 5 mg 12 hourly\nChildren\nNot recommended\nOr.",
    "title": "Acute pericarditis 1st Line Treatment Evidence Rating: [B]",
    "section": "Acute pericarditis 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "610",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "adults",
      "oral",
      "colchicine",
      "children",
      "months",
      "ibuprofen"
    ]
  },
  {
    "id": "82554aa814d28c5f9f38c1d2bc1129b4",
    "content": "Adults\n40 mg daily for 14 days and taper off\nChildren\n2 mg/kg daily for 14 days and taper off.",
    "title": "Prednisolone, oral, (restricted to connective tissue diseases and uraemic pericarditis)",
    "section": "Prednisolone, oral, (restricted to connective tissue diseases and uraemic pericarditis)",
    "chunk_id": "611",
    "type": "section",
    "keywords": [
      "days",
      "adults",
      "children",
      "taper",
      "daily"
    ]
  },
  {
    "id": "9c787b03f804d4b1c6bbb3ec20d0a1fe",
    "content": "(See appropriate section)\nReferral Criteria\nRefer all patients to a Cardiologist for further evaluation after the inital treatment. Patients with large effusions or cardiac tamponade require urgent pericardiocentesis under echocardiographic guidance and they should be referred immediately. Hypertension or ‘high blood pressure’ carries an increased risk of early death from stroke, heart attack, heart failure and kidney failure if it is not detected early and properly controlled.",
    "title": "For treatment of underlying cause",
    "section": "For treatment of underlying cause",
    "chunk_id": "612",
    "type": "section",
    "keywords": [
      "hypertension",
      "inital",
      "tamponade",
      "death",
      "properly",
      "pericardiocentesis",
      "under",
      "cardiologist",
      "echocardiographic",
      "require",
      "pressure",
      "evaluation",
      "attack",
      "immediately",
      "detected",
      "large",
      "section",
      "heart",
      "patients",
      "guidance"
    ]
  },
  {
    "id": "2ffe3eeb66291646a5240cd905a6bdc8",
    "content": "Since there are often no specific symptoms associated with hypertension, there is the need for regular blood pressure (BP) screening in the adult population for early detection. In the general adult population, treatment must be initiated at a BP of 140/90 mmHg or higher for individuals below 60 years of age, and 150/90 mmHg or higher in those above 60 years. For individuals with diabetes mellitus or non-diabetics with Chronic Kidney Disease (CKD), treatment for hypertension must be initiated at a BP of 140/90 mmHg, irrespective of age.",
    "title": "be on when to initiate treatment, rather than how hypertension should be defined.",
    "section": "be on when to initiate treatment, rather than how hypertension should be defined.",
    "chunk_id": "613",
    "type": "section",
    "keywords": [
      "hypertension",
      "years",
      "often",
      "regular",
      "mellitus",
      "associated",
      "pressure",
      "population",
      "need",
      "specific",
      "screening",
      "blood",
      "treatment",
      "disease",
      "above",
      "chronic",
      "detection",
      "adult",
      "mmhg",
      "there"
    ]
  },
  {
    "id": "f8cf4e79736a24a90498525a437642cd",
    "content": "In the majority of patients with hypertension, no specific underlying cause is identified (primary hypertension). In these individuals, increasing age, family history, excess body weight, lack of physical activity and excessive alcohol intake may be possible predisposing factors. In about 10% of cases of hypertension, there may be an underlying kidney disease, endocrine disorder, renal artery stenosis or coarctation of the aorta (secondary hypertension).",
    "title": "be on when to initiate treatment, rather than how hypertension should be defined.",
    "section": "be on when to initiate treatment, rather than how hypertension should be defined.",
    "chunk_id": "614",
    "type": "section",
    "keywords": [
      "hypertension",
      "activity",
      "weight",
      "factors",
      "family",
      "artery",
      "secondary",
      "majority",
      "primary",
      "body",
      "aorta",
      "lack",
      "predisposing",
      "alcohol",
      "identified",
      "underlying",
      "specific",
      "patients",
      "intake",
      "renal"
    ]
  },
  {
    "id": "2355c6f6239bdb69d0e988e08d745feb",
    "content": "Once a diagnosis of hypertension is made, the individual should be evaluated to exclude secondary causes and to identify other existing cardiovascular risk factors e. g. diabetes, dyslipidaemia, hyperuricaemia, etc.",
    "title": "be on when to initiate treatment, rather than how hypertension should be defined.",
    "section": "be on when to initiate treatment, rather than how hypertension should be defined.",
    "chunk_id": "615",
    "type": "section",
    "keywords": [
      "hypertension",
      "factors",
      "identify",
      "hyperuricaemia",
      "secondary",
      "individual",
      "dyslipidaemia",
      "evaluated",
      "causes",
      "diagnosis",
      "should",
      "cardiovascular",
      "once",
      "made",
      "exclude",
      "diabetes",
      "other",
      "risk",
      "existing"
    ]
  },
  {
    "id": "544dc5cf041862923c4a3bad01508ce9",
    "content": "Endocrine - phaeochromocytoma, Cushing’s syndrome, Conn’s syndrome, hypothyroidism, hyperthyroidism, acromegaly.",
    "title": "Kidney related- CKD, polycystic kidney disease",
    "section": "Kidney related- CKD, polycystic kidney disease",
    "chunk_id": "616",
    "type": "section",
    "keywords": [
      "acromegaly",
      "cushing",
      "hyperthyroidism",
      "hypothyroidism",
      "phaeochromocytoma",
      "syndrome",
      "endocrine",
      "conn"
    ]
  },
  {
    "id": "d400a6afa30f91b8bde389130015a63a",
    "content": "Vascular - renal artery stenosis, coarctation of the aorta\nSymptoms\nUsually none\nOccasionally,\nHeadaches\nPalpitations\nDizziness\nEasy fatiguability\nSigns\nBlood pressure ≥ 140/90 mmHg\nDisplaced apex beat\nSigns pointing to a specific cause for secondary hypertension\ninvestigations\nFBC\nUrinalysis\nBlood urea, electrolytes and creatinine\nBlood glucose\nSerum lipids\nSerum uric acid\nChest X-ray\n12-lead ECG\nUltrasound scan of kidneys and adrenals (in suspected secondary hypertension)\nEchocardiogram.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "617",
    "type": "section",
    "keywords": [
      "hypertension",
      "usually",
      "ultrasound",
      "beat",
      "pointing",
      "lead",
      "glucose",
      "artery",
      "secondary",
      "lipids",
      "creatinine",
      "aorta",
      "pressure",
      "apex",
      "chest",
      "specific",
      "easy",
      "signs",
      "urinalysis",
      "adrenals"
    ]
  },
  {
    "id": "ef981a5b782a8238a9adaeec1f3d0ddd",
    "content": "To reduce blood pressure levels to recommended targets:\n< 140/90 mmHg for age below 60 years, diabetes, CKD\n< 150/90 mmHg for age above 60 years\nTo manage co-morbid conditions e. g. obesity, diabetes, lipids etc.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "618",
    "type": "section",
    "keywords": [
      "targets",
      "above",
      "recommended",
      "pressure",
      "below",
      "years",
      "diabetes",
      "manage",
      "conditions",
      "reduce",
      "levels",
      "mmhg",
      "obesity",
      "morbid",
      "blood",
      "lipids"
    ]
  },
  {
    "id": "397c70f8aee9fa5120f4eea7162b4edf",
    "content": "To prevent cardiovascular, cerebrovascular and renal complications\nTo promote therapeutic lifestyle changes e. g. smoking cessation, regular physical activity, reduction in alchohol intake\nTo identify and manage secondary hypertension appropriately.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "619",
    "type": "section",
    "keywords": [
      "hypertension",
      "activity",
      "regular",
      "identify",
      "lifestyle",
      "secondary",
      "cerebrovascular",
      "prevent",
      "appropriately",
      "intake",
      "changes",
      "renal",
      "reduction",
      "manage",
      "therapeutic",
      "promote",
      "cardiovascular",
      "alchohol",
      "cessation",
      "complications"
    ]
  },
  {
    "id": "ad3894be9b748056c51e6b6d8ce151f4",
    "content": "Reduce salt intake\nReduce animal fat intake\nEnsure regular fruit and vegetable intake\nWeight reduction in obese and overweight individuals\nRegular exercise e. g. brisk walking for 30 minutes 3 times a week\nReduction in alcohol consumption\nAvoid or quit smoking.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "620",
    "type": "section",
    "keywords": [
      "obese",
      "salt",
      "avoid",
      "ensure",
      "overweight",
      "weight",
      "regular",
      "brisk",
      "exercise",
      "times",
      "fruit",
      "minutes",
      "alcohol",
      "week",
      "quit",
      "intake",
      "consumption",
      "reduction",
      "vegetable",
      "walking"
    ]
  },
  {
    "id": "91cdd75940175165029e55fe4f83572a",
    "content": "Thiazide Diuretics:\nBendroflumethiazide, oral, 2. 5 mg daily\nOr\nHydrochlorothiazide, oral, 12. 5 mg-25 mg daily\nAnd/Or.",
    "title": "A.\tTreatment of hypertension 1st Line Treatment Evidence Rating: [A]",
    "section": "A.\tTreatment of hypertension 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "621",
    "type": "section",
    "keywords": [
      "diuretics",
      "hydrochlorothiazide",
      "oral",
      "thiazide",
      "daily",
      "bendroflumethiazide"
    ]
  },
  {
    "id": "535c61aa137b9d0f910ebe48dea8d6a3",
    "content": "Calcium Channel Blockers:\nAmlodipine, oral, 5-10 mg daily\nOr\nNifedipine retard, oral, 10-40 mg 12 hourly\nAnd/Or\nAngiotensin-converting enzyme (ACE) inhibitors\nLisinopril, oral, 5-40 mg daily\nOr\nRamipril, oral, 2. 5-10 mg daily\nOr\nAngiotensin receptor blockers\nLosartan, oral, 25-100 mg daily\nOr\nCandesartan, oral, 4-32 mg daily\nOr\nValsartan, oral, 80-160 mg daily\nAnd/Or\nBeta-blockers:\nAtenolol, oral, 50 -100 mg daily\nOr\nBisoprolol, oral, 5-20 mg daily\nOr\nMetoprolol, oral, 50-200 mg 12 hourly\nOr\nCarvedilol, oral, 12. 5-50 mg daily\nOr\nLabetalol, oral, 100-400 mg 12 hourly.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "622",
    "type": "section",
    "keywords": [
      "angiotensin",
      "lisinopril",
      "atenolol",
      "metoprolol",
      "bisoprolol",
      "nifedipine",
      "hourly",
      "candesartan",
      "carvedilol",
      "valsartan",
      "retard",
      "calcium",
      "enzyme",
      "receptor",
      "amlodipine",
      "converting",
      "channel",
      "losartan",
      "ramipril",
      "blockers"
    ]
  },
  {
    "id": "084aa000084d6c9d7b3ed1b567e8b951",
    "content": "Methyldopa, oral, 250 mg-1g 8-12 hourly\nAnd/Or\nVasodilators\nHydralazine, oral, 25-50 mg 12 hourly\nAnd/Or\nAlpha-blockers\nPrazosin, oral, 0. 5 mg 8-12 hourly and increasing gradually to a max. dose of 20 mg\nAnd/Or\nAldosterone antagonists\nSpironolactone, oral, 25-50 mg daily.",
    "title": "2nd Line Treatment Evidence Rating: [C] Centrally acting agents",
    "section": "2nd Line Treatment Evidence Rating: [C] Centrally acting agents",
    "chunk_id": "623",
    "type": "section",
    "keywords": [
      "antagonists",
      "hydralazine",
      "methyldopa",
      "vasodilators",
      "hourly",
      "aldosterone",
      "prazosin",
      "spironolactone",
      "alpha",
      "blockers",
      "oral",
      "dose",
      "increasing",
      "daily",
      "gradually"
    ]
  },
  {
    "id": "97de1a0693f95ad1b026606f1bbd516e",
    "content": "Referral Criteria\nRefer the following categories of hypertensive patients to an\nappropriate specialist:.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "624",
    "type": "section",
    "keywords": [
      "categories",
      "referral",
      "specialist",
      "appropriate",
      "following",
      "refer",
      "hypertensive",
      "patients",
      "criteria"
    ]
  },
  {
    "id": "d74907a43209a80be820063ce482508b",
    "content": "Those on three or more anti-hypertensive drugs, yet have poor BP\ncontrol\nThose with worsening of BP over a few weeks or months\nThose with plasma creatinine levels above the upper limit of normal\nThose with diabetes mellitus\nThose with multiple risk factors (diabetes, dyslipidaemia, obesity, family history of heart disease)\nThose not on diuretics but have persistently low potassium on\nrepeated blood tests\nAll children, young adults and pregnant women with elevated BP\nFlowchart.",
    "title": "Those not achieving the target blood pressure (BP) level after several months of treatment",
    "section": "Those not achieving the target blood pressure (BP) level after several months of treatment",
    "chunk_id": "625",
    "type": "section",
    "keywords": [
      "plasma",
      "levels",
      "mellitus",
      "factors",
      "family",
      "hypertensive",
      "poor",
      "potassium",
      "repeated",
      "flowchart",
      "creatinine",
      "multiple",
      "dyslipidaemia",
      "persistently",
      "heart",
      "weeks",
      "children",
      "blood",
      "disease",
      "above"
    ]
  },
  {
    "id": "74fd1fbc6753728ac35ed2cb9fb5d247",
    "content": "Hypertension in children is defined as an average systolic and/or diastolic blood pressure that is ≥ 95th percentile for gender, age, and height on 3 or more separate occasions taken in the right arm (in view of possibility of coarctation of aorta). An appropriate cuff size that covers two thirds (⅔) of the length of the arm (between shoulder and elbow) and encircling the whole arm, should be used. In general, a blood pressure of > 110/70 mmHg in children aged 2-5 years and > 115/76 mmHg in those aged 6-12 years and more than 128/82 mmHg in adolescents is considered abnormal and would require a referral to, and evaluation by a paediatrician.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "626",
    "type": "section",
    "keywords": [
      "hypertension",
      "adolescents",
      "years",
      "encircling",
      "view",
      "thirds",
      "possibility",
      "aorta",
      "pressure",
      "diastolic",
      "cuff",
      "systolic",
      "right",
      "require",
      "evaluation",
      "paediatrician",
      "elbow",
      "abnormal",
      "children",
      "whole"
    ]
  },
  {
    "id": "83e46d0f44fa2a94eb05e9b1ef839198",
    "content": "Most adolescent and childhood hypertension, especially in infants and younger children, is due to secondary causes (See section on ‘Hypertension in Adults’). Adolescents, however, may have early onset primary hypertension. Causes\nRenal e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "627",
    "type": "section",
    "keywords": [
      "hypertension",
      "adolescents",
      "especially",
      "secondary",
      "primary",
      "section",
      "childhood",
      "most",
      "children",
      "renal",
      "causes",
      "onset",
      "infants",
      "adults",
      "younger",
      "adolescent",
      "early",
      "however",
      "have"
    ]
  },
  {
    "id": "35e9f5874a5d8c2497218747329a4212",
    "content": "g. chronic pyelonephritis, hydronephrosis\nVascular e. g.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "628",
    "type": "section",
    "keywords": [
      "hydronephrosis",
      "pyelonephritis",
      "chronic",
      "vascular"
    ]
  },
  {
    "id": "099abb78cdbd15b5f1939a113e86a8b6",
    "content": "coarctation of aorta, renal artery stenosis\nEndocrine e. g. phaeochromocytoma, Cushing’s syndrome, adrenal.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "629",
    "type": "section",
    "keywords": [
      "aorta",
      "cushing",
      "stenosis",
      "phaeochromocytoma",
      "adrenal",
      "artery",
      "syndrome",
      "renal",
      "coarctation",
      "endocrine"
    ]
  },
  {
    "id": "3f6c2126265b15632076369abbde5bd6",
    "content": "Obesity\nPrimary hypertension\nSymptoms\nChest pain\nHeadaches\nDyspnoea on exertion\nExcessive sweating\nLeg swelling\nPalpitations\nHaematuria\nUnconsciousness (hypertensive encephalopathy)\nSigns\nBP >110/70 mmHg in children aged 2-5 years\n>115/76 mmHg in children aged 6-12 years\n>128/82 mmHg in adolescents\nSigns pointing to a specific cause for secondary hypertension\ninvestigations\n(See section on ‘Hypertension in Adults’).",
    "title": "disorders",
    "section": "disorders",
    "chunk_id": "630",
    "type": "section",
    "keywords": [
      "hypertension",
      "unconsciousness",
      "years",
      "adolescents",
      "encephalopathy",
      "exertion",
      "swelling",
      "pointing",
      "hypertensive",
      "secondary",
      "primary",
      "dyspnoea",
      "chest",
      "section",
      "specific",
      "signs",
      "children",
      "headaches",
      "haematuria",
      "adults"
    ]
  },
  {
    "id": "14bea909e2c39a332cb01930b0e2b1db",
    "content": "To reduce blood pressure (BP) to a target of < 95th percentile for age,\ngender and height in the absence of end organ-damage (to < 90th.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "631",
    "type": "section",
    "keywords": [
      "percentile",
      "pressure",
      "target",
      "organ",
      "reduce",
      "height",
      "gender",
      "absence",
      "damage",
      "blood"
    ]
  },
  {
    "id": "c2a2374d5a2f06c3446bbb54feaaa61e",
    "content": "percentile if end organ damage present)\nTo prevent complications\nTo manage underlying secondary cause\nTo encourage weight reduction in obese and overweight children.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "632",
    "type": "section",
    "keywords": [
      "obese",
      "complications",
      "percentile",
      "reduction",
      "present",
      "overweight",
      "weight",
      "prevent",
      "organ",
      "manage",
      "cause",
      "damage",
      "underlying",
      "children",
      "encourage",
      "secondary"
    ]
  },
  {
    "id": "6444f045414ddb2f049c7c2298d07fd9",
    "content": "Therapeutic lifestyle changes\nweight control\nregular exercise\nlow fat intake\nlow sodium diet\nregular fruit and vegetable intake.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "633",
    "type": "section",
    "keywords": [
      "diet",
      "weight",
      "vegetable",
      "regular",
      "therapeutic",
      "exercise",
      "sodium",
      "intake",
      "control",
      "lifestyle",
      "changes",
      "fruit"
    ]
  },
  {
    "id": "5f68963765dd005476776382bd4c79d1",
    "content": "Evidence Rating: [A]\nAngiotensin-converting enzyme (ACE) inhibitors\nEnalapril, oral,\nChildren\n12-18 years;\tinitially 2. 5 mg daily (increased to max. 10- 20 mg daily in 1-2 divided doses)\n1 month-12 years;\tinitially 100 micrograms per kg daily (in- creased to max.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "634",
    "type": "section",
    "keywords": [
      "angiotensin",
      "rating",
      "years",
      "enzyme",
      "initially",
      "creased",
      "doses",
      "oral",
      "children",
      "converting",
      "micrograms",
      "month",
      "inhibitors",
      "increased",
      "enalapril",
      "evidence",
      "daily",
      "divided"
    ]
  },
  {
    "id": "ec29262224a42a4801bc82e3ef121e7a",
    "content": "1 mg/kg daily in 1-2 divided doses)\nNeonate\n10 microgram/kg daily (increased to max. 500 microgram/kg daily in 1-3 divided doses)\nDiuretics\nBendroflumethiazide, oral,\nChildren\n12-18 years;\t2. 5 mg daily\n2-12 years;\t50-100 microgram/kg daily\n1 month-2 years;\t50-100 microgram/kg daily\nBeta blockers\nPropranolol, oral,\nChildren\n12-18 years;\t80-160 mg 12 hourly\n1 month-12 years;\t250 microgram-1 mg/kg 8 hourly\nNeonate;\t250 microgram/kg 8 hourly Or\nAtenolol, oral,\nChildren\n0.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "635",
    "type": "section",
    "keywords": [
      "diuretics",
      "hourly",
      "years",
      "microgram",
      "atenolol",
      "doses",
      "neonate",
      "blockers",
      "oral",
      "propranolol",
      "beta",
      "month",
      "children",
      "increased",
      "divided",
      "daily",
      "bendroflumethiazide"
    ]
  },
  {
    "id": "f82d27fd3b88ef0781562c9894e48f4f",
    "content": "5-1 mg/kg daily (max. 2 mg/kg daily)\nCalcium channel blockers\nNifedipine, oral,\nChildren\n12-18 years;\t5-20 mg 8 hourly\n1 month-12 years;\t200-300 microgram/kg 8 hourly (max. 100 mg daily).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "636",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "calcium",
      "microgram",
      "blockers",
      "oral",
      "channel",
      "month",
      "children",
      "daily",
      "nifedipine"
    ]
  },
  {
    "id": "7ce82636e251271bc9dcbc9218aeed6c",
    "content": "Or\nAmlodipine, oral,\nChildren\n12-18 years;\t5-10 mg daily\n1 month-12 years;\t100-400 microgram/kg daily (max. 10 mg daily)\nVasodilators\nHydralazine, oral,\nChildren\n12-18 years;\t25 mg 12 hourly increased to usual max. 50-\n100 mg 12 hourly\n1 month-12 years;\t250-500 microgram/kg 8-12 hourly in- creased as necessary to max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "637",
    "type": "section",
    "keywords": [
      "hydralazine",
      "hourly",
      "vasodilators",
      "years",
      "microgram",
      "creased",
      "amlodipine",
      "necessary",
      "oral",
      "usual",
      "month",
      "children",
      "increased",
      "daily"
    ]
  },
  {
    "id": "2fb0d1dbb2576d37c37a94dc01c2f2c2",
    "content": "7. 5 mg/kg daily (not exceeding 200 mg) Neonate\n250-500 microgram/kg 8-12 hourly increased as necessary to max. 2-3 mg/kg every 8 hours\nIV, 250-500 microgram/kg diluted in 10 ml normal saline given over 20 minutes, then 100-200 microgram/kg 4-6 hourly (max 3 mg/kg\nin 24 hours)\nAngiotensin-receptor blockers\nLosartan, oral,\nChildren\nInitial dose;\t0.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "638",
    "type": "section",
    "keywords": [
      "angiotensin",
      "initial",
      "given",
      "neonate",
      "hourly",
      "minutes",
      "saline",
      "children",
      "exceeding",
      "receptor",
      "dose",
      "increased",
      "then",
      "every",
      "diluted",
      "losartan",
      "microgram",
      "necessary",
      "blockers",
      "oral"
    ]
  },
  {
    "id": "e83f2bff3082eb6a5e2e187f8b5bf592",
    "content": "7 mg /kg daily (max. 50 mg) Maintenance dose;\t1. 4 mg /kg daily (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "639",
    "type": "section",
    "keywords": [
      "dose",
      "daily",
      "maintenance"
    ]
  },
  {
    "id": "f87ef91ef98946a2d2b618defe6b43c8",
    "content": "100 mg)\nReferral Criteria\nRefer all cases of hypertension in children to a specialist for.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "640",
    "type": "section",
    "keywords": [
      "hypertension",
      "referral",
      "specialist",
      "refer",
      "cases",
      "children",
      "criteria"
    ]
  },
  {
    "id": "368fa0f659106a03cfa4abdd534401e2",
    "content": "A hypertensive crisis is a severe and potentially life threatening increase in blood pressures (BP) which may result in an acute stroke, subarachnoid haemorrhage, seizures (hypertensive encephalopathy), heart attack, acute dissection of aorta, heart failure, renal damage or eclampsia (during pregnancy). The underlying cause may be primary hypertension; however, secondary causes of hypertension must be excluded. In adult patients this often occurs with a BP > 180/120 mmHg, while in children this may occur at lower BP levels.",
    "title": "(See section on ‘Hypertension in Pregnancy’ under ‘Obstetric care and Obstetric Disorders’)",
    "section": "(See section on ‘Hypertension in Pregnancy’ under ‘Obstetric care and Obstetric Disorders’)",
    "chunk_id": "641",
    "type": "section",
    "keywords": [
      "hypertension",
      "pressures",
      "encephalopathy",
      "often",
      "occur",
      "levels",
      "seizures",
      "during",
      "which",
      "potentially",
      "hypertensive",
      "secondary",
      "acute",
      "while",
      "increase",
      "primary",
      "aorta",
      "attack",
      "result",
      "underlying"
    ]
  },
  {
    "id": "63089947ab9ce0d70c0dbb846c77c33b",
    "content": "These patients need careful examination to exclude target organ damage. Rapid correction of blood pressure with careful monitoring to avoid a precipitous drop is indicated to prevent organ damage. Symptoms\nHeadache\nChest pain\nShortness of breath\nNausea\nVomiting\nConfusion\nSeizures\nUnconsciousness\nSigns\nSeverely elevated blood pressure (for age)\nUnconsciousness\nSeizures\nNeck rigidity\nLung crepitations\ninvestigations\nChest X-ray\n12-lead ECG\nFBC\nUrinalysis\nBlood urea, electrolytes and creatinine\nBrain CT scan (for stroke)\nChest CT scan with angiography (for suspected aortic dissection)\nCardiac enzymes: creatinine kinase-MB (CK-MB), serum aspartate transaminase (AST), serum lactic dehydrogenase (LDH) and troponins (for acute coronary syndrome)\nEchocardiography.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "642",
    "type": "section",
    "keywords": [
      "severely",
      "urea",
      "avoid",
      "monitoring",
      "nausea",
      "unconsciousness",
      "echocardiography",
      "organ",
      "headache",
      "seizures",
      "lead",
      "angiography",
      "acute",
      "neck",
      "creatinine",
      "aortic",
      "pressure",
      "aspartate",
      "chest",
      "prevent"
    ]
  },
  {
    "id": "013aeb62aa44672c5f8381d15cc9f48c",
    "content": "To limit further organ-related complications by controlled reduction\nof BP\nTo control and subsequently prevent seizures if present\nTo manage identified target organ damage.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "643",
    "type": "section",
    "keywords": [
      "complications",
      "reduction",
      "present",
      "target",
      "controlled",
      "organ",
      "subsequently",
      "prevent",
      "manage",
      "identified",
      "seizures",
      "further",
      "damage",
      "control",
      "limit",
      "related"
    ]
  },
  {
    "id": "6ef9861883811a6daa5a532a98b9469d",
    "content": "Evidence Rating: [A]\nLabetalol, IV,\nAdults\n20-50 mg stat. (over a 2 minute period).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "644",
    "type": "section",
    "keywords": [
      "rating",
      "minute",
      "adults",
      "period",
      "labetalol",
      "evidence",
      "stat"
    ]
  },
  {
    "id": "6e9e7a82388be8d05dd3227b73d65566",
    "content": "Repeat at 10 minute intervals, if necessary, to a max. of 200 mg\nChildren\n12-18 years; 10-30 mg stat. (over a 2 minute period).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "645",
    "type": "section",
    "keywords": [
      "years",
      "intervals",
      "minute",
      "period",
      "repeat",
      "necessary",
      "children",
      "stat"
    ]
  },
  {
    "id": "9fb8d07c01d5083f92023430c2303701",
    "content": "Repeat at 15 minute intervals, if necessary (max. 200 mg)\n1 month-12 years (by IV infusion); initially 500-1000 microgram /kg body weight / hour adjusted at intervals of at least 15 minutes ac- cording to response. Max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "646",
    "type": "section",
    "keywords": [
      "body",
      "hour",
      "years",
      "least",
      "intervals",
      "minute",
      "microgram",
      "weight",
      "minutes",
      "initially",
      "cording",
      "infusion",
      "response",
      "repeat",
      "necessary",
      "month",
      "adjusted"
    ]
  },
  {
    "id": "7df51d4ba00ae9a27929212f2ef20d9e",
    "content": "3 mg /kg/hour. Or\nHydralazine, IV,\nAdults\n5-10 mg slowly (over a 2 minute period), diluted with 10 ml Normal\nSaline (0. 9%).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "647",
    "type": "section",
    "keywords": [
      "hydralazine",
      "hour",
      "diluted",
      "minute",
      "normal",
      "adults",
      "period",
      "saline",
      "slowly"
    ]
  },
  {
    "id": "e4a33877bd23669ad8f21b0f28ba7ce2",
    "content": "Repeat at 20-30 minute intervals, if necessary\nChildren\n12-18 years;\t5-10 mg stat. Repeat every 4-6 hours, if necessary\n1 month-12 years;\t100-500 microgram/kg\nRepeat every 4-6 hours, if necessary; max. 3 mg/kg daily (not ex- ceeding 60 mg per day)\n< 1 month;\t100-500 microgram/kg\nRepeat every 4-6 hours, if necessary; max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "648",
    "type": "section",
    "keywords": [
      "years",
      "intervals",
      "minute",
      "microgram",
      "daily",
      "repeat",
      "necessary",
      "ceeding",
      "month",
      "children",
      "hours",
      "stat",
      "every"
    ]
  },
  {
    "id": "de3ae7d650af522cbc49145077251f6b",
    "content": "3 mg/kg daily\nReferral Criteria\nRefer all patients to a physician specialist for further evaluation. Arrhythmias are disorders of cardiac rate, rhythm and conduction. They can be classified as bradyarrhythmias (heart rate < 60 per minute) and tachyarrhythmias (heart rate > 100 per minute).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "649",
    "type": "section",
    "keywords": [
      "rhythm",
      "conduction",
      "tachyarrhythmias",
      "specialist",
      "rate",
      "evaluation",
      "heart",
      "patients",
      "criteria",
      "arrhythmias",
      "physician",
      "referral",
      "further",
      "disorders",
      "cardiac",
      "classified",
      "minute",
      "refer",
      "bradyarrhythmias",
      "daily"
    ]
  },
  {
    "id": "6f1f17ef85df9053896755c85894bc52",
    "content": "Bradyarrhythmias include sinus bradycardia, sinus pauses and atrioventricular blocks. The tachyarrhythmias can further be classified into supraventricular and ventricular arrhythmias, based on their site of origin. Tachyarrhythmias include atrial fibrillation, atrial flutter, paroxysmal supraventricular tachycardia, ventricular tachycardia and ventricular fibrillation.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "650",
    "type": "section",
    "keywords": [
      "based",
      "paroxysmal",
      "tachyarrhythmias",
      "ventricular",
      "atrial",
      "tachycardia",
      "into",
      "blocks",
      "pauses",
      "origin",
      "flutter",
      "site",
      "their",
      "sinus",
      "arrhythmias",
      "fibrillation",
      "include",
      "further",
      "classified",
      "supraventricular"
    ]
  },
  {
    "id": "c529c53c9ddc66573bc0fc131237e93f",
    "content": "Prior to drug treatment of a suspected cardiac arrhythmia, a 12-lead ECG must be done to confirm the rhythm abnormality. It is dangerous to use an antiarrhythmic drug without doing an ECG. Refer symptomatic patients to hospital immediately.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "651",
    "type": "section",
    "keywords": [
      "rhythm",
      "dangerous",
      "lead",
      "abnormality",
      "immediately",
      "doing",
      "drug",
      "patients",
      "prior",
      "treatment",
      "suspected",
      "done",
      "antiarrhythmic",
      "symptomatic",
      "arrhythmia",
      "cardiac",
      "must",
      "refer",
      "confirm",
      "hospital"
    ]
  },
  {
    "id": "42d663c262be226635a864104edd419e",
    "content": "The choice of drug treatment depends on the type of arrhythmia and severity of symptoms. Causes.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "652",
    "type": "section",
    "keywords": [
      "choice",
      "type",
      "severity",
      "depends",
      "drug",
      "arrhythmia",
      "symptoms",
      "treatment",
      "causes"
    ]
  },
  {
    "id": "1b088933bcfc22ac5f684d01980462b3",
    "content": "Thyrotoxicosis\nHypothyroidism\nCardiomyopathies\nComplete heart block\nElectrolyte abnormalities particularly hypokalaemia.",
    "title": "Ischaemic heart disease",
    "section": "Ischaemic heart disease",
    "chunk_id": "653",
    "type": "section",
    "keywords": [
      "thyrotoxicosis",
      "block",
      "cardiomyopathies",
      "hypothyroidism",
      "abnormalities",
      "hypokalaemia",
      "heart",
      "electrolyte",
      "complete",
      "particularly"
    ]
  },
  {
    "id": "823d4618000bd45ab70ee740249807e0",
    "content": "Drugs\nSmoking, alcohol, coffee, tea, etc. Pulmonary embolism\nPost cardiac surgery\nIdiopathic\nSymptoms\nPalpitations\nDizziness\nChest discomfort/pain\nFatigue\nDifficulty in breathing\nSudden collapse\nSudden death\nSigns\nPulse\nRate may be fast, slow or normal\nRhythm\nPulse deficit (apical rate faster than radial pulse rate; seen in fast atrial fibrillation or flutter)\nHypotension or blood pressure may be unrecordable\nSigns of heart failure (may be present).",
    "title": "Pericardial disease",
    "section": "Pericardial disease",
    "chunk_id": "654",
    "type": "section",
    "keywords": [
      "collapse",
      "sudden",
      "rhythm",
      "idiopathic",
      "fatigue",
      "seen",
      "discomfort",
      "breathing",
      "faster",
      "atrial",
      "death",
      "rate",
      "pressure",
      "chest",
      "alcohol",
      "flutter",
      "signs",
      "heart",
      "blood",
      "apical"
    ]
  },
  {
    "id": "b934c8d2cf80c7c6455127fde8cc44c3",
    "content": "investigations\n12-lead ECG\nSerum electrolytes (including magnesium, calcium)\nThyroid function tests\nChest X-ray\nAmbulatory ECG (Holter)\nEchocardiography.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "655",
    "type": "section",
    "keywords": [
      "echocardiography",
      "calcium",
      "chest",
      "electrolytes",
      "including",
      "function",
      "serum",
      "holter",
      "ambulatory",
      "lead",
      "magnesium",
      "tests",
      "thyroid",
      "investigations"
    ]
  },
  {
    "id": "965ea1829f53a35fb1cd20e1e5377155",
    "content": "To control ventricular rate\nTo restore sinus rhythm\nTo relieve symptoms\nTo improve functional capacity and quality of life\nTo prevent or treat associated complications\nTo treat the underlying condition e. g. thyrotoxicosis\nTo prevent stroke or systemic thromboembolism\nTo reduce morbidity and mortality.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "656",
    "type": "section",
    "keywords": [
      "rhythm",
      "treat",
      "improve",
      "morbidity",
      "quality",
      "ventricular",
      "systemic",
      "associated",
      "capacity",
      "rate",
      "functional",
      "prevent",
      "underlying",
      "condition",
      "sinus",
      "thromboembolism",
      "restore",
      "symptoms",
      "mortality",
      "stroke"
    ]
  },
  {
    "id": "3e694ad0504513f314b5244e9f855e83",
    "content": "Reassure the patient\nAvoid excessive intake of alcohol, coffee or tea and stop smoking (if these are possible precipitating factors)\nMassage of the carotid sinus on one side for a few seconds. This may\nterminate an attack of paroxysmal supraventricular tachycardia\nElectrical cardioversion.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "657",
    "type": "section",
    "keywords": [
      "avoid",
      "carotid",
      "terminate",
      "paroxysmal",
      "factors",
      "reassure",
      "tachycardia",
      "patient",
      "precipitating",
      "attack",
      "alcohol",
      "intake",
      "sinus",
      "side",
      "cardioversion",
      "electrical",
      "stop",
      "seconds",
      "massage",
      "excessive"
    ]
  },
  {
    "id": "20e4c0180d02f193700477350eee7c02",
    "content": "Fast atrial fibrillation or atrial flutter-for rate control.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "658",
    "type": "section",
    "keywords": [
      "fast",
      "rate",
      "flutter",
      "atrial",
      "control",
      "fibrillation"
    ]
  },
  {
    "id": "e16ccea9a599d931ce1cd9f7073e7f3f",
    "content": "Atenolol, oral,\nAdults\n50-100 mg daily\nChildren\n12-18 years;\t25-50 mg daily\n1 month-12 years;\t12. 5-50 mg daily\nNeonates\nRefer to a paediatrician\nOr\nBisoprolol, oral,\nAdults\n2. 5-10 mg daily\nChildren\nSafety not establised in children\nOr\nMetoprolol tartrate, oral,.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "659",
    "type": "section",
    "keywords": [
      "tartrate",
      "paediatrician",
      "years",
      "atenolol",
      "neonates",
      "metoprolol",
      "adults",
      "refer",
      "bisoprolol",
      "oral",
      "establised",
      "safety",
      "month",
      "children",
      "daily"
    ]
  },
  {
    "id": "4f97a6ddba07d5d6e60e5c3a8efb9960",
    "content": "Adults\n50-100 mg 8 or 12 hourly daily (max. 300 mg daily)\nChildren\n12-18 years;  50 mg 8 or 12 hourly daily (max. 300 mg daily)\n< 12 years;\trefer to a paediatrician\nOr\nVerapamil, oral,\nAdults\n40-120 mg 6-8 hourly (max.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "660",
    "type": "section",
    "keywords": [
      "hourly",
      "paediatrician",
      "verapamil",
      "years",
      "adults",
      "refer",
      "oral",
      "children",
      "daily"
    ]
  },
  {
    "id": "f99796826a890cd4d1995be12a534fb5",
    "content": "Digoxin, oral,\nAdults\n125-250 micrograms daily\nChildren\nRefer to a paediatrician\nFast atrial fibrillation or atrial flutter-for rhythm control\nThis is required to restore sinus rhythm. Refer to a cardiologist, physician specialist or paediatrician as appropriate. Paroxysmal supraventricular tachycardia.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "661",
    "type": "section",
    "keywords": [
      "rhythm",
      "paroxysmal",
      "atrial",
      "required",
      "tachycardia",
      "cardiologist",
      "digoxin",
      "paediatrician",
      "specialist",
      "flutter",
      "children",
      "sinus",
      "fibrillation",
      "physician",
      "restore",
      "adults",
      "fast",
      "supraventricular",
      "appropriate",
      "refer"
    ]
  },
  {
    "id": "93f65f9f5af62b9a131e9df9048d6627",
    "content": "Atenolol, oral,\nAdults\n50-100 mg daily\nChildren\n12-18 years;\t25-50 mg daily\n1 month-12 years;\t12. 5-50 mg daily\nNeonates\nRefer to a paediatrician\nOr\nBisoprolol, oral,\nAdults\n2. 5-10 mg daily\nChildren\nSafety not establised in children.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "662",
    "type": "section",
    "keywords": [
      "paediatrician",
      "years",
      "atenolol",
      "neonates",
      "adults",
      "refer",
      "bisoprolol",
      "oral",
      "establised",
      "safety",
      "month",
      "children",
      "daily"
    ]
  },
  {
    "id": "d1b7c1185ebcc5167c2fcebd9fca812d",
    "content": "Or\nMetoprolol tartrate, oral,\nAdults\n50-100 mg 8 or 12 hourly daily (max. 300 mg daily)\nChildren\n12-18 years;\t50 mg 8 or 12 hourly daily (max. 300 mg dai- ly)\n<12 years;\trefer to a paediatrician\nOr\nVerapamil, oral,\nAdults\n40-120 mg 6-8 hourly (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "663",
    "type": "section",
    "keywords": [
      "tartrate",
      "hourly",
      "paediatrician",
      "verapamil",
      "years",
      "adults",
      "refer",
      "oral",
      "children",
      "daily",
      "metoprolol"
    ]
  },
  {
    "id": "ddd5b21e0e5d108309879856aa78196b",
    "content": "Digoxin, oral,\nAdults\n125-250 micrograms daily\nChildren\nRefer to a paediatrician\nPrevention of stroke or systemic thromboembolism in atrial\nfibrillation or flutter\nPatients should be given long-term anticoagulation. (See options for long-term anticoagulation in section on ‘DVT’ or ‘Pulmonary Embolism’). Referral Criteria\nRefer all patients to a cardiologist, physician specialist or paediatrician for further evaluation and management after the initial treatment.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "664",
    "type": "section",
    "keywords": [
      "initial",
      "given",
      "management",
      "atrial",
      "systemic",
      "cardiologist",
      "digoxin",
      "paediatrician",
      "specialist",
      "evaluation",
      "anticoagulation",
      "section",
      "flutter",
      "patients",
      "children",
      "criteria",
      "thromboembolism",
      "fibrillation",
      "physician",
      "treatment"
    ]
  },
  {
    "id": "061683dab2e97315bfdbb63936623a8b",
    "content": "All symptomatic patients, as well as those who cannot have an ECG done or interpreted, or who present with heart failure, should be referred immediately. Flowchart.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "665",
    "type": "section",
    "keywords": [
      "present",
      "immediately",
      "done",
      "cannot",
      "interpreted",
      "should",
      "symptomatic",
      "heart",
      "have",
      "patients",
      "those",
      "failure",
      "flowchart",
      "referred"
    ]
  },
  {
    "id": "8358490fbe1c0ebc9483015ca661d982",
    "content": "Acute rheumatic fever is an illness caused by an immunological reaction to group A streptococcal infection of the throat. The onset of symptoms occurs 1-3 weeks after an untreated or inadequately treated throat infection. The disease occurs mainly in children and adolescents with a peak age of 5-15 years.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "666",
    "type": "section",
    "keywords": [
      "adolescents",
      "years",
      "streptococcal",
      "acute",
      "immunological",
      "inadequately",
      "treated",
      "reaction",
      "weeks",
      "children",
      "untreated",
      "rheumatic",
      "onset",
      "peak",
      "disease",
      "caused",
      "fever",
      "occurs",
      "symptoms",
      "mainly"
    ]
  },
  {
    "id": "f4cca71790c7fba3142c55ed7e6bc323",
    "content": "Acute rheumatic fever often results in lasting damage to heart valves leading to the chronic form, which is known as rheumatic heart disease. Individuals who have had acute rheumatic fever previously are more likely to have subsequent episodes. These recurrences may cause further heart valve damage.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "667",
    "type": "section",
    "keywords": [
      "valves",
      "often",
      "which",
      "results",
      "likely",
      "form",
      "acute",
      "previously",
      "valve",
      "known",
      "recurrences",
      "lasting",
      "heart",
      "subsequent",
      "rheumatic",
      "disease",
      "episodes",
      "leading",
      "chronic",
      "fever"
    ]
  },
  {
    "id": "9293d87b8c7f965c74d0db9a684514ef",
    "content": "Following treatment of an acute episode, secondary prophylaxis should be continued for a minimum of 10 years after the recent episode of acute rheumatic fever or until age 21 years (whichever is longer). For those with severe rheumatic heart disease secondary prophylaxis should be continued indefinitely. Rheumatic heart disease is an important cause of heart failure and premature death.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "668",
    "type": "section",
    "keywords": [
      "recent",
      "years",
      "important",
      "death",
      "secondary",
      "acute",
      "whichever",
      "following",
      "episode",
      "premature",
      "continued",
      "heart",
      "rheumatic",
      "treatment",
      "severe",
      "disease",
      "should",
      "fever",
      "longer",
      "cause"
    ]
  },
  {
    "id": "0a1ca252b165957a7b669897559a2903",
    "content": "In Ghana, acute rheumatic fever may mimic malaria, typhoid fever and other febrile conditions, while the joint symptoms may mimic sickle cell disease. Jones criteria is used for diagnosis of rheumatic fever.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "669",
    "type": "section",
    "keywords": [
      "jones",
      "acute",
      "while",
      "typhoid",
      "joint",
      "malaria",
      "criteria",
      "rheumatic",
      "disease",
      "diagnosis",
      "mimic",
      "fever",
      "sickle",
      "febrile",
      "symptoms",
      "conditions",
      "cell",
      "other",
      "ghana",
      "used"
    ]
  },
  {
    "id": "13e45a0fd99432494af722cfb6a36224",
    "content": "Causes\nGroup A streptococcal infection\nSymptoms\nFever\nMalaise\nJoint pain which moves from one joint to another (knees, ankles, wrists, elbows)\nPalpitations\nEasy fatiguability\nChest pain\nSkin rash\nAbnormal body movements (chorea)\nSigns\nFever > 38°C (minor criteria)\nSingle joint tenderness and or swelling (minor criteria)\nRapid heart rate ( > 100/minute), murmur, heart failure, pericardial rub (suggests carditis) (major criteria)\nSkin rash\nSubcutaneous nodules over bony prominences\ninvestigations\nFBC\nESR > 30 or C-reactive protein > 3 mg/dL (minor criteria)\nSickling status\nChest X-ray\nThroat swab for culture\nAnti-streptolysin O titre\n12-lead ECG (prolonged PR interval for age - minor criteria)\nEchocardiogram evidence of carditis (major criteria).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "670",
    "type": "section",
    "keywords": [
      "sickling",
      "prominences",
      "minor",
      "carditis",
      "prolonged",
      "chorea",
      "interval",
      "bony",
      "which",
      "swelling",
      "wrists",
      "nodules",
      "lead",
      "streptococcal",
      "evidence",
      "murmur",
      "rash",
      "body",
      "movements",
      "rate"
    ]
  },
  {
    "id": "61e9ac375da91e0aa053a65f71c8957a",
    "content": "To eradicate streptococcal throat infection\nTo suppress inflammatory response\nTo prevent recurrent episodes of rheumatic fever and further heart valve damage\nTo treat heart failure if co-existent.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "671",
    "type": "section",
    "keywords": [
      "recurrent",
      "treat",
      "suppress",
      "streptococcal",
      "valve",
      "prevent",
      "heart",
      "rheumatic",
      "episodes",
      "existent",
      "fever",
      "response",
      "eradicate",
      "further",
      "damage",
      "failure",
      "inflammatory",
      "throat",
      "infection"
    ]
  },
  {
    "id": "46291489e1246792c22c21efd0bc3d04",
    "content": "Benzathine benzylpenicillin, IM,\n≥ 30 kg body weight;\t1,200,000 U as a single dose\n< 30 kg body weight;\t600,000 U as a single dose\nOr\nPhenoxymethyl penicillin (Penicillin V), oral,\nAdults\n500 mg 12 hourly for 10 days\nChildren\n6-12years;\t250 mg 12 hourly for 10 days\n1-5 years;\t125 mg 12 hourly for 10 days\nOr\nErythromycin, oral, (for patients allergic to penicillin)\nAdults\n500 mg 12 hourly for 10 days\nChildren\n8-12 years;\t500 mg 12 hourly for 10 days\n3-8 years;\t250 mg 12 hourly for 10 days\n1-2 years;\t125 mg 12 hourly for 10 days\nAnd\nEvidence Rating: [B]\nAspirin, oral,\nAdults\n300-900 mg 4-6 hourly until joint symptoms relieved, and gradually withdraw over 1-2 weeks. Children\nmonth-18 years;\t25 mg/kg 6 hourly until joint symptoms re- lieved, and gradually withdraw over 1-2 weeks. Or\nEvidence Rating: [B]\nIbuprofen, oral,\nAdults\n200-800 mg 6-8 hourly (max.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "672",
    "type": "section",
    "keywords": [
      "years",
      "benzylpenicillin",
      "weight",
      "penicillin",
      "lieved",
      "evidence",
      "ibuprofen",
      "relieved",
      "hourly",
      "body",
      "rating",
      "single",
      "joint",
      "withdraw",
      "allergic",
      "patients",
      "children",
      "weeks",
      "phenoxymethyl",
      "days"
    ]
  },
  {
    "id": "379199531a9ad35dfb4ad4ca1b004391",
    "content": "Children\n10-15 mg/kg 6-8 hourly (max. 40 mg per kg daily).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "673",
    "type": "section",
    "keywords": [
      "children",
      "hourly",
      "daily"
    ]
  },
  {
    "id": "4d0bfc46e0cbb2b9099ed4bf06c5679b",
    "content": "And\nPrednisolone, oral,\nAdults and Children\nmg/kg daily for 2 weeks and then gradually taper off by 20-25% per week for 1-3 weeks.",
    "title": "As in ‘treatment option A’ above",
    "section": "As in ‘treatment option A’ above",
    "chunk_id": "674",
    "type": "section",
    "keywords": [
      "then",
      "prednisolone",
      "week",
      "adults",
      "oral",
      "children",
      "weeks",
      "taper",
      "daily",
      "gradually"
    ]
  },
  {
    "id": "a6fa73f80981fca013a1d274023ab016",
    "content": "Benzathine benzylpenicillin, IM,\n≥ 30 kg body weight;\t1,200,000 U\n< 30 kg body weight;\t450 mg (600,000 U) 4-weekly.",
    "title": "1st Line Treatment",
    "section": "1st Line Treatment",
    "chunk_id": "675",
    "type": "section",
    "keywords": [
      "body",
      "benzylpenicillin",
      "weight",
      "weekly",
      "benzathine"
    ]
  },
  {
    "id": "99fbc43cf67e2570c951d38d2e9ed4a3",
    "content": "Phenoxymethyl penicillin (Penicillin V), oral,\nAdults\n500 mg 12 hourly daily\nChildren\n6-12years;\t250 mg 12 hourly\n1-5 years;\t125 mg 12 hourly\nOr\nErythromycin, oral, (for patients allergic to penicillin)\nAdults\nmg 12 hourly\nChildren\n8-12 years;\t500 mg 12 hourly\n3-8 years;\t250 mg 12 hourly\n1-2 years;\t125 mg 12 hourly\nReferral Criteria\nRefer all patients to a paediatrician, physician specialist or cardiologist as necessary for further management. Dizziness is a nonspecific term that refers to abnormal sensation of body orientation or position in space. These include feeling of unsteadiness, light-headedness and vertigo.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "676",
    "type": "section",
    "keywords": [
      "years",
      "penicillin",
      "headedness",
      "management",
      "space",
      "nonspecific",
      "position",
      "light",
      "feeling",
      "refers",
      "cardiologist",
      "hourly",
      "body",
      "paediatrician",
      "specialist",
      "sensation",
      "vertigo",
      "allergic",
      "abnormal",
      "patients"
    ]
  },
  {
    "id": "daf1d881fcf1f88b483645bebda073c5",
    "content": "sensations difficult to describe. Dizziness is almost always associated with other symptoms, therefore a careful history and focused physical examination should be performed in all cases to identify the cause. Like dizziness, “blackouts” is a vague, descriptive term implying either altered consciousness, visual disturbance or a sensation of falling.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "677",
    "type": "section",
    "keywords": [
      "either",
      "associated",
      "describe",
      "identify",
      "always",
      "therefore",
      "sensation",
      "altered",
      "almost",
      "disturbance",
      "should",
      "implying",
      "cause",
      "consciousness",
      "performed",
      "symptoms",
      "careful",
      "sensations",
      "term",
      "falling"
    ]
  },
  {
    "id": "50274e10635501a420cc51bd7a2e650a",
    "content": "A careful history, particularly from an eye-witness, is essential. Episodes of transient disturbance of consciousness and falls are common clinical problems. It is usually possible to distinguish between a fit (a seizure), an episode of fainting and other types of attack from the history given by the patient and the account of an eye witness.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "678",
    "type": "section",
    "keywords": [
      "usually",
      "falls",
      "types",
      "essential",
      "given",
      "transient",
      "fainting",
      "seizure",
      "patient",
      "witness",
      "attack",
      "episode",
      "particularly",
      "episodes",
      "disturbance",
      "consciousness",
      "between",
      "careful",
      "distinguish",
      "other"
    ]
  },
  {
    "id": "b99b2ba9712da5880a91a64ea523e19e",
    "content": "Causes\nCardiovascular\nVasovagal - (fainting)\nPostural hypotension\nAcute haemorrhage\nCardiac arrhythmias\nSevere aortic stenosis\nComplete heart block with Stokes-Adams attacks\nVertebro-basilar insufficiency\nCerebral\nTransient Ischaemic Attacks (TIA)\nStroke\nEpilepsy\nOthers\nDrug-induced\nSevere anaemia\nHypoglycaemia.",
    "title": "Chapter 7:  Dısorders of the Cardıovascular System",
    "section": "Chapter 7:  Dısorders of the Cardıovascular System",
    "chunk_id": "679",
    "type": "section",
    "keywords": [
      "vertebro",
      "block",
      "anaemia",
      "transient",
      "fainting",
      "postural",
      "induced",
      "complete",
      "acute",
      "insufficiency",
      "adams",
      "attacks",
      "aortic",
      "others",
      "epilepsy",
      "basilar",
      "drug",
      "heart",
      "causes",
      "arrhythmias"
    ]
  },
  {
    "id": "16a7463f8d0485a1b81893b69738ca9a",
    "content": "Conversion disorder (Hysterical fainting/Hyperventilation)\nSymptoms\nLight-headedness\nLoss of consciousness\nSense of motion or spinning of body\nUnsteadiness\nNausea\nVomiting\nTinnitus\nSigns\nSweating (suggests vasovagal episode/hypoglycaemia)\nTachycardia or bradycardia (suggest cardiac arrhythmia)\nHypotension\nPostural hypotension\nPallor.",
    "title": "Meniere’s disease",
    "section": "Meniere’s disease",
    "chunk_id": "680",
    "type": "section",
    "keywords": [
      "nausea",
      "headedness",
      "sense",
      "hyperventilation",
      "fainting",
      "postural",
      "light",
      "tachycardia",
      "spinning",
      "body",
      "suggests",
      "hysterical",
      "episode",
      "signs",
      "unsteadiness",
      "pallor",
      "vasovagal",
      "motion",
      "sweating",
      "consciousness"
    ]
  },
  {
    "id": "8b48e76f4ed39cdd19c81738d055dc0b",
    "content": "Nystagmus, dysdiadochokinesis, ataxia, hypotonia, dysarthria (suggests cerebellar cause)\nFocal neurological signs suggests stroke, TIA\ninvestigations\nThese vary depending on the cause\nFBC\nRandom blood sugar\nX-ray of cervical spine\nECG.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "681",
    "type": "section",
    "keywords": [
      "dysdiadochokinesis",
      "hypotonia",
      "focal",
      "suggests",
      "neurological",
      "signs",
      "vary",
      "sugar",
      "blood",
      "cause",
      "investigations",
      "ataxia",
      "random",
      "cervical",
      "depending",
      "stroke",
      "nystagmus",
      "dysarthria",
      "spine",
      "cerebellar"
    ]
  },
  {
    "id": "ad91aa12260165c8f5090f89e5b5411f",
    "content": "To identify and appropriately manage the possible underlying\ncause(s).",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "682",
    "type": "section",
    "keywords": [
      "manage",
      "appropriately",
      "cause",
      "underlying",
      "possible",
      "identify"
    ]
  },
  {
    "id": "1aa44a21bbcfb04733c9ecabe1d98681",
    "content": "Postural hypotension - review medications\nHyperventilation syndrome - breathing control exercise\nCounseling\nCervical collar\nMoulded cervical pillows.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "683",
    "type": "section",
    "keywords": [
      "review",
      "moulded",
      "medications",
      "pillows",
      "exercise",
      "hyperventilation",
      "breathing",
      "counseling",
      "postural",
      "syndrome",
      "control",
      "collar",
      "hypotension",
      "cervical"
    ]
  },
  {
    "id": "38acb371a5fd05212c6b6699e79b2ffd",
    "content": "Treat the underlying cause. (See appropriate section)\nReferral Criteria\nRefer patients to a physician specialist for evaluation if the cause is difficult to determine. If the cause is identified, refer to the appropriate specialist for further evaluation and management.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "684",
    "type": "section",
    "keywords": [
      "determine",
      "referral",
      "specialist",
      "evaluation",
      "appropriate",
      "treat",
      "management",
      "section",
      "refer",
      "identified",
      "cause",
      "further",
      "underlying",
      "difficult",
      "patients",
      "criteria",
      "physician"
    ]
  },
  {
    "id": "73b0a67f96b33a9bdfe39a5a363f5fcf",
    "content": "This is a self-limiting infection of the upper respiratory tract, particularly the nasopharyngeal mucosa and sinuses. It is contagious and spread by airborne droplets, as well as from hands and contact with contaminated surfaces. The symptoms resolve without antibiotic treatment, usually within a week.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "685",
    "type": "section",
    "keywords": [
      "usually",
      "nasopharyngeal",
      "self",
      "antibiotic",
      "contagious",
      "within",
      "surfaces",
      "week",
      "sinuses",
      "limiting",
      "particularly",
      "treatment",
      "tract",
      "resolve",
      "hands",
      "respiratory",
      "mucosa",
      "airborne",
      "symptoms",
      "contact"
    ]
  },
  {
    "id": "78b752a70dbaa03728fd7e04de2eb00e",
    "content": "If the ‘cold’ lasts longer than a week and there is persistent fever and cough, a diagnosis of influenza may be considered. With influenza, fever, systemic symptoms and prostration are more pronounced. Secondary bacterial infection may be associated with purulent phlegm or offensive nasal discharge and fever.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "686",
    "type": "section",
    "keywords": [
      "phlegm",
      "lasts",
      "systemic",
      "associated",
      "pronounced",
      "secondary",
      "prostration",
      "week",
      "influenza",
      "diagnosis",
      "fever",
      "longer",
      "bacterial",
      "there",
      "purulent",
      "persistent",
      "symptoms",
      "nasal",
      "considered",
      "discharge"
    ]
  },
  {
    "id": "80575989fd47a0455051c6761f743e16",
    "content": "Occasionally, the common cold is complicated by otitis media and pharyngotonsillitis, particularly in children, in which case one should refer to the appropriate sections for treatment. Causes\nRhinoviruses\nCorona viruses\nRespiratory Syncytial Virus (RSV)\nSymptoms\nRunny nose (rhinorrhea)\nSneezing\nNasal congestion\nMild fever\nHeadaches\nSore throat\nMuscle aches\nCough\nFatigue\nMalaise\nSigns\nLow grade fever\nNasal discharge.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "687",
    "type": "section",
    "keywords": [
      "virus",
      "corona",
      "fatigue",
      "sneezing",
      "congestion",
      "which",
      "otitis",
      "muscle",
      "signs",
      "children",
      "particularly",
      "causes",
      "treatment",
      "sections",
      "headaches",
      "grade",
      "complicated",
      "should",
      "fever",
      "syncytial"
    ]
  },
  {
    "id": "164754432c66bc7751c74d03b8c7f618",
    "content": "Nasal mucosa reddening\nWatering of eyes\ninvestigations\nNo investigations required.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "688",
    "type": "section",
    "keywords": [
      "reddening",
      "watering",
      "mucosa",
      "required",
      "investigations",
      "eyes",
      "nasal"
    ]
  },
  {
    "id": "c256ef8c79cc7a4e3bfd6a226b8fca68",
    "content": "To relieve symptoms\nResolution of infection in the shortest possible time.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "689",
    "type": "section",
    "keywords": [
      "resolution",
      "shortest",
      "infection",
      "relieve",
      "possible",
      "symptoms"
    ]
  },
  {
    "id": "af146f1efaa7d679ff5db9ffb7332541",
    "content": "Rest\nEncourage adequate fluid intake\nGargle lukewarm salt solution\nSteam inhalation.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "690",
    "type": "section",
    "keywords": [
      "salt",
      "inhalation",
      "steam",
      "lukewarm",
      "gargle",
      "rest",
      "intake",
      "encourage",
      "adequate",
      "solution",
      "fluid"
    ]
  },
  {
    "id": "d6e79055ca6942cba1dcb2146a297dfd",
    "content": "Paracetamol, oral,\nAdults\ng 6-8 hourly\nChildren\n10-15 mg/kg/dose 6-8 hourly\n6-12 years;\t250-500 mg 6-8 hourly\n1-5 years;\t120-250 mg 6-8 hourly\nmonths-1 year;\t60-120 mg 6-8 hourly\nAnd\nSodium Chloride 0. 9%, nasal drops,\nAdult and Children\n2 drops, into each nostril, 4 hourly to relieve congestion as necessary\nOr\nXylometazoline, nasal,\nAdults (0. 1% preparation)\n1-2 drops 12 hourly into each nostril\nChildren (0.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "691",
    "type": "section",
    "keywords": [
      "years",
      "drops",
      "congestion",
      "preparation",
      "nostril",
      "into",
      "hourly",
      "sodium",
      "children",
      "each",
      "adult",
      "adults",
      "paracetamol",
      "dose",
      "chloride",
      "months",
      "nasal",
      "year",
      "xylometazoline",
      "necessary"
    ]
  },
  {
    "id": "faa6ef48ed697e28ea821ed337f1f537",
    "content": "05% preparation)\n3 months;\t1-2 drops 12 hourly into each nostril\nAnd\nCetirizine, oral,\nAdults\n10 mg daily\nChildren\n12 years;\t10 mg daily\n6-2 years;\t5 mg daily\n2-6 years;\t2. 5 mg daily.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "692",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "drops",
      "each",
      "cetirizine",
      "adults",
      "preparation",
      "oral",
      "nostril",
      "children",
      "months",
      "into",
      "daily"
    ]
  },
  {
    "id": "4b0fa1e7e82143917a29100a3650ae93",
    "content": "Or\nChlorpheniramine maleate, oral,\nAdult\nmg 12 hourly\nChildren\n6-12 years;\t2 mg 6-12 hourly daily (max. 12 mg daily)\n2-6 years;\t1 mg 6-8 hourly (max. 6 mg daily)\n1-2 years;\tnot recommended\nReferral Criteria\nRefer cases suspected to have measles, influenza or complications to a paediatrician or physician for management.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "693",
    "type": "section",
    "keywords": [
      "years",
      "management",
      "hourly",
      "paediatrician",
      "children",
      "criteria",
      "influenza",
      "physician",
      "referral",
      "suspected",
      "chlorpheniramine",
      "adult",
      "measles",
      "complications",
      "recommended",
      "maleate",
      "refer",
      "oral",
      "cases",
      "have"
    ]
  },
  {
    "id": "a9f867c4501cd30377323919733ca57c",
    "content": "Pneumonia is an infection of the lung tissue caused by various bacteria, viruses or fungi. Identification of the causative organism and drug sensitivity testing is the key to correct treatment. However, because of the serious nature of the infection, antibiotic treatment should be started immediately based on knowledge of the most probable causative organism and the antibiotics used for its treatment.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "694",
    "type": "section",
    "keywords": [
      "bacteria",
      "correct",
      "based",
      "probable",
      "antibiotics",
      "causative",
      "antibiotic",
      "sensitivity",
      "nature",
      "serious",
      "immediately",
      "drug",
      "organism",
      "most",
      "knowledge",
      "treatment",
      "caused",
      "because",
      "pneumonia",
      "testing"
    ]
  },
  {
    "id": "e922a72590aa419c993f76fdb211c2da",
    "content": "Local knowledge of drug resistance patterns are also taken into account. Treatment may be maintained or changed based on culture results and assessment of the patient’s response to initial treatment. In the event that the cultures of blood or sputum prove negative, empiric treatment is continued with clinical response as a guide.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "695",
    "type": "section",
    "keywords": [
      "initial",
      "based",
      "local",
      "guide",
      "changed",
      "results",
      "patient",
      "into",
      "sputum",
      "drug",
      "continued",
      "culture",
      "knowledge",
      "maintained",
      "treatment",
      "blood",
      "empiric",
      "cultures",
      "event",
      "prove"
    ]
  },
  {
    "id": "8724d11db29236086982b9c2fee089ee",
    "content": "The severity of the illness is a key factor in the decision for admission, and the choice of first or second-line treatment.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "696",
    "type": "section",
    "keywords": [
      "choice",
      "first",
      "severity",
      "line",
      "factor",
      "illness",
      "second",
      "admission",
      "treatment",
      "decision"
    ]
  },
  {
    "id": "a43c9768534c23c548b191a17fe2c494",
    "content": "Causes\nCommunity acquired pneumonia\nStreptococcus pneumonia\nStreptococcus pyogenes\nHaemophilus influenza\nKlebsiella pneumoniae\nMycoplasma pneumonia and Legionella pneumophila (tend to occur\nin epidemics)\nStaphylococcus aureus (in children after viral illness like measles, in diabetics or in the elderly during ‘flu’ epidemics)\nAspiration pneumonia\nAnaerobic and/or gram negative organisms (associated with aspiration e. g. stroke, seizures, unconsciousness)\nHospital acquired pneumonia\nGram-negative bacteria e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "697",
    "type": "section",
    "keywords": [
      "unconsciousness",
      "bacteria",
      "streptococcus",
      "legionella",
      "klebsiella",
      "occur",
      "during",
      "seizures",
      "elderly",
      "associated",
      "epidemics",
      "aureus",
      "aspiration",
      "haemophilus",
      "hospital",
      "pyogenes",
      "acquired",
      "children",
      "pneumoniae",
      "causes"
    ]
  },
  {
    "id": "200fe3f908df782ee0e56df661da621b",
    "content": "g. Pseudomonas aeruginosa\nMRSA (Methicillin resistant)\nVRSA (Vancomycin resistant)\nStaphylococcus aureus\nOthers\nPneumocystis jiroveci pneumonia and other fungi (in immunocompromised states e. g.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "698",
    "type": "section",
    "keywords": [
      "vrsa",
      "states",
      "others",
      "pseudomonas",
      "staphylococcus",
      "vancomycin",
      "pneumonia",
      "other",
      "jiroveci",
      "fungi",
      "resistant",
      "aeruginosa",
      "immunocompromised",
      "methicillin",
      "pneumocystis",
      "aureus",
      "mrsa"
    ]
  },
  {
    "id": "151b8206e58e28ec12a1084b5360d5e9",
    "content": "haematological malignancies, HIV/ AIDS)\nViruses\nSymptoms\nFever - short history\nProductive cough\nSputum - rusty or blood stained, yellowish, greenish\nPleuritic chest pain - worse on deep breathing or coughing\nBreathlessness\nSweating\nMuscle aches\nElderly and immunocompromised patients may have minimum or no symptoms\nSigns\nRapid breathing.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "699",
    "type": "section",
    "keywords": [
      "breathing",
      "elderly",
      "aids",
      "stained",
      "worse",
      "sputum",
      "pleuritic",
      "short",
      "chest",
      "productive",
      "muscle",
      "signs",
      "patients",
      "immunocompromised",
      "yellowish",
      "blood",
      "haematological",
      "malignancies",
      "greenish",
      "deep"
    ]
  },
  {
    "id": "3997b0380b804475c899d3e2d49756aa",
    "content": "Grunting (in children)\nUse of accessory muscles of respiration and flaring of the nasal margins\nLower chest wall indrawing (in children)\nRestricted movement of the affected side of the chest (due to pain)\nFever\nRapid pulse rate\nBlood pressure may be normal or low\nSigns of consolidation or pleural effusion on chest examination\nRestlessness or confusion, drowsiness\nLow blood oxygen saturation by pulse oximetry < 92%\nComplications\nPleural effusion\nLung abscess\nEmpyema\nPericardial effusion/pericarditis\nPneumothorax particularly Staph. aureus infection, Pneumocystis jiroveci pneumonia\nMeningitis\nSepticaemia with multi organ failure\nAdult respiratory distress syndrome (ARDS)\ninvestigations\nFBC\nC-reactive protein (CRP)\nChest X-ray\nSputum gram stain and culture and sensitivity\nZiehl-Neelsen stain for acid-fast bacilli (to exclude TB)\nBlood culture and sensitivity\nBlood urea and electrolytes.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "700",
    "type": "section",
    "keywords": [
      "urea",
      "margins",
      "organ",
      "muscles",
      "pneumothorax",
      "septicaemia",
      "aureus",
      "empyema",
      "sensitivity",
      "pneumocystis",
      "sputum",
      "abscess",
      "rate",
      "pressure",
      "indrawing",
      "chest",
      "movement",
      "restricted",
      "oxygen",
      "pericardial"
    ]
  },
  {
    "id": "2e8f2efeaf4cf7ee690afc4ce49db3d9",
    "content": "To identify patients at greater risk who require in-hospital\nmanagement\nTo alleviate symptoms\nTo treat and eradicate the infection\nTo prevent and/or manage complications.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "701",
    "type": "section",
    "keywords": [
      "require",
      "complications",
      "greater",
      "treat",
      "prevent",
      "manage",
      "management",
      "symptoms",
      "infection",
      "eradicate",
      "alleviate",
      "risk",
      "patients",
      "identify",
      "hospital"
    ]
  },
  {
    "id": "5128952a72cf3dbdb11b2c3fdd6ef7d0",
    "content": "Nurse in comfortable position, usually with head raised\nSponging to control fever, especially in children < 5 years (who are at risk of febrile convulsions)\nAdequate oral hydration (if it can be tolerated)\nChest physiotherapy.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "702",
    "type": "section",
    "keywords": [
      "usually",
      "years",
      "especially",
      "position",
      "tolerated",
      "comfortable",
      "chest",
      "sponging",
      "convulsions",
      "children",
      "head",
      "nurse",
      "fever",
      "raised",
      "febrile",
      "physiotherapy",
      "oral",
      "risk",
      "control",
      "adequate"
    ]
  },
  {
    "id": "91c9fdfaf5ae6fc7c225e9de5f302b95",
    "content": "Ambulatory patient: low severity score < 2 (see above).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "703",
    "type": "section",
    "keywords": [
      "above",
      "severity",
      "score",
      "ambulatory",
      "patient"
    ]
  },
  {
    "id": "6edd35d4b106e6ad2705e500559dcade",
    "content": "Amoxicillin (Amoxycillin), oral,\nAdults\n1 g 8 hourly for 7 days (high dose)\nChildren\n5-12 years;\t500 mg 8 hourly for 7 days\n1-5 years;\t250 mg 8 hourly for 7 days\n6 months-1 year;\t125 mg 8 hourly for 7 days\nAnd\nAzithromycin, oral,\nAdult\n500 mg daily for 6 days\nChildren\n10 mg/kg daily for 6 days\nOr\nErythromycin, oral, (if patient is allergic to penicillin)\nAdult\n500 mg 6 hourly for 7 days\nChildren\n8-18 years;\t250-500 mg 6 hourly for 7 days\n2-8 years;\t250 mg 6 hourly for 7 days\n6 months-2 years;\t125 mg 6 hourly for 7 days.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "704",
    "type": "section",
    "keywords": [
      "years",
      "penicillin",
      "amoxycillin",
      "patient",
      "hourly",
      "allergic",
      "children",
      "days",
      "amoxicillin",
      "erythromycin",
      "adult",
      "adults",
      "azithromycin",
      "dose",
      "months",
      "year",
      "oral",
      "high",
      "daily"
    ]
  },
  {
    "id": "3a5109773b0e4d21ac3687cd3d4ed6ff",
    "content": "Cefuroxime, oral,\nAdults\n500 mg 12 hourly for 7 days\nChildren\n3 months-12 years;\t30 mg/kg/day in two divided doses for 7\ndays\n12 years;\t250-500 mg 12 hourly for 7 days\nOr\nDoxycycline, oral,\nAdults\n100 mg 12 hourly for 7-14 days depending on severity.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "705",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "depending",
      "years",
      "doxycycline",
      "severity",
      "adults",
      "doses",
      "oral",
      "cefuroxime",
      "children",
      "months",
      "divided"
    ]
  },
  {
    "id": "02e75e85ffdf09bf2b7a3b93227cc7d8",
    "content": "Hospitalised patient: Severity score, ≥ 2 or with additional factors as mentioned above\nOxygen, by face mask or nasal prongs,\nAdults and Children\nMaintain oxygen saturation > 92%\nAnd\nIV fluids as normal saline and dextrose saline to replace estimated\ninsensible loss\nAnd\nParacetamol, oral,\nAdults\n500 mg-1g 6-8 hourly\nChildren\n6-12 years;\t250-500 mg 6-8 hourly\n1-5 years;\t120-250 mg 6-8 hourly\n3 months-1 year;\t60-120 mg 6-8 hourly\nOr\nParacetamol suppository Adults and children doses as above\nAnd\nAmoxicillin + Clavulanic Acid, IV, (change to oral route when patient improves)\nAdults\n1. 2 g 8 hourly for 7-10 days\nChildren\n3 months-18 years;\t30 mg/kg 8 hourly, max. 1.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "706",
    "type": "section",
    "keywords": [
      "years",
      "insensible",
      "estimated",
      "face",
      "dextrose",
      "factors",
      "mentioned",
      "patient",
      "replace",
      "hourly",
      "oxygen",
      "doses",
      "saline",
      "clavulanic",
      "fluids",
      "children",
      "days",
      "amoxicillin",
      "above",
      "acid"
    ]
  },
  {
    "id": "7f8ee72fef25ef4573eb2314621b1aa2",
    "content": "2 g 8 hourly for\n7-10 days\n< 3 months;\t30 mg/kg 12 hourly for 7-10 days\nAnd\nAzithromycin, oral,\nAdult\n500 mg daily for 3-7 days\nChildren\n10 mg/kg once daily for 3-7 days\nOr\nAzithromycin, IV,\nAdult\n500 mg daily for 3 days\nRevert to oral azithromycin, when clinically stable to complete 7 days of treatment. (See section on treatment for ambulatory patients above). Children.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "707",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "stable",
      "treatment",
      "above",
      "section",
      "adult",
      "revert",
      "ambulatory",
      "azithromycin",
      "oral",
      "clinically",
      "complete",
      "patients",
      "children",
      "months",
      "once",
      "daily"
    ]
  },
  {
    "id": "d4afdd08f7a7e5d5e0213a253020751a",
    "content": "Ceftriaxone, IV,\nAdult\n2 g daily for 7-10 days\nChildren\nAll ages 25 mg/kg 12 hourly (max. 75 mg/kg daily)\nAnd\nAzithromycin, IV (as above).",
    "title": "2nd line treatment Evidence Rating: [A]",
    "section": "2nd line treatment Evidence Rating: [A]",
    "chunk_id": "708",
    "type": "section",
    "keywords": [
      "days",
      "ages",
      "hourly",
      "above",
      "ceftriaxone",
      "adult",
      "azithromycin",
      "children",
      "daily"
    ]
  },
  {
    "id": "6e6cdfb3e09adde740128b605e792a26",
    "content": "Ceftriaxone, IV,\nAdult\n2 g daily for 7-10 days\nChildren\nAll ages 50-75 mg/kg/day in divided 12 hourly doses\nOr\nAmoxicillin + Clavulanic Acid, IV, (change to oral route when patient improves)\nAdults\n1. 2 g 8 hourly for 7-10 days\nChildren\n3 months-18 years;\t30 mg/kg 8 hourly, max 1. 2 g 8 hourly for\n7-10 days\n< 3 months;\t30 mg/kg 12 hourly for 7-10 days\nOr\nCiprofloxacin, IV, (to be administered over 60 minutes)\nAdults\n400 mg 8-12 hourly for 7 days\nChildren\n10 mg/kg (max.",
    "title": "1st Line treatment Evidence Rating: [B]",
    "section": "1st Line treatment Evidence Rating: [B]",
    "chunk_id": "709",
    "type": "section",
    "keywords": [
      "ages",
      "years",
      "patient",
      "ciprofloxacin",
      "hourly",
      "minutes",
      "doses",
      "clavulanic",
      "children",
      "days",
      "amoxicillin",
      "acid",
      "adult",
      "adults",
      "change",
      "months",
      "divided",
      "improves",
      "ceftriaxone",
      "oral"
    ]
  },
  {
    "id": "dccd7e8e6db9a9f5af3b3757e404563c",
    "content": "400 mg) 12 hourly for 7 days\nAnd\nMetronidazole, IV,\nAdults\n500 mg 8 hourly for 7 days\nChildren\n7. 5 mg/kg 8 hourly for 7 days\nOr\nClindamycin, IV,\nAdults\n300-600 mg 6 hourly for 7 days.",
    "title": "1st Line treatment Evidence Rating: [B]",
    "section": "1st Line treatment Evidence Rating: [B]",
    "chunk_id": "710",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "clindamycin",
      "adults",
      "children"
    ]
  },
  {
    "id": "02283da4c48f79c1bfdd22689cba7e4a",
    "content": "Children\n3-6 mg/kg 6 hourly for 7 days\nReferral Criteria\nRefer to the paediatrician or physician specialist if no improvement occurs (i. e. fever remains high, patient is still breathless, or repeat X-rays show complications or no resolution).",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "711",
    "type": "section",
    "keywords": [
      "resolution",
      "patient",
      "hourly",
      "paediatrician",
      "specialist",
      "repeat",
      "children",
      "criteria",
      "physician",
      "days",
      "referral",
      "show",
      "fever",
      "remains",
      "occurs",
      "still",
      "complications",
      "rays",
      "refer",
      "high"
    ]
  },
  {
    "id": "9d9e919bfd3f822f0d9407d5abf5333d",
    "content": "Asthma is a chronic inflammatory disease of the bronchial airways, which manifests as recurrent episodes of wheeze, cough, chest tightness and shortness of breath, which is usually reversible with treatment. It is characterised by increased sensitivity to many environmental agents. Asthma is variable and may be associated with seasons like the rainy season or harmattan.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "712",
    "type": "section",
    "keywords": [
      "usually",
      "agents",
      "recurrent",
      "tightness",
      "which",
      "airways",
      "environmental",
      "associated",
      "characterised",
      "sensitivity",
      "reversible",
      "seasons",
      "wheeze",
      "chest",
      "manifests",
      "asthma",
      "harmattan",
      "treatment",
      "disease",
      "episodes"
    ]
  },
  {
    "id": "2a1435454e8877f91053d6593f303c1f",
    "content": "Bronchial asthma occurs at all ages but peaks in childhood. It is classified as an allergic disease, and may be associated with a personal or family history of allergic rhinitis (hay fever), eczema or allergic conjunctivitis. Complications of asthma include pneumomediastinum, pneumothorax, subcutaneous emphysema and pneumonia.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "713",
    "type": "section",
    "keywords": [
      "ages",
      "eczema",
      "pneumothorax",
      "associated",
      "personal",
      "family",
      "asthma",
      "childhood",
      "allergic",
      "emphysema",
      "subcutaneous",
      "disease",
      "include",
      "conjunctivitis",
      "pneumonia",
      "fever",
      "occurs",
      "complications",
      "classified",
      "pneumomediastinum"
    ]
  },
  {
    "id": "bf0d308deda3ff4474fcd3305cd0f3a1",
    "content": "Causes\nAllergens e. g. house dust mite, cockroach droppings, grass, pollen and animal hair\nEnvironmental factors e.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "714",
    "type": "section",
    "keywords": [
      "mite",
      "dust",
      "allergens",
      "droppings",
      "grass",
      "hair",
      "cockroach",
      "house",
      "pollen",
      "factors",
      "environmental",
      "animal",
      "causes"
    ]
  },
  {
    "id": "5d1f6ff8c6a989df975888339e5e2d5e",
    "content": "g. air pollution, climatic changes, strong\nscents and smoke (including cigarette smoke and car fumes)\nViral infections\nExercise\nEmotions and hyperventilation\nDrugs e. g.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "715",
    "type": "section",
    "keywords": [
      "infections",
      "scents",
      "drugs",
      "emotions",
      "including",
      "cigarette",
      "exercise",
      "hyperventilation",
      "fumes",
      "strong",
      "climatic",
      "smoke",
      "changes",
      "pollution",
      "viral"
    ]
  },
  {
    "id": "a89d9dc9479c8ece74805cdae0785f7b",
    "content": "aspirin, NSAIDS and beta-blockers such as propranolol\nOccupational exposure to industrial chemicals, dust and drug manufacturing\nSymptoms\nEpisodic breathlessness\nTightness of the chest\nCough - often nocturnal\nWheeze\nNocturnal symptoms. Any of the above symptoms waking up the patient at night\nSigns\nTachypnoea (fast breathing)\nUse of accessory muscles of respiration; neck and/or abdominal muscles\nRhonchi/wheeze.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "716",
    "type": "section",
    "keywords": [
      "episodic",
      "dust",
      "often",
      "tightness",
      "manufacturing",
      "muscles",
      "nocturnal",
      "breathing",
      "patient",
      "night",
      "tachypnoea",
      "neck",
      "abdominal",
      "wheeze",
      "chest",
      "drug",
      "occupational",
      "signs",
      "industrial",
      "nsaids"
    ]
  },
  {
    "id": "4b318ce56fd94ff2964f1933f93452ef",
    "content": "Signs of severe attack\nInability to complete full sentences in one breath\nRapid pulse > 110/minute in adults and adolescents or >130/ minute in children 2-5 years\nRapid respiration > 30/minute in adults and adolescents or or >\n50/minute in children 2-5 years\nPeak Expiratory Flow Rate (PEFR) is reduced < 50% of expected (for age, sex and height)\nSigns of a life-threatening attack are:\nCyanosis\nPulsus paradoxus\nSilent chest on auscultation\nDrowsiness or confusion\nExhaustion\nPeak Expiratory Flow Rate (PEFR) less than 33 % of expected\nvalue\nSpO2 less than 92% on room air\ninvestigations\nNo investigation required in most cases\nFBC, mildly high eosinophil count\nChest X-ray (only for the exclusion of other diagnoses or complications)\nSpirometry - reduction in FEV1 and FEV1/FVC ratio with reversibility demonstrated after bronchodilator use (a normal spirometry between attacks does not exclude asthma). Tests for atopy - skin prick test or specific IgE for common allergens\nStool examination, exclude helminthiasis.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "717",
    "type": "section",
    "keywords": [
      "test",
      "adolescents",
      "years",
      "expiratory",
      "auscultation",
      "silent",
      "ratio",
      "atopy",
      "required",
      "full",
      "complete",
      "reduced",
      "cyanosis",
      "room",
      "demonstrated",
      "pefr",
      "rate",
      "attacks",
      "attack",
      "chest"
    ]
  },
  {
    "id": "8a61cd8b6f02508fba53bc097051eaaa",
    "content": "To relieve bronchospasm\nTo prevent complications and recurrence\nTo treat underlying inflammation or infection.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "718",
    "type": "section",
    "keywords": [
      "complications",
      "recurrence",
      "treat",
      "prevent",
      "inflammation",
      "infection",
      "bronchospasm",
      "relieve",
      "underlying"
    ]
  },
  {
    "id": "6664a8b028a4add9e1509bfb712401d8",
    "content": "Avoid known triggers/allergens, such as dust (dust mite) where\npossible\nAvoid smoking\nEducation on asthma self management, device use and technique.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "719",
    "type": "section",
    "keywords": [
      "avoid",
      "mite",
      "education",
      "dust",
      "allergens",
      "smoking",
      "known",
      "self",
      "management",
      "asthma",
      "where",
      "possible",
      "technique",
      "triggers",
      "device"
    ]
  },
  {
    "id": "76dfeb22769210e3e5092fb8448035dc",
    "content": "Acute Exacerbation of Asthma: initial Management in the\nCommunity\nEvidence Rating: [C]\nSalbutamol inhaler, using pressurized metered dose inhaler (pMDI) with a spacer\nAdults and Children\nGive 1-2 puffs via a spacer and mask if needed (e. g. Volumatic Or.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "720",
    "type": "section",
    "keywords": [
      "inhaler",
      "initial",
      "exacerbation",
      "give",
      "management",
      "acute",
      "evidence",
      "rating",
      "asthma",
      "children",
      "metered",
      "spacer",
      "puffs",
      "adults",
      "volumatic",
      "dose",
      "salbutamol",
      "pressurized",
      "using",
      "community"
    ]
  },
  {
    "id": "93bfed042cefa500d2537ad48593cefe",
    "content": "Aerochamber, or large plastic mineral water bottle) with the patient taking 3-4 breaths after each puff. Repeat after every 15-30 minutes maximum 10 doses.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "721",
    "type": "section",
    "keywords": [
      "breaths",
      "minutes",
      "aerochamber",
      "large",
      "each",
      "taking",
      "puff",
      "repeat",
      "mineral",
      "doses",
      "water",
      "after",
      "maximum",
      "plastic",
      "bottle",
      "patient",
      "every"
    ]
  },
  {
    "id": "f85dbdf259122aca8d81214dbf0fed58",
    "content": "Acute Moderate/Severe Exacerbation of Asthma: initial.",
    "title": "If there is no improvement seek care at a health facility with a nebu- liser.",
    "section": "If there is no improvement seek care at a health facility with a nebu- liser.",
    "chunk_id": "722",
    "type": "section",
    "keywords": [
      "severe",
      "moderate",
      "initial",
      "exacerbation",
      "asthma",
      "acute"
    ]
  },
  {
    "id": "911eb82c5f5f11cac4e3ebf76558ce62",
    "content": "Oxygen\nBy nasal prongs 2-6 L/min\nOr\nOr\nAnd\nFace mask\t4-8 L/min\nNon-rebreather mask\t10-15 L/min\nSalbutamol, nebulised,\nAdults\n2. 5-5 mg repeated initially after 15-30 minutes, then every 2-4 hours until improved\nChildren\n2. 5-5 mg every 2-4 hours until improved\nAnd\nIpratropium bromide, nebulised,\nAdults\n500 microgram 4-6 hourly\nChildren\n6-12 years;\t250 microgram 4-6 hourly\n1-5 years;\t125 microgram 4-6 hourly (max.",
    "title": "Management in Hospital 1st Line Treatment Evidence Rating: [A]",
    "section": "Management in Hospital 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "723",
    "type": "section",
    "keywords": [
      "years",
      "nebulised",
      "face",
      "improved",
      "repeated",
      "hourly",
      "oxygen",
      "minutes",
      "initially",
      "children",
      "ipratropium",
      "adults",
      "salbutamol",
      "then",
      "every",
      "rebreather",
      "nasal",
      "bromide",
      "microgram",
      "after"
    ]
  },
  {
    "id": "6ae94514b727f036ef31716dd637f5f8",
    "content": "dose for children is 1 mg/24 hours)\nAnd\nHydrocortisone, IV,\nAdults\n200 mg stat. then 100 mg 6 hourly until clinical improvement\nChildren\n12-18 years;\t100 mg 6-8 hourly\n1 month-12 years;\t2-4 mg/kg 8 hourly\nThen.",
    "title": "Management in Hospital 1st Line Treatment Evidence Rating: [A]",
    "section": "Management in Hospital 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "724",
    "type": "section",
    "keywords": [
      "hourly",
      "improvement",
      "then",
      "years",
      "adults",
      "hydrocortisone",
      "until",
      "dose",
      "month",
      "children",
      "hours",
      "stat",
      "clinical"
    ]
  },
  {
    "id": "010a90cdfea7d9bc5022bcc21f215556",
    "content": "Salbutamol, nebulised,\nAdults\n2. 5-5 mg repeated every 6 hours until improved\nChildren.",
    "title": "Acute Moderate/Severe Exacerbation of Asthma: Maintenance Treatment in Hospital",
    "section": "Acute Moderate/Severe Exacerbation of Asthma: Maintenance Treatment in Hospital",
    "chunk_id": "725",
    "type": "section",
    "keywords": [
      "nebulised",
      "adults",
      "improved",
      "salbutamol",
      "children",
      "repeated",
      "hours",
      "until",
      "every"
    ]
  },
  {
    "id": "8dc729172a1c624bfbdc80faeb818e90",
    "content": "2. 5-5 mg every 6 hours until improved\nAnd\nIpratropium bromide, nebulised,\nAdults\n500 microgram 4-6 hourly\nChildren\n6-12 years;\t250 microgram 4-6 hourly\n1-5 years;\t125 microgram 4-6 hourly (max. dose for children 1 mg/24 hours)\nAnd\nPrednisolone, oral, initial dose given on admission and subsequently given as a morning dose.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "726",
    "type": "section",
    "keywords": [
      "initial",
      "years",
      "subsequently",
      "given",
      "morning",
      "nebulised",
      "improved",
      "hourly",
      "children",
      "ipratropium",
      "admission",
      "prednisolone",
      "adults",
      "dose",
      "every",
      "bromide",
      "microgram",
      "oral",
      "hours",
      "until"
    ]
  },
  {
    "id": "d89f568c0ae983ddbbb0ade23e118950",
    "content": "(Once on prednisolone, stop IV hydrocorti- sone after 24 hours)\nAdults\n30-40 mg daily for 7 days until stable. Taper off dose over a period of 2 weeks if patient has been on long term steroids. Children\n1-2 mg/kg for 3-5 days\nAcute Moderate/Severe Exacerbation of Asthma: Maintenance Treatment in Hospital (where patient is still distressed after 3-4 initial doses of nebulised salbutamol)\nAminophylline, IV,\nAdults\n250 mg slow injection over 20 minutes\nRepeat after 30 minutes with a continuous infusion by perfusor, if necessary, at a rate not exceeding 0.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "727",
    "type": "section",
    "keywords": [
      "initial",
      "exacerbation",
      "aminophylline",
      "nebulised",
      "infusion",
      "maintenance",
      "patient",
      "acute",
      "stable",
      "moderate",
      "rate",
      "minutes",
      "continuous",
      "doses",
      "asthma",
      "repeat",
      "where",
      "injection",
      "weeks",
      "children"
    ]
  },
  {
    "id": "5eb13e1945289aff5af390dc605cab5f",
    "content": "5 mg/kg/hour over 24 hours\nOr\nAminophylline, IV infusion, 250 mg in 500 ml of 5% Dextrose or 0. 9% Sodium Chloride, 6 hourly for 24 hours\nChildren\nmg/kg over 20 minutes as a slow infusion or by perfusor at 1mg/ kg/hour (max. 500 mg)\nChronic Asthma - initial management\nEvidence Rating: [A]\nSalbutamol, inhaled,\nAdults and children\n100 microgram, 2 puffs as often as needed\nAnd\n(If inhaled Salbutamol is needed more than once daily)\nBudesonide, inhaled,\nAdults.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "728",
    "type": "section",
    "keywords": [
      "initial",
      "hour",
      "aminophylline",
      "often",
      "management",
      "infusion",
      "dextrose",
      "evidence",
      "hourly",
      "rating",
      "minutes",
      "sodium",
      "asthma",
      "children",
      "chronic",
      "puffs",
      "adults",
      "slow",
      "chloride",
      "salbutamol"
    ]
  },
  {
    "id": "21db1b02cb2877e36f3b6864cca500d3",
    "content": "200 microgram (one puff 12 hourly)\nChildren\n10 years;\t200 microgram (one puff 12 hourly)\n< 10 years;\t100 microgram (one puff 12 hourly)\nOr\nFluticasone, Inhaled - MDI,\nAdults\n125-250 microgram (2 puffs 12 hourly)\nChildren\n50 microgram (2 puffs 12 hourly)\nOr\nBeclometasone (Beclomethasone), inhaled,\nAdults and Children\n100 microgram (2 puffs 12 hourly).",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "729",
    "type": "section",
    "keywords": [
      "hourly",
      "fluticasone",
      "years",
      "microgram",
      "puffs",
      "adults",
      "children",
      "beclomethasone",
      "puff",
      "inhaled",
      "beclometasone"
    ]
  },
  {
    "id": "e6d64a02a2a254e463a18c0dacfcf81a",
    "content": "Salbutamol, inhaled,\nAdults and children\n100 microgram, 2 puffs as often as needed\nAnd\nFluticasone/Salmeterol, inhaled,\nAdults and children over 5 years\n100/50-250/50 microgram; 1 puff 12 hourly\nOr\nBudesonide/Formoterol , inhaled,\nAdults\n160/4. 5 microgram (1-2 puffs 12 hourly)\nChildren over 5 years\n80/4. 5 microgram (1-2 puffs 12 hourly)\nAnd\nMontelukast, oral,\nAdult\n10 mg daily\nChildren\n4 or 5 mg granules daily\nAnd\nPrednisolone, oral,\nAdults\n30-40 mg daily and tail down slowly over 2-3 week period to a low maintenance daily dose of 5 mg daily.",
    "title": "Chronic Asthma - Maintenance treatment",
    "section": "Chronic Asthma - Maintenance treatment",
    "chunk_id": "730",
    "type": "section",
    "keywords": [
      "years",
      "often",
      "down",
      "granules",
      "maintenance",
      "hourly",
      "week",
      "montelukast",
      "children",
      "fluticasone",
      "puffs",
      "prednisolone",
      "formoterol",
      "adult",
      "adults",
      "period",
      "dose",
      "salbutamol",
      "puff",
      "budesonide"
    ]
  },
  {
    "id": "33d0831a1525b577270cbdce1b8b30eb",
    "content": "Children\n1 mg/kg tailed off by 5 mg every third day, reducing to 5-10 mg daily or alternate daily, lowest dose possible without provoking attacks.",
    "title": "Chronic Asthma - Maintenance treatment",
    "section": "Chronic Asthma - Maintenance treatment",
    "chunk_id": "731",
    "type": "section",
    "keywords": [
      "reducing",
      "attacks",
      "provoking",
      "third",
      "alternate",
      "tailed",
      "dose",
      "possible",
      "lowest",
      "children",
      "daily",
      "without",
      "every"
    ]
  },
  {
    "id": "1eb3420238bc9acf482ba56bfe876bad",
    "content": "Referral Criteria\nIn acute exacerbation, refer patients if not improving or rapidly deteriorating after initial management to a specialist. All discharged clients should be followed up within one week and referred to a specialist clinic for continued care. For chronic asthma refer patients with persistent symptoms to a specialist clinic in a regional or tertiary hospital, and patients who have recurrent acute exacerbations within a few days/ weeks of each other for specialist care and review of their treatment.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "732",
    "type": "section",
    "keywords": [
      "initial",
      "deteriorating",
      "recurrent",
      "exacerbation",
      "discharged",
      "management",
      "acute",
      "review",
      "within",
      "specialist",
      "hospital",
      "exacerbations",
      "week",
      "asthma",
      "continued",
      "patients",
      "weeks",
      "their",
      "regional",
      "criteria"
    ]
  },
  {
    "id": "07632e7d3b5c9b929815ffa870143d90",
    "content": "Also refer when a patient requires more than one course of oral prednisolone in 3 months. This refers to an acute inflammation of the bronchial mucosa. It is often found in association with upper respiratory tract infection.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "733",
    "type": "section",
    "keywords": [
      "often",
      "acute",
      "refers",
      "patient",
      "association",
      "inflammation",
      "tract",
      "prednisolone",
      "course",
      "also",
      "respiratory",
      "mucosa",
      "months",
      "bronchial",
      "requires",
      "infection",
      "refer",
      "oral",
      "found",
      "more"
    ]
  },
  {
    "id": "01a47b76894494e1f757c3ddef82daa6",
    "content": "Most cases do not require antibiotics, however, they may be prescribed if the patient’s SPO2 is less than 92% or if there is an underlying co-morbidity like malnutrition, measles, rickets, anaemia, diabetes mellitus, chronic bronchitis or HIV/AIDS. Causes\nViruses e. g.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "734",
    "type": "section",
    "keywords": [
      "malnutrition",
      "antibiotics",
      "morbidity",
      "anaemia",
      "mellitus",
      "aids",
      "patient",
      "require",
      "rickets",
      "underlying",
      "most",
      "causes",
      "chronic",
      "there",
      "measles",
      "viruses",
      "diabetes",
      "however",
      "cases",
      "less"
    ]
  },
  {
    "id": "de06a33d9e8901aaf9c32cda6c29c982",
    "content": "Influenza virus, Corona virus (common cold)\nBacteria e. g. Streptococcus pneumoniae, H.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "735",
    "type": "section",
    "keywords": [
      "virus",
      "bacteria",
      "corona",
      "streptococcus",
      "common",
      "influenza",
      "pneumoniae",
      "cold"
    ]
  },
  {
    "id": "8e9e433486fb9973897282512ae15284",
    "content": "influenza, Moraxella catarrhalis, Staph. aureus (tends to cause post-influenza chest infections, including bronchitis)\nSymptoms\nDry cough\nSputum production\nSore throat\nPleuritic chest pain\nLow grade fever\nSigns\nFever\nRhinorrhoea\nRhonchi (wheeze)\nCrepitations (rare)\ninvestigations\nFBC.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "736",
    "type": "section",
    "keywords": [
      "infections",
      "rhinorrhoea",
      "bronchitis",
      "aureus",
      "sputum",
      "pleuritic",
      "rare",
      "wheeze",
      "chest",
      "including",
      "production",
      "crepitations",
      "signs",
      "influenza",
      "post",
      "grade",
      "rhonchi",
      "fever",
      "cause",
      "investigations"
    ]
  },
  {
    "id": "31fdba8c416639870d55d73bf61034ea",
    "content": "Sputum culture and gram stain\nSputum AFBs (2 samples) for tuberculosis if symptoms have lasted more than 2 weeks\nSinus X-ray for rhinosinusitis (with post nasal drip) as a possible cause\nfor prolonged cough.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "737",
    "type": "section",
    "keywords": [
      "prolonged",
      "rhinosinusitis",
      "drip",
      "sputum",
      "culture",
      "weeks",
      "sinus",
      "post",
      "cause",
      "gram",
      "afbs",
      "tuberculosis",
      "symptoms",
      "nasal",
      "samples",
      "cough",
      "lasted",
      "stain",
      "possible",
      "have"
    ]
  },
  {
    "id": "16502f6cb3dc350fab1fbac32cf59fb0",
    "content": "To relieve symptoms\nTo treat suspected bacterial infection if any.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "738",
    "type": "section",
    "keywords": [
      "treat",
      "suspected",
      "infection",
      "bacterial",
      "relieve",
      "symptoms"
    ]
  },
  {
    "id": "acb7b098d18d503f85bbe4786c4f4c3a",
    "content": "Bed rest\nOral fluids to keep well hydrated\nHumidified air or steam inhalation if necessary.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "739",
    "type": "section",
    "keywords": [
      "inhalation",
      "steam",
      "keep",
      "oral",
      "necessary",
      "fluids",
      "rest",
      "hydrated",
      "humidified"
    ]
  },
  {
    "id": "1f3509a8d0ff803549912dcaf58244a0",
    "content": "Paracetamol, oral,\nAdults\n500 mg-1g 6-8 hourly\nChildren\n6-12 years;\t250-500 mg 6-8 hourly\n1-5 years;\t120-250 mg 6-8 hourly\n3 months-1 year;\t60-120 mg 6-8 hourly\nOr\nParacetamol, rectal,\nAdults\n500 mg-1g 6-8 hourly\nChildren\n6-12 years;\t250-500 mg 6-8 hourly\n1-5 years;\t120-250 mg 6-8 hourly\n3 months-1 year;\t60-120 mg 6-8 hourly\nUncomplicated acute infections-for irritating or chesty coughs\nGuaifenesin containing expectorant, oral,\nAdult\n200-400 mg 4 hourly (max. 2. 4 g per day)\nChildren\n>12 years;\t100-400 mg 4 hourly (max.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "740",
    "type": "section",
    "keywords": [
      "infections",
      "years",
      "acute",
      "hourly",
      "rectal",
      "expectorant",
      "children",
      "containing",
      "adult",
      "adults",
      "paracetamol",
      "uncomplicated",
      "months",
      "chesty",
      "coughs",
      "guaifenesin",
      "irritating",
      "year",
      "oral"
    ]
  },
  {
    "id": "6f0a8fd450facdff39a1dadd0f229015",
    "content": "2. 4 g per day)\n6-11 years;\t100-200 mg 4 hourly (max. 1.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "741",
    "type": "section",
    "keywords": [
      "hourly",
      "years"
    ]
  },
  {
    "id": "904e7e3ba97599e38d7bfc9f442f4def",
    "content": "2 g per day)\nyears;\t50-100 mg 4 hourly (max. 600 mg per day)\nmonths-2 years; 25-50 mg 4 hourly (max. 300 mg per day)\nOr\nSimple linctus, oral, Adults (adult formulation) 5 ml 6-8 hourly.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "742",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "linctus",
      "adult",
      "adults",
      "oral",
      "months",
      "formulation",
      "simple"
    ]
  },
  {
    "id": "ec639e55231ab9f773042f1a01f12439",
    "content": "Children (paediatric formulation)\n1 month-12 years;\t2. 5-5 ml 6-8 hourly\nOr\nCarbocysteine, oral,\nAdult\n500-750 mg 6-8 hourly\nChildren\n2-5 years;\t62. 5-125 mg 6 hourly\n<2 years;\tnot recommended\nUncomplicated acute infections-for non-productive or dry cough\nDextromethorphan containing cough preparations\nAdult\n10-20 mg 6-8 hourly\nChildren\n7-12 years;\t15 mg 6-8 hourly (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "743",
    "type": "section",
    "keywords": [
      "infections",
      "hourly",
      "recommended",
      "years",
      "dextromethorphan",
      "containing",
      "cough",
      "adult",
      "carbocysteine",
      "productive",
      "preparations",
      "oral",
      "uncomplicated",
      "month",
      "children",
      "acute",
      "formulation",
      "paediatric"
    ]
  },
  {
    "id": "eaf5d263bd0588c5d3e338e41d149b62",
    "content": "60 mg per day)\n4-6 years;\t7. 5 mg 6-8 hourly (max. 30 mg per day)\n< 4 years;\tnot recommended\nOr\nCodeine containing cough preparations\nAdult\n7.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "744",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "containing",
      "codeine",
      "cough",
      "adult",
      "preparations"
    ]
  },
  {
    "id": "cf0886fa6e0a91ccc41a40c5ae4748bd",
    "content": "5 -20 mg 4-6 hourly as needed (max. 120 mg per day)\nChildren\n7-12 years;\t1-1. 5 mg/kg per day in 4-6 divided doses (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "745",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "needed",
      "doses",
      "children",
      "divided"
    ]
  },
  {
    "id": "736558800d1bd22887310ecaa27ad465",
    "content": "60 mg per day)\n2-6 years;\t1-1. 5 mg/kg per day in 4-6 divided doses (max. 30 mg per day)\n< 2 years;\tnot recommended\nFor complicated acute infections with co-morbidities or secondary bacterial infection.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "746",
    "type": "section",
    "keywords": [
      "infections",
      "recommended",
      "years",
      "complicated",
      "infection",
      "morbidities",
      "doses",
      "bacterial",
      "secondary",
      "acute",
      "divided"
    ]
  },
  {
    "id": "cebfb742f9b5477df63cababc7291d34",
    "content": "Amoxicillin (Amoxycillin), oral,\nAdults\n500 mg 8 hourly for 5-7 days\nChildren\n6-12 years;\t250 mg 8 hourly for 7 days\n1-5 years;\t125 mg 8 hourly for 7 days\n<1 year;\t62. 5 mg 8 hourly for 7 days\nOr\nAmoxicillin + Clavulanic Acid, oral,\nAdults\n1 g 12 hourly for 5-7 days\nChildren\n12 years;\tOne 500/125 tablet 12 hourly for 7 days\n4-12 years;\t5 ml of 400/57 suspension 12 hourly for 7 days\nyears;\t5 ml of 200/28 suspension 12 hourly for 7 days.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "747",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "amoxicillin",
      "tablet",
      "years",
      "acid",
      "suspension",
      "adults",
      "clavulanic",
      "oral",
      "children",
      "amoxycillin",
      "year"
    ]
  },
  {
    "id": "0b88d58fa332794fa291234b8bad8085",
    "content": "3 months-1 year; 20 mg/kg (of amoxicillin) 12 hourly for 7 days\n< 3 months;  15 mg/kg (of amoxicillin) 12 hourly for 7 days\nFor children double the dose of the above antibiotic in severe infec- tions (bronchopneumonia)\nOr\nErythromycin, oral, (for individuals allergic to penicillin)\nAdults\n250-500 mg 6 hourly for 7 days\nChildren\n8-18 years;\t250-500 mg 6 hourly 7 days\n2-8 years;\t250 mg 6 hourly 7 days\n6 months-2 years;\t125 mg 6 hourly 7 days\nOr\nAzithromycin, oral,\nAdults\n500 mg once daily for 3 days\nChildren\n10 mg/kg once daily for 3 days\nAnd\nOxygen\nBy nasal prongs, 2-6 L/min\nOr\nFace mask, 4-8 L/min\nOr\nNon-rebreather mask, 10-15 L/min\nReferral Criteria\nRefer all complicated cases of acute bronchitis to a specialist. This is chronic inflammation of the bronchial mucosa due to irritants such as tobacco smoke. It occurs after the age of 40 years and is part of the syndrome of chronic obstructive pulmonary disease (COPD).",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "748",
    "type": "section",
    "keywords": [
      "infec",
      "tobacco",
      "years",
      "copd",
      "penicillin",
      "face",
      "antibiotic",
      "smoke",
      "prongs",
      "acute",
      "hourly",
      "specialist",
      "oxygen",
      "bronchopneumonia",
      "part",
      "inflammation",
      "obstructive",
      "double",
      "allergic",
      "irritants"
    ]
  },
  {
    "id": "3f721cd907955e367e14bd05e8089988",
    "content": "There is progressive worsening with age, eventually resulting in chronic respiratory failure. It is aggravated by recurrent viral and bacterial infections. Oxygen therapy in these patients must be given with caution to prevent carbon dioxide retention due to depression of respiration.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "749",
    "type": "section",
    "keywords": [
      "infections",
      "recurrent",
      "aggravated",
      "given",
      "therapy",
      "eventually",
      "oxygen",
      "prevent",
      "retention",
      "progressive",
      "patients",
      "chronic",
      "worsening",
      "bacterial",
      "respiratory",
      "there",
      "failure",
      "viral",
      "dioxide",
      "respiration"
    ]
  },
  {
    "id": "675b962fcdc430f33f1f5172fdf42824",
    "content": "High flow rates remove the central hypoxic drive that maintains respiratory effort and can be harmful. Causes\nCigarette smoking\nIndustrial dust\nChemical irritants\nInhaled smoke from use of biomass fuels (eg. charcoal, wood).",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "750",
    "type": "section",
    "keywords": [
      "dust",
      "hypoxic",
      "smoke",
      "charcoal",
      "rates",
      "drive",
      "chemical",
      "irritants",
      "industrial",
      "effort",
      "cigarette",
      "causes",
      "maintains",
      "respiratory",
      "harmful",
      "smoking",
      "flow",
      "fuels",
      "central",
      "high"
    ]
  },
  {
    "id": "fb520c3f1baeba28fbee7489adbec47e",
    "content": "Symptoms\nShortness of breath, particularly on exertion\nWheeze\nFever\nCough with production of sputum for most of the year\nInfective exacerbation associated with increased quantity of thick purulent sputum\nSigns\nMay be none\nBarrel chest\nPursed lip breathing\nClubbing\nCyanosis\nIncreased respiratory rate\nUse of assessory muscles i. e. neck and/or abdominal muscles, for breathing\nHyperresonance on percussion and loss of cardiac dullness\nWheeze or rhonchi\nReduced Peak Expiratory Flow Rate (PEFR)\ninvestigations\nFBC\nSpirometry, shows reduced lung volumes, particularly FEV1 which is not reversed post-bronchodilator administration\nChest X-ray\nSputum culture and gram stain.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "751",
    "type": "section",
    "keywords": [
      "barrel",
      "thick",
      "exacerbation",
      "expiratory",
      "volumes",
      "exertion",
      "muscles",
      "which",
      "breathing",
      "associated",
      "reduced",
      "cyanosis",
      "neck",
      "dullness",
      "sputum",
      "abdominal",
      "rate",
      "pefr",
      "wheeze",
      "chest"
    ]
  },
  {
    "id": "1fcfcc611614dcd5f670f4babedfcc25",
    "content": "To minimise or stop cough\nTo prevent or minimise wheeze and shortness of breath\nTo reduce quantity of sputum produced\nTo prevent infective exacerbations.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "752",
    "type": "section",
    "keywords": [
      "sputum",
      "exacerbations",
      "breath",
      "minimise",
      "wheeze",
      "produced",
      "prevent",
      "cough",
      "shortness",
      "reduce",
      "stop",
      "infective",
      "quantity"
    ]
  },
  {
    "id": "228da8d5c1391636120092082cf3e414",
    "content": "Smoking cessation\nPhysical exercise\nGood nutrition\nUse of face mask in high risk occupations.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "753",
    "type": "section",
    "keywords": [
      "cessation",
      "nutrition",
      "smoking",
      "occupations",
      "physical",
      "face",
      "exercise",
      "high",
      "risk",
      "mask"
    ]
  },
  {
    "id": "23415132dbc49db201070b96dca2c1e0",
    "content": "Stable chronic bronchitis\nEvidence Rating: [B]\nSalbutamol, inhaled, (via pMDI)\nAdults\n100 microgram (2 puffs) 4-6 hourly as required.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "754",
    "type": "section",
    "keywords": [
      "stable",
      "hourly",
      "rating",
      "chronic",
      "microgram",
      "puffs",
      "inhaled",
      "pmdi",
      "adults",
      "salbutamol",
      "bronchitis",
      "required",
      "evidence"
    ]
  },
  {
    "id": "cd9bb35a948305f15cdcd633a6a17476",
    "content": "Children (by nebulisation)\n2. 5-5 mg 4-6 hourly as required\nAnd\nTiotropium, inhaled (dry powder inhaler),\nAdults\n18 microgram (2 puffs) daily\nChildren\n12 years;\t18 microgram (2 puffs) daily\n< 12 years;\tnot recommended\nAnd\nFluticasone/salmeterol, inhaled (via accuhaler or pMDI),\nAdults\n100/50 microgram or 250/50 microgram or 500/50 microgram, 1 puff 12 hourly\nChildren\n4-12 years;\t100/50 microgram, 1 puff 12 hourly\n< 4 years;\tsafety not established\nOr\nBudesonide/formoterol, inhaled (via accuhaler or pMDI),\nAdults\n160/4. 5 microgram 1-2 puffs 12 hourly\nChildren\n>12 years;\t160/4.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "755",
    "type": "section",
    "keywords": [
      "inhaler",
      "tiotropium",
      "years",
      "nebulisation",
      "accuhaler",
      "required",
      "established",
      "hourly",
      "powder",
      "safety",
      "children",
      "fluticasone",
      "puffs",
      "formoterol",
      "adults",
      "puff",
      "budesonide",
      "recommended",
      "microgram",
      "salmeterol"
    ]
  },
  {
    "id": "b54d72ae25b3b34cb8cabfdad7125a74",
    "content": "5 microgram 1-2 puffs 12 hourly\n<12 years;\tefficacy not established\nChronic bronchitis with infective exacerbation\nEvidence Rating: [C]\nOxygen\nBy nasal prongs, 2-6 L/min\nOr\nFace mask, 4-8 L/min\nOr\nNon-rebreather mask, 10-15 L/min\nAnd\nSalbutamol, nebulised,\nAdults\n2. 5-5 mg repeated initially after 15-30 minutes, then every 2-4 hours until improved\nChildren\n2. 5-5 mg 4-6 hourly\nAnd\nIpratropium bromide, nebulised,\nAdults\n500 microgram 4-6 hourly, until improved\nChildren\n6-12 years;\t250 microgram 4-6 hourly.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "756",
    "type": "section",
    "keywords": [
      "years",
      "exacerbation",
      "nebulised",
      "efficacy",
      "face",
      "improved",
      "established",
      "repeated",
      "evidence",
      "hourly",
      "rating",
      "oxygen",
      "minutes",
      "infective",
      "initially",
      "children",
      "ipratropium",
      "chronic",
      "puffs",
      "adults"
    ]
  },
  {
    "id": "348d0eafe58d8dfc29c2f8c504abd146",
    "content": "years;\t125 microgram 4-6 hourly (max. dose for children 1 mg/24 hours)\nAnd\nAmoxicillin (Amoxycillin), oral,\nAdults\n500 mg 8 hourly for 7-14 days\nChildren\n6-12 years;\t250 mg 8 hourly for 7-14 days\n1-5 years;\t125 mg 8 hourly for 7-14 days\n<1 year;\t62. 5 mg 8 hourly for 7-14 days\nOr\nErythromycin, oral,\nAdults\n500 mg 6 hourly for 7-14 days\nChildren\n8-18 years;\t250-500 mg 6 hourly 7-14 days\n2-8 years;\t250 mg 6 hourly 7-14 days\n6 months-2 years;\t125 mg 6 hourly 7-14 days\nOr\nAzithromycin, oral,\nAdult\n500 mg daily for 6 days\nChildren\n10 mg/kg daily for 6 days\nOr\nAmoxicillin + Clavulanic Acid, oral,\nAdults\n1 g 12 hourly for 7-10 days\nChildren\n12 years;\tOne 500/125 tablet 12 hourly for 7-10 days\n4-12 years;\t5 ml of 400/57 suspension 12 hourly for 7-10 days\nyears;\t5 ml of 200/28 suspension 12 hourly for 7-10 days\n3 months-1 year; 20 mg/kg (of amoxicillin) 12 hourly for 7-10 days\n< 3 months; 15 mg/kg (of amoxicillin) 12 hourly for 7-10 days\nAnd\nPrednisolone, oral,\nAdults\n30-40 mg for 7 days\nThen\n20 mg daily for 5 days, 10 mg daily for 5 days, 5 mg daily for 5 days.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "757",
    "type": "section",
    "keywords": [
      "years",
      "amoxycillin",
      "hourly",
      "clavulanic",
      "children",
      "days",
      "amoxicillin",
      "erythromycin",
      "prednisolone",
      "acid",
      "adult",
      "adults",
      "suspension",
      "azithromycin",
      "dose",
      "months",
      "then",
      "year",
      "tablet",
      "microgram"
    ]
  },
  {
    "id": "a2045f0ca17fa59180f386446cc705eb",
    "content": "Tail down over 2-3 weeks and stop. Children\nmg/kg for 3-5 days. Tail down over 2-3 weeks and stop.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "758",
    "type": "section",
    "keywords": [
      "days",
      "stop",
      "down",
      "children",
      "weeks",
      "tail"
    ]
  },
  {
    "id": "bf3c770d755984b3ce7d4003580ec3d8",
    "content": "Adults\n10 ml 8 hourly for 5-7 days Children (paediatric formulation) 5-10 ml 8 hourly for 5-7 days\nOr\nCarbocysteine, oral,\nAdult\n500-750 mg 6-8 hourly\nChildren\n2-5 years;\t62. 5-125 mg 6 hourly\n< 2 years;\tnot recommended\nReferral Criteria\nRefer all patients not improving on initial management, with acute exacerbation, recurrent infective exacerbations or rapidly deteriorating to a specialist. In bronchiectasis, the medium and smaller sized bronchi and bronchioles are damaged.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "759",
    "type": "section",
    "keywords": [
      "initial",
      "deteriorating",
      "recurrent",
      "years",
      "exacerbation",
      "sized",
      "bronchioles",
      "management",
      "medium",
      "bronchiectasis",
      "acute",
      "formulation",
      "hourly",
      "exacerbations",
      "specialist",
      "infective",
      "smaller",
      "carbocysteine",
      "patients",
      "children"
    ]
  },
  {
    "id": "fe9569e4583a08beb10505d70fa998b0",
    "content": "Their ciliated epithelium is destroyed by inflammation and scarring, which in a vicious cycle of infection and further scarring leads to permanent dilatation and bronchial wall thickening. The mucus lining of these airways become colonized by bacteria and generate copious amounts of purulent and often offensive sputum. The disease, if not treated is characterized by frequent infective exacerbations with progressively worsening lung function.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "760",
    "type": "section",
    "keywords": [
      "amounts",
      "bacteria",
      "often",
      "which",
      "airways",
      "copious",
      "sputum",
      "exacerbations",
      "inflammation",
      "infective",
      "treated",
      "function",
      "thickening",
      "lining",
      "progressively",
      "their",
      "ciliated",
      "leads",
      "colonized",
      "disease"
    ]
  },
  {
    "id": "0cb6880c7f9180f8882efbed3186c688",
    "content": "Causes\nChildhood pneumonia e. g. whooping cough, post measles\nPost-pulmonary tuberculosis\nChronic rhinosinusitis with post-nasal drip\nAsthma and COPD.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "761",
    "type": "section",
    "keywords": [
      "post",
      "chronic",
      "copd",
      "whooping",
      "cough",
      "pneumonia",
      "pulmonary",
      "rhinosinusitis",
      "asthma",
      "childhood",
      "drip",
      "measles",
      "tuberculosis",
      "causes",
      "nasal"
    ]
  },
  {
    "id": "4ea253b9d8757ca775d9da444eeba288",
    "content": "Immune deficiency states e. g. HIV infection, agammaglobulinaemia\nInherited disorders e.",
    "title": "Fibrosing lung disease of any cause e.g. rheumatoid lung disease",
    "section": "Fibrosing lung disease of any cause e.g. rheumatoid lung disease",
    "chunk_id": "762",
    "type": "section",
    "keywords": [
      "states",
      "infection",
      "agammaglobulinaemia",
      "inherited",
      "immune",
      "disorders",
      "deficiency"
    ]
  },
  {
    "id": "9e66376be5915d4808952e2fe7e415db",
    "content": "g. cystic fibrosis, primary ciliary dyskinesia should be considered in young children presenting with bronchiectasis\nSymptoms\nPersistent cough over many months\nCopious purulent sputum which is sometimes offensive\nHaemoptysis in over one third of cases during exacerbations\nIntermittent systemic symptoms - fever, night sweats and weight loss\nChest pain\nDifficulty in breathing\nSigns\nWeight loss.",
    "title": "Fibrosing lung disease of any cause e.g. rheumatoid lung disease",
    "section": "Fibrosing lung disease of any cause e.g. rheumatoid lung disease",
    "chunk_id": "763",
    "type": "section",
    "keywords": [
      "weight",
      "during",
      "presenting",
      "bronchiectasis",
      "which",
      "systemic",
      "breathing",
      "sometimes",
      "night",
      "copious",
      "primary",
      "sputum",
      "haemoptysis",
      "exacerbations",
      "chest",
      "intermittent",
      "signs",
      "children",
      "third",
      "sweats"
    ]
  },
  {
    "id": "0baf30c7f8dfb00534e10a08ece837f1",
    "content": "Fever\nClubbing\nDull percussion note\nBronchial breath sounds\nCoarse crepitations\ninvestigations\nFBC, ESR\nSputum culture and sensitivity, gram stain\nSputum AFBs\nChest X-ray\nCT scan of the chest\nPulse oximetry.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "764",
    "type": "section",
    "keywords": [
      "coarse",
      "sensitivity",
      "sputum",
      "chest",
      "crepitations",
      "dull",
      "note",
      "culture",
      "oximetry",
      "fever",
      "gram",
      "afbs",
      "investigations",
      "percussion",
      "clubbing",
      "breath",
      "pulse",
      "bronchial",
      "scan",
      "sounds"
    ]
  },
  {
    "id": "1b9ced59db5967a32a8e08cf81078bd5",
    "content": "To treat infection\nTo aid sputum clearance\nTo minimize cough and sputum production\nTo prevent exacerbations.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "765",
    "type": "section",
    "keywords": [
      "sputum",
      "exacerbations",
      "treat",
      "prevent",
      "cough",
      "infection",
      "production",
      "clearance",
      "minimize"
    ]
  },
  {
    "id": "72ae4a530732fa4ad9d325d0240713dc",
    "content": "Chest  physiotherapy  -  Postural  drainage,  Sputum  clearance\ntechniques\nBreathing exercises\nImprove nutrition\nEncourage adequate fluid intake\nEncourage physical exercise.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "766",
    "type": "section",
    "keywords": [
      "sputum",
      "physiotherapy",
      "techniques",
      "nutrition",
      "chest",
      "drainage",
      "improve",
      "exercises",
      "physical",
      "encourage",
      "exercise",
      "breathing",
      "postural",
      "intake",
      "clearance",
      "adequate",
      "fluid"
    ]
  },
  {
    "id": "d12b1686e56082d4ac5bcba682c88011",
    "content": "Amoxicillin + Clavulanic Acid, oral,\nAdults\n1 g 12 hourly for 14 – 21 days\nChildren\n>12 years;\tOne 500/125 tablet 12 hourly\n6-12 years;\t5ml of 400/57 suspension 12 hourly 1-6 years;\t2. 5ml of 400/57 suspension 12hourly 1month-1 year; 0. 25ml/kg body weight of 125/31 suspension 8 hourly\n< 1 month;\t0.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "767",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "amoxicillin",
      "tablet",
      "body",
      "years",
      "weight",
      "acid",
      "suspension",
      "adults",
      "clavulanic",
      "oral",
      "month",
      "children",
      "year"
    ]
  },
  {
    "id": "a63855ef10834eb5a4e8dcf2ff4ce80b",
    "content": "25ml/kg body weight of 125/31 suspension 8 hourly\nAnd\nAzithromycin, oral, (for patients allergic to penicillin, given as mono- therapy).",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "768",
    "type": "section",
    "keywords": [
      "hourly",
      "body",
      "weight",
      "penicillin",
      "given",
      "suspension",
      "mono",
      "azithromycin",
      "oral",
      "allergic",
      "patients",
      "therapy"
    ]
  },
  {
    "id": "c376af87fc618387cd027e45c02a52b2",
    "content": "Adults\n500 mg once daily for 6-14 days\nChildren\n10 mg/kg once daily for 6-14 days\nReferral Criteria\nRefer all suspected cases to a specialist for confirmation and further management. A lung abscess is defined as necrosis of the pulmonary parenchyma and formation of cavities containing necrotic tissue or purulent fluid, usually caused by microbial infection. Antibiotic management should be considered as soon as it is diagnosed, while awaiting confirmation of the causative organism and must be continued for 4-6 weeks.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "769",
    "type": "section",
    "keywords": [
      "usually",
      "management",
      "causative",
      "confirmation",
      "antibiotic",
      "awaiting",
      "while",
      "fluid",
      "necrotic",
      "abscess",
      "specialist",
      "formation",
      "organism",
      "continued",
      "children",
      "weeks",
      "daily",
      "criteria",
      "days",
      "referral"
    ]
  },
  {
    "id": "1e2b99bfea5c6f239d3e2490c60e269e",
    "content": "Causes\nAspiration of infected secretions or tissue from the mouth and upper respiratory tract in the unconscious or semi-conscious patient e. g. in alcoholics, epileptics, anaesthetised or dental patients\nForeign body aspiration e.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "770",
    "type": "section",
    "keywords": [
      "conscious",
      "infected",
      "unconscious",
      "patient",
      "epileptics",
      "aspiration",
      "body",
      "foreign",
      "patients",
      "anaesthetised",
      "causes",
      "tract",
      "mouth",
      "secretions",
      "respiratory",
      "semi",
      "dental",
      "tissue",
      "alcoholics",
      "upper"
    ]
  },
  {
    "id": "5618c8e84cd3c773e60bf2ad0b70eebb",
    "content": "g. inhaled peanut, dentures, fish bone\nInadequately treated bacterial pneumonia especially, gram negative bacteria like Klebsiella pneumoniae, and beta-haemolytic streptococci\nStaphylococcus aureus causing multiple lung abscesses\nPenetrative lung injury\nPartial obstruction of an airway by tumour or lymph node\nSeptic emboli from other infected areas of the body e. g.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "771",
    "type": "section",
    "keywords": [
      "bacteria",
      "klebsiella",
      "lymph",
      "especially",
      "infected",
      "aureus",
      "body",
      "multiple",
      "partial",
      "emboli",
      "inadequately",
      "treated",
      "obstruction",
      "tumour",
      "pneumoniae",
      "causing",
      "streptococci",
      "staphylococcus",
      "pneumonia",
      "bacterial"
    ]
  },
  {
    "id": "b5630c72ac5000c8af49572dda147a03",
    "content": "Symptoms\nFever with swinging temperatures\nCough, productive of copious amounts of purulent foul smelling sputum\nHaemoptysis\nChest pain\nBreathlessness\nEasy fatiguability\nSigns\nFever\nTachycardia\nTachypnoea\nChest wall tenderness\nDull percussion note.",
    "title": "Infected bullae in chronic lung disease",
    "section": "Infected bullae in chronic lung disease",
    "chunk_id": "772",
    "type": "section",
    "keywords": [
      "amounts",
      "swinging",
      "tachycardia",
      "tachypnoea",
      "haemoptysis",
      "sputum",
      "copious",
      "foul",
      "chest",
      "productive",
      "easy",
      "signs",
      "dull",
      "note",
      "tenderness",
      "fever",
      "fatiguability",
      "temperatures",
      "purulent",
      "percussion"
    ]
  },
  {
    "id": "1fb4f576ec8e3957e529ca67240f60f7",
    "content": "Diminished breath sounds\nIncreased vocal resonance\ninvestigations\nFBC\nSputum culture and sensitivity, gram stain\nSputum AFBs\nChest X-ray.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "773",
    "type": "section",
    "keywords": [
      "sputum",
      "breath",
      "chest",
      "sensitivity",
      "vocal",
      "sounds",
      "stain",
      "gram",
      "increased",
      "resonance",
      "culture",
      "investigations",
      "afbs",
      "diminished"
    ]
  },
  {
    "id": "898772859a2c2d570dfb70dade5c2b3c",
    "content": "To drain abscess collection\nTo treat underlying infection\nTo treat predisposing conditions.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "774",
    "type": "section",
    "keywords": [
      "abscess",
      "treat",
      "predisposing",
      "conditions",
      "infection",
      "collection",
      "underlying",
      "drain"
    ]
  },
  {
    "id": "7b256ff83c150606bcc5c64754fb6286",
    "content": "Chest physiotherapy\nImprove nutritional status\nEnsure adequate fluid intake\nSurgical drainage of abscess.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "775",
    "type": "section",
    "keywords": [
      "abscess",
      "physiotherapy",
      "chest",
      "ensure",
      "surgical",
      "improve",
      "drainage",
      "nutritional",
      "intake",
      "adequate",
      "status",
      "fluid"
    ]
  },
  {
    "id": "75115e07bc00b9acee0bc1aea489a7a3",
    "content": "Cloxacillin, IV,\nAdults\n500 mg 6 hourly for 4 weeks\nChildren\n5-12 years;\t250 mg 6 hourly for 2-4 weeks\nyears;\t125 mg 6 hourly for 2-4 weeks\n< 1 year;\t62. 5 mg 6 hourly for 2-4 weeks\nAnd\nAmoxicillin + Clavulanic Acid, IV,\nAdults\n1. 2 g 8 hourly for 4 weeks\nChildren\n3 months -18 years;\t30 mg/kg 8 hourly, max.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "776",
    "type": "section",
    "keywords": [
      "hourly",
      "amoxicillin",
      "years",
      "acid",
      "adults",
      "clavulanic",
      "months",
      "children",
      "weeks",
      "cloxacillin",
      "year"
    ]
  },
  {
    "id": "6ba8d0b768cb9c35a4f7f10349b36091",
    "content": "1. 2g 8 hourly\n< 3 months;\t30 mg/kg 12 hourly for 2-4 weeks\nAnd\nCeftriaxone, IV,\nAdult\n2 g daily for 4 weeks\nChildren\nAll ages 50-75mg /kg per day in divided 12 hourly doses for 4 weeks\nOr\nGentamicin, IV,\nAdults.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "777",
    "type": "section",
    "keywords": [
      "hourly",
      "ages",
      "gentamicin",
      "ceftriaxone",
      "adult",
      "doses",
      "adults",
      "children",
      "weeks",
      "months",
      "divided",
      "daily"
    ]
  },
  {
    "id": "3ec7852a603df60c5f8041f525e868d7",
    "content": "40-80 mg 8 hourly for 14 days\nChildren\n1-12 years;\t2. 5 mg/kg 8 hourly for 14 days\n< 1 year;\t2. 5 mg/kg 12 hourly for 14 days\nAnd\nMetronidazole, IV,\nAdults\n500 mg 8 hourly for 4 weeks\nChildren\n7.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "778",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "years",
      "adults",
      "children",
      "weeks",
      "year"
    ]
  },
  {
    "id": "9217d1ede155be147a48e251afcb279e",
    "content": "5 mg/kg 8 hourly for 4 weeks\nOr\nClindamycin, IV,\nAdults\n300-600 mg 6 hourly for 4 weeks or until clinical improvement\nChildren\n3-6 mg/kg 6 hourly for 2-4 weeks.",
    "title": "Chapter 8: Dısorders of the Respıratory System",
    "section": "Chapter 8: Dısorders of the Respıratory System",
    "chunk_id": "779",
    "type": "section",
    "keywords": [
      "hourly",
      "clindamycin",
      "improvement",
      "adults",
      "children",
      "weeks",
      "until",
      "clinical"
    ]
  },
  {
    "id": "48f4126afa9550c292edf253c511b484",
    "content": "Flucloxacillin, oral,\nAdults\n500 mg 6 hourly for 2 weeks\nChildren\n5-12 years;\t250 mg 6 hourly for 2 weeks\nyears;\t125 mg 6 hourly for 2 weeks\n< 1 year;\t62. 5 mg 6 hourly for 2 weeks\nAnd\nAmoxicillin + Clavulanic Acid, oral,\nAdults\n1 g 12 hourly for 14-21 days. Children\n12 years;\tOne 500/125 tablet 12 hourly\n6-12 years;\t5 ml of 400/57 suspension 12 hourly\nyears;\t2.",
    "title": "Continuation treatment",
    "section": "Continuation treatment",
    "chunk_id": "780",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "amoxicillin",
      "tablet",
      "years",
      "acid",
      "flucloxacillin",
      "suspension",
      "adults",
      "clavulanic",
      "oral",
      "children",
      "weeks",
      "year"
    ]
  },
  {
    "id": "eaafcd75d2cce0af1024662814991529",
    "content": "5 ml of 400/57 suspension 12 hourly\n1 month-1 year;\t0. 25ml/kg body weight of 125/31 suspen- sion 8 hourly\n< 1 month;\t0. 25 ml/kg body weight of 125/31 suspen- sion 8 hourly\nAnd\nClindamycin, oral,\nAdult\n300 mg 6 hourly for 14 days\nChildren\n3 months; 15-40 mg/kg/day, in 3 divided doses, (Minimum dose - not less than 300 mg/day)\nReferral Criteria\nRefer to a specialist or higher-level facility if there is no clinical.",
    "title": "Continuation treatment",
    "section": "Continuation treatment",
    "chunk_id": "781",
    "type": "section",
    "keywords": [
      "weight",
      "hourly",
      "body",
      "specialist",
      "facility",
      "doses",
      "children",
      "criteria",
      "days",
      "clindamycin",
      "referral",
      "suspen",
      "level",
      "suspension",
      "adult",
      "dose",
      "there",
      "month",
      "months",
      "divided"
    ]
  },
  {
    "id": "a75f5fb192d028b9cd7e262034f5cc81",
    "content": "improvement within the first 2 weeks of initiating antibiotic therapy.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "782",
    "type": "section",
    "keywords": [
      "within",
      "first",
      "initiating",
      "antibiotic",
      "weeks",
      "therapy",
      "improvement"
    ]
  },
  {
    "id": "f751a46833a758b549b55c0f01fa79ac",
    "content": "Headache is caused by traction, displacement, inflammation, vascular spasm or distension of the pain sensitive structures in the head or neck. Headaches that are new in onset and clearly different from any the patient has experienced previously are commonly a symptom of serious illness and therefore demand prompt evaluation. The precipitating factors, associated symptoms and clinical findings on examination, together with the results of appropriate investigations, can provide a guide to the cause of the headache.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "783",
    "type": "section",
    "keywords": [
      "spasm",
      "guide",
      "traction",
      "headache",
      "factors",
      "associated",
      "results",
      "structures",
      "clearly",
      "distension",
      "patient",
      "neck",
      "serious",
      "therefore",
      "together",
      "previously",
      "evaluation",
      "precipitating",
      "inflammation",
      "demand"
    ]
  },
  {
    "id": "973aa34cf7abf768f435a24038f202d5",
    "content": "Infections e. g. malaria, typhoid fever, viral infections\nMeningitis or encephalitis.",
    "title": "Subarachnoid haemorrhage and other cerebrovascular diseases",
    "section": "Subarachnoid haemorrhage and other cerebrovascular diseases",
    "chunk_id": "784",
    "type": "section",
    "keywords": [
      "infections",
      "typhoid",
      "meningitis",
      "encephalitis",
      "fever",
      "malaria",
      "viral"
    ]
  },
  {
    "id": "57fc2c6d9f4a1dd51f174d2ca3349a1d",
    "content": "Post-seizures\nPost-lumbar puncture\nHypertensive encephalopathy\nSubacute\nLesions of the middle ear (otitis media, mastoiditis)\nIntracranial mass (tumour, subdural haematoma, abscess)\nIdiopathic intracranial hypertension\nTrigeminal neuralgia\nPost-herpetic neuralgia\nSevere hypertension\nAtypical facial pain\nMedication\nPost trauma\nGiant cell temporal arteritis\nChronic\nMigraine\nCluster headache\nTension headache.",
    "title": "Ocular disorders (glaucoma, acute iritis, refractive errors)",
    "section": "Ocular disorders (glaucoma, acute iritis, refractive errors)",
    "chunk_id": "785",
    "type": "section",
    "keywords": [
      "hypertension",
      "migraine",
      "intracranial",
      "encephalopathy",
      "lesions",
      "idiopathic",
      "temporal",
      "headache",
      "seizures",
      "puncture",
      "otitis",
      "trigeminal",
      "hypertensive",
      "herpetic",
      "arteritis",
      "abscess",
      "subdural",
      "haematoma",
      "neuralgia",
      "subacute"
    ]
  },
  {
    "id": "21027483ec915230df66900ffe381692",
    "content": "Psychogenic causes\nSymptoms\nVisual e. g. photophobia, flashes of light, floaters\nAura e.",
    "title": "Dental disease",
    "section": "Dental disease",
    "chunk_id": "786",
    "type": "section",
    "keywords": [
      "psychogenic",
      "flashes",
      "visual",
      "floaters",
      "light",
      "photophobia",
      "aura",
      "symptoms",
      "causes"
    ]
  },
  {
    "id": "fb3e9493fb9d24edf0b61c5c84ae4041",
    "content": "g. visual, auditory, gustatory, tactile\nAccompanying features e. g.",
    "title": "Dental disease",
    "section": "Dental disease",
    "chunk_id": "787",
    "type": "section",
    "keywords": [
      "auditory",
      "accompanying",
      "tactile",
      "visual",
      "features",
      "gustatory"
    ]
  },
  {
    "id": "dc6eb0ce73c28fc9d0dd1ee8cc701c98",
    "content": "nausea, vomiting, fever, collapse\nSite of pain e. g. occipital, ocular, unilateral, bilateral\nCharacteristics e.",
    "title": "Dental disease",
    "section": "Dental disease",
    "chunk_id": "788",
    "type": "section",
    "keywords": [
      "collapse",
      "vomiting",
      "unilateral",
      "nausea",
      "pain",
      "characteristics",
      "fever",
      "ocular",
      "occipital",
      "site",
      "bilateral"
    ]
  },
  {
    "id": "f776fd63a76e1fa68fa1265c2b706cd2",
    "content": "g. pulsating, throbbing, sharp, dull\nRelieving or exacerbating factors e. g.",
    "title": "Dental disease",
    "section": "Dental disease",
    "chunk_id": "789",
    "type": "section",
    "keywords": [
      "exacerbating",
      "throbbing",
      "factors",
      "sharp",
      "dull",
      "relieving",
      "pulsating"
    ]
  },
  {
    "id": "98f0dab45aeac5ff2e72c7769711c5e2",
    "content": "cough, coitus, lying flat\nSigns\nUsually none\nLocal tenderness\nFever\nNeck stiffness\nPositive Kernigs\nMarkedly elevated blood pressure\nDrowsiness\nExcessive lacrimation\nConjunctival redness\nPapilloedema\nFocal neurologic deficit e. g. cranial nerve deficit, hemiparesis\ninvestigations\nFBC\nESR\nSkull X-ray\nCervical X-ray\nX-ray of the paranasal sinuses\nLumbar puncture (meningitis, subarachnoid bleed)\nEye tests (tonometry, refraction, fundoscopy)\nCranial CT scan or MRI if warranted.",
    "title": "Dental disease",
    "section": "Dental disease",
    "chunk_id": "790",
    "type": "section",
    "keywords": [
      "usually",
      "conjunctival",
      "local",
      "hemiparesis",
      "coitus",
      "cranial",
      "puncture",
      "bleed",
      "fundoscopy",
      "tonometry",
      "redness",
      "neck",
      "skull",
      "focal",
      "pressure",
      "stiffness",
      "markedly",
      "sinuses",
      "warranted",
      "drowsiness"
    ]
  },
  {
    "id": "867e1e5994b580ef0f333789cf9d0e58",
    "content": "To relieve pain\nTo identify and treat underlying cause\nTo prevent complications relating to the underlying cause\nTo improve quality of life.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "791",
    "type": "section",
    "keywords": [
      "complications",
      "pain",
      "treat",
      "prevent",
      "improve",
      "quality",
      "life",
      "cause",
      "relieve",
      "underlying",
      "identify",
      "relating"
    ]
  },
  {
    "id": "b4c5edf60da5363ca51c53675a1a2810",
    "content": "Relaxation techniques\nAvoidance of stress\nPsychotherapy\nIdentification and elimination of trigger factors.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "792",
    "type": "section",
    "keywords": [
      "techniques",
      "avoidance",
      "psychotherapy",
      "stress",
      "factors",
      "relaxation",
      "identification",
      "elimination",
      "trigger"
    ]
  },
  {
    "id": "1fa96eaf523737f74fef68057c4503c9",
    "content": "Evidence Rating: [B]\nParacetamol, oral,\nAdults\n500 mg-1 g 6 - 8 hourly\nChildren\n6-12 years;\t250-500 mg 6-8 hourly\nyears;\t120-250 mg 6-8 hourly\n3 months-1 year;\t60-120 mg 6-8 hourly\nOr\nDiclofenac, oral,\nAdults\n50 mg 8 hourly or 100 mg 12 hourly\nChildren\n>12 years;\t50 mg 12 hourly\n<12 years;\tnot recommended\nOr\nIbuprofen, oral,\nAdults\n400 mg 6-8 hourly\nChildren\n6-12 years;\t200-400 mg 6-8 hourly\nyears;\t100-200 mg 6-8 hourly 3 months-1 year;\tnot recommended\nOr\nTramadol, oral,\nAdults\n50-100 mg 4-6 hourly (max. 400 mg daily)\nChildren\n12 years;\t50-100 mg 4-6 hourly\n< 12 years;\tnot recommended\nProphylaxis for Migraine headaches.",
    "title": "Acute symptomatic treatment of headaches 1st Line Treatment",
    "section": "Acute symptomatic treatment of headaches 1st Line Treatment",
    "chunk_id": "793",
    "type": "section",
    "keywords": [
      "headaches",
      "hourly",
      "rating",
      "recommended",
      "years",
      "tramadol",
      "migraine",
      "diclofenac",
      "adults",
      "prophylaxis",
      "oral",
      "paracetamol",
      "children",
      "months",
      "evidence",
      "ibuprofen",
      "daily",
      "year"
    ]
  },
  {
    "id": "75aad831451edd031ad5a88dffea2f6a",
    "content": "Propranolol, oral,\nAdults\nInitial; 40 mg 12 hourly, maintenance; 80-120 mg 12 hourly\nChildren\nInitial; 20-40 mg 12 hourly, maintenance; 40-80 mg 12 hourly\nReferral Criteria\nRefer recurrent, unresolving or unexplained headaches to a specialist for evaluation and appropriate management.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "794",
    "type": "section",
    "keywords": [
      "hourly",
      "initial",
      "referral",
      "recurrent",
      "specialist",
      "evaluation",
      "appropriate",
      "unresolving",
      "management",
      "adults",
      "propranolol",
      "refer",
      "oral",
      "unexplained",
      "maintenance",
      "children",
      "criteria",
      "headaches"
    ]
  },
  {
    "id": "33e9be5c29442d19c6f04c21ce150a54",
    "content": "A seizure is a clinical event caused by a transient disturbance of brain function due to an abnormal paroxysmal neuronal discharge in the brain. If these episodes are recurrent without an identifiable cause, they are commonly described as epilepsy. The term status epilepticus is used for repeated seizures, which occur without the patient regaining consciousness between attacks.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "795",
    "type": "section",
    "keywords": [
      "recurrent",
      "occur",
      "paroxysmal",
      "transient",
      "seizures",
      "which",
      "used",
      "identifiable",
      "repeated",
      "seizure",
      "patient",
      "attacks",
      "clinical",
      "epilepsy",
      "function",
      "abnormal",
      "status",
      "episodes",
      "event",
      "caused"
    ]
  },
  {
    "id": "b2c79d58c03f66652b66c38044f0e54b",
    "content": "(See section on ‘Epilepsy and Status epilepticus’). The clinical presentation depends on the part of the brain affected. Patients may sometimes describe the warning signals (termed a prodrome or aura), which they experienced before the event.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "796",
    "type": "section",
    "keywords": [
      "which",
      "describe",
      "sometimes",
      "prodrome",
      "epilepsy",
      "part",
      "section",
      "presentation",
      "depends",
      "patients",
      "termed",
      "signals",
      "status",
      "event",
      "before",
      "aura",
      "epilepticus",
      "warning",
      "experienced",
      "brain"
    ]
  },
  {
    "id": "3c887d6503b2775ca8211f2d85c75756",
    "content": "A detailed description by a witness is key. General anaesthesia and ventilation may be required in severe cases and where high doses of anticonvulsants are required. Causes\nCongenital, prenatal or perinatal injury\nFevers, especially in children aged 6 months to 6 years (febrile\nconvulsion)\nCerebral malaria\nInfections e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "797",
    "type": "section",
    "keywords": [
      "infections",
      "anticonvulsants",
      "years",
      "especially",
      "required",
      "witness",
      "doses",
      "where",
      "perinatal",
      "children",
      "malaria",
      "causes",
      "congenital",
      "severe",
      "description",
      "months",
      "febrile",
      "general",
      "cerebral",
      "aged"
    ]
  },
  {
    "id": "fc82db9fab1ed048a15d1fedeee27b50",
    "content": "g. meningitis, TB, HIV, abscesses in the brain\nMetabolic causes: hypoglycaemia, hypocalcaemia, hyponatraemia, hyperosmolar diabetic state, uraemia, hepatic failure\nIdiopathic epilepsy (See section on ‘Epilepsy’)\nEclampsia.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "798",
    "type": "section",
    "keywords": [
      "diabetic",
      "uraemia",
      "meningitis",
      "hyperosmolar",
      "hyponatraemia",
      "epilepsy",
      "hypocalcaemia",
      "idiopathic",
      "eclampsia",
      "section",
      "state",
      "brain",
      "failure",
      "abscesses",
      "hypoglycaemia",
      "causes",
      "hepatic",
      "metabolic"
    ]
  },
  {
    "id": "a1547426d612ad99841acc3626a70b04",
    "content": "Space occupying lesions: tumour or malformations of the brain\nHead trauma\nDrugs and toxins: alcohol, antidepressants, metronidazole, drug and alcohol withdrawal.",
    "title": "Vascular diseases: hypertensive encephalopathy, stroke, myocardial infarction",
    "section": "Vascular diseases: hypertensive encephalopathy, stroke, myocardial infarction",
    "chunk_id": "799",
    "type": "section",
    "keywords": [
      "antidepressants",
      "drugs",
      "metronidazole",
      "head",
      "lesions",
      "alcohol",
      "space",
      "drug",
      "malformations",
      "brain",
      "toxins",
      "tumour",
      "withdrawal",
      "occupying",
      "trauma"
    ]
  },
  {
    "id": "2512036ce057a18ce5cf93204016f5c6",
    "content": "Psychogenic: (See section on ‘Psychogenic Seizures’)\nSymptoms\nLoss of consciousness\nTongue biting\nFoaming at the mouth\nIncontinence of stool and/or urine\nAura (may include a strange gut feeling, somatosensory manifestations - visual, olfactory, gustatory or auditory e. g. strange smells/flashing lights)\nMuscle twitching and movements which may be focal or generalized\nAfter a seizure, the patient may be confused (post-ictal confusion) or may sleep for some time (post-ictal sleep).",
    "title": "Degenerative diseases e.g. dementia",
    "section": "Degenerative diseases e.g. dementia",
    "chunk_id": "800",
    "type": "section",
    "keywords": [
      "seizures",
      "incontinence",
      "which",
      "urine",
      "feeling",
      "somatosensory",
      "seizure",
      "patient",
      "focal",
      "movements",
      "psychogenic",
      "twitching",
      "section",
      "muscle",
      "generalized",
      "biting",
      "post",
      "include",
      "mouth",
      "auditory"
    ]
  },
  {
    "id": "41816ca36650f9529915554995a9352e",
    "content": "Signs\nA prodrome or aura with automatism (lip smacking, picking at items)\nMuscle twitching and movements which may be focal or generalized\nPost-ictal sleep\nPost-ictal confusion\nTodd’s paralysis (stroke-like weakness) may rarely occur\nExamine carefully for evidence of neurological localizing signs, tongue laceration and evidence of trauma to the face or other parts of the body\ninvestigations\nFBC, ESR\nBlood glucose\nBUE\nCalcium\nLFTs\nChest X-ray\nElectroencephalogram (EEG)\nCT scan (head).",
    "title": "Chapter 9: Dısorders of the Central Nervous System",
    "section": "Chapter 9: Dısorders of the Central Nervous System",
    "chunk_id": "801",
    "type": "section",
    "keywords": [
      "picking",
      "carefully",
      "occur",
      "face",
      "which",
      "glucose",
      "paralysis",
      "weakness",
      "evidence",
      "prodrome",
      "focal",
      "movements",
      "body",
      "items",
      "twitching",
      "neurological",
      "chest",
      "muscle",
      "signs",
      "smacking"
    ]
  },
  {
    "id": "f2c1f7bc094f1880727d5e374e119ab5",
    "content": "To stop the seizure\nTo treat underlying cause\nTo prevent injury.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "802",
    "type": "section",
    "keywords": [
      "treat",
      "prevent",
      "stop",
      "cause",
      "injury",
      "underlying",
      "seizure"
    ]
  },
  {
    "id": "3e3f4d8390936e4a0d0e2cc561cb7ba2",
    "content": "Move sharp objects, fire etc. away from patient during seizures\nEnsure clothing around the neck is loose\nEnsure the airway is clear, wipe or suction any secretions or vomitus from the mouth or nose. Do not force a spoon or tongue depressor into mouth.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "803",
    "type": "section",
    "keywords": [
      "move",
      "vomitus",
      "ensure",
      "during",
      "seizures",
      "force",
      "clear",
      "patient",
      "neck",
      "into",
      "spoon",
      "loose",
      "clothing",
      "mouth",
      "depressor",
      "away",
      "secretions",
      "tongue",
      "around",
      "sharp"
    ]
  },
  {
    "id": "f41df9e65b8e6d51483c2ece994a1d86",
    "content": "Remove false teeth if present\nAfter convulsions cease, turn the patient into semi-prone position by turning the patient on the side, with one leg bent and the other leg straight\nMonitor fits (fits chart).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "804",
    "type": "section",
    "keywords": [
      "bent",
      "position",
      "patient",
      "into",
      "chart",
      "prone",
      "fits",
      "convulsions",
      "cease",
      "side",
      "straight",
      "monitor",
      "turning",
      "semi",
      "teeth",
      "present",
      "false",
      "other",
      "after",
      "remove"
    ]
  },
  {
    "id": "0dfa347c85567aa90512908d16de250c",
    "content": "Evidence Rating: [A]\nOxygen\nBy nasal prongs, 2-6 L/min\nOr\nFace mask, 4-8 L/min\nOr\nNon-rebreather mask, 10-15 L/min.",
    "title": "Acute Seizures (immediate emergency measures) 1st Line Treatment",
    "section": "Acute Seizures (immediate emergency measures) 1st Line Treatment",
    "chunk_id": "805",
    "type": "section",
    "keywords": [
      "rating",
      "oxygen",
      "face",
      "mask",
      "rebreather",
      "evidence",
      "prongs",
      "nasal"
    ]
  },
  {
    "id": "fda36df40b7bdaaaef0d983fdbadc5e8",
    "content": "And\nLorazepam, slow IV,\nAdults\n4 mg as a single dose, repeated once after 10 minutes if necessary. Given into a large vein slowly over 3-5 minutes. Children\n12-18 years;\t4 mg as a single dose, repeated once after 10 minutes if necessary.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "806",
    "type": "section",
    "keywords": [
      "lorazepam",
      "years",
      "minutes",
      "single",
      "given",
      "large",
      "vein",
      "adults",
      "necessary",
      "slow",
      "dose",
      "after",
      "slowly",
      "children",
      "repeated",
      "into",
      "once"
    ]
  },
  {
    "id": "19588e378c0ea8d0338288b29851a4f6",
    "content": "Given into a large vein slowly over 3-5 min- utes. 1 month-12 years;\t100 microgram/kg (max. 4 mg) as a single dose, repeated once after 10 minutes if necessary.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "807",
    "type": "section",
    "keywords": [
      "years",
      "microgram",
      "minutes",
      "given",
      "large",
      "vein",
      "single",
      "month",
      "necessary",
      "utes",
      "dose",
      "after",
      "slowly",
      "repeated",
      "into",
      "once"
    ]
  },
  {
    "id": "b20b758955ec12b4e24ce0d25fe01530",
    "content": "Neonates;\t100 microgram/kg (max. 4 mg) as a single dose, repeated once after 10 minutes if necessary. Or\nMidazolam, IV,\nAdults\n150-300 microgram/kg, may repeat every 10-15 minutes as required\nChildren\n1 month-18 years;\tinitially 150-200 microgram, followed by followed by continuous infusion of 60 microgram/kg per hour.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "808",
    "type": "section",
    "keywords": [
      "hour",
      "years",
      "neonates",
      "midazolam",
      "infusion",
      "required",
      "repeated",
      "minutes",
      "single",
      "continuous",
      "initially",
      "repeat",
      "children",
      "followed",
      "adults",
      "dose",
      "month",
      "every",
      "once",
      "microgram"
    ]
  },
  {
    "id": "6240d7042cf4440edf6d6f1b973302ea",
    "content": "May increase by 60 microgram /kg per hour every 15 minutes until sei- zures are controlled. (max. 300 microgram/kg per hour)\nNeonates;\t150-200 microgram/kg followed by contin- uous infusion of 60 microgram/kg per hour.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "809",
    "type": "section",
    "keywords": [
      "followed",
      "hour",
      "microgram",
      "neonates",
      "minutes",
      "zures",
      "controlled",
      "uous",
      "contin",
      "infusion",
      "until",
      "increase",
      "every"
    ]
  },
  {
    "id": "812d780680f94c849fb29d6c738075b8",
    "content": "May increase by 60 mi- crogram /kg per hour every 15 minutes until seizures are controlled. (max. 300 microgram/kg per hour)\nOr\nMidazolam, buccal,\nAdults\n10 mg\nRepeat after 10 minutes if necessary.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "810",
    "type": "section",
    "keywords": [
      "hour",
      "microgram",
      "minutes",
      "controlled",
      "midazolam",
      "seizures",
      "adults",
      "until",
      "crogram",
      "repeat",
      "necessary",
      "after",
      "buccal",
      "increase",
      "every"
    ]
  },
  {
    "id": "3732a06b417f7309f9c3d6f7ae99204a",
    "content": "A third dose must not be given sooner than 12 hours after the sec- ond dose. Children\n6 months-18 years;\t200-500 microgram/kg (max. single dose 10 mg)\nRepeat after 10 minutes if necessary.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "811",
    "type": "section",
    "keywords": [
      "sooner",
      "years",
      "microgram",
      "minutes",
      "given",
      "third",
      "must",
      "single",
      "repeat",
      "necessary",
      "dose",
      "after",
      "children",
      "months",
      "hours"
    ]
  },
  {
    "id": "be0bedc41af07720475758b6fc8331d8",
    "content": "A third dose must not be given sooner than 6 hours after the second dose in children < 40 kg.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "812",
    "type": "section",
    "keywords": [
      "sooner",
      "given",
      "third",
      "must",
      "children",
      "dose",
      "after",
      "second",
      "hours"
    ]
  },
  {
    "id": "37446efcd07bc308b99a2c8328a95cdc",
    "content": "Diazepam, IV,\nAdults\n10 mg slowly over 2-3 minutes (approximately 2. 5 mg every 30 sec- onds)\nChildren\n200-300 microgram/kg slowly over 2-3 minutes. This may be repeated 10 minutes later if the fit continues.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "813",
    "type": "section",
    "keywords": [
      "diazepam",
      "onds",
      "later",
      "microgram",
      "minutes",
      "adults",
      "continues",
      "slowly",
      "children",
      "repeated",
      "approximately",
      "every"
    ]
  },
  {
    "id": "6be30ff79b4cfd57ce879bc0fe06830c",
    "content": "Diazepam, rectal,\nChildren\n>12 years;\t0. 2 mg/kg\n6-12 years;\t0. 3 mg/kg\n2-6 years;\t0.",
    "title": "Chapter 9: Dısorders of the Central Nervous System",
    "section": "Chapter 9: Dısorders of the Central Nervous System",
    "chunk_id": "814",
    "type": "section",
    "keywords": [
      "diazepam",
      "rectal",
      "children",
      "years"
    ]
  },
  {
    "id": "1866c00353887fd831962fbe87ab76d9",
    "content": "5 mg\nThis may be repeated 10 minutes later if the fit continues. (max. 10 mg)\nIf seizures continue (Status Epilepticus)\nPhenytoin, IV, (with ECG monitoring)\nAdults\n15 mg/kg slowly at rate no greater than 50 mg/minute.",
    "title": "Chapter 9: Dısorders of the Central Nervous System",
    "section": "Chapter 9: Dısorders of the Central Nervous System",
    "chunk_id": "815",
    "type": "section",
    "keywords": [
      "continue",
      "later",
      "monitoring",
      "rate",
      "greater",
      "minute",
      "epilepticus",
      "minutes",
      "adults",
      "seizures",
      "phenytoin",
      "continues",
      "repeated",
      "slowly",
      "status"
    ]
  },
  {
    "id": "fc0b27075523a154159df0f046c852b7",
    "content": "(max. 2 g loading dose),\nThen\nMaintenance, 100 mg 6-8 hourly\nChildren\n1-12 years; initially, 18 mg/kg slowly at a rate no greater than 50 mg/ minute. Then\nMaintenance, 5-10 mg/kg daily (max.",
    "title": "Chapter 9: Dısorders of the Central Nervous System",
    "section": "Chapter 9: Dısorders of the Central Nervous System",
    "chunk_id": "816",
    "type": "section",
    "keywords": [
      "hourly",
      "rate",
      "loading",
      "years",
      "greater",
      "minute",
      "initially",
      "dose",
      "maintenance",
      "children",
      "then",
      "slowly",
      "daily"
    ]
  },
  {
    "id": "dba5ae8f8b4e185f4e75ee6f251156ba",
    "content": "300 mg daily)\nmonths; initially, 18 mg/kg slowly at a rate no greater than 1 mg/ kg/minute. Then\nMaintenance, 2. 5-5 mg/kg 12 hourly\nNeonates; initially, 18 mg/kg slowly at a rate no greater than 1 mg/ kg/minute.",
    "title": "Chapter 9: Dısorders of the Central Nervous System",
    "section": "Chapter 9: Dısorders of the Central Nervous System",
    "chunk_id": "817",
    "type": "section",
    "keywords": [
      "hourly",
      "rate",
      "greater",
      "minute",
      "neonates",
      "initially",
      "slowly",
      "maintenance",
      "months",
      "then",
      "daily"
    ]
  },
  {
    "id": "11eeea866243014ba16b3de9ec649a53",
    "content": "Then\nMaintenance, 2. 5-5 mg/kg 12 hourly\nCaution 9-1. Or\nPhenobarbitone, IV,\nAdults\n10-20 mg/kg, repeat dose at 20 minute intervals if necessary (max.",
    "title": "Chapter 9: Dısorders of the Central Nervous System",
    "section": "Chapter 9: Dısorders of the Central Nervous System",
    "chunk_id": "818",
    "type": "section",
    "keywords": [
      "hourly",
      "minute",
      "phenobarbitone",
      "intervals",
      "adults",
      "caution",
      "repeat",
      "necessary",
      "dose",
      "maintenance",
      "then"
    ]
  },
  {
    "id": "dee6e8904c2c26d7af873fd3d67aefd9",
    "content": "total dose 30 mg/kg)\nThen (starting 12 hours after initial dose).",
    "title": "Chapter 9: Dısorders of the Central Nervous System",
    "section": "Chapter 9: Dısorders of the Central Nervous System",
    "chunk_id": "819",
    "type": "section",
    "keywords": [
      "initial",
      "hours",
      "dose",
      "after",
      "total",
      "then",
      "starting"
    ]
  },
  {
    "id": "d789f2c5bdd5238e81145ab589ab5552",
    "content": "0. 5-1. 5 mg/kg 12-24 hourly\nChildren\n1 month-12 years;\t10 mg/kg at a rate not more than 1 mg/kg/ minute.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "820",
    "type": "section",
    "keywords": [
      "hourly",
      "rate",
      "years",
      "minute",
      "more",
      "month",
      "children"
    ]
  },
  {
    "id": "66ae53ce651d1febd86f58f1b16fb370",
    "content": "Repeat after 15 minutes if necessary. Neonates\nInitially, 15-20 mg/kg stat. May repeat dose of 5-10 mg /kg at 20 minute intervals (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "821",
    "type": "section",
    "keywords": [
      "neonates",
      "minute",
      "minutes",
      "intervals",
      "initially",
      "repeat",
      "necessary",
      "dose",
      "after",
      "stat"
    ]
  },
  {
    "id": "da531624c83f44909418b62cf4c101ed",
    "content": "total dose 40 mg/kg)\nThen (starting 12 hours after initial dose) 3-4 mg/kg 24 hourly\nReferral Criteria\nIf seizures remain uncontrolled within 30 minutes after they began, refer immediately for specialist attention. Note that oxygenation should be continued during transfer. Epilepsy is a disorder of the central nervous system (CNS), which is characterized by spontaneous recurrent seizures or the tendency to have seizures.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "822",
    "type": "section",
    "keywords": [
      "initial",
      "recurrent",
      "seizures",
      "during",
      "which",
      "nervous",
      "starting",
      "hourly",
      "within",
      "specialist",
      "transfer",
      "immediately",
      "epilepsy",
      "minutes",
      "attention",
      "tendency",
      "uncontrolled",
      "continued",
      "note",
      "total"
    ]
  },
  {
    "id": "7e30425faa8f237d33402fc9af72aed0",
    "content": "Epilepsy is now classified as Generalized (tonic, clonic, absence, atonic or myoclonic) with aura and loss of consciousness or Focal. Traditionally, a single seizure has been regarded as an indication for investigation and assessment, but not for drug treatment unless the circumstances of the seizure necessitate it. Drug treatment should certainly be considered after two seizures, or if the second seizure follows closely from the first.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "823",
    "type": "section",
    "keywords": [
      "closely",
      "traditionally",
      "seizures",
      "second",
      "seizure",
      "regarded",
      "focal",
      "epilepsy",
      "single",
      "unless",
      "drug",
      "indication",
      "clonic",
      "generalized",
      "atonic",
      "treatment",
      "necessitate",
      "first",
      "should",
      "consciousness"
    ]
  },
  {
    "id": "aa454397510f25e116ed6235b7be420d",
    "content": "The type of drug used depends on the type of seizure. Drug treatment of epilepsy should be guided by the following general principles. Begin with a single drug at the lowest dosage range and increase dose gradually to the upper limit of dosage range or until side-effects appear, if seizures are not controlled.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "824",
    "type": "section",
    "keywords": [
      "seizures",
      "range",
      "seizure",
      "increase",
      "type",
      "epilepsy",
      "following",
      "single",
      "depends",
      "drug",
      "guided",
      "treatment",
      "principles",
      "side",
      "should",
      "appear",
      "dose",
      "lowest",
      "begin",
      "general"
    ]
  },
  {
    "id": "e0cecae4852b132dca8a6bb9d0dc8d3d",
    "content": "Subsequently, if seizures still remain uncontrolled, change to a different drug by gradually reducing the dose of the initial agent while simultaneously introducing the new one. This usually takes 3-4 weeks. Try three separate drugs in this fashion if no clinical response is observed, before resorting to drug combinations.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "825",
    "type": "section",
    "keywords": [
      "usually",
      "initial",
      "subsequently",
      "agent",
      "introducing",
      "seizures",
      "takes",
      "combinations",
      "while",
      "clinical",
      "drug",
      "uncontrolled",
      "weeks",
      "observed",
      "reducing",
      "before",
      "different",
      "fashion",
      "response",
      "resorting"
    ]
  },
  {
    "id": "b1677f03b9eb97ff912666d512b7da63",
    "content": "Anticonvulsant drug treatment can be totally withdrawn (gradually) in a patient with epilepsy only after a 2-year seizure-free period and after a full evaluation and discussion with the patient. Patients with epilepsy should be advised not to drive a vehicle if not certified to be seizure-free, swim alone, work at heights, operate machines, cook by open fire alone, nor ingest alcohol excessively. Causes\nIdiopathic.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "826",
    "type": "section",
    "keywords": [
      "vehicle",
      "certified",
      "work",
      "discussion",
      "idiopathic",
      "totally",
      "full",
      "alone",
      "seizure",
      "patient",
      "open",
      "evaluation",
      "epilepsy",
      "heights",
      "alcohol",
      "drug",
      "withdrawn",
      "drive",
      "patients",
      "machines"
    ]
  },
  {
    "id": "af98f25d5487090c3bad4c0c24565b9e",
    "content": "Symptoms\n(See section on ‘Seizures’)\nSigns\n(See section on ‘Seizures’)\ninvestigations\n(See section on ‘Seizures’).",
    "title": "Chapter 9: Dısorders of the Central Nervous System",
    "section": "Chapter 9: Dısorders of the Central Nervous System",
    "chunk_id": "827",
    "type": "section",
    "keywords": [
      "section",
      "seizures",
      "signs",
      "investigations",
      "symptoms"
    ]
  },
  {
    "id": "f3fd5b39025c7de1663773acb9a5a006",
    "content": "Management of Epilepsy - Acute Generalized seizures\nPhenytoin, IV,\nAdult\n10-15 mg/kg stat. over 20-30 minutes\nThen\n100 mg 6-8 hourly PRN\nChildren\n3-5 mg/kg\nOr\nPhenobarbital (daily), IM,\nAdult\n60-180 mg at night\nChildren\n2. 5-5 mg/kg daily by slow IV or oral\nOr\nCarbamazepine\nAdult\n100-200 mg once or 12 hourly\nThen\nIncrease gradually to 0.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "828",
    "type": "section",
    "keywords": [
      "management",
      "seizures",
      "phenobarbital",
      "acute",
      "night",
      "increase",
      "hourly",
      "epilepsy",
      "minutes",
      "phenytoin",
      "carbamazepine",
      "children",
      "generalized",
      "stat",
      "adult",
      "slow",
      "then",
      "once",
      "oral",
      "daily"
    ]
  },
  {
    "id": "bf8aa1b839649ad3ded83a56e66a051f",
    "content": "8-1. 2 g 8-12 hourly\nChildren\n1 month-12 years;\t2. 5-5 mg/kg at night or 12 hourly Increase when necessary\nThen (maintenance) 5 mg/kg 8-12 hourly Or\nSodium valproate (12 hourly)\nAdult\n600 mg (max.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "829",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "adult",
      "necessary",
      "sodium",
      "valproate",
      "month",
      "children",
      "then",
      "night",
      "increase",
      "maintenance"
    ]
  },
  {
    "id": "329982cb215f4474897da5bab34f4ad1",
    "content": "2 g)\nChildren\n12 years;\t600 mg (max. 2g)\n1 month-12 years;\t10-15 mg/kg, daily or two divided doses\nThen (maintenance).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "830",
    "type": "section",
    "keywords": [
      "years",
      "doses",
      "month",
      "children",
      "then",
      "divided",
      "daily",
      "maintenance"
    ]
  },
  {
    "id": "ebdefb8259802bb8f863bc0cd1fb212b",
    "content": "25-30 mg/kg daily in two divided doses\nOr\nLamotrigine\nAdult\n25-50 mg 12 hourly\nChildren\n25-50 mg daily\nOr\nLevetiracetam\nAdult\n25-50 mg 12 hourly\nChildren\n25-50 mg daily\nManagement of Epilepsy - Generalized absence seizure\nSodium valproate (8-12 hourly)\nAdult\n600 mg (max. 2 g)\nChildren\n12 years;\t600 mg (max. 2 g)\n1 month-12 years;\t10-15 mg/kg, daily or two divided doses\nThen (maintenance)\n25-30 mg/kg daily in two divided doses\nOr\nEthosuximide (daily)\nAdult\n250 mg 12 hourly, incease by 250 mg every 5-7 days to 1-1.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "831",
    "type": "section",
    "keywords": [
      "years",
      "management",
      "incease",
      "maintenance",
      "seizure",
      "levetiracetam",
      "hourly",
      "epilepsy",
      "doses",
      "sodium",
      "children",
      "generalized",
      "days",
      "adult",
      "month",
      "valproate",
      "then",
      "divided",
      "every",
      "ethosuximide"
    ]
  },
  {
    "id": "7a8304df0c7dc7495a9c97f5c22ae822",
    "content": "5 g daily in two divided doses\nChildren\n6 years;\t250 mg 12 hourly, incease by 250 mg every 5-7 days to 1-1. 5 g daily in two divided doses\n1 month-6 years;\t5 mg/kg (max. 125 mg 12 hourly)\nManagement of Epilepsy - Focal seizure\nCarbamazepine, oral,\nAdult\n100-200 mg once or 12 hourly,\nThen\nIncrease gradually to 0.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "832",
    "type": "section",
    "keywords": [
      "years",
      "management",
      "incease",
      "seizure",
      "increase",
      "hourly",
      "focal",
      "epilepsy",
      "doses",
      "carbamazepine",
      "children",
      "days",
      "adult",
      "month",
      "then",
      "divided",
      "every",
      "once",
      "oral",
      "daily"
    ]
  },
  {
    "id": "eeb8329f079ddbc6e4398a2da785b3ec",
    "content": "8-1. 2 g 8-12 hourly\nChildren\n1 month-12 years;\t2. 5-5 mg/kg at night or 12 hourly.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "833",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "month",
      "children",
      "night"
    ]
  },
  {
    "id": "b47ffe7510661989cddd1bbbc930baac",
    "content": "Increase when necessary\nThen (maintenance) 5 mg/kg 8-12 hourly\nOr\nSodium valproate (8-12 hourly)\nAdult\n600 mg (max. 2 g)\nChildren.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "834",
    "type": "section",
    "keywords": [
      "hourly",
      "adult",
      "necessary",
      "sodium",
      "valproate",
      "maintenance",
      "children",
      "then",
      "increase"
    ]
  },
  {
    "id": "829974e68a3c90fdf57b5c115dbca15b",
    "content": "12 years;\t600 mg (max. 2 g)\n1 month-12 years;\t10-15 mg/kg, daily or two divided doses\nThen (maintenance) 12. 5-15 mg/kg 12 hourly\nReferral Criteria\nRefer all patients with intractable seizures to the specialist\nUnconsciousness is a common clinical problem and may be associated with diseases of several organs in the body.",
    "title": "Chapter 9: Dısorders of the Central Nervous System",
    "section": "Chapter 9: Dısorders of the Central Nervous System",
    "chunk_id": "835",
    "type": "section",
    "keywords": [
      "unconsciousness",
      "years",
      "seizures",
      "associated",
      "maintenance",
      "hourly",
      "diseases",
      "specialist",
      "body",
      "doses",
      "patients",
      "criteria",
      "referral",
      "problem",
      "month",
      "then",
      "divided",
      "several",
      "refer",
      "common"
    ]
  },
  {
    "id": "c33d5f0e1c5eec2b61790ed0f4c90644",
    "content": "The cause of unconsciousness is often not immediately evident, and a systematic approach to its diagnosis and management is therefore important. Obtaining a thorough history from accompanying relatives, friends and the police is essential. Causes\nInfections e.",
    "title": "Chapter 9: Dısorders of the Central Nervous System",
    "section": "Chapter 9: Dısorders of the Central Nervous System",
    "chunk_id": "836",
    "type": "section",
    "keywords": [
      "infections",
      "evident",
      "unconsciousness",
      "important",
      "often",
      "essential",
      "management",
      "friends",
      "therefore",
      "immediately",
      "accompanying",
      "police",
      "obtaining",
      "systematic",
      "causes",
      "diagnosis",
      "cause",
      "thorough",
      "relatives",
      "approach"
    ]
  },
  {
    "id": "ae11581f2804a363d71ff24bcdc610f5",
    "content": "g. meningitis, cerebral malaria\nHypoglycaemia (diabetes-related or alcohol induced)\nDiabetic ketoacidosis\nSevere hypertension with encephalopathy\nCerebrovascular Accident (CVA) or stroke\nDrug ingestion or overdose e. g.",
    "title": "Chapter 9: Dısorders of the Central Nervous System",
    "section": "Chapter 9: Dısorders of the Central Nervous System",
    "chunk_id": "837",
    "type": "section",
    "keywords": [
      "hypertension",
      "encephalopathy",
      "induced",
      "cerebrovascular",
      "alcohol",
      "drug",
      "diabetic",
      "malaria",
      "severe",
      "ingestion",
      "overdose",
      "accident",
      "related",
      "ketoacidosis",
      "meningitis",
      "cerebral",
      "stroke",
      "diabetes",
      "hypoglycaemia"
    ]
  },
  {
    "id": "4d1876709b09c1ad2cb006c4db876e76",
    "content": "alcohol, salicylates, barbiturates,\ncocaine\nElectrolyte imbalance\nEpilepsy - status epilepticus\nHead injury\nMajor organ failure e. g. hepatic failure, renal failure and myocardial infarction\nHypoxia from severe anaemia\nPoisoning e.",
    "title": "Chapter 9: Dısorders of the Central Nervous System",
    "section": "Chapter 9: Dısorders of the Central Nervous System",
    "chunk_id": "838",
    "type": "section",
    "keywords": [
      "anaemia",
      "organ",
      "cocaine",
      "salicylates",
      "imbalance",
      "epilepsy",
      "myocardial",
      "alcohol",
      "electrolyte",
      "renal",
      "status",
      "severe",
      "head",
      "hypoxia",
      "major",
      "poisoning",
      "failure",
      "infarction",
      "barbiturates",
      "epilepticus"
    ]
  },
  {
    "id": "18150435a704bc7ebbb04e8926477f80",
    "content": "g. kerosene, pesticides, herbicides\nSymptoms\nDepends on the underlying cause (See appropriate sections)\nSigns\nDepends on the underlying cause (See appropriate sections)\ninvestigations\nTests depend on suspected cause\nFBC\nBF for MPs\nBlood glucose\nUrea and electrolytes.",
    "title": "Chapter 9: Dısorders of the Central Nervous System",
    "section": "Chapter 9: Dısorders of the Central Nervous System",
    "chunk_id": "839",
    "type": "section",
    "keywords": [
      "pesticides",
      "depend",
      "appropriate",
      "blood",
      "suspected",
      "electrolytes",
      "kerosene",
      "depends",
      "herbicides",
      "cause",
      "tests",
      "underlying",
      "signs",
      "glucose",
      "investigations",
      "urea",
      "symptoms",
      "sections"
    ]
  },
  {
    "id": "53139fd1cdcf3e088ca46a096d77329f",
    "content": "Liver function tests\nBlood culture and sensitivity\nUrine culture and sensitivity\nECG\nToxicology: drug screen, alcohol levels\nLumbar puncture\nHead CT scan.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "840",
    "type": "section",
    "keywords": [
      "lumbar",
      "toxicology",
      "head",
      "function",
      "alcohol",
      "scan",
      "screen",
      "drug",
      "levels",
      "puncture",
      "tests",
      "urine",
      "culture",
      "sensitivity",
      "liver",
      "blood"
    ]
  },
  {
    "id": "ad57574242c790df630275606a823fb1",
    "content": "To support life until consciousness is regained\nTo prevent complications e. g. aspiration, hypoxia\nTo determine the underlying cause and manage it appropriately.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "841",
    "type": "section",
    "keywords": [
      "aspiration",
      "determine",
      "complications",
      "support",
      "prevent",
      "manage",
      "appropriately",
      "life",
      "hypoxia",
      "cause",
      "underlying",
      "consciousness",
      "regained",
      "until"
    ]
  },
  {
    "id": "52cdc7eda58f4a73c58ba72770256bb7",
    "content": "Ensure the airway is patent and clear of secretions\nExamine and stabilize the cervical spine if any history or sign of injury\nCatheterise and monitor urine output if necessary\nPlace the patient in a position that would prevent aspiration in case of vomiting or pass an NG tube if no contraindications exist.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "842",
    "type": "section",
    "keywords": [
      "catheterise",
      "ensure",
      "urine",
      "position",
      "clear",
      "patient",
      "aspiration",
      "prevent",
      "place",
      "sign",
      "patent",
      "examine",
      "monitor",
      "tube",
      "secretions",
      "contraindications",
      "exist",
      "cervical",
      "vomiting",
      "case"
    ]
  },
  {
    "id": "b3bef673c223f3f5f93582e2243052be",
    "content": "* (See appropriate section)\nReferral Criteria\nRefer to a specialist for further definitive management if not responding to standard measures of resuscitation.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "843",
    "type": "section",
    "keywords": [
      "referral",
      "specialist",
      "appropriate",
      "standard",
      "management",
      "section",
      "refer",
      "further",
      "resuscitation",
      "definitive",
      "criteria",
      "measures",
      "responding"
    ]
  },
  {
    "id": "1628e1dc897eb5e055351c1af6098773",
    "content": "Attention Deficit Hyperactivity Disorder is the most common neurobehavioural disorder affecting children. It may present in infancy and can continue into adulthood. It affects 5-8% of children and nearly three times as many boys as girls.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "844",
    "type": "section",
    "keywords": [
      "continue",
      "infancy",
      "hyperactivity",
      "times",
      "into",
      "adulthood",
      "attention",
      "most",
      "children",
      "boys",
      "three",
      "neurobehavioural",
      "nearly",
      "disorder",
      "girls",
      "present",
      "deficit",
      "affecting",
      "common",
      "affects"
    ]
  },
  {
    "id": "c74ac5ea9d23da0425e6c31e6a9d7adf",
    "content": "Nearly half the children presenting with ADHD may also have an associated learning problem. The term is commonly applied wrongly to the normal child who is always on the go and never sits still. Recognized causes of hyperactivity in children include normal variation, boredom or understimulation or excessive restraint, learning difficulties, autism, partial seizures and drugs like clonazepam, phenobarbitone and phenytoin.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "845",
    "type": "section",
    "keywords": [
      "hyperactivity",
      "seizures",
      "presenting",
      "child",
      "associated",
      "difficulties",
      "always",
      "partial",
      "applied",
      "phenytoin",
      "clonazepam",
      "children",
      "wrongly",
      "causes",
      "include",
      "boredom",
      "sits",
      "understimulation",
      "also",
      "learning"
    ]
  },
  {
    "id": "b5cff344a0a9b628cdb0ebbf9f00f7e7",
    "content": "ADHD is also wrongly attributed to poor parenting, too much TV, poor schools, poor home environment, excess sugar or food allergies. No specific tests confirm a diagnosis of ADHD. A full physical and neurological examination must be done in all cases.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "846",
    "type": "section",
    "keywords": [
      "full",
      "poor",
      "neurological",
      "parenting",
      "schools",
      "specific",
      "sugar",
      "wrongly",
      "home",
      "diagnosis",
      "done",
      "also",
      "excess",
      "tests",
      "attributed",
      "adhd",
      "allergies",
      "physical",
      "must",
      "food"
    ]
  },
  {
    "id": "f4e83bf7217818e1e477c696997c6034",
    "content": "The behavioural deficits and excesses that constitute a diagnosis of ADHD must be present in multiple settings such as home and school. Causes\nUnknown\nRelated factors:\nHereditary\nImbalance of neurotransmitters\nSymptoms\nInattention\nchild often fails to finish things he or she starts\noften does not seem to listen\nhas difficulty concentrating on school work\nImpulsivity\nchild often acts before thinking\nhits others when upset\ninability to wait for his or her turn in a game\nengages in dangerous activities without consideration of the\nconsequences.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "847",
    "type": "section",
    "keywords": [
      "finish",
      "work",
      "hereditary",
      "often",
      "dangerous",
      "consideration",
      "factors",
      "child",
      "hits",
      "seem",
      "deficits",
      "concentrating",
      "inattention",
      "unknown",
      "multiple",
      "imbalance",
      "others",
      "wait",
      "impulsivity",
      "game"
    ]
  },
  {
    "id": "42316b3cc6f2807cac30182030f253fc",
    "content": "has difficulty organizing work (this not due to cognitive impair- ment)\nHyperactivity\nchild tries to do several things at once\ntalks incessantly,\nstruggles to sit still at a desk and fidgets\nDistractibility is evidenced by\nnot listening when spoken to\nan inclination to daydream\nnot being able to work independently\ndisorganized\nSigns\nSimilar to symptoms above\ninvestigations\nUsually none.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "848",
    "type": "section",
    "keywords": [
      "organizing",
      "usually",
      "work",
      "tries",
      "hyperactivity",
      "cognitive",
      "child",
      "disorganized",
      "fidgets",
      "listening",
      "distractibility",
      "struggles",
      "spoken",
      "impair",
      "inclination",
      "desk",
      "evidenced",
      "signs",
      "being",
      "talks"
    ]
  },
  {
    "id": "c5bbbfeef9c1abee3c0e36e3631494bb",
    "content": "To reduce hyperactivity\nTo improve attention\nTo improve compliance to instruction.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "849",
    "type": "section",
    "keywords": [
      "compliance",
      "improve",
      "instruction",
      "reduce",
      "hyperactivity",
      "attention"
    ]
  },
  {
    "id": "ec6d37caf1e252e8c0c04153e1e70f57",
    "content": "Behaviour management techniques - Evidence Rating: [A]\nA class helper in class to sit with child and focus attention to school work\nParenting class to help parents cope\nDesist from punitive physical interventions e. g. caning.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "850",
    "type": "section",
    "keywords": [
      "work",
      "management",
      "punitive",
      "child",
      "help",
      "cope",
      "evidence",
      "rating",
      "helper",
      "desist",
      "caning",
      "parenting",
      "attention",
      "class",
      "interventions",
      "behaviour",
      "focus",
      "techniques",
      "school",
      "physical"
    ]
  },
  {
    "id": "adeffd3914351a8abadd4572cc19991d",
    "content": "Methylphenidate, oral,\nAdults\n10 mg 8-12 hourly (max. 60 mg)\nThen\nIncrease weekly by 5-10 mg, if necessary, to max. of 30 mg 12 hourly\nChildren\n6-18 years;\t2.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "851",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "methylphenidate",
      "weekly",
      "adults",
      "necessary",
      "oral",
      "children",
      "then",
      "increase"
    ]
  },
  {
    "id": "723d495944cc04f50c0d1c53341e1127",
    "content": "5-5 mg 12 hourly\nIncrease weekly by 5-10 mg, if necessary, to max. of 30 mg 12 hourly 4-6 years;\t2. 5 mg 12 hourly\nIncrease weekly by 2.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "852",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "weekly",
      "necessary",
      "increase"
    ]
  },
  {
    "id": "59339429c0e2e905ffa847484a1c17a8",
    "content": "5 mg daily to max. of 1. 4 mg/kg if necessary in 2 to 3 divided doses.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "853",
    "type": "section",
    "keywords": [
      "necessary",
      "doses",
      "divided",
      "daily"
    ]
  },
  {
    "id": "7ae844d03427f512cc037e7a1458037c",
    "content": "< 4 years;\tnot recommended\nOr\nAtomoxetine, oral,\nAdults.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "854",
    "type": "section",
    "keywords": [
      "recommended",
      "years",
      "adults",
      "oral",
      "atomoxetine"
    ]
  },
  {
    "id": "089b6854fd0e9e9c642b7becb2cf901b",
    "content": "40 mg once daily for 7 days\nThen\nIncrease according to response to a max. of 100 mg\nChildren\n6 years (weight > 70 kg); 40 mg once daily for 7days\nThen\nIncrease according to response to a max. of 80 mg\n6 years (weight < 70 kg); 500 micrograms/kg daily for 7 days\nThen\nIncrease according to response to a max.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "855",
    "type": "section",
    "keywords": [
      "days",
      "years",
      "weight",
      "according",
      "response",
      "children",
      "micrograms",
      "once",
      "then",
      "increase",
      "daily"
    ]
  },
  {
    "id": "81dc0b59fec71a83794c632be1d66d3a",
    "content": "Imipramine, oral,\nAdults\n75 mg daily\nThen\nIncrease to 150 mg daily if necessary (max. 200 mg per day)\nChildren\n6-18 years;\t10-30 mg 12 hourly\nReferral Criteria\nRefer to a clinical psychologist for behaviour management. An occupational therapist, remedial teacher, speech therapist following a needs assessment.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "856",
    "type": "section",
    "keywords": [
      "years",
      "management",
      "increase",
      "imipramine",
      "hourly",
      "speech",
      "following",
      "occupational",
      "behaviour",
      "children",
      "criteria",
      "referral",
      "psychologist",
      "therapist",
      "adults",
      "then",
      "remedial",
      "refer",
      "necessary",
      "oral"
    ]
  },
  {
    "id": "9d7c36558422fa0de690d99992ffb775",
    "content": "Refer to a specialist if there is no clinical improvement after a month of the above recommended therapy. The acutely disturbed patient presents in an excited, agitated or aggressive state. There may be delusions and perceptual changes like hallucinations that overwhelm the patient.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "857",
    "type": "section",
    "keywords": [
      "overwhelm",
      "hallucinations",
      "acutely",
      "presents",
      "therapy",
      "patient",
      "excited",
      "aggressive",
      "specialist",
      "delusions",
      "changes",
      "disturbed",
      "above",
      "state",
      "there",
      "month",
      "perceptual",
      "improvement",
      "agitated",
      "recommended"
    ]
  },
  {
    "id": "23dfc64120405179a8b472f0a495a571",
    "content": "Disorientation and alteration in consciousness are often prominent when the cause is organic. The patients are usually brought in restrained by more than one person or by the police. The condition must be regarded as an emergency since a few cases are potentially fatal.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "858",
    "type": "section",
    "keywords": [
      "usually",
      "disorientation",
      "often",
      "alteration",
      "potentially",
      "regarded",
      "emergency",
      "police",
      "brought",
      "patients",
      "condition",
      "cause",
      "fatal",
      "consciousness",
      "since",
      "restrained",
      "prominent",
      "must",
      "cases",
      "organic"
    ]
  },
  {
    "id": "ecb49dcd3b85c908e73638159f6ab5cc",
    "content": "Toxic psychosis secondary to drug intoxication (amphetamines,\ncocaine, marijuana, heroin etc. )\nAbnormal reaction to alcoholic Intoxication\nAcute Alcoholic Withdrawal Syndrome (delirium tremens)\nInfective causes e. g.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "859",
    "type": "section",
    "keywords": [
      "cocaine",
      "secondary",
      "acute",
      "infective",
      "psychosis",
      "drug",
      "marijuana",
      "reaction",
      "toxic",
      "abnormal",
      "delirium",
      "heroin",
      "causes",
      "alcoholic",
      "amphetamines",
      "tremens",
      "intoxication",
      "syndrome",
      "withdrawal"
    ]
  },
  {
    "id": "90e31bf532207d5ab17715aed1257164",
    "content": "typhoid, malaria, meningitis, HIV, encephalitis, hepatitis.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "860",
    "type": "section",
    "keywords": [
      "typhoid",
      "meningitis",
      "encephalitis",
      "hepatitis",
      "malaria"
    ]
  },
  {
    "id": "2fae93212c690dd8c60385b6d6ec20cc",
    "content": "Porphyria\nOthers\nHead trauma\nSubdural hematoma\nSymptoms.",
    "title": "Thyroid disease",
    "section": "Thyroid disease",
    "chunk_id": "861",
    "type": "section",
    "keywords": [
      "porphyria",
      "hematoma",
      "subdural",
      "others",
      "head",
      "symptoms",
      "trauma"
    ]
  },
  {
    "id": "50f2bc794946617cc1ad9a4ad1c3da9a",
    "content": "Sleeplessness\nRestlessness - agitated or even combative patient\nTalking excessively and loudly, or low toned, reduced speech, even mute in some cases\nDisinhibited behaviour or speech\nHearing or seeing “imaginary” people or objects. Expression of fear, undue suspicion, inappropriate guilt or bizarre\nbeliefs\nDestructiveness\nSigns.",
    "title": "(See relevant sections for symptoms of specific disorders)",
    "section": "(See relevant sections for symptoms of specific disorders)",
    "chunk_id": "862",
    "type": "section",
    "keywords": [
      "suspicion",
      "inappropriate",
      "reduced",
      "mute",
      "patient",
      "speech",
      "talking",
      "even",
      "signs",
      "behaviour",
      "people",
      "expression",
      "sleeplessness",
      "restlessness",
      "undue",
      "excessively",
      "hearing",
      "combative",
      "toned",
      "seeing"
    ]
  },
  {
    "id": "f5c24aaad2013823863c274f5da2b1ff",
    "content": "Elated, irritable, angry or depressed mood\nPhysical aggression, agitation or restlessness\nLack of insight\nPressured or retarded speech\nHyperactivity or reduced motor activity\nDisinhibition - social and sexual\nDelusions of grandeur, guilt or paranoia\nAuditory hallucinations\nVisual hallucinations (especially in toxic, infectious and withdrawal states)\nFever (infective conditions)\nDrowsiness, altered consciousness (mainly in alcohol withdrawal)\nDisorientation and confusion (mainly in alcohol withdrawal)\nSweating\nTremors (mainly in alcohol withdrawal)\ninvestigations\nUsually none\nUrine screen (for substances like amphetamines, cocaine, heroin, cannabis).",
    "title": "(See relevant sections for signs of specific disorders)",
    "section": "(See relevant sections for signs of specific disorders)",
    "chunk_id": "863",
    "type": "section",
    "keywords": [
      "usually",
      "aggression",
      "activity",
      "disorientation",
      "withdrawal",
      "especially",
      "hyperactivity",
      "agitation",
      "hallucinations",
      "urine",
      "cocaine",
      "reduced",
      "retarded",
      "grandeur",
      "speech",
      "pressured",
      "lack",
      "disinhibition",
      "infective",
      "alcohol"
    ]
  },
  {
    "id": "bfbbe3370b92fbecc151714415cef9ba",
    "content": "FBC, Rapid Diagnostic Test for malaria parasites (when there is fever and suspected infections)\nRandom Blood Sugar\nBlood culture.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "864",
    "type": "section",
    "keywords": [
      "infections",
      "test",
      "rapid",
      "suspected",
      "fever",
      "sugar",
      "diagnostic",
      "there",
      "culture",
      "parasites",
      "malaria",
      "blood",
      "random"
    ]
  },
  {
    "id": "130e1474f55e327b392fd5c75643e330",
    "content": "Rapid tranquilisation - to calm down the patient as quickly as possible\nusing the safest drugs available without necessarily inducing sleep\nTo treat underlying cause.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "865",
    "type": "section",
    "keywords": [
      "calm",
      "necessarily",
      "drugs",
      "using",
      "rapid",
      "treat",
      "tranquilisation",
      "down",
      "safest",
      "cause",
      "quickly",
      "underlying",
      "possible",
      "inducing",
      "available",
      "sleep",
      "patient",
      "without"
    ]
  },
  {
    "id": "881a60498bcd6c915c5c6b3ac35254b7",
    "content": "Restrain patient when necessary without causing injuries\nTalk to the patient in a firm but reassuring manner\nAvoid long periods of silence especially in paranoid patients\nRemove and store away any offensive weapons on or around patient.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "866",
    "type": "section",
    "keywords": [
      "avoid",
      "injuries",
      "firm",
      "especially",
      "patient",
      "weapons",
      "reassuring",
      "manner",
      "patients",
      "causing",
      "periods",
      "restrain",
      "away",
      "around",
      "silence",
      "paranoid",
      "talk",
      "necessary",
      "remove",
      "offensive"
    ]
  },
  {
    "id": "681a288937b0259787ae679063c0deec",
    "content": "Evidence Rating: [C]\nLorazepam, IV/IM,\nAdults\nmg stat. Repeated once after 10 minutes if necessary. Children\n12 years;\t500 microgram-2 mg (max.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "867",
    "type": "section",
    "keywords": [
      "lorazepam",
      "rating",
      "years",
      "microgram",
      "minutes",
      "adults",
      "necessary",
      "after",
      "children",
      "repeated",
      "evidence",
      "stat",
      "once"
    ]
  },
  {
    "id": "84da37b081e9ae27e4207da142834383",
    "content": "4 mg)\n< 12 years;\t500 microgram-1 mg (max. 2 mg)\nOr\nHaloperidol, IM,\nAdults\nmg stat. may repeat in 4-8 hours (max.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "868",
    "type": "section",
    "keywords": [
      "years",
      "microgram",
      "haloperidol",
      "adults",
      "repeat",
      "hours",
      "stat"
    ]
  },
  {
    "id": "c0ace7ec3268aa14bb83b0ca6792cda7",
    "content": "20 mg per day)\nChildren\n13-18 years;\t2-5 mg 4-8 hourly as required\n6-12 years;\t1-3 mg 4-8 hourly as required (max. 0. 15 mg/kg per day)\n< 5 years;\tnot recommended\nThen\nHaloperidol, oral,\nAdults\n3-5 mg 8-12 hourly (max.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "869",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "haloperidol",
      "adults",
      "oral",
      "required",
      "children",
      "then"
    ]
  },
  {
    "id": "a86b4cabae19e9f2ffd016d81b4a81db",
    "content": "30 mg per day)\nChildren\n12 years;\t3-5 mg 8-12 hourly as required (max. 30 mg per day)\n3-12 years (15-40 kg);  0. 25-0.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "870",
    "type": "section",
    "keywords": [
      "children",
      "hourly",
      "years",
      "required"
    ]
  },
  {
    "id": "ae5c55f38dfb60615974f7a842b2aa97",
    "content": "5 mg per day (max. 0. 5 mg per day)\n< 3 years;\tnot recommended\nOr.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "871",
    "type": "section",
    "keywords": [
      "recommended",
      "years"
    ]
  },
  {
    "id": "6c80fcf64fa2cdf5db34dfb281dce59c",
    "content": "Chlorpromazine, IM, (for very agitated patients)\nAdults\n50-150 mg stat. repeated after 30-40 minutes if necessary\nChildren\n12-18 years;\t25-50 mg 6-8 hourly\n6-12 years;\t500 microgram/kg 6-8 hourly (max. 75 mg per day)\nyears;\t500 microgram/kg 6-8 hourly (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "872",
    "type": "section",
    "keywords": [
      "chlorpromazine",
      "agitated",
      "hourly",
      "years",
      "microgram",
      "minutes",
      "adults",
      "necessary",
      "patients",
      "after",
      "children",
      "repeated",
      "stat"
    ]
  },
  {
    "id": "dc7ab7540295f06f484de9419b52a204",
    "content": "40 mg per day)\nOr\nOlanzapine, IM,\nAdults\n10-20 mg stat. subsequent doses of 10 mg may be given 2 hours after initial dose, if necessary and 4 hours after 2nd dose (max. 30 mg per day)\nChildren\nNot recommended\nOr\nChloral hydrate, oral or rectal,\nAdults 500 mg-1g Children\n12-18 years;\t500 mg-1 g\n1 month-12 years;\t30-50 mg/kg (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "873",
    "type": "section",
    "keywords": [
      "initial",
      "chloral",
      "years",
      "given",
      "rectal",
      "doses",
      "children",
      "subsequent",
      "stat",
      "hydrate",
      "adults",
      "dose",
      "month",
      "olanzapine",
      "recommended",
      "necessary",
      "oral",
      "after",
      "hours"
    ]
  },
  {
    "id": "918e46538f7d3afa7c296aef75862d4a",
    "content": "1g)\nNeonate;\t30-50 mg/kg\nOr\nDiazepam, IV,\nAdults\n10 mg slowly over 2-3 minutes (approximately 2. 5 mg every 30 sec- onds)\nChildren\n200-300 microgram/kg slowly over 2-3 minutes. This may be repeated after 10 minutes if necessary (max 10 mg)\nOr\nDiazepam, rectal,\nChildren\n12 years;\t0.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "874",
    "type": "section",
    "keywords": [
      "diazepam",
      "onds",
      "rectal",
      "years",
      "microgram",
      "minutes",
      "adults",
      "neonate",
      "necessary",
      "after",
      "slowly",
      "children",
      "repeated",
      "approximately",
      "every"
    ]
  },
  {
    "id": "9e2564fed4fb9261642ab1af217bab51",
    "content": "2 mg /kg\n6-12 years;\t0. 3 mg/kg\nyears;\t0. 5 mg/kg\n1 month-2 years;\t2.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "875",
    "type": "section",
    "keywords": [
      "years",
      "month"
    ]
  },
  {
    "id": "3d24d7c2364955de9747634d370a14f3",
    "content": "5 mg\nNeonates;\t1. 25-2. 5 mg\nThis may be repeated after 10 minutes (max 10 mg).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "876",
    "type": "section",
    "keywords": [
      "repeated",
      "minutes",
      "after",
      "neonates"
    ]
  },
  {
    "id": "7f28af69e0425c45829dd4ab2f1f0992",
    "content": "Referral Criteria\nRefer all acutely disturbed patients to a specialist. Psychogenic seizures or pseudo seizures are non-epileptic seizures, which mimic epilepsy but actually have an underlying psychological cause. In patients with this form of disorder, there may be a history of physical, sexual or psychological abuse.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "877",
    "type": "section",
    "keywords": [
      "psychological",
      "pseudo",
      "seizures",
      "which",
      "acutely",
      "form",
      "specialist",
      "psychogenic",
      "epilepsy",
      "underlying",
      "patients",
      "epileptic",
      "criteria",
      "disturbed",
      "referral",
      "mimic",
      "cause",
      "there",
      "sexual",
      "actually"
    ]
  },
  {
    "id": "93bcfe03e08dcd435d50ec2fb42960ea",
    "content": "The symptoms may be precipitated by stress and the signs are often variable and may include resistance to eye opening upon examination. The diagnosis requires a high level of suspicion since it is often difficult to separate from epileptic seizures and may, in fact co-exist with epilepsy. Symptoms\nRecurrent tonic clonic-like seizures\nAttacks usually occur only when attention of other people can be attracted\nPatients hardly ever get injured, even when they fall (unlike in true\nseizures)\nThrusting pelvic movements are common during “seizure” attacks\nTongue biting, if it occurs is usually at the tip of the tongue instead of the sides as in true seizures\nMay have urinary incontinence as in normal seizures\ninvestigations\nSerum prolactin\nEEG.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "878",
    "type": "section",
    "keywords": [
      "usually",
      "recurrent",
      "occur",
      "often",
      "attracted",
      "seizures",
      "during",
      "sides",
      "incontinence",
      "suspicion",
      "instead",
      "seizure",
      "upon",
      "attacks",
      "unlike",
      "ever",
      "movements",
      "epilepsy",
      "stress",
      "attention"
    ]
  },
  {
    "id": "403369df8f891c371e6a727985450f69",
    "content": "Reassure parents, guardians etc. Counselling\nPsychotherapy.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "879",
    "type": "section",
    "keywords": [
      "psychotherapy",
      "counselling",
      "parents",
      "reassure",
      "guardians"
    ]
  },
  {
    "id": "61d1a9d700033a33467a6341d5f0e46e",
    "content": "Anti-epileptic medicines do not appear to have any beneficial effect on frequency of attacks.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "880",
    "type": "section",
    "keywords": [
      "attacks",
      "appear",
      "medicines",
      "anti",
      "beneficial",
      "have",
      "epileptic",
      "frequency",
      "effect"
    ]
  },
  {
    "id": "b6347c303d050b0e9114eb29eb2c5bff",
    "content": "Referral Criteria\nRefer all cases for evaluation by psychologist or psychiatrist. Insomnia is defined as a subjective report of difficulty with sleep initiation, duration, consolidation, or quality that occurs despite adequate opportunity for sleep, and that results in some form of daytime impairment. Insomnia symptoms occur quite commonly in the general population.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "881",
    "type": "section",
    "keywords": [
      "opportunity",
      "occur",
      "quality",
      "results",
      "report",
      "form",
      "initiation",
      "evaluation",
      "daytime",
      "insomnia",
      "population",
      "criteria",
      "referral",
      "psychologist",
      "consolidation",
      "psychiatrist",
      "impairment",
      "duration",
      "difficulty",
      "occurs"
    ]
  },
  {
    "id": "c8d873a96e9acb9370d53db466025c7d",
    "content": "Risk factors for insomnia include increasing age, female sex, co-morbid disorders such as medical, psychiatric, substance use, and shift work. Patients with psychiatric and chronic pain disorders have relatively high rates of insomnia. Causes\nBehavioural - spending more time in bed in an effort to “catch up”\non sleep\nStress\nLearned habits which do not enhance sleep\nCognitive distortions (e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "882",
    "type": "section",
    "keywords": [
      "work",
      "sleep",
      "psychiatric",
      "cognitive",
      "factors",
      "which",
      "morbid",
      "insomnia",
      "female",
      "stress",
      "catch",
      "rates",
      "patients",
      "effort",
      "causes",
      "distortions",
      "include",
      "behavioural",
      "chronic",
      "disorders"
    ]
  },
  {
    "id": "f5de032443d66b614387e95176f8d797",
    "content": "g. if one does not sleep throughout the night, one has not slept at all).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "883",
    "type": "section",
    "keywords": [
      "throughout",
      "does",
      "sleep",
      "slept",
      "night"
    ]
  },
  {
    "id": "37418fd0769d5eae5c73c31816da5c05",
    "content": "Caffeine-containing beverages (e. g. coffee, tea)\nWithdrawal from alcohol and other drugs of abuse (e.",
    "title": "Medicines (e.g.for treatment of common cold, hypertension, asthma)",
    "section": "Medicines (e.g.for treatment of common cold, hypertension, asthma)",
    "chunk_id": "884",
    "type": "section",
    "keywords": [
      "coffee",
      "drugs",
      "containing",
      "withdrawal",
      "alcohol",
      "other",
      "beverages",
      "caffeine",
      "abuse"
    ]
  },
  {
    "id": "f9c5a8b2b30765432c735c90569dc252",
    "content": "g. cocaine, marijuana, amphetamines)\nMedical condition (e. g.",
    "title": "Medicines (e.g.for treatment of common cold, hypertension, asthma)",
    "section": "Medicines (e.g.for treatment of common cold, hypertension, asthma)",
    "chunk_id": "885",
    "type": "section",
    "keywords": [
      "amphetamines",
      "marijuana",
      "cocaine",
      "condition",
      "medical"
    ]
  },
  {
    "id": "099b4fcbfd61d1c2637de77835fcd97a",
    "content": "Travel (especially across time zones leading to jet lag)\nShift work\nSymptoms\nProlonged average time for falling asleep - longer than 30 minutes\nTotal sleep time less than 6. 5 hours\nDifficulty falling asleep\nFrequent awakenings\nDifficulty returning to sleep\nAwakening too early in the morning\nSleep that does not feel restful, refreshing or restorative\nAnticipating poor sleep hours before bedtime, and becoming more alert and anxious as bedtime approaches\nDaytime effects of poor sleep:\nFatigue and sleepiness\nMood disturbances and cognitive difficulties\nPoor quality of life (worsened by interpersonal difficulties, or.",
    "title": "Other psychiatric disorders such as anxiety and mood disorders",
    "section": "Other psychiatric disorders such as anxiety and mood disorders",
    "chunk_id": "886",
    "type": "section",
    "keywords": [
      "prolonged",
      "work",
      "approaches",
      "morning",
      "especially",
      "quality",
      "fatigue",
      "restorative",
      "cognitive",
      "becoming",
      "travel",
      "poor",
      "difficulties",
      "asleep",
      "worsened",
      "anticipating",
      "daytime",
      "disturbances",
      "minutes",
      "interpersonal"
    ]
  },
  {
    "id": "a64aba7d18d443d1b98781f7f5d41569",
    "content": "avoidance of day activities)\nExacerbation of co-morbid conditions such as depression, high blood pressure, etc. Day-to-day variability\ninvestigations\nFBC\nBUE and creatinine\nLFTs\nBlood glucose\nThyroid function tests.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "887",
    "type": "section",
    "keywords": [
      "creatinine",
      "pressure",
      "avoidance",
      "exacerbation",
      "variability",
      "lfts",
      "function",
      "conditions",
      "activities",
      "high",
      "tests",
      "glucose",
      "thyroid",
      "investigations",
      "morbid",
      "blood",
      "depression"
    ]
  },
  {
    "id": "408e70a26accf3a6b452ac5e0369b9d6",
    "content": "Reduction of waking symptoms\nImprovement of daytime function\nReduction of distress.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "888",
    "type": "section",
    "keywords": [
      "waking",
      "reduction",
      "daytime",
      "function",
      "distress",
      "symptoms",
      "improvement"
    ]
  },
  {
    "id": "f7469d5869a12dd7f8a27f4e236199ca",
    "content": "Stimulus control therapy (avoid stimulating sleep environments such as leaving lights, TV and radio on)\nRelaxation training\nCognitive Behavior Therapy\nAvoidance of day-time sleep\nAvoidance of excessive stimulant consumption pre-bed time (e. g.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "889",
    "type": "section",
    "keywords": [
      "stimulant",
      "avoid",
      "stimulating",
      "leaving",
      "lights",
      "training",
      "avoidance",
      "behavior",
      "stimulus",
      "environments",
      "cognitive",
      "radio",
      "relaxation",
      "control",
      "sleep",
      "therapy",
      "consumption",
      "excessive"
    ]
  },
  {
    "id": "59f9382656111de061f87bafdb56d12b",
    "content": "Lorazepam, oral,\nAdults\nmg at bedtime\nChildren\nNot recommended\nOr\nTriazolam, oral,\nAdults\nElderly;\t125-250 microgram at bedtime\n< 60 years;\t125-500 microgram at bedtime\nChildren\nNot recommended.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [C]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "890",
    "type": "section",
    "keywords": [
      "lorazepam",
      "recommended",
      "years",
      "microgram",
      "bedtime",
      "adults",
      "oral",
      "elderly",
      "children",
      "triazolam"
    ]
  },
  {
    "id": "5a36e3f57e3d184d25fb3f2062ed7ffa",
    "content": "Melatonin, oral, (particularly for children)\nAdults\n3-5 mg daily, 1-2 hours before bedtime (max. 10 mg)\nChildren\n1 month-18 years;\t2-3 mg at bedtime\nIncrease if necessary after 1-2 weeks to 4-6 mg daily (max. 10 mg)\nOr\nEvidence Rating: [B]\nAmitriptyline, oral,\nAdult\n25-50 mg at night for two weeks\nChildren\nNot recommended\nReferral Criteria\nRefer to clinical psychologist for those patients who do not respond to the common non-pharmacological and pharmacological interventions for cognitive behaviour therapy.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "891",
    "type": "section",
    "keywords": [
      "pharmacological",
      "years",
      "cognitive",
      "therapy",
      "evidence",
      "increase",
      "night",
      "rating",
      "respond",
      "interventions",
      "patients",
      "behaviour",
      "weeks",
      "children",
      "particularly",
      "criteria",
      "amitriptyline",
      "referral",
      "psychologist",
      "before"
    ]
  },
  {
    "id": "e4db4273ec8bfaa9d235af958c654431",
    "content": "Refer patients with underlying physical causes to the appropriate specialists. Depression is a mood disorder, which may occur in all age groups, although the symptoms may differ in children. It is a relatively common condition and has a tendency to recur.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "892",
    "type": "section",
    "keywords": [
      "occur",
      "which",
      "differ",
      "tendency",
      "underlying",
      "patients",
      "condition",
      "children",
      "causes",
      "specialists",
      "groups",
      "symptoms",
      "recur",
      "although",
      "disorder",
      "appropriate",
      "physical",
      "refer",
      "mood",
      "common"
    ]
  },
  {
    "id": "0dce65b90220868027902991da893453",
    "content": "Some affected persons may turn out to have bipolar disorder, in which case, episodes of mania occur. Clinically significant depression, also called major depression, is.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "893",
    "type": "section",
    "keywords": [
      "disorder",
      "episodes",
      "case",
      "occur",
      "called",
      "persons",
      "significant",
      "also",
      "which",
      "major",
      "mania",
      "bipolar",
      "have",
      "clinically",
      "turn",
      "affected",
      "depression"
    ]
  },
  {
    "id": "955e0966e7aa51fbf452d3ad207b811c",
    "content": "twice as common in women as in men. Many affected individuals seek help from spiritual and traditional healers. For a good proportion of those who go to hospitals, their condition is not recognised.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "894",
    "type": "section",
    "keywords": [
      "their",
      "those",
      "women",
      "hospitals",
      "common",
      "recognised",
      "condition",
      "proportion",
      "individuals",
      "healers",
      "traditional",
      "help",
      "twice",
      "spiritual",
      "seek",
      "affected"
    ]
  },
  {
    "id": "43d4963f39645c10f316c2ad6afa4748",
    "content": "Depression is a significant cause of morbidity all over the world and most people who attempt or successfully complete suicide have depression. One should not dismiss or take for granted statements made by patients such as “I want to die”, “life is not worth living”, or “I am fed up with life”. All cases of attempted suicide should be referred to a psychiatrist after initial management of the presenting complication e.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "895",
    "type": "section",
    "keywords": [
      "initial",
      "world",
      "morbidity",
      "successfully",
      "management",
      "dismiss",
      "attempted",
      "presenting",
      "suicide",
      "living",
      "complete",
      "complication",
      "people",
      "granted",
      "most",
      "patients",
      "worth",
      "attempt",
      "statements",
      "psychiatrist"
    ]
  },
  {
    "id": "8b8a2ba68e655f5d48044e53a52ebc54",
    "content": "g. self-inflicted injuries or poisoning. Recurrent depression or unipolar depression is treated differently (with antidepressants) from bipolar depression, which responds more to mood stabilizers.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "896",
    "type": "section",
    "keywords": [
      "antidepressants",
      "injuries",
      "recurrent",
      "differently",
      "self",
      "stabilizers",
      "treated",
      "mood",
      "which",
      "bipolar",
      "poisoning",
      "more",
      "responds",
      "inflicted",
      "depression",
      "unipolar"
    ]
  },
  {
    "id": "86e224498f40b610f99326ce529617de",
    "content": "The diagnostic criteria for major depression relies on the presence of at least five (5) of the symptoms listed in the section on symptoms below, experienced every day for at least two weeks. In the treatment of depression, maximum tolerable doses of antidepressant medications must be given for at least 6 weeks before deciding a particular medication is not effective. After an episode of depression, treatment must be continued for at least 6 months, as there is a high risk of relapse within this period.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "897",
    "type": "section",
    "keywords": [
      "antidepressant",
      "given",
      "diagnostic",
      "tolerable",
      "particular",
      "within",
      "relies",
      "section",
      "doses",
      "five",
      "episode",
      "continued",
      "presence",
      "weeks",
      "criteria",
      "treatment",
      "deciding",
      "relapse",
      "before",
      "medications"
    ]
  },
  {
    "id": "064aceb8d39c29759abce5d3ac7bdc12",
    "content": "Antidepressants must be stopped immediately if a manic swing occurs. Patients with suicidal tendencies must be admitted and kept under close observation. Causes\nGenetic\nFamilial\nEnvironmental\nPsychosocial factors.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "898",
    "type": "section",
    "keywords": [
      "observation",
      "manic",
      "factors",
      "environmental",
      "close",
      "under",
      "genetic",
      "immediately",
      "swing",
      "stopped",
      "patients",
      "causes",
      "tendencies",
      "familial",
      "occurs",
      "kept",
      "antidepressants",
      "suicidal",
      "admitted",
      "psychosocial"
    ]
  },
  {
    "id": "a4e05ca2f89ee27c77b8cdd18ec02d82",
    "content": "Symptoms\nDepressed mood, often reported as feeling ‘out of sorts’\nLoss of interest or lack of pleasure in things previously of interest\nSignificant weight loss or weight gain\nInsomnia or sleeping too much\nPsychomotor agitation or retardation\nFatigue or loss of energy\nFeelings of worthlessness or excessive guilt\nImpaired thinking\nPoor concentration;\nindecisiveness;\nworrying excessively\nMultiple bodily complaints\nSuicidal ideas or thoughts of death.",
    "title": "Endocrine disorders e.g. hypothyroidism, Cushing’s syndrome",
    "section": "Endocrine disorders e.g. hypothyroidism, Cushing’s syndrome",
    "chunk_id": "899",
    "type": "section",
    "keywords": [
      "thoughts",
      "weight",
      "often",
      "fatigue",
      "agitation",
      "interest",
      "poor",
      "death",
      "feeling",
      "impaired",
      "complaints",
      "previously",
      "multiple",
      "psychomotor",
      "insomnia",
      "lack",
      "concentration",
      "worrying",
      "feelings",
      "bodily"
    ]
  },
  {
    "id": "b94243e5331ea17059c5e94597bbf1d0",
    "content": "Hallucinations or delusions of morbid themes in severe cases\nIn children\nTruancy or refusal to go to school\nPoor school performance\nBedwetting in a previously ‘dry’ child\nOdd behaviour, aggression or defiance\nIrritability\nAppetite changes\nSome of the ‘adult’ symptoms listed above\nSigns\nDepressed mood\nEvidence of weight loss or weight gain\nAgitation or retardation\nHallucinations\ninvestigations\nFBC\nBUE and Creatinine\nFBS\nThyroid function and cortisol levels if indicated\nAdminister a standardized scale of depression such as the PHQ (patient health questionnaire 9 item scale).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "900",
    "type": "section",
    "keywords": [
      "aggression",
      "weight",
      "refusal",
      "levels",
      "hallucinations",
      "child",
      "agitation",
      "health",
      "poor",
      "morbid",
      "patient",
      "evidence",
      "truancy",
      "creatinine",
      "previously",
      "defiance",
      "scale",
      "function",
      "signs",
      "behaviour"
    ]
  },
  {
    "id": "5b49517be06e12d51f7b1056a1f4b49c",
    "content": "To reduce symptoms\nTo prevent disruption to normal life at home, work or school\nTo prevent suicide.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "901",
    "type": "section",
    "keywords": [
      "school",
      "work",
      "prevent",
      "home",
      "reduce",
      "life",
      "suicide",
      "normal",
      "symptoms",
      "disruption"
    ]
  },
  {
    "id": "53f6cfb8e618a8df2b7db45c57e6688a",
    "content": "Counselling\nPsychotherapy, specifically Cognitive Behaviour Therapy\nElectroconvulsive therapy.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "902",
    "type": "section",
    "keywords": [
      "psychotherapy",
      "counselling",
      "cognitive",
      "behaviour",
      "electroconvulsive",
      "specifically",
      "therapy"
    ]
  },
  {
    "id": "d2120b9fef8dcef72091a1fe2297857d",
    "content": "Fluoxetine, oral,\nAdults\n20 mg once daily for 2-4 weeks,\nThen\nIncrease if necessary to max. of 80 mg\nChildren\n8-18 years;\t10 mg once daily for 1-2 weeks\nThen\nIncrease if necessary to max. 20 mg once daily.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "903",
    "type": "section",
    "keywords": [
      "fluoxetine",
      "years",
      "adults",
      "necessary",
      "oral",
      "children",
      "increase",
      "weeks",
      "then",
      "once",
      "daily"
    ]
  },
  {
    "id": "6aa29564fb74dd6fb13ea9507f1e1c3b",
    "content": "Or\nSertraline, oral,\nAdults\n50 mg once daily,\nThen\nIncrease if necessary by increments of 50 mg at intervals of at least 1 week, to max. of 200 mg daily. Children\n13-18 years;\t50 mg once daily\nThen\nIncrease if necessary by increments of 50 mg at intervals of at least 1 week, to max.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "904",
    "type": "section",
    "keywords": [
      "sertraline",
      "years",
      "least",
      "intervals",
      "increments",
      "week",
      "adults",
      "necessary",
      "oral",
      "increase",
      "children",
      "then",
      "once",
      "daily"
    ]
  },
  {
    "id": "25cc172e0bf85d4cd2572b4c425a2852",
    "content": "of 200 mg daily. 6-12 years;\t25 mg daily,\nThen\nIncrease if necessary to 50 mg daily after 1 week. Further increase if necessary in steps of 50 mg at intervals of at least one week to a max.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "905",
    "type": "section",
    "keywords": [
      "years",
      "least",
      "intervals",
      "week",
      "necessary",
      "further",
      "steps",
      "after",
      "then",
      "increase",
      "daily"
    ]
  },
  {
    "id": "402e04c85c9e684bc4159cba25ff850b",
    "content": "of 200 mg daily\n< 6 years;\tnot recommended\nOr\nCitalopram, oral,\nAdults\n20 mg once daily, increase if necessary in steps of 20 mg daily, at intervals of 3-4 week, max. 40 mg. Children\n12 years;\t10 mg once daily,\nThen\nIncrease if necessary to 20 mg once daily in the evening, over 2-4 weeks (max.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "906",
    "type": "section",
    "keywords": [
      "recommended",
      "years",
      "then",
      "intervals",
      "evening",
      "weeks",
      "week",
      "adults",
      "necessary",
      "oral",
      "citalopram",
      "steps",
      "children",
      "increase",
      "once",
      "daily"
    ]
  },
  {
    "id": "d3bb0b740ae846dde588c41fb8fe7b3e",
    "content": "of 40 mg once daily)\n< 12 years;\tnot recommended\nOr\nImipramine, oral,\nAdults\n25-50 mg once daily (early evening),\nThen\nIncrease by 25 mg every 3-5 days up to max. of 150 mg. Children\nNot recommeded\nOr\nAmitriptyline, oral,\nAdults\n25-50 mg once daily (early evening),\nThen\nIncrease by 25 mg every 3-5 days up to a max.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "907",
    "type": "section",
    "keywords": [
      "imipramine",
      "days",
      "recommended",
      "years",
      "evening",
      "recommeded",
      "early",
      "adults",
      "amitriptyline",
      "oral",
      "every",
      "increase",
      "children",
      "then",
      "once",
      "daily"
    ]
  },
  {
    "id": "b096fb2c0a9fee4f75ecc15bd784fa05",
    "content": "16 years;\t5-15 mg 12 hourly\n< 16 years;\tnot recocommended\nA. Management of patients with depression requiring night sedation\nLorazepam, oral,\nAdults\nmg 8-12 hourly, max. 10 mg daily\nChildren\n2-18 years;\t0.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "908",
    "type": "section",
    "keywords": [
      "hourly",
      "lorazepam",
      "years",
      "management",
      "adults",
      "oral",
      "requiring",
      "sedation",
      "patients",
      "children",
      "daily",
      "night",
      "depression",
      "recocommended"
    ]
  },
  {
    "id": "d4294551e71e7b5d967312e927d7069e",
    "content": "05 mg/kg 8 hourly, max. 2 mg daily\nOr\nDiazepam, oral,\nAdults\n5-10 mg 6-12 hourly\nChildren\n12-18 years;\t10 mg 12 hourly\n5-12 years;\t5 mg 12 hourly\nReferral Criteria\nRefer patients with atypical or unusual symptoms, hysterical or phobic features, and those who do not respond to adequate anti-depressant treatment within 2 months, to a psychiatrist, as should children suspected to suffer from depression. Patients requiring Cognitive Behaviour Therapy should be referred\nto a psychologist.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "909",
    "type": "section",
    "keywords": [
      "depressant",
      "phobic",
      "years",
      "depression",
      "cognitive",
      "features",
      "therapy",
      "diazepam",
      "hourly",
      "within",
      "hysterical",
      "respond",
      "requiring",
      "patients",
      "behaviour",
      "children",
      "criteria",
      "treatment",
      "referral",
      "psychologist"
    ]
  },
  {
    "id": "46554befb65ec4bc4b9f51af769944e7",
    "content": "Schizophrenia is probably the most severe and potentially disabling form of mental illness in every community worldwide. It may present as an acute or chronic illness. The clinical features include characteristic ‘positive’ or ‘negative’ symptoms, deterioration in social, work or interpersonal relationships and continued evidence of disturbed behaviour for at least 6 months.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "910",
    "type": "section",
    "keywords": [
      "mental",
      "work",
      "schizophrenia",
      "characteristic",
      "features",
      "potentially",
      "disabling",
      "form",
      "acute",
      "evidence",
      "relationships",
      "interpersonal",
      "continued",
      "social",
      "behaviour",
      "most",
      "deterioration",
      "severe",
      "include",
      "disturbed"
    ]
  },
  {
    "id": "d58964b6c47ea7e763b5af04237697eb",
    "content": "The clinical features may be numerous and can change over time. Psychosis associated with substance abuse and mood disorders with psychotic features may mimic schizophrenia. For this illness, a few people may recover completely after an episode or two.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "911",
    "type": "section",
    "keywords": [
      "schizophrenia",
      "features",
      "associated",
      "psychotic",
      "numerous",
      "psychosis",
      "episode",
      "people",
      "mimic",
      "recover",
      "disorders",
      "change",
      "substance",
      "mood",
      "illness",
      "completely",
      "after",
      "abuse",
      "clinical"
    ]
  },
  {
    "id": "7c63593e85f3706d0d6b51942d86922e",
    "content": "Treatment must be started once symptoms are present. A definitive diagnosis and establishment of a treatment plan is best carried out by a psychiatrist. Treatment for acute episodes can be started by a psychiatrist and follow up treatment continued by most health care givers.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "912",
    "type": "section",
    "keywords": [
      "health",
      "definitive",
      "acute",
      "plan",
      "follow",
      "continued",
      "most",
      "treatment",
      "episodes",
      "diagnosis",
      "psychiatrist",
      "symptoms",
      "once",
      "establishment",
      "present",
      "started",
      "carried",
      "must",
      "best",
      "givers"
    ]
  },
  {
    "id": "66f15ec8888bb4ec3a5c0f70e605af9b",
    "content": "Treatment must be for at least 18 months after remission of symptoms for a first episode. However, life long treatment is probably the best strategy to avoid recurrence. Side effects such as extra-pyramidal reactions (slowness, drooling, stiffness, tremors, rigidity, muscle spasms including tongue sticking.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "913",
    "type": "section",
    "keywords": [
      "avoid",
      "extra",
      "pyramidal",
      "stiffness",
      "strategy",
      "sticking",
      "including",
      "muscle",
      "episode",
      "reactions",
      "treatment",
      "drooling",
      "side",
      "first",
      "recurrence",
      "slowness",
      "rigidity",
      "tongue",
      "probably",
      "tremors"
    ]
  },
  {
    "id": "4dad407c272bc6bb4b9e465a57bc1489",
    "content": "out, neck bending, etc. ) to antipsychotics may occur especially when administered at high doses. These adverse reactions can be prevented or managed with anticholinergic agents, which must be used sparingly as they may contribute to the development of another adverse event, called tardive dyskinesia, in the long term.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "914",
    "type": "section",
    "keywords": [
      "agents",
      "contribute",
      "occur",
      "development",
      "especially",
      "which",
      "antipsychotics",
      "neck",
      "doses",
      "tardive",
      "sparingly",
      "reactions",
      "event",
      "prevented",
      "bending",
      "these",
      "another",
      "managed",
      "anticholinergic",
      "dyskinesia"
    ]
  },
  {
    "id": "a357b5ca6c7d39fe8bab1fc9c91c659e",
    "content": "(See section on ‘Adjunct Treatment’ below)\nCauses\nLargely unknown\nPossible associations:\nBio-Genetic (to do with dopamine and serotonin receptors)\nBio-Psycho social determinants; genetic predisposition coupled with stress (economic, disruptive family environments, etc. ) Birth defects in brain associated with season of birth, possible viral infections, etc. Environmental triggers\nIllicit drugs (marijuana, amphetamines etc.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "915",
    "type": "section",
    "keywords": [
      "infections",
      "illicit",
      "disruptive",
      "dopamine",
      "associated",
      "family",
      "environmental",
      "predisposition",
      "triggers",
      "psycho",
      "receptors",
      "unknown",
      "genetic",
      "stress",
      "section",
      "marijuana",
      "social",
      "causes",
      "treatment",
      "serotonin"
    ]
  },
  {
    "id": "07943eaf2e098d008ff642f52180e7c4",
    "content": ")\nSymptoms/Signs ‘Positive’ symptoms\nHallucinations (e. g. hearing voices)\nDelusions (stated beliefs which cannot be substantiated)\nIncoherent speech or illogicality\nOdd or disorganised behaviour\nPatient believes his or her thoughts are controlled by outside forces\n‘Negative’ symptoms\nPoverty of speech or content of speech (few words or with little substance)\nApathy\nReduced social contact or withdrawal\nFlattened affect (showing little facial expressive responses)\nDelusions\nMay be persecutory, such as undue suspicion, or totally bizarre, like being controlled or being made to feel emotions or sensa- tions\nGrandiose delusions may also occur but without the elevated\nmood seen in manic patients\nHallucinations\ncommonly auditory (but may involve any of the other senses)\nAuditory hallucinations of multiple voices commenting on pa- tients’ actions, arguing about the patient are almost diagnostic.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "916",
    "type": "section",
    "keywords": [
      "thoughts",
      "outside",
      "occur",
      "flattened",
      "little",
      "manic",
      "which",
      "hallucinations",
      "suspicion",
      "seen",
      "poverty",
      "totally",
      "reduced",
      "tients",
      "diagnostic",
      "patient",
      "speech",
      "believes",
      "illogicality",
      "multiple"
    ]
  },
  {
    "id": "9ef9573ef18890375024f93a96d8cedf",
    "content": "are not essential for diagnosis\ninvestigations\nUsually none required for diagnosis\nTests to rule out organic causes of psychosis\nBaseline full blood count, blood sugar, lipids, liver and kidney function.",
    "title": "Motor disorders like posturing, excitement or stupor may occur but",
    "section": "Motor disorders like posturing, excitement or stupor may occur but",
    "chunk_id": "917",
    "type": "section",
    "keywords": [
      "usually",
      "essential",
      "required",
      "full",
      "lipids",
      "count",
      "function",
      "psychosis",
      "baseline",
      "sugar",
      "blood",
      "causes",
      "diagnosis",
      "tests",
      "investigations",
      "kidney",
      "none",
      "rule",
      "organic",
      "liver"
    ]
  },
  {
    "id": "6cd0e8c3539452a79f43503c06516def",
    "content": "For Olanzapine and Risperidone, ensure that fasting blood sug- ar, lipid profiles, liver and kidney function test are carried out at least twice a year.",
    "title": "tests, for purposes of guiding treatment",
    "section": "tests, for purposes of guiding treatment",
    "chunk_id": "918",
    "type": "section",
    "keywords": [
      "test",
      "blood",
      "olanzapine",
      "ensure",
      "kidney",
      "function",
      "carried",
      "least",
      "fasting",
      "profiles",
      "lipid",
      "twice",
      "liver",
      "risperidone",
      "year"
    ]
  },
  {
    "id": "bdbadae3912d575d725d042fe89c10c7",
    "content": "To abolish symptoms\nTo restore functioning to the maximum level possible\nTo reduce the chances of recurrence\nTo monitor blood glucose, lipid profiles, liver and kidney function at least twice a year for patients on olanzapine and risperidone.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "919",
    "type": "section",
    "keywords": [
      "glucose",
      "twice",
      "abolish",
      "function",
      "profiles",
      "patients",
      "blood",
      "restore",
      "recurrence",
      "functioning",
      "monitor",
      "level",
      "symptoms",
      "olanzapine",
      "year",
      "least",
      "kidney",
      "reduce",
      "chances",
      "possible"
    ]
  },
  {
    "id": "98344eec991ef95f535247a749ec5d30",
    "content": "Supportive psychotherapy\nRehabilitation\nFamily therapy.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "920",
    "type": "section",
    "keywords": [
      "psychotherapy",
      "supportive",
      "family",
      "therapy",
      "rehabilitation"
    ]
  },
  {
    "id": "2d6bd578523f41b5afa1d7ba51d6c4c5",
    "content": "Behaviour Therapy e. g. social skills training, progressive muscle\nrelaxation, coping skills, etc.",
    "title": "Psychoeducation about cause, course, treatment, side effects and relapse prevention",
    "section": "Psychoeducation about cause, course, treatment, side effects and relapse prevention",
    "chunk_id": "921",
    "type": "section",
    "keywords": [
      "training",
      "skills",
      "progressive",
      "muscle",
      "relaxation",
      "social",
      "behaviour",
      "therapy",
      "coping"
    ]
  },
  {
    "id": "61c89db73ae517a0dc176167f979c1a2",
    "content": "Management of acute attacks\nOlanzapine, IM or oral,\nAdults\n5-10 mg stat. Then\n5-10 mg daily, max. 20 mg daily\nChildren\n12 years;\t5-10 mg stat.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "922",
    "type": "section",
    "keywords": [
      "attacks",
      "years",
      "management",
      "adults",
      "oral",
      "children",
      "then",
      "acute",
      "olanzapine",
      "stat",
      "daily"
    ]
  },
  {
    "id": "258d06b2b39eeca2b035c7fdc1ff7a1b",
    "content": "Then\n5-10 mg daily, max. 20 mg daily\n< 12 years;\tnot recommended\nOr\nChlorpromazine, IM,\nAdults\n25-50 mg 6-8 hourly, adjusting to max. of 400 mg daily\nChildren\n12-18 year;\t25-50 mg 6-8 hourly, adjusting to max.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "923",
    "type": "section",
    "keywords": [
      "chlorpromazine",
      "hourly",
      "recommended",
      "years",
      "adjusting",
      "adults",
      "children",
      "then",
      "daily",
      "year"
    ]
  },
  {
    "id": "73959937685266ab119acf997ddc6005",
    "content": "of 400 mg daily\n6-12 years;\t500 microgram/kg 6-8 hourly to max. of 75 mg daily\n1-6 year;\t500 microgram/kg 6-8 hourly to max. of 40 mg daily\nOr\nChlorpromazine, oral,\nAdults.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "924",
    "type": "section",
    "keywords": [
      "chlorpromazine",
      "hourly",
      "years",
      "microgram",
      "adults",
      "oral",
      "daily",
      "year"
    ]
  },
  {
    "id": "b73bd465574cd1fc3914aa80e16f63a3",
    "content": "25 mg 8 hourly or 75 mg at night\nThen\nAdjust according to response to 75-300 mg daily\nChildren\n12 years;\t25 mg 8 hourly or 75 mg at night\nThen\nAdjust according to response to max. of 75-300 mg daily 6-12 years;\t10 mg 8 hourly\nThen\nAdjust according to response to max. of 75 mg daily\n1-6 years;\t500 microgram/kg 4-6 hourly\nThen\nAdjust according to response to max.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "925",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "microgram",
      "according",
      "response",
      "adjust",
      "children",
      "then",
      "night",
      "daily"
    ]
  },
  {
    "id": "ac11da6403c72323f357b754c1dd473a",
    "content": "of 40 mg daily\nOr\nHaloperidol, IM,\nAdults\n2-5 mg stat. Then\nRepeat 4-8 hourly according to response, to maximum of 20 mg daily\nChildren\n6-12 years;\t1-3 mg 4-8 hourly as required\n< 6 years;\tnot recommended\nOr\nHaloperidol, oral,\nAdults\n0. 5-5 mg 8-12 hourly daily\nThen\n5-10 mg 8-12 hourly (max.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "926",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "according",
      "haloperidol",
      "adults",
      "response",
      "repeat",
      "oral",
      "required",
      "maximum",
      "children",
      "then",
      "stat",
      "daily"
    ]
  },
  {
    "id": "8fd6acb0aa36fdd7818e53bd0c49da9f",
    "content": "of 30 mg)\nChildren\n12 years;\t0. 5-5 mg 8-12 hourly daily\nThen\n5-10 mg 8-12 hourly (max. of 30 mg)\n3-12 years or body weight 15-40 kg; 0.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "927",
    "type": "section",
    "keywords": [
      "hourly",
      "body",
      "years",
      "weight",
      "children",
      "then",
      "daily"
    ]
  },
  {
    "id": "816a94092657fa4137a3e8a144c1e5c3",
    "content": "25-0. 5 mg daily\nThen\nIncrease by 0. 5 mg daily every 5-7 days\n< 3 years;\tnot recommended\nMaintenance\nRisperidone, oral,\nAdults\nmg 12-24 hourly (start at low dose and adjust daily according to patient response)\nOr\nOlanzapine, oral,\nAdults\n5-10 mg, max.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "928",
    "type": "section",
    "keywords": [
      "years",
      "according",
      "maintenance",
      "patient",
      "increase",
      "hourly",
      "start",
      "days",
      "adults",
      "response",
      "adjust",
      "dose",
      "then",
      "olanzapine",
      "every",
      "recommended",
      "oral",
      "risperidone",
      "daily"
    ]
  },
  {
    "id": "6211852ca921d38f943d1807ca3cf11b",
    "content": "Children\n12 years;\t5-10 mg, max. 20 mg daily\n< 12 years;\tnot recommended\nOr\nChlorpromazine, oral,\nAdults\n25 mg 8 houly or 75 mg at night, adjust to max. of 200 mg 8 hourly\nChildren\n12-18 years; 25 mg 8 hourly or 75 mg at night, adjust to max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "929",
    "type": "section",
    "keywords": [
      "chlorpromazine",
      "hourly",
      "recommended",
      "years",
      "adults",
      "adjust",
      "oral",
      "houly",
      "children",
      "night",
      "daily"
    ]
  },
  {
    "id": "26c16c786a636dc1966f18bf094c8c24",
    "content": "of 200\nmg 8 hourly\n< 12 years;\tnot recommended\nOr\nHaloperidol, oral,\nAdults\nmg 8 hourly, adjusted to max. daily dose of 20 mg\nChildren\n12-18 years;\t1-3 mg 8hourly, adjusted to max. daily dose of 20 mg\n3-12 years;\t500 micrograms 12 hourly, adjust up to a max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "930",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "haloperidol",
      "adults",
      "adjust",
      "oral",
      "micrograms",
      "dose",
      "children",
      "daily",
      "adjusted"
    ]
  },
  {
    "id": "478f6a1a1eb0c4cc69d51e85088295a4",
    "content": "Fluphenazine decanoate, IM,\nAdults\n25 mg monthly\nChildren\nNot recommended\nOr\nFlupenthixol decanoate, IM,\nAdults\nGive test dose of 5-20 mg, and after at least 7 days, give 40 mg monthly\nChildren\nNot recommended.",
    "title": "Maintenance treatment for patients with recurrent or chronic illness (depot preparations)",
    "section": "Maintenance treatment for patients with recurrent or chronic illness (depot preparations)",
    "chunk_id": "931",
    "type": "section",
    "keywords": [
      "days",
      "fluphenazine",
      "test",
      "recommended",
      "least",
      "give",
      "adults",
      "dose",
      "decanoate",
      "after",
      "children",
      "flupenthixol",
      "monthly"
    ]
  },
  {
    "id": "8069899db90a6ac278411313f374c082",
    "content": "Trihexyphenidyl (Benzhexol), oral,\nAdults\n2. 5-5 mg 6-8 hourly max. 20 mg daily\nChildren\n6-18 years;\t0.",
    "title": "Adjunct treatment for management or prevention of antipsychotic drug side effects",
    "section": "Adjunct treatment for management or prevention of antipsychotic drug side effects",
    "chunk_id": "932",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "benzhexol",
      "adults",
      "oral",
      "trihexyphenidyl",
      "children",
      "daily"
    ]
  },
  {
    "id": "98deafe012cdb3806351e03f0b8f896f",
    "content": "5-1 mg 12-24 hourly,\nThen\nIncrease every 3-7 days by 1 mg daily according to response\nOr\nBenzatropine (Benztropine), oral,\nAdults.",
    "title": "Adjunct treatment for management or prevention of antipsychotic drug side effects",
    "section": "Adjunct treatment for management or prevention of antipsychotic drug side effects",
    "chunk_id": "933",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "benztropine",
      "according",
      "daily",
      "adults",
      "response",
      "oral",
      "benzatropine",
      "then",
      "increase",
      "every"
    ]
  },
  {
    "id": "5c0eebaf3d5f7d567538b9e1d921d546",
    "content": "1-2 mg 8-12 hourly\nChildren\n3 years;\t20-50 microgram/kg 12-24 hourly\nOr\nBiperidine, oral,\nAdults\n1 mg 12 hourly,\nThen\nadjust to 2 mg 8 hourly up to 4 mg 8 hourly. Children\nnot recommended\nOr\nBiperidine, slow IV/IM,\nAdults\n2. 5-5 mg adjust to a max.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "934",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "microgram",
      "adults",
      "adjust",
      "oral",
      "slow",
      "children",
      "then",
      "biperidine"
    ]
  },
  {
    "id": "3fae820a0261d0057680ed7eba053671",
    "content": "of 20 mg in 24 hours\nOr\nBenztropine, IV/IM,\nAdults\n1-2 mg slowly over 2-4 minutes, repeat if symptoms persist after 8-12 hours\nOr\nDiazepam, oral,\nAdults\n5-10 mg 6-12 hourly\nChildren\n12 -18 years;\t10 mg 12 hourly\n5 - 12 years;\t5 mg 12 hourly\nOr\nDiazepam, IV,\nAdults\n5-10 mg slowly over 2-3 minutes (approximately 2. 5 mg every 30 seconds)\nChildren\n200-300 microgram/kg slowly over 2-3 minutes. This may be repeated 10 minutes.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "935",
    "type": "section",
    "keywords": [
      "years",
      "persist",
      "repeated",
      "diazepam",
      "hourly",
      "minutes",
      "repeat",
      "children",
      "adults",
      "seconds",
      "approximately",
      "symptoms",
      "every",
      "benztropine",
      "microgram",
      "oral",
      "after",
      "slowly",
      "hours"
    ]
  },
  {
    "id": "3869d56229fdd0aa30f6f4022bf4cb58",
    "content": "Or\nPromethazine hydrochloride, oral or IM,\nAdults\n12. 5-25 mg initially, may repeat dose if symptoms persist after 6\nhours Children\n6 years;\t6. 25-12.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "936",
    "type": "section",
    "keywords": [
      "years",
      "hydrochloride",
      "persist",
      "initially",
      "adults",
      "repeat",
      "oral",
      "children",
      "dose",
      "after",
      "promethazine",
      "hours",
      "symptoms"
    ]
  },
  {
    "id": "5d5bd84c6a3a2d23c650adc081a6cd49",
    "content": "5 mg\nThen\nRepeat dose after 6 hours\n< 6 years;\tnot recommended\nReferral Criteria.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "937",
    "type": "section",
    "keywords": [
      "referral",
      "recommended",
      "years",
      "hours",
      "repeat",
      "dose",
      "after",
      "then",
      "criteria"
    ]
  },
  {
    "id": "7d1bef42ef8fdfe8329eb97bf58c76ef",
    "content": "was initiated without a psychiatrist’s supervision. Likewise refer all patients with recurrent episodes and those whose symptoms cannot be controlled to a psychiatrist for further drug treatment or Electroconvulsive Therapy. Bipolar disorder is a form of mood disorder.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "938",
    "type": "section",
    "keywords": [
      "recurrent",
      "bipolar",
      "supervision",
      "form",
      "therapy",
      "drug",
      "patients",
      "whose",
      "electroconvulsive",
      "treatment",
      "episodes",
      "psychiatrist",
      "cannot",
      "further",
      "likewise",
      "those",
      "symptoms",
      "disorder",
      "controlled",
      "refer"
    ]
  },
  {
    "id": "5399e5ba1b5d63662c8e5bb1f4551225",
    "content": "The term refers to a condition in which patients experience mood swings between the two extremes of depression and mania. Bipolar disorder is referred to in older literature as manic-depressive illness. It is important to note that the affected patient usually presents with one predominant mood state at a time, either depression or mania.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "939",
    "type": "section",
    "keywords": [
      "usually",
      "either",
      "important",
      "manic",
      "which",
      "bipolar",
      "refers",
      "patient",
      "presents",
      "mania",
      "patients",
      "condition",
      "note",
      "literature",
      "depressive",
      "state",
      "between",
      "predominant",
      "referred",
      "older"
    ]
  },
  {
    "id": "e14e17208348ed710fa148b9fa56ccd3",
    "content": "A single manic episode and a history of depression qualify for classification as bipolar disorder. A current episode of depression without a past manic episode is not diagnosed as a bipolar disorder. Repeated depressive episodes are diagnosed as recurrent depression.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "940",
    "type": "section",
    "keywords": [
      "disorder",
      "episodes",
      "recurrent",
      "repeated",
      "single",
      "classification",
      "history",
      "manic",
      "depressive",
      "episode",
      "qualify",
      "bipolar",
      "past",
      "current",
      "without",
      "depression",
      "diagnosed"
    ]
  },
  {
    "id": "204831c90c8bc4aef93f611ab0593019",
    "content": "Causes\nLargely unknown\nPossible associations:\nTendency to run in families\nGenetic factors\nSymptoms\nPersistently elevated mood:- euphoria, expansiveness, feeling ‘high’\nor irritable\nOveractivity\nTalking fast and excessively\nGrandiose claims\nReduced sleep\nReckless spending and being overly generous\nSexual and social disinhibition\nAuditory hallucinations, in severe cases (patients may hear voices, often reinforcing their grandiose beliefs)\nUndue suspicion (paranoia) may exist\nImpaired judgement\nSigns\nNone typical of bipolar disorder\nSame as symptoms above\ninvestigations\nUsually no specific investigations\nRarely, thyrotoxicosis may mimic mania and must be excluded.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "941",
    "type": "section",
    "keywords": [
      "usually",
      "sleep",
      "often",
      "factors",
      "hallucinations",
      "suspicion",
      "bipolar",
      "reduced",
      "feeling",
      "expansiveness",
      "impaired",
      "unknown",
      "genetic",
      "talking",
      "hear",
      "disinhibition",
      "tendency",
      "persistently",
      "claims",
      "specific"
    ]
  },
  {
    "id": "560e38daf1506bfd4764c4df821083ca",
    "content": "To treat symptoms of mania or depression, whichever is present with\ncurrent episode\nTo reduce the level of activity in mania to a manageable state\nTo elevate mood to a normal state in depression\nTo abolish psychotic symptoms (delusions and hallucinations), if\npresent.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "942",
    "type": "section",
    "keywords": [
      "activity",
      "treat",
      "manageable",
      "hallucinations",
      "psychotic",
      "abolish",
      "whichever",
      "episode",
      "mania",
      "delusions",
      "level",
      "state",
      "symptoms",
      "elevate",
      "present",
      "reduce",
      "mood",
      "normal",
      "current",
      "depression"
    ]
  },
  {
    "id": "7401fe3b8151e5775bd644627309bc8f",
    "content": "Management of the manic patient\nRisperidone, oral,\nAdults\nmg 12-24 hourly, to a max. of 8 mg daily\nChildren\n>12 years;\t500 micrograms stat. Then\nAdjust daily in steps of 500 micrograms - 1 mg daily to a max.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "943",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "management",
      "adults",
      "manic",
      "adjust",
      "oral",
      "steps",
      "micrograms",
      "children",
      "then",
      "patient",
      "risperidone",
      "stat",
      "daily"
    ]
  },
  {
    "id": "2ad6a49ecc22f4ffe683ea755a7c490d",
    "content": "of 6 mg daily\n< 12 years;\tnot recommended\nOr\nOlanzapine, oral,\nAdults\n5-15 mg 12-24 hourly to max. 20 mg daily\nChildren\n12-18 years;\t2. 5 mg daily, up to max.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "944",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "adults",
      "oral",
      "children",
      "olanzapine",
      "daily"
    ]
  },
  {
    "id": "bcd07e64f812bcf48433b995c8c2d7c4",
    "content": "of 20mg daily\n<12 years;\tnot recommended Or\nHaloperidol, oral,\nAdults\n5-10 mg 12 hourly up to a max. of 20 mg daily\nOr\nChlorpromazine, oral,\nAdults\n25 mg 8 houly or 75 mg at night,\nThen\nIncrease by 25 mg daily to 50-100 mg 8 hourly\nOr\nSodium valproate, oral,\nAdults\n250-750 mg 12 hourly (controlled release preferable)\nChildren\n< 18 years;\tnot recommended.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "945",
    "type": "section",
    "keywords": [
      "chlorpromazine",
      "hourly",
      "recommended",
      "years",
      "controlled",
      "haloperidol",
      "adults",
      "sodium",
      "oral",
      "houly",
      "release",
      "valproate",
      "children",
      "then",
      "preferable",
      "night",
      "increase",
      "daily"
    ]
  },
  {
    "id": "00469d599174b668a75c7e331b2165d1",
    "content": "Or\nCarbamazepine, oral,\nAdults\n200-800 mg 12 hourly (controlled release preferable)\nChildren\n< 18 years;\tnot recommended\nManagement of significantly aggressive patient\n(See section on ‘The Acutely Disturbed Patient’). Management of the depressive phase\nLamotrigine, oral,\nAdults\n25 mg daily for 2 weeks\nThen\nIncrease by 25 mg every 2 weeks to a max. of 200 mg daily as re-\nquired Children\n< 18 years;\tnot recommended\nAnd\nLorazepam, oral,\nAdults\nmg 8-12 hourly, max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "946",
    "type": "section",
    "keywords": [
      "significantly",
      "years",
      "management",
      "release",
      "acutely",
      "quired",
      "patient",
      "increase",
      "hourly",
      "section",
      "carbamazepine",
      "children",
      "weeks",
      "preferable",
      "disturbed",
      "lorazepam",
      "adults",
      "depressive",
      "phase",
      "then"
    ]
  },
  {
    "id": "af99c4612e0e1f209fa9942892c2dd4b",
    "content": "10 mg daily\nChildren\n2-18 years;\t0. 05 mg/kg 8 hourly, max. 2 mg daily\nOr\nDiazepam, oral,\nAdults\n5-10 mg 6-12 hourly\nChildren\n12-18 years;\t10 mg 12 hourly\n5-12 years;\t5 mg 12 hourly\nMaintenance management after control of the acute phase\nLithium, oral,\nAdults\n200-600 mg 6-8 hourly (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "947",
    "type": "section",
    "keywords": [
      "diazepam",
      "hourly",
      "years",
      "management",
      "adults",
      "lithium",
      "oral",
      "control",
      "phase",
      "after",
      "maintenance",
      "children",
      "acute",
      "daily"
    ]
  },
  {
    "id": "ac5e1ff157c6b97fa8dd347238088193",
    "content": "2400 mg daily)\nChildren\n12-18 years;\t200-600 mg 8 hourly (max. 2400 mg daily)\n6-12 years;\t5-20 mg /kg 8 hourly\n< 6 years;\tnot recommended.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "948",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "children",
      "daily"
    ]
  },
  {
    "id": "c5283d8fbab0992fd96bc389148309da",
    "content": "Or\nSodium valproate, oral,\nAdults\n250-750 mg 12 hourly (controlled release preferable)\nChildren\n< 18 years;\tnot recommended\nOr\nCarbamazepine, oral,\nAdults\n200-800 mg 12 hourly (controlled release preferable)\nChildren\n< 18 years;\tnot recommended\nReferral Criteria\nRefer all patients suffering a first episode, not responding to treatment after one month and all children to a psychiatrist. These occur following sudden withdrawal from alcohol. They are often seen 12 to 18 hours after the last drink, but may be earlier and are worst between 24 to 48 hours after onset.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "949",
    "type": "section",
    "keywords": [
      "sudden",
      "drink",
      "years",
      "suffering",
      "occur",
      "often",
      "earlier",
      "last",
      "seen",
      "release",
      "hourly",
      "following",
      "alcohol",
      "sodium",
      "episode",
      "carbamazepine",
      "patients",
      "children",
      "criteria",
      "preferable"
    ]
  },
  {
    "id": "363f6bfb572961a14ff6bee9e5aefc49",
    "content": "This commonly occurs in patients admitted to hospital for other problems e. g. arising from accidents or physical illnesses, which keeps them from drinking.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "950",
    "type": "section",
    "keywords": [
      "accidents",
      "arising",
      "admitted",
      "illnesses",
      "physical",
      "other",
      "drinking",
      "keeps",
      "which",
      "patients",
      "occurs",
      "problems",
      "hospital",
      "commonly"
    ]
  },
  {
    "id": "7c8ba11b1727158c7bcb40545b8166dc",
    "content": "The presentation varies from minimal tremors to states of full-blown agitation and confusion, which are potentially fatal. Causes\nAbrupt cessation or significant reduction in alcohol intake in an individual with heavy drinking over many months or years.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "951",
    "type": "section",
    "keywords": [
      "years",
      "which",
      "agitation",
      "potentially",
      "varies",
      "full",
      "individual",
      "abrupt",
      "alcohol",
      "presentation",
      "intake",
      "heavy",
      "causes",
      "reduction",
      "minimal",
      "fatal",
      "tremors",
      "months",
      "cessation",
      "confusion"
    ]
  },
  {
    "id": "e328224829981bc8892f182c9956c0c8",
    "content": "To stabilise pulse and blood pressure\nTo prevent dehydration\nTo treat presenting conditions like malaria etc. To relieve pain, tremors and seizures\nTo stop hallucinations.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "952",
    "type": "section",
    "keywords": [
      "dehydration",
      "pressure",
      "pain",
      "treat",
      "pulse",
      "prevent",
      "stabilise",
      "conditions",
      "stop",
      "seizures",
      "presenting",
      "relieve",
      "hallucinations",
      "tremors",
      "malaria",
      "blood"
    ]
  },
  {
    "id": "33981a1e823561d55cf453e9a57c265c",
    "content": "Sit or lie in a quiet place\nPhysical restraints may be required temporarily for very agitated patients\nEncourage intake of fluids as can be tolerated to prevent dehydration.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "953",
    "type": "section",
    "keywords": [
      "agitated",
      "dehydration",
      "temporarily",
      "prevent",
      "physical",
      "encourage",
      "restraints",
      "intake",
      "place",
      "fluids",
      "required",
      "patients",
      "quiet",
      "tolerated"
    ]
  },
  {
    "id": "e842c03728a30bc9be99d022ce415335",
    "content": "Haloperidol, oral/IM,\nAdults\n5 mg 8 hourly as required until hallucinations cease. Children\nRefer to specialist\nOr\nOlanzapine, oral,\nAdults\n5-10 mg 24 hourly (max. of 10 mg 12 hourly)\nChildren\n12 years;\t2.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating [A]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating [A]",
    "chunk_id": "954",
    "type": "section",
    "keywords": [
      "hourly",
      "specialist",
      "years",
      "haloperidol",
      "adults",
      "refer",
      "oral",
      "hallucinations",
      "children",
      "required",
      "cease",
      "olanzapine",
      "until"
    ]
  },
  {
    "id": "0aa2b82d2f66be650caf27f6e0a877d9",
    "content": "5-5 mg stat. Then\nMay be increased up to 10 mg (max. 5 mg 12 hourly)\nReferral Criteria\nRefer all patients with alcohol withdrawal syndromes to a psychologist or psychiatrist.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating [A]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating [A]",
    "chunk_id": "955",
    "type": "section",
    "keywords": [
      "hourly",
      "referral",
      "psychologist",
      "syndromes",
      "alcohol",
      "withdrawal",
      "psychiatrist",
      "refer",
      "patients",
      "increased",
      "then",
      "criteria",
      "stat"
    ]
  },
  {
    "id": "954ec8b6e4f382be24ae560bbc18ea71",
    "content": "This is the most dramatic withdrawal syndrome. It usually starts 2-3 days after drinking stops. On average, the syndrome lasts 3 days but may continue for much longer.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "956",
    "type": "section",
    "keywords": [
      "days",
      "usually",
      "continue",
      "dramatic",
      "drinking",
      "lasts",
      "average",
      "longer",
      "syndrome",
      "most",
      "after",
      "stops",
      "withdrawal",
      "starts"
    ]
  },
  {
    "id": "54eefd060779e69e9e5c90ad4da05d32",
    "content": "Without good supportive care and adequate treatment, Delirium Tremens (DT) is associated with significant mortality. Risk factors include long history of heavy alcohol use, previous history of DT, concurrent illness, significant alcohol level during withdrawal, long duration since last drink (over 48 hours) and age over 30 years. Causes\nSudden withdrawal of alcohol from a long-term chronic user of\nalcohol\nSymptoms\nRestlessness\nShaking of hands, whole limbs or body\nSweating\nConfusion\nInappropriate behaviour\nUnintelligible speech\nMisidentification\nSeeing or talking to imaginary objects\nSigns\nTremors\nPsychomotor agitation or retardation\nSweating\nVomiting\nDisorientation\nIntermittent visual, tactile or auditory hallucinations or illusions (Visual hallucinations are frequently of small objects or frightening ‘animals’ on walls etc.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "957",
    "type": "section",
    "keywords": [
      "retardation",
      "sudden",
      "drink",
      "years",
      "disorientation",
      "withdrawal",
      "tactile",
      "last",
      "during",
      "factors",
      "agitation",
      "inappropriate",
      "associated",
      "hallucinations",
      "frequently",
      "animals",
      "speech",
      "illusions",
      "body",
      "talking"
    ]
  },
  {
    "id": "b7c74a50c967d59de8660e0b80a1ef1b",
    "content": ")\nFever > 38°C. Pulse > 100 beats/minute, Blood Pressure > 160/100mmHg\ninvestigations\nFull Blood Count\nLiver Function Tests\nScreen for malaria and common infections.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "958",
    "type": "section",
    "keywords": [
      "infections",
      "pressure",
      "full",
      "minute",
      "pulse",
      "count",
      "function",
      "fever",
      "screen",
      "common",
      "beats",
      "tests",
      "investigations",
      "malaria",
      "liver",
      "blood"
    ]
  },
  {
    "id": "ffacc2e4f2f7f95ce542a3ea5b89a93a",
    "content": "To relieve agitation and calm patient\nTo correct fluid and electrolyte imbalance\nTo prevent complications like seizures, development of amnesia and\nencephalopathy\nTo prevent or manage heart complications if present.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "959",
    "type": "section",
    "keywords": [
      "calm",
      "complications",
      "imbalance",
      "present",
      "correct",
      "encephalopathy",
      "prevent",
      "manage",
      "development",
      "seizures",
      "relieve",
      "agitation",
      "amnesia",
      "heart",
      "electrolyte",
      "patient",
      "fluid"
    ]
  },
  {
    "id": "1ac345790511de11923e86190624755c",
    "content": "Seclusion of the patient\nApplication of restraints as necessary\nPsychotherapy and psychoeducation.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "960",
    "type": "section",
    "keywords": [
      "psychoeducation",
      "psychotherapy",
      "seclusion",
      "necessary",
      "application",
      "restraints",
      "patient"
    ]
  },
  {
    "id": "bdf90a6897f842016c2a5bc4f156f7bb",
    "content": "Evidence Rating: [A]\nFor control of seizures\nLorazepam, IV, IM or oral,\nAdults\nDays 1 to 3:\t2-4 mg once daily\nDays 4 and 5:\t1-2 mg once daily\nOr\nDiazepam, IV, (administer slowly-over 2-3 minutes, approximately 2. 5 mg every 30 seconds)\nAdults\nDay 1:\t10-20 mg 6 hourly\nDay 2:\t10-20 mg 8 hourly\nDay 3:\t10-20 mg 12 hourly\nDay 4:\t5-10 mg 8 hourly\nDay 5:\t5-10 mg 12 hourly then stop\nOr\nChlordiazepoxide, oral,\nAdults\n50-100 mg 4 hourly as required (max. 300 mg)\nAnd\nThiamine, oral, IM or IV,\nAdults (oral, IM, IV)\n100 mg daily for 3 days (before any IV Glucose load)\nAnd\nFolic Acid, oral,\nAdults\n1 mg daily as needed\nAnd\nDextrose saline (5% glucose in 0.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "961",
    "type": "section",
    "keywords": [
      "thiamine",
      "chlordiazepoxide",
      "seizures",
      "dextrose",
      "glucose",
      "required",
      "evidence",
      "diazepam",
      "hourly",
      "rating",
      "minutes",
      "saline",
      "load",
      "administer",
      "days",
      "lorazepam",
      "before",
      "acid",
      "stop",
      "adults"
    ]
  },
  {
    "id": "9a7b0624c150dd2d21a9d4b5c7008df7",
    "content": "9% saline), IV,\nAdults\nAs necessary\nFor patients with seizures not controlled by benzodiazepines alone\nLorazepam, IV, IM or oral,.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "962",
    "type": "section",
    "keywords": [
      "lorazepam",
      "controlled",
      "benzodiazepines",
      "adults",
      "seizures",
      "saline",
      "necessary",
      "oral",
      "patients",
      "alone"
    ]
  },
  {
    "id": "606b29dcc15729faf7ce1d470b6ca7c1",
    "content": "Adults\nDays 1 to 3:\t2-4 mg once daily\nDays 4 and 5:\t1-2 mg once daily\nOr\nDiazepam, IV, (administer slowly-over 2-3 minutes, approximately 2. 5 mg every 30 seconds)\nAdults\nDay 1:\t10-20 mg 6 hourly\nDay 2:\t10-20 mg 8 hourly\nDay 3:\t10-20 mg 12 hourly\nDay 4:\t5-10 mg 8 hourly\nDay 5:\t5-10 mg 12 hourly then stop\nAnd\nPhenobarbitone, slow IV or IM,\nAdults\n0. 5-1.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "963",
    "type": "section",
    "keywords": [
      "days",
      "diazepam",
      "hourly",
      "administer",
      "phenobarbitone",
      "minutes",
      "stop",
      "adults",
      "every",
      "slow",
      "seconds",
      "slowly",
      "then",
      "approximately",
      "once",
      "daily"
    ]
  },
  {
    "id": "96e7af8aec9e2596012ff0694ef3cad4",
    "content": "5 mg/kg 12 hourly\nReferral Criteria\nRefer patients whose symptoms are difficult to control within 3 days or who remain agitated despite being given over 20 mg diazepam within 4 hours to a specialist. Refer patients to a psychiatrist or clinical psychologist for consideration of other treatment options to assist long-term abstinence and rehabilitation after acute phase is over. Anxiety is a common symptom that occurs in all psychiatric disorders including depressive illness and most psychoses.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "964",
    "type": "section",
    "keywords": [
      "psychiatric",
      "given",
      "consideration",
      "anxiety",
      "acute",
      "diazepam",
      "hourly",
      "within",
      "specialist",
      "assist",
      "including",
      "abstinence",
      "patients",
      "whose",
      "being",
      "most",
      "criteria",
      "treatment",
      "days",
      "referral"
    ]
  },
  {
    "id": "4d813c3dec4ba59a625e5625d6b6826f",
    "content": "Physical diseases like hyperthyroidism, cardiac disease or hypertension may also present with anxiety and therefore must be excluded. There are various forms of anxiety disorders (e. g.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "965",
    "type": "section",
    "keywords": [
      "hypertension",
      "disease",
      "diseases",
      "therefore",
      "various",
      "present",
      "physical",
      "must",
      "also",
      "forms",
      "disorders",
      "there",
      "anxiety",
      "hyperthyroidism",
      "cardiac",
      "excluded"
    ]
  },
  {
    "id": "73a5f9ced0fd16c18926f748d6b018ce",
    "content": "generalized anxiety disorders, panic disorders, phobias, obsessive compulsive disorder, acute stress disorder, post traumatic stress disorder, etc. ), but the common ones seen in general practice are generalized anxiety disorders and panic disorders. In all cases of suspected anxiety disorders, it is important to assess the scope of the anxiety, including the antecedents, behaviour and consequences of anxiety for the patient through an indepth interview.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "966",
    "type": "section",
    "keywords": [
      "important",
      "scope",
      "seen",
      "traumatic",
      "anxiety",
      "acute",
      "patient",
      "stress",
      "including",
      "phobias",
      "obsessive",
      "assess",
      "behaviour",
      "ones",
      "generalized",
      "post",
      "compulsive",
      "suspected",
      "disorders",
      "general"
    ]
  },
  {
    "id": "8ab7792e2390c9d37b7ac0a4fc79742b",
    "content": "It is also important to ask about the presence of obsessive thoughts and/ or compulsions as these are increasingly common and tend not to be reported out of embarrassment but which lead to much personal distress. In this case refer to a psychiatrist. In generalized anxiety disorders, there is excessive anxiety and worry about events or activities, such as performance at school or work,.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "967",
    "type": "section",
    "keywords": [
      "thoughts",
      "work",
      "important",
      "which",
      "lead",
      "personal",
      "anxiety",
      "compulsions",
      "obsessive",
      "presence",
      "generalized",
      "events",
      "worry",
      "psychiatrist",
      "also",
      "disorders",
      "tend",
      "there",
      "increasingly",
      "excessive"
    ]
  },
  {
    "id": "6560006a2f50aeee54e955dc7c48a7b4",
    "content": "occurring on most days, for at least 6 months. A panic disorder refers to a pattern of recurrent unexpected attacks of intense fear or discomfort over a discrete period more than 3 times a week. During attacks 4 or more of the symptoms listed below develop abruptly and reach a peak within 10 minutes.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "968",
    "type": "section",
    "keywords": [
      "recurrent",
      "during",
      "discomfort",
      "times",
      "refers",
      "discrete",
      "attacks",
      "within",
      "minutes",
      "week",
      "most",
      "peak",
      "intense",
      "days",
      "reach",
      "period",
      "unexpected",
      "months",
      "symptoms",
      "pattern"
    ]
  },
  {
    "id": "f9b5a3e9be72aae75381e08f0446a2d9",
    "content": "Panic disorders are accompanied by persistent concern about having another attack or worrying about implications of having an attack. In children especially, partial complex seizures may mimic panic attacks. Medications are required to treat panic disorders only if the attacks occur frequently enough to cause distress.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "969",
    "type": "section",
    "keywords": [
      "treat",
      "occur",
      "having",
      "especially",
      "seizures",
      "frequently",
      "required",
      "attacks",
      "partial",
      "attack",
      "worrying",
      "children",
      "enough",
      "implications",
      "mimic",
      "medications",
      "accompanied",
      "concern",
      "disorders",
      "only"
    ]
  },
  {
    "id": "b57db1a71ecd90126b31aac4c2ae268f",
    "content": "Causes\nMultiple negative life experiences\nEnvironmental factors\nPersonality trait\nGenetic predisposition\nSymptoms\nExcessive anxiety and worry occurring on most days, for at least 6 months\nAnxiety or worry associated with at least 3 of the following:\nMuscle tension (often reported as pain in various parts like neck, trunk or headaches)\nCrawling and burning sensation around the body\nRestlessness or feeling on edge\nBeing easily fatigued\nDifficulty concentrating or mind going blank\nIrritability\nSleep disturbance (difficulty falling asleep or frequent waken- ing)\nPalpitations\nSigns\nRestlessness\nSweating\nAnxious mood\nTachycardia\nTremors\ninvestigations\nNone to confirm the diagnosis. Tests to exclude probable differential diagnoses such as hyperthyroidism, phaeochromocytoma, cardiac arrhythmias etc.",
    "title": "GENERALIZED ANXIETY DISORDERS",
    "section": "GENERALIZED ANXIETY DISORDERS",
    "chunk_id": "970",
    "type": "section",
    "keywords": [
      "sleep",
      "probable",
      "often",
      "factors",
      "waken",
      "environmental",
      "associated",
      "anxiety",
      "feeling",
      "mind",
      "asleep",
      "predisposition",
      "neck",
      "easily",
      "concentrating",
      "tachycardia",
      "genetic",
      "body",
      "multiple",
      "hyperthyroidism"
    ]
  },
  {
    "id": "cc99eb7b6413c24130f1449c9438254d",
    "content": "Teach relaxation methods\nEncourage regular physical exercise if possible\nEncourage healthy social activities\nCognitive Behaviour Therapy.",
    "title": "Reassurance about the absence of physical disease once they are ruled out",
    "section": "Reassurance about the absence of physical disease once they are ruled out",
    "chunk_id": "971",
    "type": "section",
    "keywords": [
      "healthy",
      "teach",
      "regular",
      "physical",
      "activities",
      "exercise",
      "cognitive",
      "relaxation",
      "possible",
      "social",
      "behaviour",
      "encourage",
      "methods",
      "therapy"
    ]
  },
  {
    "id": "33a6790b57aa81abb2a88cba2bf2c3cb",
    "content": "Sertraline, oral,\nAdults\n50 mg as a single oral evening dose;\nThen\nIncrease by 25 mg at 1 week intervals, if necessary, to a max. of 200 mg\nChildren\n12-18 years;\t50 mg daily\n6-12 years;\t25 mg daily\n< 6 years;\tnot recommended\nOr\nFluoxetine, oral,\nAdults\n10 mg daily,\nThen\nIncrease up to 60 mg daily if necessary\nChildren\n7-18 years;\t10 mg daily\nThen\nIncrease to 20 mg after 1-2 weeks if necessary\nOr\nAmitriptyline, oral,\nAdults\n25-50 mg daily (as a single evening dose)\nChildren\n12 years;\t10 mg daily (as a single evening dose) max. 20 mg\nOr\nImipramine, oral,\nAdults\n25-50 mg daily (as a single evening dose)\nChildren\nNot recommended for this indication.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "972",
    "type": "section",
    "keywords": [
      "years",
      "increase",
      "imipramine",
      "single",
      "week",
      "indication",
      "weeks",
      "children",
      "amitriptyline",
      "evening",
      "sertraline",
      "adults",
      "dose",
      "then",
      "fluoxetine",
      "recommended",
      "intervals",
      "necessary",
      "oral",
      "after"
    ]
  },
  {
    "id": "570d7c8f6938ea325dad66b1bc92562e",
    "content": "For anxiety with prominent somatic complaints\nPropranolol, oral,\nAdults\n10-80 mg 12 hourly.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "973",
    "type": "section",
    "keywords": [
      "complaints",
      "hourly",
      "prominent",
      "propranolol",
      "somatic",
      "adults",
      "oral",
      "anxiety"
    ]
  },
  {
    "id": "2b3684c98f230db81e8362fa919fdd67",
    "content": "Diazepam, oral,\nAdults\n2-5 mg 12 hourly for 2 weeks and gradually tailed off over the next 2 weeks. (Do not give for more than one month continuously)\nChildren\n1-12 years;\t1. 25-5 mg 6 hourly as needed\nReferral Criteria\nRefer to a clinical psychologist for Cognitive Behaviour Therapy and other non-pharmacological treatment modalities.",
    "title": "Additional treatment for anxiety with significant distress",
    "section": "Additional treatment for anxiety with significant distress",
    "chunk_id": "974",
    "type": "section",
    "keywords": [
      "pharmacological",
      "years",
      "give",
      "continuously",
      "cognitive",
      "therapy",
      "diazepam",
      "hourly",
      "behaviour",
      "children",
      "weeks",
      "criteria",
      "treatment",
      "referral",
      "psychologist",
      "adults",
      "tailed",
      "month",
      "modalities",
      "needed"
    ]
  },
  {
    "id": "6d33f31a50271383f0d07ed0e19f13b9",
    "content": "Refer to a psychiatrist in severe cases not responsive to drug treatment.",
    "title": "Additional treatment for anxiety with significant distress",
    "section": "Additional treatment for anxiety with significant distress",
    "chunk_id": "975",
    "type": "section",
    "keywords": [
      "severe",
      "responsive",
      "psychiatrist",
      "refer",
      "drug",
      "cases",
      "treatment"
    ]
  },
  {
    "id": "2dd98666561a8d3a05368ff4c898907c",
    "content": "Causes\nLargely unknown\nMisinterpretation of normal internal body stimuli (e. g. a quickened heart beat interpreted as a heart attack or serious illness, etc).",
    "title": "PANIC DISORDERS",
    "section": "PANIC DISORDERS",
    "chunk_id": "976",
    "type": "section",
    "keywords": [
      "internal",
      "unknown",
      "body",
      "quickened",
      "attack",
      "serious",
      "beat",
      "stimuli",
      "interpreted",
      "heart",
      "illness",
      "normal",
      "misinterpretation",
      "causes",
      "largely"
    ]
  },
  {
    "id": "e0dc172bf7f597aa4a42b542c24446cc",
    "content": "Misinterpretation of external stimuli (crowds, enclosed spaces such\nas moving vehicles, lifts, etc. ) as signalling danger\nContributing factors:\nStress\nGenetic predisposition\nSymptoms\nFear of dying or going ‘crazy’\nPalpitations, pounding heart or rapid heart rate\nTrembling or shaking\nSensation of shortness of breath\nFeeling of choking\nChest pain or discomfort\nFeeling dizzy, unsteady or faint\nNumbness or tingling sensations\nChills or hot flushes\nDerealisation (feeling of unreality) or depersonalisation (feeling detached from oneself)\nNausea or abdominal distress\nSigns\nTachycardia\nTremors\nSweating.",
    "title": "PANIC DISORDERS",
    "section": "PANIC DISORDERS",
    "chunk_id": "977",
    "type": "section",
    "keywords": [
      "lifts",
      "crowds",
      "faint",
      "contributing",
      "choking",
      "nausea",
      "unreality",
      "chills",
      "flushes",
      "stimuli",
      "derealisation",
      "factors",
      "discomfort",
      "dizzy",
      "signalling",
      "spaces",
      "feeling",
      "predisposition",
      "crazy",
      "pounding"
    ]
  },
  {
    "id": "0fb5e027798f4714f224eb7f8e3d3922",
    "content": "To stop the attacks of panic or at least reduce the frequency and\nintensity of symptoms to a minimum\nTo help return to normal activities of daily living\nTo prevent recurrence of symptoms.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "978",
    "type": "section",
    "keywords": [
      "attacks",
      "least",
      "living",
      "recurrence",
      "prevent",
      "reduce",
      "stop",
      "activities",
      "intensity",
      "return",
      "minimum",
      "normal",
      "help",
      "daily",
      "panic",
      "symptoms",
      "frequency"
    ]
  },
  {
    "id": "fc0d93c91ef3185c422162c29c7e14d9",
    "content": "Rebreathing in and out of a paper bag closed around lips and nose (avoid polythene bags, try large paper envelopes)\nEliminate caffeine-containing foods e. g. coffee, tea, cola and\nchocolates, from their diet, as they tend to worsen anxiety\nRelaxation training\nCognitive Behaviour Therapy.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "979",
    "type": "section",
    "keywords": [
      "diet",
      "avoid",
      "envelopes",
      "cognitive",
      "foods",
      "anxiety",
      "therapy",
      "training",
      "large",
      "lips",
      "chocolates",
      "relaxation",
      "eliminate",
      "behaviour",
      "their",
      "bags",
      "containing",
      "rebreathing",
      "around",
      "tend"
    ]
  },
  {
    "id": "c7398211a325330b488af1e0ec4a428a",
    "content": "initial management for patients unresponsive to non-.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "980",
    "type": "section",
    "keywords": [
      "unresponsive",
      "initial",
      "management",
      "patients"
    ]
  },
  {
    "id": "73f8812c9f877cd7bd5c78f8734ff94f",
    "content": "Fluoxetine, oral,\nAdults\n10 mg daily (as a single morning dose)\nThen\nIncrease up to 60 mg daily if necessary\nChildren\n6-18 years;\t10 mg daily\nThen\nIncrease up to 20 mg after 1-2 weeks if necessary\nOr\nSertraline, oral,\nAdults\n25 mg daily (as a single evening dose)\nThen\nIncrease to 50 mg after 1 week if necessary\nThen\n50 mg weekly to a max. of 200 mg daily if necessary\nChildren\nNot recommended Or\nImipramine, oral,\nAdults\n25-50 mg daily (as a single evening dose) max. 150 mg daily\nChildren.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "981",
    "type": "section",
    "keywords": [
      "years",
      "morning",
      "increase",
      "imipramine",
      "single",
      "week",
      "weeks",
      "children",
      "sertraline",
      "evening",
      "adults",
      "dose",
      "then",
      "fluoxetine",
      "recommended",
      "weekly",
      "necessary",
      "oral",
      "after",
      "daily"
    ]
  },
  {
    "id": "0771697a121f5c7f5d94d68c56fee674",
    "content": "Not recommended for this indication\nFor very frequent panic attacks\nLorazepam, oral,\nAdults\nmg daily for 2 weeks\nChildren\n2-18 years;\t0. 05 mg/kg daily for 2 weeks\nFor anticipated anxiety attacks\nLorazepam, oral,\nAdults\nmg stat. Children\n0.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "982",
    "type": "section",
    "keywords": [
      "lorazepam",
      "attacks",
      "recommended",
      "years",
      "anticipated",
      "adults",
      "oral",
      "children",
      "indication",
      "weeks",
      "anxiety",
      "panic",
      "stat",
      "daily",
      "frequent"
    ]
  },
  {
    "id": "0dfe1e6658865a8c72c7abcb6a56f5bf",
    "content": "25-0. 5 mg stat. For Acute Symptomatic Control\nLorazepam, oral,\nAdults\nmg 8-12 hourly as required (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "983",
    "type": "section",
    "keywords": [
      "lorazepam",
      "hourly",
      "adults",
      "oral",
      "required",
      "symptomatic",
      "control",
      "acute",
      "stat"
    ]
  },
  {
    "id": "dff1175c9acf016f1fc100d28a401e2b",
    "content": "10 mg daily)\nChildren\nNot recommended for this indication\nOr\nAlprazolam, oral,\nAdults\n0. 25-0. 5 mg 6-8 hourly\nIncrease if necessary every 3-4 days, max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "984",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "recommended",
      "alprazolam",
      "adults",
      "necessary",
      "oral",
      "every",
      "indication",
      "children",
      "increase",
      "daily"
    ]
  },
  {
    "id": "25f146a20472612cb915d6b27ba9a886",
    "content": "4 mg daily\nChildren\n< 18 years;\tnot recommended\nOr\nDiazepam, oral,\nAdults\n2-5 mg 12 hourly for 2 weeks and gradually taper off over the next 2 weeks. (Do not give for more than one month continuously)\nChildren\n1-12 years;\t1. 25-5 mg 6 hourly as needed\nReferral Criteria\nRefer children with symptoms suggestive of a panic disorder to a paediatrician.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "985",
    "type": "section",
    "keywords": [
      "years",
      "give",
      "continuously",
      "diazepam",
      "hourly",
      "paediatrician",
      "children",
      "weeks",
      "criteria",
      "referral",
      "adults",
      "suggestive",
      "month",
      "taper",
      "symptoms",
      "disorder",
      "recommended",
      "needed",
      "refer",
      "oral"
    ]
  },
  {
    "id": "ae3eb6d45b7f113d8e8bd2593ca283bc",
    "content": "Also refer patients to a psychologist for Cognitive Behaviour Therapy and to a psychiatrist for additional drug therapy where indicated.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "986",
    "type": "section",
    "keywords": [
      "psychologist",
      "psychiatrist",
      "refer",
      "also",
      "cognitive",
      "drug",
      "where",
      "indicated",
      "patients",
      "behaviour",
      "therapy",
      "additional"
    ]
  },
  {
    "id": "553a65448c7b08082b95f73a845d7df3",
    "content": "Abuse of substances such as marijuana, benzodiazepines, heroine, cocaine etc. is prevalent in many communities around the country. Typically, individuals with such disorders request help only after they are forced to do so by family members.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "987",
    "type": "section",
    "keywords": [
      "prevalent",
      "benzodiazepines",
      "communities",
      "cocaine",
      "typically",
      "request",
      "help",
      "family",
      "country",
      "marijuana",
      "forced",
      "members",
      "around",
      "disorders",
      "only",
      "substances",
      "individuals",
      "after",
      "heroine",
      "abuse"
    ]
  },
  {
    "id": "b6ebd88df58bbed38794749557d3a7d3",
    "content": "They may also begin to have withdrawal symptoms when on admission for serious physical illness. This is because they have no access to the substance being abused. This may complicate treatment of the primary disease for which they were admitted.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "988",
    "type": "section",
    "keywords": [
      "which",
      "serious",
      "primary",
      "being",
      "admission",
      "treatment",
      "disease",
      "because",
      "also",
      "begin",
      "abused",
      "symptoms",
      "substance",
      "admitted",
      "physical",
      "access",
      "have",
      "illness",
      "withdrawal",
      "complicate"
    ]
  },
  {
    "id": "d5cc01dd1e98ea8118ee8f3daef8cc30",
    "content": "Causes\nSocial factors\nPeer pressure (e. g. family members, friends)\nLack of coping skills (e.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "989",
    "type": "section",
    "keywords": [
      "pressure",
      "lack",
      "skills",
      "factors",
      "friends",
      "peer",
      "social",
      "family",
      "members",
      "causes",
      "coping"
    ]
  },
  {
    "id": "959585d28740d0db1adacc9069e6b5f6",
    "content": "g. with life’s difficulties, aids to coping in times of trouble)\nAddiction\nTolerance (increased requirement of substance to maintain the same feeling)\nWithdrawal effects (unpleasant effects lead to a return to drug use)\nSymptoms\nCannabis withdrawal\nInsomnia\nShakiness\nIrritability\nRestlessness\nAnxiety\nAnger\nOnset: Within 24 hours of drug use\nDuration: 1-2 weeks\nBenzodiazepine withdrawal\nAnxiety\nHeadache\nInsomnia\nMuscle aching and twitching\nPerceptual changes\nFeelings of unreality\nDepersonalization\nSeizures\nOnset: 1-10 days (depending on half-life of drug)\nDuration: 3-6 weeks (may be longer)\nOpioid withdrawal\nAnxiety.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "990",
    "type": "section",
    "keywords": [
      "opioid",
      "unreality",
      "headache",
      "seizures",
      "lead",
      "times",
      "aids",
      "difficulties",
      "feeling",
      "anxiety",
      "within",
      "requirement",
      "insomnia",
      "twitching",
      "aching",
      "drug",
      "muscle",
      "feelings",
      "weeks",
      "benzodiazepine"
    ]
  },
  {
    "id": "e57fb6ee911929c53ae890db16d15837",
    "content": "Craving\nMuscle tension\nMuscle and bone ache\nMuscle cramps and sustained contractions\nSleep disturbance\nSweating\nHot and cold flushes\nPiloerection\nYawning\nLacrimation and rhinorrhoea\nAbdominal cramps\nNausea, vomiting and diarrhoea\nPalpitations\nElevated pulse and blood pressure\nDilated pupils\nOnset: 6-24 hours (may be later with longer-acting opioids)\nDuration: peaks 2-4 days, ceases 5-10 days (more prolonged for longer-acting opioids)\nPsychostimulant withdrawal\nCrash (fatigue, flat affect, increased sleep, reduced cravings)\nWithdrawal (fluctuating mood and energy levels, cravings, disturbed sleep, poor concentration)\nExtinction (persistence of withdrawal features, gradually subsiding)\nOnset: 6-12 hours (cocaine); 12-24 hours (amphetamines)\nDuration: Several weeks for withdrawal phase, then months for extinction\nSigns\nCannabis withdrawal\nSame as symptoms\nBenzodiazepine withdrawal\nSame as symptoms\nOpioid withdrawal\nSame as symptoms\nPsychostimulant withdrawal\nSame as symptoms\ninvestigations\nToxicology screen for suspected substances.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "991",
    "type": "section",
    "keywords": [
      "nausea",
      "rhinorrhoea",
      "poor",
      "abdominal",
      "yawning",
      "concentration",
      "toxicology",
      "signs",
      "weeks",
      "crash",
      "later",
      "cravings",
      "months",
      "then",
      "pulse",
      "mood",
      "acting",
      "prolonged",
      "opioid",
      "flushes"
    ]
  },
  {
    "id": "9c8fb23c25d5dd72d23a75322035bd2a",
    "content": "reassurance)\nTo teach coping skills (relaxation techniques, dietary guidelines, methods to reduce craving for the substance, sleep disturbance management)\nTo manage difficult behavior (anxiety, agitation, panic and aggression).",
    "title": "To  provide  supportive  care  (information,  stress  reduction,",
    "section": "To  provide  supportive  care  (information,  stress  reduction,",
    "chunk_id": "992",
    "type": "section",
    "keywords": [
      "aggression",
      "craving",
      "reassurance",
      "management",
      "agitation",
      "anxiety",
      "behavior",
      "dietary",
      "relaxation",
      "coping",
      "disturbance",
      "teach",
      "manage",
      "skills",
      "methods",
      "techniques",
      "substance",
      "reduce",
      "difficult",
      "sleep"
    ]
  },
  {
    "id": "2ecf6d3e0045ef6a01b2bffe514628d9",
    "content": "To manage confusion, disorientation and hallucinations.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "993",
    "type": "section",
    "keywords": [
      "manage",
      "disorientation",
      "confusion",
      "hallucinations"
    ]
  },
  {
    "id": "135db556004eda0efd897472e5597097",
    "content": "Cognitive Behaviour Therapy\nStress management to reduce craving.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "994",
    "type": "section",
    "keywords": [
      "craving",
      "stress",
      "management",
      "reduce",
      "cognitive",
      "behaviour",
      "therapy"
    ]
  },
  {
    "id": "fb303597cf98b4e471221400166ef798",
    "content": "Management of withdrawal symptoms - cannabis\nRequires no medical intervention\nManagement of withdrawal symptoms - stimulants\nRequires observation but does not require a specific intervention\nManagement of withdrawal symptoms - benzodiazapines\nSubstitute with equivalent dose of benzodiazapine for a few days, then taper off dose over 2-3 weeks\nManagement of withdrawal symptoms - opiates\nOral rehydration fluids or IV fluids may be required\nLong acting benzodiazapines e. g. diazepam, to control insomnia and muscle cramps (See drug doses under appropriate sections)\nAnti-emetics e.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "995",
    "type": "section",
    "keywords": [
      "observation",
      "intervention",
      "benzodiazapines",
      "management",
      "rehydration",
      "required",
      "substitute",
      "under",
      "diazepam",
      "require",
      "stimulants",
      "insomnia",
      "equivalent",
      "opiates",
      "drug",
      "doses",
      "muscle",
      "specific",
      "fluids",
      "cramps"
    ]
  },
  {
    "id": "a952fba546d2783bfb19439259ff8c35",
    "content": "g. promethazine etc. , for nausea and vomiting (See\ndrug doses under appropriate sections)\nMethadone, buprenorphine and clonidine may be used, where available and with caution, to reduce the severity of symptoms (See drug doses under appropriate sections)\nNSAIDs e.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "996",
    "type": "section",
    "keywords": [
      "nausea",
      "under",
      "doses",
      "drug",
      "where",
      "promethazine",
      "sections",
      "nsaids",
      "available",
      "symptoms",
      "methadone",
      "clonidine",
      "vomiting",
      "appropriate",
      "buprenorphine",
      "severity",
      "reduce",
      "caution",
      "used"
    ]
  },
  {
    "id": "2f6212467f7af6830c5a01d26fe75541",
    "content": "g. ibuprofen, diclofenac etc. , for pain relief (See drug doses\nunder appropriate sections)\nReferral Criteria\nRefer for specialist psychiatrist/clinical psychologist care and management if withdrawal symptoms are particularly distressful and do not respond to treatment or when there are repeated relapses.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "997",
    "type": "section",
    "keywords": [
      "management",
      "relief",
      "repeated",
      "ibuprofen",
      "under",
      "specialist",
      "diclofenac",
      "drug",
      "doses",
      "respond",
      "particularly",
      "criteria",
      "sections",
      "treatment",
      "referral",
      "psychologist",
      "psychiatrist",
      "relapses",
      "distressful",
      "there"
    ]
  },
  {
    "id": "e6e0257487c3a843e1de71f64933a9ed",
    "content": "Refer for Cognitive Behaviour Therapy to a clinical psychologist. Autism is a neurodevelopmental disorder characterized by qualitative impairments occuring in a child before the age of 36 months, in three key areas; social interaction (often the earliest features of Autistic Spectrum Disorder-ASD), communication, interests and activities. The clinical presentation is varied and may encompass children with severe manifestations of the above features or with more subtle behavioural deficits, hence the use of the term Autistic Spectrum Disorder.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "998",
    "type": "section",
    "keywords": [
      "interests",
      "neurodevelopmental",
      "often",
      "encompass",
      "cognitive",
      "child",
      "features",
      "communication",
      "therapy",
      "deficits",
      "presentation",
      "subtle",
      "varied",
      "social",
      "behaviour",
      "children",
      "severe",
      "behavioural",
      "above",
      "psychologist"
    ]
  },
  {
    "id": "cd67c0873491e212040bfdcd55f7d2f8",
    "content": "Learning disability in this condition is very common and the risk of epilepsy is significant.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "999",
    "type": "section",
    "keywords": [
      "epilepsy",
      "significant",
      "common",
      "learning",
      "disability",
      "risk",
      "condition"
    ]
  },
  {
    "id": "fffcbb9713bcf40b1c4a3e71879f798b",
    "content": "ASD is increasingly being recognized in Ghana. Causes\nNo clear aetiology\nGenetic\nSymptoms\nAbsence of joint attention (i. e.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "1000",
    "type": "section",
    "keywords": [
      "genetic",
      "symptoms",
      "clear",
      "attention",
      "ghana",
      "absence",
      "aetiology",
      "joint",
      "being",
      "increasingly",
      "recognized",
      "causes"
    ]
  },
  {
    "id": "529dfef8654680936c5fa8e63caf9ef1",
    "content": "failure to show interest, follow gaze, lack of social smiling and limited use of gestures e. g. shaking head, waving or clapping)\nCommunication deficit\nReceptive: fails to acquire language or delays in understanding language\nExpressive: delays in use of language\nLimited range of interests (limited play with toys and other objects)\nRepetitive activities (e.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "1001",
    "type": "section",
    "keywords": [
      "interests",
      "limited",
      "acquire",
      "toys",
      "range",
      "communication",
      "gaze",
      "interest",
      "receptive",
      "shaking",
      "follow",
      "lack",
      "waving",
      "clapping",
      "social",
      "expressive",
      "delays",
      "smiling",
      "show",
      "head"
    ]
  },
  {
    "id": "a27fb37ada846029f47726361a3b7afe",
    "content": "g. spinning objects)\nGlobal developmental delays (e. g.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "1002",
    "type": "section",
    "keywords": [
      "spinning",
      "global",
      "developmental",
      "objects",
      "delays"
    ]
  },
  {
    "id": "195b88f5c1d9184a6487a3411b14ddfa",
    "content": "walking, speech etc. )\nLearning difficulties\nAttention deficit\nSleeping difficulties\nFeeding difficulties\nSigns\nLack of pointing to objects by 24 months\nNo single words by 18 months\nNo two word spontaneous phrase by 24 months\nLoss of language\nAvoidance of eye contact\ninvestigations\nUsually none required\nElectroencephalogram (EEG) if seizures suspected\nBrain CT or MRI only in special circumstances e. g.",
    "title": "Chapter 10: Psychıatrıc Dısorders",
    "section": "Chapter 10: Psychıatrıc Dısorders",
    "chunk_id": "1003",
    "type": "section",
    "keywords": [
      "usually",
      "avoidance",
      "seizures",
      "pointing",
      "feeding",
      "special",
      "required",
      "difficulties",
      "word",
      "speech",
      "lack",
      "single",
      "attention",
      "signs",
      "words",
      "suspected",
      "phrase",
      "learning",
      "only",
      "investigations"
    ]
  },
  {
    "id": "38e1a80dac9a234d0c9497b460578af8",
    "content": "To correct social communication difficulties using a multidisciplinary\nbehavioural and educational approach.",
    "title": "features present Treatment Treatment objectives",
    "section": "features present Treatment Treatment objectives",
    "chunk_id": "1004",
    "type": "section",
    "keywords": [
      "behavioural",
      "using",
      "approach",
      "correct",
      "multidisciplinary",
      "communication",
      "educational",
      "social",
      "difficulties"
    ]
  },
  {
    "id": "26985ac66bc5cc2cc07a80d748b3e7d0",
    "content": "Applied Behaviour Analysis (ABA) - teaching based on teacher request, prompt assistance to child, child response and feedback.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1005",
    "type": "section",
    "keywords": [
      "applied",
      "based",
      "prompt",
      "teaching",
      "response",
      "child",
      "assistance",
      "teacher",
      "behaviour",
      "request",
      "feedback",
      "analysis"
    ]
  },
  {
    "id": "5ea1809ed0762c093728539fbdb8535c",
    "content": "For aggression, irritability or self-mutilation\nEvidence Rating: [B]\nRisperidone, oral,\nChildren.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1006",
    "type": "section",
    "keywords": [
      "aggression",
      "rating",
      "mutilation",
      "self",
      "risperidone",
      "oral",
      "children",
      "evidence",
      "irritability"
    ]
  },
  {
    "id": "700c134ff34a3714fe43bfa51dd15c86",
    "content": "5-18 years (body weight > 50 kg); 0. 5 mg daily. May increase by 0.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1007",
    "type": "section",
    "keywords": [
      "body",
      "years",
      "weight",
      "increase",
      "daily"
    ]
  },
  {
    "id": "3b131cfcbcaad59c39a8c68a7977336a",
    "content": "5 mg on alternate days (max. 1 mg daily)\n5-18 years (body weight < 50 kg); 0. 25-0.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1008",
    "type": "section",
    "keywords": [
      "days",
      "body",
      "years",
      "weight",
      "alternate",
      "daily"
    ]
  },
  {
    "id": "ccf53d50df73cd53e808c66c6912b7b6",
    "content": "5 mg daily. May increase by 0. 25 mg on alternate days (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1009",
    "type": "section",
    "keywords": [
      "days",
      "alternate",
      "increase",
      "daily"
    ]
  },
  {
    "id": "6c57daac6917a97a68f7cc66d3f43d51",
    "content": "0. 75 mg daily)\n< 5 years;\tnot recommended\nFor sleep problems\nEvidence Rating: [B]\nMelatonin, oral,\nChildren\n1 month-18 years;\t2-3 mg daily (before bedtime)\nThen\nIncrease if necessary after 1-2 weeks to 4-6 mg (daily before bed- time) max. 10 mg\nFor significant hyperactivity-in children ≥ 4 years\nEvidence Rating: [B]\nMethylphenidate, oral,\nChildren\n6-18 years;\t5 mg 12-24 hourly\nThen\nIncrease if necessary at weekly intervals by 5-10 mg (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1010",
    "type": "section",
    "keywords": [
      "years",
      "hyperactivity",
      "evidence",
      "increase",
      "hourly",
      "rating",
      "methylphenidate",
      "weeks",
      "children",
      "before",
      "bedtime",
      "melatonin",
      "month",
      "then",
      "recommended",
      "intervals",
      "weekly",
      "significant",
      "necessary",
      "oral"
    ]
  },
  {
    "id": "6406e75feb6d70e0c6629f6375edb2aa",
    "content": "of 20 mg 8 hourly)\n4-6 years;\t2. 5 mg 12 hourly\nThen\nIncrease if necessary by 2. 5 mg at weekly intervals (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1011",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "intervals",
      "weekly",
      "necessary",
      "then",
      "increase"
    ]
  },
  {
    "id": "af06ebc412a360661970be0da485ef4e",
    "content": "0. 4-0. 5 mg/ kg 8 hourly)\nReferral Criteria\nAll suspected cases of autism should be referred to a Tertiary centre.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1012",
    "type": "section",
    "keywords": [
      "hourly",
      "referral",
      "suspected",
      "should",
      "centre",
      "cases",
      "tertiary",
      "autism",
      "referred",
      "criteria"
    ]
  },
  {
    "id": "c0279c4521a510c0a218caed5e9a946f",
    "content": "A boil or furuncle is a deep bacterial infection of the hair follicles. A more superficial infection is termed folliculitis. Several boils grouped in an area and discharging pus from several points is termed a carbuncle.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1013",
    "type": "section",
    "keywords": [
      "carbuncle",
      "deep",
      "area",
      "several",
      "furuncle",
      "discharging",
      "points",
      "boil",
      "bacterial",
      "infection",
      "hair",
      "folliculitis",
      "superficial",
      "more",
      "termed",
      "follicles",
      "grouped",
      "boils"
    ]
  },
  {
    "id": "f55448d93862b2a5149c01e06cceb9d1",
    "content": "Patients with recurrent boils or carbuncles should be screened for diabetes mellitus and skin disorders such as scabies, pediculosis or eczema while patients with repeated folliculitis in the shaving areas, e. g. face and armpits should be educated on shaving techniques.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1014",
    "type": "section",
    "keywords": [
      "recurrent",
      "mellitus",
      "eczema",
      "face",
      "repeated",
      "while",
      "folliculitis",
      "carbuncles",
      "patients",
      "scabies",
      "shaving",
      "pediculosis",
      "should",
      "disorders",
      "skin",
      "areas",
      "armpits",
      "techniques",
      "educated",
      "diabetes"
    ]
  },
  {
    "id": "3aed510b4940adfe60958a04c69303fc",
    "content": "Causes\nStaphylococcus aureus\nSymptoms\nSingle or multiple painful swellings on the skin which may discharge\npus\nFever\nSigns\nSwellings - purulent, warm, fluctuant and/or tender (in single or multiple areas of skin)\ninvestigations\nFBC\nFasting blood glucose (if diabetes suspected)\nSwabs for culture and sensitivity in persistent or recurrent infection.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1015",
    "type": "section",
    "keywords": [
      "fluctuant",
      "recurrent",
      "swabs",
      "which",
      "glucose",
      "aureus",
      "sensitivity",
      "multiple",
      "single",
      "signs",
      "warm",
      "culture",
      "tender",
      "causes",
      "blood",
      "staphylococcus",
      "suspected",
      "fever",
      "painful",
      "skin"
    ]
  },
  {
    "id": "c786c90efd19f0258462330ec0401ef9",
    "content": "To treat infection\nTo relieve pain\nTo identify and treat any predisposing condition\nTo prevent scars and keloids.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1016",
    "type": "section",
    "keywords": [
      "pain",
      "treat",
      "predisposing",
      "prevent",
      "infection",
      "relieve",
      "identify",
      "condition",
      "keloids",
      "scars"
    ]
  },
  {
    "id": "a3e5a6aca93a187d0fddae87fcd3ae5f",
    "content": "Incision and drainage - if boil becomes fluctuant and large\nWound dressing.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1017",
    "type": "section",
    "keywords": [
      "fluctuant",
      "drainage",
      "large",
      "boil",
      "incision",
      "wound",
      "dressing",
      "becomes"
    ]
  },
  {
    "id": "8fbb9e65c431c4aaf0ea603dcd7e6a24",
    "content": "For boils or furunculosis in patients without penicillin allergy\nFlucloxacillin, oral,\nAdults\n250-500 mg 6 hourly for 7 days\nChildren\n5-12 years;\t250 mg 6 hourly for 7 days\nyears;\t125 mg 6 hourly for 7 days\n<1 year;\t62. 5 mg 6 hourly for 7 days\nFor boils or furunculosis in patients with penicillin allergy\nErythromycin, oral,\nAdults\n500 mg 6 hourly for 7 days\nChildren\n6-12 years;\t250 mg 6 hourly for 7 days\nyears;\t125 mg 6 hourly for 7 days\n< 1 year;\t62. 5 mg 6 hourly for 7 days\nAnd\nParacetamol, oral,\nAdults\n500 mg -1 g 6 to 8 hourly for 3-5 days\nChildren\n6-12 years;\t250-500 mg 6 to 8 hourly for 3-5 days\nyears;\t120-250 mg 6 to 8 hourly for 3-5 days\n3 months-1 year;\t60-120 mg 6 to 8 hourly for 3-5 days\nFor Folliculitis\nMupirocin ointment, topical,\nAdults and children\n12 hourly for 7 days\nReferral Criteria\nRefer to a specialist if the underlying condition requires further management.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [B]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "1018",
    "type": "section",
    "keywords": [
      "mupirocin",
      "years",
      "penicillin",
      "management",
      "hourly",
      "specialist",
      "flucloxacillin",
      "folliculitis",
      "underlying",
      "patients",
      "condition",
      "children",
      "criteria",
      "days",
      "topical",
      "referral",
      "erythromycin",
      "furunculosis",
      "adults",
      "allergy"
    ]
  },
  {
    "id": "0ac0f7d269f5c1cb58512418b8a600c9",
    "content": "Impetigo is a highly contagious superficial bacterial skin infection. It is common in neonates and children and may be associated with conditions such as scabies, eczema, lice infestation and herpes simplex infection as.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [B]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "1019",
    "type": "section",
    "keywords": [
      "neonates",
      "infestation",
      "herpes",
      "conditions",
      "infection",
      "bacterial",
      "common",
      "eczema",
      "superficial",
      "skin",
      "associated",
      "lice",
      "highly",
      "children",
      "contagious",
      "impetigo",
      "scabies",
      "simplex"
    ]
  },
  {
    "id": "f9c5a2709c8d0663cb8c3e58a456be3d",
    "content": "secondary infection. The condition does not cause any symptoms until four to 10 days after initial exposure. It usually improves within a week of treatment.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1020",
    "type": "section",
    "keywords": [
      "days",
      "usually",
      "initial",
      "improves",
      "within",
      "treatment",
      "infection",
      "week",
      "cause",
      "four",
      "exposure",
      "does",
      "after",
      "condition",
      "secondary",
      "symptoms",
      "until"
    ]
  },
  {
    "id": "08254f3a513f819c4086d2b73170f528",
    "content": "There are two types of impetigo. The non-bullous type typically affects the skin around the nose and mouth, causing lesions to develop, that quickly burst to leave a yellow-brown crust. The other type, bullous impetigo, typically affects the trunk causing fluid-filled blisters (bullae) to develop that burst after a few days to leave a yellow crust.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1021",
    "type": "section",
    "keywords": [
      "types",
      "lesions",
      "burst",
      "typically",
      "blisters",
      "fluid",
      "type",
      "quickly",
      "causing",
      "days",
      "yellow",
      "mouth",
      "filled",
      "around",
      "leave",
      "skin",
      "there",
      "brown",
      "nose",
      "trunk"
    ]
  },
  {
    "id": "d90e4358f39615c976a0db0ae46fc0cb",
    "content": "Both types of impetigo may leave behind marks when the crusts have cleared up, but these usually improve over the following days or weeks. Its prevention involves good hygiene, regular hand-washing, trimming of fingernails to reduce breaking of the skin through scratching, and discouraging the sharing of towels and clothing. Causes\nStaphylococcus aureus\nStreptococcus pyogenes\nSymptoms\nPus-filled blisters and sores on the body or scalp\nSigns\nSuperficial, fragile fluid-filled blisters\nIrregular spreading ulcers with yellow crusts\ninvestigations\nOften no test required\nMicroscopy and culture of the exudate from the blisters (except in recurrent or severe cases).",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1022",
    "type": "section",
    "keywords": [
      "spreading",
      "usually",
      "test",
      "types",
      "recurrent",
      "streptococcus",
      "improve",
      "regular",
      "sores",
      "often",
      "both",
      "scalp",
      "superficial",
      "required",
      "aureus",
      "blisters",
      "towels",
      "impetigo",
      "fluid",
      "body"
    ]
  },
  {
    "id": "2f7e4b2b3dca0019811b2deb8514af7e",
    "content": "To eradicate infection\nTo prevent transmission\nTo reduce the risk of developing complications (e. g. cellulitis, septicaemia)\nTo identify and treat any predisposing condition.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1023",
    "type": "section",
    "keywords": [
      "complications",
      "developing",
      "treat",
      "prevent",
      "predisposing",
      "infection",
      "transmission",
      "reduce",
      "eradicate",
      "septicaemia",
      "risk",
      "identify",
      "condition",
      "cellulitis"
    ]
  },
  {
    "id": "bd7778a59cc4802bf81e136cc1e6984c",
    "content": "Mild cases (few pustules without fever or systemic manifestations)\nEvidence Rating: [B]\nMupirocin ointment, topical,\nAdults and children\nApply 12 hourly for 7 days.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1024",
    "type": "section",
    "keywords": [
      "mupirocin",
      "topical",
      "rating",
      "hourly",
      "days",
      "pustules",
      "mild",
      "fever",
      "adults",
      "apply",
      "cases",
      "children",
      "systemic",
      "ointment",
      "evidence",
      "without",
      "manifestations"
    ]
  },
  {
    "id": "80afb0db4ec80d89d7f9e3142e7f1474",
    "content": "Moderate to severe or extensive cases in patients without\npenicillin allergy.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1025",
    "type": "section",
    "keywords": [
      "severe",
      "moderate",
      "penicillin",
      "extensive",
      "allergy",
      "cases",
      "patients",
      "without"
    ]
  },
  {
    "id": "f5dceb958d048580e792d8ade1a3a37f",
    "content": "Cloxacillin, IV,\nAdults\n500 mg 6 hourly for 3 - 5 days\nChildren\n10-18 years;\t250-500 mg 6 hourly for 3-5 days\n2-10 years;\t125-250 mg 6 hourly for 3-5 days\n< 2 years;\t62. 5-125 mg 6 hourly for 3-5 days\nThen\nFlucloxacillin, oral,\nAdults\n500 mg 6 hourly for 5-7 days\nChildren\n10-18 years;\t250-500 mg 6 hourly for 5-7 days\n2-10 years;\t125-250 mg 6 hourly for 5-7 days\n< 2 years;\t62. 5-125 mg 6 hourly for 5-7 days\nOr\nAmoxicillin + Clavulanic Acid, oral,\nAdults\n625 mg 12 hourly for 5 7 days\nChildren\n11-18 years;\t625 mg 12 hourly for 5-7 days\nyears;\t457 mg 12 hourly for 5-7 days\nyears;\t228 mg 12 hourly for 5-7 days\n< 1 year;\t114 mg 12 hourly for 5-7 days.",
    "title": "1st Line Treatment",
    "section": "1st Line Treatment",
    "chunk_id": "1026",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "amoxicillin",
      "years",
      "acid",
      "flucloxacillin",
      "adults",
      "clavulanic",
      "oral",
      "children",
      "cloxacillin",
      "then",
      "year"
    ]
  },
  {
    "id": "b85fc2c7272926f24e46c6a88520b2e9",
    "content": "Cefuroxime IV,\nAdults\n750 mg 8 hourly for 3-5 days\nChildren\n1 month-18 years;\t20 mg/kg 8 hourly for 3-5 days\nThen\nCefuroxime, oral,\nAdults\n250 mg 12 hourly\nChildren\n12-18 years;\t250 mg 12 hourly\n2-12 years;\t15 mg/kg 12 hourly, max. 250 mg 12 hourly\n3 months-2 years;\t10 mg/kg max. 125 mg 12 hourly\nModerate to severe or extensive cases in patients with penicillin\nallergy:\nAzithromycin, oral,.",
    "title": "2nd line treatment Evidence Rating: [B]",
    "section": "2nd line treatment Evidence Rating: [B]",
    "chunk_id": "1027",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "moderate",
      "severe",
      "years",
      "penicillin",
      "extensive",
      "adults",
      "allergy",
      "oral",
      "cases",
      "azithromycin",
      "cefuroxime",
      "patients",
      "month",
      "children",
      "months",
      "then"
    ]
  },
  {
    "id": "259163b46aa2179185602aeb3c415ada",
    "content": "Adult\n500 mg daily for 3-5 days\nChildren\n10 mg/kg body weight daily for 3 days\n< 6 months;\tnot recommended because of a risk of py-\nloric stenosis\nReferral Criteria\nRefer for hospital care and treatment if spreading rapidly or cellulitis, osteomyelitis or septicaemia develops.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1028",
    "type": "section",
    "keywords": [
      "spreading",
      "weight",
      "septicaemia",
      "cellulitis",
      "body",
      "hospital",
      "children",
      "criteria",
      "treatment",
      "days",
      "referral",
      "because",
      "stenosis",
      "adult",
      "loric",
      "months",
      "develops",
      "osteomyelitis",
      "recommended",
      "refer"
    ]
  },
  {
    "id": "cb87a96ad47bc88662feed2f25b854da",
    "content": "This is a chronic painless necrotising ulcer with undermined edges, which can lead to debilitating skin and soft tissue infection and permanent disfigurement. While it is known that this ulcer is caused by a bacterium, the mode of transmission remains unclear. However, trauma, insect bite and inhalation have been suggested.",
    "title": "(See section on ‘Cellulitis’ in Disorders of the Musculoskeletal system)",
    "section": "(See section on ‘Cellulitis’ in Disorders of the Musculoskeletal system)",
    "chunk_id": "1029",
    "type": "section",
    "keywords": [
      "ulcer",
      "which",
      "lead",
      "suggested",
      "while",
      "debilitating",
      "known",
      "insect",
      "necrotising",
      "disfigurement",
      "bacterium",
      "chronic",
      "caused",
      "inhalation",
      "undermined",
      "permanent",
      "edges",
      "skin",
      "remains",
      "soft"
    ]
  },
  {
    "id": "5881bc3011122dfd58410d7077959cd0",
    "content": "When detected early, the majority can be cured with a combination of antibiotics. Thus, early identification and appropriate management reduce morbidity and disability from this condition. Causes\nMycobacterium ulcerans\nSymptoms\nPainless subcutaneous nodule\nPainless swelling of the legs, arms or face\nExtensive skin ulceration\nSigns\nNodule: Painless firm lesion 1-2 cm in diameter situated in the subcutaneous tissue and attached to the skin\nDiffuse painless swelling of the legs, arms or face\nLarge painless area of induration\nExtensive skin ulceration\ninvestigations\nWound swab for AFBs, bacterial cultures and sensitivity\nSkin biopsy for histopathology.",
    "title": "(See section on ‘Cellulitis’ in Disorders of the Musculoskeletal system)",
    "section": "(See section on ‘Cellulitis’ in Disorders of the Musculoskeletal system)",
    "chunk_id": "1030",
    "type": "section",
    "keywords": [
      "firm",
      "antibiotics",
      "morbidity",
      "management",
      "face",
      "swelling",
      "wound",
      "sensitivity",
      "majority",
      "ulcerans",
      "lesion",
      "thus",
      "swab",
      "attached",
      "detected",
      "cured",
      "large",
      "extensive",
      "combination",
      "signs"
    ]
  },
  {
    "id": "93363d865786e55e4222047325f9b31b",
    "content": "To prevent disability\nTo treat both primary and secondary bacterial infection.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1031",
    "type": "section",
    "keywords": [
      "primary",
      "treat",
      "prevent",
      "infection",
      "both",
      "bacterial",
      "disability",
      "secondary"
    ]
  },
  {
    "id": "a57262db95d9f57b5ba580cb790a301a",
    "content": "Complete excision of nodules, preferably with primary closure if\npossible\nSkin grafting of ulcers if facilities are available.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1032",
    "type": "section",
    "keywords": [
      "primary",
      "preferably",
      "facilities",
      "nodules",
      "skin",
      "possible",
      "closure",
      "excision",
      "complete",
      "ulcers",
      "available",
      "grafting"
    ]
  },
  {
    "id": "3117bbe43cab4900bae81e621f578474",
    "content": "Rifampicin, oral, 10 mg/kg daily for 8 weeks\nAnd\nStreptomycin, IM, 15 mg/kg daily for 8 weeks.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1033",
    "type": "section",
    "keywords": [
      "streptomycin",
      "oral",
      "weeks",
      "rifampicin",
      "daily"
    ]
  },
  {
    "id": "c0cf158538f8c28413fc0b83566d5cb2",
    "content": "Rifampicin, oral, 10 mg/kg daily for 8 weeks\nAnd\nClarithromycin, oral, 7. 5 mg/kg 12 hourly for 8 weeks\nReferral Criteria\nRefer to centres with expertise for managing buruli ulcer. Yaws is a chronic infection by a bacterium that affects mainly the skin, bone and cartilage.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "1034",
    "type": "section",
    "keywords": [
      "managing",
      "ulcer",
      "hourly",
      "expertise",
      "weeks",
      "criteria",
      "bacterium",
      "clarithromycin",
      "referral",
      "chronic",
      "yaws",
      "skin",
      "rifampicin",
      "mainly",
      "buruli",
      "bone",
      "centres",
      "infection",
      "cartilage",
      "refer"
    ]
  },
  {
    "id": "38d3ba0fac7494b559f058e54899ea18",
    "content": "Most people affected are children under 15 years of age but adults are not exempt. It is transmitted mainly through skin contact with an infected person. A single skin lesion develops at the point of entry of the bacterium after 24 weeks.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "1035",
    "type": "section",
    "keywords": [
      "years",
      "infected",
      "under",
      "lesion",
      "single",
      "people",
      "most",
      "children",
      "weeks",
      "bacterium",
      "adults",
      "skin",
      "point",
      "develops",
      "mainly",
      "contact",
      "entry",
      "transmitted",
      "exempt",
      "through"
    ]
  },
  {
    "id": "d64964deeee34c97ee706357ed29f305",
    "content": "Without treatment, multiple lesions appear all over the body. The disease is rarely fatal, however it can lead to chronic disfigurement and disability in about 10% of affected individuals if left untreated. Treatment with antibiotics is curative and relapse is rare.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "1036",
    "type": "section",
    "keywords": [
      "lesions",
      "affected",
      "antibiotics",
      "lead",
      "curative",
      "body",
      "multiple",
      "rare",
      "untreated",
      "disfigurement",
      "treatment",
      "disease",
      "relapse",
      "chronic",
      "appear",
      "rarely",
      "fatal",
      "about",
      "however",
      "disability"
    ]
  },
  {
    "id": "bd035a89e983c42cfeab06cdfe0e9211",
    "content": "Causes\nTreponema pertenue\nSymptoms\nRaised skin lesions\nPainless skin ulcer\nBone pain\nSigns\nPapular skin lesions\nPainless skin ulcer with scab\nDeformities of the nose, bones.",
    "title": "Overcrowding, poor personal hygiene and poor sanitation facilitate the spread of the disease.",
    "section": "Overcrowding, poor personal hygiene and poor sanitation facilitate the spread of the disease.",
    "chunk_id": "1037",
    "type": "section",
    "keywords": [
      "pain",
      "scab",
      "lesions",
      "treponema",
      "symptoms",
      "papular",
      "ulcer",
      "pertenue",
      "skin",
      "raised",
      "signs",
      "deformities",
      "bones",
      "nose",
      "causes",
      "painless",
      "bone"
    ]
  },
  {
    "id": "70925f31c36e059bab257192214557e9",
    "content": "Palmar or plantar skin thickening\ninvestigations\nVDRL.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1038",
    "type": "section",
    "keywords": [
      "thickening",
      "vdrl",
      "skin",
      "plantar",
      "investigations",
      "palmar"
    ]
  },
  {
    "id": "95b35ecc04ab53416babef6686189c7c",
    "content": "To eradicate the organism and ensure cure\nTo prevent spread of the infection\nTo prevent long term complications.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1039",
    "type": "section",
    "keywords": [
      "term",
      "complications",
      "ensure",
      "cure",
      "prevent",
      "infection",
      "eradicate",
      "organism",
      "spread"
    ]
  },
  {
    "id": "4e51ec40326ee7126fb51b2ca79807ec",
    "content": "Azithromycin, oral,\nAdults\n30 mg/kg body weight (max. 2 g) as a single dose\nChildren\n15 years;\t2 g\n10-15 years;\t1. 5 g\nyears;\t1 g\n6 months-6 years;\t500 mg (syrup preferable)\n< 6 months;\tnot recommended\nFor Non-response or Non-availability of Azithromycin\nBenzathine Penicillin, IM,\nAdults\n1.",
    "title": "Single Dose Treatment for Yaws",
    "section": "Single Dose Treatment for Yaws",
    "chunk_id": "1040",
    "type": "section",
    "keywords": [
      "syrup",
      "body",
      "recommended",
      "years",
      "weight",
      "penicillin",
      "single",
      "adults",
      "response",
      "benzathine",
      "azithromycin",
      "oral",
      "dose",
      "children",
      "months",
      "preferable",
      "availability"
    ]
  },
  {
    "id": "4471d48950848e271509ff63c5f8b199",
    "content": "2 million units stat. Children\n10 years;\t1. 2 MU stat.",
    "title": "Single Dose Treatment for Yaws",
    "section": "Single Dose Treatment for Yaws",
    "chunk_id": "1041",
    "type": "section",
    "keywords": [
      "units",
      "years",
      "children",
      "million",
      "stat"
    ]
  },
  {
    "id": "970ef1a6eef7a01af92da88e9d2460b9",
    "content": "< 10 years;\t600 000 units stat. Referral Criteria\nRefer intractable cases to the dermatologist.",
    "title": "Single Dose Treatment for Yaws",
    "section": "Single Dose Treatment for Yaws",
    "chunk_id": "1042",
    "type": "section",
    "keywords": [
      "referral",
      "units",
      "years",
      "dermatologist",
      "refer",
      "intractable",
      "cases",
      "criteria",
      "stat"
    ]
  },
  {
    "id": "d242a9c4fb6bfb84962cd3df54fe54fc",
    "content": "These are fungal infections that affect the outer layers of the skin, the nails and hair. When florid, it may be associated with immunosuppression such as in diabetes and retroviral infection and corticosteroid abuse. Causes\nDermatophytes\t(tinea)\ti.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1043",
    "type": "section",
    "keywords": [
      "infections",
      "outer",
      "dermatophytes",
      "associated",
      "fungal",
      "florid",
      "nails",
      "layers",
      "immunosuppression",
      "causes",
      "affect",
      "hair",
      "corticosteroid",
      "skin",
      "tinea",
      "diabetes",
      "infection",
      "these",
      "retroviral",
      "abuse"
    ]
  },
  {
    "id": "2e6f2816da17dece40efb342a842691e",
    "content": "e. microsporum,\tepidermophyton,\ntrichophyton\nYeasts i. e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1044",
    "type": "section",
    "keywords": [
      "trichophyton",
      "microsporum",
      "yeasts",
      "epidermophyton"
    ]
  },
  {
    "id": "f732a4f23810de8f1bb3b6a1d76d1410",
    "content": "candida, malassezia\nSymptoms\nItchy scaly ring shaped rash on the skin\nScaly bald patches of the scalp\nDistorted, discoloured finger or toe nails\nItchy and sore skin folds\nScaly patches of skin with altered pigmentation\nSigns\nRound scaly patches with thickened edges and clear centre on the\nskin\nScaly bald patches of the scalp\nDistorted discoloured nails\nAltered pigmentation of skin (hypopigmented or brownish appearance)\nPustular rash in the flexures\ninvestigations\nSkin scrapings for microscopy and culture (mycology)\nNail and/or hair clippings for microscopy and culture\nFBS and HIV status (if infection is florid and/or oral candidiasis present).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1045",
    "type": "section",
    "keywords": [
      "candida",
      "appearance",
      "flexures",
      "shaped",
      "scalp",
      "clear",
      "rash",
      "microscopy",
      "candidiasis",
      "nail",
      "florid",
      "altered",
      "nails",
      "signs",
      "culture",
      "bald",
      "status",
      "malassezia",
      "finger",
      "pigmentation"
    ]
  },
  {
    "id": "6e6ea0f56abc72cf7cff879d13250c21",
    "content": "To eradicate infection\nTo prevent transmission\nTo identify and treat any predisposing conditions.",
    "title": "Treatment  Treatment/management objectives",
    "section": "Treatment  Treatment/management objectives",
    "chunk_id": "1046",
    "type": "section",
    "keywords": [
      "treat",
      "prevent",
      "predisposing",
      "conditions",
      "infection",
      "transmission",
      "eradicate",
      "identify"
    ]
  },
  {
    "id": "690b4c43618f6eb7721c1d3ee96776f7",
    "content": "Good personal hygiene\nUse of loose clothing\nOpen footwear.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1047",
    "type": "section",
    "keywords": [
      "open",
      "hygiene",
      "loose",
      "footwear",
      "personal",
      "clothing"
    ]
  },
  {
    "id": "972d2e92f7704d236e0edfe1a7886d51",
    "content": "Adults\n500 mg daily (double in severe infection) for 4 weeks\nChildren\n1 month-12 years;\t10 mg/kg (max. 500 mg) once daily or in two divided doses for 4 weeks\n12-18 years;\t500 mg once daily or in two divided doses (may be doubled in severe infections) for 4 weeks.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1048",
    "type": "section",
    "keywords": [
      "severe",
      "infections",
      "years",
      "infection",
      "adults",
      "doses",
      "double",
      "children",
      "month",
      "weeks",
      "doubled",
      "divided",
      "once",
      "daily"
    ]
  },
  {
    "id": "f73e9340c673eeaa24f00a68ab3e5775",
    "content": "Terbinafine, oral,\nAdults\nNot recommended\nChildren\nChildren over 1 year;\nBody weight > 40 kg; 250 mg once daily for 4 weeks Body weight 20-40 kg; 125 mg once daily for 4 weeks Body weight 10-20 kg;  62. 5 mg once daily for 4 weeks\nDermatophyte infection of body (tinea corporis), perineum (tinea\ncruris), hands (tinea manuum) and feet (tinea pedis).",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "1049",
    "type": "section",
    "keywords": [
      "weight",
      "body",
      "children",
      "corporis",
      "weeks",
      "cruris",
      "hands",
      "perineum",
      "adults",
      "terbinafine",
      "dermatophyte",
      "once",
      "year",
      "recommended",
      "tinea",
      "feet",
      "infection",
      "oral",
      "pedis",
      "manuum"
    ]
  },
  {
    "id": "a3948bceaf83ce9fb9b8260882c6c409",
    "content": "Benzoic Acid compound ointment (Whitfield’s ointment), topical,\nAdults and children\nApply twice daily to patches up to one or two weeks after the last\nvisible rash has cleared\nOr\nClotrimazole 1%, topical,\nAdults and children\nApply twice daily to patches up to one or two weeks after last visible\nrash has cleared\nOr\nMiconazole 2%, topical,\nAdults and children\nApply twice daily to patches up to one or two weeks after last visible\nrash has cleared\nOr\nCiclopirox olamine 1%, topical,\nAdults and children\nApply twice daily to patches up to one or two weeks after last visible\nrash has cleared.",
    "title": "Evidence Rating: [C] 1st Line Treatment",
    "section": "Evidence Rating: [C] 1st Line Treatment",
    "chunk_id": "1050",
    "type": "section",
    "keywords": [
      "compound",
      "miconazole",
      "last",
      "twice",
      "ciclopirox",
      "rash",
      "visible",
      "whitfield",
      "children",
      "weeks",
      "clotrimazole",
      "topical",
      "cleared",
      "acid",
      "olamine",
      "adults",
      "benzoic",
      "ointment",
      "patches",
      "after"
    ]
  },
  {
    "id": "8f39863364ccc6c6d2c2fd7cbd82bf4a",
    "content": "Griseofulvin, oral,\nAdults\n500 mg daily (double in severe infection) for 4 weeks\nChildren\n12-18 years;\t500 mg once daily or in two divided doses.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "1051",
    "type": "section",
    "keywords": [
      "severe",
      "griseofulvin",
      "years",
      "infection",
      "adults",
      "doses",
      "oral",
      "double",
      "children",
      "weeks",
      "divided",
      "once",
      "daily"
    ]
  },
  {
    "id": "5f54b4d13a85cb28cc201f3db33285ee",
    "content": "(may be doubled in severe infections) for 4 weeks\n1 month-12 years;\t10 mg/kg (max. 500 mg) once daily or in two divided doses for 4 weeks\nOr\nItraconazole, oral,\nAdults\n200 mg once daily or 12 hourly for 7 days\nChildren\n12 years-18 years;\t200 mg daily for 7 days\n1 month-12 years;\t3-5 mg/kg (max. 100 mg) once daily for 15 days or 30 days (for tinea pedis and manuum)\nOr\nTerbinafine, oral,\nAdults\n250 mg daily for 2-6 weeks\nChildren\nChildren over 1 year;\nBodyweight > 40 kg;\t250 mg once daily for 4 weeks, 6 weeks-3 months in nail infections\nBody weight 20-40 kg; 125 mg once daily for 4 weeks Body weight 10-20 kg;  62.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1052",
    "type": "section",
    "keywords": [
      "infections",
      "years",
      "weight",
      "bodyweight",
      "doubled",
      "hourly",
      "body",
      "nail",
      "itraconazole",
      "doses",
      "children",
      "weeks",
      "severe",
      "days",
      "adults",
      "terbinafine",
      "month",
      "months",
      "divided",
      "once"
    ]
  },
  {
    "id": "047a9f6e84094d237bea460808824d60",
    "content": "5 mg once daily for 4 weeks\nDermatophyte infection of nails (onychomycosis).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1053",
    "type": "section",
    "keywords": [
      "infection",
      "onychomycosis",
      "nails",
      "dermatophyte",
      "weeks",
      "once",
      "daily"
    ]
  },
  {
    "id": "13d17e27180c4507e45c5dcbb2bbd367",
    "content": "Itraconazole, oral,\nAdults\n200 mg 12-24 hourly for 7 days, repeated courses after 21 days in- terval (max. of 2 courses for finger nails and 3 courses for toe nails) Children\n12 years-18 years;\t200 mg 12 hourly for 7 days, repeated courses after 21 days interval (finger nails 2 courses, toe nails 3 courses)\n1 year-12 years;\t5 mg/kg (max 200 mg) daily for 7 days, re- peated courses after 21 days interval (finger nails 2 courses and toe nails 3 courses)\nOr\nTerbinafine, oral,\nAdults\n200 mg daily for 6 weeks-3 months\nChildren\nChildren over 1 year;\nBodyweight over 40 kg; 250 mg once daily for 6 weeks – 3 months Body weight 20-40 kg; 125 mg once daily for 6 weeks – 3 months Body weight 10-20 kg;  62. 5 mg once daily for 6 weeks – 3 months.",
    "title": "Evidence Rating: [C] 1st Line Treatment",
    "section": "Evidence Rating: [C] 1st Line Treatment",
    "chunk_id": "1054",
    "type": "section",
    "keywords": [
      "years",
      "weight",
      "interval",
      "bodyweight",
      "repeated",
      "hourly",
      "body",
      "itraconazole",
      "peated",
      "nails",
      "children",
      "weeks",
      "days",
      "finger",
      "adults",
      "terbinafine",
      "terval",
      "months",
      "once",
      "year"
    ]
  },
  {
    "id": "957a2ce57bf767aee4f8980882de098e",
    "content": "Adults\n500 mg daily (double in severe infection) for 4 weeks\nChildren\n12-18 years;\t500 mg once daily or in two divided doses (may be doubled in severe infections) for 4 weeks\n1 month-12 years;\t10 mg/kg (max. 500 mg) once daily or in two divided doses for 4 weeks\nFor Candida intertrigo\nEvidence Rating: [C]\nBenzoic Acid compound ointment (Whitfield’s ointment), topical, Apply twice daily to patches up to one or two weeks after the last visible rash has cleared. Or\nClotrimazole 1%, topical,\nApply twice daily to patches up to one or two weeks after last visible\nrash has cleared\nOr\nMiconazole 2%, topical,\nApply twice daily to patches up to one or two weeks after last visible\nrash has cleared\nOr\nCiclopirox olamine 1%, topical,\nApply twice daily to patches up to one or two weeks after last visible rash has cleared.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1055",
    "type": "section",
    "keywords": [
      "infections",
      "candida",
      "years",
      "compound",
      "miconazole",
      "last",
      "twice",
      "doubled",
      "evidence",
      "ciclopirox",
      "rash",
      "rating",
      "visible",
      "whitfield",
      "doses",
      "double",
      "children",
      "weeks",
      "clotrimazole",
      "severe"
    ]
  },
  {
    "id": "53400db3cb5caa013fd2d1c18f71d40a",
    "content": "For Oral candidiasis and Pityriasis versicolor\nPlease refer to section on oral candidiasis and pityriasis versicolor\nReferral Criteria.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1056",
    "type": "section",
    "keywords": [
      "candidiasis",
      "referral",
      "please",
      "section",
      "refer",
      "oral",
      "pityriasis",
      "criteria",
      "versicolor"
    ]
  },
  {
    "id": "e4b133afdd7641e24912211b4331ccfa",
    "content": "Pityriasis versicolor is a common yeast infection of the skin, in which flaky discoloured patches appear on the chest and back. It is sometimes called tinea versicolor. It is more common in hot climates, and often affects people that perspire heavily.",
    "title": "Refer to a dermatologist if patient fails to respond to treatment.",
    "section": "Refer to a dermatologist if patient fails to respond to treatment.",
    "chunk_id": "1057",
    "type": "section",
    "keywords": [
      "often",
      "which",
      "sometimes",
      "versicolor",
      "chest",
      "heavily",
      "flaky",
      "people",
      "perspire",
      "appear",
      "skin",
      "back",
      "yeast",
      "discoloured",
      "called",
      "patches",
      "tinea",
      "infection",
      "common",
      "affects"
    ]
  },
  {
    "id": "ef71ce63a14ecc2c02a620e27af7f975",
    "content": "It is a disorder of the healthy but florid cases are seen in the immunosuppressed such as those with diabetes mellitus, HIV/AIDS and topical steroid abuse. Causes\nPityrosporum orbiculare\nPityrosporum ovale (malassezia furfur)\nSymptoms\nAsymptomatic\nMildly Itchy.",
    "title": "Refer to a dermatologist if patient fails to respond to treatment.",
    "section": "Refer to a dermatologist if patient fails to respond to treatment.",
    "chunk_id": "1058",
    "type": "section",
    "keywords": [
      "orbiculare",
      "mellitus",
      "seen",
      "aids",
      "pityrosporum",
      "asymptomatic",
      "florid",
      "steroid",
      "immunosuppressed",
      "ovale",
      "causes",
      "mildly",
      "malassezia",
      "topical",
      "healthy",
      "furfur",
      "itchy",
      "those",
      "symptoms",
      "disorder"
    ]
  },
  {
    "id": "bd2384b1081132f335b20ed1dbf916af",
    "content": "Pale or dark skin patches\nSigns\nHypopigmented macules and/or patches\nWhite scaly patches\ninvestigations\nSkin scraping for microscopy\nFasting blood glucose (for florid cases)\nRetroscreen (for florid cases).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1059",
    "type": "section",
    "keywords": [
      "scraping",
      "microscopy",
      "pale",
      "macules",
      "blood",
      "patches",
      "white",
      "florid",
      "retroscreen",
      "dark",
      "hypopigmented",
      "cases",
      "skin",
      "signs",
      "scaly",
      "glucose",
      "investigations",
      "fasting"
    ]
  },
  {
    "id": "d32df33b5aef9511fdbd598f0edebfb1",
    "content": "To eradicate infection\nTo prevent transmission\nTo address predisposing factors.",
    "title": "Treatment Treatment Objectives",
    "section": "Treatment Treatment Objectives",
    "chunk_id": "1060",
    "type": "section",
    "keywords": [
      "prevent",
      "predisposing",
      "infection",
      "transmission",
      "address",
      "eradicate",
      "factors"
    ]
  },
  {
    "id": "c1e3389f58033b4cdd2740031e795213",
    "content": "Good personal hygiene\nAvoid sharing bath towels, sponges and clothing.",
    "title": "Non-Pharmacological Treatment",
    "section": "Non-Pharmacological Treatment",
    "chunk_id": "1061",
    "type": "section",
    "keywords": [
      "avoid",
      "sponges",
      "hygiene",
      "clothing",
      "bath",
      "personal",
      "sharing",
      "towels"
    ]
  },
  {
    "id": "f74ec6453c0053954427b4e278f494b6",
    "content": "For Mild Tinea Versicolor\nEvidence Rating: [C]\nMiconazole, 2%, topical,\nAdults\n12 hourly for 4 weeks\nChildren\n2 years;\t12 hourly for 4 weeks\n< 2 years;\t12 hourly for 4 weeks\nOr\nClotrimazole, 1%,\nAdults\n12 hourly for 4 weeks\nChildren\n2 years;\t12 hourly for 4 weeks\nOr\nWhitfield’s ointment, topical,\nAdults\n12 hourly for 4 weeks\nChildren\nNot recommended\nOr\nSelenium sulphide, shampoo 2. 5%, topical,\nAdults\nOnce daily for 5-7 days (washed off after 30 minutes to prevent ir- ritation)\nChildren\nOnce daily for 5-7 days.",
    "title": "Pharmacological Treatment",
    "section": "Pharmacological Treatment",
    "chunk_id": "1062",
    "type": "section",
    "keywords": [
      "years",
      "miconazole",
      "evidence",
      "versicolor",
      "shampoo",
      "hourly",
      "rating",
      "ritation",
      "minutes",
      "prevent",
      "whitfield",
      "children",
      "weeks",
      "clotrimazole",
      "days",
      "topical",
      "selenium",
      "adults",
      "ointment",
      "mild"
    ]
  },
  {
    "id": "059ae7acab0e3d409143910cf2ad91ab",
    "content": "< 5 years;\tnot recommended\nFor Severe Tinea Versicolor\nEvidence Rating: [B]\nItraconazole, oral,\nAdults\n200 mg daily for 7 days\nChildren\n12 years;\t200 mg daily for 7 days\n1 month-12 years;\t3-5 mg /kg daily for 7 days\nReferral Criteria\nRefer intractable cases to a dermatologist. These are acute self-limiting viral infections of the skin and mucous membranes resulting in blistering eruptions usually seen on the face (called “cold sores”) or the genitalia. Recurrence is common on previously affected skin areas and is due to proliferation of virus within the epidermis of the affected dermatome.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1063",
    "type": "section",
    "keywords": [
      "infections",
      "usually",
      "genitalia",
      "years",
      "dermatologist",
      "virus",
      "self",
      "affected",
      "sores",
      "face",
      "blistering",
      "seen",
      "membranes",
      "acute",
      "evidence",
      "versicolor",
      "rating",
      "within",
      "previously",
      "itraconazole"
    ]
  },
  {
    "id": "bc7720675135ce73e715345634c47b0d",
    "content": "Extensive lesions may be associated with an immunocompromised state or atopy. Causes\nHerpes simplex virus type 1\nHerpes simplex virus type 2\nSymptoms\nFever\nTingling, discomfort, or painful sensation over affected skin area\nGrouped small blisters\nGeneral malaise\nSigns\nFever\nTender grouped vesicles\nRegional lymphadenopathy\nGenital ulcers\nOral ulcers\ninvestigations\nUsually none.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1064",
    "type": "section",
    "keywords": [
      "usually",
      "virus",
      "lesions",
      "atopy",
      "discomfort",
      "associated",
      "blisters",
      "type",
      "extensive",
      "sensation",
      "signs",
      "immunocompromised",
      "tender",
      "genital",
      "herpes",
      "regional",
      "causes",
      "grouped",
      "simplex",
      "vesicles"
    ]
  },
  {
    "id": "060888c19675c295a75a08efaeeef5d5",
    "content": "Diagnosis is mainly clinical\nHSV serology (if necessary).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1065",
    "type": "section",
    "keywords": [
      "serology",
      "diagnosis",
      "necessary",
      "mainly",
      "clinical"
    ]
  },
  {
    "id": "2c9b6f7b2ca33ef0990cf1800edac1c6",
    "content": "Perioral or genital lesions\nEvidence Rating: [B]\nAciclovir cream 5%, topical,\nAdults\n4 hourly (five times daily) for 4-5 days\nChildren\n4 hourly (five times daily) for 4-5 days\nFor severe primary infections, disseminated herpes simplex, frequent recurrences and immunosuppressed patients\nAciclovir, oral,\nAdults\n400 mg 4 hourly (five times daily) for 5-7 days\nChildren\n2 years;\t200 mg 4 hourly (five times daily) for 5-7\ndays\n1 month-2 years;\t100 mg 4 hourly (five times daily) for 5-7\ndays\nAnd\nParacetamol, oral,\nAdults\n500 mg-1 g 6-8 hourly for 3-5 days\nChildren\n6-12 years;\t250-500 mg 6-8 hourly for 3-5 days\nyears;\t120-250 mg 6-8 hourly for 3-5 days\n3 months-1 year;\t60-120 mg 6-8 hourly for 3-5 days\nReferral Criteria\nRefer complicated cases to a dermatologist.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1066",
    "type": "section",
    "keywords": [
      "infections",
      "years",
      "dermatologist",
      "lesions",
      "times",
      "evidence",
      "primary",
      "hourly",
      "rating",
      "recurrences",
      "perioral",
      "five",
      "disseminated",
      "immunosuppressed",
      "aciclovir",
      "patients",
      "children",
      "genital",
      "herpes",
      "criteria"
    ]
  },
  {
    "id": "378c939b40877b00d252ee633af834be",
    "content": "This is an acute painful blistering viral infection of the skin. It can occur in childhood but is much more common in adults, especially the elderly, sick or immunosuppressed. The primary infection presents as chickenpox (varicella), usually during childhood.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1067",
    "type": "section",
    "keywords": [
      "usually",
      "occur",
      "especially",
      "during",
      "blistering",
      "elderly",
      "varicella",
      "presents",
      "acute",
      "primary",
      "immunosuppressed",
      "childhood",
      "painful",
      "adults",
      "chickenpox",
      "skin",
      "viral",
      "sick",
      "infection",
      "common"
    ]
  },
  {
    "id": "5ecb7bd651a497930da619f54b8d5b3f",
    "content": "Like herpes simplex, the virus persists usually in the anterior horn cells before it is reactivated. Post- herpetic neuralgia is a common complication and defined as persistence or recurrence of pain more than a month after the onset of shingles. Causes\nVaricella-zoster virus\nSymptoms\nFever\nSevere pain over areas involved\nHeadache\nBlisters\nSigns\nFever\nTender vesicles spread within one or more dermatomes unilaterally\nRegional lymphadenopathy\ninvestigations\nUsually none\nHIV screen (for recurrence and/or multi-dermatomal cases).",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1068",
    "type": "section",
    "keywords": [
      "usually",
      "horn",
      "unilaterally",
      "reactivated",
      "virus",
      "regional",
      "headache",
      "shingles",
      "varicella",
      "herpetic",
      "blisters",
      "within",
      "complication",
      "involved",
      "anterior",
      "signs",
      "neuralgia",
      "multi",
      "tender",
      "herpes"
    ]
  },
  {
    "id": "3ee1230d454a31d16dc4c3faebfcce6e",
    "content": "To provide adequate pain relief\nTo prevent secondary bacterial infection.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1069",
    "type": "section",
    "keywords": [
      "pain",
      "prevent",
      "secondary",
      "infection",
      "bacterial",
      "relief",
      "provide",
      "adequate"
    ]
  },
  {
    "id": "fd48931c67aea4849a758fc203b8ea29",
    "content": "Evidence Rating: [B]\nMild Herpes Zoster infection\nAciclovir cream 5%, topical,\nAdults\n4 hourly (five times daily) for 4-5 days\nChildren\n4 hourly (five times daily) for 4-5 days.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1070",
    "type": "section",
    "keywords": [
      "days",
      "topical",
      "rating",
      "hourly",
      "infection",
      "adults",
      "five",
      "times",
      "aciclovir",
      "children",
      "cream",
      "herpes",
      "zoster",
      "evidence",
      "mild",
      "daily"
    ]
  },
  {
    "id": "bd9c4d7adbfb1aed520c9578da25190a",
    "content": "And\nDiclofenac, oral,\nAdult\n50 mg 8 hourly for 7 days\nOr\nIbuprofen, oral,\nChildren\n5-10 mg/kg 6 hourly for 7 days\nAnd\nPovidone iodine 10%, topical,\nAdults\nApply to blisters daily till lesions resolve\nChildren\nApply to blisters daily till lesions resolve\nSevere Herpes Zoster infection\nEvidence Rating: [B]\nAciclovir, oral,\nAdults\n800 mg 4 hourly (five times daily) for 5-7 days\nChildren\n12 years;\t800 mg 4 hourly (five times daily) for 5-7 days\n6-12 years;\t800 mg 6 hourly for 5-7 days\n2-6 years;\t400 mg 6 hourly for 5-7 days\n< 2 years;\t200 mg 6 hourly for 5-7 days\nAnd\nDiclofenac, oral,\nAdults\n50 mg 8 hourly for 7 days\nOr\nIbuprofen, oral,\nChildren\n5-10 mg/kg 6-8 hourly for 7 days\nAnd\nPovidone iodine 10%, topical,\nAdults\nApply to blisters daily till lesions resolve\nChildren\nApply to blisters daily till lesions resolve\nPost Herpetic Neuralgia\nAmitriptyline, oral,\nAdults\n25-50 mg daily till resolution\nChildren\nNot indicated for this condition.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1071",
    "type": "section",
    "keywords": [
      "resolution",
      "years",
      "lesions",
      "povidone",
      "times",
      "evidence",
      "blisters",
      "ibuprofen",
      "herpetic",
      "hourly",
      "rating",
      "diclofenac",
      "five",
      "neuralgia",
      "aciclovir",
      "condition",
      "children",
      "herpes",
      "zoster",
      "amitriptyline"
    ]
  },
  {
    "id": "aca9d51994c4515f99541ca2da91d9c2",
    "content": "Or\nCarbamazepine, oral,\nAdults\n50-150 mg 12 hourly till resolution (maximum 600 mg 12 hourly)\nChildren\n12-18 years;\t50-100 mg 12 hourly\nThen\nIncrease to 600 mg 12 hourly if necessary\n1 month-12 years;\t2. 5 mg/kg 12 hourly\nThen\nIncrease slowly to 5 mg/kg 12 hourly\nOr\nPregabalin, oral,\nAdults\n75 mg 12 hourly till resolution\nChildren\nNot recommended\nReferral Criteria\nRefer complicated cases to a specialist. Chicken pox and shingles are caused by the same virus (Varicella or Herpes Zoster).",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1072",
    "type": "section",
    "keywords": [
      "chicken",
      "resolution",
      "years",
      "virus",
      "shingles",
      "varicella",
      "slowly",
      "increase",
      "hourly",
      "specialist",
      "carbamazepine",
      "children",
      "herpes",
      "criteria",
      "zoster",
      "referral",
      "complicated",
      "caused",
      "adults",
      "pregabalin"
    ]
  },
  {
    "id": "45efb42012e573e87ed9f1a85bd89afa",
    "content": "Humans are the only source of infection for chicken pox and shingles. Person-to-person transmission occurs by direct contact with vesicular fluid from patients with either condition. Chicken pox may additionally be transmitted by airborne spread from respiratory tract secretions.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1073",
    "type": "section",
    "keywords": [
      "chicken",
      "either",
      "shingles",
      "fluid",
      "patients",
      "condition",
      "vesicular",
      "humans",
      "tract",
      "secretions",
      "source",
      "only",
      "respiratory",
      "direct",
      "occurs",
      "additionally",
      "airborne",
      "contact",
      "transmitted",
      "infection"
    ]
  },
  {
    "id": "86197f9f755a4bac5e9a06eb3fd6794a",
    "content": "There is a risk of infection up to 21 days after contact. Chicken pox is a highly contagious viral illness usually occurring in epidemics. It is generally a benign, self-limiting disease in immuno- competent children but tends to be more severe in adolescents and adults and also in immunosuppressed patients e.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1074",
    "type": "section",
    "keywords": [
      "usually",
      "chicken",
      "adolescents",
      "self",
      "generally",
      "epidemics",
      "contagious",
      "immunosuppressed",
      "limiting",
      "competent",
      "highly",
      "children",
      "patients",
      "days",
      "disease",
      "severe",
      "adults",
      "also",
      "there",
      "viral"
    ]
  },
  {
    "id": "b6fe47714a839420c9b65a39fbf19ce7",
    "content": "g. patients on steroids. Complications include bacterial super-infection of skin lesions, pneumonia, central nervous system involvement (acute cerebellar ataxia, encephalitis), thrombocytopenia, and other rare complications such as glomerulonephritis, arthritis, and hepatitis.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1075",
    "type": "section",
    "keywords": [
      "lesions",
      "arthritis",
      "acute",
      "nervous",
      "thrombocytopenia",
      "rare",
      "involvement",
      "patients",
      "steroids",
      "include",
      "pneumonia",
      "bacterial",
      "skin",
      "ataxia",
      "hepatitis",
      "glomerulonephritis",
      "complications",
      "encephalitis",
      "infection",
      "other"
    ]
  },
  {
    "id": "f8f7d2086b5a8c37ca10e5b086708148",
    "content": "Exposure to the virus during the second 20 weeks of pregnancy can result in congenital varicella syndrome characterised by skin scarring, abnormalities of limbs, brain, eyes and low birth weight. Varicella infection can be fatal for an infant if the mother develops varicella from 5 days before to 2 days after delivery. Shingles presents with skin lesions in a dermatomal distribution and in immunocompromised individuals, can be very extensive.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1076",
    "type": "section",
    "keywords": [
      "virus",
      "weight",
      "lesions",
      "distribution",
      "abnormalities",
      "during",
      "shingles",
      "mother",
      "characterised",
      "varicella",
      "second",
      "presents",
      "delivery",
      "result",
      "extensive",
      "limbs",
      "immunocompromised",
      "pregnancy",
      "weeks",
      "congenital"
    ]
  },
  {
    "id": "a67cfbb564b08ef5e675ec9a2a42ae58",
    "content": "It may be complicated by pain persisting for weeks to years after the infection.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1077",
    "type": "section",
    "keywords": [
      "complicated",
      "pain",
      "years",
      "persisting",
      "infection",
      "after",
      "weeks"
    ]
  },
  {
    "id": "25d49edb807a8d63560874ecca8b8fbe",
    "content": "(postherpetic neuralgia). Causes\nVaricella-Zoster (or Herpes Zoster) virus\nSymptoms\nChicken pox\nFever\nMalaise\nAnorexia\nHeadache\nItchy skin rash\nShingles\nPainful rash\nFever\nSigns\nChickenpox\nVesicular rash eventually becoming crusted\nRash in different stages (papules, vesicles, crusted lesions)\nAppear first on face, scalp or trunk and spreads to rest of body, more concentrated on trunk\nPersists for 5-7 days\nPresence of pus in lesions suggests secondary bacterial infec- tion\nShingles\nVesicular rash\nAlong a dermatome\nRash eventually crusts\ninvestigations\nUsually none (diagnosis is mainly clinical)\nPolymerase Chain Reaction (PCR) or cell culture from vesicular fluid, crusts, saliva, cerebrospinal fluid or other specimens (if diagnosis in doubt).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1078",
    "type": "section",
    "keywords": [
      "usually",
      "chicken",
      "infec",
      "virus",
      "crusted",
      "lesions",
      "headache",
      "shingles",
      "face",
      "becoming",
      "scalp",
      "tion",
      "varicella",
      "secondary",
      "fluid",
      "rash",
      "eventually",
      "body",
      "chain",
      "suggests"
    ]
  },
  {
    "id": "ea745b4b8bd44becfa9ccaeb17a24c21",
    "content": "To relieve the intense itching or pain\nTo prevent or treat secondary infection\nTo prevent dehydration in children.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1079",
    "type": "section",
    "keywords": [
      "dehydration",
      "pain",
      "treat",
      "prevent",
      "infection",
      "itching",
      "relieve",
      "children",
      "secondary",
      "intense"
    ]
  },
  {
    "id": "55ce39abe710e4e279f7e6c69ffa8908",
    "content": "Avoid scratching\nRegular bathing with soap and water\nAvoid intentionally breaking up vesicles.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1080",
    "type": "section",
    "keywords": [
      "avoid",
      "vesicles",
      "regular",
      "breaking",
      "scratching",
      "water",
      "intentionally",
      "bathing",
      "soap"
    ]
  },
  {
    "id": "2e7779b1ab49df5715c568ba613bbc5f",
    "content": "Evidence Rating: [C]\nParacetamol, oral,\nAdults\n500 mg-1 g 6-8 hourly for 3-5 days\nChildren\n6-12 years;\t250-500 mg 6-8 hourly for 3-5 days\nyears;\t120-250 mg 6-8 hourly for 3-5 days\n3 months-1 year;\t60-120 mg 6-8 hourly for 3-5 days\nTo soothe the skin and relieve pruritus\nCalamine lotion/cream, topical, apply liberally to the skin\nAnd\nCetirizine\toral,\nAdults\n10 mg daily\nChildren\n12-18 years;\t10 mg daily\n6-12 years;\t5 mg 12 hourly\nyears;\t2. 5 mg 12 hourly\nOr\nPromethazine hydrochloride, oral, (sedating)\nAdults\n25 mg daily or 8 hourly daily\nOr\nChlorpheniramine maleate, oral,\nAdult\n4 mg daily or 12 hourly daily\nChildren\n6-12 years;\t2 mg 6-12 hourly daily (max. 12 mg daily)\n2-6 years;\t1 mg 6-8 hourly (max 6 mg daily)\n1-2 years;\t1 mg 12 hourly\nAntiviral therapy in immunocompetent individuals for Post\nexposure prophylaxis\nAciclovir, oral,\nAdults\n800 mg 4-6 hourly for 5 days\nChildren\n20 mg/kg 6 hourly (max 800 mg 6 hourly)\nAntiviral therapy in immuno-compromised patients (e.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1081",
    "type": "section",
    "keywords": [
      "lotion",
      "years",
      "immunocompetent",
      "therapy",
      "evidence",
      "hourly",
      "rating",
      "liberally",
      "calamine",
      "cetirizine",
      "antiviral",
      "aciclovir",
      "patients",
      "children",
      "promethazine",
      "days",
      "topical",
      "post",
      "hydrochloride",
      "compromised"
    ]
  },
  {
    "id": "8107dc0544d2407e4e9d1d6c2b957445",
    "content": "g. HiV) And\nAciclovir, oral,\nAdults\n800 mg 4 hourly (5 times daily) for 7 days or until 2 days after crust- ing of lesions\nChildren\n12-18 years;\t800 mg 4 hourly (5 times daily) daily for 7.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1082",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "crust",
      "years",
      "lesions",
      "adults",
      "oral",
      "times",
      "aciclovir",
      "after",
      "children",
      "until",
      "daily"
    ]
  },
  {
    "id": "5afd50cac4385a4c270d0e925400506b",
    "content": "days (continue for 2 more days after crusting of lesions\n6-12 years;\t800 mg 4 hourly (5 times daily) for 7 days (continue for 2 more days after crusting of lesions\n2-6 years;\t400 mg 4 hourly (5 times daily) for 5 days (continue for 2 more days after crusting of lesions)\n1 month-2 years;\t200 mg 4 hourly (5 times daily) for 5 days (continue for 2 more days after crusting of lesions\nSuperimposed bacterial skin infection in individuals not allergic to\npenicillins\nEvidence Rating: [C]\nFlucloxacillin, oral,\nAdults\n250-500 mg 6 hourly for 5-7 days\nChildren\n10-18 years;\t250-500 mg 6 hourly 5-7 days\n2-10 years;\t125-250 mg 6 hourly 5-7 days\n< 2 years;\t62. 5-125 mg 6 hourly 5-7 days\nOr\nAmoxicillin + Clavulanic Acid, oral,\nAdults\n625 mg 12 hourly for 5-7 days\nChildren\n10-18 years;\t625 mg 12 hourly for 5 days\nyears;\t457 mg 12 hourly for 5 days\n1-5 years;\t228 mg 12 hourly for 5 days\nSuperimposed bacterial skin infection in individuals allergic to\npenicillin\nAzithromycin, oral,\nAdult\n500 mg daily for 3 days\nChildren\n10 mg/kg body weight daily for 3 days\nNot recommended for children less than 6 months because of a risk\nof pyloric stenosis\nReferral Criteria\nRefer when severe complications set in. Also refer patients who are at risk of developing a disseminated rash e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1083",
    "type": "section",
    "keywords": [
      "continue",
      "years",
      "weight",
      "lesions",
      "superimposed",
      "penicillin",
      "pyloric",
      "penicillins",
      "times",
      "evidence",
      "hourly",
      "rating",
      "body",
      "rash",
      "developing",
      "crusting",
      "flucloxacillin",
      "clavulanic",
      "disseminated",
      "allergic"
    ]
  },
  {
    "id": "84214cd0deb1889f9bf7668f67ebe55d",
    "content": "g. patients on steroid therapy, other immunocompromised states and the newborn whose mother has had a recent infection.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1084",
    "type": "section",
    "keywords": [
      "recent",
      "states",
      "whose",
      "infection",
      "other",
      "newborn",
      "steroid",
      "mother",
      "patients",
      "immunocompromised",
      "therapy"
    ]
  },
  {
    "id": "d4ad89c0c39fd8f4a78a484387e1b21e",
    "content": "An ulcer or sore is a breach in the continuity of the skin and the underlying tissue. Large ulcers can cause a lot of morbidity and lead to serious complications. Predisposing and underlying disease needs to be investigated.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1085",
    "type": "section",
    "keywords": [
      "breach",
      "continuity",
      "complications",
      "disease",
      "morbidity",
      "predisposing",
      "large",
      "serious",
      "ulcer",
      "cause",
      "lead",
      "sore",
      "skin",
      "underlying",
      "needs",
      "ulcers",
      "investigated",
      "tissue"
    ]
  },
  {
    "id": "b25fa2acafd531ce1aebd4e56058a8e4",
    "content": "Complications include deformity, ankylosis of joints, osteomyelitis, cellulitis and malignant transformation of ulcers. Surgical treatment may be needed. Causes\nInfections and infestations e.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1086",
    "type": "section",
    "keywords": [
      "infections",
      "include",
      "osteomyelitis",
      "joints",
      "complications",
      "deformity",
      "surgical",
      "malignant",
      "infestations",
      "needed",
      "ankylosis",
      "transformation",
      "ulcers",
      "cellulitis",
      "causes",
      "treatment"
    ]
  },
  {
    "id": "5cceda0a7cae89a7cd500bf1567cae1e",
    "content": "g. Buruli ulcers, yaws ulcers, tuberculous ulcers, guinea worm ulcers\nNon-specific ulcers e. g.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1087",
    "type": "section",
    "keywords": [
      "yaws",
      "specific",
      "tuberculous",
      "guinea",
      "worm",
      "ulcers",
      "buruli"
    ]
  },
  {
    "id": "934cad2cba8ef1abed98747401175cae",
    "content": "pressure (decubitus), traumatic, venous,\ndiabetic, sickle cell ulcers, ischaemic\nMalignant ulcers e. g. squamous cell carcinoma, melanoma, Kaposi’s sarcoma\nSymptoms\nPain\nLoss of sensation at site of ulcer\nDischarge, which may be offensive\nSevere disfigurement\nDisability\nSigns\nSloping edges (non-specific ulcers)\nUndermined edges (buruli and tuberculous ulcers)\nPunched out edges (yaws ulcers)\nRaised everted edges (malignant ulcers)\nLoss of sensation in affected part (diabetes, leprosy, yaws or syphilis ulcers)\nDeformity of affected part\nWound discharge (purulent or offensive).",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1088",
    "type": "section",
    "keywords": [
      "venous",
      "everted",
      "ulcer",
      "squamous",
      "offensive",
      "which",
      "wound",
      "traumatic",
      "leprosy",
      "pressure",
      "sarcoma",
      "part",
      "malignant",
      "sensation",
      "site",
      "specific",
      "signs",
      "tuberculous",
      "diabetic",
      "disfigurement"
    ]
  },
  {
    "id": "08671b1e5a0c9271b23c96af95c029bf",
    "content": "Pink granulation tissue without slough (healthy wound)\ninvestigations\nFBC, ESR\nSickling test\nFasting blood glucose\nWound swab for culture and sensitivity, Ziehl Nielsen staining\nVDRL/RPR test\nX-ray of underlying bone\nBiopsy of ulcer.",
    "title": "Darkening of affected area (peripheral vascular disease, venous insufficiency)",
    "section": "Darkening of affected area (peripheral vascular disease, venous insufficiency)",
    "chunk_id": "1089",
    "type": "section",
    "keywords": [
      "sickling",
      "test",
      "ulcer",
      "wound",
      "glucose",
      "sensitivity",
      "swab",
      "pink",
      "underlying",
      "culture",
      "staining",
      "blood",
      "slough",
      "healthy",
      "ziehl",
      "investigations",
      "fasting",
      "granulation",
      "bone",
      "nielsen"
    ]
  },
  {
    "id": "f2d91d07cad398862537d57e526653fb",
    "content": "To deslough the ulcer and promote healthy granulation tissue formation\nTo promote healing\nTo identify and manage any underlying cause\nTo prevent complications.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1090",
    "type": "section",
    "keywords": [
      "complications",
      "deslough",
      "healthy",
      "healing",
      "formation",
      "manage",
      "prevent",
      "ulcer",
      "cause",
      "promote",
      "underlying",
      "identify",
      "tissue",
      "granulation"
    ]
  },
  {
    "id": "58208069e3bc96ef3ec1a01a5023f92a",
    "content": "Change dressing daily\nUse absorbent dressing for wounds that have profuse discharge\nDeslough wounds that have adherent slough\nElevate lower limb on sitting\nAdequate nutrition.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1091",
    "type": "section",
    "keywords": [
      "slough",
      "absorbent",
      "deslough",
      "limb",
      "adequate",
      "nutrition",
      "discharge",
      "adherent",
      "sitting",
      "change",
      "have",
      "dressing",
      "profuse",
      "wounds",
      "lower",
      "elevate",
      "daily"
    ]
  },
  {
    "id": "abde6c24549b2c0d5d624d1bad344eba",
    "content": "Evidence Rating: [C]\nFor non-antiseptic wound cleansing\nNormal saline solution (Do not use Eusol)\nFor antiseptic wound cleansing\nEvidence Rating: [C]\nChlorhexidine solution 4%, topical,\nOr\nCetrimide 15%, topical,\nOr\nPovidone iodine solution 10%, topical,.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1092",
    "type": "section",
    "keywords": [
      "topical",
      "rating",
      "cleansing",
      "eusol",
      "cetrimide",
      "iodine",
      "saline",
      "wound",
      "povidone",
      "chlorhexidine",
      "normal",
      "antiseptic",
      "evidence",
      "solution"
    ]
  },
  {
    "id": "c6684d0b76d38910ea03cec2529719de",
    "content": "Empiric antibiotic treatment may be initiated while awaiting culture and sensitivity results based on suspected or likely organisms. Referral Criteria\nRefer patients with ulcers failing to show signs of healing with above treatment, and patients who would require surgery either for skin grafting, wound excision or limb amputation to a surgical specialist. All ulcers suspected to be malignant should also be referred to a surgical specialist.",
    "title": "Specific antimicrobial treatment is guided by culture and sensitivity results.",
    "section": "Specific antimicrobial treatment is guided by culture and sensitivity results.",
    "chunk_id": "1093",
    "type": "section",
    "keywords": [
      "either",
      "based",
      "wound",
      "results",
      "antibiotic",
      "likely",
      "sensitivity",
      "awaiting",
      "grafting",
      "while",
      "require",
      "specialist",
      "healing",
      "malignant",
      "failing",
      "signs",
      "culture",
      "patients",
      "criteria",
      "empiric"
    ]
  },
  {
    "id": "83bb33eb39765461d44c96b487e93c34",
    "content": "Pruritus or itching is an unpleasant sensation on the skin that provokes the desire to rub or scratch the area. Itching can cause discomfort and frustration. In severe cases it can lead to disturbed sleep, anxiety and depression.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1094",
    "type": "section",
    "keywords": [
      "frustration",
      "lead",
      "discomfort",
      "anxiety",
      "sensation",
      "severe",
      "disturbed",
      "cause",
      "skin",
      "desire",
      "provokes",
      "unpleasant",
      "pruritus",
      "itching",
      "cases",
      "scratch",
      "area",
      "sleep",
      "depression"
    ]
  },
  {
    "id": "c6ef5031a22f3cd0571f558c447ded0b",
    "content": "Constant scratching to obtain relief can damage the skin and reduce its effectiveness as a major protective barrier. Treatment of pruritus must address the underlying condition. Diagnosis therefore needs to be made for effective treatment.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1095",
    "type": "section",
    "keywords": [
      "effectiveness",
      "relief",
      "therefore",
      "constant",
      "underlying",
      "condition",
      "treatment",
      "protective",
      "diagnosis",
      "address",
      "major",
      "damage",
      "scratching",
      "skin",
      "obtain",
      "effective",
      "made",
      "pruritus",
      "reduce",
      "must"
    ]
  },
  {
    "id": "01cb465464407bceef0ca10c26b13ee9",
    "content": "Causes\nLocalised pruritus (confined to a certain part of the body)\nSeborrhoiec dermatitis\nPruritus vulvae\nAnogenital pruritus\nTinea infections\nGravitational eczema\nLichen simplex chronicus.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1096",
    "type": "section",
    "keywords": [
      "infections",
      "seborrhoiec",
      "body",
      "chronicus",
      "pruritus",
      "part",
      "tinea",
      "anogenital",
      "lichen",
      "eczema",
      "vulvae",
      "confined",
      "gravitational",
      "localised",
      "certain",
      "causes",
      "simplex",
      "dermatitis"
    ]
  },
  {
    "id": "f84185f5cfda4c9cce7e4b0a61df0144",
    "content": "Atopic eczema\nDry skin\nAllergic contact dermatitis\nUrticaria\nScabies\nPrurigo\nMiliaria (heat rash)\nPediculosis\nInsect bites\nDermatitis herpetiformis\nLichen planus\nBullous pemphigoid.",
    "title": "Pruritic skin disorders (due to a primary skin disease)",
    "section": "Pruritic skin disorders (due to a primary skin disease)",
    "chunk_id": "1097",
    "type": "section",
    "keywords": [
      "urticaria",
      "prurigo",
      "eczema",
      "dermatitis",
      "rash",
      "heat",
      "lichen",
      "allergic",
      "scabies",
      "pediculosis",
      "skin",
      "contact",
      "pemphigoid",
      "bullous",
      "miliaria",
      "planus",
      "bites",
      "herpetiformis",
      "atopic",
      "insect"
    ]
  },
  {
    "id": "e7abfe8bab2f84d93630c4a3ce65502e",
    "content": "Haematological e. g. iron deficiency anaemia, polycythaemia rubra vera, lymphomas, leukaemias.",
    "title": "Generalised pruritus (usually due to a systemic disease)",
    "section": "Generalised pruritus (usually due to a systemic disease)",
    "chunk_id": "1098",
    "type": "section",
    "keywords": [
      "rubra",
      "iron",
      "anaemia",
      "leukaemias",
      "vera",
      "lymphomas",
      "polycythaemia",
      "haematological",
      "deficiency"
    ]
  },
  {
    "id": "592c698c3a9da2d3f255d53e4276fe7f",
    "content": "Pregnancy\nDiabetes mellitus\nCarcinomas\nDrug reaction\nOnchocerciasis\nPsychogenic\nSymptoms\nItching.",
    "title": "Thyroid disease",
    "section": "Thyroid disease",
    "chunk_id": "1099",
    "type": "section",
    "keywords": [
      "psychogenic",
      "onchocerciasis",
      "diabetes",
      "drug",
      "mellitus",
      "itching",
      "carcinomas",
      "reaction",
      "pregnancy",
      "symptoms"
    ]
  },
  {
    "id": "c20f9825dff3c81520f9e4c0c21d5c9d",
    "content": "Scratching\nSigns\nExcoriation\nLichenification\nScars\nFeatures of underlying conditions\ninvestigations\nFBC, film comment\nBUE, Creatinine\nLFTS\nFBS\nThyroid function test\nSkin snip and skin scrapings\nStool RE.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1100",
    "type": "section",
    "keywords": [
      "test",
      "excoriation",
      "comment",
      "features",
      "snip",
      "creatinine",
      "function",
      "film",
      "underlying",
      "signs",
      "lichenification",
      "scars",
      "lfts",
      "scrapings",
      "scratching",
      "skin",
      "investigations",
      "stool",
      "conditions",
      "thyroid"
    ]
  },
  {
    "id": "0e421008a8f4093adf6c4dd067d8ea63",
    "content": "To relieve symptoms\nTo identify and treat underlying disorder.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1101",
    "type": "section",
    "keywords": [
      "disorder",
      "treat",
      "relieve",
      "underlying",
      "identify",
      "symptoms"
    ]
  },
  {
    "id": "3429910e09fecdf67344c349c787c572",
    "content": "Avoid or minimize exposure to any identifiable causative agents e. g. soaps, detergents, drugs, clothes or fabric, foods etc.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1102",
    "type": "section",
    "keywords": [
      "avoid",
      "agents",
      "drugs",
      "soaps",
      "clothes",
      "causative",
      "fabric",
      "exposure",
      "detergents",
      "identifiable",
      "foods",
      "minimize"
    ]
  },
  {
    "id": "d4dae9d315cc54d780bc6414d3c457a1",
    "content": "Good personal hygiene\nCounselling (for psychogenic pruritus).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1103",
    "type": "section",
    "keywords": [
      "hygiene",
      "psychogenic",
      "pruritus",
      "counselling",
      "personal"
    ]
  },
  {
    "id": "12f67c4e643baf2724c0a1053ba51b05",
    "content": "Evidence Rating: [C]\nHydrocortisone 1%, topical, apply 12 hourly for 14 days\nAnd\nCetirizine, oral,\nAdults\n10 mg daily for 7 days\nChildren\n7-18 years;\t10 mg daily for 7 days\nyears;\t5 mg daily for 7 days\n< 2 years;\tsafety not established\nOr\nChlorpheniramine, oral,\nChildren\n< 2 years;\t1 mg 12 hourly for 5 days.",
    "title": "Symptomatic treatment",
    "section": "Symptomatic treatment",
    "chunk_id": "1104",
    "type": "section",
    "keywords": [
      "days",
      "topical",
      "rating",
      "hourly",
      "years",
      "cetirizine",
      "chlorpheniramine",
      "adults",
      "hydrocortisone",
      "oral",
      "safety",
      "established",
      "children",
      "evidence",
      "apply",
      "daily"
    ]
  },
  {
    "id": "ba46ef445c2f30521f0dff7020356d11",
    "content": "Evidence Rating: [A]\nPermethrin lotion 1%, topical,.",
    "title": "For treatment of Scabies",
    "section": "For treatment of Scabies",
    "chunk_id": "1105",
    "type": "section",
    "keywords": [
      "topical",
      "lotion",
      "rating",
      "permethrin",
      "evidence"
    ]
  },
  {
    "id": "b6ffc87421c619f8f40b1a64f19a0c31",
    "content": "Adult\nApply to whole body and wash off after 8-12 hours Repeat after 7 days\nChildren\nApply to whole body and wash off after 8-12 hours Repeat after 7 days\n< 2 months;\tnot recommended\nEvidence Rating: [C]\nBenzyl benzoate 25% lotion, topical,\nAdults\nApply over the whole body after a bath at night (except the face and head) for 3 nights [and wash off the next morning]\nChildren (> 2 years) (25% - half strength dilution)\nApply over the whole body after a bath at night (except the face and head) for 3 nights [and wash off the next morning]\nOr\nMalathion 0. 5%, topical,\nAdults\nApply to whole body. Leave on for 24 hours and wash off.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1106",
    "type": "section",
    "keywords": [
      "lotion",
      "years",
      "morning",
      "face",
      "malathion",
      "evidence",
      "night",
      "body",
      "rating",
      "repeat",
      "except",
      "children",
      "whole",
      "wash",
      "days",
      "topical",
      "head",
      "adult",
      "adults",
      "leave"
    ]
  },
  {
    "id": "ad3439f32fb4829fbabf92214ed0a087",
    "content": "Repeat application after 7 days\nChildren\nApply to whole body. Leave on for 24 hours and wash off. Repeat application after 7 days\n< 6 months;\tnot recommended.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1107",
    "type": "section",
    "keywords": [
      "days",
      "wash",
      "body",
      "recommended",
      "whole",
      "leave",
      "repeat",
      "application",
      "after",
      "children",
      "months",
      "hours",
      "apply"
    ]
  },
  {
    "id": "6597b17cb715a83f9c4d98876b5b2794",
    "content": "Clotrimazole 1%, topical,\nAdults\nApply to affected area 12 hourly for 14 days\nChildren\nApply to affected area 12 hourly for 14 days.",
    "title": "For treatment of Candidiasis",
    "section": "For treatment of Candidiasis",
    "chunk_id": "1108",
    "type": "section",
    "keywords": [
      "days",
      "topical",
      "hourly",
      "apply",
      "adults",
      "children",
      "area",
      "clotrimazole",
      "affected"
    ]
  },
  {
    "id": "783d247309bbd736c5a43244c3052f63",
    "content": "Or\nMiconazole 2%, topical\nAdults\nApply to affected area 12 hourly for 14 days\nChildren\nApply to affected area 12 hourly for 14 days.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1109",
    "type": "section",
    "keywords": [
      "days",
      "topical",
      "hourly",
      "miconazole",
      "apply",
      "adults",
      "children",
      "area",
      "affected"
    ]
  },
  {
    "id": "c626b7c959a99cb7440c8fb0998cf4da",
    "content": "Calamine lotion, topical,\nAdults\nApply 12 hourly for 7 days\nChildren\nApply 12 hourly for 7 days\nOr\nZinc oxide cream, topical,\nAdults\nApply 12 hourly for 7 days\nChildren\nApply 12 hourly for 7 days.",
    "title": "For treatment of Miliaria (Prickly Heat, Heat Rash)",
    "section": "For treatment of Miliaria (Prickly Heat, Heat Rash)",
    "chunk_id": "1110",
    "type": "section",
    "keywords": [
      "days",
      "lotion",
      "topical",
      "hourly",
      "zinc",
      "calamine",
      "adults",
      "oxide",
      "children",
      "cream",
      "apply"
    ]
  },
  {
    "id": "adf9eecd4250c731b3386167dc3917c1",
    "content": "Aqueous cream, topical,\nAdults and children\nApply as often as possible\nOr\nAqueous soap, topical,\nAdults and children\nUse as soap for bathing 12 hourly before applying cream\nOr\nSalicylic Acid ointment, topical,\nAdults and children Apply as needed.",
    "title": "For treatment of Atopic Eczema",
    "section": "For treatment of Atopic Eczema",
    "chunk_id": "1111",
    "type": "section",
    "keywords": [
      "topical",
      "hourly",
      "before",
      "applying",
      "often",
      "aqueous",
      "acid",
      "needed",
      "adults",
      "possible",
      "salicylic",
      "ointment",
      "children",
      "cream",
      "bathing",
      "soap",
      "apply"
    ]
  },
  {
    "id": "6e3d2f915c82ec1e80793fad20a593e8",
    "content": "Topical steroids may be used in addition to the above for Atopic Ec-\nzema\nAnd\nHydrocortisone cream, 1% topical,\nAdults and children\nApply 2-4 times daily.",
    "title": "For treatment of Atopic Eczema with acute flare-ups (see section on dermatitis)",
    "section": "For treatment of Atopic Eczema with acute flare-ups (see section on dermatitis)",
    "chunk_id": "1112",
    "type": "section",
    "keywords": [
      "topical",
      "zema",
      "above",
      "adults",
      "atopic",
      "hydrocortisone",
      "times",
      "children",
      "cream",
      "daily",
      "used",
      "addition",
      "apply",
      "steroids"
    ]
  },
  {
    "id": "698359487e134be84f3371b8f5a12909",
    "content": "Cetirizine, oral,\nAdults\n10 mg daily for 7 days\nChildren\n7-18 years;\t10 mg daily for 7 days\n2-6 years;\t5 mg daily for 7 days.",
    "title": "For treatment of Urticaria",
    "section": "For treatment of Urticaria",
    "chunk_id": "1113",
    "type": "section",
    "keywords": [
      "days",
      "years",
      "cetirizine",
      "adults",
      "oral",
      "children",
      "daily"
    ]
  },
  {
    "id": "3df0acf86555a6d1293f4f9281b68992",
    "content": "< 2 years;\tnot recommended\nOr\nChlorpheniramine, oral,\nChildren\n< 2 years;\t1 mg 12 hourly for 5 days (See section on ‘Urticaria’).",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1114",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "urticaria",
      "recommended",
      "years",
      "chlorpheniramine",
      "section",
      "oral",
      "children"
    ]
  },
  {
    "id": "fee68d127e2bbadfaeca43e3347de99d",
    "content": "Hydrocortisone 1%, topical,\nAdults and children\nApply 12 hourly for 14 days\ni. For insect Bites (e. g.",
    "title": "For treatment of Contact Dermatitis",
    "section": "For treatment of Contact Dermatitis",
    "chunk_id": "1115",
    "type": "section",
    "keywords": [
      "days",
      "topical",
      "hourly",
      "adults",
      "hydrocortisone",
      "bites",
      "children",
      "insect",
      "apply"
    ]
  },
  {
    "id": "a5e8da58d519f14184474363f5caa5df",
    "content": "Fleas, Bed Bugs)\nCetirizine, oral,\nAdults\n10 mg daily for 7 days\nChildren\n7-18 years;\t10 mg daily for 7 days\n2-6 years;\t5 mg daily for 7 days\n< 2 years;\t2. 5 mg daily for 7 days\nOr\nChlorpheniramine, oral,\nChildren\n< 2 years;\t1 mg 12 hourly for 5 days.",
    "title": "For treatment of Contact Dermatitis",
    "section": "For treatment of Contact Dermatitis",
    "chunk_id": "1116",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "years",
      "cetirizine",
      "fleas",
      "chlorpheniramine",
      "adults",
      "oral",
      "bugs",
      "children",
      "daily"
    ]
  },
  {
    "id": "6be73da47bf21f662c345ece1b3325da",
    "content": "Malathion 0. 5%, topical,\nAdults\nApply to whole body. Leave on for 24 hours and wash off.",
    "title": "J.\tFor treatment of Pediculosis (lice)",
    "section": "J.\tFor treatment of Pediculosis (lice)",
    "chunk_id": "1117",
    "type": "section",
    "keywords": [
      "wash",
      "topical",
      "body",
      "adults",
      "leave",
      "malathion",
      "whole",
      "hours",
      "apply"
    ]
  },
  {
    "id": "6ffc7c12959358fe14d30adb1bd17b51",
    "content": "Repeat application after 7 days\nChildren\nApply to whole body. Leave on for 24 hours and wash off. Repeat application after 7 days\n< 6 months;\tnot recommended\nReferral Criteria\nRefer to a dermatologist as soon as possible if diagnosis is unclear.",
    "title": "J.\tFor treatment of Pediculosis (lice)",
    "section": "J.\tFor treatment of Pediculosis (lice)",
    "chunk_id": "1118",
    "type": "section",
    "keywords": [
      "dermatologist",
      "apply",
      "application",
      "body",
      "repeat",
      "whole",
      "children",
      "criteria",
      "days",
      "wash",
      "referral",
      "diagnosis",
      "leave",
      "months",
      "recommended",
      "refer",
      "possible",
      "after",
      "hours",
      "soon"
    ]
  },
  {
    "id": "c9ff54f19171ea9b308e83ca3019bad2",
    "content": "Urticaria or wheal is a transient, itchy swelling of the skin secondary to the release of histamine. Each episode of wheal may last a few minutes or several hours and may change shape. Wheals may be round, or form.",
    "title": "J.\tFor treatment of Pediculosis (lice)",
    "section": "J.\tFor treatment of Pediculosis (lice)",
    "chunk_id": "1119",
    "type": "section",
    "keywords": [
      "urticaria",
      "wheals",
      "transient",
      "last",
      "swelling",
      "release",
      "secondary",
      "histamine",
      "form",
      "minutes",
      "episode",
      "wheal",
      "each",
      "skin",
      "itchy",
      "change",
      "several",
      "round",
      "hours",
      "shape"
    ]
  },
  {
    "id": "3654c3d916f5709eb4b06433b2be91a4",
    "content": "rings, a map-like pattern or giant patches. The surface wheals may be accompanied by deeper swelling of mucous membrane such as the eyelids, lips, hands and other parts of the body. The deeper swelling is called angioedema.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1120",
    "type": "section",
    "keywords": [
      "wheals",
      "swelling",
      "rings",
      "eyelids",
      "body",
      "lips",
      "surface",
      "mucous",
      "membrane",
      "hands",
      "accompanied",
      "parts",
      "pattern",
      "deeper",
      "called",
      "patches",
      "other",
      "angioedema",
      "giant"
    ]
  },
  {
    "id": "c12efdd3feff176a5bb79ce82e27e368",
    "content": "Urticaria is classified as acute urticaria if the condition lasts less than six (6) weeks and chronic urticaria if it lasts more than six (6) weeks. Causes of acute urticarias can easily be identified as against those for chronic urticaria. Causes\nMedicines e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1121",
    "type": "section",
    "keywords": [
      "against",
      "urticaria",
      "chronic",
      "classified",
      "those",
      "identified",
      "lasts",
      "medicines",
      "less",
      "more",
      "condition",
      "weeks",
      "urticarias",
      "acute",
      "causes",
      "easily"
    ]
  },
  {
    "id": "1220a8d443921749950bbae1642eb742",
    "content": "g. penicillins, cephalosporins, aspirin, NSAIDS, toxoids, animal sera, morphine, radiocontrast media, ACE inhibitors\nFoods e. g.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1122",
    "type": "section",
    "keywords": [
      "morphine",
      "foods",
      "sera",
      "radiocontrast",
      "media",
      "toxoids",
      "penicillins",
      "inhibitors",
      "animal",
      "aspirin",
      "cephalosporins",
      "nsaids"
    ]
  },
  {
    "id": "2ec1b05d086deb9d44fed6ee9f13d9ac",
    "content": "fish, nuts, eggs, chocolate, shellfish, pork, spices, milk,\ncheese, food dyes, additives\nInfections e. g. sepsis, hepatitis (viral)\nLatex e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1123",
    "type": "section",
    "keywords": [
      "fish",
      "infections",
      "cheese",
      "hepatitis",
      "viral",
      "shellfish",
      "latex",
      "dyes",
      "food",
      "additives",
      "spices",
      "chocolate",
      "sepsis",
      "milk",
      "nuts",
      "pork",
      "eggs"
    ]
  },
  {
    "id": "3487e4529bd253681e8de86e46156c48",
    "content": "g. gloves, medical equipment\nMedical  conditions  e. g.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1124",
    "type": "section",
    "keywords": [
      "equipment",
      "medical",
      "gloves",
      "conditions"
    ]
  },
  {
    "id": "7bba210ca3bad779ff8e639d6feb4342",
    "content": "lupus  erythematosus,  lymphoma, polycythaemia\nPlants\nIdiopathic\nEnvironmental and physical factors\nPressure urticaria: wheals appear on the area of skin experienc- ing any form of pressure e. g. soles of feet after prolong standing\nSolar, cold and heat urticaria: wheals appear when exposed to\nthese environments\nAquagenic urticaria: exposure to water leads to itchy wheals\nCholinergic urticaria: intense pruritic wheals are seen in re- sponse to sweating, exercise, emotions, and hot foods\nDermographism: linear wheals noticed as a result of scratching\nor pressure\nSymptoms\nItching\nWheals\nSigns\nWheals\nDemographism\nAngioedema\ninvestigations\nUsually none\nFull blood count (may show eosinophilia related to allergy or parasitic infestation or low white blood count from systemic lupus erythematosus)\nStool RE\nThyroid antibodies and function (in chronic urticaria if autoimmune origin is considered likely).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1125",
    "type": "section",
    "keywords": [
      "urticaria",
      "usually",
      "soles",
      "pruritic",
      "lymphoma",
      "wheals",
      "idiopathic",
      "white",
      "exercise",
      "factors",
      "solar",
      "cholinergic",
      "environmental",
      "seen",
      "systemic",
      "full",
      "foods",
      "likely",
      "form",
      "eosinophilia"
    ]
  },
  {
    "id": "86bb03ffbac1b25ad6ec4c0808f6204c",
    "content": "Skin biopsy (if wheals are prolonged, to identify vasculitis).",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1126",
    "type": "section",
    "keywords": [
      "prolonged",
      "wheals",
      "vasculitis",
      "skin",
      "biopsy",
      "identify"
    ]
  },
  {
    "id": "e2bad41b8216322ecc2dd3b68c4395b1",
    "content": "To provide immediate relief\nTo prevent complications such as anaphylaxis, shock or asphyxiation\nTo identify possible underlying cause and address it.",
    "title": "Treatment Treatment Objectives",
    "section": "Treatment Treatment Objectives",
    "chunk_id": "1127",
    "type": "section",
    "keywords": [
      "complications",
      "prevent",
      "anaphylaxis",
      "shock",
      "address",
      "relief",
      "provide",
      "cause",
      "underlying",
      "immediate",
      "possible",
      "identify",
      "asphyxiation"
    ]
  },
  {
    "id": "b86a29880fe17e8fa09bbaa12e21a6ec",
    "content": "Avoid contact with or further use of the suspected allergen or causative agent.",
    "title": "Non-Pharmacological Treatment",
    "section": "Non-Pharmacological Treatment",
    "chunk_id": "1128",
    "type": "section",
    "keywords": [
      "contact",
      "avoid",
      "suspected",
      "agent",
      "causative",
      "further",
      "allergen"
    ]
  },
  {
    "id": "2008bff70375eacd8a370005f6a4cea7",
    "content": "A. Control of wheals and itching\nEvidence Rating: [C]\nCetirizine, oral,\nAdults\n10 mg daily for 7 days\nChildren\n7-18 years;\t10 mg daily for 7 days\n2-6 years;\t5 mg daily for 7 days\n< 2 years;\t2. 5 mg daily for 7 days\nOr\nChlorphenamine, oral,\nAdults\n4 mg 4-6 hourly\nChildren\n6-12 years;\t2 mg 4-6 hourly\n2-6 years;\t1 mg 4-6 hourly\n1-2 years;\t1 mg 12 hourly\nOr\nPromethazine, oral,\nAdults\n25-50 mg 8-12 hourly\nChildren\n10-18 years;\t12.",
    "title": "Pharmacological Treatment",
    "section": "Pharmacological Treatment",
    "chunk_id": "1129",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "rating",
      "promethazine",
      "years",
      "wheals",
      "cetirizine",
      "itching",
      "adults",
      "oral",
      "children",
      "control",
      "evidence",
      "daily",
      "chlorphenamine"
    ]
  },
  {
    "id": "73932ea1a71b0a37aae16e898dd0137e",
    "content": "5-25 mg 8-12 hourly or 25 mg at night\n5-10 years;\t6. 25-12. 5 mg 12 hourly or 10-25 mg at night\n2-5 years;\t6.",
    "title": "Pharmacological Treatment",
    "section": "Pharmacological Treatment",
    "chunk_id": "1130",
    "type": "section",
    "keywords": [
      "hourly",
      "night",
      "years"
    ]
  },
  {
    "id": "8ac2ef0bd97fb00fdf443ecbce31e0d0",
    "content": "25 mg 12 hourly or 5-15 mg at night\n< 2 years;\tnot recommended\nReferral Criteria\nRefer cases of chronic urticaria to a dermatologist. These are immunologic reactions characterized by reddening with or without blistering of the skin and/or mucosa. The common types are erythema multiforme, Stevens-Johnson syndrome and toxic epidermal.",
    "title": "Pharmacological Treatment",
    "section": "Pharmacological Treatment",
    "chunk_id": "1131",
    "type": "section",
    "keywords": [
      "urticaria",
      "reddening",
      "types",
      "years",
      "dermatologist",
      "multiforme",
      "blistering",
      "night",
      "hourly",
      "erythema",
      "epidermal",
      "toxic",
      "reactions",
      "johnson",
      "criteria",
      "referral",
      "chronic",
      "immunologic",
      "skin",
      "mucosa"
    ]
  },
  {
    "id": "aee5c629cf75ca0518dc3a6e89ac6366",
    "content": "necrolysis (TEN). With all these conditions, there could be accompanying extensive denudation of skin with consequent fluid and electrolyte loss and a risk of secondary bacterial infection. All three conditions should be considered as emergencies requiring intensive care.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1132",
    "type": "section",
    "keywords": [
      "secondary",
      "fluid",
      "accompanying",
      "extensive",
      "necrolysis",
      "requiring",
      "electrolyte",
      "intensive",
      "denudation",
      "bacterial",
      "should",
      "skin",
      "there",
      "three",
      "consequent",
      "considered",
      "conditions",
      "infection",
      "emergencies",
      "loss"
    ]
  },
  {
    "id": "8929f61dabb2b65acf6287ce27923ae3",
    "content": "Erythema multiforme presents as itchy, target-like, non-scaly lesions of the palms, soles, forearms and legs. Stevens-Johnson syndrome is characterized by erythema and blister formation, which additionally involves the mucous membranes (conjunctiva, mouth, genitals etc. ).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1133",
    "type": "section",
    "keywords": [
      "soles",
      "multiforme",
      "lesions",
      "conjunctiva",
      "which",
      "membranes",
      "presents",
      "erythema",
      "formation",
      "mucous",
      "johnson",
      "palms",
      "target",
      "mouth",
      "involves",
      "forearms",
      "itchy",
      "additionally",
      "stevens",
      "characterized"
    ]
  },
  {
    "id": "f5a7f4b971a93110592035b7c4d9a2c9",
    "content": "Toxic epidermal necrolysis (TEN) is a generalized scalded type of skin reaction, often due to an allergic reaction to drugs. A similar reaction occurs in children termed staphylococcal scalded skin syndrome, which is caused by Staphylococcus aureus. Causes\nViral infections e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1134",
    "type": "section",
    "keywords": [
      "infections",
      "often",
      "scalded",
      "which",
      "aureus",
      "type",
      "necrolysis",
      "epidermal",
      "reaction",
      "toxic",
      "allergic",
      "termed",
      "children",
      "generalized",
      "causes",
      "caused",
      "staphylococcus",
      "similar",
      "skin",
      "occurs"
    ]
  },
  {
    "id": "5b2b893f657cdd5e4d49b93045a412f7",
    "content": "g. herpes simplex virus, retrovirus, cytomegalovirus\nMycoplasma pnuemoniae infection\nAdverse drug reaction e. g.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1135",
    "type": "section",
    "keywords": [
      "virus",
      "adverse",
      "infection",
      "drug",
      "mycoplasma",
      "pnuemoniae",
      "reaction",
      "herpes",
      "retrovirus",
      "cytomegalovirus",
      "simplex"
    ]
  },
  {
    "id": "8f366a7d172392341a032696b056e87b",
    "content": "to sulphonamides, penicillin, NSAIDS, anticonvulsants etc. Malignancy\nSymptoms\nFever\nBlisters\nItchy rash\nSore throat\nGeneral malaise\nDischarging painful eyes\nAsymptomatic\nSigns\nFever\nFlaccid bullae\nGenital and/or oral ulcerations\nDenuded area of skin\ninvestigations\nFBC\nBUE & creatinine\nHIV screen\nBlood and wound cultures (if indicated).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1136",
    "type": "section",
    "keywords": [
      "malignancy",
      "anticonvulsants",
      "penicillin",
      "wound",
      "ulcerations",
      "blisters",
      "asymptomatic",
      "rash",
      "creatinine",
      "flaccid",
      "denuded",
      "signs",
      "genital",
      "screen",
      "blood",
      "nsaids",
      "cultures",
      "fever",
      "painful",
      "skin"
    ]
  },
  {
    "id": "e066a957383b2eaf7d019d56d42630bb",
    "content": "To maintain adequate hydration\nTo maintain adequate nutrition\nTo correct electrolyte imbalance.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1137",
    "type": "section",
    "keywords": [
      "nutrition",
      "imbalance",
      "correct",
      "maintain",
      "electrolyte",
      "adequate",
      "hydration"
    ]
  },
  {
    "id": "676919fc85092e0205973e576125e482",
    "content": "To maintain normal body temperature\nTo prevent secondary infection\nTo identify and eliminate underlying cause\nTo prevent further exposure to the causative agent or drug.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1138",
    "type": "section",
    "keywords": [
      "body",
      "normal",
      "prevent",
      "infection",
      "maintain",
      "causative",
      "agent",
      "cause",
      "further",
      "exposure",
      "underlying",
      "drug",
      "identify",
      "temperature",
      "eliminate",
      "secondary"
    ]
  },
  {
    "id": "8b8142c35d11cc29d5083fc4cb4388cd",
    "content": "Withdrawal of identifiable causative agent or drug\nMaintenance of adequate input and output of fluid\nAdequate oral fluids\nPrevent contact of ulcerated skin with contaminated linen using a nursing cradle\nEarly ophthalmological consultation\nNutritious diet.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1139",
    "type": "section",
    "keywords": [
      "diet",
      "nursing",
      "withdrawal",
      "agent",
      "causative",
      "input",
      "identifiable",
      "maintenance",
      "fluid",
      "consultation",
      "ulcerated",
      "prevent",
      "linen",
      "drug",
      "fluids",
      "ophthalmological",
      "cradle",
      "skin",
      "nutritious",
      "contact"
    ]
  },
  {
    "id": "72ce73f79dc6502806f0b9d5c6b31da2",
    "content": "For adequate rehydration\nNormal saline, IV,\nFor Pain and Fever\nEvidence Rating: [A]\nParacetamol, oral,\nAdults\n500 mg-1 g 6-8 hourly\nChildren\n6-12 years;\t250-500 mg 6-8 hourly\nyears;\t120-250 mg 6-8 hourly\n3 months-1 year;\t60-120 mg 6-8 hourly\nFor Control of the immune Process in patients who can swallow\nEvidence Rating: [C]\nPrednisolone, oral, (at onset of condition)\nAdults\n0. 5-1 mg/kg daily and taper off over 7-10 days\nChildren\n0. 5 mg/kg daily and taper off over 7-10 days\nFor Control of the immune Process in patients who cannot\nswallow\nHydrocortisone, IV,\nAdults\n100 mg 6 hourly until able to swallow\nThen\nPrednisolone, oral, as above\nChildren\n4 mg/kg 6 hourly until able to swallow\nThen\nPrednisolone, oral, as above.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1140",
    "type": "section",
    "keywords": [
      "years",
      "rehydration",
      "evidence",
      "hourly",
      "rating",
      "process",
      "swallow",
      "saline",
      "patients",
      "condition",
      "children",
      "onset",
      "days",
      "above",
      "prednisolone",
      "fever",
      "adults",
      "cannot",
      "immune",
      "paracetamol"
    ]
  },
  {
    "id": "70133bec6c5b09021666dd054d077b7e",
    "content": "To treat Secondary Bacterial Skin infection or Mycoplasma\nPneumonia\nEvidence Rating: [B]\nAzithromycin, oral,\nAdults\n500 mg daily for 5 days\nChildren\n10 mg/kg once daily for 5 days\n< 6 months;\tnot recommended Or\nErythromycin, oral,\nAdults\n500 mg 6 hourly for 7 days\nChildren\n6-12 years;\t250 mg 6 hourly for 7 days\nyears;\t125 mg 6 hourly for 7 days\n< 1 year;\t62. 5 mg 6 hourly for 7 days\nFor prevention of skin infections\nEvidence Rating: [C]\nChlorhexidine solution 4%, topical,\nOr\nCetrimide 15%, topical,\nOr\nPovidone iodine solution 10%, topical,\nFor oral ulcers\nPovidone iodine 1% mouthwash, 12 hourly\nOr\nChlorhexidine 0. 12% mouthwash, 12 hourly\nReferral Criteria\nRefer all patients to appropriate specialist.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1141",
    "type": "section",
    "keywords": [
      "infections",
      "years",
      "treat",
      "povidone",
      "secondary",
      "evidence",
      "hourly",
      "rating",
      "specialist",
      "patients",
      "children",
      "criteria",
      "days",
      "topical",
      "referral",
      "erythromycin",
      "prevention",
      "cetrimide",
      "pneumonia",
      "bacterial"
    ]
  },
  {
    "id": "11d10aa2d9cb2c3268cffa7ec33d3239",
    "content": "Acne vulgaris (pimples or spots) is a common chronic inflammatory skin disorder involving the hair follicle and sebaceous gland which presents mainly in adolescence. A variety of spots appear mostly on the face and other parts of the body. Severe acne may require evaluation to exclude an underlying hormonal disorder.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1142",
    "type": "section",
    "keywords": [
      "adolescence",
      "face",
      "pimples",
      "which",
      "gland",
      "mostly",
      "presents",
      "body",
      "require",
      "evaluation",
      "underlying",
      "severe",
      "vulgaris",
      "chronic",
      "hormonal",
      "variety",
      "hair",
      "appear",
      "sebaceous",
      "parts"
    ]
  },
  {
    "id": "e307fd916b209487a32ea870a3510143",
    "content": "This condition may induce some psychological disturbances. The choice of treatment depends on age, severity, and whether the acne is predominantly inflammatory or.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1143",
    "type": "section",
    "keywords": [
      "choice",
      "predominantly",
      "disturbances",
      "psychological",
      "severity",
      "inflammatory",
      "induce",
      "depends",
      "whether",
      "acne",
      "condition",
      "treatment"
    ]
  },
  {
    "id": "f0d2062f9118c5495ac21cb5d25ca636",
    "content": "comedonal. Causes\nIncreased sebum secretion\nAbnormal keratinisation of the hair follicles (hereditary)\nIncreased sensitivity of the sebaceous glands to male hormones\nPropionibacterium acnes\nProlonged use of systemic and topical steroids e. g.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1144",
    "type": "section",
    "keywords": [
      "prolonged",
      "hereditary",
      "systemic",
      "sebum",
      "follicles",
      "sensitivity",
      "glands",
      "male",
      "abnormal",
      "causes",
      "steroids",
      "topical",
      "propionibacterium",
      "acnes",
      "hair",
      "sebaceous",
      "keratinisation",
      "increased",
      "comedonal",
      "hormones"
    ]
  },
  {
    "id": "b0d985623c2cf84d45cca7d79bf8c9ff",
    "content": "Anabolic steroids such as danazol, stanozolol and nandrolone\nUse of pomades, especially products that contain lanolin, petrolatum,\nvegetable oils, butyl stearate, lauryl alcohol and oleic acid\nContraceptive agents: medroxyprogesterone injection, implanted or intrauterine progesterone, and oral contraceptives\nPregnancy\nPolycystic ovarian syndrome.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1145",
    "type": "section",
    "keywords": [
      "agents",
      "oleic",
      "especially",
      "contraceptive",
      "oils",
      "butyl",
      "stearate",
      "nandrolone",
      "stanozolol",
      "lauryl",
      "pomades",
      "alcohol",
      "implanted",
      "ovarian",
      "injection",
      "pregnancy",
      "medroxyprogesterone",
      "steroids",
      "progesterone",
      "contraceptives"
    ]
  },
  {
    "id": "e2f7ddc8a9f644ed1eb60dc29b349910",
    "content": "Symptoms\nPimples (on the face and occasionally on the trunk, chest and shoulders)\nGreasy skin\nFacial disfigurement\nSigns\nComedones (blackheads and whiteheads)\nPapules\nCysts\nScars\nNodules\nPustules\nHirsutism (suggest excess androgens)\ninvestigations\nUsually none\nSerum testosterone (in females with accompanying hirsutism and virilising features)\nPelvic ultrasound (in females to exclude polycystic ovaries if hirsutism.",
    "title": "Adrenal disorders",
    "section": "Adrenal disorders",
    "chunk_id": "1146",
    "type": "section",
    "keywords": [
      "usually",
      "ultrasound",
      "hirsutism",
      "face",
      "pimples",
      "nodules",
      "features",
      "females",
      "testosterone",
      "chest",
      "accompanying",
      "pustules",
      "whiteheads",
      "cysts",
      "signs",
      "scars",
      "blackheads",
      "greasy",
      "disfigurement",
      "virilising"
    ]
  },
  {
    "id": "8759b4144cbdad9d5d55d912358fa356",
    "content": "To improve cosmetic appearance\nTo prevent complications particularly scarring\nTo reassure patient\nTo identify and avoid any causative or contributing factors.",
    "title": "present) Treatment Treatment objectives",
    "section": "present) Treatment Treatment objectives",
    "chunk_id": "1147",
    "type": "section",
    "keywords": [
      "cosmetic",
      "avoid",
      "complications",
      "scarring",
      "contributing",
      "appearance",
      "improve",
      "prevent",
      "reassure",
      "causative",
      "factors",
      "identify",
      "particularly",
      "patient"
    ]
  },
  {
    "id": "e77ca9fd4f9e0e66483507e3965c69d2",
    "content": "For mild to moderate acne\nEvidence Rating: [A]\nBenzoyl peroxide 5% lotion, topical, apply daily (avoiding mouth, eyes and the mucous membranes)\nAnd\nClindamycin, 1% lotion or gel, topical, apply daily\nOr\nTretinoin 0. 01% gel, topical, apply nocte (avoiding the sun, eyes, nos- trils, mouth, mucous membrane and broken skin)\nOr\nAdapalene 0. 1% cream or gel, topical, apply thinly once daily (at night before sleep)\nFor moderate to severe acne (or where topical therapy is\nineffective or not tolerated)\nEvidence Rating: [B].",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1148",
    "type": "section",
    "keywords": [
      "lotion",
      "sleep",
      "benzoyl",
      "peroxide",
      "membranes",
      "tolerated",
      "adapalene",
      "evidence",
      "night",
      "therapy",
      "rating",
      "moderate",
      "trils",
      "mucous",
      "where",
      "avoiding",
      "severe",
      "topical",
      "clindamycin",
      "before"
    ]
  },
  {
    "id": "b71c043670ecf8c408fd009cdc877b13",
    "content": "And\nDoxycycline, oral,\nAdults\n100 mg daily for 6 weeks-6 months (depending on response to treat- ment)\nChildren\nNot recommended\nOr\nTetracycline, oral,\nAdults.",
    "title": "Topical treatment from above (A)",
    "section": "Topical treatment from above (A)",
    "chunk_id": "1149",
    "type": "section",
    "keywords": [
      "depending",
      "tetracycline",
      "recommended",
      "doxycycline",
      "treat",
      "adults",
      "response",
      "oral",
      "children",
      "weeks",
      "months",
      "daily",
      "ment"
    ]
  },
  {
    "id": "0dcd72c6eb0fa88b20c65f9f26d77ddf",
    "content": "Change medication to erythromycin after 4 months if response is\npoor Children\n12 years;\tsame dose as for adults above\n< 12 years;\tnot recommended\nOr\nErythromycin, oral,\nAdult\n500 mg 12 hourly for 6 weeks-6 months\nChildren\n12 years;\t500 mg 12 hourly for 6 weeks - 6 months\n1-12 years;\t125 mg 12 hourly Or 250 mg once daily for.",
    "title": "250-500 mg 12 hourly for 6 weeks-6 months (depending on response to treatment)",
    "section": "250-500 mg 12 hourly for 6 weeks-6 months (depending on response to treatment)",
    "chunk_id": "1150",
    "type": "section",
    "keywords": [
      "years",
      "poor",
      "hourly",
      "children",
      "weeks",
      "above",
      "erythromycin",
      "adult",
      "medication",
      "response",
      "adults",
      "same",
      "change",
      "dose",
      "months",
      "once",
      "recommended",
      "oral",
      "after",
      "daily"
    ]
  },
  {
    "id": "26e1f13f87929e652c3e27ded5081f70",
    "content": "weeks-6 months\nReferral Criteria\nRefer patients not responding to treatment to a dermatologist. Suspected underlying endocrine conditions should be referred to an endocrinologist. Eczema or dermatitis is an acute or chronic inflammatory reaction in the skin often due to an external (exogenous) or internal (endogenous) factor.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1151",
    "type": "section",
    "keywords": [
      "internal",
      "dermatologist",
      "endocrinologist",
      "often",
      "eczema",
      "acute",
      "dermatitis",
      "endogenous",
      "factor",
      "underlying",
      "reaction",
      "patients",
      "weeks",
      "criteria",
      "exogenous",
      "treatment",
      "referral",
      "chronic",
      "suspected",
      "should"
    ]
  },
  {
    "id": "19ec486a8c9912c35e1021040c11f159",
    "content": "Exogenous eczema (contact eczema) includes primary irritant dermatitis and allergic contact dermatitis. Endogenous eczema includes atopic eczema, seborrhoiec eczema, discoid eczema, asteatotic eczema, varicose eczema and endogenous hand and soles dermatitis. Contact dermatitis may be an irritant (concentration dependent) or allergic (delayed hypersensitivity) reaction to specific external substance such as metals, rubber, chemicals etc.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1152",
    "type": "section",
    "keywords": [
      "soles",
      "asteatotic",
      "eczema",
      "delayed",
      "dermatitis",
      "primary",
      "hypersensitivity",
      "concentration",
      "endogenous",
      "reaction",
      "allergic",
      "specific",
      "discoid",
      "exogenous",
      "seborrhoiec",
      "hand",
      "dependent",
      "chemicals",
      "rubber",
      "includes"
    ]
  },
  {
    "id": "908c55a5e6c458e182935e15f8f6e9fc",
    "content": "In contrast to the endogenous types, the skin reaction is confined to the areas directly in contact with the offending substance or allergen. Atopic eczema is a common chronic but self-limiting pruritic skin disorder mainly of childhood but sometimes persists into adult life. The rash usually appears within the first year of life, mostly between ages 2 and 4 months.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1153",
    "type": "section",
    "keywords": [
      "usually",
      "ages",
      "types",
      "pruritic",
      "self",
      "eczema",
      "mostly",
      "sometimes",
      "into",
      "rash",
      "appears",
      "within",
      "endogenous",
      "reaction",
      "directly",
      "limiting",
      "childhood",
      "persists",
      "chronic",
      "first"
    ]
  },
  {
    "id": "a2105129c33444a2370876346cc19808",
    "content": "In older children the rash characteristically involves the flexural areas. A familial background of atopy (asthma, hay fever, eosinophilia, allergic rhinitis and similar skin problem) is often present. The condition is characterised by relapses and remissions.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1154",
    "type": "section",
    "keywords": [
      "often",
      "atopy",
      "characterised",
      "eosinophilia",
      "rash",
      "background",
      "asthma",
      "allergic",
      "condition",
      "children",
      "characteristically",
      "involves",
      "fever",
      "similar",
      "relapses",
      "skin",
      "problem",
      "familial",
      "older",
      "remissions"
    ]
  },
  {
    "id": "49e3c7555819f0d812d824f6f2873c68",
    "content": "Seborrhoiec eczema presents as a scaly, flaking, dry and reddened rash of the scalp, eyebrows, nasolabial folds, perioral, periorbital and periauricular skins. Sometimes it presents as hypopigmented macules. It may be associated with Pityrosporum ovale infection.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1155",
    "type": "section",
    "keywords": [
      "eczema",
      "scalp",
      "associated",
      "sometimes",
      "presents",
      "pityrosporum",
      "rash",
      "nasolabial",
      "macules",
      "perioral",
      "ovale",
      "reddened",
      "seborrhoiec",
      "periorbital",
      "periauricular",
      "hypopigmented",
      "skins",
      "eyebrows",
      "infection",
      "flaking"
    ]
  },
  {
    "id": "be4f4f7b541929dcc078581d21667ae7",
    "content": "Extensive forms are associated with immunosuppressive states, particularly HIV/AIDS and diabetes mellitus. Causes\nGenetic\nIrritants (e. g.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1156",
    "type": "section",
    "keywords": [
      "genetic",
      "states",
      "diabetes",
      "extensive",
      "mellitus",
      "forms",
      "associated",
      "aids",
      "irritants",
      "particularly",
      "immunosuppressive",
      "causes"
    ]
  },
  {
    "id": "d31f5fcb1d19ed29c7b93dafdb5c35df",
    "content": "acids, alkalis, detergents, petroleum products)\nAllergens (e. g. nickel, rubber, additives, chromates, hair dyes, topical medicaments, plants, nail varnish, cosmetics etc.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1157",
    "type": "section",
    "keywords": [
      "petroleum",
      "topical",
      "medicaments",
      "plants",
      "acids",
      "allergens",
      "nail",
      "dyes",
      "hair",
      "nickel",
      "products",
      "detergents",
      "rubber",
      "chromates",
      "alkalis",
      "cosmetics",
      "varnish",
      "additives"
    ]
  },
  {
    "id": "661fbd5b4a081a43ca7909b933bfb142",
    "content": ")\nFungal infections (e. g. Pityrosporum ovale, dermatophytosis)\nVenous stasis (e.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1158",
    "type": "section",
    "keywords": [
      "infections",
      "venous",
      "fungal",
      "stasis",
      "ovale",
      "pityrosporum",
      "dermatophytosis"
    ]
  },
  {
    "id": "9771743077c11e584d39b5286a4e4ebe",
    "content": "g. varicose veins, heart failure, lymphoedema)\nSymptoms\nItchy skin\nDry skin\nWeeping, reddened rash\nRelapses and remissions pattern.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1159",
    "type": "section",
    "keywords": [
      "reddened",
      "veins",
      "weeping",
      "rash",
      "lymphoedema",
      "remissions",
      "relapses",
      "skin",
      "heart",
      "itchy",
      "failure",
      "varicose",
      "symptoms",
      "pattern"
    ]
  },
  {
    "id": "7f6a67a824da0f0a1a31a1a111861932",
    "content": "Signs\nDry skin\nScaly skin\nErythema\nExcoriations\nLichenification\nPost inflammatory hyperpigmentation or hypopigmentation\nPapules\nVesicles\nFissuring\ninvestigations\nPatch testing for contact dermatitis\nSkin scraping for fungal elements\nHIV screen (seborrhoiec eczema in adults)\nFasting blood sugar (seborrhoiec eczema in adults).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1160",
    "type": "section",
    "keywords": [
      "fissuring",
      "eczema",
      "elements",
      "dermatitis",
      "erythema",
      "fungal",
      "patch",
      "signs",
      "sugar",
      "lichenification",
      "screen",
      "excoriations",
      "blood",
      "post",
      "seborrhoiec",
      "vesicles",
      "papules",
      "testing",
      "adults",
      "skin"
    ]
  },
  {
    "id": "931c8782a2cfe1af2492ce113b1d78cb",
    "content": "To relieve or control symptoms\nTo identify and avoid any causative or prediposing factors.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1161",
    "type": "section",
    "keywords": [
      "avoid",
      "causative",
      "relieve",
      "factors",
      "identify",
      "control",
      "symptoms",
      "prediposing"
    ]
  },
  {
    "id": "cf0270fe19baa1da499536e8e962bccf",
    "content": "Counselling of patients\nAvoidance of identifiable precipitating factors.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1162",
    "type": "section",
    "keywords": [
      "precipitating",
      "avoidance",
      "counselling",
      "factors",
      "patients",
      "identifiable"
    ]
  },
  {
    "id": "3280aff2fe447c1db349f89f4c711b4e",
    "content": "Evidence Rating: [C]\nFor Atopic Eczema\nE45 cream, topical,\nAdults\nApply 12 hourly\nChildren\nApply 12 hourly\nOr\nAqueous cream, topical,\nAdults\nApply 12 hourly\nChildren\nApply 12 hourly\nOr\nShea butter, topical,\nAdults\nApply 12 hourly\nChildren\nApply 12 hourly\nOr\nSalicylic Acid ointment 2%, topical,.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1163",
    "type": "section",
    "keywords": [
      "topical",
      "rating",
      "hourly",
      "acid",
      "aqueous",
      "ointment",
      "butter",
      "adults",
      "eczema",
      "salicylic",
      "shea",
      "children",
      "cream",
      "atopic",
      "evidence",
      "apply"
    ]
  },
  {
    "id": "7e952261d6e5919d9c434faf15f5b0bf",
    "content": "Adults\nApply 12 hourly\nChildren\nApply 12 hourly\nAnd\nOilatum soap (or bath gel), topical,\nAdults\nApply 8-12 hourly\nChildren\nApply 8-12 hourly\nAnd\nHydrocortisone cream/ointment 1-2. 5%, topical,\nAdults\nApply 8-12 hourly\nChildren (1% cream)\n3 months-12 years; apply thinly 12 to 24 hourly in area of rash\nOr\nMometasone lotion/ointment 0. 1%\nAdults\nApply thinly once daily Children\nApply thinly once daily\nOr\nBetamethasone cream/ointment 0.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1164",
    "type": "section",
    "keywords": [
      "lotion",
      "oilatum",
      "years",
      "betamethasone",
      "hourly",
      "rash",
      "mometasone",
      "children",
      "soap",
      "topical",
      "thinly",
      "adults",
      "ointment",
      "months",
      "once",
      "bath",
      "hydrocortisone",
      "area",
      "cream",
      "apply"
    ]
  },
  {
    "id": "105cbbb2707af135e66a249948675e2c",
    "content": "05-0. 1%, topical,\nAdults\nApply thinly 12-24 hours\nChildren (0. 05%)\n1-18 years;\tapply thinly 12 to 24 hours\nAnd\nChlorphenamine, oral,\nAdults\n4 mg 4-6 hourly or 4 mg once at night for 7 days\nChildren\n6-12 years;\t2 mg 4-6 hourly or 2 mg once at night for 7 days\n2-6 years;\t1 mg 4-6 hourly or 1 mg once at night for 7 days\n1-2 years;\t1 mg 12 hourly or 1 mg once at night for 7 days\nSeborrhoiec Eczema\nEvidence Rating: [C]\nMiconazole, 2% plus hydrocortisone 1% cream, topical,\nAdults\nApply 12 hourly till rash resolves\nChildren\nApply 12 hourly till rash resolves\nOr\nClotrimazole, 1% plus hydrocortisone 1% cream, topical,.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1165",
    "type": "section",
    "keywords": [
      "years",
      "miconazole",
      "eczema",
      "evidence",
      "night",
      "hourly",
      "rating",
      "rash",
      "children",
      "clotrimazole",
      "resolves",
      "chlorphenamine",
      "days",
      "topical",
      "seborrhoiec",
      "thinly",
      "adults",
      "till",
      "once",
      "plus"
    ]
  },
  {
    "id": "b10c5f43eb50e5af44cfa1b5fb9679c2",
    "content": "Adults\nApply 12 hourly till rash resolves\nChildren\nApply 12 hourly till rash resolves\nOr\nKetoconazole shampoo, topical,\nAdults\nApply twice weekly for 4 weeks with at least 3 days between each application\nChildren\n12 -18 years (shampoo); Apply twice weekly for 4 weeks with at least 3 days between each application\n< 12 years; safety and efficacy not establised Or\nSelenium sulphide shampoo\nAdults\nApply whole body 2 times per week for 2 weeks initially\nThen\nOnce every 1-2 weeks to control symptoms. Allow to remain on the scalp for 2-3 minutes then rinse thoroughly\nChildren\n5-18 years;\tsame as adult dose\n< 5 years;\tnot recommended\nOr\nItraconazole, oral,\nAdults\n100 mg daily for 3 weeks\nChildren\n12 years;\t100 mg daily for 3 weeks\n1 month-12 years;\t3-5 mg /kg daily for 3 weeks\nFor Contact Dermatitis\nBetamethasone cream/ointment, topical,\nAdults (0. 05-0.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1166",
    "type": "section",
    "keywords": [
      "years",
      "efficacy",
      "application",
      "scalp",
      "thoroughly",
      "times",
      "betamethasone",
      "twice",
      "dermatitis",
      "shampoo",
      "hourly",
      "rash",
      "body",
      "minutes",
      "itraconazole",
      "week",
      "initially",
      "safety",
      "children",
      "weeks"
    ]
  },
  {
    "id": "5dd0b1f54b40dc3d18126bee91f21283",
    "content": "1%)\nApply thinly 12 - 24 hourly for 7 days\nChildren (0. 05%)\n1-18 years; apply thinly 12 - 24 hourly for 7 days\nOr\nMometasone lotion/ointment 0. 1%\nAdults\nApply thinly once daily for 7 days\nChildren\nApply thinly once daily for 7 days.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1167",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "lotion",
      "mometasone",
      "years",
      "thinly",
      "adults",
      "ointment",
      "children",
      "daily",
      "apply",
      "once"
    ]
  },
  {
    "id": "b03a1dbf9b25478624785f6cdc7bd25b",
    "content": "For facial contact Eczema\nHydrocortisone cream, 1% topical,\nAdults and children\nApply 12 hourly\nReferral Criteria\nRefer patients not responding to treatment and those needing further investigations such as patch testing to a dermatologist. Intertrigo is the term used to describe a rash in body folds or apposing skin surfaces such as axillae, groin, submammary regions, beneath an abdominal apron of fat, finger or toe web spaces. Affected skin is reddened and uncomfortable.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1168",
    "type": "section",
    "keywords": [
      "axillae",
      "dermatologist",
      "affected",
      "eczema",
      "describe",
      "apposing",
      "spaces",
      "hourly",
      "rash",
      "body",
      "regions",
      "abdominal",
      "uncomfortable",
      "surfaces",
      "beneath",
      "patch",
      "needing",
      "patients",
      "children",
      "apron"
    ]
  },
  {
    "id": "4b89d702c2ff420d3d2a50e403e32966",
    "content": "Intertrigo is particularly common in those who are overweight and patients with diabetes mellitus. Body folds (flexures) are prone to inflammatory rashes because of relatively high skin temperature and moisture from insensible water loss. Sweating that is not easy to evaporate and friction from movement of adjacent skin, results in the sore skin.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1169",
    "type": "section",
    "keywords": [
      "overweight",
      "flexures",
      "insensible",
      "mellitus",
      "results",
      "rashes",
      "body",
      "prone",
      "moisture",
      "movement",
      "adjacent",
      "water",
      "easy",
      "patients",
      "particularly",
      "because",
      "sweating",
      "skin",
      "those",
      "friction"
    ]
  },
  {
    "id": "b66c433f8483743d23670c9ff6d3aea6",
    "content": "Causes\nCandida albicans (monilia)\nTinea infection\nEczema (e. g. seborrhoiec, atopic, contact)\nPsoriasis (flexural)\nErythrasma\nSymptoms\nItchy, scaly rash\nDry skin\nWeeping, reddened rash\nDischarging lesions\nSigns\nDry, scaly skin\nErythema\nExcoriations\nPapules\nVesicles\nCreamy satellite pustules at the margins of affected area\nPersistent brown patches\nWell-demarcated patches\nPlaques\ninvestigations\nPatch testing for contact dermatitis\nSkin scraping for fungal elements.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1170",
    "type": "section",
    "keywords": [
      "candida",
      "margins",
      "lesions",
      "affected",
      "eczema",
      "albicans",
      "elements",
      "creamy",
      "dermatitis",
      "rash",
      "erythema",
      "fungal",
      "pustules",
      "patch",
      "psoriasis",
      "plaques",
      "signs",
      "reddened",
      "causes",
      "excoriations"
    ]
  },
  {
    "id": "63c0d7025da482d282fc227525e93c9e",
    "content": "Fasting blood glucose\nSwab for culture and sensitivity.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1171",
    "type": "section",
    "keywords": [
      "swab",
      "blood",
      "glucose",
      "culture",
      "sensitivity",
      "fasting"
    ]
  },
  {
    "id": "cadb9308cde30f45d81e35798bc59c7e",
    "content": "To relieve symptoms and/or associated discomfort\nTo identify and treat any predisposing factors.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1172",
    "type": "section",
    "keywords": [
      "treat",
      "predisposing",
      "relieve",
      "discomfort",
      "factors",
      "associated",
      "identify",
      "symptoms"
    ]
  },
  {
    "id": "b2c852408fcb264bc740d70b52aae0e0",
    "content": "Wear loose cotton clothing and open footwear for aeration of folds\nWeight loss\nAvoid precipitating factors if any.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1173",
    "type": "section",
    "keywords": [
      "cotton",
      "open",
      "avoid",
      "precipitating",
      "aeration",
      "loose",
      "weight",
      "wear",
      "factors",
      "footwear",
      "folds",
      "loss",
      "clothing"
    ]
  },
  {
    "id": "f7fe2242774abe9424415cca8e2cb700",
    "content": "For candida intertrigo, seborrhoeic eczema or tinea infection\nEvidence Rating: [C]\nMiconazole 2% plus 1% hydrocortisone cream, topical,\nAdults\nApply 12 hourly for 14 days\nChildren\nApply 12 hourly for 7 days\nThen\nMiconazole 2% cream, topical,\nAdults\nApply 12-24 hourly till rash resolves\nChildren\nApply 12-24 hourly till rash resolves\nOr\nClotrimazole 1% cream, topical\nAdults\nApply 12-24 hourly till rash resolves\nChildren\nApply 12-24 hourly till rash resolves\nOr\nMiconazole, 2% powder, topical,\nAdults\nApply 12-24 hourly till rash resolves\nChildren\nApply 12-24 hourly till rash resolves\nOr\nClotrimazole, 1% powder, topical,\nAdults\nApply 12-24 hourly till rash resolves\nChildren\nApply 12-24 hourly till rash resolves\nEvidence Rating: [B]\nItraconazole, oral,.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1174",
    "type": "section",
    "keywords": [
      "candida",
      "miconazole",
      "eczema",
      "evidence",
      "hourly",
      "rating",
      "rash",
      "powder",
      "itraconazole",
      "children",
      "seborrhoeic",
      "clotrimazole",
      "resolves",
      "days",
      "topical",
      "adults",
      "then",
      "till",
      "tinea",
      "intertrigo"
    ]
  },
  {
    "id": "0734fdf19af3254699a9b4f93846eb5a",
    "content": "Adults\n200 mg daily for 7 days\nChildren\n12 years;\t200 mg daily for 7 days\n1 month-12 years;\t3-5 mg /kg daily for 7 days\nFor Erythrasma\nFusidic Acid, 2% cream, topical,\nAdults\nApply 6-8 hourly to affected parts\nChildren\nApply 6-8 hourly to affected parts\nOr\nClarithromycin, oral,\nAdults 1g stat. Children\n250-500 mg stat. Or\nErythromycin, oral,\nAdults\n500 mg 12 hourly for 5 days\nChildren\n8-18 years;\t250-500 mg 12 hourly for 5 days\n2-8 years;\t250 mg of syrup 12 hourly for 5 days\nOr\nMiconazole 2% cream, topical,\nAdults\nApply 12-24 hourly till rash resolves\nChildren\nApply 12-24 hourly till rash resolves\nOr\nWhitfield’s ointment, topical,\nAdults\nApply 12 hourly till rash resolves\nChildren\nApply 12 hourly till rash resolves\nFor Contact dermatitis, Atopic eczema or Flexural psoriasis\nHydrocortisone cream, 1% topical, Adults (1-2.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1175",
    "type": "section",
    "keywords": [
      "years",
      "miconazole",
      "apply",
      "eczema",
      "dermatitis",
      "hourly",
      "rash",
      "whitfield",
      "psoriasis",
      "children",
      "resolves",
      "stat",
      "days",
      "topical",
      "clarithromycin",
      "syrup",
      "erythromycin",
      "acid",
      "adults",
      "parts"
    ]
  },
  {
    "id": "01273dd5de8e7dbf5672794b3b900e77",
    "content": "5% cream/ointment) Apply 2-3 times daily\nChildren (1% cream)\n10 years;\tapply thinly 12-24 hourly in area of rash for.",
    "title": "Chapter 11: Dısorders of the Skın",
    "section": "Chapter 11: Dısorders of the Skın",
    "chunk_id": "1176",
    "type": "section",
    "keywords": [
      "hourly",
      "rash",
      "area",
      "years",
      "thinly",
      "children",
      "times",
      "ointment",
      "cream",
      "apply",
      "daily"
    ]
  },
  {
    "id": "9472a19d76a05084dc4b2aaecf338a07",
    "content": "days\nOr\nMometasone lotion/ointment 0. 1%\nAdults\nApply thinly once daily for 7 days\nChildren\nApply thinly once daily for 7 days\nOr\nBetamethasone cream/ointment, topical,\nAdults (0. 05-0.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1177",
    "type": "section",
    "keywords": [
      "days",
      "lotion",
      "topical",
      "mometasone",
      "thinly",
      "adults",
      "children",
      "betamethasone",
      "ointment",
      "cream",
      "daily",
      "apply",
      "once"
    ]
  },
  {
    "id": "060ed33e306563b980c6ed699c68e9c3",
    "content": "1%)\nApply thinly 12-24 hourly for 7 days\nChildren (0. 05%)\n1-18 years;\tapply thinly 12-24 hourly for 7 days\nReferral Criteria.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1178",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "referral",
      "years",
      "thinly",
      "children",
      "criteria",
      "apply"
    ]
  },
  {
    "id": "4b72ee9b088feedaec014082b482bf1e",
    "content": "Diabetes mellitus is characterised by persistently elevated blood glucose levels. If left untreated or improperly treated for long periods this will result in widespread blood vessel damage and complications relating to the eyes, kidneys, heart, brain and nerves. There is an increased risk of lower limb amputations, poor fertility and pregnancy outcomes with improper glucose control.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1179",
    "type": "section",
    "keywords": [
      "amputations",
      "levels",
      "mellitus",
      "glucose",
      "outcomes",
      "characterised",
      "poor",
      "vessel",
      "treated",
      "result",
      "persistently",
      "heart",
      "relating",
      "pregnancy",
      "widespread",
      "improper",
      "untreated",
      "blood",
      "periods",
      "kidneys"
    ]
  },
  {
    "id": "1ca033b0512eff368bd6857c0b7a8b80",
    "content": "Although children and adolescents often present with acute symptoms, many adults with diabetes are asymptomatic. It is therefore necessary to exclude diabetes in all persons, especially adults, attending health facilities for routine medical examinations, first out-patient review, ante-natal care, elective and emergency admissions or undergoing surgical procedures. The non-pharmacological and pharmacological interventions in diabetes management are usually life-long.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1180",
    "type": "section",
    "keywords": [
      "procedures",
      "usually",
      "elective",
      "adolescents",
      "pharmacological",
      "often",
      "management",
      "especially",
      "examinations",
      "attending",
      "health",
      "acute",
      "patient",
      "asymptomatic",
      "therefore",
      "review",
      "emergency",
      "undergoing",
      "facilities",
      "interventions"
    ]
  },
  {
    "id": "007abb49b84d2045a233552aea4eb305",
    "content": "Individuals found to have venous or capillary plasma glucose levels in the pre-diabetes or diabetes ranges, as shown in the table below, will need further assessment to confirm the diagnosis. HbA1c – Glycated Haemoglobin IGT – Impaired Glucose Tolerance IFG – Impaired Fasting Glycaemia.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1181",
    "type": "section",
    "keywords": [
      "venous",
      "plasma",
      "levels",
      "glucose",
      "table",
      "impaired",
      "ranges",
      "capillary",
      "glycaemia",
      "glycated",
      "need",
      "diagnosis",
      "further",
      "tolerance",
      "fasting",
      "below",
      "diabetes",
      "confirm",
      "found",
      "individuals"
    ]
  },
  {
    "id": "2ee395f94017a8abda217ac3da808072",
    "content": "Four forms of diabetes are encountered in practice:\nType 1 diabetes\nType 2 diabetes\nGestational diabetes (See section on ‘Diabetes in Pregnancy’).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1182",
    "type": "section",
    "keywords": [
      "encountered",
      "type",
      "diabetes",
      "section",
      "gestational",
      "forms",
      "practice",
      "pregnancy",
      "four"
    ]
  },
  {
    "id": "2d367556cd949f1cdc665ba93b59b8a8",
    "content": "Causes\nAutoimmune disorder (Type 1 diabetes)\nIdiopathic (Type 1 diabetes)\nGenetic factors causing a defect in the action or secretion of insulin (Type 2 diabetes)\nEnvironmental factors e. g. excessive calorie intake and lack of\nphysical activity (Type 2 diabetes)\nPregnancy (Gestational diabetes)\nSecondary diabetes:\nMedication e.",
    "title": "Secondary diabetes (related to medication use, endocrine or pancreatic disease etc.)",
    "section": "Secondary diabetes (related to medication use, endocrine or pancreatic disease etc.)",
    "chunk_id": "1183",
    "type": "section",
    "keywords": [
      "activity",
      "idiopathic",
      "factors",
      "environmental",
      "secondary",
      "genetic",
      "type",
      "calorie",
      "lack",
      "intake",
      "pregnancy",
      "causing",
      "causes",
      "defect",
      "medication",
      "gestational",
      "excessive",
      "disorder",
      "action",
      "insulin"
    ]
  },
  {
    "id": "9a36d23a05e81e24cc5b48e10182d53c",
    "content": "Symptoms\nUsually none in many adults\nPolyuria and nocturia\nPolydipsia\nUnexplained weight loss\nBlurred vision\nRecurrent boils\nRecurrent pruritus vulvae\nErectile dysfunction\nSymptoms related to chronic complications (e. g. ‘pins and needles’ sensation or numbness in the hands or feet, foot gangrene, poor vision etc.",
    "title": "Endocrine disorders e.g. Cushing’s syndrome, acromegaly etc.",
    "section": "Endocrine disorders e.g. Cushing’s syndrome, acromegaly etc.",
    "chunk_id": "1184",
    "type": "section",
    "keywords": [
      "usually",
      "recurrent",
      "weight",
      "dysfunction",
      "nocturia",
      "poor",
      "gangrene",
      "vision",
      "erectile",
      "sensation",
      "needles",
      "polydipsia",
      "chronic",
      "hands",
      "adults",
      "blurred",
      "vulvae",
      "related",
      "symptoms",
      "complications"
    ]
  },
  {
    "id": "e09e7a2dd0da19286f9f3450102a707c",
    "content": ")\nDelivery of large babies (> 4 kg)\nSigns\nUsually none in most patients\nLack of sensation in the feet or hands\nFoot gangrene\nPedal oedema\nImpaired visual acuity\nCataract\nRetinal changes on fundoscopy\ninvestigations\nNewly diagnosed patient\nFasting or random blood glucose\nOral glucose tolerance test (if required to confirm diagnosis)\nBlood urea, electrolytes and creatinine.",
    "title": "Endocrine disorders e.g. Cushing’s syndrome, acromegaly etc.",
    "section": "Endocrine disorders e.g. Cushing’s syndrome, acromegaly etc.",
    "chunk_id": "1185",
    "type": "section",
    "keywords": [
      "usually",
      "newly",
      "oedema",
      "test",
      "fundoscopy",
      "glucose",
      "required",
      "patient",
      "impaired",
      "delivery",
      "babies",
      "creatinine",
      "gangrene",
      "lack",
      "retinal",
      "large",
      "sensation",
      "signs",
      "acuity",
      "patients"
    ]
  },
  {
    "id": "473d678d6e84ae3690a54b6dc527a7b0",
    "content": "Fasting blood lipid profile (adults)\nGlycated haemoglobin (HbA1c)\nFBC\nECG (adults)\nUrinalysis\nUrine ketones (with high initial glucose levels)\nDuring routine follow ups\nBlood glucose\nRecorded results of regular self-monitoring of fasting and ran- dom tests at home by the patient using a glucose meter\nPeriodic fasting or random tests during clinic reviews\nGlycated haemoglobin (HbA1c) (at least twice a year)\nBlood lipid tests (annually, but more frequently if levels abnormal or on lipid lowering medication)\nBlood urea, electrolytes and creatinine (annually, but more frequently\nif levels abnormal)\nUrine microalbumin (annually).",
    "title": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "section": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "chunk_id": "1186",
    "type": "section",
    "keywords": [
      "urea",
      "initial",
      "monitoring",
      "self",
      "regular",
      "annually",
      "profile",
      "levels",
      "during",
      "urine",
      "glucose",
      "results",
      "frequently",
      "periodic",
      "twice",
      "patient",
      "lowering",
      "creatinine",
      "follow",
      "glycated"
    ]
  },
  {
    "id": "916a0ad18df5a758f616934a73e756f4",
    "content": "To relieve symptoms\nTo prevent acute hyperglycaemic complications (i. e. ketoacidosis and the hyperosmolar state).",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1187",
    "type": "section",
    "keywords": [
      "complications",
      "hyperosmolar",
      "hyperglycaemic",
      "prevent",
      "relieve",
      "state",
      "acute",
      "symptoms",
      "ketoacidosis"
    ]
  },
  {
    "id": "c6ff457458e7fe83dbd343de3fa1b03e",
    "content": "To achieve and maintain appropriate glycaemic targets\nFasting blood glucose between 4-7 mmol/L (less intensive gly- caemic targets in elderly patients)\n2-hour post-meal blood glucose between 5-9 mmol/L (less in-\ntensive glycaemic targets in elderly patients)\nGlycated haemoglobin 7 % or less (less intensive glycaemic tar- gets in elderly patients)\nTo ensure weight reduction in overweight and obese individuals\nTo prevent chronic complications of diabetes by maintaining\nThe glycaemic targets noted above\nBlood pressure less than 130/80 mmHg\nLDL-cholesterol less than 2. 5 mmol/L.",
    "title": "To prevent treatment-related hypoglycaemia",
    "section": "To prevent treatment-related hypoglycaemia",
    "chunk_id": "1188",
    "type": "section",
    "keywords": [
      "meal",
      "obese",
      "hour",
      "ensure",
      "overweight",
      "weight",
      "elderly",
      "glucose",
      "targets",
      "pressure",
      "prevent",
      "glycated",
      "cholesterol",
      "patients",
      "blood",
      "post",
      "mmol",
      "intensive",
      "reduction",
      "chronic"
    ]
  },
  {
    "id": "94fa9f2ef3d1d7c867a674954be1bbb9",
    "content": "Type 1 diabetes patients and Type 2 patients on insulin\nmonotherapy.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1189",
    "type": "section",
    "keywords": [
      "type",
      "insulin",
      "diabetes",
      "patients",
      "monotherapy"
    ]
  },
  {
    "id": "b6ba09c9106d0d417af878d74a164d7a",
    "content": "Evidence Rating: [A]\nInsulin Premix, SC, (30% soluble insulin and 70% NPH insulin),\n⅔ of total daily insulin requirement 30 minutes before breakfast\nAnd\n⅓ of total daily insulin requirement 30 minutes before evening meal (supper)\nOr\nSoluble insulin, SC,\n⅓ of total daily insulin requirement in 2 divided doses 30 minutes\nbefore breakfast and supper\nAnd\nInsulin NPH, SC,\n⅔ of total daily insulin requirement (⅔ of which would be given 30 minutes before breakfast and ⅓ 30 minutes before supper)\nType 2 diabetes patients on oral medications; initial management\n(Monotherapy).",
    "title": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "section": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "chunk_id": "1190",
    "type": "section",
    "keywords": [
      "meal",
      "initial",
      "breakfast",
      "given",
      "management",
      "which",
      "soluble",
      "evidence",
      "monotherapy",
      "rating",
      "type",
      "requirement",
      "minutes",
      "doses",
      "patients",
      "total",
      "evening",
      "before",
      "medications",
      "premix"
    ]
  },
  {
    "id": "fdb8bed1c3302e0e3bb8ad99539d3abd",
    "content": "Metformin, oral,\nAdults\n500 mg-1 g daily\nThen\nIncrease every 3 months to a maximum of 1 g 12 hourly if necessary\nChildren\nRefer to specialist\nType 2 diabetes patients on oral medications; patients not achieving glycaemic targets with Metformin monotherapy after approximately 3 months (Dual Therapy)\nMetformin, oral,\nAdults\n1 g 12 hourly\nChildren\nRefer to specialist\nAnd\nGlibenclamide, oral,\nAdults\n2. 5-10 mg daily\n(If required, not more than 5 mg of Glibenclamide could additionally be given in the evening maximum total dose 15 mg daily)\nChildren\nNot recommended.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1191",
    "type": "section",
    "keywords": [
      "given",
      "required",
      "therapy",
      "increase",
      "monotherapy",
      "targets",
      "hourly",
      "specialist",
      "type",
      "achieving",
      "patients",
      "dual",
      "children",
      "total",
      "evening",
      "medications",
      "glycaemic",
      "adults",
      "dose",
      "months"
    ]
  },
  {
    "id": "764700ee975f9782790cb6497c03154a",
    "content": "Or\nGliclazide, oral,\nAdults\n40-160 mg 12 hourly\nChildren\nNot recommended\nOr\nGlimepiride, oral,\nAdults\nmg daily (as a single dose in the morning)\nChildren\nNot recommended\nOr\nTolbutamide, oral,\nAdults\n250-1000 mg 8-12 hourly\nChildren\nNot recommended\nType 2 diabetes patients on oral medications; patients not achieving glycaemic targets with combination of Metformin and Sulphonylurea e. g. Glibenclamide etc.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1192",
    "type": "section",
    "keywords": [
      "morning",
      "tolbutamide",
      "targets",
      "hourly",
      "type",
      "single",
      "achieving",
      "combination",
      "patients",
      "children",
      "medications",
      "glycaemic",
      "adults",
      "dose",
      "glimepiride",
      "metformin",
      "gliclazide",
      "recommended",
      "sulphonylurea",
      "diabetes"
    ]
  },
  {
    "id": "56502eec26465b193932b19cc8f1deb1",
    "content": "Metformin and Glibenclamide (or alternative), oral, as in section C\nabove\nAnd\nSaxagliptin, oral,\nAdults\n2. 5-5 mg daily\nChildren\nNot recommended\nOr\nSitagliptin, oral,\nAdults\n50-100 mg daily\nChildren\nNot recommended\nOr\nVildagliptin, oral,\nAdults\n25-50 mg 12-24 hourly.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1193",
    "type": "section",
    "keywords": [
      "metformin",
      "hourly",
      "above",
      "recommended",
      "alternative",
      "section",
      "adults",
      "oral",
      "glibenclamide",
      "saxagliptin",
      "children",
      "sitagliptin",
      "vildagliptin",
      "daily"
    ]
  },
  {
    "id": "13147fe5b36cac3ec5dd030c91bf6f8c",
    "content": "Children\nNot recommended\nOr\nPioglitazone, oral,\nAdults\n15-45 mg daily\nChildren\nNot recommended\nType 2 diabetes patients on oral medications; not achieving\nglycaemic targets with Triple Therapy\nTriple Therapy\nAnd\nInsulin NPH, SC,\nAdults\n2-20 units before bedtime\nChildren\nRefer to specialist\nReferral Criteria\nAll individuals with diabetes must be referred to a dietician for dietary advice. All children with diabetes must be seen by a specialist (paediatrician or endocrinologist). All patients in whom glycaemic targets cannot be achieved as well as those with diabetes complications must be referred to the appropriate specialist.",
    "title": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "section": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "chunk_id": "1194",
    "type": "section",
    "keywords": [
      "units",
      "endocrinologist",
      "achieved",
      "seen",
      "advice",
      "therapy",
      "targets",
      "type",
      "specialist",
      "paediatrician",
      "whom",
      "dietary",
      "achieving",
      "patients",
      "children",
      "criteria",
      "referral",
      "before",
      "bedtime",
      "medications"
    ]
  },
  {
    "id": "3786d3ce624ec20adc741bac1c164746",
    "content": "All type 2 diabetics at diagnosis and type 1 diabetics 5 years after diagnosis should be referred to an eye specialist for screening for Diabetic Retinopathy. Diabetic ketoacidosis (DKA) is a condition associated with high blood glucose (usually > 18 mmol/L), which nonetheless, is unavailable to the body tissues as a source of energy. Fat is therefore broken down as an alternative source of energy, releasing toxic chemicals called ketones as a by-product.",
    "title": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "section": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "chunk_id": "1195",
    "type": "section",
    "keywords": [
      "usually",
      "years",
      "down",
      "which",
      "associated",
      "glucose",
      "therefore",
      "body",
      "type",
      "specialist",
      "alternative",
      "screening",
      "toxic",
      "condition",
      "unavailable",
      "diabetic",
      "blood",
      "retinopathy",
      "ketones",
      "mmol"
    ]
  },
  {
    "id": "09f72b608d2343abc16b30e8688a5400",
    "content": "Additionally, there is severe dehydration and electrolyte imbalance in DKA, especially low potassium. It is a common cause of death among diabetes patients in Ghana. It often occurs in type 1 diabetes patients but may also occur in type 2 diabetes.",
    "title": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "section": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "chunk_id": "1196",
    "type": "section",
    "keywords": [
      "occur",
      "often",
      "especially",
      "potassium",
      "death",
      "type",
      "imbalance",
      "among",
      "patients",
      "electrolyte",
      "severe",
      "dehydration",
      "also",
      "cause",
      "there",
      "occurs",
      "additionally",
      "diabetes",
      "common",
      "ghana"
    ]
  },
  {
    "id": "0990b52d998f7ce26cf496ee3a2325d9",
    "content": "In contrast, the Hyperosmolar Non-Ketotic state (HONK) in diabetes occurs primarily in Type 2 patients, and is similar in its clinical presentation to diabetic ketoacidosis in many respects. A major difference, however, is.",
    "title": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "section": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "chunk_id": "1197",
    "type": "section",
    "keywords": [
      "hyperosmolar",
      "primarily",
      "type",
      "presentation",
      "respects",
      "patients",
      "ketotic",
      "diabetic",
      "contrast",
      "similar",
      "state",
      "major",
      "occurs",
      "honk",
      "ketoacidosis",
      "diabetes",
      "however",
      "difference",
      "clinical"
    ]
  },
  {
    "id": "d8aeebe1c32da1c7d9392f9eae913e60",
    "content": "the absence of a significant amount of ketones in the urine (usually trace or 1+) and the presence of severe dehydration. The management of this condition is similar to that of DKA. Causes\nSevere deficiency of insulin\nInterruption of anti-hyperglycaemic therapy (usually for financial reasons or for alternative treatment)\nStress of intercurrent illness (e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1198",
    "type": "section",
    "keywords": [
      "usually",
      "trace",
      "management",
      "urine",
      "therapy",
      "alternative",
      "stress",
      "interruption",
      "presence",
      "condition",
      "causes",
      "ketones",
      "reasons",
      "deficiency",
      "severe",
      "treatment",
      "dehydration",
      "hyperglycaemic",
      "intercurrent",
      "amount"
    ]
  },
  {
    "id": "616e7ef11ac2de903115f90b08d74a90",
    "content": "g. infection, myocardial infarction,\nstroke, surgery, complicated pregnancy etc. )\nSymptoms\nPolyuria\nPolydipsia\nNausea, vomiting\nAbdominal pain\nAlteration in sensorium or collapse\nSymptoms of infection or other underlying condition\nSigns\nDehydration (dry skin, reduced skin turgor or sunken eyes)\nDeep and fast breathing\nLow blood pressure\nFast and weak pulse\n‘Fruity’ breath (smell of acetone)\nConfusion, stupor or unconsciousness\nEvidence of infection, recent surgery, stroke etc.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1199",
    "type": "section",
    "keywords": [
      "collapse",
      "recent",
      "acetone",
      "nausea",
      "unconsciousness",
      "turgor",
      "stupor",
      "breathing",
      "alteration",
      "reduced",
      "evidence",
      "abdominal",
      "pressure",
      "myocardial",
      "underlying",
      "signs",
      "polydipsia",
      "condition",
      "pregnancy",
      "fruity"
    ]
  },
  {
    "id": "d704786502c7b710b857d4e8e48bb6f6",
    "content": "investigations\nRandom blood glucose (usually >18 mmol/L)\nUrine glucose (usually >3+)\nUrine ketones (usually >2+)\nBlood urea and electrolytes (usually low potassium, however if in renal failure urea and potassium may be high)\nBlood film for malaria parasites\nFull blood count (raised white cell count would suggest bacterial infection)\nUrine culture\nBlood culture\nChest X-ray (for pneumonia)\nArterial blood gases\nElectrocardiogram (to identify hypokalaemia, and in adult patients to exclude acute myocardial infarction as a precipitating factor).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1200",
    "type": "section",
    "keywords": [
      "usually",
      "electrocardiogram",
      "white",
      "glucose",
      "urine",
      "potassium",
      "full",
      "identify",
      "acute",
      "precipitating",
      "chest",
      "myocardial",
      "count",
      "factor",
      "film",
      "culture",
      "patients",
      "malaria",
      "renal",
      "blood"
    ]
  },
  {
    "id": "784bd084a4874515a9707aa1f644063d",
    "content": "To replace the fluid losses\nTo replace the electrolyte losses, especially potassium.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1201",
    "type": "section",
    "keywords": [
      "replace",
      "losses",
      "especially",
      "potassium",
      "electrolyte",
      "fluid"
    ]
  },
  {
    "id": "d4d32a624605c1e45edabd2e8d8346bd",
    "content": "To replace deficient insulin\nTo seek the underlying cause and treat appropriately.",
    "title": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "section": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "chunk_id": "1202",
    "type": "section",
    "keywords": [
      "replace",
      "insulin",
      "treat",
      "deficient",
      "appropriately",
      "cause",
      "underlying",
      "seek"
    ]
  },
  {
    "id": "0f41acb8eeddb07ff82c524674e727e1",
    "content": "Management of Hyperosmolar Non-Ketotic state (HONK)\n(See ‘Management of DKA’ above).",
    "title": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "section": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "chunk_id": "1203",
    "type": "section",
    "keywords": [
      "hyperosmolar",
      "above",
      "management",
      "state",
      "ketotic",
      "honk"
    ]
  },
  {
    "id": "e436df9f58665a516821c644fadc2bb0",
    "content": "Broad-spectrum\tantibiotics\tfor\tsuspected\tinfections (See appropriate section)\nTreat malaria if suspected or confirmed (See appropriate section)\nReferral Criteria\nIf there are inadequate resources for managing the patient, start 0. 9% Sodium Chloride, IV, and give initial dose of soluble or regular insulin IV or IM after confirming blood glucose and urine ketone levels and refer to a nearby regional or teaching hospital. If the patient remains comatose or fails to pass adequate amounts of urine despite management, refer to a regional or teaching hospital for further care.",
    "title": "Adjunct Treatment for DKA and HONK",
    "section": "Adjunct Treatment for DKA and HONK",
    "chunk_id": "1204",
    "type": "section",
    "keywords": [
      "infections",
      "confirming",
      "initial",
      "amounts",
      "treat",
      "despite",
      "managing",
      "antibiotics",
      "inadequate",
      "give",
      "regular",
      "management",
      "levels",
      "glucose",
      "urine",
      "ketone",
      "teaching",
      "soluble",
      "patient",
      "start"
    ]
  },
  {
    "id": "3a75ef9acee7233ca7d7a76ef83137c3",
    "content": "Hypoglycaemia refers to a blood glucose level below 3. 6 mmol/L. It is more common in elderly diabetics and those with kidney function impairment as well as those on long-acting oral anti-hyperglycaemic medications or insulin.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1205",
    "type": "section",
    "keywords": [
      "elderly",
      "glucose",
      "refers",
      "function",
      "blood",
      "mmol",
      "hyperglycaemic",
      "level",
      "medications",
      "impairment",
      "anti",
      "those",
      "below",
      "insulin",
      "kidney",
      "common",
      "acting",
      "oral",
      "more",
      "diabetics"
    ]
  },
  {
    "id": "5b75e5bf8619301e0ab84961fd2e99c7",
    "content": "Severe hypoglycaemia (blood glucose < 2. 2 mmol/L) may result in alteration of consciousness, fits, self-injury and various degrees of irreversible brain damage. Following successful treatment of hypoglycaemia, its cause must be determined and measures, including patient education and revision of anti-hyperglycaemic drug doses, should be taken to prevent its recurrence.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1206",
    "type": "section",
    "keywords": [
      "irreversible",
      "self",
      "glucose",
      "alteration",
      "revision",
      "patient",
      "measures",
      "fits",
      "following",
      "including",
      "prevent",
      "result",
      "drug",
      "doses",
      "successful",
      "blood",
      "treatment",
      "severe",
      "mmol",
      "recurrence"
    ]
  },
  {
    "id": "a4fe4c376759bdeac91fa5cd9b8eff3a",
    "content": "Causes\nOverdose of any anti-hyperglycaemic medication i. e. insulin or oral agent\nAntihyperglycaemic medication use in renal impairment and the\nelderly\nOmitted or inadequate amount of food\nUnaccustomed physical over-activity\nExcessive alcohol intake\nSymptoms\nDizziness\nBlurred vision\nHeadaches\nPalpitation\nSweating\nShaking of the hands and body\nUnconsciousness\nConvulsions\nIrritability and abnormal behaviour especially in children\nSigns\nSweating\nTremors\nTachycardia and bounding pulse\nConfusion\nUnconsciousness\nConvulsions\ninvestigations\nRandom blood glucose (urgently done using a glucose meter)\nBlood urea and electrolytes\nLiver function tests.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1207",
    "type": "section",
    "keywords": [
      "activity",
      "unconsciousness",
      "inadequate",
      "agent",
      "especially",
      "omitted",
      "elderly",
      "glucose",
      "palpitation",
      "tachycardia",
      "body",
      "shaking",
      "alcohol",
      "function",
      "vision",
      "convulsions",
      "abnormal",
      "signs",
      "behaviour",
      "antihyperglycaemic"
    ]
  },
  {
    "id": "ca8fe89ce3bacb2d9b4954e3cc08e8a4",
    "content": "To maintain the level of blood glucose within the normal range until the patient can begin eating normally\nTo identify and address the cause.",
    "title": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "section": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "chunk_id": "1208",
    "type": "section",
    "keywords": [
      "within",
      "level",
      "begin",
      "maintain",
      "address",
      "range",
      "cause",
      "glucose",
      "normally",
      "normal",
      "identify",
      "eating",
      "patient",
      "blood",
      "until"
    ]
  },
  {
    "id": "26c36ec3f5a9b1dbbfea0581ddaf55fa",
    "content": "Mild hypoglycaemia\n2-3 teaspoons of granulated sugar or 3 cubes of sugar or ½ a bottle of soft drink (sugar-containing, not ‘diet’ drinks) to indi- viduals who are conscious. A glass of milk or fruit drink and a tablespoonful of honey are\nuseful alternatives\nThe above measures should be followed immediately by a meal\nor snack\nModerate hypoglycaemia\nSame as for mild hypoglycaemia, but repeat after 10 minutes. If no improvement is observed, treat as for severe hypoglycaemia.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1209",
    "type": "section",
    "keywords": [
      "diet",
      "conscious",
      "meal",
      "drink",
      "treat",
      "glass",
      "snack",
      "indi",
      "measures",
      "fruit",
      "moderate",
      "drinks",
      "immediately",
      "minutes",
      "repeat",
      "teaspoons",
      "bottle",
      "sugar",
      "granulated",
      "observed"
    ]
  },
  {
    "id": "6b93e5d352781685b1215fd214d984ab",
    "content": "Dextrose, IV,\nAdults\n50% solution\n25-50 ml over 1-3 minutes through a large vein\nThen\n5-10% solution\n500 ml 4 hourly until the patient is able to eat normally\nChildren\n10% solution\n4 ml/kg body weight over 1-3 minutes through a large vein\nThen\n5% solution\nAccording to total daily fluid requirement until blood glucose levels normalise.",
    "title": "A.\tSevere hypoglycaemia 1st Line Treatment Evidence Rating: [A]",
    "section": "A.\tSevere hypoglycaemia 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1210",
    "type": "section",
    "keywords": [
      "weight",
      "according",
      "vein",
      "levels",
      "dextrose",
      "solution",
      "glucose",
      "patient",
      "fluid",
      "hourly",
      "body",
      "requirement",
      "minutes",
      "large",
      "normalise",
      "children",
      "total",
      "blood",
      "adults",
      "normally"
    ]
  },
  {
    "id": "e574c3bbcd4387578ca5b6d3017fe172",
    "content": "Glucagon, IV, IM or subcutaneous,\nAdults\n1 mg stat. Children\n8-18 years (bodyweight > 25 kg); 1 mg stat. 8-18 years (bodyweight < 25 kg); 500 micrograms stat.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "1211",
    "type": "section",
    "keywords": [
      "subcutaneous",
      "years",
      "bodyweight",
      "adults",
      "glucagon",
      "micrograms",
      "children",
      "stat"
    ]
  },
  {
    "id": "d630d6492d14f98721db4fde8eaf93d8",
    "content": "1 month-8 years;\t500 micrograms stat. Neonate;\t20 microgram/kg stat.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "1212",
    "type": "section",
    "keywords": [
      "years",
      "microgram",
      "neonate",
      "micrograms",
      "month",
      "stat"
    ]
  },
  {
    "id": "f0126845ee5326012a6b1e0b3a297e4c",
    "content": "There is ample evidence linking high blood cholesterol levels to Cardiovascular Disease (CVD) events, including myocardial infarction, strokes, and peripheral vascular disease. On the other hand, there is also evidence for significant reduction in morbidity and mortality from CVDs by reducing blood cholesterol levels in those at risk (primary prevention) and those who have suffered a CVD event (secondary prevention). The commonly assessed blood lipid parameters are total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides.",
    "title": "If the patient does not respond to the above treatment recommendations, refer to a specialist.",
    "section": "If the patient does not respond to the above treatment recommendations, refer to a specialist.",
    "chunk_id": "1213",
    "type": "section",
    "keywords": [
      "morbidity",
      "levels",
      "linking",
      "ample",
      "assessed",
      "secondary",
      "evidence",
      "primary",
      "myocardial",
      "including",
      "cvds",
      "triglycerides",
      "cholesterol",
      "total",
      "blood",
      "disease",
      "hand",
      "reduction",
      "reducing",
      "events"
    ]
  },
  {
    "id": "9ecdb1d6f90b10d0d4d2532d8559ece6",
    "content": "However, the primary target for intervention is the LDL-cholesterol level. As treatment may be for long periods or lifelong, periodic monitoring of liver and muscle enzymes (transaminases and creatine kinase) and blood glucose are advisable to forestall medication-related side effects. Causes\nHigh dietary intake of saturated fats (animal fat)\nLack of physical activity\nMetabolic syndrome (a combination of several of the following; obesity, hypertension, type 2 diabetes, dyslipidaemia, gout etc.",
    "title": "If the patient does not respond to the above treatment recommendations, refer to a specialist.",
    "section": "If the patient does not respond to the above treatment recommendations, refer to a specialist.",
    "chunk_id": "1214",
    "type": "section",
    "keywords": [
      "hypertension",
      "monitoring",
      "activity",
      "intervention",
      "glucose",
      "periodic",
      "primary",
      "saturated",
      "type",
      "lifelong",
      "forestall",
      "lack",
      "following",
      "dyslipidaemia",
      "muscle",
      "dietary",
      "combination",
      "cholesterol",
      "intake",
      "gout"
    ]
  },
  {
    "id": "eddd58e3c619736b7d46cd11c0643393",
    "content": ")\nHereditary factors\nExcessive alcohol intake\nHypothyroidism\nNephrotic syndrome\nSymptoms\nUsually none\nAbdominal pain from pancreatitis related to hypertriglyceridaemia\nSigns\nUsually none\nOccasionally\nWhitish ring around the cornea (corneal arcus)\nYellowish skin eruptions around the eyes (xanthelasmata)\nWhitish blood sample (lipaemic blood)\ninvestigations\nFasting blood lipid profile\nThyroid function test (if lipid levels very high)\nPlasma protein (if lipid levels very high, to exclude nephrotic syndrome)\nUrine protein (if lipid levels very high, to exclude nephrotic syndrome).",
    "title": "If the patient does not respond to the above treatment recommendations, refer to a specialist.",
    "section": "If the patient does not respond to the above treatment recommendations, refer to a specialist.",
    "chunk_id": "1215",
    "type": "section",
    "keywords": [
      "usually",
      "test",
      "hereditary",
      "plasma",
      "profile",
      "levels",
      "factors",
      "urine",
      "lipaemic",
      "arcus",
      "abdominal",
      "pancreatitis",
      "alcohol",
      "function",
      "cornea",
      "hypothyroidism",
      "sample",
      "protein",
      "nephrotic",
      "signs"
    ]
  },
  {
    "id": "00fb97f395713ade3dae078c9503a389",
    "content": "To reduce the risk of clinical atherosclerotic cardiovascular events\nand related deaths in:\nHealthy individuals at risk (primary prevention)\nIndividuals who have suffered a CVD event (secondary preven- tion)\nTo reduce the LDL-C level to the following targets:\nAt least a 50 % LDL-C reduction for primary prevention (in the general population i. e. individuals ≥ 21 years of age with an un- treated LDL-C ≥ 4.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1216",
    "type": "section",
    "keywords": [
      "atherosclerotic",
      "years",
      "tion",
      "secondary",
      "primary",
      "targets",
      "following",
      "treated",
      "population",
      "preven",
      "event",
      "healthy",
      "events",
      "reduction",
      "prevention",
      "level",
      "related",
      "deaths",
      "cardiovascular",
      "general"
    ]
  },
  {
    "id": "4aa8c817cb27170675db093d5cc5ce4f",
    "content": "9 mmol/L)\n30-49 % LDL-C reduction for primary prevention (in individuals\n40 to 75 years of age with diabetes with an untreated LDL-C 1. 8-4. 9 mmol/L)\nLDL-C < 1.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1217",
    "type": "section",
    "keywords": [
      "primary",
      "mmol",
      "reduction",
      "years",
      "prevention",
      "diabetes",
      "individuals",
      "untreated"
    ]
  },
  {
    "id": "b422520a279286bfdca7cc55b552493a",
    "content": "Dietary measures - a low calorie, low saturated fat (animal fat), high polyunsaturated fat (plant fat) diet is recommended under the supervision of a dietician\nWeight reduction in patients who are overweight or obese\nReduction in alcohol consumption, where this is excessive\nRegular physical activity or exercise tailored to the individual patient.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1218",
    "type": "section",
    "keywords": [
      "diet",
      "obese",
      "activity",
      "overweight",
      "weight",
      "regular",
      "exercise",
      "supervision",
      "plant",
      "patient",
      "measures",
      "under",
      "saturated",
      "individual",
      "calorie",
      "alcohol",
      "dietary",
      "where",
      "patients",
      "tailored"
    ]
  },
  {
    "id": "4f48f006744eb0ff9f2f142cd20ee079",
    "content": "Simvastatin, oral,\nAdults\n10-20 mg at night\nModerate CVD risk - Diabetes and CVD risk equivalents\nEvidence Rating: [A]\nAtorvastatin, oral,\nAdults\n10-20 mg daily\nOr\nRosuvastatin, oral,\nAdults\n5-10 mg daily\nOr\nSimvastatin, oral,\nAdults\n20-40 mg at night.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1219",
    "type": "section",
    "keywords": [
      "evidence",
      "moderate",
      "rating",
      "atorvastatin",
      "diabetes",
      "adults",
      "oral",
      "rosuvastatin",
      "risk",
      "equivalents",
      "simvastatin",
      "night",
      "daily"
    ]
  },
  {
    "id": "f54f428744345fd5d586a9ce277fa376",
    "content": "High CVD risk – Secondary prevention\nAtorvastatin, oral,\nAdults\n40-80 mg daily\nOr\nRosuvastatin, oral,\nAdults\n20-40 mg daily\nReferral Criteria\nRefer all patients who remain outside the target values despite adequate dietary, exercise and medication therapy to a specialist. A goitre is a swelling of the front of the neck due to enlargement of the thyroid gland. It may affect persons of any age.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1220",
    "type": "section",
    "keywords": [
      "outside",
      "exercise",
      "swelling",
      "gland",
      "secondary",
      "therapy",
      "neck",
      "front",
      "specialist",
      "dietary",
      "patients",
      "criteria",
      "affect",
      "referral",
      "values",
      "atorvastatin",
      "target",
      "prevention",
      "persons",
      "adults"
    ]
  },
  {
    "id": "5a4e0a10abfe1540760e24c4c14974cc",
    "content": "Not all neck swellings are goitres. Goitres are usually benign but may occasionally be malignant. They could be associated with normal, reduced or excessive function of the thyroid gland.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1221",
    "type": "section",
    "keywords": [
      "usually",
      "occasionally",
      "malignant",
      "function",
      "reduced",
      "goitres",
      "associated",
      "swellings",
      "thyroid",
      "normal",
      "gland",
      "could",
      "benign",
      "neck",
      "excessive"
    ]
  },
  {
    "id": "2a1e448a4064b65c599e833df98b7e52",
    "content": "A reduction in production of thyroid hormones results in hypothyroidism while an excess results in hyperthyroidism or thyrotoxicosis. Abnormalities of thyroid hormone production may also occur in the absence of goitre. Proper diagnosis and selection of appropriate surgical or non-surgical treatment of benign and malignant goitres is by full clinical assessment and investigations.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1222",
    "type": "section",
    "keywords": [
      "occur",
      "abnormalities",
      "goitres",
      "assessment",
      "results",
      "full",
      "while",
      "hyperthyroidism",
      "malignant",
      "hypothyroidism",
      "production",
      "treatment",
      "reduction",
      "diagnosis",
      "surgical",
      "also",
      "excess",
      "goitre",
      "investigations",
      "thyrotoxicosis"
    ]
  },
  {
    "id": "a544159fea29ffd05850384e1b50fe0f",
    "content": "Treatment is not necessarily by increasing iodine intake e. g. in iodated salt.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1223",
    "type": "section",
    "keywords": [
      "necessarily",
      "salt",
      "iodated",
      "iodine",
      "intake",
      "increasing",
      "treatment"
    ]
  },
  {
    "id": "fbb9eb54c8cde1d6c9402444813f09c5",
    "content": "Excess iodine intake may actually be harmful in some cases. Causes\nSimple non-toxic goitre or endemic goitre\nHypothyroidism (See section on ‘Hypothyroidism’)\nHyperthyroidism or Thyrotoxicosis (See section on ‘Hyperthyroidism’)\nThyroid neoplasm - benign or malignant\nSymptoms\nSwelling in the neck\nBreathing and swallowing difficulty, if large\nSymptoms of hypothyroidism (See section on ‘Hypothyroidism’)\nSymptoms of hyperthyroidism (See section on ‘Hyperthyroidism’)\nSigns\nDiffuse (smooth) or nodular (irregular) thyroid swelling\nSigns of hypothyroidism (See section on ‘Hypothyroidism’)\nSigns of hyperthyroidism (See section on ‘Hyperthyroidism’)\ninvestigations\nThyroid function tests – free T3, free T4, TSH.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1224",
    "type": "section",
    "keywords": [
      "swelling",
      "breathing",
      "swallowing",
      "hyperthyroidism",
      "neck",
      "simple",
      "malignant",
      "function",
      "large",
      "section",
      "hypothyroidism",
      "toxic",
      "signs",
      "intake",
      "smooth",
      "nodular",
      "causes",
      "neoplasm",
      "iodine",
      "excess"
    ]
  },
  {
    "id": "b28c5ddb4381abd7767aa6fb9de62def",
    "content": "Thyroid ultrasound scan\nThyroid autoantibodies (if necessary)\nRadioisotope scan of thyroid (if necessary)\nFine needle aspiration cytology (if necessary)\nX-ray of the neck including thoracic inlet view for large goitres.",
    "title": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "section": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "chunk_id": "1225",
    "type": "section",
    "keywords": [
      "aspiration",
      "ultrasound",
      "radioisotope",
      "needle",
      "including",
      "autoantibodies",
      "scan",
      "large",
      "goitres",
      "necessary",
      "fine",
      "inlet",
      "thyroid",
      "view",
      "thoracic",
      "cytology",
      "neck"
    ]
  },
  {
    "id": "fbaa35bfabbd1273207b26e886f71cd0",
    "content": "To assess and correct level of thyroid hormone production\nTo reduce symptoms associated with thyrotoxicosis\nTo reduce or prevent obstructive symptoms\nTo identify thyroid neoplasms and manage appropriately.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1226",
    "type": "section",
    "keywords": [
      "thyrotoxicosis",
      "correct",
      "prevent",
      "level",
      "obstructive",
      "reduce",
      "manage",
      "neoplasms",
      "appropriately",
      "hormone",
      "production",
      "assess",
      "associated",
      "thyroid",
      "identify",
      "symptoms"
    ]
  },
  {
    "id": "77e654f318b16677c3e86c475fc074e6",
    "content": "sections on ‘Hypothyroidism’ and ‘Hyperthyroidism’)\nReferral Criteria\nRefer patients to a physician or surgical specialist where complications (e. g. hypothyroidism, hyperthyroidism, breathing difficulty etc.",
    "title": "Appropriate treatment of hypothyroidism or hyperthyroidism (See",
    "section": "Appropriate treatment of hypothyroidism or hyperthyroidism (See",
    "chunk_id": "1227",
    "type": "section",
    "keywords": [
      "referral",
      "specialist",
      "complications",
      "surgical",
      "hypothyroidism",
      "refer",
      "difficulty",
      "where",
      "breathing",
      "patients",
      "criteria",
      "sections",
      "hyperthyroidism",
      "physician"
    ]
  },
  {
    "id": "e0037bc6396829dc6e9c87d304b67870",
    "content": ") or malignancy are suspected or if full clinical assessment and investigations are not possible. Hypothyroidism is a condition associated with reduction in thyroid hormone production. Thyroid hormone is required for normal metabolism and growth.",
    "title": "Appropriate treatment of hypothyroidism or hyperthyroidism (See",
    "section": "Appropriate treatment of hypothyroidism or hyperthyroidism (See",
    "chunk_id": "1228",
    "type": "section",
    "keywords": [
      "malignancy",
      "reduction",
      "normal",
      "suspected",
      "investigations",
      "growth",
      "hypothyroidism",
      "condition",
      "hormone",
      "production",
      "possible",
      "associated",
      "thyroid",
      "full",
      "assessment",
      "required",
      "metabolism",
      "clinical"
    ]
  },
  {
    "id": "71b10dc6145d3816afe10fa6a75bfd83",
    "content": "Its deficiency has major consequences on foetal development as well as intellectual and physical development in infants and children (cause of cretinism). In adults, it may be the cause of several problems including heart disease, menstrual irregularity and infertility, mental health conditions and dementia. Iodine replacement is not the treatment for hypothyroidism.",
    "title": "Appropriate treatment of hypothyroidism or hyperthyroidism (See",
    "section": "Appropriate treatment of hypothyroidism or hyperthyroidism (See",
    "chunk_id": "1229",
    "type": "section",
    "keywords": [
      "mental",
      "irregularity",
      "development",
      "menstrual",
      "replacement",
      "health",
      "cretinism",
      "including",
      "hypothyroidism",
      "heart",
      "foetal",
      "children",
      "dementia",
      "treatment",
      "deficiency",
      "disease",
      "infertility",
      "iodine",
      "infants",
      "adults"
    ]
  },
  {
    "id": "e78420fd2b227b0d65de9b8090fef595",
    "content": "Screening for hypothyroidism in all new borns, and every 5 years in adults after age 35 years, especially females, by measuring TSH (thyroid stimulating hormone) levels in blood where this is possible, should be encouraged. Causes\nAntibody-related thyroid gland destruction\nSubtotal thyroidectomy\nPituitary surgery or lesions\nCongenital\nSevere iodine deficiency\nDrug induced (e. g.",
    "title": "Appropriate treatment of hypothyroidism or hyperthyroidism (See",
    "section": "Appropriate treatment of hypothyroidism or hyperthyroidism (See",
    "chunk_id": "1230",
    "type": "section",
    "keywords": [
      "years",
      "thyroidectomy",
      "pituitary",
      "lesions",
      "especially",
      "levels",
      "gland",
      "induced",
      "females",
      "stimulating",
      "hypothyroidism",
      "drug",
      "screening",
      "where",
      "borns",
      "blood",
      "causes",
      "destruction",
      "subtotal",
      "congenital"
    ]
  },
  {
    "id": "88e8d2af7907c7042a0b3733e964dd4b",
    "content": "Symptoms\nGeneral weakness and tiredness\nIntolerance to cold environments\nConstipation\nWeight gain\nHair loss\nDry skin\nHoarse voice\nMemory loss\nGoitre may be present\nAbnormal menstrual periods and sub-fertility (in adult females)\nPoor growth, development and poor school performance in children\nSigns\nNeonate\nProlonged neonatal jaundice\nExcessive sleep\nFeeding problems\nChildren\nCretinism (mental subnormality, short stature, large tongue, dry skin, sparse hair, protuberant abdomen, umbilical hernia, abnormal facies)\nAdults\nSlow pulse (usually <60 per minute)\nDry coarse skin\nPuffy face\nPallor\nHoarse voice\nSlow reflexes\nDementia\nGoitre may be present\ninvestigations\nThyroid function tests - free T3, free T4, TSH\nFasting blood lipids (for elevated cholesterol level).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1231",
    "type": "section",
    "keywords": [
      "usually",
      "prolonged",
      "mental",
      "weight",
      "development",
      "menstrual",
      "neonate",
      "face",
      "feeding",
      "coarse",
      "poor",
      "stature",
      "weakness",
      "voice",
      "memory",
      "females",
      "cretinism",
      "lipids",
      "tiredness",
      "short"
    ]
  },
  {
    "id": "da50140ef68ea293032ea0fc45b72bc3",
    "content": "To correct blood level of thyroid hormones\nTo maintain lifelong normal levels of thyroid hormones.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1232",
    "type": "section",
    "keywords": [
      "lifelong",
      "correct",
      "level",
      "maintain",
      "hormones",
      "levels",
      "thyroid",
      "normal",
      "blood"
    ]
  },
  {
    "id": "6f3930f22079664aaa23fcf41e7d4e2d",
    "content": "Surgical intervention for pituitary lesions where necessary.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1233",
    "type": "section",
    "keywords": [
      "intervention",
      "surgical",
      "pituitary",
      "lesions",
      "necessary",
      "where"
    ]
  },
  {
    "id": "d312e91864d7829c06f758e2d8d44a6b",
    "content": "Evidence Rating: [A]\nLevothyroxine, oral,\nAdults\n25-200 microgram daily\nChildren\n12 years;\t25 microgram daily (max. 200 micrograms)\n2-12 years;\t25 microgram daily (max. 100 micrograms)\n< 2 years;\t25-75 micrograms daily\nReferral Criteria\nRefer diagnosed or suspected cases of all ages, especially children with intellectual impairment, and individuals with pituitary disease to a specialist.",
    "title": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "section": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "chunk_id": "1234",
    "type": "section",
    "keywords": [
      "ages",
      "years",
      "pituitary",
      "especially",
      "evidence",
      "rating",
      "specialist",
      "levothyroxine",
      "children",
      "criteria",
      "disease",
      "referral",
      "suspected",
      "impairment",
      "adults",
      "microgram",
      "refer",
      "oral",
      "cases",
      "micrograms"
    ]
  },
  {
    "id": "f7a0c96ae99355e678b3fdfff72aa47e",
    "content": "Excess thyroid hormone in the blood results in hyperthyroidism (thyrotoxicosis). If left untreated, significant weight loss, eye and cardiac complications, may occur. Addition of extra iodine to the diet (e.",
    "title": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "section": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "chunk_id": "1235",
    "type": "section",
    "keywords": [
      "diet",
      "extra",
      "weight",
      "occur",
      "results",
      "addition",
      "hyperthyroidism",
      "untreated",
      "blood",
      "iodine",
      "excess",
      "cardiac",
      "thyrotoxicosis",
      "complications",
      "significant",
      "hormone",
      "left",
      "loss",
      "thyroid"
    ]
  },
  {
    "id": "82d4d2784ff472cf34ac09fc9216bccc",
    "content": "g. as in iodated salt) is not the recommended treatment and may, in fact, worsen the condition. Causes.",
    "title": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "section": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "chunk_id": "1236",
    "type": "section",
    "keywords": [
      "salt",
      "recommended",
      "iodated",
      "worsen",
      "condition",
      "fact",
      "causes",
      "treatment"
    ]
  },
  {
    "id": "46afbe08054ad38e2863ec192b04ed38",
    "content": "Toxic multi-nodular goitre\nSymptoms\nWeight loss despite increased appetite\nExcessive sweating\nHeat intolerance\nTremors of the hands\nNervousness and irritability\nMenstrual irregularity and sub-fertility\nSigns\nStaring gaze or protruding eyes\nTremors of the hands\nMoist palms\nRapid pulse rate (which may be irregular)\nWide pulse pressure (High systolic BP with low diastolic BP e. g. 170/50 mmHg)\nHeart failure\nGoitre (often present but not always).",
    "title": "Grave’s disease",
    "section": "Grave’s disease",
    "chunk_id": "1237",
    "type": "section",
    "keywords": [
      "irregularity",
      "despite",
      "staring",
      "weight",
      "often",
      "nervousness",
      "menstrual",
      "which",
      "gaze",
      "wide",
      "always",
      "rate",
      "pressure",
      "diastolic",
      "systolic",
      "heat",
      "multi",
      "toxic",
      "signs",
      "heart"
    ]
  },
  {
    "id": "cf8f78a2f25ae539cd314d753ec260d4",
    "content": "Irregular in toxic multi-nodular goitre\ninvestigations\nThyroid function tests - free T3, free T4, TSH\nThyroid ultrasound scan.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1238",
    "type": "section",
    "keywords": [
      "ultrasound",
      "irregular",
      "investigations",
      "function",
      "scan",
      "goitre",
      "tests",
      "multi",
      "toxic",
      "free",
      "thyroid",
      "nodular"
    ]
  },
  {
    "id": "e9d7001b21a91187ac9207f38e6ae389",
    "content": "To reduce thyroid hormone levels in the blood to normal\nTo reduce symptoms associated with thyrotoxicosis\nTo prevent or treat complications e. g. heart failure, ophthalmopathy.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1239",
    "type": "section",
    "keywords": [
      "thyrotoxicosis",
      "complications",
      "treat",
      "prevent",
      "symptoms",
      "reduce",
      "levels",
      "hormone",
      "associated",
      "heart",
      "thyroid",
      "normal",
      "failure",
      "ophthalmopathy",
      "blood"
    ]
  },
  {
    "id": "11b92195b1a3e55fe0a0e9dde8184dbd",
    "content": "Carbimazole, oral,\nAdults\n20-40 mg daily\nChildren\n3-18 years; Initial dose 15 mg daily (adjusted according to thyroid hormone level)\n< 2 years;\tnot recommended.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1240",
    "type": "section",
    "keywords": [
      "initial",
      "recommended",
      "years",
      "adjusted",
      "according",
      "level",
      "adults",
      "oral",
      "hormone",
      "dose",
      "thyroid",
      "children",
      "daily",
      "carbimazole"
    ]
  },
  {
    "id": "fbf20597d59227207fc853d88cfd14fa",
    "content": "Propylthiouracil, oral,\nAdults\n100 mg 8 hourly\nChildren\n12-18 years;\t50-100 mg 8 hourly\n5-12 years;\t50 mg 8 hourly\nyears;\t25 mg 8 hourly\n1 month-1 year;\tinitially 5-10mg/kg 8 hourly,\nThen\n2. 5-5 mg/kg 8 hourly based on thyroid hormone levels\n< 1 month;\t2. 5-5 mg/kg 12 hourly\nPropylthiouracil is preferred in pregnancy and in those who do not tolerate\nCarbimazole.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "1241",
    "type": "section",
    "keywords": [
      "years",
      "based",
      "levels",
      "carbimazole",
      "hourly",
      "initially",
      "tolerate",
      "children",
      "pregnancy",
      "adults",
      "those",
      "month",
      "then",
      "year",
      "propylthiouracil",
      "preferred",
      "oral",
      "hormone",
      "thyroid"
    ]
  },
  {
    "id": "8058374cf1ae3eb9d00012b398284a5a",
    "content": "Decrease the dose when thyroid hormone levels are within the.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "1242",
    "type": "section",
    "keywords": [
      "within",
      "decrease",
      "levels",
      "hormone",
      "dose",
      "thyroid"
    ]
  },
  {
    "id": "fba83b039514199d84bd5942ea191d28",
    "content": "Propranolol, oral,\nAdults\n10-40 mg 8 hourly (adjust dose till thyroid function normalises - avoid in asthmatics)\nChildren\n1 year;\t1 mg/kg (max. 40 mg) 8 hourly\nNeonates;\t1 mg/kg 12 hourly\nReferral Criteria\nRefer all cases not responding to conventional treatment to specialists in a secondary or tertiary hospital for further investigations and management. Adrenal insufficiency arises when the adrenal gland is destroyed by disease, or atrophies following pituitary failure or chronic corticosteroid use or abuse.",
    "title": "Adjunct treatment (to reduce symptoms of thyrotoxicosis)",
    "section": "Adjunct treatment (to reduce symptoms of thyrotoxicosis)",
    "chunk_id": "1243",
    "type": "section",
    "keywords": [
      "avoid",
      "neonates",
      "pituitary",
      "management",
      "conventional",
      "asthmatics",
      "gland",
      "secondary",
      "insufficiency",
      "hourly",
      "following",
      "function",
      "children",
      "normalises",
      "criteria",
      "tertiary",
      "treatment",
      "disease",
      "referral",
      "chronic"
    ]
  },
  {
    "id": "cdedf50676e97ad262dcae10a752261b",
    "content": "In these situations, the amount of cortisol produced from the adrenal gland is insufficient to meet the body’s needs during periods of physical and psychological stress or severe illness. The condition is associated with severe fluid and electrolyte imbalance and results in acute circulatory collapse. Causes\nSudden cessation of prolonged corticosteroid use or abuse.",
    "title": "Adjunct treatment (to reduce symptoms of thyrotoxicosis)",
    "section": "Adjunct treatment (to reduce symptoms of thyrotoxicosis)",
    "chunk_id": "1244",
    "type": "section",
    "keywords": [
      "collapse",
      "prolonged",
      "insufficient",
      "sudden",
      "situations",
      "psychological",
      "during",
      "associated",
      "gland",
      "results",
      "circulatory",
      "acute",
      "fluid",
      "body",
      "imbalance",
      "stress",
      "condition",
      "cortisol",
      "electrolyte",
      "causes"
    ]
  },
  {
    "id": "b0f1e2eee7206950e56781303efa58f7",
    "content": "Stress (e. g. infection, severe trauma, surgery, and dental procedures) in a patient with undiagnosed adrenal insufficiency or patients on prolonged corticosteroid treatment.",
    "title": "Adjunct treatment (to reduce symptoms of thyrotoxicosis)",
    "section": "Adjunct treatment (to reduce symptoms of thyrotoxicosis)",
    "chunk_id": "1245",
    "type": "section",
    "keywords": [
      "severe",
      "procedures",
      "undiagnosed",
      "prolonged",
      "treatment",
      "dental",
      "stress",
      "infection",
      "corticosteroid",
      "adrenal",
      "patients",
      "insufficiency",
      "patient",
      "surgery",
      "trauma"
    ]
  },
  {
    "id": "8680ee2c94c6f67032f09cf80d1cb9f0",
    "content": "Severe infections affecting the adrenal gland (e. g. meningococcus, tuberculosis, HIV)\nCongenital adrenal hyperplasia in children\nSymptoms\nNausea\nVomiting\nWeakness\nCollapse\nAbdominal pain\nDiarrhoea\nSigns\nDehydration\nLow or unrecordable blood pressure.",
    "title": "Auto-immune disease of the adrenal gland (Addison’s disease)",
    "section": "Auto-immune disease of the adrenal gland (Addison’s disease)",
    "chunk_id": "1246",
    "type": "section",
    "keywords": [
      "infections",
      "collapse",
      "nausea",
      "gland",
      "weakness",
      "diarrhoea",
      "abdominal",
      "pressure",
      "signs",
      "children",
      "blood",
      "congenital",
      "severe",
      "dehydration",
      "meningococcus",
      "adrenal",
      "tuberculosis",
      "hyperplasia",
      "unrecordable",
      "symptoms"
    ]
  },
  {
    "id": "2543d92a2b3265a6768e4ee042936f6c",
    "content": "Darkening of oral mucosa, gums, skin, palms and soles in some\nindividuals\nEvidence of corticosteroid abuse e. g. skin bleaching, Cushingoid\nappearance\nAmbiguous genitalia, short stature and failure to thrive in children\nVariable states of consciousness\ninvestigations\nFBC (may show anaemia and eosinophilia)\nBlood urea and electrolytes (may show high potassium)\nBlood glucose (may be low)\nPlasma cortisol (low)\nBlood film for malaria parasites, if indicated\nUrine and blood cultures, if indicated.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1247",
    "type": "section",
    "keywords": [
      "soles",
      "appearance",
      "anaemia",
      "plasma",
      "glucose",
      "urine",
      "potassium",
      "stature",
      "ambiguous",
      "thrive",
      "evidence",
      "eosinophilia",
      "short",
      "film",
      "cortisol",
      "children",
      "malaria",
      "blood",
      "palms",
      "cultures"
    ]
  },
  {
    "id": "7a1853b5a74e4cf50dd3c7182ae4927e",
    "content": "To correct the fluid and electrolyte imbalance\nTo correct hypoglycaemia\nTo replace corticosteroids\nTo identify cause and treat any precipitating factor.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1248",
    "type": "section",
    "keywords": [
      "replace",
      "imbalance",
      "precipitating",
      "treat",
      "correct",
      "factor",
      "cause",
      "identify",
      "electrolyte",
      "hypoglycaemia",
      "corticosteroids",
      "fluid"
    ]
  },
  {
    "id": "3ef88993e59bd9ab4b2ccb93df5c77c2",
    "content": "Intravenous fluid replacement\nAdults\n0. 9% Sodium Chloride in 5% Glucose (Dextrose Saline), IV, 1 litre 4-6 hourly, until condition is stable\nChildren\n0. 45% Sodium Chloride in 5% Glucose, IV, according to total fluid re- quirement\nAnd\nHydrocortisone, IV,\nAdults\n200 mg stat.",
    "title": "Acute treatment 1st Line Treatment Evidence Rating: [B]",
    "section": "Acute treatment 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "1249",
    "type": "section",
    "keywords": [
      "intravenous",
      "according",
      "replacement",
      "dextrose",
      "glucose",
      "fluid",
      "stable",
      "hourly",
      "quirement",
      "litre",
      "sodium",
      "saline",
      "condition",
      "children",
      "total",
      "stat",
      "adults",
      "chloride",
      "hydrocortisone",
      "until"
    ]
  },
  {
    "id": "279046fe205621f665042b048c9c2533",
    "content": "followed by 100 mg 6 hourly until condition is stable\nChildren\n6-12 years;\t100 mg 6 hourly\nyears;\t50 mg 6 hourly\n< 1 year;\t25 mg 6 hourly.",
    "title": "Acute treatment 1st Line Treatment Evidence Rating: [B]",
    "section": "Acute treatment 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "1250",
    "type": "section",
    "keywords": [
      "followed",
      "hourly",
      "stable",
      "years",
      "condition",
      "children",
      "until",
      "year"
    ]
  },
  {
    "id": "5f5db04165be7536b6cb7f61fc5e61ee",
    "content": "normal BP, cessation of vomiting etc. ) go on to maintenance therapy.",
    "title": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "section": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "chunk_id": "1251",
    "type": "section",
    "keywords": [
      "cessation",
      "vomiting",
      "normal",
      "maintenance",
      "therapy"
    ]
  },
  {
    "id": "8ce50a2f68385f8d50f463ee80a03890",
    "content": "Treat infection (e. g. malaria, pneumonia, UTI) or stress-inducing condition, if present or suspected, with appropriate medication.",
    "title": "Adjunct treatment in acute cases",
    "section": "Adjunct treatment in acute cases",
    "chunk_id": "1252",
    "type": "section",
    "keywords": [
      "treat",
      "present",
      "suspected",
      "stress",
      "appropriate",
      "pneumonia",
      "infection",
      "medication",
      "inducing",
      "condition",
      "malaria"
    ]
  },
  {
    "id": "879ce1ef93bd1c04892f9b7a32b77f4c",
    "content": "Maintenance - for patients not previously on corticosteriods.",
    "title": "Adjunct treatment in acute cases",
    "section": "Adjunct treatment in acute cases",
    "chunk_id": "1253",
    "type": "section",
    "keywords": [
      "corticosteriods",
      "previously",
      "patients",
      "maintenance"
    ]
  },
  {
    "id": "353b92392d8b272db9c1c647874cf49b",
    "content": "Prednisolone, oral, life-long\nAdults\n5 mg morning and 2. 5 mg evening each day\nChildren\n70 micrograms/kg 12 hourly.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1254",
    "type": "section",
    "keywords": [
      "hourly",
      "evening",
      "prednisolone",
      "morning",
      "each",
      "adults",
      "life",
      "oral",
      "micrograms",
      "children"
    ]
  },
  {
    "id": "b5ef681a8b9cd7968cc7b9cba99f1176",
    "content": "Hydrocortisone, oral, life-long\nAdults\n10-20 mg morning and 5-10 mg evening each day\nChildren\n280 micrograms/kg 12 hourly\nMaintenance - For patients on long term corticosteroid therapy who go into adrenocortical crisis (e. g. asthma, nephrotic syndrome)\nAdults and Children\nRestart the previous doses of oral corticosteroids given for the con- dition.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "1255",
    "type": "section",
    "keywords": [
      "dition",
      "morning",
      "given",
      "maintenance",
      "therapy",
      "corticosteroids",
      "into",
      "hourly",
      "adrenocortical",
      "doses",
      "asthma",
      "nephrotic",
      "patients",
      "children",
      "crisis",
      "previous",
      "evening",
      "each",
      "adults",
      "corticosteroid"
    ]
  },
  {
    "id": "2f3cdd94ae2bafa72e2ee2b05a44e904",
    "content": "Maintenance - For patients who abuse corticosteroids\nAdults\nRestart oral corticosteroids, or replace topical corticosteroids with oral corticosteroids\nPrednisolone, oral, 20-40 mg daily\nGradually taper off the dose over several months (e. g. reducing by 2.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "1256",
    "type": "section",
    "keywords": [
      "replace",
      "topical",
      "taper",
      "reducing",
      "prednisolone",
      "restart",
      "several",
      "adults",
      "oral",
      "dose",
      "patients",
      "maintenance",
      "months",
      "abuse",
      "corticosteroids",
      "daily",
      "gradually"
    ]
  },
  {
    "id": "e5a7725dc7f303245d908275bb6910cb",
    "content": "Referral Criteria\nAll patients suspected to have adrenal insufficiency should be referred, after resuscitation, to a regional or teaching hospital for assessment and long-term management. This condition results from high levels of cortisol in the blood and is associated with various changes in the body including the development of obesity, hypertension, diabetes and osteoporosis. The prolonged use or abuse (especially by women for cosmetic reasons) of oral or topical corticosteroids such as prednisolone, dexamethasone, hydrocortisone or cortisone, or preparations containing any of these drugs, is also a cause.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1257",
    "type": "section",
    "keywords": [
      "hypertension",
      "prolonged",
      "management",
      "development",
      "especially",
      "levels",
      "associated",
      "results",
      "teaching",
      "corticosteroids",
      "insufficiency",
      "body",
      "including",
      "preparations",
      "patients",
      "condition",
      "cortisol",
      "dexamethasone",
      "regional",
      "criteria"
    ]
  },
  {
    "id": "79cbf6cf0c9ab36f0a227be9784ad2f7",
    "content": "Causes\nPituitary tumour\nAdrenal tumour\nProlonged and excessive intake (for asthma, nephrotic syndrome etc. ) or abuse of corticosteroids\nSymptoms\nWeight gain\nExcess body hair and acne (pimples)\nEasy bruising of skin\nStretch marks (reddish or purplish)\nMenstrual irregularity and sub-fertility\nWeakness of the thigh muscles\nLightening of the skin\nSigns\nRounded or ‘moon’ face\nProminent supraclavicular fat pads\nTruncal obesity\nExcess facial and body hair\nAcne\nStriae (reddish or purplish stretch marks)\nThin skin\nEasy bruising and bleeding into the skin after venepuncture\nHypertension\nInability to rise from the squatting position\ninvestigations\nPlasma cortisol (commonly elevated in pituitary and adrenal tumours, but low in corticosteroid use or abuse).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1258",
    "type": "section",
    "keywords": [
      "pads",
      "hypertension",
      "prolonged",
      "stretch",
      "irregularity",
      "pituitary",
      "weight",
      "plasma",
      "tumours",
      "menstrual",
      "rounded",
      "muscles",
      "face",
      "pimples",
      "purplish",
      "venepuncture",
      "position",
      "weakness",
      "corticosteroids",
      "into"
    ]
  },
  {
    "id": "af4af54fa1aeab46c8cee5ad847b73fd",
    "content": "Blood electrolytes (may show low potassium)\nBlood glucose (commonly elevated)\nAbdominal ultrasound scan (may show an adrenal tumour)\nCT scan (may show evidence of a pituitary or adrenal tumour).",
    "title": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "section": "Chapter 12: Endocrıne and Metabolıc Dısorders",
    "chunk_id": "1259",
    "type": "section",
    "keywords": [
      "ultrasound",
      "abdominal",
      "evidence",
      "show",
      "electrolytes",
      "pituitary",
      "scan",
      "elevated",
      "glucose",
      "adrenal",
      "potassium",
      "tumour",
      "blood",
      "commonly"
    ]
  },
  {
    "id": "8c3e663655ed463008912aee4d63322f",
    "content": "To normalise plasma level of cortisol\nTo correct electrolyte imbalance\nTo correct plasma glucose\nTo correct blood pressure\nTo prevent complications of excess plasma cortisol.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1260",
    "type": "section",
    "keywords": [
      "complications",
      "imbalance",
      "pressure",
      "correct",
      "plasma",
      "level",
      "prevent",
      "normalise",
      "excess",
      "glucose",
      "cortisol",
      "electrolyte",
      "blood"
    ]
  },
  {
    "id": "3e767bc4a9443ff3f6fafa3e3ea138af",
    "content": "Pituitary or adrenal surgery where tumours in the respective glands have been diagnosed.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1261",
    "type": "section",
    "keywords": [
      "pituitary",
      "tumours",
      "respective",
      "where",
      "adrenal",
      "have",
      "surgery",
      "glands",
      "diagnosed"
    ]
  },
  {
    "id": "544c58df8f3f9fcf0c6049dcac308340",
    "content": "Treatment is dependent on the cause and requires specialized investigations. Manage hypertension and diabetes along standard lines (See appropriate sections) and refer patient for definitive treatment. Referral Criteria\nRefer all suspected cases to an endocrinologist or specialist physician in a regional or teaching hospital for the appropriate investigations and management.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1262",
    "type": "section",
    "keywords": [
      "hypertension",
      "endocrinologist",
      "management",
      "definitive",
      "teaching",
      "patient",
      "specialist",
      "regional",
      "criteria",
      "sections",
      "treatment",
      "physician",
      "referral",
      "dependent",
      "suspected",
      "standard",
      "manage",
      "cause",
      "investigations",
      "specialized"
    ]
  },
  {
    "id": "313b2241c40b90e8e0c2a1c86421c6fe",
    "content": "Overweight and obesity are associated with conditions that cause premature ill-health and death, such as type 2 diabetes, high blood pressure (hypertension), heart disease and stroke. Other conditions such as gout, obstructive sleep apnoea, gallstones, heartburn, arthritis, skin infections as well as various cancers have been linked to excess body weight. They also increase the risk of developing deep vein thrombosis and pulmonary embolism as well as elevated blood cholesterol, which increases the risk for heart attacks and strokes.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1263",
    "type": "section",
    "keywords": [
      "hypertension",
      "infections",
      "overweight",
      "weight",
      "vein",
      "increases",
      "cancers",
      "which",
      "associated",
      "health",
      "arthritis",
      "death",
      "increase",
      "body",
      "type",
      "pressure",
      "heartburn",
      "developing",
      "attacks",
      "obstructive"
    ]
  },
  {
    "id": "34cffd3b3330cb560ebe256ec2de7b6d",
    "content": "Weight reduction often corrects, or helps to control, these associated conditions. Occasionally rapid weight gain may be associated with an underlying endocrine condition such as hypothyroidism and Cushing’s syndrome.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1264",
    "type": "section",
    "keywords": [
      "reduction",
      "helps",
      "rapid",
      "cushing",
      "weight",
      "often",
      "corrects",
      "conditions",
      "gain",
      "hypothyroidism",
      "underlying",
      "associated",
      "syndrome",
      "condition",
      "control",
      "these",
      "occasionally",
      "endocrine"
    ]
  },
  {
    "id": "348ee6b072539713e4a6a855515ae4d5",
    "content": "Causes\nExcess intake of calories\nLack of regular physical activity\nSecondary causes e. g. hypothyroidism, Cushing’s syndrome\nSymptoms\nUsually none\nSigns\nBody Mass Index (BMI) increased\n18.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1265",
    "type": "section",
    "keywords": [
      "usually",
      "activity",
      "regular",
      "secondary",
      "body",
      "lack",
      "hypothyroidism",
      "signs",
      "intake",
      "causes",
      "calories",
      "cushing",
      "excess",
      "increased",
      "symptoms",
      "physical",
      "none",
      "mass",
      "index",
      "syndrome"
    ]
  },
  {
    "id": "74a0484a7128fbe6c41366eb22a78577",
    "content": "9 kg/m2 - Overweight\n30. 0-34. 9 kg/m2 - Obese\n> 35.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1266",
    "type": "section",
    "keywords": [
      "obese",
      "overweight"
    ]
  },
  {
    "id": "20ccbc11a7cd69095d7b0016925f0b3a",
    "content": "0 kg/m2\t- Severely obese\nMid-abdominal (waist) girth, taken roughly at the level of the umbilicus, increased\ninvestigations\nBlood glucose\nBlood lipid profile\nBlood uric acid\nECG.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1267",
    "type": "section",
    "keywords": [
      "severely",
      "obese",
      "abdominal",
      "roughly",
      "taken",
      "acid",
      "level",
      "profile",
      "uric",
      "girth",
      "glucose",
      "umbilicus",
      "investigations",
      "lipid",
      "increased",
      "blood",
      "waist"
    ]
  },
  {
    "id": "cff125c66f777a95e4bb2c1abb2d53a4",
    "content": "To ensure a loss of 10% of the initial body weight, within 6 months,\nat a rate of no more than 2-4 kg per month\nTo attain the ideal BMI and/or abdominal girth\nTo sustain the weight reduction achieved.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1268",
    "type": "section",
    "keywords": [
      "body",
      "initial",
      "within",
      "rate",
      "ensure",
      "abdominal",
      "weight",
      "reduction",
      "achieved",
      "attain",
      "girth",
      "loss",
      "more",
      "month",
      "months",
      "ideal",
      "sustain"
    ]
  },
  {
    "id": "cdaae1cc8fde79fc0902671acf095271",
    "content": "Weight reduction diet, preferably under the supervision of a dietician\nRegular physical activity comprising 30 minutes brisk walking, or equivalent activity, for a minimum of 3 days per week if there are no.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1269",
    "type": "section",
    "keywords": [
      "diet",
      "activity",
      "weight",
      "regular",
      "brisk",
      "supervision",
      "comprising",
      "under",
      "minutes",
      "equivalent",
      "week",
      "days",
      "reduction",
      "preferably",
      "there",
      "walking",
      "dietician",
      "physical",
      "minimum"
    ]
  },
  {
    "id": "d8b751b52efc9816e546783edba80040",
    "content": "Referral Criteria\nIndividuals with severe and morbid obesity may require referral to a physician specialist and occasionally may need psychological counselling. Individuals who gain weight rapidly over a short period may have an underlying hormonal disorder and will require referral to a physician or\nendocrinologist.",
    "title": "Approved anti-obesity treatments are available but should only be given under specialist guidance",
    "section": "Approved anti-obesity treatments are available but should only be given under specialist guidance",
    "chunk_id": "1270",
    "type": "section",
    "keywords": [
      "endocrinologist",
      "weight",
      "psychological",
      "morbid",
      "require",
      "specialist",
      "short",
      "counselling",
      "need",
      "underlying",
      "criteria",
      "physician",
      "severe",
      "referral",
      "hormonal",
      "gain",
      "period",
      "occasionally",
      "disorder",
      "obesity"
    ]
  },
  {
    "id": "2ec917e129ef5b57839153a0f0336cd6",
    "content": "Antenatal care refers to the comprehensive care given to a pregnant woman to ensure that she goes through pregnancy, labour and the puerperium safely with the delivery of a healthy baby. The recommended approach to antenatal care is known as Focused Antenatal Care. It has the following principles: emphasizes quality of care rather than quantity of care (four comprehensive antenatal visits recommended for women with normal pregnancy); individualized care that meets each woman’s own medical and psychosocial needs; and disease detection instead of risk categorization based on the simple principle that all pregnant women are at risk of complications.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1271",
    "type": "section",
    "keywords": [
      "baby",
      "ensure",
      "rather",
      "based",
      "given",
      "quality",
      "labour",
      "instead",
      "refers",
      "emphasizes",
      "four",
      "delivery",
      "simple",
      "following",
      "known",
      "pregnancy",
      "quantity",
      "comprehensive",
      "principles",
      "disease"
    ]
  },
  {
    "id": "e63f74a4a1356f4bb87bcddbe95f3188",
    "content": "Pregnant woman should be carefully assessed at booking and at all subsequent visits to identify problems that are likely to have an adverse effect on the pregnancy. Pregnancies with risk conditions (one or more risk factors) should be seen more frequently and also referred to a hospital and/or obstetrician for management. Another important component of antenatal care is the health education and counselling that is given to clients.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1272",
    "type": "section",
    "keywords": [
      "carefully",
      "important",
      "given",
      "management",
      "factors",
      "seen",
      "health",
      "frequently",
      "identify",
      "assessed",
      "likely",
      "effect",
      "counselling",
      "obstetrician",
      "pregnancy",
      "subsequent",
      "booking",
      "clients",
      "should",
      "visits"
    ]
  },
  {
    "id": "d99dcea0153f728b23bca8becca8e6ae",
    "content": "These promote healthy behaviour and lifestyle during the pregnancy and also enable the woman to recognize danger signs in pregnancy and prepare adequately for emergencies and safe delivery. Findings at each visit should be accurately documented. Antenatal Visits Schedule for a Normal Healthy Woman\nWomen who are healthy at booking and who remain healthy at subsequent visits and do not have any identified potential risk conditions may have four comprehensive visits as follows:\nMore frequent visits or follow up schedules are implemented to meet the client’s individual needs.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1273",
    "type": "section",
    "keywords": [
      "safe",
      "implemented",
      "accurately",
      "during",
      "lifestyle",
      "potential",
      "schedules",
      "four",
      "delivery",
      "individual",
      "schedule",
      "prepare",
      "follow",
      "identified",
      "client",
      "signs",
      "behaviour",
      "pregnancy",
      "subsequent",
      "booking"
    ]
  },
  {
    "id": "9b1400930a593bfef8ce95b10d49c287",
    "content": "In Ghana, many clients come for their first visit during their second trimester of pregnancy. In this case, the visit schedule must be modified to ensure that the client receives all the essential components of care before childbirth. Assessment of the mother at the booking visit\nTake detailed history (present health, past medical and surgical history, past obstetric history, family and social history)\nConfirm the last menstrual period and established gestational age\nExamine from head to toe and all body systems including a check for anaemia, blood pressure, pulse, general health status and manage appropriately\nConduct obstetric examination to confirm pregnancy, measure\nuterine size (SFH) and assess foetal wellbeing (FHR).",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1274",
    "type": "section",
    "keywords": [
      "conduct",
      "ensure",
      "essential",
      "anaemia",
      "menstrual",
      "last",
      "during",
      "check",
      "wellbeing",
      "mother",
      "assessment",
      "health",
      "family",
      "established",
      "second",
      "body",
      "schedule",
      "childbirth",
      "pressure",
      "examination"
    ]
  },
  {
    "id": "28fac3b6b52288093511a18cee8f18f7",
    "content": "Request for/ conduct screening test as per national protocol (See list of investigations)\nAssessment of the mother at follow-up visits:\nAsk about mother’s health status since last visit and ask about health\nconcerns\nEnquire about foetal activity (gestation > 20 weeks)\nTest urine for albumin and sugar\nExamine mother for weight gain, anaemia, and for complications such as pre-eclampsia and manage appropriately\nCheck blood pressure (the upper limit of normal is 140 mmHg for the\nsystolic pressure and 90 mmHg for the diastolic pressure). Obstetric examination:\nMeasure Uterine size: measure symphysio-fundal height in cen- timetres between 20 and 36 weeks gestation. Check the lie, presentation and position of the baby and the\ndescent of the presenting part (3rd trimester).",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1275",
    "type": "section",
    "keywords": [
      "baby",
      "conduct",
      "test",
      "activity",
      "weight",
      "anaemia",
      "last",
      "check",
      "presenting",
      "enquire",
      "mother",
      "health",
      "request",
      "urine",
      "position",
      "albumin",
      "national",
      "pressure",
      "upper",
      "diastolic"
    ]
  },
  {
    "id": "00b280681a0f43d0e596b47ce3b2fbcd",
    "content": "Check the foetal heart sounds. Normal rate is 120-160 beats per minute\ninvestigations\nFull blood count (at booking, 28 and 36 weeks or more frequently if indicated)\nFasting blood glucose must be done on all pregnant women (at\nbooking, 28 and 32 weeks) See note below\nHaemoglobin level (at booking, 28 and 36 weeks or more frequently if indicated)\nBlood film for malaria parasites\nSickling (if necessary Hb electrophoresis)\nG6PD activity\nUrine analysis at each visit (proteinuria, glucosuria)\nStool analysis at booking\nBlood group and antibody screen\nVDRL/TPHA/RPR test\nHBsAg test\nHIV antibody testing (counselling required before testing)\nUltrasound scan\nEarly ultrasound scan for foetal age estimation and to exclude ectopic pregnancy\nFoetal anomaly scanning at 18-24 weeks is beneficial\nLate screening at 36 weeks (placenta position, foetal well being etc. ).",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1276",
    "type": "section",
    "keywords": [
      "ultrasound",
      "sickling",
      "activity",
      "test",
      "placenta",
      "check",
      "beats",
      "glucose",
      "frequently",
      "urine",
      "full",
      "required",
      "scanning",
      "glucosuria",
      "late",
      "position",
      "hbsag",
      "rate",
      "anomaly",
      "count"
    ]
  },
  {
    "id": "b9f526dbb82b40606377a66211dbfb81",
    "content": "To ensure good health throughout pregnancy, labour/delivery and\nthe puerperium\nTo detect and treat adequately any existing or potential health problems\nTo prevent anaemia and malaria\nTo ensure delivery of a healthy baby.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1277",
    "type": "section",
    "keywords": [
      "problems",
      "baby",
      "healthy",
      "ensure",
      "treat",
      "prevent",
      "anaemia",
      "throughout",
      "malaria",
      "adequately",
      "detect",
      "labour",
      "health",
      "pregnancy",
      "potential",
      "puerperium",
      "existing",
      "delivery"
    ]
  },
  {
    "id": "1df6b22f8f482df0bb7bc4e56f88615a",
    "content": "Encourage use of insecticide treated nets\nCounselling and education on the following topics:\nHealthy balanced diet\nAvoid smoking and alcohol intake\nAvoid non-prescribed medications and herbs\nPregnancy discomforts and management\nMalaria prevention\nFamily planning.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1278",
    "type": "section",
    "keywords": [
      "diet",
      "avoid",
      "management",
      "family",
      "following",
      "alcohol",
      "treated",
      "planning",
      "counselling",
      "intake",
      "pregnancy",
      "malaria",
      "nets",
      "discomforts",
      "healthy",
      "prevention",
      "medications",
      "herbs",
      "insecticide",
      "balanced"
    ]
  },
  {
    "id": "9ea0e0966b1bf9dd2daf7f1dd184cbbb",
    "content": "Immunisation\nDanger signs and symptoms in pregnancy\nExercise: Mild to moderate exercise, preferably non-weight bearing, at least 3 times per week is to be encouraged. Avoid exercise in the supine position after the first trimester. Discon- tinue exercise when there are danger signs such as any of the following: bloody vaginal discharge, persistent headaches and or visual disturbances, faintness or dizziness, chest pain and un- explained abdominal pain\nExercise is contraindicated in:\nPregnancy-induced hypertension\nPreterm rupture of membranes\nPreterm labour in women with incompetent cervix sec- ond/third trimester bleeding\nUnexplained Intra uterine growth retardation\nDevelop a birth preparedness and complication readiness plan with the woman.",
    "title": "Breast feeding and new born care",
    "section": "Breast feeding and new born care",
    "chunk_id": "1279",
    "type": "section",
    "keywords": [
      "hypertension",
      "intra",
      "avoid",
      "discon",
      "weight",
      "tinue",
      "exercise",
      "contraindicated",
      "times",
      "membranes",
      "induced",
      "position",
      "labour",
      "vaginal",
      "plan",
      "moderate",
      "abdominal",
      "disturbances",
      "chest",
      "following"
    ]
  },
  {
    "id": "3852248eba741abf684330f9c9f336f3",
    "content": "Ferrous sulphate (dried or anhydrous), oral, 200 mg (65 mg elemen-\ntal iron) daily\nOr\nFerrous fumarate, oral, 200 mg (65 mg elemental iron) daily\nOr\nIron (III) hydroxide Polymaltose complex, oral, 100 mg elemental iron\ndaily\nAnd\nFolic Acid, oral, 5 mg once daily\nWhere combination pre-natal drug formulations of Iron, folate and other micronutrients are preferred, ensure that the iron content meets the minimum requirement dose of 65 mg/dayNte\nMalaria prophylaxis\n(See section on ‘Malaria in Pregnancy’)\nSulphamethoxazole-Pyrimethamine (SP), oral,\n5 doses, one month apart starting from week 16 or 1st quickening (prophylactic treatment should not exceed week 36). Tetanus prophylaxis\nTetanol, IM, 0. 5 ml:\n1st dose from 20th week gestation; 2nd dose 1 (one) month after initial dose, if patient has not previously had anti-tetanus Immuni- sation\nA course of tetanus toxoid vaccinations should be given to all women according to the following schedule:\nTT1-Give the 1st dose (0.",
    "title": "Anaemia prevention 1st Line Treatment Evidence Rating: [A]",
    "section": "Anaemia prevention 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1280",
    "type": "section",
    "keywords": [
      "pyrimethamine",
      "sulphate",
      "initial",
      "ensure",
      "according",
      "tetanus",
      "given",
      "give",
      "tetanol",
      "patient",
      "starting",
      "quickening",
      "previously",
      "schedule",
      "requirement",
      "dried",
      "following",
      "exceed",
      "section",
      "anhydrous"
    ]
  },
  {
    "id": "a62ecf8f9bd4df040c180ea8bf25c10c",
    "content": "5 ml, SC or IM) at any contact with a pregnant woman including the 1st antenatal visit\nTT2-Give the 2nd dose at least 4 weeks after TT1\nTT3-Give the 3rd dose at least 6 months after TT2 or during a subsequent pregnancy\nTT4 & TT5-One dose in each of 2 subsequent pregnancies to make up\na total of five doses. No further doses will be necessary in subsequent pregnancies. Referral Criteria\nHigh-risk pregnancies (See note above) should be referred to a hospital or obstetrician for management and delivery.",
    "title": "Anaemia prevention 1st Line Treatment Evidence Rating: [A]",
    "section": "Anaemia prevention 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1281",
    "type": "section",
    "keywords": [
      "give",
      "management",
      "during",
      "delivery",
      "including",
      "doses",
      "five",
      "obstetrician",
      "note",
      "weeks",
      "total",
      "pregnancy",
      "subsequent",
      "criteria",
      "referral",
      "above",
      "each",
      "should",
      "further",
      "pregnancies"
    ]
  },
  {
    "id": "33ab4b32fd7544713fe4770a68f33dd7",
    "content": "This refers to excessive vomiting usually during the early part of pregnancy, and is usually common. It is a diagnosis of exclusion and therefore important to rule out other causes of vomiting such as malaria, urinary tract infection, gastritis, peptic ulcer disease, hepatitis and hypoglycaemia. Surgical conditions such as acute appendicitis, bowel obstruction, cholecystitis and twisted ovarian cyst, should also be excluded.",
    "title": "Anaemia prevention 1st Line Treatment Evidence Rating: [A]",
    "section": "Anaemia prevention 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1282",
    "type": "section",
    "keywords": [
      "usually",
      "important",
      "ulcer",
      "during",
      "refers",
      "acute",
      "therefore",
      "part",
      "bowel",
      "ovarian",
      "obstruction",
      "pregnancy",
      "malaria",
      "causes",
      "disease",
      "tract",
      "twisted",
      "diagnosis",
      "surgical",
      "should"
    ]
  },
  {
    "id": "68fcea691ccb3a6d44581ed528adaa3c",
    "content": "Hyperemesis gravidarum may be associated with multiple pregnancy or molar pregnancy. Causes\nPregnancy\nSymptoms\nExcessive vomiting (sometimes with inability to keep anything down throughout the day)\nInability to eat or drink (due to fear of vomiting)\nWeight loss\nSigns\nThe patient looks unwell\nDehydration (dry skin, dry tongue, sunken eyes in extreme cases)\nThe pulse is rapid and thready in extreme cases\nThe BP may be low\nDeep and fast breathing in extreme cases\ninvestigations\nFBC\nBlood film for malaria parasites\nUrinalysis and culture\nBlood urea and electrolytes\nAbdominopelvic ultrasound.",
    "title": "Anaemia prevention 1st Line Treatment Evidence Rating: [A]",
    "section": "Anaemia prevention 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1283",
    "type": "section",
    "keywords": [
      "ultrasound",
      "drink",
      "weight",
      "down",
      "breathing",
      "associated",
      "sometimes",
      "patient",
      "gravidarum",
      "anything",
      "multiple",
      "film",
      "extreme",
      "signs",
      "urinalysis",
      "hyperemesis",
      "culture",
      "pregnancy",
      "malaria",
      "causes"
    ]
  },
  {
    "id": "2dc146214fb2b75a51af97a64bdf8c68",
    "content": "To stop the vomiting\nTo rehydrate the patient\nTo treat shock if present\nTo treat associated conditions e. g. UTI, malaria etc.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1284",
    "type": "section",
    "keywords": [
      "vomiting",
      "treat",
      "present",
      "conditions",
      "stop",
      "shock",
      "associated",
      "rehydrate",
      "malaria",
      "patient"
    ]
  },
  {
    "id": "7dc22f1a3821b8d8e6b8e65c629ee185",
    "content": "Dry foods such as biscuits may be very helpful\nDrink fluids in sips or small volumes, if able to.",
    "title": "Mild cases can have treatment at home with frequent small meals",
    "section": "Mild cases can have treatment at home with frequent small meals",
    "chunk_id": "1285",
    "type": "section",
    "keywords": [
      "drink",
      "helpful",
      "small",
      "volumes",
      "able",
      "fluids",
      "sips",
      "foods",
      "biscuits"
    ]
  },
  {
    "id": "70aaa5ad18a2900712d95cb3f9f25459",
    "content": "Promethazine theoclate, oral, 25 mg 8-12 hourly\nOr\nPromethazine hydrochloride, oral, 25 mg 8-12 hourly\nSevere Cases\nNormal saline, IV, (alternate with 5% Dextrose to meet requirements)\nOr\nRingers lactate, IV, (alternate with 5% Dextrose to meet require- ments)\nAnd.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "1286",
    "type": "section",
    "keywords": [
      "severe",
      "hourly",
      "lactate",
      "require",
      "hydrochloride",
      "dextrose",
      "saline",
      "oral",
      "cases",
      "alternate",
      "requirements",
      "ringers",
      "ments",
      "normal",
      "promethazine",
      "theoclate",
      "meet"
    ]
  },
  {
    "id": "e972181ef92249d6842420bf4e23fda1",
    "content": "Metoclopramide, IM or IV, 5-10 mg 8 hourly\nIf body weight < 60 kg, give 5 mg 8 hourly. Do not exceed 500 micro- gram/kg in a day.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1287",
    "type": "section",
    "keywords": [
      "hourly",
      "body",
      "metoclopramide",
      "weight",
      "give",
      "exceed",
      "gram",
      "micro"
    ]
  },
  {
    "id": "e470b5e2c56c6ae3fba1ed35c35bf9e6",
    "content": "Ondansetron, oral, IM, IV, 4-8 mg 8 hourly as needed.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "1288",
    "type": "section",
    "keywords": [
      "oral",
      "ondansetron",
      "needed",
      "hourly"
    ]
  },
  {
    "id": "77e675094ac0516e7b16910c362b94c0",
    "content": "Promethazine hydrochloride, IM or IV, 25 mg 8-12 hourly\n(max. daily dose, 100 mg)\nReferral Criteria\nRefer severe cases with dehydration and/or shock and metabolic disturbances to a hospital for intravenous fluid replacement and antiemetic therapy. Hypertension in pregnancy denotes a systolic blood pressure of 140 mmHg or higher and/or diastolic pressure of 90 mmHg or higher on 2 occasions at least 5 minutes apart using an appropriate-sized cuff especially in obese patients.",
    "title": "3rd Line Treatment Evidence Rating: [A]",
    "section": "3rd Line Treatment Evidence Rating: [A]",
    "chunk_id": "1289",
    "type": "section",
    "keywords": [
      "hypertension",
      "obese",
      "sized",
      "intravenous",
      "replacement",
      "especially",
      "denotes",
      "therapy",
      "fluid",
      "hourly",
      "pressure",
      "diastolic",
      "disturbances",
      "systolic",
      "cuff",
      "minutes",
      "antiemetic",
      "patients",
      "promethazine",
      "pregnancy"
    ]
  },
  {
    "id": "e8614b4220149c332d4c5ec636088455",
    "content": "It is severe when systolic blood pressure is 160 mmHg or higher and diastolic blood pressure is 110 mmHg or higher. This includes women whose hypertension was diagnosed prior to.",
    "title": "3rd Line Treatment Evidence Rating: [A]",
    "section": "3rd Line Treatment Evidence Rating: [A]",
    "chunk_id": "1290",
    "type": "section",
    "keywords": [
      "severe",
      "higher",
      "hypertension",
      "pressure",
      "diastolic",
      "systolic",
      "women",
      "prior",
      "mmhg",
      "includes",
      "whose",
      "blood",
      "diagnosed"
    ]
  },
  {
    "id": "daa951b6090c387d496e887b5623bae6",
    "content": "pregnancy as well as during pregnancy. Known hypertensives on ACE inhibitors, ARBs and alpha-blockers should be switched to medications considered safe during preganancy. Causes\nPregnancy-induced hypertension (no proteinuria)\nPre-eclampsia (hypertension with proteinuria)\nEclampsia (hypertension with proteinuria and fits)\nChronic hypertension (existing before pregnancy)\nChronic hypertension with super-imposed pre-eclampsia or eclampsia\n(See sections on ‘Hypertension’, ‘Pre-eclampsia’ and ‘Eclampsia’)\nSymptoms\n(See section on ‘Hypertension’)\nSigns\n(See section on ‘Hypertension’)\ninvestigations\nFBC\nClotting profile\nSerum Uric Acid\nBUE and Creatinine\nUrinalysis and culture\nLiver function tests\nRandom blood glucose\nDaily assessment of urine proteins (if patient on admission)\nRepeated ultrasound scans for close foetal growth monitoring.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1291",
    "type": "section",
    "keywords": [
      "hypertension",
      "ultrasound",
      "safe",
      "monitoring",
      "profile",
      "during",
      "hypertensives",
      "glucose",
      "assessment",
      "induced",
      "urine",
      "repeated",
      "patient",
      "close",
      "creatinine",
      "fits",
      "known",
      "function",
      "section",
      "growth"
    ]
  },
  {
    "id": "1442c44e9e99826d99d5e7f6a22d2af7",
    "content": "To control blood pressure\nTo detect or treat any complications that may arise especially super imposed pre-eclampsia\nTo prevent foetal complications\nTo deliver a healthy baby.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1292",
    "type": "section",
    "keywords": [
      "baby",
      "complications",
      "pressure",
      "healthy",
      "treat",
      "eclampsia",
      "imposed",
      "prevent",
      "especially",
      "detect",
      "arise",
      "foetal",
      "super",
      "control",
      "blood",
      "deliver"
    ]
  },
  {
    "id": "ce6f0ba1d7153699022f9bfbf014de8e",
    "content": "Hypertension in Pregnancy not associated with pre-eclampsia or eclampsia.",
    "title": "(See section on ‘Antenatal Care’ and on ‘Hypertension’) Pharmacological treatment",
    "section": "(See section on ‘Antenatal Care’ and on ‘Hypertension’) Pharmacological treatment",
    "chunk_id": "1293",
    "type": "section",
    "keywords": [
      "hypertension",
      "eclampsia",
      "associated",
      "pregnancy"
    ]
  },
  {
    "id": "2fe9d56ea603664de0da4885b88d69ee",
    "content": "Methyldopa, oral, 250-500 mg 8-12 hourly (max. 2g daily).",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1294",
    "type": "section",
    "keywords": [
      "oral",
      "methyldopa",
      "daily",
      "hourly"
    ]
  },
  {
    "id": "94f1aa7cd90e02bb01ad2c39a7d549d3",
    "content": "Nifedipine sustained release, oral, 10-40 mg 12 hourly\nHypertension in Pregnancy associated with pre-eclampsia and eclampsia\n(See sections on ‘Hypertension’, ‘Pre-eclampsia’ and ‘Eclampsia’)\nReferral Criteria\nRefer all cases of super-imposed pre-eclampsia or other obstetric complication promptly to a hospital or obstetrician after initiation of treatment. Pre-eclampsia is a disease specifically associated with pregnancy. It usually occurs in the second half of pregnancy and it is characterized by hypertension and proteinuria.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1295",
    "type": "section",
    "keywords": [
      "hypertension",
      "usually",
      "associated",
      "release",
      "second",
      "specifically",
      "nifedipine",
      "hourly",
      "sustained",
      "initiation",
      "complication",
      "obstetrician",
      "pregnancy",
      "criteria",
      "sections",
      "treatment",
      "disease",
      "referral",
      "occurs",
      "half"
    ]
  },
  {
    "id": "2776be8b30ee25d6a4a96fd9d4f84738",
    "content": "The presence of pedal oedema or excessive weight gain may also be a feature of pre-eclampsia. Blood pressure monitoring every 4 hours together with daily weighing of the patient are essential in the management of pre-eclampsia alongside the recommended investigations. While blood pressure reduction is essential, lowering the blood pressure below 140/90mmHg may cause foetal distress and should be avoided.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1296",
    "type": "section",
    "keywords": [
      "monitoring",
      "oedema",
      "weight",
      "essential",
      "management",
      "patient",
      "while",
      "lowering",
      "together",
      "pressure",
      "foetal",
      "presence",
      "avoided",
      "blood",
      "reduction",
      "gain",
      "should",
      "also",
      "cause",
      "feature"
    ]
  },
  {
    "id": "829cd45f984926a413731d360a7737d1",
    "content": "Primigravidae\nMaternal age (women < 18 or > 35 years)\nMultiple pregnancies\nHydatidiform mole\nMedical disorders e. g. polycystic ovaries, chronic hypertension, diabetes mellitus, kidney disorders\nFirst pregnancy with a new partner\nPrevious history of pre-eclampsia\nFamily history of pre-eclampsia\nSymptoms\nPatients with pre-eclampsia are often asymptomatic\nSwollen feet\nSigns\nMild cases\nSystolic blood pressure between 140 and 159 mmHg Diastolic blood pressure between 90 and 109 mmHg Proteinuria of 1+ or 2+\nPedal oedema\nSevere cases.",
    "title": "The cause is unknown but the disease is more commonly associated with the following:",
    "section": "The cause is unknown but the disease is more commonly associated with the following:",
    "chunk_id": "1297",
    "type": "section",
    "keywords": [
      "hypertension",
      "hydatidiform",
      "years",
      "oedema",
      "often",
      "mellitus",
      "family",
      "asymptomatic",
      "multiple",
      "pressure",
      "diastolic",
      "systolic",
      "signs",
      "patients",
      "pregnancy",
      "previous",
      "blood",
      "severe",
      "maternal",
      "chronic"
    ]
  },
  {
    "id": "45c8eb9343d0bacb5ec1dc8e1e2efcbe",
    "content": "Systolic blood pressure 160 mmHg or higher\nDiastolic blood pressure 110 mmHg or higher\nProteinuria of 3+ or 4+\nPedal or generalised oedema\ninvestigations\nFBC\nSerum Uric Acid\nBUE and Creatinine\nUrinalysis and culture\nLiver function tests\nRandom blood glucose\nDaily assessment of urine proteins\nUltrasound scan for close foetal growth monitoring.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1298",
    "type": "section",
    "keywords": [
      "ultrasound",
      "monitoring",
      "oedema",
      "glucose",
      "urine",
      "close",
      "creatinine",
      "pressure",
      "diastolic",
      "systolic",
      "function",
      "growth",
      "urinalysis",
      "proteins",
      "foetal",
      "culture",
      "generalised",
      "blood",
      "acid",
      "mmhg"
    ]
  },
  {
    "id": "e2abbac2a2f11b34110fe4fee5ee4ea2",
    "content": "To reduce elevated blood pressure, but not less than 140/90 mmHg\nTo prolong the pregnancy as much as possible to allow the foetus to grow and mature for delivery\nTo prevent foetal distress\nTo prevent or treat any complications that may arise\nTo prevent eclampsia.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1299",
    "type": "section",
    "keywords": [
      "treat",
      "arise",
      "mature",
      "delivery",
      "pressure",
      "prevent",
      "foetal",
      "pregnancy",
      "grow",
      "blood",
      "allow",
      "elevated",
      "mmhg",
      "foetus",
      "complications",
      "prolong",
      "eclampsia",
      "reduce",
      "distress",
      "possible"
    ]
  },
  {
    "id": "48abd3015d2db67b984d988229b6eeb8",
    "content": "Admit for rest if possible\nEncourage patients to lie on their sides to avoid supine hypotension.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1300",
    "type": "section",
    "keywords": [
      "avoid",
      "their",
      "admit",
      "sides",
      "possible",
      "rest",
      "patients",
      "encourage",
      "supine",
      "hypotension"
    ]
  },
  {
    "id": "dc1b6ea79d7feb7c8bcec4452d18c378",
    "content": "A. Mild pre-eclampsia\nThere is no need for drug treatment of the hypertension unless the BP rises above 150 mmHg systolic or 100 mmHg diastolic or the patient becomes symptomatic of imminent eclampsia (see below). Evidence Rating: [B]\nMethyldopa, oral, 250-500 mg 8-12 hourly (max.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1301",
    "type": "section",
    "keywords": [
      "hypertension",
      "methyldopa",
      "patient",
      "evidence",
      "hourly",
      "rating",
      "diastolic",
      "systolic",
      "unless",
      "drug",
      "need",
      "imminent",
      "treatment",
      "above",
      "rises",
      "mmhg",
      "there",
      "symptomatic",
      "becomes",
      "mild"
    ]
  },
  {
    "id": "091c6cdff7f0d6da9f7c7f1c8176e45c",
    "content": "2 g/day)\nOr\nNifedipine retard, oral, 10-40 mg 12 hourly\nOr\nNifedipine slow release, oral, 30-60 mg daily\nThis is an obstetric emergency and must be treated urgently. Treatment is the same as that of eclampsia (see below). These cases are best managed in hospital under the supervision of an obstetrician.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1302",
    "type": "section",
    "keywords": [
      "release",
      "supervision",
      "under",
      "nifedipine",
      "hourly",
      "emergency",
      "treated",
      "retard",
      "obstetrician",
      "treatment",
      "urgently",
      "slow",
      "same",
      "managed",
      "below",
      "obstetric",
      "eclampsia",
      "must",
      "best",
      "oral"
    ]
  },
  {
    "id": "5f723f1a3580279adcf81c85875e6c5f",
    "content": "While blood pressure reduction is essential, lowering the blood.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1303",
    "type": "section",
    "keywords": [
      "reduction",
      "pressure",
      "blood",
      "essential",
      "lowering",
      "while"
    ]
  },
  {
    "id": "0314286545fd654ab53bb286b1b0b465",
    "content": "pressure below 140/90mmHg may cause foetal distress and should be avoided. BP monitoring must be carried out every 15-30 minutes until the BP is reduced and the patient is stable. Thereafter monitoring can be done by 2-4 hourly.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1304",
    "type": "section",
    "keywords": [
      "monitoring",
      "reduced",
      "patient",
      "stable",
      "hourly",
      "pressure",
      "minutes",
      "foetal",
      "avoided",
      "should",
      "done",
      "cause",
      "every",
      "below",
      "thereafter",
      "carried",
      "must",
      "distress",
      "until"
    ]
  },
  {
    "id": "25887da5c30694e5acc24a81e439c212",
    "content": "Daily weighing of the patient is essential. Symptoms\nFrontal headaches\nVomiting\nVisual disturbances such as double vision (diplopia), blurred vision, flashes of light\nEpigastric pain\nDecrease in urine production (oliguria)\nSigns\nElevated blood pressure\nLiver tenderness\nUrine production of < 30 ml/hour or < 400 ml/24 hours\nIncreased tendon reflexes\nPresence of ankle clonus (occasionally)\ninvestigations\nFBC\nBlood clotting profile (bedside clotting time, prothrombin time, INR, APTT)\nSerum uric acid\nBUE and Creatinine\nUrinalysis and culture\nLiver function tests\nRandom blood glucose\nDaily assessment of urine proteins\nUltrasound scan for close foetal growth monitoring.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1305",
    "type": "section",
    "keywords": [
      "ultrasound",
      "decrease",
      "hour",
      "monitoring",
      "flashes",
      "essential",
      "aptt",
      "profile",
      "clonus",
      "urine",
      "glucose",
      "light",
      "patient",
      "tendon",
      "close",
      "creatinine",
      "pressure",
      "bedside",
      "disturbances",
      "function"
    ]
  },
  {
    "id": "adad88bd4521f45eaab8a01ba62ebc88",
    "content": "To reduce the blood pressure, but not lower than 140/90 mmHg\nTo prevent the mother from suffering from complications of the\nhypertension such as a stroke\nTo prevent fits/eclampsia\nTo stabilise the patient and deliver her if eclampsia is imminent.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1306",
    "type": "section",
    "keywords": [
      "hypertension",
      "stroke",
      "complications",
      "pressure",
      "suffering",
      "prevent",
      "fits",
      "eclampsia",
      "reduce",
      "stabilise",
      "mmhg",
      "mother",
      "lower",
      "imminent",
      "patient",
      "blood",
      "deliver"
    ]
  },
  {
    "id": "c05cd97288a98dc6c0d39a31a34a9c2a",
    "content": "Early delivery of mother if eclampsia is imminent\nIf the patient is not symptomatic and the pregnancy is less than 34 weeks allow pregnancy to continue if the foetal condition would allow\nIf the pregnancy is 34 weeks or more consider delivery after\nstabilisation.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1307",
    "type": "section",
    "keywords": [
      "continue",
      "mother",
      "patient",
      "delivery",
      "consider",
      "foetal",
      "condition",
      "pregnancy",
      "imminent",
      "weeks",
      "allow",
      "symptomatic",
      "stabilisation",
      "eclampsia",
      "early",
      "would",
      "less",
      "more",
      "after"
    ]
  },
  {
    "id": "1f9fd9f4b7157428c4d4f733da37b8c8",
    "content": "Evidence Rating: [C]\nBP management in severe pre-eclampsia and imminent eclampsia\nHydralazine, IV, 5-10 mg slowly over 20-30 minutes\nOr\nNifedipine, sublingual, 10 mg stat. Or\nLabetalol, IV, 20 mg stat. over at least 1 minute\nRepeat at 10-minute intervals if the BP remains > 160/110 mm Hg as follows: 40 mg; 80 mg; 80 mg boluses to a cumulative dose of 220 mg\nWhen the BP < 160/110 mmHg commence an infusion of 40 mg per hour.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1308",
    "type": "section",
    "keywords": [
      "hydralazine",
      "hour",
      "management",
      "infusion",
      "evidence",
      "nifedipine",
      "rating",
      "minutes",
      "repeat",
      "boluses",
      "commence",
      "imminent",
      "stat",
      "severe",
      "cumulative",
      "mmhg",
      "dose",
      "remains",
      "follows",
      "least"
    ]
  },
  {
    "id": "68d6e65037e321783620000e9ae392d1",
    "content": "Double the infusion rate at 30-minute intervals until satisfactory re- sponse or a dose of 160 mg per hour is attained. Then\nNifedipine retard, oral, 20-40 mg daily\nOr\nMethyldopa, oral, 250-500 mg 8-12 hourly\nManagement or prevention of seizures in severe pre-eclampsia\nand imminent eclampsia\nMagnesium sulphate, IV, 20 ml of the 20% solution (4 g)\nAnd\nMagnesium sulphate, IM, 10 ml of the 50% solution, (5 g) into each buttock (total of 10 g)\nReferral Criteria\nRefer all cases of severe pre-eclampsia and imminent eclampsia promptly to a hospital or obstetrician after initiation of treatment. When the “obstetrician” considers that the foetus is immature, the patient should be transferred to a hospital capable of looking after the immature baby.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1309",
    "type": "section",
    "keywords": [
      "baby",
      "methyldopa",
      "hour",
      "sulphate",
      "management",
      "infusion",
      "seizures",
      "solution",
      "magnesium",
      "patient",
      "into",
      "nifedipine",
      "hourly",
      "initiation",
      "rate",
      "sponse",
      "retard",
      "obstetrician",
      "double",
      "capable"
    ]
  },
  {
    "id": "2f89399355bb479c840e238301de8c4b",
    "content": "Eclampsia occurs as a complication of worsening pre-eclampsia. The blood pressure is high with associated proteinuria and convulsion or eclamptic fit, which is similar to an epileptic fit with tonic and clonic phases followed by coma. The fits are often repetitive and of short duration (60-90 seconds).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1310",
    "type": "section",
    "keywords": [
      "often",
      "which",
      "associated",
      "short",
      "pressure",
      "fits",
      "complication",
      "eclamptic",
      "epileptic",
      "clonic",
      "blood",
      "followed",
      "worsening",
      "coma",
      "similar",
      "duration",
      "phases",
      "seconds",
      "occurs",
      "repetitive"
    ]
  },
  {
    "id": "0e25a3ee4dcb12741c34a86cef5b6df3",
    "content": "Symptoms\nFits\nUnconsciousness\nSigns\nConvulsions\nComa\nElevated blood pressure\nProteinuria\ninvestigations\nFBC\nBlood film for malaria parasites\nUrinalysis and culture\nBlood urea and electrolytes\nUltrasound examination of the uterus to exclude multiple pregnancy and/or molar pregnancy.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1311",
    "type": "section",
    "keywords": [
      "ultrasound",
      "unconsciousness",
      "pressure",
      "multiple",
      "fits",
      "film",
      "convulsions",
      "signs",
      "urinalysis",
      "culture",
      "pregnancy",
      "malaria",
      "blood",
      "coma",
      "electrolytes",
      "molar",
      "elevated",
      "investigations",
      "symptoms",
      "exclude"
    ]
  },
  {
    "id": "e8082c7c2af535988c7819fde6a0d2e9",
    "content": "To protect the patient from injury\nTo prevent further fits\nTo lower the blood pressure\nTo monitor for organ failures (e. g. renal) as well as obstetric complications e.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1312",
    "type": "section",
    "keywords": [
      "complications",
      "pressure",
      "failures",
      "blood",
      "fits",
      "prevent",
      "monitor",
      "organ",
      "obstetric",
      "further",
      "lower",
      "protect",
      "renal",
      "injury",
      "patient"
    ]
  },
  {
    "id": "a1d496cd41eb3066b009cdcab177b340",
    "content": "g. placental abruption and foetal distress\nTo prevent maternal mortality\nTo deliver the baby when the mother is stable.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1313",
    "type": "section",
    "keywords": [
      "abruption",
      "baby",
      "maternal",
      "stable",
      "prevent",
      "placental",
      "distress",
      "mother",
      "foetal",
      "deliver",
      "mortality"
    ]
  },
  {
    "id": "ef564b1eeb0c10b1951466999835a830",
    "content": "Lay patient in the recovery position\nPrevent patient from falling\nAvoid restricting patient to prevent limb fractures and joint dislocations\nDo not put anything in patient’s mouth to prevent tongue biting\nMaintain the airway by either holding up the chin or if possible, inserting a mechanical airway to hold down the tongue\nIf postpartum and patient remains unconscious for a long period,\nconsider turning them every hour to prevent sores from developing\nArtificial respiration may be required following general anaesthesia\nAfter the fits\nObtain IV access\nCatheterise the patient\nIf no further fits and after patient is stabilized, deliver the foetus by the most appropriate method to ensure safety of both mother and baby\nMode of delivery will depend on the patient’s clinical condition, the\nstatus of the foetus and her preference.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1314",
    "type": "section",
    "keywords": [
      "baby",
      "avoid",
      "either",
      "hour",
      "catheterise",
      "ensure",
      "depend",
      "sores",
      "down",
      "both",
      "unconscious",
      "mother",
      "chin",
      "required",
      "position",
      "patient",
      "delivery",
      "anything",
      "inserting",
      "developing"
    ]
  },
  {
    "id": "714704b380e12da0275dcb1cbe98cc06",
    "content": "Evidence Rating: [A]\nFluid replacement\nSodium Chloride 0. 9%, IV, Or\nRinger’s lactate, IV, (Maximum 1 Litre in 6 hours or 4 Litres in 24\nhours).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1315",
    "type": "section",
    "keywords": [
      "rating",
      "ringer",
      "lactate",
      "litres",
      "replacement",
      "litre",
      "sodium",
      "chloride",
      "maximum",
      "hours",
      "evidence",
      "fluid"
    ]
  },
  {
    "id": "e1e5e49ce969a4fffdc72207e66cfb7c",
    "content": "Magnesium sulphate, IV, 20 ml of the 20% solution (4 g) Administer slowly over 5 to 15 minutes\nThen\nMagnesium sulphate, IM, 10 ml of the 50% solution, (5 g) into each buttock (total of 10 g).",
    "title": "Treatment of convulsions",
    "section": "Treatment of convulsions",
    "chunk_id": "1316",
    "type": "section",
    "keywords": [
      "sulphate",
      "buttock",
      "minutes",
      "each",
      "solution",
      "magnesium",
      "slowly",
      "total",
      "then",
      "administer",
      "into"
    ]
  },
  {
    "id": "fd66f9da350dcd29b1793d5947dd5a4d",
    "content": "If fits recur within 20 minutes, do not repeat Magnesium sulphate. (See other treatment options below)\nIf fits recur after 20 minutes, repeat Magnesium Sulphate, IV,\n70kg;\t20 ml of the 20% solution (4g)\n< 70kg;\t10 ml of the 20% solution (2 g) once\nMaintenance\nMagnesium sulphate, IM, 5 g in alternating buttocks every 4 hours till 24 hours after last seizure or delivery, whichever is later.",
    "title": "Treatment of recurrent convulsions",
    "section": "Treatment of recurrent convulsions",
    "chunk_id": "1317",
    "type": "section",
    "keywords": [
      "sulphate",
      "last",
      "magnesium",
      "maintenance",
      "seizure",
      "delivery",
      "within",
      "alternating",
      "whichever",
      "fits",
      "minutes",
      "repeat",
      "treatment",
      "later",
      "recur",
      "till",
      "every",
      "once",
      "below",
      "other"
    ]
  },
  {
    "id": "45ceca20b1a7f48749eae5e6b5e7ba14",
    "content": "And\nEvidence Rating: [A]\nDiazepam, IV, 10 mg slowly over 2-3 minutes (not exceeding 2. 5 mg every 30 seconds,\nThen\n60kg;\t5-10 mg 8 hourly\n< 60kg;\t5 mg 8 hourly.",
    "title": "Treatment of convulsions not responding to Magnesium sulphate",
    "section": "Treatment of convulsions not responding to Magnesium sulphate",
    "chunk_id": "1318",
    "type": "section",
    "keywords": [
      "diazepam",
      "exceeding",
      "rating",
      "hourly",
      "minutes",
      "seconds",
      "slowly",
      "then",
      "evidence",
      "every"
    ]
  },
  {
    "id": "16d01f0e944a58440765653b065015e5",
    "content": "(Do not exceed 500 microgram/kg in a day or 30 mg in 24 hours).",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1319",
    "type": "section",
    "keywords": [
      "exceed",
      "hours",
      "microgram"
    ]
  },
  {
    "id": "f2f629090392edf53f20037bc324b5d5",
    "content": "Hydralazine, IV, 5-10 mg stat. (over 5-10 mins)\nBoluses can be repeated every 20-30 mins. BP should not fall below 140/90 mmHg\nThen\nHydralazine, IV infusion,\n20-40 mg in 500 ml of Sodium Chloride 0.",
    "title": "Treatment of Hypertension in Eclampsia",
    "section": "Treatment of Hypertension in Eclampsia",
    "chunk_id": "1320",
    "type": "section",
    "keywords": [
      "hydralazine",
      "fall",
      "mins",
      "below",
      "should",
      "infusion",
      "sodium",
      "mmhg",
      "boluses",
      "chloride",
      "repeated",
      "then",
      "stat",
      "every"
    ]
  },
  {
    "id": "a8e74da11388a41ed749e55d23a1926e",
    "content": "9%\nRate of infusion to be titrated against the blood pressure readings. Or\nLabetalol, IV, 20 mg stat. over at least 1 minute\nThen\nRepeat at 10-minute intervals if the BP remains >160/110mmHg as follows: 40 mg; 80 mg; 80 mg boluses to a cumulative dose of 220 mg\nWhen the BP < 160/110 mmHg start an infusion of 40 mg per hour.",
    "title": "Treatment of Hypertension in Eclampsia",
    "section": "Treatment of Hypertension in Eclampsia",
    "chunk_id": "1321",
    "type": "section",
    "keywords": [
      "hour",
      "infusion",
      "rate",
      "pressure",
      "start",
      "repeat",
      "boluses",
      "blood",
      "stat",
      "against",
      "titrated",
      "cumulative",
      "mmhg",
      "dose",
      "readings",
      "remains",
      "follows",
      "then",
      "least",
      "minute"
    ]
  },
  {
    "id": "52d3825fc8814779719d443034709ad6",
    "content": "Double the infusion rate at 30-minute intervals until satisfactory re- sponse or a dose of 160mg per hour is attained. Referral Criteria\nTransfer all cases of eclampsia immediately to a hospital or obstetrician in a facility with operative capacity. As much as possible set up an IV line of Sodium Chloride 0.",
    "title": "Treatment of Hypertension in Eclampsia",
    "section": "Treatment of Hypertension in Eclampsia",
    "chunk_id": "1322",
    "type": "section",
    "keywords": [
      "hour",
      "infusion",
      "capacity",
      "rate",
      "facility",
      "transfer",
      "immediately",
      "sponse",
      "sodium",
      "obstetrician",
      "double",
      "criteria",
      "satisfactory",
      "referral",
      "line",
      "dose",
      "chloride",
      "attained",
      "operative",
      "intervals"
    ]
  },
  {
    "id": "6a4269b85841062e4cb51e615d2fa252",
    "content": "9% or Ringer’s lactate and administer the IV dose of Magnesium Sulphate slowly at the health facility. Follow this with the IM dose and accompany the patient to a referral facility. If the IV dose cannot be given, simply give the IM dose of 5 g into each buttock and transfer.",
    "title": "Treatment of Hypertension in Eclampsia",
    "section": "Treatment of Hypertension in Eclampsia",
    "chunk_id": "1323",
    "type": "section",
    "keywords": [
      "sulphate",
      "give",
      "given",
      "magnesium",
      "health",
      "patient",
      "into",
      "facility",
      "transfer",
      "simply",
      "follow",
      "administer",
      "ringer",
      "referral",
      "each",
      "cannot",
      "dose",
      "accompany",
      "lactate",
      "slowly"
    ]
  },
  {
    "id": "a892fb078f3e6aabc81860915ffc8b7d",
    "content": "(See section on ‘Malaria’)\nAnaemia in pregnancy is a haemoglobin concentration of < 11 g/ dL (World Health Organisation). It is described as severe if the Hb is < 7 g/dL. Anaemia has adverse effects on the health of the woman and the outcome of the pregnancy.",
    "title": "Treatment of Hypertension in Eclampsia",
    "section": "Treatment of Hypertension in Eclampsia",
    "chunk_id": "1324",
    "type": "section",
    "keywords": [
      "severe",
      "described",
      "concentration",
      "world",
      "anaemia",
      "effects",
      "woman",
      "section",
      "outcome",
      "health",
      "pregnancy",
      "adverse",
      "malaria",
      "organisation",
      "haemoglobin"
    ]
  },
  {
    "id": "74bce87ca1409bb73b6b0e2cde11230e",
    "content": "miscarriage, preterm delivery, foetal growth restriction, foetal death and increased perinatal loss. It is also associated with ante- and post-partum haemorrhage and an increased maternal mortality rate. Ideally no woman should go into labour with anaemia.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1325",
    "type": "section",
    "keywords": [
      "anaemia",
      "labour",
      "associated",
      "death",
      "ideally",
      "into",
      "delivery",
      "restriction",
      "rate",
      "growth",
      "foetal",
      "perinatal",
      "post",
      "maternal",
      "ante",
      "should",
      "also",
      "increased",
      "partum",
      "mortality"
    ]
  },
  {
    "id": "f4ef941329a92ef4fc60d7269a4506ca",
    "content": "Appropriate measures including blood transfusion may be required to correct the anaemia especially if a woman is close to her expected delivery date. Causes\nPhysiological (due to blood volume expansion in pregnancy)\nPoor dietary intake of iron, folate and vitamin B12.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1326",
    "type": "section",
    "keywords": [
      "correct",
      "anaemia",
      "especially",
      "required",
      "poor",
      "close",
      "vitamin",
      "measures",
      "delivery",
      "including",
      "expected",
      "dietary",
      "intake",
      "pregnancy",
      "volume",
      "blood",
      "causes",
      "date",
      "transfusion",
      "physiological"
    ]
  },
  {
    "id": "0aa25c57d3df3021f0cc2a9065162caf",
    "content": "Malaria\nInfestations with hookworm, ascaris, schistosomes\nChronic infections e. g. TB, UTI, HIV\nBleeding complications in pregnancy e.",
    "title": "Haemolytic disorders (e.g. sickle cell disease, G6PD defect)",
    "section": "Haemolytic disorders (e.g. sickle cell disease, G6PD defect)",
    "chunk_id": "1327",
    "type": "section",
    "keywords": [
      "infections",
      "chronic",
      "complications",
      "ascaris",
      "infestations",
      "bleeding",
      "pregnancy",
      "hookworm",
      "malaria",
      "schistosomes"
    ]
  },
  {
    "id": "e74145dd3b5a63aeaba2a6d7cab47000",
    "content": "g. APH\nSymptoms\nDizziness\nSwelling of the feet\nGeneral weakness\nEasy fatiguability\nSigns\nMucosal pallor\nJaundice (may or may not be present)\nHepato-splenomegaly (may or may not be present)\nHeart failure in severe cases\ninvestigations\nFBC\nPeripheral blood film comment\nBlood film for malaria parasites\nSickling and Hb electrophoresis\nG6PD activity\nSerum iron, total iron binding capacity, ferritin\nStool analysis for hookworm ova\nUrinalysis for schistosoma ova and urobilinogen.",
    "title": "Haemolytic disorders (e.g. sickle cell disease, G6PD defect)",
    "section": "Haemolytic disorders (e.g. sickle cell disease, G6PD defect)",
    "chunk_id": "1328",
    "type": "section",
    "keywords": [
      "sickling",
      "activity",
      "comment",
      "swelling",
      "mucosal",
      "weakness",
      "capacity",
      "jaundice",
      "film",
      "splenomegaly",
      "urinalysis",
      "easy",
      "signs",
      "heart",
      "urobilinogen",
      "total",
      "malaria",
      "blood",
      "severe",
      "pallor"
    ]
  },
  {
    "id": "30079f03a717cb91d1963f96cf236c04",
    "content": "To relieve symptoms\nTo correct haemoglobin level before patient reaches term or goes\ninto labour\nTo identify and treat underlying cause\nTo recognize and manage the associated complications in mother\ne. g. cardiac failure, and baby e.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1329",
    "type": "section",
    "keywords": [
      "baby",
      "treat",
      "correct",
      "reaches",
      "labour",
      "associated",
      "mother",
      "identify",
      "patient",
      "into",
      "underlying",
      "before",
      "goes",
      "level",
      "manage",
      "cause",
      "failure",
      "symptoms",
      "cardiac",
      "term"
    ]
  },
  {
    "id": "708208053779fcf932359d604e9ff65d",
    "content": "Encourage intake of foods such as red meat, poultry, fish, dark.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1330",
    "type": "section",
    "keywords": [
      "fish",
      "dark",
      "intake",
      "foods",
      "encourage",
      "meat",
      "poultry"
    ]
  },
  {
    "id": "f05b5e02dfcad8649ad12313f025164a",
    "content": "leafy vegetables, shell fish, dried fruits which are rich in iron, folate, Vitamins B and C\nAvoid tea, coffee, bran, cola and unhealthy habits such as eating of\nclay, which inhibits iron absorption\nEncourage intake of folate and vitamin rich foods including beans, avocado, citrus fruits, spinach and mangoes\nProtein rich foods must also be included in the diet\nEnsure these anaemic patients are seen more frequently in the antenatal clinic and their response to treatment monitored with haemoglobin level checks.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1331",
    "type": "section",
    "keywords": [
      "bran",
      "diet",
      "avoid",
      "ensure",
      "which",
      "seen",
      "shell",
      "frequently",
      "foods",
      "vitamin",
      "dried",
      "avocado",
      "including",
      "checks",
      "protein",
      "anaemic",
      "patients",
      "intake",
      "eating",
      "their"
    ]
  },
  {
    "id": "17949805f84ae35d22527fc5ce568e6d",
    "content": "Evidence Rating: [A]\nFerrous sulphate, oral, 325 mg 8 hourly\nOr\nFerrous gluconate, oral, 300 mg 8-12 hourly. Evaluate after 4-6 weeks\nAnd\nFolic Acid, oral, 5 mg daily\nBlood transfusion\nAdd\nFurosemide IV, 20-40 mg if giving whole blood\nReferral Criteria\nRefer patients with anaemia to a dietician or diet nurse for counselling and support. Treatment for severe anaemia (Hb < 7g/dL) is best given in health facilities with blood transfusion capability.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1332",
    "type": "section",
    "keywords": [
      "diet",
      "sulphate",
      "giving",
      "evaluate",
      "anaemia",
      "given",
      "health",
      "evidence",
      "hourly",
      "rating",
      "support",
      "ferrous",
      "counselling",
      "facilities",
      "capability",
      "patients",
      "whole",
      "weeks",
      "criteria",
      "blood"
    ]
  },
  {
    "id": "ec843e770ec89cd47d38463ecb5da0f8",
    "content": "All women who do not respond satisfactorily to oral treatment should be referred for further evaluation. Those with associated conditions like HIV and Haemogobinopathies should be managed in the hospital. HIV patients on antiretroviral medication may need modification of their drug combinations to exclude those that aggravate anaemia e.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1333",
    "type": "section",
    "keywords": [
      "anaemia",
      "associated",
      "combinations",
      "evaluation",
      "drug",
      "respond",
      "need",
      "modification",
      "patients",
      "aggravate",
      "their",
      "treatment",
      "women",
      "should",
      "antiretroviral",
      "medication",
      "further",
      "those",
      "referred",
      "satisfactorily"
    ]
  },
  {
    "id": "45434026ef8de79fa6005b4b302ad85f",
    "content": "Pregnancy in the Sickle Cell Disease (SCD) patient is associated with poor obstetric outcomes for both the mother and her baby. Data from referral centres in Ghana show that sickle cell complications during pregnancy leads to high maternal and perinatal mortality. Common pregnancy complications of the mother with SCD include miscarriages, frequent vaso-occlusive crises, severe anaemia, recurrent urinary tract infections, acute chest syndrome, preterm labour and.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1334",
    "type": "section",
    "keywords": [
      "baby",
      "infections",
      "recurrent",
      "anaemia",
      "both",
      "vaso",
      "during",
      "mother",
      "associated",
      "outcomes",
      "labour",
      "poor",
      "patient",
      "acute",
      "occlusive",
      "crises",
      "chest",
      "pregnancy",
      "perinatal",
      "severe"
    ]
  },
  {
    "id": "fab861ec3ae82e4fc94b51ab2c1e660f",
    "content": "pulmonary embolism. In the foetus, complications include intrauterine growth restriction, prematurity and intrauterine foetal death. Care by a multidisciplinary team consisting of the Obstetricican, Physician specialist, Haematologist, Clinical Pharmacist, Anaesthetist, Nurse and Midwife ensures good health outcomes for these patients.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1335",
    "type": "section",
    "keywords": [
      "team",
      "health",
      "outcomes",
      "death",
      "pharmacist",
      "prematurity",
      "obstetricican",
      "restriction",
      "specialist",
      "growth",
      "multidisciplinary",
      "haematologist",
      "foetal",
      "patients",
      "physician",
      "include",
      "nurse",
      "pulmonary",
      "foetus",
      "anaesthetist"
    ]
  },
  {
    "id": "76b756032763f86932128096a80ec030",
    "content": "Symptoms\nRecurrent Jaundice\nBone and joint pain (recurrent episodes)\nDelayed puberty\nSub-fertility\nAnaemic complications (easy fatiguability, palpitations)\nSigns.",
    "title": "(See section on ‘Sickle Cell Disease’)",
    "section": "(See section on ‘Sickle Cell Disease’)",
    "chunk_id": "1336",
    "type": "section",
    "keywords": [
      "episodes",
      "complications",
      "recurrent",
      "pain",
      "fertility",
      "jaundice",
      "fatiguability",
      "joint",
      "anaemic",
      "easy",
      "palpitations",
      "signs",
      "delayed",
      "puberty",
      "symptoms",
      "bone"
    ]
  },
  {
    "id": "fdbae6480add0578d0d59ffb7f6749e8",
    "content": "investigations\nSickling test and Haemoglobin electrophoresis\nFull blood count including reticulocyte count\nRDT or blood film for malaria parasites\nMidstream urine for Culture and sensitivity at booking and whenever\nindicated\nRenal function test (BUN, Creatinine, electrolytes)\nLiver function tests\nSerum iron, TIBC and Ferritin (if possible)\nAll other antenatal screening test.",
    "title": "(See section on ‘Sickle Cell Disease’)",
    "section": "(See section on ‘Sickle Cell Disease’)",
    "chunk_id": "1337",
    "type": "section",
    "keywords": [
      "sickling",
      "test",
      "urine",
      "full",
      "sensitivity",
      "creatinine",
      "including",
      "count",
      "function",
      "film",
      "screening",
      "culture",
      "whenever",
      "malaria",
      "reticulocyte",
      "blood",
      "booking",
      "renal",
      "ferritin",
      "electrolytes"
    ]
  },
  {
    "id": "e4017f9829c595fe4edacf810ec08815",
    "content": "To identify patients with condition early during pregnancy for closer\nmonitoring\nTo correct anaemia\nTo prevent known crises triggers\nTo detect and manage promptly all associated complications and\ncrises\nTo deliver client safely as soon as baby is viable.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1338",
    "type": "section",
    "keywords": [
      "baby",
      "monitoring",
      "correct",
      "anaemia",
      "during",
      "associated",
      "identify",
      "triggers",
      "crises",
      "prevent",
      "known",
      "client",
      "patients",
      "condition",
      "pregnancy",
      "deliver",
      "manage",
      "viable",
      "promptly",
      "safely"
    ]
  },
  {
    "id": "a05234dc4c77d986cf7ba68cf63951ad",
    "content": "Provide genetic counselling\nAssist patient to plan pregnancy in a status of optimum health\nEducate on potential risk and health problems of SCD in Pregnancy.",
    "title": "Pre-pregnancy Care",
    "section": "Pre-pregnancy Care",
    "chunk_id": "1339",
    "type": "section",
    "keywords": [
      "status",
      "problems",
      "genetic",
      "optimum",
      "assist",
      "educate",
      "counselling",
      "provide",
      "health",
      "risk",
      "pregnancy",
      "potential",
      "patient",
      "plan"
    ]
  },
  {
    "id": "d28b78ee1a516a194c56cd7cbfcfa895",
    "content": "Examine\tfor\tnutritional\tstatus,\tanaemia,\tjaundice,\tand\nhepatosplenomegally\nPerform ultrasound to date pregnancy and exclude foetal abnormality and growth retardation\nPerform the above listed investigations to screen for and detect\ncomplications\nManage identified problems at booking (e. g. urinary tract infection, malaria etc.",
    "title": "Assess patient carefully for risk of frequent crises, and previous obstetric complications",
    "section": "Assess patient carefully for risk of frequent crises, and previous obstetric complications",
    "chunk_id": "1340",
    "type": "section",
    "keywords": [
      "ultrasound",
      "anaemia",
      "abnormality",
      "jaundice",
      "growth",
      "perform",
      "identified",
      "foetal",
      "pregnancy",
      "malaria",
      "screen",
      "booking",
      "status",
      "examine",
      "above",
      "tract",
      "date",
      "manage",
      "investigations",
      "complications"
    ]
  },
  {
    "id": "a2e58995bd793f6b17a01455aa405a95",
    "content": ") appropriately and promptly\nFollow up visits\nIf low risk, schedule follow up visits monthly until 2nd trimester, then 2 weekly until 28th week and thereafter weekly\nIf high-risk, schedule visits 2 weekly until third trimester, then weekly\nuntil term\nAt review visits, enquire about maternal well-being, symptoms of crises, infection and foetal activity. Examine for pallor, jaundice, fever and proteinuria. Check for foetal growth and compare to gestational age\nLabour and delivery\nStress and pain of labour and delivery can trigger crisis.",
    "title": "Assess patient carefully for risk of frequent crises, and previous obstetric complications",
    "section": "Assess patient carefully for risk of frequent crises, and previous obstetric complications",
    "chunk_id": "1341",
    "type": "section",
    "keywords": [
      "activity",
      "compare",
      "check",
      "enquire",
      "labour",
      "monthly",
      "delivery",
      "review",
      "crises",
      "schedule",
      "follow",
      "stress",
      "appropriately",
      "week",
      "jaundice",
      "growth",
      "foetal",
      "being",
      "trigger",
      "crisis"
    ]
  },
  {
    "id": "330a4f1d14dbae88e93b9ea45f9fb62f",
    "content": "Risks of crisis is increased if dehydration, fever, infection, hypothermia develop during labour. Care during labour/delivery is targeted at preventing these triggers.",
    "title": "Assess patient carefully for risk of frequent crises, and previous obstetric complications",
    "section": "Assess patient carefully for risk of frequent crises, and previous obstetric complications",
    "chunk_id": "1342",
    "type": "section",
    "keywords": [
      "develop",
      "dehydration",
      "preventing",
      "infection",
      "fever",
      "hypothermia",
      "during",
      "labour",
      "increased",
      "these",
      "risks",
      "crisis",
      "care",
      "targeted",
      "triggers",
      "delivery"
    ]
  },
  {
    "id": "c2066e06d7c2bc553113ae44b4652f64",
    "content": "most experienced midwife and obstetrician should be involved in.",
    "title": "All women with Sickle cell Disease must deliver in hospital, and the",
    "section": "All women with Sickle cell Disease must deliver in hospital, and the",
    "chunk_id": "1343",
    "type": "section",
    "keywords": [
      "involved",
      "should",
      "midwife",
      "experienced",
      "obstetrician",
      "most"
    ]
  },
  {
    "id": "0719b9182d4c6ac96fbcf932b95ffe07",
    "content": "In uncomplicated pregnancies, spontaneous vaginal delivery must be aimed at until 40 weeks (term). Induction must be undertaken only if the woman has not delivered after this time. For the high risk women with recurrent complications deliver as soon\nas baby is viable\nAt admission in labour;\nLabour should be monitored closely with partograph\nCheck for haemoglobin level\nGroup and cross-match a unit of blood on standby\nMaintain good hydration with IV fluids\nProvide adequate pain relief (See section on ‘Analgesia in La-\nbour’)\nProvide prophylactic antibiotics (See section on ‘Antibiotic pro- phylaxis in labour and puerperium’ below)\nVaginal delivery should be the aim unless there are obstetric reasons\nfor cesarean section.",
    "title": "their care",
    "section": "their care",
    "chunk_id": "1344",
    "type": "section",
    "keywords": [
      "baby",
      "recurrent",
      "closely",
      "antibiotics",
      "bour",
      "check",
      "relief",
      "labour",
      "antibiotic",
      "partograph",
      "vaginal",
      "delivery",
      "hydration",
      "unless",
      "analgesia",
      "delivered",
      "section",
      "fluids",
      "standby",
      "cesarean"
    ]
  },
  {
    "id": "23ebe343d6673580d57ed983686817b0",
    "content": "Prolonged second stage labour should be avoided by offering assisted delivery (vacuum)\nActive  Management  of  Third  Stage  of  Labour  (AMTSL)  is\nrecommended to prevent PPH.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1345",
    "type": "section",
    "keywords": [
      "prolonged",
      "recommended",
      "offering",
      "amtsl",
      "prevent",
      "management",
      "third",
      "should",
      "active",
      "labour",
      "stage",
      "avoided",
      "assisted",
      "second",
      "vacuum",
      "delivery"
    ]
  },
  {
    "id": "32a0da1e25bd50c622a2c48d5525925c",
    "content": "All Sickle Cell Disease patients must be hospitalized and monitored closely for at least 72 hours postpartum\nCheck for pallor, puerperal sepsis, acute chest syndrome, vaso-\nocclusive crises and urinary tract infection\nContinue with prophylactic antibiotics for at least 72 hours postpartum\nCounsel women and their support persons to avoid crises triggers\nsuch as stress, pain, lack of sleep, fatigue etc. Encourage early ambulation (especially after operative delivery)\nReview client at 7 days postpartum and thereafter weekly until 6 weeks.",
    "title": "Postpartum care",
    "section": "Postpartum care",
    "chunk_id": "1346",
    "type": "section",
    "keywords": [
      "continue",
      "avoid",
      "closely",
      "antibiotics",
      "especially",
      "puerperal",
      "vaso",
      "fatigue",
      "check",
      "ambulation",
      "acute",
      "occlusive",
      "triggers",
      "delivery",
      "review",
      "crises",
      "chest",
      "support",
      "stress",
      "lack"
    ]
  },
  {
    "id": "23b592e771a1653c674d046d7226da4e",
    "content": "Counsel on family planning and offer contraception\nBaby.",
    "title": "Refer patient to physician for continuing care",
    "section": "Refer patient to physician for continuing care",
    "chunk_id": "1347",
    "type": "section",
    "keywords": [
      "baby",
      "offer",
      "contraception",
      "planning",
      "counsel",
      "family"
    ]
  },
  {
    "id": "75c4e68f5fa897c282ae1aa515a1f0c5",
    "content": "Closely monitor the babies with associated complications e. g. IUGR, prematurity etc.",
    "title": "The baby should be screened for sickle cell disease",
    "section": "The baby should be screened for sickle cell disease",
    "chunk_id": "1348",
    "type": "section",
    "keywords": [
      "babies",
      "prematurity",
      "complications",
      "closely",
      "monitor",
      "iugr",
      "associated"
    ]
  },
  {
    "id": "4c5ce16c0912c405f439a55b148bec25",
    "content": "Sickling crises in pregnancy\nAdmit all sickle cell patients with sickling and/or obstetric complications during pregnancy to a hospital\nAvoid NSAIDs e. g. Diclofenac in the 3rd trimester\nOpiods like pethidine and morphine for pain management should be used with care during labour due to respiration depression effects on baby (See section on Analgesia in Labour)\nIdentify and treat underlying triggers e.",
    "title": "The baby should be screened for sickle cell disease",
    "section": "The baby should be screened for sickle cell disease",
    "chunk_id": "1349",
    "type": "section",
    "keywords": [
      "baby",
      "sickling",
      "avoid",
      "admit",
      "treat",
      "management",
      "during",
      "labour",
      "identify",
      "triggers",
      "crises",
      "diclofenac",
      "analgesia",
      "section",
      "underlying",
      "patients",
      "pregnancy",
      "trimester",
      "nsaids",
      "pethidine"
    ]
  },
  {
    "id": "9472c98a12bf3bf3251c24cd7038e341",
    "content": "g UTI, malaria, dehydration\netc. (See appropriate sections)\nBlood transfusion is recommended if haemogloblin level is less than 7g/dl at 36 weeks and/or during crises (See section on ‘Sickle Cell Disease’)\nIf in vaso-oclusive crises maintain hydration with IV fluids (crystalloids).",
    "title": "The baby should be screened for sickle cell disease",
    "section": "The baby should be screened for sickle cell disease",
    "chunk_id": "1350",
    "type": "section",
    "keywords": [
      "haemogloblin",
      "vaso",
      "during",
      "crises",
      "section",
      "fluids",
      "weeks",
      "malaria",
      "blood",
      "sections",
      "disease",
      "dehydration",
      "level",
      "oclusive",
      "sickle",
      "transfusion",
      "recommended",
      "appropriate",
      "cell",
      "crystalloids"
    ]
  },
  {
    "id": "16bbec321a8b74decb3567230ed0ac4c",
    "content": "Acute chest syndrome (ACS)- foetal monitoring is essential during\nthis crisis (See section on ‘Acute Chest Syndrome’).",
    "title": "litres in 24 hours, and provide analgesia (See section on ‘Sickle Cell Disease’)",
    "section": "litres in 24 hours, and provide analgesia (See section on ‘Sickle Cell Disease’)",
    "chunk_id": "1351",
    "type": "section",
    "keywords": [
      "crisis",
      "monitoring",
      "chest",
      "essential",
      "section",
      "during",
      "foetal",
      "syndrome",
      "acute"
    ]
  },
  {
    "id": "a06634610ec1a02d3e7669d1069e5e3e",
    "content": "And\nMultivitamin, oral, once daily\nAntibiotic prophylaxis in labour and puerperium\nCeftriaxone, IV/IM, 1 g daily for 72 hours\nOr\nAmoxicillin + Clavulanic Acid, IV, 1. 2 g stat. Then\nAmoxicillin + Clavulanic Acid, oral, 625 mg 12 hourly for 72 hours\nReferral Criteria\nAll patients with sickle cell disease with obstetric complications should be referred to a specialist for continuing care.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1352",
    "type": "section",
    "keywords": [
      "labour",
      "antibiotic",
      "multivitamin",
      "hourly",
      "specialist",
      "clavulanic",
      "patients",
      "criteria",
      "stat",
      "disease",
      "amoxicillin",
      "referral",
      "acid",
      "should",
      "sickle",
      "referred",
      "continuing",
      "then",
      "puerperium",
      "once"
    ]
  },
  {
    "id": "3aa8c48a76448bd4685f8530eea388a5",
    "content": "Diabetes Mellitus in pregnancy includes individuals known to be diabetic prior to pregnancy and those who develop impaired glucose tolerance during pregnancy. Gestational diabetes refers to impaired glucose tolerance of any degree that develops or is first recognized during the current pregnancy, irrespective of whether it resolves after delivery or not. Diabetes is associated with poor health outcomes for a mother and her baby if not properly managed.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1353",
    "type": "section",
    "keywords": [
      "baby",
      "mellitus",
      "during",
      "mother",
      "glucose",
      "associated",
      "health",
      "poor",
      "outcomes",
      "properly",
      "refers",
      "impaired",
      "delivery",
      "known",
      "whether",
      "pregnancy",
      "diabetic",
      "prior",
      "resolves",
      "first"
    ]
  },
  {
    "id": "346c855bf5fb849940bd31dec5b1f668",
    "content": "Many patients with gestational diabetes are asymptomatic making screening for all pregnant women mandatory to identify those at risk. A fasting blood glucose test must be done on all pregnant women at booking and also at 28-32 weeks (See section on ‘Antenatal Care’). The management of diabetes mellitus in pregnancy and the puerperium involves close monitoring of the woman by a multidisciplinary approach comprising a team of obstetricians, midwives, nurses, dieticians, physicians, anaesthetists and paediatricians.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1354",
    "type": "section",
    "keywords": [
      "mandatory",
      "test",
      "monitoring",
      "team",
      "management",
      "mellitus",
      "glucose",
      "identify",
      "paediatricians",
      "comprising",
      "close",
      "asymptomatic",
      "nurses",
      "dieticians",
      "anaesthetists",
      "section",
      "multidisciplinary",
      "screening",
      "patients",
      "weeks"
    ]
  },
  {
    "id": "c6ac6b982a2637b013e290fc7f2b415f",
    "content": "Labour (induced or spontaneous) and Caesarean section are best supervised in hospital under specialist care. Anti-diabetic treatment requirements reduce dramatically after delivery hence, post delivery treatment doses must be tailored to each individual patient’s needs. The newborn baby of a diabetic mother needs special care and is best managed by a paediatrician/ neonatologist.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1355",
    "type": "section",
    "keywords": [
      "baby",
      "labour",
      "mother",
      "special",
      "induced",
      "patient",
      "under",
      "delivery",
      "individual",
      "specialist",
      "paediatrician",
      "dramatically",
      "section",
      "doses",
      "diabetic",
      "tailored",
      "treatment",
      "post",
      "each",
      "requirements"
    ]
  },
  {
    "id": "7067645f949f818c56725c72300999e1",
    "content": "Hypoglycaemia in the baby in the first few hours of birth is a major problem. It can be prevented by initiating early (within 1 hour) breastfeeding. They may also require management for respiratory distress syndrome, electrolyte imbalances (e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1356",
    "type": "section",
    "keywords": [
      "baby",
      "hour",
      "management",
      "breastfeeding",
      "initiating",
      "within",
      "require",
      "electrolyte",
      "first",
      "prevented",
      "also",
      "respiratory",
      "major",
      "problem",
      "imbalances",
      "birth",
      "early",
      "distress",
      "hypoglycaemia",
      "syndrome"
    ]
  },
  {
    "id": "bb306caaf6657d76cb52a663e7526af9",
    "content": "g. hypercalcaemia, hypokalaemia, hypomagnesaemia) and hyperbilirubinaemia. All diabetic mothers must be counselled on family planning.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1357",
    "type": "section",
    "keywords": [
      "hypercalcaemia",
      "counselled",
      "must",
      "hypokalaemia",
      "planning",
      "hyperbilirubinaemia",
      "family",
      "hypomagnesaemia",
      "diabetic",
      "mothers"
    ]
  },
  {
    "id": "22e6b0f76660cc0c30bfcbf12849bbbb",
    "content": "Causes\nPre-existing Type 1 diabetes mellitus\nPre-existing Type 2 diabetes mellitus\nGestational diabetes mellitus\nSymptoms\nUsually asymptomatic\nPrevious history of large babies ( > 4 kg)\nPrevious poor obstetric history (foetal deaths, miscarriages etc. )\nOther features of diabetes (See section on ‘Diabetes Mellitus’)\nSigns\nFoetus larger than gestational age (as assessed by serial symphysio- fundal height or by ultrasound scan)\nFoetus smaller than gestational age (IUGR)\nPresence of polyhydramnios\nOther signs of diabetic complications (See section on ‘Diabetes\nMellitus’)\ninvestigations.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1358",
    "type": "section",
    "keywords": [
      "usually",
      "ultrasound",
      "polyhydramnios",
      "mellitus",
      "features",
      "poor",
      "assessed",
      "asymptomatic",
      "babies",
      "type",
      "large",
      "section",
      "smaller",
      "signs",
      "foetal",
      "presence",
      "diabetic",
      "previous",
      "causes",
      "foetus"
    ]
  },
  {
    "id": "ba2600867be0b9a166f69e5170a6d6a8",
    "content": "Ultrasound scan\nFoetal anomaly scan at 16-22 weeks\nSerial scans for growth assessment in third trimester\nUrine culture and sensitivity (monthly)\nHigh vaginal swab for candidiasis\nBlood urea, electrolytes and creatinine\nBlood glucose profile (Fasting blood glucose and 2-hour post- prandial blood glucose monthly in the lab; more frequently by self- monitoring)\nGlycated haemoglobin (HbA1C) every 6-8 weeks.",
    "title": "All basic Antenatal Care Investigations",
    "section": "All basic Antenatal Care Investigations",
    "chunk_id": "1359",
    "type": "section",
    "keywords": [
      "urea",
      "ultrasound",
      "hour",
      "monitoring",
      "self",
      "profile",
      "urine",
      "glucose",
      "frequently",
      "sensitivity",
      "monthly",
      "vaginal",
      "creatinine",
      "swab",
      "candidiasis",
      "anomaly",
      "growth",
      "glycated",
      "foetal",
      "culture"
    ]
  },
  {
    "id": "3d0c7c36895592cc91fc40cb6c1c9a9d",
    "content": "To achieve normal blood glucose and glycated haemoglobin levels\nthroughout pregnancy, labour, delivery and puerperium\nTo prevent maternal and foetal complications\nTo prevent neonatal morbidity and mortality\nTo detect and manage other associated complications e. g. pre- eclampsia.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1360",
    "type": "section",
    "keywords": [
      "morbidity",
      "levels",
      "labour",
      "glucose",
      "associated",
      "delivery",
      "prevent",
      "glycated",
      "foetal",
      "pregnancy",
      "blood",
      "maternal",
      "neonatal",
      "manage",
      "puerperium",
      "mortality",
      "achieve",
      "complications",
      "eclampsia",
      "throughout"
    ]
  },
  {
    "id": "b48ff33ca33fbe61b834d1b435bed28d",
    "content": "General measures (dietary modification, exercise, patient counselling and education, blood glucose monitoring must be discussed with a dietician, obstetrician or midwife, respectively)\nFrequent ANC visits are required\nDelivery\nby 40 weeks gestation: in well controlled patients with no com- plications\nby 38 weeks gestation; in Insulin treated patients and those\nwith complications\nCaesarean section; for patients with either of the following;\nsevere pre-eclampsia, previous caesarean section,\nadvanced maternal age, malpresentation or foetal\nmacrosomia\nIf elective preterm delivery is necessary, mature the foetal lungs with corticosteroids under specialist care\nPuerperium\nClose blood glucose monitoring in the first 48 hours after de-\nlivery.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1361",
    "type": "section",
    "keywords": [
      "monitoring",
      "either",
      "elective",
      "advanced",
      "exercise",
      "mature",
      "glucose",
      "required",
      "patient",
      "corticosteroids",
      "measures",
      "under",
      "delivery",
      "close",
      "specialist",
      "livery",
      "following",
      "treated",
      "section",
      "counselling"
    ]
  },
  {
    "id": "f3efc190dbd4cb6bab31aa052a6dff7d",
    "content": "Evidence Rating: [B]\nMetformin, oral, 500 mg 8-12 hourly. (max. dose 2g per day)\nAnd/Or.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1362",
    "type": "section",
    "keywords": [
      "metformin",
      "rating",
      "hourly",
      "oral",
      "dose",
      "evidence"
    ]
  },
  {
    "id": "5cd41cb9412607560fdc62054fd2ad36",
    "content": "Glibenclamide, oral, 2. 5-5 mg 12-24 hourly. Increase dose by 5 mg if necessary until max.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1363",
    "type": "section",
    "keywords": [
      "hourly",
      "necessary",
      "oral",
      "glibenclamide",
      "until",
      "dose",
      "increase"
    ]
  },
  {
    "id": "493012cf951ae55d768e1c02522d42c6",
    "content": "dose of 15 mg/day\nAnd/Or\nInsulin\nEvidence Rating: [A]\n(See section on Insulin Therapy in ‘Diabetes Mellitus’)\nStart with small doses (e. g. total daily dose of 6-10 units) of NPH insulin or premixed insulin (which has 30% of regular and 70% of NPH insulin), subcutaneously.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1364",
    "type": "section",
    "keywords": [
      "rating",
      "units",
      "insulin",
      "start",
      "small",
      "diabetes",
      "premixed",
      "regular",
      "section",
      "subcutaneously",
      "doses",
      "mellitus",
      "which",
      "dose",
      "total",
      "therapy",
      "evidence",
      "daily"
    ]
  },
  {
    "id": "288562f172d012be8954bf64a26f9f9d",
    "content": "Give approximately two-thirds of the total daily dose before breakfast\nand one-third before dinner. Adjust the insulin doses before breakfast and/or dinner by plus or minus 2 units according to results of blood glucose tests. Monitor insulin therapy with 2-4 weekly FBS (and 2-hour post-\nprandial blood glucose where possible) up to 34 weeks then weekly till delivery.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1365",
    "type": "section",
    "keywords": [
      "hour",
      "units",
      "give",
      "breakfast",
      "according",
      "glucose",
      "results",
      "thirds",
      "therapy",
      "delivery",
      "doses",
      "where",
      "weeks",
      "total",
      "blood",
      "post",
      "before",
      "monitor",
      "third",
      "adjust"
    ]
  },
  {
    "id": "9b944dbc8e439e2edade86b93411e5f6",
    "content": "Keep fasting glucose levels between 4-6 mmol/L and 2-hour\npostprandial glucose between 4-7 mmol/L. This is often achievable on an out-patient basis. However, some patients would need to be admitted to hospital for short periods to ensure good glycaemic control.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1366",
    "type": "section",
    "keywords": [
      "achievable",
      "hour",
      "ensure",
      "often",
      "levels",
      "postprandial",
      "glucose",
      "patient",
      "basis",
      "short",
      "need",
      "patients",
      "mmol",
      "periods",
      "glycaemic",
      "keep",
      "between",
      "fasting",
      "admitted",
      "however"
    ]
  },
  {
    "id": "af79fff72ca9838f784f43e14eb3ec86",
    "content": "Insulin requirements during labour should be given according to a\nsliding scale (See section on ‘Diabetic ketoacidosis’ and Sliding scale)\nInsulin requirements during caesarean section and other operative procedures (using a sliding scale or Glucose-Potassium-Insulin infusion or GKI) should be discussed with the anaesthetist\nReferral Criteria\nRefer to hospital for specialist care. For the convenience of patients shared care between specialist and medical officer may be appropriate. Cardiac diseases are associated with high maternal and foetal mortality and morbidity.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1367",
    "type": "section",
    "keywords": [
      "procedures",
      "according",
      "given",
      "convenience",
      "morbidity",
      "infusion",
      "during",
      "labour",
      "glucose",
      "associated",
      "potassium",
      "shared",
      "diseases",
      "specialist",
      "scale",
      "section",
      "foetal",
      "patients",
      "diabetic",
      "criteria"
    ]
  },
  {
    "id": "88cf2b843ed217bfead94dfe45531630",
    "content": "They may be present before the pregnancy or develop during the pregnancy or puerperium (e. g. peripartum cardiomyopathy).",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1368",
    "type": "section",
    "keywords": [
      "develop",
      "present",
      "before",
      "cardiomyopathy",
      "during",
      "peripartum",
      "pregnancy",
      "puerperium"
    ]
  },
  {
    "id": "3695d2ee4cfe71db2c54ff4e71a9f854",
    "content": "Pregnancy places additional burden on the heart and makes pre-existing cardiac disease worse.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1369",
    "type": "section",
    "keywords": [
      "disease",
      "places",
      "burden",
      "heart",
      "makes",
      "pregnancy",
      "existing",
      "additional",
      "cardiac",
      "worse"
    ]
  },
  {
    "id": "5658714fbe543f6a5bdc76afab6a3046",
    "content": "Some of the signs of pregnancy may mimic cardiac disease. Careful assessment of all patients must be undertaken to determine if they have cardiac disease or not. Management requires a multi-disciplinary team including the obstetrician, neonatologist, anaesthetist and physician specialist or cardiologist.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1370",
    "type": "section",
    "keywords": [
      "determine",
      "team",
      "management",
      "cardiologist",
      "specialist",
      "disciplinary",
      "including",
      "obstetrician",
      "multi",
      "signs",
      "patients",
      "pregnancy",
      "physician",
      "disease",
      "undertaken",
      "mimic",
      "anaesthetist",
      "careful",
      "cardiac",
      "requires"
    ]
  },
  {
    "id": "d0f140919b9cfba488dc1ac2019d361b",
    "content": "Patients with known cardiac disease must plan their pregnancies carefully in full consultation with their cardiologist and obstetrician. They must book early as soon as they become pregnant for antenatal care in hospital. All patients needing pharmacological treatment must be managed by a physician specialist or cardiologist and obstetrician.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1371",
    "type": "section",
    "keywords": [
      "pharmacological",
      "carefully",
      "full",
      "plan",
      "cardiologist",
      "consultation",
      "book",
      "specialist",
      "hospital",
      "known",
      "obstetrician",
      "needing",
      "patients",
      "their",
      "treatment",
      "physician",
      "disease",
      "pregnancies",
      "cardiac",
      "managed"
    ]
  },
  {
    "id": "92bf62dda482acacfe9375b820c830d9",
    "content": "Thyrotoxicosis\nSymptoms\nAsymptomatic\nPalpitations\nEasy fatiguability\nChest pain\nDyspnoea - orthopnoea, paroxysmal nocturnal dyspnoea\nCough\nLeg swelling\nSigns\nCardiac murmurs\nOther signs of cardiac disease depending on the type of lesion (See section on ‘Disorders of the cardiovascular system’)\nPresence of heart failure (See section on ‘Heart failure’)\ninvestigations\nFBC\nBlood urea and electrolytes\nThyroid function test, if indicated\nElectrocardiogram\nEchocardiogram\nChest X-ray (with protection of foetus)\nAll other antenatal investigations.",
    "title": "Congenital heart diseases",
    "section": "Congenital heart diseases",
    "chunk_id": "1372",
    "type": "section",
    "keywords": [
      "test",
      "electrocardiogram",
      "paroxysmal",
      "swelling",
      "nocturnal",
      "asymptomatic",
      "dyspnoea",
      "type",
      "lesion",
      "chest",
      "function",
      "section",
      "easy",
      "signs",
      "presence",
      "heart",
      "blood",
      "disease",
      "electrolytes",
      "fatiguability"
    ]
  },
  {
    "id": "cdb6cc5323a93ac7a0e317a918c3d9e5",
    "content": "To maintain good cardiac function throughout the pregnancy, labour,.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1373",
    "type": "section",
    "keywords": [
      "function",
      "throughout",
      "maintain",
      "labour",
      "pregnancy",
      "cardiac"
    ]
  },
  {
    "id": "5beffbf348e2dde988c80a79fb451218",
    "content": "delivery and puerperium\nTo prevent maternal and foetal complications\nTo prevent maternal death.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1374",
    "type": "section",
    "keywords": [
      "maternal",
      "complications",
      "prevent",
      "foetal",
      "death",
      "puerperium",
      "delivery"
    ]
  },
  {
    "id": "94dad8e4ab43e7c00b447d92f4a1f9e5",
    "content": "Referral Criteria\nAll patients with cardiac disease must be referred to a specialist physician or cardiologist and an obstetrician. Jaundice occurring in pregnancy may be a symptom or sign of a severe disease and should not be underestimated. Causes\nObstetric\nSevere pre-eclampsia/eclampsia/HELLP Syndrome (Haemolysis, Elevated Liver enzymes, Low Platelets syndrome)\nSevere hyperemesis gravidarum\nCholestatic jaundice of pregnancy\nAcute Fatty Liver of pregnancy\nNon-obstetric\nViral hepatitis.",
    "title": "(See appropriate cardiac disease)",
    "section": "(See appropriate cardiac disease)",
    "chunk_id": "1375",
    "type": "section",
    "keywords": [
      "platelets",
      "acute",
      "underestimated",
      "cardiologist",
      "gravidarum",
      "specialist",
      "jaundice",
      "obstetrician",
      "patients",
      "hyperemesis",
      "pregnancy",
      "fatty",
      "sign",
      "criteria",
      "causes",
      "physician",
      "severe",
      "disease",
      "enzymes",
      "referral"
    ]
  },
  {
    "id": "26afbc0da4e9b7ef8c68e909530d9980",
    "content": "Surgical: acute cholecystitis, cholelithiasis, obstructive jaundice\nSymptoms\nYellowish discoloration of eyes\nDeep yellow or dark urine\nGeneralized itching\nOther symptoms relating to the cause (e. g. general malaise, dizziness, fever etc.",
    "title": "Haemolytic: malaria, sickle cell disease, G6PD defect, septicaemia, drugs and herbal medications",
    "section": "Haemolytic: malaria, sickle cell disease, G6PD defect, septicaemia, drugs and herbal medications",
    "chunk_id": "1376",
    "type": "section",
    "keywords": [
      "urine",
      "acute",
      "obstructive",
      "jaundice",
      "relating",
      "yellowish",
      "generalized",
      "yellow",
      "deep",
      "surgical",
      "cholelithiasis",
      "fever",
      "discoloration",
      "cause",
      "symptoms",
      "eyes",
      "general",
      "cholecystitis",
      "other",
      "itching"
    ]
  },
  {
    "id": "986b9c020dd94d25b8df2de8eb3db79c",
    "content": ")\nSigns\nYellow discoloration of mucous membranes and skin\nDelirium and coma (if severe).",
    "title": "Haemolytic: malaria, sickle cell disease, G6PD defect, septicaemia, drugs and herbal medications",
    "section": "Haemolytic: malaria, sickle cell disease, G6PD defect, septicaemia, drugs and herbal medications",
    "chunk_id": "1377",
    "type": "section",
    "keywords": [
      "severe",
      "yellow",
      "coma",
      "discoloration",
      "mucous",
      "membranes",
      "signs",
      "skin",
      "delirium"
    ]
  },
  {
    "id": "1ea09e1c13137164a5a0c5e9f3cfb5d2",
    "content": "Other signs relating to the cause (e. g. fever, elevated blood pressure)\ninvestigations\nFBC, blood film for malaria parasites, RDT\nSickling status\nG6PD status.",
    "title": "Liver enlargement (If associated with liver disease)",
    "section": "Liver enlargement (If associated with liver disease)",
    "chunk_id": "1378",
    "type": "section",
    "keywords": [
      "sickling",
      "pressure",
      "other",
      "fever",
      "film",
      "cause",
      "elevated",
      "signs",
      "investigations",
      "relating",
      "parasites",
      "malaria",
      "blood",
      "status"
    ]
  },
  {
    "id": "8aeb4afb64dd8dd2492081c9145c800b",
    "content": "Blood group and cross matching\nBlood urea, electrolytes, and creatinine\nLiver function tests\nHepatitis B surface antigen\nAbdominal ultrasound scan with emphasis on the hepato-biliary system and pancreas.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1379",
    "type": "section",
    "keywords": [
      "ultrasound",
      "pancreas",
      "creatinine",
      "abdominal",
      "function",
      "surface",
      "blood",
      "electrolytes",
      "biliary",
      "tests",
      "hepato",
      "hepatitis",
      "matching",
      "cross",
      "antigen",
      "scan",
      "emphasis",
      "system",
      "urea",
      "group"
    ]
  },
  {
    "id": "4737b555c6e6eb65ebf250ed8778994f",
    "content": "To identify and treat cause\nTo prevent related maternal and foetal complications.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1380",
    "type": "section",
    "keywords": [
      "maternal",
      "complications",
      "treat",
      "prevent",
      "cause",
      "foetal",
      "identify",
      "related"
    ]
  },
  {
    "id": "1001505d81ea0388ef7b07a4902fb547",
    "content": "Depends on the underlying cause (See appropriate sections).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1381",
    "type": "section",
    "keywords": [
      "appropriate",
      "depends",
      "cause",
      "underlying",
      "sections"
    ]
  },
  {
    "id": "a78133203bf371c2387a67419dee594a",
    "content": "Depends on the underlying cause (See appropriate sections)\nReferral Criteria\nSevere cases of jaundice and those associated with abdominal pain must be referred for specialist care. Post-partum haemorrhage may be primary or secondary. Primary postpartum haemorrhage refers to bleeding of more than 500 ml from the genital tract within the first twenty-four hours of delivery or any amount of blood loss that result in haemodynamic compromise of the patient.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1382",
    "type": "section",
    "keywords": [
      "associated",
      "twenty",
      "secondary",
      "refers",
      "patient",
      "four",
      "delivery",
      "primary",
      "abdominal",
      "specialist",
      "within",
      "jaundice",
      "postpartum",
      "depends",
      "bleeding",
      "result",
      "underlying",
      "genital",
      "criteria",
      "sections"
    ]
  },
  {
    "id": "870345300a78aac2ee195049a734c7f0",
    "content": "It usually occurs during or immediately after the third stage of labour. Secondary post-partum haemorrhage is defined as excessive vaginal bleeding occurring from twenty-four hours to six weeks after delivery. The bleeding may occur with the placenta retained or after its expulsion from the uterus.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1383",
    "type": "section",
    "keywords": [
      "usually",
      "haemorrhage",
      "occur",
      "placenta",
      "during",
      "labour",
      "expulsion",
      "twenty",
      "secondary",
      "four",
      "vaginal",
      "delivery",
      "immediately",
      "bleeding",
      "stage",
      "weeks",
      "retained",
      "post",
      "third",
      "occurs"
    ]
  },
  {
    "id": "b0ccfa7ad622d1b26494fe3ec1883791",
    "content": "Postpartum haemorrhage becomes life threatening if the mother is already anaemic. Blood loss of more than 500 ml may lead to shock. Causes\nUterine atony (70-90% of cases)\nRetention of all or part of placental tissue within the uterine cavity\nInfection within the uterine cavity (endo-myometritis)\nGenital tract trauma.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1384",
    "type": "section",
    "keywords": [
      "myometritis",
      "lead",
      "mother",
      "within",
      "part",
      "postpartum",
      "retention",
      "anaemic",
      "genital",
      "causes",
      "blood",
      "already",
      "endo",
      "tract",
      "atony",
      "uterine",
      "placental",
      "shock",
      "becomes",
      "threatening"
    ]
  },
  {
    "id": "b44723e884b9e5ddbf1dce4b1fd59cf5",
    "content": "Symptoms\nExcessive or prolonged vaginal bleeding after delivery\nLower abdominal pains\nSigns\nActive bleeding from the genital tract.",
    "title": "Clotting disorders",
    "section": "Clotting disorders",
    "chunk_id": "1385",
    "type": "section",
    "keywords": [
      "prolonged",
      "abdominal",
      "tract",
      "bleeding",
      "active",
      "signs",
      "lower",
      "after",
      "pains",
      "genital",
      "symptoms",
      "excessive",
      "vaginal",
      "delivery"
    ]
  },
  {
    "id": "bb2f20861055bb754fb9ab9090421efb",
    "content": "Conjunctival pallor\nRapid pulse\nBlood pressure may be low or normal\nDeterioration of maternal levels of consciousness\nFlabby poorly contracted uterus\nObvious tears in birth canal and/or perineum\nObvious retained placenta\nSuprapubic tenderness\ninvestigations\nFBC, sickling status\nBedside clotting test\nBlood grouping and cross-matching\nUltrasound scan (if patient is stable to check for retained placenta tissue).",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1386",
    "type": "section",
    "keywords": [
      "conjunctival",
      "sickling",
      "test",
      "ultrasound",
      "placenta",
      "levels",
      "grouping",
      "check",
      "poorly",
      "patient",
      "stable",
      "suprapubic",
      "pressure",
      "bedside",
      "contracted",
      "deterioration",
      "retained",
      "blood",
      "status",
      "pallor"
    ]
  },
  {
    "id": "a2953c35e5df229412508fc4542dd25e",
    "content": "To identify the cause and stop bleeding as quickly as possible\nTo correct hypotension\nTo correct resulting anaemia.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1387",
    "type": "section",
    "keywords": [
      "correct",
      "anaemia",
      "bleeding",
      "stop",
      "cause",
      "quickly",
      "resulting",
      "possible",
      "identify",
      "hypotension"
    ]
  },
  {
    "id": "e4996779a9485620ebedc8095a9f1e50",
    "content": "Due to uterine atony (70-90% of cases), with no placental retention\nMassage fundus of uterus to stimulate contraction\nEncourage woman to empty bladder or pass a urethral catheter to empty the bladder and monitor urine output\nBimanual compression of the uterus and balloon tamponade if\nuterus fails to contract with massage\nDue to retained placenta\nAttempt removal of the placenta by controlled cord traction as soon as a contraction is felt. If not successful await the next contraction and repeat the procedure\nIf the placenta cannot be expelled in this fashion, manual removal\nunder anaesthesia is indicated\nIf the placenta has been delivered and is incomplete, exploration the uterus and manual removal under anaesthesia is indicated\nIf the facilities for manual removal of placenta under anaesthesia are\nnot immediately available refer to hospital\nBleeding with uterus well contracted and placenta completely delivered\nExamine the patient in the lithotomy position with adequate\nanalgesia and/or anaesthesia, good lighting to identify and suture perineal, vaginal and cervical tears\nIf the tear(s) extends into the uterine body, effective suturing cannot.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1388",
    "type": "section",
    "keywords": [
      "stimulate",
      "balloon",
      "traction",
      "catheter",
      "identify",
      "position",
      "analgesia",
      "retention",
      "encourage",
      "successful",
      "lighting",
      "uterine",
      "placental",
      "cannot",
      "procedure",
      "fashion",
      "cervical",
      "perineal",
      "uterus",
      "controlled"
    ]
  },
  {
    "id": "a925d8cfd39cf4e5c86b1daa1b2e4a3a",
    "content": "be performed and repair will involve a laparotomy\nFor ruptured uterus, repair or hysterectomy is required\nBleeding associated with coagulopathy\nBedside clotting test - 5 ml of blood placed in a 10 ml round bottomed glass tube should clot in 6 minutes.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1389",
    "type": "section",
    "keywords": [
      "test",
      "glass",
      "associated",
      "required",
      "laparotomy",
      "bedside",
      "minutes",
      "bleeding",
      "ruptured",
      "blood",
      "clot",
      "placed",
      "tube",
      "should",
      "repair",
      "clotting",
      "hysterectomy",
      "performed",
      "involve",
      "uterus"
    ]
  },
  {
    "id": "fd084648cff233596ae8265552b25cad",
    "content": "Oxytocin, IM, 10 units stat. Then\nOxytocin, IV, infusion, 10-40 units in 500 ml Dextrose saline or 0. 9% or Normal saline.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1390",
    "type": "section",
    "keywords": [
      "units",
      "oxytocin",
      "infusion",
      "dextrose",
      "saline",
      "normal",
      "then",
      "stat"
    ]
  },
  {
    "id": "fe345db76df31c9c9fa7b3d24c4a1052",
    "content": "Misoprostol, sublingual, 600 microgram (for PPH prophylaxis within\n1 minute of delivery).",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "1391",
    "type": "section",
    "keywords": [
      "within",
      "microgram",
      "minute",
      "prophylaxis",
      "misoprostol",
      "sublingual",
      "delivery"
    ]
  },
  {
    "id": "ba00f7b1997a2bb096eaf2a2a855e4d8",
    "content": "Ergometrine, IV, 500 microgram stat. Or\nEvidence Rating: [B]\nOxytocin-ergometrine, IM, (Oxytocin 10 units and Ergometrine 500 microgram) stat. Or\nEvidence Rating: [B]\nOxytocin-misoprostol, (Oxytocin, IV, 10 units and Misoprostol, rectal, 600 micrograms) stat.",
    "title": "3rd Line Treatment Evidence Rating: [B]",
    "section": "3rd Line Treatment Evidence Rating: [B]",
    "chunk_id": "1392",
    "type": "section",
    "keywords": [
      "rating",
      "rectal",
      "units",
      "microgram",
      "ergometrine",
      "oxytocin",
      "misoprostol",
      "micrograms",
      "evidence",
      "stat"
    ]
  },
  {
    "id": "f8947b4808b5ec9c5c7d469e24155923",
    "content": "Protracted bleeding uncontrolled by Oxytocin and other\nUterotonics or if bleeding is due partly to trauma\nEvidence Rating: [B]\nTranexamic Acid, slow IV (not to exceed 100 mg per minute), 1 g stat. Then\n1 g 8 hourly (Maximum 3 g in 24 hours)\nHypovolaemia\nSodium Chloride 0. 9% or Ringers lactate, IV, and blood transfusion as\nclinically indicated\n(See section on ‘Shock’)\nAnaesthesia for manual removal of placenta\nMorphine, IV, 2.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1393",
    "type": "section",
    "keywords": [
      "placenta",
      "evidence",
      "hourly",
      "rating",
      "oxytocin",
      "tranexamic",
      "bleeding",
      "exceed",
      "hypovolaemia",
      "section",
      "sodium",
      "uncontrolled",
      "removal",
      "blood",
      "stat",
      "partly",
      "uterotonics",
      "manual",
      "acid",
      "shock"
    ]
  },
  {
    "id": "96874490c19abb0a5937e2e6ba9aaa9f",
    "content": "5 - 5 mg stat. as required (if no anaesthetist is avail- able)\nOr\nPethidine, IV slowly or IM, 1 mg/kg 6 - 8 hourly as required (max. 100 mg per dose)\nAnd\nDiazepam, slow IV, 5-10 mg 8 hourly as required (NOT more than 2.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1394",
    "type": "section",
    "keywords": [
      "diazepam",
      "hourly",
      "avail",
      "able",
      "pethidine",
      "slow",
      "dose",
      "more",
      "required",
      "slowly",
      "anaesthetist",
      "stat"
    ]
  },
  {
    "id": "a7cc757ab99788730b4486db71f550c1",
    "content": "5 mg per minute)\nDo not mix pethidine and diazepam in the same syringe. Monitor respiratory\nrate of patient closely. Stop drugs if respiratory rate is less than 12 per minute.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1395",
    "type": "section",
    "keywords": [
      "diazepam",
      "rate",
      "drugs",
      "closely",
      "minute",
      "monitor",
      "pethidine",
      "stop",
      "respiratory",
      "same",
      "less",
      "patient",
      "syringe"
    ]
  },
  {
    "id": "517fc1000a46c3eb45da8820f984b64b",
    "content": "Or\nKetamine, IM, 5-10 mg/kg stat. Or\nKetamine, IV, 0. 5-2 mg/kg stat.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1396",
    "type": "section",
    "keywords": [
      "stat",
      "ketamine"
    ]
  },
  {
    "id": "d09d0a92e024bc7de8ae080345651bf9",
    "content": "Secondary Postpartum Haemorrhage\nOxytocin, IV infusion, 20 units in 1 L of Normal Saline\nOr\nErgometrine, oral, 500 microgram 8 hourly for 3 days\nAntibiotic prophylaxis\nAmoxycillin, oral, 500 mg 8 hourly for 7 days\nAnd\nMetronidazole, oral, 400 mg 8 hourly for 7 days.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1397",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "units",
      "ergometrine",
      "microgram",
      "oxytocin",
      "postpartum",
      "infusion",
      "saline",
      "oral",
      "prophylaxis",
      "antibiotic",
      "normal",
      "secondary",
      "amoxycillin",
      "haemorrhage"
    ]
  },
  {
    "id": "40c725bb0e5859aa714c40a3391c0f2c",
    "content": "Referral Criteria\nRefer patients who do not respond to the treatments above to a specialist. Also refer promptly to a hospital with theatre and blood transfusion facilities for examination under anaesthesia and/or laparotomy if these are not immediately available.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1398",
    "type": "section",
    "keywords": [
      "under",
      "laparotomy",
      "specialist",
      "immediately",
      "facilities",
      "respond",
      "patients",
      "criteria",
      "blood",
      "referral",
      "above",
      "also",
      "treatments",
      "available",
      "theatre",
      "promptly",
      "transfusion",
      "anaesthesia",
      "refer",
      "examination"
    ]
  },
  {
    "id": "48697c89cfe68d7d0770e6a7628a8c58",
    "content": "Post-partum pyrexia refers to body temperature of 38°C or more on 2 or more occasions during the first 10 days of the puerperium excluding the first day. Risk Factors include prolonged labour, prolonged premature rupture of membranes, retained placental tissue, instrumental deliveries and birth canal injuries. Causes\nMalaria\nUterine infection (endo-myometritis)\nPerineal Infections (e.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1399",
    "type": "section",
    "keywords": [
      "infections",
      "prolonged",
      "injuries",
      "instrumental",
      "myometritis",
      "during",
      "factors",
      "labour",
      "membranes",
      "excluding",
      "refers",
      "body",
      "premature",
      "retained",
      "malaria",
      "causes",
      "post",
      "days",
      "include",
      "occasions"
    ]
  },
  {
    "id": "88881a6391ab9840a16faa1ccc1c5b78",
    "content": "g. infected episiotomy)\nBreast problems (engorgement, mastitis, abscess formation)\nUrinary tract infection\nRespiratory tract infection\nSymptoms\nFever\nOther symptoms as related to cause\nSigns\nFever\nOther signs as related to cause\ninvestigations\nFBC\nRDT\nBlood film for malaria parasites\nBlood for culture and sensitivity\nUrine for culture and sensitivity\nHigh vaginal swab\nFasting or Random Blood Glucose\nPelvic scan to exclude retained products of conception or pelvic.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1400",
    "type": "section",
    "keywords": [
      "infected",
      "urine",
      "glucose",
      "sensitivity",
      "conception",
      "mastitis",
      "vaginal",
      "breast",
      "abscess",
      "swab",
      "formation",
      "film",
      "signs",
      "culture",
      "retained",
      "malaria",
      "blood",
      "problems",
      "pelvic",
      "tract"
    ]
  },
  {
    "id": "ddba0a06afedbb6208eea3649b34d3c9",
    "content": "Examination under anaesthesia with possible uterine curettage for retained products of conception\nEncourage frequent emptying of breasts if cause is due to\nengorgement\nIncision and drainage for breast and perianal abscess.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1401",
    "type": "section",
    "keywords": [
      "emptying",
      "perianal",
      "conception",
      "under",
      "breast",
      "abscess",
      "incision",
      "retained",
      "drainage",
      "uterine",
      "cause",
      "breasts",
      "anaesthesia",
      "engorgement",
      "products",
      "possible",
      "curettage",
      "encourage",
      "examination",
      "frequent"
    ]
  },
  {
    "id": "c6cef53432b81ac795516b70f4aaee60",
    "content": "Breast problems - engorgement\nEvidence Rating: [B]\nParacetamol, oral, 1 g 6-8 hourly as required\nBreast problems - mastitis/abscess\nEvidence Rating: [A]\nFlucloxacillin, oral, 500 mg 6 hourly for 5-7 days\nEndo-myometritis and perineal infections\nEvidence Rating: [B]\nAmoxicillin + Clavulanic Acid, IV, 600 mg-1. 2 g 8 hourly for 72 hours\nAnd\nMetronidazole, IV, 500 mg 8 hourly for 72 hours\nThen\nAmoxicillin + Clavulanic Acid, oral, 625 mg-1 g 12 hourly for 7 days\nAnd\nMetronidazole, oral, 400 mg 8 hourly for 7 days\nReferral Criteria\nRefer all cases of severe sepsis to hospital for management.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1402",
    "type": "section",
    "keywords": [
      "infections",
      "metronidazole",
      "management",
      "myometritis",
      "required",
      "evidence",
      "mastitis",
      "breast",
      "hourly",
      "rating",
      "abscess",
      "flucloxacillin",
      "clavulanic",
      "criteria",
      "days",
      "problems",
      "endo",
      "amoxicillin",
      "referral",
      "severe"
    ]
  },
  {
    "id": "b32d325d9e963e19364000b619f7d75c",
    "content": "The pain threshold may be low during labour on account of fear, anxiety and uncertainty. Adequate pain relief during labour results in less anxiety and good progress. In the first stage of labour pain relief may be required for painful uterine contractions, whereas in the second stage of labour, analgesia is required for instrumental delivery and when an episiotomy is given.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1403",
    "type": "section",
    "keywords": [
      "instrumental",
      "given",
      "during",
      "relief",
      "labour",
      "results",
      "required",
      "second",
      "anxiety",
      "delivery",
      "uncertainty",
      "analgesia",
      "stage",
      "first",
      "uterine",
      "painful",
      "progress",
      "fear",
      "pain",
      "threshold"
    ]
  },
  {
    "id": "fdceeb4383b4d192fed9f77ac2eb3f44",
    "content": "During the first stage of labour - parenteral\nEvidence Rating: [C]\nMorphine, IV, 2. 5-5 mg 4 hourly as required\nAnd\nMetoclopramide, IV, 5-10 mg 8 hourly as required for vomiting\nOr\nPethidine hydrochloride, IM, 50-100 mg stat. repeated as required 3-4 hours later (Maximum 400 mg in 24 hours)\nAnd\nPromethazine, IV/IM, 25 mg as required (Maximum 25 mg 6 hourly) as required to reduce the chances of vomiting and to potentiate the analgesic effect of Pethidine\nDuring the first stage of labour – inhalational\nNitrous oxide and Oxygen mixture, 50:50.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1404",
    "type": "section",
    "keywords": [
      "parenteral",
      "during",
      "labour",
      "required",
      "repeated",
      "evidence",
      "effect",
      "hourly",
      "rating",
      "oxygen",
      "metoclopramide",
      "stage",
      "promethazine",
      "stat",
      "analgesic",
      "first",
      "later",
      "hydrochloride",
      "nitrous",
      "pethidine"
    ]
  },
  {
    "id": "6666d8ae1490846a6b77c2d769b0c572",
    "content": "During the first stage of labour - epidural\nDuring the second stage of labour\nLocal Anaesthetics for episiotomy and pudendal block anaesthesia to facilitate instrumental delivery. Lidocaine hydrochloride (Xylocaine/Lignocaine) 1%, with or without\nadrenaline, infiltrated in the perineum before an episiotomy. If not given before delivery it can be given before the repair of the episi- otomy\nAnaesthesia for short obstetric procedures e.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1405",
    "type": "section",
    "keywords": [
      "procedures",
      "local",
      "block",
      "instrumental",
      "given",
      "otomy",
      "during",
      "labour",
      "facilitate",
      "adrenaline",
      "second",
      "delivery",
      "anaesthetics",
      "short",
      "lignocaine",
      "pudendal",
      "stage",
      "lidocaine",
      "epidural",
      "infiltrated"
    ]
  },
  {
    "id": "304690d6ca8626983d172c02571da493",
    "content": "g. manual removal of placenta, repair of large vaginal and cervical tears\nPethidine, IM or IV, 1 mg/kg slowly (max. 100 mg) if no anaesthetist\nis available\nAnd\nPromethazine hydrochloride, IM, 25 mg stat.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1406",
    "type": "section",
    "keywords": [
      "manual",
      "hydrochloride",
      "placenta",
      "large",
      "pethidine",
      "repair",
      "removal",
      "available",
      "slowly",
      "promethazine",
      "anaesthetist",
      "tears",
      "stat",
      "vaginal",
      "cervical"
    ]
  },
  {
    "id": "ee12bce9f7c8693cad3e350fc85b692e",
    "content": "(if vomiting occurs)\nOr\nMetoclopramide, IV, 5-10 mg 8 hourly as required\nAnd\nDiazepam, slow IV, 5-10 mg (at a rate of 2. 5 mg per minute).",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1407",
    "type": "section",
    "keywords": [
      "diazepam",
      "hourly",
      "vomiting",
      "rate",
      "metoclopramide",
      "minute",
      "slow",
      "required",
      "occurs"
    ]
  },
  {
    "id": "8d92f2b9ccb3e0c9df46d5b516b744bd",
    "content": "Ketamine, IM, 5-10 mg/kg stat. Or\nKetamine, IV slowly, 1-2 mg/kg\nOr\nKetamine, IV infusion, (For longer procedures) 1 mg per ml of ket- amine in dextrose 5% or normal saline (maintenance dose 10-45 mi- crogram per kg per minute adjusted according to response. And\nDiazepam, slow IV, 5-10 mg, administered over 2-3 minutes (approx- imately 2.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "1408",
    "type": "section",
    "keywords": [
      "procedures",
      "approx",
      "according",
      "infusion",
      "dextrose",
      "maintenance",
      "slowly",
      "diazepam",
      "minutes",
      "amine",
      "saline",
      "crogram",
      "ketamine",
      "stat",
      "longer",
      "response",
      "slow",
      "dose",
      "imately",
      "adjusted"
    ]
  },
  {
    "id": "9743530f99e8bfd1e6f5a62db4b97c4f",
    "content": "5 mg per minute) to prevent Hallucinations\nPremedication before Ketamine administration\nAtropine, IM, 600 microgram stat. And\nOxygen, by face mask, 6-8 L/minute.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "1409",
    "type": "section",
    "keywords": [
      "ketamine",
      "oxygen",
      "administration",
      "before",
      "minute",
      "prevent",
      "microgram",
      "face",
      "hallucinations",
      "atropine",
      "stat",
      "mask",
      "premedication"
    ]
  },
  {
    "id": "686033005f89273b6fb397e45a55cdf5",
    "content": "Preterm labour refers to labour occurring after 28 weeks but before\n37 completed weeks resulting in premature delivery. The preterm newborn is at risk of death because all its body systems such as lungs, brain, digestive and immune systems are not fully developed. There is increased susceptibility to infection and impaired clotting mechanisms.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1410",
    "type": "section",
    "keywords": [
      "mechanisms",
      "completed",
      "labour",
      "death",
      "refers",
      "fully",
      "impaired",
      "delivery",
      "digestive",
      "body",
      "premature",
      "weeks",
      "because",
      "before",
      "clotting",
      "immune",
      "there",
      "increased",
      "preterm",
      "susceptibility"
    ]
  },
  {
    "id": "8ace80a47b781adc20d65808a20beceb",
    "content": "The baby is also at risk of birth injuries such as cerebral haemorrhage because the fragile cranial bones do not provide sufficient protection for the brain. Some risk factors for preterm labour include young age of mothers, poor socio-economic class and smoking. Causes\nMaternal infections e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1411",
    "type": "section",
    "keywords": [
      "baby",
      "infections",
      "injuries",
      "cranial",
      "factors",
      "labour",
      "poor",
      "mothers",
      "class",
      "causes",
      "include",
      "maternal",
      "socio",
      "because",
      "fragile",
      "also",
      "young",
      "birth",
      "economic",
      "protection"
    ]
  },
  {
    "id": "51c1ff130475f9f752926c5d8ca8f836",
    "content": "g. pyelonephritis, malaria\nIncompetent cervix\nPremature rupture of membranes\nMultiple pregnancies\nAbruptio placentae\nDiabetes mellitus\nPre-eclampsia/eclampsia\nSymptoms\nRegular and painful uterine contractions or abdominal pains\nThere may be a show\nSigns\nSmall maturity\nPalpable regular uterine contractions\nProgressive effacement and dilatation of the cervix\nRuptured membranes\ninvestigations\nFBC\nFasting or Random Blood Glucose\nUltrasound scan (for those not in established labour) for\nGestational age\nFoetal lie\nPresentation\nAmniotic fluid volume\nPlacental site\nEstimation of the foetal weight.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1412",
    "type": "section",
    "keywords": [
      "ultrasound",
      "weight",
      "regular",
      "mellitus",
      "membranes",
      "glucose",
      "labour",
      "established",
      "effacement",
      "fluid",
      "abdominal",
      "multiple",
      "placentae",
      "presentation",
      "progressive",
      "cervix",
      "premature",
      "ruptured",
      "signs",
      "foetal"
    ]
  },
  {
    "id": "384fa720ddc4ea94539ea0e1fd7fce97",
    "content": "To stop uterine contractions if labour is not fully established\nTo allow foetal growth and maturation in utero if feasible\nTo promote foetal lung maturity (gestations 28-34 weeks)\nTo allow labour to progress if it is already well established\nTo treat any underlying cause (e. g. malaria, pyelonephritis).",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1413",
    "type": "section",
    "keywords": [
      "treat",
      "labour",
      "established",
      "fully",
      "feasible",
      "growth",
      "underlying",
      "gestations",
      "foetal",
      "maturation",
      "weeks",
      "malaria",
      "already",
      "allow",
      "uterine",
      "stop",
      "progress",
      "cause",
      "promote",
      "pyelonephritis"
    ]
  },
  {
    "id": "44f4161e0842eb5ae2ad0dd2fa3ac3b2",
    "content": "Avoid sexual intercourse\nAvoid strenuous physical activity\nBed rest\nCervical cerclage suture for cases diagnosed as due to cervical incompetence.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1414",
    "type": "section",
    "keywords": [
      "avoid",
      "activity",
      "cerclage",
      "physical",
      "intercourse",
      "incompetence",
      "strenuous",
      "suture",
      "cases",
      "sexual",
      "rest",
      "diagnosed",
      "cervical"
    ]
  },
  {
    "id": "14e3dbf6bfd5b78b7aa2d3d39acdd101",
    "content": "Tocolysis\nEvidence Rating: [B]\nSalbutamol, IV infusion, 2. 5 mg in 500 ml of Dextrose 5%;\nStart infusion at 10 micrograms per minute (i. e.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1415",
    "type": "section",
    "keywords": [
      "rating",
      "start",
      "minute",
      "infusion",
      "dextrose",
      "micrograms",
      "salbutamol",
      "tocolysis",
      "evidence"
    ]
  },
  {
    "id": "f1d3eafaf3f26f224ebda75a1ed1da26",
    "content": "2 ml per minute) and increase rate gradually according to response at 10 min intervals un- til contractions dimish, then increase rate slowly until contractions cease (Maximum rate 45 micrograms per minute);\nMaintain rate for one hour after contraction has stoped, then grad- ually reduce by 50% every 6 hours; (Maximum duration 48 hours. ) Or\nEvidence Rating: [A]\nNifedipine, oral, 20 mg initially,\nThen\n20 mg after 90 minutes\nIf contractions persist therapy can be continued with 20 mg every 3-8 hours for 48-72 hours as tolerated by patient (max. 160 mg per day)\nMagnesium sulphate, IV, 6 g intravenous load initial over 20 minutes\nThen\n2 g infusion per hour After\nInfusion rate is based on response\nFoetal lung Maturation with Antenatal corticosteroids Gestations between 28-34 weeks\nEvidence Rating: [A]\nBetamethasone, oral, 0.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1416",
    "type": "section",
    "keywords": [
      "sulphate",
      "hour",
      "initial",
      "based",
      "persist",
      "according",
      "intravenous",
      "infusion",
      "magnesium",
      "betamethasone",
      "ually",
      "tolerated",
      "slowly",
      "evidence",
      "increase",
      "therapy",
      "nifedipine",
      "patient",
      "corticosteroids",
      "rating"
    ]
  },
  {
    "id": "07be693ebb5a0392b3987bd87b7e9aea",
    "content": "Dexamethasone, 6 mg 12 hourly for (4 doses)\nReferral Criteria\nTreatment is best done in a hospital where the facilities can support the adequate care of the preterm neonate. Therefore, refer the mother if the clinic cannot adequately care for the immature neonate. It is better to transfer the foetus in-utero to the referral centre.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1417",
    "type": "section",
    "keywords": [
      "neonate",
      "mother",
      "hourly",
      "therefore",
      "hospital",
      "transfer",
      "support",
      "doses",
      "facilities",
      "where",
      "dexamethasone",
      "criteria",
      "treatment",
      "referral",
      "done",
      "cannot",
      "adequately",
      "foetus",
      "clinic",
      "preterm"
    ]
  },
  {
    "id": "f84faac61e3f3d620acd1e4d07114815",
    "content": "This is the rupture of the membranes before the onset of labour. The two types are preterm (before 37 completed weeks) and term (after 37 weeks, but ≥ 1 hour before onset of labour). Causes\nCervical Incompetence\nGenital tract infection\nTrauma\nSymptoms\nGush or leakage of copious fluid from the vagina\nSigns\nSpeculum examination reveals clear fluid from the cervical os or pool of fluid in the posterior vaginal fornix\nSmaller uterine size for the gestational age\nIf complicated by infection (chorioamnionitis)\nFever\nPurulent vaginal discharge\nFoetal tachycardia or bradycardia\nMaternal tachycardia\nUterine tenderness\ninvestigations\nFBC\nSterile speculum examination including swab for culture\nUltrasound scan (if available) for the gestational age, foetal lie and.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1418",
    "type": "section",
    "keywords": [
      "ultrasound",
      "hour",
      "types",
      "completed",
      "chorioamnionitis",
      "sterile",
      "pool",
      "gush",
      "membranes",
      "labour",
      "clear",
      "tachycardia",
      "vaginal",
      "copious",
      "fluid",
      "swab",
      "speculum",
      "including",
      "smaller",
      "incompetence"
    ]
  },
  {
    "id": "bdb3f5a49dd116eba330695d2084f60e",
    "content": "presentation, amniotic fluid volume (normal or reduced), and the placental site. Estimate the foetal weight. Urinalysis and culture.",
    "title": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "section": "Chapter 13:  Obstetrıc Care and Obstetrıc Dısorders",
    "chunk_id": "1419",
    "type": "section",
    "keywords": [
      "amniotic",
      "weight",
      "reduced",
      "placental",
      "presentation",
      "site",
      "urinalysis",
      "foetal",
      "culture",
      "normal",
      "estimate",
      "volume",
      "fluid"
    ]
  },
  {
    "id": "05b7d37bde220308a69d5f1827901891",
    "content": "To prevent and/or treat infection\nTo prevent labour if preterm and baby is very immature\nTo improve foetal survival through improved foetal lung maturity.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1420",
    "type": "section",
    "keywords": [
      "baby",
      "preterm",
      "survival",
      "maturity",
      "treat",
      "prevent",
      "improve",
      "infection",
      "immature",
      "labour",
      "foetal",
      "through",
      "improved",
      "lung"
    ]
  },
  {
    "id": "0a7d4ddbb4039f2c894fc521f10f36ee",
    "content": "Amoxicillin (Amoxycillin), oral, 500 mg 8 hourly for 7 days\nAnd\nMetronidazole, oral, 400 mg 8 hourly for 7 days.",
    "title": "infection Prevention 1st Line Treatment Evidence Rating: [B]",
    "section": "infection Prevention 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "1421",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "amoxicillin",
      "metronidazole",
      "oral",
      "amoxycillin"
    ]
  },
  {
    "id": "282ac2b11f18349d261a21833f9197d9",
    "content": "Amoxicillin + Clavulanic Acid, oral, 625 mg - 1 g 12 hourly for 7 days\ninfection Prevention – patients with penicillin allergy\nErythromycin, oral, 500 mg 6 hourly for 7 days\nAnd\nMetronidazole, oral, 400 mg 8 hourly for 7 days\nFoetal lung maturation – for babies 28-34 weeks\nEvidence Rating: [A]\nBetamethasone, oral, 0. 6-7 mg every 24 hours (2 doses)\nOr\nDexamethasone, oral, 6 mg 12 hourly for (4 doses)\nReferral Criteria\nIf at sub-district level refer patients to hospital or specialist for further management if signs of maternal infection, pregnancy is less than 37 weeks and or premature labour occurs.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "1422",
    "type": "section",
    "keywords": [
      "metronidazole",
      "penicillin",
      "management",
      "labour",
      "betamethasone",
      "evidence",
      "babies",
      "hourly",
      "rating",
      "specialist",
      "district",
      "hospital",
      "doses",
      "clavulanic",
      "premature",
      "signs",
      "foetal",
      "patients",
      "maturation",
      "weeks"
    ]
  },
  {
    "id": "3e4ea6f14221d97cc6518abaf6bd5a92",
    "content": "Dysmenorrhea refers to cyclical lower abdominal pain associated with menstruation. The pain is thought to result from uterine contractions. It may be primary when there is no identifiable cause or secondary when associated with an underlying cause.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1423",
    "type": "section",
    "keywords": [
      "primary",
      "abdominal",
      "pain",
      "identifiable",
      "thought",
      "uterine",
      "result",
      "dysmenorrhea",
      "cause",
      "menstruation",
      "underlying",
      "associated",
      "lower",
      "cyclical",
      "contractions",
      "there",
      "secondary",
      "refers"
    ]
  },
  {
    "id": "425c4c8e1c34cdfa20c9d2f91bec15d1",
    "content": "Causes\nOften no underlying cause (primary)\nUterine fibroids\nChronic pelvic infections e. g. Chlamydial infections\nEndometriosis\nSymptoms\nLower abdominal pain that is cramping or colicky in nature but may\nbe dull and constant\nPain may radiate to the lower back or legs\nNausea, vomiting, headaches and dizziness may sometimes be associated with the pain\nSigns\nNo typical physical signs\ninvestigations\nFBC\nSickling\nPelvic ultrasound scan to rule out pelvic lesions such as fibroids.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1424",
    "type": "section",
    "keywords": [
      "infections",
      "ultrasound",
      "sickling",
      "radiate",
      "nausea",
      "often",
      "lesions",
      "associated",
      "nature",
      "sometimes",
      "primary",
      "abdominal",
      "constant",
      "endometriosis",
      "underlying",
      "signs",
      "dull",
      "cramping",
      "causes",
      "headaches"
    ]
  },
  {
    "id": "977091e0e1043fed44b01e596e8ef0eb",
    "content": "Paracetamol, oral, 1 g 6-8 hourly\nSevere cases\nIbuprofen, oral, 200-400 mg 8 hourly\nOr\nMefenamic Acid, oral, 500 mg 8 hourly\nReferral Criteria\nRefer to a gynaecologist if pain interferes with normal activity especially if treatment is ineffective or an underlying cause is identified. Abortion refers to the expulsion of the foetus and other products of conception before the 28th week of pregnancy. It may occur spontaneously (threatened, inevitable, incomplete, complete or missed) or be induced (therapeutic, criminal).",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1425",
    "type": "section",
    "keywords": [
      "activity",
      "incomplete",
      "occur",
      "especially",
      "expulsion",
      "induced",
      "complete",
      "refers",
      "conception",
      "ibuprofen",
      "criminal",
      "abortion",
      "hourly",
      "mefenamic",
      "week",
      "identified",
      "underlying",
      "missed",
      "pregnancy",
      "criteria"
    ]
  },
  {
    "id": "151f0f7dcde82137b7cc972ed81270cd",
    "content": "Both spontaneous and induced abortion may become complicated by infection (sepsis) and/or profuse bleeding. After appropriate treatment and discharge from hospital, it is recommended that patients report back to hospital if there is lower abdominal pain, fever, vaginal bleeding and malodorous discharge. A follow up review should also be done in two weeks.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1426",
    "type": "section",
    "keywords": [
      "both",
      "induced",
      "report",
      "vaginal",
      "abortion",
      "review",
      "abdominal",
      "follow",
      "bleeding",
      "patients",
      "weeks",
      "treatment",
      "complicated",
      "fever",
      "should",
      "also",
      "done",
      "there",
      "profuse",
      "back"
    ]
  },
  {
    "id": "96eff4ec64c879adeac22729c9c9a54d",
    "content": "Causes\nSpontaneous Abortions\nInfections e. g. malaria, UTI, bacterial vaginosis etc.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1427",
    "type": "section",
    "keywords": [
      "infections",
      "abortions",
      "spontaneous",
      "vaginosis",
      "bacterial",
      "malaria",
      "causes"
    ]
  },
  {
    "id": "886025b0e21b366ffdbf523600ca3b47",
    "content": "Trauma\nUnsafe Abortions\nInterference of the pregnancy with medications (oral, parenter- al or douches) or instrumentation\nTHREATENED ABORTiON\nSymptoms\nScanty to moderate painless vaginal bleeding\nMild pelvic discomfort\nSigns\nThe uterine size is compatible with the gestational age.",
    "title": "Chronic illness e.g. diabetes, thyroid disorders, sickle cell dis- ease etc.",
    "section": "Chronic illness e.g. diabetes, thyroid disorders, sickle cell dis- ease etc.",
    "chunk_id": "1428",
    "type": "section",
    "keywords": [
      "abortions",
      "discomfort",
      "instrumentation",
      "vaginal",
      "abortion",
      "interference",
      "moderate",
      "bleeding",
      "unsafe",
      "parenter",
      "signs",
      "pregnancy",
      "pelvic",
      "scanty",
      "medications",
      "threatened",
      "uterine",
      "size",
      "compatible",
      "symptoms"
    ]
  },
  {
    "id": "8a109c807403cb9febca3b818404d07f",
    "content": "There is no cervical effacement or dilatation\ninvestigations\nFBC and sickling\nUltrasound scan (to confirm viable foetus in utero with closed cervix)\nOther investigations for potential underlying causes e. g. malaria.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1429",
    "type": "section",
    "keywords": [
      "ultrasound",
      "sickling",
      "effacement",
      "potential",
      "cervix",
      "underlying",
      "malaria",
      "causes",
      "dilatation",
      "viable",
      "there",
      "foetus",
      "investigations",
      "cervical",
      "closed",
      "scan",
      "other",
      "utero",
      "confirm"
    ]
  },
  {
    "id": "b894894b1d48073b95873020fd54b8d5",
    "content": "Bed rest at home or hospital\nTo abstain from sexual intercourse\nTo report back if bleeding or pain increases.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1430",
    "type": "section",
    "keywords": [
      "pain",
      "abstain",
      "increases",
      "intercourse",
      "bleeding",
      "sexual",
      "rest",
      "back",
      "report",
      "hospital",
      "home"
    ]
  },
  {
    "id": "a6632786f20993aa9deeea0adb9e101a",
    "content": "Treat any underlying illnesses e. g. malaria\niNEViTABLE ABORTiON\nSymptoms\nLower abdominal pain\nHeavy vaginal bleeding\nNo foetus or products of conception passed per vagina\nPainless loss of liquor per vaginam\nSigns\nThe cervix is dilated with the membranes bulging\nThere may be loss of liquor\nThe uterine size is compatible with the gestational age\nThere may be signs of shock pallor, collapsed peripheral vessels, rising pulse with reducing volume, falling BP and cold clammy skin\ninvestigations\nFBC and sickling\nBlood grouping and cross matching\nUltrasound scan (shows the foetus dead or alive)\nCervix may be dilated with membranes bulging through it\nIn instances associated with loss of liquor there may be oligohydraminios\nUltrasound is necessary only if the diagnosis is in doubt.",
    "title": "No specific treatment required",
    "section": "No specific treatment required",
    "chunk_id": "1431",
    "type": "section",
    "keywords": [
      "ultrasound",
      "sickling",
      "bulging",
      "clammy",
      "instances",
      "treat",
      "oligohydraminios",
      "grouping",
      "membranes",
      "associated",
      "liquor",
      "conception",
      "vaginal",
      "abortion",
      "vessels",
      "abdominal",
      "doubt",
      "vaginam",
      "bleeding",
      "cervix"
    ]
  },
  {
    "id": "d2477e6a2a22ac5f36ea30e1d58e8dd4",
    "content": "To resuscitate patient and/or prevent shock\nTo relieve pain\nTo allow the patient to abort (assist uterine contractions if weak)\nTo evacuate the retained products of conception from the uterus.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1432",
    "type": "section",
    "keywords": [
      "allow",
      "pain",
      "resuscitate",
      "abort",
      "assist",
      "prevent",
      "weak",
      "uterine",
      "evacuate",
      "uterus",
      "shock",
      "relieve",
      "products",
      "contractions",
      "retained",
      "patient",
      "conception"
    ]
  },
  {
    "id": "8f483d36452e6ba15ab16707f1bcde53",
    "content": "To determine cause of abortion if recurrent\nTo prevent infection with antibiotic prophylaxis\nTo prevent risk of Rhesus incompatibility in future pregnancies.",
    "title": "Chapter 14: Gynaecologıcal Dısorders",
    "section": "Chapter 14: Gynaecologıcal Dısorders",
    "chunk_id": "1433",
    "type": "section",
    "keywords": [
      "determine",
      "recurrent",
      "prevent",
      "infection",
      "cause",
      "prophylaxis",
      "pregnancies",
      "risk",
      "antibiotic",
      "incompatibility",
      "rhesus",
      "future",
      "abortion"
    ]
  },
  {
    "id": "5d5c33aaa36360ec37031d195001fd13",
    "content": "Evacuation of the uterus is done by either of the following techniques after the expulsion of the foetus or before the expulsion of the foetus if it is less than 12-14 weeks size\nManual Vacuum Aspiration (MVA) with or without paracervical\nblock anaesthesia\nOr\nUterine curettage under paracervical block or general anaes- thesia (Gestations 12 weeks or less\nUterine evacuation under anaesthesia especially when the\nuterine size is larger than 12 weeks size.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1434",
    "type": "section",
    "keywords": [
      "either",
      "vacuum",
      "block",
      "especially",
      "expulsion",
      "under",
      "aspiration",
      "following",
      "paracervical",
      "gestations",
      "weeks",
      "anaes",
      "manual",
      "before",
      "uterine",
      "done",
      "evacuation",
      "size",
      "foetus",
      "larger"
    ]
  },
  {
    "id": "59b907f0fc2b5e097c9e931564b75906",
    "content": "if patient is in shock or bleeding is severe\nIV fluids and blood transfusion as necessary\nTo relieve severe pain\nEvidence Rating: [C]\nMorphine, IV, 2. 5-5 mg 4 hourly as required\nAnd\nMetoclopramide, IV, 5-10 mg 8 hourly as required for vomiting\nOr\nPethidine, IM, 75-100 mg stat. Then\n50-100 mg 6-8 hourly if required\nAnd\nPromethazine, IV/IM, 25 mg as required (max.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1435",
    "type": "section",
    "keywords": [
      "required",
      "patient",
      "evidence",
      "hourly",
      "rating",
      "metoclopramide",
      "bleeding",
      "fluids",
      "promethazine",
      "blood",
      "stat",
      "severe",
      "pethidine",
      "shock",
      "then",
      "transfusion",
      "morphine",
      "vomiting",
      "pain",
      "necessary"
    ]
  },
  {
    "id": "ad16aaae7560f5585dcc7d37eef512d2",
    "content": "25 mg 6 hourly) as required to reduce the chances of vomiting and to potentiate the analgesic effect of Pethidine\nEvacuate uterus\nIf uterine size > 12-14 weeks Evidence Rating: [A]\nOxytocin, IV, 10-20 units per litre of Normal saline\nOr\nUterine size <12 weeks Evidence Rating: [C]\nMisoprostol, oral/SL, 600 microgram stat. To Prevent infection\nAmoxicillin, oral, 500 mg 8 hourly for 5-7days\nAnd\nMetronidazole, oral, 400 mg 8 hourly for 5-7days.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1436",
    "type": "section",
    "keywords": [
      "metronidazole",
      "units",
      "required",
      "evidence",
      "effect",
      "hourly",
      "rating",
      "prevent",
      "oxytocin",
      "litre",
      "saline",
      "misoprostol",
      "weeks",
      "stat",
      "analgesic",
      "amoxicillin",
      "evacuate",
      "uterine",
      "pethidine",
      "size"
    ]
  },
  {
    "id": "5335a43278644c45c27370ee7813fc1b",
    "content": "To prevent Rhesus isommunization in Rhesus negative women\nEvidence Rating: [A]\nAnti D Rh Immune Globulin, IM, 300 microgram (1,500 Units), stat. within 72 hours of abortion\niNCOMPLETE ABORTiON\nSymptoms\nPassage of large blood clots and/or the foetus and some products per vaginam\nSevere lower abdominal pain\nSigns\nIf bleeding is severe: Pallor and/or Shock (collapsed peripheral vessels, fast pulse, falling BP and cold clammy skin)\nUterine size is smaller than the dates\nCervix is dilated with the foetus already aborted\nWhole placenta or parts thereof may be present within the uterine\ncavity\ninvestigations\nFBC and sickling\nBlood grouping and cross matching\nUltrasound scan (to be requested if doubt exists in the diagnosis especially in early pregnancies).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1437",
    "type": "section",
    "keywords": [
      "ultrasound",
      "sickling",
      "units",
      "clammy",
      "incomplete",
      "globulin",
      "placenta",
      "especially",
      "exists",
      "grouping",
      "requested",
      "evidence",
      "abortion",
      "vessels",
      "rating",
      "within",
      "abdominal",
      "doubt",
      "prevent",
      "vaginam"
    ]
  },
  {
    "id": "a03c635ee03b041f298bf77fd0d8ede0",
    "content": "To resuscitate patient\nTo evacuate the retained products of conception from the uterus\nTo prevent infection with antibiotic prophylaxis\nTo determine cause of abortion, if recurrent\nTo prevent risk of Rhesus incompatibility in future pregnancies.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1438",
    "type": "section",
    "keywords": [
      "determine",
      "recurrent",
      "antibiotic",
      "patient",
      "conception",
      "future",
      "abortion",
      "resuscitate",
      "prevent",
      "retained",
      "evacuate",
      "cause",
      "pregnancies",
      "incompatibility",
      "rhesus",
      "uterus",
      "infection",
      "prophylaxis",
      "products",
      "risk"
    ]
  },
  {
    "id": "b865a5f8deffa85eb49c7e9b1006cc49",
    "content": "Digital curettage during vaginal examination to remove as much of the retained tissues as possible\nSurgical evacuation of retained products of conception e. g. manual\nvacuum aspiration (MVA) with or without anaesthesia\nPost abortion abstention from sexual intercourse for at least 2 weeks\nPost abortion counselling and psychological support (including Family Planning).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1439",
    "type": "section",
    "keywords": [
      "vacuum",
      "digital",
      "abstention",
      "psychological",
      "during",
      "family",
      "conception",
      "vaginal",
      "abortion",
      "aspiration",
      "support",
      "including",
      "planning",
      "counselling",
      "weeks",
      "retained",
      "post",
      "manual",
      "surgical",
      "evacuation"
    ]
  },
  {
    "id": "c01cea48118f2bda0dd9f84695c22ea0",
    "content": "if in shock and/or severe bleeding\nIV fluids and blood transfusion as necessary\nAbortion with uterine size < 12 weeks\nEvidence Rating: [A]\nErgometrine, IM/IV, 500 microgram stat.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1440",
    "type": "section",
    "keywords": [
      "severe",
      "transfusion",
      "evidence",
      "rating",
      "ergometrine",
      "microgram",
      "uterine",
      "bleeding",
      "shock",
      "necessary",
      "size",
      "fluids",
      "weeks",
      "blood",
      "stat",
      "abortion"
    ]
  },
  {
    "id": "32bed0ba8e7f69642bbaf36fc202749b",
    "content": "Or\nMisoprostol, oral, 600 microgram stat. Or\nMisoprostol, sublingual, 400 microgram stat. Abortion with uterine size > 12 weeks and ≤ 24 weeks\nEvidence Rating: [A]\nMisoprostol, oral, 600 micrograms stat.",
    "title": "Chapter 14: Gynaecologıcal Dısorders",
    "section": "Chapter 14: Gynaecologıcal Dısorders",
    "chunk_id": "1441",
    "type": "section",
    "keywords": [
      "rating",
      "microgram",
      "uterine",
      "size",
      "misoprostol",
      "oral",
      "sublingual",
      "micrograms",
      "weeks",
      "evidence",
      "stat",
      "abortion"
    ]
  },
  {
    "id": "80a82a8408900a6b53a1c0cd0a9313c7",
    "content": "Or\nMisoprostol, sublingual, 400 micrograms stat. Abortion with uterine size > 24 weeks\nEvidence Rating: [B]\nOxytocin, IV, 20 units into 1 L of Sodium Chloride 0. 9% and infuse at 30-60 drops per minute\nOr\nMisoprostol, oral, 600 micrograms stat.",
    "title": "Chapter 14: Gynaecologıcal Dısorders",
    "section": "Chapter 14: Gynaecologıcal Dısorders",
    "chunk_id": "1442",
    "type": "section",
    "keywords": [
      "units",
      "drops",
      "infuse",
      "evidence",
      "into",
      "abortion",
      "rating",
      "oxytocin",
      "sodium",
      "misoprostol",
      "weeks",
      "stat",
      "uterine",
      "size",
      "chloride",
      "minute",
      "oral",
      "sublingual",
      "micrograms"
    ]
  },
  {
    "id": "698930376f9fb2f32893c7f34f48fa69",
    "content": "Or\nMisoprostol, sublingual, 400 micrograms stat. To prevent infection\nAmoxicillin, oral, 500 mg 8 hourly for 5-7days\nAnd\nMetronidazole, oral, 400 mg 8 hourly for 5-7days\nTo prevent infection – in patients with penicllin allergy\nErythromycin, oral, 500 mg 8 hourly for 5-7days\nAnd\nMetronidazole, oral, 400 mg 8 hourly for 5-7days\nTo prevent Rhesus isommunization\nEvidence Rating: [A]\n(See section under ‘Inevitable Abortion’ above)\nCOMPLETE ABORTiON\nSymptoms\nCessation or reduction of vaginal bleeding following heavy bleeding with passage of clots and/or the foetus and placenta. Resolution or abatement of pain\nSigns\nThe uterus is smaller than the gestational age\nThe cervix is closed and firm\nNo pelvic tenderness\ninvestigations\nFBC\nBlood grouping and cross matching\nUltrasound scan: to confirm empty uterine cavity.",
    "title": "Chapter 14: Gynaecologıcal Dısorders",
    "section": "Chapter 14: Gynaecologıcal Dısorders",
    "chunk_id": "1443",
    "type": "section",
    "keywords": [
      "ultrasound",
      "metronidazole",
      "resolution",
      "empty",
      "placenta",
      "abatement",
      "firm",
      "grouping",
      "complete",
      "evidence",
      "under",
      "abortion",
      "vaginal",
      "hourly",
      "rating",
      "following",
      "prevent",
      "smaller",
      "section",
      "isommunization"
    ]
  },
  {
    "id": "4154a425afee0c55a2a52eb47db7e7b7",
    "content": "To confirm abortion is complete\nTo assess for and manage anaemia if present\nTo assess for and manage pelvic infection if present\nTo prevent risk of Rhesus incompatibility in future pregnancies.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1444",
    "type": "section",
    "keywords": [
      "pelvic",
      "present",
      "anaemia",
      "manage",
      "prevent",
      "infection",
      "confirm",
      "assess",
      "pregnancies",
      "risk",
      "incompatibility",
      "complete",
      "rhesus",
      "future",
      "abortion"
    ]
  },
  {
    "id": "dce02a98194f907d259ad208af492e21",
    "content": "Counselling and psychological support (including family Planning).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1445",
    "type": "section",
    "keywords": [
      "support",
      "psychological",
      "including",
      "planning",
      "counselling",
      "family"
    ]
  },
  {
    "id": "fee04b617390983d6450841ce023831e",
    "content": "Treat anaemia if present (See section on ‘Anaemia in Pregnancy’).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1446",
    "type": "section",
    "keywords": [
      "present",
      "treat",
      "anaemia",
      "section",
      "pregnancy"
    ]
  },
  {
    "id": "9e6a60925308583f633a22b2a0fbedf7",
    "content": "Provide Anti D Immune globulin if Indicated (See section under ‘Inev-\nitable Abortion’ above)\nSEPTiC ABORTiON\nThis is a life threatening complication of abortion. Most often there is a history of criminal interference with the pregnancy. It may lead to complications such as septic shock, uterine damage, peritonitis, haemorrhage, disseminated intravascular coagulation (DIC), acute renal failure, adult respiratory distress syndrome, tetanus or gas gangrene.",
    "title": "Provide antibiotics if needed (See section on treatment of ‘Incomplete Abortion’)",
    "section": "Provide antibiotics if needed (See section on treatment of ‘Incomplete Abortion’)",
    "chunk_id": "1447",
    "type": "section",
    "keywords": [
      "peritonitis",
      "intravascular",
      "globulin",
      "often",
      "tetanus",
      "lead",
      "acute",
      "under",
      "abortion",
      "criminal",
      "interference",
      "gangrene",
      "complication",
      "section",
      "inev",
      "disseminated",
      "most",
      "pregnancy",
      "renal",
      "above"
    ]
  },
  {
    "id": "0908aeb7410ae7635a598a49f3096fc4",
    "content": "Causes\nInfected retained products of conception\nSymptoms\nSevere lower abdominal pain\nFever\nVomiting\nHeadache\nOffensive, bloody vaginal discharge\nSigns\nFever (but temperature may be normal)\nTachycardia\nIf in septic shock: low blood pressure\nPeritonism\nBulky tender uterus\nCervix may be opened or closed\nRetained offensive products of conception\ninvestigations\nFBC and sickling test\nClotting screen\nBlood grouping and cross matching\nBlood culture and sensitivity\nUrine culture and sensitivity.",
    "title": "Provide antibiotics if needed (See section on treatment of ‘Incomplete Abortion’)",
    "section": "Provide antibiotics if needed (See section on treatment of ‘Incomplete Abortion’)",
    "chunk_id": "1448",
    "type": "section",
    "keywords": [
      "sickling",
      "test",
      "headache",
      "offensive",
      "grouping",
      "infected",
      "urine",
      "peritonism",
      "tachycardia",
      "sensitivity",
      "conception",
      "opened",
      "vaginal",
      "abdominal",
      "pressure",
      "cervix",
      "signs",
      "culture",
      "tender",
      "retained"
    ]
  },
  {
    "id": "0d87824cf0e66e3cfb88177303c6e12f",
    "content": "Endo-cervical swab for culture and sensitivity\nBlood urea and electrolytes\nChest and abdominal X-ray (to exclude foreign body, gas under the diaphragm suggesting uterine perforation)\nAbdomino-pelvic ultrasonography (for intra-abdominal and pelvic\nabscesses, presence of products in uterus, fluids and gas in the pelvis).",
    "title": "Chapter 14: Gynaecologıcal Dısorders",
    "section": "Chapter 14: Gynaecologıcal Dısorders",
    "chunk_id": "1449",
    "type": "section",
    "keywords": [
      "intra",
      "sensitivity",
      "diaphragm",
      "under",
      "swab",
      "abdominal",
      "body",
      "chest",
      "foreign",
      "pelvis",
      "fluids",
      "culture",
      "presence",
      "abdomino",
      "blood",
      "endo",
      "pelvic",
      "electrolytes",
      "ultrasonography",
      "uterine"
    ]
  },
  {
    "id": "a7a98c504778c9f3d71e0405bc5ceb7a",
    "content": "To resuscitate patient\nTo treat infection\nTo evacuate uterus\nTo provide post-abortion counselling.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1450",
    "type": "section",
    "keywords": [
      "post",
      "evacuate",
      "resuscitate",
      "treat",
      "uterus",
      "infection",
      "counselling",
      "provide",
      "patient",
      "abortion"
    ]
  },
  {
    "id": "60911aa9821d7661e15c596fb0317b00",
    "content": "Evacuate the retained products of conception (careful evacuation of the uterus must be done as risk of uterine perforation is high)\nGentle digital curettage followed by the instrumental curettage\nunder general anaesthesia within 6 hours of initiation of antibiotic\ntherapy\nExamine to confirm if uterus is perforated and determine if surgery\nis required\nPsychological support and family planning counselling.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1451",
    "type": "section",
    "keywords": [
      "determine",
      "digital",
      "instrumental",
      "psychological",
      "family",
      "antibiotic",
      "required",
      "therapy",
      "conception",
      "under",
      "gentle",
      "within",
      "initiation",
      "support",
      "planning",
      "counselling",
      "retained",
      "followed",
      "examine",
      "evacuate"
    ]
  },
  {
    "id": "029b52a8b989958133d6095a3a29c721",
    "content": "Resuscitation for shock Evidence Rating: [A]\nIV fluids and blood transfusion as necessary.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1452",
    "type": "section",
    "keywords": [
      "transfusion",
      "rating",
      "blood",
      "shock",
      "necessary",
      "resuscitation",
      "fluids",
      "evidence"
    ]
  },
  {
    "id": "4271285d33d08fc8606b8b05c28cc120",
    "content": "Amoxicillin + Clavulanic Acid, IV, 1. 2 g 8 hourly for 24-72 hours\nAnd\nGentamicin, IV, 80 mg 8 hourly for 5 days\nAnd\nMetronidazole, IV, 500 mg 8 hourly for 24-72 hours\nEvacuate uterus.",
    "title": "Treatment of Sepsis",
    "section": "Treatment of Sepsis",
    "chunk_id": "1453",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "amoxicillin",
      "gentamicin",
      "metronidazole",
      "evacuate",
      "acid",
      "uterus",
      "clavulanic",
      "hours"
    ]
  },
  {
    "id": "43b32574ffc11c62ce338c082b58651e",
    "content": "Oxytocin, IV infusion\n(See section on ‘Inevitable Abortion’)\nOr\nMisoprostol, sublingual oral or vaginal, 600 microgram stat. (See section on ‘Incomplete Abortion’ above)\nSevere Pain management\nEvidence Rating: [C]\nMorphine, IV, 2. 5-5 mg 4 hourly as required\nAnd\nMetoclopramide, IV, 5-10 mg 8 hourly as required for vomiting\nOr\nPethidine, IM, 50-100 mg 4-6 hourly (Maximum 400 mg in 24 hours)\nAnd\nPromethazine, IV/IM, 25 mg 8-12 hourly as required (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1454",
    "type": "section",
    "keywords": [
      "incomplete",
      "management",
      "infusion",
      "required",
      "evidence",
      "vaginal",
      "abortion",
      "hourly",
      "rating",
      "metoclopramide",
      "oxytocin",
      "section",
      "misoprostol",
      "promethazine",
      "stat",
      "severe",
      "above",
      "pethidine",
      "morphine",
      "vomiting"
    ]
  },
  {
    "id": "b7fe8739b1d86fcda37f364eb4f1d639",
    "content": "25 mg 6 hourly) to reduce the chances of vomiting and to potentiate the analgesic effect of Pethidine\nTetanus Prophylaxis\nTetanol, IM, 0. 5 ml stat. And\nHuman Immune Tetanus Globulin, IM, 250-500 units stat.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1455",
    "type": "section",
    "keywords": [
      "hourly",
      "vomiting",
      "human",
      "units",
      "globulin",
      "tetanus",
      "reduce",
      "pethidine",
      "chances",
      "effect",
      "prophylaxis",
      "potentiate",
      "immune",
      "tetanol",
      "stat",
      "analgesic"
    ]
  },
  {
    "id": "4dac32266ea2317715ca832e8a7004c0",
    "content": "MISSED ABORTION\nThis refers to foetal death in-utero before 28 weeks gestation. Symptoms\nThere is reversal of the symptoms of pregnancy\nThere may be recurrent bloody vaginal discharge\nAbsent maternal perception of foetal movements (if quickening has already occurred)\nSigns\nUterus is smaller than gestational age / dates\nFoetal heart tones are not heard either with the Pinards stethoscope or with a foetal Doppler device such as Sonicaid\ninvestigations\nFBC and sickling test\nBlood grouping and cross matching\nBlood film for malaria parasites if necessary\nBlood clotting profile for the larger pregnancies\nPregnancy test\nUltrasound scan\nFasting blood sugar.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1456",
    "type": "section",
    "keywords": [
      "ultrasound",
      "sickling",
      "either",
      "recurrent",
      "test",
      "sonicaid",
      "profile",
      "absent",
      "grouping",
      "death",
      "refers",
      "vaginal",
      "abortion",
      "quickening",
      "stethoscope",
      "occurred",
      "movements",
      "doppler",
      "smaller",
      "film"
    ]
  },
  {
    "id": "590b56a887972798c963c1de616c4fc8",
    "content": "To make patient fit for uterine evacuation\nTo ensure safe uterine evacuation\nTo establish cause of foetal death if possible.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1457",
    "type": "section",
    "keywords": [
      "safe",
      "ensure",
      "uterine",
      "establish",
      "evacuation",
      "cause",
      "possible",
      "foetal",
      "death",
      "patient"
    ]
  },
  {
    "id": "46b440cc13d786774ec0a2f0c0199a14",
    "content": "Evacuation of the uterus by suction curettage (manual or with machine); < 12 weeks gestation\nSurgical evacuation of uterus (D&E) after cervical ripening with\nmedication; second trimester.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1458",
    "type": "section",
    "keywords": [
      "manual",
      "surgical",
      "ripening",
      "uterus",
      "machine",
      "gestation",
      "medication",
      "evacuation",
      "second",
      "after",
      "suction",
      "curettage",
      "weeks",
      "trimester",
      "cervical"
    ]
  },
  {
    "id": "ef192251122dcf9069128af5ee78ada4",
    "content": "Ripening of cervix to facilitate surgical evacuation\nEvidence Rating: [A]\nMisoprostol, oral or vaginal, 400 micrograms stat. at least 3 hours prior to surgical evacuation\nEmptying uterus with Medication in Missed Abortion.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1459",
    "type": "section",
    "keywords": [
      "emptying",
      "facilitate",
      "evidence",
      "vaginal",
      "abortion",
      "rating",
      "cervix",
      "misoprostol",
      "missed",
      "prior",
      "stat",
      "surgical",
      "medication",
      "evacuation",
      "ripening",
      "least",
      "uterus",
      "oral",
      "micrograms",
      "hours"
    ]
  },
  {
    "id": "d3a30fecd372b3e2371926a872826e8d",
    "content": "Or\nEvidence Rating: [B]\nOxytocin drip may be used for induction where other cervical ripen- ing methods (e. g. Foleys catheter balloon) are used.",
    "title": "(See section on Misoprostol treatment under ‘Induced Abortion’ below)",
    "section": "(See section on Misoprostol treatment under ‘Induced Abortion’ below)",
    "chunk_id": "1460",
    "type": "section",
    "keywords": [
      "rating",
      "balloon",
      "ripen",
      "oxytocin",
      "other",
      "catheter",
      "foleys",
      "where",
      "drip",
      "methods",
      "induction",
      "used",
      "evidence",
      "cervical"
    ]
  },
  {
    "id": "98a76d13c7b60c206f02dfc1ed2e6d64",
    "content": "iNDUCED (SAFE) ABORTiON\nThis refers to the deliberate termination of pregnancy. Termination of pregnancy is requested for and done for reasons permissible by law either through a surgical procedure or by pharmacological means. Under the current provisions for Ghana, an induced abortion may be carried out legally only under the following conditions: in case of rape, defilement or incest; threat to the physical and mental health of the mother; presence of foetal abnormality and mental retardation of the mother.",
    "title": "(See section on Misoprostol treatment under ‘Induced Abortion’ below)",
    "section": "(See section on Misoprostol treatment under ‘Induced Abortion’ below)",
    "chunk_id": "1461",
    "type": "section",
    "keywords": [
      "safe",
      "either",
      "pharmacological",
      "incest",
      "mental",
      "mother",
      "health",
      "threat",
      "induced",
      "requested",
      "refers",
      "abnormality",
      "under",
      "abortion",
      "deliberate",
      "following",
      "permissible",
      "termination",
      "foetal",
      "presence"
    ]
  },
  {
    "id": "f8b8eaedc1776499d2cda167456fcdbe",
    "content": "Patients given a pharmacological option for abortion will need to be monitored closely for completeness of the abortion process. They should be informed to report back immediately in cases of profuse or heavy vaginal bleeding, fever or offensive vaginal discharge. investigations\nFBC\nBlood group and Rhesus factor.",
    "title": "(See section on Misoprostol treatment under ‘Induced Abortion’ below)",
    "section": "(See section on Misoprostol treatment under ‘Induced Abortion’ below)",
    "chunk_id": "1462",
    "type": "section",
    "keywords": [
      "pharmacological",
      "closely",
      "given",
      "report",
      "vaginal",
      "abortion",
      "process",
      "immediately",
      "informed",
      "bleeding",
      "factor",
      "need",
      "patients",
      "heavy",
      "blood",
      "option",
      "monitored",
      "should",
      "fever",
      "back"
    ]
  },
  {
    "id": "5131c0b739f6a5c3f36eb9e460e0d6ef",
    "content": "Special Investigations for medico-legal indications e. g. rape (DNA, HIV status etc.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1463",
    "type": "section",
    "keywords": [
      "indications",
      "legal",
      "special",
      "investigations",
      "medico",
      "status",
      "rape"
    ]
  },
  {
    "id": "6185e395a8ea0c5ca903e32a01a4a7cf",
    "content": "To ensure that legal requirements for termination are met\nTo ensure safe abortion\nTo provide family planning counselling and services as needed\nTo prevent risk of Rhesus incompatibility in future pregnancies.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1464",
    "type": "section",
    "keywords": [
      "safe",
      "ensure",
      "prevent",
      "planning",
      "counselling",
      "needed",
      "legal",
      "termination",
      "requirements",
      "provide",
      "pregnancies",
      "family",
      "risk",
      "incompatibility",
      "rhesus",
      "services",
      "future",
      "abortion"
    ]
  },
  {
    "id": "c0fbd72d0704b76b8ae4ca0d0b849d6a",
    "content": "Manual Vacuum Aspiration (4-12 week gestation)\nDilatation and curettage (4-12 week gestation)\nCervical ripening followed by Dilatation and Evacuation (D&E)\n(> 12 weeks gestation).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1465",
    "type": "section",
    "keywords": [
      "aspiration",
      "followed",
      "manual",
      "ripening",
      "gestation",
      "week",
      "dilatation",
      "evacuation",
      "curettage",
      "weeks",
      "vacuum",
      "cervical"
    ]
  },
  {
    "id": "2110d33d0906d713810b91afc844c433",
    "content": "A. Medication Abortion\nEvidence Rating: [A]\nMifepristone\nThen\nMisoprostol\n(See Table below for dosage regimes for the various gestational ages. ).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1466",
    "type": "section",
    "keywords": [
      "ages",
      "rating",
      "various",
      "below",
      "mifepristone",
      "regimes",
      "medication",
      "dosage",
      "misoprostol",
      "table",
      "then",
      "evidence",
      "gestational",
      "abortion"
    ]
  },
  {
    "id": "f4ea83f5e9721d9c0d8e6ad10f150537",
    "content": "Referral Criteria\nFor all types of abortion, refer early for specialist care if the uterus is suspected or found to be perforated or if complications e. g. infection or profuse bleeding are severe.",
    "title": "Chapter 14: Gynaecologıcal Dısorders",
    "section": "Chapter 14: Gynaecologıcal Dısorders",
    "chunk_id": "1467",
    "type": "section",
    "keywords": [
      "severe",
      "referral",
      "types",
      "specialist",
      "perforated",
      "complications",
      "suspected",
      "uterus",
      "infection",
      "early",
      "refer",
      "bleeding",
      "found",
      "profuse",
      "criteria",
      "care",
      "abortion"
    ]
  },
  {
    "id": "d11c9531b4b4be084eec5ab987d755e9",
    "content": "stat = single dose taken immediately, PPH = postpartum haemorrhage\nNote: Misoprostol is associated with an increase in shivering, diarrhoea, and temperature high- er than 38°C.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1468",
    "type": "section",
    "keywords": [
      "diarrhoea",
      "shivering",
      "immediately",
      "taken",
      "single",
      "postpartum",
      "misoprostol",
      "high",
      "dose",
      "associated",
      "note",
      "increase",
      "temperature",
      "stat",
      "haemorrhage"
    ]
  },
  {
    "id": "491fa44d7f66dc4b2968352f593ace15",
    "content": "This refers to bleeding which deviates from the normal menstrual pattern (in terms of the amount, duration or interval). Abnormal menstrual patterns and bleeding are common in young adolescents and women within the ages of 45-50 years. No cause may be found on investigation in these age groups as it is mostly due to immaturity or ageing of the ovaries and its pituitary controls.",
    "title": "Chapter 14: Gynaecologıcal Dısorders",
    "section": "Chapter 14: Gynaecologıcal Dısorders",
    "chunk_id": "1469",
    "type": "section",
    "keywords": [
      "ages",
      "adolescents",
      "years",
      "pituitary",
      "menstrual",
      "interval",
      "which",
      "controls",
      "mostly",
      "refers",
      "deviates",
      "within",
      "bleeding",
      "abnormal",
      "terms",
      "women",
      "amount",
      "duration",
      "cause",
      "young"
    ]
  },
  {
    "id": "c170d807d18f7af062944f5140339722",
    "content": "Bleeding may be mild or severe and life threatening. In other age groups, the causes are multiple and may be associated with the identifiable disorders. Postmenopausal bleeding is said to occur when a woman who has stopped having menstruation for 6-12 or more months begins to bleed per vagina.",
    "title": "Chapter 14: Gynaecologıcal Dısorders",
    "section": "Chapter 14: Gynaecologıcal Dısorders",
    "chunk_id": "1470",
    "type": "section",
    "keywords": [
      "occur",
      "having",
      "bleed",
      "associated",
      "identifiable",
      "said",
      "multiple",
      "bleeding",
      "stopped",
      "causes",
      "severe",
      "begins",
      "menstruation",
      "disorders",
      "groups",
      "postmenopausal",
      "threatening",
      "months",
      "mild",
      "woman"
    ]
  },
  {
    "id": "a95cbdb7d277c87dca327c7bbd9dd7bb",
    "content": "Occasionally bleeding from the rectum and urethra may be confused with genital tract bleeding.",
    "title": "Chapter 14: Gynaecologıcal Dısorders",
    "section": "Chapter 14: Gynaecologıcal Dısorders",
    "chunk_id": "1471",
    "type": "section",
    "keywords": [
      "tract",
      "bleeding",
      "confused",
      "rectum",
      "genital",
      "urethra",
      "occasionally"
    ]
  },
  {
    "id": "aba8189a0f978ce835ee64808364006d",
    "content": "Causes\nPre-pubertal girls\nUrethral mucosal prolapse\nCoital lacerations due to rape and defilement\nTrauma\nYoung Adolescents\nDysfunctional uterine bleeding\nComplications of pregnancy\nCoital lacerations due to rape and defilement\nAccidental traumatic lesions of vulva and vagina\nWomen of Child Bearing Age\nComplications of pregnancy, including ectopic pregnancy, abortion and choriocarcinoma\nCoital lacerations\nUse of hormonal methods of contraception or intrauterine contraceptive device (IUCD)\nCervical cancer\nFibroids\nDysfunctional bleeding\nPeri-menopausal Women\nDysfunctional uterine bleeding\nAll other causes listed for women of childbearing age also apply\nPost-menopausal Women\nPelvic cancers such as cervical cancer, endometrial cancer, vaginal or vulva cancer and ovarian tumours\nWithdrawal from oestrogen therapy\nAtrophic vaginitis\nEndometritis\nCoital tears\nUrethral caruncle.",
    "title": "Treatment is directed at the cause found.",
    "section": "Treatment is directed at the cause found.",
    "chunk_id": "1472",
    "type": "section",
    "keywords": [
      "urethral",
      "adolescents",
      "oestrogen",
      "lesions",
      "tumours",
      "withdrawal",
      "contraceptive",
      "contraception",
      "apply",
      "mucosal",
      "child",
      "cancers",
      "traumatic",
      "vaginitis",
      "therapy",
      "vaginal",
      "abortion",
      "atrophic",
      "lacerations",
      "including"
    ]
  },
  {
    "id": "fb5b0eb23b5177fb49031d0eca1a9a8f",
    "content": "Symptoms\nVaginal bleeding which deviates from normal menstrual pattern\nMay be associated lower abdominal pain or dysmenorrhoea\nSymptoms of anaemia (dizziness, palpitations, easy fatigue etc. )\nSigns\nSigns of anaemia (if heavy bleeding)\nOther signs related to cause\ninvestigations\nFBC\nSickling test\nBlood clotting screen e. g.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1473",
    "type": "section",
    "keywords": [
      "sickling",
      "test",
      "anaemia",
      "menstrual",
      "fatigue",
      "which",
      "associated",
      "vaginal",
      "deviates",
      "abdominal",
      "dysmenorrhoea",
      "bleeding",
      "easy",
      "signs",
      "heavy",
      "screen",
      "blood",
      "clotting",
      "cause",
      "investigations"
    ]
  },
  {
    "id": "89eb31027e52a7e45866286a5937ee01",
    "content": "Prothrombin time, INR\nPelvic ultrasound scan (to rule out pelvic lesions)\nUrinalysis\nDiagnostic Dilatation and Curettage (DD & C) for women of child bearing age and postmenopausal women.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1474",
    "type": "section",
    "keywords": [
      "ultrasound",
      "pelvic",
      "lesions",
      "women",
      "scan",
      "dilatation",
      "child",
      "rule",
      "urinalysis",
      "prothrombin",
      "diagnostic",
      "postmenopausal",
      "curettage",
      "bearing"
    ]
  },
  {
    "id": "407175ff489a27b1e28d88203ae1a8ae",
    "content": "To resuscitate patient where necessary\nTo find the cause of bleeding\nTo treat and stop the bleeding.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1475",
    "type": "section",
    "keywords": [
      "resuscitate",
      "find",
      "treat",
      "bleeding",
      "stop",
      "necessary",
      "cause",
      "where",
      "patient"
    ]
  },
  {
    "id": "bbfc52cc683e2f8553cb642ecc7e60fa",
    "content": "Vaginal coital tear - suturing in theatre\nInevitable or incomplete abortion - uterine evacuation\nSurgery (myomectomy, hysterectomy, oophorectomy etc. )\nRadiation therapy for cancers.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1476",
    "type": "section",
    "keywords": [
      "suturing",
      "therapy",
      "incomplete",
      "oophorectomy",
      "uterine",
      "evacuation",
      "cancers",
      "coital",
      "tear",
      "myomectomy",
      "hysterectomy",
      "theatre",
      "radiation",
      "surgery",
      "inevitable",
      "vaginal",
      "abortion"
    ]
  },
  {
    "id": "56822cd6f6b19b9d8188f1a54956f12f",
    "content": "Norethisterone acetate, oral, 5 mg 8 hourly for 10-12 days (to stop\nbleeding)\nThen\n5 mg 12 hourly (days 19 to 26 of cycle to prevent bleeding).",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "1477",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "acetate",
      "cycle",
      "prevent",
      "norethisterone",
      "bleeding",
      "stop",
      "oral",
      "then"
    ]
  },
  {
    "id": "b1ad41037a24c2a629e4d0f775093665",
    "content": "Mefenamic Acid, oral, 500 mg 8 hourly on days 1 to 5 of cycle\n(Especially if associated with dysmenorrhoea).",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "1478",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "cycle",
      "mefenamic",
      "dysmenorrhoea",
      "acid",
      "especially",
      "oral",
      "associated"
    ]
  },
  {
    "id": "f4a1bc9f81341924c594e8a6b2533d49",
    "content": "And\nEvidence Rating: [A]\nTranexamic Acid, oral or IV, 1 g 6-8 hourly for 4-7 days.",
    "title": "Chapter 14: Gynaecologıcal Dısorders",
    "section": "Chapter 14: Gynaecologıcal Dısorders",
    "chunk_id": "1479",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "rating",
      "acid",
      "tranexamic",
      "oral",
      "evidence"
    ]
  },
  {
    "id": "bc6a6f7dec22950e9067e65beb2d21ef",
    "content": "Mefenamic Acid, slow IV injection, 500 mg 8 hourly (days 1 to 5 of\ncycle)\nFor recurrent or protracted abnormal bleeding.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "1480",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "cycle",
      "mefenamic",
      "recurrent",
      "protracted",
      "acid",
      "bleeding",
      "slow",
      "abnormal",
      "injection"
    ]
  },
  {
    "id": "1ed535bb10201c8e06167446a20c0e49",
    "content": "Low dose oral contraceptive pill daily for 3-6 cycles or longer\nEthinylestradiol + levonorgestrel\nOr\nEthinylestradiol + norethisterone.",
    "title": "1st Line Treatment Evidence Rating [A]",
    "section": "1st Line Treatment Evidence Rating [A]",
    "chunk_id": "1481",
    "type": "section",
    "keywords": [
      "ethinylestradiol",
      "norethisterone",
      "contraceptive",
      "cycles",
      "longer",
      "oral",
      "dose",
      "pill",
      "levonorgestrel",
      "daily"
    ]
  },
  {
    "id": "6439998506f9f121a763f74d1f88bf67",
    "content": "Conjugated oestrogen, oral, 1. 25-2. 5 mg daily for 10-12 days\nAnd\nEvidence Rating: [A]\nNorethisterone, oral, 5-10 mg 8 hourly for 21 days (days 5-25)\nOr\nEvidence Rating: [B]\nMedroxyprogesterone acetate, oral, 5-10 mg daily for 5-10 days (days 19 to 26 of cycle)\nReferral Criteria\nRefer all women with heavy menstrual bleeding and/or abnormal vaginal bleeding not responding to therapy to a gynaecologist for comprehensive assessment and management.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "1482",
    "type": "section",
    "keywords": [
      "oestrogen",
      "management",
      "conjugated",
      "menstrual",
      "therapy",
      "evidence",
      "vaginal",
      "hourly",
      "rating",
      "bleeding",
      "abnormal",
      "heavy",
      "criteria",
      "medroxyprogesterone",
      "days",
      "comprehensive",
      "referral",
      "women",
      "responding",
      "acetate"
    ]
  },
  {
    "id": "d4fe65c67e2f2c52267efbda68f47dfa",
    "content": "While a vaginal discharge is a notable clinical feature of a Sexually Transmitted Infection (STI), not all forms of vaginal discharge are abnormal or indicative of an STI. Vaginal discharge may be associated with normal physiological changes such as the menstrual cycle or pregnancy. Increased discharge may also occur with the presence or use of foreign substances such as the Intra Uterine Contraceptive Device (IUCD).",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "1483",
    "type": "section",
    "keywords": [
      "notable",
      "intra",
      "occur",
      "menstrual",
      "contraceptive",
      "indicative",
      "associated",
      "while",
      "vaginal",
      "foreign",
      "sexually",
      "abnormal",
      "presence",
      "pregnancy",
      "changes",
      "device",
      "uterine",
      "also",
      "forms",
      "feature"
    ]
  },
  {
    "id": "12ea06dcb1093b1a5d5c111aa04b858b",
    "content": "Careful history taking should reveal whether a vaginal discharge is abnormal and if it is associated with use of chemical substances e. g. topical self-medication, repeated douching with abrasive substances or indeed due to STI.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "1484",
    "type": "section",
    "keywords": [
      "self",
      "associated",
      "repeated",
      "vaginal",
      "indeed",
      "taking",
      "chemical",
      "whether",
      "abnormal",
      "abrasive",
      "topical",
      "reveal",
      "should",
      "medication",
      "substances",
      "careful",
      "history",
      "discharge",
      "douching"
    ]
  },
  {
    "id": "7832cca04ef87b5e112b259cb676e03b",
    "content": "Changes in the characteristics of a woman’s vaginal discharge either in colour, odour, amount and presence of additional.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "1485",
    "type": "section",
    "keywords": [
      "colour",
      "either",
      "odour",
      "characteristics",
      "woman",
      "amount",
      "presence",
      "discharge",
      "changes",
      "additional",
      "vaginal"
    ]
  },
  {
    "id": "289849129f82550c6966ff79038ce2b6",
    "content": "symptoms and signs such as soreness and itchiness indicate a need for medical attention. Abnormal vaginal discharge due to STIs may result in serious pelvic inflammation with sequelae such as ectopic pregnancy and infertility. Careful risk assessment is therefore required (see note below) of women presenting with a vaginal discharge in order to identify the possible causes and provide appropriate treatment regimens based on the most likely aetiology of the vaginal discharge.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1486",
    "type": "section",
    "keywords": [
      "soreness",
      "based",
      "presenting",
      "assessment",
      "required",
      "identify",
      "likely",
      "serious",
      "vaginal",
      "therefore",
      "inflammation",
      "result",
      "attention",
      "need",
      "aetiology",
      "signs",
      "abnormal",
      "note",
      "pregnancy",
      "most"
    ]
  },
  {
    "id": "ae3e003700b764d153c10c09fab0550a",
    "content": "Factors that must also be considered when selecting treatment for patients include pregnancy status and patient discomfort. Additionally, the syndromic approach must be used to assess the patient, identify risk factors and treat the likely cause of infection. Causes\nSTI-related\nNeisseria gonorrhoea\nChlamydia trachomatis\nTrichomonas vaginalis (green or yellow, smelly, bubbly or frothy discharge associated with itching)\nHerpes simplex virus (following extensive first episode of infec-\ntion)\nNon STI-related\nCandidiasis (white, lumpy or thick discharge associated with itching)\nBacterial vaginosis (grey or white, fishy smelling discharge, es-\npecially after sexual intercourse)\nGardnerella vaginalis\nForeign bodies\nHerbal preparations\nSymptoms\nAbnormal vaginal discharge - change in colour, odour, consistency or amount\nVulval itching\nVulval swelling\nPain on urination\nLower abdominal or back pain\nSigns\nAbnormal vaginal discharge\nVulval swelling\nVulval erythema\nLower abdominal tenderness\nCervical excitation tenderness\nCervical mucopus or erosions (on speculum examination)\ninvestigations\nHigh vaginal swab for microscopy, culture and sensitivity (if available).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1487",
    "type": "section",
    "keywords": [
      "virus",
      "treat",
      "white",
      "tion",
      "swelling",
      "identify",
      "likely",
      "consistency",
      "trichomonas",
      "abdominal",
      "syndromic",
      "selecting",
      "foreign",
      "signs",
      "gonorrhoea",
      "causes",
      "treatment",
      "simplex",
      "include",
      "first"
    ]
  },
  {
    "id": "2752f116d992712cc229065f5ac57021",
    "content": "To identify and treat non-STI vaginitis\nTo assess STI risk and treat STI-related infections appropriately\nTo prevent complications and sequelae\nTo treat both partners simultaneously as much as possible.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1488",
    "type": "section",
    "keywords": [
      "infections",
      "complications",
      "treat",
      "prevent",
      "appropriately",
      "both",
      "sequelae",
      "partners",
      "assess",
      "possible",
      "risk",
      "identify",
      "vaginitis",
      "simultaneously",
      "related"
    ]
  },
  {
    "id": "1af647e983afaabe633355254b5c3677",
    "content": "Promote good peri-anal and genital hygiene\nEncourage use of loose cotton underwear\nDry underwear out in the sun\nKeep underwear dry\nAvoid douching with herbal or chemical preparations\nAvoid use of medicated soaps.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1489",
    "type": "section",
    "keywords": [
      "anal",
      "cotton",
      "avoid",
      "hygiene",
      "loose",
      "peri",
      "soaps",
      "encourage",
      "preparations",
      "keep",
      "promote",
      "chemical",
      "underwear",
      "herbal",
      "medicated",
      "genital",
      "douching"
    ]
  },
  {
    "id": "65b32696eeedb5efec837e6a1397bd13",
    "content": "Evidence Rating: [B]\nMetronidazole, oral, 400 mg 8 hourly for 5 days (contraindicated during the 1st trimester of pregnancy)\nOr\nMetronidazole, oral, 2 g stat. (contraindicated during the 1st trimes- ter of pregnancy)\nOr\nSecnidazole, oral, 2 g stat. (contraindicated during the 1st trimester of pregnancy)\nTreatment for Vaginitis due to trichomoniasis and bacterial vaginosis for pregnant women in the 1st trimester\nClindamycin cream, 2%, vaginal, One applicator full at bedtime for\n7 days.",
    "title": "Treatment for Vaginitis due to trichomoniasis and bacterial vaginosis",
    "section": "Treatment for Vaginitis due to trichomoniasis and bacterial vaginosis",
    "chunk_id": "1490",
    "type": "section",
    "keywords": [
      "metronidazole",
      "during",
      "full",
      "vaginitis",
      "evidence",
      "vaginal",
      "trichomoniasis",
      "hourly",
      "rating",
      "pregnancy",
      "trimester",
      "treatment",
      "stat",
      "days",
      "clindamycin",
      "bedtime",
      "women",
      "bacterial",
      "secnidazole",
      "trimes"
    ]
  },
  {
    "id": "67513a1bf463900468ec02cc57923efb",
    "content": "Fluconazole, oral,\nUncomplicated: 150 mg stat. as a single dose Complicated: 150 mg 72 hourly for 3 doses\nRecurrent: 150 mg daily for 10 to 14 days followed by 150 mg once weekly for 6 months\nOr\nClotrimazole, vaginal tablets, 200 mg inserted into vagina at night for 3 days\nOr\nMiconazole vaginal tablets, 200 mg inserted into vagina at night for 3 days\nAnd\nClotrimazole cream, vaginal, 1% or 2%, Apply twice daily for 3 to 7 days (for vulval irritation).",
    "title": "Treatment for Vaginitis due to Candidiasis",
    "section": "Treatment for Vaginitis due to Candidiasis",
    "chunk_id": "1491",
    "type": "section",
    "keywords": [
      "recurrent",
      "tablets",
      "miconazole",
      "twice",
      "night",
      "into",
      "vaginal",
      "hourly",
      "single",
      "doses",
      "clotrimazole",
      "fluconazole",
      "stat",
      "days",
      "followed",
      "complicated",
      "inserted",
      "uncomplicated",
      "dose",
      "months"
    ]
  },
  {
    "id": "c5fcea6fe9cff3002bc11a2000336830",
    "content": "Cefixime, oral, 400 mg stat. And\nAzithromycin, oral, 1 g stat.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "1492",
    "type": "section",
    "keywords": [
      "cefixime",
      "oral",
      "azithromycin",
      "stat"
    ]
  },
  {
    "id": "1ef2dbcce3c02b020a85cc762686f5c9",
    "content": "Ceftriaxone, IM, 250 mg stat. And\nAzithromycin, oral, 1 g stat.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "1493",
    "type": "section",
    "keywords": [
      "azithromycin",
      "oral",
      "stat",
      "ceftriaxone"
    ]
  },
  {
    "id": "c724c848f6b9a950c6544f11a10e9673",
    "content": "Doxycycline, oral, 100 mg 12 hourly for 7 days (avoid in pregnant and\nnursing mothers)\nOr\nErythromycin, oral, 500 mg 6 hourly for 7 days\nOr\nAzithromycin, oral, 1 g stat. (recommended in pregnancy)\nReferral Criteria\nRefer all cases of recurrent vaginal discharge and/or treatment failures to a health facility where speculum examination can be carried out and microbiological culture and antimicrobial sensitivity tests can be done on the vaginal discharge.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1494",
    "type": "section",
    "keywords": [
      "avoid",
      "recurrent",
      "nursing",
      "health",
      "sensitivity",
      "microbiological",
      "failures",
      "mothers",
      "antimicrobial",
      "vaginal",
      "hourly",
      "speculum",
      "facility",
      "where",
      "culture",
      "pregnancy",
      "criteria",
      "stat",
      "treatment",
      "days"
    ]
  },
  {
    "id": "d268d7c0ed6e8af118c18cbd2a5277f7",
    "content": "Acute lower abdominal pain in a woman may have several causes. These include Pelvic Inflammatory Disease (PID), ruptured ectopic pregnancy and septic abortion. The latter two are surgical emergencies, which require extreme urgency in their management (See sections on ‘Ectopic Pregnancy’ and ‘Abortions’).",
    "title": "Chapter 14: Gynaecologıcal Dısorders",
    "section": "Chapter 14: Gynaecologıcal Dısorders",
    "chunk_id": "1495",
    "type": "section",
    "keywords": [
      "abortions",
      "management",
      "which",
      "acute",
      "abortion",
      "abdominal",
      "require",
      "ruptured",
      "extreme",
      "pregnancy",
      "their",
      "causes",
      "sections",
      "include",
      "pelvic",
      "disease",
      "surgical",
      "septic",
      "latter",
      "ectopic"
    ]
  },
  {
    "id": "e45f1ee4098fb88b604fe89fa98cb79f",
    "content": "PID is caused by organisms which may be Sexually Transmitted Infection (STI)-related or other bacteria that ascend from the lower genital tract and produce inflammation of the uterus, fallopian tubes and other structures in the pelvis. However, after excluding ectopic pregnancy, STI-related organisms are the most likely cause of lower abdominal pain in a sexually active woman who has not recently delivered a baby, or has no past or recent history of uterine instrumentation. The presence of intrauterine contraceptive devices (IUCD) favours the development of PID particularly in the month following insertion.",
    "title": "Chapter 14: Gynaecologıcal Dısorders",
    "section": "Chapter 14: Gynaecologıcal Dısorders",
    "chunk_id": "1496",
    "type": "section",
    "keywords": [
      "baby",
      "recent",
      "ascend",
      "bacteria",
      "development",
      "contraceptive",
      "which",
      "structures",
      "excluding",
      "likely",
      "instrumentation",
      "favours",
      "insertion",
      "devices",
      "abdominal",
      "following",
      "inflammation",
      "delivered",
      "sexually",
      "pelvis"
    ]
  },
  {
    "id": "37e15fc44fdb27bc99ae8ca8ecdfb5e0",
    "content": "Causes\nEctopic pregnancy\nAppendicitis\nOvarian torsion\nSTI-related\nNon STI-related (e. g urinary tract infection)\nSeptic abortion\nPost partum sepsis\nForeign body including IUCD\nSymptoms\nFever\nLower abdominal pain\nPain with sexual intercourse (dyspareunia)\nOffensive vaginal discharge\nDysuria or urethral discomfort\nSigns\nAbnormal vaginal discharge\nTenderness on moving the cervix (cervical excitation) on bimanual vaginal examination\nLower abdominal tenderness\nAdnexal tenderness\nAdnexal masses\ninvestigations\nPelvic ultrasound\nPregnancy test (if sexually active and amenorrhoea present)\nHigh vaginal swab culture and sensitivity.",
    "title": "Chapter 14: Gynaecologıcal Dısorders",
    "section": "Chapter 14: Gynaecologıcal Dısorders",
    "chunk_id": "1497",
    "type": "section",
    "keywords": [
      "urethral",
      "torsion",
      "excitation",
      "ultrasound",
      "test",
      "adnexal",
      "discomfort",
      "sensitivity",
      "bimanual",
      "masses",
      "vaginal",
      "abortion",
      "body",
      "abdominal",
      "swab",
      "including",
      "foreign",
      "ovarian",
      "sexually",
      "cervix"
    ]
  },
  {
    "id": "11e05a4e7c25327e7dacbf2ebb357ae3",
    "content": "To identify and manage potential life threatening causes e. g. ectopic\nTo treat any underlying bacterial infection\nTo relieve pain and inflammation.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1498",
    "type": "section",
    "keywords": [
      "pain",
      "treat",
      "manage",
      "inflammation",
      "infection",
      "bacterial",
      "life",
      "relieve",
      "underlying",
      "identify",
      "threatening",
      "potential",
      "causes",
      "ectopic"
    ]
  },
  {
    "id": "b283a829a24ddbdfa0dc7b34c411f81a",
    "content": "Surgery where indicated\nRemove IUD, if present, 3 days after initiation of drug therapy.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1499",
    "type": "section",
    "keywords": [
      "days",
      "initiation",
      "present",
      "drug",
      "where",
      "indicated",
      "remove",
      "after",
      "therapy",
      "surgery"
    ]
  },
  {
    "id": "7090d2a5a53015cb852544ad3e063a80",
    "content": "Ciprofloxacin, oral, 500 mg 12 hourly for 3 days\nAnd\nDoxycycline, oral, 100 mg 12 hourly for 14 days\nAnd\nMetronidazole, oral, 400 mg 12 hourly for 14 days.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "1500",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "doxycycline",
      "oral",
      "ciprofloxacin"
    ]
  },
  {
    "id": "3d71ea1491cc02f5019555701f41d41c",
    "content": "Ceftriaxone, IM, 250 mg daily for 3 days\nAnd\nDoxycycline, oral, 100 mg 12 hourly for 3 days\nAnd\nMetronidazole, IV, 500 mg 8 hourly for 3 days\nThen\nDoxycycline, oral, 100 mg 12 hourly for 14 days\nAnd\nMetronidazole, oral, 400 mg 12 hourly for 14 days.",
    "title": "For Pelvic inflammatory Disease (severe cases)",
    "section": "For Pelvic inflammatory Disease (severe cases)",
    "chunk_id": "1501",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "doxycycline",
      "ceftriaxone",
      "oral",
      "then",
      "daily"
    ]
  },
  {
    "id": "b789185fdd07a35e2aa02d0dc4340bf1",
    "content": "Pain relief\nDiclofenac, rectal, oral, IM, 50-100 mg 8 to 12 hourly (max. 100 mg twice daily)\nOr\nMefenamic Acid, oral, 500 mg 8 hourly\nReferral Criteria\nRefer to a gynaecologist or general surgeon if there is no improvement or if a pelvic abscess is suspected. Flowchart.",
    "title": "Chapter 14: Gynaecologıcal Dısorders",
    "section": "Chapter 14: Gynaecologıcal Dısorders",
    "chunk_id": "1502",
    "type": "section",
    "keywords": [
      "relief",
      "twice",
      "hourly",
      "rectal",
      "abscess",
      "mefenamic",
      "diclofenac",
      "criteria",
      "pelvic",
      "referral",
      "suspected",
      "acid",
      "there",
      "general",
      "pain",
      "refer",
      "oral",
      "gynaecologist",
      "surgeon",
      "flowchart"
    ]
  },
  {
    "id": "ca4af15b16201d52009ea8e7134ba363",
    "content": "Primary infertility is said to occur when a couple has never achieved a pregnancy despite at least one year of uninterrupted and adequate unprotected sexual intercourse. Secondary infertility implies that there has been a previous pregnancy. It is often necessary to evaluate both partners simultaneously and to elicit sexual, menstrual and obstetric history, a past history of Pelvic Inflammatory Disease (PID) and Sexually Transmitted Infections (STIs), contraception use and other significant past medical history.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1503",
    "type": "section",
    "keywords": [
      "infections",
      "couple",
      "despite",
      "occur",
      "often",
      "evaluate",
      "achieved",
      "both",
      "menstrual",
      "contraception",
      "secondary",
      "primary",
      "said",
      "sexually",
      "pregnancy",
      "previous",
      "stis",
      "disease",
      "pelvic",
      "infertility"
    ]
  },
  {
    "id": "d2d4862bfc5195ceb816a06ffecf423e",
    "content": "Causes\nFemale factors\nOvulation failure\nPolycystic ovarian syndrome (PCOS)\nHyperprolactinaemia\nPelvic factors\nCongenital malformations of uterus etc.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1504",
    "type": "section",
    "keywords": [
      "pelvic",
      "female",
      "uterus",
      "ovarian",
      "ovulation",
      "pcos",
      "factors",
      "hyperprolactinaemia",
      "malformations",
      "polycystic",
      "syndrome",
      "failure",
      "causes",
      "congenital"
    ]
  },
  {
    "id": "52faee99ca619c11e97718b3f1bb6809",
    "content": "Pelvic adhesions\nUterine fibroids\nEndometriosis\nCervical factors\nMale factors\nOligospermia\nAzoospermia\nPenile and testicular abnormalities\nErectile dysfunction\nSymptoms\nInability to achieve pregnancy despite regular unprotected sex at least 2-3 times weekly\nAmenorrhoea (females)\nImpotence (males)\nSigns\nFemale\nAbsence of secondary sexual characteristics\nVirilisation changes (hirsutism, clitoromegaly, deepening of voice etc. )\nGalactorrhoea\nAbdominal masses due to uterine or ovarian enlargement\nAbnormal vaginal discharge indicative of infection\nMale\nAbnormal penile discharge indicative of infection\nAbsence of secondary sexual characteristics\nTesticular abnormalities e. g.",
    "title": "Tubal disease",
    "section": "Tubal disease",
    "chunk_id": "1505",
    "type": "section",
    "keywords": [
      "hirsutism",
      "azoospermia",
      "regular",
      "characteristics",
      "dysfunction",
      "abnormalities",
      "virilisation",
      "factors",
      "males",
      "indicative",
      "times",
      "secondary",
      "voice",
      "females",
      "masses",
      "vaginal",
      "deepening",
      "abdominal",
      "oligospermia",
      "female"
    ]
  },
  {
    "id": "88e880671db7e4174e7d22e9a0b03d52",
    "content": "investigations\nFBC, Sickling\nHigh vaginal swab\nBlood glucose\nHystero-Salpingogram (best done under fluoroscopic guidance). Semen analysis\nSerum progesterone level in mid-luteal phase (day 21-23 of menstrual cycle) to check for ovulation\nThyroid function tests\nFurther hormonal studies e. g.",
    "title": "Chapter 14: Gynaecologıcal Dısorders",
    "section": "Chapter 14: Gynaecologıcal Dısorders",
    "chunk_id": "1506",
    "type": "section",
    "keywords": [
      "sickling",
      "menstrual",
      "check",
      "glucose",
      "under",
      "vaginal",
      "swab",
      "function",
      "guidance",
      "blood",
      "semen",
      "fluoroscopic",
      "progesterone",
      "hormonal",
      "level",
      "done",
      "further",
      "tests",
      "phase",
      "investigations"
    ]
  },
  {
    "id": "c0eaf37d942ce55e03855cee1f72d723",
    "content": "Serum LH, FSH, Serum Testosterone, Prolactin to be done by specialist.",
    "title": "Chapter 14: Gynaecologıcal Dısorders",
    "section": "Chapter 14: Gynaecologıcal Dısorders",
    "chunk_id": "1507",
    "type": "section",
    "keywords": [
      "testosterone",
      "specialist",
      "serum",
      "done",
      "prolactin"
    ]
  },
  {
    "id": "ae455572cdc3928f01696185e1a2f120",
    "content": "To treat the underlying cause of the infertility if possible\nTo achieve pregnancy within the shortest possible time.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1508",
    "type": "section",
    "keywords": [
      "achieve",
      "within",
      "infertility",
      "treat",
      "shortest",
      "cause",
      "underlying",
      "possible",
      "pregnancy"
    ]
  },
  {
    "id": "2c2aab68fa5d34094ebf51ac4d464e54",
    "content": "Counselling\nUterine, Tubal and Testicular surgery where needed\nAssisted Reproduction Technologies e. g. Artificial insemination, In- vitro-fertilization with embryo transfer where indicated.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1509",
    "type": "section",
    "keywords": [
      "tubal",
      "fertilization",
      "embryo",
      "transfer",
      "insemination",
      "artificial",
      "uterine",
      "testicular",
      "needed",
      "counselling",
      "reproduction",
      "vitro",
      "where",
      "indicated",
      "assisted",
      "technologies",
      "surgery"
    ]
  },
  {
    "id": "1a2c0497a4f51b3bd497fe1d3aca2f5c",
    "content": "Clomifene citrate, oral, 50 mg daily for 5 days, starting between the\n2nd and 5th day of the menstrual cycle.",
    "title": "Failure of ovulation 1st Line Treatment Evidence Rating: [A]",
    "section": "Failure of ovulation 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1510",
    "type": "section",
    "keywords": [
      "days",
      "cycle",
      "citrate",
      "clomifene",
      "menstrual",
      "oral",
      "between",
      "starting",
      "daily"
    ]
  },
  {
    "id": "5579110b4dae448aeb188c26b3ebc9e0",
    "content": "Bromocriptine, oral, 1. 25 mg nocte for 7 days (with the evening meal\nor at bedtime). Increase weekly to a max.",
    "title": "Hyperprolactinaemia 1st Line Treatment Evidence Rating: [A]",
    "section": "Hyperprolactinaemia 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1511",
    "type": "section",
    "keywords": [
      "days",
      "meal",
      "nocte",
      "evening",
      "bedtime",
      "bromocriptine",
      "weekly",
      "oral",
      "increase"
    ]
  },
  {
    "id": "34d0c2cd751ad44348e9527b02578e46",
    "content": "of 2. 5 mg 8 hourly\nReferral Criteria\nEarly referral of all patients with infertility to a specialist is preferred, particularly women with uterine, ovarian or tubal disease requiring surgery or who require ovulation induction not responsive to clomifene citrate. Also refer male partners for review by a urologist.",
    "title": "Hyperprolactinaemia 1st Line Treatment Evidence Rating: [A]",
    "section": "Hyperprolactinaemia 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1512",
    "type": "section",
    "keywords": [
      "citrate",
      "urologist",
      "hourly",
      "review",
      "specialist",
      "require",
      "clomifene",
      "ovarian",
      "male",
      "requiring",
      "patients",
      "particularly",
      "induction",
      "criteria",
      "disease",
      "referral",
      "infertility",
      "tubal",
      "women",
      "uterine"
    ]
  },
  {
    "id": "4e34f005baefd93903aacfe8891e4f9f",
    "content": "Menopause refers to the point in time when permanent cessation of menstruation occurs due to loss of ovarian function. The cessation of menses is preceded by a peri-menopausal phase during which there may be menstrual irregularity. The age at onset is usually between 45 and 55 years.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1513",
    "type": "section",
    "keywords": [
      "usually",
      "irregularity",
      "years",
      "menstrual",
      "during",
      "which",
      "refers",
      "function",
      "ovarian",
      "preceded",
      "menopausal",
      "onset",
      "peri",
      "permanent",
      "menstruation",
      "point",
      "phase",
      "there",
      "between",
      "occurs"
    ]
  },
  {
    "id": "6987cd995c8022db4228cf8537e421d0",
    "content": "A woman is considered to be menopausal if there has not been menstruation for a period of at least 12 months in the absence of pregnancy. Menopause may be associated with physical, emotional, and psychological upheaval of varying intensity in some women. Sixty percent of menopausal women however have mild symptoms or are asymptomatic.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1514",
    "type": "section",
    "keywords": [
      "emotional",
      "psychological",
      "associated",
      "varying",
      "asymptomatic",
      "sixty",
      "intensity",
      "menopausal",
      "pregnancy",
      "percent",
      "upheaval",
      "women",
      "period",
      "menstruation",
      "there",
      "months",
      "symptoms",
      "mild",
      "considered",
      "least"
    ]
  },
  {
    "id": "a45a697f6a1529acc4150f128e4e9985",
    "content": "The risk of osteoporosis and cardiovascular disease increase after the menopause. Causes\nA natural life event due to the ageing of the individual\nSurgical removal of the ovaries (bilateral oophorectomy)\nPelvic irradiation\nPremature ovarian failure\nPituitary damage from primary post-partum haemorrhage (Sheehan’s syndrome)\nCytotoxic (anticancer) therapy\nSymptoms\nHot flushes (heat or burning in the face, neck and chest with resultant sweating)\nThe flushes may be associated with\nPalpitations\nFaintness\nDizziness\nFatigue\nWeakness\nEmotional and psychological problems include:\nMood changes\nDepression\nAnxiety\nNervousness\nIrritability\nLoss of libido\nVaginal dryness and dyspareunia\nSymptoms due to atrophic changes in the genital tract:\nIncreased frequency of micturition and dysuria. Stress incontinence (urinary incontinence with coughing or straining)\nSigns\nUsually none.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1515",
    "type": "section",
    "keywords": [
      "haemorrhage",
      "pituitary",
      "incontinence",
      "atrophic",
      "heat",
      "premature",
      "signs",
      "causes",
      "irritability",
      "dryness",
      "disease",
      "include",
      "failure",
      "partum",
      "faintness",
      "none",
      "dizziness",
      "natural",
      "mood",
      "risk"
    ]
  },
  {
    "id": "1af94f91621062da8e899600da21a46b",
    "content": "investigations\nSerum LH, FSH, Oestradiol\nRoutine investigations e. g. FBC, blood glucose, lipid profile\nUrine or blood pregnancy tests (to exclude pregnancy).",
    "title": "Chapter 14: Gynaecologıcal Dısorders",
    "section": "Chapter 14: Gynaecologıcal Dısorders",
    "chunk_id": "1516",
    "type": "section",
    "keywords": [
      "oestradiol",
      "exclude",
      "serum",
      "profile",
      "tests",
      "glucose",
      "urine",
      "pregnancy",
      "investigations",
      "lipid",
      "blood",
      "routine"
    ]
  },
  {
    "id": "868e3f6c502487f824f4b30e99131311",
    "content": "To control bothersome symptoms e. g. severe hot flushes, atrophic\nvaginitis and recurrent cystitis\nTo prevent cardiovascular morbidity\nTo prevent osteoporosis especially in individuals with premature menopause.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1517",
    "type": "section",
    "keywords": [
      "severe",
      "recurrent",
      "atrophic",
      "prevent",
      "morbidity",
      "osteoporosis",
      "especially",
      "flushes",
      "menopause",
      "cystitis",
      "premature",
      "cardiovascular",
      "individuals",
      "control",
      "vaginitis",
      "bothersome",
      "symptoms"
    ]
  },
  {
    "id": "0dd769a7e4f89c38c3785e391a3fb3ea",
    "content": "Counselling and reassurance\nEncourage active lifestyles, healthy diet, exercise and regular physical checkups for common medical problems.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1518",
    "type": "section",
    "keywords": [
      "problems",
      "diet",
      "healthy",
      "checkups",
      "reassurance",
      "regular",
      "physical",
      "active",
      "counselling",
      "exercise",
      "common",
      "medical",
      "encourage",
      "lifestyles"
    ]
  },
  {
    "id": "fa8409e5557413c24697e946315b26b1",
    "content": "Hormone Replacement Therapy (HRT) for women with intact uterus.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1519",
    "type": "section",
    "keywords": [
      "intact",
      "women",
      "uterus",
      "replacement",
      "hormone",
      "therapy"
    ]
  },
  {
    "id": "9c9a823e2424a5b23b57969abe4c643a",
    "content": "Combined conjugated oestrogens and progestogen, oral,\n(28 tablets each containing conjugated oestrogens-625 micrograms including 12 tablets containing norgestrel-150 micrograms)\nOne tablet daily\nOr\nConjugated oestrogen and norgestrel tablet, oral, (625 microgram and 150 microgram).",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1520",
    "type": "section",
    "keywords": [
      "tablet",
      "combined",
      "containing",
      "oestrogen",
      "tablets",
      "including",
      "each",
      "conjugated",
      "norgestrel",
      "microgram",
      "progestogen",
      "oral",
      "micrograms",
      "oestrogens",
      "daily"
    ]
  },
  {
    "id": "445fb9ddef9ec62865d2d6782bab9252",
    "content": "Hormone Replacement Therapy (HRT) for women with previous hysterectomy\nEvidence Rating: [A]\nConjugated oestrogens, oral, 625 microgram daily\nFor relief of vaginal symptoms only\nEvidence Rating: [A]\nOestrogen cream, vaginal, apply topically once daily.",
    "title": "1 tablet daily on days 17-28 of each 28-day treatment cycle;",
    "section": "1 tablet daily on days 17-28 of each 28-day treatment cycle;",
    "chunk_id": "1521",
    "type": "section",
    "keywords": [
      "oestrogen",
      "replacement",
      "conjugated",
      "relief",
      "oestrogens",
      "therapy",
      "evidence",
      "vaginal",
      "rating",
      "topically",
      "previous",
      "women",
      "only",
      "hysterectomy",
      "symptoms",
      "once",
      "microgram",
      "hormone",
      "oral",
      "cream"
    ]
  },
  {
    "id": "01f30293dcbb7cb83df6b912f7c2119b",
    "content": "Referral Criteria\nRefer cases with osteoporosis or severe unremitting symptoms to the specialist. Carcinoma of the cervix is the commonest form of female genital cancer seen in Ghana. While the disease is preventable, in Ghana, the absence of an effective screening system has resulted in most cases presenting late with advanced disease.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1522",
    "type": "section",
    "keywords": [
      "advanced",
      "seen",
      "presenting",
      "late",
      "form",
      "resulted",
      "while",
      "specialist",
      "female",
      "cervix",
      "screening",
      "most",
      "genital",
      "criteria",
      "severe",
      "disease",
      "referral",
      "osteoporosis",
      "symptoms",
      "cancer"
    ]
  },
  {
    "id": "886417343917fa4151f76686bb7cd04b",
    "content": "In developed countries, the incidence of cervical cancer has fallen considerably due to regular screening procedures (e. g. Pap smear, visual inspection with acetic acid, Human Papilloma Virus [HPV] test).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1523",
    "type": "section",
    "keywords": [
      "procedures",
      "test",
      "virus",
      "regular",
      "screening",
      "inspection",
      "smear",
      "acid",
      "acetic",
      "incidence",
      "countries",
      "cervical",
      "cancer",
      "human",
      "considerably",
      "visual",
      "papilloma",
      "developed",
      "fallen"
    ]
  },
  {
    "id": "cc17a56f70b79e138d3cbad3c83356eb",
    "content": "Vaccination against cancer-causing HPV infection is the ideal method for primary prevention of cervical cancer. Treatment of cervical cancer requires the services of a gynaecological oncologist and radiotherapist. Treatment includes surgery and/or radiation and/or chemotherapy.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1524",
    "type": "section",
    "keywords": [
      "radiation",
      "ideal",
      "primary",
      "gynaecological",
      "radiotherapist",
      "oncologist",
      "causing",
      "services",
      "treatment",
      "against",
      "prevention",
      "includes",
      "vaccination",
      "chemotherapy",
      "cervical",
      "cancer",
      "requires",
      "infection",
      "method",
      "surgery"
    ]
  },
  {
    "id": "e3c7d8331ad3741ea74d61984fc3309a",
    "content": "Surgery involves removal of the central tumour as well as the lymphatics draining the area (Wertheim’s hysterectomy). This extensive surgery should be carried out only by trained specialists. Radiation treatment often involves localized pelvic irradiation.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1525",
    "type": "section",
    "keywords": [
      "often",
      "radiation",
      "draining",
      "extensive",
      "removal",
      "tumour",
      "treatment",
      "pelvic",
      "specialists",
      "involves",
      "should",
      "wertheim",
      "only",
      "hysterectomy",
      "irradiation",
      "carried",
      "localized",
      "central",
      "trained",
      "area"
    ]
  },
  {
    "id": "741d87fe45b70595f1b2ef5bea483913",
    "content": "Causes\nHuman papilloma virus (accounts for 80% of cases)\nAssociated risk factors include:\nSexual promiscuity\nMultiple child births\nInfections with Herpes Simplex Hominis type II, HIV\nSmoking\nLow socio-economic status\nFamily history\nSymptoms\nAsymptomatic (diagnosed on routine cervical screening).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1526",
    "type": "section",
    "keywords": [
      "infections",
      "virus",
      "factors",
      "child",
      "associated",
      "family",
      "accounts",
      "asymptomatic",
      "type",
      "multiple",
      "screening",
      "herpes",
      "promiscuity",
      "causes",
      "routine",
      "simplex",
      "status",
      "include",
      "hominis",
      "socio"
    ]
  },
  {
    "id": "89349f1d33a7e123f5ebcd99b9e9084a",
    "content": "Abnormal vaginal bleeding\nIn between regular menstrual periods\nAfter sexual intercourse\nPost menopausal bleeding\nAbnormal vaginal discharge\nLower abdominal pain\nPain during sexual intercourse\nWeight loss\nUrinary symptoms e. g. dysuria, frequency, incontinence\nRectal pain.",
    "title": "Symptomatic (advanced disease)",
    "section": "Symptomatic (advanced disease)",
    "chunk_id": "1527",
    "type": "section",
    "keywords": [
      "weight",
      "regular",
      "menstrual",
      "during",
      "incontinence",
      "vaginal",
      "abdominal",
      "rectal",
      "bleeding",
      "menopausal",
      "abnormal",
      "post",
      "periods",
      "sexual",
      "between",
      "dysuria",
      "symptoms",
      "frequency",
      "pain",
      "intercourse"
    ]
  },
  {
    "id": "4333347ddc61d6122b70f91c81da36df",
    "content": "investigations\nCervical biopsy\nFBC and sickling status\nBlood urea and electrolytes\nSerum Creatinine\nSerum uric acid\nChest X-ray\nUltrasound of Kidneys\nCT Scan and or Magnetic Resonance Imaging (to detect aortic nodes and metastases to the lungs and liver)\nPelvic examination under anaesthesia\nCystoscopy and proctoscopy with or without biopsy to allow visualisation of vesical or rectal mucosa.",
    "title": "Late/advanced disease: Ulcerative or fungating cervical lesion on speculum examination",
    "section": "Late/advanced disease: Ulcerative or fungating cervical lesion on speculum examination",
    "chunk_id": "1528",
    "type": "section",
    "keywords": [
      "ultrasound",
      "sickling",
      "vesical",
      "visualisation",
      "cystoscopy",
      "under",
      "creatinine",
      "rectal",
      "aortic",
      "chest",
      "examination",
      "nodes",
      "magnetic",
      "blood",
      "status",
      "allow",
      "pelvic",
      "metastases",
      "kidneys",
      "electrolytes"
    ]
  },
  {
    "id": "b863d2902c8c56e68b2a6fbe9de9accf",
    "content": "To treat central tumour\nTo treat areas of tumour spread with the aim of eradicating the.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1529",
    "type": "section",
    "keywords": [
      "areas",
      "treat",
      "eradicating",
      "central",
      "tumour",
      "spread"
    ]
  },
  {
    "id": "fdaca29864bfd25fbab61939b2ba15dd",
    "content": "Surgery\nRadiotherapy\nA combination of surgery, and radiotherapy.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1530",
    "type": "section",
    "keywords": [
      "combination",
      "surgery",
      "radiotherapy"
    ]
  },
  {
    "id": "70d3fd7b4a878e3e1c9b3f965217957c",
    "content": "Evidence Rating: [A]\nAdjuvant chemotherapy (See section on referral below)\nReferral Criteria\nAll patients must be referred to a specialist for evaluation to decide on stage of disease and best mode of treatment. Treatment of carcinoma of the cervix is best done in hospital under specialist team care.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1531",
    "type": "section",
    "keywords": [
      "team",
      "evidence",
      "under",
      "rating",
      "specialist",
      "evaluation",
      "section",
      "cervix",
      "stage",
      "patients",
      "criteria",
      "treatment",
      "disease",
      "referral",
      "adjuvant",
      "done",
      "decide",
      "referred",
      "care",
      "chemotherapy"
    ]
  },
  {
    "id": "dff8ffaaad29657d788060b9504fcec7",
    "content": "This is a disease characterised by damage to the glomerular filtration apparatus, which causes protein and blood to leak into the urine. Mechanisms for the glomerular damage may be immune-mediated. This condition may be associated with hypertension and fluid retention.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1532",
    "type": "section",
    "keywords": [
      "hypertension",
      "mechanisms",
      "which",
      "urine",
      "associated",
      "characterised",
      "into",
      "fluid",
      "retention",
      "filtration",
      "protein",
      "condition",
      "leak",
      "blood",
      "causes",
      "disease",
      "mediated",
      "apparatus",
      "immune",
      "damage"
    ]
  },
  {
    "id": "be4ba2cbbbdfc4ccbbedbd9aceaec326",
    "content": "Causes\nPost streptococcal infections (pharyngeal or skin infections)\nInfected scabies\nOther bacterial Infections e. g. salmonella\nHepatitis B virus, Hepatitis C virus, HIV\nParasitic e.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1533",
    "type": "section",
    "keywords": [
      "post",
      "infections",
      "virus",
      "pharyngeal",
      "parasitic",
      "other",
      "bacterial",
      "salmonella",
      "skin",
      "infected",
      "streptococcal",
      "hepatitis",
      "causes",
      "scabies"
    ]
  },
  {
    "id": "3217eadd0ac8b24d482b0664e41feae0",
    "content": "g. Schistosoma, Malaria\nSystemic lupus erythematosus and other vasculitides\nSymptoms\nA history of preceding infection\nGeneralized oedema most marked around the eyes\nBreathlessness\nAnorexia (sometimes associated with vomiting and abdominal pain)\nFever\nSeizures\nScanty urine\nHaematuria\nSigns\nOedema\nOliguria (urine volumes < 400 ml/day)\nHypertension\nHaematuria\nDark coloured urine\nAcute heart failure\nComa\ninvestigations\nUrinalysis.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1534",
    "type": "section",
    "keywords": [
      "hypertension",
      "oedema",
      "volumes",
      "seizures",
      "systemic",
      "associated",
      "urine",
      "sometimes",
      "acute",
      "abdominal",
      "urinalysis",
      "signs",
      "heart",
      "most",
      "marked",
      "malaria",
      "generalized",
      "coloured",
      "haematuria",
      "scanty"
    ]
  },
  {
    "id": "8f6b4aa82df58139c132365e9736ff4d",
    "content": "Sediment shows erythrocytes, leukocytes and a variety of casts including erythrocyte casts\nProteinuria usually less than 2 g/24 hours but may be in the nephrotic\nrange\nFBC\nBUE and Creatinine\nThroat cultures (in children may be useful)\nChest X-ray (may show pulmonary oedema)\nECG\nImmunology (e. g. ANA, AntiDsDNA)\nASO (antistreptolysin O) titres\nUltrasound of kidneys.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1535",
    "type": "section",
    "keywords": [
      "usually",
      "ultrasound",
      "oedema",
      "leukocytes",
      "antidsdna",
      "range",
      "sediment",
      "immunology",
      "creatinine",
      "antistreptolysin",
      "chest",
      "including",
      "casts",
      "nephrotic",
      "children",
      "titres",
      "cultures",
      "show",
      "kidneys",
      "variety"
    ]
  },
  {
    "id": "43e1fa4bf719a1e743cf52b29007a896",
    "content": "To identify and stop the cause of renal injury\nTo prevent and control complications.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1536",
    "type": "section",
    "keywords": [
      "complications",
      "prevent",
      "stop",
      "cause",
      "identify",
      "control",
      "renal",
      "injury"
    ]
  },
  {
    "id": "71407e9a85bf9d9168acbc22c276b94d",
    "content": "Bed rest\nSalt restriction in diet\nControl fluid balance:\nAdults\nControl fluid retention by restricting daily fluid intake to 800 ml plus previous day’s urine output. Children\nRestrict fluids to 400 ml/m2 of body surface area and previous day’s urine output.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1537",
    "type": "section",
    "keywords": [
      "diet",
      "salt",
      "restrict",
      "urine",
      "fluid",
      "restriction",
      "body",
      "retention",
      "surface",
      "fluids",
      "intake",
      "restricting",
      "children",
      "previous",
      "adults",
      "rest",
      "area",
      "plus",
      "output",
      "balance"
    ]
  },
  {
    "id": "f13fc095c9c3555475421b8856570172",
    "content": "For fluid retention in Post-infectious Glomerulonephritis\nEvidence Rating: [B]\nFurosemide, oral or IV,\nAdult\n40 mg daily, increasing to 80 mg daily\nChildren\n1 month-12 years; 1-2 mg/kg/day initially. Increase by 1-2 mg/kg 8 hourly to a max. of 6 mg/kg per day, not to exceed 80 mg per day.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1538",
    "type": "section",
    "keywords": [
      "years",
      "evidence",
      "increase",
      "fluid",
      "hourly",
      "rating",
      "exceed",
      "initially",
      "retention",
      "children",
      "post",
      "adult",
      "month",
      "glomerulonephritis",
      "furosemide",
      "oral",
      "increasing",
      "infectious",
      "daily"
    ]
  },
  {
    "id": "87e45620182be25e40ba0bbb4846202d",
    "content": "For hypertension in Post-infectious Glomerulonephritis\nTreat blood pressure (See section on ‘Hypertension’)\nReferral Criteria\nRefer all patients with complications of renal failure, severe cardiac failure and hypertensive encephalopathy that arise following post infectious glomerulonephritis to a physician specialist or a nephrologist.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1539",
    "type": "section",
    "keywords": [
      "hypertension",
      "treat",
      "encephalopathy",
      "nephrologist",
      "arise",
      "hypertensive",
      "specialist",
      "pressure",
      "following",
      "section",
      "patients",
      "renal",
      "criteria",
      "blood",
      "physician",
      "post",
      "severe",
      "referral",
      "failure",
      "glomerulonephritis"
    ]
  },
  {
    "id": "7b1d5d914a2145dba413ae85aa614b03",
    "content": "Patients with other causes such as lupus nephritis or systemic vasculitis, should also be referred to a physician specialist or a nephrologist. This condition is associated with proteinuria in excess of 3-3. 5 g/1.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1540",
    "type": "section",
    "keywords": [
      "specialist",
      "lupus",
      "vasculitis",
      "nephritis",
      "other",
      "should",
      "also",
      "nephrologist",
      "condition",
      "proteinuria",
      "systemic",
      "associated",
      "excess",
      "patients",
      "referred",
      "causes",
      "physician"
    ]
  },
  {
    "id": "4c4abcf97a674f81fe984e7b66080492",
    "content": "73 m2 daily accompanied by hypoalbuminaemia, oedema, hyperlipidaemia and hypercoagulable state. Diuretics should be used with caution and not given as a routine in children with nephrotic syndrome. Causes.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1541",
    "type": "section",
    "keywords": [
      "diuretics",
      "oedema",
      "hypercoagulable",
      "given",
      "hyperlipidaemia",
      "should",
      "accompanied",
      "caution",
      "state",
      "nephrotic",
      "syndrome",
      "children",
      "hypoalbuminaemia",
      "used",
      "causes",
      "routine",
      "daily"
    ]
  },
  {
    "id": "f3d68b84afc83ea6053d02a2d6ea2de4",
    "content": "Focal and segmental glomerulosclerosis\nMembranous nephropathy\nMembranous proliferative glomerulonephritis\nInfections\nBacterial (Post streptococcal infection)\nViral-Hepatitis B and C, HIV\nParasitic (Plasmodium malariae, Schistosoma mansoni, Filaria-\nsis).",
    "title": "Minimal change disease - common in children",
    "section": "Minimal change disease - common in children",
    "chunk_id": "1542",
    "type": "section",
    "keywords": [
      "infections",
      "malariae",
      "nephropathy",
      "streptococcal",
      "focal",
      "mansoni",
      "filaria",
      "post",
      "plasmodium",
      "parasitic",
      "schistosoma",
      "membranous",
      "proliferative",
      "bacterial",
      "hepatitis",
      "viral",
      "glomerulonephritis",
      "glomerulosclerosis",
      "infection",
      "segmental"
    ]
  },
  {
    "id": "0af1b6efd40f42a229b3ac5f402fcaad",
    "content": "Diabetes mellitus\nSystemic Lupus Erythematosus\nAmyloidosis\nDrug-related\nNon steroidal anti-inflammatory drugs\nSymptoms\nEarly morning facial puffiness\nGeneralized body swelling\nFoamy appearance of urine\nWeight gain (unintentional)\nPoor appetite\nSigns\nPeriorbital, peripheral, genital oedema\nAscites\nPleural effusion\nProtein malnutrition particularly in children with long standing.",
    "title": "Systemic Diseases",
    "section": "Systemic Diseases",
    "chunk_id": "1543",
    "type": "section",
    "keywords": [
      "oedema",
      "malnutrition",
      "appearance",
      "weight",
      "morning",
      "mellitus",
      "swelling",
      "systemic",
      "urine",
      "unintentional",
      "poor",
      "puffiness",
      "foamy",
      "body",
      "standing",
      "drug",
      "protein",
      "steroidal",
      "signs",
      "children"
    ]
  },
  {
    "id": "6e9f9842ebaa69bd684cd0b8eeb312a8",
    "content": "investigations\nUrinalysis\nBUE and creatinine\nSerum albumin\nSerum lipids\nFasting blood glucose.",
    "title": "disease",
    "section": "disease",
    "chunk_id": "1544",
    "type": "section",
    "keywords": [
      "creatinine",
      "blood",
      "serum",
      "urinalysis",
      "glucose",
      "investigations",
      "albumin",
      "fasting",
      "lipids"
    ]
  },
  {
    "id": "c305e8a8830e92854ee80f6a34b8c267",
    "content": "Serology - Hepatitis B, C, HIV\nHb electrophoresis\nAntinuclear antibody (ANA)\nUltrasound of kidneys.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1545",
    "type": "section",
    "keywords": [
      "ultrasound",
      "serology",
      "antinuclear",
      "kidneys",
      "electrophoresis",
      "antibody",
      "hepatitis"
    ]
  },
  {
    "id": "1a56b56b3d32d6f8d16c560e72313ebf",
    "content": "To relieve symptoms\nTo treat underlying condition\nTo prevent and manage complications\nTo delay progressive kidney damage.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1546",
    "type": "section",
    "keywords": [
      "complications",
      "treat",
      "prevent",
      "manage",
      "kidney",
      "progressive",
      "relieve",
      "underlying",
      "damage",
      "delay",
      "condition",
      "symptoms"
    ]
  },
  {
    "id": "dfd4a902730a12758774d8447347a179",
    "content": "Restrict salt intake\nAdequate protein diet; 0. 6-0. 8 g/kg body weight of 1st class protein (eggs, meat, fish, dairy products) per day for adult and 2-4 g/kg per day for children.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1547",
    "type": "section",
    "keywords": [
      "fish",
      "diet",
      "salt",
      "body",
      "restrict",
      "weight",
      "dairy",
      "adult",
      "protein",
      "meat",
      "products",
      "class",
      "intake",
      "children",
      "adequate",
      "eggs"
    ]
  },
  {
    "id": "2b4fe0bb63f41b3a64206b55eaa49deb",
    "content": "Furosemide, IV,\nAdult\n40-80 mg 8-12 hourly (max. 160 mg daily)\nChildren\nRefer to specialist. Or\nFurosemide, oral,\nAdult\n40 mg daily, increasing to 80 mg daily; max.",
    "title": "For control of oedema 1st Line Treatment Evidence Rating: [C]",
    "section": "For control of oedema 1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "1548",
    "type": "section",
    "keywords": [
      "furosemide",
      "hourly",
      "specialist",
      "adult",
      "refer",
      "oral",
      "children",
      "increasing",
      "daily"
    ]
  },
  {
    "id": "5750138534918d9e217e5b680b04f83b",
    "content": "240 mg daily\nChildren\nRefer to specialist. For control of resistant oedema\nFurosemide, IV or oral. (as above for adults and children)\nAnd\nMetolazone, oral,\nAdults\n2.",
    "title": "For control of oedema 1st Line Treatment Evidence Rating: [C]",
    "section": "For control of oedema 1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "1549",
    "type": "section",
    "keywords": [
      "furosemide",
      "specialist",
      "oedema",
      "above",
      "refer",
      "adults",
      "oral",
      "control",
      "resistant",
      "metolazone",
      "children",
      "daily"
    ]
  },
  {
    "id": "f6afba8c18583619531398d132b3b0fa",
    "content": "For control of proteinuria\nLisinopril, oral,\nAdult\n5-20 mg daily\nAnd\nPrednisolone, oral,\nAdults\n1 mg/kg daily\nChildren\n60 mg/m2 or 2 mg/kg daily (max. 80 mg). For long-term manage- ment, refer to a paediatrician.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1550",
    "type": "section",
    "keywords": [
      "lisinopril",
      "term",
      "paediatrician",
      "prednisolone",
      "manage",
      "adult",
      "adults",
      "proteinuria",
      "refer",
      "oral",
      "children",
      "control",
      "daily",
      "ment"
    ]
  },
  {
    "id": "188ac200d753501851ecc4661fa59e72",
    "content": "Referral Criteria\nRefer all patients to a physician specialist, paediatrician or nephrologist immediately after diagnosis and stabilisation. Acute Kidney Injury (AKI) is a term that has now replaced the term Acute Renal Failure (ARF). It describes a sudden decrease in renal function occurring over a period of hours to days resulting in accumulation of nitrogenous waste products and disruption of blood volume, electrolyte and acid-base balance.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1551",
    "type": "section",
    "keywords": [
      "sudden",
      "decrease",
      "nephrologist",
      "acute",
      "specialist",
      "paediatrician",
      "describes",
      "immediately",
      "function",
      "base",
      "nitrogenous",
      "patients",
      "electrolyte",
      "volume",
      "renal",
      "criteria",
      "blood",
      "physician",
      "days",
      "replaced"
    ]
  },
  {
    "id": "339f3c07cc452a596e3b3fb5a1f6eaec",
    "content": "The differential diagnosis of AKI includes prerenal azotaemia, renal (intrinsic) and post renal (obstructive nephropathy) forms of AKI. The most important risk factor for the development of AKI is the presence of pre-existing chronic kidney disease. Other than good medical care with avoidance of volume contraction, prevention of hypotension and avoidance of nephrotoxic agents, no specific interventions have been reliably demonstrated to prevent the development of AKI.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1552",
    "type": "section",
    "keywords": [
      "agents",
      "avoidance",
      "important",
      "prerenal",
      "nephropathy",
      "development",
      "demonstrated",
      "obstructive",
      "prevent",
      "factor",
      "specific",
      "interventions",
      "presence",
      "most",
      "volume",
      "renal",
      "reliably",
      "post",
      "disease",
      "chronic"
    ]
  },
  {
    "id": "b2ca2f954cb441d5d4777a22f93c7f7c",
    "content": "During management, a strict fluid input and output chart should be maintained. AKI has been staged by the Kidney Disease: Improving Global Outcomes (KDIGO), AKI working group for severity according to the\ncriteria below:\nKDiGO AKi DEFINITION\nInjury, based on the AKIN Criteria.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1553",
    "type": "section",
    "keywords": [
      "definition",
      "based",
      "according",
      "management",
      "working",
      "input",
      "during",
      "outcomes",
      "staged",
      "strict",
      "chart",
      "fluid",
      "akin",
      "criteria",
      "maintained",
      "disease",
      "should",
      "below",
      "kdigo",
      "kidney"
    ]
  },
  {
    "id": "6a253def1899d4a71d9f27f9abc6ecee",
    "content": "Causes\nObstetric\nSeptic abortion\nPost-caesarean section\nSevere pre-eclampsia/Eclampsia\nPostpartum Haemorrhage (PPH)\nHELLP (Haemolysis Elevated Liver Enzymes Low Platelet) Syndrome\nGynaecological\nBilateral ligation of ureters following abdominal hysterectomy\nMedical\nAcute Glomerulonephritis\nHaemolysis due to:\nMalaria\nInfection\nHerbal medicines\nTyphoid fever\nG6PD deficiency\nDiarrhoea, vomiting and dehydration\nSurgical\nHaemorrhage\nPeritonitis\nAcute Pancreatitis\nObstructive uropathy\nBurns\nSymptoms\nNausea and vomiting\nOliguria\nAnuria\nOedema\nDecreased appetite\nMetallic taste in mouth\nHiccups\nChange in mood\nFlank pain\nFatigue.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1554",
    "type": "section",
    "keywords": [
      "decreased",
      "nausea",
      "peritonitis",
      "oedema",
      "fatigue",
      "herbal",
      "acute",
      "abortion",
      "diarrhoea",
      "abdominal",
      "typhoid",
      "pancreatitis",
      "gynaecological",
      "following",
      "obstructive",
      "metallic",
      "section",
      "postpartum",
      "hiccups",
      "burns"
    ]
  },
  {
    "id": "5c849059589a076b6040ef7d40cf7317",
    "content": "Diarrhoea\nSigns\nUsually no specific signs\ninvestigations\nUrinalysis\nFBC\nBUE and creatinine\nSerum uric acid\nBlood culture\nUrine culture\nAbdomino-pelvic ultrasound scan\nPlain X-ray of abdomen.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1555",
    "type": "section",
    "keywords": [
      "usually",
      "ultrasound",
      "urine",
      "diarrhoea",
      "creatinine",
      "specific",
      "signs",
      "urinalysis",
      "culture",
      "abdomino",
      "blood",
      "pelvic",
      "acid",
      "uric",
      "investigations",
      "abdomen",
      "serum",
      "scan",
      "plain"
    ]
  },
  {
    "id": "c6ccbaf6cd1281acdeb21cea0d803ddc",
    "content": "To recognise and correct reversible causes\nTo prevent further renal injury\nTo maintain a normal electrolyte and fluid volume milieu\nTo remove toxic waste from the body (dialysis).",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1556",
    "type": "section",
    "keywords": [
      "correct",
      "fluid",
      "milieu",
      "reversible",
      "body",
      "prevent",
      "toxic",
      "electrolyte",
      "volume",
      "renal",
      "causes",
      "recognise",
      "further",
      "dialysis",
      "waste",
      "maintain",
      "remove",
      "normal",
      "injury"
    ]
  },
  {
    "id": "89d8b4996aede7bb57b2c17a2c0e2dc7",
    "content": "Nutrition: Give protein of high biological value at 40 g protein/day in adults. In children 0. 8-1 g/kg of 1st class protein/day\nDaily weighing\nMaintain fluid balance\nBeware of hyperkalaemia - avoid potassium containing foods e.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1557",
    "type": "section",
    "keywords": [
      "avoid",
      "give",
      "potassium",
      "foods",
      "fluid",
      "nutrition",
      "protein",
      "class",
      "children",
      "beware",
      "containing",
      "value",
      "biological",
      "adults",
      "hyperkalaemia",
      "maintain",
      "high",
      "weighing",
      "balance",
      "daily"
    ]
  },
  {
    "id": "a75e27e375bb500015aba9c904ee3aa6",
    "content": "Sodium Chloride, 0. 9%, IV,\nOr\nRingers lactate (if there is no hyperkalaemia) in cases of diarrhoea and vomiting\nOr\nBlood transfusion (in severe bleeding)\nOr\nPlasma replacement (in cases of severe burns). To re-establish diuresis after adequate fluid replacement\nFurosemide, IV,.",
    "title": "Treatment of hypovolaemia",
    "section": "Treatment of hypovolaemia",
    "chunk_id": "1558",
    "type": "section",
    "keywords": [
      "plasma",
      "replacement",
      "fluid",
      "diarrhoea",
      "bleeding",
      "sodium",
      "burns",
      "blood",
      "severe",
      "ringers",
      "there",
      "chloride",
      "transfusion",
      "furosemide",
      "vomiting",
      "lactate",
      "hyperkalaemia",
      "establish",
      "diuresis",
      "cases"
    ]
  },
  {
    "id": "64d0f5094c60b77bae2ec056cadad297",
    "content": "Adult\n40-80 mg stat. Children\nmg/kg stat. Do not repeat.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1559",
    "type": "section",
    "keywords": [
      "children",
      "repeat",
      "stat",
      "adult"
    ]
  },
  {
    "id": "e8247eb8fc6b8808fe9a0652b68a6419",
    "content": "Control of hyperkalaemia\nAdult\nCalcium gluconate 10%, IV, 10-20 ml, slow IV, over 2-5 minutes\nAnd\nSoluble Insulin, IV, 10 units in 50-100 ml Dextrose 50%\nAnd\nSodium bicarbonate, IV, 8. 4% (50 mEq in 50ml) 1-2 ml/kg over 5 min-\nutes\nChildren\nSalbutamol, nebulised, (preferred)\n25 kg;\t5 mg\n< 25 kg;\t2. 5 mg\nOr\nCalcium gluconate 10%, IV, 0.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1560",
    "type": "section",
    "keywords": [
      "units",
      "calcium",
      "insulin",
      "preferred",
      "minutes",
      "hyperkalaemia",
      "nebulised",
      "adult",
      "dextrose",
      "sodium",
      "slow",
      "utes",
      "children",
      "gluconate",
      "salbutamol",
      "control",
      "bicarbonate",
      "soluble"
    ]
  },
  {
    "id": "67753adad94adaf26957373cd7080f2c",
    "content": "5-1 ml/kg, slow IV, over 5-10 minutes\nAnd\nSoluble Insulin, IV, 0. 2 units in 5 ml Dextrose 20%, give 2. 5-5 ml/kg/ hour.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1561",
    "type": "section",
    "keywords": [
      "hour",
      "units",
      "insulin",
      "minutes",
      "give",
      "dextrose",
      "slow",
      "soluble"
    ]
  },
  {
    "id": "4721806255a524fa243dbb7b0d310110",
    "content": "Keep blood glucose at 10-15 mmol/L. And\nSodium bicarbonate, IV, 8. 4% (50 mEq in 50ml) 1-2 ml/kg over 5 min-\nutes.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1562",
    "type": "section",
    "keywords": [
      "mmol",
      "keep",
      "sodium",
      "utes",
      "glucose",
      "bicarbonate",
      "blood"
    ]
  },
  {
    "id": "1848bb969aa475a0d7e78c3daa5a0b57",
    "content": "Referral Criteria\nAll patients with clinical indications for dialysis must be referred promptly to a centre with facilities for dialysis. Chronic Kidney Disease (CKD) refers to kidney damage of more than 3 months duration. The early stage of CKD is usually asymptomatic but can be detected through laboratory tests of serum creatinine and estimation of Glomerular Filtration Rate (eGFR), measurement of urine albumin creatinine ratio and screening of individuals at increased risk such as those with hypertension, diabetes mellitus or a past history of glomerulonephritis.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1563",
    "type": "section",
    "keywords": [
      "hypertension",
      "usually",
      "mellitus",
      "ratio",
      "urine",
      "refers",
      "albumin",
      "asymptomatic",
      "indications",
      "creatinine",
      "rate",
      "detected",
      "facilities",
      "filtration",
      "screening",
      "stage",
      "patients",
      "criteria",
      "disease",
      "referral"
    ]
  },
  {
    "id": "3cc208f029d1450394ece238e26ccd01",
    "content": "CKD may manifest either as urine abnormalities (e. g. persistent microalbuminuria, proteinuria, haematuria), blood abnormalities (e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1564",
    "type": "section",
    "keywords": [
      "haematuria",
      "either",
      "manifest",
      "abnormalities",
      "microalbuminuria",
      "proteinuria",
      "urine",
      "persistent",
      "blood"
    ]
  },
  {
    "id": "5ba54c6f906e7f1e95515f3c63cf6c68",
    "content": "g. elevated urea and creatinine and estimated GFR < 90 ml/minute/1. 73 m2) and structural kidney changes on ultrasonography.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1565",
    "type": "section",
    "keywords": [
      "creatinine",
      "minute",
      "kidney",
      "ultrasonography",
      "estimated",
      "elevated",
      "structural",
      "urea",
      "changes"
    ]
  },
  {
    "id": "db936459b9fb941ac3136946e5e6e93b",
    "content": "For all stages of CKD, patients should be encouraged to cease smoking, reduce weight if obese, check lipids and treat, and avoid NSAIDs and other nephrotoxic drugs. Causes\nChronic hypertension\nChronic glomerulonephritis\nDiabetes mellitus\nObstructive uropathy\nRenal calculi.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1566",
    "type": "section",
    "keywords": [
      "hypertension",
      "obese",
      "avoid",
      "treat",
      "weight",
      "mellitus",
      "check",
      "lipids",
      "calculi",
      "obstructive",
      "uropathy",
      "patients",
      "cease",
      "renal",
      "causes",
      "nsaids",
      "chronic",
      "should",
      "encouraged",
      "stages"
    ]
  },
  {
    "id": "d2a27f215d49e8ff430fa59fe3050828",
    "content": "Symptoms\nNone in the early stages\nReduced attention and concentration\nAnorexia, nausea, vomiting.",
    "title": "Connective tissue disease",
    "section": "Connective tissue disease",
    "chunk_id": "1567",
    "type": "section",
    "keywords": [
      "vomiting",
      "anorexia",
      "nausea",
      "concentration",
      "none",
      "early",
      "attention",
      "reduced",
      "stages",
      "symptoms"
    ]
  },
  {
    "id": "213d139ea85c402ab5c4b205eead5fa4",
    "content": "Gastrointestinal bleeding\nHiccups\nBreathlessness on exertion\nThirst\nNocturia, polyuria\nMuscle Cramps\nParaesthesia\nPruritus\nInsomnia\nSigns\nLethargy\nBleeding tendency\nPallor\nHypertension\nPericarditis\nPeripheral neuropathy\nPeripheral oedema\nAsterixis (flapping tremor)\nIncreased skin pigmentation and/or excoriation\ninvestigations\nFBC, Sickling, Blood film comment\nUrinalysis\nBlood Urea, Electrolytes, Serum Creatinine\nCalcium, Phosphate\nFasting blood glucose\nLipids\nChest X-ray\nUltrasound of kidneys.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1568",
    "type": "section",
    "keywords": [
      "hypertension",
      "ultrasound",
      "sickling",
      "oedema",
      "excoriation",
      "phosphate",
      "exertion",
      "comment",
      "glucose",
      "lethargy",
      "lipids",
      "creatinine",
      "chest",
      "insomnia",
      "flapping",
      "bleeding",
      "hiccups",
      "tendency",
      "film",
      "muscle"
    ]
  },
  {
    "id": "12312b05b3a2d725b9a6a9df3e95028f",
    "content": "To control hypertension\nTo control blood glucose\nTo manage underlying causes\nTo prevent complications and further worsening of kidney function.",
    "title": "To detect chronic kidney disease early in susceptible individuals",
    "section": "To detect chronic kidney disease early in susceptible individuals",
    "chunk_id": "1569",
    "type": "section",
    "keywords": [
      "hypertension",
      "complications",
      "worsening",
      "prevent",
      "manage",
      "kidney",
      "function",
      "further",
      "underlying",
      "glucose",
      "control",
      "blood",
      "causes"
    ]
  },
  {
    "id": "15f8dd340b967f1675369cfddfe8fa83",
    "content": "Avoid nephrotoxins e. g. NSAIDs, herbal medication\nDaily intake of fluid of 600 ml over previous day’s urine output for adults (400 ml/m2 body surface area in children)\nRestrict salt intake\nRestrict dietary protein to 1 gram/kg/day\nAvoid potassium containing foods e.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1570",
    "type": "section",
    "keywords": [
      "avoid",
      "salt",
      "restrict",
      "herbal",
      "urine",
      "potassium",
      "foods",
      "nephrotoxins",
      "fluid",
      "body",
      "surface",
      "protein",
      "dietary",
      "intake",
      "children",
      "previous",
      "nsaids",
      "containing",
      "medication",
      "adults"
    ]
  },
  {
    "id": "e8247eb8fc6b8808fe9a0652b68a6419",
    "content": "Control of hyperkalaemia\nAdult\nCalcium gluconate 10%, IV, 10-20 ml, slow IV, over 2-5 minutes\nAnd\nSoluble Insulin, IV, 10 units in 50-100 ml Dextrose 50%\nAnd\nSodium bicarbonate, IV, 8. 4% (50 mEq in 50ml) 1-2 ml/kg over 5 min-\nutes\nChildren\nSalbutamol, nebulised, (preferred)\n25 kg;\t5 mg\n< 25 kg;\t2. 5 mg\nOr\nCalcium gluconate 10%, IV, 0.",
    "title": "(See section on ‘Anaemia in Chronic Kidney Disease’)",
    "section": "(See section on ‘Anaemia in Chronic Kidney Disease’)",
    "chunk_id": "1571",
    "type": "section",
    "keywords": [
      "units",
      "calcium",
      "insulin",
      "preferred",
      "minutes",
      "hyperkalaemia",
      "nebulised",
      "adult",
      "dextrose",
      "sodium",
      "slow",
      "utes",
      "children",
      "gluconate",
      "salbutamol",
      "control",
      "bicarbonate",
      "soluble"
    ]
  },
  {
    "id": "67753adad94adaf26957373cd7080f2c",
    "content": "5-1 ml/kg, slow IV, over 5-10 minutes\nAnd\nSoluble Insulin, IV, 0. 2 units in 5 ml Dextrose 20%, give 2. 5-5 ml/kg/ hour.",
    "title": "(See section on ‘Anaemia in Chronic Kidney Disease’)",
    "section": "(See section on ‘Anaemia in Chronic Kidney Disease’)",
    "chunk_id": "1572",
    "type": "section",
    "keywords": [
      "hour",
      "units",
      "insulin",
      "minutes",
      "give",
      "dextrose",
      "slow",
      "soluble"
    ]
  },
  {
    "id": "0c2cc3828ac2046a5b7422e2f53cff42",
    "content": "Keep blood glucose at 10-15 mmol/L. And\nSodium bicarbonate, IV, 8. 4% (45 mEq) over 5 minutes, 1-2 mmol/\nkg (1-2 ml/kg)\nReferral Criteria\nRefer all patients with predisposing factors and complications to a physician specialist or nephrologist for further definitive management of chronic kidney disease.",
    "title": "(See section on ‘Anaemia in Chronic Kidney Disease’)",
    "section": "(See section on ‘Anaemia in Chronic Kidney Disease’)",
    "chunk_id": "1573",
    "type": "section",
    "keywords": [
      "management",
      "nephrologist",
      "factors",
      "glucose",
      "definitive",
      "specialist",
      "minutes",
      "predisposing",
      "sodium",
      "patients",
      "criteria",
      "blood",
      "physician",
      "mmol",
      "disease",
      "referral",
      "chronic",
      "keep",
      "further",
      "bicarbonate"
    ]
  },
  {
    "id": "66fef649df3164f2ff3f58250f317c2e",
    "content": "Refer all patients requiring dialysis to a nephrologist.",
    "title": "(See section on ‘Anaemia in Chronic Kidney Disease’)",
    "section": "(See section on ‘Anaemia in Chronic Kidney Disease’)",
    "chunk_id": "1574",
    "type": "section",
    "keywords": [
      "refer",
      "nephrologist",
      "requiring",
      "dialysis",
      "patients"
    ]
  },
  {
    "id": "65b3fdb6307fcb122c31a9517ef7e504",
    "content": "Anaemia develops early in the course of Chronic Kidney Disease (CKD) and is nearly universal in patients with CKD stage 5 (End-stage kidney disease). The prevalence of anaemia at higher levels of glomerular filtration rate (GFR) (i. e.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1575",
    "type": "section",
    "keywords": [
      "disease",
      "higher",
      "chronic",
      "rate",
      "universal",
      "anaemia",
      "kidney",
      "course",
      "early",
      "levels",
      "filtration",
      "stage",
      "patients",
      "prevalence",
      "nearly",
      "glomerular",
      "develops"
    ]
  },
  {
    "id": "d4495ccafee4743526917ca4a858c8e5",
    "content": "CKD stage 1-2) is relatively low in individuals from the general population. Anaemia of CKD is primarily caused by deficiency of erythropoietin. The kidneys are the major source of erythropoietin and, as renal function declines, production of erythropoietin declines proportionately.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1576",
    "type": "section",
    "keywords": [
      "caused",
      "kidneys",
      "anaemia",
      "erythropoietin",
      "function",
      "population",
      "source",
      "major",
      "relatively",
      "individuals",
      "stage",
      "production",
      "proportionately",
      "renal",
      "declines",
      "general",
      "primarily",
      "deficiency"
    ]
  },
  {
    "id": "8ed5cd31df100530f3a1fef00010a847",
    "content": "Though erythropoietin deficiency is common among patients with anaemia in CKD, other potential causes and contributing disorders should be identified or excluded if initial evaluation yields evidence for disorders other than iron deficiency or erythropoietin deficiency. Correction of anaemia in CKD patients improves survival and quality of life. Causes\nDeficiency of erythropoietin.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1577",
    "type": "section",
    "keywords": [
      "initial",
      "contributing",
      "anaemia",
      "erythropoietin",
      "quality",
      "potential",
      "evidence",
      "evaluation",
      "among",
      "identified",
      "patients",
      "causes",
      "yields",
      "deficiency",
      "though",
      "should",
      "disorders",
      "correction",
      "excluded",
      "survival"
    ]
  },
  {
    "id": "f61afdab10d51f13ed840ba1970448c4",
    "content": "hypertension\nIncreased gastrointestinal bleeding\nIncreased oxidative stress leading to shortened red cell survival\nSymptoms\n(See section on ‘Anaemia’).",
    "title": "Red cell destruction from microvascular disease from diabetes or",
    "section": "Red cell destruction from microvascular disease from diabetes or",
    "chunk_id": "1578",
    "type": "section",
    "keywords": [
      "hypertension",
      "survival",
      "oxidative",
      "leading",
      "shortened",
      "stress",
      "anaemia",
      "cell",
      "bleeding",
      "section",
      "increased",
      "symptoms",
      "gastrointestinal"
    ]
  },
  {
    "id": "7bb31251fbf72b55bdfe9ff58bdcd8c6",
    "content": "Signs\n(See section on ‘Anaemia’)\ninvestigations\nFBC\nReticulocyte count\nTransferrin saturation\nSerum ferritin\nStool occult blood.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1579",
    "type": "section",
    "keywords": [
      "ferritin",
      "anaemia",
      "count",
      "serum",
      "section",
      "occult",
      "saturation",
      "signs",
      "transferrin",
      "investigations",
      "stool",
      "reticulocyte",
      "blood"
    ]
  },
  {
    "id": "5c934937e3b65f289d453e700ff69d9c",
    "content": "To achieve and maintain a target-range Hb level of 11-12 g/dL.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1580",
    "type": "section",
    "keywords": [
      "achieve",
      "target",
      "level",
      "maintain",
      "range"
    ]
  },
  {
    "id": "3767c38e372d76d826b79ef9b267a1fe",
    "content": "Ferrous sulphate, oral, 325 mg 8 hourly for 4 weeks\nCKD Stages 3-4\nIron replacement: Target Hb should be 11-12 g/dL\nFerrous sulphate, oral, 325 mg 8 hourly\nOr\nFerrous gluconate, oral, 300 mg 8-12 hourly. Evaluate after 4-6 weeks\nOr\nIron sucrose, IV, consult specialist\nOr\nFerric sodium gluconate complex, consult specialist\nAnd\nEpoietin beta, SC, consult specialist\nOr\nMethoxy polyethylene glycol epoietin beta (pegylated form of Epo), SC, consult specialist\nOr\nDarbepoietin alfa, SC, consult specialist\nReferral Criteria\nRefer all (adults and children) patients with CKD and anaemia to a specialist or nephrologist.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1581",
    "type": "section",
    "keywords": [
      "sulphate",
      "alfa",
      "evaluate",
      "anaemia",
      "replacement",
      "nephrologist",
      "polyethylene",
      "glycol",
      "form",
      "hourly",
      "specialist",
      "ferrous",
      "methoxy",
      "sodium",
      "patients",
      "weeks",
      "children",
      "criteria",
      "epoietin",
      "referral"
    ]
  },
  {
    "id": "1692e8bb4bfe7d9cffcdeaef5f0c6ca3",
    "content": "Urinary tract infection (UTI) is the presence of micro-organisms in the urine or tissues of the normally sterile genitourinary tract. Infection may be localized to the bladder alone or the kidneys or, in men the prostate. Acute uncomplicated UTI occurs in women with a normal genitourinary tract and usually manifests as acute cystitis (bladder infection or lower tract infection).",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1582",
    "type": "section",
    "keywords": [
      "usually",
      "genitourinary",
      "sterile",
      "urine",
      "alone",
      "micro",
      "acute",
      "prostate",
      "manifests",
      "cystitis",
      "presence",
      "tract",
      "kidneys",
      "women",
      "uncomplicated",
      "organisms",
      "occurs",
      "normally",
      "tissues",
      "localized"
    ]
  },
  {
    "id": "8c846c79b5fe4d9ed526c5b1a5775c1b",
    "content": "Complicated UTI occurs in individuals with structural or functional abnormalities of the genitourinary tract, including those with indwelling devices such as urethral catheters. Congenital abnormalities of the genito-urinary tract predispose children to UTI. Proven UTI in a child or recurrent UTI requires further urogenital evaluation.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1583",
    "type": "section",
    "keywords": [
      "urethral",
      "recurrent",
      "proven",
      "genitourinary",
      "abnormalities",
      "genito",
      "child",
      "urogenital",
      "devices",
      "evaluation",
      "functional",
      "including",
      "structural",
      "children",
      "indwelling",
      "congenital",
      "tract",
      "complicated",
      "further",
      "catheters"
    ]
  },
  {
    "id": "11b604789f4896b731ea550d2c7d9109",
    "content": "Definitive treatment of UTI depends on culture and sensitivity reports. However, empirical treatment may be initiated while awaiting the report. Causes\nBacteraemia or septicaemia\nUrinary tract obstruction e.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1584",
    "type": "section",
    "keywords": [
      "empirical",
      "tract",
      "bacteraemia",
      "depends",
      "however",
      "urinary",
      "septicaemia",
      "obstruction",
      "initiated",
      "culture",
      "awaiting",
      "definitive",
      "sensitivity",
      "report",
      "while",
      "treatment",
      "causes",
      "reports"
    ]
  },
  {
    "id": "10000845b2c05dc793368bf6b467bf75",
    "content": "g. enlarged prostate in adult males, posterior urethral valves in infants/children\nSymptoms\nFrequent painful urination\nHaematuria\nCloudy/foul smelling urine\nVomiting\nSuprapubic pain\nFever - may be persistent and unexplained (in children)\nThere may be feeding problems, diarrhoea, and failure to thrive as well (in children)\nSigns\nFever\nLoin tenderness\nSuprapubic tenderness\nFoul smelling urine\ninvestigations\nFBC\nMid-stream specimen of urine for microscopy, culture and sensitivity (re-culture urine after treatment)\nAbdominal ultrasound scan in children if indicated.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1585",
    "type": "section",
    "keywords": [
      "urethral",
      "ultrasound",
      "valves",
      "males",
      "urine",
      "feeding",
      "thrive",
      "sensitivity",
      "prostate",
      "diarrhoea",
      "suprapubic",
      "microscopy",
      "abdominal",
      "foul",
      "signs",
      "loin",
      "culture",
      "children",
      "posterior",
      "stream"
    ]
  },
  {
    "id": "7a92abadb3592893b7cef19aa9dea283",
    "content": "To relieve symptoms such as fever and pain (See section on ‘Fever’ and ‘Pain Management’)\nTo eradicate causative agent\nTo prevent complications\nTo identify patients with abnormalities of the genito-urinary tract.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1586",
    "type": "section",
    "keywords": [
      "complications",
      "pain",
      "tract",
      "prevent",
      "management",
      "section",
      "fever",
      "causative",
      "agent",
      "eradicate",
      "relieve",
      "abnormalities",
      "genito",
      "identify",
      "patients",
      "symptoms",
      "urinary"
    ]
  },
  {
    "id": "8dc76e6dd0ef0aae3009d1d7970f12fc",
    "content": "Liberal oral fluids to encourage good urinary output\nPersonal hygiene and proper cleaning after defaecation.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1587",
    "type": "section",
    "keywords": [
      "cleaning",
      "hygiene",
      "proper",
      "defaecation",
      "liberal",
      "output",
      "oral",
      "fluids",
      "personal",
      "after",
      "encourage",
      "urinary"
    ]
  },
  {
    "id": "f1b729e14272ea47fbcdea31199bfaca",
    "content": "Ciprofloxacin, oral,\nAdults\n500 mg 12 hourly for 7 days (female); 10-14 days (male)\nChildren\n15-20 mg/kg 12 hourly; (max. of 750 mg daily in two divided doses)\nOr\nCefuroxime, oral,\nAdults\n250-500 mg 12 hourly for 5-7 days (female); 10-14 days (male)\nChildren\n12-18 years; 250 mg 12 hourly for 5-7 days\n2-12 years; 15 mg/ kg 12 hourly (max. 250 mg) for 5-7 days\n3 months-2 years; 10 mg/kg 12 hourly (max.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "1588",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "years",
      "female",
      "adults",
      "doses",
      "male",
      "oral",
      "cefuroxime",
      "children",
      "months",
      "divided",
      "ciprofloxacin",
      "daily"
    ]
  },
  {
    "id": "4a2bc2f529980b37682adbefc015134f",
    "content": "125 mg) for 5-7 days\nTreatment of Complicated UTi (including catheter-related, stones, prostate enlargement, urologic abnormalities and pregnancy).",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "1589",
    "type": "section",
    "keywords": [
      "days",
      "prostate",
      "urologic",
      "complicated",
      "stones",
      "including",
      "catheter",
      "abnormalities",
      "pregnancy",
      "enlargement",
      "related",
      "treatment"
    ]
  },
  {
    "id": "25d47e8aad2cdb6f5d3fb5cf53a2b8ce",
    "content": "Ciprofloxacin, IV,\nAdults\n400 mg 8-12 hourly for 7 days (to be administered over 60 minutes)\nOr\nGentamicin, IV, (if kidney function is normal)\nAdults\n40-80 mg 8 hourly for 7 days\nChildren\n12-18 years;\t2 mg/kg 8 hourly for 7 days\n1 month-12 years;\t2. 5 mg/kg 8 hourly for 7 days\nOr\nCeftriaxone, IV,\nAdults\n1-2 g daily for 7 days.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "1590",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "gentamicin",
      "years",
      "ceftriaxone",
      "minutes",
      "kidney",
      "function",
      "adults",
      "month",
      "administered",
      "normal",
      "children",
      "ciprofloxacin",
      "daily"
    ]
  },
  {
    "id": "84322ef2ba014b3f58f9026f6ee0e0d0",
    "content": "Children\nAll ages 25 mg/kg 12 hourly (max. 75 mg/kg daily)\nOr\nAmoxicillin + Clavulanic Acid, IV,\nChildren\n1 month-18 years;\t20-30 mg/kg 8 hourly (max. 500 mg) for 5-7\ndays\nNeonates (dose doubled in severe infection)\n7-28 days;\t30 mg/kg 8 hourly for 5-7days\n< 7 days;\t30 mg/kg 12 hourly for 5-7days\nAnd\nGentamicin, IV, (slow intravenous injection over at least 3 minutes)\nChildren\n12-18 years;\t2 mg/kg 8 hourly\n1 month-12 years;\t2.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1591",
    "type": "section",
    "keywords": [
      "ages",
      "years",
      "neonates",
      "intravenous",
      "doubled",
      "hourly",
      "minutes",
      "clavulanic",
      "injection",
      "children",
      "days",
      "severe",
      "amoxicillin",
      "acid",
      "slow",
      "dose",
      "month",
      "gentamicin",
      "least",
      "infection"
    ]
  },
  {
    "id": "1ce86597966b09d53966aacdeb74a410",
    "content": "5 mg/kg 8 hourly\nOr\nCefuroxime, IV,\nChildren\n1 month-18 years;\t20 mg/kg 8 hourly max. 750 mg, (increase to 40-50 mg/kg max. 1.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1592",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "cefuroxime",
      "month",
      "children",
      "increase"
    ]
  },
  {
    "id": "047dc00f83beba617c5ba8413dc598b8",
    "content": "5g 6-8 hourly in severe infections)\nNeonates (double the dose in severe infections, IV route only) 21-28 days;\t25 mg/kg 6 hourly\n7-12 days;\t25 mg/kg 8 hourly\n< 7 days;\t25 mg/kg 12 hourly\nReferral Criteria\nRefer patients who are very ill, with recurrent UTI, persistent haematuria and congenital abnormalities to the appropriate specialist. Medicines can lead to renal damage in a number of different ways and examples are given below. In the wrong circumstances life-saving medicines can do more harm than good.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1593",
    "type": "section",
    "keywords": [
      "infections",
      "recurrent",
      "neonates",
      "given",
      "abnormalities",
      "lead",
      "wrong",
      "saving",
      "hourly",
      "specialist",
      "double",
      "patients",
      "renal",
      "criteria",
      "harm",
      "number",
      "congenital",
      "severe",
      "days",
      "haematuria"
    ]
  },
  {
    "id": "a274f1f6f03e5db3522bfe943668d98d",
    "content": "Doctors, pharmacists and nurses can help their patients by checking their treatment charts in hospital or at the outpatients department. The medicines listed below may cause renal impairment and must therefore be stopped or not prescribed in patients with deteriorating renal function. All medicines in this table should be dosed based on kidney function (estimated GFR).",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1594",
    "type": "section",
    "keywords": [
      "charts",
      "deteriorating",
      "based",
      "estimated",
      "department",
      "table",
      "help",
      "nurses",
      "therefore",
      "dosed",
      "function",
      "stopped",
      "patients",
      "their",
      "renal",
      "treatment",
      "outpatients",
      "checking",
      "impairment",
      "should"
    ]
  },
  {
    "id": "1a48aa608184a3c51394ae7295b33009",
    "content": "Avoid concomitant use of nephrotoxic medications and diuretics. Monitor renal function before and during treatment. Patient-related risk factors for all these medicines include age, pre-existing chronic kidney disease, volume depletion, and concurrent use of nephrotoxic medicines.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1595",
    "type": "section",
    "keywords": [
      "avoid",
      "during",
      "factors",
      "patient",
      "depletion",
      "function",
      "volume",
      "renal",
      "treatment",
      "concurrent",
      "include",
      "disease",
      "chronic",
      "before",
      "monitor",
      "medications",
      "concomitant",
      "medicines",
      "related",
      "diuretics"
    ]
  },
  {
    "id": "7faba741873959f8505389a7bc44ee3c",
    "content": "AKI – Acute Kidney Injury\nACE – Angiotensin converting enzyme HETE – Hydroxyeisosatetraenoic acid PG – Prostaglandin\nAcute cystitis is an acute inflammation of the bladder. Women are affected 10 times more than men due to the shortness of their urethra compared to that of men. 40%-50% of all women will develop cystitis in their lifetime.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1596",
    "type": "section",
    "keywords": [
      "lifetime",
      "angiotensin",
      "times",
      "acute",
      "inflammation",
      "cystitis",
      "their",
      "urethra",
      "hete",
      "enzyme",
      "acid",
      "prostaglandin",
      "women",
      "shortness",
      "converting",
      "compared",
      "hydroxyeisosatetraenoic",
      "develop",
      "kidney",
      "more"
    ]
  },
  {
    "id": "15a8b961b739fff380667e1f90f8a100",
    "content": "The ascending faecal-perineal-urethral route is the primary mode of infection. Occasionally sexually transmitted organisms are involved. Risk factors include urethral catheterization and diabetes.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1597",
    "type": "section",
    "keywords": [
      "urethral",
      "primary",
      "include",
      "transmitted",
      "ascending",
      "faecal",
      "perineal",
      "involved",
      "diabetes",
      "infection",
      "sexually",
      "mode",
      "factors",
      "organisms",
      "risk",
      "route",
      "catheterization",
      "occasionally"
    ]
  },
  {
    "id": "af67e5a148c3e755349f13b6d5864709",
    "content": "Causes\nE. coli (about 80%)\nStaphylococcus saprophyticus\nKlebsiella\nProteus mirabilis\nGonococcus\nEnterococci\nSymptoms\nLow grade fever\nFrequency\nNocturia\nUrgency\nDysuria\nHaematuria\nCloudy and foul smelling urine\nLow back and suprapubic pain\nSigns\nLow grade fever\nSuprapubic tenderness\nHaematuria\ninvestigations\nUrinalysis.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1598",
    "type": "section",
    "keywords": [
      "klebsiella",
      "urine",
      "suprapubic",
      "foul",
      "urinalysis",
      "signs",
      "proteus",
      "causes",
      "grade",
      "enterococci",
      "haematuria",
      "tenderness",
      "staphylococcus",
      "fever",
      "gonococcus",
      "mirabilis",
      "saprophyticus",
      "back",
      "investigations",
      "dysuria"
    ]
  },
  {
    "id": "14707532a4ae57213e4b847d85eadb4d",
    "content": "Mid-stream urine for culture and sensitivity\nFBC\nFBS\nImaging of urinary tract in recurrent or persistent cases to exclude anatomical abnormalities, lower urinary tract obstruction etc. Urethrocystoscopy in selected cases.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1599",
    "type": "section",
    "keywords": [
      "tract",
      "recurrent",
      "exclude",
      "urethrocystoscopy",
      "anatomical",
      "abnormalities",
      "cases",
      "obstruction",
      "urine",
      "imaging",
      "culture",
      "persistent",
      "lower",
      "sensitivity",
      "selected",
      "stream",
      "urinary"
    ]
  },
  {
    "id": "0d5d8c3f4c67daefd6c9a64993543896",
    "content": "To eradicate infection\nTo prevent recurrence and complications\nTo relieve pain.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1600",
    "type": "section",
    "keywords": [
      "complications",
      "pain",
      "recurrence",
      "prevent",
      "infection",
      "eradicate",
      "relieve"
    ]
  },
  {
    "id": "dccb03ae0242ffd4e623a53e80068f4a",
    "content": "Liberal oral fluids to encourage good urinary output\nPre-coital and post-coital emptying of the bladder\nPersonal hygiene and proper cleaning after defaecation especially in females.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1601",
    "type": "section",
    "keywords": [
      "post",
      "emptying",
      "cleaning",
      "hygiene",
      "proper",
      "defaecation",
      "liberal",
      "output",
      "bladder",
      "especially",
      "oral",
      "fluids",
      "personal",
      "coital",
      "after",
      "encourage",
      "females",
      "urinary"
    ]
  },
  {
    "id": "70e51ed5be6ba92badd0d8214a03ba93",
    "content": "Acute uncomplicated cystitis (absence of fever and flank pain).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1602",
    "type": "section",
    "keywords": [
      "pain",
      "fever",
      "cystitis",
      "uncomplicated",
      "absence",
      "flank",
      "acute"
    ]
  },
  {
    "id": "74bb62fdb0a37c00991d39e372d1ce0a",
    "content": "Nitrofurantoin, oral,\nAdults\n100 mg 6 hourly for 5-7 days\nChildren\n12-18 years;\t50 mg 6 hourly for 7 days\n3 months-12 years;\t750 micrograms/kg 6 hourly for 7 days.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1603",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "years",
      "adults",
      "oral",
      "micrograms",
      "children",
      "months",
      "nitrofurantoin"
    ]
  },
  {
    "id": "88c733e7908753d625122c554dea6866",
    "content": "Ciprofloxacin, oral,\nAdults\n500 mg 12 hourly for 5-7 days\nChildren\n12-18 years;\t250-750 mg 12 hourly\n1 month-12 years;\t7. 5 mg /kg 12 hourly (dose doubled in se- vere cases)\nNeonates\n7. 5 mg/kg 12 hourly\nOr\nCefuroxime, oral,\nAdults\n500 mg 12 hourly for 5-7days\nChildren\n12-18 years;\t250 mg 12 hourly (dose reduced to 125 mg 12 hourly in lower urinary tract infections)\n2-12 years;\t15 mg/kg 12 hourly (max.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "1604",
    "type": "section",
    "keywords": [
      "infections",
      "years",
      "neonates",
      "reduced",
      "doubled",
      "ciprofloxacin",
      "hourly",
      "children",
      "days",
      "tract",
      "adults",
      "dose",
      "month",
      "vere",
      "oral",
      "cases",
      "cefuroxime",
      "lower",
      "urinary"
    ]
  },
  {
    "id": "ee98467b6e933bfb23266404930c18c9",
    "content": "ly)\n3 months-2 years;\t10 mg/kg 12 hourly (max. 125 mg 12 hour- ly)\nAnd\nEvidence Rating: [C]\nMist Potassium citrate, oral,\n10 ml 8 hourly if urine is acidic (pH of 6 or below). To reduce bladder pain and dysuria.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1605",
    "type": "section",
    "keywords": [
      "mist",
      "hourly",
      "rating",
      "hour",
      "acidic",
      "years",
      "citrate",
      "below",
      "pain",
      "dysuria",
      "reduce",
      "bladder",
      "oral",
      "urine",
      "potassium",
      "months",
      "evidence"
    ]
  },
  {
    "id": "95f18ba7b775e8e4c3703e91d08098bd",
    "content": "Or\nParacetamol, oral, 500 mg-1g 6-8 hourly when required\nFor symptomatic cystitis and UTi in pregnancy\nCefuroxime, oral,\nAdults\n500 mg 12 hourly for 5-7days\nAnd\nEvidence Rating: [C]\nMist Potassium citrate, oral,\n10 ml 8 hourly if urine is acidic (pH of 6 or below). To reduce bladder pain and dysuria. Referral Criteria\nRefer all cases, which require cystoscopy and all cases of persistent haematuria, recurrent cystitis or bacterial resistance to the specialist.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1606",
    "type": "section",
    "keywords": [
      "acidic",
      "citrate",
      "recurrent",
      "which",
      "urine",
      "cystoscopy",
      "required",
      "potassium",
      "evidence",
      "hourly",
      "rating",
      "require",
      "specialist",
      "cystitis",
      "pregnancy",
      "criteria",
      "haematuria",
      "referral",
      "bacterial",
      "adults"
    ]
  },
  {
    "id": "bd0d456c267005e52186fe7b74751da1",
    "content": "Benign Prostatic Hyperplasia (BPH) refers to non-cancerous enlargement of the prostate gland which results in obstruction of urine flow from the bladder. BPH is the commonest cause of male urinary symptoms in Ghana. The average age at which lower urinary tract symptoms (LUTS) related to BPH occurs is about 50 years.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1607",
    "type": "section",
    "keywords": [
      "cancerous",
      "years",
      "prostatic",
      "which",
      "urine",
      "gland",
      "results",
      "luts",
      "refers",
      "prostate",
      "male",
      "obstruction",
      "tract",
      "cause",
      "hyperplasia",
      "occurs",
      "enlargement",
      "related",
      "symptoms",
      "about"
    ]
  },
  {
    "id": "70b18c1386b1d43159070807a6c705a4",
    "content": "Men may seek treatment for LUTS either because the symptoms are bothersome or they feel that it may lead to acute urinary retention or out of fear that it may be an indication of prostate cancer. It is important to establish what the patient wants from the consultation. In some patients, once reassured that the likelihood of urinary retention and prostate cancer is low, they may not wish treatment.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1608",
    "type": "section",
    "keywords": [
      "either",
      "wish",
      "important",
      "lead",
      "luts",
      "acute",
      "seek",
      "prostate",
      "patient",
      "consultation",
      "likelihood",
      "retention",
      "indication",
      "patients",
      "bothersome",
      "treatment",
      "feel",
      "wants",
      "because",
      "symptoms"
    ]
  },
  {
    "id": "63feee30d414a0a2e4b71fd99c177be8",
    "content": "for the symptoms. Currently available medicines can either relax prostatic smooth muscles or cause reduction in the prostate size and therefore ease the symptoms of BPH. A combination of available medications, especially in patients with a prostate size more than 40 ml, produce better responses than monotherapy.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1609",
    "type": "section",
    "keywords": [
      "either",
      "especially",
      "prostatic",
      "muscles",
      "ease",
      "prostate",
      "monotherapy",
      "therefore",
      "relax",
      "combination",
      "patients",
      "currently",
      "smooth",
      "reduction",
      "produce",
      "medications",
      "cause",
      "size",
      "medicines",
      "available"
    ]
  },
  {
    "id": "d0838172dd9f370b5cfdce21939e62e0",
    "content": "BPH may lead to complications such as recurrent urinary tract infection, acute urine retention with painful distension of the bladder, chronic urine retention with painless gross distension of the bladder, haematuria, and renal failure. Causes\nIncrease in number of prostate cells due to stimulation by\ntestosterone\nSymptoms\nLower Urinary Tract Symptoms (previously referred to as prostatism)\nHesitancy - delay in initiating urination\nPoor or weak urinary stream\nStraining\nTerminal dribbling\nSensation of incomplete bladder emptying\nUrinary incontinence (overflow) or bedwetting\nFrequent passage of urine especially at night (Nocturia)\nUrgency and urge incontinence\nSigns\nEnlarged prostate gland on rectal examination\nTender palpable bladder (acute urinary retention)\nNon-tender palpable bladder (chronic retention)\nUraemic signs (e. g.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1610",
    "type": "section",
    "keywords": [
      "emptying",
      "urge",
      "recurrent",
      "dribbling",
      "incomplete",
      "especially",
      "incontinence",
      "lead",
      "urine",
      "initiating",
      "delay",
      "poor",
      "nocturia",
      "gland",
      "distension",
      "acute",
      "increase",
      "prostate",
      "night",
      "testosterone"
    ]
  },
  {
    "id": "3980965ef7392f27a70a8870f5d1e924",
    "content": "drowsiness, confusion etc. )\nPalpable kidneys in hydronephrosis\ninvestigations\nSerum creatinine\nProstate specific antigen (PSA) - to exclude prostate cancer\nUrine for culture and sensitivity\nAbdominal and pelvic ultrasound – to exclude hydronephrosis if serum creatinine is elevated.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1611",
    "type": "section",
    "keywords": [
      "ultrasound",
      "urine",
      "sensitivity",
      "prostate",
      "creatinine",
      "abdominal",
      "drowsiness",
      "specific",
      "culture",
      "palpable",
      "pelvic",
      "kidneys",
      "elevated",
      "investigations",
      "hydronephrosis",
      "confusion",
      "cancer",
      "exclude",
      "serum",
      "antigen"
    ]
  },
  {
    "id": "2dc4746e822a4b0786d2c4729a1bf9d5",
    "content": "To exclude prostate cancer and reassure patients accordingly\nTo relieve symptoms and prevent development of complications\nTo identify and treat any associated complications.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1612",
    "type": "section",
    "keywords": [
      "cancer",
      "complications",
      "exclude",
      "treat",
      "prevent",
      "development",
      "accordingly",
      "relieve",
      "associated",
      "patients",
      "identify",
      "reassure",
      "symptoms",
      "prostate"
    ]
  },
  {
    "id": "ed6b58d3018c32c43ac7d354c24487d8",
    "content": "Programme of monitoring and watchful waiting through regular check-ups for mild symptoms.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1613",
    "type": "section",
    "keywords": [
      "monitoring",
      "watchful",
      "regular",
      "waiting",
      "check",
      "programme",
      "through",
      "symptoms",
      "mild"
    ]
  },
  {
    "id": "a3a78af47f95cf3776c333bd919f93ab",
    "content": "Urethral catheterization for acute retention of urine or suprapubic cystostomy if urethral catheterization fails\nSuprapubic needle puncture and aspiration/drainage of urine to\npartially decompress the bladder and relieve pain, when suprapubic cystostomy is delayed.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1614",
    "type": "section",
    "keywords": [
      "urethral",
      "suprapubic",
      "aspiration",
      "acute",
      "needle",
      "pain",
      "drainage",
      "fails",
      "cystostomy",
      "retention",
      "puncture",
      "decompress",
      "partially",
      "urine",
      "relieve",
      "bladder",
      "delayed",
      "catheterization"
    ]
  },
  {
    "id": "920dbadda60ec03f581a23768dda8e28",
    "content": "Patients with bothersome symptoms and prostate size less than 40 ml (small prostate).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1615",
    "type": "section",
    "keywords": [
      "small",
      "size",
      "less",
      "patients",
      "bothersome",
      "symptoms",
      "prostate"
    ]
  },
  {
    "id": "2e029e44abdd82a4718aa5819265ec9d",
    "content": "Terazosin, oral, 2-10 mg at night, (start with 2 mg at night; double\ndose at weekly intervals) max. 10 mg. Or\nTamsulosin, oral, 400 microgram once daily\nOr\nAlfuzosin, oral, 10 mg daily\nPatients with bothersome symptoms and prostate size more than 40 ml (big prostate)\nEvidence Rating: [A]\nFinasteride, 5 mg daily\nAnd\nTerazosin, oral, 2-10 mg at night, (start with 2 mg at night; double dose at weekly intervals) max.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1616",
    "type": "section",
    "keywords": [
      "night",
      "prostate",
      "evidence",
      "rating",
      "start",
      "double",
      "tamsulosin",
      "patients",
      "bothersome",
      "size",
      "dose",
      "alfuzosin",
      "symptoms",
      "once",
      "terazosin",
      "intervals",
      "microgram",
      "finasteride",
      "weekly",
      "oral"
    ]
  },
  {
    "id": "00f7b93dc66468ee5f5c2da3c6cce5d4",
    "content": "10 mg. Or\nTamsulosin, oral, 400 microgram daily\nOr\nAlfuzosin, oral, 10 mg daily\nReferral Criteria\nRefer patients who don’t respond to pharmacological treatment, or have complications (urine retention, haematuria, renal failure and recurrent urinary tract infection) to a Urologist or Surgical specialist. Prostatitis is inflammation of the prostate gland, which may be bacterial or abacterial.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1617",
    "type": "section",
    "keywords": [
      "pharmacological",
      "recurrent",
      "urologist",
      "which",
      "urine",
      "gland",
      "prostate",
      "specialist",
      "inflammation",
      "retention",
      "prostatitis",
      "respond",
      "tamsulosin",
      "patients",
      "renal",
      "criteria",
      "treatment",
      "haematuria",
      "referral",
      "tract"
    ]
  },
  {
    "id": "77dfbed15b620c3f6c8dd9c416e30203",
    "content": "Bacterial prostatitis is more common than abacterial prostatitis. It may present as an acute condition which may either be sexually transmitted or result from urethral reflux of infected urine into the prostatic ducts. Other potential sources may be bacteria spread from rectum or bloodstream.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1618",
    "type": "section",
    "keywords": [
      "urethral",
      "either",
      "bacteria",
      "ducts",
      "prostatic",
      "which",
      "reflux",
      "infected",
      "urine",
      "potential",
      "acute",
      "into",
      "prostatitis",
      "sexually",
      "result",
      "condition",
      "sources",
      "bacterial",
      "rectum",
      "abacterial"
    ]
  },
  {
    "id": "4a677516b1c75357edcd0233e3ffa8cb",
    "content": "If inadequately treated this may progress to chronic prostatitis. It is more common in men below below 50 years.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1619",
    "type": "section",
    "keywords": [
      "chronic",
      "below",
      "years",
      "inadequately",
      "treated",
      "prostatitis",
      "progress",
      "common",
      "more"
    ]
  },
  {
    "id": "7478cb6ca61116e44c09b1512501d1a0",
    "content": "Causes\nGram-negative bacterial infections e. g. from E.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1620",
    "type": "section",
    "keywords": [
      "infections",
      "bacterial",
      "gram",
      "negative",
      "causes"
    ]
  },
  {
    "id": "5cbe65920393ed4221c4d514634c76e9",
    "content": "coli, Pseudomonas,\nStreptococcus\tfaecalis,\tProteus,\tKlebsiella,\tSerratia\tand Enterobacteria. Sexually transmitted infections e. g.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1621",
    "type": "section",
    "keywords": [
      "infections",
      "faecalis",
      "serratia",
      "enterobacteria",
      "transmitted",
      "streptococcus",
      "pseudomonas",
      "klebsiella",
      "sexually",
      "proteus",
      "coli"
    ]
  },
  {
    "id": "013361322e4a89261a7ba72328081b81",
    "content": "from Gonococcus and Chlamydia. Symptoms Acute\nFever\nChills and malaise\nLow back and waist pain\nMyalgia and arthralgia\nRectal /perineal pain\nUrinary urgency and frequency\nNocturia\nDysuria\nDifficulty in urination/retention of urine\nHaematuria\nHaemospermia and loss of libido\nChronic\nInsiduous onset\nRelapsing UTI.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1622",
    "type": "section",
    "keywords": [
      "chills",
      "urine",
      "libido",
      "acute",
      "haemospermia",
      "rectal",
      "chlamydia",
      "insiduous",
      "retention",
      "onset",
      "haematuria",
      "chronic",
      "myalgia",
      "fever",
      "gonococcus",
      "difficulty",
      "back",
      "dysuria",
      "symptoms",
      "waist"
    ]
  },
  {
    "id": "63272a80970d5c7d2e28da435a44ecd9",
    "content": "Low back and waist pain\nUrinary urgency and frequency\nNocturia\nDifficulty in urination\nHaematuria\nHaemospermia\nSigns Acute\nSwollen and tender prostate on Digital Rectal Examination (DRE). (Avoid prostatic massage as this could lead to septicaemia). The rectum feels “hot” from the inflammation.",
    "title": "Persistence of bacteria in seminal fluid despite antibiotic treatment",
    "section": "Persistence of bacteria in seminal fluid despite antibiotic treatment",
    "chunk_id": "1623",
    "type": "section",
    "keywords": [
      "avoid",
      "digital",
      "prostatic",
      "lead",
      "septicaemia",
      "acute",
      "prostate",
      "haemospermia",
      "rectal",
      "inflammation",
      "feels",
      "signs",
      "tender",
      "haematuria",
      "difficulty",
      "back",
      "massage",
      "rectum",
      "waist",
      "frequency"
    ]
  },
  {
    "id": "30d7deeae758485685ef341183e21cc2",
    "content": "Chronic\nFindings on DRE may be normal or a tender prostate occasionally for longstanding disease it may feel very firm or hard as in prostate cancer. investigations\nUrinalysis and culture\nFBC, ESR\nPSA\nBlood culture\nExpressed prostatic secretions for culture and sensitivity through DRE. Voided specimen before and after prostate massage compared.",
    "title": "Persistence of bacteria in seminal fluid despite antibiotic treatment",
    "section": "Persistence of bacteria in seminal fluid despite antibiotic treatment",
    "chunk_id": "1624",
    "type": "section",
    "keywords": [
      "firm",
      "prostatic",
      "sensitivity",
      "prostate",
      "voided",
      "longstanding",
      "urinalysis",
      "hard",
      "culture",
      "expressed",
      "tender",
      "blood",
      "feel",
      "disease",
      "specimen",
      "chronic",
      "findings",
      "before",
      "secretions",
      "investigations"
    ]
  },
  {
    "id": "534fe7a082ed07989283deb76deae0d9",
    "content": "To relieve pain and fever\nTo control infection\nTo relieve lower urinary tract obstruction\nTo prevent chronic prostatitis.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1625",
    "type": "section",
    "keywords": [
      "tract",
      "pain",
      "chronic",
      "prevent",
      "infection",
      "fever",
      "prostatitis",
      "relieve",
      "obstruction",
      "lower",
      "control",
      "urinary"
    ]
  },
  {
    "id": "4b45680e669bad857a71bbc58d2f3896",
    "content": "Bed rest\nHydration\nHospitalisation may be required in severe cases or when the condition is complicated by acute urinary retention and significant haematuria. Suprapubic cystostomy for acute urinary retention. (Urethral\ncatheterization should be avoided.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1626",
    "type": "section",
    "keywords": [
      "urethral",
      "required",
      "acute",
      "suprapubic",
      "retention",
      "avoided",
      "condition",
      "severe",
      "haematuria",
      "complicated",
      "should",
      "rest",
      "hospitalisation",
      "cystostomy",
      "significant",
      "cases",
      "catheterization",
      "hydration",
      "urinary"
    ]
  },
  {
    "id": "38e3826f80f0447442e5da23aa1442fa",
    "content": "Ciprofloxacin, oral, 500 mg 12 hourly for 4-6 weeks\nAnd\nDoxycycline, oral, 100 mg 12 hourly for 4-6 weeks.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "1627",
    "type": "section",
    "keywords": [
      "hourly",
      "doxycycline",
      "oral",
      "weeks",
      "ciprofloxacin"
    ]
  },
  {
    "id": "b5a447a5d968b2bd5ec5370fb5bd3e04",
    "content": "Levofloxacin, oral, 500 mg daily for 4-6 weeks\nAnd\nDoxycycline, oral, 100 mg 12 hourly for 4-6 weeks\nSevere infections\nCiprofloxacin, IV, 400 mg 8-12 hourly (to be administered over 60 minutes)\nOr\nLevofloxacin, IV, 500 mg 12 hourly\nOr\nCeftriaxone, IV, 1-2g Daily\nAnd\nGentamicin, IV, 80 mg 12 Hourly\nFor improvement of urinary flow\nTamsulosin, 400 micrograms daily (at night)\nOr\nAlfuzosin, 10 mg daily\nOr.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "1628",
    "type": "section",
    "keywords": [
      "infections",
      "night",
      "ciprofloxacin",
      "hourly",
      "minutes",
      "tamsulosin",
      "weeks",
      "daily",
      "severe",
      "doxycycline",
      "alfuzosin",
      "levofloxacin",
      "gentamicin",
      "ceftriaxone",
      "flow",
      "oral",
      "micrograms",
      "administered",
      "urinary",
      "improvement"
    ]
  },
  {
    "id": "feef216eef7828fe20fce36501fb3657",
    "content": "Evidence Rating: [C]\nSodium chloride 0. 9%, IV, as required in severe systemic infections. And\nIbuprofen, oral, 400 mg 8 hourly when required\nOr\nDiclofenac, oral, 75 mg 12 hourly when required\nAnd\nLactulose, oral, 10-15 ml 12 hourly and adjust dose accordingly\nReferral Criteria\nRefer all cases of severe infections or chronic prostatitis for specialist.",
    "title": "Adjunct treatment in severe presentations",
    "section": "Adjunct treatment in severe presentations",
    "chunk_id": "1629",
    "type": "section",
    "keywords": [
      "infections",
      "systemic",
      "required",
      "evidence",
      "lactulose",
      "ibuprofen",
      "hourly",
      "rating",
      "specialist",
      "diclofenac",
      "prostatitis",
      "sodium",
      "accordingly",
      "criteria",
      "severe",
      "referral",
      "chronic",
      "adjust",
      "dose",
      "chloride"
    ]
  },
  {
    "id": "ba61d74f1165a8ceea4624f16871bb09",
    "content": "These are swellings found in the scrotum. Causes\nPainless Swellings\nTesticular tumour\nInguinoscrotal hernia\nHydrocoele\nHydrocoele of spermatic cord\nSpermatocoele/epididymal cysts\nVaricocoele\nEpididymal tumours\nChronic epididymo-orchitis\nPainful Swellings\nTesticular torsion\nAcute epididymitis (STI or non-STI related)\nAcute epididymo-orchitis\nStrangulated inguinoscrotal hernia\nTesticular tumour (usually painless except rapidly growing type or tumour necrosis)\nVaricocoeles are occasionally accompanied by pain/discomfort\nSymptoms\nSwelling and/or pain of scrotum or its contents\nSudden onset e. g.",
    "title": "care.",
    "section": "care.",
    "chunk_id": "1630",
    "type": "section",
    "keywords": [
      "torsion",
      "usually",
      "sudden",
      "tumours",
      "spermatic",
      "varicocoele",
      "epididymitis",
      "discomfort",
      "swelling",
      "acute",
      "scrotum",
      "type",
      "hernia",
      "cysts",
      "inguinoscrotal",
      "except",
      "varicocoeles",
      "tumour",
      "causes",
      "onset"
    ]
  },
  {
    "id": "3de9e703b9b594ff858689700aa0083a",
    "content": "torsion of testis\nGradual onset e. g. spermatocoele, hydrocoeles\nGradual onset becoming suddenly painful e.",
    "title": "care.",
    "section": "care.",
    "chunk_id": "1631",
    "type": "section",
    "keywords": [
      "torsion",
      "testis",
      "spermatocoele",
      "gradual",
      "painful",
      "becoming",
      "suddenly",
      "onset",
      "hydrocoeles"
    ]
  },
  {
    "id": "37a8b4e0745fb8602ee1077ecfe8de55",
    "content": "g. obstructed hernia\nFever, may be present in infections e. g.",
    "title": "care.",
    "section": "care.",
    "chunk_id": "1632",
    "type": "section",
    "keywords": [
      "infections",
      "obstructed",
      "present",
      "fever",
      "hernia"
    ]
  },
  {
    "id": "34d2dcecd0984a6030459b0bea56de88",
    "content": "Signs\nTender or non-tender swelling restricted to the scrotum (except a\nhernia which may extend into the inguinal area)\nFever may be present in infections\nTransillumination for cystic swellings e. g. hydrocoeles and spermatoceles\nHard swelling e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1633",
    "type": "section",
    "keywords": [
      "inguinal",
      "infections",
      "swelling",
      "which",
      "spermatoceles",
      "extend",
      "transillumination",
      "into",
      "scrotum",
      "restricted",
      "hernia",
      "except",
      "signs",
      "hard",
      "tender",
      "fever",
      "swellings",
      "hydrocoeles",
      "cystic",
      "present"
    ]
  },
  {
    "id": "aa5b2fdac3bbc1ff3435dd4d34df2df3",
    "content": "g. Tumour\ninvestigations\nUltrasound scan with or without colour doppler.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1634",
    "type": "section",
    "keywords": [
      "colour",
      "ultrasound",
      "doppler",
      "scan",
      "investigations",
      "tumour",
      "without"
    ]
  },
  {
    "id": "07257965de7df2326d1fed21e9b54c97",
    "content": "To relieve pain\nTo prevent complications\nTo expedite emergency intervention eg Testicular Torsion.",
    "title": "To make an accurate diagnosis to ensure appropriate treatment",
    "section": "To make an accurate diagnosis to ensure appropriate treatment",
    "chunk_id": "1635",
    "type": "section",
    "keywords": [
      "torsion",
      "complications",
      "pain",
      "emergency",
      "intervention",
      "prevent",
      "testicular",
      "relieve",
      "expedite"
    ]
  },
  {
    "id": "0c5591717911b1d4609b8bb8f67e368c",
    "content": "Surgery: elective or emergency\nEmergency surgery within 6 hours is required for testicular torsion to salvage the testis.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1636",
    "type": "section",
    "keywords": [
      "torsion",
      "within",
      "emergency",
      "elective",
      "testis",
      "testicular",
      "salvage",
      "required",
      "hours",
      "surgery"
    ]
  },
  {
    "id": "2b3851f57f234766da7cb87dae30b3eb",
    "content": "A. For sexually transmitted infection\nEvidence Rating: [B]\nCiprofloxacin, oral, 500 mg single dose\nAnd\nDoxycycline, oral, 100 mg 12 hourly for 10 days\nOr\nCeftriaxone, IM, 250 mg single dose\nAnd\nDoxycycline, oral, 100 mg 12 hourly for 10 days\nReferral Criteria\nRefer all emergency cases and those suspected to be tumours to a urologist or surgical specialist. This refers to the absence of testis(es) in the scrotum/hemiscrotum.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1637",
    "type": "section",
    "keywords": [
      "tumours",
      "urologist",
      "refers",
      "evidence",
      "ciprofloxacin",
      "scrotum",
      "hourly",
      "rating",
      "emergency",
      "specialist",
      "single",
      "sexually",
      "criteria",
      "days",
      "referral",
      "testis",
      "doxycycline",
      "surgical",
      "suspected",
      "dose"
    ]
  },
  {
    "id": "17af0e86cb4775dcc6c3182db40a51ab",
    "content": "Ten percent of cases are bilateral. Seventy-five percent of full term infants with undescended testes and 90% of premature infants would have spontaneous descent of testes from the intra-abdominal site by the age of one year. Persistent undescent of the testis is associated with an increased.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1638",
    "type": "section",
    "keywords": [
      "intra",
      "testes",
      "associated",
      "full",
      "abdominal",
      "five",
      "site",
      "premature",
      "percent",
      "testis",
      "descent",
      "infants",
      "persistent",
      "increased",
      "year",
      "term",
      "spontaneous",
      "undescended",
      "undescent",
      "cases"
    ]
  },
  {
    "id": "74cc5f6a5a2d92e41b09f1e4ae4a69a4",
    "content": "risk of malignancy, subfertility, atrophy of the testis and torsion. All health workers who see neonates and children should do routine examination of the scrotum and testis to prevent late presentations and complications. Causes\nUndescended testes\nUnknown/idiopathic; most cases are congenital\nPremature birth.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1639",
    "type": "section",
    "keywords": [
      "malignancy",
      "torsion",
      "neonates",
      "idiopathic",
      "testes",
      "health",
      "late",
      "atrophy",
      "scrotum",
      "unknown",
      "prevent",
      "premature",
      "most",
      "children",
      "workers",
      "causes",
      "routine",
      "congenital",
      "testis",
      "should"
    ]
  },
  {
    "id": "9ed7741816a668807d2454c457b132cf",
    "content": "Associated  with  anomalies  like  Prune  Belly  syndrome  and\nhypospadias\nEctopic testis\nRetractile testis\nSevere atrophy\nOrchidectomy\nAgenesis of the testes (rarely)\nSymptoms\nAbsence of one or both testes\nIn children, parents or the health worker may notice this at birth\nSigns\nAbsent testis in both supine and upright positions\ninvestigations\nUltrasound scan of abdomen, pelvis and inguinal canal.",
    "title": "Genetically inherited diseases",
    "section": "Genetically inherited diseases",
    "chunk_id": "1640",
    "type": "section",
    "keywords": [
      "inguinal",
      "orchidectomy",
      "ultrasound",
      "prune",
      "testes",
      "both",
      "absent",
      "associated",
      "health",
      "atrophy",
      "pelvis",
      "positions",
      "retractile",
      "signs",
      "children",
      "supine",
      "notice",
      "severe",
      "testis",
      "anomalies"
    ]
  },
  {
    "id": "ff8cde0c63a1d93c9bb095754dd8e6aa",
    "content": "To decrease potential for cancer\nTo improve fertility\nTo repair hernia\nTo decrease risk of torsion\nTo avoid social and psychological complications.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1641",
    "type": "section",
    "keywords": [
      "torsion",
      "cancer",
      "decrease",
      "avoid",
      "complications",
      "fertility",
      "improve",
      "psychological",
      "repair",
      "hernia",
      "risk",
      "social",
      "potential"
    ]
  },
  {
    "id": "3034e9d4fc77595e37672bf788e5e212",
    "content": "Surgical intervention before two years of age. (All ectopic testes should be operated because they will not descend).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1642",
    "type": "section",
    "keywords": [
      "years",
      "intervention",
      "before",
      "surgical",
      "operated",
      "because",
      "testes",
      "should",
      "ectopic",
      "descend"
    ]
  },
  {
    "id": "f2ffd62b6d0a4533ec799ce654694af7",
    "content": "None\nReferral Criteria\nRefer patients aged over one year with no evidence of testicular descent to a urologist or surgical specialist.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1643",
    "type": "section",
    "keywords": [
      "referral",
      "specialist",
      "descent",
      "aged",
      "surgical",
      "none",
      "testicular",
      "urologist",
      "refer",
      "patients",
      "criteria",
      "evidence",
      "year"
    ]
  },
  {
    "id": "251ec9e33c11877f48633805949bc0ba",
    "content": "This refers to a spontaneous, prolonged, persistent, usually painful erection, which is unwanted and not associated with sexual desire and not relieved by coitus. Priapism is classified into three types namely: Low-flow or ischaemic (commonest), High-flow (non-ischaemic) and Stuttering Priapism. It is commonly seen as a prolongation of Nocturnal Penile Tumescence (NPT) or early morning erection.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1644",
    "type": "section",
    "keywords": [
      "usually",
      "prolonged",
      "types",
      "morning",
      "coitus",
      "namely",
      "which",
      "seen",
      "nocturnal",
      "associated",
      "refers",
      "into",
      "relieved",
      "priapism",
      "tumescence",
      "painful",
      "sexual",
      "three",
      "prolongation",
      "erection"
    ]
  },
  {
    "id": "e00a8aae556be1b972e2bc1fe19d4b6e",
    "content": "This is a well-known complication of sickle cell disease. Patients are usually shy and reluctant to come to the hospital due to stigmatisation. Late presentation is therefore common and herbal medicine applications and spiritual remedies may have been tried to relieve symptoms prior to being seen in hospital.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1645",
    "type": "section",
    "keywords": [
      "usually",
      "medicine",
      "remedies",
      "seen",
      "herbal",
      "late",
      "therefore",
      "known",
      "complication",
      "presentation",
      "patients",
      "being",
      "spiritual",
      "prior",
      "disease",
      "sickle",
      "tried",
      "stigmatisation",
      "symptoms",
      "applications"
    ]
  },
  {
    "id": "0d31d519efb49f96a4fa475cf1f45c56",
    "content": "Early reversal within 24-48 hours may reduce the high impotence complication rate of 50%. Although the occurrence is usually in adults, it may periodically occur in older children. Causes\nIdiopathic or unknown in 60% of cases\nDrugs e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1646",
    "type": "section",
    "keywords": [
      "usually",
      "occur",
      "idiopathic",
      "occurrence",
      "within",
      "rate",
      "unknown",
      "complication",
      "children",
      "causes",
      "impotence",
      "periodically",
      "adults",
      "older",
      "reversal",
      "although",
      "drugs",
      "reduce",
      "early",
      "high"
    ]
  },
  {
    "id": "331a86c525b0665523c7db79c67d2841",
    "content": "g. marijuana and herbal concoctions\nOther causes:\nLeukaemia.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1647",
    "type": "section",
    "keywords": [
      "leukaemia",
      "other",
      "marijuana",
      "concoctions",
      "herbal",
      "causes"
    ]
  },
  {
    "id": "03a00526adbfff33062b9775f270d06a",
    "content": "Penile trauma\nSpinal cord injury\nPelvic infections\nPelvic tumour\nIatrogenic e. g. Intracavernosal prostaglandin E1 for impotence, sildenafil citrate, psychotropics e.",
    "title": "Sickle cell disease and thalassaemia",
    "section": "Sickle cell disease and thalassaemia",
    "chunk_id": "1648",
    "type": "section",
    "keywords": [
      "infections",
      "pelvic",
      "impotence",
      "citrate",
      "tumour",
      "intracavernosal",
      "iatrogenic",
      "psychotropics",
      "prostaglandin",
      "cord",
      "sildenafil",
      "spinal",
      "penile",
      "injury",
      "trauma"
    ]
  },
  {
    "id": "5a8c8d84b7eb0b0763843996b022b720",
    "content": "g. chlorpromazine\nSymptoms\nPainful persistent erection\nSigns\nErect, tender penis.",
    "title": "Sickle cell disease and thalassaemia",
    "section": "Sickle cell disease and thalassaemia",
    "chunk_id": "1649",
    "type": "section",
    "keywords": [
      "chlorpromazine",
      "penis",
      "painful",
      "erect",
      "signs",
      "erection",
      "tender",
      "symptoms",
      "persistent"
    ]
  },
  {
    "id": "8ed245738c7a72666738aca61b9b9e32",
    "content": "investigations\nFBC, blood film comment\nSickling status - Hb electrophoresis\nUrinalysis.",
    "title": "Clinical signs of sickle cell disease",
    "section": "Clinical signs of sickle cell disease",
    "chunk_id": "1650",
    "type": "section",
    "keywords": [
      "sickling",
      "comment",
      "electrophoresis",
      "film",
      "urinalysis",
      "investigations",
      "blood",
      "status"
    ]
  },
  {
    "id": "f4f7149ed0d239990afada5de266af04",
    "content": "To relieve pain\nTo ensure early relief of penile congestion\nTo prevent complications.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1651",
    "type": "section",
    "keywords": [
      "complications",
      "pain",
      "ensure",
      "prevent",
      "early",
      "relief",
      "relieve",
      "congestion",
      "penile"
    ]
  },
  {
    "id": "8c714f14cdf8cb333b047b53de85f1cb",
    "content": "Evidence Rating: [A]\nMaintain adequate hydration\nWinter’s Procedure\nCorpora Irrigation\nSurgery: Shunts.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1652",
    "type": "section",
    "keywords": [
      "rating",
      "irrigation",
      "maintain",
      "procedure",
      "shunts",
      "surgery",
      "corpora",
      "adequate",
      "evidence",
      "hydration",
      "winter"
    ]
  },
  {
    "id": "5adb90a8f26bc485b46c7afd6e8c76de",
    "content": "Conservative management\nEvidence Rating: [C]\nSodium Chloride 0. 9%, IV,\nAdults\n1 L 6 hourly and liberal oral fluids\nChildren\n500 ml 6 hourly and liberal oral fluids\nAnd\nPethidine, IM,\nAdults\n100 mg 8 hourly if required\nChildren\n1 mg/kg (max. 50 mg) 8 hourly if required\nAnd\nDiazepam, IV,\nAdult\n10 mg stat.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1653",
    "type": "section",
    "keywords": [
      "diazepam",
      "hourly",
      "rating",
      "management",
      "liberal",
      "pethidine",
      "adults",
      "adult",
      "sodium",
      "oral",
      "stat",
      "fluids",
      "chloride",
      "required",
      "children",
      "evidence",
      "conservative"
    ]
  },
  {
    "id": "fe7a57a65643d1afb98ae7220f931901",
    "content": "(given slowly over 2-3 minutes, approximately 2. 5 mg every 30 seconds) then refer\nChildren\n0. 3 mg/kg stat.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1654",
    "type": "section",
    "keywords": [
      "minutes",
      "given",
      "refer",
      "seconds",
      "slowly",
      "children",
      "then",
      "approximately",
      "stat",
      "every"
    ]
  },
  {
    "id": "da61e6a5af1c06a472649cd5c67adcc4",
    "content": "(given slowly over 2-3 minutes) then refer\nSpecialist management\nIntracavernosal injections (see referral criteria)\nReferral Criteria\nPatients not responding to conservative management should be promptly referred to a urologist or surgical specialist. These valves or folds of tissue are congenital obstructing membranes within the lumen of the urethra. It affects between 1 in 5,000 – 8,000 males.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1655",
    "type": "section",
    "keywords": [
      "valves",
      "given",
      "management",
      "urologist",
      "males",
      "membranes",
      "injections",
      "within",
      "specialist",
      "intracavernosal",
      "minutes",
      "patients",
      "urethra",
      "criteria",
      "lumen",
      "congenital",
      "referral",
      "surgical",
      "obstructing",
      "should"
    ]
  },
  {
    "id": "a87a782573bc758993dd7115668b42de",
    "content": "It is the commonest cause of congenital bladder outlet obstruction. They obstruct urinary outflow from the bladder but permit easy urethral catheterisation. Because the obstruction starts in-utero, secondary changes in the bladder and upper urinary tract are advanced at birth.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1656",
    "type": "section",
    "keywords": [
      "urethral",
      "advanced",
      "obstruct",
      "secondary",
      "obstruction",
      "easy",
      "changes",
      "permit",
      "congenital",
      "tract",
      "because",
      "cause",
      "birth",
      "starts",
      "outlet",
      "commonest",
      "catheterisation",
      "urinary",
      "utero",
      "bladder"
    ]
  },
  {
    "id": "ca0382073db1209b9c4a9b53f4bcca69",
    "content": "Some patients may be born with severe renal impairment or this may develop soon after birth if recognition is delayed. Most patients present as neonates or infants. Occasionally presentation is late in childhood.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1657",
    "type": "section",
    "keywords": [
      "neonates",
      "late",
      "delayed",
      "born",
      "presentation",
      "childhood",
      "patients",
      "most",
      "recognition",
      "renal",
      "severe",
      "impairment",
      "infants",
      "birth",
      "occasionally",
      "develop",
      "present",
      "after",
      "soon"
    ]
  },
  {
    "id": "607d500067debfcc53193c5d1d3f6ae1",
    "content": "male newborn babies should be closely watched to ensure good stream of urine. Prenatal diagnosis is possible using ultrasound. Causes\nCongenital valves or folds within the lumen of the posterior urethra\nSymptoms\nPoor urinary stream\nCrying while voiding\nStraining to void with dribbling of urine\nIntermittent stream\nFailure to thrive\nFever\nPoor feeding\nAbdominal distension\nSigns\nVoiding dysfunction\nPalpable bladder and kidneys\nRespiratory distress\nSigns of sepsis e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1658",
    "type": "section",
    "keywords": [
      "ultrasound",
      "dribbling",
      "closely",
      "ensure",
      "valves",
      "dysfunction",
      "urine",
      "feeding",
      "poor",
      "thrive",
      "distension",
      "while",
      "crying",
      "babies",
      "within",
      "abdominal",
      "intermittent",
      "male",
      "signs",
      "palpable"
    ]
  },
  {
    "id": "f2669337d5671e231e057dde2993478e",
    "content": "g. Fever\nAzotaemia/uraemia\nPoor physical growth/growth retardation\ninvestigations\nFBC\nBlood urea, electrolytes and creatinine\nUrinalysis\nUrine culture\nAbdominal ultrasound\nMicturating cysto-urethrogram.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1659",
    "type": "section",
    "keywords": [
      "uraemia",
      "ultrasound",
      "cysto",
      "urine",
      "poor",
      "creatinine",
      "abdominal",
      "growth",
      "urinalysis",
      "culture",
      "micturating",
      "blood",
      "electrolytes",
      "fever",
      "urethrogram",
      "investigations",
      "azotaemia",
      "physical",
      "urea",
      "retardation"
    ]
  },
  {
    "id": "7e9a0a5dcbe9d60afe2fff9321c75f9b",
    "content": "To prevent and treat renal failure\nTo remove obstructing valves.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1660",
    "type": "section",
    "keywords": [
      "treat",
      "valves",
      "prevent",
      "obstructing",
      "remove",
      "failure",
      "renal"
    ]
  },
  {
    "id": "26a3b4ccaae20df7b83041f50edb5cfd",
    "content": "Prompt bladder decompression and continuous drainage to protect the upper tract from back pressure damage. This is preferably done by vesicostomy in most infants. Indwelling catheters should be avoided in most cases due to complications and death from septicaemia\nSurgical removal or destruction of the valve.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1661",
    "type": "section",
    "keywords": [
      "vesicostomy",
      "septicaemia",
      "decompression",
      "death",
      "pressure",
      "valve",
      "continuous",
      "removal",
      "avoided",
      "most",
      "indwelling",
      "destruction",
      "tract",
      "prompt",
      "drainage",
      "preferably",
      "surgical",
      "done",
      "infants",
      "should"
    ]
  },
  {
    "id": "d949d8dd4a1774e9d8aa3272c7d2a25e",
    "content": "Referral Criteria\nRefer immediately after diagnosis for specialist evaluation and.",
    "title": "Treatment of urinary tract infections (See appropriate section)",
    "section": "Treatment of urinary tract infections (See appropriate section)",
    "chunk_id": "1662",
    "type": "section",
    "keywords": [
      "referral",
      "specialist",
      "evaluation",
      "immediately",
      "diagnosis",
      "refer",
      "after",
      "criteria"
    ]
  },
  {
    "id": "2dc9394ffd2a1594e60f744a07080ce2",
    "content": "These are crystal-like objects, which form in various parts of the urinary tract. They consist mainly of mineral salts i. e.",
    "title": "treatment.",
    "section": "treatment.",
    "chunk_id": "1663",
    "type": "section",
    "keywords": [
      "crystal",
      "various",
      "tract",
      "salts",
      "which",
      "parts",
      "mineral",
      "consist",
      "form",
      "these",
      "mainly",
      "objects",
      "urinary"
    ]
  },
  {
    "id": "a1f486ddb26802bccc0d422a4eac3390",
    "content": "crystal-forming ions. Some of the common stone-types include calcium oxalate, calcium phosphate, magnesium ammonium phosphate and uric acid. Some risk factors in developing stones include crystalluria, afluence, diet, occupation, climate (dehydration), family history and medications.",
    "title": "treatment.",
    "section": "treatment.",
    "chunk_id": "1664",
    "type": "section",
    "keywords": [
      "diet",
      "types",
      "phosphate",
      "factors",
      "magnesium",
      "crystalluria",
      "family",
      "oxalate",
      "developing",
      "ions",
      "afluence",
      "stone",
      "include",
      "ammonium",
      "dehydration",
      "calcium",
      "acid",
      "occupation",
      "medications",
      "forming"
    ]
  },
  {
    "id": "0ef16b2154c11a0bb5882068f8752d33",
    "content": "Majority of stones less than 5 mm in diameter will pass spontaneously. Causes\nHypercalcaemia\nHyperuricaemia\nHyperoxaluria\nUrinary stasis and obstruction\nUrinary tract infection: struvite (infection) stones\nForeign body including urinary catheter and suture material\nIdiopathic hypercalciuria\nDehydration\nImmobilisation especially in the elderly\nInborn errors of metabolism e. g.",
    "title": "treatment.",
    "section": "treatment.",
    "chunk_id": "1665",
    "type": "section",
    "keywords": [
      "hyperoxaluria",
      "hypercalciuria",
      "idiopathic",
      "especially",
      "catheter",
      "elderly",
      "hyperuricaemia",
      "majority",
      "body",
      "stasis",
      "including",
      "foreign",
      "errors",
      "obstruction",
      "causes",
      "inborn",
      "material",
      "tract",
      "dehydration",
      "immobilisation"
    ]
  },
  {
    "id": "46ca957cb450371b3be4e6cfa4501827",
    "content": "investigations\nUrinalysis\nUrine culture\nBlood urea, electrolytes and creatinine\nSerum uric acid, calcium, phosphate, magnesium\nPlain X-ray of abdomen\nUltrasound scan of abdomen\nIntravenous urogram\nRetrograde ureteropyelogram\nCT scan\nStone analysis.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1666",
    "type": "section",
    "keywords": [
      "ultrasound",
      "ureteropyelogram",
      "phosphate",
      "intravenous",
      "magnesium",
      "urine",
      "creatinine",
      "urinalysis",
      "culture",
      "blood",
      "stone",
      "calcium",
      "electrolytes",
      "acid",
      "urogram",
      "uric",
      "investigations",
      "analysis",
      "abdomen",
      "serum"
    ]
  },
  {
    "id": "7067b8463ef8e8d59dfc654f9ec81ca3",
    "content": "To control pain during acute attack\nTo aid passage of the calculus or ensure complete removal of calculus\nTo remove large stones\nTo prevent recurrence if the cause is known\nTo treat associated infections.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1667",
    "type": "section",
    "keywords": [
      "infections",
      "ensure",
      "treat",
      "during",
      "associated",
      "complete",
      "acute",
      "attack",
      "prevent",
      "known",
      "large",
      "removal",
      "calculus",
      "recurrence",
      "cause",
      "passage",
      "pain",
      "stones",
      "remove",
      "control"
    ]
  },
  {
    "id": "545648e44bb55dcb5f143268407901e0",
    "content": "Encourage oral fluid intake (2-3 L daily in an adult) and avoid dehydration\nAvoid low calcium diet (it encourages increased oxalate excretion)\nDiet-therapy\nManage acute urinary retention due to bladder or urethral stones by urethral catheterisation or suprapubic cystostomy respectively.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1668",
    "type": "section",
    "keywords": [
      "urethral",
      "diet",
      "avoid",
      "oxalate",
      "acute",
      "therapy",
      "fluid",
      "suprapubic",
      "retention",
      "intake",
      "daily",
      "dehydration",
      "calcium",
      "manage",
      "adult",
      "bladder",
      "encourages",
      "increased",
      "respectively",
      "stones"
    ]
  },
  {
    "id": "5380dbf0a989ced4f6e4484ba48444ba",
    "content": "Evidence Rating: [B]\nPethidine, IM, 100 mg 4 hourly as required\nOr\nDiclofenac, IM, 75 mg 12 hourly\nOr\nDiclofenac, rectal, 100 mg 12 hourly.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1669",
    "type": "section",
    "keywords": [
      "hourly",
      "rating",
      "rectal",
      "diclofenac",
      "pethidine",
      "required",
      "evidence"
    ]
  },
  {
    "id": "0261e939e232c627a15da986746bf742",
    "content": "And\nHyoscine butylbromide, IV, 20 mg 8 hourly\nOr\nMebeverine, oral, 135 mg 8 hourly may be useful\nCaution 14-1. Give antibiotics if urinary tract infection is present. (See section on ‘Urinary Tract Infection’)\nReferral Criteria.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1670",
    "type": "section",
    "keywords": [
      "hourly",
      "tract",
      "referral",
      "present",
      "give",
      "antibiotics",
      "mebeverine",
      "infection",
      "hyoscine",
      "useful",
      "caution",
      "oral",
      "section",
      "butylbromide",
      "criteria",
      "urinary"
    ]
  },
  {
    "id": "0c68092f4ce18aa98245a03238f3b7c8",
    "content": "This refers to a narrowing or complete obstruction of the urethral lumen due to fibrosis (scarring). It is the second commonest cause of retention of urine in Ghana and the most common in young males usually resulting from previous inadequately treated STI. The commonest site is the anterior urethra i.",
    "title": "Refer to a urologist or surgical specialist for definitive treatment after initial management.",
    "section": "Refer to a urologist or surgical specialist for definitive treatment after initial management.",
    "chunk_id": "1671",
    "type": "section",
    "keywords": [
      "urethral",
      "usually",
      "males",
      "urine",
      "complete",
      "second",
      "narrowing",
      "refers",
      "inadequately",
      "treated",
      "retention",
      "site",
      "obstruction",
      "anterior",
      "most",
      "urethra",
      "previous",
      "lumen",
      "fibrosis",
      "cause"
    ]
  },
  {
    "id": "b84f3760796d97d786155455da53f281",
    "content": "e. bulbar and penile urethra in males. It may be complicated by periurethral abscess, superficial extravasation of urine and urethrocutaneous fistulae, retention of urine and post-renal renal failure.",
    "title": "Refer to a urologist or surgical specialist for definitive treatment after initial management.",
    "section": "Refer to a urologist or surgical specialist for definitive treatment after initial management.",
    "chunk_id": "1672",
    "type": "section",
    "keywords": [
      "post",
      "abscess",
      "complicated",
      "periurethral",
      "renal",
      "bulbar",
      "retention",
      "males",
      "superficial",
      "extravasation",
      "urine",
      "urethrocutaneous",
      "fistulae",
      "failure",
      "penile",
      "urethra"
    ]
  },
  {
    "id": "b7cf3a041497fc87e9bbbf752202c406",
    "content": "Causes\nGonococcal or non-gonococcal urethritis\nExternal trauma e. g. road traffic injuries, falls, straddle or astride injury and pelvic fractures\nIatrogenic: Urethral instrumentation e.",
    "title": "Refer to a urologist or surgical specialist for definitive treatment after initial management.",
    "section": "Refer to a urologist or surgical specialist for definitive treatment after initial management.",
    "chunk_id": "1673",
    "type": "section",
    "keywords": [
      "astride",
      "urethral",
      "falls",
      "injuries",
      "pelvic",
      "fractures",
      "traffic",
      "instrumentation",
      "iatrogenic",
      "gonococcal",
      "urethritis",
      "road",
      "straddle",
      "external",
      "injury",
      "causes",
      "trauma"
    ]
  },
  {
    "id": "658843401d991ccc6f37afd699109b1a",
    "content": "prostatectomy\nCongenital strictures (rare)\nSymptoms\nLower Urinary Tract Symptoms (LUTS) e. g. poor urinary stream, split or splayed stream, reduced caliber of stream improved by straining, frequency and dysuria, post-void dribbling, incomplete emptying of bladder\nUrinary (overflow) incontinence\nUrinary retention (acute or chronic)\nSigns\nThere may be none in uncomplicated cases\nPalpable induration of urethra\nPeriurethral abscesses\nExtravasation of urine into scrotum and superficial tissue\nUrethrocutaneous fistulas/watering-can scrotum.",
    "title": "Refer to a urologist or surgical specialist for definitive treatment after initial management.",
    "section": "Refer to a urologist or surgical specialist for definitive treatment after initial management.",
    "chunk_id": "1674",
    "type": "section",
    "keywords": [
      "emptying",
      "dribbling",
      "incomplete",
      "incontinence",
      "superficial",
      "urine",
      "improved",
      "reduced",
      "poor",
      "luts",
      "acute",
      "into",
      "caliber",
      "scrotum",
      "rare",
      "retention",
      "extravasation",
      "watering",
      "signs",
      "palpable"
    ]
  },
  {
    "id": "c0c322d5be494c8dbd41152bb51f50f8",
    "content": "Bladder may be palpable if there is retention\nKidney may be palpable in hydronephrosess\nLocalized induration may be felt along the urethra\nFailure of catheterisation - this heightens the suspicion of a stricture\ninvestigations\nUrinalysis\nUrine culture and sensitivity\nBlood urea, electrolytes and creatinine\nUltrasound Scan of kidneys, bladder, postvoid residual urine and spongiofibrosis\nRetrograde urethrogram\nAntegrade  urethrogram/Micturating  Cysto-uretrogram  (MCUG)\nprovided a suprapubic catheter is in place\nUroflowmetry\nUrethrocystoscopy.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1675",
    "type": "section",
    "keywords": [
      "ultrasound",
      "residual",
      "cysto",
      "postvoid",
      "catheter",
      "suspicion",
      "urine",
      "sensitivity",
      "felt",
      "creatinine",
      "suprapubic",
      "mcug",
      "antegrade",
      "retention",
      "urinalysis",
      "uretrogram",
      "place",
      "culture",
      "palpable",
      "micturating"
    ]
  },
  {
    "id": "8dd91c76d3248577b82aec8f7d80f527",
    "content": "To relieve symptoms and prevent complication\nTo treat underlying cause.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1676",
    "type": "section",
    "keywords": [
      "treat",
      "complication",
      "prevent",
      "cause",
      "relieve",
      "underlying",
      "symptoms"
    ]
  },
  {
    "id": "3c81fe7c851930c52365f6b3e84ab673",
    "content": "Try catheterisation - a gentle attempt is made to pass a urethral catheter, which will be held up, at the site of stricture in patients who present with retention of urine. Confirmation of site of obstruction is still needed by urethrography or urethroscopy. If catherization fails and patient is in acute retention\nSuprapubic cystostomy or suprapubic needle puncture and aspiration (try this procedure if facilities for suprapubic cystostomy are lacking).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1677",
    "type": "section",
    "keywords": [
      "urethral",
      "lacking",
      "catheter",
      "confirmation",
      "which",
      "urethrography",
      "puncture",
      "urine",
      "patient",
      "acute",
      "aspiration",
      "suprapubic",
      "gentle",
      "retention",
      "held",
      "facilities",
      "site",
      "obstruction",
      "patients",
      "attempt"
    ]
  },
  {
    "id": "358c7625fd2edba64a8bb6b8fe524a5d",
    "content": "Aspirate as much urine as possible to decompress the bladder and relieve pain before referral.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1678",
    "type": "section",
    "keywords": [
      "referral",
      "pain",
      "before",
      "aspirate",
      "relieve",
      "decompress",
      "possible",
      "urine",
      "bladder"
    ]
  },
  {
    "id": "bdf3b945ad0bd22a8b69171e53e93e2e",
    "content": "None except for Urinary Tract Infection (See appropriate section)\nReferral Criteria.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1679",
    "type": "section",
    "keywords": [
      "tract",
      "referral",
      "appropriate",
      "none",
      "infection",
      "section",
      "except",
      "criteria",
      "urinary"
    ]
  },
  {
    "id": "3d4ea4e51a1aaf6966266a1171056d64",
    "content": "Vasectomy is a permanent male contraceptive method, which is a simple, short and safe surgical procedure. It is carried out by trained surgeons usually under local anaesthesia after careful counselling and informed consent.",
    "title": "Refer to specialist for further investigations prior to definitive treatment.",
    "section": "Refer to specialist for further investigations prior to definitive treatment.",
    "chunk_id": "1680",
    "type": "section",
    "keywords": [
      "usually",
      "safe",
      "local",
      "contraceptive",
      "which",
      "under",
      "simple",
      "short",
      "informed",
      "counselling",
      "male",
      "surgical",
      "permanent",
      "procedure",
      "vasectomy",
      "surgeons",
      "careful",
      "consent",
      "carried",
      "anaesthesia"
    ]
  },
  {
    "id": "b8a5001ee7cc18653fbe18e2ca4b5298",
    "content": "Vasectomy is the most effective male family planning method. Involving males in issues of reproductive health and family planning has several benefits with a positive impact on society. Vasectomy should be encouraged for appropriate clients.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1681",
    "type": "section",
    "keywords": [
      "issues",
      "males",
      "health",
      "family",
      "planning",
      "male",
      "most",
      "clients",
      "benefits",
      "society",
      "should",
      "vasectomy",
      "encouraged",
      "positive",
      "impact",
      "effective",
      "appropriate",
      "several",
      "reproductive",
      "method"
    ]
  },
  {
    "id": "22ab391898ec28a3f559c4f91a42c23f",
    "content": "It is less invasive and simpler than female sterilisation. Reversal of vasectomy is a difficult surgery using loupes/microscope with success rate of 60-80% if done in less than 3 years after vasectomy. Referral Criteria\nClients should be referred to a Family Planning Unit or Urologist for the procedure.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1682",
    "type": "section",
    "keywords": [
      "years",
      "simpler",
      "urologist",
      "family",
      "rate",
      "female",
      "invasive",
      "planning",
      "microscope",
      "criteria",
      "clients",
      "success",
      "loupes",
      "referral",
      "done",
      "should",
      "procedure",
      "vasectomy",
      "referred",
      "reversal"
    ]
  },
  {
    "id": "7c56450e3277484f482ed33dfa70d876",
    "content": "This is an acute inflammation of the epididymis and testis usually due to a bacterial infection. It may follow ascending infection from the urethra (including STIs), instrumentation/catheterization, untreated lower urinary.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1683",
    "type": "section",
    "keywords": [
      "stis",
      "usually",
      "testis",
      "ascending",
      "follow",
      "including",
      "inflammation",
      "catheterization",
      "infection",
      "bacterial",
      "epididymis",
      "lower",
      "instrumentation",
      "urethra",
      "acute",
      "untreated",
      "urinary"
    ]
  },
  {
    "id": "1364636d801cd9b8ddd69fb1c6b4e087",
    "content": "tract obstruction and genito-urinary surgery. It is a known complication of mumps. Poorly managed acute epididymo-orchitis may be complicated by septicaemia, abscess formation, chronic epididymo-orchitis, secondary hydrocoele, infertility and Fournier’s gangrene.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1684",
    "type": "section",
    "keywords": [
      "fournier",
      "genito",
      "poorly",
      "septicaemia",
      "secondary",
      "acute",
      "abscess",
      "gangrene",
      "known",
      "complication",
      "formation",
      "obstruction",
      "mumps",
      "tract",
      "complicated",
      "chronic",
      "infertility",
      "hydrocoele",
      "epididymo",
      "orchitis"
    ]
  },
  {
    "id": "b2b71b38567a5477484038a64c2ae80a",
    "content": "Before managing as acute epidymoorchitis make sure testicular torsion has been conclusively excluded. Causes\nMumps virus (orchitis)\nEscherichia coli\nChlamydia\nGonococcus\nStaphylococcus\nStreptococcus\nPseudomonas\nMycobacterium tuberculosis\nSymptoms\nFever\nScrotal/testicular pain\nScrotal swelling\nUrethral discharge\nDysuria\nMalaise\nSigns\nFever\nTender and swollen hemiscrotum\nInflamed epididymis and testis\nSecondary hydrocoele\nPositive Prehn’s sign (lifting of scrotum towards pubic symphysis in the palm relieves pain)\ninvestigations\nUrinalysis\nUrine culture and sensitivity - first catch of urine preferred to midstream urine\nFBC and ESR\nBlood culture and sensitivity\nScrotal ultrasound/MRI.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1685",
    "type": "section",
    "keywords": [
      "urethral",
      "torsion",
      "ultrasound",
      "virus",
      "streptococcus",
      "managing",
      "pseudomonas",
      "inflamed",
      "relieves",
      "swelling",
      "lifting",
      "urine",
      "conclusively",
      "scrotal",
      "symphysis",
      "sensitivity",
      "secondary",
      "acute",
      "scrotum",
      "escherichia"
    ]
  },
  {
    "id": "97cf9cabf58bc376812ba52a85956b0d",
    "content": "To relieve symptoms\nTo eradicate the infection\nTo prevent recurrence\nTo prevent complications e. g. abscess and sterility.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1686",
    "type": "section",
    "keywords": [
      "abscess",
      "complications",
      "recurrence",
      "prevent",
      "infection",
      "eradicate",
      "relieve",
      "sterility",
      "symptoms"
    ]
  },
  {
    "id": "72aeb577e4395088a4c98116711151fa",
    "content": "Ciprofloxacin, oral,\nAdult\n500 mg 12 hourly for 14 days\nChildren\n5-15 mg/kg 12 hourly for 14 days\nAnd\nDoxycycline, oral, 100 mg 12 hourly for 4 weeks in cases of sexually transmitted infections\nOr\nAzithromycin, oral,\nAdult\n500 mg daily for 3 days\nChildren\n10 mg/kg daily for 3 days.",
    "title": "1st Line Treatment",
    "section": "1st Line Treatment",
    "chunk_id": "1687",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "infections",
      "doxycycline",
      "transmitted",
      "adult",
      "sexually",
      "oral",
      "cases",
      "azithromycin",
      "children",
      "weeks",
      "ciprofloxacin",
      "daily"
    ]
  },
  {
    "id": "9fb43825e2b4da8ee1f932a183c586fd",
    "content": "Norfloxacin, oral, 400 mg 12 hourly for 14 days\nAnd.",
    "title": "2nd Line treatment",
    "section": "2nd Line treatment",
    "chunk_id": "1688",
    "type": "section",
    "keywords": [
      "norfloxacin",
      "oral",
      "days",
      "hourly"
    ]
  },
  {
    "id": "9adadbea0dcfac12c23898898fb8844a",
    "content": "And\nDiclofenac sodium, oral, 50 mg 8 hourly\nOr\nIbuprofen, oral, 400 mg 8 hourly\nReferral Criteria\nRefer all cases of persistent fever and complications to the surgical specialist or urologist. This is cessation of blood supply to the testis due to twisting of the spermatic cord. This is a medical emergency that needs to be recognized before the cardinal signs and symptoms are fully manifest as prompt.",
    "title": "Doxycycline or Azithromycin (as above in 1st Line Treatment)",
    "section": "Doxycycline or Azithromycin (as above in 1st Line Treatment)",
    "chunk_id": "1689",
    "type": "section",
    "keywords": [
      "supply",
      "urologist",
      "spermatic",
      "fully",
      "ibuprofen",
      "hourly",
      "specialist",
      "emergency",
      "manifest",
      "diclofenac",
      "sodium",
      "signs",
      "criteria",
      "blood",
      "referral",
      "testis",
      "prompt",
      "surgical",
      "before",
      "fever"
    ]
  },
  {
    "id": "34ccdbb370e69754ed7ef3a7ac33ee95",
    "content": "surgery saves the testes. Delay in treatment could result in testicular atrophy, abnormal sperm count leading to infertility/sterility. It can be classified into intravaginal torsion, which constitute more than 95% and extra-vaginal torsion, which is usually found in infants.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1690",
    "type": "section",
    "keywords": [
      "torsion",
      "usually",
      "extra",
      "saves",
      "testes",
      "which",
      "delay",
      "atrophy",
      "into",
      "vaginal",
      "count",
      "result",
      "abnormal",
      "treatment",
      "intravaginal",
      "leading",
      "infertility",
      "infants",
      "sterility",
      "classified"
    ]
  },
  {
    "id": "a66041ba830b77eb42b761203e822c30",
    "content": "About 50% of torsion occurs during sleep and early in the morning. It is rare in older children and adults but common in children under 15 years. Causes\nUndescended testis\nBell-clapper malformation\nHorizontal lie of testis/inversion of testis\nLong mesorchium\nTrauma\nSpasm of cremaster muscles\nSymptoms\nSudden onset of acute severe pain in one testicle or recurrent pain which resolves spontaneously (recurrent torsion and detorsion)\nPain may occur typically early in the morning\nLower abdominal pain on affected side\nNausea and vomiting\nNo urinary symptoms\nNo fever\nSigns\nSwollen, tender and abnormal position of testis and epididymis.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1691",
    "type": "section",
    "keywords": [
      "torsion",
      "spasm",
      "sudden",
      "recurrent",
      "years",
      "nausea",
      "occur",
      "morning",
      "affected",
      "muscles",
      "during",
      "which",
      "typically",
      "position",
      "acute",
      "under",
      "abdominal",
      "rare",
      "inversion",
      "testicle"
    ]
  },
  {
    "id": "8883d4380d9d97d990d3be717c574f65",
    "content": "Shortened & twisted cord. Oedema/reddening of scrotal wall\nRight testis - twisted clockwise\nLeft testis - twisted anticlockwise\nPrehn’s sign is absent (elevation of scrotum in the palm towards the Pubic symphysis does not relieve pain).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1692",
    "type": "section",
    "keywords": [
      "reddening",
      "shortened",
      "oedema",
      "elevation",
      "absent",
      "scrotal",
      "symphysis",
      "scrotum",
      "right",
      "towards",
      "sign",
      "prehn",
      "testis",
      "twisted",
      "does",
      "clockwise",
      "wall",
      "pain",
      "pubic",
      "palm"
    ]
  },
  {
    "id": "2669df6bf6c7d45040cde39d3dd675dc",
    "content": "investigations\nUrinalysis\nFBC\nDoppler stethoscope\nColour Doppler Ultrasound Scan\n99mTc-pertechnetate scintillation scan (90-100% accurate).",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1693",
    "type": "section",
    "keywords": [
      "stethoscope",
      "colour",
      "ultrasound",
      "pertechnetate",
      "doppler",
      "scan",
      "scintillation",
      "accurate",
      "urinalysis",
      "investigations"
    ]
  },
  {
    "id": "7a3ff832d147503594e4b35140c59814",
    "content": "To have surgical intervention within 6 hours of onset\nTo surgically explore all doubtful cases\nTo prevent testicular loss.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1694",
    "type": "section",
    "keywords": [
      "explore",
      "within",
      "intervention",
      "surgical",
      "prevent",
      "surgically",
      "testicular",
      "cases",
      "doubtful",
      "have",
      "loss",
      "hours",
      "onset"
    ]
  },
  {
    "id": "b69a28416e316b8f215d8eca4798379d",
    "content": "If surgery is delayed then manual detorsion should be carried out carefully to prevent loss of testis. Manual detorsion procedure-under local anaesthesia (see below)\nand standing at the foot of bed untwist: Right testis anticlockwise, Left testis - clockwise\nEmergency surgery should follow this procedure as soon as possible.",
    "title": "Emergency surgery is the standard treatment",
    "section": "Emergency surgery is the standard treatment",
    "chunk_id": "1695",
    "type": "section",
    "keywords": [
      "carefully",
      "local",
      "delayed",
      "under",
      "emergency",
      "standing",
      "right",
      "prevent",
      "follow",
      "testis",
      "manual",
      "should",
      "procedure",
      "detorsion",
      "clockwise",
      "then",
      "foot",
      "below",
      "carried",
      "anaesthesia"
    ]
  },
  {
    "id": "4391a299f7c34ad5783153fbe1547975",
    "content": "Evidence Rating: [C]\nLignocaine 1%, into the spermatic cord on both sides - for cord block anaesthesia 10-20 ml\nReferral Criteria\nRefer as soon as possible (if surgical intervention is not available) to a surgeon or urologist. Beware testicular torsion has potential medico-legal implications. It is an acute fulminant polymicrobial necrotising fascitis or gangrene affecting the scrotum and sometimes extending to the perineum, penis and lower abdomen.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1696",
    "type": "section",
    "keywords": [
      "torsion",
      "intervention",
      "block",
      "extending",
      "fascitis",
      "urologist",
      "both",
      "fulminant",
      "sides",
      "spermatic",
      "legal",
      "polymicrobial",
      "potential",
      "acute",
      "evidence",
      "into",
      "sometimes",
      "scrotum",
      "rating",
      "gangrene"
    ]
  },
  {
    "id": "fedd41756d85ee9486940f583cae558e",
    "content": "It is also called idiopathic gangrene of the scrotum. The synergistic infections of anaerobic and aerobic bacteria coupled with obliterative arteritis results in the extensive gangrene. The risk factors.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1697",
    "type": "section",
    "keywords": [
      "infections",
      "gangrene",
      "bacteria",
      "called",
      "synergistic",
      "coupled",
      "idiopathic",
      "extensive",
      "also",
      "factors",
      "aerobic",
      "results",
      "risk",
      "obliterative",
      "anaerobic",
      "arteritis",
      "scrotum"
    ]
  },
  {
    "id": "d9d336192b4bc10f88ea4e6d5cc82819",
    "content": "include diabetes mellitus, HIV/Immunosuppression, perineal abscess/ infection of scrotum and contents, trauma, extravasation of urine, periurethral abscess and urethral stricture/calculi. The complications of Fournier’s gangrene include septicaemia, extravasation of urine, exposure of testes and fistula formation. Causes\nStaphylococcus spp\nMicroaerophilic Streptococcus\nE.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1698",
    "type": "section",
    "keywords": [
      "urethral",
      "streptococcus",
      "testes",
      "mellitus",
      "septicaemia",
      "urine",
      "scrotum",
      "calculi",
      "abscess",
      "gangrene",
      "formation",
      "extravasation",
      "immunosuppression",
      "causes",
      "include",
      "fistula",
      "staphylococcus",
      "periurethral",
      "exposure",
      "microaerophilic"
    ]
  },
  {
    "id": "8d62f8a71d776ee2bddfd02434aad2e6",
    "content": "coli\nFusibacteria\nClostridium welchii\nBacteroides\nSymptoms\nAcute onset of painful anterior scrotal swelling in previously healthy tissue\nFever\nPain in affected scrotum\nGeneral malaise\nSigns\nFever\nProstration\nRapidly progressing gangrene\nFoetid odour\nSharp demarcation between ‘dead’ tissue and healthy tissue\nCrepitus on palpation of affected tissue\nTestis is usually spared\nUrinary extravasation\nPresence of risk or predisposing factors\ninvestigations\nWound culture and sensitivity\nSerum culture and sensitivity\nUrinalysis\nFBC and ESR\nGrouping and cross-matching\nFasting blood glucose\nHIV screening\nPlain X-ray of pelvis will reveal gas in affected tissue.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1699",
    "type": "section",
    "keywords": [
      "usually",
      "odour",
      "demarcation",
      "grouping",
      "swelling",
      "factors",
      "wound",
      "glucose",
      "scrotal",
      "progressing",
      "sensitivity",
      "prostration",
      "acute",
      "scrotum",
      "gangrene",
      "previously",
      "predisposing",
      "pelvis",
      "extravasation",
      "anterior"
    ]
  },
  {
    "id": "2dabea48ecb2fc6035f9971dd93e571d",
    "content": "To resuscitate patient\nTo treat the infection\nTo manage concomitant risk factors\nTo salvage the testes.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1700",
    "type": "section",
    "keywords": [
      "resuscitate",
      "treat",
      "manage",
      "testes",
      "infection",
      "salvage",
      "concomitant",
      "factors",
      "risk",
      "patient"
    ]
  },
  {
    "id": "6525eb9ab4a27efff57ef2c26361a5ae",
    "content": "Surgical intervention\nRadical debridement\nReconstructive surgery:\nTestis buried in upper thigh temporarily to prevent dessication\nSkin grafting and reconstruction of scrotum (scrotoplasty)\nMyocutaneous flaps\nNutrition supplement.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1701",
    "type": "section",
    "keywords": [
      "intervention",
      "grafting",
      "dessication",
      "scrotum",
      "flaps",
      "thigh",
      "radical",
      "nutrition",
      "supplement",
      "prevent",
      "buried",
      "reconstructive",
      "testis",
      "reconstruction",
      "surgical",
      "temporarily",
      "scrotoplasty",
      "skin",
      "surgery",
      "myocutaneous"
    ]
  },
  {
    "id": "75eb6244c2df3b25ef44b93e509d6585",
    "content": "Management of diabetes mellitus if present\nManagement of HIV/AIDS if present.",
    "title": "Wound care",
    "section": "Wound care",
    "chunk_id": "1702",
    "type": "section",
    "keywords": [
      "present",
      "diabetes",
      "management",
      "mellitus",
      "aids"
    ]
  },
  {
    "id": "32650431706867ebc4ef9521a034a637",
    "content": "Evidence Rating: [C]\niV fluids, haemotransfusion and hyperbaric oxygen\nAs required for patients clinical state\nAntibiotics\nGentamicin, IV, 80 mg 8 hourly\nAnd\nAmpicillin, IV, 500 mg 6 hourly\nAnd\nMetronidazole, IV, 500 mg 8 hourly\nOr\nAmoxicillin + Clavulanic Acid, IV, 1 g 12 hourly\nAnd\nMetronidazole, IV, 500 mg 8 hourly\nOr\nCefuroxime, IV, 750 mg 8 hourly\nAnd\nMetronidazole, IV, 500 mg 8 hourly\nReferral Criteria\nRefer all cases with septic shock after resuscitation and all those who require reconstructive surgery to a urologist or surgical specialist. Bladder cancer is the second commonest urological cancer after prostate cancer. It is the commonest of all the cancers, which affect the urinary tract lining (urothelium).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1703",
    "type": "section",
    "keywords": [
      "metronidazole",
      "antibiotics",
      "urologist",
      "cancers",
      "which",
      "required",
      "second",
      "evidence",
      "prostate",
      "hourly",
      "rating",
      "require",
      "haemotransfusion",
      "oxygen",
      "ampicillin",
      "specialist",
      "urothelium",
      "clavulanic",
      "lining",
      "fluids"
    ]
  },
  {
    "id": "4e099e4db14a195d4412d9d5ca0687ae",
    "content": "Males are more affected than females in a ratio of about 3:1. It is more common in the white race compared to the black race in a ratio of 4:1. More than 80% of clients with bladder cancer are above 50 years.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1704",
    "type": "section",
    "keywords": [
      "about",
      "cancer",
      "above",
      "black",
      "years",
      "white",
      "bladder",
      "common",
      "males",
      "ratio",
      "race",
      "more",
      "compared",
      "females",
      "affected",
      "clients"
    ]
  },
  {
    "id": "2a525805914efc5134e5d64d075a3c5c",
    "content": "transitional cell carcinoma TCC (90%), Squamous cell carcinoma (8%) and adenocarcinoma and carcinoma in-situ (2%). Causes\nChronic Infections of the bladder like Schistosoma haematobium\n(Bilharzia) and chronic bacterial infections\nSmoking of cigarettes: cancer usually develops 10-20 years after smoking and 20 sticks a day/a packet carries a high risk of cancer development. Passive smoking may also carry the risk of cancer\nOccupational risks; environmental exposure to cancer-causing\nchemicals used in industries e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1705",
    "type": "section",
    "keywords": [
      "infections",
      "usually",
      "years",
      "development",
      "squamous",
      "sticks",
      "environmental",
      "industries",
      "carcinoma",
      "occupational",
      "packet",
      "risks",
      "causing",
      "situ",
      "bilharzia",
      "causes",
      "chronic",
      "adenocarcinoma",
      "schistosoma",
      "bacterial"
    ]
  },
  {
    "id": "17465f245df2df909348ecc4f8e69099",
    "content": "g. dye, textile, rubber, cable, printing etc. Genetic and familial factors\nSymptoms.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1706",
    "type": "section",
    "keywords": [
      "genetic",
      "cable",
      "textile",
      "rubber",
      "factors",
      "printing",
      "familial",
      "symptoms"
    ]
  },
  {
    "id": "3d1cd5bb9267212423a4ace12a3801fd",
    "content": "Irritative symptoms: frequency, urgency, dysuria\nFlank pain (hydronephrosis)\nPelvic pain from cancer invasion.",
    "title": "Haematuria (usually painless). Painful only in advanced disease and infection/UTI",
    "section": "Haematuria (usually painless). Painful only in advanced disease and infection/UTI",
    "chunk_id": "1707",
    "type": "section",
    "keywords": [
      "hydronephrosis",
      "pelvic",
      "cancer",
      "pain",
      "invasion",
      "irritative",
      "urgency",
      "flank",
      "dysuria",
      "symptoms",
      "frequency"
    ]
  },
  {
    "id": "03bef7489e70476857da91fa269df790",
    "content": "Signs\nPallor\nWasting\nPalpable bladder mass\nPalpable kidney from ureteric obstruction and hydronephrosis\nLymphoedema of lower limb/limbs\nSecondary UTI in 30% of cases\ninvestigations\nFBC and ESR\nUrine analysis and culture\nUrine cytology\nUrea, creatinine, electrolytes\nUltrasound scan: Abdominopelvic\nCT Scan /MRI for staging (By specialist)\nSpecial Investigations: Abdominopelvic IVU\nUrethrocystoscopy and biopsies (By specialist)\nExamination under anaesthesia (Bimanual palpation of bladder through DRE and Pelvic examinations).",
    "title": "Oedema of lower limbs from advanced disease",
    "section": "Oedema of lower limbs from advanced disease",
    "chunk_id": "1708",
    "type": "section",
    "keywords": [
      "ureteric",
      "ultrasound",
      "examinations",
      "urine",
      "special",
      "secondary",
      "bimanual",
      "under",
      "wasting",
      "creatinine",
      "specialist",
      "obstruction",
      "signs",
      "limbs",
      "culture",
      "palpable",
      "staging",
      "pallor",
      "pelvic",
      "electrolytes"
    ]
  },
  {
    "id": "cd02ab8af0d3d5edd379465bc06d7015",
    "content": "Prevention of recurrence, progression and metastases\nManagement of complications.",
    "title": "Surgical cure for early disease",
    "section": "Surgical cure for early disease",
    "chunk_id": "1709",
    "type": "section",
    "keywords": [
      "complications",
      "metastases",
      "recurrence",
      "prevention",
      "progression",
      "management"
    ]
  },
  {
    "id": "bb0d9edfd0b5b481a2bad71b97ddf025",
    "content": "Additional treatment with cancer drugs and radiotherapy where necessary (Neoadjuvant and adjuvant therapy).",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1710",
    "type": "section",
    "keywords": [
      "cancer",
      "drugs",
      "additional",
      "adjuvant",
      "necessary",
      "where",
      "neoadjuvant",
      "radiotherapy",
      "therapy",
      "treatment"
    ]
  },
  {
    "id": "9f41e50e961c2f53f54421e9ddcf1287",
    "content": "Cystectomy: Partial or radical with or without bladder replacement. Radiotherapy.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1711",
    "type": "section",
    "keywords": [
      "radical",
      "partial",
      "replacement",
      "radiotherapy",
      "cystectomy",
      "bladder",
      "without"
    ]
  },
  {
    "id": "a5e03f86330f51aeef92a56474d5fae8",
    "content": "Evidence Rating: [C]\nEarly Stage\nBCG or Thiotepa bladder instillation for superficial tumours after Trans-Urethral Resection of Bladder Tumour (TURBT).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1712",
    "type": "section",
    "keywords": [
      "urethral",
      "rating",
      "thiotepa",
      "tumours",
      "resection",
      "early",
      "instillation",
      "superficial",
      "stage",
      "trans",
      "after",
      "tumour",
      "bladder",
      "evidence",
      "turbt"
    ]
  },
  {
    "id": "3486499d9fefbb9b58e4a3d849d622aa",
    "content": "Chemotherapeutic agents recommended for advanced stage include Methotrexate, Vinblastine, Adriamycin and Cisplatin. Referral Criteria\nRefer all cases of bladder cancer for specialist evaluation and treatment. All cases of chronic cystitis should be referred to specialist to exclude bladder cancer.",
    "title": "Advanced Disease",
    "section": "Advanced Disease",
    "chunk_id": "1713",
    "type": "section",
    "keywords": [
      "agents",
      "advanced",
      "chemotherapeutic",
      "specialist",
      "evaluation",
      "cystitis",
      "stage",
      "criteria",
      "treatment",
      "include",
      "referral",
      "chronic",
      "cisplatin",
      "vinblastine",
      "should",
      "referred",
      "cancer",
      "recommended",
      "exclude",
      "refer"
    ]
  },
  {
    "id": "76403bb52ca5298d8360cfa9f54b03ae",
    "content": "Ninety-five per cent of these tumours are adenocarcinomas. The majority of men affected are aged between 65 and 85 years. The incidence increases with age.",
    "title": "Advanced Disease",
    "section": "Advanced Disease",
    "chunk_id": "1714",
    "type": "section",
    "keywords": [
      "ninety",
      "years",
      "adenocarcinomas",
      "aged",
      "tumours",
      "increases",
      "incidence",
      "five",
      "between",
      "cent",
      "these",
      "majority",
      "affected"
    ]
  },
  {
    "id": "b86622e528d6c4a996af8c265e894716",
    "content": "It is recommended that every male, 40 years and above, should have annual screening by Prostate Specific Antigen (PSA) tests and Digital Rectal Examination (DRE) since early detection is associated with better prognosis. The benefit or otherwise of screening should be discussed with patients. Patients with a family history of prostate cancer and should consider annual screening from 40 years and above with PSA and DRE.",
    "title": "Advanced Disease",
    "section": "Advanced Disease",
    "chunk_id": "1715",
    "type": "section",
    "keywords": [
      "years",
      "digital",
      "associated",
      "family",
      "prostate",
      "rectal",
      "annual",
      "consider",
      "male",
      "screening",
      "specific",
      "benefit",
      "patients",
      "above",
      "detection",
      "should",
      "discussed",
      "tests",
      "since",
      "every"
    ]
  },
  {
    "id": "8d02056785174d6597fbce69204188bc",
    "content": "It is worth noting that not every hard prostate on DRE is malignant. Likewise a normal-feeling prostate does not exclude a malignancy. A prostatic biopsy is therefore necessary to establish a diagnosis.",
    "title": "Advanced Disease",
    "section": "Advanced Disease",
    "chunk_id": "1716",
    "type": "section",
    "keywords": [
      "malignancy",
      "therefore",
      "exclude",
      "diagnosis",
      "malignant",
      "establish",
      "prostatic",
      "noting",
      "necessary",
      "likewise",
      "hard",
      "does",
      "biopsy",
      "normal",
      "worth",
      "feeling",
      "prostate",
      "every"
    ]
  },
  {
    "id": "70deec1b6898d904d84ca2e8a32f7f98",
    "content": "Causes\nAgeing\nFunctional testes\nFamily history of prostate cancer, breast cancer, ovarian cancer\nRace (more common in blacks)\nHigh dietary fat intake\nSymptoms\nAsymptomatic: prostate cancer may be present without symptoms in the early stage\nLower Urinary Tract Symptoms (LUTS) and IPSS.",
    "title": "Advanced Disease",
    "section": "Advanced Disease",
    "chunk_id": "1717",
    "type": "section",
    "keywords": [
      "testes",
      "race",
      "family",
      "ipss",
      "luts",
      "prostate",
      "asymptomatic",
      "breast",
      "functional",
      "ovarian",
      "dietary",
      "stage",
      "intake",
      "causes",
      "tract",
      "symptoms",
      "blacks",
      "cancer",
      "present",
      "early"
    ]
  },
  {
    "id": "a07ee60bd5fa76e447abbf43b3413f08",
    "content": "Retention of urine\nHaematuria\nGeneral debility anorexia, weight loss, listlessness\nBone pain (commonly in the waist or limbs)\nParalysis in the lower limbs or inability to walk\nPathological Fracture\nImpotence\nHaemospermia\nTenesmus\nSigns\nOn DRE clinical signs include;\nHard prostate gland with an irregular surface and edges\nObliterated median sulcus\nAdherent rectal mucosa.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1718",
    "type": "section",
    "keywords": [
      "weight",
      "urine",
      "gland",
      "paralysis",
      "prostate",
      "haemospermia",
      "rectal",
      "listlessness",
      "obliterated",
      "adherent",
      "retention",
      "surface",
      "limbs",
      "signs",
      "hard",
      "sulcus",
      "include",
      "haematuria",
      "fracture",
      "impotence"
    ]
  },
  {
    "id": "e7a7e5e85da17ee69825f97de46ce312",
    "content": "Anaemia\nUraemia\nWasting\nBone tenderness\nParaplegia\nPathological fracture\ninvestigations\nFBC\nBlood urea, electrolytes and creatinine\nProstate Specific Antigen (PSA)\nLiver function tests\nAbdominal and pelvic ultrasound\nTransrectal Ultrasound (TRUS) of the prostate, if available\nTransrectal needle biopsy of the prostate\nTRUS-guided or finger-guided.",
    "title": "Advanced or metastatic disease:",
    "section": "Advanced or metastatic disease:",
    "chunk_id": "1719",
    "type": "section",
    "keywords": [
      "uraemia",
      "ultrasound",
      "anaemia",
      "prostate",
      "creatinine",
      "abdominal",
      "function",
      "guided",
      "specific",
      "paraplegia",
      "blood",
      "fracture",
      "tenderness",
      "pelvic",
      "finger",
      "electrolytes",
      "tests",
      "available",
      "investigations",
      "bone"
    ]
  },
  {
    "id": "a95b1d64b8175e31db581a240ea8bf81",
    "content": "Urethral catheterisation to relieve urinary retention where needed.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1720",
    "type": "section",
    "keywords": [
      "urethral",
      "catheterisation",
      "retention",
      "needed",
      "relieve",
      "where",
      "urinary"
    ]
  },
  {
    "id": "91b7040739bfd09e0445eaef231a6ff2",
    "content": "involves hormonal manipulation, which inhibits growth of the tumour by depriving it of androgens, is best carried out under specialist care. The common drugs used in advanced prostate cancer therapy are:\nAntiandrogens\nBicalutamide, oral, 50 mg daily (refer to specialist)\nOr\nFlutamide, oral, 250 mg 8 hourly (refer to specialist)\nOestrogen\nStilboestrol, oral, 2-5 mg daily (Avoid in clients with cardiovascular diseases), (refer to specialist)\nLHRH Analogues\nGoserelin, SC, preferably in the abdominal wall (refer to specialist)\nOr\nLeuprolide acetate, IM, (refer to specialist)\nAnd\nBiphosphonates and Fentanyl patches (refer to specialist)\nReferral Criteria\nRefer all cases to a specialist centre for evaluation and management. It means the persistent inability of a man to achieve an erection, which is adequate in terms of hardness and duration for satisfactory sexual intercourse.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1721",
    "type": "section",
    "keywords": [
      "avoid",
      "oestrogen",
      "goserelin",
      "advanced",
      "management",
      "leuprolide",
      "which",
      "therapy",
      "prostate",
      "under",
      "hourly",
      "diseases",
      "specialist",
      "abdominal",
      "fentanyl",
      "evaluation",
      "growth",
      "antiandrogens",
      "stilboestrol",
      "biphosphonates"
    ]
  },
  {
    "id": "b00e889cb04dbc4834ce0ec06c680920",
    "content": "So long as a man can achieve a hard enough erection to permit vaginal penetration, with a long enough “staying power” to perform the sexual act till ejaculation is attained, he is judged to be potent. The number of “rounds” per session is irrelevant. The condition may be classified as organic, psychogenic or mixed in terms of aetiology; primary (never been able to attain and/or maintain an erection for satisfactory sexual intercourse) or secondary, where impotence occurs in men who have previously had a satisfactory sexual performance.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1722",
    "type": "section",
    "keywords": [
      "rounds",
      "secondary",
      "vaginal",
      "primary",
      "previously",
      "psychogenic",
      "perform",
      "where",
      "aetiology",
      "hard",
      "condition",
      "irrelevant",
      "terms",
      "enough",
      "number",
      "permit",
      "satisfactory",
      "impotence",
      "power",
      "ejaculation"
    ]
  },
  {
    "id": "1348be6f7b07c189529476b48119c24f",
    "content": "Causes\nPsychogenic\nAnxiety\nDepression\nStress\nMarital conflict\nOrganic\nVasculogenic: arterial insufficiency/occlusion; venous incompetence\nNeurogenic: peripheral neuropathy; spinal cord lesions\nTraumatic: penectomy; pelvic fracture (with urethral rupture);.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1723",
    "type": "section",
    "keywords": [
      "urethral",
      "venous",
      "lesions",
      "traumatic",
      "spinal",
      "anxiety",
      "occlusion",
      "insufficiency",
      "psychogenic",
      "stress",
      "incompetence",
      "marital",
      "vasculogenic",
      "causes",
      "pelvic",
      "fracture",
      "arterial",
      "conflict",
      "penectomy",
      "neuropathy"
    ]
  },
  {
    "id": "016c6bcb3e5fdf7727a1725a83cc8514",
    "content": "perineal trauma\nEndocrine: diabetes mellitus, hypogonadism; hyperprolactinaemia; pituitary, adrenal and thyroid disorders\nDrugs: e. g. antihypertensives, antidepressants\nPost-operative:\tCystectomy,\tRadical\tProstatectomy; Abdominoperineal resection\nInflammation; urethritis; prostatitis.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1724",
    "type": "section",
    "keywords": [
      "pituitary",
      "mellitus",
      "hyperprolactinaemia",
      "radical",
      "inflammation",
      "resection",
      "prostatitis",
      "post",
      "abdominoperineal",
      "prostatectomy",
      "antihypertensives",
      "disorders",
      "adrenal",
      "endocrine",
      "antidepressants",
      "drugs",
      "operative",
      "perineal",
      "diabetes",
      "hypogonadism"
    ]
  },
  {
    "id": "cf168063a711660b2cd7226e40849633",
    "content": "Endurance related: heart/renal/liver failure; pulmonary insufficiency\nPost-priapism\nSymptoms\nInability to achieve erection\nInability to sustain erection\nReduced sexual desire\nSigns\nFeatures related to underlying causes\nHypogonadal features e. g. gynaecomastia, lack of male sexual characteristics.",
    "title": "Mechanical: congenital penile abnormalities; Peyronies disease",
    "section": "Mechanical: congenital penile abnormalities; Peyronies disease",
    "chunk_id": "1725",
    "type": "section",
    "keywords": [
      "characteristics",
      "features",
      "liver",
      "reduced",
      "insufficiency",
      "lack",
      "hypogonadal",
      "male",
      "underlying",
      "heart",
      "signs",
      "renal",
      "causes",
      "post",
      "gynaecomastia",
      "pulmonary",
      "sexual",
      "inability",
      "erection",
      "failure"
    ]
  },
  {
    "id": "8506f7381725a8db9a51703539c99c53",
    "content": "investigations\nFBC and sickling status\nLipid profile\nUrinalysis\nFasting blood glucose\nSerum prolactin\nSerum LH, FSH and testosterone.",
    "title": "Penile plaques and curvature (Peyronies disease)",
    "section": "Penile plaques and curvature (Peyronies disease)",
    "chunk_id": "1726",
    "type": "section",
    "keywords": [
      "testosterone",
      "sickling",
      "blood",
      "serum",
      "profile",
      "prolactin",
      "urinalysis",
      "glucose",
      "investigations",
      "lipid",
      "fasting",
      "status"
    ]
  },
  {
    "id": "cb4813206ac5b13258734020f8a100e8",
    "content": "To determine causative factors and treat appropriately\nTo restore sexual potency.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1727",
    "type": "section",
    "keywords": [
      "determine",
      "restore",
      "treat",
      "appropriately",
      "causative",
      "factors",
      "sexual",
      "potency"
    ]
  },
  {
    "id": "ebb4bff3f644ac15d1b0754701ce0de8",
    "content": "Patients should avoid excessive alcohol consumption, cigarette smoking, recreational drug abuse and excessive weight gain\nPsychosexual counseling.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1728",
    "type": "section",
    "keywords": [
      "avoid",
      "psychosexual",
      "smoking",
      "weight",
      "alcohol",
      "gain",
      "should",
      "drug",
      "recreational",
      "counseling",
      "patients",
      "abuse",
      "cigarette",
      "consumption",
      "excessive"
    ]
  },
  {
    "id": "e56a88785b030a189b18777a0bb4cf02",
    "content": "Sildenafil citrate, 50 or 100 mg 30 minutes to 1 hour before coitus\nOr\nTadalafil, 20 mg 30-60 minutes before coitus\nOr\nVerdanafil, 10 or 20 mg 30-60 minutes before coitus.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1729",
    "type": "section",
    "keywords": [
      "hour",
      "citrate",
      "before",
      "minutes",
      "coitus",
      "sildenafil",
      "verdanafil",
      "tadalafil"
    ]
  },
  {
    "id": "d45c0fcce1040ff95580ca8b6bd354d5",
    "content": "Referral Criteria\nReferral to a specialist centre is necessary for proper evaluation and management in most cases. Infertility is the failure of a couple to achieve conception within 12 months of adequate unprotected coitus. About one third of cases of infertility result from pathologic factors in men, one third from factors in both men and women and one third from factors in females.",
    "title": "Prostaglandin E1 must only be used under specialist care.",
    "section": "Prostaglandin E1 must only be used under specialist care.",
    "chunk_id": "1730",
    "type": "section",
    "keywords": [
      "couple",
      "management",
      "both",
      "coitus",
      "factors",
      "conception",
      "females",
      "within",
      "specialist",
      "evaluation",
      "result",
      "most",
      "criteria",
      "referral",
      "infertility",
      "women",
      "third",
      "failure",
      "months",
      "achieve"
    ]
  },
  {
    "id": "fce560eb7aa67083ab4e80d9f8ec6239",
    "content": "Male causes therefore account for 50% of infertility. About 15% of all married couples experience reproductive difficulties. Components of infertility history include medical, surgical, fertility, sexual, family, medication, social and occupational history.",
    "title": "Prostaglandin E1 must only be used under specialist care.",
    "section": "Prostaglandin E1 must only be used under specialist care.",
    "chunk_id": "1731",
    "type": "section",
    "keywords": [
      "couples",
      "family",
      "difficulties",
      "therefore",
      "male",
      "occupational",
      "social",
      "causes",
      "include",
      "infertility",
      "surgical",
      "medication",
      "sexual",
      "medical",
      "about",
      "fertility",
      "reproductive",
      "history",
      "account",
      "experience"
    ]
  },
  {
    "id": "ee7251a41c65f22df6eeab5753cb82c3",
    "content": "Causes\nFor practical purposes the main causes can be divided into three:\nTreatable causes\nPotentially treatable causes\nUntreatable causes\nThe causes can also be classified under three categories: Pre- testicular, Testicular and Post-testicular.",
    "title": "Prostaglandin E1 must only be used under specialist care.",
    "section": "Prostaglandin E1 must only be used under specialist care.",
    "chunk_id": "1732",
    "type": "section",
    "keywords": [
      "post",
      "untreatable",
      "categories",
      "under",
      "classified",
      "testicular",
      "also",
      "practical",
      "three",
      "potentially",
      "treatable",
      "into",
      "divided",
      "purposes",
      "causes",
      "main"
    ]
  },
  {
    "id": "4d692954f055e11d8c2e89e831103748",
    "content": "Symptoms\nPatients usually complain of their wives’ inability to give them a child. Such patients are quite often very apprehensive, frustrated and reluctant to undergo investigations\nSymptoms suggestive of history of STI, UTI, mumps, genital, pelvic or\ninguinoscrotal surgery and injuries\nSigns\nAbsence of male secondary sexual characteristics\nGynaecomastia\nExamine external genitalia to assess:\nTestes: presence or absence, size and consistency\nEpididymis: thickening\nVas deferens: absence, thickening\nVaricocoeles\nInguinoscrotal region: scar from previous herniorrhaphy\nPenis: size, curvature, hypospadias, epispadias\nUrethra: discharge, meatal stenosis, stricture\ninvestigations\nFBC and sickling\nSemen analysis\nUrinalysis\nFasting blood glucose\nSpecific investigations relating to various causes e. g.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1733",
    "type": "section",
    "keywords": [
      "usually",
      "wives",
      "injuries",
      "herniorrhaphy",
      "sickling",
      "give",
      "often",
      "characteristics",
      "testes",
      "region",
      "specific",
      "relating",
      "child",
      "glucose",
      "frustrated",
      "scar",
      "consistency",
      "meatal",
      "secondary",
      "thickening"
    ]
  },
  {
    "id": "b2899f177779324e726cea909401054a",
    "content": "scrotal\nultrasound\nSpecialised investigations e. g. hormonal profile done by specialists\nEvaluation of female partner by gynaecologist.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1734",
    "type": "section",
    "keywords": [
      "ultrasound",
      "evaluation",
      "specialists",
      "hormonal",
      "female",
      "profile",
      "done",
      "gynaecologist",
      "specialised",
      "partner",
      "scrotal",
      "investigations"
    ]
  },
  {
    "id": "141f3057d2632f744db7e7957d4328bf",
    "content": "To improve fertility potential\nTo achieve pregnancy with partner.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1735",
    "type": "section",
    "keywords": [
      "achieve",
      "fertility",
      "improve",
      "partner",
      "pregnancy",
      "potential"
    ]
  },
  {
    "id": "c8701e87bb8df591c35308622dfca4db",
    "content": "Sexual counselling\nSmoking cessation\nReduction in alcohol intake\nAvoid local (scrotal) exposure to excessive heat, cold and chemicals\nAvoid tight underwear. Use of boxer shorts and cotton briefs (not silk/nylon) is recommended. (This reduces heat around the testes to promote spermatogenesis).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1736",
    "type": "section",
    "keywords": [
      "avoid",
      "local",
      "testes",
      "scrotal",
      "cotton",
      "reduces",
      "alcohol",
      "heat",
      "silk",
      "counselling",
      "nylon",
      "spermatogenesis",
      "underwear",
      "boxer",
      "intake",
      "tight",
      "reduction",
      "chemicals",
      "around",
      "promote"
    ]
  },
  {
    "id": "abdefeb687820e13e644cf25e1c62c89",
    "content": "Referral Criteria\nRefer all cases that require special investigation, pharmacological or surgical treatment to specialist. This is the passage of blood in the urine. It may be microscopic or macroscopic, intermittent or continuous.",
    "title": "This is best provided under specialist care.",
    "section": "This is best provided under specialist care.",
    "chunk_id": "1737",
    "type": "section",
    "keywords": [
      "microscopic",
      "passage",
      "referral",
      "require",
      "pharmacological",
      "specialist",
      "surgical",
      "continuous",
      "investigation",
      "intermittent",
      "refer",
      "cases",
      "special",
      "urine",
      "macroscopic",
      "criteria",
      "blood",
      "treatment"
    ]
  },
  {
    "id": "f9d5e165738f634151d2f7ea9907de6a",
    "content": "The pattern of blood in the urine may be initial, terminal or frank/total. Blood in urine is a serious symptom and must always be fully investigated especially to exclude cancer. Certain drugs and food products may colour urine red resulting in false haematuria and these should be differentiated from true haematuria, which is detected by microscopic examination of the urine.",
    "title": "This is best provided under specialist care.",
    "section": "This is best provided under specialist care.",
    "chunk_id": "1738",
    "type": "section",
    "keywords": [
      "microscopic",
      "initial",
      "differentiated",
      "especially",
      "which",
      "urine",
      "certain",
      "fully",
      "serious",
      "always",
      "detected",
      "total",
      "investigated",
      "blood",
      "haematuria",
      "should",
      "terminal",
      "true",
      "pattern",
      "colour"
    ]
  },
  {
    "id": "d7fcd1c49defb578e4c36edb27a8688d",
    "content": "Examples of such substances are rifampicin and rhodamine B food colouring used in cakes, cookies and soft drinks. Occasionally vaginal bleeding may be mistaken for haematuria.",
    "title": "This is best provided under specialist care.",
    "section": "This is best provided under specialist care.",
    "chunk_id": "1739",
    "type": "section",
    "keywords": [
      "haematuria",
      "cakes",
      "drinks",
      "occasionally",
      "rhodamine",
      "examples",
      "soft",
      "bleeding",
      "food",
      "colouring",
      "mistaken",
      "cookies",
      "rifampicin",
      "used",
      "substances",
      "vaginal"
    ]
  },
  {
    "id": "a86137e8a6f2b727eb779d489a2927ac",
    "content": "Causes\nGlomerular\nGlomerulonephritis usually presents with dysmorphic red blood cells in the urine or red blood cellcasts with proteinuria\nNon-Glomerular\nUrethra: Trauma, Infection\nBladder: Infection, stone, bladder cancer, varices, BPH, prostate cancer drug reaction (cyclophosphamide) radiation cystititis, parasite infestation (S. haematobium)\nUreter: Infection, stone, tumour\nKidney: Infection (pyelonephritis), stone, anatomic anomalies (Polycystic Kidney Disease, A-V Fistula) renal vein or artery thrombosis,\nNeoplasms: Renal cell carcinoma (Wilms Tumour)\nTrauma.",
    "title": "Definitive treatment depends on the cause.",
    "section": "Definitive treatment depends on the cause.",
    "chunk_id": "1740",
    "type": "section",
    "keywords": [
      "usually",
      "vein",
      "cystititis",
      "urine",
      "artery",
      "radiation",
      "presents",
      "prostate",
      "wilms",
      "infestation",
      "carcinoma",
      "drug",
      "parasite",
      "ureter",
      "anatomic",
      "reaction",
      "tumour",
      "urethra",
      "renal",
      "blood"
    ]
  },
  {
    "id": "877889e91907331a849262d929eca510",
    "content": "Carcinoma of prostate, bladder and kidney\nUrinary tract infection\nUrinary calculi.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1741",
    "type": "section",
    "keywords": [
      "calculi",
      "tract",
      "carcinoma",
      "kidney",
      "infection",
      "bladder",
      "prostate",
      "urinary"
    ]
  },
  {
    "id": "70543eadfe924f759322b14c5a3d82dd",
    "content": "Symptoms\nFever suggests infection e. g. pyelonephritis, cystitis and prostatitis\nColicky flank pain suggests urinary stones\nAssociated lower urinary tract symptoms suggest bladder or prostatic\ncause\nBlood in the urine (on initiation, mixed with the urine, or at the end of passing urine)\nPain/discomfort on passing urine usually associated with infection,\ncalculi or trauma\nPainless intermittent haematuria associated with cancers eg bladder\nand kidney cancers\nLower Urinary Tract Symptoms (LUTS)\nLoin pain\nSigns\nPallor\nAbdominal masses e.",
    "title": "Medical causes e.g. sickle cell disease, acute glomerulonephritis and anticoagulant therapy",
    "section": "Medical causes e.g. sickle cell disease, acute glomerulonephritis and anticoagulant therapy",
    "chunk_id": "1742",
    "type": "section",
    "keywords": [
      "usually",
      "prostatic",
      "cancers",
      "discomfort",
      "associated",
      "urine",
      "passing",
      "luts",
      "masses",
      "calculi",
      "initiation",
      "abdominal",
      "suggests",
      "prostatitis",
      "intermittent",
      "cystitis",
      "signs",
      "loin",
      "blood",
      "pallor"
    ]
  },
  {
    "id": "ff8916a6434babf07c102a6bc7bb9eba",
    "content": "g. kidney, bladder\nLow or suprapubic tenderness from urinary tract infection or calculus\ninvestigations\nFBC and sickling status (Hb electrophoresis if sickling test is positive)\nBlood urea, electrolyte and creatinine\nUrinalysis\nUrine culture and sensitivity\nAbdominal and pelvic ultrasound.",
    "title": "Medical causes e.g. sickle cell disease, acute glomerulonephritis and anticoagulant therapy",
    "section": "Medical causes e.g. sickle cell disease, acute glomerulonephritis and anticoagulant therapy",
    "chunk_id": "1743",
    "type": "section",
    "keywords": [
      "ultrasound",
      "sickling",
      "test",
      "urine",
      "sensitivity",
      "suprapubic",
      "creatinine",
      "abdominal",
      "urinalysis",
      "culture",
      "electrolyte",
      "blood",
      "calculus",
      "status",
      "pelvic",
      "tenderness",
      "tract",
      "investigations",
      "positive",
      "kidney"
    ]
  },
  {
    "id": "acf8e40d8e6f9f1fa764f120d19f1d66",
    "content": "High fluid intake is advised in order to prevent clot formation in the\nurinary bladder\nIf patient presents with clot retention, then catheterise and refer.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1744",
    "type": "section",
    "keywords": [
      "clot",
      "presents",
      "catheterise",
      "prevent",
      "formation",
      "order",
      "retention",
      "refer",
      "high",
      "fluid",
      "intake",
      "bladder",
      "then",
      "patient",
      "urinary",
      "advised"
    ]
  },
  {
    "id": "b606f39b89d9fbd0d326398e08526b46",
    "content": "For Urinary Schistosomiasis\nEvidence Rating: [A]\nPraziquantel, oral,\n(See section on ‘Urinary Schistosomiasis’).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1745",
    "type": "section",
    "keywords": [
      "rating",
      "praziquantel",
      "section",
      "urinary",
      "oral",
      "evidence",
      "schistosomiasis"
    ]
  },
  {
    "id": "0cf30a7ec5833798dad916101b34e38a",
    "content": "For Urinary Tract infection\nGive appropriate antibiotics (See section on ‘Urinary Tract Infection’)\nReferral Criteria\nRefer all other cases as well as those with persistent haematuria for appropriate investigations and treatment. This is a water-borne disease caused by penetration of the skin or mucous membranes by the early stages of the causative organism (Schistosoma haematobium), which in the adult form settles in the blood vessels of the urinary bladder resulting in the common presentation of haematuria. This disease is common in Ghana with several endemic areas along the lakes, slow-flowing rivers and irrigation systems.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1746",
    "type": "section",
    "keywords": [
      "rivers",
      "irrigation",
      "lakes",
      "give",
      "antibiotics",
      "borne",
      "causative",
      "which",
      "membranes",
      "form",
      "vessels",
      "settles",
      "section",
      "presentation",
      "organism",
      "mucous",
      "water",
      "criteria",
      "blood",
      "treatment"
    ]
  },
  {
    "id": "9b06aae09bd71cb92036c5b541c5cd0a",
    "content": "The commonest body sites affected are the bladder, ureters and pelvic organs. Prevention entails avoiding contact with infested water. Chronic infestation may lead to severe anaemia, ureteric stricture and hydronephrosis as well as carcinoma of the bladder.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1747",
    "type": "section",
    "keywords": [
      "ureteric",
      "anaemia",
      "lead",
      "body",
      "infestation",
      "carcinoma",
      "sites",
      "water",
      "avoiding",
      "severe",
      "pelvic",
      "chronic",
      "prevention",
      "ureters",
      "infested",
      "entails",
      "hydronephrosis",
      "contact",
      "stricture",
      "commonest"
    ]
  },
  {
    "id": "aba55ca8a9a4bda45a056bbac429fc65",
    "content": "Cause\nSchistosoma haematobium\nSymptoms initial\nItching and redness of skin at site of penetration of parasite\nFatigue, low grade fever, malaise, lassitude, excessive sweating,\nheadache and backache\nLater\nTerminal haematuria\nPainful urination (dysuria)\nLower abdominal pain (bladder pain)\nSigns\nPallor\nPalpable kidney from hydronephrosis due to ureteric stricture\nPalpable bladder from bladder cancer or retention of urine due to\nclots or bladder neck stenosis\nDRE may reveal a fibrosed prostate, enlarged seminal vesicle or\nthickened bladder base\ninvestigations\nFBC\nUrine for red blood cells, pus cells, and schistosoma ova (mid-day urine specimen preferably taken after physical exercise is ideal)\nMidstream urine for culture in associated urinary tract infections\nImaging: Ultrasound scan; Intravenous Urogram (IVU) may show.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1748",
    "type": "section",
    "keywords": [
      "infections",
      "ureteric",
      "initial",
      "ultrasound",
      "intravenous",
      "headache",
      "fatigue",
      "exercise",
      "backache",
      "urine",
      "associated",
      "redness",
      "ideal",
      "neck",
      "prostate",
      "abdominal",
      "base",
      "retention",
      "parasite",
      "site"
    ]
  },
  {
    "id": "0dd4d229653f1c828bc04fd165cadd19",
    "content": "calcification of bladder, ureters, hydronephrosis and hydroureters.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1749",
    "type": "section",
    "keywords": [
      "hydronephrosis",
      "hydroureters",
      "calcification",
      "ureters",
      "bladder"
    ]
  },
  {
    "id": "2b933c33e2b4998467b93e0c9a81105c",
    "content": "To eliminate the causative organism\nTo manage the complications.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1750",
    "type": "section",
    "keywords": [
      "complications",
      "manage",
      "causative",
      "organism",
      "eliminate"
    ]
  },
  {
    "id": "3b53cbe2ea05ebeca70361ca0fdd3a32",
    "content": "Avoid repeated exposure to infested water bodies if possible.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1751",
    "type": "section",
    "keywords": [
      "avoid",
      "exposure",
      "water",
      "possible",
      "repeated",
      "infested",
      "bodies"
    ]
  },
  {
    "id": "bf00e64d0081bd6b1f02f3e6b922e485",
    "content": "Evidence Rating: [A]\nPraziquantel, oral,\nAdults and Children\n40 mg/kg as a single dose\nTreat anaemia if present (See section on ‘Anaemia’)\nReferral Criteria\nRefer patient after adequate treatment if: haematuria and/ or symptoms of urinary infection persist or if complications like hydronephrosis, bladder mass, retention of urine, severe wasting and severe anaemia are present. (See section on ‘STI-related persistent or recurrent urethral discharge’). Retention of urine is inability to empty a full bladder.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1752",
    "type": "section",
    "keywords": [
      "urethral",
      "recurrent",
      "treat",
      "empty",
      "persist",
      "anaemia",
      "urine",
      "full",
      "patient",
      "evidence",
      "wasting",
      "rating",
      "single",
      "section",
      "retention",
      "children",
      "criteria",
      "treatment",
      "severe",
      "haematuria"
    ]
  },
  {
    "id": "f3c68ec9e1c156daeb9c41d675cad6f7",
    "content": "It is the commonest urological emergency in Ghana and worldwide. Adult males are more commonly affected. It is rare in children and in females.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1753",
    "type": "section",
    "keywords": [
      "emergency",
      "rare",
      "worldwide",
      "commonest",
      "adult",
      "ghana",
      "males",
      "urological",
      "more",
      "children",
      "females",
      "affected",
      "commonly"
    ]
  },
  {
    "id": "ef3c85013ceb326c8beec621064f52f3",
    "content": "The causes differ in different age groups as well as in males and females. A family history of retention of urine in Benign Prostatic Hyperplasia (BPH), prostate cancer, breast cancer and ovarian cancer are risk factors. Retention of urine can be classified into three:\nAcute retention of Urine is of sudden onset with a palpable tender bladder.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1754",
    "type": "section",
    "keywords": [
      "sudden",
      "prostatic",
      "males",
      "factors",
      "urine",
      "family",
      "acute",
      "females",
      "prostate",
      "into",
      "differ",
      "breast",
      "retention",
      "ovarian",
      "palpable",
      "tender",
      "causes",
      "onset",
      "different",
      "groups"
    ]
  },
  {
    "id": "d0d154b5fae7d7a5c612a3972f9b5418",
    "content": "Chronic Retention of Urine is of insidious onset and presents with a palpable non-tender bladder and overflow incontinence resulting in more damage to the bladder, ureters and kidneys. Post-renal renal failure may complicate this type of retention with hydronephroses and hydroureters. Acute-on-chronic retention of urine is when a chronic retention of urine is suddenly complicated by acute retention of urine.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1755",
    "type": "section",
    "keywords": [
      "incontinence",
      "urine",
      "presents",
      "acute",
      "type",
      "hydroureters",
      "retention",
      "palpable",
      "tender",
      "renal",
      "onset",
      "post",
      "chronic",
      "complicated",
      "kidneys",
      "overflow",
      "damage",
      "ureters",
      "failure",
      "insidious"
    ]
  },
  {
    "id": "fa6d31fe298aa5bc0549648e46a6c046",
    "content": "Causes\nAdult males - (above 50 years): BPH, urethral strictures, bladder neck\nstenosis\nAdult males - (below 50 years/young males): urethral strictures, urethral injuries, bladder neck stenosis, neurogenic bladder/spinal injury, paraphimosis, urethral caculi, acute prostatitis\nMale children - posterior urethral valves, meatal stenosis, phimosis,\nurethral calculi, congenital strictures\nAdult females - retroverted gravid uterus, uterine fibroids/myomas, impacted ovarian cysts, neurogenic (postoperative and pelvic inflammatory disease), carcinoma of cervix with infiltration into the urethra\nSymptoms\nRetention of urine in BPH precipitated by postponement of micturition, alcohol abuse and infection\nSudden inability to pass urine with painful bulge in lower abdomen\nfor acute retention of urine\nGradual onset of inability to pass urine with painless bulge in lower abdomen for chronic retention of urine\nHistory of urethritis, urethral instrumentation (e. g. catheterisation)\nor perineal injury, pelvic fracture or surgery in urethral strictures\nInternational Prostate Symptom Score (IPSS)\nSigns\nPalpable tender bladder in acute retention of urine\nPalpable non-tender bladder for chronic retention of urine\nUraemia/Azotaemia in renal failure\nFever in infections: UTI and prostatitis\nPalpable kidneys in hydronephrosis\nHaematuria in BPH, prostate cancer and urethral strictures\nReferral Criteria\nPatients with hydronephroses on ultrasound scan and renal failure should be referred to specialist.",
    "title": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "section": "Chapter 14: Dısorders of the Kıdney and Genıtourınary System",
    "chunk_id": "1756",
    "type": "section",
    "keywords": [
      "paraphimosis",
      "sudden",
      "valves",
      "prostate",
      "calculi",
      "alcohol",
      "retention",
      "signs",
      "causes",
      "congenital",
      "disease",
      "haematuria",
      "chronic",
      "uterine",
      "caculi",
      "should",
      "gradual",
      "failure",
      "strictures",
      "hydronephrosis"
    ]
  },
  {
    "id": "50ac66a7df468fd052c566d8005b6ebd",
    "content": "Sexually Transmitted Infections (STIs) result in several clinical syndromes caused by organisms that can be acquired and transmitted through sexual activity. They cause acute morbidity in adults and may result in long-term complications such as urethral stricture, infertility, ectopic pregnancy, anal fistula, cervical cancer, foetal wastage, prematurity, low birth weight, ophthalmia neonatorum and congenital syphilis. Their control is the cornerstone in improving reproductive health and reducing Human Immunodeficiency Virus (HIV) infections.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1757",
    "type": "section",
    "keywords": [
      "infections",
      "urethral",
      "activity",
      "virus",
      "weight",
      "morbidity",
      "immunodeficiency",
      "cornerstone",
      "health",
      "acute",
      "prematurity",
      "result",
      "sexually",
      "ophthalmia",
      "acquired",
      "foetal",
      "neonatorum",
      "pregnancy",
      "their",
      "congenital"
    ]
  },
  {
    "id": "25917b92a2b77b02aee30a307053318d",
    "content": "Comprehensive management of STI is important and comprises prompt and effective case detection and treatment. However, owing to the lack of laboratory equipment and manpower in primary care facilities where most patients first present, an accurate diagnosis is often not possible. Also with most STIs, one cannot usually tell which organism is causing the infection from the history and physical examination alone.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1758",
    "type": "section",
    "keywords": [
      "usually",
      "important",
      "often",
      "management",
      "which",
      "alone",
      "primary",
      "examination",
      "lack",
      "facilities",
      "organism",
      "where",
      "patients",
      "most",
      "causing",
      "treatment",
      "comprehensive",
      "stis",
      "tell",
      "first"
    ]
  },
  {
    "id": "78c34739994557baa2c8904787ce2ca7",
    "content": "Multiple infections also occur, with each needing to be treated. Failure to treat one infection adequately may result in the development of serious complications. It is therefore more practical in managing STIs to base treatment on a ‘syndromic diagnosis’, which identifies all STIs that could cause a particular symptom or sign and provide treatment for each of them simultaneously.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1759",
    "type": "section",
    "keywords": [
      "infections",
      "treat",
      "occur",
      "managing",
      "development",
      "which",
      "particular",
      "serious",
      "therefore",
      "multiple",
      "syndromic",
      "base",
      "treated",
      "result",
      "needing",
      "practical",
      "sign",
      "treatment",
      "stis",
      "diagnosis"
    ]
  },
  {
    "id": "7e58ca0cd641e5e0703fa4f4bb49b171",
    "content": "The common clinical syndromes associated with STIs include urethral discharge in males, persistent/recurrent urethral discharge, vaginal discharge,\tlower\tabdominal\tpain, genital ulcer, scrotal swellings, inguinal lymphadenopathy (buboes), ano-rectal syndromes (ano-rectal discharge, ulcers and vesicles), and genital warts. Scabies and pediculosis\npubis may also be transmitted by sexual contact. In dealing with patients with STI, privacy and confidentiality, especially with the history taking and examination, are paramount.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1760",
    "type": "section",
    "keywords": [
      "urethral",
      "inguinal",
      "privacy",
      "recurrent",
      "paramount",
      "especially",
      "ulcer",
      "dealing",
      "males",
      "associated",
      "scrotal",
      "vaginal",
      "abdominal",
      "rectal",
      "taking",
      "patients",
      "genital",
      "scabies",
      "stis",
      "include"
    ]
  },
  {
    "id": "a6123bd25aa7fd1009140d2b4b445bbd",
    "content": "Education and counselling of STI patients and concurrent management of their partners provide additional opportunities to reduce the risk of STI in the community.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1761",
    "type": "section",
    "keywords": [
      "education",
      "community",
      "management",
      "reduce",
      "counselling",
      "partners",
      "provide",
      "opportunities",
      "risk",
      "patients",
      "their",
      "additional",
      "concurrent"
    ]
  },
  {
    "id": "d5b98c5398ca604d31f3a9c6f1285120",
    "content": "Causes\nNeisseria gonorrhoea (Gonococcal urethrits)\nChlamydia trachomatis (Non-gonococcal urethritis)\nSymptoms\nUrethral discharge\nDysuria or discomfort on urination\nSigns\nUrethral discharge\ninvestigations\nUrethral swab culture and sensitivity (if available).",
    "title": "(See section on ‘Sexually Transmitted Diseases in Children’ for STIs in children)",
    "section": "(See section on ‘Sexually Transmitted Diseases in Children’ for STIs in children)",
    "chunk_id": "1762",
    "type": "section",
    "keywords": [
      "urethral",
      "discomfort",
      "sensitivity",
      "swab",
      "signs",
      "culture",
      "gonorrhoea",
      "causes",
      "gonococcal",
      "available",
      "investigations",
      "dysuria",
      "symptoms",
      "urination",
      "neisseria",
      "urethritis",
      "urethrits",
      "discharge",
      "chlamydia",
      "trachomatis"
    ]
  },
  {
    "id": "f0d8364feb9ad81a95dc60dd9b934839",
    "content": "To treat gonorrhoea and chlamydia urethritis simultaneously\nTo prevent further transmission to sexual partners. To treat both partners simultaneously as much as possible\nTo prevent development of complications and sequelae\nTo reduce risk of HIV infection.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1763",
    "type": "section",
    "keywords": [
      "complications",
      "treat",
      "prevent",
      "development",
      "transmission",
      "both",
      "reduce",
      "partners",
      "urethritis",
      "further",
      "sequelae",
      "infection",
      "sexual",
      "possible",
      "risk",
      "gonorrhoea",
      "chlamydia",
      "simultaneously"
    ]
  },
  {
    "id": "5c5765deaf6230ec32bd0684cf3c8e76",
    "content": "Evidence Rating: [C]\nFor Gonorrhoea\nCeftriaxone, IM, 250 mg stat\nOr\nCefixime, oral, 400 mg stat\nOr\nCiprofloxacin, oral, 500 mg stat\nAnd\nFor Chlamydia and Mycoplasma:\nDoxycycline, oral, 100 mg 12 hourly for 7 days\nOr\nTetracycline, oral, 500 mg 6 hourly for 7 days\nOr\nErythromycin, oral, 500 mg 6 hourly for 7 days\nOr\nAzithromycin, oral, 1 g stat. This may occur due to drug resistance, poor treatment compliance or re-infection following treatment for an STI. In some cases persistence of urethral discharge may be due to infection with Trichomonas vaginalis.",
    "title": "Pharmacological Treatment",
    "section": "Pharmacological Treatment",
    "chunk_id": "1764",
    "type": "section",
    "keywords": [
      "cefixime",
      "urethral",
      "occur",
      "poor",
      "evidence",
      "ciprofloxacin",
      "trichomonas",
      "hourly",
      "rating",
      "following",
      "drug",
      "gonorrhoea",
      "stat",
      "treatment",
      "days",
      "erythromycin",
      "doxycycline",
      "compliance",
      "persistence",
      "azithromycin"
    ]
  },
  {
    "id": "0512aad6061982f53640beb952f952bd",
    "content": "Causes\nNeisseria gonorrhoeae, Chlamydia trachomatis or Mycoplasma genitalum following drug resistance, poor compliance or re-infection after treatment\nTrichomonas vaginalis.",
    "title": "Pharmacological Treatment",
    "section": "Pharmacological Treatment",
    "chunk_id": "1765",
    "type": "section",
    "keywords": [
      "trichomonas",
      "treatment",
      "following",
      "genitalum",
      "compliance",
      "infection",
      "drug",
      "vaginalis",
      "neisseria",
      "mycoplasma",
      "gonorrhoeae",
      "after",
      "poor",
      "chlamydia",
      "trachomatis",
      "causes",
      "resistance"
    ]
  },
  {
    "id": "fdfa46f8edd0104e167e335964261b86",
    "content": "To re-treat for gonococcal or non-gonococcal urethritis if suspected to be due to previous poor treatment compliance or re-infection\nTo treat infection with Trichomonas vaginalis\nTo prevent transmission to sexual partners\nTo treat both partners simultaneously as much as possible\nTo prevent development of complications and sequelae\nTo reduce risk of HIV infection.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1766",
    "type": "section",
    "keywords": [
      "treat",
      "development",
      "both",
      "poor",
      "trichomonas",
      "prevent",
      "previous",
      "treatment",
      "suspected",
      "compliance",
      "gonococcal",
      "partners",
      "sexual",
      "complications",
      "infection",
      "transmission",
      "reduce",
      "vaginalis",
      "urethritis",
      "sequelae"
    ]
  },
  {
    "id": "615606d85dcad4b71b2bcb8fc3bc1678",
    "content": "Evidence Rating: [C]\nFor Gonorrhoea, Chlamydia, Mycoplasma.",
    "title": "Pharmacological Treatment",
    "section": "Pharmacological Treatment",
    "chunk_id": "1767",
    "type": "section",
    "keywords": [
      "rating",
      "mycoplasma",
      "gonorrhoea",
      "chlamydia",
      "evidence"
    ]
  },
  {
    "id": "066366ce732487928069975f0ba40d2b",
    "content": "For Trichomonas vaginalis\nMetronidazole, oral, 400 mg 12 hourly for 7 days\nOr\nMetronidazole, oral, 2 g stat. Or\nT inidazole, oral, 2 g stat. Or\nSecnidazole, oral, 2 g stat.",
    "title": "Repeat treatment for urethral discharge",
    "section": "Repeat treatment for urethral discharge",
    "chunk_id": "1768",
    "type": "section",
    "keywords": [
      "trichomonas",
      "hourly",
      "metronidazole",
      "days",
      "inidazole",
      "vaginalis",
      "oral",
      "secnidazole",
      "stat"
    ]
  },
  {
    "id": "29023304efa4098f0edc762a60fadd58",
    "content": "Referral Criteria\nRefer all cases of treatment failure to a health facility where microbiological culture and antimicrobial sensitivity tests can be done on the urethral discharge. While a vaginal discharge is a notable clinical feature of an STI, not all forms of vaginal discharge are abnormal or indicative of an STI. A vaginal discharge may be associated with a physiological state such as menses or pregnancy, or with the presence or use of foreign substances and chemicals in the vagina.",
    "title": "Repeat treatment for urethral discharge",
    "section": "Repeat treatment for urethral discharge",
    "chunk_id": "1769",
    "type": "section",
    "keywords": [
      "urethral",
      "notable",
      "indicative",
      "health",
      "associated",
      "sensitivity",
      "microbiological",
      "antimicrobial",
      "while",
      "vaginal",
      "facility",
      "foreign",
      "where",
      "abnormal",
      "culture",
      "presence",
      "pregnancy",
      "criteria",
      "treatment",
      "referral"
    ]
  },
  {
    "id": "d5fd1a30a65b17184d78136aef869f0e",
    "content": "A careful risk assessment (See note below) of women with a vaginal discharge may help identify STIs and non-STIs and selection of appropriate treatment regimens based on the most likely aetiology of the vaginal discharge. Other considerations for selecting treatment include pregnancy status and patient discomfort. Causes\nNeisseria gonorrhoea\nChlamydia trachomatis\nTrichomonas vaginalis (green or yellow, smelly, bubbly or frothy discharge associated with itching)\nHerpes simplex virus (following first episode of infection)\nSymptoms\nVaginal discharge - change in colour, odour, consistency or amount\nVulval swelling\nPain on urination\nLower abdominal or back pain\nSigns\nVaginal discharge\nVulval swelling\nVulval erythema\nLower abdominal tenderness\nCervical excitation tenderness\nCervical mucopus or erosions (on speculum examination)\ninvestigations\nHigh vaginal swab for microscopy, culture and sensitivity (if available).",
    "title": "Repeat treatment for urethral discharge",
    "section": "Repeat treatment for urethral discharge",
    "chunk_id": "1770",
    "type": "section",
    "keywords": [
      "virus",
      "swelling",
      "identify",
      "likely",
      "consistency",
      "trichomonas",
      "abdominal",
      "selecting",
      "signs",
      "note",
      "gonorrhoea",
      "causes",
      "treatment",
      "simplex",
      "stis",
      "include",
      "first",
      "change",
      "back",
      "cervical"
    ]
  },
  {
    "id": "1a1e9cd2722159f404685aa2efe92ab8",
    "content": "To identify and treat non-STI vaginitis (especially candidiasis, which is frequently diagnosed in women being evaluated for STIs)\nTo assess STI risk and treat STI-related infections appropriately\nTo prevent complications and sequelae\nTo treat both partners simultaneously as much as possible.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1771",
    "type": "section",
    "keywords": [
      "infections",
      "treat",
      "especially",
      "both",
      "which",
      "frequently",
      "identify",
      "vaginitis",
      "candidiasis",
      "prevent",
      "appropriately",
      "assess",
      "being",
      "evaluated",
      "stis",
      "women",
      "partners",
      "related",
      "complications",
      "sequelae"
    ]
  },
  {
    "id": "51b5e91adbd16e247b655f524a35ae2a",
    "content": "Metronidazole, oral, 2 g stat. (contraindicated during the 1st trimes- ter of pregnancy)\nOr\nMetronidazole, oral, 400 mg 8 hourly for 5 days (contraindicated during the 1st trimester of pregnancy)\nOr\nSecnidazole, oral, 2 g stat. (contraindicated during the 1st trimester of pregnancy)\nOr\nTinidazole, oral, 2 g stat.",
    "title": "Treatment for trichomoniasis and bacterial vaginosis",
    "section": "Treatment for trichomoniasis and bacterial vaginosis",
    "chunk_id": "1772",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "tinidazole",
      "secnidazole",
      "during",
      "oral",
      "contraindicated",
      "pregnancy",
      "trimes",
      "trimester",
      "stat"
    ]
  },
  {
    "id": "92b3633432fbc97f820f02c78ee2456c",
    "content": "(contraindicated during the 1st trimester of pregnancy)\nOr\nClindamycin cream (2%), topical (preferred in pregnancy)\nAnd.",
    "title": "Treatment for trichomoniasis and bacterial vaginosis",
    "section": "Treatment for trichomoniasis and bacterial vaginosis",
    "chunk_id": "1773",
    "type": "section",
    "keywords": [
      "topical",
      "clindamycin",
      "preferred",
      "during",
      "contraindicated",
      "pregnancy",
      "cream",
      "trimester"
    ]
  },
  {
    "id": "474cf831d49fc91327445d8a78f58979",
    "content": "Miconazole vaginal tablets, 200 mg inserted into vagina at night for 3 days\nOr\nClotrimazole, vaginal tablets, 200 mg inserted into vagina at night for 3 days\nAnd\nClotrimazole cream, apply 12 hourly (for vulval irritation).",
    "title": "Treatment for candidiasis",
    "section": "Treatment for candidiasis",
    "chunk_id": "1774",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "miconazole",
      "inserted",
      "tablets",
      "irritation",
      "apply",
      "vagina",
      "vulval",
      "cream",
      "clotrimazole",
      "night",
      "into",
      "vaginal"
    ]
  },
  {
    "id": "a7307428f70f82303fb214ed30844378",
    "content": "Ceftriaxone, IM, 250 mg stat. Or\nCefixime, oral, 400 mg stat\nOr\nCiprofloxacin, oral, 500 mg stat. (avoid in pregnant and lactating mothers)\nAnd.",
    "title": "Treatment for gonorrhoea",
    "section": "Treatment for gonorrhoea",
    "chunk_id": "1775",
    "type": "section",
    "keywords": [
      "cefixime",
      "avoid",
      "ceftriaxone",
      "oral",
      "stat",
      "pregnant",
      "lactating",
      "mothers",
      "ciprofloxacin"
    ]
  },
  {
    "id": "74f2f3c20164f853f82fae7b06dc2374",
    "content": "Doxycycline, oral, 100 mg 12 hourly for 7 days (avoid in pregnant and lactating mothers)\nOr\nTetracycline, oral, 500 mg 6 hourly for 7 days (avoid in pregnant and lactating mothers)\nOr\nErythromycin, oral, 500 mg 6 hourly for 7 days\nOr\nAzithromycin, oral, 2 g stat. Referral Criteria\nRefer all cases of recurrent vaginal discharge and/or treatment failures to a health facility where speculum examination can be carried out and microbiological culture and antimicrobial sensitivity tests can be done on the vaginal discharge. Causes\nNeisseria gonorrhoea\nChlamydia trachomatis\nAnaerobic bacteria (often relating to recurrent infections)\nSymptoms\nLower abdominal pain\nPain with sexual intercourse (dyspareunia)\nVaginal discharge\nDysuria or urethral discomfort\nFever\nSigns\nLower abdominal tenderness\nVaginal discharge\nTenderness on moving the cervix (cervical excitation) on bimanual vaginal examination\nAdnexal tenderness\nAdnexal masses\ninvestigations\nHigh vaginal swab culture and sensitivity.",
    "title": "Treatment for chlamydia",
    "section": "Treatment for chlamydia",
    "chunk_id": "1776",
    "type": "section",
    "keywords": [
      "infections",
      "urethral",
      "avoid",
      "excitation",
      "recurrent",
      "bacteria",
      "adnexal",
      "often",
      "discomfort",
      "health",
      "anaerobic",
      "sensitivity",
      "microbiological",
      "failures",
      "mothers",
      "antimicrobial",
      "vaginal",
      "bimanual",
      "masses",
      "hourly"
    ]
  },
  {
    "id": "fc30cc743dd1d5878d213863c8b0d898",
    "content": "To treat for gonorrhoea, chlamydia and anaerobic bacterial infection\nTo relieve pain and inflammation.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1777",
    "type": "section",
    "keywords": [
      "pain",
      "treat",
      "inflammation",
      "infection",
      "bacterial",
      "relieve",
      "gonorrhoea",
      "chlamydia",
      "anaerobic"
    ]
  },
  {
    "id": "47b05eded12f5b998ad4ca198e7dc165",
    "content": "Remove IUD, if present, 3 days after initiation of drug therapy.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1778",
    "type": "section",
    "keywords": [
      "days",
      "initiation",
      "present",
      "drug",
      "after",
      "remove",
      "therapy"
    ]
  },
  {
    "id": "7f455e56fee75415dc2a682b46d8687d",
    "content": "Evidence Rating: [C]\nOut-Patients\nCefixime, oral, 400 mg stat. Or\nCiprofloxacin, oral, 500 mg 12 hourly for 3 days\nAnd\nDoxycycline, oral, 100 mg 12 hourly for 14 days\nAnd\nMetronidazole, oral, 400 mg 12 hourly for 14 days\nIn-Patients\nCeftriaxone, IM, 250 mg daily for 3 days\nAnd\nDoxycycline, oral, 100 mg 12 hourly for 17 days\nAnd\nMetronidazole, oral, 400 mg 12 hourly for 17 days\nCauses\nHerpes simplex\nTreponema pallidum (syphilis)\nHaemophilus ducreyi (chancroid)\nCalymmatobacterium granulomatis (granuloma inguinale)\nSymptoms\nGenital ulcer (painful or painless)\nUrethral discharge\nInguinal swelling (lymphadenopathy)\nSigns\nInguinal lymphadenopathy\nHerpes simplex\nMultiple, recurrent vesicular lesions (Herpes simplex)\nSyphilitic ulcers\nOften single, painless and indurated lesions with a clear base and well-defined edges.",
    "title": "Pharmacological Treatment",
    "section": "Pharmacological Treatment",
    "chunk_id": "1779",
    "type": "section",
    "keywords": [
      "cefixime",
      "urethral",
      "metronidazole",
      "inguinal",
      "recurrent",
      "syphilitic",
      "lesions",
      "often",
      "ducreyi",
      "ulcer",
      "granuloma",
      "swelling",
      "calymmatobacterium",
      "clear",
      "granulomatis",
      "evidence",
      "ciprofloxacin",
      "hourly",
      "rating",
      "haemophilus"
    ]
  },
  {
    "id": "c081b9cc06c388316a514b0a7a20af22",
    "content": "Occasionally multiple, painful, non-indurated or have a puru-\nlent base\nDiscrete, firm, painless, inguinal lymphadenopathy a week after the primary lesion\nPrimary ulcer usually heals within six weeks, usually without\nleaving a scar. Chancroid\nPainful with undermined ragged edges\nThe base is covered with a purulent exudate and easily bleeds\nto touch\nSeveral ulcers may coalesce to form serpiginous lesions\nLymphadenopathy is usually unilateral and may become fluc-\ntuant\nGranuloma inguinale\nBegins with a small papule that progresses into an enlarging granulomatous ulcer with trauma\nEdges are well defined\nHealing is not spontaneous and is accompanied by extensive scarring\ninvestigations\nVDRL (if available)\nTPHA (if available).",
    "title": "Chapter 16:  Sexually Transmıtted Infectıons",
    "section": "Chapter 16:  Sexually Transmıtted Infectıons",
    "chunk_id": "1780",
    "type": "section",
    "keywords": [
      "inguinal",
      "usually",
      "unilateral",
      "firm",
      "lesions",
      "ulcer",
      "granuloma",
      "scar",
      "papule",
      "trauma",
      "form",
      "progresses",
      "discrete",
      "covered",
      "into",
      "easily",
      "primary",
      "lesion",
      "within",
      "multiple"
    ]
  },
  {
    "id": "51b21a6a03ea4f6ebbba797d29933855",
    "content": "To treat small ulcers and vesicles, especially if recurrent for Herpes simplex\nTo direct initial management of all ulcers at herpes simplex, syphilis\nand chancroid concurrently.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1781",
    "type": "section",
    "keywords": [
      "vesicles",
      "initial",
      "recurrent",
      "treat",
      "small",
      "concurrently",
      "management",
      "especially",
      "syphilis",
      "chancroid",
      "direct",
      "ulcers",
      "herpes",
      "simplex"
    ]
  },
  {
    "id": "4057483cf54d338fc500d79b7a17e4a5",
    "content": "Evidence Rating: [C]\nFor Herpes simplex\nAciclovir, oral, 200 mg 4-6 hourly for 7-10 days (5 doses daily)\nOr\nAciclovir, oral, 400 mg 8 hourly for 7-10 days\nFor individuals with herpes and HIV co-infection\nAciclovir, oral, 400 mg 8 hourly for 7-10 days\nOr\nAciclovir, oral, 800 mg 12 hourly for 7-10 days\nEpisodic therapy for recurrent episodes\nAciclovir, oral, 400 mg 8 hourly for 5 days\nOr\nAciclovir, oral, 800 mg 12 hourly for 5 days\nOr.",
    "title": "Pharmacological Treatment",
    "section": "Pharmacological Treatment",
    "chunk_id": "1782",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "rating",
      "episodic",
      "recurrent",
      "episodes",
      "infection",
      "daily",
      "doses",
      "oral",
      "individuals",
      "aciclovir",
      "herpes",
      "therapy",
      "evidence",
      "simplex"
    ]
  },
  {
    "id": "3a4f86b317841ad0ef079618c3607536",
    "content": "Aciclovir, oral, 800 mg 8 hourly for 2 days Suppressive therapy in HIV infected individuals\nAciclovir, oral, 400-800 mg 8-12 hourly for 2-6 years\nFor Syphilis\nBenzathine Penicillin G, IM, 1. 2 MU in each buttock (total dose 2. 4 MU) stat.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1783",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "suppressive",
      "years",
      "penicillin",
      "syphilis",
      "each",
      "benzathine",
      "oral",
      "infected",
      "individuals",
      "dose",
      "aciclovir",
      "total",
      "buttock",
      "therapy",
      "stat"
    ]
  },
  {
    "id": "87ff56112ec9f90099b0f7b203b2e2aa",
    "content": "Or\nProcaine Penicillin Aqueous, IM (by deep injection), 1. 2 MU daily for 10 days\nFor persons allergic to penicillin\nDoxycycline, oral, 100 mg 12 hourly for 14 days\nOr\nTetracycline, oral, 500 mg 6 hourly for 14 days\nFor pregnant women allergic to penicillin\nErythromycin, oral, 500 mg 6 hourly for 14 days\nOr\nAzithromycin, oral, 500 mg daily for 10 days\nFor Chancroid\nCeftriaxone, IM, 250 mg stat. Or\nAzithromycin, oral, 1 g stat.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1784",
    "type": "section",
    "keywords": [
      "penicillin",
      "hourly",
      "allergic",
      "injection",
      "stat",
      "days",
      "deep",
      "erythromycin",
      "doxycycline",
      "women",
      "aqueous",
      "persons",
      "chancroid",
      "azithromycin",
      "tetracycline",
      "ceftriaxone",
      "oral",
      "pregnant",
      "procaine",
      "daily"
    ]
  },
  {
    "id": "d8fb27078852ba2cad38a9633754d575",
    "content": "Or\nCiprofloxacin, oral, 500 mg 12 hourly for 3 days\nOr\nErythromycin, oral, 500 mg 6 hourly for 7 days\nCauses\nChlamydia trachomatis\nNeisseria gonorrhoea\nTreponema pallidum (very rarely)\nSymptoms\nScrotal swelling\nScrotal pain\nUrethral discharge\nDysuria\nFrequency of micturition\nFever\nSigns\nScrotal swelling, oedema and/or erythema\nScrotal tenderness\nUrethral discharge.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1785",
    "type": "section",
    "keywords": [
      "urethral",
      "oedema",
      "swelling",
      "scrotal",
      "ciprofloxacin",
      "hourly",
      "erythema",
      "micturition",
      "signs",
      "gonorrhoea",
      "causes",
      "days",
      "tenderness",
      "erythromycin",
      "pallidum",
      "fever",
      "rarely",
      "dysuria",
      "symptoms",
      "frequency"
    ]
  },
  {
    "id": "d3cc8c54a3b862acd5f657b31e5b23ab",
    "content": "Fever\ninvestigations\nUrethral swab for culture\nUrine culture and sensitivity\nUltrasound scan of the scrotum.",
    "title": "Chapter 16:  Sexually Transmıtted Infectıons",
    "section": "Chapter 16:  Sexually Transmıtted Infectıons",
    "chunk_id": "1786",
    "type": "section",
    "keywords": [
      "urethral",
      "ultrasound",
      "swab",
      "scan",
      "fever",
      "urine",
      "culture",
      "investigations",
      "sensitivity",
      "scrotum"
    ]
  },
  {
    "id": "3d159329286da7545e610829206da3bb",
    "content": "To provide pain relief\nTo identify and treat STI and non-STI related causes appropriately\nTo treat for gonorrhea and chlamydia simultaneously.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1787",
    "type": "section",
    "keywords": [
      "gonorrhea",
      "pain",
      "treat",
      "appropriately",
      "relief",
      "provide",
      "identify",
      "simultaneously",
      "chlamydia",
      "related",
      "causes"
    ]
  },
  {
    "id": "723a7b27dee0ddd0f40241c825c96cf3",
    "content": "Bed rest\nScrotal support until inflammation and fever subside.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1788",
    "type": "section",
    "keywords": [
      "support",
      "inflammation",
      "fever",
      "subside",
      "rest",
      "scrotal",
      "until"
    ]
  },
  {
    "id": "f0cc38751caed53f6e561e0d056eb83e",
    "content": "Evidence Rating: [C]\nFor Gonorrhoea\nCeftriaxone, IM, 250 mg stat. Or\nCefixime, oral, 400 mg stat. Or\nCiprofloxacin, oral, 500 mg stat.",
    "title": "Pharmacological Treatment",
    "section": "Pharmacological Treatment",
    "chunk_id": "1789",
    "type": "section",
    "keywords": [
      "cefixime",
      "rating",
      "ceftriaxone",
      "oral",
      "ciprofloxacin",
      "gonorrhoea",
      "evidence",
      "stat"
    ]
  },
  {
    "id": "12ca9a07f66312da04a38478b31cfe8d",
    "content": "And\nFor Chlamydia\nDoxycycline, oral, 100 mg 12 hourly for 7 days\nOr\nTetracycline, oral, 500 mg 6 hourly for 7 days\nOr\nAzithromycin, oral, 1 g stat. Or\nErythromycin, oral, 500 mg 6 hourly for 7 days\nCauses\nChlamydia trachomatis (Lymphogranuloma venereum)\nHaemophilus ducreyi (Chancroid)\nSymptoms\nPainful or painless inguinal swelling(s)\nSigns\nInguinal swellings:\nunilateral or bilateral\ntender or non-tender.",
    "title": "Pharmacological Treatment",
    "section": "Pharmacological Treatment",
    "chunk_id": "1790",
    "type": "section",
    "keywords": [
      "inguinal",
      "unilateral",
      "ducreyi",
      "swelling",
      "hourly",
      "haemophilus",
      "signs",
      "tender",
      "causes",
      "stat",
      "days",
      "venereum",
      "erythromycin",
      "doxycycline",
      "chancroid",
      "painful",
      "lymphogranuloma",
      "azithromycin",
      "swellings",
      "symptoms"
    ]
  },
  {
    "id": "b173534483c0b47908cf75cc86010541",
    "content": "fluctuant\nsuppurating\nGenital ulcer\ninvestigations\nNo investigations required, in view of the syndromic approach\nRecommended in managing STIs.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1791",
    "type": "section",
    "keywords": [
      "stis",
      "fluctuant",
      "recommended",
      "syndromic",
      "approach",
      "managing",
      "ulcer",
      "required",
      "investigations",
      "view",
      "genital",
      "suppurating"
    ]
  },
  {
    "id": "3b03454fc6e67c8d63dcba8fc5c0af2f",
    "content": "To relieve pain\nTo relieve the swelling\nTo treat the infection of lymphogranuloma venereum and chancroid\nconcurrently.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1792",
    "type": "section",
    "keywords": [
      "venereum",
      "pain",
      "treat",
      "concurrently",
      "chancroid",
      "infection",
      "lymphogranuloma",
      "relieve",
      "swelling"
    ]
  },
  {
    "id": "5000002dc95a5930da4bd5d84abcf4bd",
    "content": "Aspiration of fluctuant buboes using a wide bore needle through adjacent healthy skin every second or third day. An incision and drainage should not be attempted. If buboes persist, the patient should be referred.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1793",
    "type": "section",
    "keywords": [
      "fluctuant",
      "persist",
      "attempted",
      "wide",
      "second",
      "patient",
      "aspiration",
      "bore",
      "adjacent",
      "incision",
      "healthy",
      "drainage",
      "third",
      "should",
      "skin",
      "referred",
      "every",
      "using",
      "needle",
      "through"
    ]
  },
  {
    "id": "429ca42ebd5eeda811b029e3a07ef5c9",
    "content": "Sequelae such as strictures and/or fistula may require surgery.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1794",
    "type": "section",
    "keywords": [
      "require",
      "fistula",
      "sequelae",
      "surgery",
      "strictures"
    ]
  },
  {
    "id": "e43f21a9cc5d1b7b5e55f20f87378c24",
    "content": "A. For Lymphogranuloma Venereum (LGV) andChancroid\nEvidence Rating: [C]\nDoxycycline, oral, 100 mg 12 hourly for 21 days\nOr\nAzithromycin, oral, 1 g stat. Or\nErythromycin, oral, 500 mg 6 hourly for 14 days\nCauses\nHuman papilloma virus\nSymptoms\nUsually no symptoms\nSmall painless swellings in the ano-genital region\nItching or discomfort in the genital area\nMay cause increased vaginal discharge\nAnal or vaginal bleeding during or after sex\nSigns\nSmall, flat, papular, pedunculated, flesh-coloured swellings on the skin and mucous membranes of the genitals (penis, vulva, vagina, cervix, urethra, perianal region).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1795",
    "type": "section",
    "keywords": [
      "usually",
      "perianal",
      "virus",
      "region",
      "pedunculated",
      "during",
      "discomfort",
      "membranes",
      "evidence",
      "vaginal",
      "genitals",
      "hourly",
      "rating",
      "andchancroid",
      "bleeding",
      "cervix",
      "mucous",
      "vulva",
      "signs",
      "genital"
    ]
  },
  {
    "id": "2df89d1d0ef8d8ac01ee2279063e216f",
    "content": "Protect normal skin with vaseline (paraffin) while applying Podophyllin\nExternal genital and perianal warts should be washed thoroughly\n1- 4 hours after application of Podophyllin and 6-10 hours after application of Imiquimod. Cryotherapy with liquid nitrogen, solid carbon dioxide, or a\ncryoprobe. Repeat applications every 1-2 weeks\nElectrosurgery\nSurgical removal.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1796",
    "type": "section",
    "keywords": [
      "perianal",
      "imiquimod",
      "application",
      "thoroughly",
      "paraffin",
      "nitrogen",
      "while",
      "electrosurgery",
      "repeat",
      "removal",
      "cryotherapy",
      "weeks",
      "genital",
      "solid",
      "warts",
      "surgical",
      "vaseline",
      "should",
      "liquid",
      "skin"
    ]
  },
  {
    "id": "c7d38847120c4cb84c30b2d27b5a3daf",
    "content": "Evidence Rating: [C]\nPodophyllin 10-25% tincture of benzoin, topical, apply directly to the warts avoiding normal skin tissue. Protect normal skin with vaseline (paraffin).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1797",
    "type": "section",
    "keywords": [
      "topical",
      "rating",
      "benzoin",
      "warts",
      "avoiding",
      "tissue",
      "vaseline",
      "directly",
      "skin",
      "paraffin",
      "normal",
      "protect",
      "tincture",
      "evidence",
      "apply",
      "podophyllin"
    ]
  },
  {
    "id": "7b1daa8b28c3c4266e6e07230efda662",
    "content": "Or\nTrichloroacetic Acid (TCA) (80-90%), topical,\napply carefully to the warts avoiding normal tissue, followed by powdering of the treated area with talcum powder to remove unreacted acid.",
    "title": "Repeat treatment at weekly intervals until complete resolution.",
    "section": "Repeat treatment at weekly intervals until complete resolution.",
    "chunk_id": "1798",
    "type": "section",
    "keywords": [
      "followed",
      "topical",
      "warts",
      "carefully",
      "area",
      "avoiding",
      "powder",
      "acid",
      "talcum",
      "treated",
      "powdering",
      "unreacted",
      "remove",
      "normal",
      "trichloroacetic",
      "tissue",
      "apply"
    ]
  },
  {
    "id": "ed7cb72696924b80063d2736ba089bb5",
    "content": "Or\nPodophyllotoxin, 0. 5%, topical, apply 12 hourly three times a week for 4 weeks\nOr\nImiquimod, 5% cream, topical, apply three times a week for 16 weeks. Should be washed 6-10 hours after application.",
    "title": "Repeat treatment at weekly intervals until complete resolution.",
    "section": "Repeat treatment at weekly intervals until complete resolution.",
    "chunk_id": "1799",
    "type": "section",
    "keywords": [
      "topical",
      "hourly",
      "week",
      "imiquimod",
      "should",
      "application",
      "three",
      "times",
      "washed",
      "after",
      "weeks",
      "cream",
      "hours",
      "apply",
      "podophyllotoxin"
    ]
  },
  {
    "id": "c1757b8f285bf0fee0400927a22595a6",
    "content": "Causes\nC. Trachomatis\nHerpes Simplex Virus-2 (HSV-2)\nN. Gonorrhoea.",
    "title": "Repeat treatment at weekly intervals until complete resolution.",
    "section": "Repeat treatment at weekly intervals until complete resolution.",
    "chunk_id": "1800",
    "type": "section",
    "keywords": [
      "virus",
      "gonorrhoea",
      "herpes",
      "trachomatis",
      "causes",
      "simplex"
    ]
  },
  {
    "id": "76233ae7336501949916ebdc6f1e0acb",
    "content": "Treponema pallidum\nSymptoms\nAnal discharge\nRectal Bleeding\nPruritus\nRectal pain,\nTenesmus\nConstipation\nSigns\nAnal ulcers or blisters\nAnal growth\nTenderness on rectal examination\nAnal discharge or bleeding.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1801",
    "type": "section",
    "keywords": [
      "anal",
      "rectal",
      "tenderness",
      "pain",
      "pallidum",
      "examination",
      "pruritus",
      "treponema",
      "bleeding",
      "growth",
      "signs",
      "tenesmus",
      "discharge",
      "ulcers",
      "constipation",
      "symptoms",
      "blisters"
    ]
  },
  {
    "id": "6c13faf0981d9204413ffa13e6587fad",
    "content": "To relive pain\nTo treat for the major causes simultaneously.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1802",
    "type": "section",
    "keywords": [
      "pain",
      "treat",
      "relive",
      "major",
      "simultaneously",
      "causes"
    ]
  },
  {
    "id": "46f7997f5b58f1abb37985df5ddae8df",
    "content": "For anorectal discharge, treat for gonorrhea and chlamydia\n(See sections above)\nFor anorectal ulcers or vesicles\nFor 1st episode of vesicular lesions treat for herpes simplex virus\nAciclovir, 200 mg, 4-6 hourly for 7 days (5 doses per day)\nOr\nAciclovir, 400 mg, 8 hourly for 7 days\nEpisodic treatment for recurrent HSV vesicular lesions to be started on first day of appearance of lesions\nAciclovir, 400 mg, 8 hourly for 5 days\nOr\nAciclovir, 800 mg, 12 hourly for 5 days\nOr\nAciclovir, 800 mg, 8 hourly for 2 days\nAnd\nFor Syphilis\nBenzathine Penicillin G, IM, 1. 2 MU in each buttock (total dose 2. 4 MU) stat.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1803",
    "type": "section",
    "keywords": [
      "episodic",
      "buttock",
      "recurrent",
      "virus",
      "treat",
      "appearance",
      "lesions",
      "penicillin",
      "gonorrhea",
      "hourly",
      "doses",
      "episode",
      "aciclovir",
      "total",
      "herpes",
      "vesicular",
      "sections",
      "simplex",
      "treatment",
      "days"
    ]
  },
  {
    "id": "6085fda7077fdd786306efdca191c184",
    "content": "Or\nProcaine Penicillin Aqueous, IM (by deep injection), 1. 2 MU daily for 10 days\nOr.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1804",
    "type": "section",
    "keywords": [
      "days",
      "deep",
      "penicillin",
      "aqueous",
      "injection",
      "procaine",
      "daily"
    ]
  },
  {
    "id": "f9dc337a0cc6b3a4ce6bddcb2ea38fb3",
    "content": "For persons allergic to penicillins\nDoxycycline, oral, 100 mg 12 hourly for 14 days\nOr\nTetracycline, oral, 500 mg 6 hourly for 14 days\nOr\nErythromycin, oral, 500 mg 6 hourly for 14 days\nAnd\nFor Chlamydia\nDoxycycline, oral, 100 mg 12 hourly for 7 days\nOr\nTetracycline, oral, 500 mg 6 hourly for 7 days\nOr\nErythromycin, oral, 500 mg 6 hourly for 7 days\nAnd\nFor Chanchroid\nCeftriaxone, IM, 250 mg stat. Or\nAzithromycin, oral, 1g stat. Or\nCiprofloxacin, oral, 500 mg 12 hourly for 3 days\nOr\nErythromycin, oral, 500 mg 6 hourly for 7 days\nReferral Criteria\nIf the symptoms or lesions do not improve after treatment refer to a health facility with microbiology support for appropriate treatment and exclusion of other causes to exclude other causes.",
    "title": "Chapter 16:  Sexually Transmıtted Infectıons",
    "section": "Chapter 16:  Sexually Transmıtted Infectıons",
    "chunk_id": "1805",
    "type": "section",
    "keywords": [
      "lesions",
      "improve",
      "penicillins",
      "health",
      "ciprofloxacin",
      "hourly",
      "facility",
      "support",
      "chanchroid",
      "allergic",
      "criteria",
      "causes",
      "stat",
      "treatment",
      "days",
      "referral",
      "erythromycin",
      "microbiology",
      "doxycycline",
      "persons"
    ]
  },
  {
    "id": "1bbe1572132fa283be981013badb6cc0",
    "content": "Neonates, pre-pubertal and pubertal children are also at risk of contracting STIs. The modes of transmission in these children are mostly through maternal infections, sexual abuse or exploitation and voluntary sexual activity in older children. The STls in this age group include neonatal conjunctivitis (ophthalmia neonatorum), and other STI-related syndromes similar to that in adults.",
    "title": "Chapter 16:  Sexually Transmıtted Infectıons",
    "section": "Chapter 16:  Sexually Transmıtted Infectıons",
    "chunk_id": "1806",
    "type": "section",
    "keywords": [
      "infections",
      "stls",
      "activity",
      "neonates",
      "voluntary",
      "modes",
      "mostly",
      "ophthalmia",
      "neonatorum",
      "children",
      "stis",
      "include",
      "maternal",
      "neonatal",
      "conjunctivitis",
      "contracting",
      "similar",
      "also",
      "adults",
      "sexual"
    ]
  },
  {
    "id": "159c68f3c15f9d576620fe2bd4d63243",
    "content": "Some of these STls (e. g. , gonorrhea, syphilis, and chlamydia), if acquired after the neonatal period, are indicative of sexual contact.",
    "title": "Chapter 16:  Sexually Transmıtted Infectıons",
    "section": "Chapter 16:  Sexually Transmıtted Infectıons",
    "chunk_id": "1807",
    "type": "section",
    "keywords": [
      "stls",
      "gonorrhea",
      "contact",
      "neonatal",
      "syphilis",
      "period",
      "indicative",
      "acquired",
      "sexual",
      "after",
      "chlamydia",
      "these"
    ]
  },
  {
    "id": "c7dd169761a96fe2f547a02d15b23fb8",
    "content": "For other STls, (e. g. HPV infections and vaginitis), the association with sexual contact is not clear.",
    "title": "Chapter 16:  Sexually Transmıtted Infectıons",
    "section": "Chapter 16:  Sexually Transmıtted Infectıons",
    "chunk_id": "1808",
    "type": "section",
    "keywords": [
      "infections",
      "stls",
      "contact",
      "association",
      "other",
      "clear",
      "sexual",
      "vaginitis"
    ]
  },
  {
    "id": "119fb9b78943c5c5634416e903a93d04",
    "content": "For Gonorrhea\nChildren < 12 years (or child < 45 kg)\nCeftriaxone, IM, 125 mg stat. Children > 12 years (or child > 45 kg)\nCefixime, oral, 400 mg stat. Or\nCeftriaxone, IM,250 mg stat.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1809",
    "type": "section",
    "keywords": [
      "cefixime",
      "gonorrhea",
      "years",
      "ceftriaxone",
      "oral",
      "child",
      "children",
      "stat"
    ]
  },
  {
    "id": "8b799ebc579281b6fb944a6f6b8f7b41",
    "content": "And\nFor Chlamydia\nChildren < 12 years\nErythromycin, oral, 12. 5 mg/kg 6 hourly for 14 days\nChildren > 12 years\nAzithromycin, oral, 1g stat. Or\nDoxycycline, oral, 100 mg 12 hourly for 7 days\nOr\nErythromycin, oral, 500 mg 6 hourly for 7 days.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1810",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "erythromycin",
      "years",
      "doxycycline",
      "oral",
      "azithromycin",
      "children",
      "chlamydia",
      "stat"
    ]
  },
  {
    "id": "c5687810483efbb2671c3187896e1962",
    "content": "Ensure good genital hygiene\nEncourage use of loose underwear\nDry underwear in the sun or iron with hot plate\nEnsure good peri-anal hygiene\nAvoid douching with herbal or chemical preparations\nAvoid medicated soaps.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1811",
    "type": "section",
    "keywords": [
      "anal",
      "avoid",
      "hygiene",
      "ensure",
      "loose",
      "iron",
      "plate",
      "peri",
      "soaps",
      "encourage",
      "preparations",
      "chemical",
      "underwear",
      "herbal",
      "medicated",
      "genital",
      "douching"
    ]
  },
  {
    "id": "02de67c56b4f88e7b9ef78cf8815f4f8",
    "content": "For Vaginitis (Trichomoniasis and B a c t e r i a l vaginosis)\nChildren < 12 years (or < 45 kg)\nMetronidazole, oral, 7. 5 mg/kg 12 hourly for 7days\nChildren > 12years (or > 45 kg)\nMetronidazole, oral, 400 mg 12 hourly for 7days.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1812",
    "type": "section",
    "keywords": [
      "hourly",
      "metronidazole",
      "years",
      "oral",
      "children",
      "vaginitis",
      "vaginosis",
      "trichomoniasis"
    ]
  },
  {
    "id": "b52cef7eb77bc17b7d9f1f915456c8c1",
    "content": "Or\nMetronidazole, oral, 2 g stat. And\nFor Candidiasis\nClotrimazole 2% cream, topical (vaginal), apply 8-12 hourly for 7\ndays\nOr\nFluconazole, oral, 3-6 mg/kg stat. And\nFor Cervicitis\nFor Gonorrhea\nChildren < 12 years (or < 45 kg)\nCeftriaxone, IM, 125 mg stat.",
    "title": "Chapter 16:  Sexually Transmıtted Infectıons",
    "section": "Chapter 16:  Sexually Transmıtted Infectıons",
    "chunk_id": "1813",
    "type": "section",
    "keywords": [
      "days",
      "topical",
      "candidiasis",
      "metronidazole",
      "hourly",
      "gonorrhea",
      "years",
      "ceftriaxone",
      "cervicitis",
      "apply",
      "oral",
      "children",
      "cream",
      "clotrimazole",
      "fluconazole",
      "stat",
      "vaginal"
    ]
  },
  {
    "id": "fcb2caab3b71892ed2bf42223a997075",
    "content": "Children > 12 years (or > 45 kg)\nCefixime, oral, 400 mg stat. Or\nCeftriaxone, IM, 250 mg stat. And\nFor Chlamydia\nChildren < 12 years\nErythromycin, oral, 12.",
    "title": "Chapter 16:  Sexually Transmıtted Infectıons",
    "section": "Chapter 16:  Sexually Transmıtted Infectıons",
    "chunk_id": "1814",
    "type": "section",
    "keywords": [
      "cefixime",
      "erythromycin",
      "years",
      "ceftriaxone",
      "oral",
      "children",
      "chlamydia",
      "stat"
    ]
  },
  {
    "id": "a9ea6197f080f9cb19396b98f08aa30c",
    "content": "5 mg/kg 6 hourly for 14 days\nChildren > 12years\nAzithromycin, oral, 1 g stat. Or\nDoxycycline, oral, 100 mg 12 hourly for 7 days\nOr\nErythromycin, oral, 500 mg 6 hourly for 7 days\nChildren < 12 years (or < 45 kg)\nCeftriaxone, IM, 125 mg stat. And\nErythromycin, oral, 12.",
    "title": "Chapter 16:  Sexually Transmıtted Infectıons",
    "section": "Chapter 16:  Sexually Transmıtted Infectıons",
    "chunk_id": "1815",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "erythromycin",
      "years",
      "doxycycline",
      "ceftriaxone",
      "azithromycin",
      "oral",
      "children",
      "stat"
    ]
  },
  {
    "id": "65ac42dc6c83d1ae25b170b3fa357ba8",
    "content": "5 mg/kg 6 hourly for 14 days\nAnd\nMetronidazole, oral, 7. 5 mg/kg 12 hourly for 14 days\nChildren > 12 years\nCeftriaxone, IM, 250 mg stat. And.",
    "title": "Chapter 16:  Sexually Transmıtted Infectıons",
    "section": "Chapter 16:  Sexually Transmıtted Infectıons",
    "chunk_id": "1816",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "years",
      "ceftriaxone",
      "oral",
      "children",
      "stat"
    ]
  },
  {
    "id": "496ccbb47f5a5330b87eefb34cf521ff",
    "content": "Doxycycline, oral, 100 mg 12 hourly for 14 days\nAnd\nMetronidazole, oral, 400 mg 12 hourly for 14 days\nFor Syphilis\nBenzyl penicillin, IV,\nChildren\n12 years;\t50,000 units/kg 4-6 hourly for 10 days\n< 12 years;\t50,000 units/kg 4-6 hourly for 10 days\nOr\nProcaine penicillin, IM (deep),\nChildren\n12 years;\t1. 2 MU daily for 10 days\n< 12 years;\t50,000 IU/kg daily for 10 days (max. daily dose 750,000 units)\nOr\nBenzathine Penicillin, IM,\n12 years;\t1.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1817",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "deep",
      "units",
      "years",
      "doxycycline",
      "penicillin",
      "syphilis",
      "benzathine",
      "oral",
      "dose",
      "children",
      "procaine",
      "benzyl",
      "daily"
    ]
  },
  {
    "id": "33addbdfa43ed15e1aed5533af594104",
    "content": "2 MU into each buttock during one clinic visit (total 2. 4 MU)\nFor persons allergic to penicillin:\nDoxycycline, oral, 100 mg 12 hourly for 14 days\nOr\nTetracycline, oral, 500 mg 6 hourly for 14 days\nAnd\nFor Chancroid\nChildren > 12 years\nCefixime, oral, 400 mg stat. Or\nAzithromycin, oral, 1 g stat.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1818",
    "type": "section",
    "keywords": [
      "cefixime",
      "years",
      "penicillin",
      "during",
      "into",
      "hourly",
      "allergic",
      "children",
      "total",
      "stat",
      "days",
      "doxycycline",
      "each",
      "persons",
      "chancroid",
      "azithromycin",
      "visit",
      "clinic",
      "tetracycline",
      "oral"
    ]
  },
  {
    "id": "181e4a1e3eb585e63e7c65dfe8323bfd",
    "content": "Or\nDoxycycline, oral, 100 mg 12 hourly for 7 days\nOr\nErythromycin, oral, 500 mg 6 hourly for 7 days\nChildren < 12 years (or < 45 kg)\nCeftriaxone, IM, 250 mg stat. Or\nErythromycin, oral, 12. 5 mg/kg 6 hourly for 7 days\nAnd\nFor Genital Herpes Simplex\nAciclovir, oral,\nChildren.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1819",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "erythromycin",
      "years",
      "doxycycline",
      "ceftriaxone",
      "oral",
      "aciclovir",
      "children",
      "genital",
      "herpes",
      "stat",
      "simplex"
    ]
  },
  {
    "id": "93ac45638ebfd7a93e5019e04d4a3f3c",
    "content": "2 years;\t200 mg 4-6 hourly for 5 days\n1 month-2 years;\t100 mg 4-6 hourly for 5 days\nFor Infants with Known or Suspected Neonatal Herpes\nAciclovir, IV,\nChildren < 1 month.",
    "title": "Chapter 16:  Sexually Transmıtted Infectıons",
    "section": "Chapter 16:  Sexually Transmıtted Infectıons",
    "chunk_id": "1820",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "neonatal",
      "years",
      "suspected",
      "known",
      "infants",
      "aciclovir",
      "month",
      "children",
      "herpes"
    ]
  },
  {
    "id": "308a36355c04da8730b24982fd32d413",
    "content": "Or\n20 mg/kg every 8 hours for 21 days (for disseminated and CNS dis- ease)\nAno-rectal Discharge\nFor Gonorrhea\nChildren > 12 years (or > 45 kg)\nCefixime, oral, 400 mg stat. Or\nCeftriaxone, IM, 250 mg stat. Children < 12 years (or < 45 kg)\nCeftriaxone, IM, 125 mg stat.",
    "title": "20 mg/kg every 8 hours for 14 days ( for disease limited to the skin and mucous membranes)",
    "section": "20 mg/kg every 8 hours for 14 days ( for disease limited to the skin and mucous membranes)",
    "chunk_id": "1821",
    "type": "section",
    "keywords": [
      "days",
      "gonorrhea",
      "rectal",
      "cefixime",
      "years",
      "ceftriaxone",
      "ease",
      "disseminated",
      "oral",
      "children",
      "discharge",
      "hours",
      "stat",
      "every"
    ]
  },
  {
    "id": "6cd217a55702943ef20ae09fc943083c",
    "content": "And\nFor Chlamydia\nChildren > 12 years\nAzithromycin, oral, 1 g stat. Or\nDoxycycline, oral, 100 mg 12 hourly for 7 days\nOr\nErythromycin, oral, 500 mg 6 hourly for 7 day\nChildren < 12 years\nErythromycin, oral, 12. 5 mg/kg 6 hourly for 14 days\nAnorectal ulcers / vesicles\nFor Syphilis.",
    "title": "20 mg/kg every 8 hours for 14 days ( for disease limited to the skin and mucous membranes)",
    "section": "20 mg/kg every 8 hours for 14 days ( for disease limited to the skin and mucous membranes)",
    "chunk_id": "1822",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "vesicles",
      "erythromycin",
      "years",
      "doxycycline",
      "anorectal",
      "syphilis",
      "azithromycin",
      "oral",
      "children",
      "ulcers",
      "chlamydia",
      "stat"
    ]
  },
  {
    "id": "82ac68ceebda6838514bba567649a563",
    "content": "For Genital Herpes\n(See sections above under ‘Genital Ulcer Syndrome in Children’ for.",
    "title": "(See sections above under ‘Genital Ulcer Syndrome in Children’ for treatment of Chancroid’)",
    "section": "(See sections above under ‘Genital Ulcer Syndrome in Children’ for treatment of Chancroid’)",
    "chunk_id": "1823",
    "type": "section",
    "keywords": [
      "above",
      "ulcer",
      "syndrome",
      "children",
      "genital",
      "herpes",
      "sections",
      "under"
    ]
  },
  {
    "id": "782291717557e9b479ccafb4250326ea",
    "content": "Genital Warts in Children\n(See section on treatment of ‘Genital Warts’ in adults. Podophyllotoxin and Imiquimod are not used in children)\nScabies\n(See section on ‘Pruritus’)\nPubic Lice\nMalathion liquid 0. 5% in aqueous base\nApply over whole body and allow to dry naturally.",
    "title": "treatment of Genital Herpes’)",
    "section": "treatment of Genital Herpes’)",
    "chunk_id": "1824",
    "type": "section",
    "keywords": [
      "imiquimod",
      "malathion",
      "body",
      "base",
      "section",
      "whole",
      "children",
      "genital",
      "scabies",
      "treatment",
      "allow",
      "warts",
      "naturally",
      "aqueous",
      "adults",
      "liquid",
      "podophyllotoxin",
      "pubic",
      "pruritus",
      "lice"
    ]
  },
  {
    "id": "06c9469c75820bd10ade87076f52b68a",
    "content": "Wash off after 12 hours or overnight. Repeat after 1 week\nReferral Criteria\nIf the symptoms or lesions do not improve after treatment refer to a health facility with microbiology support for appropriate treatment and exclusion of other causes to exclude other causes.",
    "title": "treatment of Genital Herpes’)",
    "section": "treatment of Genital Herpes’)",
    "chunk_id": "1825",
    "type": "section",
    "keywords": [
      "lesions",
      "improve",
      "health",
      "facility",
      "support",
      "week",
      "repeat",
      "criteria",
      "causes",
      "treatment",
      "wash",
      "referral",
      "microbiology",
      "symptoms",
      "exclusion",
      "appropriate",
      "exclude",
      "other",
      "refer",
      "overnight"
    ]
  },
  {
    "id": "f2399831622c84192e759505c01b765f",
    "content": "Acquired Immune Deficiency Syndrome (AIDS) is a late stage of infection with the Human Immune Deficiency Virus (HIV). It can affect both adults and children often predisposing them to opportunistic infections and certain malignancies. Co-infection with tuberculosis (TB) and Hepatitis B are particularly frequent in HIV infected individuals and must be screened for in all cases.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1826",
    "type": "section",
    "keywords": [
      "infections",
      "virus",
      "often",
      "both",
      "infected",
      "aids",
      "opportunistic",
      "late",
      "certain",
      "predisposing",
      "acquired",
      "stage",
      "children",
      "particularly",
      "deficiency",
      "affect",
      "malignancies",
      "adults",
      "immune",
      "tuberculosis"
    ]
  },
  {
    "id": "7621b810add68829af1c85bf862fb0ff",
    "content": "The main risk factors for HIV/AIDS remain transmission by exchange of body fluids and blood products through sexual contact, transfusion, needle-stick injury, non-sterile surgical practices and mother to child transfer. HIV infection is currently not curable. However, for persons living with HIV infection (PLHIV), effective anti-retroviral therapy (ART) is available country-wide at accredited centres at the regional and district level in both public and private health care facilities to which all diagnosed patients must be referred.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1827",
    "type": "section",
    "keywords": [
      "both",
      "sterile",
      "factors",
      "stick",
      "mother",
      "child",
      "aids",
      "wide",
      "living",
      "health",
      "which",
      "therapy",
      "country",
      "body",
      "district",
      "transfer",
      "private",
      "curable",
      "facilities",
      "public"
    ]
  },
  {
    "id": "bdaeb9283a8e1980718a6d1f655219f8",
    "content": "Prevention of infection remains the key to reducing its spread. Causes\nHuman Immunodeficiency Virus\nSymptoms\nPersistent cough\nPersistent or recurrent diarrhoea\nWeight loss\nSkin rashes\nPersistent or recurrent fever\nMouth ulcers\nSigns\nWeight loss\nChronic diarrhoea\nProlonged fever\nGeneralised lymphadenopathy.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1828",
    "type": "section",
    "keywords": [
      "prolonged",
      "recurrent",
      "virus",
      "weight",
      "immunodeficiency",
      "rashes",
      "diarrhoea",
      "signs",
      "generalised",
      "causes",
      "reducing",
      "chronic",
      "prevention",
      "mouth",
      "fever",
      "skin",
      "remains",
      "persistent",
      "ulcers",
      "lymphadenopathy"
    ]
  },
  {
    "id": "8f43463b3c4193fd33328c5a7af5c10a",
    "content": "Oropharyngeal candidiasis\nPersistent cough\nGeneralised dermatitis\nRecurrent herpes zoster (adults)\nChronic progressive and disseminated herpes simplex infections (adults)\nFinger nail changes e. g. blue discoloration of the nails (adults)\nFailure to thrive or slow growth (infants and children)\nRecurrent common infections e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1829",
    "type": "section",
    "keywords": [
      "infections",
      "recurrent",
      "thrive",
      "dermatitis",
      "candidiasis",
      "nail",
      "growth",
      "progressive",
      "disseminated",
      "nails",
      "children",
      "changes",
      "zoster",
      "herpes",
      "generalised",
      "simplex",
      "oropharyngeal",
      "chronic",
      "finger",
      "adults"
    ]
  },
  {
    "id": "c92f56d785c8cf16eae72bf8a400d12d",
    "content": "g. otitis media, pharyngitis (infants and children)\ninvestigations\nConfirmatory HIV test (HIV1, HIV2, HIV1 and 2)\nHIV Viral load\nCD4 count\nOther tests asOther tests asOther tests as required (See Table 17-1 on page )d (See Table 17-1 on page )d (See Table 17-1 on page 462).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1830",
    "type": "section",
    "keywords": [
      "test",
      "count",
      "confirmatory",
      "other",
      "infants",
      "pharyngitis",
      "tests",
      "otitis",
      "table",
      "asother",
      "investigations",
      "children",
      "required",
      "media",
      "page",
      "load",
      "viral"
    ]
  },
  {
    "id": "813366180fdffdf15132dafb67e43e74",
    "content": "To suppress HIV replication to as low as possible and for as long as\npossible\nTo preserve and enhance the immune function (CD4 restoration)\nTo improve quality of life\nTo reduce morbidity and mortality related to HIV\nTo promote growth and neurological development in children.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1831",
    "type": "section",
    "keywords": [
      "replication",
      "restoration",
      "suppress",
      "improve",
      "morbidity",
      "development",
      "quality",
      "neurological",
      "function",
      "growth",
      "children",
      "immune",
      "promote",
      "related",
      "mortality",
      "preserve",
      "reduce",
      "life",
      "enhance",
      "possible"
    ]
  },
  {
    "id": "daa3040845357a5fd5de8c8d4969b4fb",
    "content": "Post-exposure prophylaxis (PEP) is short-term antiretroviral treatment to reduce the likelihood of HIV infection after potential exposure by preventing the establishment of infection or preventing new infection. PEP reduces staff exposure to HIV infections at work and also clears possible HIV infection from infected dendritic cells. Workplace accidents or injury expose health workers to body fluids of patients.",
    "title": "Refer all HIV positive patients to an accredited treatment centre in Ghana.",
    "section": "Refer all HIV positive patients to an accredited treatment centre in Ghana.",
    "chunk_id": "1832",
    "type": "section",
    "keywords": [
      "infections",
      "work",
      "infected",
      "health",
      "accidents",
      "potential",
      "workplace",
      "staff",
      "clears",
      "short",
      "reduces",
      "likelihood",
      "body",
      "fluids",
      "patients",
      "workers",
      "treatment",
      "post",
      "expose",
      "antiretroviral"
    ]
  },
  {
    "id": "11993129bc4854762c14d6a75426744e",
    "content": "Risk of exposure to blood and blood borne pathogens is slightly higher for healthcare personnel. The risk of infection for HIV from a percutaneous injury is approximately 0-3% and that of mucous membranes or non- intact skin are much lower. PEP is particularly effective within 1-2 hours and not more than 72 hours after exposure.",
    "title": "Refer all HIV positive patients to an accredited treatment centre in Ghana.",
    "section": "Refer all HIV positive patients to an accredited treatment centre in Ghana.",
    "chunk_id": "1833",
    "type": "section",
    "keywords": [
      "borne",
      "membranes",
      "intact",
      "within",
      "mucous",
      "particularly",
      "blood",
      "slightly",
      "healthcare",
      "exposure",
      "skin",
      "approximately",
      "pathogens",
      "higher",
      "effective",
      "percutaneous",
      "infection",
      "risk",
      "personnel",
      "lower"
    ]
  },
  {
    "id": "2a8890e1a2a4db62b3a3688a44286b50",
    "content": "Causes\nAn exposure considered as possible risk is defined as “an exposure from possibly infected blood, tissue or other body fluids through:\nA percutaneous injury (e. g. a needle stick or cut with a sharp\nobject) or\nA mucocutaneous membrane or non-intact (chapped, abraded skin) contact\nThe risk of infection appears to be higher after:\nExposure to a large quantity of blood or to other infectious flu-\nids.",
    "title": "Refer all HIV positive patients to an accredited treatment centre in Ghana.",
    "section": "Refer all HIV positive patients to an accredited treatment centre in Ghana.",
    "chunk_id": "1834",
    "type": "section",
    "keywords": [
      "stick",
      "infected",
      "mucocutaneous",
      "abraded",
      "intact",
      "body",
      "appears",
      "large",
      "fluids",
      "blood",
      "causes",
      "quantity",
      "membrane",
      "exposure",
      "possibly",
      "sharp",
      "skin",
      "infectious",
      "object",
      "higher"
    ]
  },
  {
    "id": "caad1e1bba820cf72d57bc2dae4c4220",
    "content": "stage\nA deep percutaneous injury or an injury with a hollow bore, blood filled needle. Signs\nNone\nSymptoms\nNone\ninvestigations\nFull blood count\nLiver and renal function tests\nHepatitis B Surface Antigen\nHIV serology or PCR if available.",
    "title": "Chapter 17: HIV Infectıons and AIDS",
    "section": "Chapter 17: HIV Infectıons and AIDS",
    "chunk_id": "1835",
    "type": "section",
    "keywords": [
      "full",
      "bore",
      "count",
      "function",
      "surface",
      "stage",
      "signs",
      "renal",
      "hollow",
      "injury",
      "blood",
      "deep",
      "filled",
      "tests",
      "available",
      "investigations",
      "hepatitis",
      "symptoms",
      "serology",
      "needle"
    ]
  },
  {
    "id": "52448bfa50e70ced3587488337574de0",
    "content": "Counselling and Testing:\nExposed health workers must receive counselling and testing immediately from a trained counsellor. The session is to continue throughout the PEP period and thereafter if necessary. Refusal of HIV test by any exposed worker should be documented\nCounsellor must emphasize safe sex including condom use.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1836",
    "type": "section",
    "keywords": [
      "continue",
      "test",
      "safe",
      "refusal",
      "health",
      "condom",
      "immediately",
      "including",
      "counselling",
      "exposed",
      "workers",
      "testing",
      "should",
      "period",
      "receive",
      "worker",
      "emphasize",
      "documented",
      "counsellor",
      "thereafter"
    ]
  },
  {
    "id": "d81014f9f9659ebc1be57521943f90df",
    "content": "All known source-patients shall also be counselled and tested.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1837",
    "type": "section",
    "keywords": [
      "counselled",
      "shall",
      "known",
      "also",
      "source",
      "patients",
      "tested"
    ]
  },
  {
    "id": "d915302bb1896b29de033898a4459bdf",
    "content": "Evidence Rating: [A]\nVery Low Risk\nWash exposed area immediately with soap and water\nLow Risk\nTenofovir 300 mg daily for 28 days\nAnd\nEmtricitabine 200 mg daily for 28 days\nOr\nZidovudine 300 mg 12 hourly for 28 days\nAnd\nLamivudine 150 mg 12 hourly for 28 days\nHigh Risk\nTenofovir 300 mg daily for 28 days\nAnd\nEmtricitabine 200 mg daily for 28 days\nAnd\nLopinavir/r 400 mg/100 mg 12 hourly for 28 days\nOr\nZidovudine 300 mg 12 hourly for 28 days\nAnd\nLamivudine 150 mg 12 hourly for 28 days\nAnd\nLopinavir/r 400 mg/100 mg 12 hourly for 28 days\nFollow up\nDuring the period of prophylaxis a number of baseline and follow- up investigations need to be done to determine HIV sero-status, and to monitor the level of drug toxicity.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1838",
    "type": "section",
    "keywords": [
      "tenofovir",
      "determine",
      "lamivudine",
      "during",
      "zidovudine",
      "evidence",
      "hourly",
      "rating",
      "immediately",
      "follow",
      "emtricitabine",
      "drug",
      "need",
      "water",
      "baseline",
      "exposed",
      "toxicity",
      "lopinavir",
      "soap",
      "number"
    ]
  },
  {
    "id": "ec8eb2433054eebd98d22e9aef5a0fd3",
    "content": "Fever is a common complaint, which is usually related to an infection of viral, bacterial or parasitic origin. It may be a valuable guide to the diagnosis and severity of infections. Fever is defined as an axillary temperature above 37.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1839",
    "type": "section",
    "keywords": [
      "infections",
      "usually",
      "guide",
      "which",
      "origin",
      "above",
      "parasitic",
      "diagnosis",
      "valuable",
      "fever",
      "bacterial",
      "related",
      "complaint",
      "viral",
      "axillary",
      "severity",
      "infection",
      "common",
      "temperature",
      "defined"
    ]
  },
  {
    "id": "45eb172f7f7e69bfe0ce1bdc6a786704",
    "content": "5 °C (read after keeping the thermometer in place for 3 minutes). Fever above 38 °C in children and adults often needs urgent attention, especially if the patient is restless or delirious. Not every fever is due to malaria or typhoid.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1840",
    "type": "section",
    "keywords": [
      "read",
      "delirious",
      "often",
      "especially",
      "patient",
      "typhoid",
      "minutes",
      "attention",
      "place",
      "children",
      "malaria",
      "thermometer",
      "above",
      "fever",
      "adults",
      "urgent",
      "every",
      "restless",
      "keeping",
      "after"
    ]
  },
  {
    "id": "26a768083837976d06faeefa12a6f594",
    "content": "Every fever should be investigated and treated appropriately. A thorough history, physical examination and appropriate investigation would usually reveal the cause of the fever. In neonates and the elderly, severe infections may not be accompanied by a fever.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1841",
    "type": "section",
    "keywords": [
      "infections",
      "usually",
      "neonates",
      "elderly",
      "appropriately",
      "treated",
      "investigated",
      "severe",
      "reveal",
      "should",
      "fever",
      "cause",
      "thorough",
      "accompanied",
      "every",
      "appropriate",
      "physical",
      "investigation",
      "history",
      "would"
    ]
  },
  {
    "id": "8b42f13422592d85869ff14043d18fd6",
    "content": "In infants and young children, fever may be associated with convulsions, collapse or coma. (See table below for possible differential diagnoses and appropriate action)\nCauses\nViral infection\nBacterial infection\nFungal infections\nParasitic infestations\nHaematological malignancies e. g.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1842",
    "type": "section",
    "keywords": [
      "infections",
      "collapse",
      "associated",
      "table",
      "fungal",
      "infestations",
      "convulsions",
      "children",
      "causes",
      "haematological",
      "malignancies",
      "parasitic",
      "coma",
      "fever",
      "infants",
      "diagnoses",
      "bacterial",
      "young",
      "viral",
      "differential"
    ]
  },
  {
    "id": "77c2a0e6a0b6c86f38cda46fa8d312cf",
    "content": "Medicine-related\nSymptoms\nChills, rigors\nBody aches\nSigns\nTemperature > 37. 5 oC\nEvidence of dehydration e. g.",
    "title": "Connective tissue disease",
    "section": "Connective tissue disease",
    "chunk_id": "1843",
    "type": "section",
    "keywords": [
      "evidence",
      "medicine",
      "body",
      "dehydration",
      "rigors",
      "chills",
      "signs",
      "temperature",
      "aches",
      "related",
      "symptoms"
    ]
  },
  {
    "id": "0221ff28dbdb040c39115c47e0d60be5",
    "content": "sunken eyes\nEvidence of underlying conditions (refer guidelines below)\nTachypnoea\nTachycardia\ninvestigations\nFBC\nBlood film for malaria parasites\nRapid diagnostic test for malaria\nCultures of urine, blood, sputum, ear discharge, throat swab, wound swab, cerebrospinal fluid depending on presentation.",
    "title": "Connective tissue disease",
    "section": "Connective tissue disease",
    "chunk_id": "1844",
    "type": "section",
    "keywords": [
      "test",
      "wound",
      "diagnostic",
      "urine",
      "tachycardia",
      "tachypnoea",
      "evidence",
      "fluid",
      "sputum",
      "swab",
      "film",
      "presentation",
      "cerebrospinal",
      "underlying",
      "malaria",
      "blood",
      "cultures",
      "rapid",
      "investigations",
      "eyes"
    ]
  },
  {
    "id": "912e9641393191cfeb94ba88c3d42de0",
    "content": "To reduce body temperature to normal\nTo relieve symptoms\nTo identify and treat the underlying cause of the fever (see guidelines below).",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1845",
    "type": "section",
    "keywords": [
      "body",
      "below",
      "treat",
      "reduce",
      "fever",
      "cause",
      "relieve",
      "underlying",
      "identify",
      "normal",
      "temperature",
      "symptoms",
      "guidelines"
    ]
  },
  {
    "id": "cda98543c8add749e11a379e158f6734",
    "content": "Keep the patient well hydrated with fluids e. g. water, fruit juices, light porridge, “rice-water” or coconut milk\nMaintain nutrition, continue breast-feeding in babies\nTepid sponge the child.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1846",
    "type": "section",
    "keywords": [
      "continue",
      "rice",
      "coconut",
      "child",
      "hydrated",
      "feeding",
      "light",
      "sponge",
      "patient",
      "juices",
      "fruit",
      "breast",
      "babies",
      "porridge",
      "nutrition",
      "water",
      "fluids",
      "tepid",
      "keep",
      "maintain"
    ]
  },
  {
    "id": "9a87b802ff9f8dbc23e3043fde11a36e",
    "content": "(Wet a towel with lukewarm water and apply to the body starting from the extremities and gradually work your way upwards to the head. Leave a film of water on the body to dry on the skin. Repeat the process as often as needed).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1847",
    "type": "section",
    "keywords": [
      "extremities",
      "work",
      "often",
      "lukewarm",
      "starting",
      "body",
      "your",
      "process",
      "film",
      "repeat",
      "water",
      "head",
      "leave",
      "upwards",
      "skin",
      "towel",
      "needed",
      "apply",
      "gradually"
    ]
  },
  {
    "id": "58ef3ebd67a90e11911a4482b83bb05f",
    "content": "Evidence Rating: [A]\nParacetamol, oral,\nAdults\n1 g 6-8 hourly\nChildren\n10-15 mg/kg/dose. May repeat dose 6-8 hourly as necessary\nOr\nParacetamol, rectal suppository,\nAdults\n1 g 6-8 hourly\nChildren\n125-250 mg 6-8 hourly\nOr\nIbuprofen, oral,\nAdults\n200-400 mg 6-8 hourly\nChildren\n7-18 years;\t200 mg 6-8 hourly\nyears;\t100 mg 8 hourly\n6 months-2 years;\t50 mg 8 hourly\nmonths;\t5 mg/kg 6-8 hourly\nTreat the cause of the fever appropriately (See appropriate section)\nReferral Criteria\nFever persisting for more than 10 days in spite of treatment should be considered as pyrexia of unknown origin (PUO) and should be referred for further investigation. Tuberculosis (TB) may affect any part of the body, but the commonest site is the lung (Pulmonary TB).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1848",
    "type": "section",
    "keywords": [
      "years",
      "treat",
      "evidence",
      "ibuprofen",
      "hourly",
      "rating",
      "rectal",
      "unknown",
      "body",
      "part",
      "appropriately",
      "section",
      "origin",
      "repeat",
      "site",
      "children",
      "criteria",
      "treatment",
      "days",
      "spite"
    ]
  },
  {
    "id": "0e68f46891bb0b658121adcafc0a6efc",
    "content": "Other sites affected include the spine, bone and joints, brain, urinary tract, abdomen and lymph nodes etc. Pulmonary TB patients who have acid-fast bacilli (AFB) in their sputum (bacteriologically positive TB) are most infectious and spread the disease through airborne droplets when they cough, spit or sneeze. Drinking unpasteurized milk may cause bovine TB, which manifests as abdominal TB.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1849",
    "type": "section",
    "keywords": [
      "spit",
      "lymph",
      "which",
      "sputum",
      "sneeze",
      "abdominal",
      "manifests",
      "sites",
      "patients",
      "nodes",
      "most",
      "their",
      "include",
      "disease",
      "joints",
      "tract",
      "acid",
      "pulmonary",
      "cause",
      "bacteriologically"
    ]
  },
  {
    "id": "40b4557b535639006485d28d7bae02bd",
    "content": "Persons with lowered resistance to infection, such as HIV/AIDS and diabetes, are especially at risk of developing TB. Such individuals tend not to have the typical symptoms and signs of TB. They may have features such as fever, weight loss and diarrhoea, which could also be attributed to the condition.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1850",
    "type": "section",
    "keywords": [
      "weight",
      "especially",
      "which",
      "features",
      "aids",
      "diarrhoea",
      "developing",
      "signs",
      "condition",
      "persons",
      "fever",
      "also",
      "tend",
      "attributed",
      "symptoms",
      "could",
      "typical",
      "diabetes",
      "infection",
      "individuals"
    ]
  },
  {
    "id": "b2ba8bc9e80436cb840e3910635f4c50",
    "content": "In children with severe malnutrition who show poor response to dietary treatment, TB must be considered and excluded.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1851",
    "type": "section",
    "keywords": [
      "severe",
      "show",
      "malnutrition",
      "considered",
      "must",
      "response",
      "dietary",
      "poor",
      "children",
      "treatment",
      "excluded"
    ]
  },
  {
    "id": "bf425101c1ae8cb616c77695ec690c32",
    "content": "Causes\nMycobacterium tuberculosis\nMycobacterium bovis (bovine TB)\nMycobacterium africanum I and II\nM. microti, M. kansasii and M.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1852",
    "type": "section",
    "keywords": [
      "microti",
      "bovis",
      "bovine",
      "africanum",
      "kansasii",
      "tuberculosis",
      "mycobacterium",
      "causes"
    ]
  },
  {
    "id": "c622ed876d65f700ec075e671334d433",
    "content": "malmoensi (rarer causes)\nSymptoms Adults\nCough often for 2 weeks or more\nChest pain\nLoss of weight\nLoss of appetite\nBlood stained sputum\nFever\nDrenching night sweats\nChildren\nAll adult symptoms and the following\nMalnourished and chronically ill looking (cachexia)\nPersistent low grade fever (lasting ≥ 2-3 weeks)\nFailure to thrive\nFatigue, malaise, poor appetite\nBack pain and/or lower limb weakness\nIrritability\nVomiting and impaired consciousness (due to TB meningitis)\nSigns\nSigns of malnutrition\nCachexia\nPallor\nSigns of pneumonia or pleural effusion\nLymphadenopathy\nNeck stiffness, altered level of consciousness in TB meningitis.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1853",
    "type": "section",
    "keywords": [
      "malnutrition",
      "weight",
      "often",
      "fatigue",
      "stained",
      "poor",
      "thrive",
      "weakness",
      "night",
      "impaired",
      "neck",
      "sputum",
      "stiffness",
      "chest",
      "cachexia",
      "following",
      "lasting",
      "altered",
      "signs",
      "weeks"
    ]
  },
  {
    "id": "b37b377aa8a41a6de430c2322031c202",
    "content": "investigations\nSputum smear microscopy\nChest X-ray\nMantoux test\nGene Xpert (Xpert MTB/Rif)\nLine Probe Assay\nMycobacterial culture\nFull blood count\nESR\nLiver function test (for monitoring medication side effects)\nHIV screening.",
    "title": "Signs of extrapulmonary disease",
    "section": "Signs of extrapulmonary disease",
    "chunk_id": "1854",
    "type": "section",
    "keywords": [
      "test",
      "monitoring",
      "probe",
      "full",
      "mycobacterial",
      "sputum",
      "microscopy",
      "chest",
      "count",
      "function",
      "mantoux",
      "screening",
      "culture",
      "smear",
      "blood",
      "side",
      "line",
      "medication",
      "gene",
      "investigations"
    ]
  },
  {
    "id": "9273df7a4c73d57e79125c0d83c2c12c",
    "content": "To prevent further transmission\nTo prevent the development of drug resistance\nTo manage drug side effects\nTo offer psychosocial support\nTo investigate close contacts. Where a child is affected, always check adult contacts with productive cough.",
    "title": "To cure the disease",
    "section": "To cure the disease",
    "chunk_id": "1855",
    "type": "section",
    "keywords": [
      "development",
      "offer",
      "check",
      "child",
      "close",
      "always",
      "support",
      "prevent",
      "drug",
      "productive",
      "where",
      "investigate",
      "contacts",
      "side",
      "manage",
      "adult",
      "further",
      "resistance",
      "effects",
      "psychosocial"
    ]
  },
  {
    "id": "bd708195d9a960112978531afc78332f",
    "content": "Counselling\nEncourage good nutrition (some food supplementation is provided by National TB Programme)\nEncourage adequate rest\nAdmit severely ill patients.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1856",
    "type": "section",
    "keywords": [
      "severely",
      "nutrition",
      "admit",
      "supplementation",
      "food",
      "counselling",
      "programme",
      "rest",
      "patients",
      "provided",
      "encourage",
      "adequate",
      "national"
    ]
  },
  {
    "id": "732288d268255ff60bf2f0adf8f3ff26",
    "content": "Isoniazid (H), Rifampicin (R), Pyrazinamide (Z), Ethambutol (E), Streptomycin (S).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1857",
    "type": "section",
    "keywords": [
      "pyrazinamide",
      "isoniazid",
      "streptomycin",
      "ethambutol",
      "rifampicin"
    ]
  },
  {
    "id": "10d2a88720357fde0ddd74dc14dea827",
    "content": "Pyridoxine (Vitamin B6), oral,\nAdults\n50-100 mg daily for 3- 8 months\nChildren\n25-50 mg daily for 8 months\nAnd\nPrednisolone, oral, (in cases of TB meningitis and TB pericarditis)\nAdults\n40-60 mg daily, 2-4 weeks then taper off on improvement over 2-4 weeks and discontinue\nChildren\n1-2 mg/kg daily, 2-4 weeks then taper off on improvement over 2-4 weeks and discontinue.",
    "title": "Adjunctive treatment",
    "section": "Adjunctive treatment",
    "chunk_id": "1858",
    "type": "section",
    "keywords": [
      "meningitis",
      "taper",
      "then",
      "prednisolone",
      "pyridoxine",
      "discontinue",
      "pericarditis",
      "adults",
      "oral",
      "cases",
      "children",
      "months",
      "weeks",
      "vitamin",
      "daily",
      "improvement"
    ]
  },
  {
    "id": "18e9ff80ca822a0bc7e477477c50babd",
    "content": "New cases (Adults and children)\nOwing to a high risk of uveitis, give the following\nIntensive phase\t- HRZ for 2 months\nContinuation phase\t- HR for 4 months\nPregnancy and breastfeeding.",
    "title": "Chronic kidney disease",
    "section": "Chronic kidney disease",
    "chunk_id": "1859",
    "type": "section",
    "keywords": [
      "uveitis",
      "intensive",
      "following",
      "owing",
      "give",
      "adults",
      "continuation",
      "cases",
      "high",
      "breastfeeding",
      "phase",
      "risk",
      "pregnancy",
      "children",
      "months"
    ]
  },
  {
    "id": "4d28bb5e7286f2a5a519eccd839e1136",
    "content": "Drug resistant tuberculosis (DR-TB) must be presumed (suspected) in persons who remain bacteriologically positive (either smear positive, culture positive or Gene Xpert positive) after intensive phase of standard first-line TB treatment with or without clinical improvement. Persons who test rifampicin resistance positive at initial diagnosis with Gene Xpert must also be treated as cases of DR-TB. These persons must be further evaluated using TB culture and Drug Susceptibility Testing (DST) or newer molecular diagnostic tests such as Line Probe Assays (LPA).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1860",
    "type": "section",
    "keywords": [
      "initial",
      "either",
      "test",
      "probe",
      "resistant",
      "molecular",
      "diagnostic",
      "newer",
      "treated",
      "drug",
      "culture",
      "evaluated",
      "smear",
      "treatment",
      "intensive",
      "first",
      "diagnosis",
      "suspected",
      "standard",
      "persons"
    ]
  },
  {
    "id": "2b7dd02c8cd2e5ff94c6fbd84bbee17d",
    "content": "Persons at high risk of drug resistance are TB patients failing Category I+III or Category II treatment, contacts of confirmed DR-TB patients and TB/HIV co-infected patients not improving on treatment. Persons at medium risk of drug resistance are relapsed TB patients, return after lost-to-follow up and health care workers newly diagnosed with TB. Patients are classified according to the pattern of documented drug resistance profile.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1861",
    "type": "section",
    "keywords": [
      "newly",
      "according",
      "profile",
      "medium",
      "infected",
      "health",
      "relapsed",
      "follow",
      "failing",
      "drug",
      "contacts",
      "patients",
      "workers",
      "treatment",
      "persons",
      "return",
      "category",
      "pattern",
      "documented",
      "confirmed"
    ]
  },
  {
    "id": "316826ab09de37face69a67765b7ba76",
    "content": "principles:\nHistory of drugs used to treat TB patients, profile of drug resistance in Ghana and/or DST profile of the patient\nA minimum of four new core medicines that are known to be effective\nKanamycin/Capreomycin an injectable medicine, is the backbone of the four core medicines and should be used in the intensive phase\nAn effective fluoroquinolone should be used due to the extensive\nuse of earlier generation fluoroquinolones\nMay include a first line drug to which the strain is susceptible. Cross-resistance may occur between drugs of the same group and this is taken into consideration. Drugs are administered daily under strict DOT throughout the\ninjectable and continuation phases.",
    "title": "The drug regimen for treatment is selected based on the following",
    "section": "The drug regimen for treatment is selected based on the following",
    "chunk_id": "1862",
    "type": "section",
    "keywords": [
      "medicine",
      "treat",
      "strain",
      "occur",
      "consideration",
      "earlier",
      "profile",
      "continuation",
      "fluoroquinolones",
      "which",
      "patient",
      "strict",
      "four",
      "injectable",
      "kanamycin",
      "into",
      "under",
      "known",
      "extensive",
      "drug"
    ]
  },
  {
    "id": "b91a8a4fb45da13a6c76a65415e66b80",
    "content": "Treatment of Multi Drug Resistant-TB (MDR-TB) and Rifampicin Resistant-TB (RR-TB) patients is prioritised. Treatment duration is 20-24.",
    "title": "The drug regimen for treatment is selected based on the following",
    "section": "The drug regimen for treatment is selected based on the following",
    "chunk_id": "1863",
    "type": "section",
    "keywords": [
      "drug",
      "duration",
      "multi",
      "resistant",
      "patients",
      "rifampicin",
      "treatment",
      "prioritised"
    ]
  },
  {
    "id": "1e116626aedf7f96c3f377450bb5c3db",
    "content": "months and is determined by sputum smear and culture (bacteriological) conversion (Treatment lasts 16-18 months after bacteriological conversion). Progression from initial to continuation phase is dependent on at least four (4) consecutive months of negative sputum cultures. Community-based care is promoted in Ghana over facility-based care except in situations requiring admission for management of complications.",
    "title": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "section": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "chunk_id": "1864",
    "type": "section",
    "keywords": [
      "initial",
      "based",
      "situations",
      "management",
      "continuation",
      "lasts",
      "four",
      "sputum",
      "determined",
      "facility",
      "consecutive",
      "requiring",
      "except",
      "culture",
      "admission",
      "smear",
      "treatment",
      "cultures",
      "dependent",
      "phase"
    ]
  },
  {
    "id": "1b3cf16dd419c9cb90a5922323414a43",
    "content": "The practice of infection prevention and control should be maintained at all times during treatment of these patients. Treatment adherence is critical in the treatment of DR-TB due to limited number of available, effective medicines. Treatment is challenging due to long duration, drug toxicities and side effects.",
    "title": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "section": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "chunk_id": "1865",
    "type": "section",
    "keywords": [
      "limited",
      "during",
      "toxicities",
      "times",
      "drug",
      "patients",
      "maintained",
      "treatment",
      "number",
      "side",
      "prevention",
      "should",
      "adherence",
      "duration",
      "critical",
      "medicines",
      "available",
      "challenging",
      "effective",
      "effects"
    ]
  },
  {
    "id": "65b54f36057a80cc8c198374c6ed6553",
    "content": "Clinical teams must use a patient-centred care approach and support patients throughout treatment until cured. Psychosocial and economic support is required from treatment supporters, patient families and clinical teams throughout treatment. Early detection and prompt management of drug side effects ensures successful outcomes.",
    "title": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "section": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "chunk_id": "1866",
    "type": "section",
    "keywords": [
      "teams",
      "management",
      "outcomes",
      "required",
      "patient",
      "support",
      "cured",
      "drug",
      "successful",
      "patients",
      "treatment",
      "side",
      "prompt",
      "detection",
      "economic",
      "ensures",
      "supporters",
      "approach",
      "effects",
      "psychosocial"
    ]
  },
  {
    "id": "f68b34a3b570caa9e2325689bd4fa488",
    "content": "Multi Drug Resistant-TB (MDR-TB)\n# For every 250mg of Cycloserine give 50mg of Pyridoxine (Vitamin B6) to prevent Peripheral Neuropathy. Dose of Pyridoxine should be doubled in HIV patients. * PAS is an alternative to Cs.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "1867",
    "type": "section",
    "keywords": [
      "cycloserine",
      "pyridoxine",
      "give",
      "prevent",
      "neuropathy",
      "peripheral",
      "should",
      "drug",
      "alternative",
      "multi",
      "resistant",
      "dose",
      "patients",
      "doubled",
      "vitamin",
      "every"
    ]
  },
  {
    "id": "0dcb3e16fea34dd81c37e02ef6bb692d",
    "content": "Referral Criteria\nRefer all patients to a DOTS treatment centre for management and monitoring under Ghana National Tuberculosis Programme. Typhoid fever (enteric fever) is a severe bacterial illness, which occurs where sanitary conditions are poor permitting contamination of food or water with faeces. The bacteria which are spread by the faeco-oral route invade the intestinal wall and spread through the bloodstream to all organs.",
    "title": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "section": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "chunk_id": "1868",
    "type": "section",
    "keywords": [
      "monitoring",
      "bacteria",
      "faeces",
      "management",
      "which",
      "programme",
      "poor",
      "faeco",
      "under",
      "national",
      "typhoid",
      "where",
      "water",
      "intestinal",
      "patients",
      "dots",
      "criteria",
      "treatment",
      "severe",
      "referral"
    ]
  },
  {
    "id": "41e014ebda81fb85d46497d71e08032e",
    "content": "They are passed into the stool and urine of infected patients. Organisms may continue to be present in the stool of healthy carriers, i. e.",
    "title": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "section": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "chunk_id": "1869",
    "type": "section",
    "keywords": [
      "continue",
      "healthy",
      "present",
      "infected",
      "urine",
      "passed",
      "patients",
      "organisms",
      "stool",
      "carriers",
      "into"
    ]
  },
  {
    "id": "c0d5ae896db2fed235560d88cc5e656a",
    "content": "patients with positive stool cultures, 12 months after treatment or those with long-term subclinical disease. If improperly treated typhoid fever may result in complications such as intestinal perforation with peritonitis, bloody stools, acute psychosis and severe intravascular haemolysis leading to acute kidney injury (especially in G6PD deficiency). Public education on good personal hygiene, hand washing and appropriate disposal of solid waste would often prevent the disease.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1870",
    "type": "section",
    "keywords": [
      "subclinical",
      "peritonitis",
      "intravascular",
      "often",
      "especially",
      "personal",
      "acute",
      "typhoid",
      "prevent",
      "treated",
      "result",
      "psychosis",
      "stools",
      "intestinal",
      "public",
      "patients",
      "solid",
      "treatment",
      "bloody",
      "cultures"
    ]
  },
  {
    "id": "1c597cac5be0e0c7e3257519250be526",
    "content": "Screening of food handlers by carrying out stool cultures to exclude carrier status and safe handling of food, fruits and vegetables are also helpful preventive measures. Causes\nSalmonella typhi and paratyphi\nSymptoms\nFever which increases gradually to a high fever and persists for weeks (fever does not respond to antimalarials)\nConstipation in the early stages\nAbdominal pain and diarrhoea in the second week of illness\nSevere headache\nDry cough\nPsychosis and confusion may occur\nSigns\nHigh fever with a relatively slow pulse rate (occasionally pulse is fast especially with myocarditis or intestinal perforation)\nAbdominal tenderness\nHepato-splenomegaly (tender)\nConfusion\nSigns of chest infection (pneumonitis)\ninvestigations\nFBC, differential,\nRDT / blood film for malaria parasite (to exclude malaria)\nBlood culture\nStool culture\nUrine culture.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1871",
    "type": "section",
    "keywords": [
      "safe",
      "occur",
      "increases",
      "especially",
      "salmonella",
      "headache",
      "which",
      "urine",
      "pneumonitis",
      "second",
      "measures",
      "diarrhoea",
      "abdominal",
      "handlers",
      "rate",
      "helpful",
      "chest",
      "paratyphi",
      "week",
      "psychosis"
    ]
  },
  {
    "id": "995dc0f9a4698689222ec0bfdeabf8de",
    "content": "To eradicate the infection\nTo detect and manage complications\nTo prevent transmission of infection to other people.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1872",
    "type": "section",
    "keywords": [
      "complications",
      "prevent",
      "manage",
      "infection",
      "transmission",
      "other",
      "eradicate",
      "detect",
      "people"
    ]
  },
  {
    "id": "043788d1a84e799dab8f703be4660675",
    "content": "Tepid sponging to reduce body temperature if required.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1873",
    "type": "section",
    "keywords": [
      "body",
      "tepid",
      "reduce",
      "required",
      "temperature",
      "sponging"
    ]
  },
  {
    "id": "30e2b43d710d760162cb2982e24b8d9b",
    "content": "Evidence Rating: [B]\nCiprofloxacin, oral,\nAdults\n500 mg 12 hourly for 10-14 days\nChildren\n10 mg/kg 12 hourly for 10-14 days\nOr\nCiprofloxacin, IV, (to be administered over 60 minutes)\nAdults\n400 mg 8-12 hourly for 10-14 days\nChildren\n10 mg/kg (max. 400 mg) 12 hourly for 10-14 days.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1874",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "rating",
      "minutes",
      "adults",
      "oral",
      "administered",
      "children",
      "evidence",
      "ciprofloxacin"
    ]
  },
  {
    "id": "3105749b47066daf5389d02831c2cc23",
    "content": "Ceftriaxone, IV,\nAdults\n2-4 g daily for 7-10 days\nChildren\n100 mg/kg daily for 7-10 days\nOr\nAzithromycin, oral,\nAdults\n500 mg daily for 7 days\nChildren\n10-20 mg/kg for 7 days\nReferral Criteria\nRefer very ill patients and those with complications such as intestinal perforation, intravascular haemolysis and peritonitis to the appropriate specialist. Healthy carriers should also be referred for specialist management.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "1875",
    "type": "section",
    "keywords": [
      "peritonitis",
      "intravascular",
      "management",
      "specialist",
      "intestinal",
      "patients",
      "children",
      "criteria",
      "days",
      "referral",
      "healthy",
      "haemolysis",
      "should",
      "adults",
      "also",
      "azithromycin",
      "those",
      "referred",
      "perforation",
      "complications"
    ]
  },
  {
    "id": "b03a24fe81e0e8b6c20b3ea878960e75",
    "content": "Malaria is a very common infection in Ghana. It follows the introduction of protozoan malaria parasites into the bloodstream by the bite of an infected female Anopheles mosquito. Malaria is a major cause of significant morbidity and mortality especially among vulnerable individuals, such as children under 5 years of age, pregnant women (sometimes with adverse foetal and maternal outcomes), patients with sickle cell disease and visiting non-resident Ghanaians and expatriates.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1876",
    "type": "section",
    "keywords": [
      "protozoan",
      "years",
      "morbidity",
      "resident",
      "especially",
      "infected",
      "outcomes",
      "sometimes",
      "into",
      "under",
      "expatriates",
      "female",
      "among",
      "mosquito",
      "foetal",
      "patients",
      "children",
      "malaria",
      "disease",
      "maternal"
    ]
  },
  {
    "id": "48e49c80a4dc16f73a643b1f8144a769",
    "content": "Based on the clinical severity, cases of malaria are categorized as either ‘uncomplicated’ or ‘severe’. A diagnosis of malaria can be suspected based on the patient’s symptoms and the physical findings at examination. However, for a definitive diagnosis to be made laboratory tests (blood film and/or Rapid Diagnostic Test) must demonstrate the malaria parasites or their components since the clinical presentation of the condition can be similar to other common diseases such as typhoid fever, urinary tract infection, septicaemia, pneumonia and meningitis in both adults and children and measles, otitis media, tonsillitis, etc.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1877",
    "type": "section",
    "keywords": [
      "either",
      "test",
      "based",
      "both",
      "septicaemia",
      "otitis",
      "diagnostic",
      "definitive",
      "patient",
      "diseases",
      "typhoid",
      "categorized",
      "film",
      "presentation",
      "condition",
      "demonstrate",
      "their",
      "malaria",
      "children",
      "blood"
    ]
  },
  {
    "id": "b06fd1c82a095289bdff559655bb3476",
    "content": "in children. In Ghana, diagnosis is progressively being shifted from clinical to laboratory confirmation as the basis for treatment. Rapid Diagnostic Test (RDT) may be used to confirm a diagnosis if microscopy (blood film) is not available.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1878",
    "type": "section",
    "keywords": [
      "test",
      "confirmation",
      "diagnostic",
      "basis",
      "microscopy",
      "film",
      "progressively",
      "being",
      "children",
      "blood",
      "treatment",
      "shifted",
      "rapid",
      "diagnosis",
      "available",
      "laboratory",
      "ghana",
      "confirm",
      "used",
      "clinical"
    ]
  },
  {
    "id": "f6a1d39ecfd52c93aebf9d748f68c358",
    "content": "Preventive measures in the community mainly target elimination of the insect vector or prevention of mosquito bites while additional chemoprophylaxis is required for vulnerable individuals. The development of resistance of malaria parasites to anti-malarial medications is a matter of major public health concern. This phenomenon is largely the result of ‘over-diagnosis’ and wrong diagnosis of malaria by healthcare practitioners and patients alike, with its attendant over- treatment and sometimes partial or incomplete treatment, leading to over-exposure of the parasites to the anti-malarial drug (drug pressure).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1879",
    "type": "section",
    "keywords": [
      "alike",
      "incomplete",
      "development",
      "chemoprophylaxis",
      "health",
      "required",
      "attendant",
      "wrong",
      "sometimes",
      "while",
      "measures",
      "partial",
      "pressure",
      "result",
      "vector",
      "drug",
      "practitioners",
      "preventive",
      "public",
      "mosquito"
    ]
  },
  {
    "id": "119b3455d5ef60d2ee094d4309f406c5",
    "content": "Additionally, Artemisinin Combination Therapy (ACT), rather than monotherapy with artemisinin derivatives, is currently recommended for the treatment of uncomplicated malaria to prevent the development of drug resistance. It is therefore necessary to obtain laboratory confirmation of a diagnosis of malaria before starting treatment. Exceptions to this principle are children under 5 years and cases of suspected severe malaria where laboratory confirmation is not immediately possible.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1880",
    "type": "section",
    "keywords": [
      "years",
      "rather",
      "development",
      "confirmation",
      "therapy",
      "derivatives",
      "starting",
      "monotherapy",
      "under",
      "therefore",
      "immediately",
      "prevent",
      "drug",
      "where",
      "combination",
      "currently",
      "exceptions",
      "children",
      "malaria",
      "treatment"
    ]
  },
  {
    "id": "607e3db5b5e6907c581b28c815e2119a",
    "content": "In such circumstances, a complete course of the appropriate anti-malarial medication(s) must be given. Causes\nPlasmodium falciparum (commonest and responsible for most of the deaths and morbidity associated with malaria in Ghana).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1881",
    "type": "section",
    "keywords": [
      "morbidity",
      "given",
      "falciparum",
      "associated",
      "complete",
      "responsible",
      "most",
      "malaria",
      "causes",
      "plasmodium",
      "course",
      "medication",
      "anti",
      "deaths",
      "appropriate",
      "commonest",
      "circumstances",
      "must",
      "ghana",
      "malarial"
    ]
  },
  {
    "id": "483c24f1167d6436aa1477dd504a0d05",
    "content": "Plasmodium malariae\nPlasmodium ovale\nSymptoms\nFever\nChills\nRigors\nSweating\nHeadache\nGeneralized body and joint pain\nNausea and/or vomiting\nLoss of appetite\nAbdominal pain (especially in children)\nIrritability and refusal to feed (in infants)\nSigns\nFever\nMild pallor\nMild jaundice\nSplenomegaly\ninvestigations\nMicroscopy - thick and thin blood films for malaria parasites\nRapid Diagnostic Test (RDT)\nFBC\nOther tests as indicated.",
    "title": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "section": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "chunk_id": "1882",
    "type": "section",
    "keywords": [
      "thick",
      "nausea",
      "malariae",
      "rigors",
      "test",
      "chills",
      "especially",
      "headache",
      "refusal",
      "diagnostic",
      "thin",
      "body",
      "abdominal",
      "microscopy",
      "films",
      "jaundice",
      "joint",
      "splenomegaly",
      "signs",
      "ovale"
    ]
  },
  {
    "id": "8700d5db1ae3b5ded36e77cb8c04f6f6",
    "content": "To avoid progression to severe malaria\nTo limit the duration of the illness\nTo minimize the development of drug resistant parasites.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1883",
    "type": "section",
    "keywords": [
      "severe",
      "avoid",
      "progression",
      "development",
      "duration",
      "drug",
      "resistant",
      "illness",
      "parasites",
      "limit",
      "malaria",
      "minimize"
    ]
  },
  {
    "id": "b3ab2c4f9b7dfefc910b1950cbbe923b",
    "content": "In children, tepid sponging to reduce body temperature.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1884",
    "type": "section",
    "keywords": [
      "body",
      "tepid",
      "reduce",
      "temperature",
      "children",
      "sponging"
    ]
  },
  {
    "id": "7e34d150e5e47ab0048a1c541876d8b1",
    "content": "Artesunate + Amodiaquine, oral, (See Table 18-5 on page 484, Table\n18-6 on page 484, Table 18-7 on page 484 )\nOr\nArtemether + Lumefantrine, oral, (See Table 18-8 on page 485)\nOr\nDihydroartemisinin + Piperaquine, oral, (See Table 18-9 on page 485).",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1885",
    "type": "section",
    "keywords": [
      "artemether",
      "dihydroartemisinin",
      "artesunate",
      "oral",
      "piperaquine",
      "table",
      "page",
      "lumefantrine",
      "amodiaquine"
    ]
  },
  {
    "id": "8cc70e17be72d0e78d1593a54af7164f",
    "content": "The dose in mg/body weight is: Amodiaquine 10 mg/kg + Artesunate 4 mg/ kg, taken as a single dose daily for three (3) days, after meals. The dose in mg/body weight is: Amodiaquine 10 mg/kg + Artesunate 4 mg/kg, taken as two divided doses daily for three (3) days, after meals.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1886",
    "type": "section",
    "keywords": [
      "days",
      "body",
      "taken",
      "weight",
      "single",
      "doses",
      "artesunate",
      "dose",
      "three",
      "after",
      "meals",
      "divided",
      "daily",
      "amodiaquine"
    ]
  },
  {
    "id": "b8752fd2d44e06780a6ea161e25b52c9",
    "content": "Each Fixed Dose Combination tablet contains both Artesunate (AS) and Amodiaquine (AQ), at the dosages indicated. The product packaging clearly indicates which dosing strength applies to which age group. The maximum daily dose of Artesunate/Amodiaquine is 200 mg/600 mg.",
    "title": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "section": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "chunk_id": "1887",
    "type": "section",
    "keywords": [
      "applies",
      "both",
      "which",
      "contains",
      "clearly",
      "indicates",
      "amodiaquine",
      "dosing",
      "combination",
      "each",
      "dose",
      "tablet",
      "fixed",
      "product",
      "artesunate",
      "indicated",
      "maximum",
      "packaging",
      "strength",
      "group"
    ]
  },
  {
    "id": "b214f8a68244309bffcdceeee1adc132",
    "content": "Severe or ‘complicated malaria’ can arise from delay in diagnosis or inappropriate treatment of uncomplicated malaria. It mostly occurs in children under 5 years of age, pregnant women and non-immune individuals. The events causing most deaths in severe malaria are related to cerebral involvement (cerebral malaria), severe anaemia, hypoglycaemia, severe dehydration, renal failure and respiratory acidosis.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1888",
    "type": "section",
    "keywords": [
      "years",
      "anaemia",
      "acidosis",
      "arise",
      "inappropriate",
      "delay",
      "mostly",
      "under",
      "involvement",
      "most",
      "children",
      "malaria",
      "causing",
      "renal",
      "treatment",
      "severe",
      "dehydration",
      "complicated",
      "events",
      "diagnosis"
    ]
  },
  {
    "id": "9d9f163b8eced470c8802ace03e597d0",
    "content": "The diagnosis of severe malaria is based on clinical features and confirmed with laboratory testing. Not all cases of severe malaria have high parasitaemia and initial blood film examination may be negative. Where the diagnosis is suspected, treatment must be started without delay while awaiting confirmation.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1889",
    "type": "section",
    "keywords": [
      "initial",
      "based",
      "confirmation",
      "features",
      "delay",
      "parasitaemia",
      "awaiting",
      "while",
      "film",
      "where",
      "malaria",
      "blood",
      "treatment",
      "severe",
      "diagnosis",
      "suspected",
      "testing",
      "laboratory",
      "confirmed",
      "started"
    ]
  },
  {
    "id": "d430dcfd92b384327343a6f432d31cd9",
    "content": "Symptoms\nPoor oral intake (e. g. breast milk in children)\nRepeated profuse vomiting\nDark or ‘cola-coloured’ urine\nPassing of very little urine\nDifficulty in breathing\nGeneralised weakness, inability to walk or sit without assistance\nAltered consciousness (change of behaviour, confusion, delirium, coma)\nRepeated generalized convulsions\nSigns\nHyperpyrexia (axillary temperature > 38.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1890",
    "type": "section",
    "keywords": [
      "little",
      "breathing",
      "urine",
      "passing",
      "poor",
      "repeated",
      "weakness",
      "breast",
      "altered",
      "convulsions",
      "signs",
      "behaviour",
      "intake",
      "children",
      "delirium",
      "generalised",
      "generalized",
      "coloured",
      "coma",
      "difficulty"
    ]
  },
  {
    "id": "384f73aa48931d5981b14fae01354632",
    "content": "5°C)\nExtreme pallor (severe anaemia; Hb < 5 g/dl)\nMarked jaundice\nCirculatory collapse or shock (cold limbs, weak rapid pulse)\nTachypnoea (Rapid breathing)\nCrepitations on chest examination\nSweating (due to hypoglycaemia)\nHaemoglobinuria (dark or ‘cola-coloured’ urine)\nOliguria\nSpontaneous\tunexplained\theavy\tbleeding\t(disseminated intravascular coagulation)\nAltered consciousness (change of behaviour, confusion, delirium,\ncoma)\ninvestigations\nRapid diagnostic test\nBlood film for malaria parasites - thick and thin blood films (should be done where available)\nFBC\nSickling test.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1891",
    "type": "section",
    "keywords": [
      "collapse",
      "sickling",
      "test",
      "thick",
      "intravascular",
      "anaemia",
      "breathing",
      "urine",
      "circulatory",
      "diagnostic",
      "tachypnoea",
      "thin",
      "films",
      "chest",
      "jaundice",
      "bleeding",
      "film",
      "disseminated",
      "altered",
      "where"
    ]
  },
  {
    "id": "27743e6fbefceddc749a1b9cbb26ff9d",
    "content": "Random blood glucose\nBUE and creatinine\nBlood grouping and cross-matching\nLumbar puncture in the convulsing or comatose patient to exclude meningitis or encephalitis.",
    "title": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "section": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "chunk_id": "1892",
    "type": "section",
    "keywords": [
      "creatinine",
      "cross",
      "matching",
      "lumbar",
      "meningitis",
      "exclude",
      "comatose",
      "encephalitis",
      "grouping",
      "puncture",
      "glucose",
      "convulsing",
      "patient",
      "blood",
      "random"
    ]
  },
  {
    "id": "025bf7c988359e723b05233d7b868247",
    "content": "To ensure rapid clearance of parasitaemia\nTo provide urgent treatment for life threatening complications or conditions e. g. convulsions, hypoglycaemia, dehydration, renal impairment.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1893",
    "type": "section",
    "keywords": [
      "complications",
      "dehydration",
      "rapid",
      "ensure",
      "conditions",
      "renal",
      "impairment",
      "life",
      "provide",
      "hypoglycaemia",
      "convulsions",
      "parasitaemia",
      "threatening",
      "clearance",
      "urgent",
      "treatment"
    ]
  },
  {
    "id": "a8c6e18cca10c9e558c92ce488a6fbc8",
    "content": "Place patients who are unconscious or having seizures in an appropriate position to prevent aspiration.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1894",
    "type": "section",
    "keywords": [
      "aspiration",
      "appropriate",
      "prevent",
      "having",
      "seizures",
      "unconscious",
      "place",
      "patients",
      "position"
    ]
  },
  {
    "id": "e96b10d88aa6fea949df1a84e4c8e524",
    "content": "Artesunate, IM,\nAdults and Children > 20 kg\n2. 4 mg/kg Children < 20 kg 3 mg/kg\nOr\nArtemether, IM,\nAdults and Children\n3. 2 mg/kg\nOr\nQuinine, IM, 10Artesunate, rectal, 10 mg/kg (preferred in children under 6 years;ee Table 110)\nOr\nArtesunate, rectal, 10 mg/kg (preferred in children under 6 years;.",
    "title": "Pre-referral treatment",
    "section": "Pre-referral treatment",
    "chunk_id": "1895",
    "type": "section",
    "keywords": [
      "rectal",
      "years",
      "quinine",
      "preferred",
      "artemether",
      "adults",
      "artesunate",
      "table",
      "children",
      "under"
    ]
  },
  {
    "id": "2894d6059f6cfd31f7bd24988e160954",
    "content": "The dosage for IM Quinine is 10 mg (0. 2 ml) per kg of bodyweight every 8 hours. How to give intramuscular Quinine intramuscular Quinine in Young Children:\nWeigh the child\nPrepare a Quinine dilution of 50 mg/ml: Use a 10 ml sterile syringe and needle to draw up 5 mls of sterile water for injection or saline (not dextrose).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1896",
    "type": "section",
    "keywords": [
      "give",
      "bodyweight",
      "dextrose",
      "sterile",
      "child",
      "prepare",
      "saline",
      "water",
      "weigh",
      "injection",
      "children",
      "syringe",
      "intramuscular",
      "young",
      "every",
      "needle",
      "quinine",
      "dilution",
      "dosage",
      "hours"
    ]
  },
  {
    "id": "b20784ca07a27a493a17d355598edd15",
    "content": "Then into the same syringe draw up 300 mg (1ml) from an ampoule of Qui- nine. The syringe now contains 50 mg Quinine per ml. The dosage is 10 mg (0.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1897",
    "type": "section",
    "keywords": [
      "syringe",
      "quinine",
      "dosage",
      "same",
      "ampoule",
      "nine",
      "contains",
      "then",
      "draw",
      "into"
    ]
  },
  {
    "id": "88873f434918845b0855980a7daf2ff5",
    "content": "2 ml) per kg or body weight every 8 hours. Calculate\nthe volume to give based on body weight. (For examples of body weights and doses in children < 30 kg, sArtesunate, rectal, 10 mg/kg (preferred in children under 6 years;110).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1898",
    "type": "section",
    "keywords": [
      "sartesunate",
      "body",
      "rectal",
      "under",
      "years",
      "based",
      "weight",
      "calculate",
      "give",
      "examples",
      "preferred",
      "doses",
      "weights",
      "children",
      "volume",
      "hours",
      "every"
    ]
  },
  {
    "id": "7fbcd4b5b416d41c2c03ee5898679c81",
    "content": "Administer by intramuscular injection to the thigh. If the diluted volume ex-\nceeds 3 ml, inject half the dose into each thigh. intramuscular Quinine in Adults:\nUse a Quinine dilution of 100 mg/ml.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1899",
    "type": "section",
    "keywords": [
      "thigh",
      "diluted",
      "intramuscular",
      "quinine",
      "dilution",
      "each",
      "adults",
      "dose",
      "injection",
      "ceeds",
      "volume",
      "inject",
      "half",
      "administer",
      "into"
    ]
  },
  {
    "id": "59091e2cbd52da8b49da6f8c93e8b730",
    "content": "To prepare this, draw 2 mls of Quinine 600 mg and add 4 mls of sterile water or saline (not dextrose)\nThe dosage is 10 mg/kg body weight of Quinine given 8 hourly by deep IM\ninjection, to a maximum dose of 600 mg\nSmall adults (weighing less than 60 kg) should be weighed to calculate the correct dose. Larger adults will simply receive the maximum dose (600 mg)\nIf the required volume is more than 5 ml, divide it into two and inject at\nseparate sites.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1900",
    "type": "section",
    "keywords": [
      "correct",
      "weight",
      "given",
      "weighed",
      "dextrose",
      "sterile",
      "required",
      "divide",
      "into",
      "hourly",
      "body",
      "simply",
      "prepare",
      "saline",
      "water",
      "sites",
      "injection",
      "volume",
      "deep",
      "calculate"
    ]
  },
  {
    "id": "3c123b7859949b5871c697a9fe3a3271",
    "content": "Artesunate, IV or IM,\nAdults and Children > 20 kg\n2. 4 mg/kg 12 hourly\nGiven at time 0 hour (i. e.",
    "title": "Treatment in Referral Centre",
    "section": "Treatment in Referral Centre",
    "chunk_id": "1901",
    "type": "section",
    "keywords": [
      "hourly",
      "hour",
      "given",
      "adults",
      "artesunate",
      "children"
    ]
  },
  {
    "id": "fe40456ec81473a48baa09d321a69b84",
    "content": "on admission), at 12 hours and 24 hours\nThen\n2. 4 mg/kg daily until patient can swallow (max. 7 days)\nThen\nA full 3-day course of recommended oral artemisinin combination\ntherapy (ACT) Children < 20 kg\n3 mg/kg 12 hourly\nGiven at time 0 hour (i.",
    "title": "Treatment in Referral Centre",
    "section": "Treatment in Referral Centre",
    "chunk_id": "1902",
    "type": "section",
    "keywords": [
      "hour",
      "given",
      "full",
      "patient",
      "therapy",
      "hourly",
      "swallow",
      "combination",
      "children",
      "admission",
      "days",
      "course",
      "then",
      "artemisinin",
      "recommended",
      "oral",
      "hours",
      "until",
      "daily"
    ]
  },
  {
    "id": "a416643362311689a5d83248c0535344",
    "content": "e. on admission), at 12 hours and 24 hours\nThen\n3. 0 mg/kg daily until patient can swallow (max.",
    "title": "Treatment in Referral Centre",
    "section": "Treatment in Referral Centre",
    "chunk_id": "1903",
    "type": "section",
    "keywords": [
      "then",
      "swallow",
      "hours",
      "admission",
      "patient",
      "until",
      "daily"
    ]
  },
  {
    "id": "42adff122e410f2ced1ad2b16a7cd9b3",
    "content": "7 days)\nThen\nA full 3-day course of recommended oral ACT.",
    "title": "Treatment in Referral Centre",
    "section": "Treatment in Referral Centre",
    "chunk_id": "1904",
    "type": "section",
    "keywords": [
      "days",
      "recommended",
      "course",
      "oral",
      "full",
      "then"
    ]
  },
  {
    "id": "c3911caf16094bc723d196de3d48c1d5",
    "content": "Or\nArtemether, IM,\nAdults and Children\n3. 2 mg/kg stat. Then (8 hours later)\n1.",
    "title": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "section": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "chunk_id": "1905",
    "type": "section",
    "keywords": [
      "later",
      "artemether",
      "adults",
      "hours",
      "children",
      "then",
      "stat"
    ]
  },
  {
    "id": "475d2280a7647638cafea8cadc8e6bc9",
    "content": "1. 6 mg/kg once daily until patient can swallow (up to 5 days)\nThen\nA full 3-day course of recommended oral artemisinin combination\ntherapy (ACT)\nOr\nQuinine, IV, (in Dextrose saline or in 5% Dextrose [5-10 ml/kg])\nAdults and Children\n10 mg/kg (max. dose 600 mg) infused over 4-8 hours.",
    "title": "Then (24 hours after initiation of treatment)",
    "section": "Then (24 hours after initiation of treatment)",
    "chunk_id": "1906",
    "type": "section",
    "keywords": [
      "dextrose",
      "infused",
      "full",
      "patient",
      "therapy",
      "swallow",
      "saline",
      "combination",
      "children",
      "days",
      "course",
      "adults",
      "dose",
      "then",
      "artemisinin",
      "once",
      "recommended",
      "quinine",
      "oral",
      "hours"
    ]
  },
  {
    "id": "c0470ae15fee6907ed906f1c899e7829",
    "content": "Repeat infusion 8 hourly until patient can swallow. Then.",
    "title": "Then (24 hours after initiation of treatment)",
    "section": "Then (24 hours after initiation of treatment)",
    "chunk_id": "1907",
    "type": "section",
    "keywords": [
      "hourly",
      "swallow",
      "infusion",
      "repeat",
      "then",
      "patient",
      "until"
    ]
  },
  {
    "id": "b25b92b6708dcc76eab6695aafa74955",
    "content": "And\nClindamycin, oral, 10 mg/kg, 12 hourly for 7 days\nOr\nQuinine, IM,\nAdults and Children\n10 mg/kg (max. dose 600 mg), 8 hourly until patient can swallow\nThen.",
    "title": "Quinine, oral, 10 mg/kg 8 hourly to complete 7 days of treatment",
    "section": "Quinine, oral, 10 mg/kg 8 hourly to complete 7 days of treatment",
    "chunk_id": "1908",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "clindamycin",
      "quinine",
      "swallow",
      "adults",
      "oral",
      "dose",
      "children",
      "then",
      "patient",
      "until"
    ]
  },
  {
    "id": "773fddec44670f1669340ba16f84d586",
    "content": "And\nClindamycin, oral, 10 mg/kg, 12 hourly for 7 days\nReferral Criteria\nPatients diagnosed as having severe malaria or who fail to respond to the recommended antimalarial medications must be referred. Appropriate treatment as indicated above must be initiated prior to transferring the patient. If referral is not possible immediately, continue the treatment regimen as shown above for severe malaria until referral is possible.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1909",
    "type": "section",
    "keywords": [
      "transferring",
      "continue",
      "having",
      "patient",
      "hourly",
      "immediately",
      "respond",
      "patients",
      "malaria",
      "criteria",
      "prior",
      "treatment",
      "days",
      "severe",
      "clindamycin",
      "referral",
      "antimalarial",
      "above",
      "medications",
      "referred"
    ]
  },
  {
    "id": "9cc8813057d2e7436f6ac1fab5c8f527",
    "content": "Pregnancy makes women more likely to get malaria or die from malaria. Malaria infection is more severe during pregnancy while pregnancy and its outcomes can become complicated by it. The effects of malaria on the pregnant mother include a severe form of the illness, anaemia, miscarriage, pre-term labour, and post-partum haemorrhage.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1910",
    "type": "section",
    "keywords": [
      "anaemia",
      "during",
      "mother",
      "outcomes",
      "labour",
      "likely",
      "form",
      "while",
      "pregnancy",
      "malaria",
      "severe",
      "include",
      "post",
      "complicated",
      "women",
      "makes",
      "partum",
      "term",
      "effects",
      "infection"
    ]
  },
  {
    "id": "f76aadfc3cb51db282966e8525dbf35f",
    "content": "Risks to the foetus include foetal anaemia, pre-maturity, intra-uterine growth restriction, low birth weight, stillbirth, congenital malaria, and increased perinatal mortality. Preventive measures must be emphasised (i. e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1911",
    "type": "section",
    "keywords": [
      "intra",
      "weight",
      "anaemia",
      "emphasised",
      "measures",
      "restriction",
      "growth",
      "preventive",
      "foetal",
      "perinatal",
      "risks",
      "malaria",
      "congenital",
      "include",
      "uterine",
      "foetus",
      "birth",
      "increased",
      "mortality",
      "maturity"
    ]
  },
  {
    "id": "2694ed3e32821410920434cf4f5e7cfd",
    "content": "Insecticide-treated Nets [ITNs] and Intermittent Preventive Treatment in pregnancy [IPTp] under direct observation) while confirmed cases must be treated promptly.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1912",
    "type": "section",
    "keywords": [
      "confirmed",
      "nets",
      "observation",
      "iptp",
      "treated",
      "intermittent",
      "must",
      "itns",
      "preventive",
      "cases",
      "promptly",
      "direct",
      "pregnancy",
      "insecticide",
      "while",
      "treatment",
      "under"
    ]
  },
  {
    "id": "99ef297de9691a5d8b8b370d1d497707",
    "content": "Quinine, oral, (may be given as monotherapy if Clindamycin is not\navailable)\n10 mg/kg (max. 600 mg) 8 hourly for 7 days\nAnd\nClindamycin, oral, 10 mg/kg, twice daily for 7 days.",
    "title": "Treatment of Uncomplicated Malaria in the First Trimester",
    "section": "Treatment of Uncomplicated Malaria in the First Trimester",
    "chunk_id": "1913",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "clindamycin",
      "quinine",
      "given",
      "oral",
      "available",
      "twice",
      "daily",
      "monotherapy"
    ]
  },
  {
    "id": "729f5cde7389efd337347f3413af6b4f",
    "content": "Artesunate + AmodiArtesunate + Amodiaquine co-blistered formu-\nlation (Regimen for TWICE DAILY DOSING)orThe dose in mg/body weight is: Amodiaquine 10 mg/kg + Artesunate 4 mg/kg, taken as two divided doses daily for three (3) days, after meals. Table 15, Ta- ble 16, Table 17)\nOr\nArtemet efantrine, oral, (See Table 18)\nOr.",
    "title": "Treatment of Uncomplicated Malaria in the Second and Third Trimesters",
    "section": "Treatment of Uncomplicated Malaria in the Second and Third Trimesters",
    "chunk_id": "1914",
    "type": "section",
    "keywords": [
      "weight",
      "table",
      "artemet",
      "twice",
      "orthe",
      "amodiaquine",
      "body",
      "doses",
      "dosing",
      "lation",
      "days",
      "dose",
      "three",
      "divided",
      "blistered",
      "taken",
      "amodiartesunate",
      "formu",
      "artesunate",
      "oral"
    ]
  },
  {
    "id": "28ad5847bf97f16fd5751727425b15cf",
    "content": "puerperium)\nEvidence Rating: [A]\nArtesunate, IV or IM,\nThen\nACT, oral, for 3 days.",
    "title": "Treatment of Severe Malaria in Pregnancy (All trimesters and",
    "section": "Treatment of Severe Malaria in Pregnancy (All trimesters and",
    "chunk_id": "1915",
    "type": "section",
    "keywords": [
      "days",
      "rating",
      "then",
      "artesunate",
      "oral",
      "puerperium",
      "evidence"
    ]
  },
  {
    "id": "7e75d7849f1d3e499571cfae8fc5f15c",
    "content": "Or\nQuinine, IV or IM,\nThen\nQuinine + clindamycin combination, oral,.",
    "title": "(See section on Treatment of ‘Severe Malaria’ above)",
    "section": "(See section on Treatment of ‘Severe Malaria’ above)",
    "chunk_id": "1916",
    "type": "section",
    "keywords": [
      "clindamycin",
      "quinine",
      "oral",
      "combination",
      "then"
    ]
  },
  {
    "id": "2752c4c21c86248aa802643b96e7a302",
    "content": "IPTp consists of giving the fixed-dose combination medication Sulphadoxine Pyrimethamine (SP) in treatment doses at predefined intervals after quickening (16 gestational weeks). Current recommendation is that IPTp with sulfadoxine-pyrimethamine (IPTp-SP) be given to all pregnant women at each scheduled antenatal care visit except during the first trimester. WHO recommends a schedule of four focused antenatal care visits for normal pregnancy.",
    "title": "intermittent Preventive Treatment in Pregnancy (iPTp)",
    "section": "intermittent Preventive Treatment in Pregnancy (iPTp)",
    "chunk_id": "1917",
    "type": "section",
    "keywords": [
      "pyrimethamine",
      "giving",
      "sulfadoxine",
      "given",
      "scheduled",
      "during",
      "four",
      "quickening",
      "schedule",
      "doses",
      "except",
      "combination",
      "consists",
      "weeks",
      "pregnancy",
      "trimester",
      "treatment",
      "recommends",
      "first",
      "women"
    ]
  },
  {
    "id": "6e34672fd07eaeafa1dc4a20def1916b",
    "content": "In Ghana, the national malaria control strategy reserves SP for the purpose of intermittent preventive treatment only. To prevent the development of drug resistance, SP is not to be used for other purposes such as treatment of acute attacks of malaria. Sulphadoxine (500 mg)-Pyrimethamine (25 mg), oral,.",
    "title": "intermittent Preventive Treatment in Pregnancy (iPTp)",
    "section": "intermittent Preventive Treatment in Pregnancy (iPTp)",
    "chunk_id": "1918",
    "type": "section",
    "keywords": [
      "pyrimethamine",
      "development",
      "acute",
      "purposes",
      "national",
      "attacks",
      "strategy",
      "prevent",
      "intermittent",
      "drug",
      "preventive",
      "malaria",
      "treatment",
      "only",
      "purpose",
      "other",
      "ghana",
      "oral",
      "reserves",
      "control"
    ]
  },
  {
    "id": "6396d8fd3662775df43131f8069c9356",
    "content": "This is the intermittent administration of full treatment courses using the recommended anti-malarial medicine during peak malaria transmission seasons to prevent malaria illness. A complete treatment course is given to children aged between 3 and 59 months at monthly intervals to a maximum of 4 doses during the malaria transmission season. In Ghana, SMC has been implemented in the Northern Savannah using Sulphadoxine-Pyrimethamine and Amodiaquine (SP + AQ).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1919",
    "type": "section",
    "keywords": [
      "pyrimethamine",
      "medicine",
      "implemented",
      "given",
      "during",
      "full",
      "complete",
      "savannah",
      "monthly",
      "amodiaquine",
      "seasons",
      "prevent",
      "intermittent",
      "doses",
      "children",
      "malaria",
      "peak",
      "treatment",
      "course",
      "maximum"
    ]
  },
  {
    "id": "016f9b2b8b2e5934ab1ebc63fed34479",
    "content": "Sulphadoxine-Pyrimethamine, oral,\nAnd\nAmodiaquine, oral,\nThis is an infection of the coverings of the brain, and is most commonly caused by bacteria, viruses, fungi and protozoa. One type, Cerebrospinal Meningitis (CSM), caused by Neisseria meningitides, is common in the Northern and Upper Regions of Ghana, and usually occurs in epidemics during the harmattan season. The presentation may sometimes be confused with cerebral malaria.",
    "title": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "section": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "chunk_id": "1920",
    "type": "section",
    "keywords": [
      "pyrimethamine",
      "usually",
      "bacteria",
      "during",
      "epidemics",
      "sometimes",
      "amodiaquine",
      "type",
      "upper",
      "regions",
      "presentation",
      "cerebrospinal",
      "protozoa",
      "most",
      "harmattan",
      "malaria",
      "caused",
      "confused",
      "fungi",
      "season"
    ]
  },
  {
    "id": "f57ceadecbe83e5d6b39a3637e0ac2e2",
    "content": "Meningitis is a medical emergency. Failure to recognise and adequately manage meningitis results in serious complications. Inform regional or district health authorities immediately in epidemic meningitis.",
    "title": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "section": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "chunk_id": "1921",
    "type": "section",
    "keywords": [
      "meningitis",
      "emergency",
      "complications",
      "district",
      "immediately",
      "inform",
      "manage",
      "adequately",
      "recognise",
      "health",
      "results",
      "epidemic",
      "failure",
      "medical",
      "regional",
      "serious",
      "authorities"
    ]
  },
  {
    "id": "6fcdc42d01f30565937e6854e2771cdd",
    "content": "Causes\nBacterial\nNeisseria meningitides\nStreptococcus pneumoniae\nHaemophilus influenza\nMycobacterium tuberculosis\nStaphylococcus aureus\nEscherichia coli (neonates)\nViruses e. g. Herpes viruses\nProtozoa e.",
    "title": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "section": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "chunk_id": "1922",
    "type": "section",
    "keywords": [
      "haemophilus",
      "escherichia",
      "viruses",
      "streptococcus",
      "staphylococcus",
      "neonates",
      "herpes",
      "coli",
      "bacterial",
      "neisseria",
      "protozoa",
      "mycobacterium",
      "tuberculosis",
      "aureus",
      "pneumoniae",
      "meningitides",
      "causes",
      "influenza"
    ]
  },
  {
    "id": "cb47a53d9097b3ace5118eb06352e951",
    "content": "Cryptococcus neoformans\nSymptoms\nFor Adults and Children > 5 years\nFever\nNeck pains\nSevere headaches\nPhotophobia\nChange in behaviour\nConvulsions\nVomiting\nChildren < 1 year\nFever\nIrritability\nRefusal to eat\nPoor sucking\nVomiting\nDrowsiness and weak cry.",
    "title": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "section": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "chunk_id": "1923",
    "type": "section",
    "keywords": [
      "years",
      "refusal",
      "cryptococcus",
      "poor",
      "neck",
      "drowsiness",
      "convulsions",
      "behaviour",
      "children",
      "photophobia",
      "irritability",
      "headaches",
      "severe",
      "weak",
      "fever",
      "adults",
      "change",
      "symptoms",
      "sucking",
      "year"
    ]
  },
  {
    "id": "24645048ed31c5ac39c336b23d7d06b2",
    "content": "Focal or generalized convulsions after which the child is sleepy\nLethargy\nBulging fontanelle\nSigns\nFor Adults and Children > 5 years\nFever\nNeck stiffness\nPositive Kernig’s sign\nAltered consciousness\nComa\nChildren < 1 year\nNeck retraction\nPresence or absence of neck stiffness\nPresence or absence of fever\nBulging fontanelle\nComa\nHypotonia or hypertonia\nConvulsion\ninvestigations\nFBC\nRapid diagnostic test (to exclude cerebral malaria)\nBlood film for malarial parasites (to exclude cerebral malaria)\nLumbar puncture (only after excluding raised intracranial pressure)\nBlood culture and sensitivity.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1924",
    "type": "section",
    "keywords": [
      "bulging",
      "test",
      "years",
      "intracranial",
      "which",
      "child",
      "puncture",
      "diagnostic",
      "excluding",
      "sensitivity",
      "hypotonia",
      "lethargy",
      "neck",
      "focal",
      "pressure",
      "stiffness",
      "film",
      "altered",
      "convulsions",
      "sleepy"
    ]
  },
  {
    "id": "8044a47d4d8aef8a6f491fade8ec5c53",
    "content": "To identify and eradicate the causative organisms\nTo prevent complications\nTo prevent spread to contacts\nTo maintain good nutrition.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1925",
    "type": "section",
    "keywords": [
      "complications",
      "nutrition",
      "prevent",
      "maintain",
      "causative",
      "eradicate",
      "contacts",
      "organisms",
      "identify",
      "spread"
    ]
  },
  {
    "id": "8457eaf8d7fd5daa7a42a676d883ade3",
    "content": "Tepid sponging\nKeep the airway clear\nNasogastric tube feeding if applicable.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1926",
    "type": "section",
    "keywords": [
      "tepid",
      "nasogastric",
      "tube",
      "applicable",
      "keep",
      "feeding",
      "airway",
      "clear",
      "sponging"
    ]
  },
  {
    "id": "94880e179914a84fa4d53b1f77a1ff55",
    "content": "Ceftriaxone, IV/deep IM,\nAdults\n2-4 g daily for 7-10 days\nChildren\n12 years;\t2-4 g daily for 7-10 days.",
    "title": "A.\tBacterial Meningitis 1st Line Treatment Evidence Rating: [A]",
    "section": "A.\tBacterial Meningitis 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "1927",
    "type": "section",
    "keywords": [
      "days",
      "deep",
      "years",
      "ceftriaxone",
      "adults",
      "children",
      "daily"
    ]
  },
  {
    "id": "f605831b314841fa0bdcd288c646e0d7",
    "content": "< 12 years;\t50-80 mg/kg for 10-14 days\nNeonates;\t20-50 mg/kg once daily for 21 days\nAnd\nVancomycin, IV,\nAdults\n15 mg/kg 12 hourly for 7-10 days\nChildren\n12 years;\t15 mg/kg 12 hourly for 7-10 days\n2-12 years;\t15 mg/kg 12 hourly for 7-10 days\n1 month-2 years;\t15 mg/kg 8 hourly for 10-14 days\n< 1 month;\tnot recommended\nOr\nEvidence Rating: [B]\nBenzylpenicillin, IV,\nAdults\n4 MU 4 hourly for 14 days\nChildren\n0. 2 MU/kg 6 hourly for 14 days\nAnd\nChloramphenicol, IV,\nAdults\n1 g 6 hourly for 14 days\nChildren\n25 mg/kg 6 hourly for 14 days\nThis may be subsequently changed to oral therapy with significant clinical improvement\nOr\nChloramphenicol, IM, (oily preparation)\nAdults\n100 mg/kg as a single dose\nChildren\n100 mg/kg as a single dose\nFor penicillin allergy\nClindamycin, IV,\nAdults\n600-900 mg 8 hourly for 14 days\nChildren\n13 mg/kg 8 hourly for for 14 days\nAnd\nChloramphenicol, IV,\nAdults\n1 g 6 hourly for 14 days.",
    "title": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "section": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "chunk_id": "1928",
    "type": "section",
    "keywords": [
      "years",
      "neonates",
      "benzylpenicillin",
      "subsequently",
      "penicillin",
      "changed",
      "preparation",
      "therapy",
      "evidence",
      "hourly",
      "rating",
      "single",
      "children",
      "days",
      "clindamycin",
      "vancomycin",
      "adults",
      "allergy",
      "dose",
      "month"
    ]
  },
  {
    "id": "9585ee1081577d1e91be2fbad41c9617",
    "content": "Cefotaxime, IV,\nAdults\n2g 6 hourly for 7 days\nChildren\n12 years or body weight > 50kg; 2 g 6 hourly\n< 12 years or body weight < 50kg; 50 mg/kg 6 hourly\nAnd\nVancomycin, IV,\nAdults\n15 mg/kg 12 hourly for 7-10 days\nChildren\n12 years;\t15 mg/kg 12 hourly for 7-10 days\n2-12 years;\t15 mg/kg 12 hourly for 7-10 days\n1 month-2 years;\t15 mg/kg 8 hourly for 10-14days\n< 1 month;\tnot recommended\nProphylaxis for CSM\nProphylactic treatment is recommended for patients 2 days prior to discharge and also for their close contacts\nCiprofloxacin, oral,\nAdults\n500 mg as a single dose (Avoid in Pregnancy)\nChildren\n5-12 years;\t250 mg as a single dose\nOr\nCeftriaxone, IM,\nAdults\n250 mg as a single dose\nChildren\n< 12 years;\t125 mg as a single dose\nDexamethasone, IV, 4-10 mg 6 hourly for 5-7 days\nReferral Criteria.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "1929",
    "type": "section",
    "keywords": [
      "avoid",
      "years",
      "weight",
      "close",
      "ciprofloxacin",
      "hourly",
      "body",
      "single",
      "contacts",
      "patients",
      "children",
      "their",
      "pregnancy",
      "dexamethasone",
      "prior",
      "treatment",
      "criteria",
      "days",
      "referral",
      "vancomycin"
    ]
  },
  {
    "id": "4fa6961c85f7494a9ad6a081684d240e",
    "content": "Infestation with worms is very common. Poor hygiene or contact of bare skin with soil in which the worm or its eggs live predisposes individuals to infestation. Causes\nHookworm\nAscaris\nStrongyloides\nTape worm\nThread worm\nWhip worm\nSymptoms\nGeneralised Itching\nPerianal itching (threadworm)\nDry cough (when the larvae pass through the lungs)\nWheeze (when the larvae pass through the lungs)\nAbdominal discomfort and or pain\nEasy fatiguability\nPassage of worm(s) in the stool\nAltered bowel habit\nVomiting of worms\nSigns\nPallor\nFeatures of malnutrition.",
    "title": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "section": "Chapter 18: Infectıous Dıseases and Infestatıons",
    "chunk_id": "1930",
    "type": "section",
    "keywords": [
      "perianal",
      "malnutrition",
      "threadworm",
      "which",
      "discomfort",
      "features",
      "live",
      "poor",
      "eggs",
      "abdominal",
      "wheeze",
      "infestation",
      "bowel",
      "altered",
      "tape",
      "easy",
      "signs",
      "generalised",
      "causes",
      "thread"
    ]
  },
  {
    "id": "35ed0f42f25383e0b3c0ce076c892198",
    "content": "Poor physical growth in children\nLarge distended abdomen in children\nWheezing\ninvestigations\nStool for routine examination\nFBC.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1931",
    "type": "section",
    "keywords": [
      "investigations",
      "large",
      "physical",
      "growth",
      "stool",
      "poor",
      "children",
      "abdomen",
      "distended",
      "examination",
      "routine",
      "wheezing"
    ]
  },
  {
    "id": "27c6560d0f849ca5697e1106e527e5dc",
    "content": "To eliminate the worms\nTo treat the complications of infestation e. g. anaemia, malnutrition\nTo ensure proper sanitation.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1932",
    "type": "section",
    "keywords": [
      "sanitation",
      "complications",
      "worms",
      "treat",
      "malnutrition",
      "infestation",
      "anaemia",
      "ensure",
      "proper",
      "eliminate"
    ]
  },
  {
    "id": "485a6c11eb3598683bfc3d85c7c80aec",
    "content": "Ensure proper nutrition\nProper hand washing with soap and running water.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1933",
    "type": "section",
    "keywords": [
      "hand",
      "nutrition",
      "ensure",
      "proper",
      "washing",
      "water",
      "soap",
      "running"
    ]
  },
  {
    "id": "c408d1faaa0787464f48592ab90c21d8",
    "content": "Referral Criteria\nRefer patients with intestinal obstruction from a heavy load of suspected worm infestation to a surgical specialist.",
    "title": "(See table below on ‘Pharmacological treatment of Worm Infestations’)",
    "section": "(See table below on ‘Pharmacological treatment of Worm Infestations’)",
    "chunk_id": "1934",
    "type": "section",
    "keywords": [
      "referral",
      "specialist",
      "surgical",
      "suspected",
      "infestation",
      "refer",
      "intestinal",
      "obstruction",
      "worm",
      "patients",
      "heavy",
      "criteria",
      "load"
    ]
  },
  {
    "id": "4b936113e11ddc6b61e3bab1382ad088",
    "content": "This condition is common in children. It is associated with inadequate intake of foods that contain Vitamin A. It is a common cause of blindness in children.",
    "title": "(See section on ‘Neonatal Conjunctivitis’ under Neonatal Disorders)",
    "section": "(See section on ‘Neonatal Conjunctivitis’ under Neonatal Disorders)",
    "chunk_id": "1935",
    "type": "section",
    "keywords": [
      "foods",
      "inadequate",
      "common",
      "cause",
      "intake",
      "contain",
      "blindness",
      "associated",
      "condition",
      "children",
      "vitamin"
    ]
  },
  {
    "id": "7a306feabe0cb0b4b0f2319fcba08a64",
    "content": "It is important to prevent this condition by examining the eyes of all sick and malnourished children. The diet of children should include foods that contain Vitamin A (dark green leafy vegetables e. g.",
    "title": "(See section on ‘Neonatal Conjunctivitis’ under Neonatal Disorders)",
    "section": "(See section on ‘Neonatal Conjunctivitis’ under Neonatal Disorders)",
    "chunk_id": "1936",
    "type": "section",
    "keywords": [
      "examining",
      "diet",
      "include",
      "important",
      "leafy",
      "sick",
      "prevent",
      "foods",
      "vegetables",
      "should",
      "green",
      "dark",
      "contain",
      "condition",
      "children",
      "malnourished",
      "vitamin",
      "eyes"
    ]
  },
  {
    "id": "afa5799099bb9568a3926af25508061e",
    "content": "nkontomire, yellow fruits and vegetables, palm oil, milk, eggs). Parents and other caregivers should be discouraged from putting any traditional preparations such as herbs, sea water, saliva, urine, etc. or drugs into the eye unless prescribed by a physician.",
    "title": "(See section on ‘Neonatal Conjunctivitis’ under Neonatal Disorders)",
    "section": "(See section on ‘Neonatal Conjunctivitis’ under Neonatal Disorders)",
    "chunk_id": "1937",
    "type": "section",
    "keywords": [
      "nkontomire",
      "discouraged",
      "urine",
      "eggs",
      "into",
      "unless",
      "preparations",
      "saliva",
      "caregivers",
      "water",
      "physician",
      "yellow",
      "should",
      "herbs",
      "fruits",
      "traditional",
      "drugs",
      "vegetables",
      "palm",
      "other"
    ]
  },
  {
    "id": "f34f8a6ac8dc4cdd144c92a67c755eef",
    "content": "Causes\nVitamin A deficiency resulting from\nProtein calorie malnutrition\nMeasles\nMalabsorption states\nSymptoms\nPoor night vision (in the early stages)\nSigns\nDry conjunctiva\nGrey sclera\nConjunctival folding (wrinkling)\nKeratomalacia (cloudy cornea, soft and easy ulceration)\ninvestigations\nNil.",
    "title": "(See section on ‘Neonatal Conjunctivitis’ under Neonatal Disorders)",
    "section": "(See section on ‘Neonatal Conjunctivitis’ under Neonatal Disorders)",
    "chunk_id": "1938",
    "type": "section",
    "keywords": [
      "conjunctival",
      "malnutrition",
      "conjunctiva",
      "wrinkling",
      "poor",
      "night",
      "vitamin",
      "malabsorption",
      "calorie",
      "vision",
      "cornea",
      "protein",
      "signs",
      "easy",
      "causes",
      "deficiency",
      "ulceration",
      "measles",
      "investigations",
      "keratomalacia"
    ]
  },
  {
    "id": "79dc168aeee439d60b4ba7debc6882fe",
    "content": "To recognize and correct vitamin A deficiency\nTo prevent complications e. g. blindness.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1939",
    "type": "section",
    "keywords": [
      "complications",
      "correct",
      "prevent",
      "recognize",
      "blindness",
      "vitamin",
      "deficiency"
    ]
  },
  {
    "id": "411dc4ccf3646a9ab8c26c9eb9896b11",
    "content": "High vitamin A containing foods should be encouraged.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1940",
    "type": "section",
    "keywords": [
      "containing",
      "should",
      "high",
      "encouraged",
      "foods",
      "vitamin"
    ]
  },
  {
    "id": "76b76b7f3721da6b2296fa0824e9f0b8",
    "content": "Give Vitamin A to children as soon as the illness is diagnosed and also in patients with measles and malnutrition\nEvidence Rating: [A]\nVitamin A, oral,\nChildren\nimmediately after diagnosis\nyears;\t200,000 Units\nmonths;\t100,000 Units\nThen (after 24 hours)\nyears;\t200,000 Units\nmonths;\t100,000 Units\nThen (after 1 week)\nyears;\t200,000 Units\n6-11 months;\t100,000 Units\nReferral Criteria\nRefer all established cases of xerophthalmia to an eye specialist if the condition is severe with an uneven or bulging cornea. Foreign bodies refer to specks of dust, small insects or other tiny objects that get into the eyes. The foreign body may be either in the conjunctival sac, on the cornea or inside the eyeball (intraocular).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1941",
    "type": "section",
    "keywords": [
      "conjunctival",
      "xerophthalmia",
      "units",
      "years",
      "malnutrition",
      "bulging",
      "dust",
      "give",
      "either",
      "established",
      "evidence",
      "vitamin",
      "insects",
      "into",
      "intraocular",
      "uneven",
      "rating",
      "specialist",
      "body",
      "immediately"
    ]
  },
  {
    "id": "9831db2b1444e7e9842ab014e922c447",
    "content": "A history of the likely nature of the foreign body aids in its detection and removal. The foreign body may be seen by careful inspection of the cornea or conjunctival sac. Adequate lighting is needed to detect corneal foreign bodies.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1942",
    "type": "section",
    "keywords": [
      "conjunctival",
      "seen",
      "aids",
      "likely",
      "nature",
      "body",
      "foreign",
      "cornea",
      "removal",
      "inspection",
      "bodies",
      "lighting",
      "detection",
      "careful",
      "corneal",
      "needed",
      "history",
      "detect",
      "adequate"
    ]
  },
  {
    "id": "70a8a769bedd2967bd2fa5c53186d2b7",
    "content": "Causes\nSpecks of dust\nSmall insects\nFerrous metallic specs (such as occurs with metal grinders)\nOther tiny objects\nSymptoms\nFeeling of something in the eye which may be irritating\nSudden discomfort or severe pain\nWatering of the eye\nRed eye(s).",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1943",
    "type": "section",
    "keywords": [
      "metal",
      "grinders",
      "sudden",
      "dust",
      "which",
      "discomfort",
      "feeling",
      "insects",
      "metallic",
      "ferrous",
      "watering",
      "causes",
      "specks",
      "specs",
      "severe",
      "something",
      "tiny",
      "occurs",
      "symptoms",
      "irritating"
    ]
  },
  {
    "id": "a43afd832a890341d7b88b8523eff9f7",
    "content": "Photophobia i. e. intolerance to light\nInability to open the eye\nSigns\nEvidence of foreign body\nConjunctivitis\nTearing of the eyes\nPhotophobia\nChemosis\nSub-conjunctival haemorrhage\nIrregular pupil in penetrating eye injury with retained intraocular foreign body\nBlood in the anterior chamber (hyphaema)\ninvestigations\nX-ray of the orbit (suspected metallic foreign body).",
    "title": "Chapter 19: Eye Dısorders",
    "section": "Chapter 19: Eye Dısorders",
    "chunk_id": "1944",
    "type": "section",
    "keywords": [
      "conjunctival",
      "chemosis",
      "light",
      "evidence",
      "intraocular",
      "open",
      "body",
      "hyphaema",
      "metallic",
      "foreign",
      "anterior",
      "signs",
      "photophobia",
      "retained",
      "blood",
      "penetrating",
      "conjunctivitis",
      "suspected",
      "intolerance",
      "chamber"
    ]
  },
  {
    "id": "5ed6eedf69300305b1c99bae7cdbc169",
    "content": "To remove superficial foreign bodies\nTo treat associated injury\nTo prevent complications.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1945",
    "type": "section",
    "keywords": [
      "complications",
      "treat",
      "prevent",
      "foreign",
      "superficial",
      "associated",
      "remove",
      "injury",
      "bodies"
    ]
  },
  {
    "id": "960579926f3503637d3b76f8e4b44a6e",
    "content": "Where the foreign body is under the upper eyelid, evert the eyelid and remove the foreign body. If the foreign body cannot be removed, apply topical antibiotic, pad\nthe eye and REFER to an eye specialist clinic.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1946",
    "type": "section",
    "keywords": [
      "clinic",
      "eyelid",
      "body",
      "topical",
      "specialist",
      "foreign",
      "cannot",
      "refer",
      "where",
      "evert",
      "removed",
      "remove",
      "antibiotic",
      "upper",
      "apply",
      "under"
    ]
  },
  {
    "id": "8591dd43588ceb07701bfed33e341090",
    "content": "Foreign body identification\nTetracaine hydrochloride, 0. 5% eye drop, Instill one or two drops pri- or to evaluation\nFor eye irrigation\nNormal Saline, 0. 9%,.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1947",
    "type": "section",
    "keywords": [
      "drop",
      "body",
      "evaluation",
      "drops",
      "hydrochloride",
      "irrigation",
      "foreign",
      "saline",
      "identification",
      "tetracaine",
      "normal",
      "instill"
    ]
  },
  {
    "id": "fb063f52ddebe78eac37c37fde9fc8ce",
    "content": "Chloramphenicol eye ointment, 1% topical, (After removal of foreign\nbody)\nPain control\nParacetamol, oral,\nAdults\n500 mg-1 g 6 -8 hourly as required\nChildren\n6-12 years;\t250-500 mg 6-8 hourly as required\n1-5 years;\t120-250 mg 6-8 hourly as required\n3 months-1 year;\t60-120 mg 6-8 hourly as required.",
    "title": "Prevention of infection 1st Line Treatment Evidence Rating: [C]",
    "section": "Prevention of infection 1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "1948",
    "type": "section",
    "keywords": [
      "topical",
      "body",
      "hourly",
      "pain",
      "years",
      "foreign",
      "adults",
      "removal",
      "oral",
      "paracetamol",
      "children",
      "control",
      "months",
      "after",
      "required",
      "ointment",
      "chloramphenicol",
      "year"
    ]
  },
  {
    "id": "6af177bb0addafaed70776e3bae35621",
    "content": "Referral Criteria\nRefer patients with corneal foreign bodies, intraocular foreign bodies, persistent pain and redness of the eye to the eye specialist. Red eyes are either the result of inflammation of ocular tissue or bleeding into the sub conjunctival space. The pattern of the redness, nature of the discharge, associated pain and its intensity, vision loss and appearance of the cornea are helpful in characterising the red eye.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1949",
    "type": "section",
    "keywords": [
      "conjunctival",
      "either",
      "characterising",
      "appearance",
      "space",
      "associated",
      "redness",
      "nature",
      "into",
      "intraocular",
      "specialist",
      "helpful",
      "inflammation",
      "foreign",
      "result",
      "bleeding",
      "intensity",
      "vision",
      "cornea",
      "patients"
    ]
  },
  {
    "id": "b870289f380ebdf0dbbdaecc641e6c2f",
    "content": "Red eye is a potentially very serious condition especially in situations where the redness is around the cornea. Causes\nConjunctivitis\nCorneal ulcer or keratitis\nAcute anterior uveitis (inflammation of the uveal tract)\nAcute angle closure glaucoma\nEpiscleritis\nScleritis\nSubconjunctival haemorrhage.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1950",
    "type": "section",
    "keywords": [
      "situations",
      "subconjunctival",
      "especially",
      "ulcer",
      "uveal",
      "potentially",
      "redness",
      "closure",
      "acute",
      "serious",
      "inflammation",
      "cornea",
      "where",
      "anterior",
      "angle",
      "episcleritis",
      "condition",
      "causes",
      "tract",
      "conjunctivitis"
    ]
  },
  {
    "id": "282daecdd02efc580286d14c40de427c",
    "content": "*WHO Grading of Trachoma\nTF - at least five follicles in the upper tarsal conjunctiva. Indicates active disease and need for treatment.",
    "title": "Chapter 19: Eye Dısorders",
    "section": "Chapter 19: Eye Dısorders",
    "chunk_id": "1951",
    "type": "section",
    "keywords": [
      "disease",
      "least",
      "indicates",
      "conjunctiva",
      "grading",
      "active",
      "five",
      "tarsal",
      "need",
      "follicles",
      "trachoma",
      "upper",
      "treatment"
    ]
  },
  {
    "id": "d16cdb591e76c706130b5afff297df3a",
    "content": "CO - corneal opacities. Visual loss from previous infection\ninvestigations\nConjunctival swab for culture and sensitivity (purulent or mucopurulent discharge).",
    "title": "TT- trachoma trichiasis. Need surgical treatment",
    "section": "TT- trachoma trichiasis. Need surgical treatment",
    "chunk_id": "1952",
    "type": "section",
    "keywords": [
      "conjunctival",
      "swab",
      "corneal",
      "discharge",
      "opacities",
      "visual",
      "infection",
      "loss",
      "culture",
      "investigations",
      "purulent",
      "sensitivity",
      "mucopurulent",
      "previous"
    ]
  },
  {
    "id": "1ac2eb665fa35e53ce2c627a0ce60af7",
    "content": "To treat the infection in the case of acute conjunctivitis\nTo relieve pain and refer immediately to the specialist for urgent management to prevent blindness in the case of corneal ulcers, acute anterior uveitis, acute angle closure glaucoma, episcleritis and scleritis.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1953",
    "type": "section",
    "keywords": [
      "treat",
      "management",
      "closure",
      "acute",
      "specialist",
      "immediately",
      "prevent",
      "blindness",
      "angle",
      "anterior",
      "episcleritis",
      "conjunctivitis",
      "ulcers",
      "urgent",
      "scleritis",
      "glaucoma",
      "uveitis",
      "pain",
      "corneal",
      "case"
    ]
  },
  {
    "id": "40042646ff22d0a05e4c23ec3bae30f1",
    "content": "Acute conjunctivitis\nWipe discharges with tissue, discard it and wash hands after each wipe\nDon’t share towels with others\nAdults and children should avoid close contact with others e. g. from.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1954",
    "type": "section",
    "keywords": [
      "avoid",
      "close",
      "acute",
      "towels",
      "others",
      "discharges",
      "children",
      "wash",
      "conjunctivitis",
      "discard",
      "each",
      "hands",
      "should",
      "adults",
      "share",
      "contact",
      "wipe",
      "after",
      "tissue"
    ]
  },
  {
    "id": "de89cf3859d8d3d88c4a1847b300bcb2",
    "content": "Tetracycline, 1% ointment, apply at night for 7 days\nAnd\nChloramphenicol, 0. 5% eye drops, 1 drop 2 hourly for 48 hours\nThen\n1 drop 6-8 hourly for 7 days\nOr\nCiprofloxacin, 0. 3% eye drops, 1-2 drops 6-12 hourly\nReferral Criteria\nRefer corneal ulcers, acute anterior uveitis, acute angle closure glaucoma, episceritis and scleritis immediately to the eye specialist.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "1955",
    "type": "section",
    "keywords": [
      "drops",
      "closure",
      "acute",
      "night",
      "ciprofloxacin",
      "hourly",
      "specialist",
      "immediately",
      "angle",
      "anterior",
      "criteria",
      "days",
      "referral",
      "ointment",
      "ulcers",
      "then",
      "scleritis",
      "glaucoma",
      "tetracycline",
      "drop"
    ]
  },
  {
    "id": "c0d0646d389fe06d3a949c995cf07865",
    "content": "Also refer acute conjunctivitis, which shows no improvement after 48 hours of treatment. Glaucoma is an optic neuropathy usually but not always associated with raised intraocular pressure. It is the second leading cause of preventable blindness in the world.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "1956",
    "type": "section",
    "keywords": [
      "usually",
      "world",
      "which",
      "associated",
      "second",
      "acute",
      "intraocular",
      "always",
      "pressure",
      "blindness",
      "treatment",
      "leading",
      "conjunctivitis",
      "also",
      "cause",
      "raised",
      "glaucoma",
      "shows",
      "preventable",
      "neuropathy"
    ]
  },
  {
    "id": "0d3d8d65510adc72d6ed9613a0eaedeb",
    "content": "Chronic Glaucoma may produce severe loss of vision and blindness without prior warning symptoms and must therefore be screened for in all adults beyond the age of 40 years. Acute glaucoma is however associated with very high intraocular pressures and very severe pain and inflammation of the eye and can lead to blindness quickly if not treated. When congenital, glaucoma causes enlargement of the eyeball associated with increased sensitivity to light and watering.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "1957",
    "type": "section",
    "keywords": [
      "beyond",
      "pressures",
      "years",
      "lead",
      "associated",
      "sensitivity",
      "light",
      "acute",
      "intraocular",
      "therefore",
      "inflammation",
      "vision",
      "treated",
      "blindness",
      "quickly",
      "watering",
      "prior",
      "causes",
      "congenital",
      "severe"
    ]
  },
  {
    "id": "6117768a007c0323099abc881bd39e7e",
    "content": "Pharmacological treatment may vary from patient to patient according to local availability, affordability, and individual response to treatment. Causes\nAcute closure of the drainage angle (due to pupil block in primary angle closure glaucoma)\nInadequate drainage of aqueous from the anterior chamber (despite\nopen drainage angles in chronic open angle glaucoma)\nNeovascular membrane in the drainage angle in ischaemic eye diseases such as proliferative diabetic retinopathy\nDisplaced lens in secondary angle closure glaucoma\nMalformation of the drainage angle in congenital glaucoma.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "1958",
    "type": "section",
    "keywords": [
      "pharmacological",
      "local",
      "according",
      "block",
      "inadequate",
      "closure",
      "angles",
      "secondary",
      "acute",
      "patient",
      "primary",
      "open",
      "individual",
      "diseases",
      "malformation",
      "angle",
      "anterior",
      "vary",
      "diabetic",
      "availability"
    ]
  },
  {
    "id": "415a44ff5e5b9a4b95f683f708883352",
    "content": "Symptoms and signs\ninvestigations\nGonioscopy\nCentral retinal thickness measurement\nVisual field analysis\nOptic Disc photography\nRetinal Nerve Fibre Thickness Analysis\nExamination of children under anaesthesia.",
    "title": "Chapter 19: Eye Dısorders",
    "section": "Chapter 19: Eye Dısorders",
    "chunk_id": "1959",
    "type": "section",
    "keywords": [
      "thickness",
      "under",
      "disc",
      "retinal",
      "fibre",
      "nerve",
      "signs",
      "children",
      "field",
      "gonioscopy",
      "photography",
      "investigations",
      "analysis",
      "symptoms",
      "visual",
      "measurement",
      "anaesthesia",
      "central",
      "examination",
      "optic"
    ]
  },
  {
    "id": "5a718df2ff870f18557c18839dce2cb1",
    "content": "Drainage Surgery\nLaser Surgery\nGlaucoma Drainage device\nVarious other implants.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1960",
    "type": "section",
    "keywords": [
      "glaucoma",
      "various",
      "drainage",
      "other",
      "laser",
      "implants",
      "surgery",
      "device"
    ]
  },
  {
    "id": "c99eb9099ba505a6bf9edf60102bed04",
    "content": "Bimatoprost, eye drops, 300 microgram/ml\nTravoprost, eye drops, 40 microgram/ml\nAnd/Or\nTimolol 0. 5% eye drops\nLevobunolol 0. 5% eye drops\nBetaxolol 0.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1961",
    "type": "section",
    "keywords": [
      "levobunolol",
      "drops",
      "microgram",
      "travoprost",
      "betaxolol",
      "bimatoprost",
      "timolol"
    ]
  },
  {
    "id": "6b1d6ba0a1b412b2d4bc749ea50a9a30",
    "content": "5% eye drops\nAnd /Or\nBrimornidine, 1 mg/ml or 1. 5 mg/ml\nAnd/Or\nAcetazolamide, oral, 250 mg\nBrinzolamide, eye drops, 10 mg/ml\nDorzolamide, eye drops, 20 mg/ml\nAnd/Or\nPilocarpine 1-4%, eye drops\nReferral Criteria.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1962",
    "type": "section",
    "keywords": [
      "referral",
      "brinzolamide",
      "drops",
      "acetazolamide",
      "oral",
      "dorzolamide",
      "brimornidine",
      "criteria",
      "pilocarpine"
    ]
  },
  {
    "id": "69c5254b494987ca05b5b5fd226950bf",
    "content": "It is the opacity of the crystalline lens of the eye. It is the leading cause of blindness worldwide. Causes\nOld age\nTrauma to the eye\nInflammation within the eye\nMetabolic conditions such as diabetes mellitus\nCongenital\nSymptoms\nVariable disturbance of vision (sometimes worse when sunny or reading)\nGlare especially at night during driving\nMonocular double vision in the affected eye\nChange in refractive status:\nmore short sighted (myopic shift)\nmore long sighted (hypermetropic shift)\nWhite spot in the eye (children)\nSigns\nLens opacity\nReduced visual acuity\nReduced contrast sensitivity.",
    "title": "Refer all suspected cases of glaucoma to the ophthalmologist for assessment and initial treatment.",
    "section": "Refer all suspected cases of glaucoma to the ophthalmologist for assessment and initial treatment.",
    "chunk_id": "1963",
    "type": "section",
    "keywords": [
      "affected",
      "glare",
      "white",
      "especially",
      "mellitus",
      "during",
      "reduced",
      "sensitivity",
      "sometimes",
      "night",
      "driving",
      "worse",
      "refractive",
      "within",
      "sunny",
      "short",
      "inflammation",
      "vision",
      "hypermetropic",
      "blindness"
    ]
  },
  {
    "id": "bb6387cfdd48ad2146df79ffa8f2023a",
    "content": "To improve vision\nTo prevent the development of amblyopia in the child.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1964",
    "type": "section",
    "keywords": [
      "improve",
      "prevent",
      "development",
      "vision",
      "amblyopia",
      "child"
    ]
  },
  {
    "id": "eab01d004dfb3c56e4d41f18907686a3",
    "content": "Nil\nReferral Criteria\nRefer all cases to the eye specialist. Exposure keratopathy is the drying of the cornea as a result of inability to close the eyelids or blink adequately. If not detected and treated can result in corneal ulceration and perforation leading to blindness.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1965",
    "type": "section",
    "keywords": [
      "close",
      "eyelids",
      "specialist",
      "detected",
      "cornea",
      "result",
      "treated",
      "blindness",
      "criteria",
      "drying",
      "referral",
      "leading",
      "blink",
      "ulceration",
      "adequately",
      "exposure",
      "inability",
      "keratopathy",
      "perforation",
      "corneal"
    ]
  },
  {
    "id": "4b9a697231c6ba9a6bfdeed36e837f45",
    "content": "Causes\nFacial nerve palsy e. g. Bell’s palsy or leprosy\nScarring of the eyelids\nComa.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1966",
    "type": "section",
    "keywords": [
      "facial",
      "scarring",
      "coma",
      "nerve",
      "palsy",
      "leprosy",
      "bell",
      "causes",
      "eyelids"
    ]
  },
  {
    "id": "12fc791ad30128a993ef6d20c29b536d",
    "content": "Proptosis\nSteven Johnson’s Syndrome\nSymptoms\nFeeling of drying of the eye\nForeign body sensations in the eye\nPhotophobia\nBlurring of vision\nSigns\nLagophthalmos (inability to close the eyes)\nIncomplete blink (the upper eyelid does not cover the whole cornea during blink)\nInfrequent blink\nSuperficial punctate stains on the cornea\nLarge coalescent corneal epithelial defect\nCorneal ulceration\nCorneal perforation.",
    "title": "Parkinson’s disease",
    "section": "Parkinson’s disease",
    "chunk_id": "1967",
    "type": "section",
    "keywords": [
      "eyelid",
      "incomplete",
      "during",
      "superficial",
      "punctate",
      "feeling",
      "close",
      "epithelial",
      "body",
      "stains",
      "lagophthalmos",
      "cover",
      "coalescent",
      "large",
      "foreign",
      "vision",
      "cornea",
      "signs",
      "johnson",
      "whole"
    ]
  },
  {
    "id": "4d3891d19c6204258c481e6b8ced2469",
    "content": "To moisten the cornea artificially\nTo prevent the complications of dry eyes.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "1968",
    "type": "section",
    "keywords": [
      "complications",
      "prevent",
      "cornea",
      "artificially",
      "moisten",
      "eyes"
    ]
  },
  {
    "id": "9dc68ac8ac3ae77851f793c13ffe9b68",
    "content": "Taping the eyelids closed in the comatose patient\nPartial tarsorrhaphy\nEducation of patients with Parkinson’s or thyroid eye disease to to blink frequently voluntarily rather than rely on reflex blink.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1969",
    "type": "section",
    "keywords": [
      "disease",
      "closed",
      "partial",
      "education",
      "parkinson",
      "comatose",
      "rather",
      "rely",
      "blink",
      "tarsorrhaphy",
      "reflex",
      "frequently",
      "patients",
      "thyroid",
      "voluntarily",
      "taping",
      "patient",
      "eyelids"
    ]
  },
  {
    "id": "5ec9e2183f629d4cbb6e8ff2ed67d6ed",
    "content": "Hydroxymethyl cellulose, 0. 3% eye drops, 1-2 hourly during waking\ntime.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "1970",
    "type": "section",
    "keywords": [
      "waking",
      "hourly",
      "drops",
      "during",
      "cellulose",
      "hydroxymethyl"
    ]
  },
  {
    "id": "000c1757a7b779a32a6f4d794653d4df",
    "content": "Polyvinyl alcohol, 1. 4-2% eye drops, 1-2 hourly during waking time\nAnd\nChloramphenicol, 1% eye ointment, at night before bedtime\nOr\nTetracycline, 1% eye ointment, at bedtime\nReferral Criteria\nRefer patients whose exposure keratopathy is not improving to the eye specialist. Strabismus is misalignment usually of one eye preventing simultaneous viewing of an object by both eyes.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "1971",
    "type": "section",
    "keywords": [
      "misalignment",
      "usually",
      "drops",
      "viewing",
      "both",
      "during",
      "night",
      "simultaneous",
      "hourly",
      "specialist",
      "alcohol",
      "strabismus",
      "patients",
      "whose",
      "criteria",
      "waking",
      "referral",
      "before",
      "bedtime",
      "exposure"
    ]
  },
  {
    "id": "8e4b8b5d97d10adae73269c85a9f1ba9",
    "content": "Onset in children under 7 years interferes with the development of the visual system of the deviating eye in the brain leading to amblyopia. Acute onset at an older age causes double vision. Diplopia does not occur in children because of the ability to suppress the second image or development of amblyopia.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "1972",
    "type": "section",
    "keywords": [
      "years",
      "occur",
      "suppress",
      "development",
      "ability",
      "second",
      "acute",
      "under",
      "vision",
      "double",
      "image",
      "children",
      "causes",
      "onset",
      "diplopia",
      "leading",
      "because",
      "amblyopia",
      "interferes",
      "does"
    ]
  },
  {
    "id": "4f3af9d4382182604c7971593464bd5c",
    "content": "Amblyopia does not occur if the deviation alternated from one eye to the other. The more frequent types are horizontal misalignment. Esotropia is convergent deviation and exotropia is divergent deviation.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "1973",
    "type": "section",
    "keywords": [
      "misalignment",
      "esotropia",
      "exotropia",
      "types",
      "divergent",
      "occur",
      "alternated",
      "amblyopia",
      "other",
      "convergent",
      "deviation",
      "does",
      "more",
      "horizontal",
      "frequent"
    ]
  },
  {
    "id": "10c86477642514d43c82ee71200ae002",
    "content": "Causes\nCongenital misalignment\nAcquired deviation\nParalysis of the cranial nerve VI, III or IV.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "1974",
    "type": "section",
    "keywords": [
      "misalignment",
      "cranial",
      "nerve",
      "acquired",
      "deviation",
      "paralysis",
      "causes",
      "congenital"
    ]
  },
  {
    "id": "6047163d4ca5f25566631d24409ea118",
    "content": "Fibrosis in an extraocular muscle\nMyasthenia gravis\nIntraocular lesion e. g. retinoblastoma and macular scar\nSymptoms\nMisalignment of the eye\nImpaired judgement of depth or distance\nDiplopia or double vision\nSigns\nDeviation of the corneal light reflex in one eye from a central position\nMovement of the deviating eye to take up fixation when the fixing\neye is covered\nNormal extraocular eye movement (in non-paralytic strabismus)\nLimitation of eye movement (in paralytic or restrictive strabismus)\nHypermetropia on refraction in children\nRetinal lesion e.",
    "title": "Chapter 19: Eye Dısorders",
    "section": "Chapter 19: Eye Dısorders",
    "chunk_id": "1975",
    "type": "section",
    "keywords": [
      "misalignment",
      "depth",
      "hypermetropia",
      "scar",
      "position",
      "light",
      "paralytic",
      "impaired",
      "covered",
      "intraocular",
      "lesion",
      "movement",
      "restrictive",
      "retinal",
      "vision",
      "strabismus",
      "extraocular",
      "muscle",
      "double",
      "reflex"
    ]
  },
  {
    "id": "a65eeabcb0671a53b8d16a588869e81b",
    "content": "g. retinoblastoma\ninvestigations\nCycloplegic refraction in children\nOther specific tests for suspected causes e. g.",
    "title": "Chapter 19: Eye Dısorders",
    "section": "Chapter 19: Eye Dısorders",
    "chunk_id": "1976",
    "type": "section",
    "keywords": [
      "suspected",
      "cycloplegic",
      "refraction",
      "other",
      "tests",
      "specific",
      "retinoblastoma",
      "investigations",
      "children",
      "causes"
    ]
  },
  {
    "id": "4e304cf260d3af3a485ff7bceff79326",
    "content": "To identify and correct any significant refractive error\nTo treat any amblyopia\nTo relieve any diplopia\nTo correct the misalignment\nTo treat any underlying condition.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1977",
    "type": "section",
    "keywords": [
      "refractive",
      "misalignment",
      "error",
      "treat",
      "correct",
      "amblyopia",
      "significant",
      "relieve",
      "underlying",
      "identify",
      "condition",
      "diplopia"
    ]
  },
  {
    "id": "df3d6592b9b0ec1f1c0f3c405ba06ba6",
    "content": "Use of prisms to correct small deviations\nPatching of the deviating eye to relieve diplopia in older patients.",
    "title": "Treatment of amblyopia in the deviating eye by patching the non- deviating eye",
    "section": "Treatment of amblyopia in the deviating eye by patching the non- deviating eye",
    "chunk_id": "1978",
    "type": "section",
    "keywords": [
      "small",
      "correct",
      "deviating",
      "relieve",
      "deviations",
      "patients",
      "older",
      "prisms",
      "patching",
      "diplopia"
    ]
  },
  {
    "id": "dcc6f32d77458d1061eed3df9925d6c7",
    "content": "Nil\nReferral Criteria\nAll patients diagnosed with strabismus must be referred to the eye specialist for further management. Symptoms\nSudden loss of vision especially in sickle cell “SC” patients.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1979",
    "type": "section",
    "keywords": [
      "referral",
      "specialist",
      "sudden",
      "management",
      "must",
      "strabismus",
      "vision",
      "especially",
      "further",
      "sickle",
      "cell",
      "loss",
      "patients",
      "referred",
      "criteria",
      "symptoms",
      "diagnosed"
    ]
  },
  {
    "id": "0b5090b5d2215968f644e50f36218f70",
    "content": "Referral Criteria\nAll Sickle Cell “SC” patients 12 years and above should be referred to the eye specialist for screening for proliferative sickle cell retinopathy. Refer all sickle cell patients with eye complications to the eye specialist. Referral Criteria\nPatients with persistently poor blood glucose control, poor blood pressure control, frequent diabetes-related admissions, visual impairment, cataract or any retinal changes, foot ulcers or gangrene, persistent proteinuria, or other chronic complications of diabetes should be referred to the eye specialist.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1980",
    "type": "section",
    "keywords": [
      "years",
      "glucose",
      "poor",
      "gangrene",
      "specialist",
      "pressure",
      "retinal",
      "persistently",
      "screening",
      "patients",
      "changes",
      "criteria",
      "blood",
      "retinopathy",
      "referral",
      "above",
      "chronic",
      "proliferative",
      "should",
      "impairment"
    ]
  },
  {
    "id": "bc954851a8c101e78b736c4ce98a305e",
    "content": "Stridor is an emergency condition. It has a characteristic noise in the inspiratory phase of breathing. This occurs when there is an obstruction of the upper airway from the nasopharnyx down to the trachea and main bronchi.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1981",
    "type": "section",
    "keywords": [
      "emergency",
      "stridor",
      "trachea",
      "characteristic",
      "down",
      "occurs",
      "main",
      "bronchi",
      "breathing",
      "obstruction",
      "phase",
      "there",
      "inspiratory",
      "condition",
      "nasopharnyx",
      "airway",
      "upper",
      "noise"
    ]
  },
  {
    "id": "90cdab52266e28142a5cb5314c1590a6",
    "content": "The obstruction is usually in the subglottic area. It is commonly a viral illness, and may be preceded usually by the common cold. Measles may also be complicated by Laryngotracheobronchitis (LTB).",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1982",
    "type": "section",
    "keywords": [
      "usually",
      "complicated",
      "common",
      "preceded",
      "cold",
      "also",
      "subglottic",
      "obstruction",
      "illness",
      "measles",
      "laryngotracheobronchitis",
      "area",
      "viral",
      "commonly"
    ]
  },
  {
    "id": "69c700f74f6e89b2a99309806a586a80",
    "content": "Two important causes of stridor in children are viral croup (LTB) and acute epiglottitis. In the management of stridor, steroids are most useful when given within 6 hours of onset of symptoms. Cough syrups containing opiates and atropine are contraindicated.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1983",
    "type": "section",
    "keywords": [
      "important",
      "given",
      "management",
      "acute",
      "within",
      "stridor",
      "opiates",
      "syrups",
      "atropine",
      "most",
      "children",
      "causes",
      "onset",
      "steroids",
      "epiglottitis",
      "containing",
      "croup",
      "symptoms",
      "viral",
      "cough"
    ]
  },
  {
    "id": "32446862c9b8e67c65800f1aeabb9b0a",
    "content": "STRiDOR iN CHiLDREN\nCauses\nViral (laryngotracheobronchitis)\nBacterial infection\nAcute epiglottitis\nInflammatory obstruction\nInhalation of hot fumes e. g. in fire outbreaks\nAngioneurotic oedema\nRetropharyngeal abscess\nInhalation of a foreign body\nCongenital malformation of the larynx e.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1984",
    "type": "section",
    "keywords": [
      "oedema",
      "angioneurotic",
      "fumes",
      "acute",
      "abscess",
      "body",
      "stridor",
      "retropharyngeal",
      "foreign",
      "malformation",
      "obstruction",
      "children",
      "causes",
      "congenital",
      "outbreaks",
      "epiglottitis",
      "inhalation",
      "bacterial",
      "laryngotracheobronchitis",
      "viral"
    ]
  },
  {
    "id": "4c003e5e764f0d55452db4a17c900d26",
    "content": "g. laryngomalacia\nSymptoms\nLow grade fever\nHoarse voice\nBarking cough\nBreathing difficulty\nRestlessness\nSigns\nStridor.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "1985",
    "type": "section",
    "keywords": [
      "laryngomalacia",
      "grade",
      "restlessness",
      "barking",
      "stridor",
      "hoarse",
      "cough",
      "fever",
      "difficulty",
      "breathing",
      "signs",
      "voice",
      "symptoms"
    ]
  },
  {
    "id": "74fc4146e7a5e4254d6c71ca49549cbb",
    "content": "Low grade fever\nRestless apprehensive child when obstruction is severe\nHoarse voice\nBarking cough\nLaboured breathing e. g. suprasternal, supraclavicular, substernal and intercostals retractions\nTachypnoea\nCyanosis in severe obstruction\nReddened throat\ninvestigations\nSputum culture\nLateral soft tissue X-ray of neck\nChest X-ray.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1986",
    "type": "section",
    "keywords": [
      "barking",
      "child",
      "breathing",
      "cyanosis",
      "voice",
      "suprasternal",
      "tachypnoea",
      "neck",
      "sputum",
      "lateral",
      "chest",
      "hoarse",
      "retractions",
      "obstruction",
      "laboured",
      "culture",
      "apprehensive",
      "reddened",
      "grade",
      "severe"
    ]
  },
  {
    "id": "37ccf8499944a67203a241880304f932",
    "content": "To avoid aggravation of the obstruction with thick or crusted\nsecretions\nTo ensure early and timely relief of obstruction.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "1987",
    "type": "section",
    "keywords": [
      "avoid",
      "thick",
      "ensure",
      "crusted",
      "timely",
      "secretions",
      "early",
      "relief",
      "obstruction",
      "aggravation"
    ]
  },
  {
    "id": "2bad481611aad3b69923d69c5ffb8971",
    "content": "Ensuring good hydration including liberal oral fluids\nEnsure maximum rest for the child\nEstablish the airway by intubation or tracheostomy in severe obstruction.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1988",
    "type": "section",
    "keywords": [
      "tracheostomy",
      "severe",
      "intubation",
      "ensure",
      "including",
      "liberal",
      "establish",
      "oral",
      "child",
      "obstruction",
      "fluids",
      "rest",
      "maximum",
      "ensuring",
      "airway",
      "hydration"
    ]
  },
  {
    "id": "e33b575a1e42ad062f2a59788d5ff681",
    "content": "For hydration of very sick patients who cannot drink.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "1989",
    "type": "section",
    "keywords": [
      "drink",
      "sick",
      "cannot",
      "patients",
      "hydration"
    ]
  },
  {
    "id": "d154aee63a3b9d8b1de3f003a726a638",
    "content": "Dextrose saline, IV, 5%\nFor restless and distressed children who require oxygen\nOxygen, 1-6 L as required (based on oxygen saturation level)\nFor steroid therapy\nDexamethasone, oral/IM/IV,\nChildren\n0. 6 mg/kg stat. Or\nBudesonide, nebulised,\nChildren 2 mg stat.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "1990",
    "type": "section",
    "keywords": [
      "require",
      "oxygen",
      "based",
      "level",
      "budesonide",
      "restless",
      "nebulised",
      "dextrose",
      "saline",
      "saturation",
      "steroid",
      "distressed",
      "oral",
      "required",
      "children",
      "dexamethasone",
      "therapy",
      "stat"
    ]
  },
  {
    "id": "ce4bb86e608e1ab5c861fbfe47e7b8f4",
    "content": "Hydrocortisone, IV,\nChildren\n4 mg/kg 6 hourly for 2-3 days\nin superimposed bacterial infection.",
    "title": "Chapter 20: Ear, Nose and Throat Dısorders",
    "section": "Chapter 20: Ear, Nose and Throat Dısorders",
    "chunk_id": "1991",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "superimposed",
      "infection",
      "bacterial",
      "hydrocortisone",
      "children"
    ]
  },
  {
    "id": "e9360d7fd171c89e19468f78bda5aef9",
    "content": "Cloxacillin, IV,\nChildren\n5-12 years;\t250 mg 6 hourly for 7 days\n1-5 years;\t125 mg 6 hourly for 7 days\n< 1 year;\t62. 5 mg 6 hourly for 7 days\nAnd\nGentamicin, IV,\nChildren\n1-12 years;\t2. 5 mg/kg 8 hourly for 7 days\n< 1 year;\t2.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "1992",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "gentamicin",
      "years",
      "children",
      "cloxacillin",
      "year"
    ]
  },
  {
    "id": "6dc9468075a6eda850ce439150c744c6",
    "content": "5 mg/kg 12 hourly for 7 days\nAnd\nMetronidazole, IV,\nChildren\n7. 5 mg/kg 8 hourly for 7 days.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "1993",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "children"
    ]
  },
  {
    "id": "2d9b850c182c5d79bb86dfe8d164df52",
    "content": "Cefuroxime, IV,\nChildren\n20 mg/kg 8 hourly\nAnd\nMetronidazole, IV,\nChildren\n7. 5 mg/kg 8 hourly for 7 days\nFor severe Croup\nAdrenaline, 1:1000 solution, nebulised, 2 ml stat. Then\nRepeat hourly if effective\nSTRiDOR iN ADULTS\nCauses\nInflammatory obstruction\nAcute epiglottitis\nLaryngeal tumour\nVocal cord paralysis.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "1994",
    "type": "section",
    "keywords": [
      "metronidazole",
      "nebulised",
      "adrenaline",
      "paralysis",
      "acute",
      "hourly",
      "stridor",
      "repeat",
      "laryngeal",
      "obstruction",
      "children",
      "tumour",
      "causes",
      "stat",
      "days",
      "severe",
      "epiglottitis",
      "adults",
      "croup",
      "then"
    ]
  },
  {
    "id": "a768778436883a8f2224c21f6d1b9dc2",
    "content": "Retropharyngeal abscess\nInhalation of a foreign body\nSymptoms\nHoarse voice\nBreathing difficulty\nRestlessness\nSigns\nStridor\nLaboured breathing\nTachypnoea\nCyanosis in severe obstruction\ninvestigations\nLateral soft tissue X ray of neck\nChest X-ray.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "1995",
    "type": "section",
    "keywords": [
      "breathing",
      "cyanosis",
      "voice",
      "tachypnoea",
      "neck",
      "abscess",
      "body",
      "lateral",
      "retropharyngeal",
      "stridor",
      "chest",
      "hoarse",
      "foreign",
      "obstruction",
      "signs",
      "laboured",
      "restlessness",
      "severe",
      "inhalation",
      "difficulty"
    ]
  },
  {
    "id": "702fc2e394093b39096bf04ca3331a56",
    "content": "Establish the airway by intubation or tracheostomy in severe obstruction.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "1996",
    "type": "section",
    "keywords": [
      "tracheostomy",
      "severe",
      "intubation",
      "establish",
      "obstruction",
      "airway"
    ]
  },
  {
    "id": "38d71dbbcfdca3b91fe26b682334b12d",
    "content": "For oxygen therapy\nOxygen, 1-6 L as required (based on oxygen saturation level)\nFor steroid therapy\nHydrocortisone, IV,\nAdults\n100 mg 6 hourly for 2-3 days\nFor superimposed bacterial infection.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [C]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "1997",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "oxygen",
      "based",
      "level",
      "superimposed",
      "infection",
      "bacterial",
      "adults",
      "steroid",
      "saturation",
      "hydrocortisone",
      "required",
      "therapy"
    ]
  },
  {
    "id": "5050a151052cbb5ff7d4899cbd09779a",
    "content": "Amoxicillin + Clavulanic Acid, IV,\nAdults\n600 mg 8 hourly\nOr\n1. 2 g 12 hourly\nAnd\nMetronidazole, IV,\nAdults\n500 mg 8 hourly for 7 days.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "1998",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "amoxicillin",
      "metronidazole",
      "acid",
      "adults",
      "clavulanic"
    ]
  },
  {
    "id": "cb319bd47595f939a400e22560b78cd5",
    "content": "Cefuroxime, IV,\nAdults\n750 mg 8 hourly\nAnd\nMetronidazole, IV,\nAdults\n500 mg 8 hourly for 7 days\nReferral Criteria\nRefer cases with severe obstruction and complications in children to a Paediatrician or ENT specialist. Also refer all cases of stridor if there is no expertise to intubate or perform tracheostomy to a specialist. This is an acute and life-threatening infection in which the epiglottis and surrounding tissue become acutely inflamed and oedematous causing severe obstruction of the upper airways.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "1999",
    "type": "section",
    "keywords": [
      "metronidazole",
      "surrounding",
      "inflamed",
      "which",
      "airways",
      "acutely",
      "acute",
      "tracheostomy",
      "hourly",
      "expertise",
      "paediatrician",
      "specialist",
      "stridor",
      "upper",
      "perform",
      "obstruction",
      "children",
      "criteria",
      "causing",
      "days"
    ]
  },
  {
    "id": "db8cc6c6f27679a627810599653d08a4",
    "content": "The disease tends to run an extremely rapid course (4-6 hours) to respiratory failure and death. It is more common in children. However, the incidence has reduced significantly due to the current immunisation schedule with the pentavalent vaccine.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "2000",
    "type": "section",
    "keywords": [
      "significantly",
      "extremely",
      "reduced",
      "death",
      "schedule",
      "children",
      "vaccine",
      "disease",
      "rapid",
      "pentavalent",
      "course",
      "incidence",
      "respiratory",
      "immunisation",
      "failure",
      "tends",
      "however",
      "common",
      "more",
      "hours"
    ]
  },
  {
    "id": "32988e783a7ced892f6b252c25f84679",
    "content": "Examination of the throat in patients with this condition must be done only in the presence of a doctor capable and ready to intubate. Causes\nHaemophilus influenzae type B\nStreptococcus pyogenes\nStreptococcus pneumoniae\nStaphylococcus aureus\nSymptoms\nSudden onset of high fever\nDrooling of saliva\nDysphagia\nBreathing difficulty\nSigns\nExtremely ill and toxic child\nFever\nHead is held forward to extend the neck\nBreathing difficulty\nWeak voice (not hoarse)\nReduced air entry on auscultation\nStridor.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "2001",
    "type": "section",
    "keywords": [
      "sudden",
      "streptococcus",
      "auscultation",
      "ready",
      "extremely",
      "breathing",
      "child",
      "reduced",
      "aureus",
      "extend",
      "voice",
      "neck",
      "dysphagia",
      "haemophilus",
      "type",
      "stridor",
      "hoarse",
      "pyogenes",
      "held",
      "saliva"
    ]
  },
  {
    "id": "ece36b3763e808243eec77d0d466d6e9",
    "content": "Cyanosis in very sick children\nSwollen and reddened epiglottis\ninvestigations\nFBC\nBlood culture\nLateral soft tissue X-ray of the neck.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2002",
    "type": "section",
    "keywords": [
      "lateral",
      "sick",
      "tissue",
      "swollen",
      "epiglottis",
      "culture",
      "investigations",
      "children",
      "cyanosis",
      "soft",
      "reddened",
      "blood",
      "neck"
    ]
  },
  {
    "id": "d214d9b44c2cc21b996d0f85c803bd83",
    "content": "Establishment of airway if necessary by intubation or tracheostomy.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2003",
    "type": "section",
    "keywords": [
      "tracheostomy",
      "establishment",
      "intubation",
      "necessary",
      "airway"
    ]
  },
  {
    "id": "f50ed2f1948f0298007d606c6727cfbf",
    "content": "Cefuroxime, IV,\nAdults\n750 mg-1. 5 g 8 hourly for 7 days\nChildren\n25 mg/kg 8 hourly for 7 days\nAnd\nMetronidazole, IV,\nAdults\n500 mg 8 hourly for 7 days\nChildren\n7. 5 mg/kg 6 hourly for 7 days.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2004",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "adults",
      "cefuroxime",
      "children"
    ]
  },
  {
    "id": "076b4a8367cd7758e0343881c2f6579a",
    "content": "Cefotaxime, IV,\nAdults\n1-2 g IV or IM 8 hourly for 7 days\nChildren\n50 mg/kg 8 hourly for 7 days\nOr\nAmoxicillin + Clavulanic Acid, IV,\nAdults\n1. 2 g 12 hourly,\nIncreased to 1. 2 g 8 hourly for 7 days in severe infections\nChildren\n12-18 years;\t600 mg to 1.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2005",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "amoxicillin",
      "severe",
      "cefotaxime",
      "infections",
      "years",
      "acid",
      "adults",
      "clavulanic",
      "children",
      "increased"
    ]
  },
  {
    "id": "38f9cfa648e7e19197615ed41b39df1b",
    "content": "2 g 12 hourly, Increased to 1. 2g 8 hourly for 7 days in severe infections 3 months-12 years;\t30 mg/kg 12 hourly,\nIncreased to 30 mg/kg 8 hourly for 7 days in severe infections.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2006",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "severe",
      "infections",
      "years",
      "months",
      "increased"
    ]
  },
  {
    "id": "893bff4aa6d0d2b90898e28a66d7f107",
    "content": "7 days-3 months;\t30 mg/kg 8 hourly for 7 days\nPreterm and < 7 days;  30 mg/kg 12 hourly for 7 days\nReferral Criteria\nRefer all patients immediately to a specialist if there is no expertise available for intubation or tracheostomy. This emergency condition refers to collection of pus in the retropharyngeal space. Early diagnosis and treatment will prevent mortality.",
    "title": "Chapter 20: Ear, Nose and Throat Dısorders",
    "section": "Chapter 20: Ear, Nose and Throat Dısorders",
    "chunk_id": "2007",
    "type": "section",
    "keywords": [
      "space",
      "refers",
      "tracheostomy",
      "hourly",
      "expertise",
      "specialist",
      "emergency",
      "retropharyngeal",
      "immediately",
      "prevent",
      "patients",
      "condition",
      "criteria",
      "treatment",
      "days",
      "referral",
      "diagnosis",
      "collection",
      "there",
      "available"
    ]
  },
  {
    "id": "030bb3f0e8662482e9c2d271b8dc5bdf",
    "content": "Causes\nGroup A -haemolytic Streptococcus\nStaphylococcus aureus\nOsteomyelitis of cervical vertebrae from tuberculosis\nSymptoms\nFever\nSore throat\nDifficulty in swallowing\nHyperextension of neck\nLaboured and noisy breathing\nSigns\nFever\nReddened throat, large and inflammed tonsils\nLaboured respiration with intercostal retractions\nStridor\nBulge in the posterior pharyngeal wall\ninvestigations\nFBC\nThroat swab for culture and sentivity testing\nZiehl-Neelsen stain to exclude tuberculosis\nLateral soft tissue X-ray of neck\nChest X-ray to exclude tuberculosis.",
    "title": "Chapter 20: Ear, Nose and Throat Dısorders",
    "section": "Chapter 20: Ear, Nose and Throat Dısorders",
    "chunk_id": "2008",
    "type": "section",
    "keywords": [
      "vertebrae",
      "pharyngeal",
      "streptococcus",
      "intercostal",
      "breathing",
      "sentivity",
      "aureus",
      "swallowing",
      "neck",
      "swab",
      "lateral",
      "stridor",
      "chest",
      "retractions",
      "large",
      "hyperextension",
      "tonsils",
      "signs",
      "laboured",
      "culture"
    ]
  },
  {
    "id": "adfebb78de51afa942a5259fd3e4b170",
    "content": "To treat infection\nTo relieve the obstruction by draining the abscess\nTo relieve pain.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2009",
    "type": "section",
    "keywords": [
      "abscess",
      "draining",
      "pain",
      "treat",
      "infection",
      "relieve",
      "obstruction"
    ]
  },
  {
    "id": "7bb18f7324b8167ecc5e11073ba49532",
    "content": "Incision and drainage of pus under general anaesthesia.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2010",
    "type": "section",
    "keywords": [
      "drainage",
      "anaesthesia",
      "incision",
      "general",
      "under"
    ]
  },
  {
    "id": "6fb9d1adaa43e7dded2badf1a647562a",
    "content": "Cefuroxime, IV,\nAdults\n750 mg-1. 5 g 8 hourly for 72 hours\nChildren\n25 mg/kg 8 hourly for 72 hours\nAnd\nMetronidazole, IV,\nAdults\n500 mg 8 hourly for 72 hours\nChildren\n7. 5 mg/kg 8 hourly for 72 hours\nThen\nCefuroxime, oral,\nAdults\n500 mg 12 hourly for 7 days\nChildren\n12-18 years;\t250 mg 12 hourly for 7 days\n2-12 years;\t15 mg/kg (max.",
    "title": "For treatment of infection 1st Line Treatment Evidence Rating: [B]",
    "section": "For treatment of infection 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2011",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "then",
      "years",
      "adults",
      "oral",
      "cefuroxime",
      "children",
      "hours"
    ]
  },
  {
    "id": "2856f53b2a85955973105c123ec112d9",
    "content": "250 mg) 12 hourly for 7\ndays\n3 months-2 years;\t10 mg/kg (max. 125 mg) 12 hourly for 7\ndays\nAnd\nMetronidazole, oral,\nAdults\n400 mg 8 hourly for 7 days\nChildren\n7. 5 mg/kg 8 hourly for 7 days.",
    "title": "For treatment of infection 1st Line Treatment Evidence Rating: [B]",
    "section": "For treatment of infection 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2012",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "years",
      "adults",
      "oral",
      "children",
      "months"
    ]
  },
  {
    "id": "8154c2ea262a8c7cd7d6986fc7113b25",
    "content": "Flucloxacillin, IV,\nAdults\n500 mg 6 hourly for 72 hours\nChildren\n50-100 mg/kg 6 hourly for 72 hours\nAnd\nMetronidazole, IV,\nAdults\n500 mg 8 hourly for 72 hours\nChildren\n7. 5 mg/kg 8 hourly for 72 hours\nThen\nMetronidazole, oral,\nAdults\n400 mg 8 hourly for 7 days\nChildren\n7. 5 mg/kg 8 hourly for 7 days\nAnd\nFlucloxacillin, oral,\nAdults\n500 mg 6 hourly for 7 days if patient is able to swallow\nChildren\n50 mg/kg 6 hourly for 7 days if patient is able to swallow\nReferral Criteria\nRefer all cases to the ENT specialist.",
    "title": "Chapter 20: Ear, Nose and Throat Dısorders",
    "section": "Chapter 20: Ear, Nose and Throat Dısorders",
    "chunk_id": "2013",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "referral",
      "specialist",
      "then",
      "swallow",
      "flucloxacillin",
      "able",
      "adults",
      "refer",
      "oral",
      "criteria",
      "cases",
      "children",
      "hours",
      "patient"
    ]
  },
  {
    "id": "54a414d5729d94b68ddd5291f4bc6b1d",
    "content": "This is an infection of the throat and tonsils. Most sore throats are due to viral infections and should NOT be treated with antibiotics as they subside within 3 to 5 days. However, it is important to diagnose streptococcal pharyngitis since it may give rise to abscesses in the throat (retropharyngeal and peritonsillar abscess) as well as complications that involve organs like the kidneys and the heart.",
    "title": "Chapter 20: Ear, Nose and Throat Dısorders",
    "section": "Chapter 20: Ear, Nose and Throat Dısorders",
    "chunk_id": "2014",
    "type": "section",
    "keywords": [
      "infections",
      "important",
      "antibiotics",
      "give",
      "streptococcal",
      "throats",
      "abscess",
      "within",
      "retropharyngeal",
      "treated",
      "tonsils",
      "heart",
      "most",
      "days",
      "kidneys",
      "should",
      "subside",
      "peritonsillar",
      "involve",
      "viral"
    ]
  },
  {
    "id": "97a6509c26be6a7b080e11d6d898302d",
    "content": "Streptococcal throat infections require treatment with antibiotics in order to reduce the complications noted above. Causes\nViruses\nHeamolytic streptococcus\nHaemophilus influenza\nOther gram positive bacteria\nSymptoms\nFever\nDifficulty in swallowing\nSore throat.",
    "title": "Chapter 20: Ear, Nose and Throat Dısorders",
    "section": "Chapter 20: Ear, Nose and Throat Dısorders",
    "chunk_id": "2015",
    "type": "section",
    "keywords": [
      "infections",
      "bacteria",
      "streptococcus",
      "antibiotics",
      "streptococcal",
      "swallowing",
      "haemophilus",
      "require",
      "heamolytic",
      "causes",
      "influenza",
      "treatment",
      "above",
      "fever",
      "difficulty",
      "gram",
      "symptoms",
      "positive",
      "complications",
      "viruses"
    ]
  },
  {
    "id": "7c28cf11249aa868e0a34cd995b2a3ae",
    "content": "Runny nose\nCough\nSigns\nReddened throat\nEnlarged and reddened tonsils\nSustained high grade fever\nPalpable tonsillar lymph glands (streptococcal pharyngitis)\nRunny nose (suggests viral)\nCough (suggests viral)\nRed eyes (suggests viral)\nWhitish exudate at the back of the throat as well as whitish tonsillar exudate\nScarlet fever rash\ninvestigations\nFBC\nMonospot test\nThroat swab for culture and sensitivity.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2016",
    "type": "section",
    "keywords": [
      "test",
      "lymph",
      "streptococcal",
      "sensitivity",
      "scarlet",
      "glands",
      "tonsillar",
      "rash",
      "sustained",
      "swab",
      "suggests",
      "exudate",
      "tonsils",
      "signs",
      "culture",
      "palpable",
      "reddened",
      "grade",
      "whitish",
      "fever"
    ]
  },
  {
    "id": "c63e51e159407103f9bd05a698fab716",
    "content": "To relieve symptoms\nTo recognise and treat streptococcal throat infection\nTo relieve pain.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2017",
    "type": "section",
    "keywords": [
      "pain",
      "treat",
      "throat",
      "infection",
      "recognise",
      "relieve",
      "streptococcal",
      "symptoms"
    ]
  },
  {
    "id": "a087350288d56fda119cf330e6bfa206",
    "content": "Paracetamol, oral,\nAdults\n500 mg-1 g 6-8 hourly\nChildren\nyears;\t250-500 mg 6-8 hourly\n1-5 years;\t120-250 mg 6-8 hourly\n3 months-1 year;\t60-120 mg 6-8 hourly\nOr\nIbuprofen, oral,\nAdults\n200-400 mg 8 hourly\nChildren\n7-12 year; 7. 5-10 mg/kg 6-8 hourly (max. 30 mg/kg or 600 mg per day)\n4-7 years; 7.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2018",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "adults",
      "oral",
      "paracetamol",
      "children",
      "months",
      "ibuprofen",
      "year"
    ]
  },
  {
    "id": "ace545ae6ba904d5159568a4bc85cfd4",
    "content": "5-10 mg/kg 8 hourly (max. 30 mg/kg or 450 mg per day).",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2019",
    "type": "section",
    "keywords": [
      "hourly"
    ]
  },
  {
    "id": "1d0612a6df2a6a58379012be65c31fdf",
    "content": "Amoxicillin, oral,\nAdults\n500 mg 8 hourly for 10 days\nChildren\nyears;\t250 mg 8 hourly for 10 days\nyears;\t125 mg 8 hourly for 10 days\n< 1 year;\t62. 5 mg 8 hourly for 10 days\nOr\nAmoxicillin + Clavulanic Acid, oral,\nAdults\n1 gram 12 hourly for 10 days\nChildren\n12 years;\tOne 500/125 mg strength tablet, 12 hourly for 10\ndays\n6-12 years; 5 ml of 400/57 mg suspension 12 hourly (5 ml of 250/62 mg suspension 8 hourly for 10 days; dose doubled in severe infection)\nyears;  5 ml of 200/28. 5 mg suspension 12 hourly for 10 days; dose doubled in severe infection\n1 month-1 year; 2.",
    "title": "For treating the infection 1st Line Treatment Evidence Rating: [A]",
    "section": "For treating the infection 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2020",
    "type": "section",
    "keywords": [
      "years",
      "doubled",
      "hourly",
      "clavulanic",
      "children",
      "days",
      "severe",
      "amoxicillin",
      "acid",
      "suspension",
      "adults",
      "gram",
      "dose",
      "month",
      "year",
      "tablet",
      "infection",
      "oral",
      "strength"
    ]
  },
  {
    "id": "7408e173e3191fb190251fb28622c9b0",
    "content": "5 ml of 200/28. 5 mg suspension 12 hourly for 10 days; dose doubled in severe infection\nNeonate;  2. 5 ml of 200/28.",
    "title": "For treating the infection 1st Line Treatment Evidence Rating: [A]",
    "section": "For treating the infection 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2021",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "severe",
      "infection",
      "suspension",
      "neonate",
      "dose",
      "doubled"
    ]
  },
  {
    "id": "815474e51b4643605bac3a990fd4d449",
    "content": "5 mg suspension 12 hourly for 10 days; dose doubled in severe infection\nOr\nAmoxicillin + Clavulanic Acid, IV,\nAdults\n600 mg-1. 2 g 12 hourly for 10 days\nChildren\n1-12 years;\t15 mg/kg 12 hourly for 10 days\nOr\nCrystalline Penicillin, IV,\nAdults\n2-4 MU 6 hourly for 10 days\nChildren\n12 years;\t2-4 MU 6 hourly for 10 days\n1-12 years;\t0. 6-1.",
    "title": "For treating the infection 1st Line Treatment Evidence Rating: [A]",
    "section": "For treating the infection 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2022",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "severe",
      "amoxicillin",
      "crystalline",
      "years",
      "acid",
      "penicillin",
      "infection",
      "suspension",
      "adults",
      "clavulanic",
      "dose",
      "children",
      "doubled"
    ]
  },
  {
    "id": "72631e1b1dc925692364ab63ce81d437",
    "content": "Cefuroxime, oral,\nAdult\n250 mg 12 hourly for 10 days\nChildren\n12 years;\t250 mg 12 hourly for 10 days\n3 months-12 years;\t10 mg/kg 12 hourly for 10 days\nOr\nCefuroxime, IV,\nAdult\n750 mg 8 hourly for 10 days\nChildren\n12 years;\t750 mg 8 hourly for 10 days\n3 months-12 years;\t25-50 mg/kg 8 hourly for 10 days\nFor treating the infection in patients allergic to penicillin\nErythromycin, oral,\nAdults\n500 mg 6 hourly for 10 days\nChildren\nyears;\t250 mg 6 hourly for 10 days\n1 month-2 years;\t125 mg 6 hourly for 10 days\nNeonates;\t12. 5 mg/kg 6 hourly\nOr\nAzithromycin, oral,\nAdults\n500 mg daily for 3 days\nChildren\n6 months;\t10 mg/kg daily for 3 days\nReferral Criteria\nRefer patients with recurrent tonsillitis, retropharyngeal and peritonsillar abcess to an ENT specialist. This is an acute infection of the para-nasal sinuses.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2023",
    "type": "section",
    "keywords": [
      "recurrent",
      "years",
      "neonates",
      "penicillin",
      "treating",
      "acute",
      "hourly",
      "specialist",
      "retropharyngeal",
      "abcess",
      "sinuses",
      "allergic",
      "patients",
      "children",
      "criteria",
      "days",
      "referral",
      "erythromycin",
      "adult",
      "adults"
    ]
  },
  {
    "id": "9ed6bcf1feb3abeeb71bcd475ef88d2e",
    "content": "It may lead to complications with attendant morbidity and mortality. Early recognition of this clinical condition is mandatory. Swimming in dirty waters, dental infection or dental extraction, fractures involving the sinuses, nasal obstruction from polyps and allergic rhinitis are predisposing factors to developing acute sinusitis.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2024",
    "type": "section",
    "keywords": [
      "polyps",
      "mandatory",
      "waters",
      "morbidity",
      "lead",
      "factors",
      "attendant",
      "acute",
      "developing",
      "predisposing",
      "sinuses",
      "extraction",
      "obstruction",
      "allergic",
      "condition",
      "dirty",
      "recognition",
      "fractures",
      "rhinitis",
      "mortality"
    ]
  },
  {
    "id": "aad4b5e72f1a5710a68db0632652a62e",
    "content": "Causes\nViral (common cold)\nBacterial\nGroup A haemolytic Streptococci.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2025",
    "type": "section",
    "keywords": [
      "streptococci",
      "viral",
      "bacterial",
      "common",
      "haemolytic",
      "group",
      "causes",
      "cold"
    ]
  },
  {
    "id": "be2e1bd4c36c59008ebb5e4f87e00473",
    "content": "influenzae\nM. catarrhalis\nAllergy\nSymptoms\nCough\nNasal congestion\nPressure in the face and head\nFrontal headaches\nPostnasal drip\nSigns\nYellow or green thick nasal discharge, which may be foul smelling\nHalitosis\nPersistent fever\nTenderness above and below the eyes, when patient bends over or when these areas are tapped lightly\ninvestigations\nFBC\nX-ray of paranasal sinuses.",
    "title": "Chapter 20: Ear, Nose and Throat Dısorders",
    "section": "Chapter 20: Ear, Nose and Throat Dısorders",
    "chunk_id": "2026",
    "type": "section",
    "keywords": [
      "thick",
      "face",
      "congestion",
      "which",
      "drip",
      "patient",
      "pressure",
      "foul",
      "halitosis",
      "lightly",
      "sinuses",
      "signs",
      "frontal",
      "bends",
      "headaches",
      "yellow",
      "tenderness",
      "above",
      "paranasal",
      "head"
    ]
  },
  {
    "id": "b289e66697806b17baddb9ba57269b87",
    "content": "To reduce symptoms of pain and fever\nTo eradicate infection\nTo encourage drainage of sinuses.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2027",
    "type": "section",
    "keywords": [
      "pain",
      "drainage",
      "reduce",
      "fever",
      "infection",
      "sinuses",
      "eradicate",
      "encourage",
      "symptoms"
    ]
  },
  {
    "id": "cd341860f81d59ca2757eaa205335bf9",
    "content": "Adequate hydration\nSteam inhalation\nTooth extraction under antibiotic cover (if dental focus of infection is present).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2028",
    "type": "section",
    "keywords": [
      "focus",
      "dental",
      "present",
      "cover",
      "inhalation",
      "steam",
      "infection",
      "extraction",
      "tooth",
      "antibiotic",
      "adequate",
      "hydration",
      "under"
    ]
  },
  {
    "id": "312ad48fd0dbf5b1b7f2625c8797e47a",
    "content": "Amoxicillin, oral,\nAdults\n500 mg 8 hourly for 10 days\nChildren\n6-12 years;\t250 mg 8 hourly for 10 days\nyears;\t125 mg 8 hourly for 10 days\n< 1 year;\t62. 5 mg 8 hourly for 10 days\nOr\nAmoxicillin + Clavulanic Acid, oral,.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2029",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "amoxicillin",
      "years",
      "acid",
      "adults",
      "clavulanic",
      "oral",
      "children",
      "year"
    ]
  },
  {
    "id": "e1da5bffaaaec140141973b1b9610849",
    "content": "Adults\n1g 12 hourly for 7 days\nChildren\n>12 years;\tOne 500/125 mg tablet 12 hourly for 10 days\n6-12 years;\t5 ml of 400/57 mg suspension 12 hourly for 10 days\nyears;  5 ml of 200/28. 5 mg suspension 12 hourly for 10 days 1 month-1 year; 2. 5 ml of 200/28.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2030",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "tablet",
      "years",
      "suspension",
      "adults",
      "month",
      "children",
      "year"
    ]
  },
  {
    "id": "0db51258c88092377c599ecb366058e3",
    "content": "5 mg suspension 12 hourly; dose doubled in severe infection\n2 weeks-1 month;\t1. 25 ml of 200/28. 5 mg suspension 12 hourly; dose doubled in severe infection.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2031",
    "type": "section",
    "keywords": [
      "severe",
      "hourly",
      "infection",
      "suspension",
      "dose",
      "month",
      "weeks",
      "doubled"
    ]
  },
  {
    "id": "011250c3a6e1f6b6db70347c32b65f51",
    "content": "Cefuroxime, oral,\nAdults\n250-500 mg 12 hourly for 5 - 7 days\nChildren\n3 months-12 years;\t125 mg 12 hourly, double in severe infec- tion.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2032",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "severe",
      "infec",
      "years",
      "adults",
      "oral",
      "double",
      "tion",
      "cefuroxime",
      "children",
      "months"
    ]
  },
  {
    "id": "90fc8885c2018034b42b83ae912f9063",
    "content": "allergy\nErythromycin, oral,\nAdults\n500 mg 6 hourly for 10 days\nChildren\n2-8 years;\t250 mg 6 hourly for 10 days\n1 month-2 years;\t125 mg 6 hourly for 10 days\nNeonate;\t12. 5 mg/kg 6 hourly\nOr\nAzithromycin, oral,\nAdults\n500 mg daily for 5 days\nChildren\n10 mg/kg daily for 5 days\nFor pain relief\nParacetamol, oral, (to relieve pain if present)\nAdults\n500 mg-1 g 6-8 hourly\nChildren\n6-12 years;\t250-500 mg 6-8 hourly\n1-5 years;\t120-250 mg 6-8 hourly\n3 months-1year;\t60-120 mg 6-8 hourly\nFor nasal decongestion\nEphedrine nasal drops Adults (1%).",
    "title": "For treatment of bacterial infection in patients with penicillin",
    "section": "For treatment of bacterial infection in patients with penicillin",
    "chunk_id": "2033",
    "type": "section",
    "keywords": [
      "decongestion",
      "years",
      "drops",
      "neonate",
      "relief",
      "hourly",
      "children",
      "days",
      "erythromycin",
      "adults",
      "allergy",
      "azithromycin",
      "paracetamol",
      "month",
      "months",
      "nasal",
      "pain",
      "present",
      "ephedrine",
      "oral"
    ]
  },
  {
    "id": "d250bc6f6aaf4c5aa63141064d7c0675",
    "content": "1-2 drops into each nostril up to 4 times daily when required\nChildren (0. 5%)\ndrops into each nostril up to 4 times daily when required\nOr\nNeomycin 0. 5%/Hydrocortisone 1.",
    "title": "Chapter 20: Ear, Nose and Throat Dısorders",
    "section": "Chapter 20: Ear, Nose and Throat Dısorders",
    "chunk_id": "2034",
    "type": "section",
    "keywords": [
      "drops",
      "each",
      "hydrocortisone",
      "times",
      "nostril",
      "required",
      "children",
      "neomycin",
      "into",
      "daily"
    ]
  },
  {
    "id": "d249c71730a03ee7c83a155460ab1b06",
    "content": "5% nasal drops,\nAdults\n2 drops 12 hourly\nChildren\n1 drop 12 hourly\nReferral Criteria.",
    "title": "Chapter 20: Ear, Nose and Throat Dısorders",
    "section": "Chapter 20: Ear, Nose and Throat Dısorders",
    "chunk_id": "2035",
    "type": "section",
    "keywords": [
      "hourly",
      "drop",
      "referral",
      "drops",
      "adults",
      "children",
      "criteria",
      "nasal"
    ]
  },
  {
    "id": "abbea600a85104bf60931d008b8baa4f",
    "content": "the ENT Specialist\nThis is an infection of the middle ear, which communicates with the throat. It is important in a febrile child to look for it and treat it. Untreated or poorly managed cases may lead to complications such as mastoiditis, chronic otitis media, deafness, meningitis and brain abscess.",
    "title": "Refer all cases, which do not improve after 1 week of treatment to",
    "section": "Refer all cases, which do not improve after 1 week of treatment to",
    "chunk_id": "2036",
    "type": "section",
    "keywords": [
      "important",
      "treat",
      "communicates",
      "which",
      "child",
      "poorly",
      "lead",
      "otitis",
      "abscess",
      "specialist",
      "mastoiditis",
      "untreated",
      "deafness",
      "chronic",
      "febrile",
      "managed",
      "meningitis",
      "complications",
      "middle",
      "throat"
    ]
  },
  {
    "id": "803eb19048f562ffdf2067c79831b999",
    "content": "Precursors to the bacteria infections are viral upper respiratory tract infections. Causes\nHaemophilus influenzae\nHaemolytic streptococcus\nStreptococcus pneumoniae\nStaphylococcus aureus\nSymptoms\nFever\nSudden and persistent ear ache\nPurulent discharge from the ear\nVomiting\nDiarrhoea\nCrying and agitation\nImpaired hearing\nSigns\nRed eardrum\nDischarging ear\nOccasionally inflamed throat\nPerforated eardrum\ninvestigations\nFBC\nEar swab for culture and sensitivity.",
    "title": "Refer all cases, which do not improve after 1 week of treatment to",
    "section": "Refer all cases, which do not improve after 1 week of treatment to",
    "chunk_id": "2037",
    "type": "section",
    "keywords": [
      "infections",
      "sudden",
      "bacteria",
      "streptococcus",
      "inflamed",
      "agitation",
      "aureus",
      "sensitivity",
      "impaired",
      "crying",
      "diarrhoea",
      "haemophilus",
      "swab",
      "signs",
      "culture",
      "pneumoniae",
      "causes",
      "tract",
      "hearing",
      "perforated"
    ]
  },
  {
    "id": "162613ee4b1909187766657e533c2136",
    "content": "To relieve symptoms\nTo ensure prompt and adequate antibiotic therapy\nTo prevent chronicity and other complications.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "2038",
    "type": "section",
    "keywords": [
      "complications",
      "prompt",
      "ensure",
      "prevent",
      "other",
      "relieve",
      "chronicity",
      "antibiotic",
      "adequate",
      "therapy",
      "symptoms"
    ]
  },
  {
    "id": "21014de50dfc955108b7b6831449c1f1",
    "content": "Adequate hydration\nSurgical repair and drainage of abscess.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2039",
    "type": "section",
    "keywords": [
      "abscess",
      "drainage",
      "surgical",
      "repair",
      "adequate",
      "hydration"
    ]
  },
  {
    "id": "85ce16658ae5a016ac8ecad6eee29949",
    "content": "Amoxicillin, oral,\nAdults\n500 mg 8 hourly for 10 days\nChildren\n6-12 years;\t250 mg 8 hourly for 10 days\nyears;\t125 mg 8 hourly for 10 days\n< 1 year;\t62. 5 mg 8hourly for 10 days\nOr\nAmoxicillin + Clavulanic Acid, oral,\nAdults\n1 g 12 hourly for 7 days\nChildren\n12 years;\tOne 500/125 mg tablet 12 hourly for 10\ndays\n6-12 years;\t5 ml of 400/57mg suspension 12 hourly for 10 days\nyears;\t5 ml of 200/28. 5 mg suspension 12 hourly for 10 days\nmonth-1 year;\t2.",
    "title": "For treatment of infection 1st Line Treatment Evidence Rating: [B]",
    "section": "For treatment of infection 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2040",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "amoxicillin",
      "tablet",
      "years",
      "acid",
      "suspension",
      "adults",
      "clavulanic",
      "oral",
      "month",
      "children",
      "year"
    ]
  },
  {
    "id": "fe7f8e6c127ffad20e9776eb225bbf0f",
    "content": "5 ml of 200/28. 5 mg suspension 12 hour- ly; dose doubled in severe infection\nweeks-1 month;\t1. 25 ml of 200/28.",
    "title": "For treatment of infection 1st Line Treatment Evidence Rating: [B]",
    "section": "For treatment of infection 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2041",
    "type": "section",
    "keywords": [
      "severe",
      "hour",
      "infection",
      "suspension",
      "dose",
      "month",
      "weeks",
      "doubled"
    ]
  },
  {
    "id": "656d4d25449c143503978bd6dcd69f3f",
    "content": "5 mg suspension 12 hourly; dose doubled in severe infections.",
    "title": "For treatment of infection 1st Line Treatment Evidence Rating: [B]",
    "section": "For treatment of infection 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2042",
    "type": "section",
    "keywords": [
      "severe",
      "hourly",
      "infections",
      "suspension",
      "dose",
      "doubled"
    ]
  },
  {
    "id": "cbfb64e517f25c132ec2a679cbc09bfe",
    "content": "Cefuroxime, oral,\nAdults\n250 mg 12 hourly for 5 days\nChildren\n125 mg 12 hourly for 5 days.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2043",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "adults",
      "oral",
      "cefuroxime",
      "children"
    ]
  },
  {
    "id": "9c25680eb97826e5b64f6f36d9855686",
    "content": "Erythromycin, oral,\nAdults\n250-500mg 6 hourly for 10 days\nChildren\n2-8 years;\t250 mg 6 hourly for 10 days\n1 month-2 years;\t125 mg 6 hourly for 10 days\nNeonate;\t12. 5 mg/kg 6 hourly\nOr\nAzithromycin, oral,\nAdults\n500 mg once daily for 5 days\nChildren\n10 mg/kg once daily for 5 days\nReferral Criteria.",
    "title": "For treatment of infection in patients with penicillin allergy",
    "section": "For treatment of infection in patients with penicillin allergy",
    "chunk_id": "2044",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "referral",
      "erythromycin",
      "years",
      "adults",
      "neonate",
      "oral",
      "azithromycin",
      "month",
      "children",
      "daily",
      "criteria",
      "once"
    ]
  },
  {
    "id": "62acdb3d1f2df4e6ea229e9a444b275d",
    "content": "This is a chronic infection of the middle ear with perforation of the tympanic membrane and pus discharging from the ear for more than 2 weeks. Causes\nSecondary bacterial infections:\nPseudomonas aeruginosa\nProteus vulgaris\nPnuemococci\nSymptoms\nChronic ear discharge (otorrhoea)\nHearing loss\nSigns\nPerforation of tympanic membrane\nConductive hearing loss\nEar discharge.",
    "title": "Refer patient to ENT specialist if there is no response after 10 days of treatment.",
    "section": "Refer patient to ENT specialist if there is no response after 10 days of treatment.",
    "chunk_id": "2045",
    "type": "section",
    "keywords": [
      "infections",
      "tympanic",
      "pnuemococci",
      "pseudomonas",
      "aeruginosa",
      "secondary",
      "otorrhoea",
      "signs",
      "proteus",
      "weeks",
      "causes",
      "vulgaris",
      "chronic",
      "hearing",
      "membrane",
      "bacterial",
      "symptoms",
      "perforation",
      "discharging",
      "middle"
    ]
  },
  {
    "id": "191579a8c438d0f60542f9c6e7094858",
    "content": "investigations\nEar swab for culture and sensitivity.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2046",
    "type": "section",
    "keywords": [
      "sensitivity",
      "swab",
      "culture",
      "investigations"
    ]
  },
  {
    "id": "84322d682044bafe240dc88867b90334",
    "content": "To keep the ear dry\nTo treat any acute exacerbations and complications e. g. mastoiditis.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2047",
    "type": "section",
    "keywords": [
      "exacerbations",
      "complications",
      "treat",
      "keep",
      "mastoiditis",
      "acute"
    ]
  },
  {
    "id": "8635c308b275b0b8dbcdcba3c14cc11c",
    "content": "Roll a piece of clean absorbent gauze into a wick and insert carefully into the ear. Leave for one minute then remove and replace with a clean wick. Do frequently (at least 4 times a day)\nIf bleeding occurs, drying the ear should be stopped temporarily\nNothing should be left in the ear between wicking\nAvoid swimming or getting the inside of the ear wet\nRe-assess weekly to ensure that the mother is drying the ear correctly.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2048",
    "type": "section",
    "keywords": [
      "roll",
      "avoid",
      "carefully",
      "ensure",
      "mother",
      "times",
      "frequently",
      "gauze",
      "into",
      "wicking",
      "insert",
      "replace",
      "absorbent",
      "wick",
      "bleeding",
      "stopped",
      "nothing",
      "assess",
      "correctly",
      "drying"
    ]
  },
  {
    "id": "975d9b64ecafc95da2940f15c56d35a0",
    "content": "For topical antibiotic therapy\nEvidence Rating: [B]\nGentamicin ear drops, 0. 3%, 2-3 drops 6-8 hourly and at night\nOr\nCiprofloxacin eye/ear drops, 0. 3%, 1 drop 6 hourly daily\nReferral Criteria\nRefer all chronically discharging ears to the ENT Specialist.",
    "title": "(See section on Treatment for ‘Acute Otitis Media’)",
    "section": "(See section on Treatment for ‘Acute Otitis Media’)",
    "chunk_id": "2049",
    "type": "section",
    "keywords": [
      "drops",
      "antibiotic",
      "therapy",
      "night",
      "evidence",
      "ciprofloxacin",
      "hourly",
      "rating",
      "specialist",
      "criteria",
      "chronically",
      "topical",
      "referral",
      "drop",
      "gentamicin",
      "discharging",
      "refer",
      "ears",
      "daily"
    ]
  },
  {
    "id": "b428d0189171e5b7aa4e60c7668b1f81",
    "content": "Epistaxis also called nosebleed is a common medical emergency, which requires prompt management to avoid morbidity and mortality. Causes\nPicking of the nose, especially when there is an upper respiratory tract infection\nTrauma\nSinonasal and nasopharyngeal neoplasms\nHypertension.",
    "title": "(See section on Treatment for ‘Acute Otitis Media’)",
    "section": "(See section on Treatment for ‘Acute Otitis Media’)",
    "chunk_id": "2050",
    "type": "section",
    "keywords": [
      "picking",
      "hypertension",
      "avoid",
      "nasopharyngeal",
      "morbidity",
      "management",
      "especially",
      "which",
      "sinonasal",
      "emergency",
      "causes",
      "nosebleed",
      "tract",
      "prompt",
      "also",
      "respiratory",
      "there",
      "nose",
      "medical",
      "mortality"
    ]
  },
  {
    "id": "cd7eec4c1a01217f958c9f0624bbe1ef",
    "content": "Atrophic rhinitis\nSymptoms\nNose bleed\nSigns\nNose bleed.",
    "title": "Bleeding disorders",
    "section": "Bleeding disorders",
    "chunk_id": "2051",
    "type": "section",
    "keywords": [
      "atrophic",
      "bleed",
      "signs",
      "nose",
      "symptoms",
      "rhinitis"
    ]
  },
  {
    "id": "c027f92c76107aa057c94bb2ca7458c6",
    "content": "Signs related to underlying cause\nSigns of shock (if severe)\ninvestigations\nFBC\nSickling test\nCoagulation screen\nLiver function test\nRetroviral screen, if indicated.",
    "title": "Chapter 20: Ear, Nose and Throat Dısorders",
    "section": "Chapter 20: Ear, Nose and Throat Dısorders",
    "chunk_id": "2052",
    "type": "section",
    "keywords": [
      "severe",
      "sickling",
      "test",
      "function",
      "screen",
      "shock",
      "cause",
      "coagulation",
      "underlying",
      "signs",
      "liver",
      "indicated",
      "investigations",
      "related",
      "retroviral"
    ]
  },
  {
    "id": "ae725ed3ff7f30d7b4a2b0905113862d",
    "content": "To stop epistaxis\nTo prevent recurrence\nTo detect shock and replace blood if necessary.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2053",
    "type": "section",
    "keywords": [
      "replace",
      "recurrence",
      "prevent",
      "epistaxis",
      "stop",
      "shock",
      "necessary",
      "detect",
      "blood"
    ]
  },
  {
    "id": "d175905fccf17d13d81c2f58a4413a3c",
    "content": "Sit patient up and flex head to prevent blood running down throat and airway\nPinch soft part of nose for 10 minutes (patient must breathe through\nmouth)\nApply ice-pack to nasal bridge.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2054",
    "type": "section",
    "keywords": [
      "pinch",
      "down",
      "flex",
      "patient",
      "breathe",
      "bridge",
      "part",
      "prevent",
      "minutes",
      "pack",
      "blood",
      "running",
      "head",
      "mouth",
      "nose",
      "soft",
      "nasal",
      "throat",
      "must",
      "through"
    ]
  },
  {
    "id": "5d8ebe39857ea83d297fbffb125e22e2",
    "content": "Oxymetazoline, nasal spray, 2-3 sprays per nostril 12 hourly\nOr\nAdrenaline, topical, (as nose pack, on cotton wool) 1:1000 solutions\nReferral Criteria\nRefer patients with recurrent or severe epistaxis to the ENT specialist.",
    "title": "1st Line Treatment",
    "section": "1st Line Treatment",
    "chunk_id": "2055",
    "type": "section",
    "keywords": [
      "recurrent",
      "nostril",
      "adrenaline",
      "spray",
      "hourly",
      "cotton",
      "specialist",
      "pack",
      "patients",
      "criteria",
      "solutions",
      "severe",
      "topical",
      "referral",
      "wool",
      "nose",
      "sprays",
      "nasal",
      "oxymetazoline",
      "epistaxis"
    ]
  },
  {
    "id": "2f256148518434579f6b6ce1d34370b0",
    "content": "Dental caries is a tooth surface cavity caused by acid demineralization of tooth hard tissue. It occurs as a result bacterial conversion of refined carbohydrates to acids, which in prolonged contact with tooth surface leads to the demineralisation. This process is entirely preventable but can progress to severe decay and tooth loss or complicated by infection.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2056",
    "type": "section",
    "keywords": [
      "prolonged",
      "acids",
      "entirely",
      "which",
      "process",
      "surface",
      "demineralization",
      "result",
      "hard",
      "severe",
      "leads",
      "caused",
      "complicated",
      "refined",
      "acid",
      "decay",
      "bacterial",
      "caries",
      "progress",
      "carbohydrates"
    ]
  },
  {
    "id": "1eeac8117b22e4e78035e28250e03abd",
    "content": "Causes\nAcid demineralisation of hard tooth surface\nSymptoms\nUsually asymptomatic\nToothache precipitated by hot, cold or sweet foods or drinks\nPain may be intermittent or severe, sharp and constant if the nerve endings are exposed\nSigns\nA hole or black spot may be visible on any surface of a tooth\nTenderness on percussion of the affected tooth.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2057",
    "type": "section",
    "keywords": [
      "usually",
      "affected",
      "foods",
      "asymptomatic",
      "constant",
      "drinks",
      "visible",
      "surface",
      "intermittent",
      "precipitated",
      "nerve",
      "hard",
      "signs",
      "exposed",
      "causes",
      "severe",
      "tenderness",
      "endings",
      "acid",
      "sweet"
    ]
  },
  {
    "id": "ed75a736c5a8eb7b6588b72347f3e699",
    "content": "To relieve pain\nTo arrest process by excavation and filling of cavities\nTo educate on good dental habits\nTo prevent complications.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2058",
    "type": "section",
    "keywords": [
      "arrest",
      "complications",
      "pain",
      "dental",
      "process",
      "habits",
      "cavities",
      "excavation",
      "educate",
      "prevent",
      "relieve",
      "filling"
    ]
  },
  {
    "id": "dcd50330d8fec6a8bb7f347e1c8a6381",
    "content": "Regular mouth rinse after refined carbohydrate intake\nBrushing of teeth before bedtime.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2059",
    "type": "section",
    "keywords": [
      "before",
      "mouth",
      "refined",
      "regular",
      "carbohydrate",
      "bedtime",
      "rinse",
      "after",
      "intake",
      "brushing",
      "teeth"
    ]
  },
  {
    "id": "0298cb6682b619911486b075a01a57a7",
    "content": "A. For pain relief\nEvidence Rating: [C]\nParacetamol, oral,\nAdults\n500 mg-1 g 6-8 hourly\nChildren\n6-12 years;\t250-500 mg 6-8 hourly\n1-5 years;\t120-250 mg 6-8 hourly\nOr\nIbuprofen, oral,\nAdults\n200-400 mg 8 hourly\nChildren\n4-7 years;\t150 mg 8 hourly (max. 7.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2060",
    "type": "section",
    "keywords": [
      "hourly",
      "rating",
      "pain",
      "years",
      "adults",
      "relief",
      "oral",
      "paracetamol",
      "children",
      "evidence",
      "ibuprofen"
    ]
  },
  {
    "id": "bf0e3e32756ea619b2db54336c58a146",
    "content": "5-10 mg/kg daily\n6-8 hourly)\n7-12 year;\t200 mg 8 hourly (max. 7. 5-10 mg/kg daily\n6-8 hourly)\nReferral Criteria.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2061",
    "type": "section",
    "keywords": [
      "hourly",
      "referral",
      "criteria",
      "daily",
      "year"
    ]
  },
  {
    "id": "4528d0fcebc2aee2bbefaae68b691b66",
    "content": "Oral candidiasis (oral thrush) is an infection of the mouth by yeast. It mainly affects the very young, the very old or those whose immunity is impaired. It occurs more frequently in HIV/AIDS patients, the malnourished, diabetics, patients on long-term antibiotics and corticosteroids and those with poor oral hygiene.",
    "title": "Refer patient to a dentist for definitive treatment.",
    "section": "Refer patient to a dentist for definitive treatment.",
    "chunk_id": "2062",
    "type": "section",
    "keywords": [
      "antibiotics",
      "frequently",
      "aids",
      "poor",
      "corticosteroids",
      "impaired",
      "candidiasis",
      "thrush",
      "patients",
      "whose",
      "mouth",
      "young",
      "occurs",
      "those",
      "malnourished",
      "mainly",
      "yeast",
      "term",
      "hygiene",
      "infection"
    ]
  },
  {
    "id": "7e36c2ee65db62c4ac1fbe8811e35d78",
    "content": "Causes\nCandida albicans (monilia)\nSymptoms\nWhite patches in the mouth\nBurning sensation in the mouth\nDifficulty in swallowing\nBreast fed babies may refuse to suck\nSore mouth\nSigns\nWell defined white or cream–coloured pustules and patches in the mouth\ninvestigations\nBuccal mucosal scraping for fungal elements\nFBS\nRetroscreen.",
    "title": "Refer patient to a dentist for definitive treatment.",
    "section": "Refer patient to a dentist for definitive treatment.",
    "chunk_id": "2063",
    "type": "section",
    "keywords": [
      "candida",
      "white",
      "retroscreen",
      "mucosal",
      "albicans",
      "elements",
      "swallowing",
      "breast",
      "babies",
      "fungal",
      "pustules",
      "sensation",
      "signs",
      "burning",
      "suck",
      "causes",
      "coloured",
      "mouth",
      "difficulty",
      "investigations"
    ]
  },
  {
    "id": "23f8989136b75a2dd200e4a809d6d552",
    "content": "To eradicate infection\nTo identify and treat any underlying condition.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2064",
    "type": "section",
    "keywords": [
      "treat",
      "infection",
      "eradicate",
      "underlying",
      "identify",
      "condition"
    ]
  },
  {
    "id": "b42583a75e5a2c71affe6365259c2a57",
    "content": "Nystatin suspension, oral,\nAdults\n100,000 units 6 hourly after food for 14 days\nChildren\n100,000 units 6 hourly after each feed for at least 10 days. Make sure it is spread well in the mouth.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2065",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "units",
      "least",
      "mouth",
      "sure",
      "each",
      "suspension",
      "adults",
      "food",
      "feed",
      "oral",
      "children",
      "after",
      "nystatin",
      "spread"
    ]
  },
  {
    "id": "7ca2a30c9fe261d20ec2dabee2d98d3d",
    "content": "Miconazole, oral gel,\nAdults and Children\n2. 5 ml smeared on the oral mucosa twice daily for 7-10 days\nFor immunocompromised patients with oral candidiasis\nEvidence Rating: [B]\nFluconazole, oral,\nAdults\n50-100 mg daily for 7-14 days\nChildren\n12-18 years;\t50-100 mg daily for 7-14 days 14 days-12 years;\t3-6 mg/kg on first day,\nThen\nmg/kg (max. 100 mg) daily for 14 days\n7-14 days;\t3-6 mg/kg on first day\nThen\n3 mg/kg every 48 hours for 14 days\n< 7 days;\t3-6 mg/kg on first day\nThen\n3 mg/kg every 72 hours for 14 days\nReferral Criteria\nRefer patients not responding to above treatment or if there is the presence of an underlying illness e.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "2066",
    "type": "section",
    "keywords": [
      "years",
      "miconazole",
      "twice",
      "evidence",
      "candidiasis",
      "rating",
      "underlying",
      "patients",
      "immunocompromised",
      "children",
      "presence",
      "criteria",
      "fluconazole",
      "treatment",
      "days",
      "first",
      "referral",
      "above",
      "adults",
      "there"
    ]
  },
  {
    "id": "c10ca966413fce1c1d6a11b4fe4f0144",
    "content": "g. diabetes mellitus, immunosuppression to appropriate specialist. It is a specific gum disease affecting mainly the interdental papillae and gum margin.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "2067",
    "type": "section",
    "keywords": [
      "disease",
      "interdental",
      "specialist",
      "papillae",
      "appropriate",
      "diabetes",
      "affecting",
      "mellitus",
      "mainly",
      "specific",
      "margin",
      "immunosuppression"
    ]
  },
  {
    "id": "6e4abbf3731bc1a9ffd6a2a1a5f0fa8f",
    "content": "It affects usually healthy young adults with poor oral hygiene. Causes\nSpirochaetes\nGram-negative fusiforms\nHost factors of poor oral hygiene, cigarette smoking and immune-\nsuppression\nSymptoms\nGum margin soreness or pain of sudden onset\nBleeding\nMalaise\nBad taste and foul breath\nSigns\nCrater-like ulcers and necrosis mainly limited to gum margin and inter-dental gingiva\nPoor oral hygiene\nFever\nLymph node enlargement\ninvestigations\nSwab for culture and sensitivity.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "2068",
    "type": "section",
    "keywords": [
      "usually",
      "sudden",
      "soreness",
      "spirochaetes",
      "lymph",
      "limited",
      "factors",
      "poor",
      "sensitivity",
      "inter",
      "swab",
      "foul",
      "fusiforms",
      "bleeding",
      "signs",
      "culture",
      "cigarette",
      "causes",
      "suppression",
      "onset"
    ]
  },
  {
    "id": "5d57f350aa02bd1e1738b1af927af97a",
    "content": "To eradicate bacterial overgrowth\nTo establish good oral hygiene\nTo control fever and pain.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2069",
    "type": "section",
    "keywords": [
      "pain",
      "hygiene",
      "establish",
      "bacterial",
      "fever",
      "eradicate",
      "oral",
      "control",
      "overgrowth"
    ]
  },
  {
    "id": "ab31da9940587c9befdb3ae01969745c",
    "content": "Improve oral hygiene habits e. g. brushing at least two times daily, frequent antiseptic oral rinse.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2070",
    "type": "section",
    "keywords": [
      "hygiene",
      "least",
      "habits",
      "improve",
      "rinse",
      "oral",
      "times",
      "brushing",
      "antiseptic",
      "daily",
      "frequent"
    ]
  },
  {
    "id": "b8e123a4306d2178ecc379b6448e3e64",
    "content": "Amoxicillin (Amoxycillin), oral,\nAdult\n1 g stat. Then\n500 mg 6 hourly for 7 days\nChildren\n7-10 years;\t250 mg 6 hourly for 7 days\n3-7 years;\t125 mg 6 hourly for 7 days\nyears;\t62. 5 mg 6 hourly for 7 days\nFor Individuals with penicillin allergy\nEvidence Rating: [C]\nClindamycin, oral,\nAdults\n150-300 mg 6-8 hourly for 7 days\nChildren\n12-18 years;\t150-300 mg 6 hourly for 7 days\n1 month-11 years;\t3-6 mg/kg 6 hourly for 7 days\nFor pain and fever control\nParacetamol, oral,\nAdults\n500 mg-1 g 6 hourly as required\nChildren\n6-12 years;\t250-500 mg 6 hourly as required\n1-5 years;\t125-250 mg 6 hourly as required\n3 months-1 year;\t62.",
    "title": "For treatment of infection 1st Line Treatment Evidence Rating: [B]",
    "section": "For treatment of infection 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2071",
    "type": "section",
    "keywords": [
      "years",
      "penicillin",
      "required",
      "amoxycillin",
      "evidence",
      "hourly",
      "rating",
      "children",
      "stat",
      "days",
      "amoxicillin",
      "clindamycin",
      "adult",
      "adults",
      "fever",
      "allergy",
      "paracetamol",
      "month",
      "months",
      "then"
    ]
  },
  {
    "id": "f3da23e7b304162d3c757732c5467f13",
    "content": "5-125 mg 6 hourly as required\nReferral Criteria\nRefer all patients after initiating therapy to a dentist. Antibiotic prophylaxis is an established requirement in the management of patients with cardiac related diseases at risk of bacterial endocarditis in the course of dental manipulation. Predisposing risk factors include previous history of bacterial endocarditis, history of heart valve disease and a history of heart valve replacement.",
    "title": "For treatment of infection 1st Line Treatment Evidence Rating: [B]",
    "section": "For treatment of infection 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2072",
    "type": "section",
    "keywords": [
      "management",
      "replacement",
      "factors",
      "initiating",
      "required",
      "antibiotic",
      "established",
      "therapy",
      "hourly",
      "diseases",
      "valve",
      "requirement",
      "endocarditis",
      "predisposing",
      "heart",
      "dentist",
      "patients",
      "criteria",
      "previous",
      "include"
    ]
  },
  {
    "id": "4314d9829081fe5198692c68c0ff71c0",
    "content": "Causes\nStreptococcus sanguis\nStreptococcus mitis\nStreptococcus mutans\nStreptococcus salivarius\nOther oral bacterial flora.",
    "title": "For treatment of infection 1st Line Treatment Evidence Rating: [B]",
    "section": "For treatment of infection 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2073",
    "type": "section",
    "keywords": [
      "mitis",
      "streptococcus",
      "other",
      "bacterial",
      "flora",
      "oral",
      "salivarius",
      "causes",
      "mutans",
      "sanguis"
    ]
  },
  {
    "id": "f3a0b942a6bdd091fb9bfef4f0906a85",
    "content": "To prevent seeding of oral bacteria during the transient bacteraemic\nphase during dental manipulation unto intra-cardiac defects and\nvalvular lesions.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2074",
    "type": "section",
    "keywords": [
      "intra",
      "bacteria",
      "dental",
      "prevent",
      "lesions",
      "transient",
      "during",
      "unto",
      "oral",
      "defects",
      "phase",
      "valvular",
      "manipulation",
      "bacteraemic",
      "cardiac",
      "seeding"
    ]
  },
  {
    "id": "6b00451b9961d44b92783071f5376234",
    "content": "Amoxicillin (Amoxycillin), oral,\nAdults\n2 g stat. (2 hours before procedure)\nChildren\n50 mg/kg stat. (2 hours before procedure).",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [B]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2075",
    "type": "section",
    "keywords": [
      "amoxicillin",
      "before",
      "adults",
      "procedure",
      "oral",
      "children",
      "hours",
      "amoxycillin",
      "stat"
    ]
  },
  {
    "id": "bf7791a55d2120d9f144b99b79559350",
    "content": "Or\nClindamycin, oral,\nAdults\n600 mg stat. (1 hour before procedure)\nChildren\n20 mg/kg stat. (1 hour before procedure)\nReferral Criteria\nRefer to a cardiologist if cardiac status cannot be ascertained or history is not clear.",
    "title": "Chapter 21: Oral and Dental Condıtıons",
    "section": "Chapter 21: Oral and Dental Condıtıons",
    "chunk_id": "2076",
    "type": "section",
    "keywords": [
      "cardiologist",
      "status",
      "clindamycin",
      "hour",
      "referral",
      "before",
      "clear",
      "adults",
      "procedure",
      "refer",
      "oral",
      "cannot",
      "ascertained",
      "history",
      "children",
      "criteria",
      "stat",
      "cardiac"
    ]
  },
  {
    "id": "42c597fcbcc7ef176352b7c7ed31c49e",
    "content": "Bacterial infection usually of the parotid glands. It is mostly unilateral. Seen exclusively in debilitated, elderly, dehydrated patients or who have drug or disease-induced xerostomia.",
    "title": "Chapter 21: Oral and Dental Condıtıons",
    "section": "Chapter 21: Oral and Dental Condıtıons",
    "chunk_id": "2077",
    "type": "section",
    "keywords": [
      "usually",
      "unilateral",
      "disease",
      "infection",
      "bacterial",
      "parotid",
      "drug",
      "xerostomia",
      "seen",
      "debilitated",
      "elderly",
      "exclusively",
      "have",
      "patients",
      "induced",
      "mostly",
      "dehydrated",
      "glands"
    ]
  },
  {
    "id": "91403f4373d318440d01f6fbeb94956e",
    "content": "Causes\nStaphylococcus aureus\nAnaerobes\nStreptococcus (occasionally)\nSymptoms\nPainful parotid swelling of sudden onset\nFever\nChills\nSigns\nErythematous swelling\nTense and shiny overlying skin\nPurulent discharge from duct\ninvestigations\nFBC\nCulture and sensitivity of discharge.",
    "title": "Chapter 21: Oral and Dental Condıtıons",
    "section": "Chapter 21: Oral and Dental Condıtıons",
    "chunk_id": "2078",
    "type": "section",
    "keywords": [
      "sudden",
      "shiny",
      "streptococcus",
      "chills",
      "swelling",
      "aureus",
      "sensitivity",
      "anaerobes",
      "signs",
      "culture",
      "causes",
      "tense",
      "onset",
      "staphylococcus",
      "fever",
      "painful",
      "parotid",
      "skin",
      "purulent",
      "investigations"
    ]
  },
  {
    "id": "adf2d17e9f0f56ba91d32fc04ce2c336",
    "content": "Encourage bed-rest\nAdequate fluid intake\nDiscontinue medications that can cause xerostomia\nSurgical drainage if indicated.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2079",
    "type": "section",
    "keywords": [
      "surgical",
      "drainage",
      "medications",
      "discontinue",
      "cause",
      "xerostomia",
      "rest",
      "indicated",
      "intake",
      "encourage",
      "adequate",
      "fluid"
    ]
  },
  {
    "id": "8b2a09925452ff972aa1383b840ec74c",
    "content": "Flucloxacillin, oral,\nAdults\n500 mg 6 hourly for 7-10 days\nChildren\n5-12 years;\t250 mg 6 hourly for 7-10 days\n1-5 years;\t125 mg 6 hourly for 7-10 days\n< 1 year;\t62. 5 mg 6 hourly for 7-10 days.",
    "title": "For treatment of infection 1st Line Treatment Evidence Rating: [B]",
    "section": "For treatment of infection 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2080",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "years",
      "flucloxacillin",
      "adults",
      "oral",
      "children",
      "year"
    ]
  },
  {
    "id": "035bacf5a963f7b0002c4a9f0fbea60d",
    "content": "Evidence Rating: [C]\nClindamycin, oral,\nAdults\n150-300 mg 6-8 hourly for 7 days\nChildren\n12-18 years;\t150-300 mg 6 hourly for 7 days\n1 month-11 years;\t3-6 mg/kg 6 hourly for 7 days\nFor pain relief\nParacetamol, oral,\nAdults\n500 mg-1 g 6 hourly as required\nChildren\n6-12 years;\t250-500 mg 6 hourly as required\nyears;\t125-250 mg 6 hourly as required\n3 months-1 year;\t62. 5-125 mg 6 hourly as required\nReferral Criteria.",
    "title": "For treatment of infection in patients with penicillin allergy",
    "section": "For treatment of infection in patients with penicillin allergy",
    "chunk_id": "2081",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "rating",
      "clindamycin",
      "pain",
      "years",
      "referral",
      "adults",
      "relief",
      "oral",
      "paracetamol",
      "required",
      "month",
      "children",
      "months",
      "criteria",
      "evidence",
      "year"
    ]
  },
  {
    "id": "39086bd7017bbd71f594b5cf27b62237",
    "content": "It is a spreading infection originating usually from a molar tooth into the fascial spaces of the sub-lingual, sub-mandibular and para-pharynx. This happens when a periapical abscess erodes through the lingual cortical plate of the mandible and gains access to these neck fascial spaces. The infection can then track down and enter the thorax.",
    "title": "Refer to a dentist after initiation of treatment.",
    "section": "Refer to a dentist after initiation of treatment.",
    "chunk_id": "2082",
    "type": "section",
    "keywords": [
      "spreading",
      "usually",
      "plate",
      "down",
      "thorax",
      "gains",
      "pharynx",
      "spaces",
      "into",
      "neck",
      "abscess",
      "enter",
      "erodes",
      "periapical",
      "fascial",
      "lingual",
      "molar",
      "track",
      "cortical",
      "tooth"
    ]
  },
  {
    "id": "e7e5f8aaec9d60ee2219147478ac69af",
    "content": "Another source of infection is the tonsillar crypt abscess. The initial presentation with swelling of the floor of the mouth and spread, with upper neck involvement is termed Ludwig’s angina. As it spreads down the neck, the term cervico-facial abscess is used.",
    "title": "Refer to a dentist after initiation of treatment.",
    "section": "Refer to a dentist after initiation of treatment.",
    "chunk_id": "2083",
    "type": "section",
    "keywords": [
      "initial",
      "down",
      "swelling",
      "neck",
      "tonsillar",
      "abscess",
      "presentation",
      "involvement",
      "angina",
      "floor",
      "termed",
      "spreads",
      "crypt",
      "facial",
      "mouth",
      "cervico",
      "source",
      "another",
      "term",
      "infection"
    ]
  },
  {
    "id": "457c22cf0343cb9919a5ea2884ca89a1",
    "content": "This condition is an emergency and must be treated as such.",
    "title": "Refer to a dentist after initiation of treatment.",
    "section": "Refer to a dentist after initiation of treatment.",
    "chunk_id": "2084",
    "type": "section",
    "keywords": [
      "emergency",
      "must",
      "treated",
      "condition"
    ]
  },
  {
    "id": "c2380239b137d6a0c5778db6f0dd6683",
    "content": "Causes\nOdontogenic infection\nα-haemolytic Streptococci\nStaphylococci\nBacteriodes\nTonsillar crypt abscess\nSymptoms\nFacial swelling with floor of the mouth elevated with oedema\nProtruding tongue\nDrooling of saliva\nFever\nChills\nSigns\nTense and tender jaw swelling\nBoard-like firmness of jaw swelling\nSevere systemic upset\nRaised floor of the mouth with limitation of mouth-closing and saliva drooling\nDehydration\ninvestigations\nFBC\nBUE/CR\nX-ray of jaw.",
    "title": "Chapter 21: Oral and Dental Condıtıons",
    "section": "Chapter 21: Oral and Dental Condıtıons",
    "chunk_id": "2085",
    "type": "section",
    "keywords": [
      "oedema",
      "chills",
      "board",
      "swelling",
      "systemic",
      "tonsillar",
      "abscess",
      "saliva",
      "signs",
      "floor",
      "tender",
      "causes",
      "tense",
      "crypt",
      "drooling",
      "facial",
      "streptococci",
      "severe",
      "dehydration",
      "firmness"
    ]
  },
  {
    "id": "1f16e91e56003d5bca41a4f6be93f1d3",
    "content": "To treat the infection\nTo prevent dehydration\nTo control fever and pain.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2086",
    "type": "section",
    "keywords": [
      "dehydration",
      "pain",
      "treat",
      "prevent",
      "infection",
      "fever",
      "control"
    ]
  },
  {
    "id": "a3e7b599e275cf7f9f2d31d8b5b92d46",
    "content": "Adequate hydration\nIntubation if airway obstruction present\nIncision and drainage as appropriate\nExtraction of tooth if it is the source of infection.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2087",
    "type": "section",
    "keywords": [
      "intubation",
      "present",
      "drainage",
      "appropriate",
      "infection",
      "incision",
      "source",
      "obstruction",
      "extraction",
      "airway",
      "tooth",
      "adequate",
      "hydration"
    ]
  },
  {
    "id": "da5c8111ee55a85fbb5dfb9c8eeee33c",
    "content": "Amoxicillin + Clavulanic Acid, IV,\nAdults\n1. 2 g 8 hourly for 7-10 days\nChildren\n3 months-18 years;\t30 mg/kg 8 hourly (max. 1.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2088",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "amoxicillin",
      "years",
      "acid",
      "adults",
      "clavulanic",
      "children",
      "months"
    ]
  },
  {
    "id": "e48df287cd11281af8d011833db6d61c",
    "content": "7-10 days)\n< 3 months;\t30 mg/kg 12 hourly for 7-10 days\nAnd\nCeftriaxone, IV,\nAdult\n2 g daily for 7-10 days,\nChildren\nAll ages 25 mg/kg 12 hourly (max. 75 mg/kg daily).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2089",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "ages",
      "ceftriaxone",
      "adult",
      "children",
      "months",
      "daily"
    ]
  },
  {
    "id": "f9e132a2e1bfe38aeeb094940e18360e",
    "content": "Clindamycin, IV,\nAdults\n300-600 mg 6 hourly for 7-10 days\nChildren\n3-6 mg/kg 6 hourly for 7-10 days\nAnd\nCeftriaxone, IV,\nAdult\n2 g daily for 7-10 days\nChildren\nAll ages 25 mg/kg 12 hourly (max. 75 mg/kg daily).",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2090",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "clindamycin",
      "ages",
      "ceftriaxone",
      "adult",
      "adults",
      "children",
      "daily"
    ]
  },
  {
    "id": "48196315a5c7e29be522b0756f139453",
    "content": "Procaine Penicillin, IM,\nAdult\n600,000-1,000,000 units daily\nChildren\n27 kg;\t600,000 units daily\n< 27 kg;\t25,000-50,000 units/kg daily\nNeonates;\tnot recommended\nAnd\nGentamicin, IV,\nAdults\n40-80 mg 8 hourly for 7-10 days\nChildren\n1-12 years;\t2. 5 mg/kg 8 hourly for 7-10 days\n< 1 year;\t2. 5 mg/kg 12 hourly for 7-10 days\nAnd\nMetronidazole, IV,\nAdults\n500 mg 8 hourly for 7-10 days\nChildren\n7.",
    "title": "3rd Line Treatment Evidence Rating: [C]",
    "section": "3rd Line Treatment Evidence Rating: [C]",
    "chunk_id": "2091",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "gentamicin",
      "units",
      "recommended",
      "years",
      "neonates",
      "penicillin",
      "adult",
      "adults",
      "children",
      "procaine",
      "daily",
      "year"
    ]
  },
  {
    "id": "546e13ee18103e3624ff3f8f1fdea785",
    "content": "5 mg/kg 8 hourly for 7-10 days\nReferral Criteria\nRefer to the specialist as soon as possible.",
    "title": "3rd Line Treatment Evidence Rating: [C]",
    "section": "3rd Line Treatment Evidence Rating: [C]",
    "chunk_id": "2092",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "referral",
      "specialist",
      "refer",
      "possible",
      "criteria",
      "soon"
    ]
  },
  {
    "id": "edf0d83a8ef107ac427ea476df970012",
    "content": "Chronic periodontal infections are due to prolonged bacterial infection around the teeth, which leads to destruction of periodontal and bony supporting tissue of the tooth. This usually leads to pocket formation, gum recession, tooth mobility and or loss. Causes\nBacteria\nSymptoms\nRecurrent painful chewing\nMobility of teeth\nBleeding gum margin\nSigns\nGum recession\nPocket formation\nLoss of supporting bony tissue\ninvestigations\nX-ray of involved teeth and supporting tissues.",
    "title": "Chapter 21: Oral and Dental Condıtıons",
    "section": "Chapter 21: Oral and Dental Condıtıons",
    "chunk_id": "2093",
    "type": "section",
    "keywords": [
      "infections",
      "usually",
      "prolonged",
      "recurrent",
      "bacteria",
      "bony",
      "which",
      "periodontal",
      "pocket",
      "formation",
      "involved",
      "bleeding",
      "chewing",
      "signs",
      "causes",
      "destruction",
      "leads",
      "chronic",
      "mobility",
      "bacterial"
    ]
  },
  {
    "id": "8697b1cecf23fef2b38ec1eddb59933f",
    "content": "To restore tooth function\nTo treat infection\nTo relieve pain\nNon-pharmacological management\nDebridement\nReconstructive surgery.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2094",
    "type": "section",
    "keywords": [
      "restore",
      "pharmacological",
      "pain",
      "treat",
      "function",
      "management",
      "infection",
      "relieve",
      "reconstructive",
      "tooth",
      "debridement",
      "surgery"
    ]
  },
  {
    "id": "5ba5b34bc8504dede70c04a08b6af4b1",
    "content": "Adjunctive Antimicrobial therapy\nClindamycin, oral,\nAdults\n300-450 mg 6-8 hourly for 7 days\nChildren\n12-18 years;\t150-300 mg 6 hourly for 7 days\n1 month-11 years;\t3-6 mg/kg 6 hourly for 7 days\nOr\nAmoxicillin + Clavulanic Acid, oral,\nAdults\n1 g 12 hourly for 14-21 days\nChildren\n>12 years;\tOne 500/125 tablet 12 hourly\n6-12 years;\t5 ml of 400/57 suspension 12 hourly.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2095",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "clindamycin",
      "amoxicillin",
      "tablet",
      "years",
      "acid",
      "suspension",
      "adults",
      "clavulanic",
      "adjunctive",
      "oral",
      "month",
      "children",
      "antimicrobial",
      "therapy"
    ]
  },
  {
    "id": "9b329fe6661882757af1c7b59aa933b8",
    "content": "years;\t2. 5 ml of 400/57 suspension 12 hourly 1 month-1 year;\t0. 25 ml/kg body weight of 125/31 suspension 8 hourly\n< 1 month;\t0.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2096",
    "type": "section",
    "keywords": [
      "hourly",
      "body",
      "years",
      "weight",
      "suspension",
      "month",
      "year"
    ]
  },
  {
    "id": "877af887a4bc23208f365a97f5bcd9a6",
    "content": "25 ml/kg body weight of 125/31 suspension 8 hourly\nFor pain relief\nParacetamol, oral,\nAdults\n500 mg-1 g 6 hourly as required\nChildren\n6-12 years;\t250-500 mg 6 hourly as required\n1-5 years;\t125-250 mg 6 hourly as required\n3 months-1 year;\t62. 5-125 mg 6 hourly as required\nReferral Criteria\nRefer all patients to the dental specialist. Mouth ulcers are generally due to infection (bacterial, viral or fungal), neutropaenia, malignancy-related or trauma.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2097",
    "type": "section",
    "keywords": [
      "malignancy",
      "years",
      "weight",
      "relief",
      "generally",
      "required",
      "hourly",
      "body",
      "specialist",
      "fungal",
      "patients",
      "children",
      "criteria",
      "neutropaenia",
      "referral",
      "mouth",
      "suspension",
      "adults",
      "bacterial",
      "paracetamol"
    ]
  },
  {
    "id": "0431bd69e2570e0b0cade6945530f851",
    "content": "The common ones are apthous and viral ulcers. APTHOUS ULCERS\nApthous ulcer is a recurrent ulcer of non-viral origin that occurs on the movable surfaces of the oral cavity. Size is variable but may have a rim of erythema with yellowish base, and later becoming a greyish hue.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2098",
    "type": "section",
    "keywords": [
      "greyish",
      "recurrent",
      "movable",
      "ulcer",
      "becoming",
      "apthous",
      "erythema",
      "surfaces",
      "base",
      "origin",
      "yellowish",
      "ones",
      "later",
      "size",
      "variable",
      "occurs",
      "ulcers",
      "viral",
      "common",
      "oral"
    ]
  },
  {
    "id": "18db0d75db4c2af29162ce31e97dbed6",
    "content": "They are classified into minor, major or herpetiform on clinical presentation. The minor is < 1 cm, and the major 1-3 cm in diameter. The herpetiform comes in multiple crops of 1-3 cm.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2099",
    "type": "section",
    "keywords": [
      "minor",
      "classified",
      "multiple",
      "comes",
      "presentation",
      "major",
      "herpetiform",
      "diameter",
      "crops",
      "into",
      "clinical"
    ]
  },
  {
    "id": "979d51bb6ceeda63c53ec68de09ef416",
    "content": "Though the cause is unknown, systemic conditions associated with apthous ulcer include Behcet’s syndrome, HIV, Vitamin deficiency states (vitamin B group, folic acid). Herpetiform ulcers are a crop of oral apthous ulcers resembling oral viral ulcers.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2100",
    "type": "section",
    "keywords": [
      "ulcer",
      "systemic",
      "associated",
      "apthous",
      "vitamin",
      "unknown",
      "deficiency",
      "include",
      "acid",
      "though",
      "cause",
      "herpetiform",
      "ulcers",
      "viral",
      "states",
      "crop",
      "conditions",
      "resembling",
      "folic",
      "oral"
    ]
  },
  {
    "id": "ae2959f7084b8ff0c23b30b961923028",
    "content": "Causes\nUnknown\nSymptoms\nTingling on the oral mucosa (prodromal phase)\nPainful ulcer\nSIGNS\nCrater-like soft tissue ulcer with a yellowish-grey floor\nTenderness.",
    "title": "Behcet’s disease is a more severe and generalised form involving the eye, skin and genitalia.",
    "section": "Behcet’s disease is a more severe and generalised form involving the eye, skin and genitalia.",
    "chunk_id": "2101",
    "type": "section",
    "keywords": [
      "unknown",
      "prodromal",
      "tenderness",
      "tissue",
      "grey",
      "painful",
      "ulcer",
      "oral",
      "tingling",
      "mucosa",
      "phase",
      "signs",
      "crater",
      "floor",
      "soft",
      "yellowish",
      "symptoms",
      "causes"
    ]
  },
  {
    "id": "3d1a4aed47235b8202867f6b04d5db49",
    "content": "To control pain\nTo treat ulcer\nTo control stress\nTo prevent secondary infection.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "2102",
    "type": "section",
    "keywords": [
      "pain",
      "treat",
      "stress",
      "prevent",
      "infection",
      "ulcer",
      "control",
      "secondary"
    ]
  },
  {
    "id": "4abd3c00a97cb1d6cae2a6802e094e87",
    "content": "Local anaesthetic gel, oral, applied with a cotton tip locally to the\nulcer base Adults\nApplied not less than every 3 hours as needed and not more than 6 applications daily\nChildren\nApplied not less than every 3 hours as needed and not more than 6 applications daily. And\nIbuprofen, oral,\nAdults\n400 mg 6-8 hourly as needed\nChildren\n6-12 years;\t200-400 mg 6-8 hourly as needed\n1-5 years;\t100-200 mg 6-8 hourly as needed 3 months-1 year;\tnot recommended\nReferral Criteria\nRefer to a dentist if the ulcer does not heal within 2 weeks. Odontogenic infections are infections arising primarily from the tooth.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "2103",
    "type": "section",
    "keywords": [
      "infections",
      "years",
      "local",
      "locally",
      "anaesthetic",
      "ulcer",
      "ibuprofen",
      "primarily",
      "cotton",
      "hourly",
      "within",
      "applied",
      "base",
      "heal",
      "dentist",
      "children",
      "weeks",
      "criteria",
      "referral",
      "adults"
    ]
  },
  {
    "id": "f9a8925a1d97a1a3c9d01d5f24900bff",
    "content": "This occurs as the result of intraoral bacteria gaining access to pulp via a dental cavity such as a carious lesion. The pulp undergoes necrosis and an abscess collects at the tooth apex over time. Causes\nStreptococci.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "2104",
    "type": "section",
    "keywords": [
      "bacteria",
      "intraoral",
      "abscess",
      "lesion",
      "carious",
      "apex",
      "result",
      "undergoes",
      "causes",
      "collects",
      "streptococci",
      "gaining",
      "tooth",
      "occurs",
      "necrosis",
      "dental",
      "access",
      "pulp",
      "cavity"
    ]
  },
  {
    "id": "40c5fcd7da235cba804b6f9373c94186",
    "content": "Symptoms\nPain on chewing\nJaw swelling with persistent gnawing pain\nFever\nChills\nSigns\nTooth tenderness to percussion\nLymphadenopathy\ninvestigations\nX-ray of affected tooth.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2105",
    "type": "section",
    "keywords": [
      "tenderness",
      "pain",
      "chills",
      "investigations",
      "fever",
      "gnawing",
      "chewing",
      "swelling",
      "signs",
      "tooth",
      "persistent",
      "percussion",
      "lymphadenopathy",
      "symptoms",
      "affected"
    ]
  },
  {
    "id": "80b1ca1183c73b84bfbf570d022c4a7f",
    "content": "To control infection\nTo control pain\nTo remove source of infection\nTo restore tooth integrity and function.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2106",
    "type": "section",
    "keywords": [
      "restore",
      "pain",
      "function",
      "integrity",
      "infection",
      "source",
      "remove",
      "tooth",
      "control"
    ]
  },
  {
    "id": "b380ab688976513610ccf85119734087",
    "content": "Root canal therapy with drainage, debridement, epicectomy etc. Restoration of structure and function.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2107",
    "type": "section",
    "keywords": [
      "structure",
      "restoration",
      "drainage",
      "debridement",
      "function",
      "epicectomy",
      "canal",
      "therapy",
      "root"
    ]
  },
  {
    "id": "371f343c49b4e6ff8bba75e32717a2e8",
    "content": "Evidence Rating: [B]\nAmoxicillin, oral,\nAdults\n500 mg 8 hourly for 7 days\nChildren\n5-18 years;\t500 mg 8 hourly for 7 days\n1-5 years;\t250 mg 8 hourly for 7 days\n1 month-1 year;\t125 mg 8 hourly for 7 days.",
    "title": "1st Line Treatment:",
    "section": "1st Line Treatment:",
    "chunk_id": "2108",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "amoxicillin",
      "rating",
      "years",
      "adults",
      "oral",
      "month",
      "children",
      "evidence",
      "year"
    ]
  },
  {
    "id": "11dbe640ae0f319801c367b243b60741",
    "content": "Evidence Rating: [B]\nDoxycycline, oral,\nAdults\n100 mg 12 hourly for 7 days.",
    "title": "For treatment of mild infection-in patients allergic to penicillins",
    "section": "For treatment of mild infection-in patients allergic to penicillins",
    "chunk_id": "2109",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "rating",
      "doxycycline",
      "adults",
      "oral",
      "evidence"
    ]
  },
  {
    "id": "fcf517e79766084c128ffa83eb820e2b",
    "content": "Adults\n625 mg 8 hourly for 7 days\nChildren\n12 years;\tOne 500/125 tablet 12 hourly for 7-10 days 4-12 years;\t5 ml of 400/57 suspension 12 hourly for 7-10 days\nyears;\t5 ml of 200/28 suspension 12 hourly for 7-10 days\n3 months - 1 year;\t20 mg/kg (of amoxicillin) 12 hourly for 7-10\ndays\n< 3 months;\t15 mg/kg (of amoxicillin) 12 hourly for 7-10\ndays\nOr\nAzithromycin, oral,\nAdults\n500 mg daily for 5 days\nChildren\n10 mg/kg body weight daily for 5 days. Not recommended for children less than 6 months because of a risk\nof pyloric stenosis.",
    "title": "Chapter 21: Oral and Dental Condıtıons",
    "section": "Chapter 21: Oral and Dental Condıtıons",
    "chunk_id": "2110",
    "type": "section",
    "keywords": [
      "years",
      "weight",
      "pyloric",
      "hourly",
      "body",
      "children",
      "days",
      "amoxicillin",
      "because",
      "stenosis",
      "suspension",
      "adults",
      "azithromycin",
      "months",
      "year",
      "tablet",
      "recommended",
      "oral",
      "less",
      "risk"
    ]
  },
  {
    "id": "5e93fd38067fe2335726566aa93fb7f5",
    "content": "Evidence Rating: [B]\nAzithromycin, oral,\nAdults\n500 mg daily for 5 days\nChildren\n10 mg/kg body weight daily for 5 days\nNot recommended for children less than 6 months because of a risk\nof pyloric stenosis. Or\nClindamycin, oral,\nAdults\n150-300 mg 6-8 hourly for 7 days\nChildren\n12-18 years;\t150-300 mg 6 hourly for 7 days\n1 month-11 years;\t3-6 mg / kg 6 hourly for 7 days\nFor pain relief\nEvidence Rating: [B]\nParacetamol, oral,\nAdults\n500 mg-1 g 6 hourly as required\nChildren\n6-12 years;\t250-500 mg 6 hourly as required\nyears;\t125-250 mg 6 hourly as required\n3 months-1 year;\t62. 5-125 mg 6 hourly as required.",
    "title": "For treatment of severe infection-in patients allergic to penicillins",
    "section": "For treatment of severe infection-in patients allergic to penicillins",
    "chunk_id": "2111",
    "type": "section",
    "keywords": [
      "years",
      "weight",
      "pyloric",
      "relief",
      "required",
      "evidence",
      "hourly",
      "rating",
      "body",
      "children",
      "days",
      "clindamycin",
      "because",
      "stenosis",
      "adults",
      "azithromycin",
      "paracetamol",
      "month",
      "months",
      "year"
    ]
  },
  {
    "id": "8db0a72b9b3b528ec3be4ffd960d21aa",
    "content": "Referral Criteria\nRefer all patients with odontogenic infections to a dental specialist after initiation of treatment. This condition presents as a non-healing ulcer of more than two weeks in the mouth. There may be a genetic predisposition but environmental causes have been identified.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2112",
    "type": "section",
    "keywords": [
      "infections",
      "ulcer",
      "environmental",
      "presents",
      "predisposition",
      "initiation",
      "specialist",
      "genetic",
      "healing",
      "identified",
      "patients",
      "condition",
      "weeks",
      "criteria",
      "causes",
      "treatment",
      "referral",
      "mouth",
      "there",
      "odontogenic"
    ]
  },
  {
    "id": "20995596a535fa5e8ea77983af7b0480",
    "content": "For an oral ulcer, 2 weeks observation for healing is usually adequate. If suspected to be due to an infection, an appropriate antimicrobial is given. Causes\nUsually unknown\nAssociations:\nTobacco/betel nut chewing\nAlcohol\nSmoking\nHPV infections\nSymptoms\nNon-healing ulcer in the mouth\nPain\nJaw swelling and deformity\nSigns\nIntra-oral mass ulcer\nWhite mucosal patch\nNeck mass\ninvestigations\nIncisional biopsy for histopathology.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2113",
    "type": "section",
    "keywords": [
      "infections",
      "usually",
      "observation",
      "intra",
      "given",
      "white",
      "ulcer",
      "swelling",
      "mucosal",
      "antimicrobial",
      "neck",
      "incisional",
      "betel",
      "unknown",
      "healing",
      "alcohol",
      "patch",
      "chewing",
      "signs",
      "weeks"
    ]
  },
  {
    "id": "7919f8e30c9b81b7f61c9f0eab37002d",
    "content": "Chemotherapy (+/- surgery +/- radiotherapy)\nReferral Criteria\nRefer immediately to the oncologist for further management.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2114",
    "type": "section",
    "keywords": [
      "referral",
      "chemotherapy",
      "immediately",
      "management",
      "refer",
      "further",
      "oncologist",
      "radiotherapy",
      "criteria",
      "surgery"
    ]
  },
  {
    "id": "336b36b589ea89610a0e9b96afdbdd77",
    "content": "Temporo-mandibular Joint (TMJ) dysfunction and or masticatory muscle dysfunction is a complex of derangements affecting only the joint, the muscles of mastication or both. The pathological process may be due to joint arthropathy, disc disease or tension in tendons and masticatory muscles from abnormal movement behaviour or occlusal disharmony. Causes\nBehavioural induced bruxism\nArthropathy\nTrauma (physical)\nOcclusal disharmony\nSymptoms\nPre-auricular pain associated with opening and closing the mouth\nClicking noise on opening and closing\nDull, persistent pain in masticatory muscles\nSigns\nTenderness in the TMJ associated with mouth opening\nClicking in TMJ on mouth opening and closing\nTenderness in muscles of mastication on contraction\nOcclusal abnormalities\ninvestigations\nX-ray-TMJ views\nESR.",
    "title": "Chapter 21: Oral and Dental Condıtıons",
    "section": "Chapter 21: Oral and Dental Condıtıons",
    "chunk_id": "2115",
    "type": "section",
    "keywords": [
      "dysfunction",
      "both",
      "muscles",
      "abnormalities",
      "associated",
      "induced",
      "disharmony",
      "trauma",
      "views",
      "disc",
      "derangements",
      "process",
      "arthropathy",
      "movement",
      "auricular",
      "muscle",
      "opening",
      "joint",
      "abnormal",
      "signs"
    ]
  },
  {
    "id": "738d82eaa31187d771c381a6da83d936",
    "content": "To control pain\nTo relax muscles of mastication\nTo correct any stress inducing imbalance.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2116",
    "type": "section",
    "keywords": [
      "pain",
      "imbalance",
      "correct",
      "stress",
      "muscles",
      "relax",
      "inducing",
      "control",
      "mastication"
    ]
  },
  {
    "id": "ac1d893ea26278628c6b6785e2df8db0",
    "content": "Occlusal splints\nOn-lays\nReduce stress and encourage relaxation in masticatory apparatus.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2117",
    "type": "section",
    "keywords": [
      "splints",
      "stress",
      "reduce",
      "encourage",
      "apparatus",
      "relaxation",
      "lays",
      "masticatory",
      "occlusal"
    ]
  },
  {
    "id": "8eaa7b29ff706671c9650b520d5d12cc",
    "content": "Children\n12-18 years;\t5 mg 12 hourly\n5-12 years;\t2. 5 mg 12 hourly\nFor pain relief\nIbuprofen, oral,\nAdults\n400 mg 12 hourly as required\nChildren\n6-12 years;\t200-400 mg 6-8 hourly as required\n1-5 years;\t100-200 mg 6-8 hourly as required 3 months-1 year;\tnot recommended\nReferral Criteria\nRefer all cases to the dentist for further management. Trigerminal neuralgia is a condition characterised by unilateral facial pain that follows the distribution of the trigerminal nerve.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2118",
    "type": "section",
    "keywords": [
      "unilateral",
      "years",
      "management",
      "distribution",
      "relief",
      "required",
      "characterised",
      "ibuprofen",
      "hourly",
      "nerve",
      "dentist",
      "neuralgia",
      "condition",
      "children",
      "criteria",
      "facial",
      "referral",
      "adults",
      "further",
      "follows"
    ]
  },
  {
    "id": "12376361cfd5187b1bc92459fb420af1",
    "content": "It presents with recurrent, sudden onset sharp-shooting pain in the face and may have a trigger-point. The patient may present with marked anxiety and may mimic a psychiatric disorder. Causes\nDegenerative\nInflammatory\nPressure-induced\nSymptoms\nSudden sharp-shooting pain in the face\nSevere anxiety\nSigns\nAnxiety\nHypesthesia of affected area (transient)\ninvestigations\nX-ray to rule out a fractured tooth\nMRI to rule out intracranial pathology.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2119",
    "type": "section",
    "keywords": [
      "sudden",
      "recurrent",
      "psychiatric",
      "intracranial",
      "transient",
      "face",
      "fractured",
      "induced",
      "hypesthesia",
      "anxiety",
      "presents",
      "patient",
      "pathology",
      "shooting",
      "pressure",
      "signs",
      "trigger",
      "marked",
      "causes",
      "onset"
    ]
  },
  {
    "id": "f4dbb3eb05d1429ef422a61ca0e04db4",
    "content": "To reassure patient\nTo allay anxiety\nTo manage the neuropathy.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2120",
    "type": "section",
    "keywords": [
      "anxiety",
      "neuropathy",
      "manage",
      "allay",
      "reassure",
      "patient"
    ]
  },
  {
    "id": "aaa6e569bfd11b4e990e6f15d2fc69e5",
    "content": "Diazepam, oral,\nAdults\n5 mg at night\nChildren\n12-18 years;\t2. 5-5 mg at night\n5-12 years;\t2. 5 mg at night.",
    "title": "For the control of anxiety 1st Line Treatment Evidence Rating: [C]",
    "section": "For the control of anxiety 1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "2121",
    "type": "section",
    "keywords": [
      "diazepam",
      "years",
      "adults",
      "oral",
      "children",
      "night"
    ]
  },
  {
    "id": "3ddf05c9d2a05771526957591f858b61",
    "content": "Carbamazepine, oral,\nAdults\n50-150 mg 12 hourly till resolution (max. 600 mg 12 hourly)\nChildren\n12-18 years;\t50-100 mg 12 hourly\nThen\nIncrease to 600 mg 12 hourly if necessary\n1 month-12 years;\t2. 5 mg/kg 12 hourly\nThen\nIncrease slowly to 5 mg/kg 12 hourly\nOr\nPregabalin, oral,\nAdults\n75 mg 12 hourly till resolution\nChildren\nNot recommended\nFor additional pain relief\nIbuprofen, oral,\nAdults\n400 mg 8 hourly as required\nChildren\n6-12 years;\t200-400 mg 8 hourly as required\n1-5 years;\t100-200 mg 8 hourly as required 3 months-1 year;\tnot recommended\nReferral Criteria\nRefer to the neurologist for further management.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2122",
    "type": "section",
    "keywords": [
      "resolution",
      "years",
      "management",
      "relief",
      "required",
      "ibuprofen",
      "increase",
      "hourly",
      "carbamazepine",
      "children",
      "criteria",
      "referral",
      "neurologist",
      "adults",
      "pregabalin",
      "further",
      "month",
      "months",
      "then",
      "additional"
    ]
  },
  {
    "id": "3cb6aa6b6ad412422d3d8245b78d2bef",
    "content": "This is a degenerative articular cartilage disease of varied aetiology. It can affect all joints, but mostly the hips and knees. Important differentials include, rheumatoid arthritis and tuberculosis affecting the joints.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2123",
    "type": "section",
    "keywords": [
      "disease",
      "affect",
      "joints",
      "differentials",
      "include",
      "important",
      "rheumatoid",
      "knees",
      "affecting",
      "cartilage",
      "degenerative",
      "varied",
      "aetiology",
      "articular",
      "hips",
      "arthritis",
      "tuberculosis",
      "mostly"
    ]
  },
  {
    "id": "380c32236c57a5c374f44d5f9591c72d",
    "content": "Primary osteoarthritis is usually age-related (old age), whiles secondary osteoarthritis may be due to other causes. Causes\nTrauma\nInfections\nInflammatory arthritides\nSymptoms\nPain on activity and relieved by rest initially\nJoint stiffness\nJoint swelling\nLimping\nSigns\nLimping\nJoint swelling\nJoint effusion\nDeformities\nLeg length discrepancy\ninvestigations\nX-ray of affected joint.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2124",
    "type": "section",
    "keywords": [
      "infections",
      "usually",
      "activity",
      "whiles",
      "affected",
      "swelling",
      "deformities",
      "limping",
      "secondary",
      "relieved",
      "primary",
      "stiffness",
      "initially",
      "joint",
      "signs",
      "osteoarthritis",
      "causes",
      "arthritides",
      "rest",
      "investigations"
    ]
  },
  {
    "id": "9feb4c75c6221d33548dc50df49166ad",
    "content": "Relieve pain\nPrevent progression\nImprove function of joint\nPrevent deformities or complications.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2125",
    "type": "section",
    "keywords": [
      "complications",
      "pain",
      "progression",
      "improve",
      "prevent",
      "function",
      "relieve",
      "joint",
      "deformities"
    ]
  },
  {
    "id": "42caa67dd47b7b6b1deb447ab2730609",
    "content": "Physiotherapy\nWeight loss\nWalking aid\nBraces\nSurgery\nAspiration of excessive synovial fluid\nOsteotomies\nArthroplasties\nArthrodesis.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2126",
    "type": "section",
    "keywords": [
      "aspiration",
      "physiotherapy",
      "weight",
      "synovial",
      "arthroplasties",
      "loss",
      "braces",
      "osteotomies",
      "arthrodesis",
      "walking",
      "surgery",
      "excessive",
      "fluid"
    ]
  },
  {
    "id": "226a171643f92ca45a935360940fc057",
    "content": "Naproxen EC, oral,\nAdults\n250-500 mg 12 hourly as required\nChildren\nNot indicated\nOr\nCelecoxib, oral,\nAdults\n400 mg stat. Then\n200 mg 12-24 hourly as required\nChildren\nNot indicated\nOr\nDiclofenac, oral,\nAdults\n50 mg 8 hourly or 100 mg 12 hourly\nChildren\n12 years;\t50 mg 12 hourly\n< 12 years;\tnot recommended\nOr\nIbuprofen, oral,\nAdults\n200-800 mg 6-8 hourly as required (max. 2.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2127",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "naproxen",
      "diclofenac",
      "adults",
      "ibuprofen",
      "oral",
      "stat",
      "indicated",
      "required",
      "children",
      "then",
      "celecoxib"
    ]
  },
  {
    "id": "e0223aee7e048cc7d8ec02976661b3f8",
    "content": "4 g daily)\nChildren\n10-15 mg/kg 6-8 hourly as required (max. 40 mg per kg daily)\nAnd\nDiclofenac gel, topical,\nAdults and Children\nApply 12 hourly as necessary\nOr.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2128",
    "type": "section",
    "keywords": [
      "hourly",
      "topical",
      "diclofenac",
      "adults",
      "necessary",
      "required",
      "children",
      "apply",
      "daily"
    ]
  },
  {
    "id": "77100ce8ae9c8303bbccaa39aee0c790",
    "content": "Diclofenac spray, topical,\nAdults and Children\nApply 12 hourly as necessary.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2129",
    "type": "section",
    "keywords": [
      "topical",
      "hourly",
      "diclofenac",
      "adults",
      "necessary",
      "children",
      "spray",
      "apply"
    ]
  },
  {
    "id": "45c0b88aa1ded70c039814803616f896",
    "content": "For any of the following therapy, consult a specialist\nMethyl prednisolone acetate, Intra-articular\nTriamcinolone, Intra-articular\nBetamethasone, Intra-articular\nReferral Criteria\nRefer complicated cases to the orthopaedic specialist. Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease of unknown cause. An external trigger (e.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "2130",
    "type": "section",
    "keywords": [
      "intra",
      "rheumatoid",
      "systemic",
      "betamethasone",
      "arthritis",
      "therapy",
      "unknown",
      "specialist",
      "following",
      "orthopaedic",
      "trigger",
      "methyl",
      "criteria",
      "disease",
      "referral",
      "complicated",
      "chronic",
      "prednisolone",
      "cause",
      "articular"
    ]
  },
  {
    "id": "4a74c83f416d291546c691aa28ffeee6",
    "content": "g. cigarette smoking, infection, or trauma) triggers an autoimmune reaction, leading to synovial hypertrophy and chronic joint inflammation along with the prospect for extra-articular manifestations. It is believed to occur in genetically susceptible individuals and more common in middle aged women.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "2131",
    "type": "section",
    "keywords": [
      "extra",
      "occur",
      "genetically",
      "trauma",
      "triggers",
      "inflammation",
      "synovial",
      "hypertrophy",
      "joint",
      "reaction",
      "cigarette",
      "leading",
      "chronic",
      "prospect",
      "women",
      "articular",
      "susceptible",
      "smoking",
      "aged",
      "middle"
    ]
  },
  {
    "id": "1d20f16dcf8ea4f1c8b2c09adfca5bbc",
    "content": "Causes\nUnknown\nAutoimmune disorder\nLikely a combination of genetic and environmental factors\nSymptoms\nJoint stiffness\nPainful joints\nSwelling of affected joints\nDeformity of affected joints\nLimitation of motion\nSkin nodules\nDifficulty in breathing\nEasy fatiguability\nSigns\nPersistent symmetric polyarthritis (synovitis) of hands and feet\nJoint stiffness\nJoint tenderness\nJoint swelling\nJoint deformity\nLimitation of joint movement\nRheumatoid nodules\nSigns relating to extra-articular involvement e. g. lung disease, uveitis, pericardial or pleural effusions.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "2132",
    "type": "section",
    "keywords": [
      "rheumatoid",
      "extra",
      "factors",
      "swelling",
      "nodules",
      "environmental",
      "breathing",
      "likely",
      "unknown",
      "genetic",
      "stiffness",
      "movement",
      "polyarthritis",
      "pericardial",
      "joint",
      "involvement",
      "combination",
      "easy",
      "signs",
      "relating"
    ]
  },
  {
    "id": "5736cdb6cbf8f684fc37d56766524d33",
    "content": "investigations\nFBC, ESR\nC-reactive protein level\nRheumatoid Factor assay\nAntinuclear Antibody (ANA) assay\nAnti−Cyclic Citrullinated Peptide (Anti-CCP)\nJoint aspiration and analysis of synovial fluid\nHepatitis B and C tests\nHIV test\nX-rays of hands and feet\nMRI of cervical spine (to detect subluxation)\nUltrasonography of joints.",
    "title": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "section": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "chunk_id": "2133",
    "type": "section",
    "keywords": [
      "rheumatoid",
      "test",
      "fluid",
      "aspiration",
      "antinuclear",
      "factor",
      "synovial",
      "protein",
      "joint",
      "peptide",
      "joints",
      "ultrasonography",
      "level",
      "reactive",
      "hands",
      "subluxation",
      "tests",
      "anti",
      "antibody",
      "investigations"
    ]
  },
  {
    "id": "0b95c3871bc13163b71c5ab8a6b0ce2c",
    "content": "To reduce pain, swelling and stiffness\nTo prevent deformities.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2134",
    "type": "section",
    "keywords": [
      "pain",
      "stiffness",
      "prevent",
      "reduce",
      "swelling",
      "deformities"
    ]
  },
  {
    "id": "aaba409044e7bca6560dff4024a7ccf5",
    "content": "Heat and cold therapies\nOrthotics and splints\nPhysiotherapy\nOccupational therapy\nAdaptive equipment\nJoint-protection education\nCouselling and education\nSynovectomy\nTenosynovectomy\nTendon realignment\nReconstructive surgery or arthroplasty\nArthrodesis.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2135",
    "type": "section",
    "keywords": [
      "arthroplasty",
      "couselling",
      "synovectomy",
      "realignment",
      "therapy",
      "tendon",
      "orthotics",
      "heat",
      "therapies",
      "occupational",
      "joint",
      "reconstructive",
      "tenosynovectomy",
      "arthrodesis",
      "adaptive",
      "protection",
      "physiotherapy",
      "splints",
      "education",
      "equipment"
    ]
  },
  {
    "id": "b978fb51791263df81643a5ac45bcb15",
    "content": "Symptoms present more than 6 weeks or antibody positive.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2136",
    "type": "section",
    "keywords": [
      "present",
      "more",
      "antibody",
      "weeks",
      "symptoms",
      "positive"
    ]
  },
  {
    "id": "ee13941d8b9f6a00c6f3bdb5608377db",
    "content": "Prednisolone, oral, 0. 5-1 mg/kg body weight\nCaution 22-1. And\nOmeprazole, oral,\nAdults\n20 mg daily.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2137",
    "type": "section",
    "keywords": [
      "body",
      "prednisolone",
      "weight",
      "adults",
      "caution",
      "oral",
      "omeprazole",
      "daily"
    ]
  },
  {
    "id": "bb0dbf10f7c1709fcb4aa1b4f071ecce",
    "content": "Children\n20 kg;\t20 mg daily\n10-20 kg;\t10 mg daily\n5-10 kg;\t5 mg daily\nOr\nEsomeprazole, oral,\nAdults\n20-40 mg daily\nChildren\n12-18 years;\t20-40 mg daily\n1-12 years;\t10-20 mg daily\n< 1 year;\tnot recommended\nAnd\nDiclofenac, oral,\nAdults\n50 mg 8 hourly or 100 mg 12 hourly as required\nChildren\n>12 years;\t50 mg 12 hourly as required\n<12 years;\tnot recommended\nOr\nDiclofenac, rectal,\nAdults\n100 mg 12 hourly as required\nChildren\n12 years;\t75-100 mg daily as required\n< 12 years;\tnot recommended\nOr\nCelecoxib, oral,\nAdults\n400 mg stat. Then\n200 mg 12-24 hourly as required\nChildren\n2 years (> 25 kg);\t100 mg 12 hourly as required\n2 years (and 10-25 kg);50 mg 12 hourly as required\n< 2 years;\tnot recommended\nOr\nParacetamol, oral,\nAdults\n500 mg-1 g 6 - 8 hourly as required\nChildren\n6-12 years;\t250-500 mg 6-8 hourly as required\n1-5 years;\t120-250 mg 6-8 hourly as required\n3 months-1 year;\t60-120 mg 6-8 hourly as required\nAnd\nCalcium supplements.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2138",
    "type": "section",
    "keywords": [
      "years",
      "supplements",
      "required",
      "celecoxib",
      "hourly",
      "rectal",
      "diclofenac",
      "esomeprazole",
      "children",
      "stat",
      "calcium",
      "adults",
      "paracetamol",
      "months",
      "then",
      "year",
      "recommended",
      "oral",
      "daily"
    ]
  },
  {
    "id": "3572c4f0bea3fc9f912160523680b117",
    "content": "Hydroxychloroquine, consult specialist\nSulfasalazine, consult specialist\nMethotrexate, consult specialist\nLeflunomide, consult specialist\nOr\nEtanercept, consult specialist\nInfliximab, consult specialist\nAdalimumab, consult specialist\nCertolizumab, consult specialist\nGolimumab, consult specialist\nOr\nRituximab, consult specialist\nAnakinra, consult specialist\nAbatacept, consult specialist\nTocilizumab, consult specialist\nTofacitinib, consult specialist.",
    "title": "or antibody positive 1st Line Treatment Evidence Rating: [B]",
    "section": "or antibody positive 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2139",
    "type": "section",
    "keywords": [
      "infliximab",
      "adalimumab",
      "specialist",
      "leflunomide",
      "hydroxychloroquine",
      "etanercept",
      "certolizumab",
      "tocilizumab",
      "tofacitinib",
      "sulfasalazine",
      "anakinra",
      "methotrexate",
      "abatacept",
      "golimumab",
      "consult",
      "rituximab"
    ]
  },
  {
    "id": "14318cd60eb09493ac945c3163e4c552",
    "content": "Cyclosporine, consult specialist\nAzathioprine, consult specialist\nGold salts, consult specialist\nD-penicillamine, consult specialist\nMinocycline, consult specialist\nReferral Criteria\nRefer all cases to a physician specialist or rheumatologist. Juvenile idiopathic arthritis results from abnormally regulated immune responses that lead to inflammation of joints, surrounding tissues and other organs. Often, non-rheumatic diseases that can cause similar features need to be excluded during evaluation.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "2140",
    "type": "section",
    "keywords": [
      "surrounding",
      "idiopathic",
      "often",
      "during",
      "responses",
      "lead",
      "features",
      "arthritis",
      "results",
      "cyclosporine",
      "regulated",
      "minocycline",
      "diseases",
      "specialist",
      "evaluation",
      "salts",
      "inflammation",
      "gold",
      "need",
      "criteria"
    ]
  },
  {
    "id": "2c6e87b09cfc8a7f1815b63367c54c59",
    "content": "Rheumatoid arthritis in children may present in one of three forms; a systemic onset arthritis (Still’s disease), poly-articular onset arthritis (5 or more joints usually of both large and small affected) or pauci-articular onset arthritis (fewer than 5 of mainly large joints affected) either of which may be rheumatoid factor positive or negative. Those with positive.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "2141",
    "type": "section",
    "keywords": [
      "usually",
      "rheumatoid",
      "either",
      "both",
      "which",
      "systemic",
      "arthritis",
      "pauci",
      "large",
      "factor",
      "children",
      "onset",
      "fewer",
      "disease",
      "joints",
      "poly",
      "forms",
      "three",
      "articular",
      "those"
    ]
  },
  {
    "id": "51755ed0fa28e53aa6b0918fc0d98428",
    "content": "Antinuclear Antibodies (ANA) tests need regular eye checks for uveitis. For this condition, it is mandatory for arthritis to be present for at least 6 weeks for the diagnosis to be made. Causes.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2142",
    "type": "section",
    "keywords": [
      "antibodies",
      "uveitis",
      "antinuclear",
      "mandatory",
      "present",
      "least",
      "diagnosis",
      "made",
      "regular",
      "checks",
      "tests",
      "need",
      "arthritis",
      "condition",
      "weeks",
      "causes"
    ]
  },
  {
    "id": "9def0d5865c33c5fc840fb872b7834aa",
    "content": "Symptoms\nMorning stiffness\nJoint pain\nPainful red eyes\nRash\nJoint swelling\nFever\nSigns\nSwollen warm joints\nRestricted range of joint movement\nSystemic onset\nFever\nMacular rash\nHepatosplenomegaly\nLymphadenopathy\nSerositis e. g. pericardial effusion\nRed eyes\ninvestigations\nFBC\nESR\nBUE and creatinine\nLiver function tests\nC-reactive protein\nRheumatoid Factor (RF)\nAnti-Cyclic Citrullinated Peptide (CCP) antibody\nAntinuclear Antibodies (ANA)\nX-Ray of affected joints\nSlit lamp examination\nOther tests as determined by specialist.",
    "title": "Autoimmune disease",
    "section": "Autoimmune disease",
    "chunk_id": "2143",
    "type": "section",
    "keywords": [
      "rheumatoid",
      "morning",
      "affected",
      "slit",
      "lamp",
      "range",
      "swelling",
      "systemic",
      "rash",
      "creatinine",
      "antinuclear",
      "specialist",
      "stiffness",
      "movement",
      "restricted",
      "function",
      "pericardial",
      "factor",
      "protein",
      "joint"
    ]
  },
  {
    "id": "11552a4bfc8fd99f0738859d2bd83938",
    "content": "To control pain and inflammation\nTo prevent deformities and growth retardation\nTo control extra articular complications\nTo minimise drug side effects\nTo optimise chance for normal social development.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2144",
    "type": "section",
    "keywords": [
      "extra",
      "development",
      "deformities",
      "chance",
      "prevent",
      "inflammation",
      "growth",
      "optimise",
      "drug",
      "social",
      "side",
      "articular",
      "complications",
      "pain",
      "minimise",
      "effects",
      "normal",
      "control",
      "retardation"
    ]
  },
  {
    "id": "6119a12f3c9ac0eba280082e38d05453",
    "content": "Psychotherapy\nOccupational therapy\nDiet therapy\nPatient counselling.",
    "title": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "section": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "chunk_id": "2145",
    "type": "section",
    "keywords": [
      "diet",
      "psychotherapy",
      "counselling",
      "occupational",
      "therapy",
      "patient"
    ]
  },
  {
    "id": "b341ba11ead630181c597b4901c57988",
    "content": "Ibuprofen, oral,\nChildren\n6-12 years;\t200-400 mg 8 hourly as required\n1-5 years;\t100-200 mg 8 hourly as required 3 months - 1 year;\tnot recommended\nOr\nIndomethacin, oral,\nChildren\n14 years;\t25-50 mg 8-12 hourly (max. 200 mg per day)\n2-14 years;\t500 microgram-1 mg/kg 12 hourly (max. 150 mg per day)\n< 2 years;\tnot recommended\nOr\nNaproxen, oral,\nChildren\n5 years;\t5-7.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2146",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "microgram",
      "indomethacin",
      "naproxen",
      "oral",
      "required",
      "children",
      "months",
      "ibuprofen",
      "year"
    ]
  },
  {
    "id": "c97793cc5bc0de82ef182e50b45c63b6",
    "content": "5 mg/kg 12 hourly (max. 1 g per day)\n< 5 years;\tnot recommended for this condition.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2147",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "condition"
    ]
  },
  {
    "id": "da5d8512b69d8fab667523844b98b395",
    "content": "Celecoxib, oral,\nChildren\n2 years ( > 25 kg);\t100 mg 12 hourly\n2 years (and 10-25 kg);\t50 mg 12 hourly\n< 2 years;\tnot recommended\nCaution 22-2. Steroid therapy to control inflammation.",
    "title": "2nd Line Treatment Evidence Rating: [A]",
    "section": "2nd Line Treatment Evidence Rating: [A]",
    "chunk_id": "2148",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "inflammation",
      "steroid",
      "caution",
      "oral",
      "control",
      "children",
      "therapy",
      "celecoxib"
    ]
  },
  {
    "id": "41ffd0a572d9c8551ef7ee6a7b5a03cb",
    "content": "And\nPrednisolone, oral,\nChildren\n0. 5-2 mg/kg daily or 12 hourly (max. 60 mg per day).",
    "title": "(See treatment ‘to control pain and inflammation’ in (A) above)",
    "section": "(See treatment ‘to control pain and inflammation’ in (A) above)",
    "chunk_id": "2149",
    "type": "section",
    "keywords": [
      "hourly",
      "prednisolone",
      "oral",
      "children",
      "daily"
    ]
  },
  {
    "id": "a2c2d194b9d8806c0d3f5e852e794525",
    "content": "Intra-articular corticosteroid injection, consult specialist\nMethotrexate, consult specialist\nEtarnecept, consult specialist\nInfliximab, consult specialist\nAdalimumab, consult specialist\nAnakinra, consult specialist\nReferral Criteria\nRefer all suspected cases to a paediatrician or rheumatologist. This is the commonest cause of reported pain to healthcare facilities. More than 80% of people will have at least one episode in their lifetime.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2150",
    "type": "section",
    "keywords": [
      "lifetime",
      "intra",
      "etarnecept",
      "infliximab",
      "specialist",
      "paediatrician",
      "facilities",
      "episode",
      "injection",
      "people",
      "anakinra",
      "their",
      "criteria",
      "healthcare",
      "adalimumab",
      "referral",
      "suspected",
      "cause",
      "corticosteroid",
      "articular"
    ]
  },
  {
    "id": "ca47357eaaba426e0a7c6965703493db",
    "content": "Most are benign and will resolve. However, 33%-66% will have a recurrence within a year. It is important to identify red, and yellow flags.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2151",
    "type": "section",
    "keywords": [
      "within",
      "yellow",
      "recurrence",
      "important",
      "resolve",
      "flags",
      "however",
      "have",
      "identify",
      "most",
      "benign",
      "year"
    ]
  },
  {
    "id": "9659e374e52793fdbe3423589663ec67",
    "content": "It may be acute if it is less than 3 months and chronic if it is more. Causes\nMechanical (e. g.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2152",
    "type": "section",
    "keywords": [
      "chronic",
      "mechanical",
      "less",
      "more",
      "months",
      "acute",
      "causes"
    ]
  },
  {
    "id": "2490972e603e45a51248b23cbcaea7ac",
    "content": "disc degeneration, fractured vertebrae, instability,.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2153",
    "type": "section",
    "keywords": [
      "vertebrae",
      "instability",
      "fractured",
      "degeneration",
      "disc"
    ]
  },
  {
    "id": "0f691d8a44bd84af82a3a11a9ddf1d72",
    "content": "unknown cause [most cases])\nNeurogenic (e. g. , herniated disc, spinal stenosis, osteophyte damage to nerve root)\nNon-mechanical spinal conditions  (e.",
    "title": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "section": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "chunk_id": "2154",
    "type": "section",
    "keywords": [
      "osteophyte",
      "unknown",
      "stenosis",
      "mechanical",
      "conditions",
      "cause",
      "cases",
      "herniated",
      "damage",
      "nerve",
      "neurogenic",
      "most",
      "spinal",
      "root",
      "disc"
    ]
  },
  {
    "id": "610a94a94e811c09e7a172c8bf4126e3",
    "content": "Other (e. g. , fibromyalgia, somatoform disorder, “faking” pain)\nSymptoms\nPain\nNociceptive\nDiffuse pain\nNeuropathic\nPricking, tingling, pins and needles\nElectric shocks of shooting\nHot or burning\nNumbness\nAltered sensation\nRadicular pain\nIncontinence of urine and faeces\nSigns\nDeformity of spine\nTenderness in affected region\nWeakness of the affected limb\nMuscle wasting in the affected limb\nAltered sensation in the affected limb\ninvestigations\nFBC, ESR,\nMantoux\nChest X-ray (if TB is suspected)\nRheumatoid factor.",
    "title": "Referred visceral pain (e.g., gastrointestinal disease, kidney disease, abdominal aortic aneurism)",
    "section": "Referred visceral pain (e.g., gastrointestinal disease, kidney disease, abdominal aortic aneurism)",
    "chunk_id": "2155",
    "type": "section",
    "keywords": [
      "faking",
      "rheumatoid",
      "faeces",
      "region",
      "incontinence",
      "urine",
      "pricking",
      "weakness",
      "shooting",
      "chest",
      "factor",
      "sensation",
      "mantoux",
      "muscle",
      "altered",
      "needles",
      "signs",
      "burning",
      "tenderness",
      "deformity"
    ]
  },
  {
    "id": "24e8e79338eb2c95eb3fa26e14318994",
    "content": "HLA-B27 (if inflammatory arthritides is suspected)\nCT scan of spine\nCT myelogram\nPlain X-rays of spine.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2156",
    "type": "section",
    "keywords": [
      "suspected",
      "inflammatory",
      "scan",
      "spine",
      "plain",
      "rays",
      "myelogram",
      "arthritides"
    ]
  },
  {
    "id": "2148e0c8038fd9e45923328a1056d81e",
    "content": "Pain relief\nPrevention of recurrence\nIdentification of red and yellow flags.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2157",
    "type": "section",
    "keywords": [
      "yellow",
      "pain",
      "recurrence",
      "prevention",
      "flags",
      "relief",
      "identification"
    ]
  },
  {
    "id": "3daef9211788b2105c9bb2fb637f8d6d",
    "content": "Splints\nPhysiotherapy\nWeight loss and lifestyle adjustment\nAcupuncture\nSleep hygiene\nOccupational therapy.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2158",
    "type": "section",
    "keywords": [
      "physiotherapy",
      "splints",
      "sleep",
      "hygiene",
      "weight",
      "adjustment",
      "occupational",
      "loss",
      "acupuncture",
      "lifestyle",
      "therapy"
    ]
  },
  {
    "id": "4fca9f3bd3da745a6ea6141890257a90",
    "content": "Paracetamol, oral, 500 mg-1 g 6-8 hourly\nAnd\nNaproxen EC, oral,\n250-500 mg 12 hourly as required\nOr\nCelecoxib, oral, 400 mg stat. Then\n200 mg 12-24 hourly as required\nOr\nDiclofenac, oral, 50 mg 8 hourly or 100 mg 12 hourly\nOr\nIbuprofen, oral, 400 mg 6-8 hourly\nAnd\nDiazepam, oral, 5 mg 12 hourly\nOr\nMethocarbamol, consult specialist\nOr\nTizanidine, consult specialist.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2159",
    "type": "section",
    "keywords": [
      "diazepam",
      "hourly",
      "specialist",
      "naproxen",
      "diclofenac",
      "tizanidine",
      "ibuprofen",
      "oral",
      "paracetamol",
      "stat",
      "required",
      "then",
      "methocarbamol",
      "celecoxib",
      "consult"
    ]
  },
  {
    "id": "9bd1e5faad984d3208f5faa5bcd41f52",
    "content": "Evidence Rating: [B]\nAmitriptyline, oral, (when there are neuropathic signs and symp- toms), 25-50 mg daily\nOr\nPregabalins, oral, consult specialist\nAnd\nTramadol, oral, 25 mg stat. Then\nIncrease by 25-50 mg daily up to 50-100 mg 6 hourly as necessary; (max. 400 mg per day)\nOr\nCodeine, oral, 15-60 mg 4-6 hourly as required\nOr\nMorphine sulphate, oral, 5-10 mg 8-12 hourly\nFor inflammatory Arthritides\nPrednisolone, oral, consult specialist\nMethotrexate, oral, consult specialist\nRituximab, IV, consult specialist\nReferral Criteria\nIndividuals may need to be referred to the orthopaedic specialist, neurosurgeon or rheumatologist based on the red and yellow flag criteria above.",
    "title": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "section": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "chunk_id": "2160",
    "type": "section",
    "keywords": [
      "sulphate",
      "based",
      "required",
      "evidence",
      "increase",
      "hourly",
      "rating",
      "specialist",
      "symp",
      "neurosurgeon",
      "orthopaedic",
      "flag",
      "need",
      "signs",
      "criteria",
      "stat",
      "amitriptyline",
      "arthritides",
      "yellow",
      "referral"
    ]
  },
  {
    "id": "6fc894b76b2df5953d2add4a80145093",
    "content": "Fibromyalgia is a disorder of chronic, widespread pain and tenderness. It typically presents in young women in the third decade or middle-aged women but can affect patients of either sex and at any age. Fibromyalgia is a diagnosis of exclusion and often occurs in patients with other conditions, such as autoimmune inflammatory arthritis and osteoarthritis.",
    "title": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "section": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "chunk_id": "2161",
    "type": "section",
    "keywords": [
      "either",
      "often",
      "typically",
      "arthritis",
      "presents",
      "patients",
      "widespread",
      "osteoarthritis",
      "affect",
      "chronic",
      "tenderness",
      "diagnosis",
      "women",
      "third",
      "young",
      "occurs",
      "decade",
      "exclusion",
      "disorder",
      "pain"
    ]
  },
  {
    "id": "44bb2fc871683578ac3a62ed9c510443",
    "content": "The clinical evaluation may reveal objective evidence for other co-morbid illness, such as hypothyroidism, rheumatoid arthritis, systemic lupus erythematosus, polymyalgia rheumatica and other inflammatory or autoimmune disorders. No clear pathophysiological mechanism for fibromyalgia has been established, but evidence suggests that there is an abnormality in central pain processing. Although there is no cure for fibromyalgia, treatment can relieve some of the symptoms.",
    "title": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "section": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "chunk_id": "2162",
    "type": "section",
    "keywords": [
      "rheumatoid",
      "mechanism",
      "systemic",
      "arthritis",
      "established",
      "polymyalgia",
      "morbid",
      "clear",
      "evidence",
      "abnormality",
      "evaluation",
      "suggests",
      "hypothyroidism",
      "rheumatica",
      "treatment",
      "pathophysiological",
      "objective",
      "reveal",
      "cure",
      "disorders"
    ]
  },
  {
    "id": "a8dea3fa618d1c80a089063ba4f60b05",
    "content": "Since symptoms are numerous and vary among patients, treatment programs must be individualized for each patient. Treatment includes patient education, stress reduction, regular exercise and medications. Always combine pharmacologic and non-pharmacologic.",
    "title": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "section": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "chunk_id": "2163",
    "type": "section",
    "keywords": [
      "regular",
      "exercise",
      "patient",
      "always",
      "numerous",
      "stress",
      "among",
      "vary",
      "patients",
      "treatment",
      "reduction",
      "combine",
      "medications",
      "each",
      "individualized",
      "includes",
      "pharmacologic",
      "symptoms",
      "since",
      "programs"
    ]
  },
  {
    "id": "110fc4dfc225270567d619d75afa0e70",
    "content": "Causes\nUsually unknown\nSymptoms\nChronic widespread pain\nUnrefreshing sleep and tiredness\nAnxiety\nDepression\nMigraine or tension headaches\nNumbness or tingling of different parts of the body\nAbdominal pain\nConstipation or diarrhoea\nIrritable bladder\nSigns\nTender Points (commonly found around the elbows, shoulders, knees, hips, back of the head, and the sides of the breastbone)\nMyalgia (more than three months)\ninvestigations\nFBC, ESR\nBUE and creatinine\nUrinalysis\nThyroid stimulating hormone level\n25-hydroxy vitamin D level\nVitamin B12 level\nIron studies\nMagnesium level.",
    "title": "therapy in the treatment of fibromyalgia.",
    "section": "therapy in the treatment of fibromyalgia.",
    "chunk_id": "2164",
    "type": "section",
    "keywords": [
      "usually",
      "migraine",
      "points",
      "sides",
      "magnesium",
      "anxiety",
      "vitamin",
      "diarrhoea",
      "creatinine",
      "unknown",
      "tiredness",
      "body",
      "abdominal",
      "stimulating",
      "unrefreshing",
      "breastbone",
      "urinalysis",
      "signs",
      "hydroxy",
      "tender"
    ]
  },
  {
    "id": "24a841d8cdda268469448e7187fc3ac7",
    "content": "To reduce pain\nTo aggressively treat co-morbid depression\nTo improve sleep\nTo reduce fatigue.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2165",
    "type": "section",
    "keywords": [
      "aggressively",
      "pain",
      "sleep",
      "treat",
      "improve",
      "reduce",
      "fatigue",
      "morbid",
      "depression"
    ]
  },
  {
    "id": "3865b40dee4d2dd43a5a6231c0635ab3",
    "content": "Stress management\nExercise\nBalanced diet\nSleep therapy\nPsychologic/behavioural therapy.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2166",
    "type": "section",
    "keywords": [
      "diet",
      "behavioural",
      "stress",
      "management",
      "psychologic",
      "exercise",
      "sleep",
      "therapy",
      "balanced"
    ]
  },
  {
    "id": "3bc06bffe93c28683ec2b95443ed464e",
    "content": "Paracetamol\nAdults\n500 mg-1 g 6-8 hourly as required\nChildren\n6-12 years;\t250-500 mg 6-8 hourly as required\n1-5 years;\t125-250 mg 6-8 hourly as required\n3 months-1 year;\t62. 5 mg-125 mg 6-8 hourly as required\nOr\nDiclofenac, oral,\nAdults\n50 mg 8 hourly or 100 mg 12 hourly as required\nChildren\n12 years;\t50 mg 12 hourly as required\n< 12 years;\tnot recommended\nOr\nDiclofenac, rectal,\nAdults\n100 mg 12 hourly as required\nChildren\n12 years;\t75-100 mg daily as required\n< 12 years;\tnot recommended.",
    "title": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "section": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "chunk_id": "2167",
    "type": "section",
    "keywords": [
      "hourly",
      "rectal",
      "recommended",
      "years",
      "diclofenac",
      "adults",
      "oral",
      "paracetamol",
      "required",
      "children",
      "months",
      "daily",
      "year"
    ]
  },
  {
    "id": "3d8fecda987f60df2e486a4818a52582",
    "content": "Tramadol, oral,\n25 mg stat. Then\nIncrease by 25-50 mg daily up to 50-100 mg 6 hourly as necessary; (max. 400 mg per day)\nAnd\nAmitriptyline, oral, 10 mg nocte\nThen\nGradually increase to 75 mg daily as required.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2168",
    "type": "section",
    "keywords": [
      "hourly",
      "nocte",
      "tramadol",
      "amitriptyline",
      "necessary",
      "oral",
      "stat",
      "required",
      "then",
      "increase",
      "daily",
      "gradually"
    ]
  },
  {
    "id": "6938a1019e0401bb570fe135fe12dd2f",
    "content": "Clonazepam, oral,\nAdults\n250 microgram 12 hourly (max. 1 mg 12 hourly)\nChildren\nNot recommended for this condition.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2169",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "microgram",
      "adults",
      "oral",
      "condition",
      "clonazepam",
      "children"
    ]
  },
  {
    "id": "2dc184100eeb98f6720828311c0c4c5b",
    "content": "Fluoxetine, oral,\nAdults\n20 mg daily (max. 80 mg per day)\nChildren\n8-18 years;\t10 mg daily (max. 20 mg per day)\n< 8 years;\tnot recommended\nOr\nAmitriptyline, oral,\nAdults\n25-50 mg once daily (early evening),\nThen\nIncrease by 25 mg every 3-5 days up to a max.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2170",
    "type": "section",
    "keywords": [
      "fluoxetine",
      "once",
      "days",
      "recommended",
      "years",
      "evening",
      "early",
      "adults",
      "oral",
      "every",
      "increase",
      "children",
      "then",
      "amitriptyline",
      "daily"
    ]
  },
  {
    "id": "ce93164f76c9a8d3dd571e7af6d1f01f",
    "content": "of 150 mg\nChildren\n16 years;\t5-15 mg 12 hourly\n< 16 years;\tnot recocommended\nOr\nDuloxetine, oral,\nAdults\n20-30 mg 12-24 hourly (max. 60 mg per day)\nChildren\n7-17 years;\t20-30 mg daily (max. 60 mg per day).",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2171",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "duloxetine",
      "adults",
      "oral",
      "children",
      "daily",
      "recocommended"
    ]
  },
  {
    "id": "92269916dba11813ec00f5d2c0beba8f",
    "content": "Tizanidine, oral,\nAdults\n2 mg 8 hourly\nMay increase to 4 mg 8 hourly after 7 days\nChildren\nNot recommended\nOr\nCyclobenzaprine, oral,\nAdults\n5-10 mg 8 hourly as required\nChildren\n5 mg 8 hourly as required.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2172",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "recommended",
      "tizanidine",
      "adults",
      "oral",
      "after",
      "required",
      "children",
      "cyclobenzaprine",
      "increase"
    ]
  },
  {
    "id": "e36443291bd9c6166ea4b9739b7c789c",
    "content": "Evidence Rating: [B]\nPregabalin, oral,\nAdults\n50-75 mg 12 hourly till resolution (max. 300 mg per day)\nChildren\nNot recommended\nOr\nGabapentin, oral,\nAdults\n300 mg daily\nThen\nIncrease by 300 mg daily to a max. of 600 mg 8 hourly\nChildren\nNot recommended.",
    "title": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "section": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "chunk_id": "2173",
    "type": "section",
    "keywords": [
      "hourly",
      "rating",
      "resolution",
      "recommended",
      "adults",
      "pregabalin",
      "oral",
      "increase",
      "children",
      "gabapentin",
      "then",
      "evidence",
      "till",
      "daily"
    ]
  },
  {
    "id": "3ae9e9c4d640835fdbc415d15dbaf745",
    "content": "And\nClonidine, oral,\nAdults\n50-75 microgram 12 hourly\nChildren\nNot recommended\nReferral Criteria.",
    "title": "(See ‘treatment for mild symptoms’ as above)",
    "section": "(See ‘treatment for mild symptoms’ as above)",
    "chunk_id": "2174",
    "type": "section",
    "keywords": [
      "clonidine",
      "hourly",
      "referral",
      "recommended",
      "microgram",
      "adults",
      "oral",
      "children",
      "criteria"
    ]
  },
  {
    "id": "07c89d5e112cd8a0e4a62f51cae620b2",
    "content": "The idiopathic inflammatory myopathies (IIM) are systemic connective tissue diseases, which are characterized by symmetrical, proximal muscle weakness, reduced muscle strength and chronic inflammation in muscle tissue. These are rare disorders, and affects more women than men. Although the peak age of onset is in the 50s, the disorders can occur at any age.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2175",
    "type": "section",
    "keywords": [
      "symmetrical",
      "proximal",
      "occur",
      "idiopathic",
      "which",
      "systemic",
      "reduced",
      "weakness",
      "diseases",
      "rare",
      "inflammation",
      "muscle",
      "peak",
      "onset",
      "chronic",
      "women",
      "disorders",
      "although",
      "myopathies",
      "inflammatory"
    ]
  },
  {
    "id": "9ee6fbd09938e9eb799b926d550258e5",
    "content": "The word “juvenile” is used in the name when a child is affected by myositis. Adults with inflammatory myopathies, have an increased risk of cancer including cancer of the lung, breast, prostate, and ovaries etc. Causes\nUnknown\nAutoimmune\nSymptoms\nMuscle weakness (around the neck, shoulders and hips)\nTrouble climbing stairs, getting up from a seat, or reaching for objects\noverhead\nPain in the muscles\nChoking while eating\nAspiration of food\nSigns\nProximal muscle weakness\nAspiration pneumonia\nGottron’s sign or Gottron’s papules (rash over the back of the fingers, elbows or knees)\nShawl sign (flat, reddened area that appears on the upper back,\nshoulders, and back of the neck)\nPhotosensitive rash\nHeliotrope rash\nNail bed abnormalities\nMechanic’s hands\nAlopecia.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2176",
    "type": "section",
    "keywords": [
      "heliotrope",
      "choking",
      "stairs",
      "proximal",
      "abnormalities",
      "muscles",
      "child",
      "word",
      "weakness",
      "while",
      "prostate",
      "neck",
      "breast",
      "aspiration",
      "unknown",
      "rash",
      "juvenile",
      "appears",
      "upper",
      "photosensitive"
    ]
  },
  {
    "id": "028930a9799bc7907c42a20a68edffb3",
    "content": "Calcium deposits in the skin (calcinosis)\ninvestigations\nCreatine kinase levels\nAntinuclear Antibodies (ANA)\nHepatitis B and C screen\nHIV Test\nMuscle biopsy\nMRI scan of the muscles\nElectromyogram (EMG).",
    "title": "Interstitial lung disease",
    "section": "Interstitial lung disease",
    "chunk_id": "2177",
    "type": "section",
    "keywords": [
      "calcinosis",
      "antibodies",
      "deposits",
      "antinuclear",
      "test",
      "calcium",
      "kinase",
      "scan",
      "electromyogram",
      "levels",
      "muscles",
      "muscle",
      "skin",
      "biopsy",
      "investigations",
      "hepatitis",
      "screen",
      "creatine"
    ]
  },
  {
    "id": "d190f71958fe0dda459ff239dd997bfa",
    "content": "To improve muscle strength\nTo minimise long-term muscle damage\nTo prevent complications from muscle weakness.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "2178",
    "type": "section",
    "keywords": [
      "term",
      "complications",
      "minimise",
      "improve",
      "prevent",
      "muscle",
      "damage",
      "strength",
      "weakness"
    ]
  },
  {
    "id": "28f45ce6b1c507abcc50ea319e3a3747",
    "content": "Physical therapy and rehabilitation to prevent contractures\nAvoidance of exposure to direct sunlight\nAppropriate feeding techniques to prevent aspiration.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2179",
    "type": "section",
    "keywords": [
      "aspiration",
      "contractures",
      "techniques",
      "avoidance",
      "appropriate",
      "prevent",
      "physical",
      "exposure",
      "feeding",
      "direct",
      "sunlight",
      "therapy",
      "rehabilitation"
    ]
  },
  {
    "id": "8a69f656d1a3364fd8722124a91f7a80",
    "content": "Prednisolone, oral, 0. 5-1 mg/kg body weight\nAnd\nOmeprazole, oral,\nAdults\n20 mg daily\nChildren\n20 kg;\t20 mg daily\n10-20 kg;\t10 mg daily\n5-10 kg;\t5 mg daily\nOr\nEsomeprazole, oral,\nAdults\n20-40 mg daily\nChildren\n12-18 years;\t20-40 mg daily\n1-12 years;\t10-20 mg daily\n< 1 year;\tnot recommended\nAnd\nCalcium supplements with vitamin D\nAdults and Children As required\nOr\nBisphosphonates Adults and Children Consult specialist.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2180",
    "type": "section",
    "keywords": [
      "years",
      "supplements",
      "bisphosphonates",
      "weight",
      "required",
      "vitamin",
      "body",
      "specialist",
      "children",
      "daily",
      "calcium",
      "prednisolone",
      "adults",
      "omeprazole",
      "consult",
      "year",
      "recommended",
      "oral",
      "esomeprazole"
    ]
  },
  {
    "id": "1bdbde1d94d47149eb0693509f2c50e5",
    "content": "200-400 mg daily\nChildren\n5-6. 5 mg/kg (max. 400 mg per day).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2181",
    "type": "section",
    "keywords": [
      "children",
      "daily"
    ]
  },
  {
    "id": "3756d541980b39715821570f214a1dad",
    "content": "Methotrexate, consult specialist\nOr\nAzathioprine, consult specialist\nOr\nIntravenous immunoglobulin, consult specialist\nOr\nMycophenolate mofetil, consult specialist\nOr\nRituximab, consult specialist\nReferral Criteria\nRefer all patients to a physician specialist or rheumatologist. The hot swollen joint is a common presentation and has extensive differential diagnosis. Some of the most serious causes are septic arthritis (with a case fatality of 11%) and acute leukemia in children.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2182",
    "type": "section",
    "keywords": [
      "intravenous",
      "arthritis",
      "leukemia",
      "acute",
      "serious",
      "mycophenolate",
      "specialist",
      "extensive",
      "presentation",
      "joint",
      "patients",
      "most",
      "children",
      "criteria",
      "azathioprine",
      "causes",
      "physician",
      "referral",
      "immunoglobulin",
      "diagnosis"
    ]
  },
  {
    "id": "b61629f24eeaf4c271153ebf48383ecf",
    "content": "Late diagnosis and poor treatment leads to joint damage and death. The commonest affected joint is the big toe, typically due to gout and can be diagnosed on clinical grounds. Patients with a short history of a hot, swollen and tender joint (or joints) with restriction of movement should be regarded as having septic arthritis until proven otherwise.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2183",
    "type": "section",
    "keywords": [
      "proven",
      "having",
      "typically",
      "arthritis",
      "poor",
      "late",
      "death",
      "regarded",
      "restriction",
      "short",
      "movement",
      "grounds",
      "joint",
      "patients",
      "tender",
      "gout",
      "treatment",
      "leads",
      "joints",
      "diagnosis"
    ]
  },
  {
    "id": "f6a39647fec3c16b153f674fd8ba9df3",
    "content": "If clinical suspicion is high, then it is imperative to treat as septic arthritis even in the absence of fever. Causes\nSeptic arthritis\nReactive arthritis\nMonoarticular presentation of polyarthritis\nInflammatory arthritis\nGout or crystal arthritis\nHaemarthrosis\nTrauma\nBursitis/cellulitis\nLeukaemia (in children)\nHaemophilia\nSymptoms\nFever\nJoint swelling (monoarthritis).",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2184",
    "type": "section",
    "keywords": [
      "monoarthritis",
      "treat",
      "bursitis",
      "swelling",
      "suspicion",
      "arthritis",
      "cellulitis",
      "imperative",
      "haemarthrosis",
      "leukaemia",
      "haemophilia",
      "polyarthritis",
      "presentation",
      "even",
      "joint",
      "children",
      "gout",
      "causes",
      "reactive",
      "fever"
    ]
  },
  {
    "id": "5af6556ef37d274ff362b2913357a3a8",
    "content": "Joint pain\nLimited mobility of affected joints\nSigns\nHot swollen native joint\nFever\nJoint tenderness\ninvestigations\nFBC, ESR\nBlood culture\nBlood film comment\nC-reactive protein (CRP)\nSerum uric acid level\nBUE and creatinine\nLiver function tests\nSynovial fluid aspirate for microscopy and culture\nX-ray of affected joint\nMRI of the affected joint\nUltrasonography to aid diagnostic aspiration.",
    "title": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "section": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "chunk_id": "2185",
    "type": "section",
    "keywords": [
      "limited",
      "comment",
      "native",
      "diagnostic",
      "fluid",
      "aspiration",
      "creatinine",
      "microscopy",
      "function",
      "synovial",
      "film",
      "protein",
      "joint",
      "signs",
      "culture",
      "blood",
      "joints",
      "tenderness",
      "acid",
      "level"
    ]
  },
  {
    "id": "84b826a4c82dad5e62a6139d368ac821",
    "content": "To reduce pain\nTo reduce swelling and stiffness\nTo prevent deformities.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2186",
    "type": "section",
    "keywords": [
      "pain",
      "stiffness",
      "prevent",
      "reduce",
      "swelling",
      "deformities"
    ]
  },
  {
    "id": "1bd40de08cabdf932ee8fa3df8a9c376",
    "content": "Rest of affected joints using bedrest, splints\nPhysiotherapy\nJoint aspiration.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2187",
    "type": "section",
    "keywords": [
      "aspiration",
      "physiotherapy",
      "joints",
      "bedrest",
      "using",
      "splints",
      "joint",
      "rest",
      "affected"
    ]
  },
  {
    "id": "63bf9d66be7400bd413458880fed4205",
    "content": "Diclofenac, oral,\nAdults\n50 mg 8 hourly or 100 mg 12 hourly as required\nChildren\n12 years;\t50 mg 12 hourly as required\n< 12 years;\tnot recommended\nOr\nDiclofenac, rectal,\nAdults\n100 mg 12 hourly as required\nChildren.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2188",
    "type": "section",
    "keywords": [
      "hourly",
      "rectal",
      "recommended",
      "years",
      "diclofenac",
      "adults",
      "oral",
      "required",
      "children"
    ]
  },
  {
    "id": "59e9a03080a8d43d57e14828deeff138",
    "content": "12 years;\t75-100 mg daily as required\n< 12 years;\tnot recommended\nCaution 22-3. For control of inflammation in the absence of infection\nPrednisolone, oral,\nAdults\n0. 5-2 mg/kg daily or 12 hourly (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2189",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "prednisolone",
      "inflammation",
      "infection",
      "adults",
      "caution",
      "oral",
      "absence",
      "required",
      "control",
      "daily"
    ]
  },
  {
    "id": "eb89ed5e59f60dc4128528bb7f4edad2",
    "content": "80 mg per day)\nChildren\n0. 5 mg/kg daily or 12 hourly (max. 60 mg per day)\nOr\nIntra-articular corticosteroid injection – consult specialist.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2190",
    "type": "section",
    "keywords": [
      "hourly",
      "intra",
      "specialist",
      "consult",
      "corticosteroid",
      "articular",
      "injection",
      "children",
      "daily"
    ]
  },
  {
    "id": "71740c787bc76afd6ecded8bd71c367d",
    "content": "(See section on ‘Septic Arthritis’)\nReferral Criteria\nRefer patients with an acutely swollen joint to the orthopedic surgeon or rheumatologist. This condition, which typically affects males with cardiovascular risk factors and women after menopause, results from the deposition of uric acid crystals in joints and periarticular tissues. Gout is characterised by pain and inflammation of the affected joints.",
    "title": "For treatment of infection in Septic arthritis",
    "section": "For treatment of infection in Septic arthritis",
    "chunk_id": "2191",
    "type": "section",
    "keywords": [
      "orthopedic",
      "crystals",
      "which",
      "males",
      "factors",
      "arthritis",
      "typically",
      "acutely",
      "results",
      "characterised",
      "inflammation",
      "section",
      "joint",
      "patients",
      "condition",
      "gout",
      "criteria",
      "referral",
      "joints",
      "women"
    ]
  },
  {
    "id": "3b07297217dfec61d75b5e319adb1ac9",
    "content": "It is often, but not always, associated with raised blood uric acid levels and may be present even when the level of uric acid in the blood is normal, while patients with high levels of uric acid may not necessarily have attacks of gout. Individual gout flares are often triggered by acute increases or decreases in uric acid levels which may be associated with acute alcohol ingestion, acute overindulgence in foods high in purines, rapid weight loss, dehydration, or trauma. Causes\nOverproduction of uric acid in disorders that cause high cell turnover with release of purines found in cell nuclei.",
    "title": "For treatment of infection in Septic arthritis",
    "section": "For treatment of infection in Septic arthritis",
    "chunk_id": "2192",
    "type": "section",
    "keywords": [
      "necessarily",
      "triggered",
      "weight",
      "often",
      "increases",
      "levels",
      "which",
      "associated",
      "release",
      "foods",
      "overproduction",
      "acute",
      "while",
      "always",
      "attacks",
      "individual",
      "decreases",
      "purines",
      "alcohol",
      "nuclei"
    ]
  },
  {
    "id": "cf566719dd183e032547de10472de6ad",
    "content": "Psoriasis\nHaemolytic anemias\nCell lysis from chemotherapy, especially those of the haemato- poietic or lymphatic systems\nExcessive exercise\nMetabolic syndrome (obesity, diabetes, hypertension, elevated cholesterol etc. )\nImpaired excretion of uric acid.",
    "title": "Myeloproliferative and lymphoproliferative disorders",
    "section": "Myeloproliferative and lymphoproliferative disorders",
    "chunk_id": "2193",
    "type": "section",
    "keywords": [
      "hypertension",
      "lymphatic",
      "especially",
      "exercise",
      "lysis",
      "impaired",
      "psoriasis",
      "cholesterol",
      "acid",
      "anemias",
      "haemolytic",
      "elevated",
      "uric",
      "those",
      "chemotherapy",
      "metabolic",
      "excessive",
      "poietic",
      "diabetes",
      "cell"
    ]
  },
  {
    "id": "af501e51695b90267de9185f11fe0c97",
    "content": "Renal impairment\nLead nephropathy\nStarvation or dehydration\nDrugs e. g. thiazide and loop diuretics, cytotoxic drugs, pyrazin- amide\nAlcohol ingestion.",
    "title": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "section": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "chunk_id": "2194",
    "type": "section",
    "keywords": [
      "diuretics",
      "pyrazin",
      "ingestion",
      "dehydration",
      "drugs",
      "amide",
      "nephropathy",
      "loop",
      "alcohol",
      "impairment",
      "lead",
      "thiazide",
      "cytotoxic",
      "starvation",
      "renal"
    ]
  },
  {
    "id": "d1395508cda551380b607acfd4a5f3f3",
    "content": "Symptoms\nExcruciating pain and swelling usually of a joint (classically the big toe but may affect the knee, ankles or wrists)\nMultiple joint pain\nJoint swelling\nSigns\nInflamed, swollen and tender joint\nMigratory polyarthritis\nTophi in soft tissues (helix of the ear, fingers, toes, prepatellar bursa, olecranon)\nFever\ninvestigations\nFBC, ESR\nBUE, creatinine\nSerum uric acid\nBlood glucose\nSerum lipids\nX-ray of affected joint\nJoint aspirate for culture and polarised microscopy.",
    "title": "Inherited purine metabolic disorders e.g. Lesch-Nyhan syndrome",
    "section": "Inherited purine metabolic disorders e.g. Lesch-Nyhan syndrome",
    "chunk_id": "2195",
    "type": "section",
    "keywords": [
      "usually",
      "inflamed",
      "swelling",
      "wrists",
      "glucose",
      "polarised",
      "olecranon",
      "lipids",
      "migratory",
      "creatinine",
      "microscopy",
      "multiple",
      "polyarthritis",
      "fingers",
      "joint",
      "prepatellar",
      "signs",
      "culture",
      "tender",
      "knee"
    ]
  },
  {
    "id": "dca19f407305ceb0f98f5f531affddd9",
    "content": "To relieve acute pain\nTo reduce joint inflammation\nTo prevent recurrent attacks and joint damage\nTo prevent uric acid crystal deposition in soft tissues.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2196",
    "type": "section",
    "keywords": [
      "crystal",
      "attacks",
      "pain",
      "recurrent",
      "prevent",
      "inflammation",
      "acid",
      "reduce",
      "soft",
      "relieve",
      "joint",
      "damage",
      "uric",
      "tissues",
      "deposition",
      "acute"
    ]
  },
  {
    "id": "e9530c767e1ae64d1c8e09a33a8c6dc8",
    "content": "Optimize weight\nReduce protein in diet e. g. liver, kidneys, shellfish and yeast extracts\nReduce alcohol intake to < 14 units/week (men and women)\nAvoid highly sweetened soft drinks and other beverages or foods\nEncourage to drink > 2 litres of water daily and avoid dehydration.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2197",
    "type": "section",
    "keywords": [
      "diet",
      "avoid",
      "units",
      "drink",
      "weight",
      "foods",
      "extracts",
      "drinks",
      "alcohol",
      "week",
      "protein",
      "water",
      "highly",
      "intake",
      "optimize",
      "dehydration",
      "kidneys",
      "women",
      "sweetened",
      "soft"
    ]
  },
  {
    "id": "c9e7f5ca54f54268b34fce295e504dde",
    "content": "Affected joints should be elevated and exposed in a cool environment. ‘Bed cages’ and ice packs can be effective adjuncts to therapy\nIntense physical exercise should be avoided but moderate physical\nexercise encouraged\nIdentify and treat underlying cardiovascular (metabolic syndrome)\nrisk factors.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2198",
    "type": "section",
    "keywords": [
      "treat",
      "exercise",
      "factors",
      "identify",
      "therapy",
      "moderate",
      "packs",
      "underlying",
      "avoided",
      "cool",
      "exposed",
      "intense",
      "joints",
      "cages",
      "should",
      "elevated",
      "encouraged",
      "cardiovascular",
      "metabolic",
      "effective"
    ]
  },
  {
    "id": "4f47e682b54811328eff7b7ada3a6b2c",
    "content": "Diclofenac, oral\nAdults\n50 mg 8 hourly or 75 mg 12 hourly ORDERS ORY\nChildren\n12 years;\t50 mg 8 hourly\n< 12 years;\tnot recommended\nOr\nDiclofenac, rectal,\nAdults\n100 mg daily\nChildren\n12 years;\t75-100 mg daily\n< 12 years;\tnot recommended\nCaution 22-4.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "2199",
    "type": "section",
    "keywords": [
      "hourly",
      "rectal",
      "recommended",
      "years",
      "orders",
      "diclofenac",
      "adults",
      "caution",
      "oral",
      "children",
      "daily"
    ]
  },
  {
    "id": "07dbd529d90ba988966e7fd18f32ffe7",
    "content": "Colchicine, oral,\n500 microgram 6-12 hourly until symptoms relieved (max. 6 mg per course. Course should not to be repeated within 3 days)\nOr\nPrednisolone, oral,\nAdults\n10-40 mg for 1-3 days.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "2200",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "within",
      "microgram",
      "prednisolone",
      "course",
      "should",
      "adults",
      "oral",
      "colchicine",
      "repeated",
      "symptoms",
      "until",
      "relieved"
    ]
  },
  {
    "id": "f0753c12cb8b69e841f0a0c00d1a83d4",
    "content": "Evidence Rating: [B]\nAllopurinol, oral, 100 mg daily Then\nIncrease by 100 mg every 2-5 weeks, adjusted if necessary for renal function, until the therapeutic target (Serum Uric Acid [SUA] < 300 micromol/L) is reached (max. dose 900 mg)\nCaution 22-5.",
    "title": "Chronic Gout – following treatment of acute gout",
    "section": "Chronic Gout – following treatment of acute gout",
    "chunk_id": "2201",
    "type": "section",
    "keywords": [
      "evidence",
      "increase",
      "rating",
      "function",
      "weeks",
      "renal",
      "target",
      "acid",
      "therapeutic",
      "uric",
      "dose",
      "then",
      "every",
      "adjusted",
      "reached",
      "serum",
      "necessary",
      "oral",
      "micromol",
      "caution"
    ]
  },
  {
    "id": "a254a05ac6b36fbe180a06076c72c4df",
    "content": "Referral Criteria\nRefer patients to a dietician for dietary modification and a weight reducing diet in obese and overweight individuals. Patients with co-morbid conditions such as Type 2 diabetes, hypertension, dyslipidaemia, renal impairment or not responding to Allupurinol etc. should be referred to a physician specialist or rheumatologist.",
    "title": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "section": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "chunk_id": "2202",
    "type": "section",
    "keywords": [
      "hypertension",
      "diet",
      "obese",
      "allupurinol",
      "overweight",
      "weight",
      "morbid",
      "type",
      "specialist",
      "dyslipidaemia",
      "dietary",
      "modification",
      "patients",
      "renal",
      "criteria",
      "physician",
      "reducing",
      "referral",
      "impairment",
      "should"
    ]
  },
  {
    "id": "6e90cff1750527783cba46e186eeb4ce",
    "content": "This refers to attacks of synovitis induced by deposition of Calcium Pyrophosphate Dihydrate (CPPD) crystals. Most patients are old females. It behaves like gout in many respects, but unlike gout, attacks persist longer and affect the knee most commonly.",
    "title": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "section": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "chunk_id": "2203",
    "type": "section",
    "keywords": [
      "persist",
      "crystals",
      "induced",
      "refers",
      "females",
      "attacks",
      "dihydrate",
      "unlike",
      "respects",
      "patients",
      "most",
      "gout",
      "knee",
      "pyrophosphate",
      "affect",
      "calcium",
      "longer",
      "commonly",
      "behaves",
      "cppd"
    ]
  },
  {
    "id": "2ba4ba523032eea7343ffb68a8d58236",
    "content": "Common risk factors include trauma, surgery, severe illness, parathyroidectomy, pamidronate therapy. Co-morbidities for this condition are usually cardiovascular, renal and metabolic diseases e. g.",
    "title": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "section": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "chunk_id": "2204",
    "type": "section",
    "keywords": [
      "severe",
      "include",
      "usually",
      "diseases",
      "parathyroidectomy",
      "morbidities",
      "common",
      "factors",
      "cardiovascular",
      "risk",
      "illness",
      "condition",
      "pamidronate",
      "renal",
      "therapy",
      "surgery",
      "trauma",
      "metabolic"
    ]
  },
  {
    "id": "e5e8a7a6a88a014fa1c4ddd674c47036",
    "content": "diabetes mellitus. Cause\nDeposition of Calcium Pyrophosphate Dihydrate (CPPD) crystals in\nand around joints\nSymptoms\nJoint pain\nSwollen joint\nSigns\nSwollen joint\nTenderness\nJoint effusion\ninvestigations\nSerum uric acid\nX-ray of joint\nMicroscopic examination of joint or bursa fluid aspirate.",
    "title": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "section": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "chunk_id": "2205",
    "type": "section",
    "keywords": [
      "microscopic",
      "crystals",
      "mellitus",
      "fluid",
      "dihydrate",
      "joint",
      "signs",
      "pyrophosphate",
      "joints",
      "tenderness",
      "calcium",
      "acid",
      "bursa",
      "around",
      "cause",
      "uric",
      "investigations",
      "symptoms",
      "effusion",
      "pain"
    ]
  },
  {
    "id": "cd0115fb44b7a508efbcd46f55c11ca2",
    "content": "Evidence Rating: [C]\nNaproxen EC, oral,\nAdults\n250-500 mg 12 hourly as required\nChildren\nNot indicated\nOr\nCelecoxib, oral,\nAdults\n400 mg stat. Then\n200 mg 12-24 hourly as required\nChildren\nNot indicated\nOr\nDiclofenac, oral,\nAdults\n50 mg 8 hourly or 100 mg 12 hourly\nChildren\n12 years;\t50 mg 12 hourly\n< 12 years;\tnot recommended\nOr\nIbuprofen, oral,\nAdults\n200-800 mg 6-8 hourly as required (max. 2.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2206",
    "type": "section",
    "keywords": [
      "hourly",
      "rating",
      "recommended",
      "years",
      "naproxen",
      "diclofenac",
      "adults",
      "ibuprofen",
      "oral",
      "stat",
      "indicated",
      "required",
      "children",
      "then",
      "evidence",
      "celecoxib"
    ]
  },
  {
    "id": "531e805167ca81d8a3ee22945464b883",
    "content": "4 g daily)\nChildren\n10-15 mg/kg 6-8 hourly as required (max. 40 mg per kg daily)\nOr\nColchicine, oral,\nAdult\n500 micrograms 6-12 hourly\nChildren\nNot recommended.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2207",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "adult",
      "oral",
      "micrograms",
      "colchicine",
      "required",
      "children",
      "daily"
    ]
  },
  {
    "id": "980e6e3f75e5111ffc7f45e4ed23a9de",
    "content": "Prednisolone, oral, consult specialist\nMethyl prednisolone acetate, Intra-articular, consult specialist\nTriamcinolone, Intra-articular, consult specialist\nBetamethasone, Intra-articular, consult specialist.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "2208",
    "type": "section",
    "keywords": [
      "intra",
      "acetate",
      "specialist",
      "prednisolone",
      "triamcinolone",
      "oral",
      "articular",
      "betamethasone",
      "methyl",
      "consult"
    ]
  },
  {
    "id": "6b7875c6bd5f8f2121e3ba9a81317cba",
    "content": "Probenecid, consult specialist\nMethotrexate, consult specialist\nPhosphocitrate, consult specialist\nAnakinra, consult specialist.",
    "title": "3rd Line Treatment",
    "section": "3rd Line Treatment",
    "chunk_id": "2209",
    "type": "section",
    "keywords": [
      "specialist",
      "probenecid",
      "anakinra",
      "methotrexate",
      "consult",
      "phosphocitrate"
    ]
  },
  {
    "id": "6b3bc3e21a008b35d9c490a441cedda3",
    "content": "Referral Criteria\nStart analgesia and refer to rheumatologist/orthopaedic surgeon. Systemic Lupus Erythematosus (SLE) is a chronic multisystem autoimmune inflammatory disease that has variable signs and follows a relapsing and remitting course. More than 90% of cases of SLE occur in women, commonly of childbearing age.",
    "title": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "section": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "chunk_id": "2210",
    "type": "section",
    "keywords": [
      "occur",
      "systemic",
      "start",
      "orthopaedic",
      "analgesia",
      "signs",
      "criteria",
      "disease",
      "referral",
      "chronic",
      "women",
      "course",
      "variable",
      "childbearing",
      "follows",
      "commonly",
      "inflammatory",
      "lupus",
      "refer",
      "remitting"
    ]
  },
  {
    "id": "64d87d086f4ca5912dc525a417c41d31",
    "content": "This condition can lead to complications such as acute or chronic renal failure, seizures, psychosis, pleurisy, pleural effusion, pneumonitis, pulmonary hypertension, pericarditis, myocarditis, leukopaenia, lymphopaenia, thrombocytopaenia and interstitial lung disease. Management of SLE often depends on the individual patient’s disease severity and disease manifestations. Causes\nAutoimmune\nGenetic and environmental factors\nSymptoms\nFatigue\nMalaise\nFever\nWeight loss\nRash\nHair loss\nMouth sores\nJoint pains\nSensitivity to sunlight\nSeizures\nNausea\nDyspepsia\nAbdominal pain\nSigns\nLymphadenopathy\nFever\nMalar rash\nDiscoid rash\nFatigue\nArthralgia\nArthropathy\nMyalgia\nArthritis\nPhotosensitivity rash.",
    "title": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "section": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "chunk_id": "2211",
    "type": "section",
    "keywords": [
      "hypertension",
      "nausea",
      "weight",
      "often",
      "photosensitivity",
      "management",
      "sores",
      "fatigue",
      "seizures",
      "lead",
      "factors",
      "environmental",
      "arthritis",
      "pneumonitis",
      "sensitivity",
      "arthralgia",
      "acute",
      "patient",
      "rash",
      "individual"
    ]
  },
  {
    "id": "1de4780975ae999696cf5cf8a9db6730",
    "content": "Anaemia\ninvestigations\nFBC, ESR\nBUE and Creatinine\nUrinalysis with microscopy\nC - reactive protein\nAntinuclear Antibodies (ANA)\nAnti-Double stranded DNA (dsDNA)\nComplement levels\nLiver function tests\nSpot Urine protein/spot creatinine ratio\nOther Autoantibody tests e. g. Extractable Nuclear Antigens (ENA)\nHepatitis B and C screen\nHIV screen\nJoint radiography\nChest radiography\nEchocardiography\nBrain MRI/MRA.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2212",
    "type": "section",
    "keywords": [
      "echocardiography",
      "anaemia",
      "levels",
      "ratio",
      "urine",
      "autoantibody",
      "creatinine",
      "microscopy",
      "antinuclear",
      "extractable",
      "chest",
      "function",
      "protein",
      "double",
      "urinalysis",
      "joint",
      "dsdna",
      "nuclear",
      "screen",
      "antibodies"
    ]
  },
  {
    "id": "b40c7554deb0602058934777018ebea8",
    "content": "To prevent and treat complications\nTo avoid possible long-term side effects of the drugs.",
    "title": "To adequately control underlying disease",
    "section": "To adequately control underlying disease",
    "chunk_id": "2213",
    "type": "section",
    "keywords": [
      "side",
      "avoid",
      "complications",
      "term",
      "drugs",
      "treat",
      "effects",
      "prevent",
      "possible"
    ]
  },
  {
    "id": "5d7a1a1bdfc14862ce30f9d129ce1f9b",
    "content": "Avoidance of excessive sunlight\nRest as appropriate\nA low-fat diet with added fish oil\nAvoidance of oestrogen-containing contraceptive pills\nCounselling and Education.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2214",
    "type": "section",
    "keywords": [
      "fish",
      "diet",
      "education",
      "avoidance",
      "appropriate",
      "oestrogen",
      "containing",
      "pills",
      "contraceptive",
      "added",
      "counselling",
      "rest",
      "sunlight",
      "excessive"
    ]
  },
  {
    "id": "5db51cf09024611ada98da9944144c02",
    "content": "Methylprednisolone, IV infusion, (infuse over 1 hour)\nAdults\n1 g daily for 3-5 days.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2215",
    "type": "section",
    "keywords": [
      "days",
      "hour",
      "adults",
      "infusion",
      "infuse",
      "methylprednisolone",
      "daily"
    ]
  },
  {
    "id": "f74b7ccb604b9326541745f2344fd51a",
    "content": "Children\n1 month-18 years; 10-30 mg/kg every other day for 6 doses (max. 1 g daily)\nThen\nPrednisolone, oral,\nAdults and Children\n0. 5-1 mg/kg body weight\nAnd\nOmeprazole, oral,\nAdults\n20 mg daily\nChildren\n20 kg;\t20 mg daily\n10-20 kg;\t10 mg daily\n5-10 kg;\t5 mg daily\nOr\nEsomeprazole, oral,\nAdults\n20-40 mg daily\nChildren\n12-18 years;\t20-40 mg daily\n1-12 years;\t10-20 mg daily\n< 1 year;\tnot recommended\nAnd\nDiclofenac, oral,\nAdults\n50 mg 8 hourly or 100 mg 12 hourly as required\nChildren\n12 years;\t50 mg 12 hourly as required\n< 12 years;\tnot recommended\nOr\nDiclofenac, rectal,\nAdults\n100 mg 12 hourly as required\nChildren\n12 years;\t50-100 mg daily as required\n< 12 years;\tnot recommended\nOr\nCelecoxib, oral,\nAdults\n400 mg stat.",
    "title": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "section": "Chapter 22:  Dısorders Of The Musculoskeletal System",
    "chunk_id": "2216",
    "type": "section",
    "keywords": [
      "years",
      "weight",
      "required",
      "celecoxib",
      "hourly",
      "body",
      "rectal",
      "diclofenac",
      "doses",
      "children",
      "daily",
      "stat",
      "prednisolone",
      "adults",
      "omeprazole",
      "month",
      "then",
      "every",
      "year",
      "recommended"
    ]
  },
  {
    "id": "a53c40a2e227ee6851dd47fe6411b584",
    "content": "200 mg 12-24 hourly as required\nChildren\n2 years (>25kg);\t100 mg 12 hourly as required\n2 years (and 10-25kg); 50 mg 12 hourly as required\n< 2 years;\tnot recommended\nOr\nParacetamol, oral,\nAdults\n500 mg-1 g 6-8 hourly as required\nChildren\n6-12 years;\t250-500 mg 6-8 hourly as required\n1-5 years;\t120-250 mg 6-8 hourly as required\n3 months-1 year;\t60-120 mg 6-8 hourly as required\nAnd\nCalcium with Vitamin D supplements\nAdults and Children As required\nAnd.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2217",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "calcium",
      "supplements",
      "adults",
      "oral",
      "paracetamol",
      "required",
      "children",
      "months",
      "vitamin",
      "year"
    ]
  },
  {
    "id": "1217966b48acbd0b2d0f2196b08acc56",
    "content": "Biologic DMARDs:\nBelimumab, consult specialist\nRituximab, consult specialist\nIntravenous immunoglobulin, consult specialist\nNon-Biologic DMARDs:\nCyclophosphamide, consult specialist\nMethotrexate, consult specialist\nAzathioprine, consult specialist\nMycophenolate, consult specialist\nCyclosporine, consult specialist\nAntimalarials:\nHydroxychloroquine, consult specialist\nReferral Criteria\nRefer all cases to a physician or rheumatologist.",
    "title": "The following medications will be used in addition to the treatments above under specialist care.",
    "section": "The following medications will be used in addition to the treatments above under specialist care.",
    "chunk_id": "2218",
    "type": "section",
    "keywords": [
      "hydroxychloroquine",
      "intravenous",
      "dmards",
      "cyclosporine",
      "mycophenolate",
      "specialist",
      "biologic",
      "belimumab",
      "criteria",
      "azathioprine",
      "physician",
      "antimalarials",
      "referral",
      "immunoglobulin",
      "consult",
      "rituximab",
      "refer",
      "cases",
      "cyclophosphamide",
      "rheumatologist"
    ]
  },
  {
    "id": "3dc81f7b9dfac3902c4ea5571187e6c1",
    "content": "These are injuries in which the scalp, skull, meninges, brain, or the blood vessels within the brain may be affected separately or together. They are a common cause of death and disability especially in young people. With the advent of increased use of motorbikes as public transport, the incidence has gone up.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2219",
    "type": "section",
    "keywords": [
      "injuries",
      "advent",
      "especially",
      "which",
      "scalp",
      "death",
      "skull",
      "vessels",
      "together",
      "within",
      "gone",
      "public",
      "people",
      "separately",
      "blood",
      "meninges",
      "transport",
      "incidence",
      "cause",
      "young"
    ]
  },
  {
    "id": "aa70f4c5bc6212a899a33a3e44b64846",
    "content": "Head injuries may be open or close, mild, moderate or severe. Symptoms and signs, as well as the treatment modality, will depend on the severity of the injury. Significant head injury is defined as a Glasgow Coma Scale (GCS) of less than 10.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2220",
    "type": "section",
    "keywords": [
      "glasgow",
      "injuries",
      "depend",
      "close",
      "open",
      "moderate",
      "scale",
      "signs",
      "treatment",
      "severe",
      "head",
      "coma",
      "symptoms",
      "mild",
      "severity",
      "significant",
      "modality",
      "less",
      "injury",
      "defined"
    ]
  },
  {
    "id": "23e64997e20d6277af690cfdc7595ed3",
    "content": "However, take even mild injuries seriously as these may evolve with time. Continuous monitoring of the patient is required as the situation can change quickly. Corticosteriods have demonstrated no benefits in the treatment of acute head injury and are no longer recommended for routine management.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2221",
    "type": "section",
    "keywords": [
      "injuries",
      "monitoring",
      "evolve",
      "management",
      "situation",
      "required",
      "demonstrated",
      "patient",
      "acute",
      "continuous",
      "quickly",
      "even",
      "injury",
      "treatment",
      "routine",
      "head",
      "benefits",
      "longer",
      "change",
      "corticosteriods"
    ]
  },
  {
    "id": "7b0612d40040e5a9bd246299a0317cd1",
    "content": "Sedatives must also not be given except in cases of transporting an aggressive patient. Causes\nRoad traffic accidents\nFalls, especially from heights\nBlows to the head (fights, including domestic violence, street fights)\nGunshot wounds\nStab wounds\nChild abuse\nSymptoms\nHeadaches\nDrowsiness\nLoss of consciousness\nVomiting\nSeizures\nMemory loss\nLeakage of clear fluid or bleeding from the ears or nostrils\nIntolerance to light (photophobia).",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2222",
    "type": "section",
    "keywords": [
      "falls",
      "given",
      "especially",
      "transporting",
      "seizures",
      "child",
      "accidents",
      "clear",
      "memory",
      "patient",
      "light",
      "nostrils",
      "fluid",
      "traffic",
      "heights",
      "including",
      "bleeding",
      "drowsiness",
      "except",
      "violence"
    ]
  },
  {
    "id": "74dec29e406e9ea0ee3769c38ec93701",
    "content": "Signs\nLevel of consciousness - may vary from fully conscious to deeply\nunconscious (use the Glasgow Coma Scale whenever possible)\nExternal signs of injuries - abrasions, contusions, lacerations, darkening around the eyes and the back of the ears\nCSF or blood leakage from the ears/nostrils\nPupillary abnormalities - unequal size, pin point or dilated\nFocal neurological deficits - paralysis, loss of speech or vision\nSigns of raised intracranial pressure such as deepening coma, a rising blood pressure, slowing of the pulse rate and irregular respiration\nOther associated injuries\nAlcoholic breath (in cases of intoxication)\ninvestigations\nFBC\nBUE, Creatinine\nBlood glucose\nX-ray (skull, cervical spine, chest, pelvis)\nHead CT scan (also for children).",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2223",
    "type": "section",
    "keywords": [
      "conscious",
      "glasgow",
      "injuries",
      "abrasions",
      "contusions",
      "intracranial",
      "abnormalities",
      "unconscious",
      "associated",
      "glucose",
      "paralysis",
      "fully",
      "nostrils",
      "deficits",
      "deepening",
      "speech",
      "creatinine",
      "focal",
      "rate",
      "pressure"
    ]
  },
  {
    "id": "239cc1b734b5995e1f212568b0a0017d",
    "content": "To prevent further injury to the brain\nTo treat associated injuries.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2224",
    "type": "section",
    "keywords": [
      "injuries",
      "treat",
      "prevent",
      "further",
      "brain",
      "associated",
      "injury"
    ]
  },
  {
    "id": "89bdd0e85592eb8e13617d7ce5cb266d",
    "content": "Maintain a clear airway, suck out any secretions and assist ventilation\nif necessary\nMaintain the blood pressure (if patient hypotensive or hypertensive)\nPrevent hypoglycaemia\nNurse with head end of bed elevated\nStabilize the neck with a collar till cervical spine injury has been excluded\nIf patient is unconscious, turn every 2 hours\nCatheterize patient.",
    "title": "Assess level of consciousness and provide appropriate treatment",
    "section": "Assess level of consciousness and provide appropriate treatment",
    "chunk_id": "2225",
    "type": "section",
    "keywords": [
      "unconscious",
      "hypotensive",
      "hypertensive",
      "clear",
      "patient",
      "neck",
      "pressure",
      "assist",
      "prevent",
      "suck",
      "collar",
      "blood",
      "nurse",
      "head",
      "secretions",
      "hours",
      "elevated",
      "till",
      "every",
      "cervical"
    ]
  },
  {
    "id": "1aa583a3c50022325c89ba25724db2ea",
    "content": "Pass nasogastric tube for feeding if patient is unconscious. Do NOT pass nasogastric tube if there is suspected fracture of the skull base (i. e if there is fluid or blood coming from the nostrils, or ears).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2226",
    "type": "section",
    "keywords": [
      "fracture",
      "suspected",
      "tube",
      "base",
      "coming",
      "pass",
      "ears",
      "unconscious",
      "feeding",
      "there",
      "nasogastric",
      "patient",
      "blood",
      "nostrils",
      "skull",
      "fluid"
    ]
  },
  {
    "id": "6bee47359b7f623751c4b4565768f653",
    "content": "For lowering of raised intracranial pressure\nEvidence Rating: [B]\nMannitol 20%, IV, (may be given over 30 to 60 minutes)\nAdults\n2. 5-10 ml/kg (0. 5-2g/kg)\nChildren\n2.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2227",
    "type": "section",
    "keywords": [
      "rating",
      "pressure",
      "intracranial",
      "minutes",
      "given",
      "adults",
      "raised",
      "mannitol",
      "children",
      "lowering",
      "evidence"
    ]
  },
  {
    "id": "6cef5dfc07cd2e9acb3368fde435e4cf",
    "content": "5-5 ml/kg (0. 5-1g/kg)\nOr\nHypertonic saline 3%, IV (particularly for children)\nAdults and Children\n3-5 ml/kg over 10-20 minutes (max. 250 ml)\nFor mild pain management\nEvidence Rating: [A]\nParacetamol, oral,\nAdults\n500 mg-1 g 6-8 hourly as required\nChildren\n6-12 years;\t250-500 mg 6-8 hourly as required\n1-5 years;\t120-250 mg 6-8 hourly as required\n3 months-1 year;\t60-120 mg 6-8 hourly as required\nFor fracture base of skull\nEvidence Rating: [A]\nCloxacillin, IV,\nAdults\n500 mg 6 hourly\nChildren\n5-12 years;\t250 mg 6 hourly\n1-5 years;\t125 mg 6 hourly\n< 1 year;\t62.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2228",
    "type": "section",
    "keywords": [
      "years",
      "management",
      "required",
      "evidence",
      "skull",
      "hourly",
      "rating",
      "minutes",
      "base",
      "saline",
      "children",
      "particularly",
      "fracture",
      "adults",
      "paracetamol",
      "months",
      "cloxacillin",
      "mild",
      "year",
      "pain"
    ]
  },
  {
    "id": "c6c6f63c78581798b9725222716fd3b5",
    "content": "5 mg 6 hourly\nFor open skull fractures\nAmoxicillin + Clavulanic Acid, IV,\nAdults\n600 mg 8 hourly\nChildren\n25 mg/kg 6 hourly\nAnd\nMetronidazole, IV,\nAdults\n500 mg 8 hourly\nChildren.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2229",
    "type": "section",
    "keywords": [
      "hourly",
      "amoxicillin",
      "open",
      "metronidazole",
      "fractures",
      "acid",
      "adults",
      "clavulanic",
      "children",
      "skull"
    ]
  },
  {
    "id": "ae615669e5be6195fbdf5ea4502a04c9",
    "content": "7. 5 mg/kg 8 hourly\nAnd\nEvidence Rating: [B]\nBenzylpenicillin, IV,\nAdults\n1. 2-2.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2230",
    "type": "section",
    "keywords": [
      "hourly",
      "rating",
      "benzylpenicillin",
      "adults",
      "evidence"
    ]
  },
  {
    "id": "2b192f50edb436157e8b138d26ac2970",
    "content": "4 g 6 hourly\nChildren\n50 mg /kg 6 hourly\nFor aggressive patients requiring sedation.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2231",
    "type": "section",
    "keywords": [
      "hourly",
      "requiring",
      "sedation",
      "patients",
      "children",
      "aggressive"
    ]
  },
  {
    "id": "2db1cfeab3845ce73a2925d2cb2b5c02",
    "content": "Haloperidol, IM,\nAdults\n2-5 mg 4-8 hourly as required (max. 20 mg in 24 hours)\nChildren\n12 years;\t2-5 mg 4-8 hourly as required\n(max. 20 mg in 24 hours)\n6-12 years;\t1-3 mg 4-8 hourly as required (max.",
    "title": "1st Line Treatment",
    "section": "1st Line Treatment",
    "chunk_id": "2232",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "haloperidol",
      "adults",
      "required",
      "children",
      "hours"
    ]
  },
  {
    "id": "c824db9d269336f5ad089ae350d3fee6",
    "content": "150 microgram per kg per day)\n< 6 years;\tnot recommended.",
    "title": "1st Line Treatment",
    "section": "1st Line Treatment",
    "chunk_id": "2233",
    "type": "section",
    "keywords": [
      "recommended",
      "years",
      "microgram"
    ]
  },
  {
    "id": "6fdf1563b03c2ed5d2799345a37503e2",
    "content": "Lorazepam, IV/IM,\nAdults\n500 microgram-2 mg 6 hourly as needed (max. 10 mg per day)\nChildren\n>2years;\t50 microgram 4-8 hourly as needed (max. 2 mg per dose)\nReferral Criteria\nRefer all patients with significant head injuries immediately to a neurosurgeon.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "2234",
    "type": "section",
    "keywords": [
      "lorazepam",
      "hourly",
      "referral",
      "injuries",
      "neurosurgeon",
      "microgram",
      "head",
      "immediately",
      "needed",
      "adults",
      "refer",
      "significant",
      "dose",
      "patients",
      "children",
      "criteria"
    ]
  },
  {
    "id": "60daa7a41b150540bb8e7104a649ea2c",
    "content": "Acute abdomen is sudden onset of severe abdominal pain, which may require surgical intervention. Some medical conditions may present as acute abdominal pain. Causes\nInflammatory conditions e.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "2235",
    "type": "section",
    "keywords": [
      "severe",
      "abdominal",
      "sudden",
      "pain",
      "require",
      "intervention",
      "surgical",
      "present",
      "inflammatory",
      "conditions",
      "which",
      "medical",
      "abdomen",
      "acute",
      "causes",
      "onset"
    ]
  },
  {
    "id": "b7557759e44edc3276e82e4f817a1686",
    "content": "g. appendicitis, salpingitis, cholecystitis\nPerforations e. g.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "2236",
    "type": "section",
    "keywords": [
      "cholecystitis",
      "appendicitis",
      "salpingitis",
      "perforations"
    ]
  },
  {
    "id": "0eeacabdcacc23c8aed39f87079022c4",
    "content": "typhoid, peptic ulcer, trauma\nIntestinal obstruction e. g. strangulated hernia, adhesions, volvulus\nHaemorrhage e.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "2237",
    "type": "section",
    "keywords": [
      "typhoid",
      "strangulated",
      "volvulus",
      "ulcer",
      "hernia",
      "peptic",
      "adhesions",
      "intestinal",
      "obstruction",
      "trauma",
      "haemorrhage"
    ]
  },
  {
    "id": "c2bef69cf18c8332241bc533d9e4e5ac",
    "content": "g. ruptured ectopic pregnancy, ruptured spleen\nAcute pancreatitis\nColics e. g.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "2238",
    "type": "section",
    "keywords": [
      "pancreatitis",
      "colics",
      "spleen",
      "ruptured",
      "pregnancy",
      "ectopic",
      "acute"
    ]
  },
  {
    "id": "02b6905d9504f134d2973232d2fa0851",
    "content": "ureteric, biliary or intestinal\nMedical conditions e. g. diabetic ketoacidosis, gastro-enteritis, gastritis, malaria, pneumonia, UTI, sickle cell crises, adrenocortical.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "2239",
    "type": "section",
    "keywords": [
      "ureteric",
      "crises",
      "enteritis",
      "adrenocortical",
      "biliary",
      "conditions",
      "malaria",
      "pneumonia",
      "cell",
      "sickle",
      "intestinal",
      "gastro",
      "medical",
      "diabetic",
      "gastritis",
      "ketoacidosis"
    ]
  },
  {
    "id": "d0481f2c5734e396934591548ac3ef50",
    "content": "crises, porphyria, nephrotic syndrome\nSymptoms\nAbdominal pain\nAnorexia, nausea and vomiting\nDyspepsia\nFever\nHeadaches\nJoint pains\nDizziness\nVaginal discharge\nDysuria\nWatery mucoid blood-stained stools\nSigns\nDehydration\nFever\nHypotension\nRapid pulse\nAbdominal distension with fluid or gas\nAbdominal surgical scars\nStrangulated hernia (especially femoral hernia)\nTenderness, rebound tenderness and guarding\nAbsent bowel sounds\nIncreased bowel sounds\nTenderness in the recto-vesical or recto-uterine pouch\nSigns of basal pneumonia or myocardial infarction.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2240",
    "type": "section",
    "keywords": [
      "vesical",
      "nausea",
      "especially",
      "absent",
      "rebound",
      "stained",
      "distension",
      "vaginal",
      "fluid",
      "mucoid",
      "recto",
      "porphyria",
      "crises",
      "abdominal",
      "guarding",
      "basal",
      "myocardial",
      "bowel",
      "hernia",
      "stools"
    ]
  },
  {
    "id": "d20043ba7c9f667b66ad8928f31b4d1a",
    "content": "investigations\nFBC\nBlood film for malaria parasites\nSickling test\nChest X-ray\nPlain abdominal X-ray (erect and supine)\n4-quadrant abdominal tap\nRandom blood glucose\nUrine examination\nBUE and Creatinine\nUltrasound scan of abdomen.",
    "title": "Pallor, gnathopathy, frontal bossing in sickle cell disease",
    "section": "Pallor, gnathopathy, frontal bossing in sickle cell disease",
    "chunk_id": "2241",
    "type": "section",
    "keywords": [
      "ultrasound",
      "sickling",
      "test",
      "glucose",
      "urine",
      "creatinine",
      "abdominal",
      "chest",
      "film",
      "malaria",
      "supine",
      "blood",
      "investigations",
      "abdomen",
      "random",
      "erect",
      "scan",
      "plain",
      "quadrant",
      "examination"
    ]
  },
  {
    "id": "e6d1e223347590ab339e193b6c3d7bab",
    "content": "To resuscitate patient\nTo relieve pain\nTo control infection if present\nTo treat the underlying cause.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2242",
    "type": "section",
    "keywords": [
      "pain",
      "resuscitate",
      "present",
      "treat",
      "infection",
      "cause",
      "relieve",
      "underlying",
      "control",
      "patient"
    ]
  },
  {
    "id": "29fcba21de5b604bc528e70faacfa5cb",
    "content": "Pass nasogastric tube and aspirate the stomach in suspected surgical\ncases.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2243",
    "type": "section",
    "keywords": [
      "stomach",
      "surgical",
      "suspected",
      "tube",
      "aspirate",
      "pass",
      "cases",
      "nasogastric"
    ]
  },
  {
    "id": "095122056e54282cb1e1d4d276ff9476",
    "content": "50-100 mg 4 hourly as required (max. 400 mg/day)\nChildren\n0. 5-2 mg/kg repeated 4 hourly as required\nOr\nMorphine, IV/IM,\nAdults\n2-5 mg 4 hourly as required\nChildren\n50-200 microgram/kg 4 hourly as required\nFor infectious consitions, perforations and intestinal obstruction.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2244",
    "type": "section",
    "keywords": [
      "perforations",
      "hourly",
      "morphine",
      "microgram",
      "adults",
      "intestinal",
      "obstruction",
      "consitions",
      "required",
      "children",
      "repeated",
      "infectious"
    ]
  },
  {
    "id": "ce1805762ea9813218953ba889fb0e8d",
    "content": "Gentamicin, IV/IM,\nAdults\n1-1. 5 mg/kg 8 hourly\nChildren\n2. 5 mg/kg 8 hourly\nDo not give if urine output is less than 30 ml/hour.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2245",
    "type": "section",
    "keywords": [
      "hourly",
      "gentamicin",
      "hour",
      "give",
      "output",
      "adults",
      "urine",
      "less",
      "children"
    ]
  },
  {
    "id": "347f776f198725d4d0467edab8d70bb4",
    "content": "Avoid in renal impairment. And\nMetronidazole, IV,\nAdults.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2246",
    "type": "section",
    "keywords": [
      "avoid",
      "metronidazole",
      "impairment",
      "adults",
      "renal"
    ]
  },
  {
    "id": "9bac77cca8ee87b5e626aff2c4a5bef5",
    "content": "Ceftriaxone, IV,\nAdults\n1-2 g daily\nChildren\n50 mg/kg daily.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2247",
    "type": "section",
    "keywords": [
      "children",
      "daily",
      "adults",
      "ceftriaxone"
    ]
  },
  {
    "id": "b16afbcce174e55a665749442996a2e9",
    "content": "And\nMetronidazole, IV,\nAdults\n500 mg 8 hourly\nChildren\n7. 5 mg/kg 8 hourly.",
    "title": "Further treatment will depend on the diagnosis.",
    "section": "Further treatment will depend on the diagnosis.",
    "chunk_id": "2248",
    "type": "section",
    "keywords": [
      "children",
      "hourly",
      "metronidazole",
      "adults"
    ]
  },
  {
    "id": "64e042393e1fd599d1f20156fe3660e8",
    "content": "Ciprofloxacin, IV,\nAdults\n400 mg 8-12 hourly infused over 30-60 minutes (may be added for typhoid perforation)\nChildren (Use only when benefit outweighs the risk) 5-12 years;\t10 mg/kg 12 hourly\n1-5 years;\t5 mg/kg 12 hourly\n< 1 year;\tnot recommended\nAnd\nMetronidazole, IV,\nAdults\n500 mg 8 hourly\nChildren\n7. 5 mg/kg 8 hourly\nReferral Criteria\nRefer all cases to the appropriate specialist depending on the suspected diagnosis. This may present as a blunt or penetrating injury to the abdomen.",
    "title": "3rd Line Treatment Evidence Rating: [B]",
    "section": "3rd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2249",
    "type": "section",
    "keywords": [
      "metronidazole",
      "years",
      "infused",
      "ciprofloxacin",
      "hourly",
      "typhoid",
      "specialist",
      "minutes",
      "added",
      "benefit",
      "children",
      "criteria",
      "penetrating",
      "referral",
      "diagnosis",
      "suspected",
      "blunt",
      "adults",
      "only",
      "outweighs"
    ]
  },
  {
    "id": "518ef38c1136f09c16390574a5952bbf",
    "content": "Trauma to the abdomen\nSymptoms\nPain\nVomiting\nDistended abdomen\nSigns\nDistended abdomen\nTenderness and rebound tenderness\nGuarding\nTympanitic percussion sound\nReduced or absent bowel sounds\nPoint of penetration\ninvestigations\nPlain and erect abdominal X-ray\nAbdominal CT scan\nBUE and Creatinine\nAbdominal ultrasound scan\nDiagnostic peritoneal lavage\nBlood grouping and cross matching.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2250",
    "type": "section",
    "keywords": [
      "ultrasound",
      "sound",
      "tympanitic",
      "absent",
      "grouping",
      "rebound",
      "diagnostic",
      "reduced",
      "distended",
      "creatinine",
      "abdominal",
      "guarding",
      "bowel",
      "signs",
      "lavage",
      "blood",
      "tenderness",
      "point",
      "investigations",
      "percussion"
    ]
  },
  {
    "id": "4b784e0b72f8da03e2c73fed6f3ea9df",
    "content": "To correct fuid and electrolyte imbalance\nTo decompress bowel\nTo repair damaged viscus\nTo prevent infection\nTo relieve pain.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2251",
    "type": "section",
    "keywords": [
      "imbalance",
      "pain",
      "correct",
      "viscus",
      "prevent",
      "bowel",
      "infection",
      "fuid",
      "repair",
      "relieve",
      "decompress",
      "damaged",
      "electrolyte"
    ]
  },
  {
    "id": "aa30484dcf0254d6d1d2d20fff43ec25",
    "content": "Insert an NG tube\nSurgical repair of damaged viscus if necessary.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2252",
    "type": "section",
    "keywords": [
      "insert",
      "surgical",
      "viscus",
      "tube",
      "repair",
      "necessary",
      "damaged"
    ]
  },
  {
    "id": "cd73b8127a2e2758271ee967f6c3052f",
    "content": "Cefuroxime, IV,\nAdults\n750 mg 8 hourly for 7-14 days\nChildren\n3 months\t25 mg/kg body weight 12 hourly for 7-14\ndays\nAnd\nMetronidazole, IV,\nAdults\n500 mg 8 hourly for 7-14 days.",
    "title": "A.\tFor infection control 1st Line Treatment Evidence Rating: [A]",
    "section": "A.\tFor infection control 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2253",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "body",
      "metronidazole",
      "weight",
      "adults",
      "cefuroxime",
      "children",
      "months"
    ]
  },
  {
    "id": "11763dc37a34642038ae16e0f53936b4",
    "content": "Children\n7. 5 mg/kg 8 hourly for 7-14 days\nReferral Criteria\nRefer all cases to a general surgeon. This is a break in the continuity of the bony cortex with associated soft tissue injury.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2254",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "continuity",
      "referral",
      "break",
      "bony",
      "refer",
      "cortex",
      "cases",
      "surgeon",
      "injury",
      "associated",
      "children",
      "soft",
      "criteria",
      "tissue",
      "general"
    ]
  },
  {
    "id": "897960a7024bd55b3daba5e34c795fae",
    "content": "As opposed to open fractures (See section on ‘Open fractures’), closed fractures do not communicate with an epithelial surface like skin, bowel mucosa, bladder mucosa etc. Resuscitation and stabilisation of the patient is paramount. Patients should never be sent for imaging unless haemodynamically stable.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2255",
    "type": "section",
    "keywords": [
      "sent",
      "communicate",
      "paramount",
      "patient",
      "epithelial",
      "stable",
      "open",
      "bowel",
      "unless",
      "section",
      "surface",
      "patients",
      "fractures",
      "should",
      "never",
      "resuscitation",
      "skin",
      "opposed",
      "mucosa",
      "haemodynamically"
    ]
  },
  {
    "id": "69f12e69725c49f081381fbde3747bb0",
    "content": "Causes\nRoad traffic accidents\nDomestic violence\nWork place injuries\nPathological fractures\nFall from a height\nAssaults\nSymptoms\nPain\nSwelling\nInability to move the part\nSigns\nPain\nSwelling\nDeformity\nInability to move the part\nCrepitus\nShock if there has been significant blood loss\nConfusion if there is shock or associated head injury\ninvestigations\nHaemoglobin\nBlood for grouping and cross matching\nX-rays of suspected part to include joints above and below\nTrauma series X-rays (Cervical spine, Chest and Pelvis) if injury is deemed severe or if patient is confused or unconscious\nCT scan (for fractures involving the following areas):\nHead\nSpine\nPelvis\nFractures around joints.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2256",
    "type": "section",
    "keywords": [
      "move",
      "injuries",
      "work",
      "grouping",
      "swelling",
      "unconscious",
      "associated",
      "accidents",
      "patient",
      "traffic",
      "chest",
      "part",
      "following",
      "assaults",
      "pelvis",
      "place",
      "violence",
      "signs",
      "causes",
      "blood"
    ]
  },
  {
    "id": "3940371af22cf973293e2182760ca6cc",
    "content": "CT angiograms (if significant vascular injury is suspected)\nMRI (to assess spinal cord and soft tissue injuries of the knee)\nAbdominal USG (if intra-abdominal injury is suspected).",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2257",
    "type": "section",
    "keywords": [
      "knee",
      "abdominal",
      "injuries",
      "intra",
      "vascular",
      "suspected",
      "angiograms",
      "significant",
      "cord",
      "assess",
      "spinal",
      "soft",
      "injury",
      "tissue"
    ]
  },
  {
    "id": "8f32485442953fb1a756826285c3e3ce",
    "content": "To resuscitate the patient (save a life first) - ATLS protocol (ABCDE)\nTo save the affected limb(s) (save a limb next)\nTo restore function of the affected limb(s).",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2258",
    "type": "section",
    "keywords": [
      "restore",
      "limb",
      "first",
      "save",
      "resuscitate",
      "function",
      "life",
      "abcde",
      "next",
      "atls",
      "patient",
      "protocol",
      "affected"
    ]
  },
  {
    "id": "eb76888982a266e4fd9f8f9f056b059e",
    "content": "backslab\nPrefabricated splints\nCustomized splint\nElevation of limb(s)\nNil per os until a final decision about surgical or non-surgical management has been made\nManipulation Under Anaesthesia (MUA) if possible.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2259",
    "type": "section",
    "keywords": [
      "final",
      "limb",
      "splints",
      "elevation",
      "about",
      "made",
      "decision",
      "surgical",
      "under",
      "prefabricated",
      "management",
      "anaesthesia",
      "customized",
      "possible",
      "manipulation",
      "backslab",
      "until",
      "splint"
    ]
  },
  {
    "id": "3ede492d610e8b2360752282962d5a00",
    "content": "A. For pain relief Evidence Rating: [A] Morphine, IV/IM, Adults\n2-5 mg 4 hourly as required\nChildren\n50-200 microgram/kg 4 hourly as required\nOr\nPethidine, IV/IM,\nAdults\n50-100 mg 4 hourly as required (max. 400 mg/day)\nChildren\n0.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2260",
    "type": "section",
    "keywords": [
      "morphine",
      "rating",
      "hourly",
      "pain",
      "microgram",
      "pethidine",
      "adults",
      "relief",
      "required",
      "children",
      "evidence"
    ]
  },
  {
    "id": "57b1358b9be04acbd881b3079c57f087",
    "content": "5-2 mg/kg repeated 4 hourly as required\nOr\nParacetamol, IV,\nAdults\n50 kg;\t1 g 6 hourly as required\n< 50 kg;\t1 g 8 hourly as required (max. 3 g daily)\nChildren\n12-18 years (> 50 kg);\t1 g 8 hourly as required (max. 3 g daily)\n12-18 years (< 50 kg);\t15 mg/kg 6 hourly as required (max.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2261",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "adults",
      "paracetamol",
      "required",
      "children",
      "repeated",
      "daily"
    ]
  },
  {
    "id": "59dbae25b5796b18e7aa9c5720f77313",
    "content": "750 mg per dose)\n2-12 years (< 50 kg);\t15 mg/kg 6 hourly as required (max. 75 mg/ kg per day)\nOr\nDiclofenac, IM,\nAdults.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2262",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "diclofenac",
      "adults",
      "dose",
      "required"
    ]
  },
  {
    "id": "37dccab81ed01e1a908626c6b802bc1e",
    "content": "50-75 mg 8-12 hourly (max. 150 mg daily)\nChildren\nNot recommended.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2263",
    "type": "section",
    "keywords": [
      "children",
      "hourly",
      "recommended",
      "daily"
    ]
  },
  {
    "id": "ff823347ca8356b96c932ac6baa9cc5b",
    "content": "Ibuprofen, oral,\nAdults\n200-800 mg 6-8 hourly as required (max. 2400 mg daily)\nChildren\n10-15 mg/kg 6-8 hourly as required (max. 40 mg/kg daily)\nOr\nNaproxen EC, oral,\nAdults\n250-500 mg 12 hourly as required\nChildren\nNot indicated\nOr\nCelecoxib, oral,\nAdults\n400 mg stat.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2264",
    "type": "section",
    "keywords": [
      "hourly",
      "naproxen",
      "celecoxib",
      "adults",
      "oral",
      "stat",
      "indicated",
      "required",
      "children",
      "ibuprofen",
      "daily"
    ]
  },
  {
    "id": "fb93f0abe3cd51b140c4c062738dcb2f",
    "content": "Then\n200 mg 12-24 hourly as required\nChildren\nNot indicated\nOr\nCodeine, oral,\nAdults\n15-60 mg 4-6 hourly as required\nChildren\nNot recommended\nReferral Criteria\nRefer individuals with the following conditions associated with closed fractures to an orthopaedic surgeon; difficult reduction, fractures with intra articular extension, fractures around growth plates and when there is neuro-vascular compromise. Open fractures imply communication of the fracture haematoma with an epithelial surface like skin, bowel mucosa, bladder mucosa etc. The main problem here is infection, and therefore, every effort should be made to prevent it.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2265",
    "type": "section",
    "keywords": [
      "intra",
      "communication",
      "associated",
      "required",
      "plates",
      "epithelial",
      "hourly",
      "open",
      "therefore",
      "following",
      "prevent",
      "orthopaedic",
      "imply",
      "growth",
      "surface",
      "bowel",
      "haematoma",
      "children",
      "criteria",
      "effort"
    ]
  },
  {
    "id": "9dd1d3b396a5648f99747b89720df5c1",
    "content": "In some cases, the degree of bone loss may warrant amputation. Exclude a neurological deficit especially when the injury is extensive. It is prudent to take a photograph of the affected part(s) for documentation and medico-legal purposes.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2266",
    "type": "section",
    "keywords": [
      "especially",
      "legal",
      "purposes",
      "neurological",
      "part",
      "extensive",
      "prudent",
      "photograph",
      "documentation",
      "warrant",
      "degree",
      "medico",
      "bone",
      "exclude",
      "deficit",
      "cases",
      "loss",
      "amputation",
      "injury",
      "affected"
    ]
  },
  {
    "id": "bc5989f1b4c36fd5c8e1f57bf7fb4811",
    "content": "Patients should never be sent for imaging unless haemodynamically stable. Causes\nRoad traffic accidents\nDomestic violence\nAssaults\nWork place injuries\nFall from a height\nSymptoms\nLocalised pain\nSwelling\nBleeding\nExposed bone, muscle and fascia\nInability to move the part\nSigns\nSwelling\nDeformity\nBlood\nLaceration over the fracture\nCrepitus\nShock if there has been significant blood loss\nConfusion or unconsciousness if there is shock or associated head\ninjury\ninvestigations\nHaemoglobin\nBlood for grouping and cross matching\nX-rays of suspected part to include joints above and below\nTrauma series X-rays (Cervical spine, Chest and Pelvis) if injury is deemed severe or if patient is confused or unconscious\nCT scan (for fractures involving the following areas):\nHead\nSpine\nPelvis\nFractures around joints\nCT angiograms (if significant vascular injury is suspected)\nMRI (to assess spinal cord and soft tissue injuries of the knee)\nAbdominal USG (if intra-abdominal injury is suspected).",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2267",
    "type": "section",
    "keywords": [
      "sent",
      "move",
      "unconsciousness",
      "grouping",
      "swelling",
      "unconscious",
      "localised",
      "abdominal",
      "unless",
      "signs",
      "causes",
      "severe",
      "fascia",
      "include",
      "series",
      "fractures",
      "should",
      "haemodynamically",
      "cervical",
      "cross"
    ]
  },
  {
    "id": "bbf6cb1763b9c298162a7a6b744ebf2a",
    "content": "To resuscitate the patient (save a life first) - ATLS protocol (ABCDE)\nTo save the affected limb(s) (save a limb next)\nTo prevent and eradicate infection\nTo restore function of the affected limb(s).",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2268",
    "type": "section",
    "keywords": [
      "restore",
      "limb",
      "first",
      "save",
      "resuscitate",
      "prevent",
      "function",
      "infection",
      "life",
      "abcde",
      "eradicate",
      "next",
      "atls",
      "patient",
      "protocol",
      "affected"
    ]
  },
  {
    "id": "a0aa74a12dcea1033892f963086f43c4",
    "content": "Remove all foreign bodies\nCover with sterile dressing\nSplinting of affected limb(s)\nP. O. P.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2269",
    "type": "section",
    "keywords": [
      "limb",
      "splinting",
      "cover",
      "foreign",
      "sterile",
      "remove",
      "dressing",
      "bodies",
      "affected"
    ]
  },
  {
    "id": "e7d54a10423b1cb4e18521ab3114bbbd",
    "content": "backslab\nPrefabricated splints\nCustomized splint\nElevation of affected limb(s)\nEarly range of motion physiotherapy\nKeep nil per os until final decision about management has been made. Surgical - under general anaesthesia\nIrrigation\nDebridement\nExternal fixation or backslab.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2270",
    "type": "section",
    "keywords": [
      "elevation",
      "irrigation",
      "affected",
      "prefabricated",
      "management",
      "range",
      "decision",
      "under",
      "customized",
      "backslab",
      "final",
      "motion",
      "surgical",
      "keep",
      "external",
      "general",
      "about",
      "limb",
      "splints",
      "physiotherapy"
    ]
  },
  {
    "id": "f6f2fa2b629c6bd8766cc2dc20b8f824",
    "content": "Cefuroxime, IV,\nAdults\n750 mg 8 hourly\nChildren\n25 mg/kg body weight 12 hourly\nOr\nClindamycin, IV,\nAdults\n300-600 mg 6 hourly for 4 weeks or until clinical improvement\nChildren\n3-6 mg/kg 6 hourly for 2-4 weeks\nIf the fracture is in perineal region\nAbove antibiotics in section A. And\nMetronidazole, IV,\nAdults\n500 mg 8 hourly for 7 days\nChildren\n7. 5 mg/kg 8 hourly for 7 days\nTetanus prophylaxis\nAll patients with open fractures must have tetanus prophylaxis.",
    "title": "For treatment of infection 1st Line Treatment Evidence Rating: [A]",
    "section": "For treatment of infection 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2271",
    "type": "section",
    "keywords": [
      "metronidazole",
      "weight",
      "region",
      "antibiotics",
      "tetanus",
      "hourly",
      "body",
      "open",
      "clinical",
      "section",
      "patients",
      "children",
      "weeks",
      "days",
      "clindamycin",
      "fracture",
      "above",
      "fractures",
      "adults",
      "perineal"
    ]
  },
  {
    "id": "8c7d70575bd9ac8a281cc26ec379aeac",
    "content": "(See appropriate section). Referral Criteria\nRefer complicated fractures e. g.",
    "title": "For treatment of infection 1st Line Treatment Evidence Rating: [A]",
    "section": "For treatment of infection 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2272",
    "type": "section",
    "keywords": [
      "referral",
      "complicated",
      "fractures",
      "appropriate",
      "section",
      "refer",
      "criteria"
    ]
  },
  {
    "id": "a41a9aa066d9158843bd6a5bf67dd874",
    "content": "pelvic and intra-articular, and multiple injuries to an orthopaedic surgeon.",
    "title": "For treatment of infection 1st Line Treatment Evidence Rating: [A]",
    "section": "For treatment of infection 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2273",
    "type": "section",
    "keywords": [
      "intra",
      "pelvic",
      "injuries",
      "multiple",
      "orthopaedic",
      "surgeon",
      "articular"
    ]
  },
  {
    "id": "48b45c0451e3749df3b35fe521e2a9d4",
    "content": "This refers to the dissociation of articular surfaces. Since there are important neuro-vascular structures around most joints, it is important to assess and document the neuro-vascular status of the limb(s) involved after a dislocation. Causes\nRoad traffic accidents\nDomestic violence\nAssaults\nWork place injuries\nSports injuries\nFalls\nConvulsions\nSymptoms\nPain\nSwelling\nInability to move the part\nSigns\nTenderness\nSwelling\nInability to move the part\ninvestigations\nX-ray of affected part(s)\nCT scan or MRI if available\nCT angiogram or Doppler scan (if vascular status assessment is abnormal).",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2274",
    "type": "section",
    "keywords": [
      "angiogram",
      "falls",
      "injuries",
      "move",
      "work",
      "important",
      "dislocation",
      "swelling",
      "structures",
      "accidents",
      "refers",
      "document",
      "traffic",
      "surfaces",
      "part",
      "involved",
      "doppler",
      "assaults",
      "assess",
      "place"
    ]
  },
  {
    "id": "205626336789445950413d291232714d",
    "content": "Save a life first - ATLS (advanced trauma life support)\nSave a limb\nAchieve a congruently reduced joint\nAchieve a stable reduction of the dislocated joint\nPrevent joint stiffness.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2275",
    "type": "section",
    "keywords": [
      "achieve",
      "stable",
      "limb",
      "first",
      "save",
      "congruently",
      "reduction",
      "dislocated",
      "advanced",
      "support",
      "prevent",
      "stiffness",
      "life",
      "joint",
      "reduced",
      "atls",
      "trauma"
    ]
  },
  {
    "id": "27c4eb5fc7f43f123fb3ec8e047aaeea",
    "content": "Traction\nSplinting of affected part\nKeep nil per os until reduction has been achieved\nEarly range of motion physiotherapy.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2276",
    "type": "section",
    "keywords": [
      "physiotherapy",
      "reduction",
      "motion",
      "part",
      "traction",
      "achieved",
      "early",
      "keep",
      "until",
      "range",
      "splinting",
      "affected"
    ]
  },
  {
    "id": "24b1b7b75cfe743133df03f87a5b259f",
    "content": "A. Analgesia for dislocations\nEvidence Rating: [A]\nMorphine, IV/IM,\nAdults\nmg 4 hourly as required\nChildren\n50-200 microgram/kg 4 hourly as required\nOr\nPethidine, IV/IM,\nAdults\n50-100 mg 4 hourly as required (max. 400 mg/day)\nChildren\n0.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2277",
    "type": "section",
    "keywords": [
      "morphine",
      "rating",
      "hourly",
      "dislocations",
      "microgram",
      "analgesia",
      "pethidine",
      "adults",
      "required",
      "children",
      "evidence"
    ]
  },
  {
    "id": "aa6176852ba360b4c4abf3e36671eba2",
    "content": "5-2 mg/kg repeated 4 hourly as required\nOr\nParacetamol, IV,\nAdults\n50 kg;\t1 g 6 hourly as required\n< 50 kg;\t1 g 8 hourly as required (max. 3g daily)\nChildren\n12-18 years (> 50 kg);\t1 g 8 hourly as required (max. 3g daily)\n12-18 years (< 50 kg);\t15 mg/kg 6 hourly as required (max.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2278",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "adults",
      "paracetamol",
      "required",
      "children",
      "repeated",
      "daily"
    ]
  },
  {
    "id": "2054a94318d5077e8eb6d494b72470ec",
    "content": "750 mg per dose)\n2-12 years (< 50 kg);\t15 mg/kg 6 hourly as required (max. 75 mg per kg per day)\nOr\nDiclofenac, IM,\nAdults\n50-75 mg 8-12 hourly (max. 150 mg daily)\nChildren\nNot recommended.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2279",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "diclofenac",
      "adults",
      "dose",
      "required",
      "children",
      "daily"
    ]
  },
  {
    "id": "d09fc075ffb2605f927826e1a804fb27",
    "content": "Ibuprofen, oral,\nAdults\n200-800 mg 6-8 hourly as required (max. 2400 mg daily)\nChildren\n10-15 mg/kg 6-8 hourly as required (max. 40 mg/kg daily)\nOr\nNaproxen EC, oral,\nAdults\n250-500 mg 12 hourly as required\nChildren\nNot indicated\nOr\nCelecoxib, oral,.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2280",
    "type": "section",
    "keywords": [
      "hourly",
      "naproxen",
      "celecoxib",
      "adults",
      "oral",
      "indicated",
      "required",
      "children",
      "ibuprofen",
      "daily"
    ]
  },
  {
    "id": "ef8b82b4aa61fbddff1ced5b218b93fe",
    "content": "Adults\n400 mg stat. Then\n200 mg 12-24 hourly as required\nChildren\nNot indicated\nOr\nCodeine, oral,\nAdults\n15-60 mg 4-6 hourly as required\nChildren\nNot recommended\nReferral Criteria\nRefer all complicated dislocations to an orthopaedic specialist. Acute orthopaedic infections, which often present as emergencies, include acute osteomyelitis, acute septic arthritis, acute pyomyositis, acute-on-chronic osteomyelitis, and acute-on-chronic septic arthritis.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2281",
    "type": "section",
    "keywords": [
      "infections",
      "often",
      "which",
      "arthritis",
      "required",
      "acute",
      "hourly",
      "specialist",
      "orthopaedic",
      "children",
      "criteria",
      "stat",
      "include",
      "referral",
      "complicated",
      "chronic",
      "adults",
      "septic",
      "then",
      "pyomyositis"
    ]
  },
  {
    "id": "3b14ac8ef02ac7de882701d3e15801a6",
    "content": "Acute osteomyelitis and septic arthritis can co-exist in the same individual. They are more common in children and in patients with sickle- cell disease. When the diagnosis is made in an adult, it is important to exclude immune-suppression.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2282",
    "type": "section",
    "keywords": [
      "important",
      "arthritis",
      "acute",
      "individual",
      "patients",
      "children",
      "suppression",
      "disease",
      "diagnosis",
      "adult",
      "sickle",
      "immune",
      "same",
      "septic",
      "exist",
      "osteomyelitis",
      "made",
      "exclude",
      "cell",
      "common"
    ]
  },
  {
    "id": "f13b84096b281838447b5d29285ae70a",
    "content": "Staph. aureus and epidermidis account for the majority of the above infections. The commonest route of infection is haematogenous and may originate from skin lesions and ENT infections.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2283",
    "type": "section",
    "keywords": [
      "infections",
      "above",
      "originate",
      "commonest",
      "staph",
      "lesions",
      "infection",
      "haematogenous",
      "epidermidis",
      "account",
      "skin",
      "aureus",
      "route",
      "majority"
    ]
  },
  {
    "id": "9734e8c89f60e002d91c33dc85c1e3fb",
    "content": "It is important to cover empirically with appropriate antibiotics without necessarily waiting for the culture and sensitivity report. Causes\nStaph. aureus\nStaph.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2284",
    "type": "section",
    "keywords": [
      "empirically",
      "necessarily",
      "appropriate",
      "important",
      "cover",
      "antibiotics",
      "staph",
      "waiting",
      "culture",
      "aureus",
      "sensitivity",
      "report",
      "causes",
      "without"
    ]
  },
  {
    "id": "92c431063c68f28c1030e91ca22375cb",
    "content": "Haemophilus influenza\nStrept. pyogenes\nStrept. faecalis\nE.",
    "title": "Salmonella (common in sickle-cell disease)",
    "section": "Salmonella (common in sickle-cell disease)",
    "chunk_id": "2285",
    "type": "section",
    "keywords": [
      "haemophilus",
      "faecalis",
      "pyogenes",
      "strept",
      "influenza"
    ]
  },
  {
    "id": "80dab3b8a5d35b9e1f971f7231342936",
    "content": "coli\nOpen fractures\nIatrogenic\nImplant surgery\nJoint aspirations\nFemoral vessel procedures\nIntra-osseous infusions and transfusions\nUmbilical vessel catheterization.",
    "title": "Salmonella (common in sickle-cell disease)",
    "section": "Salmonella (common in sickle-cell disease)",
    "chunk_id": "2286",
    "type": "section",
    "keywords": [
      "procedures",
      "open",
      "intra",
      "implant",
      "fractures",
      "catheterization",
      "iatrogenic",
      "osseous",
      "infusions",
      "transfusions",
      "joint",
      "umbilical",
      "femoral",
      "coli",
      "surgery",
      "vessel",
      "aspirations"
    ]
  },
  {
    "id": "34e96237d9fcf63b63c164da9779c558",
    "content": "Symptoms\nFever\nPain\nInability to move affected limb\nSwelling\nLethargy\nRefusal to feed (children)\nSigns\nFebrile\nSwelling\nInability to use the limb\ninvestigations\nFBC, ESR\nSickling\nCRP\nBlood culture\nX-ray of affected part\nUltrasound scan of affected part (may also be used for guided aspiration)\nGram stain and culture of aspirate\nMRI (if available)\nRadionuclide scans.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2287",
    "type": "section",
    "keywords": [
      "ultrasound",
      "move",
      "sickling",
      "radionuclide",
      "refusal",
      "swelling",
      "lethargy",
      "aspiration",
      "part",
      "guided",
      "signs",
      "culture",
      "children",
      "blood",
      "fever",
      "scans",
      "feed",
      "also",
      "gram",
      "inability"
    ]
  },
  {
    "id": "b95360ee97d716c7c0dac970b6c04fda",
    "content": "Eradicate infection\nPrevent development of chronicity\nPrevent complications.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2288",
    "type": "section",
    "keywords": [
      "complications",
      "prevent",
      "development",
      "infection",
      "eradicate",
      "chronicity"
    ]
  },
  {
    "id": "1ec35f6d687dd10909a27caa815567e3",
    "content": "Splinting\nUltrasound guided aspiration\nIncision and drainage.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2289",
    "type": "section",
    "keywords": [
      "aspiration",
      "ultrasound",
      "drainage",
      "guided",
      "incision",
      "splinting"
    ]
  },
  {
    "id": "f254845a810a9d3cf63961dcf0e5576d",
    "content": "Cloxacillin, IV,\nAdults\n500 mg 6 hourly for 2-4 weeks\nChildren\n5-12 years;\t250 mg 6 hourly for 2-4 weeks\n1-5 years;\t125 mg 6 hourly for 2-4 weeks\n< 1 year;\t62. 5 mg 6 hourly for 2-4 weeks\nAnd.",
    "title": "Anti-infective therapy 1st Line Treatment Evidence Rating: [B]",
    "section": "Anti-infective therapy 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2290",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "adults",
      "children",
      "weeks",
      "cloxacillin",
      "year"
    ]
  },
  {
    "id": "bace1ae65eea2f55361f85dac2f86e10",
    "content": "Ciprofloxacin, IV, (to be administered over 60 minutes)\nAdults\n400 mg 8-12 hourly for 14 days\nChildren\n10 mg/kg (max. 400 mg) 12 houly for 14 days.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2291",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "minutes",
      "adults",
      "administered",
      "houly",
      "children",
      "ciprofloxacin"
    ]
  },
  {
    "id": "ba73e70f15cc0fa1b75038306420590b",
    "content": "Clindamycin, IV,\nAdults\n300 mg 6 hourly for 7 days\nChildren\n3-6 mg/kg 6 hourly for 7 days\nOr\nAmoxicillin + Clavulanic Acid, IV,\nAdults\n1. 2 g 12 hourly\nIncreased to 1. 2 g 8 hourly for 7 days in severe infections\nChildren\n12-18 years;\t600 mg to 1.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2292",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "clindamycin",
      "amoxicillin",
      "severe",
      "infections",
      "years",
      "acid",
      "adults",
      "clavulanic",
      "children",
      "increased"
    ]
  },
  {
    "id": "7f7e69c77647a33f7dc307f41b358563",
    "content": "2 g 12 hourly, Increased to 1. 2 g 8 hourly for 7 days in severe infections 3 months-12 years;\t30 mg/kg 12 hourly,\nIncreased to 30 mg/kg 8 hourly for 7 days in severe infections 7 days-3 months;\t30 mg/kg 8 hourly for 7 days\nPreterm and < 7 days;  30 mg/kg 12 hourly for 7 days\nFor individuals with penicillin sensitivity.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2293",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "severe",
      "infections",
      "preterm",
      "years",
      "penicillin",
      "sensitivity",
      "months",
      "individuals",
      "increased"
    ]
  },
  {
    "id": "a1f07b821f482d2bd34981839ee8c48a",
    "content": "Clindamycin, IV,\nAdults\n300 mg 6 hourly for 7 days\nChildren\n3-6 mg/kg 6 hourly for 7 days\nAnd\nGentamicin, IV,\nAdults\n40-80 mg 8 hourly for 14 days\nChildren\n1-12 years;\t2. 5 mg/kg 8 hourly for 14 days\n< 1 year;\t2. 5 mg/kg 12 hourly for 14 days\nFor individuals with sickle cell anaemia\nEvidence Rating: [B]\nCloxacillin, IV,.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2294",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "clindamycin",
      "gentamicin",
      "rating",
      "years",
      "anaemia",
      "cell",
      "adults",
      "sickle",
      "individuals",
      "children",
      "cloxacillin",
      "evidence",
      "year"
    ]
  },
  {
    "id": "048a24f3d269edac61d375e59693fac9",
    "content": "Adults\n500 mg 6 hourly for 2-4 weeks\nChildren\n5-12 years;\t250 mg 6 hourly for 2-4 weeks\n1-5 years;\t125 mg 6 hourly for 2-4 weeks\n<1 year;\t62. 5 mg 6 hourly for 2-4 weeks\nAnd\nCiprofloxacin, IV,\nAdults\n200-400 mg 12 hourly for 2-4 weeks\nChildren\n10 mg/kg 12 hourly for 2-4 weeks\nAnalgesia.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2295",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "analgesia",
      "adults",
      "children",
      "weeks",
      "ciprofloxacin",
      "year"
    ]
  },
  {
    "id": "161c8538247e91a458ccdf5359c18dd8",
    "content": "Ibuprofen, oral,\nAdults\n200-800 mg 6-8 hourly (max. 2400 mg daily)\nChildren\n10-15 mg/kg 6-8 hourly (max. 40 mg/kg daily)\nOr\nDiclofenac, oral,\nAdults\n50 mg 8 hourly or 100 mg 12 hourly\nChildren\n12 years;\t50 mg 12 hourly\n< 12 years;\tnot recommended\nOr\nDiclofenac, IM,\nAdults\n50-75 mg 8-12 hourly (max.",
    "title": "1st Line Treatment",
    "section": "1st Line Treatment",
    "chunk_id": "2296",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "diclofenac",
      "adults",
      "oral",
      "children",
      "ibuprofen",
      "daily"
    ]
  },
  {
    "id": "9ba2c6ea56aec2172f6dcbb396b2696e",
    "content": "150 mg daily)\nChildren\nNot recommended\nOr\nMorphine, oral,\nAdults\n15-30 mg 4-6 hourly as required\nChildren\n200-500 micrograms/kg 4-6 hourly as required\nOr\nMorphine, IV/IM,\nAdults\nmg 4 hourly as required\nChildren\n50-200 micrograms/kg 4 hourly as required\nOr\nCodeine, oral,.",
    "title": "1st Line Treatment",
    "section": "1st Line Treatment",
    "chunk_id": "2297",
    "type": "section",
    "keywords": [
      "morphine",
      "hourly",
      "recommended",
      "codeine",
      "adults",
      "oral",
      "micrograms",
      "required",
      "children",
      "daily"
    ]
  },
  {
    "id": "9ae78ba22b82b063431f308a678cca99",
    "content": "Adults\n15-60 mg 4-6 hourly as required\nChildren\nNot recommended\nFor control of fever\nParacetamol, oral,\nAdults\n500 mg-1g 6-8 hourly\nChildren\n6-12 years;\t250-500 mg 6-8 hourly\n1-5 years;\t120-250 mg 6-8 hourly\n3 months-1 year;\t60-120 mg 6-8 hourly\nOr\nParacetamol, IV,\nAdults\n50 kg;\t1 g 6 hourly as required\n< 50 kg;\t1 g 8 hourly as required (max. 3 g daily)\nChildren\n12-18 years (>50kg);\t1 g 8 hourly as required (max. 3g daily)\n12-18 years (<50kg);\t15 mg/kg 6 hourly as required (max.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2298",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "fever",
      "adults",
      "oral",
      "paracetamol",
      "control",
      "required",
      "children",
      "months",
      "daily",
      "year"
    ]
  },
  {
    "id": "c87c0ba38eda3a8cc75b1700229c7953",
    "content": "750 mg per dose)\n2-12 years (<50kg);\t15 mg/kg 6 hourly as required (max. 75 mg per kg per day)\nReferral Criteria\nRefer to an orthopaedic specialist if there is collection of pus and no improvement in 36 hours. These are usually from inadequately treated acute episodes, which include acute osteomyelitis, acute septic arthritis, acute-on-chronic osteomyelitis, and acute-on-chronic septic arthritis.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2299",
    "type": "section",
    "keywords": [
      "usually",
      "years",
      "which",
      "arthritis",
      "required",
      "acute",
      "hourly",
      "specialist",
      "orthopaedic",
      "inadequately",
      "treated",
      "criteria",
      "include",
      "episodes",
      "referral",
      "chronic",
      "collection",
      "dose",
      "there",
      "septic"
    ]
  },
  {
    "id": "95d855ebb5461c2be5e5a5984f261e52",
    "content": "Some may arise from the onset as a chronic infection due to mycobacteria or fungi. The patient is usually not ill-looking unless there is an acute exacerbation. Causes\nAcute bacterial infections of bone and joints\nMycobacterium tuberculosis and fungal infections\nInfected orthopaedic implants\nIatrogenic\nSymptoms\nChronic discharging sinuses\nPain\nDeformity.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2300",
    "type": "section",
    "keywords": [
      "infections",
      "usually",
      "exacerbation",
      "arise",
      "infected",
      "acute",
      "patient",
      "fungal",
      "iatrogenic",
      "unless",
      "orthopaedic",
      "sinuses",
      "implants",
      "causes",
      "onset",
      "chronic",
      "joints",
      "deformity",
      "bacterial",
      "mycobacteria"
    ]
  },
  {
    "id": "c54afd8db3db760746c942fd625f77b2",
    "content": "Signs\nSwelling\nTenderness\nDeformity\nScarring\nChronic discharging sinuses\nHyper-pigmentation of the involved part\ninvestigations\nFBC, ESR\nX-ray\nCT scan.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2301",
    "type": "section",
    "keywords": [
      "tenderness",
      "scarring",
      "deformity",
      "chronic",
      "discharging",
      "pigmentation",
      "part",
      "involved",
      "scan",
      "sinuses",
      "swelling",
      "signs",
      "hyper",
      "investigations"
    ]
  },
  {
    "id": "6eee6e01300fcc4d5c2eb29e540b893a",
    "content": "Eradicate infection\nRestore function\nPrevent and correct deformities.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2302",
    "type": "section",
    "keywords": [
      "restore",
      "correct",
      "prevent",
      "function",
      "infection",
      "eradicate",
      "deformities"
    ]
  },
  {
    "id": "d21ac3b22c8d410c79f15e2cbb9d3d87",
    "content": "Wound dressing\nSplinting\nSurgery\nSequestrectomy\nImplant removal.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2303",
    "type": "section",
    "keywords": [
      "splinting",
      "implant",
      "sequestrectomy",
      "removal",
      "wound",
      "dressing",
      "surgery"
    ]
  },
  {
    "id": "1e3c014169b89d30877334b36c3ccf8d",
    "content": "Cloxacillin, IV,\nAdults\n500 mg 6 hourly for 2-4 weeks\nChildren\n5-12 years;\t250 mg 6 hourly for 2-4 weeks\n1-5 years;\t125 mg 6 hourly for 2-4 weeks\n< 1 year;\t62. 5 mg 6 hourly for 2-4 weeks\nAnd\nCiprofloxacin, IV, (to be infused over 60 minutes)\nAdults\n400 mg 8-12 hourly for 14 days\nChildren\n10 mg/kg 12 hourly for 14 days\nFor acute flare up of infection in patients with penicillin sensitivity.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2304",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "years",
      "minutes",
      "flare",
      "penicillin",
      "infection",
      "sensitivity",
      "adults",
      "infused",
      "children",
      "patients",
      "weeks",
      "cloxacillin",
      "acute",
      "ciprofloxacin",
      "year"
    ]
  },
  {
    "id": "1603216643d985e43aa986672a355a5f",
    "content": "Clindamycin, IV,\nAdults\n300 mg 6 hourly for 7 days\nChildren\n3-6 mg/kg 6 hourly for 7 days\nAnd\nCiprofloxacin, IV, (to be infused over 60 minutes)\nAdults\n400 mg 8-12 hourly for 14 days\nChildren\n10 mg/kg 12 hourly for 14 days.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2305",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "clindamycin",
      "minutes",
      "adults",
      "infused",
      "children",
      "ciprofloxacin"
    ]
  },
  {
    "id": "bd73bd5cf633420f469c911ca285ab55",
    "content": "Cloxacillin, IV,\nAdults\n500 mg 6 hourly for 2-4 weeks\nChildren\n5-12 years;\t250 mg 6 hourly for 2-4 weeks\n1-5 years;\t125 mg 6 hourly for 2-4 weeks\n< 1 year;\t62. 5 mg 6 hourly for 2-4 weeks\nAnd\nCiprofloxacin, IV, (to be infused over 60 minutes)\nAdults\n400 mg 8-12 hourly for 14 days\nChildren\n10 mg/kg 12 hourly for 14 days.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2306",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "years",
      "minutes",
      "adults",
      "infused",
      "children",
      "weeks",
      "cloxacillin",
      "ciprofloxacin",
      "year"
    ]
  },
  {
    "id": "dc0dab516b2ed9e09c02e22662cfecdf",
    "content": "Clindamycin, IV,\nAdults\n300 mg 6 hourly for 4 weeks or until clinical improvement\nChildren\n3-6 mg/kg 6 hourly for 2-4 weeks\nAnd\nCiprofloxacin, IV, (to be infused over 60 minutes)\nAdults\n400 mg 8-12 hourly for 14 days\nChildren\n10 mg/kg 12 hourly for 14 days\nOr\nAmoxicillin + Clavulanic Acid, IV,\nAdults\n1. 2 g 12 hourly,\nIncreased to 1. 2 g 8 hourly for 7 days in severe infections\nChildren.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2307",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "clindamycin",
      "improvement",
      "amoxicillin",
      "severe",
      "infections",
      "minutes",
      "acid",
      "adults",
      "clavulanic",
      "infused",
      "children",
      "ciprofloxacin",
      "weeks",
      "increased",
      "until",
      "clinical"
    ]
  },
  {
    "id": "a86afe1fb7e73d227d4aab548f42ef96",
    "content": "12-18 years;\t600 mg to 1. 2 g 12 hourly, Increased to 1. 2 g 8 hourly for 7 days in severe infections 3 months-12 years;\t30 mg/kg 12 hourly,\nIncreased to 30 mg/kg 8 hourly for 7 days in severe infections 7 days-3 months;\t30 mg/kg 8 hourly for 7 days\nPreterm and < 7 days;  30 mg/kg 12 hourly for 7 days\nAnd\nCiprofloxacin, IV, (to be infused over 60 minutes)\nAdults\n400 mg 8-12 hourly for 14 days\nChildren\n10 mg/kg 12 hourly for 14 days\nFor pain relief\n(See section on pain relief in ‘Acute Orthopaedic Infections’)\nReferral Criteria\nAll patients should be referred as soon as possible to an orthopaedic specialist.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2308",
    "type": "section",
    "keywords": [
      "infections",
      "years",
      "relief",
      "infused",
      "acute",
      "ciprofloxacin",
      "hourly",
      "specialist",
      "minutes",
      "orthopaedic",
      "section",
      "patients",
      "children",
      "criteria",
      "days",
      "severe",
      "referral",
      "should",
      "adults",
      "referred"
    ]
  },
  {
    "id": "313c7d725a0da327f6f09f4da2205e49",
    "content": "Cellulitis is an infection of skin, specifically the dermis and subcutaneous tissues usually following a break in the skin such as infected wound or prick by a pin, nail, thorn, insect bite or cracks between the toes from athletes’s foot. It may affect any part of the body, but it affects the legs mostly. Obesity and leg swelling are risk factors.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2309",
    "type": "section",
    "keywords": [
      "cracks",
      "usually",
      "dermis",
      "wound",
      "swelling",
      "infected",
      "factors",
      "specifically",
      "cellulitis",
      "athletes",
      "mostly",
      "body",
      "nail",
      "following",
      "part",
      "prick",
      "subcutaneous",
      "affect",
      "skin",
      "between"
    ]
  },
  {
    "id": "b5a62f3149baa7154181ef0e3093be12",
    "content": "It is important to rule out acute osteomyelitis, necrotizing fasciitis and Deep Vein Thrombosis (DVT). Causes\nStreptococcus pyogenes (the commonest cause)\nStaphylococcus aureus\nSymptoms\nPain over area affected\nSwelling of the affected parts\nReddening or darkening of the overlying skin\nBlistering\nUlcers\nFever\nRigors\nMalaise\nVomiting\nConfusion\nSigns\nSwelling of affected part.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2310",
    "type": "section",
    "keywords": [
      "reddening",
      "important",
      "streptococcus",
      "rigors",
      "vein",
      "swelling",
      "necrotizing",
      "blistering",
      "aureus",
      "acute",
      "part",
      "pyogenes",
      "signs",
      "causes",
      "deep",
      "staphylococcus",
      "fever",
      "thrombosis",
      "cause",
      "parts"
    ]
  },
  {
    "id": "2bf18c056b7d2ab4d4359afedabad93b",
    "content": "Blisters\nLocalised tenderness and skin colour change\nLocalised warmth\nUlcers including the web spaces\nEnlarged and tender regional lymph nodes\nUnderlying pus\nOffensive wound\nFever\ninvestigations\nFBC, ESR\nCRP\nBlood culture\nFasting blood glucose\nGram stain and culture of discharge\nX-ray of affected part.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2311",
    "type": "section",
    "keywords": [
      "lymph",
      "wound",
      "glucose",
      "localised",
      "spaces",
      "blisters",
      "part",
      "including",
      "underlying",
      "culture",
      "nodes",
      "tender",
      "regional",
      "blood",
      "tenderness",
      "fever",
      "skin",
      "gram",
      "change",
      "investigations"
    ]
  },
  {
    "id": "b63e56b31d18844429f114f95856d71e",
    "content": "To relieve pain\nTo control and eradicate the infection\nTo treat predisposing conditions\nTo prevent complications like ulceration and osteomyelitis.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2312",
    "type": "section",
    "keywords": [
      "osteomyelitis",
      "complications",
      "pain",
      "treat",
      "predisposing",
      "prevent",
      "conditions",
      "infection",
      "ulceration",
      "eradicate",
      "relieve",
      "control"
    ]
  },
  {
    "id": "7f60c9ba80c2805780f3303532255508",
    "content": "Rest and elevate the affected part if possible\nClean and dress any open wounds\nIncision and drainage if pus forms\nDebridement\nSplit skin graft (if indicated).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2313",
    "type": "section",
    "keywords": [
      "open",
      "clean",
      "part",
      "drainage",
      "graft",
      "dress",
      "incision",
      "forms",
      "skin",
      "possible",
      "rest",
      "split",
      "indicated",
      "debridement",
      "wounds",
      "affected",
      "elevate"
    ]
  },
  {
    "id": "cc2caf0b5f32e02b5f6655bb40d0ec80",
    "content": "For pain relief\nEvidence Rating: [B]\n(See section for pain relief in ‘Closed fractures’ under Trauma and Injuries)\nAntibiotic therapy for individuals stable enough to be treated as outpatients.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2314",
    "type": "section",
    "keywords": [
      "stable",
      "rating",
      "closed",
      "pain",
      "fractures",
      "injuries",
      "enough",
      "outpatients",
      "section",
      "treated",
      "relief",
      "individuals",
      "antibiotic",
      "therapy",
      "evidence",
      "trauma",
      "under"
    ]
  },
  {
    "id": "b6ed7ec517aca85efad30598167e5285",
    "content": "Amoxicillin, oral,\nAdults\n500 mg-1 g 8 hourly for 7 days\nChildren\n6-12 years;\t250 mg 8 hourly for 7 days\n1-5 years;\t125 mg 8 hourly for 7 days\n< 1 year;\t62. 5 mg 8 hourly for 7 days.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "2315",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "amoxicillin",
      "years",
      "adults",
      "oral",
      "children",
      "year"
    ]
  },
  {
    "id": "4794ed0eda8616a8296becf5b7eeebc5",
    "content": "And\nFlucloxacillin, oral,\nAdults\n500 mg 6 hourly for 7 days\nChildren\n10 years;\t250-500 mg 6 hourly for 7 days\n2-10 years;\t125-250 mg 6 hourly for 7 days\n< 2 years;\t62. 5-125 mg 6 hourly for 7 days.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2316",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "years",
      "flucloxacillin",
      "adults",
      "oral",
      "children"
    ]
  },
  {
    "id": "b1f1835688d97fe131961da9fa69276c",
    "content": "Co-amoxyclav, oral,\nAdults\n625 mg 8-12 hourly for 5-7 days\nChildren\n11-18 years;\t625 mg 8-12 hourly for 5-7 days\n6-10 years;\t457 mg 8-12 hourly for 5-7 days\n1-5 years;\t228 mg 8-12 hourly for 5-7 days\n< 1 year;\t114 mg 8-12 hourly for 5-7 days\nFor Individuals with penicillin allergy Evidence Rating: [C]\nErythromycin, oral,\nAdults\n250-500 mg 6 hourly for 7 days\nChildren\n8-18 years;\t250-500 mg 6 hourly for 7 days\n2-7 years;\t250 mg 6 hourly for 7 days\n< 2 years;\t125 mg 6 hourly for 7 days\nOr\nClindamycin, oral,\nAdults\n150-300 mg 6-8 hourly for 7 days\nChildren\n12-18 years;\t150-300 mg 6 hourly for 7 days\n1 month-11 years;\t3-6 mg/kg 6 hourly for 7 days\nAntibiotic therapy for patients who require admission.",
    "title": "2nd Line Treatment Evidence Rating: [C]",
    "section": "2nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "2317",
    "type": "section",
    "keywords": [
      "years",
      "penicillin",
      "antibiotic",
      "therapy",
      "evidence",
      "hourly",
      "rating",
      "require",
      "patients",
      "children",
      "admission",
      "days",
      "clindamycin",
      "erythromycin",
      "amoxyclav",
      "adults",
      "allergy",
      "month",
      "year",
      "oral"
    ]
  },
  {
    "id": "0901e72d40a41a19ceb285baf4bc435b",
    "content": "Amoxicillin + Clavulanic Acid, IV,\nAdults\n1. 2 g 12 hourly,\nIncreased to 1. 2 g 8 hourly in severe infections\nChildren\n12-18 years;\t600 mg to 1.",
    "title": "1st Line Treatment",
    "section": "1st Line Treatment",
    "chunk_id": "2318",
    "type": "section",
    "keywords": [
      "severe",
      "hourly",
      "amoxicillin",
      "infections",
      "years",
      "acid",
      "adults",
      "clavulanic",
      "children",
      "increased"
    ]
  },
  {
    "id": "f462bd3fba3c99d5eae95b5ff26fa9bc",
    "content": "2 g 12 hourly, Increased to 1. 2 g 8 hourly in severe infections\n3 months-12 years;\t30 mg/kg 12 hourly, Increased to 30 mg/kg 8 hourly in severe infections 7 days-3 months;\t30 mg/kg 8 hourly.",
    "title": "1st Line Treatment",
    "section": "1st Line Treatment",
    "chunk_id": "2319",
    "type": "section",
    "keywords": [
      "severe",
      "hourly",
      "infections",
      "days",
      "years",
      "months",
      "increased"
    ]
  },
  {
    "id": "609e8f3cde125e837b0df1de0e9d93a5",
    "content": "Preterm and < 7 days;  30 mg/kg 12 hourly\nThen\nAmoxicillin + Clavulanic Acid, oral,\nAdults\n1 g 12 hourly\nChildren\n12 years;\t500/125 mg 12 hourly\n4-12 years;  5 ml of 400/57 mg suspension 12 hourly 1-4 years;  5 ml of 200/28 mg suspension 12 hourly 3 months-1 year; 20 mg/kg (of amoxicillin) 12 hourly\n< 3 months;  15 mg/kg (of amoxicillin) 12 hourly\nAnd\nEvidence Rating: [B]\nCloxacillin, IV,\nAdults\n500 mg 6 hourly\nChildren\n5-12 years;\t250 mg 6 hourly\n1-5 years;\t125 mg 6 hourly\n< 1 year;\t62. 5 mg 6 hourly\nThen\nFlucloxacillin, oral,\nAdults\n500 mg 6 hourly\nChildren\n5-12 years;\t250 mg 6 hourly\n1-5 years;\t125 mg 6 hourly\n< 1 year;\t62. 5 mg 6 hourly.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2320",
    "type": "section",
    "keywords": [
      "days",
      "preterm",
      "amoxicillin",
      "hourly",
      "rating",
      "years",
      "cloxacillin",
      "acid",
      "flucloxacillin",
      "suspension",
      "adults",
      "clavulanic",
      "oral",
      "children",
      "months",
      "then",
      "evidence",
      "year"
    ]
  },
  {
    "id": "0901e72d40a41a19ceb285baf4bc435b",
    "content": "Amoxicillin + Clavulanic Acid, IV,\nAdults\n1. 2 g 12 hourly,\nIncreased to 1. 2 g 8 hourly in severe infections\nChildren\n12-18 years;\t600 mg to 1.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "2321",
    "type": "section",
    "keywords": [
      "severe",
      "hourly",
      "amoxicillin",
      "infections",
      "years",
      "acid",
      "adults",
      "clavulanic",
      "children",
      "increased"
    ]
  },
  {
    "id": "99872c75e956f161502e37ec620d432e",
    "content": "2 g 12 hourly, Increased to 1. 2 g 8 hourly in severe infections\n3 months-12 years;\t30 mg/kg 12 hourly, Increased to 30 mg/kg 8 hourly in severe infections 7 days-3 months;\t30 mg/kg 8 hourly\nPreterm and < 7 days;  30 mg/kg 12 hourly\nThen\nAmoxicillin + Clavulanic Acid, oral,\nAdults\n1 g 12 hourly\nChildren\n12 years;\t500/125 mg 12 hourly.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "2322",
    "type": "section",
    "keywords": [
      "severe",
      "hourly",
      "infections",
      "days",
      "preterm",
      "years",
      "amoxicillin",
      "acid",
      "adults",
      "months",
      "clavulanic",
      "oral",
      "children",
      "increased",
      "then"
    ]
  },
  {
    "id": "08aeb9f2bb19789d24f52f2e6741d63e",
    "content": "4-12 years;  5 ml of 400/57 mg suspension 12 hourly 1-4 years;  5 ml of 200/28 mg suspension 12 hourly 3 months-1 year; 20 mg/kg (of amoxicillin) 12 hourly\n< 3 months;  15 mg/kg (of amoxicillin) 12 hourly\nAnd\nClindamycin, IV,\nAdults\n300 mg 6 hourly or 600 mg 8 hourly\nChildren\n3-6 mg/kg 6 hourly\nThen\nClindamycin, oral,\nAdults\n150-300 mg 6-8 hourly\nChildren\n12-18 years;\t150-300 mg 6 hourly\n1 month-11 years;\t3-6 mg/kg 6 hourly\nFor methicillin resistant Staph. aureus\nEvidence Rating: [B]\nVancomycin, IV,\nAdults\n1 g 12 hourly by slow infusion over 1 hour (max. 2 g daily)\nChildren\n1 month-12 years;\t10 mg/kg per day in divided doses 6-12 hourly (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2323",
    "type": "section",
    "keywords": [
      "hour",
      "years",
      "infusion",
      "resistant",
      "aureus",
      "evidence",
      "hourly",
      "rating",
      "doses",
      "children",
      "amoxicillin",
      "clindamycin",
      "vancomycin",
      "suspension",
      "adults",
      "slow",
      "month",
      "methicillin",
      "months",
      "then"
    ]
  },
  {
    "id": "caf4e1b3c84b9260a515d649aa132894",
    "content": "1 g daily)\nReferral Criteria\nRefer all cases with treatment failure, complications or ulceration requiring debridement and grafting to a plastic or general surgeon. It is a rapidly progressive inflammatory infection of the fascia with progressive destruction of the skin and subcutaneous tissue (also known as ‘flesh-eating’ disease). It is a life threathening condition and if not properly managed may be fatal.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2324",
    "type": "section",
    "keywords": [
      "properly",
      "grafting",
      "known",
      "progressive",
      "requiring",
      "condition",
      "eating",
      "criteria",
      "treatment",
      "threathening",
      "destruction",
      "subcutaneous",
      "fascia",
      "disease",
      "referral",
      "debridement",
      "ulceration",
      "also",
      "flesh",
      "fatal"
    ]
  },
  {
    "id": "93ad630de809f93b4aead8af4e66b3e3",
    "content": "It must be managed as an emergency. It is commoner in the immune-compromised state e. g.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2325",
    "type": "section",
    "keywords": [
      "emergency",
      "compromised",
      "must",
      "commoner",
      "immune",
      "state",
      "managed"
    ]
  },
  {
    "id": "2d7ddf1aa96f3fccf3542500cb67ae86",
    "content": "diabetes, HIV, malignancies. Causes\nMixed bacterial infections\nStrept. spp\nStaph.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2326",
    "type": "section",
    "keywords": [
      "infections",
      "malignancies",
      "diabetes",
      "mixed",
      "staph",
      "bacterial",
      "strept",
      "causes"
    ]
  },
  {
    "id": "3241df88b63382bad3440df268535498",
    "content": "Symptoms\nPain\nFever\nSwelling\nDischarge\nSigns\nFever\nSwelling\nDischarge which may be serosanguinous or purulent\nSkin colour change\ninvestigations\nFBC, ESR\nCRP\nBlood culture\nRandom blood sugar\nHIV screening\nGram stain and culture of discharge\nX-ray\nBUE and Creatinine.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2327",
    "type": "section",
    "keywords": [
      "serosanguinous",
      "swelling",
      "which",
      "creatinine",
      "screening",
      "signs",
      "culture",
      "sugar",
      "blood",
      "fever",
      "gram",
      "skin",
      "change",
      "purulent",
      "investigations",
      "symptoms",
      "random",
      "colour",
      "pain",
      "stain"
    ]
  },
  {
    "id": "afbe96d7c469d345507423454f8d2916",
    "content": "Resuscitate (Save life first)\nEradicate infection\nTreat underlying cause.",
    "title": "Treatment",
    "section": "Treatment",
    "chunk_id": "2328",
    "type": "section",
    "keywords": [
      "save",
      "first",
      "resuscitate",
      "treat",
      "infection",
      "life",
      "eradicate",
      "cause",
      "underlying"
    ]
  },
  {
    "id": "3f023cca2954f63e6ce4e55235641e03",
    "content": "Clindamycin, IV,\nAdults\n600 mg 8 hourly for 4 weeks or until clinical improvement\nChildren\n3-6 mg/kg 6 hourly for 2-4 weeks\nAnd\nAmoxicillin + Clavulanic Acid, IV,\nAdults\n1. 2 g 8 hourly for 4 weeks or until clinical improvement\nChildren\n12-18 years;\t600 mg-1. 2 g 8 hourly for 4 weeks or until clinical improvement\n3 months-12 years;\t30 mg/kg 8 hourly, for 4 weeks or until clin-.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2329",
    "type": "section",
    "keywords": [
      "hourly",
      "clindamycin",
      "improvement",
      "amoxicillin",
      "years",
      "clin",
      "acid",
      "adults",
      "clavulanic",
      "children",
      "weeks",
      "months",
      "until",
      "clinical"
    ]
  },
  {
    "id": "a8cee1e30e460aec32c4dde36ffeefd4",
    "content": "ical improvement\n7 days-3 months;\t30 mg/kg 8 hourly for 4 weeks or until clini- cal improvement\nPreterm and < 7 days;  30 mg/kg 12 hourly for 4 weeks or until clin- ical improvement.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2330",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "preterm",
      "clin",
      "ical",
      "weeks",
      "months",
      "clini",
      "until",
      "improvement"
    ]
  },
  {
    "id": "462e47b0c322cd4185c7f251c0129db3",
    "content": "Vancomycin, IV,\nAdults\n1 g 12 hourly by slow infusion over 1 hour (max. 2 g daily)\nChildren\n1 month-12 years;\t10 mg/kg per day in divided doses 6-12 hourly (max. 1 g daily)\nFor pain relief\nEvidence Rating: [B]\n(See section for pain relief in ‘Closed fractures’ under Trauma and Injuries)\nReferral Criteria\nRefer all patients to the plastic, general or orthopaedic surgeons as soon as the patient has been resuscitated.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2331",
    "type": "section",
    "keywords": [
      "hour",
      "injuries",
      "years",
      "infusion",
      "relief",
      "patient",
      "evidence",
      "under",
      "hourly",
      "rating",
      "orthopaedic",
      "section",
      "doses",
      "patients",
      "children",
      "criteria",
      "referral",
      "fractures",
      "vancomycin",
      "adults"
    ]
  },
  {
    "id": "bc45df1543345b86f035ff8e6817a06e",
    "content": "These are emergencies and require early diagnosis and prompt treatment. Staph. spp are responsible for the majority of cases and it is commoner in manual workers, farmers and fishmongers.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2332",
    "type": "section",
    "keywords": [
      "require",
      "farmers",
      "prompt",
      "diagnosis",
      "responsible",
      "staph",
      "manual",
      "early",
      "emergencies",
      "commoner",
      "cases",
      "fishmongers",
      "workers",
      "these",
      "majority",
      "treatment"
    ]
  },
  {
    "id": "dbd259cca069431561680b49f6af82f2",
    "content": "They can be classified as simple or severe infections.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2333",
    "type": "section",
    "keywords": [
      "severe",
      "classified",
      "infections",
      "simple"
    ]
  },
  {
    "id": "e08a89ca08f98746ef3bbcf589d7ac02",
    "content": "Causes\nStaph. aureus and epidermidis\nStrept. pyogenes\nFungi\nViruses\nSymptoms\nPain\nSwelling\nBlistering\nFever\nSkin discoloration\nLoss of function\nSigns\nFever\nSwelling\nTenderness\nDischarge\nStiffness\ninvestigations\nFBC, ESR\nCRP\nBlood culture\nRandom blood sugar\nGram stain and culture of discharge\nX-ray\nNail clippings for chronic paronychia.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2334",
    "type": "section",
    "keywords": [
      "epidermidis",
      "swelling",
      "blistering",
      "aureus",
      "stiffness",
      "nail",
      "function",
      "pyogenes",
      "strept",
      "signs",
      "culture",
      "sugar",
      "causes",
      "blood",
      "tenderness",
      "chronic",
      "fever",
      "discoloration",
      "fungi",
      "skin"
    ]
  },
  {
    "id": "7a62a71b8b3f44d78c0702d0ca9f31a6",
    "content": "Eradicate infection early and aggressively\nPrevent complications such as stiffness of the joints and septicaemia.",
    "title": "Treatment objectives",
    "section": "Treatment objectives",
    "chunk_id": "2335",
    "type": "section",
    "keywords": [
      "aggressively",
      "complications",
      "stiffness",
      "joints",
      "prevent",
      "infection",
      "early",
      "eradicate",
      "septicaemia"
    ]
  },
  {
    "id": "0a979272d6626b7b7e4b9a10668f5322",
    "content": "Elevation of the affected hand\nBandaging\nProtective wear\nPhysiotherapy\nSurgical drainage of abscesses\nFasciotomy in compartment syndrome.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2336",
    "type": "section",
    "keywords": [
      "protective",
      "hand",
      "elevation",
      "bandaging",
      "physiotherapy",
      "surgical",
      "drainage",
      "wear",
      "compartment",
      "fasciotomy",
      "syndrome",
      "abscesses",
      "affected"
    ]
  },
  {
    "id": "91a56b7c377b6edf198632a24ced00f6",
    "content": "Flucloxacillin, oral,\nAdults\n250-500 mg 6 hourly for 7-14 days\nChildren\n5-12 years;\t250 mg 6 hourly for 7-14 days\n1-5 years;\t125 mg 6 hourly for 7-14 days\n<1 year;\t62. 5 mg 6 hourly for 7-14 days.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2337",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "years",
      "flucloxacillin",
      "adults",
      "oral",
      "children",
      "year"
    ]
  },
  {
    "id": "fbc3e3fd1ddf0a4aec05a208ac56a8f1",
    "content": "Clindamycin, oral,\nAdults\n150-300 mg 6-8 hourly for 7-14 days\nChildren\n12-18 years;\t150-300 mg 6 hourly for 7-14 days\n1 month-11 years;\t3-6 mg/kg 6 hourly for 7-14 days.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2338",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "clindamycin",
      "years",
      "adults",
      "oral",
      "month",
      "children"
    ]
  },
  {
    "id": "2006fb2c5f4184ea21ceecccb5632f23",
    "content": "Cloxacillin, IV,\nAdults\n500 mg 6 hourly for 7-14 days\nChildren\n5-12 years;\t250 mg 6 hourly for 7-14 days\n1-5 years;\t125 mg 6 hourly for 7-14 days\n< 1 year;\t62. 5 mg 6 hourly for 7-14 days.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2339",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "years",
      "adults",
      "children",
      "cloxacillin",
      "year"
    ]
  },
  {
    "id": "c1c4bc4a87b8f5872f080bd08e4c5d61",
    "content": "300-600 mg 8 hourly for 14 days\nChildren\n12 years-18 years;\t150-675 mg 6 hourly for 14 days\n1 month-12 years;\t3. 75-6. 25 mg/kg 6 hourly for 14 days.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2340",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "years",
      "month",
      "children"
    ]
  },
  {
    "id": "8e56acb1e7a4f25bbabb6065c8fb85e6",
    "content": "Itraconazole, oral,\nAdults\n200 mg daily for 7 days\nChildren\n12 years;\t200 mg daily for 7 days\n1 month-12 years;\t3-5 mg/kg daily for 7 days\nCaution 23-1. And\nMiconazole tincture, topical, Adults and Children > 2 years Apply 12 hourly to affected area.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2341",
    "type": "section",
    "keywords": [
      "days",
      "topical",
      "hourly",
      "area",
      "years",
      "itraconazole",
      "miconazole",
      "affected",
      "adults",
      "caution",
      "oral",
      "month",
      "children",
      "tincture",
      "apply",
      "daily"
    ]
  },
  {
    "id": "ae3a1b1ef7bd8b7eb334109d72276bd5",
    "content": "Fluconazole, oral,\nAdult\n150-300 mg weekly\nChildren\n12-18 years;\t50-100 mg weekly\n14 days-12 years;\t3-6 mg/kg weekly\nOr\nClotrimazole, topical,\nAdults and Children\nApply 8-12 hourly to affected area\nOr\nNystatin cream, topical,\nAdults and Chidren\nApply 8-12 hourly to affected area\nOr\nEconazole cream, topical,\nAdults and Children\nApply 8-12 hourly to affected area\nOr\nCiclopirox cream, topical,\nAdults\nApply 8-12 hourly to affected area\nChildren\n10 years;\tapply 8-12 hourly to affected area.",
    "title": "2nd Line Treatment Evidence Rating: [B]",
    "section": "2nd Line Treatment Evidence Rating: [B]",
    "chunk_id": "2342",
    "type": "section",
    "keywords": [
      "years",
      "econazole",
      "apply",
      "ciclopirox",
      "hourly",
      "nystatin",
      "children",
      "clotrimazole",
      "fluconazole",
      "days",
      "topical",
      "adult",
      "adults",
      "weekly",
      "oral",
      "chidren",
      "area",
      "cream",
      "affected"
    ]
  },
  {
    "id": "6449aea1ac8bb51ea6153a3aaa09c1f1",
    "content": "Griseofulvin, oral,\nAdults\n500 mg daily (double in severe infection) for 4 weeks\nChildren\n12-18 years;\t500 mg once daily or in two divided doses (may be doubled in severe infections) for 4 weeks\n1 month-12 years;\t10 mg/kg (max. 500 mg) once daily or in two divided doses for 4 weeks\nAnd\nMiconazole tincture, topical,\nAdults and Children\nApply 12 hourly to affected area.",
    "title": "3nd Line Treatment Evidence Rating: [C]",
    "section": "3nd Line Treatment Evidence Rating: [C]",
    "chunk_id": "2343",
    "type": "section",
    "keywords": [
      "infections",
      "years",
      "miconazole",
      "affected",
      "doubled",
      "hourly",
      "doses",
      "double",
      "children",
      "weeks",
      "tincture",
      "severe",
      "topical",
      "adults",
      "month",
      "divided",
      "once",
      "griseofulvin",
      "infection",
      "oral"
    ]
  },
  {
    "id": "7c304f70dee6aaad6aeccbc737bfb95a",
    "content": "Copper sulphate stone (blue stone), topical,\nAdults and Children\nApply to the affected site 12 hourly\nOr\nEvidence Rating: [B]\nHydrocortisone cream, 0. 5-2. 5%, topical,\nAdults (0.",
    "title": "1st Line Treatment",
    "section": "1st Line Treatment",
    "chunk_id": "2344",
    "type": "section",
    "keywords": [
      "topical",
      "sulphate",
      "hourly",
      "rating",
      "blue",
      "affected",
      "copper",
      "apply",
      "adults",
      "site",
      "hydrocortisone",
      "children",
      "cream",
      "evidence",
      "stone"
    ]
  },
  {
    "id": "09bdf27073523fb2dd6fb8b271f47708",
    "content": "5-2. 5%)\nApply 8-12 hourly to affected area(s)\nChildren (0. 5-1%)\nApply 8-12 hourly to affected area(s)\nOr\nClobetasol propionate cream (0.",
    "title": "1st Line Treatment",
    "section": "1st Line Treatment",
    "chunk_id": "2345",
    "type": "section",
    "keywords": [
      "hourly",
      "propionate",
      "clobetasol",
      "apply",
      "children",
      "area",
      "cream",
      "affected"
    ]
  },
  {
    "id": "b36bdf7f7fa2fb9bb7c93ac42f775c91",
    "content": "05%), topical,\nAdults\nApply 8-12 hourly to affected area(s)\nChildren\n12 years;\tapply 8-12 hourly to affected area(s)\n< 12 years;\tnot recommended\nOr\nBetamethasone dipropionate cream (0. 05%), topical,\nAdults and Children < 12 years Apply 12 hourly to affected area(s)\nReferral Criteria\nRefer to appropriate specialists if patient does not improve.",
    "title": "1st Line Treatment",
    "section": "1st Line Treatment",
    "chunk_id": "2346",
    "type": "section",
    "keywords": [
      "years",
      "affected",
      "improve",
      "betamethasone",
      "patient",
      "hourly",
      "dipropionate",
      "children",
      "criteria",
      "topical",
      "referral",
      "specialists",
      "adults",
      "does",
      "recommended",
      "appropriate",
      "refer",
      "area",
      "cream",
      "apply"
    ]
  },
  {
    "id": "0723898c181ec38502fdf655727c0ad3",
    "content": "Tuberculosis can affect all bones and joints. The spine is affected in 50% of all cases. It affects all ages but commoner in the extremes of age.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2347",
    "type": "section",
    "keywords": [
      "ages",
      "affect",
      "joints",
      "spine",
      "extremes",
      "affects",
      "commoner",
      "cases",
      "tuberculosis",
      "affected",
      "bones"
    ]
  },
  {
    "id": "1f04d334a9968582a694a3c9e531c944",
    "content": "May co-exist with pulmonary TB in some cases and also in HIV positive patients. There may be a positive history of contact with a TB infected patient. Causes\nMycobacterium tuberculosis\nMycobacterium africanum\nMycobacterium bovis\nSymptoms\nPain especially at night\nSwelling\nDeformity\nNight sweats\nLow grade fever\nChronic cough\nWeight loss\nSigns\nSwelling\nTenderness\nDeformities\nDischarging sinuses\nCold abscesses\nMuscle wasting\ninvestigations\nChest X-Ray to rule out pulmonary TB\nX-ray of the suspected part\nSputum/gastric washings for AFBs\nFBC, ESR\nMRI of suspected parts (if available)\nBone and soft tissue biopsy for culture and histology\nMantoux test.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2348",
    "type": "section",
    "keywords": [
      "test",
      "bovis",
      "weight",
      "especially",
      "swelling",
      "infected",
      "deformities",
      "patient",
      "night",
      "sputum",
      "chest",
      "part",
      "sinuses",
      "gastric",
      "mantoux",
      "muscle",
      "signs",
      "patients",
      "culture",
      "causes"
    ]
  },
  {
    "id": "6fbcd65b25f60012019ca2d0b2e4b90f",
    "content": "Eradicate infection\nPrevent and correct deformity\nPrevent stiffness.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2349",
    "type": "section",
    "keywords": [
      "deformity",
      "stiffness",
      "correct",
      "prevent",
      "infection",
      "eradicate"
    ]
  },
  {
    "id": "91e4c57eff15369a8d6972f81eb142ab",
    "content": "For bone and joint tuberculosis\n(See section on ‘Tuberculosis’)\nFor pain relief\nEvidence Rating: [B]\n(See section for pain relief in ‘Closed fractures’ under Trauma and Injuries)\nReferral Criteria\nRefer to appropriate specialist as soon as diagnosis is made. Rickets is caused by failure of osteoid to calcify in a growing person resulting in softening and weakening of bones, due to extreme or prolonged vitamin-D deficiency. Osteomalacia is essentially its equivalent in the skeletally mature.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2350",
    "type": "section",
    "keywords": [
      "prolonged",
      "injuries",
      "essentially",
      "relief",
      "mature",
      "trauma",
      "evidence",
      "vitamin",
      "under",
      "rating",
      "specialist",
      "equivalent",
      "section",
      "rickets",
      "joint",
      "extreme",
      "softening",
      "criteria",
      "deficiency",
      "growing"
    ]
  },
  {
    "id": "01b090940fd4f061024edd6800b0f711",
    "content": "Causes\nVitamin-D deficiency due to:\nReduced intake (nutritional is the commonest)\nMalabsorption\nReduced sunlight\nVitamin-D resistance\nVitamin-D dependence\nSymptoms\nUsually none\nPain in the wrists\nSigns\nMalnourished with discoloured hair\nDeformities\nSmall for age\nSwelling of wrists\nRachitic rosary\ninvestigations\nSerum vitamin-D level\nSerum calcium\nSerum and urine phosphate levels\nX-ray of deformed bones.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2351",
    "type": "section",
    "keywords": [
      "usually",
      "phosphate",
      "levels",
      "swelling",
      "wrists",
      "deformities",
      "urine",
      "reduced",
      "vitamin",
      "malabsorption",
      "signs",
      "intake",
      "causes",
      "deficiency",
      "calcium",
      "level",
      "hair",
      "deformed",
      "dependence",
      "investigations"
    ]
  },
  {
    "id": "74c45974d872cbe64b1eeb926ca0ca79",
    "content": "Correct metabolic derangement\nPrevent and treat deformities.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2352",
    "type": "section",
    "keywords": [
      "treat",
      "correct",
      "prevent",
      "derangement",
      "deformities",
      "metabolic"
    ]
  },
  {
    "id": "d99e7b6d77b2c3fcb09a85dbb2ee6c15",
    "content": "Vitamin-D, oral,\nAdults and Children\n125-250 microgram (5 000-10 000 Units) daily for 2-3 months until healing is well established\nFor rickets in patients with malabsorption\nVitamin-D, IM,\nAdults and Children\n12-18 years;  10 000-40 000 Units daily\n1-12 years;\t10 000-25 000 Units daily\nOr\nVitamin-D, oral,\nAdults and Children\n10 000-300 000 Units daily based on severity of condition\nAnd\nCalcium, oral, Adults and Children 1000-1500 mg daily\nFor patients with osteomalacia.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2353",
    "type": "section",
    "keywords": [
      "units",
      "years",
      "based",
      "established",
      "vitamin",
      "malabsorption",
      "healing",
      "rickets",
      "patients",
      "condition",
      "children",
      "calcium",
      "adults",
      "months",
      "microgram",
      "severity",
      "oral",
      "osteomalacia",
      "until",
      "daily"
    ]
  },
  {
    "id": "90b409efc7cc8c20597a6aac37dace63",
    "content": "Vitamin-D, oral,\nAdults\n2 000-5 000 Units daily for 2-3 months until healing is well estab-\nlished\nOr\nVitamin-D, lM,\nAdults\n10 000 Units daily for 2-3 months until healing is well established\nReferral Criteria\nRefer to a paediatrician and orthopaedic surgeon once diagnosis is made.",
    "title": "1st Line Treatment",
    "section": "1st Line Treatment",
    "chunk_id": "2354",
    "type": "section",
    "keywords": [
      "units",
      "established",
      "vitamin",
      "paediatrician",
      "healing",
      "orthopaedic",
      "lished",
      "estab",
      "criteria",
      "referral",
      "diagnosis",
      "adults",
      "months",
      "once",
      "made",
      "refer",
      "oral",
      "surgeon",
      "until",
      "daily"
    ]
  },
  {
    "id": "c9e7a364c832adfe2c19b15fc2939c8e",
    "content": "Scurvy is a multi-system disease, which may present with bony deformities and soft tissue scarring. It is caused by dietary deficiency of Vitamin-C (ascorbic acid). It is rare globally but seen in the low-middle income countries.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2355",
    "type": "section",
    "keywords": [
      "bony",
      "globally",
      "which",
      "seen",
      "deformities",
      "vitamin",
      "rare",
      "dietary",
      "multi",
      "deficiency",
      "disease",
      "caused",
      "acid",
      "countries",
      "soft",
      "scurvy",
      "income",
      "scarring",
      "present",
      "middle"
    ]
  },
  {
    "id": "2e37a74c858228187fa1b02f9f9e1f28",
    "content": "Presentation may be dramatic, but once the diagnosis is made, the treatment is effective and rewarding. Causes\nVitamin-C deficiency\nSymptoms\nPain and swelling of long bones\nSigns\nTenderness of the legs\nBleeding gums\nSwelling of long bones\ninvestigations\nX-ray\nVitamin-C assay.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2356",
    "type": "section",
    "keywords": [
      "rewarding",
      "swelling",
      "vitamin",
      "dramatic",
      "bleeding",
      "presentation",
      "signs",
      "causes",
      "treatment",
      "deficiency",
      "tenderness",
      "diagnosis",
      "investigations",
      "assay",
      "symptoms",
      "once",
      "bones",
      "effective",
      "pain",
      "made"
    ]
  },
  {
    "id": "c659c68a1309a18d722fad38b807cd5a",
    "content": "Fruits rich in Vitamin-C e. g. oranges\nSurgery to correct deformities.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2357",
    "type": "section",
    "keywords": [
      "correct",
      "oranges",
      "fruits",
      "deformities",
      "vitamin",
      "surgery",
      "rich"
    ]
  },
  {
    "id": "d1b7780c9183802b3d66410cad8bf833",
    "content": "Vitamin-C, oral,\nAdults\n500 mg 12-24 hourly (max. 1 g daily)\nChildren\n12-18 years;\t500 mg 12-24 hourly (max. 1 g daily)\n4-12 years;\t250 mg 12-24 hourly (max.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "2358",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "adults",
      "oral",
      "children",
      "vitamin",
      "daily"
    ]
  },
  {
    "id": "76e0f5280c107a6ba77840b3125d8bf4",
    "content": "500 mg daily)\n1 month-4 years; 125 mg daily 12-24 hourly (max. 250 mg daily)\nReferral Criteria\nRefer all cases to paediatrician and orthopaedic specialist.",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "2359",
    "type": "section",
    "keywords": [
      "hourly",
      "referral",
      "paediatrician",
      "years",
      "specialist",
      "orthopaedic",
      "refer",
      "cases",
      "month",
      "criteria",
      "daily"
    ]
  },
  {
    "id": "cd111e6098dc01ca8caf2e798b969f16",
    "content": "Osteoporosis is a systemic skeletal disease characterized by low bone mass and small areas of deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture. Risk of fractures is higher in elderly individuals with poor walking balance and vision. Some risk factors include parental hip fractures, advanced age - especially women after menopause, smoking, alcohol abuse, immobilization, inadequate intake of vitamin-D and calcium, prolonged steroid use, hyperthyroidism, hyperparathyroidism, type-I diabetes mellitus, rheumatoid arthritis, malabsorption syndromes, and low femoral neck Bone Mineral Density (BMD).",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2360",
    "type": "section",
    "keywords": [
      "prolonged",
      "rheumatoid",
      "advanced",
      "fragility",
      "inadequate",
      "especially",
      "skeletal",
      "mellitus",
      "factors",
      "elderly",
      "systemic",
      "arthritis",
      "poor",
      "vitamin",
      "increase",
      "hyperthyroidism",
      "neck",
      "density",
      "type",
      "malabsorption"
    ]
  },
  {
    "id": "92625453c3a3d438f0d95b58ce971a5d",
    "content": "Cause\nImbalance between new bone formation and old bone breakdown\nBone mineral loss\nLow bone density\nSymptoms\nBack pain\nInability to walk after a very trivial fall\nSigns\nDeformed limbs\nFractures\nStooping stance\ninvestigations\nX-rays of wrists/hips\nBone Mineral Density (BMD) scan\nQuantitative CT scan.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2361",
    "type": "section",
    "keywords": [
      "wrists",
      "breakdown",
      "density",
      "stooping",
      "imbalance",
      "formation",
      "signs",
      "limbs",
      "fall",
      "stance",
      "fractures",
      "deformed",
      "cause",
      "mineral",
      "hips",
      "between",
      "back",
      "inability",
      "investigations",
      "symptoms"
    ]
  },
  {
    "id": "9a1ee7679187a7c96aa27f26e09f64d0",
    "content": "Management of underlying risk factors\nPrevention of fractures.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2362",
    "type": "section",
    "keywords": [
      "fractures",
      "prevention",
      "management",
      "factors",
      "underlying",
      "risk"
    ]
  },
  {
    "id": "f6cfa1676c6b52aa25b3de4ec29c0b4e",
    "content": "Dietary (adequate intake of calcium and vitamin-D containing foods)\nTherapeutic Lifestyle Changes (refer to risk factors in the preamble above).",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2363",
    "type": "section",
    "keywords": [
      "preamble",
      "above",
      "calcium",
      "containing",
      "therapeutic",
      "changes",
      "refer",
      "dietary",
      "factors",
      "risk",
      "intake",
      "foods",
      "lifestyle",
      "adequate",
      "vitamin"
    ]
  },
  {
    "id": "6e061abfaa3ab9a0b2e60213d2bea1dc",
    "content": "1000-1300 mg daily of Calcium and 200-800 IU vitamin-D daily\nFor moderate fracture risk\nEvidence Rating: [A]\nCalcium with Vitamin-D, oral,\nAdults\n1000-1500 mg daily of Calcium and 200-800 IU vitamin-D daily\nFor high fracture risk\nHormone replacement therapy (HRT)\nEstrogen therapy (ET)\nBisphosphonates\nCalcitonin\nSelective estrogen receptor modulators (SERMs)\nDenosumab\nStrontium\nTeriparatide\nReferral Criteria\nRefer all cases to a physician or orthopaedic specialist. This is a painful complication of sickle-cell disease, induced by obstruction of small blood vessels by crystallized sickle cells leading to ischaemic injury to several organs, including bone. The bone pain is usually difficult to distinguish from acute osteomyelitis.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2364",
    "type": "section",
    "keywords": [
      "usually",
      "bisphosphonates",
      "denosumab",
      "replacement",
      "strontium",
      "induced",
      "therapy",
      "evidence",
      "vitamin",
      "acute",
      "calcitonin",
      "vessels",
      "moderate",
      "rating",
      "estrogen",
      "specialist",
      "modulators",
      "orthopaedic",
      "complication",
      "including"
    ]
  },
  {
    "id": "fbfda96a3145bb025da2215002e654ba",
    "content": "Causes\nPyogenic infection\nMalaria\nDehydration\nSevere anaemia\nStress and anxiety\nSymptoms\nBone pain\nFever\nSickle-cell anaemia\nSigns\nBone tenderness\nFever.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2365",
    "type": "section",
    "keywords": [
      "severe",
      "dehydration",
      "pain",
      "tenderness",
      "anaemia",
      "stress",
      "symptoms",
      "infection",
      "fever",
      "cell",
      "sickle",
      "signs",
      "pyogenic",
      "anxiety",
      "malaria",
      "causes",
      "bone"
    ]
  },
  {
    "id": "0a88a2694eb4290e1bbbb8013e215509",
    "content": "investigations\nFBC, ESR\nCRP\nSickling and Hb Electrophoresis (if not previously known)\nBlood film or Rapid Diagnostic Test (RDT) for malaria parasites\nUrinalysis and culture\nBUE and Creatinine\nBlood culture and sensitivity.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2366",
    "type": "section",
    "keywords": [
      "creatinine",
      "sickling",
      "test",
      "previously",
      "rapid",
      "known",
      "sensitivity",
      "electrophoresis",
      "film",
      "urinalysis",
      "diagnostic",
      "culture",
      "investigations",
      "parasites",
      "malaria",
      "blood"
    ]
  },
  {
    "id": "28dbbfaac77cebd67abff7e3cec810d2",
    "content": "Non-pharmacological treatment Encourage adequate fluid intake (See section on ‘Sickle Cell Disease’).",
    "title": "(See section on ‘Sickle Cell Disease’)",
    "section": "(See section on ‘Sickle Cell Disease’)",
    "chunk_id": "2367",
    "type": "section",
    "keywords": [
      "disease",
      "pharmacological",
      "cell",
      "section",
      "sickle",
      "intake",
      "encourage",
      "adequate",
      "treatment",
      "fluid"
    ]
  },
  {
    "id": "3f7a56f2261ce1f2afbcfa51575e0459",
    "content": "Referral Criteria\nRefer all patients with complications to a paediatrician, physician specialist or haematologist. This is bone death caused by reduced blood supply. Causes\nNon-traumatic\nSickle-cell anaemia\nInfection – septic arthritis\nSlipped capital femoral epiphyses / slipped upper femoral\nepiphyses\nHIV\nProlonged steroid use\nAlcohol abuse\nVasculitis\nIdiopathic.",
    "title": "(See section for pharmacological treatment in ‘Sickle Cell Disease’)",
    "section": "(See section for pharmacological treatment in ‘Sickle Cell Disease’)",
    "chunk_id": "2368",
    "type": "section",
    "keywords": [
      "prolonged",
      "supply",
      "anaemia",
      "idiopathic",
      "traumatic",
      "arthritis",
      "reduced",
      "death",
      "capital",
      "paediatrician",
      "specialist",
      "alcohol",
      "vasculitis",
      "steroid",
      "haematologist",
      "patients",
      "criteria",
      "blood",
      "causes",
      "slipped"
    ]
  },
  {
    "id": "c8af29d4f1a819895fda6502b8ae922b",
    "content": "Developmental dysplasia of hip\nTraumatic\nDisplaced femoral neck fractures\nDislocations of joints\nSymptoms\nPain in the affected joint\nLimping\nSigns\nLimping\nTenderness on joint movement\nDeformity\nLeg length discrepancy\ninvestigations\nX-ray\nMRI.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2369",
    "type": "section",
    "keywords": [
      "traumatic",
      "limping",
      "neck",
      "movement",
      "joint",
      "signs",
      "developmental",
      "dysplasia",
      "joints",
      "tenderness",
      "fractures",
      "deformity",
      "investigations",
      "femoral",
      "symptoms",
      "length",
      "pain",
      "dislocations",
      "discrepancy",
      "displaced"
    ]
  },
  {
    "id": "4e5000a73f3945da979d5ee884508a66",
    "content": "Treat underlying cause\nPrevent progression\nEncourage recovery\nPain relief.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2370",
    "type": "section",
    "keywords": [
      "pain",
      "treat",
      "prevent",
      "progression",
      "cause",
      "relief",
      "underlying",
      "recovery",
      "encourage"
    ]
  },
  {
    "id": "72663ca41d8afb8f8c037edbf2300466",
    "content": "Physiotherapy\nWalking aid when lower limb is involved\nSurgery\nCore decompression\nOsteotomies.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2371",
    "type": "section",
    "keywords": [
      "physiotherapy",
      "limb",
      "involved",
      "core",
      "lower",
      "decompression",
      "osteotomies",
      "walking",
      "surgery"
    ]
  },
  {
    "id": "8630a55a279c1662336b5aeda85ffc66",
    "content": "Naproxen EC, oral,\nAdults\n250-500mg 12 hourly as required\nChildren\nNot indicated\nOr\nCelecoxib, oral,\nAdults\n400 mg stat. Then\n200 mg 12-24 hourly as required\nChildren.",
    "title": "1st Line Treatment Evidence Rating: [A]",
    "section": "1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2372",
    "type": "section",
    "keywords": [
      "hourly",
      "naproxen",
      "adults",
      "oral",
      "stat",
      "indicated",
      "required",
      "children",
      "then",
      "celecoxib"
    ]
  },
  {
    "id": "4214f235c32200d76b4c74786ebf1f3d",
    "content": "Not indicated\nOr\nDiclofenac, oral,\nAdults\n50 mg 8 hourly or 100 mg 12 hourly\nChildren\n12 years;\t50 mg 12 hourly\n< 12 years;\tnot recommended\nOr\nIbuprofen, oral,\nAdults\n200-800 mg 6-8 hourly as required (max. 2. 4 g daily)\nChildren\n10-15 mg/kg 6-8 hourly as required (max.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2373",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "diclofenac",
      "adults",
      "oral",
      "indicated",
      "required",
      "children",
      "ibuprofen",
      "daily"
    ]
  },
  {
    "id": "8f02873a71338586ba74ed362f5fa20c",
    "content": "40 mg per kg daily)\nFor prevention of bone collapse Pamidronate, consult specialist Alendronate, consult specialist\nReferral Criteria\nRefer once the diagnosis is made to orthopaedic specialist. This is also known as brittle bone disease. It is a genetic disorder characterised by low bone mass, skeletal fragility and recurrent fractures.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2374",
    "type": "section",
    "keywords": [
      "collapse",
      "recurrent",
      "fragility",
      "skeletal",
      "characterised",
      "genetic",
      "specialist",
      "known",
      "orthopaedic",
      "pamidronate",
      "criteria",
      "disease",
      "referral",
      "fractures",
      "brittle",
      "diagnosis",
      "prevention",
      "also",
      "consult",
      "once"
    ]
  },
  {
    "id": "c845b1bbb8410c1c44314b41b4da1e53",
    "content": "Causes\nGene mutation leading to defective collagen formation\nSymptoms\nIncessant crying\nSigns\nBluish sclera\nDentinogenesis imperfecta (blueish-grey or yellowish-brown colouration of teeth)\nMultiple fractures with callus formation\nBone deformities\ninvestigations\nX-ray – Baby-gram (multiple fractures at different stages).",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2375",
    "type": "section",
    "keywords": [
      "baby",
      "defective",
      "mutation",
      "callus",
      "bluish",
      "deformities",
      "blueish",
      "crying",
      "multiple",
      "formation",
      "signs",
      "yellowish",
      "imperfecta",
      "causes",
      "dentinogenesis",
      "leading",
      "incessant",
      "fractures",
      "different",
      "gene"
    ]
  },
  {
    "id": "b64c3bbd963bd0f599c13ddf0c66ec98",
    "content": "Make child comfortable\nPrevent recurrent fractures\nPrevent deformities.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2376",
    "type": "section",
    "keywords": [
      "recurrent",
      "fractures",
      "comfortable",
      "prevent",
      "child",
      "deformities"
    ]
  },
  {
    "id": "318285ca8be8418b60cb69852861b5ea",
    "content": "Counsel parents\nSplints\nBaby handling techniques\nSurgical prevention and correction of deformities.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2377",
    "type": "section",
    "keywords": [
      "baby",
      "splints",
      "techniques",
      "surgical",
      "prevention",
      "counsel",
      "deformities",
      "parents",
      "correction",
      "handling"
    ]
  },
  {
    "id": "4cab8351046830f7ba264787c757b783",
    "content": "Alendronate, IV,\nChildren\nConsult specialist\nFor pain relief\nParacetamol, oral or rectal,\nChildren\n6-12 years;\t250-500 mg 6-8 hourly\n1-5 years;\t120-250 mg 6-8 hourly\n3 months-1 year;\t60-120 mg 6-8 hourly\nReferral Criteria\nRefer as soon as diagnosis is made to a paediatrician and orthopaedic specialist. A burn is basically destruction of the skin. In certain situations deeper tissues such as subcutaneous tissue, muscle and bone may be involved.",
    "title": "For prevention of fractures 1st Line Treatment Evidence Rating: [B]",
    "section": "For prevention of fractures 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2378",
    "type": "section",
    "keywords": [
      "basically",
      "years",
      "situations",
      "relief",
      "certain",
      "hourly",
      "rectal",
      "specialist",
      "paediatrician",
      "orthopaedic",
      "involved",
      "muscle",
      "children",
      "criteria",
      "destruction",
      "subcutaneous",
      "referral",
      "burn",
      "diagnosis",
      "paracetamol"
    ]
  },
  {
    "id": "8a4fd27057d074f6820a0729900469a6",
    "content": "The burn may be superficial or deep depending on the extent of the injury. This condition, which can have devastating effects on affected people, can be prevented most of the time. It affects young and fit people in most cases and they must be managed properly so that they can return to their normal life.",
    "title": "For prevention of fractures 1st Line Treatment Evidence Rating: [B]",
    "section": "For prevention of fractures 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2379",
    "type": "section",
    "keywords": [
      "which",
      "superficial",
      "properly",
      "people",
      "most",
      "condition",
      "their",
      "deep",
      "burn",
      "prevented",
      "return",
      "young",
      "extent",
      "managed",
      "depending",
      "devastating",
      "effects",
      "must",
      "life",
      "affects"
    ]
  },
  {
    "id": "cf63e70f123e9fa0f9aefcecdf268ea3",
    "content": "Causes\nDry heat (fire)\nWet heat (scalds) from hot liquids, steam, soups etc. Electrical (low or high voltage)\nChemical (acids and alkalis)\nSymptoms\nPain (very severe in superficial type and less in deeper burns)\nSwelling\nDifficulty in breathing\nBlisters.",
    "title": "For prevention of fractures 1st Line Treatment Evidence Rating: [B]",
    "section": "For prevention of fractures 1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2380",
    "type": "section",
    "keywords": [
      "acids",
      "swelling",
      "superficial",
      "breathing",
      "alkalis",
      "blisters",
      "type",
      "liquids",
      "heat",
      "steam",
      "soups",
      "chemical",
      "burns",
      "causes",
      "severe",
      "electrical",
      "difficulty",
      "scalds",
      "symptoms",
      "deeper"
    ]
  },
  {
    "id": "41ef431f749c1dbd2c819f027a066520",
    "content": "Signs\nShock\nInhalational injury (burnt nasal hairs, soot in the throat, hoarseness\nof the voice and black particles in sputum)\nSwelling\nBlister formation\nCharring of tissue (deep burns)\nECG changes (electrical burns)\ninvestigations\nFBC and sickling\nBUE and Creatinine\nWound swab\nBlood gases\nChest X-ray.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2381",
    "type": "section",
    "keywords": [
      "sickling",
      "hoarseness",
      "swelling",
      "wound",
      "voice",
      "sputum",
      "creatinine",
      "swab",
      "hairs",
      "chest",
      "formation",
      "burns",
      "signs",
      "particles",
      "changes",
      "blood",
      "charring",
      "deep",
      "electrical",
      "shock"
    ]
  },
  {
    "id": "3a240c041db8a6c465888ed681db804f",
    "content": "Prevent further injury from burns\nRelieve pain\nReplace lost fluid\nPrevent infection of burn wound\nAid healing of the burn wound\nAvoid complications.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2382",
    "type": "section",
    "keywords": [
      "replace",
      "avoid",
      "complications",
      "pain",
      "burn",
      "healing",
      "prevent",
      "lost",
      "infection",
      "further",
      "relieve",
      "burns",
      "wound",
      "injury",
      "fluid"
    ]
  },
  {
    "id": "d198a7f60b99c8b95ca079af061a96ac",
    "content": "Remove clothing from affected part\nPut affected part under running water if available till pain goes away\nor it is reduced\nIf chemical is in powder form brush it off the affected part and put under running water\nSecure airway\nLeave intact blisters alone\nDo not apply any creams or ointment\nAffected limbs should be elevated\nGood nutrition\nPsychological therapy\nPhysiotherapy\nReassure patient.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2383",
    "type": "section",
    "keywords": [
      "psychological",
      "creams",
      "apply",
      "reduced",
      "alone",
      "reassure",
      "form",
      "therapy",
      "patient",
      "blisters",
      "under",
      "intact",
      "nutrition",
      "powder",
      "part",
      "chemical",
      "water",
      "limbs",
      "running",
      "clothing"
    ]
  },
  {
    "id": "1abbacb8bde91d2f5ac1e4b0cd3954eb",
    "content": "For burns with Total Body Surface Area (TBSA) of less than 10% in children and 15% in adults.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2384",
    "type": "section",
    "keywords": [
      "body",
      "surface",
      "adults",
      "burns",
      "children",
      "tbsa",
      "less",
      "area",
      "total"
    ]
  },
  {
    "id": "4cb8ee0cef80beecc311ae34f04a545f",
    "content": "Paracetamol, oral,\nAdults\n500 mg-1 g 6-8 hourly\nChildren\n6-12 years;\t250-500 mg 6-8 hourly\n1-5 years;\t120-250 mg 6-8 hourly\n3 months-1 year;\t60-120 mg 6-8 hourly\nOr\nNaproxen EC, oral,\nAdults\n250-500 mg 12 hourly as required\nChildren\nNot indicated\nOr\nCelecoxib, oral,\nAdults\n400 mg stat. Then\n200 mg 12-24 hourly as required\nChildren\nNot indicated\nOr\nDiclofenac, oral,\nAdults\n50 mg 8 hourly or 100 mg 12 hourly\nChildren\n12 years;\t50 mg 12 hourly\n< 12 years;\tnot recommended\nOr\nIbuprofen, oral,\nAdults\n200-800 mg 6-8 hourly as required (max. 2.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2385",
    "type": "section",
    "keywords": [
      "hourly",
      "recommended",
      "years",
      "naproxen",
      "diclofenac",
      "adults",
      "ibuprofen",
      "oral",
      "paracetamol",
      "stat",
      "indicated",
      "required",
      "children",
      "months",
      "then",
      "celecoxib",
      "year"
    ]
  },
  {
    "id": "fc0c23ba880b171886586fa223235e47",
    "content": "4 g daily)\nChildren\n10-15 mg/kg 6-8 hourly as required (max. 40 mg per kg daily)\nAnd\nFlucloxacillin, oral,\nAdults\n500 mg 6 hourly for 2 weeks\nChildren\n5-12 years;\t250 mg 6 hourly for 2 weeks\n1-5 years;\t125 mg 6 hourly for 2 weeks\n< 1 year;\t62. 5 mg 6 hourly for 2 weeks.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2386",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "flucloxacillin",
      "adults",
      "oral",
      "required",
      "children",
      "weeks",
      "daily",
      "year"
    ]
  },
  {
    "id": "a1e421c384547adc3e204cc6692a3150",
    "content": "if the Patient has burns (TBSA) of more than 10% in children and 15% in adults\nMorphine, IV,\nAdults\n2. 5-5 mg 4 hourly\nChildren\n0. 1 mg/kg (max.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2387",
    "type": "section",
    "keywords": [
      "morphine",
      "hourly",
      "adults",
      "burns",
      "tbsa",
      "more",
      "children",
      "patient"
    ]
  },
  {
    "id": "49cf8c80a9ec26a38cf7d45db4e2d890",
    "content": "5 mg) 4 hourly\nOr\nPethidine, IV,\nAdults\n25-50 mg 4 hourly. Lower dose in the elderly. Children\n1 mg/kg (max.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2388",
    "type": "section",
    "keywords": [
      "hourly",
      "pethidine",
      "adults",
      "elderly",
      "dose",
      "lower",
      "children"
    ]
  },
  {
    "id": "ee0bf1a91e146cda8bf6a2cd7a21e6b1",
    "content": "50 mg) 4 hourly\nAnd\nCloxacillin, IV,\nAdults\n500 mg 6 hourly for 7 days\nChildren\n5-12 years;\t250 mg 6 hourly for 7 days\n1-5 years;\t125 mg 6 hourly for 7 days\n< 1 year;\t62. 5 mg 6 hourly for 7 days\nif the Patient has burns (TBSA) of more than 10% in children and 15% in adults – and allergic to penicillins\nClindamycin, IV, (if patient is allergic to penicillin)\nAdults\n300-600 mg 6 hourly for 7 days\nChildren\n3-6 mg/kg 6 hourly for 7 days\nAnd\nMetronidazole, IV,\nAdults\n500 mg 8 hourly for 7 days.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2389",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "clindamycin",
      "metronidazole",
      "years",
      "penicillin",
      "adults",
      "burns",
      "penicillins",
      "tbsa",
      "allergic",
      "more",
      "children",
      "cloxacillin",
      "patient",
      "year"
    ]
  },
  {
    "id": "438cca06f9823eafeff0189bd1d2049c",
    "content": "Children\n7. 5 mg/kg 8 hourly for 7 days\nif the Patient has burns (TBSA) of more than 20% in children and 30% in adults (considered as severe burns)\nCefuroxime, IV,\nAdults\n750 mg-1. 5 g 8 hourly for 7 days\nChildren\n25 mg/kg 8 hourly for 7 days\nAnd\nMetronidazole, IV,\nAdults\n500 mg 8 hourly for 7 days\nChildren\n7.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2390",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "severe",
      "metronidazole",
      "considered",
      "adults",
      "burns",
      "tbsa",
      "cefuroxime",
      "more",
      "children",
      "patient"
    ]
  },
  {
    "id": "9735a4ac599ace3dfa99c9f5ae1cf8b5",
    "content": "5 mg/kg 6 hourly for 7 days\nAnd\nOmeprazole, IV,\nAdults\n40 mg 12 hourly\nOr\nEsomeprazole, IV,\nAdults\n40 mg daily\nFor DVT prophylaxis\nEnoxaparin, SC,\nAdults\n40 mg daily\nChildren\n2 months-18 years;\t1 mg/kg 12 hourly\n1-2 months;\t1. 5 mg/kg 12 hourly\nNeonates;\t1. 5-2 mg/kg 12 hourly.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2391",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "years",
      "neonates",
      "adults",
      "enoxaparin",
      "prophylaxis",
      "omeprazole",
      "children",
      "months",
      "daily",
      "esomeprazole"
    ]
  },
  {
    "id": "4d8ae2a3d6a762f961ca613c056bddb3",
    "content": "Or\nDalteparin, SC,\nAdults\n5000 units daily\nChildren\n12-18 years;\t2500-5000 units daily\n1 month-12 years;\t100 units/kg 12 hourly\nNeonates;\t100 units/kg 12 hourly\nIf a burn is clinically infected.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2392",
    "type": "section",
    "keywords": [
      "hourly",
      "units",
      "years",
      "burn",
      "neonates",
      "adults",
      "infected",
      "clinically",
      "month",
      "children",
      "dalteparin",
      "daily"
    ]
  },
  {
    "id": "d984c7786ec18fde4463d1d04c314b63",
    "content": "Gentamicin, IV,\nAdults\n40-80 mg 8 hourly for 14 days\nChildren\n1-12 years;\t2. 5 mg/kg 8 hourly for 14 days\n< 1 year;\t2. 5 mg/kg 12 hourly for 14 days\nOr\nCeftazidime, IV,\nAdults\n1-2 g 8 hourly\nChildren\n1 month-18 years;\t25 mg/kg 8 hourly\nNeonates\n21-28 days;\t25 mg/kg 8 hourly\n7-21 days;\t25 mg/kg 12 hourly\n< 7 days;\t25 mg/kg daily\nAnd\nMetronidazole, IV, (doses as indicated in section B.",
    "title": "1st Line Treatment",
    "section": "1st Line Treatment",
    "chunk_id": "2393",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "metronidazole",
      "gentamicin",
      "years",
      "neonates",
      "section",
      "adults",
      "doses",
      "ceftazidime",
      "indicated",
      "month",
      "children",
      "daily",
      "year"
    ]
  },
  {
    "id": "ff8379bb1ca6326d31bbe952b1c5a6be",
    "content": "above)\nAnd\nCloxacillin, IV, (doses as indicated in section B. above).",
    "title": "1st Line Treatment",
    "section": "1st Line Treatment",
    "chunk_id": "2394",
    "type": "section",
    "keywords": [
      "above",
      "section",
      "doses",
      "indicated",
      "cloxacillin"
    ]
  },
  {
    "id": "30fc94d3d256d0ff9ecfe3545b9b28f3",
    "content": "Meropenem, IV,\nAdults\n0. 5-1 g 8 hourly\nChildren\n12-18 years;\t0. 5-1 g 8 hourly.",
    "title": "2nd Line Treatment",
    "section": "2nd Line Treatment",
    "chunk_id": "2395",
    "type": "section",
    "keywords": [
      "hourly",
      "years",
      "adults",
      "meropenem",
      "children"
    ]
  },
  {
    "id": "72c778007e5d65bd25a82be8272e3a0f",
    "content": "1 month-12 years (> 50 kg); 0. 5-1 g 8 hourly\n1 month-12 years (< 50 kg); 10-20 mg/kg 8 hourly\nNeonate\n7 days;\t20 mg/kg 8 hourly\n< 7 days;\t20 mg/kg 12 hourly\nOr\nAmikacin, slow IV over 3-5 minutes, (monitor serum Amikacin levels)\nAdults\n7. 5 mg/kg 12 hourly (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2396",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "years",
      "monitor",
      "minutes",
      "serum",
      "neonate",
      "levels",
      "adults",
      "slow",
      "month",
      "amikacin"
    ]
  },
  {
    "id": "b0d1a485782875765f0853ecbc9a601e",
    "content": "1. 5 g daily and 15 g per course)\nChildren\n12-18 years;\t7. 5 mg/kg every 12 hours (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2397",
    "type": "section",
    "keywords": [
      "years",
      "course",
      "hours",
      "children",
      "daily",
      "every"
    ]
  },
  {
    "id": "354c0dc6674c18999d9c2d94cc2fcd85",
    "content": "500 mg 8 hourly, and 15 g per course)\nReferral Criteria\nRefer all cases of burns with the following characteristics to a specialist. Partial-thickness burns more than 10% of TBSA Deep burns of any percentage. Burns involving face, hands, feet, genitalia, perineum, or major joints Chemical burns\nElectrical burns\nAny burn with concomitant trauma in which burn poses greatest risk to patient\nInhalation injury Infected burns\nBurns with pre-existing diabetes, renal failure etc.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2398",
    "type": "section",
    "keywords": [
      "thickness",
      "characteristics",
      "face",
      "which",
      "infected",
      "patient",
      "hourly",
      "specialist",
      "partial",
      "following",
      "burns",
      "chemical",
      "renal",
      "criteria",
      "injury",
      "existing",
      "referral",
      "deep",
      "joints",
      "burn"
    ]
  },
  {
    "id": "f1460409723a57a1809d9d8601f2a893",
    "content": "A wound is a break in the continuity of tissues in the body. It may involve overlying epithelium like skin. Wounds are usually caused by injury.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2399",
    "type": "section",
    "keywords": [
      "continuity",
      "body",
      "usually",
      "caused",
      "epithelium",
      "break",
      "wound",
      "overlying",
      "skin",
      "wounds",
      "tissues",
      "injury",
      "involve"
    ]
  },
  {
    "id": "92ebde9ffdc1fe051e24186f6d3955d7",
    "content": "Tissues affected include subcutaneous tissue, muscles and even bones. It may be small or large and may be deep or superficial. It may bleed, may be contaminated with dirt and other foreign matter and become infected.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2400",
    "type": "section",
    "keywords": [
      "muscles",
      "superficial",
      "bleed",
      "infected",
      "large",
      "foreign",
      "even",
      "subcutaneous",
      "include",
      "deep",
      "dirt",
      "matter",
      "tissues",
      "bones",
      "contaminated",
      "small",
      "other",
      "become",
      "tissue",
      "affected"
    ]
  },
  {
    "id": "1f1b6dbdb35d47efcd3cefdaad767644",
    "content": "Causes\nMechanical agents e. g. cut from cutlass or knife, gunshot, accidents, contusion from blunt injury.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2401",
    "type": "section",
    "keywords": [
      "agents",
      "cutlass",
      "mechanical",
      "blunt",
      "gunshot",
      "injury",
      "knife",
      "accidents",
      "contusion",
      "causes"
    ]
  },
  {
    "id": "5b1171c16c8239ec7a208599abf891f0",
    "content": "Wounds may follow snake or insect bites, animal or human bites\nChemical agents e. g. strong acids or alkalis, other corrosive chemicals\nThermal injury resulting in burns\nSymptoms\nLocal pain\nBleeding\nDischarge of pus if infected.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2402",
    "type": "section",
    "keywords": [
      "agents",
      "acids",
      "local",
      "infected",
      "alkalis",
      "follow",
      "corrosive",
      "bleeding",
      "chemical",
      "burns",
      "strong",
      "thermal",
      "chemicals",
      "wounds",
      "symptoms",
      "human",
      "pain",
      "other",
      "snake",
      "resulting"
    ]
  },
  {
    "id": "978ca2274e85b80e98aa4937287d7d9f",
    "content": "Signs\nLocal swelling and tenderness\nLook for other injuries e. g. , head, chest, abdomen, bone, nerves\nDetermine the physical characteristics of the wound e.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2403",
    "type": "section",
    "keywords": [
      "determine",
      "tenderness",
      "injuries",
      "chest",
      "head",
      "local",
      "physical",
      "characteristics",
      "other",
      "look",
      "swelling",
      "wound",
      "signs",
      "abdomen",
      "nerves",
      "bone"
    ]
  },
  {
    "id": "6bb058d8aad182ea8284b4b37a5865a8",
    "content": "g. site, size,\nshape and depth\ninvestigations\nHaemoglobin level if patient has bled\nGroup and cross-match blood if indicated\nX-ray of injured part may be required to rule out osteomyelitis and\nbone fractures\nWound swab for culture and sensitivity if wound is infected.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2404",
    "type": "section",
    "keywords": [
      "depth",
      "wound",
      "infected",
      "required",
      "sensitivity",
      "patient",
      "swab",
      "part",
      "site",
      "culture",
      "bled",
      "injured",
      "blood",
      "fractures",
      "level",
      "size",
      "investigations",
      "bone",
      "cross",
      "osteomyelitis"
    ]
  },
  {
    "id": "462adaba8d0574e4d3743590abc46130",
    "content": "To control bleeding\nTo relieve pain\nTo prevent or treat infection\nTo protect against tetanus\nTo promote wound healing.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2405",
    "type": "section",
    "keywords": [
      "against",
      "pain",
      "treat",
      "healing",
      "prevent",
      "tetanus",
      "bleeding",
      "infection",
      "relieve",
      "promote",
      "wound",
      "control",
      "protect"
    ]
  },
  {
    "id": "d9c9075b65c2696421b91493e224ab28",
    "content": "Apply sterile pressure dressing to bleeding site and raise the injured part to control bleeding. If a bleeding vessel can be identified, it should be ligated. (the use of\ntourniquet to stop bleeding is discouraged)\nBleeding from a tooth socket - put a small piece of sterile gauze in the socket and ask the patient to bite on it.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2406",
    "type": "section",
    "keywords": [
      "tourniquet",
      "discouraged",
      "sterile",
      "gauze",
      "patient",
      "vessel",
      "pressure",
      "part",
      "bite",
      "ligated",
      "bleeding",
      "identified",
      "site",
      "injured",
      "socket",
      "should",
      "stop",
      "piece",
      "tooth",
      "raise"
    ]
  },
  {
    "id": "ce279901d0689f13c678a2e34e0e95b3",
    "content": "Tetanus prophylaxis for all potentially contaminated wounds, fol- lowed by booster doses of tetanus toxoid as appropriate (See section on ‘Immunisation’)\nAnd\nParacetamol, oral,\nAdults\n500 mg-1 g 6-8 hourly\nChildren\n6-12 years;\t250-500mg 6-8 hourly\n1-5 years;\t120-250 mg 6-8 hourly\n3 month-1 year;\t60-120 mg 6-8 hourly\nAnd\nIV fluids and blood transfusion as required. And\nAmoxicillin (Amoxycillin), oral,\nAdults\n500 mg 8 hourly\nChildren\n6 -12 years;\t250 mg 8 hourly\n1-5 years;\t125 mg 8 hourly\n1 year;\t62. 5 mg 8 hourly\nReferral Criteria\nComplicated wounds (e.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2407",
    "type": "section",
    "keywords": [
      "years",
      "tetanus",
      "booster",
      "lowed",
      "potentially",
      "required",
      "amoxycillin",
      "hourly",
      "section",
      "doses",
      "fluids",
      "children",
      "criteria",
      "blood",
      "amoxicillin",
      "referral",
      "complicated",
      "adults",
      "paracetamol",
      "immunisation"
    ]
  },
  {
    "id": "576c204b1d667c0b529129e63ba912b8",
    "content": "g. wounds associated with fractures, division of tendons, blood vessels and nerves). SNAKE BiTE\nMost snake bites are non-poisonous.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2408",
    "type": "section",
    "keywords": [
      "vessels",
      "poisonous",
      "tendons",
      "fractures",
      "nerves",
      "bite",
      "snake",
      "associated",
      "bites",
      "most",
      "division",
      "wounds",
      "blood"
    ]
  },
  {
    "id": "f31ce2f738605743b0ed7f1d2334b2a6",
    "content": "Vipers are the commonest cause of poisonous snake bites in tropical Africa. Others are the cobras and water snakes. All cases of snake bites (venomous/non-venomous) should be observed for at least 6 hours.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2409",
    "type": "section",
    "keywords": [
      "venomous",
      "poisonous",
      "vipers",
      "africa",
      "others",
      "commonest",
      "least",
      "should",
      "tropical",
      "cause",
      "snake",
      "cases",
      "cobras",
      "water",
      "bites",
      "snakes",
      "hours",
      "observed"
    ]
  },
  {
    "id": "775733da1bffd52b39ba7df5a6457417",
    "content": "Identify the type of snake if possible. Don’t rely too much on fang marks; however multiple fang marks usually indicate a non-poisonous bite whereas one or two fang marks suggest a poisonous bite. It is important to determine whether envenomation has occurred.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2410",
    "type": "section",
    "keywords": [
      "usually",
      "determine",
      "fang",
      "important",
      "identify",
      "poisonous",
      "occurred",
      "type",
      "multiple",
      "rely",
      "whether",
      "marks",
      "suggest",
      "envenomation",
      "indicate",
      "whereas",
      "however",
      "snake",
      "possible",
      "bite"
    ]
  },
  {
    "id": "98f117786b8005f0c4fbf11b3c183ab0",
    "content": "The role of tourniquets and incision over the site of the bite are controversial issues and are to be avoided. Causes\nSnakes\nSymptoms\nPain\nBleeding\nSwelling.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2411",
    "type": "section",
    "keywords": [
      "issues",
      "pain",
      "snakes",
      "symptoms",
      "bleeding",
      "incision",
      "site",
      "swelling",
      "role",
      "avoided",
      "bite",
      "tourniquets",
      "causes",
      "controversial"
    ]
  },
  {
    "id": "951dbac71364e70dfd12cf0aa3bc55e8",
    "content": "Fainting\nDark-coloured urine\nHeadache\nMuscle ache\nFear\nLoss of consciousness\nSigns\n(Poisonous snake bites) Cardiovascular:\nHypotension, shock, cardiac arrhythmias\nSpontaneous systemic bleeding, from bite site, mucosa and old wounds, haematuria\nDark urine from myoglobinuria and intravascular haemolysis\nNeuromuscular:\nCranial nerve paralysis - ptosis, opthalmoplegia, slurred speech\nBulbar respiratory paralysis - drooling, and inability to breath\nproperly\nImpaired consciousness, seizures\nMeningism\nTender and stiff muscles\nLocal effects:\nRapid progression of swelling to more than half of bitten limb\nBlistering, necrosis and bruising\nFascial compartmentalisation on bitten digits\ninvestigations\nFull blood count\nRenal function test\n20 minutes whole blood clotting test (leave 2-5 ml of blood in dried test tube. Failure to clot after 20 minutes implies incoagulable blood)\nLiver function test.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2412",
    "type": "section",
    "keywords": [
      "swelling",
      "systemic",
      "full",
      "speech",
      "opthalmoplegia",
      "dried",
      "count",
      "compartmentalisation",
      "site",
      "nerve",
      "signs",
      "coloured",
      "haematuria",
      "digits",
      "respiratory",
      "failure",
      "spontaneous",
      "effects",
      "dark",
      "bites"
    ]
  },
  {
    "id": "e06772c6b795e11b47cc4ec2cf3a94eb",
    "content": "To relieve pain and anxiety\nTo support the respiration or circulation if indicated\nTo counteract the spread and effect of the snake venom\nTo prevent secondary infection.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2413",
    "type": "section",
    "keywords": [
      "respiration",
      "circulation",
      "pain",
      "support",
      "prevent",
      "venom",
      "infection",
      "effect",
      "snake",
      "relieve",
      "counteract",
      "indicated",
      "anxiety",
      "secondary",
      "spread"
    ]
  },
  {
    "id": "3e0d7a7d8e71c9deaf371c8521e5f855",
    "content": "First Aid\nImmobilization/splinting of the affected limb. Do not move the limb that has been bitten - the more it is moved, the faster the poison spreads. Carry the person on a stretcher and tie the limb to a straight piece of wood.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2414",
    "type": "section",
    "keywords": [
      "limb",
      "first",
      "splinting",
      "move",
      "straight",
      "person",
      "bitten",
      "poison",
      "carry",
      "stretcher",
      "faster",
      "piece",
      "more",
      "wood",
      "spreads",
      "moved",
      "immobilization",
      "affected"
    ]
  },
  {
    "id": "9e8cdcff32fb7f787854c3867993948c",
    "content": "If ice is available, wrap pieces in cloth and place it.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2415",
    "type": "section",
    "keywords": [
      "pieces",
      "place",
      "cloth",
      "available",
      "wrap"
    ]
  },
  {
    "id": "4862f873706b0d8c05d0f48593893339",
    "content": "around the bite. Clean the wound and reassure the patient. At the hospital\nBed rest, reassure, keep warm\nAssess patient’s airway, breathing and circulation (ABC of resuscitation)\nFor probable venomous bites:\nClean site of bite with antiseptic lotion or soap and water\nDo not attempt to suck or make any incisions at the site of the bite\nLeave wound open; punctured wounds are especially likely to be infected.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2416",
    "type": "section",
    "keywords": [
      "circulation",
      "lotion",
      "probable",
      "especially",
      "wound",
      "breathing",
      "infected",
      "likely",
      "reassure",
      "patient",
      "venomous",
      "open",
      "incisions",
      "punctured",
      "site",
      "assess",
      "warm",
      "water",
      "suck",
      "soap"
    ]
  },
  {
    "id": "f1ca10a97e1dccc0fed5351ae52a1175",
    "content": "If the snake is identified as non-poisonous or there is absence of\nswelling or systemic signs after 6 hours reassure the patient\nSurgical debridement when required.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2417",
    "type": "section",
    "keywords": [
      "poisonous",
      "surgical",
      "identified",
      "snake",
      "swelling",
      "absence",
      "systemic",
      "there",
      "signs",
      "after",
      "required",
      "debridement",
      "reassure",
      "hours",
      "patient"
    ]
  },
  {
    "id": "80637d7eee8a65aa988f97edf6ece7c4",
    "content": "Presence of symptoms and signs of local and systemic effects of envenomation. Anti-snake serum (ASS) - polyvalent\nHave resuscitation tray ready (adrenalin 1: 1000)\nTest dose - 0. 2 ml, subcutaneous, to test for anaphylaxis\nASS 50-100 ml (5-10 ampoules) depending on severity by IV drip in 0.",
    "title": "indication for anti-venom treatment",
    "section": "indication for anti-venom treatment",
    "chunk_id": "2418",
    "type": "section",
    "keywords": [
      "test",
      "adrenalin",
      "local",
      "ready",
      "systemic",
      "drip",
      "signs",
      "presence",
      "subcutaneous",
      "tray",
      "anaphylaxis",
      "resuscitation",
      "anti",
      "dose",
      "symptoms",
      "depending",
      "ampoules",
      "effects",
      "severity",
      "envenomation"
    ]
  },
  {
    "id": "7291b4fad5f135de8ffc72fc959da78b",
    "content": "9% N/S or 5% Dextrose over 2-4 hours. Monitor signs and repeat as required\nMonitor patient and correct:\nHypovolaemic shock - crystalloids/colloids/blood\nDefects of haemostasis - clotting factors/fresh frozen Plasma/plate-\nlets\nRespiratory distress - oxygen /intubate/ventilate\nAnti-tetanus therapy,\nTetanol, IM, 0. 5 ml stat.",
    "title": "indication for anti-venom treatment",
    "section": "indication for anti-venom treatment",
    "chunk_id": "2419",
    "type": "section",
    "keywords": [
      "plate",
      "correct",
      "plasma",
      "tetanus",
      "dextrose",
      "factors",
      "required",
      "patient",
      "therapy",
      "tetanol",
      "oxygen",
      "colloids",
      "frozen",
      "repeat",
      "fresh",
      "signs",
      "blood",
      "stat",
      "hypovolaemic",
      "haemostasis"
    ]
  },
  {
    "id": "69c9c1f5f966608f8da89153f8c207cb",
    "content": "And\nDiazepam, oral, 5-10 mg stat. For Pain relief\nParacetamol, oral,\nAdults\n500 mg-1 g 6-8 hourly\nChildren.",
    "title": "indication for anti-venom treatment",
    "section": "indication for anti-venom treatment",
    "chunk_id": "2420",
    "type": "section",
    "keywords": [
      "diazepam",
      "hourly",
      "pain",
      "adults",
      "relief",
      "oral",
      "paracetamol",
      "children",
      "stat"
    ]
  },
  {
    "id": "a22d80b972286a180aa0ccc85b8cb72b",
    "content": "6-12 years;\t250-500 mg 6-8hourly\n1-5 years;\t120-250 mg 6-8hourly\n3 months-1 year;\t60-120 mg 6-8hourly\nOr\nMorphine, IV, IM, SC,\nAdults\n10 mg stat. Children\n2 years;\t200 micrograms/kg\n< 2 years;\t100-200 micrograms/kg\nPrevention of secondary infection\nAmoxicillin (Amoxycillin), oral,\nAdults\n500mg 8 hourly for 5 days\nChildren\n6-12 years;\t250 mg 8 hourly for 5 days\n1-5 years;\t125 mg 8 hourly for 5 days\n1 year;\t62. 5 mg 8 hourly for 5 days N\nReferral Criteria\nRefer all patients with respiratory failure, heart failure, renal failure, muscle paralysis, muscle necrosis, bleeding or intravascular haemolysis to a regional hospital for specialist care.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2421",
    "type": "section",
    "keywords": [
      "years",
      "intravascular",
      "secondary",
      "amoxycillin",
      "paralysis",
      "hourly",
      "specialist",
      "bleeding",
      "muscle",
      "heart",
      "patients",
      "children",
      "renal",
      "criteria",
      "regional",
      "stat",
      "days",
      "amoxicillin",
      "referral",
      "prevention"
    ]
  },
  {
    "id": "061bb21d3da1ccc61cb670699116578c",
    "content": "SNAKE SPiT iN THE EYES\nThe black-necked cobra or the spitting cobra sprays its venom into the eyes of its victim. It causes irritation of the eyes and may cause conjunctivitis and even blindness if not washed away immediately.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2422",
    "type": "section",
    "keywords": [
      "spit",
      "necked",
      "into",
      "immediately",
      "blindness",
      "even",
      "causes",
      "cobra",
      "conjunctivitis",
      "away",
      "venom",
      "cause",
      "sprays",
      "eyes",
      "black",
      "irritation",
      "snake",
      "victim",
      "washed",
      "spitting"
    ]
  },
  {
    "id": "19581ff720dc8cec0cc038d53a71cb77",
    "content": "Irrigate the eye with any liquid available (water, milk, saline etc). Instil diluted anti-venom (one part to five parts of Sodium Chloride 0. 9%).",
    "title": "Treatment",
    "section": "Treatment",
    "chunk_id": "2423",
    "type": "section",
    "keywords": [
      "irrigate",
      "diluted",
      "part",
      "venom",
      "liquid",
      "five",
      "saline",
      "parts",
      "sodium",
      "water",
      "anti",
      "available",
      "chloride",
      "milk",
      "instil"
    ]
  },
  {
    "id": "89387052203d75c6883ca5dae7bd16ab",
    "content": "Treat as corneal abrasion with topical antibiotics (See section on ‘Eye\nInjuries’)\nSCORPiON STiNG\nScorpion stings leave a single mark, and the stings are extremely painful. Symptoms\nPain at the site of bite.",
    "title": "Treatment",
    "section": "Treatment",
    "chunk_id": "2424",
    "type": "section",
    "keywords": [
      "injuries",
      "treat",
      "antibiotics",
      "stings",
      "extremely",
      "scorpion",
      "single",
      "section",
      "site",
      "sting",
      "topical",
      "abrasion",
      "mark",
      "painful",
      "leave",
      "symptoms",
      "pain",
      "corneal",
      "bite"
    ]
  },
  {
    "id": "24eacbd3a54015e0a8dde4f91e84147b",
    "content": "Localized swelling\nVomiting\nAbdominal pain\nSigns\nExcessive salivation\nSweating\nRapid respiration\nSingle-puncture wound.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2425",
    "type": "section",
    "keywords": [
      "respiration",
      "vomiting",
      "abdominal",
      "pain",
      "salivation",
      "rapid",
      "localized",
      "single",
      "swelling",
      "sweating",
      "puncture",
      "signs",
      "wound",
      "excessive"
    ]
  },
  {
    "id": "85046c900ce248cdd8f5a2c10c95102a",
    "content": "To relieve pain\nTo maintain hydration\nTo reassure patient.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2426",
    "type": "section",
    "keywords": [
      "pain",
      "maintain",
      "relieve",
      "reassure",
      "patient",
      "hydration"
    ]
  },
  {
    "id": "35ed80467b85281edfa9b807c36328d5",
    "content": "Detain for observation. Put ice compresses on the area. Give the patient plenty of fluids to drink.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2427",
    "type": "section",
    "keywords": [
      "observation",
      "compresses",
      "drink",
      "detain",
      "give",
      "fluids",
      "area",
      "patient",
      "plenty"
    ]
  },
  {
    "id": "ab24f8638bd434196d038f362606a039",
    "content": "Paracetamol, Aspirin, Ibuprofen or Diclofenac, oral,\nAnd\n1% Lidocaine (Lignocaine), 2-5 ml for local infiltration to relieve pain\nBEE AND WASP STiNGS\nMajority of bee and wasp stings only produce localized pain. They may occasionally cause allergic reactions, which may lead to anaphylaxis with local pain, generalized urticaria, hypotension, and difficulty in breathing as a result of bronchospasm and oedema of the glottis. Death may occur.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [C]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "2428",
    "type": "section",
    "keywords": [
      "urticaria",
      "oedema",
      "local",
      "occur",
      "stings",
      "which",
      "lead",
      "breathing",
      "death",
      "majority",
      "ibuprofen",
      "diclofenac",
      "lignocaine",
      "result",
      "bronchospasm",
      "infiltration",
      "allergic",
      "reactions",
      "lidocaine",
      "generalized"
    ]
  },
  {
    "id": "02488b7064e4b4d09b17d6f63693eca9",
    "content": "Symptoms\nLocalized pain at the site of sting\nSigns\nSwelling at site\nUrticuria\nHypotension\nDifficulty in breathing\nBronchospasm.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [C]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "2429",
    "type": "section",
    "keywords": [
      "pain",
      "urticuria",
      "localized",
      "difficulty",
      "site",
      "swelling",
      "breathing",
      "signs",
      "bronchospasm",
      "sting",
      "symptoms",
      "hypotension"
    ]
  },
  {
    "id": "62a81372b43d0b0ef215f8632e8a5d66",
    "content": "Detain for observation\nPut ice compresses on the area\nGive the patient plenty of fluids to drink\nIn the case of bee sting remove stinger from skin by scraping. Do not\npull it out.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2430",
    "type": "section",
    "keywords": [
      "scraping",
      "observation",
      "compresses",
      "drink",
      "case",
      "detain",
      "give",
      "stinger",
      "skin",
      "fluids",
      "pull",
      "remove",
      "area",
      "sting",
      "patient",
      "plenty"
    ]
  },
  {
    "id": "ef79a07cbb4221f90918f117a300cbe2",
    "content": "Adrenaline, SC, (1:1000) 0. 5-1 ml stat. Promethazine, IM,\nAdults\n50 mg stat.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [C]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "2431",
    "type": "section",
    "keywords": [
      "promethazine",
      "stat",
      "adults",
      "adrenaline"
    ]
  },
  {
    "id": "fdfb0a9c825fef608fa1ebe99a3b038a",
    "content": "Children\n12. 5-25 mg stat. Hydrocortisone, IV, 100-200 mg repeated 6 hours later if necessary\nFor shock\nIV fluids\nFor pain\nParacetamol, oral,\nAdults\n500 mg-1 g 6 - 8 hourly\nChildren\n6-12 years;\t250-500 mg 6-8hourly\n1-5 years;\t120-250 mg 6-8hourly\n3 months-1 year;\t60-120 mg 6-8hourly\nReferral Criteria.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [C]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "2432",
    "type": "section",
    "keywords": [
      "years",
      "repeated",
      "hourly",
      "fluids",
      "children",
      "criteria",
      "stat",
      "later",
      "referral",
      "shock",
      "adults",
      "paracetamol",
      "months",
      "year",
      "pain",
      "necessary",
      "hydrocortisone",
      "oral",
      "hours"
    ]
  },
  {
    "id": "71428ab2799792b47c5683c5dc648964",
    "content": "HUMAN BiTES\nHuman bites (which usually occur during fights) lead to infections, which if neglected, almost invariably produce a highly destructive, necrotizing lesion contaminated by a mixture of aerobic and anaerobic organisms. A deliberately inflicted bite on the hand or elsewhere should be considered as contaminated. Symptoms\nPain\nSwelling\nBleeding\nFever, if bites get infected\nSigns\nTeeth impression on bitten site.",
    "title": "Refer all patients with anaphylaxis who are not responding to treatment",
    "section": "Refer all patients with anaphylaxis who are not responding to treatment",
    "chunk_id": "2433",
    "type": "section",
    "keywords": [
      "infections",
      "usually",
      "destructive",
      "impression",
      "occur",
      "deliberately",
      "during",
      "which",
      "lead",
      "necrotizing",
      "aerobic",
      "swelling",
      "infected",
      "lesion",
      "bleeding",
      "site",
      "signs",
      "highly",
      "almost",
      "hand"
    ]
  },
  {
    "id": "d5d95bfc7678e34e2224eeef67f3ff0c",
    "content": "Tetanus prophylaxis (See section on ‘Tetanus prophylaxis’)\nFlucloxacillin, oral,\nAdults\n500 mg 6 hourly for 7 days\nChildren\n5-12 years;\t250 mg 6 hourly for 7 days\n1-5 years;\t125 mg 6 hourly for 7 days\n1 year;\t62. 5 mg 6 hourly for 7 days\nAnd\nAmoxicillin (Amoxycillin), oral,\nAdults\n500 mg 8 hourly for 7 days\nChildren\n6-12 years;\t250 mg 8 hourly for 7 days\n1-5 years;\t125 mg 8 hourly for 7 days\n< 1 year;\t62. 5 mg 8 hourly for 7 days\nAnd\nParacetamol, oral,\nAdults\n500mg-1g 6-8 hourly\nChildren\n6-12 years;\t250-500 mg 6-8 hourly\n1-5 years;\t120-250 mg 6-8 hourly\n3 months-1 year;\t60-120 mg 6-8 hourly\nReferral Criteria\nRefer if there is necrotising fasciitis.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [C]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "2434",
    "type": "section",
    "keywords": [
      "years",
      "tetanus",
      "amoxycillin",
      "hourly",
      "flucloxacillin",
      "section",
      "necrotising",
      "children",
      "criteria",
      "days",
      "amoxicillin",
      "referral",
      "adults",
      "paracetamol",
      "there",
      "months",
      "year",
      "refer",
      "prophylaxis",
      "oral"
    ]
  },
  {
    "id": "1195e41a4eab7dcbf3c80f4b4b5d3172",
    "content": "DOG AND OTHER ANiMAL BiTES\nMammals, including dogs, may carry the rabies virus. Saliva from an infected animal contains large numbers of the rabies virus which is inoculated through a bite, laceration, or a break in the skin. There is also.",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [C]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "2435",
    "type": "section",
    "keywords": [
      "virus",
      "which",
      "infected",
      "contains",
      "including",
      "large",
      "saliva",
      "also",
      "skin",
      "mammals",
      "there",
      "rabies",
      "laceration",
      "dogs",
      "break",
      "other",
      "inoculated",
      "carry",
      "numbers",
      "bites"
    ]
  },
  {
    "id": "0f4d02616d008fa85729ec0369f0f50a",
    "content": "risk of tetanus and other bacterial infection following the bites of any mammal. Symptoms\nPain\nSwelling\nBleeding\nFever, if bites get infected\nSigns\nTeeth impression on bitten site\nWound.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2436",
    "type": "section",
    "keywords": [
      "impression",
      "tetanus",
      "swelling",
      "wound",
      "infected",
      "following",
      "bleeding",
      "site",
      "signs",
      "bacterial",
      "fever",
      "symptoms",
      "teeth",
      "pain",
      "bitten",
      "infection",
      "other",
      "risk",
      "bites",
      "mammal"
    ]
  },
  {
    "id": "79f9c7733c1d56a31f8dc4781a6f799d",
    "content": "To treat laceration\nTo prevent rabies infection\nTo prevent other infections\nTo treat any secondary infection.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2437",
    "type": "section",
    "keywords": [
      "infections",
      "treat",
      "prevent",
      "infection",
      "other",
      "rabies",
      "laceration",
      "secondary"
    ]
  },
  {
    "id": "f8894f1f34f4959a99ab6a523ab1bb44",
    "content": "Wash site with soap and water\nAll injuries-abraded skin: minor bites and scratches, major bites and scratches are treated in the same way by thorough irrigation with copious amounts of saline solution or cleansing with cetrimide plus chlorhexidine solution.",
    "title": "Immediate local care",
    "section": "Immediate local care",
    "chunk_id": "2438",
    "type": "section",
    "keywords": [
      "amounts",
      "injuries",
      "minor",
      "irrigation",
      "abraded",
      "copious",
      "treated",
      "saline",
      "site",
      "water",
      "soap",
      "wash",
      "cleansing",
      "cetrimide",
      "scratches",
      "thorough",
      "major",
      "skin",
      "same",
      "chlorhexidine"
    ]
  },
  {
    "id": "2fe6a75e9f3c8dfeffec333a1df38c64",
    "content": "Flucloxacillin, oral,\nAdults\n500 mg 6 hourly for 7 days\nChildren\n5-12 years;\t250 mg 6 hourly for 7 days\n1-5 years;\t125 mg 6 hourly for 7 days\n1 year;\t62. 5 mg 6 hourly for 7 days\nAnd\nAmoxicillin (Amoxycillin), oral,\nAdults\n500 mg 8 hourly for 7 days\nChildren\n6-12 years;\t250 mg 8 hourly for 7 days\n1-5 years;\t125 mg 8 hourly for 7 days\n< 1 year;\t62. 5 mg 8 hourly for 7 days\nUpdate or provide (if not previously immunised) tetanus Immunisation (See section on ‘Tetanus Immunisation’).",
    "title": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "section": "Pharmacological treatment 1st Line Treatment Evidence Rating: [A]",
    "chunk_id": "2439",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "amoxicillin",
      "previously",
      "years",
      "tetanus",
      "flucloxacillin",
      "immunised",
      "section",
      "adults",
      "oral",
      "update",
      "provide",
      "immunisation",
      "children",
      "amoxycillin",
      "year"
    ]
  },
  {
    "id": "05aa913badefc485dddc7868d02626de",
    "content": "indication for use of Rabies immunoglobulin and Rabies vaccine\nIt should be remembered that not every animal carries rabies, although the possibility should be borne in mind for every animal bite. The treatment provided is dependent on both the certainty of the presence of the rabies virus in the animal and the Immunisation state of the patient. Rabies immunisation post exposure\nPatients vaccinated within last three years\nDay 0\nInfiltrate wound and around wound with\nRabies immunoglobulin (10 IU/kg body weight);\nAnd\nRabies Immunoglobulin (10 IU/kg body weight) by IM injection; 1 ml Rabies vaccine by IM injection*\nDay 3 (or any day up to day 7)\n1 ml Rabies vaccine by IM injection*\nPatients with no vaccination or more than 3 years since vaccination\nDay 0\nInfiltrate wound and around wound with\nRabies immunoglobulin (10 IU/kg body weight);.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2440",
    "type": "section",
    "keywords": [
      "virus",
      "remembered",
      "years",
      "weight",
      "borne",
      "both",
      "last",
      "wound",
      "mind",
      "patient",
      "possibility",
      "within",
      "body",
      "indication",
      "presence",
      "patients",
      "injection",
      "treatment",
      "vaccine",
      "post"
    ]
  },
  {
    "id": "e05ab5804f85592e2feb2ae5d6afe8c8",
    "content": "And\nRabies Immunoglobulin (10 IU/kg body weight) by IM injection; 1 ml Rabies vaccine by IM injection* Days 3, 7, 14, 30\nRABiES iMMUNiSATiON\nProphylactic immunisation should be offered to those at high risk (eg. laboratory staff working with rabies virus, animal handlers, veterinary surgeons, and wildlife officers likely to be exposed to bites of possibly infected wild animals). Rabies vaccine, IM, 1 ml on each of days 0, 7 and 28 Booster doses should be given every 2-3 years\nReferral Criteria\nRefer to a tertiary centre when symptoms of rabies set in.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2441",
    "type": "section",
    "keywords": [
      "veterinary",
      "virus",
      "years",
      "weight",
      "given",
      "booster",
      "working",
      "animals",
      "infected",
      "likely",
      "staff",
      "body",
      "handlers",
      "doses",
      "injection",
      "exposed",
      "criteria",
      "tertiary",
      "vaccine",
      "days"
    ]
  },
  {
    "id": "79ddbfff30c8062a324af4d362a8f13e",
    "content": "Shock is a clinical state of cellular dysfunction as a result of decreased circulating blood volume leading to reduction in delivery of oxygen and other nutrients to vital organs which if prolonged leads to irreversible multiple organ failure. Causes\nHypovolemia e. g.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2442",
    "type": "section",
    "keywords": [
      "decreased",
      "prolonged",
      "irreversible",
      "organ",
      "dysfunction",
      "nutrients",
      "which",
      "vital",
      "delivery",
      "oxygen",
      "multiple",
      "result",
      "volume",
      "blood",
      "causes",
      "leads",
      "leading",
      "reduction",
      "circulating",
      "shock"
    ]
  },
  {
    "id": "bd1b445a0c5133d8edd932b5162fe095",
    "content": "haemorrhage, vomiting, diarrhoea, acute intestinal obstruction\nCardiogenic e. g. myocardial infarction, Massive pulmonary embolus\nObstructive e.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2443",
    "type": "section",
    "keywords": [
      "diarrhoea",
      "vomiting",
      "myocardial",
      "obstructive",
      "pulmonary",
      "massive",
      "intestinal",
      "obstruction",
      "cardiogenic",
      "embolus",
      "acute",
      "infarction",
      "haemorrhage"
    ]
  },
  {
    "id": "a716e0f3a1a13d08da6850b71a9477af",
    "content": "g. Pericardial tamponade, tension pneumothorax\nSevere sepsis\nSymptoms\nThirst\nFeeling faint\nPalpitations\nSweating\nRestlessness.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2444",
    "type": "section",
    "keywords": [
      "severe",
      "restlessness",
      "faint",
      "tension",
      "pericardial",
      "pneumothorax",
      "sweating",
      "palpitations",
      "tamponade",
      "sepsis",
      "thirst",
      "feeling",
      "symptoms"
    ]
  },
  {
    "id": "abf050293f60116989b14d0e106945f0",
    "content": "Clouding of consciousness, confusion\nSigns\nAltered sensorium\nPallor\nCold extremities\nCollapsed peripheral veins\nTachycardia, pulse > 90 bpm\nHypotension, Systolic BP < 90 mmHg\ninvestigations\nSeptic screen if sepsis is suspected\nCXR, ECG and Echocardiogram if cardiogenic shock suspected\nSupportive tests like FBC, BUE, Creatinine and LFT is done to detect any derangement and correct them.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2445",
    "type": "section",
    "keywords": [
      "extremities",
      "veins",
      "correct",
      "tachycardia",
      "creatinine",
      "systolic",
      "altered",
      "signs",
      "screen",
      "pallor",
      "suspected",
      "done",
      "shock",
      "mmhg",
      "tests",
      "derangement",
      "consciousness",
      "septic",
      "investigations",
      "cardiogenic"
    ]
  },
  {
    "id": "72d196fbdfd21edc1a5f162496657c80",
    "content": "To reverse shock\nTo secure airway, breathing and circulation\nTo prevent complications and multiple organ failure\nTo prevent death.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2446",
    "type": "section",
    "keywords": [
      "circulation",
      "complications",
      "multiple",
      "prevent",
      "organ",
      "shock",
      "breathing",
      "reverse",
      "secure",
      "failure",
      "death",
      "airway"
    ]
  },
  {
    "id": "a0987df19ee43f080dfbfc0906aecf6a",
    "content": "Evidence Rating: [C]\nA. Hypovolaemic shock\nInsert the largest bore cannula (size 14 or 16) in the largest vein visible. Two cannulae may be inserted at separate sites for rapid IV infusion\nRaise drip stand or squeeze bag to increase infusion rate\nGive colloids\nIn haemorrhagic states cross-matched blood is preferred but in the meantime resuscitate with crystalloids e.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2447",
    "type": "section",
    "keywords": [
      "matched",
      "give",
      "vein",
      "infusion",
      "drip",
      "haemorrhagic",
      "evidence",
      "increase",
      "insert",
      "rating",
      "rate",
      "colloids",
      "bore",
      "cannulae",
      "visible",
      "resuscitate",
      "sites",
      "meantime",
      "largest",
      "blood"
    ]
  },
  {
    "id": "ebbd744b8d53fbd0884e9205fc7fcc3d",
    "content": "g. normal saline. Ringers lactate, IV,\nAdults\n70 ml/kg body weight\nChildren\n(See section on ‘Management of severe dehydration’)\nNormal saline should be given quickly and slowed only when BP rises and urine flow is adequate.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2448",
    "type": "section",
    "keywords": [
      "weight",
      "given",
      "management",
      "urine",
      "body",
      "section",
      "saline",
      "quickly",
      "slowed",
      "children",
      "severe",
      "dehydration",
      "rises",
      "should",
      "adults",
      "ringers",
      "only",
      "lactate",
      "flow",
      "normal"
    ]
  },
  {
    "id": "b8e983a3036988660a29890dd544813e",
    "content": "Adults and older children\n0. 5-1 ml/kg per hour of urine Smaller children\n1 ml/kg per hour of urine\nCatheterise the bladder to monitor the urine output. Oxygen, nasally or by facial masks, 6 L/minute.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2449",
    "type": "section",
    "keywords": [
      "facial",
      "hour",
      "catheterise",
      "oxygen",
      "nasally",
      "minute",
      "monitor",
      "smaller",
      "output",
      "adults",
      "children",
      "urine",
      "masks",
      "older",
      "bladder"
    ]
  },
  {
    "id": "7d2bef22e0549be9b4c9bb9e9061f4cc",
    "content": "Continue to monitor BP, pulse and urine output\nMULTiPLE ORGAN DYSFUNCTiON SYNDROME\nThis is a life-threatening complication of shock. Different organs may be affected moderately or severely in the process as follows:\nCNS - Encephalopathy\nHeart - Tachyarrhythmias\nPulmonary - Acute Respiratory Failure\n- ARDS\nKidney - Acute Tubular Necrosis\nGastrointestinal - Ileus, Pancreatitis\nLiver - Ischemic hepatitis\nBlood - Disseminated Intravascular Coagulation\nMetabolic - Hyperglycemia, Hypoglycemia\nImmune system - Immune depression\nReferral Criteria\nRefer all patients to the appropriate physician specialist.",
    "title": "Chapter 23: Trauma And Injurıes",
    "section": "Chapter 23: Trauma And Injurıes",
    "chunk_id": "2450",
    "type": "section",
    "keywords": [
      "severely",
      "continue",
      "intravascular",
      "encephalopathy",
      "organ",
      "dysfunction",
      "ileus",
      "tachyarrhythmias",
      "urine",
      "acute",
      "specialist",
      "multiple",
      "pancreatitis",
      "process",
      "tubular",
      "complication",
      "disseminated",
      "heart",
      "patients",
      "ischemic"
    ]
  },
  {
    "id": "999b2bb434c448b63a65c77af60466e6",
    "content": "An acute allergic reaction or anaphylaxis is a life-threatening but rapidly reversible condition if treated promptly. Anaphylaxis can develop within minutes of injection or ingestion of medicines or contact with allergen. Persons who are aware of the risk of anaphylaxis are to be informed of avoidance measures, and may be taught the use of an epinephrine (adrenaline) pen.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2451",
    "type": "section",
    "keywords": [
      "avoidance",
      "aware",
      "adrenaline",
      "acute",
      "measures",
      "reversible",
      "within",
      "taught",
      "minutes",
      "informed",
      "treated",
      "epinephrine",
      "reaction",
      "allergic",
      "injection",
      "condition",
      "ingestion",
      "anaphylaxis",
      "persons",
      "medicines"
    ]
  },
  {
    "id": "40736443b433e7e7dc9df9d280324ba5",
    "content": "Causes\nBee or other insect stings\nDrugs e. g. penicillins, sulphonamides\nVaccines\nAntisera e.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2452",
    "type": "section",
    "keywords": [
      "vaccines",
      "drugs",
      "other",
      "stings",
      "penicillins",
      "sulphonamides",
      "antisera",
      "insect",
      "causes"
    ]
  },
  {
    "id": "ab6ddd2c8496532619dc49d1968876d4",
    "content": "g. snake serum, anti-tetanus serum\nIntravenous contrast media\nFoods like seafood, groundnuts, fruit etc. Symptoms\nSevere itching\nUrticarial rash\nFacial and peri-oral swelling\nDifficulty in breathing\nWheeze\nCollapse\nSyncope\nSigns\nAngio-oedema\nDifficulty in breathing\nBronchospasm with wheeze\nTachycardia\nHypotension\nCold clammy extremities\nFacial oedema\nUrticaria\nCyanosis.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2453",
    "type": "section",
    "keywords": [
      "collapse",
      "extremities",
      "urticaria",
      "oedema",
      "clammy",
      "intravenous",
      "tetanus",
      "swelling",
      "breathing",
      "syncope",
      "foods",
      "cyanosis",
      "tachycardia",
      "fruit",
      "rash",
      "wheeze",
      "urticarial",
      "groundnuts",
      "bronchospasm",
      "signs"
    ]
  },
  {
    "id": "a9a963d14381270c38433a08b70615e0",
    "content": "investigations\nFBC (eosinophilia)\nSkin prick test for specific allergens\nSerum specific IgE.",
    "title": "Chapter 24:  General Emergencıes",
    "section": "Chapter 24:  General Emergencıes",
    "chunk_id": "2454",
    "type": "section",
    "keywords": [
      "test",
      "allergens",
      "serum",
      "skin",
      "specific",
      "investigations",
      "prick",
      "eosinophilia"
    ]
  },
  {
    "id": "d56f7970c9608f7ad9825551410fc77a",
    "content": "Secure airways, breathing and circulation\nReverse symptoms\nRemove the offending cause if possible\nRapidly intervene and correct abnormal vital signs.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2455",
    "type": "section",
    "keywords": [
      "circulation",
      "vital",
      "correct",
      "cause",
      "intervene",
      "airways",
      "reverse",
      "breathing",
      "secure",
      "remove",
      "offending",
      "possible",
      "abnormal",
      "signs",
      "rapidly",
      "symptoms"
    ]
  },
  {
    "id": "f6fe7b68673916df394462a7211f207d",
    "content": "Oxygen\nBy nasal prongs\t2-6 L/min\nOr\nFace mask\t4-8 L/min\nOr\nNon-rebreather mask,  10-15 L/min\nAnd\nAdrenaline (Epinephrine), IM,\nAdults\n0. 3-0. 5 ml of 1:1000 solution (i.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2456",
    "type": "section",
    "keywords": [
      "oxygen",
      "epinephrine",
      "face",
      "adults",
      "adrenaline",
      "rebreather",
      "mask",
      "solution",
      "prongs",
      "nasal"
    ]
  },
  {
    "id": "722a2f7076c08307e41dda10012a37af",
    "content": "e. 300-500 micrograms) repeated if necessary every 10 minutes and while monitoring blood pressure and pulse\nChildren\n0. 3 ml of 1:1000 solution (i.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2457",
    "type": "section",
    "keywords": [
      "monitoring",
      "pressure",
      "blood",
      "pulse",
      "minutes",
      "necessary",
      "micrograms",
      "children",
      "repeated",
      "while",
      "solution",
      "every"
    ]
  },
  {
    "id": "4970380dba16258d018610a518b372bb",
    "content": "e. 300 micrograms) Repeat as for adults. And\nHydrocortisone, IV,\nAdults\n100-200 mg 6-8 hourly, to control any late allergic reaction that may\noccur Children\nAll ages;\t2 mg/kg 6 hourly for 4 doses, not to exceed 250 mg/day\nThen\nPrednisolone, oral,\nAdults.",
    "title": "1st Line Treatment Evidence Rating: [B]",
    "section": "1st Line Treatment Evidence Rating: [B]",
    "chunk_id": "2458",
    "type": "section",
    "keywords": [
      "hourly",
      "ages",
      "prednisolone",
      "occur",
      "exceed",
      "adults",
      "doses",
      "repeat",
      "hydrocortisone",
      "children",
      "micrograms",
      "allergic",
      "reaction",
      "oral",
      "control",
      "late",
      "then"
    ]
  },
  {
    "id": "b4d4f9f89420e1490359bb3aacb68268",
    "content": "40 mg daily for 14 days and taper off\nChildren\n2 mg/kg daily for 14 days and taper off\nAnd\nPromethazine hydrochloride, IM,\nAdults\n25 mg repeat after 2 hours if necessary,\nThen 12 hourly for 24 hours\nChildren\n2 years-12 years;\t6. 25-12. 5 mg 8-12 hourly for 24 hours\n< 2 years;\tnot recommended\nOr\nChlorpheniramine, IM,\nAdults\n5-10 mg 6 hourly (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2459",
    "type": "section",
    "keywords": [
      "days",
      "hourly",
      "promethazine",
      "recommended",
      "then",
      "years",
      "hydrochloride",
      "chlorpheniramine",
      "adults",
      "repeat",
      "necessary",
      "after",
      "children",
      "hours",
      "taper",
      "daily"
    ]
  },
  {
    "id": "2e06f99f243bd53d4e8f6c276f9c2d6a",
    "content": "of 40 mg daily)\nChildren\n6-12 years;\t5mg up to a max. of 4 doses in 24 hours\n6 months-6 years;\t2. 5 mg,\n< 6 month;\t250 microgram/kg (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2460",
    "type": "section",
    "keywords": [
      "years",
      "microgram",
      "doses",
      "month",
      "children",
      "months",
      "hours",
      "daily"
    ]
  },
  {
    "id": "804fbe9af335d537f8b305ff350c9e3c",
    "content": "1. 5 mg)\nAcute Anaphylactic Reaction with severe airway obstruction And\nSalbutamol, nebulised,\nAdults\n5 mg 4-6 hourly until resolved\nChildren\n2. 5 mg 4-6 hourly until resolved\nOr\nAminophylline, IV,\nAdults\n250 mg over 20 minutes, then continuous infusion by perfusor at 0.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2461",
    "type": "section",
    "keywords": [
      "aminophylline",
      "nebulised",
      "infusion",
      "acute",
      "hourly",
      "minutes",
      "anaphylactic",
      "continuous",
      "reaction",
      "obstruction",
      "children",
      "severe",
      "adults",
      "salbutamol",
      "then",
      "resolved",
      "perfusor",
      "airway",
      "until"
    ]
  },
  {
    "id": "982f260f50dc0cbe8c9322989949fe5c",
    "content": "5 mg/kg/hour for 24 hours if necessary\nChildren\n3-5 mg/kg over 20 minutes as a slow bolus injection or by infusion in 500 ml Sodium Chloride 0. 9%, IV, 4-6 hourly for 24 hours\nAcute Anaphylactic Reaction with severe hypotension And\nNormal saline, 0. 9%, IV, 1 L- 4 L, rate determined by clinical assess-\nment\nReferral Criteria\nRefer to district or regional hospital if symptoms of anaphylaxis persist after stabilizing the patient and giving initial treatment.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2462",
    "type": "section",
    "keywords": [
      "initial",
      "hour",
      "giving",
      "persist",
      "infusion",
      "acute",
      "bolus",
      "patient",
      "hourly",
      "rate",
      "district",
      "stabilizing",
      "clinical",
      "minutes",
      "anaphylactic",
      "sodium",
      "saline",
      "reaction",
      "assess",
      "injection"
    ]
  },
  {
    "id": "4bba0609799c277fed18b9fa826f6587",
    "content": "Antibiotic prophylaxis refers to the administration of antibiotics in patients to reduce the risk of perioperative sepsis. The main cause of morbidity and mortality in surgery is infectious complications. Antibiotic prophylaxis is indicated in cases where sepsis is expected and could have disastrous local or generalised effects.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2463",
    "type": "section",
    "keywords": [
      "disastrous",
      "local",
      "antibiotics",
      "morbidity",
      "antibiotic",
      "refers",
      "expected",
      "where",
      "patients",
      "perioperative",
      "generalised",
      "cause",
      "surgery",
      "mortality",
      "main",
      "complications",
      "administration",
      "effects",
      "reduce",
      "prophylaxis"
    ]
  },
  {
    "id": "ad99fd92e2dbdb7d72e79d8a33430654",
    "content": "For prophylaxis to be effective, antibiotics must be given before contamination takes place or at the earliest possible time before infection is established. For surgery, therefore, it must be given IV about the time of induction of anaesthesia, so that tissues are saturated with the antibiotic before contamination occurs. Causes\nStaphylococcus aureus\nStreptococcus spp.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2464",
    "type": "section",
    "keywords": [
      "streptococcus",
      "antibiotics",
      "given",
      "takes",
      "established",
      "antibiotic",
      "aureus",
      "therefore",
      "saturated",
      "place",
      "induction",
      "causes",
      "before",
      "contamination",
      "earliest",
      "staphylococcus",
      "occurs",
      "tissues",
      "about",
      "effective"
    ]
  },
  {
    "id": "09c18160cdc4e7449b478519acfe3585",
    "content": "Enterobacteriaceae (GI)\nAnaerobes (GI)\nCoagulase negative staphylococci (especially cardiac surgery, and implantation surgery), etc. Objectives\nPrevent infections\nPrevent complications\nindications Proven indications\nAcute appendicitis and intestinal obstruction\nSurgery on the colon and rectum\nSurgery on the biliary tract\nGastro-oesophageal and oro-pharyngeal surgery for carcinoma\nHysterectomy\nSurgery in the presence of pus.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2465",
    "type": "section",
    "keywords": [
      "infections",
      "proven",
      "pharyngeal",
      "especially",
      "implantation",
      "objectives",
      "coagulase",
      "acute",
      "indications",
      "prevent",
      "carcinoma",
      "anaerobes",
      "intestinal",
      "obstruction",
      "presence",
      "tract",
      "biliary",
      "oesophageal",
      "hysterectomy",
      "enterobacteriaceae"
    ]
  },
  {
    "id": "f2ccfa3cffce193a4043381a62e72d5f",
    "content": "Accepted indications\nImplant surgery where prosthesis and device implants are used\nCardiovascular surgery\nCaesarean section\nPossible indications\nThoracic surgery\nNeurosurgery\nSurgery on the genito-urinary tract\nTrauma surgery\nChoice of Antibiotics\nThe antibiotic chosen must:\nHave antibacterial activity against the anticipated pathogens\nNot easily induce antimicrobial resistance\nHave a high concentration at the site of infection\nBe safely metabolised and excreted\nHave few toxic or adverse reactions\nBe affordable.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2466",
    "type": "section",
    "keywords": [
      "choice",
      "activity",
      "implant",
      "antibiotics",
      "genito",
      "antibiotic",
      "antimicrobial",
      "easily",
      "indications",
      "concentration",
      "prosthesis",
      "section",
      "site",
      "where",
      "implants",
      "toxic",
      "metabolised",
      "reactions",
      "accepted",
      "thoracic"
    ]
  },
  {
    "id": "6db18dd013a31151faed63e95df3c2c6",
    "content": "Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage. Many factors influence the feeling and emotion of pain and these factors vary from person to person. Pain is what the patient says it is.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2467",
    "type": "section",
    "keywords": [
      "emotional",
      "factors",
      "associated",
      "actual",
      "potential",
      "feeling",
      "patient",
      "emotion",
      "vary",
      "influence",
      "damage",
      "these",
      "pain",
      "unpleasant",
      "says",
      "what",
      "sensory",
      "experience",
      "person",
      "tissue"
    ]
  },
  {
    "id": "f4f8841129cb3a710a51044689168b8e",
    "content": "Acute pain (as opposed to chronic pain) is defined as lasting for less than three months and is due to noxious stimuli from identifiable causes such as trauma, surgery, or acute illness. Management of acute pain must be individualized to each patient and should include analgesia as well as treatment of the underlying condition. Special attention must be given, and precautions taken in providing pain relief in children, the elderly, pregnant women, as well as those with concurrent hepatic or renal disease, and those who are opiate tolerant or have a history of substance abuse.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2468",
    "type": "section",
    "keywords": [
      "given",
      "management",
      "providing",
      "stimuli",
      "relief",
      "elderly",
      "special",
      "identifiable",
      "acute",
      "patient",
      "opiate",
      "analgesia",
      "lasting",
      "attention",
      "underlying",
      "condition",
      "children",
      "renal",
      "causes",
      "treatment"
    ]
  },
  {
    "id": "2932f5afa6380cd9f06c26174cebb6c2",
    "content": "Causes\nTraumatic musculoskeletal injury\nSurgery\nBurns\nLabour and delivery\nHeadache\nSickle-cell crisis\nMyocardial infarction\nAcute abdomen e. g. acute pancreatitis\nJoint inflammation\nOthers\nSymptoms\nDepend on the underlying cause\nSigns\nDepend on the underlying cause\ninvestigations\nDepend on the underlying cause.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2469",
    "type": "section",
    "keywords": [
      "depend",
      "headache",
      "labour",
      "traumatic",
      "acute",
      "delivery",
      "pancreatitis",
      "others",
      "myocardial",
      "inflammation",
      "burns",
      "joint",
      "underlying",
      "signs",
      "crisis",
      "causes",
      "sickle",
      "cause",
      "investigations",
      "abdomen"
    ]
  },
  {
    "id": "9b7e9bf2af4a3301377a1bea222764dd",
    "content": "Resuscitate the patient if necessary\nRelieve pain\nTreat any underlying disorder.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2470",
    "type": "section",
    "keywords": [
      "disorder",
      "pain",
      "resuscitate",
      "treat",
      "necessary",
      "relieve",
      "underlying",
      "patient"
    ]
  },
  {
    "id": "8bd8a5c0ba8380a087ad7a56b421ab8c",
    "content": "Place affected part in most comfortable position where appropriate\nElevation of affected part where indicated\nSplinting when indicated\nCold or warm compresses where indicated\nReassurance.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2471",
    "type": "section",
    "keywords": [
      "elevation",
      "position",
      "compresses",
      "comfortable",
      "appropriate",
      "part",
      "reassurance",
      "cold",
      "where",
      "place",
      "indicated",
      "warm",
      "most",
      "splinting",
      "affected"
    ]
  },
  {
    "id": "74af82679b3b7dcf4df0426a9894a16c",
    "content": "Paracetamol\nNon-Steroidal Anti-Inflammatory Drugs (NSAIDS)\nOpioids\nNerve blocks with local anaesthetics.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2472",
    "type": "section",
    "keywords": [
      "drugs",
      "blocks",
      "local",
      "inflammatory",
      "paracetamol",
      "anti",
      "steroidal",
      "nerve",
      "opioids",
      "nsaids",
      "anaesthetics"
    ]
  },
  {
    "id": "a77159ab7cbb348024ff2ed02ed528ea",
    "content": "Paracetamol (Acetaminophen)\nAdults\nOral:\n0. 5-1 g 6 hourly (max. 4 g/24 hours)\nFor adults body weight < 60 kg, dose is 15 mg/kg 6 hourly (max.",
    "title": "Multimodal treatment",
    "section": "Multimodal treatment",
    "chunk_id": "2473",
    "type": "section",
    "keywords": [
      "hourly",
      "body",
      "acetaminophen",
      "weight",
      "adults",
      "oral",
      "paracetamol",
      "dose",
      "hours"
    ]
  },
  {
    "id": "2a5d3a4dbbbea2dfd9129cb0bedca70b",
    "content": "60 mg/kg/24 hours)\nRectal:\n1 g 6 hourly (max. 4 g/24 hours)\nFor adults body weight < 60kg, dose is 15 mg/kg 6 hourly (max. 60 mg/kg/24 hours)\nIV (Intravenous):\nShould be given slowly over 15 minutes 1 g 6 hourly (max.",
    "title": "Multimodal treatment",
    "section": "Multimodal treatment",
    "chunk_id": "2474",
    "type": "section",
    "keywords": [
      "hourly",
      "body",
      "rectal",
      "weight",
      "intravenous",
      "given",
      "minutes",
      "should",
      "adults",
      "dose",
      "slowly",
      "hours"
    ]
  },
  {
    "id": "0cf842ee7b455678a05da25fa5c713ef",
    "content": "4 g/24 hours)\nFor adults body weight < 60 kg, dose is 15 mg/kg 6 hourly (max. 60 mg/kg/day)\nPaediatric doses\nOral:\nChildren:\t15 mg/kg 6 hourly (max. 60 mg/kg/24 hours)\nNeonates:\t10-15 mg/kg 8-12 hourly (max.",
    "title": "Multimodal treatment",
    "section": "Multimodal treatment",
    "chunk_id": "2475",
    "type": "section",
    "keywords": [
      "hourly",
      "body",
      "neonates",
      "weight",
      "adults",
      "doses",
      "oral",
      "dose",
      "children",
      "hours",
      "paediatric"
    ]
  },
  {
    "id": "5db0d8b96b737a8da1753ace756c5327",
    "content": "30 mg/kg/24 hours)\nRectal:\nSame as oral dose above but a loading dose is given (First dose only)\nLoading dose for children and Full term neonates is 30 mg/kg. IV (Intravenous):\nShould be given slowly over 15 minutes\nChildren body weight > 10 kg weight:\n15 mg/kg 6 hourly (max. 60 mg/kg/24 hours)\nChildren body weight < 10 kg and above the age of 2 months:\n7.",
    "title": "Multimodal treatment",
    "section": "Multimodal treatment",
    "chunk_id": "2476",
    "type": "section",
    "keywords": [
      "loading",
      "neonates",
      "weight",
      "intravenous",
      "given",
      "full",
      "hourly",
      "rectal",
      "body",
      "minutes",
      "children",
      "above",
      "first",
      "should",
      "only",
      "same",
      "dose",
      "months",
      "term",
      "oral"
    ]
  },
  {
    "id": "52f7795d697f017c528a23cf72d6804a",
    "content": "5 mg/kg 6 hourly (max. 30 mg/kg/24 hours)\nNon-Steroidal Anti-inflammatory Drugs (NSAiDS)\nNote 26-1\nNSAIDs should be used with caution. Before starting any patient on NSAIDs, one must make sure the patient is not likely be affected by the adverse effects of the NSAIDS.",
    "title": "Multimodal treatment",
    "section": "Multimodal treatment",
    "chunk_id": "2477",
    "type": "section",
    "keywords": [
      "likely",
      "patient",
      "starting",
      "hourly",
      "steroidal",
      "note",
      "nsaids",
      "before",
      "should",
      "anti",
      "drugs",
      "effects",
      "inflammatory",
      "sure",
      "must",
      "caution",
      "adverse",
      "hours",
      "used",
      "affected"
    ]
  },
  {
    "id": "c7fa9cd0ef7b07e78f87ec70b977dfd5",
    "content": "Causes platelet dysfunction\nAffects renal function – decreases renal blood flow\nTriggers bronchospasm in some asthmatic patients\nCauses fluid retention\nThus NSAIDS should not be given to several groups of patients, including the following:-.",
    "title": "Excacerbates peptic ulcer disease",
    "section": "Excacerbates peptic ulcer disease",
    "chunk_id": "2478",
    "type": "section",
    "keywords": [
      "given",
      "dysfunction",
      "asthmatic",
      "triggers",
      "fluid",
      "decreases",
      "thus",
      "following",
      "including",
      "function",
      "retention",
      "bronchospasm",
      "patients",
      "renal",
      "blood",
      "causes",
      "nsaids",
      "platelet",
      "should",
      "groups"
    ]
  },
  {
    "id": "958472fedf877c712ee3373b08ba1053",
    "content": "Patients with coagulation or bleeding problems\nPatients who are at risk of postoperative bleeding eg tonsillectomies\nPatients with impaired renal function or patients who are at risk of going into renal failure (eg septic patients)\nPatients with heart failure. Pregnant women, particularly in the third trimester, as it causes early closure\nof the patent ductus arteriolosis\nShould be used with increased caution in elderly patients. There have been concerns about the cardiovascular safety of the COX-2 selec- tive inhibitor group of NSAIDS.",
    "title": "Patients with peptic ulcer disease",
    "section": "Patients with peptic ulcer disease",
    "chunk_id": "2479",
    "type": "section",
    "keywords": [
      "elderly",
      "closure",
      "impaired",
      "into",
      "function",
      "bleeding",
      "heart",
      "patients",
      "safety",
      "particularly",
      "renal",
      "trimester",
      "causes",
      "patent",
      "nsaids",
      "going",
      "concerns",
      "tonsillectomies",
      "women",
      "third"
    ]
  },
  {
    "id": "24f3b518cce40d113f982a3204c85f77",
    "content": "The recommendations are that this group of drugs should not be given to patients with ischaemic heart disease or cerebro- vascular disease. Adult\nDiclofenac, oral, 25-50 mg 8 hourly or 75 mg 12 hourly\nOr\nRectal, 50 mg 12 hourly or 100 mg 18 hourly\nOr\nIM, 25-50 mg 8 hourly or 75 mg 12 hourly (max. 150 mg/day)\nIbuprofen, oral,\nAdult\n400 mg 6-8 hourly\nChildren\n20-30 mg/kg daily in 3 divided doses (max.",
    "title": "Patients with peptic ulcer disease",
    "section": "Patients with peptic ulcer disease",
    "chunk_id": "2480",
    "type": "section",
    "keywords": [
      "given",
      "cerebro",
      "ibuprofen",
      "hourly",
      "rectal",
      "diclofenac",
      "doses",
      "heart",
      "patients",
      "children",
      "recommendations",
      "disease",
      "vascular",
      "should",
      "adult",
      "divided",
      "drugs",
      "oral",
      "ischaemic",
      "group"
    ]
  },
  {
    "id": "d4c7bc7148bd2224ff8561d3041cb591",
    "content": "1. 2 g per day)\nOpioids\nThese are used for severe pain. Tramadol\nAdults.",
    "title": "Patients with peptic ulcer disease",
    "section": "Patients with peptic ulcer disease",
    "chunk_id": "2481",
    "type": "section",
    "keywords": [
      "severe",
      "pain",
      "tramadol",
      "adults",
      "used",
      "opioids",
      "these"
    ]
  },
  {
    "id": "c7bdd99986f4de5e5bc5d4981c308773",
    "content": "Oral, 50-100 mg 4-6 hourly (max. 400 mg daily)\nPethidine, IM,\nAdults\n25-50 mg (approx. 1 mg/kg) 4 hourly.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2482",
    "type": "section",
    "keywords": [
      "hourly",
      "approx",
      "pethidine",
      "adults",
      "oral",
      "daily"
    ]
  },
  {
    "id": "b8309b1bcca402f315babdf53dd1509a",
    "content": "Lower dose in the elderly\nChildren\n1 mg/kg (max. 50 mg) 4 hourly\nPethidine, IV,\nAdults\n25 mg repeated if necessary with caution\nMorphine, IV,\nAdult\n1-2 mg boluses repeated if necessary with caution\nMorphine, IM,\nAdults\n5-10 mg 4 hourly\nChildren\n0. 1 mg/kg (max.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2483",
    "type": "section",
    "keywords": [
      "hourly",
      "morphine",
      "pethidine",
      "adults",
      "adult",
      "necessary",
      "caution",
      "elderly",
      "boluses",
      "dose",
      "lower",
      "children",
      "repeated"
    ]
  },
  {
    "id": "22aa0d98f245b0dba6923012f7625d64",
    "content": "5 mg) 4 hourly\nNerve blocks with local anaesthetic agents\nLidocaine\nBupivacaine.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2484",
    "type": "section",
    "keywords": [
      "hourly",
      "agents",
      "bupivacaine",
      "blocks",
      "local",
      "anaesthetic",
      "nerve",
      "lidocaine"
    ]
  },
  {
    "id": "f0ecec9405e0202878ae68797a4f205b",
    "content": "Paracetamol And Opioid\nOr\nParacetamol And NSAID\nOr\nParacetamol And NSAID And Opioid\nReferral Criteria\nIf underlying condition does not improve or pain relief is not achieved with recommended doses.",
    "title": "Multimodal Treatment",
    "section": "Multimodal Treatment",
    "chunk_id": "2485",
    "type": "section",
    "keywords": [
      "referral",
      "pain",
      "opioid",
      "recommended",
      "improve",
      "achieved",
      "doses",
      "nsaid",
      "relief",
      "paracetamol",
      "underlying",
      "does",
      "condition",
      "criteria"
    ]
  },
  {
    "id": "deff70fa23bb99b4b52f6bd7765cb680",
    "content": "Breast cancer is the commonest cancer affecting women. Early detection of this cancer is possible through monthly breast self- examination and is recommended for women of child-bearing age. Periodic screening through clinical breast examination is required for women below 40 years (1 in every 3 years) and yearly for women above 40 years.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2486",
    "type": "section",
    "keywords": [
      "years",
      "self",
      "child",
      "required",
      "periodic",
      "monthly",
      "breast",
      "screening",
      "yearly",
      "above",
      "women",
      "detection",
      "bearing",
      "every",
      "cancer",
      "recommended",
      "below",
      "commonest",
      "affecting",
      "early"
    ]
  },
  {
    "id": "52ca13436e2ecd1081f69ca41aa38525",
    "content": "Mammography is recommended every 2 years for women 40 years and above. Five treatment modalities are available, but each patient’s treatment is personalized and depends on the biological characteristics of the tumour, stage of disease and other patient factors. Two percent of breast cancers in Ghana occur in males.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2487",
    "type": "section",
    "keywords": [
      "years",
      "occur",
      "characteristics",
      "factors",
      "cancers",
      "males",
      "patient",
      "breast",
      "depends",
      "five",
      "stage",
      "mammography",
      "tumour",
      "percent",
      "treatment",
      "disease",
      "above",
      "women",
      "each",
      "biological"
    ]
  },
  {
    "id": "8a92c6e6583a53514a910fe24cfa42b2",
    "content": "Causes\nUnknown\nSymptoms\nLump in the breast\nChange in size or shape of breast\nSwelling in axilla\nSwelling of upper limb\nPeau d’orange\nSkin nodules\nUlceration.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2488",
    "type": "section",
    "keywords": [
      "breast",
      "unknown",
      "limb",
      "upper",
      "orange",
      "lump",
      "ulceration",
      "size",
      "swelling",
      "peau",
      "skin",
      "nodules",
      "change",
      "symptoms",
      "axilla",
      "causes",
      "shape"
    ]
  },
  {
    "id": "93e5474995b919fe35c977e4dd337f72",
    "content": "Nipple discharge\nNipple retraction\nEczema/ulceration of nipple or areola\nSigns\nBreast lump\nPeau d’orange\nSkin tethering, nodules or ulceration\nNipple retraction\nBloody nipple discharge\nPalpable axillary nodes\ninvestigations\nMammography\nUltrasonography of the breast\nFine needle aspiration for cytology\nCore biopsy.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2489",
    "type": "section",
    "keywords": [
      "areola",
      "eczema",
      "nodules",
      "orange",
      "breast",
      "aspiration",
      "lump",
      "signs",
      "mammography",
      "nodes",
      "palpable",
      "bloody",
      "ultrasonography",
      "retraction",
      "ulceration",
      "peau",
      "core",
      "skin",
      "investigations",
      "nipple"
    ]
  },
  {
    "id": "bee84413774b44c320facd030269e38a",
    "content": "Achieve a cure\nPrevent local and distant metastasis.",
    "title": "Treatment Treatment objectives",
    "section": "Treatment Treatment objectives",
    "chunk_id": "2490",
    "type": "section",
    "keywords": [
      "achieve",
      "local",
      "cure",
      "prevent",
      "metastasis",
      "distant"
    ]
  },
  {
    "id": "90d53e8d110b2441d21450a53d50bc9b",
    "content": "Chemotherapy\nHormonal therapy\nImmunotherapy\nReferral Criteria\nAll cases of suspected breast cancer must be referred for specialist attention.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2491",
    "type": "section",
    "keywords": [
      "breast",
      "cancer",
      "referral",
      "specialist",
      "immunotherapy",
      "hormonal",
      "suspected",
      "must",
      "attention",
      "criteria",
      "cases",
      "referred",
      "chemotherapy",
      "therapy"
    ]
  },
  {
    "id": "0bb485f302cca86f78e7f464263de20c",
    "content": "Poisoning represents the harmful effects of toxic amounts of any substance on the body. In many cases, only mild symptoms and signs will develop. However, suspected poisoning should always be considered a medical emergency since the situation may rapidly evolve to become critical.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2492",
    "type": "section",
    "keywords": [
      "amounts",
      "evolve",
      "situation",
      "always",
      "body",
      "emergency",
      "represents",
      "toxic",
      "signs",
      "suspected",
      "should",
      "critical",
      "only",
      "poisoning",
      "medical",
      "harmful",
      "symptoms",
      "mild",
      "since",
      "develop"
    ]
  },
  {
    "id": "badddf3af1488b0f38d96ced6c429a7c",
    "content": "Many deaths due to poisoning can be prevented with early initiation of good supportive care and general treatment measures. Symptoms and signs of poisoning depend on the specific exposure, and may be local, systemic, or both. Effects may occur immediately, or several hours or days later.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2493",
    "type": "section",
    "keywords": [
      "depend",
      "local",
      "occur",
      "both",
      "systemic",
      "measures",
      "initiation",
      "immediately",
      "specific",
      "signs",
      "treatment",
      "days",
      "later",
      "prevented",
      "exposure",
      "poisoning",
      "symptoms",
      "deaths",
      "general",
      "effects"
    ]
  },
  {
    "id": "b509411ad7639f33b3abb1bcee3a0ea3",
    "content": "The severity depends on many factors, including the type of substance, the route of exposure (ingestion, inhalation, injection, dermal application, etc. ), the dose and duration of exposure, and patient or environmental factors. Obtaining the original container or a sample of the substance is often most helpful, along with a thorough history and physical examination and laboratory analysis to look for characteristic features of poisoning with specific agents.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2494",
    "type": "section",
    "keywords": [
      "agents",
      "often",
      "characteristic",
      "original",
      "factors",
      "application",
      "features",
      "environmental",
      "patient",
      "type",
      "helpful",
      "including",
      "obtaining",
      "sample",
      "depends",
      "dermal",
      "specific",
      "injection",
      "most",
      "ingestion"
    ]
  },
  {
    "id": "508d3c292eb9fbe81b307a006e7bb924",
    "content": "Judicious use of antidotes for poisoning with specific substances may be added to general treatment measures based on these findings. A Poison Control Centre exists in Ghana to support health professionals in developing rational and timely strategies for diagnosis and treatment of poisoning. Causes\nHousehold chemicals\nPesticides\nMedications\nToxic plants\nVenomous bites and stings\nToxic alcohols\nIndustrial chemicals.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2495",
    "type": "section",
    "keywords": [
      "based",
      "professionals",
      "strategies",
      "poison",
      "exists",
      "antidotes",
      "stings",
      "health",
      "measures",
      "judicious",
      "venomous",
      "plants",
      "developing",
      "support",
      "added",
      "specific",
      "toxic",
      "industrial",
      "rational",
      "causes"
    ]
  },
  {
    "id": "92daddd09a426180a477b6138283f1bd",
    "content": "Symptoms\nNausea, vomiting\nDiarrhoea\nAbdominal pain\nDifficulty in breathing\nPalpitations\nSkin rash\nHeadache\nConfusion\nLethargy, weakness\nSigns\nAbnormal vital signs (pulse, temperature, respiratory rate)\nSmall pupils (miosis)\nLarge pupils (mydriasis)\nExcessive sweating\nHypersalivation\nFrequent urination\nDiarrhoea\nWheezing\nFlushed dry skin\nDehydration\nShock\nLow urine output (oliguria, anuria) or retention\nAbdominal tenderness\nJaundice\nAltered mentation\nTremors\nSeizure\nComa\ninvestigations\nBlood glucose (random)\nFBC\nBUE and Creatinine\nUrinalysis\nECG\nLiver function tests\nClotting time\nCoagulation profile.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2496",
    "type": "section",
    "keywords": [
      "nausea",
      "headache",
      "profile",
      "breathing",
      "urine",
      "glucose",
      "vital",
      "weakness",
      "seizure",
      "lethargy",
      "diarrhoea",
      "rash",
      "abdominal",
      "rate",
      "creatinine",
      "function",
      "large",
      "jaundice",
      "retention",
      "altered"
    ]
  },
  {
    "id": "3fcb53d09955ac733a47ac7c2fb1182d",
    "content": "Prevent or limit absorption\nEnhance elimination\nPrevent or manage organ damage\nPrevent recurrence.",
    "title": "Provide good supportive care",
    "section": "Provide good supportive care",
    "chunk_id": "2497",
    "type": "section",
    "keywords": [
      "recurrence",
      "prevent",
      "manage",
      "absorption",
      "organ",
      "enhance",
      "damage",
      "elimination",
      "limit"
    ]
  },
  {
    "id": "4ad85e9267792cef6df7c2dc36883d49",
    "content": "Airway protection\nDecontamination\nDetain patient for close monitoring\nResuscitation when necessary\nGastric lavage if indicated\nEducation and counselling.",
    "title": "Non-pharmacological treatment",
    "section": "Non-pharmacological treatment",
    "chunk_id": "2498",
    "type": "section",
    "keywords": [
      "monitoring",
      "education",
      "detain",
      "decontamination",
      "gastric",
      "lavage",
      "counselling",
      "close",
      "necessary",
      "resuscitation",
      "indicated",
      "protection",
      "airway",
      "patient"
    ]
  },
  {
    "id": "433c9ff510fd5d48fce9f9868557f4a6",
    "content": "A. Gastrointestinal decontamination, acute poison ingestion or oral\noverdose.",
    "title": "Pharmacological treatment",
    "section": "Pharmacological treatment",
    "chunk_id": "2499",
    "type": "section",
    "keywords": [
      "ingestion",
      "overdose",
      "poison",
      "decontamination",
      "oral",
      "acute",
      "gastrointestinal"
    ]
  },
  {
    "id": "491769daf0f47c9f9930a17a60dc902c",
    "content": "Activated charcoal powder, oral,\nAdults and Children\n50 g initially (1 g/kg, max. 100 g) given as 50 g/500 ml slurry in water\nThen\n20-50 g every 2-6 hours as required\n(See table below on antidotes for specific poisons).",
    "title": "1st Line Treatment Evidence Rating: [C]",
    "section": "1st Line Treatment Evidence Rating: [C]",
    "chunk_id": "2500",
    "type": "section",
    "keywords": [
      "given",
      "antidotes",
      "table",
      "required",
      "slurry",
      "powder",
      "charcoal",
      "poisons",
      "initially",
      "water",
      "specific",
      "children",
      "activated",
      "adults",
      "then",
      "every",
      "below",
      "oral",
      "hours"
    ]
  },
  {
    "id": "ad05748b0329c11e802a99b9a3ea149b",
    "content": "Referral Criteria\nRefer patients for specialist management if they do not improve with general supportive care or if they require specific antidotes.",
    "title": "Chapter 28:  General Management Of Poısonıng",
    "section": "Chapter 28:  General Management Of Poısonıng",
    "chunk_id": "2501",
    "type": "section",
    "keywords": [
      "referral",
      "specialist",
      "require",
      "supportive",
      "improve",
      "management",
      "refer",
      "antidotes",
      "specific",
      "patients",
      "criteria",
      "care",
      "general"
    ]
  },
  {
    "id": "d1a66918c5a63b4039ec36300df29acc",
    "content": "Prescribing for older patients presents unique challenges. Many medications need to be used with special caution because of age-related changes in the absorption, distribution, metabolism, and excretion of the drug as well as the physiologic effects of the drug. In particular, physiologic changes in body composition, renal and hepatic functions play vital roles in determining changes in drug levels and the risk of adverse drug events in the elderly.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2502",
    "type": "section",
    "keywords": [
      "distribution",
      "levels",
      "elderly",
      "special",
      "roles",
      "determining",
      "vital",
      "presents",
      "particular",
      "body",
      "drug",
      "need",
      "patients",
      "composition",
      "changes",
      "renal",
      "challenges",
      "because",
      "events",
      "prescribing"
    ]
  },
  {
    "id": "6e82bdf2b7183d9e37912acac27c2413",
    "content": "There is also the issue of multi-morbidity in the elderly, which leads to the prescribing of multiple medications. The more medications prescribed for an elderly person, the higher the risk of adverse effects and other drug interactions. The ‘Beers criteria’ (The American Geriatrics Society 2012 Beers Criteria Update Expert Panel) gives a list of medications considered inappropriate for older patients; either because of ineffectiveness or high risk for adverse events.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2503",
    "type": "section",
    "keywords": [
      "either",
      "morbidity",
      "which",
      "elderly",
      "inappropriate",
      "multiple",
      "panel",
      "geriatrics",
      "drug",
      "multi",
      "patients",
      "criteria",
      "update",
      "leads",
      "ineffectiveness",
      "because",
      "interactions",
      "beers",
      "gives",
      "prescribing"
    ]
  },
  {
    "id": "e771996a0d042d32c6d880249203c89f",
    "content": "Causes of Adverse Drug Events\nPolypharmacy\nUse of inappropriate medications\nUnderutilization of appropriate medication.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2504",
    "type": "section",
    "keywords": [
      "events",
      "appropriate",
      "polypharmacy",
      "medications",
      "drug",
      "medication",
      "underutilization",
      "inappropriate",
      "adverse",
      "causes"
    ]
  },
  {
    "id": "36cc9fc9768dd34a4449c64dae4fd568",
    "content": "Prevent Adverse Drug Events (ADE)\nPreventive measures.",
    "title": "Management Treatment objectives",
    "section": "Management Treatment objectives",
    "chunk_id": "2505",
    "type": "section",
    "keywords": [
      "events",
      "prevent",
      "drug",
      "preventive",
      "adverse",
      "measures"
    ]
  },
  {
    "id": "c3cbc0a868e413da284abbd15b525437",
    "content": "Quality measures of drug prescribing\nAvoidance of inappropriate medications\nAppropriate use of indicated medications\nMonitoring for side effects and drug levels.",
    "title": "Proper drug history taking by the healthcare provider",
    "section": "Proper drug history taking by the healthcare provider",
    "chunk_id": "2506",
    "type": "section",
    "keywords": [
      "side",
      "monitoring",
      "avoidance",
      "appropriate",
      "effects",
      "prescribing",
      "medications",
      "quality",
      "drug",
      "levels",
      "inappropriate",
      "indicated",
      "measures"
    ]
  },
  {
    "id": "0b225bafdaa25a5d775f9a1672ae1095",
    "content": "Avoidance of drug-drug and drug-food interactions\nInvolvement of the patient/family and integration of patient\nvalues\nMaintenance of an accurate list of all medications that a patient is currently using\nPeriodic ‘polythene bag check-ups’; i. e. instruct patients to bring all\npill bottles and containers on each medical visit (including empty packets and containers); these should be checked against the medication list\nPatients should be made aware of potential drug confusions i.",
    "title": "Chapter 29:  Medıcınes Use In The Elderly",
    "section": "Chapter 29:  Medıcınes Use In The Elderly",
    "chunk_id": "2507",
    "type": "section",
    "keywords": [
      "avoidance",
      "empty",
      "bottles",
      "aware",
      "check",
      "family",
      "maintenance",
      "integration",
      "periodic",
      "potential",
      "patient",
      "containers",
      "including",
      "drug",
      "packets",
      "involvement",
      "patients",
      "currently",
      "pill",
      "against"
    ]
  },
  {
    "id": "440d99eeac306f0eccedc304ca06f4e3",
    "content": "e. sound-alike names, look-alike pills, and combination medications\nInform patients of both generic and brand names, including spelling, as well as the reasons for taking their medications\nMedicine organisers prepared by the pharmacist, can also be helpful\nin ensuring that patients take their medications correctly.",
    "title": "Chapter 29:  Medıcınes Use In The Elderly",
    "section": "Chapter 29:  Medıcınes Use In The Elderly",
    "chunk_id": "2508",
    "type": "section",
    "keywords": [
      "alike",
      "sound",
      "medicine",
      "inform",
      "both",
      "generic",
      "brand",
      "organisers",
      "ensuring",
      "pharmacist",
      "helpful",
      "including",
      "taking",
      "names",
      "combination",
      "patients",
      "their",
      "reasons",
      "correctly",
      "pills"
    ]
  },
  {
    "id": "cf9c38dbf97915ecd8441c187e1e223f",
    "content": "Local anaesthetic (LA) agents are drugs that reversibly block nerve transmission. They are used to provide anaesthesia to specific areas of the body and can also be used for analgesia. Local anaesthetics also affect transmission in motor nerves; hence, motor weakness may occur following a local anaesthetic, depending on the site of application.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2509",
    "type": "section",
    "keywords": [
      "agents",
      "local",
      "block",
      "occur",
      "anaesthetic",
      "application",
      "weakness",
      "anaesthetics",
      "body",
      "following",
      "analgesia",
      "site",
      "nerve",
      "specific",
      "motor",
      "affect",
      "also",
      "reversibly",
      "hence",
      "depending"
    ]
  },
  {
    "id": "aab8991368e65e29a27ae0c8d1930206",
    "content": "Adrenaline is added to local anaesthetics to delay absorption and thus prolong their action. The usual concentration of adrenaline added to a local anaesthetic is 1:200,000. Local anaesthetics with adrenaline should never be used where the blood supply is by end arteries e.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2510",
    "type": "section",
    "keywords": [
      "arteries",
      "local",
      "supply",
      "anaesthetic",
      "usual",
      "delay",
      "adrenaline",
      "anaesthetics",
      "thus",
      "concentration",
      "added",
      "where",
      "their",
      "blood",
      "should",
      "never",
      "prolong",
      "action",
      "absorption",
      "used"
    ]
  },
  {
    "id": "4ed32a0f4796af3d93600c4053945d44",
    "content": "g. should not be used for digital nerve blocks. They are also contraindicated in intravenous regional anaesthesia (IVRA).",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2511",
    "type": "section",
    "keywords": [
      "blocks",
      "digital",
      "intravenous",
      "ivra",
      "anaesthesia",
      "should",
      "also",
      "nerve",
      "contraindicated",
      "regional",
      "used"
    ]
  },
  {
    "id": "5b9e0c78b837e76ee51141c55b662e41",
    "content": "Commonly used LAs in our sub-region are lignocaine and bupivacaine. Lidocaine (Lignocaine)\nAdvantage - rapid onset of action\nDuration - about 1 hour\nMaximum dose of plain lidocaine - 3 mg/kg (approx. 200 mg in adult)\nMaximum dose of lidocaine with adrenaline - 7 mg/kg\nLidocaine is not recommended for spinal anaesthesia\nBupivacaine\nAdvantage - long acting\nDisadvantages - cardiotoxic, slow onset of action\nMaximum dose is 2 mg/kg (for both plain and with adrenaline added)\nRopivacaine\nAdvantage - long acting, less cardiotoxic\nMaximum dose is 3 mg/kg.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2512",
    "type": "section",
    "keywords": [
      "hour",
      "approx",
      "region",
      "both",
      "adrenaline",
      "spinal",
      "cardiotoxic",
      "bupivacaine",
      "lignocaine",
      "ropivacaine",
      "added",
      "lidocaine",
      "advantage",
      "onset",
      "rapid",
      "adult",
      "duration",
      "slow",
      "dose",
      "commonly"
    ]
  },
  {
    "id": "c98d423ac19532a933db8efee7b81a37",
    "content": "Uses of local anaesthetic agents\nTopical\nLocal infiltration\nNerve blocks\nIntravenous regional anaesthesia\nSpinal anaesthesia (subarachnoid block)\nEpidural anaesthesia/analgesia\nNebulisation for anaesthetizing upper airway\nInravenous preparation of lignocaine used as an antiarrhythmic\nPrevention of local anaesthetic toxicity\nAlways aspirate before injecting, to prevent inadvertent intravascular injection\nDo not inject large volumes at a time\nCaution when injecting into areas of high vascularity\nSymptoms and signs of local anaesthesia toxicity\nPeri-oral tingling, tinnitus, light headedness\nVisual disturbances, slurred speech\nAltered consciousness, seizures, loss of consciousness, respiratory\narrest\nHypotension, cardiac arrhythmias, cardiac arrest.",
    "title": "Chapter 30:  Local Anaesthetıc Agents",
    "section": "Chapter 30:  Local Anaesthetıc Agents",
    "chunk_id": "2513",
    "type": "section",
    "keywords": [
      "agents",
      "intravascular",
      "local",
      "intravenous",
      "block",
      "volumes",
      "headedness",
      "anaesthetic",
      "seizures",
      "nebulisation",
      "preparation",
      "spinal",
      "light",
      "into",
      "speech",
      "anaesthetizing",
      "always",
      "disturbances",
      "blocks",
      "prevent"
    ]
  },
  {
    "id": "2756917b3cdd4b2f6e7e7a3673f53de5",
    "content": "Stop injection of LA\nStart ABC (Airway, Breathing, Circulation) of resuscitation\nGive 100% oxygen. If necessary intubate patient\nGive Midazolam (3-5 mg) or diazepam (5-10 mg) to treat seizures. If seizures persist, an anaesthetist can give thiopentone 1-2 mg/kg or more midazolam and paralyse, intubate and ventilate patient\nTreat cardiovascular instability with IV fluids, inotropes, and when\nbupivacaine or ropivacaine has been used, give Intralipid 20% using regime below\nIf cardiac arrest occurs, start CPR and call for help\nUse of 20% intralipid in treatment of local anaesthetic toxicity (follow- ing bupivacaine or ropivacaine)\nIn addition to other resuscitative measures outlined above:\nGive an intravenous bolus of Intralipid 20%, 1.",
    "title": "Treatment of local anaesthetic toxicity",
    "section": "Treatment of local anaesthetic toxicity",
    "chunk_id": "2514",
    "type": "section",
    "keywords": [
      "circulation",
      "treat",
      "persist",
      "give",
      "local",
      "intravenous",
      "midazolam",
      "seizures",
      "anaesthetic",
      "breathing",
      "help",
      "patient",
      "addition",
      "measures",
      "bolus",
      "diazepam",
      "bupivacaine",
      "oxygen",
      "inotropes",
      "start"
    ]
  },
  {
    "id": "d2403839bce887a976fe6b751d708807",
    "content": "5 ml/kg fast (approx. 100 ml for a 70kg patient)\nStart an infusion of 20% Intralipid at 0. 25 ml/kg/min (approx.",
    "title": "Treatment of local anaesthetic toxicity",
    "section": "Treatment of local anaesthetic toxicity",
    "chunk_id": "2515",
    "type": "section",
    "keywords": [
      "fast",
      "approx",
      "start",
      "infusion",
      "patient",
      "intralipid"
    ]
  },
  {
    "id": "8a9c3e069b0ce7b9331942407c8d940f",
    "content": "400 ml\nover 20 mins for a 70 kg patient)\nRepeat initial bolus twice at 5 minute intervals, if adequate circulation\nhas not been restored\nMaximum dose of 12 ml/kg of Intralipid 20% should not be exceeded.",
    "title": "Treatment of local anaesthetic toxicity",
    "section": "Treatment of local anaesthetic toxicity",
    "chunk_id": "2516",
    "type": "section",
    "keywords": [
      "circulation",
      "initial",
      "exceeded",
      "mins",
      "minute",
      "intervals",
      "restored",
      "should",
      "repeat",
      "dose",
      "maximum",
      "twice",
      "adequate",
      "patient",
      "bolus",
      "intralipid"
    ]
  },
  {
    "id": "88129eca94928673f3bb743f9531411e",
    "content": "A seriously ill child is one whose vitals are compromised. A structured approach in determining the cause and subsequent successful management of the child is necessary. Rapid assessment and urgent intervention are the major requirements in the approach.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2517",
    "type": "section",
    "keywords": [
      "intervention",
      "management",
      "child",
      "determining",
      "structured",
      "successful",
      "whose",
      "subsequent",
      "vitals",
      "rapid",
      "compromised",
      "cause",
      "major",
      "requirements",
      "urgent",
      "seriously",
      "approach",
      "necessary",
      "assessment"
    ]
  },
  {
    "id": "a642ca2ecc5d44a457ecc6555a9e8c78",
    "content": "Triaging soon after their arrival in hospital for emergency signs like severe respiratory distress or coma and priority signs like high temperature, restlessness or severe pain is important. Presentations of serious illness may be classified under the following problem areas; airway/breathing, cardiac, shock and neurological disability. The structured approach includes:\nPrimary assessment\nResuscitation\nSecondary assessment.",
    "title": "Chapter",
    "section": "Chapter",
    "chunk_id": "2518",
    "type": "section",
    "keywords": [
      "triaging",
      "important",
      "breathing",
      "secondary",
      "serious",
      "under",
      "primary",
      "emergency",
      "neurological",
      "structured",
      "following",
      "signs",
      "arrival",
      "their",
      "severe",
      "restlessness",
      "coma",
      "shock",
      "respiratory",
      "includes"
    ]
  },
  {
    "id": "f4ff9cbebc63254c74ca5cd01a72f0aa",
    "content": "AiRWAY/BREATHiNG PROBLEMS\nCauses\nSevere Pneumonia\nBronchiolitis\nUpper airway obstruction or stridor\nOthers\nSigns And Symptoms\nDepends on condition\nApproach\nPrimary assessment\nCan child speak. Indicates airway patency\nCan infant cry. Indicates airway patency\nAdequacy of breathing assessed by recession, respiratory rate, grunting, inspiratory or expiratory noises, flaring of the alae nasi.",
    "title": "Definitive care",
    "section": "Definitive care",
    "chunk_id": "2519",
    "type": "section",
    "keywords": [
      "expiratory",
      "noises",
      "breathing",
      "child",
      "assessed",
      "patency",
      "indicates",
      "primary",
      "rate",
      "stridor",
      "bronchiolitis",
      "others",
      "depends",
      "obstruction",
      "signs",
      "condition",
      "causes",
      "speak",
      "alae",
      "severe"
    ]
  },
  {
    "id": "d236ab20b1aeeb42aa715b5944dee857",
    "content": "Effectiveness of breathing is assessed by breath sounds, chest expansion and abdominal excursion\nFinal effects of inadequate respiration are determined from the\nheart rate, skin colour and mental status\nPulse oximetry desirable. A saturation of less than 90% while breathing air or less than 95% while breathing oxygen is very low\nHigh flow oxygen should be given to all children with respiratory\ndifficulty or hypoxia. In a child with inadequate ventilation, bag valve mask oxygenation or intubation may be required\ninvestigations\nChest X-ray\nArterial blood gas\nPeak flow (if asthma a possibility)\nManagement\nIf a chin lift or jaw thrust can secure airway then do so, otherwise consider intubation\nRESPIRATORY; if bubbly noises heard, airway full of secretions, suction required\nHarsh stridor with barking cough and severe respiratory distress, more likely to be upper airway obstruction, nebulise with adrenaline (5ml of 1:1000 in oxygen)\nIf symptoms had a sudden onset and there is history of inhalation, consider laryngeal foreign body.",
    "title": "Chapter 31:  Structured Approach to the Serıously Ill Chıld",
    "section": "Chapter 31:  Structured Approach to the Serıously Ill Chıld",
    "chunk_id": "2520",
    "type": "section",
    "keywords": [
      "sudden",
      "child",
      "assessed",
      "full",
      "likely",
      "while",
      "abdominal",
      "oxygen",
      "stridor",
      "consider",
      "excursion",
      "foreign",
      "severe",
      "thrust",
      "should",
      "hypoxia",
      "respiratory",
      "secure",
      "then",
      "oxygenation"
    ]
  },
  {
    "id": "44a9e6fc6e1cadd5295b701661a92c37",
    "content": "Call an ENT surgeon immediately\nChildren with a history of asthma and respiratory distress require nebulized salbutamol 2. 5 mg or 5 mg if 7 years plus and oxygen\nCiRCULATiON/CARDiOVASCULAR\nWhen normal capillary refill time is more than 2 seconds, then there is no problem with cardiac output. Cardiac arrest predominantly occurs secondary to hypoxia or hypovolaemia.",
    "title": "Chapter 31:  Structured Approach to the Serıously Ill Chıld",
    "section": "Chapter 31:  Structured Approach to the Serıously Ill Chıld",
    "chunk_id": "2521",
    "type": "section",
    "keywords": [
      "circulation",
      "years",
      "secondary",
      "capillary",
      "require",
      "oxygen",
      "immediately",
      "hypovolaemia",
      "asthma",
      "children",
      "arrest",
      "call",
      "predominantly",
      "nebulized",
      "hypoxia",
      "respiratory",
      "problem",
      "there",
      "salbutamol",
      "seconds"
    ]
  },
  {
    "id": "2bae6d2b55604bc12c964fcd0858f8b5",
    "content": "Primary myocardial disease is rare. Causes\nHeart failure\nArrhythmias (heart rhythm abnormalities)\nApproach\nPrimary assessment, with regard to circulation;\nHeart rate\nPulse volume\nCapillary refill\nBlood pressure\nLook for tachycardia, bradycardia, abnormal pulse volume, hypotension or hypertension, hepatomegaly, murmurs and peripheral oedema\nCheck the effects of circulatory inadequacy on other organs by.",
    "title": "Chapter 31:  Structured Approach to the Serıously Ill Chıld",
    "section": "Chapter 31:  Structured Approach to the Serıously Ill Chıld",
    "chunk_id": "2522",
    "type": "section",
    "keywords": [
      "circulation",
      "hypertension",
      "oedema",
      "rhythm",
      "hepatomegaly",
      "abnormalities",
      "check",
      "assessment",
      "circulatory",
      "tachycardia",
      "capillary",
      "primary",
      "rate",
      "rare",
      "pressure",
      "myocardial",
      "heart",
      "abnormal",
      "volume",
      "causes"
    ]
  },
  {
    "id": "bea8010eafe9602078829b8dc1c23b03",
    "content": "checking the respiratory rate\nskin appearance and temperature\nmental status and urinary output\ninvestigations\nUrea electrolytes\nChest X-ray\nECG\nFull blood count\nBlood culture\nManagement\nAddress airways and breathing before commencing external cardiac massage\nIf cardiac output is not responding to CPR, reconsider the adequacy\nof airway and breathing support\nSHOCK (iNADEQUATE CiRCULATiON)\nCauses\nSevere gastroenteritis\nDiarrhoea.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2523",
    "type": "section",
    "keywords": [
      "circulation",
      "mental",
      "appearance",
      "reconsider",
      "inadequate",
      "management",
      "airways",
      "breathing",
      "full",
      "gastroenteritis",
      "diarrhoea",
      "rate",
      "chest",
      "support",
      "count",
      "culture",
      "blood",
      "causes",
      "status",
      "severe"
    ]
  },
  {
    "id": "34861e854d9a75cd6c8cdb4ea1a6b4ce",
    "content": "Management\nResuscitation – every child in shock should have oxygen at a high flow rate. Venous or intraosseous access should be obtained and an infusion of normal saline at 20 ml/kg given\nIn drowsiness with sighing respirations check blood sugar and acid base balance. Treat diabetic ketoacidosis with IV normal saline and insulin In an unconscious child with pinpoint pupils consider opiate\npoisoning.",
    "title": "Cardiac disease",
    "section": "Cardiac disease",
    "chunk_id": "2524",
    "type": "section",
    "keywords": [
      "venous",
      "obtained",
      "treat",
      "given",
      "management",
      "pinpoint",
      "infusion",
      "check",
      "child",
      "unconscious",
      "rate",
      "oxygen",
      "intraosseous",
      "consider",
      "opiate",
      "base",
      "sighing",
      "saline",
      "drowsiness",
      "sugar"
    ]
  },
  {
    "id": "f3329294eab1ff04e8ef456aa6bbeb41",
    "content": "Try naloxone. Gastrointestinal: Usually presents with shock from fluid loss. Symptoms include vomiting, abdominal pain or bloody stools; signs may include abdominal tenderness or a mass.",
    "title": "Cardiac disease",
    "section": "Cardiac disease",
    "chunk_id": "2525",
    "type": "section",
    "keywords": [
      "naloxone",
      "usually",
      "include",
      "vomiting",
      "abdominal",
      "pain",
      "bloody",
      "tenderness",
      "mass",
      "shock",
      "stools",
      "signs",
      "loss",
      "presents",
      "symptoms",
      "gastrointestinal",
      "fluid"
    ]
  },
  {
    "id": "9e126d455f939b3a3d78d0654de75b0e",
    "content": "Consider surgical intervention\nGive boluses of fluid to shocked children if first one not effective. Consider IV antibiotics in shocked children with no obvious fluid loss\nNEUROLOGiCAL DiSABiLiTY\nCauses\nStatus\tepilepticus\t(continuous\tseizures\twithout\tregaining consciousness)\nMeningitis\nEncephalitis.",
    "title": "Cardiac disease",
    "section": "Cardiac disease",
    "chunk_id": "2526",
    "type": "section",
    "keywords": [
      "intervention",
      "give",
      "antibiotics",
      "seizures",
      "fluid",
      "neurological",
      "consider",
      "continuous",
      "boluses",
      "children",
      "causes",
      "status",
      "first",
      "shocked",
      "surgical",
      "consciousness",
      "regaining",
      "obvious",
      "meningitis",
      "effective"
    ]
  },
  {
    "id": "327aee8fa13455d3d17012fe4b279350",
    "content": "Signs\nAltered conscious level\nConvulsions\nAltered pupil size and reactivity\nAbnormal posture\nMeningism\nPapilloedema\nHypertension\ninvestigation\nUrea and electrolyte\nBlood sugar\nBlood culture\nManagement\nIf low blood sugar, give 5 ml/kg of 10% dextrose by rapid infusion\nProlonged fits – give rectal diazepam. If convulsions persist begin status epilepticus protocol using phenobarbitone, phenytoin and midazolam IV in that order. If evidence of raised intracranial pressure.",
    "title": "Chapter 31:  Structured Approach to the Serıously Ill Chıld",
    "section": "Chapter 31:  Structured Approach to the Serıously Ill Chıld",
    "chunk_id": "2527",
    "type": "section",
    "keywords": [
      "hypertension",
      "conscious",
      "prolonged",
      "intracranial",
      "persist",
      "give",
      "management",
      "infusion",
      "dextrose",
      "midazolam",
      "evidence",
      "diazepam",
      "rectal",
      "pressure",
      "meningism",
      "fits",
      "altered",
      "convulsions",
      "signs",
      "abnormal"
    ]
  },
  {
    "id": "bfd0d1a729a395285a8688a387cfcd39",
    "content": "Give Mannitol. In a child with depressed conscious level and convulsions consider meningitis. Give cefotaxime/Aciclovir.",
    "title": "Chapter 31:  Structured Approach to the Serıously Ill Chıld",
    "section": "Chapter 31:  Structured Approach to the Serıously Ill Chıld",
    "chunk_id": "2528",
    "type": "section",
    "keywords": [
      "conscious",
      "meningitis",
      "cefotaxime",
      "consider",
      "give",
      "level",
      "child",
      "convulsions",
      "aciclovir",
      "mannitol",
      "depressed"
    ]
  },
  {
    "id": "ba86d75ab3c297cecf2cca374fa8cd10",
    "content": "SYSTEMiC CAUSES\nCauses\nPoisoning (ingestion of kerosene, corrosives, pesticides, paracetamol)\nHypoglycaemia (think of severe malaria)\nDiabetic ketoacidosis\nAngio-oedema\nSymptoms\nRash, urticarial rash\nFever\nAbdominal pain\nVomiting\nExcessive thirst or excessive drinking\nSigns\nSevere dehydration\nDeep and rapid respiration\nSmell of ketones in breath\nPin-point pupils, large pupils\nTachypnoea\nSighing respirations\nHypothermia\nHyperthermia.",
    "title": "Chapter 31:  Structured Approach to the Serıously Ill Chıld",
    "section": "Chapter 31:  Structured Approach to the Serıously Ill Chıld",
    "chunk_id": "2529",
    "type": "section",
    "keywords": [
      "oedema",
      "systemic",
      "hyperthermia",
      "tachypnoea",
      "rash",
      "abdominal",
      "urticarial",
      "large",
      "sighing",
      "think",
      "signs",
      "diabetic",
      "malaria",
      "causes",
      "ketones",
      "severe",
      "ingestion",
      "dehydration",
      "deep",
      "rapid"
    ]
  },
  {
    "id": "1673c156a479bbcc21da08ca83980f21",
    "content": "Seriously ill children may need supplemental oxygen. Convulsing child\nEvidence Rating: [A]\nLorazepam or diazepam, phenobarbitone, or phenytoin or midazol- am in that order\nSuspected meningitis\nEvidence Rating: [A]\nCefotaxime\nSuspected Croup\nEvidence Rating: [A]\nNebulised adrenaline\nAnd\nDexamethasone\nOr\nPrednisolone\nSuspected Asthma\nEvidence Rating: [A]\nSalbutamol\nIpratropium bromide\nHydrocortisone\nPrednisolone\nAminophylline\nReferral Criteria\nRefer the seriously ill child to the appropriate specialist. FORMS\nGhana Natıonal Drugs Programme Mınıstry of Health.",
    "title": "1st Line Treatment",
    "section": "1st Line Treatment",
    "chunk_id": "2530",
    "type": "section",
    "keywords": [
      "aminophylline",
      "nebulised",
      "child",
      "programme",
      "health",
      "adrenaline",
      "evidence",
      "diazepam",
      "rating",
      "specialist",
      "oxygen",
      "supplemental",
      "asthma",
      "need",
      "phenytoin",
      "midazol",
      "convulsing",
      "children",
      "dexamethasone",
      "ipratropium"
    ]
  },
  {
    "id": "498a035dd6963056841ce606c294823a",
    "content": "Ghana Natıonal Drugs Programme Mınıstry of Health\nFeedback on Essentıal Medıcınes Lıst (EML)\nFORMS\nREPORTING FORM FOR ADVERSE EVENTS FOLLOWING IMMUNISATION (AEFI)\nMOH-Ghana Health Service/Food & Drugs Authority\nSMC/SMD/GEN- 10/1. 0\nFor District Level Office\nFor National/Central Level Office\n¶All serious AEFIs & AEFI clusters (two or more cases of the same adverse event related in time, place or vaccine administered) should be investigated. *Mandatory fields\nVaccine Safety/AEFI Surveillance\tMinistry of Health / Ghana Health Service/Food and Drugs Authority April 2017.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2531",
    "type": "section",
    "keywords": [
      "mandatory",
      "office",
      "ministry",
      "programme",
      "health",
      "clusters",
      "feedback",
      "form",
      "reporting",
      "serious",
      "fields",
      "national",
      "district",
      "following",
      "service",
      "surveillance",
      "place",
      "safety",
      "investigated",
      "vaccine"
    ]
  },
  {
    "id": "452f3bf36ef511599f696404bd093f5d",
    "content": "ABA 243\nAbatacept 557\nABC 98, 665\nAbdominal Trauma 588\nAbdominal tuberculosis 46 Abnormal Vaginal Bleeding 371 Abnormal Vaginal Discharge 373 ABO 102\nAbortion 359, 362, 363, 364, 366, 367, 368\nAcetaminophen 652\nAcetylcysteine 186, 404\nAciclovir 258, 259, 260, 263, 404, 669\nAcne Vulgaris 276\nAcquired Immune Deficiency Syndrome 461\nACT 482, 489, 491, 493\nActinomycin D 111\nActivated Charcoal Powder 57, 659, 660\nAcupuncture 562\nAcute Abdomen 585, 651\nAcute Allergic Reaction (Anaphylaxis) 644 Acute Bacterial Sialoadenitis 539\nAcute Bronchitis 180\nAcute Otitis Media 529\nAcute Rheumatic Fever 161, 163, 164\nAcute septic arthritis 597, 601\nAcute Sinusitis 526\nAcute Symptomatic Control 238 Adalimumab 557, 560\nAdapalene 278.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2532",
    "type": "section",
    "keywords": [
      "otitis",
      "arthritis",
      "abatacept",
      "acute",
      "adapalene",
      "vaginal",
      "abortion",
      "abdominal",
      "acetaminophen",
      "powder",
      "charcoal",
      "bleeding",
      "reaction",
      "abnormal",
      "acetylcysteine",
      "aciclovir",
      "acquired",
      "acupuncture",
      "allergic",
      "rheumatic"
    ]
  },
  {
    "id": "f2298afe5b3b7635583abdddbd458a8e",
    "content": "ADHD 207\nAdjuvant chemotherapy 387\nAdrenaline 517, 533, 645, 664\nAdrenal Insufficiency 307, 311\nAdult respiratory distress syndrome (ARDS) 171\nAedes aegypti 92\nAIDS 461, 495\nAKI 392, 404, 405, 406\nAlbendazole 500, 501, 502 Alcoholic Delirium Tremens 231 Alcoholic Hallucinosis 229\nAlcoholic Seizures 229\nAlcohol Withdrawal Syndromes 229 Aldosterone antagonists 150\nAlendronate 623, 624\nAcute Chest Syndrome (ACS) 69, 73, 113, 334, Alfuzosin 410\n337\nAcute Coronary Syndrome 113, 117\nAcute Cystitis 406\nAcute Epiglottitis 519\nAcute Glomerulonephritis 388, 393\nAcute heart failure 136, 137, 138, 388\nAcute Hepatitis 37\nAcute Kidney Injury 392, 406 Acute Lower Abdominal Pain 379\nAcute lymphoid leukaemia (ALL) 75 Acute myeloid leukaemia (AML) 75\nAcute Necrotizing Ulcerative Gingivitis 536 Acute-on-chronic osteomyelitis 597, 601\nacute-on-chronic septic arthritis 597, 601 Acute orthopaedic infections 597\nAcute osteomyelitis 597, 601, 604, 611, 620\nAlginate-containing antacids 26\nAllergic rhinitis 175, 279, 526\nAllopurinol 75, 77, 79, 574\nAlpha-blockers 150\nAlprazolam 238\nAmblyopia 511, 512, 513\nAmenorrhoea 382\nAminophylline 178, 646, 670\nAmiodarone 55, 303\nAmitriptyline 216, 219, 235, 260, 563, 565,\n566\nAmlodipine 149, 150, 154\nAmoebiasis 11, 12\nAmoebic dysentery 14 Amoebic Liver Access 33\nAmoxicillin 24, 31, 60, 92, 172, 182, 186, 357,.",
    "title": "Addison’s disease 307",
    "section": "Addison’s disease 307",
    "chunk_id": "2533",
    "type": "section",
    "keywords": [
      "infections",
      "hallucinosis",
      "aminophylline",
      "alginate",
      "seizures",
      "necrotizing",
      "liver",
      "aids",
      "arthritis",
      "adrenaline",
      "lymphoid",
      "acute",
      "gingivitis",
      "insufficiency",
      "antacids",
      "aegypti",
      "abdominal",
      "leukaemia",
      "chest",
      "alcohol"
    ]
  },
  {
    "id": "9157d7eb7273618d94f7b4bf616821f6",
    "content": "361, 363, 365, 525, 527, 530, 537, 538, 546, 133, 163, 175, 272, 470\n605, 649, 650\nAmpicillin 99, 499, 648, 649, 650\nAmyloidosis 390\nANA 389, 391, 555, 558, 568, 578\nAsteatotic eczema 279\nAsterixis 37, 43, 55, 397\nAsthma 25, 121, 149, 175, 176, 177, 178, 179,\n180, 187, 318, 670\nAnaemia 12, 62, 64, 106, 121, 317, 331, 364, Ataxia 166, 232, 261\n398, 399, 400, 578\nAnaemia In Pregnancy 331\nAnaerobes 539, 647\nAnakinra 557, 560, 576\nAnalgesia in Labour 336, 337\nAnaphylaxis 82, 122, 273, 644, 646 Angiotensin Converting Enzyme Inhibitor 149 Angiotensin Receptor Blocker 149\nAniridia 110\nAtazanavir 463\nAtenolol 116, 119, 120, 150, 153, 158, 159\nAtherosclerosis 115, 118\nAtomoxetine 208\nAtopic Eczema 270, 279, 280\nAtorvastatin 120, 131, 301, 302\nAtrial Fibrillation 129, 133, 137, 139, 156, 157,\n158, 159, 160\nAtrial flutter 156, 158, 159\nAnorexia 12, 33, 37, 53, 55, 262, 388, 396, 586 Atropine 18, 19, 353, 515, 517, 660.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2534",
    "type": "section",
    "keywords": [
      "angiotensin",
      "asteatotic",
      "atenolol",
      "anaemia",
      "eczema",
      "atrial",
      "labour",
      "atomoxetine",
      "aniridia",
      "ampicillin",
      "analgesia",
      "anaerobes",
      "asthma",
      "flutter",
      "atropine",
      "pregnancy",
      "anakinra",
      "fibrillation",
      "atherosclerosis",
      "atorvastatin"
    ]
  },
  {
    "id": "c6cd5d8ef1826b5c7ca968a17654075c",
    "content": "Antibiotic Prophylaxis in Surgery 45, 336, 338, (ADHD) 207\n538, 647\tAutistic Spectrum Disorder 242\nAnticoagulation 119, 126, 129, 133, 138, 160 Avascular Necrosis 621\nAnti–cyclic citrullinated peptide (CCP) anti- Azathioprine 55, 557, 570, 580, 581\nbody 558\nAnti-Double stranded DNA 578 Anti D Rh Immune Globulin 362 Anti Nuclear Antibodies (ANA) 558\nAnxiety 23, 48, 49, 114, 115, 214, 215, 229,\n233, 234, 235, 236, 237, 238, 239, 241, 267,\n384, 550, 551, 560, 564, 565, 620.",
    "title": "Antenatal Care 89, 314, 324, 337, 338, 339\tAttention Deficit Hyperactivity Disorder",
    "section": "Antenatal Care 89, 314, 324, 337, 338, 339\tAttention Deficit Hyperactivity Disorder",
    "chunk_id": "2535",
    "type": "section",
    "keywords": [
      "globulin",
      "antibiotic",
      "anxiety",
      "body",
      "anticoagulation",
      "double",
      "peptide",
      "nuclear",
      "azathioprine",
      "antibodies",
      "autistic",
      "stranded",
      "avascular",
      "immune",
      "anti",
      "necrosis",
      "disorder",
      "cyclic",
      "adhd",
      "citrullinated"
    ]
  },
  {
    "id": "79b7ca8b62facd5ddd8d25df2ea02054",
    "content": "Aortic dissection 113\nAphthous Ulcers 544\nApnoea 84, 98\nApplied Behaviour Analysis (ABA) 243 Aqueous cream 270\nAqueous soap 270\nArrhythmias 156, 161, 667\nArtemether 485, 487, 491, 493\nArtemether + Lumefantrine 483, 493\nAzithromycin 85, 92, 172, 173, 174, 183, 186,\n188, 248, 251, 264, 276, 376, 481, 507, 526,\n528, 531, 547\nAzoospermia 382\nBack pain 472, 560, 619, 656\nBacterial Endocarditis and Prophylaxis in Den- tistry 538\nBacterial Skin Infections 245 Bacterial vaginosis 359, 375\nBacteriodes 541\nBacteroides 608\nBarium meal 23\nBarium swallow 26, 28\nBCG 80, 82\nArtemisinin Combination Therapy (ACT) 482, Beclometasone 179\n489, 491\nBeclomethasone 179\nArtesunate 484, 485, 487, 488, 489, 490, 491, Behcet’s syndrome 544\n493\nArtesunate + Amodiaquine 483, 484\nArthralgia 39, 577, 580\nArthrodesis 553, 555, 616\nArthropathy 549, 577\nArthroplasties 553\nBelimumab 580\nBendroflumethiazide 149, 153 Benign Prostatic Hyperplasia 408\nBenign Prostatic Hyperplasia (BPH) 408, 409\nBenzathine benzylpenicillin 163, 164\nBenzathine Penicillin 251\nAscites 36, 39, 41, 42, 46, 47, 48, 54, 122, 135, Benzatropine 224\n390\nAscitic fluid accumulation 47 ASD 242, 243\nAsphyxia 100\nAspiration pneumonia 133, 170, 568\nBenzhexol 224\nBenzodiazepines 659\nBenzodiazepine withdrawal 239, 240\nBenzoic acid compound ointment 253, 255\nBenzoyl peroxide 278\nAspirin 48, 66, 73, 116, 119, 120, 121, 131, Benztropine 224, 225\nBenzyl benzoate 269\nBenzylpenicillin 87, 497, 585\nBenzyl Penicillin 92\nBeta-blockers 149, 150\nBeta-haemolytic streptococci 189\nINDEX\nCalcium Channel Blockers 25, 149, 150\nCalcium gluconate 395, 398\nCalcium pyrophosphate dihydrate (CPPD) 575 Calcium with Vitamin D supplements 569, 580 Campylobacter 11\nBetamethasone 281, 282, 286, 355, 357, 554, Candesartan 120, 139, 150\n576, 614.",
    "title": "Anxiety Disorders 233",
    "section": "Anxiety Disorders 233",
    "chunk_id": "2536",
    "type": "section",
    "keywords": [
      "meal",
      "supplements",
      "penicillin",
      "arthropathy",
      "swallow",
      "benzhexol",
      "behaviour",
      "benzatropine",
      "belimumab",
      "lumefantrine",
      "bendroflumethiazide",
      "pyrophosphate",
      "apnoea",
      "calcium",
      "acid",
      "azithromycin",
      "benzoic",
      "back",
      "hyperplasia",
      "bacteriodes"
    ]
  },
  {
    "id": "dd2c0dbe3701b60d1a1508a036fa1375",
    "content": "Bilirubin 35, 36, 56, 101, 102, 103, 104, 105\nBilirubin encephalopathy 35, 101, 103\nBiperidine 225\nBipolar Disorder 226\nBirth asphyxia 97\nBirth Injuries 104\nBisacodyl 21\nBisoprolol 116, 120, 139, 150, 158, 159\nBisphosphonates 569, 620 Biventricular failure (BVF) 134 Blackouts 165\nCandida 252, 255, 283, 284, 535\nCandida albicans 283, 535\nCandidiasis 269, 374, 376, 535\nCannabis withdrawal 239, 240\nCarbamate 660\ncarbamazepine 55\nCarbamazepine 201, 202, 228, 229, 261, 551\nCarbimazole 306\nCarbocysteine 182, 187\nCarboplatin 109, 111 Carcinoma of the Cervix 386 Cardiac Arrhythmias 121, 134\nCardiac failure 46\nCardiac neurosis 113\nBleeding 24, 36, 62, 65, 66, 67, 93, 318, 332, Cardiogenic shock 114, 120, 122, 138\n371, 397, 532, 537, 543, 593, 618.",
    "title": "Bethamethsone 356 Biliary tree disease 113",
    "section": "Bethamethsone 356 Biliary tree disease 113",
    "chunk_id": "2537",
    "type": "section",
    "keywords": [
      "bilirubin",
      "candida",
      "injuries",
      "bisphosphonates",
      "encephalopathy",
      "neurosis",
      "bisoprolol",
      "bipolar",
      "albicans",
      "carbimazole",
      "candidiasis",
      "bleeding",
      "carbocysteine",
      "cervix",
      "carboplatin",
      "carbamazepine",
      "bisacodyl",
      "biventricular",
      "biperidine",
      "arrhythmias"
    ]
  },
  {
    "id": "6e26c11cc686fa805bfa12dd70ff0833",
    "content": "Cardiomegaly 141\nCardiomyopathies 134, 157\nCarvedilol 138, 150\nBlood transfusion 32, 65, 72, 106, 333, 337, Cataract 288, 510\n394, 587\nBlue stone 614\nBoils 245\nBone Marrow Failure 62 Bordetella pertussis 84\nBradyarrhythmias 156\nBradycardia 98\nBreast Cancer 655\nBromocriptine 383\nBronchial Asthma 175\nBronchiectasis 187, 189\nBruxism 549\nBudesonide 178, 179, 185, 516\nBullous pemphigoid 267\nBullous Reaction 273\nBupivacaine 654, 664\nBuprenorphine 242\nBurkitt’s lymphoma 77\nBurns 393, 624, 630, 651\nBursitis 570\nBuruli Ulcer 9, 249, 250\nCachexia 54, 472\nCalamine lotion 84, 263, 270\nCalcitonin 620\nCefixime 376\nCefotaxime 46, 99, 498, 499, 520, 670\nCeftazidime 499\nCeftriaxone 45, 46, 110, 112, 174, 190, 338,\n376, 380, 402, 481, 496, 498, 499, 542, 588\nCefuroxime 14, 60, 172, 248, 402, 403, 407,\n408, 517, 519, 520, 522, 526, 528, 531, 589,\n594, 628, 649\nCelecoxib 553, 556, 559, 562, 576, 579, 592,\n596, 622, 626\nCellulitis 249, 470, 604 Centrally acting agents 150\nCephalhaematoma 36, 102, 104, 105\nCerebrospinal meningitis 495\nCertolizumab 557\nCervicitis 376\nCervico-Facial Abscess 540\nCetirizine 168, 263, 268, 270, 271, 273\nCetrimide 266, 276\nChemosis 505\nchest pain 28, 69, 115, 116, 145, 170, 180, 317\nChest Pain 28, 113\nchickenpox 259\nChicken pox 261, 262.",
    "title": "Bleeding Disorders 65 Bleeding peptic ulcer 24",
    "section": "Bleeding Disorders 65 Bleeding peptic ulcer 24",
    "chunk_id": "2538",
    "type": "section",
    "keywords": [
      "cefixime",
      "lotion",
      "centrally",
      "burkitt",
      "agents",
      "chicken",
      "lymphoma",
      "cervicitis",
      "bursitis",
      "pain",
      "ulcer",
      "chemosis",
      "bronchiectasis",
      "pertussis",
      "cellulitis",
      "celecoxib",
      "bordetella",
      "breast",
      "calcitonin",
      "abscess"
    ]
  },
  {
    "id": "5baeeea8d833a539886a83f5187d4a2e",
    "content": "Chloral hydrate 212\nCalcium 25, 149, 150, 153, 197, 330, 395, 397, Chloramphenicol 107, 497, 505, 508, 512\n398, 405, 556, 568, 569, 580, 617, 619, 620\nChlordiazepoxide 232.",
    "title": "Childhood Immunisable Diseases 80 Chlamydia trachomatis 106, 374",
    "section": "Childhood Immunisable Diseases 80 Chlamydia trachomatis 106, 374",
    "chunk_id": "2539",
    "type": "section",
    "keywords": [
      "chloral",
      "chlordiazepoxide",
      "calcium",
      "hydrate",
      "chloramphenicol"
    ]
  },
  {
    "id": "2dd346080d1f71bb5cd1da036547942f",
    "content": "Chlorhexidine 266, 276\nChlorhexidine solution 266, 276\nChlorinated Hydrocarbon 660\nChlorphenamine 273, 281\nChlorpheniramine 169, 263, 268, 271, 646\nChlorpromazine 88, 212, 222, 224, 227\nCholera 15\nCholestatic jaundice 36\nCholestyramine 37, 660\nChondrocalcinosis 575 Chronic Active Hepatitis 40 Chronic Asthma 178\nChronic Bronchitis 183\nChronic Hepatitis 38\n609, 650\nCocaine 203, 210, 214, 239, 240\nCodeine 18, 19, 72, 182, 563, 592, 597, 600\nCodeine containing cough preparations 182\nCodeine phosphate 72\nCognitive Behaviour Therapy 215, 218, 220,\n235, 236, 237, 238, 242\nColchicine 146, 574, 576\nCold sores 257\nColonoscopy 20\nComa 43, 44, 84, 143, 328, 329, 388, 468, 486,\n496, 511, 583, 658, 659, 660, 661, 666\nCombined conjugated oestrogens and pro- gestogen, 385.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2540",
    "type": "section",
    "keywords": [
      "chondrocalcinosis",
      "phosphate",
      "sores",
      "conjugated",
      "cognitive",
      "chlorinated",
      "oestrogens",
      "cocaine",
      "colchicine",
      "therapy",
      "hydrocarbon",
      "jaundice",
      "preparations",
      "asthma",
      "cold",
      "behaviour",
      "chlorphenamine",
      "chlorpromazine",
      "chronic",
      "combined"
    ]
  },
  {
    "id": "6206b7d3c7951c1e5edcd0c5b2bc38aa",
    "content": "398, 399, 400\nChronic lymphoid leukaemia (CLL) 75 Chronic myeloid leukaemia (CML) 75 Chronic Osteomyelitis 601\nChronic Otitis Media 531\nChronic Periodontal Infections 543 chronic pyelonephritis 152 Chronic Septic Arthritis 601 Ciclopirox 253, 255, 613\nCiclopirox olamine 253, 255\nCinnarizine 51\nCommunity acquired pneumonia 170 Compelling indications for the choice of anti- hypertensives 149\nConcentrated red cell transfusion 67 Congenital Heart Disease 140 Congestive cardiac failure (CCF) 134 Conjugated oestrogens 373, 385\nConjunctivitis 83, 505, 506, 507\nConstipation 19, 86, 304, 480, 564\nContact Dermatitis 271, 279, 282\nConversion disorder 165\nCiprofloxacin 14, 31, 45, 46, 174, 380, 402, Convulsions 81, 97, 143, 196, 298, 328, 329,\n407, 481, 498, 508, 532, 588, 600, 602, 603, 495, 595, 669\n604, 649\nCisplatin 405\nCitalopram 219\nClarithromycin 24, 85, 250, 285\nClavulanic acid 357, 365\nCOPD 121, 122, 123, 183, 187\nCopper sulphate stone 614 Corneal Ulcer 506.",
    "title": "Chronic kidney disease (CKD) 147, 148, 396, Common Cold 167",
    "section": "Chronic kidney disease (CKD) 147, 148, 396, Common Cold 167",
    "chunk_id": "2541",
    "type": "section",
    "keywords": [
      "infections",
      "choice",
      "sulphate",
      "copd",
      "conjugated",
      "copper",
      "ulcer",
      "hypertensives",
      "otitis",
      "oestrogens",
      "arthritis",
      "lymphoid",
      "ciclopirox",
      "ciprofloxacin",
      "dermatitis",
      "indications",
      "periodontal",
      "leukaemia",
      "clavulanic",
      "convulsions"
    ]
  },
  {
    "id": "ca5c3aabc97f6356300ba08dc30ff2a8",
    "content": "Clindamycin 174, 191, 278, 375, 491, 492, Corona virus 167, 180\n497, 537, 539, 540, 542, 543, 547, 594, 599, Corynebacterium diphtheriae 91\n603, 606, 608, 609, 612, 627, 649, 650\nClobetasol propionate 614\nClomifene citrate 383\nClonazepam 565\nClonidine 242, 567\nclopidogrel 66\nClopidogrel 116, 119\nClosed Fractures 590\nClostridium perfringens 608\nClostridium tetani 86, 87\nCost-effectiveness 3\nCostochondritis 113\nCough 33, 82, 114, 127, 134, 167, 175, 184,\n189, 470, 472, 515, 517, 524, 527, 656\nCPPD 575\nCrash 240\nC-reactive protein 115, 118, 162, 171, 555,\n558, 571\nCreatinine kinase-MB (CK-MB) 116, 118, 123,\n155\nClotrimazole 253, 255, 256, 269, 281, 284, Crepitus 590, 593\n376, 613\tCretinism 303\nCloxacillin 99, 110, 112, 190, 248, 517, 584, Croup 517, 670\n598, 599, 602, 603, 607, 612, 627, 629\nCoagulase negative staphylococci 647 Coagulation factor 68\nCryoprecipitate 68\nCryptococcus neoformans 495\nCSM 495, 498\nCo-amoxiclav 173, 174, 182, 186, 188, 190, Cushing’s Syndrome 147, 152, 217, 288, 310,\n191, 248, 264, 338, 403, 518, 520, 525, 527, 311\n530, 541, 543, 546, 584, 599, 603, 606, 607, Cyanide 661\nINDEX\nCyanosis 43, 84, 86, 97, 122, 127, 141, 176, Digital rectal examination 20\n184, 516, 518, 520, 644\nCyclizine 51, 52\nCyclobenzaprine 566\nCyclophosphamide 109, 111, 580, 581\nCyclosporin 405, 557, 580\nCystitis 385, 401, 406, 407, 408\nCytomegalovirus 274\nDaCosta’s syndrome 113\nDalteparin 126, 128, 629\nDarbepoietin alfa 400\nD-Dimer test 124, 128\nDDT 660\nDecompensated liver cirrhosis 40\nDigoxin 137, 139, 159, 160\nDihydroartemisinin-Piperaquine 483\nDiloxanide furoate 34\nDiphenoxylate 18\nDiphtheria 81, 90, 91\nDiphtheria antitoxin 91\nDiplopia 512, 513\nDiscoid eczema 279\nDislocations 595, 622\ndisopyramide 20\nDisorders Of The Musculoskeletal System 552 Disorders Of The Respiratory System 167 Disorders of the Skin 245\nDisseminated intravascular coagulation (DIC) 66, 68, 364\nDizziness 63, 148, 157, 164, 298, 332, 384,\nDeep Vein Thrombosis (DVT) 123, 124, 125, 586\n126, 127, 128, 133, 160, 604\nDizziness and Blackouts 164\nDehydration 11, 12, 13, 15, 16, 17, 18, 20, 44, DKA 205, 293\n48, 49, 50, 69, 70, 74, 83, 84, 125, 143, 230, DMARDs 580\n262, 293, 294, 307, 322, 323, 336, 337, 393, Dobutamine 138\n406, 468, 486, 487, 541, 572, 573, 586, 620, Domperidone 27, 50, 51\n658, 669\nDelirium Tremens (DT) 231 Delusions 210, 221\nDenosumab 620\nDental Caries 534\nDoxorubicin 111\nDoxycycline 15, 172, 278, 376, 380, 546\nD-penicillamine 557\nDPT 81\nDrug-induced liver injury (DILI) 55\nDepression 48, 49, 183, 209, 215, 216, 217, Drug resistant tuberculosis (DR-TB) 476\n218, 220, 226, 227, 267, 337, 384, 560, 564, Drugs and the Liver 55\n565, 659\nDermatitis 267, 270, 279, 280, 283, 285, 462\nDermatitis herpetiformis 267\nDesferrioxamine 661\nDesmopressin 67, 68\nDrug susceptibility testing (DST) 474 dsDNA 578\nDuloxetine 566\nDuodenal ulcers 22\nDVT Prophylaxis 125.",
    "title": "Coronary Heart Disease 121 Coronary vasospasm 113",
    "section": "Coronary Heart Disease 121 Coronary vasospasm 113",
    "chunk_id": "2542",
    "type": "section",
    "keywords": [
      "virus",
      "citrate",
      "antitoxin",
      "dobutamine",
      "induced",
      "cryptococcus",
      "duloxetine",
      "cretinism",
      "dalteparin",
      "doxorubicin",
      "cyanide",
      "protein",
      "clotrimazole",
      "crash",
      "clindamycin",
      "fractures",
      "doxycycline",
      "reactive",
      "thrombosis",
      "respiratory"
    ]
  },
  {
    "id": "9a459d23673bc616dc339797a423ce36",
    "content": "516, 670\nDextromethorphan 182\nDysarthria 130\nDyslipidaemia 147, 300\nDextrose 44, 71, 72, 98, 101, 178, 199, 204, Dysmenorrhea 358\n232, 299, 308, 323, 355, 395, 398, 405, 489, Dyspepsia 23, 25, 577, 586\n490, 491, 516\nDextrose saline 44, 232, 491, 516\nDiabetes Mellitus 147, 149, 267, 287, 318,\n338, 339, 354, 390, 396\nDiabetes Mellitus in Pregnancy 338\nDiabetic Ketoacidosis 121, 203, 205, 293, 669\nDysphagia 27, 91, 130, 519\nDyspnoea 54, 114, 121, 127, 134, 152\nE45 cream 280.",
    "title": "Dexamethasone 52, 133, 310, 356, 357, 498, DVT Treatment 125",
    "section": "Dexamethasone 52, 133, 310, 356, 357, 498, DVT Treatment 125",
    "chunk_id": "2543",
    "type": "section",
    "keywords": [
      "dyspnoea",
      "dyslipidaemia",
      "dextromethorphan",
      "diabetes",
      "dysarthria",
      "dextrose",
      "dysmenorrhea",
      "saline",
      "mellitus",
      "dyspepsia",
      "pregnancy",
      "cream",
      "diabetic",
      "dysphagia",
      "ketoacidosis"
    ]
  },
  {
    "id": "71e14da3d5588699a5d8577e136ffea3",
    "content": "394, 529, 658, 668\tEcchymosis 66, 93\nDiazepam 25, 88, 198, 199, 205, 212, 213, Eclampsia 196, 324, 325, 328, 331, 393\n220, 225, 228, 232, 233, 236, 238, 330, 353, Econazole 613\n549, 551, 562, 660\tEczema 175, 245, 246, 258, 267, 270, 279,\nDiclofenac 71, 72, 195, 242, 260, 337, 381, 280, 281, 283, 284, 285, 656\n553, 554, 556, 559, 562, 565, 571, 572, 574, Efavirenz 463, 464\n576, 579, 591, 596, 600, 623, 626, 653\tEmpyema 33, 94, 95.",
    "title": "Diarrhoea 11, 12, 18, 19, 49, 83, 93, 307, 393, Ear, Nose And Throat Disorders 515",
    "section": "Diarrhoea 11, 12, 18, 19, 49, 83, 93, 307, 393, Ear, Nose And Throat Disorders 515",
    "chunk_id": "2544",
    "type": "section",
    "keywords": [
      "diazepam",
      "econazole",
      "eclampsia",
      "diclofenac",
      "eczema",
      "efavirenz",
      "ecchymosis",
      "empyema"
    ]
  },
  {
    "id": "ccc5f7ab93ba0383fe9de7fcf7071e06",
    "content": "Emtricitabine 463, 466\nEnalapril 153\nEndobronchial TB 475.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2545",
    "type": "section",
    "keywords": [
      "enalapril",
      "emtricitabine",
      "endobronchial"
    ]
  },
  {
    "id": "57d6df6b6fd16603730daef4193c239f",
    "content": "complications 514\nEndometriosis 358, 382\nEndosulfan 660\nEnoxaparin 119, 125, 126, 128, 138, 628\nEntamoeba histolytica 11, 33, 34\nEntecavir 40\nEnteric fever 479\nEnterobacteriaceae 647\nEnterococci 406\nEphedrine 528\nEpidermidis 597, 611\nEpidermophyton 252\nFerric sodium gluconate complex 400 Ferritin 335, 399\nFerrous fumarate 64, 317\nFerrous gluconate 333, 400\nFerrous sulphate 64, 317, 333, 400\nFever 18, 33, 37, 43, 74, 76, 78, 83, 90, 93,\n94, 95, 110, 114, 122, 145, 162, 170, 171, 180,\n184, 188, 189, 194, 210, 231, 245, 257, 259,\n262, 274, 275, 356, 364, 379, 388, 401, 468,\n470, 471, 472, 479, 480, 483, 495, 496, 519,\n521, 523, 529, 537, 539, 541, 546, 558, 570,\n571, 573, 577, 586, 598, 604, 609, 611, 620,\nEpilepsy 81, 165, 196, 200, 201, 202, 203, 205, 669\n213, 219, 242\nEpiscleritis 506\nEpistaxis 532\nEpoietin beta 400\nEpstein-Barr 73\nErbs Palsy 105\nErectile dysfunction 288, 382\nErgometrine 362\nErysipelas 249, 470\nErythema multiforme 273\nErythrasma 283, 285\nFibromyalgia 561, 563, 567\nFilariasis 390\nFinasteride 410\nFive In One 80, 81\nFlaccid paralysis 90\nFlucloxacillin 55, 191, 246, 248, 264, 523, 540,\n606, 607, 612, 626\nFluconazole 29, 110, 112, 376, 536, 613\nFlumazenil 659\nFluoroquinolones 499\nFluoxetine 218, 235, 237, 566\nErythromycin 15, 85, 163, 164, 172, 183, 186, Flupenthixol 224\n246, 276, 278, 285, 357, 363, 376, 526, 528, Fluphenazine 224\n531, 606\nEscherichia coli 11, 406, 495, 597\nFluticasone 179, 185\nFocal and segmental glomerulosclerosis\nEsomeprazole 23, 24, 27, 28, 29, 556, 569, (FSGS) 390\n579, 628\nEsotropia 512\nEstrogen therapy (ET) 620\nEtanercept 557, 560\nEthambutol 474, 475\nEthanol 661\nEthinylestradiol + levonorgestrel 373 Ethinylestradiol + norethisterone 373 Ethosuximide 202\nEthylene glycol 661\nEtoposide 109, 111\nEusol 266\nExchange transfusion 102\nExotropia 512.",
    "title": "Endocrine and metabolic disorders with eye Female Infertility 382",
    "section": "Endocrine and metabolic disorders with eye Female Infertility 382",
    "chunk_id": "2546",
    "type": "section",
    "keywords": [
      "esotropia",
      "etanercept",
      "fluoroquinolones",
      "palsy",
      "epstein",
      "escherichia",
      "erysipelas",
      "episcleritis",
      "epoietin",
      "erythromycin",
      "ethanol",
      "ferritin",
      "fsgs",
      "ethambutol",
      "ethosuximide",
      "fluoxetine",
      "transfusion",
      "complications",
      "glomerulosclerosis",
      "exotropia"
    ]
  },
  {
    "id": "cc0a928b49396e4f8f682d3b0c635b2a",
    "content": "Folic Acid 62, 65, 72, 232, 317, 333\nFolliculitis 246\nFomepizole 661\nForeign body in the eye 504 Fractures 105, 590, 592, 593, 619\nFresh Frozen Plasma 45, 67, 68, 94, 660 Fulminant liver failure 40\nFungal Skin Infections 251, 252\nFurosemide 48, 136, 137, 138, 333, 389, 391,\n394, 398\nFuruncle 245\nFurunculosis 246\nExpanded Programme on Immunisation (EPI) Fusidic acid 285 38, 61\nExposure Keratopathy 511\nExtensive Caput Succedaneum 104, 105\nExtra-pyramidal reactions 220.",
    "title": "Focused Antenatal Care 314 Folate Deficiency 65",
    "section": "Focused Antenatal Care 314 Folate Deficiency 65",
    "chunk_id": "2547",
    "type": "section",
    "keywords": [
      "infections",
      "extra",
      "plasma",
      "fulminant",
      "succedaneum",
      "programme",
      "pyramidal",
      "body",
      "fungal",
      "expanded",
      "frozen",
      "foreign",
      "extensive",
      "folliculitis",
      "fresh",
      "reactions",
      "fractures",
      "caput",
      "acid",
      "furunculosis"
    ]
  },
  {
    "id": "2369c5ca581885a41b41c19e26a8fdc3",
    "content": "Gabapentin 567\nGangrene 288, 364, 514\nGardnerella vaginalis 374\nGastric ulcers 22\nGastroenteritis 14, 48, 49, 668\nINDEX\nHaloperidol 211, 223, 224, 227, 230, 585\nHalothane 43, 55\nHand Infections 610.",
    "title": "Eye Disorders 503",
    "section": "Eye Disorders 503",
    "chunk_id": "2548",
    "type": "section",
    "keywords": [
      "infections",
      "gangrene",
      "hand",
      "gardnerella",
      "haloperidol",
      "halothane",
      "gastric",
      "gastroenteritis",
      "vaginalis",
      "ulcers",
      "index",
      "gabapentin"
    ]
  },
  {
    "id": "e9111bd89e64ce694ea5afadc06374ed",
    "content": "HBSS 69\nHBS βthalassaemia 69\nGentamicin 31, 87, 99, 110, 112, 190, 365, Headache 90, 93, 155, 193, 239, 259, 262,\n402, 403, 517, 532, 542, 587, 599, 629, 648, 364, 470, 471, 483, 651, 656, 658, 661\n649, 650\nGestational diabetes 288, 338, 339\nGlaucoma 506, 508, 509\nGlibenclamide 291, 292\nGliclazide 292\nGlimepiride 292\nGlomerular filtration rate (eGFR) 396 Glomerular filtration rate (GFR) 399 Glucagon 299\nHead Injuries 582\nHeartburn 25, 49\nHeart Failure 121, 134, 135, 138, 142, 164\nHelicobacter pylori 22, 24, 78\nHELLP (Haemolysis Elevated Liver Enzymes Low Platelet) Syndrome 393\nHemianopia 130\nHemihypertrophy 110\nHemiparesis 143\nGlucose-6-phosphate dehydrogenase (G6PD) Heparin 66, 125, 126, 129, 133\ndeficiency 35, 36, 62, 102, 316, 320, 332, 393, Hepatic Encephalopathy 42, 45, 46, 54\n480, 494\nGlycerol 21\nGlyceryl trinitrate 116, 119\nGnathopathy 70\nGoitre 302, 304, 305, 306\nGold salts 557\nGolimumab 557\nGonioscopy 509\nGonococcus 406\nGonorrhoea 376\nGottron’s papules 568\nGottron’s sign 568\nGout 149, 300, 311, 570, 572, 574, 575\nGranisetron 52, 109, 111.",
    "title": "General Emergencies 644 Generalised Anxiety Disorders 234",
    "section": "General Emergencies 644 Generalised Anxiety Disorders 234",
    "chunk_id": "2549",
    "type": "section",
    "keywords": [
      "injuries",
      "encephalopathy",
      "phosphate",
      "trinitrate",
      "hemiparesis",
      "headache",
      "hemihypertrophy",
      "glucose",
      "pylori",
      "hbss",
      "heparin",
      "rate",
      "heartburn",
      "salts",
      "dehydrogenase",
      "gold",
      "filtration",
      "heart",
      "gonorrhoea",
      "gout"
    ]
  },
  {
    "id": "9c1aac0238e8ae1ab0233e00f1e8aebd",
    "content": "Haematuria 63, 110, 152, 388, 401, 406\nHaemolysis 35, 62, 102, 393\nHaemophilia A 67, 68\nHaemophilia B 68\nHepatitis 35, 36, 37, 38, 39, 40, 41, 42, 43, 54,\n56, 73, 81, 96, 388, 390, 391, 461, 462, 464,\n471, 555, 568, 578\nHepatocellular Carcinoma 53, 54\nHepatomegaly 36, 37, 54, 69, 141\nHeptachlor 660\nHeroine 239\nHerpes Simplex Infections 257\nHerpes Simplex Virus 106, 257, 274, 374\nHerpes Virus 73\nHerpes Zoster 113, 259, 260, 261, 262\nHerpetiform ulcers 544\nHiatus hernia 25, 28, 113 High potency Vitamin B 44 HLA-B27 562\nHodgkin’s Lymphoma 77, 79\nHole-in-Heart 140\nHookworm 499, 500\nHormone Replacement Therapy (HRT) 385, 620, 655\nHospital acquired pneumonia 170 How to prepare ORS 16\nHRZE 473, 474\nHuman Immune Deficiency Virus 11, 12, 39,\n41, 42, 58, 59, 73, 82, 170, 180, 187, 196, 210,\n252, 255, 259, 263, 274, 279, 280, 307, 316,\n318, 320, 321, 332, 333, 368, 380, 386, 388,\n390, 391, 461, 462, 464, 471, 472, 473, 474,\nHaemophilus influenzae 94, 170, 180, 495, 475, 495, 535, 544, 555, 568, 578, 608, 609,\n519, 523, 527, 529, 597.",
    "title": "Haematological Disorders 62",
    "section": "Haematological Disorders 62",
    "chunk_id": "2550",
    "type": "section",
    "keywords": [
      "infections",
      "hepatomegaly",
      "virus",
      "lymphoma",
      "replacement",
      "hodgkin",
      "hrze",
      "therapy",
      "vitamin",
      "haemophilus",
      "haemophilia",
      "prepare",
      "hernia",
      "heart",
      "acquired",
      "herpes",
      "zoster",
      "simplex",
      "deficiency",
      "haematuria"
    ]
  },
  {
    "id": "fbae24df500086dd9c5ce9ed516cb9fa",
    "content": "Haemorrhagic Stroke 131\nHaemorrhoids 29, 31, 62\nHallucinations 218, 221, 353\n615, 621\nHuman Immune Tetanus Globulin 366 Human Papilloma Virus [HPV] 386, 462, 548 Human Tetanus Immunoglobulin 88 Hydralazine 150, 154, 156, 331\nHydrochlorothiazide 149.",
    "title": "Haemophilus Influenzae type b Disease 94 Haemoptysis 127, 187, 189",
    "section": "Haemophilus Influenzae type b Disease 94 Haemoptysis 127, 187, 189",
    "chunk_id": "2551",
    "type": "section",
    "keywords": [
      "hydralazine",
      "stroke",
      "human",
      "hydrochlorothiazide",
      "virus",
      "immunoglobulin",
      "globulin",
      "tetanus",
      "papilloma",
      "immune",
      "hallucinations",
      "haemorrhagic",
      "haemorrhoids"
    ]
  },
  {
    "id": "b2bfb04afcc1387270dc67f417e9fbd3",
    "content": "Hydrocortisone 177, 178, 268, 270, 271, 275, cy (IPTp) 492, 493, 494\n281, 283, 284, 285, 308, 309, 310, 517, 518, Intertrigo 255, 283, 284\n529, 614, 645, 670\nHydrops fetalis 104\nHydroxycarbamide 73\nHydroxychloroquine 557, 569, 580, 581\nHydroxycobalamin 661\nHydroxymethyl cellulose 512\nHyoscine butylbromide 25\nHyperbilirubinaemia 35, 102, 338\nHypercalcaemia 19, 48, 73, 338\nHypercyanotic attack 141, 142, 143, 144, 145\nHyperemesis Gravidarum 322\nHypermetropia 513\nHyperpyrexia 486\nIntrauterine contraceptive device (IUCD) 371, 373, 379\nIntravenous immunoglobulin 570 intravenous regional anaesthesia (IVRA) 664 Invasive Pneumococcal Diseases (IPD) 95 Ipratropium bromide 177, 178, 185, 670\nIPTp with sulfadoxine-pyrimethamine (IPTp- SP) 493\nIron Deficiency Anaemia 25, 64\nIron dextran 64\nIron (III) hydroxide Polymaltose complex 317 Iron preparation 32\nIron sucrose 64, 400.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2552",
    "type": "section",
    "keywords": [
      "pyrimethamine",
      "hydroxychloroquine",
      "intravenous",
      "sulfadoxine",
      "anaemia",
      "contraceptive",
      "hyperbilirubinaemia",
      "preparation",
      "hypermetropia",
      "fetalis",
      "gravidarum",
      "diseases",
      "attack",
      "hydroxycobalamin",
      "invasive",
      "hydroxycarbamide",
      "hyperemesis",
      "hydroxymethyl",
      "regional",
      "ipratropium"
    ]
  },
  {
    "id": "b01b9689debcb0b47d25184377dc9413",
    "content": "324, 325, 331, 354, 388, 389, 395, 397, 398, Isoniazid 43, 55, 474, 475, 476\n405, 532, 669\tIsosorbide Dinitrate 117, 121\nHypertension in children and adolescents 152 Itraconazole 254, 257, 282, 284, 613 Hypertension In Pregnancy 323\nHypertensive Emergencies 154\nHypertensive encephalopathy 152, 154, 196,\n389\nJaundice 33, 35, 37, 39, 43, 49, 53, 54, 55, 63,\nHyperthyroidism 11, 147, 233, 234, 302, 303, 69, 93, 98, 101, 102, 103, 105, 332, 335, 471,\n305, 619\nHypertonic Saline 584\nHypoalbuminaemia 39, 41, 42, 390\nHypoglycaemia 165, 203, 204, 210, 298, 338,\n669\n658\nJuvenile Idiopathic Arthritis 557\nKDIGO 392\nHypothyroidism 19, 63, 102, 147, 157, 217, Keratitis 506\n300, 302, 303, 563\nKeratomalacia 503\nKeratopathy 512\nKernicterus 35, 101, 102, 103\nIbuprofen 71, 146, 163, 195, 242, 260, 359, Ketamine 353, 354\n404, 469, 524, 535, 545, 550, 551, 553, 559, Ketoconazole 55\n562, 572, 576, 592, 596, 600, 623, 626, 653\nKetoconazole shampoo 282\nIdiopathic inflammatory myopathies (IIM) 568 Klebsiella 170, 189, 406\nImipramine 209, 219, 235, 237\nImmune globulin 580\nKlebsiella pneumoniae 170, 189\nKlumpke’s Palsy 105\nImmunisation 38, 60, 80, 81, 84, 86, 88, 89, Koplik spots 83\n317, 318\nImpetigo 246\nImpotence 382\nIndomethacin 559\nInfarctive Strokes 131\nInfliximab 557, 560\nInfluenza virus 180\nKwashiorkor 58, 59\nLabetalol 150, 155, 156, 331\nLactulose 21, 44, 45\nLagophthalmos 511\nLamivudine 40, 463, 464, 466\nINR 36, 39, 44, 45, 47, 54, 56, 57, 66, 126, 129, Lamotrigine 228\n372, 660\nInsomnia 214, 217, 229, 239, 397\nInsulin Premix 291\nInterferon 40, 42, 405.",
    "title": "Hypertension 110, 146, 152, 310, 318, 323, Ischaemic Heart Disease 115, 134, 157",
    "section": "Hypertension 110, 146, 152, 310, 318, 323, Ischaemic Heart Disease 115, 134, 157",
    "chunk_id": "2553",
    "type": "section",
    "keywords": [
      "hypertension",
      "adolescents",
      "virus",
      "encephalopathy",
      "klebsiella",
      "idiopathic",
      "globulin",
      "lamivudine",
      "dinitrate",
      "palsy",
      "arthritis",
      "hypertensive",
      "hyperthyroidism",
      "ibuprofen",
      "isosorbide",
      "shampoo",
      "imipramine",
      "impetigo",
      "infliximab",
      "lactulose"
    ]
  },
  {
    "id": "128b5fcf61887b1d498ca5e10c42a1e0",
    "content": "Large Chronic Ulcers 265 Laryngotracheobronchitis (LTB) 515\nLeflunomide 557\nLegionella pneumophila 170\nINDEX\nLethargy 39, 43, 55, 100, 397, 496, 581, 598, Mefenamic acid 359, 372, 373, 381\n658, 659, 661\nLeukaemia 75, 76, 570\nLevothyroxine 305\nLichen planus 267\nLichen simplex chronicus 267 Lidocaine 654, 664\nLignocaine 664\nLindane 76, 660\nLiquid paraffin 21, 31\nLisinopril 120, 138, 139, 150, 392, 404\nListeria 499\nLithium 228, 229, 406\nLocal anaesthetic (LA) Agents 664 loperamide 18\nLopinavir 463, 466\nMefipristone 368\nMelatonin 216, 244\nMembranous nephropathy 390\nMembranous proliferative glomerulonephritis (MPGN) 390.",
    "title": "Intermittent Preventive Treatment in Pregnan-",
    "section": "Intermittent Preventive Treatment in Pregnan-",
    "chunk_id": "2554",
    "type": "section",
    "keywords": [
      "lisinopril",
      "agents",
      "leflunomide",
      "legionella",
      "local",
      "nephropathy",
      "anaesthetic",
      "lithium",
      "mpgn",
      "mefipristone",
      "paraffin",
      "lethargy",
      "leukaemia",
      "mefenamic",
      "lignocaine",
      "large",
      "lichen",
      "levothyroxine",
      "lidocaine",
      "lopinavir"
    ]
  },
  {
    "id": "bda949b77b2203d1253107af3e48c2cd",
    "content": "Meningitis 48, 94, 95, 96, 171, 193, 194, 196,\n203, 205, 210, 470, 472, 474, 475, 482, 487,\n495, 496, 499, 529, 668, 669, 670\nMenopause 384\nMeropenem 499\nMetformin 291, 292\nMethadone 242\nMethanol 661\nMethicillin resistant Staph. aureus 608\nLorazepam 52, 198, 211, 216, 220, 228, 232, Methotrexate 405, 557, 560, 563, 570, 576,\n238, 585, 670\nLosartan 120, 139, 150, 154, 404\n580, 581\nMethoxy polyethylene glycol epoietin beta\nLower urinary tract symptoms (LUTS) 408, 409 400\nLudwigs Angina 540\nLung Abscess 189\nLymphadenopathy 472, 546, 558, 577\nMagnesium sulphate 330, 355\nMagnesium trisilicate 23, 29\nMajor depression 216, 217\nMethyldopa 150, 324\nMethylphenidate 208, 244\nMethylprednisolone 554, 576, 578\nMetoclopramide 27, 50, 51, 53, 109, 111, 119,\n137, 323, 361, 366\nMetolazone 391\nMetoprolol 116, 120, 139, 150, 158, 160\nMetronidazole 14, 24, 31, 32, 34, 45, 87, 174,\n191, 357, 361, 363, 365, 375, 380, 517, 518,\nMalaria 205, 317, 331, 332, 388, 393, 470, 519, 520, 522, 523, 542, 584, 587, 588, 589,\n482, 492, 493, 620, 621\nMalaria In Pregnancy 331, 492\nmalassezia furfur 252, 255\nMalathion 269, 271\nMalignancies 655\nMalignant Lymphoma 77\nMalnutrition 58, 59\n594, 627, 628, 629, 648, 649\nMiconazole 253, 255, 256, 270, 281, 284, 285,\n376, 536, 613, 614\nMicrosporum 252\nMidazolam 198, 665\nMigraine 193, 195, 564\nMiliaria 267, 270\nManagement algorithm for Acute Parac- Milk of Magnesia 21\netamol Poisioning 56 Management of Acute Pain 651\nManagement of the Hot Swollen Joint 570\nMania 216, 226, 227\nMannitol 131, 584, 669\nMantoux test 472, 561, 615\nMarasmus 58, 59\nMarijuana 210, 214, 221, 239 Masticatory muscle dysfunction 549\nM. catarrhalis 527\nMDR-TB 477\nMeasles 81, 82, 83, 503, 515\nMebendazole 320, 500, 501 Medicines and the Kidney 403 Medicines Use In The Elderly 662 Medroxyprogesterone acetate 373.",
    "title": "Meniere’s disease 165",
    "section": "Meniere’s disease 165",
    "chunk_id": "2555",
    "type": "section",
    "keywords": [
      "malnutrition",
      "lymphoma",
      "miconazole",
      "midazolam",
      "abscess",
      "methanol",
      "methylphenidate",
      "mantoux",
      "joint",
      "malassezia",
      "lorazepam",
      "epoietin",
      "furfur",
      "major",
      "measles",
      "methicillin",
      "lymphadenopathy",
      "methadone",
      "catarrhalis",
      "metformin"
    ]
  },
  {
    "id": "7b4de2f919d0f881ec9878088acecb72",
    "content": "Minocycline 557\nMinor Withdrawal 229\nMisoprostol 361, 363, 366, 367, 368, 369, 370\nMist Kaolin 18\nMitral valve prolapse 113\nM. kansasii 472\nM. malmoensi 472\nM.",
    "title": "Minimal change disease (MCD) 390",
    "section": "Minimal change disease (MCD) 390",
    "chunk_id": "2556",
    "type": "section",
    "keywords": [
      "mist",
      "minor",
      "valve",
      "kaolin",
      "misoprostol",
      "kansasii",
      "mitral",
      "withdrawal",
      "prolapse",
      "malmoensi",
      "minocycline"
    ]
  },
  {
    "id": "63c7735257337a327b13c0772ea3c0db",
    "content": "microti 472\nMometasone 281, 282, 286\nMonilia 283, 535\nMontelukast 179\nMoraxella catarrhalis 180\nMorphine 19, 25, 55, 71, 119, 128, 136, 144,\n272, 337, 361, 366, 563, 587, 591, 596, 600,\n627, 654\nMouth Ulcers 544.",
    "title": "Minimal change disease (MCD) 390",
    "section": "Minimal change disease (MCD) 390",
    "chunk_id": "2557",
    "type": "section",
    "keywords": [
      "catarrhalis",
      "morphine",
      "microti",
      "mometasone",
      "mouth",
      "montelukast",
      "moraxella",
      "ulcers",
      "monilia"
    ]
  },
  {
    "id": "f490b85de41cad075023214f1366919e",
    "content": "323, 361, 489, 490, 505, 646\nMRSA (Methicillin resistant) 170\nMulti Drug Resistant-TB (MDR-TB) 477 Multiple myeloma 73\nMultivitamin 338\nMupirocin 246, 247\nMyalgia 145, 564, 577, 580\nMyasthenia gravis 513\nMycobacterium africanum 472, 615\nMycobacterium bovis 472, 615\nMycobacterium tuberculosis 472, 495, 601,\n615\nMycobacterium ulcerans 249\nMycophenolate 570, 580, 581\nMycophenolate mofetil 570, 581\nMycoplasma pnuemoniae 170, 274\nN-Acetylcysteine 56, 57, 204, 660, 661\nNaloxone 659\nNorovirus 11\nNSAID-associated duodenal or gastric ulcer and gastro-duodenal erosions 23\nNSAIDs 11, 22, 26, 242, 337, 396, 397, 404,\n559, 572, 574, 581, 653.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2558",
    "type": "section",
    "keywords": [
      "mupirocin",
      "bovis",
      "ulcer",
      "pnuemoniae",
      "resistant",
      "associated",
      "multivitamin",
      "ulcerans",
      "mycophenolate",
      "naloxone",
      "multiple",
      "norovirus",
      "drug",
      "gastric",
      "multi",
      "acetylcysteine",
      "nsaids",
      "erosions",
      "myalgia",
      "gravis"
    ]
  },
  {
    "id": "fce30507d5042ebe02280a7e11cc43e2",
    "content": "NYHA 134\nNystagmus 49, 232\nNystatin 29, 536, 613\nObesity 25, 147, 152, 311, 604\nOcclusal disharmony 549\nOccupational therapy 555, 559, 562\nOdontogenic Infections 545\nOesophageal candidiasis 28, 29\nOesophageal manometry 28\nOesophageal pain 27\nOesophageal spasm 113\nNaproxen 553, 559, 562, 572, 576, 592, 596, Oesophagitis 25\n622, 626\tOestrogen cream 385\nNausea 37, 55, 56, 93, 114, 118, 155, 165, Ogilvie syndrome 20\n229, 236, 240, 294, 307, 358, 393, 483, 577, Oilatum soap 281\n658, 660, 661\nNebulised adrenaline 670\nNecrotizing Fasciitis 608\nNeisseria gonorrhoea 106, 374\nNeisseria meningitides 495\nNeomycin 529\nNeonatal conjunctivitis 106, 503\nNeonatal Hypoglycaemia 98, 100\nNeonatal Jaundice 35, 101\nOlanzapine 212, 222, 223, 227, 230\nOligospermia 382\nOmeprazole 23, 24, 26, 27, 28, 29, 555, 569,\n579, 628\nOnchocerciasis 267\nOndansetron 52, 109, 111, 112, 323\nonychomycosis 254\nOpen Fractures 592\nOpioid withdrawal 239, 240\nNeonate 97, 100, 101, 102, 103, 106, 356, 503 Opisthotonus 86\nNephroblastoma 110\nNephrotic Syndrome 46, 300, 390\nNerve injuries 105\nNevirapine 55, 463, 464\nOral and Dental Conditions 534 Oral Candidiasis 255, 535\nOral Squamous Cell Carcinoma 548 Organochlorine 660\nNewborn 35, 82, 97, 100, 101, 264, 321, 338, ORS 16, 17, 19\n354, 357\tOsteoarthritis 552\nNew York Heart Association (NYHA) Classifica- Osteogenesis Imperfecta 623\ntion 134\nNiclosamide 502\nNifedipine 150, 153, 325, 355\nNitrofurantoin 407\nNon-erosive GERD 26\nNon-Hodgkin’s Lymphoma 77, 79 Non-Specific Skin Infections 264\nOsteomalacia 616\nOsteoporosis 619\nOsteotomies 553, 622\nOtitis media 49, 58, 82, 84, 94, 95, 167, 193,\n462, 482, 529, 532\nOverweight 311, 312\nOxygen 86, 98, 119, 128, 136, 142, 144, 173,\nNon-ST-segment elevation myocardial infarc- 177, 183, 185, 197, 353, 516, 518, 645, 670\ntion (NSTEMI) 118\nNorethisterone 372, 373\nNorfloxacin 45\nNormal Saline 72, 98, 144, 156, 199, 266, 275,\nOxygen Therapy 98\nOxymetazoline 533\nOxytocin 361, 363, 366, 367\nINDEX\nPimples 276, 277, 310\nPioglitazone 293\nPacked red cells 65, 72, 75, 77, 79, 104, 333 Pain Originating from the Oesophagus 27 Pamidronate 623.",
    "title": "Nutritional Disorders 58",
    "section": "Nutritional Disorders 58",
    "chunk_id": "2559",
    "type": "section",
    "keywords": [
      "nausea",
      "oilatum",
      "lymphoma",
      "ogilvie",
      "tion",
      "otitis",
      "disharmony",
      "erosive",
      "open",
      "ondansetron",
      "nstemi",
      "oxygen",
      "niclosamide",
      "saline",
      "nerve",
      "gonorrhoea",
      "pamidronate",
      "osteoarthritis",
      "oesophagitis",
      "fractures"
    ]
  },
  {
    "id": "d0b4898bd9e2290090225202f870d3f9",
    "content": "Pap smear 386, 462\nPityriasis 255\nPityriasis Versicolor 255\nPityrosporum orbiculare 255\nPityrosporum ovale 255, 279\nPlamodium malariae 483\nParacetamol 38, 43, 44, 55, 56, 57, 70, 71, 83, Plasma Cell Myeloma 73\n133, 168, 173, 181, 195, 204, 246, 258, 263, Plasma replacement 394\n275, 359, 408, 469, 471, 505, 522, 524, 528, Plasmodium. See Malaria\n530, 534, 538, 540, 544, 547, 556, 562, 565, Plasmodium falciparum 482\n580, 584, 587, 591, 596, 601, 624, 626, 652, Plasmodium malariae 390\n654, 661, 669\nParacetamol toxicity 56\nParaplegia 74, 656\nParaquat 661.",
    "title": "Panic Disorders 236",
    "section": "Panic Disorders 236",
    "chunk_id": "2560",
    "type": "section",
    "keywords": [
      "plamodium",
      "malariae",
      "orbiculare",
      "plasma",
      "replacement",
      "falciparum",
      "pityrosporum",
      "versicolor",
      "paraplegia",
      "ovale",
      "toxicity",
      "malaria",
      "smear",
      "plasmodium",
      "paraquat",
      "paracetamol",
      "myeloma",
      "cell",
      "pityriasis"
    ]
  },
  {
    "id": "4a226cbefaecf9679c8d507294164a14",
    "content": "Paromomycin 34\nParoxysmal supraventricular tachycardia 159 PCV 2 81\nPCV 3 81\nPediculosis 267, 271\nPegylated Interferon Alpha 2a 40, 42 Pegylated Interferon Alpha 2b 42\nPlasmodium ovale 483\nPlatelet Concentrate 68\nred cell concentrate 68\nPlatelet transfusion 68, 75, 77, 79.",
    "title": "Parkinson’s disease 511",
    "section": "Parkinson’s disease 511",
    "chunk_id": "2561",
    "type": "section",
    "keywords": [
      "transfusion",
      "plasmodium",
      "supraventricular",
      "interferon",
      "paroxysmal",
      "pediculosis",
      "cell",
      "alpha",
      "pegylated",
      "concentrate",
      "paromomycin",
      "ovale",
      "tachycardia",
      "platelet"
    ]
  },
  {
    "id": "424aab727931d4ae1d6b023335696fc6",
    "content": "Pneumococcal (PCV) 80\nPneumococcal\tPolysaccharide\tVaccine (PPSV23) 95\nPneumococcus 499, 531\nPneumocystis jiroveci 170.",
    "title": "Pleural effusion 113, 127, 171, 390 Pneumococcal Conjugate Vaccine (PCV) 95 Pneumococcal Disease 95",
    "section": "Pleural effusion 113, 127, 171, 390 Pneumococcal Conjugate Vaccine (PCV) 95 Pneumococcal Disease 95",
    "chunk_id": "2562",
    "type": "section",
    "keywords": [
      "vaccine",
      "pneumococcus",
      "polysaccharide",
      "jiroveci",
      "pneumococcal",
      "pneumocystis"
    ]
  },
  {
    "id": "c27ede02d0ea5e501d9e105ec86ff1f1",
    "content": "382\nPneumothorax 121, 171\nPenicillin allergy 246, 248, 357, 497, 531, 537, Polio 80, 81\n540, 606\nPenicillin V 163, 164\nPenta-Vaccine 80, 81.",
    "title": "Pelvic Inflammatory disease (PID) 379, 380, Pneumonia 113, 114, 121, 169, 276, 470, 666",
    "section": "Pelvic Inflammatory disease (PID) 379, 380, Pneumonia 113, 114, 121, 169, 276, 470, 666",
    "chunk_id": "2563",
    "type": "section",
    "keywords": [
      "vaccine",
      "penta",
      "penicillin",
      "allergy",
      "pneumothorax",
      "polio"
    ]
  },
  {
    "id": "18c7c3af337e08c64111f1dd7e73e4af",
    "content": "Pericardial effusion 121, 171\nPericarditis 113, 114, 145, 397\nPermethrin 268\nPernicious anaemia 63\nPersons living with HIV infection (PLHIV) 461 Pertussis 81, 84\nPertussis vaccine 81\nPetechiae 63, 66, 93\nPoliomyelitis 89\nPoliovirus 90\npolyarthritis 554, 570, 573\nPolycystic ovarian syndrome 277, 382 Polymerase chain reaction (PCR) 262 Polyvinyl alcohol 512\nPost Exposure Prophylaxis 464\nPost Herpetic Neuralgia 193, 259, 260\nPotassium citrate 408\nPovidone iodine 260, 266, 276\nPPH 337, 370, 393\nPPI 24, 29\nPethidine 25, 361, 366, 587, 591, 596, 627, Praziquantel 502\n654\nPhaeochromocytoma 152, 234\nPharyngitis 523\nPhenobarbital 88, 201\nPhenobarbitone 88, 99, 199, 233\nPhenoxymethyl penicillin 163, 164\nPhenytoin 55, 199, 201, 207, 669, 670\nPhosphocitrate 576\nPhotophobia 495, 505, 509, 511\nPhototherapy 103, 105\nPrazosin 150\nPrednisolone 146, 164, 178, 179, 186, 275,\n309, 475, 516, 555, 559, 563, 569, 572, 574,\n576, 579, 581, 645, 670.",
    "title": "Peptic Ulcer Disease 22, 62, 113, 114",
    "section": "Peptic Ulcer Disease 22, 62, 113, 114",
    "chunk_id": "2564",
    "type": "section",
    "keywords": [
      "citrate",
      "anaemia",
      "penicillin",
      "prazosin",
      "permethrin",
      "petechiae",
      "povidone",
      "potassium",
      "living",
      "pertussis",
      "phenobarbital",
      "herpetic",
      "phototherapy",
      "chain",
      "polyarthritis",
      "alcohol",
      "pericardial",
      "ovarian",
      "reaction",
      "phenytoin"
    ]
  },
  {
    "id": "614ea0a1a41d9e59ebaf608d21fec548",
    "content": "Premature Rupture of the Membranes 356 Prematurity 97, 100, 141\nPreterm labour 319, 354\nPreterm Labour in Premature Delivery 354\nPhysiotherapy 67, 74, 90, 105, 553, 555, 558, Priapism 69, 76\n562, 571, 575, 612, 615, 622, 625\nPhytomenadione 106, 660\nPID 379, 380, 382.",
    "title": "Pregabalin 261, 551, 563, 567 Pregnancy in the sickle cell disease 334",
    "section": "Pregabalin 261, 551, 563, 567 Pregnancy in the sickle cell disease 334",
    "chunk_id": "2565",
    "type": "section",
    "keywords": [
      "prematurity",
      "preterm",
      "physiotherapy",
      "premature",
      "membranes",
      "rupture",
      "labour",
      "phytomenadione",
      "priapism",
      "delivery"
    ]
  },
  {
    "id": "580d262d283ed7fd5b87c766826f09da",
    "content": "Procaine Penicillin 542\nProctoscopy 20, 30\nProctosigmoidoscopy 20\nRapid Diagnostic Test (RDT) 211, 335, 480,\n482, 483, 621\nReactive Erythema 273\nPromethazine 53, 225, 263, 273, 323, 361, Ready to Eat Therapeutic Food (RUTF) 60\n366, 646\nPropantheline bromide 25\nPropionibacterium acnes 277\nPropranolol 142, 144, 153, 195, 236, 307\nProptosis 511\nPropylthiouracil 306\nProstate specific antigen (PSA) 409 Prostatism 409\nProtein energy malnutrition 58 Proteus mirabilis 406\nProteus vulgaris 531\nProthrombin time 44, 66, 372\nPrurigo 267\nPruritus 30, 36, 55, 263, 267, 268, 288, 397\nPSA 409\nPseudo-gout 575\nPseudomonas 170, 499, 531\nPseudo seizures 213\nPsoriasis 283, 572.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2566",
    "type": "section",
    "keywords": [
      "test",
      "malnutrition",
      "prurigo",
      "pseudomonas",
      "penicillin",
      "pseudo",
      "ready",
      "seizures",
      "diagnostic",
      "prostate",
      "erythema",
      "proctosigmoidoscopy",
      "propantheline",
      "protein",
      "psoriasis",
      "specific",
      "prothrombin",
      "proteus",
      "promethazine",
      "gout"
    ]
  },
  {
    "id": "35b7e92539cc8c5f711e5ff1c5231dbb",
    "content": "Psychoeducation 222, 227, 232\nPsychogenic Seizures 213\nPsychosis 220, 480\nPsychostimulant withdrawal 240\nPsychotherapy 194, 213, 218, 227, 232, 559\nRecombinant Factor VIII 67\nRed Eye 506\nReed Sternberg (RS) cell 77 Relaxation training 215, 237 Respiratory Syncytial Virus (RSV) 167 Retained placenta 318\nRetinoblastoma 108\nRetropharyngeal Abscess 521\nRetrovirus 274\nRhesus 102, 319, 361, 362, 363, 364, 367, 368\nRhesus factor 367\nRhesus Isommunization 363.",
    "title": "Psychiatric Disorders 207, 209",
    "section": "Psychiatric Disorders 207, 209",
    "chunk_id": "2567",
    "type": "section",
    "keywords": [
      "recombinant",
      "virus",
      "placenta",
      "seizures",
      "abscess",
      "psychostimulant",
      "training",
      "retropharyngeal",
      "psychogenic",
      "psychotherapy",
      "psychosis",
      "factor",
      "isommunization",
      "relaxation",
      "retinoblastoma",
      "sternberg",
      "retained",
      "retrovirus",
      "syncytial",
      "respiratory"
    ]
  },
  {
    "id": "5bc9787bef19fa7758f3f6b19d380ee3",
    "content": "Rheumatoid arthritis 554, 557\nRheumatoid factor 555, 558, 561\nRhinoviruses 167\nRibavirin 42\nRickets 616\nRifampicin 250, 474, 475, 477\nRifaximin 45\nRinger’s lactate 17, 18, 144, 323, 330, 331,\n394\nRisperidone 222, 223, 227, 243\nRituximab 557, 563, 570, 580, 581\nRivaroxaban 66\nPuerperium 123, 314, 316, 336, 338, 339, 493 Robaxin 562\nPulmonary arterial hypertension 134 Pulmonary Embolus (PE) 113, 121, 127, 160\nPulmonary thromboembolism 123 Purified factor IX 68\nPurified factor VIII 68 Purpura 39, 63, 66\nPyelonephritis 354, 355\nPyloric stenosis 49, 85, 92, 249, 264, 547\nPyrazinamide 474, 475\nPyrethrin 660\nPyrethroid 660\nPyrexia 133\nPyridoxine 474, 475\nPyrimethamine 317, 493\nQuinine 487, 488, 491, 492, 493\nRabeprazole 24, 27\nRadiocontrast 404\nRamipril 138, 139, 150\nRopivacaine 664\nRosuvastatin 120, 131, 301, 302\nRotavirus 11, 18, 19, 80, 81\nRotavirus vaccine 19\nRPR 265, 316, 320\nRUTF 60\nSalbutamol 176, 177, 178, 179, 184, 185, 355,\n646, 670\nSalicylic acid 270, 280\nSalmonella 11, 480, 597\nSalt-poor human albumin solution 48 Saxagliptin 292\nScabies 267, 268\nSCD 334, 335\nSchistosoma mansoni 390\nSchizophrenia 209, 220\nScleritis 506\nScurvy 618\nSeasonal Malaria Chemoprevention (SMC) 494\nSeborrhoiec dermatitis 267\nSeborrhoiec Eczema 279, 281\nSecnidazole 375\nINDEX\nStaphylococcus saprophyticus 406\nStatus Epilepticus 199\nSeizures 98, 100, 130, 133, 155, 196, 197, 201, Stevens-Johnson syndrome 273, 274, 511\n213, 229, 239, 388, 470, 577, 582\tSTI 320, 373, 374, 375, 379.",
    "title": "Rheumatic heart disease 134, 157, 161",
    "section": "Rheumatic heart disease 134, 157, 161",
    "chunk_id": "2568",
    "type": "section",
    "keywords": [
      "hypertension",
      "robaxin",
      "pyrimethamine",
      "rheumatoid",
      "salt",
      "pyloric",
      "schizophrenia",
      "salmonella",
      "seizures",
      "rivaroxaban",
      "eczema",
      "saxagliptin",
      "arthritis",
      "poor",
      "albumin",
      "dermatitis",
      "pyrazinamide",
      "mansoni",
      "pyridoxine",
      "seasonal"
    ]
  },
  {
    "id": "32baf348182b9e5243556a89d72b5baf",
    "content": "(SERMs) 620\nSelenium sulphide 256, 282\nSenna 21, 31\nSepticaemia 94, 95, 247, 249, 401, 482, 612\nSeptic granuloma 614\nSertraline 219, 235, 237\nSevere Malaria 486 Severe or Erosive GERD 27\nStimulus control therapy 215 Strabismus 108, 512, 513\nStrept. faecalis 597\nStreptococcus 95, 106, 170, 180, 247, 495,\n519, 521, 523, 526, 529, 538, 539, 541, 545,\n604, 608, 647\nStreptococcus mitis 538\nStreptococcus pneumonia 170, 527\nSexually Transmitted Infection (STI) 373, 379, Streptococcus pneumoniae 95, 180, 495, 519,\n442\nShea butter 280\nShigella 11\n529\nStreptococcus pyogenes 170, 247, 519, 604\nStreptococcus salivarius 538.",
    "title": "Selective estrogen receptor modulators Still’s disease 557",
    "section": "Selective estrogen receptor modulators Still’s disease 557",
    "chunk_id": "2569",
    "type": "section",
    "keywords": [
      "streptococcus",
      "butter",
      "granuloma",
      "septicaemia",
      "senna",
      "therapy",
      "erosive",
      "faecalis",
      "strabismus",
      "sexually",
      "pyogenes",
      "strept",
      "malaria",
      "pneumoniae",
      "shigella",
      "severe",
      "sertraline",
      "selenium",
      "stimulus",
      "pneumonia"
    ]
  },
  {
    "id": "ff13a353cda371f2a3e6d4f86a6bcce8",
    "content": "337, 513, 621, 668\nSickle Cell Disease In Pregnancy 334 Sickle Cell Disease – Retinopathy 513 Sickle-cell Vaso-occlusive Crisis 620 Sick newborn 97\nSigmoidoscopy 30\nSilver nitrate 106\nSimple linctus 181\nSimvastatin 121, 301\nSinus bradycardia 156\nSinusitis 194, 526\nSirdalud 562\nSitagliptin 292\nSLE 63, 577\nSleep hygiene 562\nSodium Bicarbonate 144, 395, 398, 490\nStreptomycin 250, 474, 475\nStrept. pyogenes 597, 611\nStridor 84, 91, 515, 518, 519, 521, 666, 667\nStroke 48, 73, 123, 129, 131, 132, 133, 146,\n147, 149, 154, 155, 158, 160, 165, 166, 170,\n196, 197, 203, 205, 294, 311\nStrongyloides 499, 502\nStrontium 620\nStructured Approach to the Seriously Ill Child 666\nST-segment elevation myocardial infarction STEMI 118, 120, 121\nSubarachnoid haemorrhage 130, 154\nSubconjunctival haemorrhage 506.",
    "title": "Sickle Cell Disease 62, 69, 95, 113, 334, 335, Streptococcus sanguis 538",
    "section": "Sickle Cell Disease 62, 69, 95, 113, 334, 335, Streptococcus sanguis 538",
    "chunk_id": "2570",
    "type": "section",
    "keywords": [
      "sigmoidoscopy",
      "elevation",
      "sleep",
      "subconjunctival",
      "linctus",
      "vaso",
      "strontium",
      "sirdalud",
      "child",
      "occlusive",
      "simple",
      "stridor",
      "structured",
      "streptomycin",
      "myocardial",
      "pyogenes",
      "sodium",
      "strept",
      "pregnancy",
      "crisis"
    ]
  },
  {
    "id": "3d735c811edd84f8be0633b1a0f5657a",
    "content": "Sodium Chloride 67, 71, 91, 168, 178, 308, Sulfasalazine 557\n330, 331, 363, 394, 646\nSodium Thiosulfate 661\nSodium valproate 201, 202, 227, 229\nSoluble Insulin 291, 395, 398\nSoothing agent (with or without steroids) 31\nSpirochaetes 537\nSpirometry 176, 184\nSpironolactone 47, 139, 150\nSplenomegaly 36, 70, 76, 78, 483\nSpots 83, 276\nSquint 108\nStable Angina 113\nStable angina pectoris 115 Stable chronic bronchitis 184 Staph. epidermidis 597\nStaphylococci 106, 499, 541, 608, 610\nSulphadoxine 493, 494, 495\nSulphamethoxazole-Pyrimethamine (SP) 317 Superficial Fungal Skin Infections 252 Systemic arterial hypertension 134\nSystemic Lupus Erythematosus 388, 390, 577 Systemic onset arthritis (Still’s disease) 557 Systemic thromboembolism 158, 160\nTachycardia 98, 100, 127, 135, 141, 143, 165,\n189, 234, 236, 298, 364, 468, 644\nTachypnoea 127, 135, 141, 175, 189, 468,\n486, 516, 518, 669\nTacrolimus 405, 581\nTamsulosin 410\nStaphylococcus aureus 170, 171, 180, 189, TB meningitis 472\n245, 247, 274, 495, 519, 521, 527, 529, 539, Temporo-mandibular joint 549\n597, 604, 608, 611, 647\nTemporo-mandibular joint dysfunction 549.",
    "title": "Subgaleal Haemorrhage 104, 105 Substance Use disorders 239",
    "section": "Subgaleal Haemorrhage 104, 105 Substance Use disorders 239",
    "chunk_id": "2571",
    "type": "section",
    "keywords": [
      "infections",
      "pyrimethamine",
      "hypertension",
      "squint",
      "spirochaetes",
      "agent",
      "dysfunction",
      "epidermidis",
      "superficial",
      "systemic",
      "arthritis",
      "sulfasalazine",
      "pectoris",
      "soluble",
      "tachycardia",
      "tachypnoea",
      "aureus",
      "stable",
      "fungal",
      "spironolactone"
    ]
  },
  {
    "id": "d2bde691f3b4e77407f0576d2fbdbc2e",
    "content": "Tenofovir 40, 405, 463, 464, 466\nTerazosin 410\nTerbinafine 253, 254\nTeriparatide 620\nTetanol 318, 366\nTrichomonas vaginalis 374\nTrichomoniasis 375\nTrichophyton 252\nTrigeminal neuralgia 193\nTrigerminal neuralgia 550\nTetanus 81, 86, 87, 88, 89, 318, 366, 594, 625, Trigerminal Neuralgia 550\n627, 628, 629\nTetanus Prophylaxis 366\nTetracaine hydrochloride 505\nTetracycline 15, 278, 507, 508, 512 Tetralogy of Fallot (TOF) 140\nThe Acutely Disturbed Patient 209, 228 The Unconscious Patient 203\nThiamine 204, 232\nThiazide Diuretics 149\nThrombocytopaenia 68, 110, 112, 261.",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2572",
    "type": "section",
    "keywords": [
      "tenofovir",
      "thiamine",
      "tetanus",
      "unconscious",
      "trigeminal",
      "acutely",
      "tetanol",
      "patient",
      "trichomoniasis",
      "trichomonas",
      "thrombocytopaenia",
      "neuralgia",
      "tetralogy",
      "disturbed",
      "hydrochloride",
      "thiazide",
      "terbinafine",
      "tetracaine",
      "teriparatide",
      "diuretics"
    ]
  },
  {
    "id": "6a740853f5cceb56f77043306bbda757",
    "content": "Trihexyphenidyl 224\nTrimethoprim/Sulphamethoxazole 85\nTroponin 116, 118, 123, 155\nTuberculosis 62, 471, 615\nTuberculosis in orthopaedics 615\nTyphoid Fever 35, 161, 193, 393, 479, 480,\n482\nUncomplicated Malaria 483\nThyrotoxicosis 134, 138, 157, 158, 226, 302, Unconsciousness 100, 130, 152, 155, 203,\n303, 305, 306, 307, 318\nTIA 129, 131, 165, 166\nTiabendazole 502\nTIBC 335\nTinea 256, 257, 267, 283\nTinea capitis 252\nTinea corporis 253\nTinea cruris 253\nTinea manuum 253\nTinea pedis 253, 254\nTinea Versicolor 256, 257\nTinidazole 34\nTiotropium 185\nTizanidine 566\nTMJ 549\nTocilizumab 557\nTocolysis 355\nTodd’s paralysis 197\nTofacitinib 557\nTolbutamide 292\nTonsillitis 471, 523\nToxic alcohols 657, 661\nToxic epidermal necrolysis (TEN) 274 Toxic multi-nodular goitre 305 Toxoplasma 495\nTPHA 316\nTramadol 54, 72, 195, 563, 565, 653\nTranexamic acid 68, 373\ntransient ischaemic attack (TIA) 129 Transposition of the Great Arteries (TGA) 140 Trauma And Injuries 582.",
    "title": "Thyroid eye disease 511",
    "section": "Thyroid eye disease 511",
    "chunk_id": "2573",
    "type": "section",
    "keywords": [
      "injuries",
      "unconsciousness",
      "tiotropium",
      "arteries",
      "tolbutamide",
      "transient",
      "troponin",
      "trihexyphenidyl",
      "paralysis",
      "versicolor",
      "trimethoprim",
      "typhoid",
      "attack",
      "orthopaedics",
      "great",
      "tranexamic",
      "toxoplasma",
      "necrolysis",
      "epidermal",
      "tocilizumab"
    ]
  },
  {
    "id": "c062d4ff4f21d22bf8c6be3542038104",
    "content": "Tretinoin 278\nTriamcinolone 554, 576\nTriazolam 216\n205, 298, 329\nUraemia 145\nUric acid 74, 118, 148, 312, 387, 394, 571,\n572, 573, 575\nUrinary Tract Infection (UTI) 309, 322, 332,\n337, 359, 401, 402, 403, 408, 470, 585\nUrticaria 267, 270, 271, 272, 644\nVaccine-associated paralytic poliomyelitis (VAPP) 89\nVaginitis 375, 376\nValsatan 150.",
    "title": "Treatment Induced Hypoglycaemia 298 Treponema pertenue 250",
    "section": "Treatment Induced Hypoglycaemia 298 Treponema pertenue 250",
    "chunk_id": "2574",
    "type": "section",
    "keywords": [
      "uraemia",
      "urticaria",
      "vaccine",
      "tract",
      "poliomyelitis",
      "valsatan",
      "acid",
      "tretinoin",
      "triamcinolone",
      "infection",
      "urinary",
      "uric",
      "associated",
      "vapp",
      "paralytic",
      "vaginitis",
      "triazolam"
    ]
  },
  {
    "id": "6ddf6aac297222df503eceadfbc70069",
    "content": "Vancomycin 170, 497, 498, 499, 608, 610\nVaricella 259, 261, 262 Varicella – zoster virus 259 Varicose eczema 279\nVasodilators 150, 154\nVaso-occlusive bone pain crises 70 VDRL 251, 265, 316\nVerapamil 116, 159, 160\nVertigo 49, 164\nVestibular Nausea 51\nVibrio cholerae 11\nVildagliptin 292\nVincristine 109, 111 Viral Skin Infections 257\nVitamin A 59, 60, 83, 503, 504\nVitamin A supplementation 60 Vitamin B6 474, 475\nVitamin B12 Deficiency 65\nVitamin B12 (Hydroxocobalamin) 62, 63, 65,\n564\nVitamin-C 618\nINDEX\nVitamin-C deficiency 618\nVitamin-D 616, 617, 619, 620\nVitamin K 66, 67, 106\nVomiting 11, 12, 15, 18, 19, 20, 22, 25, 37,\n48, 49, 50, 53, 56, 57, 58, 84, 93, 97, 109, 111,\n114, 118, 119, 137, 155, 165, 194, 204, 229,\n231, 240, 242, 294, 307, 309, 322, 358, 361,\n364, 366, 380, 388, 393, 394, 396, 401, 470,\n472, 483, 486, 495, 499, 509, 529, 582, 583,\n586, 589, 604, 656, 658, 660, 661, 668, 669.",
    "title": "Valvular Heart Disease 121",
    "section": "Valvular Heart Disease 121",
    "chunk_id": "2575",
    "type": "section",
    "keywords": [
      "infections",
      "nausea",
      "virus",
      "vaso",
      "eczema",
      "varicella",
      "vitamin",
      "verapamil",
      "occlusive",
      "crises",
      "vasodilators",
      "supplementation",
      "vertigo",
      "vestibular",
      "zoster",
      "deficiency",
      "vibrio",
      "vincristine",
      "vancomycin",
      "hydroxocobalamin"
    ]
  },
  {
    "id": "0a7b494be70e49e7b1206b317d7ef748",
    "content": "Warfarin 66, 126, 129, 660\nWertheim’s hysterectomy 386\nWheals 272, 273\nWhitfield’s ointment 253, 255, 256, 285 WHO Grading of Trachoma 507\nWilms Tumour 110\nWorm Infestation (Intestinal) 499 Worm infestations 61\nWorms 499, 500\nXerophthalmia 503\nXylometazoline 168\nYaws 250, 251\nYellow Fever 37, 81, 92 Yellow fever virus 93\nZidovudine 463, 466\nZiehl-Neelsen stain 171, 521\nZinc 15, 19, 270\nZinc oxide 270\nZinc supplementation for diarrhoea 15.",
    "title": "Von Willebrand Disease 66, 68 VRSA (Vancomycin resistant) 170",
    "section": "Von Willebrand Disease 66, 68 VRSA (Vancomycin resistant) 170",
    "chunk_id": "2576",
    "type": "section",
    "keywords": [
      "xerophthalmia",
      "zinc",
      "virus",
      "wheals",
      "zidovudine",
      "diarrhoea",
      "wilms",
      "infestation",
      "infestations",
      "supplementation",
      "whitfield",
      "intestinal",
      "warfarin",
      "tumour",
      "trachoma",
      "neelsen",
      "yellow",
      "worms",
      "fever",
      "ziehl"
    ]
  },
  {
    "id": "c28b7edeb0531355de36f7786af16db1",
    "content": "Other Publications\nGhana Assessment of Medicines Procurement and Supply Manage- ment systems in the Public Health Sector, A country Report (2009)\nPartners Mapping for Medicines Procurement and Supply Manage-\nment in Ghana (2009).",
    "title": "Standard Treatment Guidelines, 7th Edition, 2017",
    "section": "Standard Treatment Guidelines, 7th Edition, 2017",
    "chunk_id": "2577",
    "type": "section",
    "keywords": [
      "country",
      "report",
      "supply",
      "manage",
      "other",
      "partners",
      "ghana",
      "medicines",
      "publications",
      "systems",
      "public",
      "health",
      "sector",
      "assessment",
      "mapping",
      "procurement",
      "ment"
    ]
  },
  {
    "id": "f1bb4a2bb9e0c7424a035321a69e8f0e",
    "content": "Ghana Essential Medicines List (2004)\nNational Drugs Policy (2004)\nCode of Ethics and Standards of Practice for Traditional Medicines Practitioners in Ghana (2003).",
    "title": "Standard Treatment Guidelines (2004)",
    "section": "Standard Treatment Guidelines (2004)",
    "chunk_id": "2578",
    "type": "section",
    "keywords": [
      "ethics",
      "drugs",
      "list",
      "essential",
      "policy",
      "practitioners",
      "ghana",
      "medicines",
      "traditional",
      "practice",
      "code",
      "standards",
      "national"
    ]
  },
  {
    "id": "3b4dec442318f1436a918c85b2ddbf6c",
    "content": "(2003)\nIncreasing Access to Medicines: An Assessment and Policy Options for Ghana (2003)\nAn Assessment of the Pharmaceutical Sector in Ghana (2002)\nLogistics Management of Public Sector Health Commodities in Gha- na: standard Operating Procedures – Regional Medical Stores to Ser- vice Delivery Points (2002)\nDrugs and Therapeutics Committee (DTC) Training Manual (2002).",
    "title": "Standard of Pharmaceutical Care for Health Institutions in Ghana",
    "section": "Standard of Pharmaceutical Care for Health Institutions in Ghana",
    "chunk_id": "2579",
    "type": "section",
    "keywords": [
      "procedures",
      "therapeutics",
      "points",
      "management",
      "policy",
      "operating",
      "health",
      "assessment",
      "delivery",
      "training",
      "pharmaceutical",
      "sector",
      "public",
      "vice",
      "regional",
      "stores",
      "manual",
      "logistics",
      "standard",
      "medicines"
    ]
  },
  {
    "id": "48e031176f6257003af7ffc24336ef87",
    "content": "Ghana Essential Drugs List (2000)\nBaseline Survey on the Pharmaceutical Sector in Ghana (1999)\nProcurement Procedure Manual (1999)\nProcurement Training Manual\nRational Drug Use Training Manual.",
    "title": "Standard Treatment Guidelines (2000)",
    "section": "Standard Treatment Guidelines (2000)",
    "chunk_id": "2580",
    "type": "section",
    "keywords": [
      "drugs",
      "training",
      "manual",
      "list",
      "essential",
      "drug",
      "procedure",
      "ghana",
      "pharmaceutical",
      "sector",
      "baseline",
      "survey",
      "procurement",
      "rational"
    ]
  }
]